PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, YH; Wang, S; He, MF; Wang, YY; Zhao, H; Zhu, HY; Yu, XM; Ma, J; Che, XJ; Wang, JF; Wang, Y; Wang, XN				Chen, Yu-hui; Wang, Shan; He, Mei-fang; Wang, Yanyi; Zhao, Hua; Zhu, Han-yu; Yu, Xiao-min; Ma, Jian; Che, Xiao-juan; Wang, Ju-fang; Wang, Ying; Wang, Xiao-ning			Prevalence of Heterotypic Tumor/Immune Cell-In-Cell Structure In Vitro and In Vivo Leading to Formation of Aneuploidy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TUMOR-CELLS; CANCER; EMPERIPOLESIS; INFLAMMATION; LYMPHOCYTES; MELANOMA; ENTOSIS; DISEASE; DEATH	Cell-in-cell structures refer to a unique phenomenon that one living cell enters into another living cell intactly, occurring between homotypic tumor cells or tumor (or other tissue cells) and immune cells (named as heterotypic cell-in-cell structure). In the present study, through a large scale of survey we observed that heterotypic cell-in-cell structure formation occurred commonly in vitro with host cells derived from different human carcinomas as well as xenotypic mouse tumor cell lines. Most of the lineages of human immune cells, including T, B, NK cells, monocytes as well as in vitro activated LAK cells, were able to invade tumor cell lines. Poorly differentiated stem cells were capable of internalizing immune cells as well. More significantly, heterotypic tumor/immune cell-in-cell structures were observed in a higher frequency in tumor-derived tissues than those in adjacent tissues. In mouse hepatitis models, heterotypic immune cell/hepatocyte cell-in-cell structures were also formed in a higher frequency than in normal controls. After in vitro culture, different forms of internalized immune cells in heterotypic cell-in-cell structures were observed, with one or multiple immune cells inside host cells undergoing resting, degradation or mitosis. More strikingly, some internalized immune cells penetrated directly into the nucleus of target cells. Multinuclear cells with aneuploid nucleus were formed in target tumor cells after internalizing immune cells as well as in situ tumor regions. Therefore, with the prevalence of heterotypic cell-in-cell structures observed, we suggest that shielding of immune cells inside tumor or inflammatory tissue cells implies the formation of aneuploidy with the increased multinucleation as well as fine-tuning of microenvironment under pathological status, which may define distinct mechanisms to influence the etiology and progress of tumors.	[Chen, Yu-hui; Wang, Shan; He, Mei-fang; Wang, Yanyi; Zhao, Hua; Zhu, Han-yu; Ma, Jian; Che, Xiao-juan; Wang, Ju-fang; Wang, Xiao-ning] Chinese Peoples Liberat Army Gen Hosp, Inst Life Sci, Beijing Prov Key Lab Biotechnol, State Key Lab Kidney, Guangzhou, Guangdong, Peoples R China; [Chen, Yu-hui; Wang, Shan; He, Mei-fang; Wang, Yanyi; Zhao, Hua; Zhu, Han-yu; Ma, Jian; Che, Xiao-juan; Wang, Ju-fang; Wang, Xiao-ning] SCUT, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China; [Yu, Xiao-min; Wang, Xiao-ning] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Shan] Southern Med Univ, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital; South China University of Technology; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Southern Medical University - China	Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China.	ywang@sibs.ac.cn; xnwang88@gmail.com			National Natural Science Foundation of China [30900746, 30972681]; Shanghai Science and Technology Committee [10JC14012000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was funded by grants from National Natural Science Foundation of China (30900746, 30972681) and from Shanghai Science and Technology Committee (10JC14012000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Chang CC, 2006, J BIOL CHEM, V281, P18763, DOI 10.1074/jbc.M511525200; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cresswell AC, 2001, MELANOMA RES, V11, P275, DOI 10.1097/00008390-200106000-00009; Deshpande AH, 2000, DIAGN CYTOPATHOL, V22, P181, DOI 10.1002/(SICI)1097-0339(20000301)22:3<181::AID-DC10>3.0.CO;2-6; Eberth J., 1864, NATURWEISS, V5; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Hallermalm K, 2004, CANCER RES, V64, P6775, DOI 10.1158/0008-5472.CAN-04-0508; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; HUMBLE JG, 1956, BRIT J HAEMATOL, V2, P283, DOI 10.1111/j.1365-2141.1956.tb06700.x; INO T, 1981, SCAND J HAEMATOL, V26, P91; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Lewis WH, 1925, ANAT REC, V31, P43, DOI 10.1002/ar.1090310106; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Pezzano M, 2001, MICROBIOL MOL BIOL R, V65, P390, DOI 10.1128/MMBR.65.3.390-403.2001; Qian YC, 2009, CELL RES, V19, P1320, DOI 10.1038/cr.2009.134; Saxena S, 2002, ACTA CYTOL, V46, P883, DOI 10.1159/000327064; Shen RL, 2004, ARCH PATHOL LAB MED, V128, P1435; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Takeuchi M, 2010, J MOL CELL BIOL, V2, P139, DOI 10.1093/jmcb/mjq002; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; Wang S, 2009, CELL RES, V19, P1350, DOI 10.1038/cr.2009.114; Wang X, 1987, J MED COLL PLA, V2, P107; WEKERLE H, 1980, NATURE, V283, P402, DOI 10.1038/283402a0; Yang YQ, 2012, ANAT REC, V295, P372, DOI 10.1002/ar.21537	31	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59418	10.1371/journal.pone.0059418	http://dx.doi.org/10.1371/journal.pone.0059418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555668	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200021
J	Fernandez-Juricic, E; Ojeda, A; Deisher, M; Burry, B; Baumhardt, P; Stark, A; Elmore, AG; Ensminger, AL				Fernandez-Juricic, Esteban; Ojeda, Agustin; Deisher, Marcella; Burry, Brianna; Baumhardt, Patrice; Stark, Amy; Elmore, Amanda G.; Ensminger, Amanda L.			Do Male and Female Cowbirds See Their World Differently? Implications for Sex Differences in the Sensory System of an Avian Brood Parasite	PLOS ONE			English	Article							BROWN-HEADED COWBIRDS; VISUAL ECOLOGY; COLOR-VISION; HIPPOCAMPUS SIZE; M-CONE; SONG; DISPLAYS; MOTION; BIRDS; SENSITIVITY	Background: Male and female avian brood parasites are subject to different selection pressures: males compete for mates but do not provide parental care or territories and only females locate hosts to lay eggs. This sex difference may affect brain architecture in some avian brood parasites, but relatively little is known about their sensory systems and behaviors used to obtain sensory information. Our goal was to study the visual resolution and visual information gathering behavior (i.e., scanning) of brown-headed cowbirds. Methodology/Principal Findings: We measured the density of single cone photoreceptors, associated with chromatic vision, and double cone photoreceptors, associated with motion detection and achromatic vision. We also measured head movement rates, as indicators of visual information gathering behavior, when exposed to an object. We found that females had significantly lower density of single and double cones than males around the fovea and in the periphery of the retina. Additionally, females had significantly higher head-movement rates than males. Conclusions: Overall, we suggest that female cowbirds have lower chromatic and achromatic visual resolution than males (without sex differences in visual contrast perception). Females might compensate for the lower visual resolution by gazing alternatively with both foveae in quicker succession than males, increasing their head movement rates. However, other physiological factors may have influenced the behavioral differences observed. Our results bring up relevant questions about the sensory basis of sex differences in behavior. One possibility is that female and male cowbirds differentially allocate costly sensory resources, as a recent study found that females actually have greater auditory resolution than males.	[Fernandez-Juricic, Esteban; Deisher, Marcella; Burry, Brianna; Baumhardt, Patrice; Stark, Amy; Elmore, Amanda G.; Ensminger, Amanda L.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ojeda, Agustin] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; California State University System; California State University Long Beach	Fernandez-Juricic, E (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	efernan@purdue.edu	Ensminger, Amanda/M-6196-2013	Ensminger, Amanda/0000-0002-2913-6951	National Science Foundation [IOS-0641550/0937187]; Direct For Biological Sciences [1103725] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the National Science Foundation (IOS-0641550/0937187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIMONOS J, 1987, INT J COMPUT VISION, V1, P333; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Clotfelter ED, 1998, ANIM BEHAV, V55, P1181, DOI 10.1006/anbe.1997.0638; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Cummings ME, 2008, J EXP BIOL, V211, P1203, DOI 10.1242/jeb.012963; Dangles O, 2009, Q REV BIOL, V84, P51, DOI 10.1086/596463; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dawkins MS, 2000, NATURE, V403, P652, DOI 10.1038/35001064; DAWLEY EM, 1992, COPEIA, P113, DOI 10.2307/1446542; Day LB, 2008, BEHAV NEUROSCI, V122, P527, DOI 10.1037/0735-7044.122.3.527; Dolan T, 2010, BRAIN BEHAV EVOLUT, V75, P111, DOI 10.1159/000305025; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Dowling J. E., 2012, RETINA APPROACHABLE; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; Fernandez-Juricic E, 2012, BEHAV PROCESS, V89, P143, DOI 10.1016/j.beproc.2011.10.006; Fernandez-Juricic E, 2011, ANIM BEHAV, V82, P573, DOI 10.1016/j.anbehav.2011.06.014; Fernandez-Juricic E, 2011, ANIM BEHAV, V81, P705, DOI 10.1016/j.anbehav.2010.11.014; Gall MD, 2010, J COMP PHYSIOL A, V196, P559, DOI 10.1007/s00359-010-0543-3; Gloag R, 2012, P ROY SOC B-BIOL SCI, V279, P1831, DOI 10.1098/rspb.2011.2047; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; Gunther KL, 2002, VISION RES, V42, P1367, DOI 10.1016/S0042-6989(02)00043-3; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hauber ME, 1999, BEHAV NEUROSCI, V113, P1095, DOI 10.1037/0735-7044.113.5.1095; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; JAEGER RG, 1991, J HERPETOL, V25, P370, DOI 10.2307/1564603; Jagle H, 2006, DOC OPHTHALMOL, V113, P105, DOI 10.1007/s10633-006-9019-8; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Land M., 2009, LOOKING ACTING VISIO; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lowther PE, 1993, BIRDS N AM ONLINE; MALDONADO PE, 1988, BRAIN BEHAV EVOLUT, V32, P57, DOI 10.1159/000116532; Martin G.R., 2008, SENSES COMPREHENSIVE, V1, P25, DOI 10.1016/B978-012370880-9.00401-1; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martins EP, 2005, BEHAV ECOL SOCIOBIOL, V58, P351, DOI 10.1007/s00265-005-0954-2; Mcllwain JT, 1990, INTRO BIOL VISION; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; Montgomerie R, 2006, BIRD COLORATION MECH; Muchlinski MN, 2011, ANAT REC, V294, P2179, DOI 10.1002/ar.21507; MULLER B, 1989, J COMP NEUROL, V282, P581, DOI 10.1002/cne.902820409; Nava SS, 2012, BEHAV ECOL SOCIOBIOL, V66, P1357, DOI 10.1007/s00265-012-1392-6; Nava SS, 2009, BIOL LETTERS, V5, P732, DOI 10.1098/rsbl.2009.0348; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; O'Loghlen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036130; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Osorio D, 1999, J EXP BIOL, V202, P2951; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; RAUSCHECKER JP, 1994, EUR J NEUROSCI, V6, P149, DOI 10.1111/j.1460-9568.1994.tb00256.x; Reboreda JC, 1996, NEUROREPORT, V7, P505, DOI 10.1097/00001756-199601310-00031; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; Rothstein S.I., 1986, Current Ornithology, V3, P127; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Sabbah S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-133; SHERRY DF, 1993, P NATL ACAD SCI USA, V90, P7839, DOI 10.1073/pnas.90.16.7839; Tomasi D, 2008, NEUROSCIENCE, V151, P1006, DOI 10.1016/j.neuroscience.2007.08.040; Uchiyama M, 2008, TOHOKU J EXP MED, V216, P277, DOI 10.1620/tjem.216.277; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Wilczynski W, 2010, CURR OPIN NEUROBIOL, V20, P754, DOI 10.1016/j.conb.2010.08.021; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514	74	17	17	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58985	10.1371/journal.pone.0058985	http://dx.doi.org/10.1371/journal.pone.0058985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544049	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700012
J	Vaidya, JG; Knutson, B; O'Leary, DS; Block, RI; Magnotta, V				Vaidya, Jatin G.; Knutson, Brian; O'Leary, Daniel S.; Block, Robert I.; Magnotta, Vincent			Neural Sensitivity to Absolute and Relative Anticipated Reward in Adolescents	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; NUCLEUS-ACCUMBENS; AGE-DIFFERENCES; BRAIN; BEHAVIOR; DOPAMINE; IMPULSIVITY; ACTIVATION; NEUROBIOLOGY	Adolescence is associated with a dramatic increase in risky and impulsive behaviors that have been attributed to developmental differences in neural processing of rewards. In the present study, we sought to identify age differences in anticipation of absolute and relative rewards. To do so, we modified a commonly used monetary incentive delay (MID) task in order to examine brain activity to relative anticipated reward value (neural sensitivity to the value of a reward as a function of other available rewards). This design also made it possible to examine developmental differences in brain activation to absolute anticipated reward magnitude (the degree to which neural activity increases with increasing reward magnitude). While undergoing fMRI, 18 adolescents and 18 adult participants were presented with cues associated with different reward magnitudes. After the cue, participants responded to a target to win money on that trial. Presentation of cues was blocked such that two reward cues associated with $.20, $1.00, or $5.00 were in play on a given block. Thus, the relative value of the $1.00 reward varied depending on whether it was paired with a smaller or larger reward. Reflecting age differences in neural responses to relative anticipated reward (i.e., reference dependent processing), adults, but not adolescents, demonstrated greater activity to a $1 reward when it was the larger of the two available rewards. Adults also demonstrated a more linear increase in ventral striatal activity as a function of increasing absolute reward magnitude compared to adolescents. Additionally, reduced ventral striatal sensitivity to absolute anticipated reward (i.e., the difference in activity to medium versus small rewards) correlated with higher levels of trait Impulsivity. Thus, ventral striatal activity in anticipation of absolute and relative rewards develops with age. Absolute reward processing is also linked to individual differences in Impulsivity.	[Vaidya, Jatin G.; O'Leary, Daniel S.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Block, Robert I.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Magnotta, Vincent] Univ Iowa, Dept Anesthesia, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Stanford University; University of Iowa; University of Iowa	Vaidya, JG (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	jatin-vaidya@uiowa.edu		O'Leary, Daniel/0000-0003-1959-6521; Vaidya, Jatin/0000-0002-2375-816X; Block, Robert/0000-0003-4971-1981; Magnotta, Vincent/0000-0001-8639-5354; Knutson, Brian/0000-0002-7669-426X	National Institutes of Health [DA023442]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an R03 grant from the National Institutes of Health (DA023442) to JGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Berns GS, 2007, ANN NY ACAD SCI, V1104, P301, DOI 10.1196/annals.1390.013; Bjork JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011440; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Cooper JC, 2009, SOC COGN AFFECT NEUR, V4, P409, DOI 10.1093/scan/nsp031; Costa PT, 2007, REVISED NEO PERSONAL; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Elliott R, 2008, EUR J NEUROSCI, V27, P2213, DOI 10.1111/j.1460-9568.2008.06202.x; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Hahn T, 2009, NEUROIMAGE, V46, P1148, DOI 10.1016/j.neuroimage.2009.03.038; Jarcho JM, 2012, DEV COGN NEUROSCI; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kenny D. A., 1987, STAT SOCIAL BEHAV SC; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B., 2006, BIOL PERSONALITY IND, P116; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfeifer JH, 2011, NEURON, V69, P1029, DOI 10.1016/j.neuron.2011.02.019; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Sripada CS, 2011, HUM BRAIN MAPP, V32, P1637, DOI 10.1002/hbm.21136; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Vaidya JG, 2010, PERS INDIV DIFFER, V48, P815, DOI 10.1016/j.paid.2010.02.002; Van Leijenhorst L, 2010, CEREB CORTEX, V20, P61, DOI 10.1093/cercor/bhp078; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7	60	15	15	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58708	10.1371/journal.pone.0058708	http://dx.doi.org/10.1371/journal.pone.0058708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544046	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700009
J	Zhang, W; Gao, ZY; Shao, DP; Zhang, L; Wang, CX; Zhang, YP				Zhang, Wei; Gao, Zongyin; Shao, Dongping; Zhang, Liu; Wang, Caixia; Zhang, Yuping			Atomic Force Microscopy Analysis of Progenitor Corneal Epithelial Cells Fractionated by a Rapid Centrifugation Isolation Technique	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; POPULATION; SHEETS; RABBIT	Purpose: To investigate the use of atomic force microscopy (AFM) to image the three groups of corneal epithelial cells fractionated by a novel rapid centrifugation isolation technique. Methods: Epithelial cells harvested from primary cultures of rabbit limbal rings were centrifuged onto uncoated dishes, first at 1400 rpm and then at 1800 rpm. The adherent cells after centrifugation at 1400 rpm (ATC1), the adherent cells at 1800 rpm (ATC2) and the non-adherent cells at 1800 rpm (NAC) were investigated for BrdU retention and were subjected to contact mode AFM and Transmission Electron Microscopy (TEM). Results: Compared with unfractionated cells, the ATC1 group, accounting for about 10% of the whole population, was enriched in BrdU label-retaining cells. There were dramatic overall shape, surface membrane and intra-cellular ultrastructure differences noted among ATC1, ATC2 and NAC populations. The whole cell roughness measurements were 21.1 +/- 1.5 nm, 79.5 +/- 3.4 nm and 103 +/- 4.6 nm for the ATC1, ATC2 and NAC groups, respectively. The mero-nucleus roughness measurements were 34.2 +/- 1.7 nm, 13.0 +/- 0.8 nm and 8.5 +/- 0.5 nm in the ATC1, ATC2 and NAC populations, respectively. Conclusions: AFM was found to be a good tool for distinguishing among the three groups of cells. BrdU label retention, the AFM parameters and TEM together suggest that the ATC1, ATC2 and NAC populations may be progenitor corneal epithelial cells, transit amplifying cells and terminal differentiation cells, respectively.	[Zhang, Wei; Gao, Zongyin; Zhang, Liu] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Shao, Dongping] Southern Med Univ, Affiliated Nanhai Hosp, Dept Ophthalmol, Foshan, Guangdong, Peoples R China; [Wang, Caixia; Zhang, Yuping] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Guangzhou Medical University	Zhang, YP (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	jnzhangyuping@163.com			Key Programs of Health Bureau of Guangzhou City [201102A212025]; Medical Scientific Research Foundation of Guangdong Province, China [WSTJJ20111023342124197509260867]; Key Programs of Guangzhou Municipal Science and Technology Plan Project [2011J4100028]; Programs of Health Bureau of Guangzhou City [20121A011011]	Key Programs of Health Bureau of Guangzhou City; Medical Scientific Research Foundation of Guangdong Province, China; Key Programs of Guangzhou Municipal Science and Technology Plan Project; Programs of Health Bureau of Guangzhou City	This work was supported by the Key Programs of Health Bureau of Guangzhou City (Project No. 201102A212025); the Medical Scientific Research Foundation of Guangdong Province, China (Project No. WSTJJ20111023342124197509260867); the Key Programs of Guangzhou Municipal Science and Technology Plan Project (Project No. 2011J4100028); and the Programs of Health Bureau of Guangzhou City (Project No. 20121A011011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeloglu EU, 2011, METHODS MOL BIOL, V736, P303, DOI 10.1007/978-1-61779-105-5_19; BREWITT H, 1979, ACTA OPHTHALMOL, V57, P945; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; DOUGHTY MJ, 1991, CORNEA, V10, P149, DOI 10.1097/00003226-199103000-00010; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Lombardo M, 2006, J BIOMECH, V39, P2719, DOI 10.1016/j.jbiomech.2005.08.013; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Nieto-Miguel T, 2011, MOL VIS, V17, P2102; Ojeda JL, 2001, J ANAT, V199, P567, DOI 10.1046/j.1469-7580.2001.19950567.x; Pajooresh-Ganji A, 2006, STEM CELLS, V24, P1075, DOI 10.1634/stemcells.2005-0382; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; Puntheeranurak T, 2011, NAT PROTOC, V6, P1443, DOI 10.1038/nprot.2011.370; Rejinold NS, 2011, J BIOMED NANOTECHNOL, V7, P521, DOI 10.1166/jbn.2011.1320; Selver OB, 2011, INVEST OPHTH VIS SCI, V52, P4330, DOI 10.1167/iovs.10-5897; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; Sinniah K, 2002, CURR EYE RES, V25, P61, DOI 10.1076/ceyr.25.1.61.9963; Tsilimbaris MK, 2000, INVEST OPHTH VIS SCI, V41, P680; VERSURA P, 1985, SCAN ELECTRON MICROS, V1985, P1695; Wang H, 2009, STEM CELLS, V27, P2516, DOI 10.1002/stem.174; Zhang W, 2011, TISSUE ENG PART C-ME, V17, P569, DOI [10.1089/ten.TEC.2010.0529, 10.1089/ten.tec.2010.0529]	21	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59282	10.1371/journal.pone.0059282	http://dx.doi.org/10.1371/journal.pone.0059282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555648	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500031
J	Serrano, MD; Cascales, C; Han, XM; Zaldo, C; Jezowski, A; Stachowiak, P; Ter-Gabrielyan, N; Fromzel, V; Dubinskii, M				Dolores Serrano, Maria; Cascales, Concepcion; Han, Xiumei; Zaldo, Carlos; Jezowski, Andrzej; Stachowiak, Piotr; Ter-Gabrielyan, Nikolay; Fromzel, Viktor; Dubinskii, Mark			Thermal Characterization, Crystal Field Analysis and In-Band Pumped Laser Performance of Er Doped NaY(WO4)(2) Disordered Laser Crystals	PLOS ONE			English	Article							DIODE; OPERATION	Undoped and Er-doped NaY(WO4)2 disordered single crystals have been grown by the Czochralski technique. The specific heat and thermal conductivity (k) of these crystals have been characterized from T = 4 K to 700 K and 360 K, respectively. It is shown that k exhibits anisotropy characteristic of single crystals as well as a k(T) behavior observed in glasses, with a saturation mean free phonon path of 3.6 angstrom and 4.5 angstrom for propagation along a and c crystal axes, respectively. The relative energy positions and irreducible representations of Stark Er3+ levels up to (4)G7/2 multiplet have been determined by the combination of experimental low (, 10 K) temperature optical absorption and photoluminescence measurements and simulations with a single-electron Hamiltonian including both free-ion and crystal field interactions. Absorption, emission and gain cross sections of the I-4(13/2) < > I-4(15/2) laser related transition have been determined at 77 K. The I-4(13/2) Er3+ lifetime (tau) was measured in the temperature range of 77-300 K, and was found to change from tau (77K) approximate to 4.5 ms to tau (300K) approximate to 3.5 ms. Laser operation is demonstrated at 77 K and 300 K by resonantly pumping the I-4(13/2) multiplet at lambda approximate to 1500 nm with a broadband (FWHM approximate to 20 nm) diode laser source perfectly matching the 77 K crystal I-4(15/2) -> R I-4(13/2) absorption profile. At 77 K as much as 5.5 W of output power were obtained in pi-polarized configuration with a slope efficiency versus absorbed pump power of 57%, the free running laser wavelength in air was lambda approximate to 1611 nm with the laser output bandwidth of 3.5 nm. The laser emission was tunable over 30.7 nm, from 1590.7 nm to 1621.4 nm, for the same pi-polarized configuration.	[Dolores Serrano, Maria; Cascales, Concepcion; Han, Xiumei; Zaldo, Carlos] CSIC, Inst Ciencia Mat Madrid, Dept Photon Mat, Madrid, Spain; [Jezowski, Andrzej; Stachowiak, Piotr] Polish Acad Sci, Inst Low Temp & Struct Res, Div Low Temp & Superconduct, Wroclaw, Poland; [Ter-Gabrielyan, Nikolay; Fromzel, Viktor; Dubinskii, Mark] USA, Sensors & Electron Devices Directorate, Res Lab, Adelphi, MD USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Polish Academy of Sciences; Institute of Low Temperature & Structure Research; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Zaldo, C (corresponding author), CSIC, Inst Ciencia Mat Madrid, Dept Photon Mat, Madrid, Spain.	cezaldo@icmm.csic.es	CASCALES, Concepción/C-3930-2011; Serrano, Maria Dolores/B-9629-2013; Zaldo, Carlos/K-4321-2013; Jezowski, Andrzej/ABG-2013-2020	CASCALES, Concepción/0000-0003-2513-5887; Serrano, Maria Dolores/0000-0001-7754-0417; Zaldo, Carlos/0000-0001-9586-7771; Jezowski, Andrzej/0000-0002-4955-8051	USAITC [W911NF-10-1-0234]; Spanish Ministry of Economy and Competitiveness [MAT2011-29255-C02-01]	USAITC; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work has been partially supported by the USAITC W911NF-10-1-0234 contract and by the Spanish Ministry of Economy and Competitiveness under project MAT2011-29255-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULL BF, 1982, IEEE J QUANTUM ELECT, V18, P925, DOI 10.1109/JQE.1982.1071611; Berman R, 1976, THERMAL CONDUCTION S; Boudeile J, 2007, OPT LETT, V32, P1962, DOI 10.1364/OL.32.001962; Cascales C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174114; Chenais S, 2001, APPL PHYS B-LASERS O, V72, P389, DOI 10.1007/s003400100477; Druon F, 2002, OPT LETT, V27, P1914, DOI 10.1364/OL.27.001914; Fan JD, 2006, J PHYS D APPL PHYS, V39, P1034, DOI 10.1088/0022-3727/39/6/007; Fan JD, 2008, J APPL CRYSTALLOGR, V41, P584, DOI 10.1107/S0021889808008649; Garcia-Cortes A, 2007, IEEE J QUANTUM ELECT, V43, P758, DOI 10.1109/JQE.2007.902769; Han X, 2012, APPL PHYS B-LASERS O, V108, P509, DOI 10.1007/s00340-012-4936-6; Han X, 2007, CHEM MATER, V19, P3002, DOI 10.1021/cm070237v; Huang JH, 2010, J OPT SOC AM B, V27, P2605, DOI 10.1364/JOSAB.27.002605; KITTEL C, 1949, PHYS REV, V75, P972, DOI 10.1103/PhysRev.75.972; Kobelev NP, 2004, PHYS STATUS SOLIDI A, V201, P450, DOI 10.1002/pssa.200306731; Krupke WF, 2000, IEEE J SEL TOP QUANT, V6, P1287, DOI 10.1109/2944.902180; Lagatsky AA, 2010, OPT LETT, V35, P3027, DOI 10.1364/OL.35.003027; Mateos X, 2010, OPT EXPRESS, V18, P20793, DOI 10.1364/OE.18.020793; MCCUMBER DE, 1964, PHYS REV A-GEN PHYS, V136, pA954, DOI 10.1103/PhysRev.136.A954; Mougel F, 1999, J OPT SOC AM B, V16, P164, DOI 10.1364/JOSAB.16.000164; NAITO K, 1993, APPL OPTICS, V32, P7387, DOI 10.1364/AO.32.007387; Rico M, 2002, CHEM PHYS, V279, P73, DOI 10.1016/S0301-0104(02)00486-X; Rico M, 2006, J OPT SOC AM B, V23, P2066, DOI 10.1364/JOSAB.23.002066; RIETVELD HM, 1967, ACTA CRYSTALLOGR, V22, P151, DOI 10.1107/S0365110X67000234; Schmidt A, 2010, OPT COMMUN, V283, P567, DOI 10.1016/j.optcom.2009.10.084; Ter-Gabrielyan N, 2009, OPT LETT, V34, P1949, DOI 10.1364/OL.34.001949; Ter-Gabrielyan N, 2011, OPT MATER EXPRESS, V1, P223, DOI 10.1364/OME.1.000223; Ter-Gabrielyan N, 2009, OPT EXPRESS, V17, P7159, DOI 10.1364/OE.17.007159; Valle FJ, 2009, X-RAY SPECTROM, V38, P287, DOI 10.1002/xrs.1177; Yoshida A, 2010, OPT EXPRESS, V18, P24325, DOI 10.1364/OE.18.024325; Zapata LE, 2010, OPT LETT, V35, P1854, DOI 10.1364/OL.35.001854; Zhang YY, 2011, IEEE J QUANTUM ELECT, V47, P1506, DOI 10.1109/JQE.2011.2172975	31	9	9	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59381	10.1371/journal.pone.0059381	http://dx.doi.org/10.1371/journal.pone.0059381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555664	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400036
J	Li, T; Liu, H; Cai, K; Tian, MR; Wang, Q; Shi, J; Gao, X; Wang, H				Li, Tao; Liu, Hao; Cai, Kun; Tian, Maoren; Wang, Qin; Shi, Jing; Gao, Xiang; Wang, Hui			Hypersensitive Detection and Quantitation of BoNT/A by IgY Antibody against Substrate Linear-Peptide	PLOS ONE			English	Article							BOTULINUM TYPE-A; NEUROTOXIN TYPE-A; CLOSTRIDIUM-BOTULINUM; ENDOPEPTIDASE IMMUNOASSAYS; SEROTYPE-A; TOXIN-F; ASSAYS; TETANUS; RELEASE; SNAP-25	Botulinum neurotoxin A (BoNT/A), the most acutely poisonous substance to humans known, cleave its SNAP-25 substrate with high specificity. Based on the endopeptidase activity, different methods have been developed to detect BoNT/A, but most lack ideal reproducibility or sensitivity, or suffer from long-term or unwanted interferences. In this study, we developed a simple method to detect and quantitate trace amounts of botulinum neurotoxin A using the IgY antibody against a linear-peptide substrate. The effects of reaction buffer, time, and temperature were analyzed and optimized. When the optimized assay was used to detect BoNT/A, the limit of detection of the assay was 0.01 mouse LD50 (0.04 pg), and the limit of quantitation was 0.12 mouse LD50/ml (0.48 pg). The findings also showed favorable specificity of detecting BoNT/A. When used to detect BoNT/A in milk or human serum, the proposed assay exhibited good quantitative accuracy (88%, < recovery, < 111%; inter- and intra- assay CVs, < 18%). This method of detection took less than 3 h to complete, indicating that it can be a valuable method of detecting BoNT/A in food or clinical diagnosis.	[Li, Tao; Liu, Hao; Cai, Kun; Tian, Maoren; Wang, Qin; Shi, Jing; Gao, Xiang; Wang, Hui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, H (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogens & Biosecur, Beijing, Peoples R China.	geno0109@vip.sina.com			National Natural Science Foundation of China [31201352]; Beijing Natural Science Foundation [7122134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work is supported by National Natural Science Foundation of China (No. 31201352) and Beijing Natural Science Foundation (No. 7122134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC International, 2001, OFFICIAL METHODS ANA; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; EKONG TAN, 1995, J IMMUNOL METHODS, V180, P181, DOI 10.1016/0022-1759(94)00313-L; Gaines Das R E, 1999, Dev Biol Stand, V101, P267; Hallis B, 1996, J CLIN MICROBIOL, V34, P1934, DOI 10.1128/JCM.34.8.1934-1938.1996; Johnson EA, 2001, TOXICON, V39, P1703, DOI 10.1016/S0041-0101(01)00157-X; Jones RGA, 2008, J IMMUNOL METHODS, V329, P92, DOI 10.1016/j.jim.2007.09.014; Jones RGA, 2009, J IMMUNOL METHODS, V343, P21, DOI 10.1016/j.jim.2009.01.001; Joshi SG, 2012, J PHARMACOL TOX MET, V65, P8, DOI 10.1016/j.vascn.2011.11.002; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kautter DA, 1997, J ASS ANAL CHEM, V60, P541; Kovacs-Nolan J, 2004, AVIAN POULT BIOL REV, V15, P25, DOI 10.3184/147020604783637462; Liu ZJ, 2012, ANAL CHIM ACTA, V735, P23, DOI 10.1016/j.aca.2012.05.008; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2001, ANAL BIOCHEM, V296, P130, DOI 10.1006/abio.2001.5236; Shone C, 2006, NEUROTOX RES, V9, P205, DOI 10.1007/BF03033940; TSE CK, 1982, EUR J BIOCHEM, V122, P493; Wang DX, 2012, ANAL CHEM, V84, P4652, DOI 10.1021/ac3006439; Wang HH, 2010, APPL ENVIRON MICROB, V76, P6658, DOI 10.1128/AEM.00731-10; Wang Q, 2010, CAN J MICROBIOL, V56, P1003, DOI 10.1139/W10-087	30	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58908	10.1371/journal.pone.0058908	http://dx.doi.org/10.1371/journal.pone.0058908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555605	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400015
J	Hernandez-Cervantes, R; Quintanar-Stephano, A; Moreno-Mendoza, N; Lopez-Griego, L; Lopez-Salazar, V; Hernandez-Bello, R; Carrero, JC; Morales-Montor, J				Hernandez-Cervantes, Rosalia; Quintanar-Stephano, Andres; Moreno-Mendoza, Norma; Lopez-Griego, Lorena; Lopez-Salazar, Valeria; Hernandez-Bello, Romel; Cesar Carrero, Julio; Morales-Montor, Jorge			Regulation of Intestinal Immune Response by Selective Removal of the Anterior, Posterior, or Entire Pituitary Gland in Trichinella spiralis Infected Golden Hamsters	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM INFECTION; HUMAN MONONUCLEAR PHAGOCYTES; NECROSIS-FACTOR-ALPHA; GROWTH-HORMONE; ADRENAL AXIS; ARGININE-VASOPRESSIN; NEUROENDOCRINE REGULATION; HELMINTH INFECTION; PORCINE JEJUNUM; HUMAN MONOCYTES	The influence of anterior pituitary hormones on the gastrointestinal tract of humans and animals has been previously reported. Hypophysectomy (HYPOX) in the rat causes atrophy of the intestinal mucosa, and reduction of gastric secretion and intestinal absorption, as well as increased susceptibility to bacterial and viral infections. However, to our knowledge, no findings have been published concerning the immune response following HYPOX during worm infection, particularly that which is caused by the nematode Trichinella spiralis. The aim of this work was to analyze the effects of total or partial HYPOX on colonization of T. spiralis in the intestinal lumen, together with duodenal and splenic cytokine expression. Our results indicate that 5 days post infection, only neurointermediate pituitary lobectomy (NIL) reduces the number of intestinally recovered T. spiralis larvae. Using semiquantitative inmunofluorescent laser confocal microscopy, we observed that the mean intensity of all tested Th1 cytokines was markedly diminished, even in the duodenum of infected controls. In contrast, a high level of expression of these cytokines was noted in the NIL infected hamsters. Likewise, a significant decrease in the fluorescence intensity of Th2 cytokines (with the exception of IL-4) was apparent in the duodenum of control and sham infected hamsters, compared to animals with NIL surgeries, which showed an increase in the expression of IL-5 and IL-13. Histology of duodenal mucosa from NIL hamsters showed an exacerbated inflammatory infiltrate located along the lamina propria, which was related to the presence of the parasite. We conclude that hormones from each pituitary lobe affect the gastrointestinal immune responses to T. spiralis through various mechanisms.	[Hernandez-Cervantes, Rosalia; Lopez-Griego, Lorena; Lopez-Salazar, Valeria; Hernandez-Bello, Romel; Cesar Carrero, Julio; Morales-Montor, Jorge] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Quintanar-Stephano, Andres] Univ Autonoma Aguascalientes, Ctr Ciencias Basicas, Dept Fisiol & Farmacol, Aguascalientes, Mexico; [Moreno-Mendoza, Norma] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular, Mexico City 04510, DF, Mexico; [Hernandez-Bello, Romel] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Aguascalientes; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Nuevo Leon	Morales-Montor, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	jmontor66@biomedicas.unam.mx	Montor, Jorge/B-1224-2012	Montor, Jorge/0000-0002-9461-610X; Carrero, Julio/0000-0003-1055-5774; Quintanar-Stephano, Andres/0000-0002-3688-080X	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT) [IN 214011-3]; Direccion General de Asuntos del Personal Academico (DGAPA) [213108]; Universidad Nacional Autonoma de Mexico; Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF); Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT); Sistema Nacional de Investigadoers (SNI)	Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academico (DGAPA); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF); Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT); Sistema Nacional de Investigadoers (SNI)	Financial support was provided by grant IN 214011-3 from the Programa de Apoyo a Proyectos de Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Romel Hernandez-Bello was a Post Doctoral fellowship from the Instituto de Ciencia y Tecnologia del Distrito Federal (ICyTDF). Rosalia Hernandez-Cervantes had a Bachelorete scholarship from PAPIIT, DGAPA (# 213108), from Sistema Nacional de Investigadoers (SNI) as a research helper, and from Red Farmed, Consejo Nacional de Ciencia y Tecnologia (CONACyT). Dr. Lilia Graue corrected the English version of the manuscript.	ALVAREZ-BUYLLA R, 1991, Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico, V39, P33; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; BARRABES A, 1979, CR SOC BIOL, V173, P153; BELL J, 1993, LIFE SCI, V52, P95, DOI 10.1016/0024-3205(93)90292-B; BENJONATHAN N, 1982, ENDOCRINOLOGY, V110, P1861, DOI 10.1210/endo-110-6-1861; BERCZI I, 1981, ACTA ENDOCRINOL-COP, V98, P506, DOI 10.1530/acta.0.0980506; BERCZI I, 1984, ARTHRITIS RHEUM, V27, P682, DOI 10.1002/art.1780270612; Berczi I, 2009, ANN NY ACAD SCI, V1153, P220, DOI 10.1111/j.1749-6632.2008.03975.x; Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014; BIENENSTOCK J, 1992, ANN NY ACAD SCI, V664, P1, DOI 10.1111/j.1749-6632.1992.tb39743.x; BLOCK LH, 1981, J CLIN INVEST, V68, P374, DOI 10.1172/JCI110265; Campos-Rodriguez R, 2006, INFECT IMMUN, V74, P1883, DOI 10.1128/IAI.74.3.1883-1889.2006; Chikanza IC, 1998, BRIT J RHEUMATOL, V37, P131; Chikanza IC, 2000, ANN NY ACAD SCI, V917, P825; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Correa-De-Santana E, 2006, J NEUROIMMUNOL, V173, P12, DOI 10.1016/j.jneuroim.2005.08.015; Crofford LJ, 2002, ENDOCRIN METAB CLIN, V31, P1, DOI 10.1016/S0889-8529(01)00004-4; Damian RT, 1997, PARASITOLOGY, V115, pS169, DOI 10.1017/S0031182097002357; DICARLO R, 1993, LIFE SCI, V53, P981, DOI 10.1016/0024-3205(93)90120-R; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; EDWARDS CK, 1991, ENDOCRINOLOGY, V128, P989, DOI 10.1210/endo-128-2-989; EDWARDS CK, 1992, INFECT IMMUN, V60, P2514, DOI 10.1128/IAI.60.6.2514-2521.1992; EDWARDS CK, 1992, CELL MOL NEUROBIOL, V12, P499, DOI 10.1007/BF00711550; EDWARDS CK, 1991, P NATL ACAD SCI USA, V88, P2274, DOI 10.1073/pnas.88.6.2274; ELANDS J, 1990, ENDOCRINOLOGY, V126, P2703, DOI 10.1210/endo-126-5-2703; Elenkov IJ, 1999, ANN NY ACAD SCI, V876, P1, DOI 10.1111/j.1749-6632.1999.tb07618.x; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; FERNANDEZREPOLLET E, 1983, J HISTOCHEM CYTOCHEM, V31, P956, DOI 10.1177/31.7.6854008; FIGALLOVA V, 1988, FOLIA PARASIT, V35, P59; GALA RR, 1991, P SOC EXP BIOL MED, V198, P513; Garside P, 2000, PARASITE IMMUNOL, V22, P605, DOI 10.1046/j.1365-3024.2000.00344.x; Green BT, 2003, J NEUROIMMUNOL, V141, P74, DOI 10.1016/S0165-5728(03)00225-X; GROSSMAN CJ, 1983, J STEROID BIOCHEM, V19, P461, DOI 10.1016/0022-4731(83)90204-2; HEIJNEN CJ, 1991, IMMUNOL REV, V119, P41, DOI 10.1111/j.1600-065X.1991.tb00577.x; Hernandez-Bello R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/625380; Hu SB, 2003, J NEUROIMMUNOL, V135, P72, DOI 10.1016/S0165-5728(02)00442-3; Ierna MX, 2009, INFECT IMMUN, V77, P3879, DOI 10.1128/IAI.01461-08; Imai S, 2004, CURR TOP MED CHEM, V4, P539, DOI 10.2174/1568026043451285; Karmanska Krystyna, 1997, Wiadomosci Parazytologiczne, V43, P245; Kelley KW, 2007, BRAIN BEHAV IMMUN, V21, P384, DOI 10.1016/j.bbi.2006.11.010; Khegai II, 2003, B EXP BIOL MED+, V136, P448, DOI 10.1023/B:BEBM.0000017089.28428.1c; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Kolodziej-Sobocinska M, 2007, PARASITOL RES, V101, P629, DOI 10.1007/s00436-007-0527-6; Kulkarni-Narla A, 1999, CELL TISSUE RES, V298, P275, DOI 10.1007/s004419900096; Lingnau A., 1993, Applied Parasitology, V34, P153; LOCHER R, 1983, J CLIN INVEST, V71, P884, DOI 10.1172/JCI110842; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; Cardenas-Jaramillo LM, 2012, ANN NY ACAD SCI, V1261, P72, DOI 10.1111/j.1749-6632.2012.06648.x; Meli R, 1996, IMMUNOPHARMACOLOGY, V34, P1, DOI 10.1016/0162-3109(95)00052-6; Mena F, 1996, ENDOCRINE, V5, P285, DOI 10.1007/BF02739061; Morales-Montor J, 2005, PARASITOLOGY, V131, P287, DOI 10.1017/S0031182005007894; MUNCK A, 1992, MOL CELL ENDOCRINOL, V90, pC1, DOI 10.1016/0303-7207(92)90091-J; NAGY E, 1991, ENDOCRINOLOGY, V128, P2776, DOI 10.1210/endo-128-6-2776; NAGY E, 1981, ALLERGY, V36, P429, DOI 10.1111/j.1398-9995.1981.tb01850.x; NAGY E, 1983, ACTA ENDOCRINOL-COP, V102, P351, DOI 10.1530/acta.0.1020351; Navolotskaya EV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P357, DOI 10.1023/A:1014844718799; Nunez GG, 2005, PARASITOLOGY, V131, P255, DOI 10.1017/S0031182005007468; Nunez GG, 2002, PARASITOL RES, V88, P661, DOI 10.1007/s00436-002-0599-2; OTTAWAY CA, 1991, GASTROENTEROL CLIN N, V20, P511; Quintanar-Stephano A, 2004, NEUROIMMUNOMODULAT, V11, P233, DOI 10.1159/000078441; Quintanar-Stephano A, 2010, J PHYSIOL BIOCHEM, V66, P7, DOI 10.1007/s13105-010-0004-z; Quintanar-Stephano A, 2012, NEUROIMMUNOMODULAT, V19, P148, DOI 10.1159/000330578; REDDINGTON JJ, 1981, J PARASITOL, V67, P548, DOI 10.2307/3280489; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Remoue F, 2001, CLIN EXP IMMUNOL, V124, P62, DOI 10.1046/j.1365-2249.2001.01495.x; SANI BP, 1985, BIOCHEM J, V232, P577, DOI 10.1042/bj2320577; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHOBITZ B, 1994, CRIT REV NEUROBIOL, V8, P263; Shoheib Zeinab S., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P31; Silverman MN, 2005, VIRAL IMMUNOL, V18, P41, DOI 10.1089/vim.2005.18.41; Sternberg EM, 2001, J ENDOCRINOL, V169, P429, DOI 10.1677/joe.0.1690429; Torres BA, 1997, CHEM IMMUNOL, V69, P155; WARWICKDAVIES J, 1995, J IMMUNOL, V154, P1909; WARWICKDAVIES J, 1995, INFECT IMMUN, V63, P4312, DOI 10.1128/IAI.63.11.4312-4316.1995; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wiegers GJ, 1998, TRENDS PHARMACOL SCI, V19, P317, DOI 10.1016/S0165-6147(98)01229-2; ZAHNER H, 1989, TROP MED PARASITOL, V40, P322	78	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59486	10.1371/journal.pone.0059486	http://dx.doi.org/10.1371/journal.pone.0059486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555042	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000316409800098
J	Jacob, F; Guertler, R; Naim, S; Nixdorf, S; Fedier, A; Hacker, NF; Heinzelmann-Schwarz, V				Jacob, Francis; Guertler, Rea; Naim, Stephanie; Nixdorf, Sheri; Fedier, Andre; Hacker, Neville F.; Heinzelmann-Schwarz, Viola			Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines	PLOS ONE			English	Article							REAL-TIME PCR; EXPRESSION; RNA; TOOL	Reverse Transcription - quantitative Polymerase Chain Reaction (RT-qPCR) is a standard technique in most laboratories. The selection of reference genes is essential for data normalization and the selection of suitable reference genes remains critical. Our aim was to 1) review the literature since implementation of the MIQE guidelines in order to identify the degree of acceptance; 2) compare various algorithms in their expression stability; 3) identify a set of suitable and most reliable reference genes for a variety of human cancer cell lines. A PubMed database review was performed and publications since 2009 were selected. Twelve putative reference genes were profiled in normal and various cancer cell lines (n = 25) using 2-step RT-qPCR. Investigated reference genes were ranked according to their expression stability by five algorithms (geNorm, Normfinder, BestKeeper, comparative Delta Ct, and RefFinder). Our review revealed 37 publications, with two thirds patient samples and one third cell lines. qPCR efficiency was given in 68.4% of all publications, but only 28.9% of all studies provided RNA/cDNA amount and standard curves. GeNorm and Normfinder algorithms were used in 60.5% in combination. In our selection of 25 cancer cell lines, we identified HSPCB, RRN18S, and RPS13 as the most stable expressed reference genes. In the subset of ovarian cancer cell lines, the reference genes were PPIA, RPS13 and SDHA, clearly demonstrating the necessity to select genes depending on the research focus. Moreover, a cohort of at least three suitable reference genes needs to be established in advance to the experiments, according to the guidelines. For establishing a set of reference genes for gene normalization we recommend the use of ideally three reference genes selected by at least three stability algorithms. The unfortunate lack of compliance to the MIQE guidelines reflects that these need to be further established in the research community.	[Jacob, Francis; Fedier, Andre; Heinzelmann-Schwarz, Viola] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Jacob, Francis; Guertler, Rea; Naim, Stephanie; Nixdorf, Sheri; Heinzelmann-Schwarz, Viola] Univ New S Wales, Lowy Canc Res Ctr, Adult Canc Program, Ovarian Canc Grp, Sydney, NSW, Australia; [Hacker, Neville F.; Heinzelmann-Schwarz, Viola] Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia	University of Basel; University of New South Wales Sydney	Jacob, F (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	francis.jacob@unibas.ch	Nixdorf, Sheri/F-3269-2013; Jacob, Francis/C-7910-2009	Jacob, Francis/0000-0002-0446-1942; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225; Hacker, Neville/0000-0002-1445-2302	Swiss National Foundation [PBZHP3-133289, 2138752, 320030-120543]; Cancer Institute New South Wales [09/CRF/2-02]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Cancer Institute New South Wales; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	This work was supported by the Swiss National Foundation (PBZHP3-133289 and 2138752 to FJ; 320030-120543 to VHS.); Cancer Institute New South Wales (09/CRF/2-02 to VHS); Royal Australian and New Zealand College of Obstetricians and Gynaecologists (to VHS); William Maxwell Trust (to VHS) and the Royal Hospital for Women Foundation (to VHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHAO CCK, 1990, BIOCHEM BIOPH RES CO, V171, P431, DOI 10.1016/0006-291X(90)91411-K; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Harper LV, 2003, MOL CELL PROBE, V17, P261, DOI 10.1016/S0890-8508(03)00063-X; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Mehdi Khanlou K, 2012, PLANTA; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557	27	153	158	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59180	10.1371/journal.pone.0059180	http://dx.doi.org/10.1371/journal.pone.0059180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554992	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800067
J	Rhee, S; Guerrero-Zayas, MI; Wallingford, MC; Ortiz-Pineda, P; Mager, J; Tremblay, KD				Rhee, Siyeon; Guerrero-Zayas, Mara-Isel; Wallingford, Mary C.; Ortiz-Pineda, Pablo; Mager, Jesse; Tremblay, Kimberly D.			Visceral Endoderm Expression of Yin-Yang1 (YY1) Is Required for VEGFA Maintenance and Yolk Sac Development	PLOS ONE			English	Article							YIN YANG 1; NUCLEAR FACTOR 4-ALPHA; POLYCOMB GROUP GENE; VASCULAR DEVELOPMENT; SKELETAL-MUSCLE; MOUSE EMBRYO; MICE LACKING; TRANSCRIPTION; GROWTH; GASTRULATION	Mouse embryos lacking the polycomb group gene member Yin-Yang1 (YY1) die during the peri-implantation stage. To assess the post-gastrulation role of YY1, a conditional knock-out (cKO) strategy was used to delete YY1 from the visceral endoderm of the yolk sac and the definitive endoderm of the embryo. cKO embryos display profound yolk sac defects at 9.5 days post coitum (dpc), including disrupted angiogenesis in mesoderm derivatives and altered epithelial characteristics in the visceral endoderm. Significant changes in both cell death and proliferation were confined to the YY1-expressing yolk sac mesoderm indicating that loss of YY1 in the visceral endoderm causes defects in the adjacent yolk sac mesoderm. Production of Vascular Endothelial Growth Factor A (VEGFA) by the visceral endoderm is essential for normal growth and development of the yolk sac vasculature. Reduced levels of VEGFA are observed in the cKO yolk sac, suggesting a cause for the angiogenesis defects. Ex vivo culture with exogenous VEGF not only rescued angiogenesis and apoptosis in the cKO yolk sac mesoderm, but also restored the epithelial defects observed in the cKO visceral endoderm. Intriguingly, blocking the activity of the mesoderm-localized VEGF receptor, FLK1, recapitulates both the mesoderm and visceral endoderm defects observed in the cKO yolk sac. Taken together, these results demonstrate that YY1 is responsible for maintaining VEGF in the developing visceral endoderm and that a VEGF-responsive paracrine signal, originating in the yolk sac mesoderm, is required to promote normal visceral endoderm development.	[Rhee, Siyeon; Guerrero-Zayas, Mara-Isel; Wallingford, Mary C.; Ortiz-Pineda, Pablo; Mager, Jesse; Tremblay, Kimberly D.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Tremblay, KD (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	kdtrembl@vasci.umass.edu		Ortiz-Pineda, Pablo Andres/0000-0003-3945-2023; Tremblay, Kimberly/0000-0002-3059-9910	National Institutes of Health [R01DK87753]; University of Massachusetts, Amherst; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts, Amherst; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by a grant number R01DK87753 from National Institutes of Health and start-up funds from the University of Massachusetts, Amherst to KDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Angelo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040707; Atchison Michael, 2011, Critical Reviews in Oncogenesis, V16, P143; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Bohnsack BL, 2004, GENE DEV, V18, P1345, DOI 10.1101/gad.1184904; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Byrd N, 2002, DEVELOPMENT, V129, P361; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Damert A, 2002, DEVELOPMENT, V129, P1881; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Duncan SA, 1997, DEVELOPMENT, V124, P279; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hayhurst GP, 2008, J HEPATOL, V49, P384, DOI 10.1016/j.jhep.2008.04.024; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V306, P1008, DOI 10.1016/S0006-291X(03)01071-4; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Nagy A., 2003, MANIPULATING MOUSE E; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58828	10.1371/journal.pone.0058828	http://dx.doi.org/10.1371/journal.pone.0058828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554936	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800034
J	Vaithilingam, V; Fung, C; Ratnapala, S; Foster, J; Vaghjiani, V; Manuelpillai, U; Tuch, BE				Vaithilingam, Vijayaganapathy; Fung, Cherry; Ratnapala, Sabina; Foster, Jayne; Vaghjiani, Vijesh; Manuelpillai, Ursula; Tuch, Bernard E.			Characterisation of the Xenogeneic Immune Response to Microencapsulated Fetal Pig Islet-Like Cell Clusters Transplanted into Immunocompetent C57BL/6 Mice	PLOS ONE			English	Article							NEONATAL PORCINE ISLETS; NATURAL-KILLER-CELL; BETA-CELLS; XENOGRAFT REJECTION; MACROPHAGE DEPLETION; PROLONGED SURVIVAL; DIABETIC-PATIENT; NUDE-MICE; DIFFERENTIATION; ACTIVATION	Xenotransplantation of microencapsulated fetal pig islet-like cell clusters (FP ICCs) offers a potential cellular therapy for type 1 diabetes. Although microcapsules prevent direct contact of the host immune system with the xenografted tissue, poor graft survival is still an issue. This study aimed to characterise the nature of the host immune cells present on the engrafted microcapsules and effects on encapsulated FP ICCs that were transplanted into immunocompetent mice. Encapsulated FP ICCs were transplanted into the peritoneal cavity of C57BL/6 mice. Grafts retrieved at days 1, 3, 7, 14 and 21 post-transplantation were analysed for pericapsular fibrotic overgrowth (PFO), cell viability, intragraft porcine gene expression, macrophages, myofibroblasts and intraperitoneal murine cytokines. Graft function was assessed ex vivo by insulin secretion studies. Xenogeneic immune response to encapsulated FP ICCs was associated with enhanced intragraft mRNA expression of porcine antigens MIP-1 alpha, IL-8, HMGB1 and HSP90 seen within the first two weeks post-transplantation. This was associated with the recruitment of host macrophages, infiltration of myofibroblasts and collagen deposition leading to PFO which was evident from day 7 post-transplantation. This was accompanied by a decrease in cell viability and loss of FP ICC architecture. The only pro-inflammatory cytokine detected in the murine peritoneal flushing was TNF-alpha with levels peaking at day 7 post transplantation. This correlated with the onset of PFO at day 7 implying activated macrophages as its source. The anti-inflammatory cytokines detected were IL-5 and IL-4 with levels peaking at days 1 and 7, respectively. Porcine C-peptide was undetectable at all time points post-transplantation. PFO was absent and murine intraperitoneal cytokines were undetectable when empty microcapsules were transplanted. In conclusion, this study demonstrated that the macrophages are direct effectors of the xenogeneic immune response to encapsulated FP ICCs leading to PFO mediated by a combination of both pro-and anti-inflammatory cytokines.	[Vaithilingam, Vijayaganapathy; Fung, Cherry; Ratnapala, Sabina; Foster, Jayne; Tuch, Bernard E.] Univ New S Wales, Sch Med Sci, Prince Wales Hosp, Diabet Transplant Unit, Randwick, NSW, Australia; [Vaghjiani, Vijesh; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Vaithilingam, Vijayaganapathy; Tuch, Bernard E.] Commonwealth Sci & Ind Res Org, Mat Sci & Engn, N Ryde, NSW, Australia	University of New South Wales Sydney; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tuch, BE (corresponding author), Univ New S Wales, Sch Med Sci, Prince Wales Hosp, Diabet Transplant Unit, Randwick, NSW, Australia.	bernie.tuch@csiro.au	Tuch, Bernard E/D-8041-2013	Vaghjiani, Vijesh/0000-0001-8004-3876	National Health and Medical Research Council (NHMRC) of Australia [455241]; Ursula Manuelpillai [606473]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ursula Manuelpillai; Victorian Government's Operational Infrastructure Support Program	This research was supported by Project Grant 455241 from the National Health and Medical Research Council (NHMRC) of Australia and Ursula Manuelpillai by 606473. Vijesh Vaghjiani and Ursula Manuelpillai are supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga A, 2001, ENDOCRINOLOGY, V142, P4314, DOI 10.1210/en.142.10.4314; Bai L, 2004, XENOTRANSPLANTATION, V11, P426, DOI 10.1111/j.1399-3089.2004.00158.x; Bai LJ, 2002, TRANSPLANTATION, V73, P714, DOI 10.1097/00007890-200203150-00010; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316; Bottino R, 2007, XENOTRANSPLANTATION, V14, P74, DOI 10.1111/j.1399-3089.2006.00374.X; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Candinas D, 1996, TRANSPLANTATION, V62, P1920, DOI 10.1097/00007890-199612270-00042; COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922; Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x; El-Ouaghlidi A, 1999, J MOL MED, V77, P115, DOI 10.1007/s001090050315; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Foster JL, 2007, TRANSPLANTATION, V83, P1440, DOI 10.1097/01.tp.0000264555.46417.7d; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Kobayashi T, 2005, TRANSPLANTATION, V80, P821, DOI 10.1097/01.TP.0000173773.01811.88; Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; KORSGREN O, 1991, DIABETOLOGIA, V34, P379, DOI 10.1007/BF00403174; Koulmanda M, 2004, XENOTRANSPLANTATION, V11, P525, DOI 10.1111/j.1399-3089.2004.00174.x; Kovarik J, 1997, TRANSPL IMMUNOL, V5, P307, DOI 10.1016/S0966-3274(97)80014-7; Krook H, 2002, DIABETES, V51, P79, DOI 10.2337/diabetes.51.1.79; Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004; Lin Y, 1997, J IMMUNOL, V158, P5658; MORRIS CF, 1995, J IMMUNOL, V154, P2470; Omer A, 2003, XENOTRANSPLANTATION, V10, P240, DOI 10.1034/j.1399-3089.2003.01150.x; Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69; Rayat GR, 2000, TRANSPLANTATION, V69, P1084, DOI 10.1097/00007890-200003270-00011; Reinholt FP, 1998, XENOTRANSPLANTATION, V5, P222, DOI 10.1111/j.1399-3089.1998.tb00031.x; Siebers U, 1999, J MOL MED-JMM, V77, P215, DOI 10.1007/s001090050339; Simeonovic CJ, 1999, TRANSPLANTATION, V67, P963, DOI 10.1097/00007890-199904150-00006; Solomon MF, 2003, XENOTRANSPLANTATION, V10, P164, DOI 10.1034/j.1399-3089.2003.01146.x; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Trivedi N, 2001, ENDOCRINOLOGY, V142, P2115, DOI 10.1210/en.142.5.2115; Tu J, 2004, CELL TRANSPLANT, V13, P525, DOI 10.3727/000000004783983693; Tuch BE, 2001, CELL TRANSPLANT, V10, P285, DOI 10.3727/000000001783986819; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; Vaithilingam Vijayaganapathy, 2010, Rev Diabet Stud, V7, P62, DOI 10.1900/RDS.2010.7.62; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; Vo L, 2001, TRANSPLANTATION, V71, P1671, DOI 10.1097/00007890-200106150-00029; WEBER CJ, 1990, TRANSPLANTATION, V49, P396, DOI 10.1097/00007890-199002000-00034; Weinhaus AJ, 2003, J CLIN ENDOCR METAB, V88, P2753, DOI 10.1210/jc.2002-021542; Zamorano J, 2003, IMMUNOLOGIA, V22, P215	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59120	10.1371/journal.pone.0059120	http://dx.doi.org/10.1371/journal.pone.0059120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554983	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800060
J	Yakob, L; Clements, ACA				Yakob, Laith; Clements, Archie C. A.			A Mathematical Model of Chikungunya Dynamics and Control: The Major Epidemic on Reunion Island	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; VIRUS-INFECTION; INDIAN-OCEAN; AEDES-ALBOPICTUS; MALARIA CONTROL; DENGUE; FEVER; TRANSMISSION; SURVIVAL; NUMBER	Chikungunya is a re-emerging arboviral disease transmitted by Aedes spp. mosquitoes. Although principally endemic to Africa and Asia, recent outbreaks have occurred in Europe following introductions by returning travellers. A particularly large outbreak occurred on Reunion Island in 2006, the published data from which forms the basis of the current study. A simple, deterministic mathematical model of the transmission of the virus between humans and mosquitoes was constructed and parameterised with the up-to-date literature on infection biology. The model is fitted to the large Reunion epidemic, resulting in an estimate of 4.1 for the type reproduction number of chikungunya. Although simplistic, the model provided a close approximation of both the peak incidence of the outbreak and the final epidemic size. Sensitivity analysis using Monte Carlo simulation demonstrated the strong influence that both the latent period of infection in humans and the pre-patent period have on these two epidemiological outcomes. We show why separating these variables, which are epidemiologically distinct in chikungunya infections, is not only necessary for accurate model fitting but also important in informing control.	[Yakob, Laith; Clements, Archie C. A.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Queensland	Yakob, L (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	laith.yakob@uq.edu.au	Yakob, Laith/AAD-4521-2019; Clements, Archie/D-9619-2013; Clements, Archie/ABD-1615-2020; Yakob, Laith/B-1059-2012	Yakob, Laith/0000-0001-8639-4511; 				Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1; Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Renault P, 2007, AM J TROP MED HYG, V77, P727; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Yakob L, 2011, BIOL LETTERS, V7, P947, DOI 10.1098/rsbl.2011.0453; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537; Yakob L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006921; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	33	77	78	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57448	10.1371/journal.pone.0057448	http://dx.doi.org/10.1371/journal.pone.0057448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554860	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000316936100026
J	Billich, A; Baumruker, T; Beerli, C; Bigaud, M; Bruns, C; Calzascia, T; Isken, A; Kinzel, B; Loetscher, E; Metzler, B; Mueller, M; Nuesslein-Hildesheim, B; Kleylein-Sohn, B				Billich, Andreas; Baumruker, Thomas; Beerli, Christian; Bigaud, Marc; Bruns, Christian; Calzascia, Thomas; Isken, Andrea; Kinzel, Bernd; Loetscher, Erika; Metzler, Barbara; Mueller, Matthias; Nuesslein-Hildesheim, Barbara; Kleylein-Sohn, Bernadette			Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; LYMPHOCYTE SEQUESTRATION; S1P LYASE; FTY720; INHIBITION; HOMEOSTASIS; DRUG	Background: Sphingosine-I-phosphate (SIP) regulates the egress of T cells from lymphoid organs; levels of SIP in the tissues are controlled by SIP lyase (Sgpl1). Hence, Sgpl1 offers a target to block T cell-dependent inflammatory processes. However, the involvement of Sgpl1 in models of disease has not been fully elucidated yet, since Sgpl1 KO mice have a short life-span. Methodology: We generated inducible Sgpl1 KO mice featuring partial reduction of Sgpl1 activity and analyzed them with respect to sphingolipid levels, T-cell distribution, and response in models of inflammation. Principal Findings:The partially Sgpl1 deficient mice are viable but feature profound reduction of peripheral T cells, similar to the constitutive KO mice. While thymic T cell development in these mice appears normal, mature T cells are retained in thymus and lymph nodes, leading to reduced T cell numbers in spleen and blood, with a skewing towards increased proportions of memory T cells and T regulatory cells. The therapeutic relevance of Sgpl1 is demonstrated by the fact that the inducible KO mice are protected in experimental autoimmune encephalomyelitis (EAE). T cell immigration into the CNS was found to be profoundly reduced. Since SIP levels in the brain of the animals are unchanged, we conclude that protection in EAE is due to the peripheral effect on T cells, leading to reduced CNS immigration, rather than on local effects in the CNS. Significance:The data suggest Sgpl1 as a novel therapeutic target for the treatment of multiple sclerosis.	[Billich, Andreas; Baumruker, Thomas; Beerli, Christian; Bigaud, Marc; Bruns, Christian; Calzascia, Thomas; Isken, Andrea; Kinzel, Bernd; Loetscher, Erika; Metzler, Barbara; Mueller, Matthias; Nuesslein-Hildesheim, Barbara; Kleylein-Sohn, Bernadette] Novartis Inst BioMed Res, Basel, Switzerland	Novartis	Billich, A (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.	andreas.billich@novartis.com		Calzascia, Thomas/0000-0001-8225-6744				Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Bagdanoff JT, 2009, J MED CHEM, V52, P3941, DOI 10.1021/jm900278w; Bandhuvula P, 2007, J LIPID RES, V48, P2769, DOI 10.1194/jlr.D700010-JLR200; Bandhuvula P, 2011, AM J PHYSIOL-HEART C, V300, pH1753, DOI 10.1152/ajpheart.00946.2010; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dickson MA, 2011, CLIN CANCER RES, V17, P2484, DOI 10.1158/1078-0432.CCR-10-2323; Ettmayer P, 2004, BIOORG MED CHEM LETT, V14, P1555, DOI 10.1016/j.bmcl.2003.12.099; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Fleischmann R, 2012, CURR OPIN RHEUMATOL, V24, P335, DOI 10.1097/BOR.0b013e32835190ef; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Goodman WA, 2012, CRIT REV IMMUNOL, V32, P65, DOI 10.1615/CritRevImmunol.v32.i1.40; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Jagle U, 2007, GENESIS, V45, P659, DOI 10.1002/dvg.20342; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Metzler B, 2008, INT IMMUNOL, V20, P633, DOI 10.1093/intimm/dxn023; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Pitman MR, 2010, CURR CANCER DRUG TAR, V10, P354, DOI 10.2174/156800910791208599; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sabbadini RA, 2011, BRIT J PHARMACOL, V162, P1225, DOI 10.1111/j.1476-5381.2010.01118.x; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Swan DJ, 2010, J CELL MOL MED, V14, P2211, DOI 10.1111/j.1582-4934.2010.01136.x; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Youm JK, 2008, J DERMATOL SCI, V51, P89, DOI 10.1016/j.jdermsci.2008.03.002; Yu XQ, 2010, XENOBIOTICA, V40, P350, DOI 10.3109/00498251003611376; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	44	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59630	10.1371/journal.pone.0059630	http://dx.doi.org/10.1371/journal.pone.0059630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544080	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700040
J	Cogo-Moreira, H; de Avila, CRB; Ploubidis, GB; Mari, JD				Cogo-Moreira, Hugo; Brandao de Avila, Clara Regina; Ploubidis, George B.; Mari, Jair de Jesus			Effectiveness of Music Education for the Improvement of Reading Skills and Academic Achievement in Young Poor Readers: A Pragmatic Cluster-Randomized, Controlled Clinical Trial	PLOS ONE			English	Article							INTERVENTIONS	Introduction: Difficulties in word-level reading skills are prevalent in Brazilian schools and may deter children from gaining the knowledge obtained through reading and academic achievement. Music education has emerged as a potential method to improve reading skills because due to a common neurobiological substratum. Objective: To evaluate the effectiveness of music education for the improvement of reading skills and academic achievement among children (eight to 10 years of age) with reading difficulties. Method:235 children with reading difficulties in 10 schools participated in a five-month, randomized clinical trial in cluster (RCT) in an impoverished zone within the city of So Paulo to test the effects of music education intervention while assessing reading skills and academic achievement during the school year. Five schools were chosen randomly to incorporate music classes (n=114), and five served as controls (n=121). Two different methods of analysis were used to evaluate the effectiveness of the intervention: The standard method was intention-to-treat (ITT), and the other was the Complier Average Causal Effect (CACE) estimation method, which took compliance status into account. Results:The ITT analyses were not very promising; only one marginal effect existed for the rate of correct real words read per minute. Indeed, considering ITT, improvements were observed in the secondary outcomes (slope of Portuguese = 0.21 [p<0.001] and slope of math = 0.25 [p<0.001]). As for CACE estimation (i.e., complier children versus non-complier children), more promising effects were observed in terms of the rate of correct words read per minute [beta=13.98, p<0.001] and phonological awareness [beta = 19.72, p<0.001] as well as secondary outcomes (academic achievement in Portuguese [beta = 0.77, p<0.0001] and math [beta=0.49, p<0.001] throughout the school year). Conclusion:The results may be seen as promising, but they are not, in themselves, enough to make music lessons as public policy.	[Cogo-Moreira, Hugo; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Brandao de Avila, Clara Regina] Univ Fed Sao Paulo, Dept Hearing & Speech Pathol, Sao Paulo, Brazil; [Ploubidis, George B.] Univ London, Dept Populat Studies, London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of London; London School of Hygiene & Tropical Medicine	Cogo-Moreira, H (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil.	hugocogobr@gmail.com	de Jesus Mari, Jair/A-7309-2008; Avila, Clara R B/J-6066-2012; Cogo-Moreira, Hugo/U-6442-2019; Cogo-Moreira, Hugo/E-4602-2011; Ploubidis, George B/G-9531-2011; Cogo-Moreira, Hugo/GSD-6132-2022	de Jesus Mari, Jair/0000-0002-5403-0112; Avila, Clara R B/0000-0002-5708-8299; Cogo-Moreira, Hugo/0000-0001-9411-9237; Cogo-Moreira, Hugo/0000-0001-9411-9237; Ploubidis, George B/0000-0002-8198-5790; Cogo-Moreira, Hugo/0000-0001-9411-9237	Instituto ABCD; CNPq; National Council for Scientific and Technological Development (CNPq) [482321/2010-5]; ABCD Institute	Instituto ABCD; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ABCD Institute	The ONGs were: Instituto ABCD (http://www.institutoabcd.org.br/portal) and the CNPq (http://www.cnpq.br/) (main funders). Regarding PhD scholarship, CAPES's URL is http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Council for Scientific and Technological Development (CNPq - grant no 482321/2010-5) and the ABCD Institute [which is a non-governmental organization (NGO) that supports research on dyslexia in Brazil] for the grants that made this study possible.	ALTMAN DG, 1985, J ROY STAT SOC D-STA, V34, P125; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brazil, 1997, INTR AOS PAR CURR NA; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Capovilla A. G. S., 1998, TEMAS DESENVOLVIMENT, V7, P14; Cogo-Moreira H, 2012, COCHRANE DB SYST REV, V15; Cogo-Moreira H, 2012, NEUROPSYCH DIS TREAT, V8, P443, DOI 10.2147/NDT.S36196; Cruz M, 2005, AVAL PSICOL, V4, P199; Cunningham A. E., 2001, J DIRECT INSTRUCTION, V1, P137; Duff FJ, 2011, J CHILD PSYCHOL PSYC, V52, P3, DOI 10.1111/j.1469-7610.2010.02310.x; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Hotopf M, 2002, ADV PSYCHIAT TREATME, P326; Hulme C, 2002, J EXP CHILD PSYCHOL, V82, P2, DOI 10.1006/jecp.2002.2670; Jo B, 2002, STAT MED, V21, P3161, DOI 10.1002/sim.1267; Jo B, 2001, NEW DEV TECHNIQUES S, P57; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kolinsky R, 2009, MUSIC PERCEPT, V26, P235, DOI 10.1525/MP.2009.26.3.235; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pasqua L, 2002, AVALIACAO PSICOLOGIC, V1, P95; Patel AD, 2008, NATURE, V453, P726, DOI 10.1038/453726a; Patel AD, 2007, TRENDS COGN SCI, V11, P369, DOI 10.1016/j.tics.2007.08.003; Pereira L, 1993, TEMAS DESENVOLVIMENT, V12, P7; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Snow C.E., 1998, PREVENTING READING D, DOI DOI 10.1002/PITS.10011; Snowling M, 1997, TRENDS COGN SCI, V1, P88, DOI 10.1016/S1364-6613(97)89053-5; Snowling MJ, 2011, BRIT J EDUC PSYCHOL, V81, P1, DOI 10.1111/j.2044-8279.2010.02014.x; Sobel ME, 2006, J AM STAT ASSOC, V101, P1398, DOI 10.1198/016214506000000636; Torgesen JK., 2000, LEARNING DISABILITIE, V15, P55, DOI [10.1207/sldrp1501_6, 10.1207/SLDRP1501_6, DOI 10.1207/SLDRP1501_6]; Trzesniewski KH, 2006, CHILD DEV, V77, P72, DOI 10.1111/j.1467-8624.2006.00857.x; Weschler D., 1991, WECHSLER INTELLIGENC; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a	38	30	32	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59984	10.1371/journal.pone.0059984	http://dx.doi.org/10.1371/journal.pone.0059984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544117	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317480700076
J	Truchon, MH; Measures, L; L'Herault, V; Brethes, JC; Galbraith, PS; Harvey, M; Lessard, S; Starr, M; Lecomte, N				Truchon, Marie-Helene; Measures, Lena; L'Herault, Vincent; Brethes, Jean-Claude; Galbraith, Peter S.; Harvey, Michel; Lessard, Sylvie; Starr, Michel; Lecomte, Nicolas			Marine Mammal Strandings and Environmental Changes: A 15-Year Study in the St. Lawrence Ecosystem	PLOS ONE			English	Article							RECENT CLIMATE-CHANGE; SEA-ICE; ALEXANDRIUM-TAMARENSE; CETACEAN STRANDINGS; HUDSON-BAY; BAFFIN-BAY; VARIABILITY; ESTUARY; WHALES; CANADA	Understanding the effects of climatic variability on marine mammals is challenging due to the complexity of ecological interactions. We used general linear models to analyze a 15-year database documenting marine mammal strandings (1994 2008; n=1,193) and nine environmental parameters known to affect marine mammal survival, from regional (sea ice) to continental scales (North Atlantic Oscillation, NAO). Stranding events were more frequent during summer and fall than other seasons, and have increased since 1994. Poor ice conditions observed during the same period may have affected marine mammals either directly, by modulating the availability of habitat for feeding and breeding activities, or indirectly, through changes in water conditions and marine productivity (krill abundance). For most species (75%, n = 6 species), a low volume of ice was correlated with increasing frequency of stranding events (e.g. R-adj(2)=0.59, hooded seal, Cystophora cristata). This likely led to an increase in seal mortality during the breeding period, but also to increase habitat availability for seasonal migratory cetaceans using ice-free areas during winter. We also detected a high frequency of stranding events for mysticete species (minke whale, Balaenoptera acutorostrata) and resident species (beluga, Delphinapterus leucas), correlated with low krill abundance since 1994. Positive NAO indices were positively correlated with high frequencies of stranding events for resident and seasonal migratory cetaceans, as well as rare species (R-adj(2)=0.53, 0.81 and 0.34, respectively). This contrasts with seal mass stranding numbers, which were negatively correlated with a positive NAO index. In addition, an unusual multiple species mortality event (n=114, 62% of total annual mortality) in 2008 was caused by a harmful algal bloom. Our findings provide an empirical baseline in understanding marine mammal survival when faced with climatic variability. This is a promising step in integrating stranding records to monitor the consequences of environmental changes in marine ecosystems over long time scales.	[Truchon, Marie-Helene; L'Herault, Vincent; Lecomte, Nicolas] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Measures, Lena; Galbraith, Peter S.; Harvey, Michel; Lessard, Sylvie; Starr, Michel] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Dept Fisheriesand Oceans, Mont Joli, PQ G5H 3Z4, Canada; [Brethes, Jean-Claude] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada; [Lecomte, Nicolas] Govt Nunavut, Dept Environm, Igloolik, NU, Canada	University of Quebec; Fisheries & Oceans Canada; University of Quebec	Truchon, MH (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	marie-helene_truchon@uqar.qc.ca; nlecomte@gov.nu.ca	Galbraith, Peter/B-3797-2012	Galbraith, Peter/0000-0002-5587-6881; Lecomte, Nicolas/0000-0002-8473-5375	Fisheries and Oceans Canada	Fisheries and Oceans Canada	This research was funded by Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CONTRIBUTION WORKING; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Blasco D, 2003, SCI MAR, V67, P261, DOI 10.3989/scimar.2003.67n3261; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen W. Donald, 1999, P423; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cotte C, 2005, MAR ECOL PROG SER, V288, P199, DOI 10.3354/meps288199; Cyr F, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007359; DFO, 2003, DFO CAN SCI ADV SECR, V2003/031; DFO, 2007, REV IC COND POT IMP; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Evans PGH, 2010, J MAR BIOL ASSOC UK, V90, P1483, DOI 10.1017/S0025315410001815; Fauchot J, 2005, J PHYCOL, V41, P263, DOI 10.1111/j.1529-8817.2005.03092.x; Ferguson SH, 2005, MAR MAMMAL SCI, V21, P121, DOI 10.1111/j.1748-7692.2005.tb01212.x; Ferguson SH, 2010, MAR ECOL PROG SER, V411, P285, DOI 10.3354/meps08652; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Forchhammer MC, 2004, POPUL ECOL, V46, P1, DOI 10.1007/s10144-004-0176-x; Galbraith PS, 2012, DEEP-SEA RES PT II, V77-80, P10, DOI 10.1016/j.dsr2.2012.04.001; Galbraith PS, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003159; Galbraith PS, 2011, TECHNICAL REPORT; Geraci JR, 2005, MARINE MAMMALS ASHOR, P113; Gilbert DBP, 1997, CAN J FISH AQUAT S1, V54; Harvey M, 2008, TECHNICAL REPORT; Harvey M, 2009, PROG OCEANOGR, V80, P1, DOI 10.1016/j.pocean.2008.09.001; Hemery G, 2008, GLOBAL CHANGE BIOL, V14, P27, DOI 10.1111/j.1365-2486.2007.01471.x; Higdon JW, 2009, ECOL APPL, V19, P1365, DOI 10.1890/07-1941.1; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Johnston DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029158; Johnston DW, 2005, CLIM RES, V29, P209, DOI 10.3354/cr029209; Koutitonsky V.G., 1991, CAN SPEC PUBL FISH A, V113, P57; Le Boeuf B. J., 2000, Journal of Cetacean Research and Management, V2, P85; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Lesage V, 2007, TECHNICAL REPORT; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; Maldini Daniela, 2005, Pacific Science, V59, P55, DOI 10.1353/psc.2005.0009; Marchand C, 1999, CAN J FISH AQUAT SCI, V56, P1832, DOI 10.1139/cjfas-56-10-1832; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Mitchell MR, 2002, CAN TEC REP HYDROG O, V23; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Mysak LA, 1996, ATMOS OCEAN, V34, P313, DOI 10.1080/07055900.1996.9649567; Nemiroff L, 2010, CAN FIELD NAT, V124, P32, DOI 10.22621/cfn.v124i1.1027; Norman S. A., 2004, Journal of Cetacean Research and Management, V6, P87; Plourde S, 2011, J PLANKTON RES, V33, P703, DOI 10.1093/plankt/fbq144; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; R Core Team, 2018, R LANG ENV STAT COMP; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Savenkoff C, 2007, ESTUAR COAST SHELF S, V73, P711, DOI 10.1016/j.ecss.2007.03.011; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Sears RJ, 1990, REPORT INT WHALING C, P335; Simard Y, 1999, CAN J FISH AQUAT SCI, V56, P1182, DOI 10.1139/cjfas-56-7-1182; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stern HL, 2003, POLAR RES, V22, P11, DOI 10.1111/j.1751-8369.2003.tb00090.x; Taylor M, 2003, HABITAT DEGRADATION, P12; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weise AM, 2002, CAN J FISH AQUAT SCI, V59, P464, DOI 10.1139/F02-024; Zar JH, 1999, BIOSTATISTICAL ANAL	63	25	27	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59311	10.1371/journal.pone.0059311	http://dx.doi.org/10.1371/journal.pone.0059311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544059	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700021
J	Lorente, E; Infantes, S; Barnea, E; Beer, I; Barriga, A; Garcia-Medel, N; Lasala, F; Jimenez, M; Admon, A; Lopez, D				Lorente, Elena; Infantes, Susana; Barnea, Eilon; Beer, Ilan; Barriga, Alejandro; Garcia-Medel, Noel; Lasala, Fatima; Jimenez, Mercedes; Admon, Arie; Lopez, Daniel			Diversity of Natural Self-Derived Ligands Presented by Different HLA Class I Molecules in Transporter Antigen Processing-Deficient Cells	PLOS ONE			English	Article							T-LYMPHOCYTES; PEPTIDE REPERTOIRE; MHC MOLECULES; MULTIPLE; EXPRESSION; PROTEIN; REVEALS; HLA-B27; AMINOPEPTIDASE; IDENTIFICATION	The transporter associated with antigen processing (TAP) translocates the cytosol-derived proteolytic peptides to the endoplasmic reticulum lumen where they complex with nascent human leukocyte antigen (HLA) class I molecules. Nonfunctional TAP complexes and viral or tumoral blocking of these transporters leads to reduced HLA class I surface expression and a drastic change in the available peptide repertoire. Using mass spectrometry to analyze complex human leukocyte antigen HLA-bound peptide pools isolated from large numbers of TAP-deficient cells, we identified 334 TAP-independent ligands naturally presented by four different HLA-A, -B, and -C class I molecules with very different TAP dependency from the same cell line. The repertoire of TAP-independent peptides examined favored increased peptide lengths and a lack of strict binding motifs for all four HLA class I molecules studied. The TAP-independent peptidome arose from 182 parental proteins, the majority of which yielded one HLA ligand. In contrast, TAP-independent antigen processing of very few cellular proteins generated multiple HLA ligands. Comparison between TAP-independent peptidome and proteome of several subcellular locations suggests that the secretory vesicle-like organelles could be a relevant source of parental proteins for TAP-independent HLA ligands. Finally, a predominant endoproteolytic peptidase specificity for Arg/Lys or Leu/Phe residues in the P-1 position of the scissile bond was found for the TAP-independent ligands. These data draw a new and intricate picture of TAP-independent pathways.	[Lorente, Elena; Infantes, Susana; Barriga, Alejandro; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen Inmunol Viral, Madrid, Spain; [Barnea, Eilon; Beer, Ilan; Admon, Arie] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Garcia-Medel, Noel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Lasala, Fatima; Jimenez, Mercedes] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Prote, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Technion Israel Institute of Technology; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen Inmunol Viral, Madrid, Spain.	dlopez@isciii.es	López, Daniel/I-2632-2014; Lorente, Elena/B-1219-2019	López, Daniel/0000-0003-0268-5878; Lorente, Elena/0000-0002-2246-6851; Barriga, Alejandro/0000-0001-6357-1917; LASALA, FATIMA/0000-0001-8183-1866; Admon, Arie/0000-0003-0504-3950	Ministerio de Ciencia e Innovacion; FIPSE Foundation; Israel Science Foundation [916/05]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FIPSE Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants to DL from the Ministerio de Ciencia e Innovacion and the FIPSE Foundation and to AA from the Israel Science Foundation 916/05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Apostolopoulos V, 1997, J IMMUNOL, V159, P5211; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; Brunner Y, 2009, MASS SPECTROM REV, V28, P844, DOI 10.1002/mas.20211; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Del Val M, 2011, CELL MOL LIFE SCI, V68, P1543, DOI 10.1007/s00018-011-0661-2; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ERLICH H, 1986, HUM IMMUNOL, V16, P205, DOI 10.1016/0198-8859(86)90049-2; Fairchild PJ, 1996, IMMUNOL TODAY, V17, P80, DOI 10.1016/0167-5699(96)80584-6; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Infantes S, 2010, J IMMUNOL, V184, P3351, DOI 10.4049/jimmunol.0901560; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; Kuipers JG, 1996, CLIN EXP RHEUMATOL, V14, P523; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lorente E, 2012, J BIOL CHEM, V287, P9990, DOI 10.1074/jbc.M111.314856; Lorente E, 2012, J VIROL, V86, P527, DOI 10.1128/JVI.05737-11; Lorente E, 2011, J BIOL CHEM, V286, P38054, DOI 10.1074/jbc.M111.281808; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Mukherjee P, 2001, J IMMUNOL, V167, P2632, DOI 10.4049/jimmunol.167.5.2632; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schmidt H, 2011, J PROTEOME RES, V10, P1603, DOI 10.1021/pr100967v; Schmidt H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-4; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; Suciu D, 1997, PROTEIN ENG, V10, P1057, DOI 10.1093/protein/10.9.1057; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; Suri A, 2003, P NATL ACAD SCI USA, V100, P5330, DOI 10.1073/pnas.0330859100; Uriarte SM, 2008, J IMMUNOL, V180, P5575, DOI 10.4049/jimmunol.180.8.5575; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	60	8	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59118	10.1371/journal.pone.0059118	http://dx.doi.org/10.1371/journal.pone.0059118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555621	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500021
J	Kwak, K; Jiang, R; Jagu, S; Wang, JW; Wang, CG; Christensen, ND; Roden, RBS				Kwak, Kihyuck; Jiang, Rosie; Jagu, Subhashini; Wang, Joshua W.; Wang, Chenguang; Christensen, Neil D.; Roden, Richard B. S.			Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN EXPRESSION; IN-VIVO; ESCHERICHIA-COLI; SKELETAL-MUSCLE; TYPE-16 L1; L2; HPV; ANTIBODIES; NEUTRALIZATION	Objectives: Naked DNA vaccines can be manufactured simply and are stable at ambient temperature, but require improved delivery technologies to boost immunogenicity. Here we explore in vivo electroporation for multivalent codon-optimized human papillomavirus (HPV) L1 and L2 DNA vaccination. Methods: Balb/c mice were vaccinated three times at two week intervals with a fusion protein comprising L2 residues similar to 11-88 of 8 different HPV types (11-88x8) or its DNA expression vector, DNA constructs expressing L1 only or L1+L2 of a single HPV type, or as a mixture of several high-risk HPV types and administered utilizing electroporation, i.m. injection or gene gun. Serum was collected two weeks and 3 months after the last vaccination. Sera from immunized mice were tested for in-vitro neutralization titer, and protective efficacy upon passive transfer to naive mice and vaginal HPV challenge. Heterotypic interactions between L1 proteins of HPV6, HPV16 and HPV18 in 293TT cells were tested by co-precipitation using type-specific monoclonal antibodies. Results: Electroporation with L2 multimer DNA did not elicit detectable antibody titer, whereas DNA expressing L1 or L1+L2 induced L1-specific, type-restricted neutralizing antibodies, with titers approaching those induced by Gardasil. Co-expression of L2 neither augmented L1-specific responses nor induced L2-specific antibodies. Delivery of HPV L1 DNA via in vivo electroporation produces a stronger antibody response compared to i.m. injection or i.d. ballistic delivery via gene gun. Reduced neutralizing antibody titers were observed for certain types when vaccinating with a mixture of L1 (or L1+L2) vectors of multiple HPV types, likely resulting from heterotypic L1 interactions observed in co-immunoprecipitation studies. High titers were restored by vaccinating with individual constructs at different sites, or partially recovered by co-expression of L2, such that durable protective antibody titers were achieved for each type. Discussion: Multivalent vaccination via in vivo electroporation requires spatial separation of individual type L1 DNA vaccines.	[Kwak, Kihyuck; Jiang, Rosie; Jagu, Subhashini; Wang, Joshua W.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Wang, Chenguang] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Christensen, Neil D.] Penn State Univ, Dept Pathol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Microbiol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Dept Immunol, Hershey, PA USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	roden@jhmi.edu	Kwak, Kihyuck/Y-4377-2018	Kwak, Kihyuck/0000-0002-7386-9589	US Public Health Service [CA118790, P50 CA098252]; Shantha Biotechnics Ltd.; Sanofi Pasteur; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [R01CA118790, R01CA047622] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Shantha Biotechnics Ltd.; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by US Public Health Service grants CA118790 and P50 CA098252 (grants.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Subhashini Jagu and Richard Roden are co-inventors on L2 patents (20090047301 Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies and 20100297144 MULTITYPE HPV PEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION) licensed to Shantha Biotechnics Ltd., GlaxoSmithKline, PaxVax, Inc. and Acambis, Inc and have received research funding from Shantha Biotechnics Ltd., Sanofi Pasteur and GlaxoSmithKline and Richard Roden is a founder of Papivax LLC. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict of interest policies. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Bronnimann MP, 2013, J VIROL, V87, P464, DOI 10.1128/JVI.01539-12; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buonamassa DT, 2002, VIROLOGY, V293, P335, DOI 10.1006/viro.2001.1289; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Campo MS, 1997, VIROLOGY, V234, P261, DOI 10.1006/viro.1997.8649; Chen HS, 2010, VIROLOGY, V405, P289, DOI 10.1016/j.virol.2010.05.019; Chen XJS, 2001, J MOL BIOL, V307, P173, DOI 10.1006/jmbi.2000.4464; Christensen ND, 1996, VIROLOGY, V224, P477, DOI 10.1006/viro.1996.0554; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cristillo AD, 2011, J GEN VIROL, V92, P128, DOI 10.1099/vir.0.023242-0; Cukjati D, 2007, BIOELECTROCHEMISTRY, V70, P501, DOI 10.1016/j.bioelechem.2006.11.001; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; Dolter KE, 2011, VACCINE, V29, P795, DOI 10.1016/j.vaccine.2010.11.011; Donnelly JJ, 1996, J INFECT DIS, V173, P314, DOI 10.1093/infdis/173.2.314; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Fleury MJJ, 2009, PROTEIN SCI, V18, P1425, DOI 10.1002/pro.156; Fuller DH, 2006, METHODS, V40, P86, DOI 10.1016/j.ymeth.2006.05.022; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gasparic M, 2007, VACCINE, V25, P4540, DOI 10.1016/j.vaccine.2007.04.001; Geraets D., 2012, J PATHOLOGY; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hitzeroth II, 2009, VACCINE, V27, P6432, DOI 10.1016/j.vaccine.2009.06.015; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kim D, 2008, VACCINE, V26, P351, DOI 10.1016/j.vaccine.2007.11.019; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Leder C, 2001, J VIROL, V75, P9201, DOI 10.1128/JVI.75.19.9201-9209.2001; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Li ML, 1997, J VIROL, V71, P2988, DOI 10.1128/JVI.71.4.2988-2995.1997; Liu WJ, 2001, VACCINE, V20, P862, DOI 10.1016/S0264-410X(01)00406-6; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Low L, 2009, HUM GENE THER, V20, P1269, DOI 10.1089/hum.2009.067; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Luxembourg A, 2006, VACCINE, V24, P4490, DOI 10.1016/j.vaccine.2005.08.014; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Moscicki Anna-Barbara, 2010, Adolesc Med State Art Rev, V21, P347; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nardelli-Haefliger D, 1999, J VIROL, V73, P9609, DOI 10.1128/JVI.73.11.9609-9613.1999; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Okun MM, 2001, J VIROL, V75, P4332, DOI 10.1128/JVI.75.9.4332-4342.2001; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; RODEN RBS, 1994, J VIROL, V68, P7570, DOI 10.1128/JVI.68.11.7570-7574.1994; Roden RBS, 1996, J VIROL, V70, P5875, DOI 10.1128/JVI.70.9.5875-5883.1996; Roden RBS, 1996, J VIROL, V70, P3298, DOI 10.1128/JVI.70.5.3298-3301.1996; ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993; ROSE RC, 1994, J GEN VIROL, V75, P2445, DOI 10.1099/0022-1317-75-9-2445; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Senger T, 2009, J VIROL, V83, P12692, DOI 10.1128/JVI.01582-09; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Steele KE, 2001, VET PATHOL, V38, P203, DOI 10.1354/vp.38-2-203; Sundaram P, 1998, VACCINE, V16, P613, DOI 10.1016/S0264-410X(97)84510-0; Trollet C, 2006, CURR GENE THER, V6, P561, DOI 10.2174/156652306778520656; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Ulmer JB, 1999, VACCINE, V18, P18, DOI 10.1016/S0264-410X(99)00151-6; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	78	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60507	10.1371/journal.pone.0060507	http://dx.doi.org/10.1371/journal.pone.0060507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536912	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200060
J	Liu, C; Qi, X; Zhao, Q; Yu, JJ				Liu, Chen; Qi, Xin; Zhao, Qian; Yu, Jingjuan			Characterization and Functional Analysis of the Potato Pollen-Specific Microtubule-Associated Protein SBgLR in Tobacco	PLOS ONE			English	Article							ELONGATION FACTOR-1-ALPHA; CORTICAL MICROTUBULES; GENE; PROMOTERS; CLONING; GROWTH; DOMAIN; ALPHA; SHAPE; MOR1	Microtubule-associated proteins play a crucial role in the regulation of microtubule dynamics, and are very important for plant cell and organ development. SBgLR is a potato pollen-specific protein, with five imperfect V-V-E-K-K-N/E-E repetitive motifs that are responsible for microtubule binding activity. In present study, SBgLR showed typical microtubule-associated protein characteristics; it bound tubulin and microtubules, and colocalized with microtubules in vitro. We also found that SBgLR could form oligomers, and that both the SBgLR monomers and oligomers bundle microtubules in vitro. Constitutive expression of SBgLR in tobacco caused curving and right-handed twisting root growth, abnormal directional cell expansion and cell layer arrangement, and pollen abortion. Immunofluorescence staining assays revealed that microtubule organization is altered in root epidermal cells in SBgLR-overexpressing lines. These suggest that SBgLR functions as a microtubule-associated protein in pollen development. Our results indicate that normal organization of MTs may be crucial for pollen development.	[Liu, Chen; Qi, Xin; Zhao, Qian; Yu, Jingjuan] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Yu, JJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yujj@cau.edu.cn			National Natural Science Foundation of China [30971555]; National Transgenic Major Program of China [2011ZX003-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program of China	This work was supported by National Natural Science Foundation of China (Grant No. 30971555), National Transgenic Major Program of China (Grant no. 2011ZX003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hashimoto T, 2003, CURR OPIN PLANT BIOL, V6, P568, DOI 10.1016/j.pbi.2003.09.011; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Ishida T, 2007, J PLANT RES, V120, P61, DOI 10.1007/s10265-006-0039-y; JIANG CJ, 1993, J CELL SCI, V105, P891; Kumagai F, 1995, BOT ACTA, V108, P467, DOI 10.1111/j.1438-8677.1995.tb00523.x; LANCELLE SA, 1986, PROTOPLASMA, V131, P153, DOI 10.1007/BF01285037; Lang ZH, 2004, PLANT SCI, V166, P1227, DOI 10.1016/j.plantsci.2003.12.036; Lang ZH, 2008, PLANTA, V227, P387, DOI 10.1007/s00425-007-0625-9; Liu JQ, 1997, PLANT MOL BIOL, V33, P291, DOI 10.1023/A:1005746713759; Lloyd C, 2004, NAT REV MOL CELL BIO, V5, P13, DOI 10.1038/nrm1277; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mineyuki Y, 2007, J PLANT RES, V120, P45, DOI 10.1007/s10265-006-0063-y; Moore RC, 2000, CELL MOTIL CYTOSKEL, V45, P279, DOI 10.1002/(SICI)1097-0169(200004)45:4<279::AID-CM4>3.3.CO;2-W; Moore RC, 1998, CELL MOTIL CYTOSKEL, V41, P168, DOI 10.1002/(SICI)1097-0169(1998)41:2<168::AID-CM7>3.0.CO;2-A; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Perrin RM, 2007, PLANT J, V49, P961, DOI 10.1111/j.1365-313X.2006.03015.x; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Sivaguru M, 2003, PLANT CELL PHYSIOL, V44, P667, DOI 10.1093/pcp/pcg094; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Smith LG, 2003, CURR OPIN PLANT BIOL, V6, P63, DOI 10.1016/S1369-5266(02)00012-2; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Twell D, 2002, NAT CELL BIOL, V4, P711, DOI 10.1038/ncb844; VANDERLEEDEPLEGT LM, 1992, PLANT CELL REP, V11, P20, DOI 10.1007/BF00231833; Wang X, 2007, PLANT CELL, V19, P877, DOI 10.1105/tpc.106.048579; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Wasteneys GO, 2003, PLANT CELL PHYSIOL, V44, P653, DOI 10.1093/pcp/pcg103; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wilkinson JE, 1997, J EXP BOT, V48, P265, DOI 10.1093/jxb/48.2.265; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Yao M, 2008, J CELL SCI, V121, P2372, DOI 10.1242/jcs.030221; Yasuhara H, 2002, PLANT CELL PHYSIOL, V43, P595, DOI 10.1093/pcp/pcf074; [赵倩 Zhao Qian], 2004, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V20, P275; Zhao Y, 2006, PLANTA, V224, P405, DOI 10.1007/s00425-006-0226-z	42	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60543	10.1371/journal.pone.0060543	http://dx.doi.org/10.1371/journal.pone.0060543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536914	Green Submitted, Green Published, gold			2022-12-27	WOS:000317397200062
J	Schwarzkopf, DS; Rees, G				Schwarzkopf, D. Samuel; Rees, Geraint			Subjective Size Perception Depends on Central Visual Cortical Magnification in Human V1	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; EBBINGHAUS ILLUSION; GABA CONCENTRATION; RECEPTIVE-FIELDS; SIMILARITY; FREQUENCY; REPRESENTATION; PREDICTS; AREAS	In the Ebbinghaus illusion, the context surrounding an object modulates its subjectively perceived size. Previous work implicates human primary visual cortex (V1) as the neural substrate mediating this contextual effect. Here we studied in healthy adult humans how two different types of context (large or small inducers) in this illusion affected size perception by comparing each to a reference stimulus without any context. We found that individual differences in the magnitudes of the illusion produced by either type of context were correlated with V1 area defined through retinotopic mapping using functional MRI. However, participants' objective ability to discriminate the size of objects presented in isolation was unrelated to illusion strength and did not correlate with V1 area. Control analyses showed no correlations between behavioral measures and the overall V1 area estimated probabilistically on the basis of neuroanatomy alone. Therefore, subjective size perception correlated with variability in central cortical magnification rather than the anatomical extent of primary visual cortex. We propose that such changes in subjective perception of size are mediated by mechanisms that scale with the extent to which an individual's V1 selectively represents the central visual field.	[Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Schwarzkopf, D. Samuel; Rees, Geraint] UCL, Inst Cognit Neurosci, London, England; [Schwarzkopf, D. Samuel] UCL, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	s.schwarzkopf@ucl.ac.uk	Rees, Geraint/C-1493-2008	Rees, Geraint/0000-0002-9623-7007	Wellcome Trust; Wellcome Trust [091593/Z/10/Z]; Wellcome Trust [100227/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Senior Clinical Research Fellowship to GR. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benson NC, 2012, CURR BIOL, V22, P2081, DOI 10.1016/j.cub.2012.09.014; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choplin JM, 1999, PERCEPT PSYCHOPHYS, V61, P3, DOI 10.3758/BF03211944; COREN S, 1979, PERCEPTION, V8, P303, DOI 10.1068/p080303; COREN S, 1993, PERCEPT PSYCHOPHYS, V54, P579, DOI 10.3758/BF03211782; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delboeuf J., 1892, B ACAD ROYALE BELGIQ, V24, P545; Deni JR, 1997, PERCEPT MOTOR SKILL, V84, P1171, DOI 10.2466/pms.1997.84.3c.1171; Doherty MJ, 2010, DEVELOPMENTAL SCI, V13, P714, DOI 10.1111/j.1467-7687.2009.00931.x; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Ebbinghaus H, 1902, GRUNDZUUGE PSYCHOL L; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gaetz W, 2011, HUMAN BRAIN MAPPING; Harvey BM, 2011, J NEUROSCI, V31, P13604, DOI 10.1523/JNEUROSCI.2572-11.2011; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hughes M, 2010, J VISION, V10, P954, DOI [DOI 10.1167/10.7.954, 10.1167/10.7.954]; Lee S, 2012, 42 ANN M SOC NEUR NE, V723.08; Muise JG, 1997, PERCEPT MOTOR SKILL, V85, P1203, DOI 10.2466/pms.1997.85.3f.1203; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Palmer CR, 2012, J NEUROPHYSIOL, V107, P1857, DOI 10.1152/jn.00117.2011; Pelt van S, 2012, 42 ANN M SOC NEUR NE, V570.20; Phillips WA, 2004, PERCEPTION, V33, P79, DOI 10.1068/p5110; Ress D., 2011, J VIS, V11, P1197, DOI DOI 10.1167/11.11.1197; Roberts B, 2005, PERCEPTION, V34, P847, DOI 10.1068/p5273; Rose D, 2002, SPATIAL VISION, V15, P191, DOI 10.1163/15685680252875165; Schwarzkopf DS, 2012, J NEUROSCI, V32, P1507, DOI 10.1523/JNEUROSCI.4771-11.2012; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Schwarzkopf DS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00200; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Silverstein SM, 2011, SCHIZOPHRENIA BULL, V37, P690, DOI 10.1093/schbul/sbr052; Song C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-27; Sperandio I, 2012, NAT NEUROSCI, V15, P540, DOI 10.1038/nn.3069; Sperandio I, 2012, J VISION, V12, DOI 10.1167/12.2.18; Thelen L., 2010, J VIS, V10, P487, DOI DOI 10.1167/10.7.487; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Zuiderbaan W, 2012, J VISION, V12, DOI 10.1167/12.3.10	43	53	56	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60550	10.1371/journal.pone.0060550	http://dx.doi.org/10.1371/journal.pone.0060550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536915	Green Published, Green Submitted, gold			2022-12-27	WOS:000317397200063
J	Deistung, A; Schweser, F; Wiestler, B; Abello, M; Roethke, M; Sahm, F; Wick, W; Nagel, AM; Heiland, S; Schlemmer, HP; Bendszus, M; Reichenbach, JR; Radbruch, A				Deistung, Andreas; Schweser, Ferdinand; Wiestler, Benedikt; Abello, Mario; Roethke, Matthias; Sahm, Felix; Wick, Wolfgang; Nagel, Armin Michael; Heiland, Sabine; Schlemmer, Heinz-Peter; Bendszus, Martin; Reichenbach, Juergen Rainer; Radbruch, Alexander			Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma	PLOS ONE			English	Article							WEIGHTED IMAGING SWI; HIGH-RESOLUTION; OLIGODENDROGLIAL COMPONENT; MAGNETIC-SUSCEPTIBILITY; GENETIC ALTERATIONS; CEREBRAL-LESIONS; CONTRAST AGENT; BRAIN-TUMORS; HIGH-FIELD; MR	Objectives: The application of susceptibility weighted imaging (SWI) in brain tumor imaging is mainly used to assess tumor-related "susceptibility based signals" (SBS). The origin of SBS in glioblastoma is still unknown, potentially representing calcifications or blood depositions. Reliable differentiation between both entities may be important to evaluate treatment response and to identify glioblastoma with oligodendroglial components that are supposed to present calcifications. Since calcifications and blood deposits are difficult to differentiate using conventional MRI, we investigated whether a new post-processing approach, quantitative susceptibility mapping (QSM), is able to distinguish between both entities reliably. Materials and Methods: SWI, FLAIR, and T1-w images were acquired from 46 patients with glioblastoma (14 newly diagnosed, 24 treated with radiochemotherapy, 8 treated with radiochemotherapy and additional anti-angiogenic medication). Susceptibility maps were calculated from SWI data. All glioblastoma were evaluated for the appearance of hypointense or hyperintense correlates of SBS on the susceptibility maps. Results: 43 of 46 glioblastoma presented only hyperintense intratumoral SBS on susceptibility maps, indicating blood deposits. Additional hypointense correlates of tumor-related SBS on susceptibility maps, indicating calcification, were identified in 2 patients being treated with radiochemotherapy and in one patient being treated with additional anti-angiogenic medication. Histopathologic reports revealed an oligodendroglial component in one patient that presented calcifications on susceptibility maps. Conclusions: QSM provides a quantitative, local MRI contrast, which reliably differentiates between blood deposits and calcifications. Thus, quantitative susceptibility mapping appears promising to identify rare variants of glioblastoma with oligodendroglial components non-invasively and may allow monitoring the role of calcification in the context of different therapy regimes.	[Deistung, Andreas; Schweser, Ferdinand; Reichenbach, Juergen Rainer] Univ Jena, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena Univ Hosp, Jena, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Dept Neurooncol, INF 400, Heidelberg, Germany; [Roethke, Matthias; Schlemmer, Heinz-Peter] German Canc Res Ctr, Dept Radiol, INF 280, Heidelberg, Germany; [Sahm, Felix] Heidelberg Univ, Dept Neuropathol, INF 220 221, Heidelberg, Germany; [Nagel, Armin Michael] German Canc Res Ctr, Inst Med Phys, INF 280, Heidelberg, Germany; [Abello, Mario; Heiland, Sabine; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, INF 400, Heidelberg, Germany; [Radbruch, Alexander] German Canc Res Ctr, Sect Neurooncol Imaging 012, INF 280, Heidelberg, Germany	Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, INF 400, Heidelberg, Germany.	a.radbruch@dkfz.de	Radbruch, Alexander/ABA-6277-2021; Reichenbach, Jürgen R./B-4333-2011; Deistung, Andreas/AAN-9412-2021; Schweser, Ferdinand/Q-6932-2019; Wick, Wolfgang/AAA-2545-2020; Roethke, Matthias/D-5805-2015; Sahm, Felix/GQY-8202-2022; Nagel, Armin M/C-4671-2016	Reichenbach, Jürgen R./0000-0002-2640-0630; Schweser, Ferdinand/0000-0003-0399-9211; Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Nagel, Armin M/0000-0003-0948-1421; Roethke, Matthias/0000-0002-7723-4353; Radbruch, Alexander/0000-0001-6238-6525; Wiestler, Benedikt/0000-0002-2963-7772; Deistung, Andreas/0000-0002-2427-1302	Carl Zeiss Foundation; German Research Foundation (DFG) [RE 1123/9-2]	Carl Zeiss Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by a Carl Zeiss Foundation dissertation fellowship for Ferdinand Schweser and a research grant by the German Research Foundation (DFG, RE 1123/9-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAYOMI O, 1990, J NATL MED ASSOC, V82, P833; Anderson H C, 1980, Pathol Annu, V15, P45; Bahr O, 2011, NEURO-ONCOLOGY, V13, P1020, DOI 10.1093/neuonc/nor099; Blum EY, 1984, MAGNETOHYDRODYNAMICS, V19, P349; Deistung A, 2008, RADIOGRAPHICS, V28, P639, DOI 10.1148/rg.283075715; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; GRONEMEYER SA, 1992, J MAGN RESON IMAGING, V2, P271, DOI 10.1002/jmri.1880020304; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hammond KE, 2008, NEUROIMAGE, V39, P1682, DOI 10.1016/j.neuroimage.2007.10.037; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x; Kim HS, 2009, AM J NEURORADIOL, V30, P1574, DOI 10.3174/ajnr.A1635; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Li CT, 2010, EUR J RADIOL, V75, pE81, DOI 10.1016/j.ejrad.2009.08.003; Nakamura H, 2011, BRAIN TUMOR PATHOL, V28, P185, DOI 10.1007/s10014-011-0039-z; OOT RF, 1986, AM J NEURORADIOL, V7, P801; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Park SM, 2010, BRIT J RADIOL, V83, P466, DOI 10.1259/bjr/34304111; Peters S, 2012, ROFO-FORTSCHR RONTG, V184, P713, DOI 10.1055/s-0032-1312862; Pinker K, 2008, NEURORADIOLOGY, V50, P9, DOI 10.1007/s00234-007-0298-x; Radbruch A, 2012, EUR J RADIOL; Rauscher A, 2005, ROFO-FORTSCHR RONTG, V177, P1065, DOI 10.1055/s-2005-858428; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Reichenbach J R, 2011, P INT SOC MAG RESON, V19, P2553; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schweser F, 2011, IMPACT REGULARIZATIO, P2267; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Sedlacik J, 2008, NEUROIMAGE, V43, P36, DOI 10.1016/j.neuroimage.2008.07.008; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; The WHO, 2020, CLASSIFICATION TUMOU; Toh CH, 2012, AM J NEURORADIOL, V33, P1534, DOI 10.3174/ajnr.A2986; TSUCHIYA K, 1993, NEURORADIOLOGY, V35, P341, DOI 10.1007/BF00588364; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373; Ziener CH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031915; Ziener CH, 2005, MAGNET RESON MED, V54, P702, DOI 10.1002/mrm.20634	48	113	118	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e57924	10.1371/journal.pone.0057924	http://dx.doi.org/10.1371/journal.pone.0057924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555565	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400004
J	Djulbegovic, B; Kumar, A; Miladinovic, B; Reljic, T; Galeb, S; Mhaskar, A; Mhaskar, R; Hozo, I; Tu, DS; Stanton, HA; Booth, CM; Meyer, RM				Djulbegovic, Benjamin; Kumar, Ambuj; Miladinovic, Branko; Reljic, Tea; Galeb, Sanja; Mhaskar, Asmita; Mhaskar, Rahul; Hozo, Iztok; Tu, Dongsheng; Stanton, Heather A.; Booth, Christopher M.; Meyer, Ralph M.			Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials	PLOS ONE			English	Article							CLINICAL-TRIALS; SYSTEMATIC REVIEWS; DRUG TRIALS; HEALTH-CARE; EQUIPOISE; ONCOLOGY; BIAS; INTERVENTIONS; ASSOCIATION; UNCERTAINTY	Objective: To assess if commercially sponsored trials are associated with higher success rates than publicly-sponsored trials. Study Design and Settings: We undertook a systematic review of all consecutive, published and unpublished phase III cancer randomized controlled trials (RCTs) conducted by GlaxoSmithKline (GSK) and the NCIC Clinical Trials Group (CTG). We included all phase III cancer RCTs assessing treatment superiority from 1980 to 2010. Three metrics were assessed to determine treatment successes: (1) the proportion of statistically significant trials favouring the experimental treatment, (2) the proportion of the trials in which new treatments were considered superior according to the investigators, and (3) quantitative synthesis of data for primary outcomes as defined in each trial. Results: GSK conducted 40 cancer RCTs accruing 19,889 patients and CTG conducted 77 trials enrolling 33,260 patients. 42% (99% CI 24 to 60) of the results were statistically significant favouring experimental treatments in GSK compared to 25% (99% CI 13 to 37) in the CTG cohort (RR = 1.68; p = 0.04). Investigators concluded that new treatments were superior to standard treatments in 80% of GSK compared to 44% of CTG trials (RR = 1.81; p<0.001). Meta-analysis of the primary outcome indicated larger effects in GSK trials (odds ratio = 0.61 [99% CI 0.47-0.78] compared to 0.86 [0.74-1.00]; p = 0.003). However, testing for the effect of treatment over time indicated that treatment success has become comparable in the last decade. Conclusions: While overall industry sponsorship is associated with higher success rates than publicly-sponsored trials, the difference seems to have disappeared over time.	[Djulbegovic, Benjamin; Kumar, Ambuj; Miladinovic, Branko; Reljic, Tea; Mhaskar, Asmita; Mhaskar, Rahul] Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin; Kumar, Ambuj; Miladinovic, Branko; Reljic, Tea; Mhaskar, Asmita; Mhaskar, Rahul] Univ S Florida, Dept Internal Med, Div Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin; Kumar, Ambuj; Galeb, Sanja] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Djulbegovic, Benjamin; Kumar, Ambuj; Galeb, Sanja] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA; [Hozo, Iztok] Indiana Univ, Dept Math, Gary, IN USA; [Tu, Dongsheng; Stanton, Heather A.; Booth, Christopher M.; Meyer, Ralph M.] Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada; [Tu, Dongsheng; Booth, Christopher M.; Meyer, Ralph M.] Queens Univ, Dept Community Hlth, Kingston, ON, Canada; [Tu, Dongsheng; Booth, Christopher M.; Meyer, Ralph M.] Queens Univ, Dept Epidemiol, Kingston, ON, Canada; [Booth, Christopher M.; Meyer, Ralph M.] Queens Univ, Dept Oncol, Kingston, ON, Canada	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Indiana University System; Indiana University Northwest; Queens University - Canada; Canadian Cancer Trials Group; Queens University - Canada; Queens University - Canada; Queens University - Canada	Djulbegovic, B (corresponding author), Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012; Reljic, Tea/N-2758-2019; Reljic, Tea/I-7578-2013; Hozo, ihozo@iun.edu/R-3498-2016; Kumar, Ambuj/I-4940-2012; Miladinovic, Branko/I-4938-2012; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/U-5268-2019; Florida, University of South/GRT-0107-2022	Djulbegovic, Benjamin/0000-0003-0671-1447; Reljic, Tea/0000-0003-2029-6753; Reljic, Tea/0000-0003-2029-6753; Hozo, ihozo@iun.edu/0000-0003-2349-5707; Miladinovic, Branko/0000-0002-7000-1258; KUMAR, ASHOK/0000-0002-9244-0622; Florida, University of South/0000-0002-3728-6052	National Institutes of Health (NIH/NCI) [1R01CA140408-01/02]; NATIONAL CANCER INSTITUTE [R01CA140408] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant (NIH/NCI, 1R01CA140408-01/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Angell M., 2004, TRUTH DRUG CO; Antes G, 2003, LANCET, V361, P978, DOI 10.1016/S0140-6736(03)12838-3; Bercu B, 2002, WHAT LEVEL COLLECTIV; Booth CM, 2008, J CLIN ONCOL, V26, P5458, DOI 10.1200/JCO.2008.16.5456; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Dent L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-109; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 2002, BRIT MED J, V325, P1420, DOI 10.1136/bmj.325.7377.1420; Djulbegovic B, 2001, Curr Oncol Rep, V3, P389, DOI 10.1007/s11912-001-0024-5; Djulbegovic B, 2007, J MED PHILOS, V32, P79, DOI 10.1080/03605310701255719; Djulbegovic B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000024.pub3; Djulbegovic B, 2011, AM J MED SCI, V342, P282, DOI 10.1097/MAJ.0b013e318227e0b8; Djulbegovic B, 2009, CANCER CONTROL, V16, P342, DOI 10.1177/107327480901600409; Djulbegovic B, 2008, ARCH INTERN MED, V168, P632, DOI 10.1001/archinte.168.6.632; Dyer O, 2004, BMJ-BRIT MED J, V329, P590; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fries JF, 2004, ARTHRITIS RES THER, V6, pR250, DOI 10.1186/ar1170; GlaxoSmithKline, 2011, CLIN TRIAL REG; Hedges LV, 2010, RES SYNTH METHODS, V1, P39, DOI 10.1002/jrsm.5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; HILL AB, 1987, BRIT MED J, V294, P1419, DOI 10.1136/bmj.294.6584.1419; JOHNSON N, 1991, J MED ETHICS, V17, P30, DOI 10.1136/jme.17.1.30; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kassirer J. P., 2005, TAKE MED COMPLICITY; Kumar A, 2005, BMJ-BRIT MED J, V331, P1295, DOI 10.1136/bmj.38628.561123.7C; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Machin D, 1997, Clin Oncol (R Coll Radiol), V9, P100; Mann Howard, 2003, BMC Med Res Methodol, V3, P7, DOI 10.1186/1471-2288-3-7; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Meyer R, 2011, ONCOLOGY, P72; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Orloff J, 2009, NAT REV DRUG DISCOV, V8, P949, DOI 10.1038/nrd3025; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Scoggins JF, 2010, J NATL CANCER I, V102, P1371, DOI 10.1093/jnci/djq291; Soares HP, 2005, JAMA-J AM MED ASSOC, V293, P970, DOI 10.1001/jama.293.8.970; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	48	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58711	10.1371/journal.pone.0058711	http://dx.doi.org/10.1371/journal.pone.0058711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555593	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400010
J	Feuth, T; Arends, JE; Fransen, JH; Nanlohy, NM; van Erpecum, KJ; Siersema, PD; Hoepelman, AIM; van Baarle, D				Feuth, Thijs; Arends, Joop E.; Fransen, Justin H.; Nanlohy, Nening M.; van Erpecum, Karel J.; Siersema, Peter D.; Hoepelman, Andy I. M.; van Baarle, Debbie			Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; EXPRESSION; RESPONSES	Objectives: To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell characteristics in HIV/HCV coinfected patients and controls. Methods: 14 HIV/HCV coinfected, 19 HCV monoinfected, 10 HIV monoinfected patients and 15 healthy controls were included in this cross-sectional study. Differences in expression of activation and exhaustion markers (HLA-DR, CD38, PD-1, Tim-3 and Fas) and phenotypic markers on CD4(+) and CD8(+) T-cells were analysed by flow cytometry and were related to HCV disease parameters (HCV-viremia, ALT and liver fibrosis). Results: Frequencies of activated CD4(+) and CD8(+) T-cells were higher in HIV/HCV-coinfected compared to healthy controls and HCV or HIV mono-infected individuals. Coinfected patients also showed high expression of the exhaustion marker PD-1 and death receptor Fas. In contrast, the exhaustion marker Tim-3 was only elevated in HIV-monoinfected patients. T-cell activation and exhaustion were correlated with HCV-RNA, suggesting that viral antigen influences T-cell activation and exhaustion. Interestingly, increased percentages of effector CD8(+) T-cells were found in patients with severe (F3-F4) liver fibrosis compared to those with no to minimal fibrosis (F0-F2). Conclusions: HIV/HCV coinfected patients display a high level of T-cell activation and exhaustion in the peripheral blood. Our data suggest that T-cell activation and exhaustion are influenced by the level of HCV viremia. Furthermore, high percentages of cytotoxic/effector CD8(+) T-cells are associated with liver fibrosis in both HCV monoinfected and HIV/HCV coinfected patients.	[Feuth, Thijs; Arends, Joop E.; Fransen, Justin H.; Hoepelman, Andy I. M.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Fransen, Justin H.; Nanlohy, Nening M.; van Baarle, Debbie] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [van Erpecum, Karel J.; Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Baarle, D (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	dvanbaarle@umcutrecht.nl	Siersema, Peter/V-1636-2019; Feuth, Thijs/F-6264-2013	Feuth, Thijs/0000-0001-6691-556X				Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Ando K, 1997, J IMMUNOL, V158, P5283; Arends JE, 2011, APOPTOSIS, V16, P959, DOI 10.1007/s10495-011-0620-2; Arends JE, 2010, ANTIVIR RES, V87, P353, DOI 10.1016/j.antiviral.2010.06.002; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Capa L, 2007, J MED VIROL, V79, P503, DOI 10.1002/jmv.20856; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Deeks Steven G, 2009, Top HIV Med, V17, P118; Dianzani U, 2003, CURR HIV RES, V1, P405, DOI 10.2174/1570162033485131; Dutoit V, 2005, EUR J IMMUNOL, V35, P3493, DOI 10.1002/eji.200535035; Fowke KR, 2000, J IMMUNOL METHODS, V244, P139, DOI 10.1016/S0022-1759(00)00263-5; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Heydtmann M, 2006, J IMMUNOL, V177, P729, DOI 10.4049/jimmunol.177.1.729; Hiroishi K, 1997, HEPATOLOGY, V25, P705, DOI 10.1002/hep.510250336; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kang WZ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-102; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kaufmann GR, 2000, RAPID RESTORATION CD; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Klenerman P, 2012, GUT, V61, P1226, DOI 10.1136/gutjnl-2011-300620; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Mehal W, 2010, SEMIN LIVER DIS, V30, P226, DOI 10.1055/s-0030-1255352; MINUTELLO MA, 1993, J EXP MED, V178, P17, DOI 10.1084/jem.178.1.17; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Nunez M, 2006, CLIN INFECT DIS, V43, P1209, DOI 10.1086/508355; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Rallon NI, 2011, JAIDS-J ACQ IMM DEF, V57, P1, DOI 10.1097/QAI.0b013e31821024e7; Rockstroh JK, 2004, LANCET INFECT DIS, V4, P437, DOI 10.1016/S1473-3099(04)01059-X; Roe B, 2009, VIRAL IMMUNOL, V22, P39, DOI 10.1089/vim.2008.0074; Sandberg JK, 2010, VIRULENCE, V1, P177, DOI 10.4161/viru.1.3.11206; SHERMAN KE, 1993, J CLIN MICROBIOL, V31, P2679, DOI 10.1128/JCM.31.10.2679-2682.1993; Sosner P, 2012, ATHEROSCLEROSIS, V222, P274, DOI 10.1016/j.atherosclerosis.2012.02.027; Spengler U, 2007, CLIN SCI, V112, P141, DOI 10.1042/CS20060171; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004	48	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59302	10.1371/journal.pone.0059302	http://dx.doi.org/10.1371/journal.pone.0059302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555014	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800082
J	Lilja, AM; Rojdner, J; Mustafiz, T; Thome, CM; Storelli, E; Gonzalez, D; Unger-Lithner, C; Greig, NH; Nordberg, A; Marutle, A				Lilja, Anna M.; Rojdner, Jennie; Mustafiz, Tamanna; Thome, Carina M.; Storelli, Elisa; Gonzalez, Daniel; Unger-Lithner, Christina; Greig, Nigel H.; Nordberg, Agneta; Marutle, Amelia			Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-beta Levels	PLOS ONE			English	Article							NEURAL STEM-CELLS; TRANSGENIC MICE; A-BETA; HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC-FACTOR; PRECURSOR PROTEIN; MOUSE MODEL; DISEASE; INFLAMMATION; PEPTIDE	The objective of this study was to investigate the effects of modulating brain amyloid-beta (A beta) levels at different stages of amyloid pathology on synaptic function, inflammatory cell changes and hippocampal neurogenesis, i.e. processes perturbed in Alzheimer's disease (AD). Young (4- to 6-month-old) and older (15- to 18-month-old) APP(SWE) transgenic (Tg2576) mice were treated with the AD candidate drug (+)-phenserine for 16 consecutive days. We found significant reductions in insoluble A beta 1-42 levels in the cortices of both young and older transgenic mice, while significant reductions in soluble A beta 1-42 levels and insoluble A beta 1-40 levels were only found in animals aged 15-18 months. Autoradiography binding with the amyloid ligand Pittsburgh Compound B (H-3-PIB) revealed a trend for reduced fibrillar A beta deposition in the brains of older phenserine-treated Tg2576 mice. Phenserine treatment increased cortical synaptophysin levels in younger mice, while decreased interleukin-1 beta and increased monocyte chemoattractant protein-1 and tumor necrosis factor-alpha levels were detected in the cortices of older mice. The reduction in A beta 1-42 levels was associated with an increased number of bromodeoxyuridine-positive proliferating cells in the hippocampi of both young and older Tg2576 mice. To determine whether the increased cell proliferation was accompanied by increased neuronal production, the endogenous early neuronal marker doublecortin (DCX) was examined in the dentate gyrus (DG) using immunohistochemical detection. Although no changes in the total number of DCX+-expressing neurons were detected in the DG in Tg2576 mice at either age following (+)-phenserine treatment, dendritic arborization was increased in differentiating neurons in young Tg2576 mice. Collectively, these findings indicate that reducing A beta 1-42 levels in Tg2576 mice at an early pathological stage affects synaptic function by modulating the maturation and plasticity of newborn neurons in the brain. In contrast, lowering A beta levels in Tg2576 mice when Ab plaque pathology is prominent mainly alters the levels of proinflammatory cytokines and chemokines.	[Lilja, Anna M.; Rojdner, Jennie; Mustafiz, Tamanna; Thome, Carina M.; Storelli, Elisa; Gonzalez, Daniel; Unger-Lithner, Christina; Nordberg, Agneta; Marutle, Amelia] Karolinska Inst, Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Rojdner, Jennie; Nordberg, Agneta] Karolinska Univ, Huddinge Hosp, Dept Geriatr Med, Stockholm, Sweden; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Marutle, A (corresponding author), Karolinska Inst, Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	amelia.marutle@ki.se	nordberg, agneta/ABD-2479-2021	Unger Lithner, Christina/0000-0001-9775-0411; Storelli, Elisa/0000-0002-5515-4803; Gonzalez, Daniel/0000-0002-3919-1380; Nordberg, Agneta/0000-0001-7345-5151	Swedish Medical Research Council [05817]; Stockholm County Council-Karolinska Institutet; Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Power; Brain Foundation; European Union; Gun and Bertil Stohne's Foundation; Foundation for Old Servants; Magnus Bergvall's Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; Karolinska Institutet Foundations; Johnson & Johnson administered through the Karolinska Institutet; Alzheimer Association Sweden; Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID); Erik and Edith Fernstrom's Foundation; Intramural Research Program, National Institute on Aging, National Institutes of Health; Torrey pines Therapeutics; GSK; Wyeth; Novartis; Pfizer; GE Healthcare; Johnson Johnson; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council-Karolinska Institutet(Stockholm County Council); Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Power; Brain Foundation; European Union(European Commission); Gun and Bertil Stohne's Foundation; Foundation for Old Servants; Magnus Bergvall's Foundation; Dementia Association; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; Karolinska Institutet Foundations(Karolinska Institutet); Johnson & Johnson administered through the Karolinska Institutet; Alzheimer Association Sweden; Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID); Erik and Edith Fernstrom's Foundation; Intramural Research Program, National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Torrey pines Therapeutics; GSK(GlaxoSmithKline); Wyeth(Wyeth); Novartis(Novartis); Pfizer(Pfizer); GE Healthcare(General ElectricGE Healthcare); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Swedish Medical Research Council (Project no. 05817), the Stockholm County Council-Karolinska Institutet (ALF grant), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Power, the Brain Foundation, the INMiND consortium (Imaging of Neuroinflammation in Neurodegenerative Diseases) under the Seventh Research Framework Program of the European Union, Gun and Bertil Stohne's Foundation, the Foundation for Old Servants, Magnus Bergvall's Foundation, The Dementia Association, The Lars Hierta Memorial Foundation, the Olle Engkvist Byggmastare Foundation, Karolinska Institutet Foundations, an academic grant from Johnson & Johnson administered through the Karolinska Institutet, and the Alzheimer Association Sweden. AML was supported by a long-term scholarship from the Karolinska Institutet for Funding for new doctoral students at Karolinska Institutet (KID), a grant from Erik and Edith Fernstrom's Foundation, and a stipend from Gun and Bertil Stohne's Foundation. NHG was supported by the Intramural Research Program, National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agneta Nordberg is PI for clinical trials sponsored by Torrey pines Therapeutics, GSK, Wyeth, and has been a consultant for AstraZeneca, served on the advisory board for Elan, Pfizer, GSK, Novartis, Lundbeck AB, GE Health Care, and received honorarium for lectures from Novartis, Jansen-Cilag, Pfizer, Merck and received research grants from Novartis, Pfizer, GE Healthcare, Johnson & Johnson. The experimental Alzheimer drugs, (2)- phenserine and (+)phenserine, both derive from Nigel H. Greig's research and are covered in patents that have been assigned to the National Institutes of Health and Dr. Greig has no ownership of these patents. None of the other authors have any conflicts of interest and potential competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Biscaro B, 2009, J NEUROSCI, V29, P14108, DOI 10.1523/JNEUROSCI.2055-09.2009; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Burger C, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00140; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Combs CK, 2001, J NEUROSCI, V21, P1179; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; HATTORI A, 1993, J BIOL CHEM, V268, P2577; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Hellstrom-Lindahl E, 2004, EUR J NEUROSCI, V19, P2703, DOI 10.1111/j.1460-9568.2004.03377.x; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johnson AE, 2009, J NEUROCHEM, V108, P1177, DOI 10.1111/j.1471-4159.2008.05861.x; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Kuhn HG, 2007, EUR ARCH PSY CLIN N, V257, P281, DOI 10.1007/s00406-007-0732-4; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Lithner CU, 2011, CURR ALZHEIMER RES, V8, P818; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rockenstein E, 2011, J ALZHEIMERS DIS, V27, P743, DOI 10.3233/JAD-2011-110914; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	65	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58752	10.1371/journal.pone.0058752	http://dx.doi.org/10.1371/journal.pone.0058752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554921	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800027
J	Radziwon-Balicka, A; de la Rosa, CM; Zielnik, B; Doroszko, A; Jurasz, P				Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Zielnik, Barbara; Doroszko, Adrian; Jurasz, Paul			Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR; ANGIOGENESIS INHIBITOR; ALPHA-GRANULES; PROTEINS; PROSTACYCLIN; PLASMINOGEN; ACTIVATION; ENDOSTATIN; APOPTOSIS; VEGF	Platelets play an important role in thrombosis and in neo-vascularisation as they release and produce factors that both promote and suppress angiogenesis. Amongst these factors is the angiogenesis inhibitor angiostatin, which is released during thrombus formation. The impact of anti-thrombotic agents and the kinetics of platelet angiostatin release are unknown. Hence, our objectives were to characterize platelet angiostatin release temporally and pharmacologically and to determine how angiostatin release influences endothelial cell migration, an early stage of angiogenesis. We hypothesized anti-platelet agents would suppress angiostatin release but not generation by platelets. Human platelets were aggregated and temporal angiostatin release was compared to vascular endothelial growth factor (VEGF). Immuno-gold electron microscopy and immunofluorescence microscopy identified a-granules as storage organelles of platelet angiostatin. Acetylsalicylic acid, MRS2395, GPIIb/IIIa blocking peptide, and aprotinin were used to characterize platelet angiostatin release and generation. An endothelial cell migration assay was performed under hypoxic conditions to determine the effects of pharmacological platelet and angiostatin inhibition. Compared to VEGF, angiostatin generation and release from a-granules occurred later temporally during platelet aggregation. Consequently, collagen-activated platelet releasates stimulated endothelial cell migration more potently than maximally-aggregated platelets. Platelet inhibitors prostacyclin, S-nitroso-glutathione, acetylsalicylic acid, and GPIIb/IIIa blocking peptide, but not a P2Y12 inhibitor, suppressed angiostatin release but not generation. Suppression of angiostatin generation in the presence of acetylsalicylic acid enhanced platelet-stimulated endothelial migration. Hence, the temporal and pharmacological modulation of platelet angiostatin release may have significant consequences for neo-vascularization following thrombus formation.	[Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Zielnik, Barbara; Jurasz, Paul] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Jurasz, Paul] Univ Alberta, Dept Pharmacol, Fac Med & Dent, Edmonton, AB, Canada; [Radziwon-Balicka, Aneta; de la Rosa, Cesar Moncada; Jurasz, Paul] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Doroszko, Adrian] Wroclaw Med Univ, Dept Internal Med Occupat Dis & Hypertens, Wroclaw, Poland	University of Alberta; University of Alberta; University of Alberta; Wroclaw Medical University	Jurasz, P (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	Jurasz@ualberta.ca	Radziwon-Balicka, Aneta/AAA-3787-2021	Doroszko, Adrian/0000-0001-5472-028X; Radziwon-Balicka, Aneta/0000-0002-5123-5710	Heart and Stroke Foundation of Alberta; NWT; Nunavut; Canadian Institutes of Health Research [MOP-102948]; Alberta Cancer Foundation	Heart and Stroke Foundation of Alberta; NWT; Nunavut; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation	This work is supported by a grant-in aid from the Heart and Stroke Foundation of Alberta, NWT, and Nunavut and operating grant from the Canadian Institutes of Health Research [MOP-102948] to P.J. C. M. R. is supported by a studentship from the Alberta Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 1999, PLATELETS, V10, P285; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Falcone DJ, 1998, J BIOL CHEM, V273, P31480, DOI 10.1074/jbc.273.47.31480; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Folkman J, 2008, ANGIOGENESIS INTEGRA; Gately S, 1996, CANCER RES, V56, P4887; Griscelli F, 1998, P NATL ACAD SCI USA, V95, P6367, DOI 10.1073/pnas.95.11.6367; Hagberg IA, 1999, PLATELETS, V10, P382; Hanford HA, 2003, CANCER RES, V63, P4275; Howell N, 2012, J THOR IN PRESS 0810; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jurasz P, 2006, J THROMB HAEMOST, V4, P1095, DOI 10.1111/j.1538-7836.2006.01878.x; Jurasz P, 2011, ANGIOGENESIS, V14, P199, DOI 10.1007/s10456-011-9204-6; Jurasz P, 2010, THROMB RES, V125, P53, DOI 10.1016/j.thromres.2009.04.005; Kamykowski J, 2011, BLOOD, V118, P1370, DOI 10.1182/blood-2011-01-330910; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Ma L, 2001, P NATL ACAD SCI USA, V98, P6470, DOI 10.1073/pnas.111150798; MENTER DG, 1987, JNCI-J NATL CANCER I, V78, P961; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Radomski A, 2002, BRIT J PHARMACOL, V137, P1330, DOI 10.1038/sj.bjp.0704936; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x; Radziwon-Balicka A, 2012, VASC PHARM IN PRESS; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Sharma MR, 2004, J CELL BIOCHEM, V91, P398, DOI 10.1002/jcb.10762; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754; Zhang C, 2012, BLOOD IN PRESS  0724	32	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59281	10.1371/journal.pone.0059281	http://dx.doi.org/10.1371/journal.pone.0059281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555012	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800080
J	Abromaitis, S; Nelson, CS; Previte, D; Yoon, KS; Clark, JM; DeRisi, JL; Koehler, JE				Abromaitis, Stephanie; Nelson, Christopher S.; Previte, Domenic; Yoon, Kyong S.; Clark, J. Marshall; DeRisi, Joseph L.; Koehler, Jane E.			Bartonella quintana Deploys Host and Vector Temperature-Specific Transcriptomes	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; RICKETTSIA-QUINTANA; GENE-EXPRESSION; ESCHERICHIA-COLI; STATIONARY-PHASE; BODY LICE; VIRULENCE; SYSTEM; HENSELAE; FAMILY	The bacterial pathogen Bartonella quintana is passed between humans by body lice. B. quintana has adapted to both the human host and body louse vector niches, producing persistent infection with high titer bacterial loads in both the host (up to 10(5) colony-forming units [CFU]/ml) and vector (more than 10(8) CFU/ml). Using a novel custom microarray platform, we analyzed bacterial transcription at temperatures corresponding to the host (37 degrees C) and vector (28 degrees C), to probe for temperature-specific and growth phase-specific transcriptomes. We observed that transcription of 7% (93 genes) of the B. quintana genome is modified in response to change in growth phase, and that 5% (68 genes) of the genome is temperature-responsive. Among these transcriptional changes in response to temperature shift and growth phase was the induction of known B. quintana virulence genes and several previously unannotated genes. Hemin binding proteins, secretion systems, response regulators, and genes for invasion and cell attachment were prominent among the differentially-regulated B. quintana genes. This study represents the first analysis of global transcriptional responses by B. quintana. In addition, the in vivo experiments provide novel insight into the B. quintana transcriptional program within the body louse environment. These data and approaches will facilitate study of the adaptation mechanisms employed by Bartonella during the transition between human host and arthropod vector.	[Abromaitis, Stephanie; Koehler, Jane E.] Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA; [Abromaitis, Stephanie; Koehler, Jane E.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Nelson, Christopher S.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Nelson, Christopher S.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Previte, Domenic; Yoon, Kyong S.; Clark, J. Marshall] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [DeRisi, Joseph L.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Koehler, JE (corresponding author), Univ Calif San Francisco, Microbial Pathogenesis & Host Def Program, San Francisco, CA 94143 USA.	jkoehler@medicine.ucsf.edu		Nelson, Christopher/0000-0002-5608-2338; Yoon, Kyong/0000-0002-1866-1339	Grand Challenges Explorations Phase 1 grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; California HIV Research Program Award; National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID) [R01AI52813]; NIH [T32A1007641];  [1R56AI081933-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052813, R56AI081933] Funding Source: NIH RePORTER	Grand Challenges Explorations Phase 1 grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); California HIV Research Program Award; National Institutes of Health (NIH) from the National Institute of Allergy and Infectious Diseases (NIAID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JDR is a Howard Hughes Medical Institute Investigator (http://www.hhmi.org/research/investigators/).The work was funded in part by a Grand Challenges Explorations Phase 1 grant (http://www.grandchallenges.org/Explorations/Pages/Introduction.aspx) to JDR. JEK received funding support from a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (http://www.bwfund.org/pages/177/Clinical-Scientist-Awards-in-TranslationalResearch/), a California HIV Research Program Award (http://www.californiaaidsresearch.org/), and National Institutes of Health (NIH) grant R01AI52813 from the National Institute of Allergy and Infectious Diseases (NIAID). SA was supported by NIH grant T32A1007641. JMC, KSY and DP were supported by 1R56AI081933-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; CULPEPPER GH, 1946, J ECON ENTOMOL, V39, P472, DOI 10.1093/jee/39.4.472; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Eicher SC, 2012, CELL MICROBIOL, V14, P1166, DOI 10.1111/j.1462-5822.2012.01806.x; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Foucault C, 2002, CLIN INFECT DIS, V35, P684, DOI 10.1086/342065; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gillaspie D, 2009, APPL ENVIRON MICROB, V75, P5434, DOI 10.1128/AEM.00949-09; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Greub G, 2004, EMERG INFECT DIS, V2, P35; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; ITO S, 1965, J BACTERIOL, V89, P481, DOI 10.1002/path.1700890205; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lynch T, 2011, J CLIN MICROBIOL, V49, P1363, DOI 10.1128/JCM.02403-10; Maggi RG, 2005, J CLIN MICROBIOL, V43, P2651, DOI 10.1128/JCM.43.6.2651-2655.2005; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; MYERS WF, 1972, J BACTERIOL, V109, P89, DOI 10.1128/JB.109.1.89-95.1972; MYERS WF, 1969, J BACTERIOL, V97, P663, DOI 10.1128/JB.97.2.663-666.1969; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Quebatte M, 2010, J BACTERIOL, V192, P3352, DOI 10.1128/JB.01676-09; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Roden JA, 2012, INFECT IMMUN; Sander A, 2000, FEMS MICROBIOL LETT, V189, P55, DOI 10.1111/j.1574-6968.2000.tb09205.x; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Seki N, 2007, AM J TROP MED HYG, V77, P562, DOI 10.4269/ajtmh.2007.77.562; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; VINSON JW, 1969, AM J TROP MED HYG, V18, P713, DOI 10.4269/ajtmh.1969.18.713; WIGGLESWORTH V. B., 1941, PARASITOLOGY, V33, P67, DOI 10.1017/S0031182000024288; WU JH, 1993, J BIOL CHEM, V268, P52; Yoon KS, 2006, PESTIC BIOCHEM PHYS, V86, P195, DOI 10.1016/j.pestbp.2006.04.001; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0	51	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58773	10.1371/journal.pone.0058773	http://dx.doi.org/10.1371/journal.pone.0058773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554923	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500041
J	Monzen, S; Yoshino, H; Kasai-Eguchi, K; Kashiwakura, I				Monzen, Satoru; Yoshino, Hironori; Kasai-Eguchi, Kiyomi; Kashiwakura, Ikuo			Characteristics of Myeloid Differentiation and Maturation Pathway Derived from Human Hematopoietic Stem Cells Exposed to Different Linear Energy Transfer Radiation Types	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; IN-VITRO; MEGAKARYOCYTOPOIESIS; EXPRESSION; THROMBOPOIESIS; POPULATIONS; PROGENITOR; BASOPHILS; BIOLOGY; CD14	Exposure of hematopoietic stem/progenitor cells (HSPCs) to ionizing radiation causes a marked suppression of mature functional blood cell production in a linear energy transfer (LET)- and/or dose-dependent manner. However, little information about LET effects on the proliferation and differentiation of HSPCs has been reported. With the aim of characterizing the effects of different types of LET radiations on human myeloid hematopoiesis, in vitro hematopoiesis in Human CD34(+) cells exposed to carbon-ion beams or X-rays was compared. Highly purified CD34(+) cells exposed to each form of radiation were plated onto semi-solid culture for a myeloid progenitor assay. The surviving fractions of total myeloid progenitors, colony-forming cells (CFC), exposed to carbon-ion beams were significantly lower than of those exposed to Xrays, indicating that CFCs are more sensitive to carbon-ion beams (D-0 = 0.65) than to X-rays (D-0 = 1.07). Similar sensitivities were observed in granulocyte-macrophage and erythroid progenitors, respectively. However, the sensitivities of mixed-type progenitors to both radiation types were similar. In liquid culture for 14 days, no significant difference in total numbers of mononuclear cells was observed between non-irradiated control culture and cells exposed to 0.5 Gy X-rays, whereas 0.5 Gy carbon-ion beams suppressed cell proliferation to 4.9% of the control, a level similar to that for cells exposed to 1.5 Gy Xrays. Cell surface antigens associated with terminal maturation, such as CD13, CD14, and CD15, on harvest from the culture of X-ray-exposed cells were almost the same as those from the non-irradiated control culture. X-rays increased the CD235a(+) erythroid-related fraction, whereas carbon-ion beams increased the CD34(+)CD38(-) primitive cell fraction and the CD13(+)CD14(+/-)CD15(-) fraction. These results suggest that carbon-ion beams inflict severe damage on the clonal growth of myeloid HSPCs, although the intensity of cell surface antigen expression by mature myeloid cells derived from HSPCs exposed to each type of radiation was similar to that by controls.	[Monzen, Satoru; Yoshino, Hironori; Kashiwakura, Ikuo] Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan; [Kasai-Eguchi, Kiyomi] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiat Effect Mech Res Grp, Chiba 260, Japan	Hirosaki University; National Institutes for Quantum Science & Technology	Kashiwakura, I (corresponding author), Hirosaki Univ, Grad Sch Hlth Sci, Dept Radiol Life Sci, Hirosaki, Aomori, Japan.	ikashi@cc.hirosaki-u.ac.jp	monzen, satoru/F-1468-2013; Monzen, Satoru/AAF-9870-2021; Yoshino, Hironori/E-7961-2013; Kashiwakura, Ikuo/F-2080-2013	monzen, satoru/0000-0003-2436-8048; Monzen, Satoru/0000-0003-2436-8048; Yoshino, Hironori/0000-0003-2705-9929; 	Ministry of Education, Culture, Sports, Science and Technology, Japan [23791382, 21390336]; Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant for Hirosaki University Institutional Research, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant for Hirosaki University Institutional Research, Japan	This work was supported by KAKENHI, Grant-in-Aid for Young Scientists (B) (No. 23791382 SM), Grant-in-Aid for Scientific Research (B; No. 21390336 IK), and Grant for Co-medical Education Program in Radiation Emergency Medicine by the Ministry of Education, Culture, Sports, Science and Technology, Japan (2011). This work also received support from a Grant for Hirosaki University Institutional Research, Japan (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Edvardsson L, 2006, EXP HEMATOL, V34, P599, DOI 10.1016/j.exphem.2006.01.017; Gorczyca W, 2011, METHOD CELL BIOL, V103, P221, DOI 10.1016/B978-0-12-385493-3.00010-3; Goussetis E, 2000, J HEMATOTH STEM CELL, V9, P827, DOI 10.1089/152581600750062255; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Hirayama R, 2009, RADIAT RES, V171, P212, DOI 10.1667/RR1490.1; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kadhim MA, 1998, ADV SPACE RES, V22, P587, DOI 10.1016/S0273-1177(98)00081-7; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Krause DS, 1996, BLOOD, V87, P1; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Liu HC, 2007, J FORMOS MED ASSOC, V106, P365, DOI 10.1016/S0929-6646(09)60321-1; Monks TJ, 2006, DRUG METAB REV, V38, P755, DOI 10.1080/03602530600959649; Monzen S, 2011, RADIAT RES, V176, P716, DOI 10.1667/RR2725.1; Monzen S, 2011, RADIAT RES, V176, P8, DOI 10.1667/RR2392.1; Monzen S, 2009, J RADIAT RES, V50, P477, DOI 10.1269/jrr.09058; Nagayama H, 2002, BONE MARROW TRANSPL, V29, P197, DOI 10.1038/sj.bmt.1703356; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Reimer JM, 2006, ALLERGY, V61, P1063, DOI 10.1111/j.1398-9995.2006.01149.x; Ricceri F, 2011, DNA REPAIR, V10, P1044, DOI 10.1016/j.dnarep.2011.08.003; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; SIMMONS DL, 1989, BLOOD, V73, P284; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; SUTHERLAND DR, 1993, STEM CELLS, V11, P50, DOI 10.1002/stem.5530110914; Takahashi K, 2007, RADIAT RES, V168, P545, DOI 10.1667/rr1008.1; Takahashi K, 2010, RADIAT RES, V173, P184, DOI 10.1667/RR1839.1; Terato Hiroaki, 2004, Biol Sci Space, V18, P206, DOI 10.2187/bss.18.206; Tobias F, 2010, MUTAT RES-REV MUTAT, V704, P54, DOI 10.1016/j.mrrev.2009.11.004; Traore K, 2007, J CELL BIOCHEM, V100, P1010, DOI 10.1002/jcb.21101; USUKI Y, 1986, INT J CELL CLONING, V4, P447; Vandersickel V, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-30; Winnicka B, 2010, J LEUKOCYTE BIOL, V88, P347, DOI 10.1189/jlb.0210065	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59385	10.1371/journal.pone.0059385	http://dx.doi.org/10.1371/journal.pone.0059385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555027	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500088
J	Pincus, D; Ryan, CJ; Smith, RD; Brent, R; Resnekov, O				Pincus, David; Ryan, Christopher J.; Smith, Richard D.; Brent, Roger; Resnekov, Orna			Assigning Quantitative Function to Post-Translational Modifications Reveals Multiple Sites of Phosphorylation That Tune Yeast Pheromone Signaling Output	PLOS ONE			English	Article							MAP KINASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-PHOSPHORYLATION; INTRINSIC DISORDER; ADAPTER PROTEIN; GENE-EXPRESSION; PLASMA-MEMBRANE; TRANSDUCTION; SCAFFOLD; SWITCH	Cell signaling systems transmit information by post-translationally modifying signaling proteins, often via phosphorylation. While thousands of sites of phosphorylation have been identified in proteomic studies, the vast majority of sites have no known function. Assigning functional roles to the catalog of uncharacterized phosphorylation sites is a key research challenge. Here we present a general approach to address this challenge and apply it to a prototypical signaling pathway, the pheromone response pathway in Saccharomyces cerevisiae. The pheromone pathway includes a mitogen activated protein kinase (MAPK) cascade activated by a G-protein coupled receptor (GPCR). We used published mass spectrometry-based proteomics data to identify putative sites of phosphorylation on pheromone pathway components, and we used evolutionary conservation to assign priority to a list of candidate MAPK regulatory sites. We made targeted alterations in those sites, and measured the effects of the mutations on pheromone pathway output in single cells. Our work identified six new sites that quantitatively tuned system output. We developed simple computational models to find system architectures that recapitulated the quantitative phenotypes of the mutants. Our results identify a number of putative phosphorylation events that contribute to adjust the input-output relationship of this model eukaryotic signaling system. We believe this combined approach constitutes a general means not only to reveal modification sites required to turn a pathway on and off, but also those required for more subtle quantitative effects that tune pathway output. Our results suggest that relatively small quantitative influences from individual phosphorylation events endow signaling systems with plasticity that evolution may exploit to quantitatively tailor signaling outcomes.	[Pincus, David; Ryan, Christopher J.; Brent, Roger; Resnekov, Orna] Inst Mol Sci, Berkeley, CA 94704 USA; [Smith, Richard D.] Pacific NW Natl Lab, Richland, WA 99352 USA	The Molecular Sciences Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Resnekov, O (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.	resnekov@molsci.org	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	National Human Genome Research Institute [P50 HG002370]; National Institute of General Medical Sciences [8P41 GM103493-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493, R01GM097479] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by grant number P50 HG002370 (PI, R. Brent) from National Human Genome Research Institute. R. D. Smith acknowledges additional funding from grant number 8P41 GM103493-10 (PI, R. D. Smith) from National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chernomoretz A., 2008, CURR PROTOC MOL BIOL; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Heiman MG, 2000, J CELL BIOL, V151, P719, DOI 10.1083/jcb.151.3.719; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Houser JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.18; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; Nagiec MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002437; NEIMAN AM, 1994, P NATL ACAD SCI USA, V91, P3398, DOI 10.1073/pnas.91.8.3398; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pincus D, 2010, YEAST, V27, P423, DOI 10.1002/yea.1758; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Sneddon MW, 2011, NAT METHODS, V8, P177, DOI [10.1038/nmeth.1546, 10.1038/NMETH.1546]; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Stroud RM, 1991, CURR OPIN STRUC BIOL, V1, P826, DOI 10.1016/0959-440X(91)90186-W; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910	54	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e56544	10.1371/journal.pone.0056544	http://dx.doi.org/10.1371/journal.pone.0056544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554854	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500002
J	Berthold, HK; Seidah, NG; Benjannet, S; Gouni-Berthold, I				Berthold, Heiner K.; Seidah, Nabil G.; Benjannet, Suzanne; Gouni-Berthold, Ioanna			Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; REDUCTASE GENE-EXPRESSION; COENZYME-A REDUCTASE; MONONUCLEAR-CELLS; HEALTHY-MEN; PRIMARY HYPERCHOLESTEROLEMIA; CHOLESTEROL-METABOLISM; AND/OR SIMVASTATIN; LDL CHOLESTEROL; ATORVASTATIN	Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted inhibitor of the low-density lipoprotein (LDL) receptor and an important regulator of LDL metabolism. Elevated PCSK9 levels have been associated with cardiovascular risk. The purpose of this study was to investigate how ezetimibe and simvastatin, alone and in combination, affect PCSK9 circulating concentrations. Methods: A single center, randomized, open-label parallel 3-group study in healthy men (mean age 32 +/- 9 years, body mass index 25.7 +/- 3.2 kg/m(2)) was performed. Each group of 24 subjects was treated for 14 days with either simvastatin 40 mg/d, ezetimibe 10 mg/d, or with both drugs. Multivariate analysis was used to investigate parameters influencing the change in PCSK9 concentrations under treatment. Results:The baseline plasma PCSK9 concentrations in the total cohort were 52 +/- 20 ng/mL with no statistically significant differences between the groups. They were increased by 68 +/- 85% by simvastatin (P = 0.0014), by 10 +/- 38% by ezetimibe (P = 0.51) and by 67 +/- 91% by simvastatin plus ezetimibe (P = 0.0013). The increase in PCSK9 was inversely correlated with baseline PCSK9 concentrations (Spearman's R=-0.47, P<0.0001) and with the percent change in LDL cholesterol concentrations (Spearman's R = -0.30, P<0.01). In multivariate analyses, only baseline PCSK9 concentrations (beta = -1.68, t = -4.04, P<0.0001), percent change in LDL cholesterol from baseline (beta = 1.94, t = 2.52, P=0.014), and treatment with simvastatin (P=0.016), but not ezetimibe (P = 0.42), significantly influenced changes in PCSK9 levels. Parameters without effect on PCSK9 concentration changes were age, body mass index, body composition, thyroid function, kidney function, glucose metabolism parameters, adipokines, markers of cholesterol synthesis and absorption, and molecular markers of cholesterol metabolism. Conclusions: Ezetimibe does not increase circulating PCSK9 concentrations while simvastatin does. When added to simvastatin, ezetimibe does not cause an incremental increase in PCSK9 concentrations. Changes in PCSK9 concentrations are tightly regulated and mainly influenced by baseline PCSK9 levels and changes in LDL cholesterol.	[Berthold, Heiner K.] Charite, Evangel Geriatr Ctr Berlin EGZB, D-13353 Berlin, Germany; [Berthold, Heiner K.] Charite, Virchow Clin Campus, Lipid Clin, Interdisciplinary Metab Ctr, D-13353 Berlin, Germany; [Seidah, Nabil G.; Benjannet, Suzanne] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Cologne	Berthold, HK (corresponding author), Charite, Evangel Geriatr Ctr Berlin EGZB, D-13353 Berlin, Germany.	heiner.berthold@charite.de	Seidah, Nabil/I-3596-2013; Berthold, Heiner/E-6017-2011	Seidah, Nabil/0000-0001-6503-9342; Berthold, Heiner/0000-0002-1457-2216	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany); CIHR [MOP-102741, CTP 82946]; Canada Chair [216684]	MSD Sharp & Dohme (Munich, Germany); Wilhelm-Doerenkamp Foundation (Cologne, Germany); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Chair	The parent trial was supported by an investigator-initiated grant from MSD Sharp & Dohme (Munich, Germany) and the Wilhelm-Doerenkamp Foundation (Cologne, Germany). This work was also supported (to NGS) by CIHR grants MOP-102741 and CTP 82946, and a Canada Chair 216684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal D, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-22; Awan Z, 2012, CLIN CHEM, V58, P183, DOI 10.1373/clinchem.2011.172932; Bays HE, 2001, CLIN THER, V23, P1209, DOI 10.1016/S0149-2918(01)80102-8; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Davignon Jean, 2009, Trans Am Clin Climatol Assoc, V120, P163; de Mello VDF, 2012, MOL NUTR FOOD RES, V56, P1160, DOI 10.1002/mnfr.201100685; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Gouni-Berthold I, 2008, CLIN ENDOCRINOL, V68, P536, DOI 10.1111/j.1365-2265.2007.03080.x; Gouni-Berthold I, 2008, ATHEROSCLEROSIS, V198, P198, DOI 10.1016/j.atherosclerosis.2007.09.034; Han L, 2012, PHARMACOLOGY, V89, P74, DOI 10.1159/000335783; Huijgen R, 2012, J AM COLL CARDIOL, V59, P1778, DOI 10.1016/j.jacc.2011.12.043; Jones JL, 2011, NUTR RES, V31, P659, DOI 10.1016/j.nutres.2011.08.011; Knapp HH, 2001, AM J MED, V110, P352, DOI 10.1016/S0002-9343(01)00638-6; Konrad RJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-38; Lakoski SG, 2010, J CLIN ENDOCR METAB, V95, P800, DOI 10.1210/jc.2009-1952; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Monte A. A., 2012, J PHARMACOGENOMICS P, VS5; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Pocathikorn A, 2010, CLIN EXP PHARMACOL P, V37, P471, DOI 10.1111/j.1440-1681.2009.05337.x; POWELL EE, 1994, J CLIN INVEST, V93, P2168, DOI 10.1172/JCI117213; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144	32	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60095	10.1371/journal.pone.0060095	http://dx.doi.org/10.1371/journal.pone.0060095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544125	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700084
J	Park, SO; Wamsley, HL; Bae, K; Hu, ZB; Li, XM; Choe, SW; Slayton, WB; Oh, SP; Wagner, KU; Sayeski, PP				Park, Sung O.; Wamsley, Heather L.; Bae, Kyungmi; Hu, Zhongbo; Li, Xiaomiao; Choe, Se-woon; Slayton, William B.; Oh, S. Paul; Wagner, Kay-Uwe; Sayeski, Peter P.			Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; MUTATION; MYELOFIBROSIS; MICE; RUXOLITINIB; DISORDERS; RECEPTOR; IDENTIFICATION	Germline deletion of Jak2 in mice results in embryonic lethality at E12.5 due to impaired hematopoiesis. However, the role that Jak2 might play in late gestation and postnatal life is unknown. To understand this, we utilized a conditional knockout approach that allowed for the deletion of Jak2 at various stages of prenatal and postnatal life. Specifically, Jak2 was deleted beginning at either mid/late gestation (E12.5), at postnatal day 4 (PN4), or at similar to 2 months of age. Deletion of Jak2 beginning at E12.5 resulted in embryonic death characterized by a lack of hematopoiesis. Deletion beginning at PN4 was also lethal due to a lack of erythropoiesis. Deletion of Jak2 in young adults was characterized by blood cytopenias, abnormal erythrocyte morphology, decreased marrow hematopoietic potential, and splenic atrophy. However, death was observed in only 20% of the mutants. Further analysis of these mice suggested that the increased survivability was due to an incomplete deletion of Jak2 and subsequent re-population of Jak2 expressing cells, as conditional deletion in mice having one floxed Jak2 allele and one null allele resulted in a more severe phenotype and subsequent death of all animals. We found that the deletion of Jak2 in the young adults had a differential effect on hematopoietic lineages; specifically, conditional Jak2 deletion in young adults severely impaired erythropoiesis and thrombopoiesis, modestly affected granulopoiesis and monocytopoiesis, and had no effect on lymphopoiesis. Interestingly, while the hematopoietic organs of these mutant animals were severely affected by the deletion of Jak2, we found that the hearts, kidneys, lungs, and brains of these same mice were histologically normal. From this, we conclude that Jak2 plays an essential and non-redundant role in hematopoiesis during both prenatal and postnatal life and this has direct implications regarding the inhibition of Jak2 in humans.	[Park, Sung O.; Choe, Se-woon; Oh, S. Paul; Sayeski, Peter P.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; [Wamsley, Heather L.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Bae, Kyungmi] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA; [Hu, Zhongbo; Li, Xiaomiao; Slayton, William B.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sayeski, PP (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA.	psayeski@ufl.edu	Hu, Zhongbo/ABB-8527-2020	Hu, Zhongbo/0000-0002-8935-0626; Wagner, Kay-Uwe/0000-0002-5081-0226; Choe, Se-woon/0000-0002-7298-4147	NIH [R01-HL67277-09, R01-CA117930]; NATIONAL CANCER INSTITUTE [R01CA117930] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH awards R01-HL67277-09 (PPS) and R01-CA117930 (KUW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; Frenzel K, 2006, EXP CELL RES, V312, P2735, DOI 10.1016/j.yexcr.2006.05.004; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; HARPUR AG, 1992, ONCOGENE, V7, P1347; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Huang H, 2012, NAT NEUROSCI, V15, P1391, DOI 10.1038/nn.3207; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Khwaja A, 2006, BRIT J HAEMATOL, V134, P366, DOI 10.1111/j.1365-2141.2006.06206.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li XM, 2010, EXP HEMATOL, V38, P1251, DOI 10.1016/j.exphem.2010.08.005; Mascarenhas J, 2012, CLIN CANCER RES, V18, P3008, DOI 10.1158/1078-0432.CCR-11-3145; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; Neria F, 2009, KIDNEY INT, V75, P227, DOI 10.1038/ki.2008.487; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Sandberg EM, 2004, CELL BIOCHEM BIOPHYS, V41, P207, DOI 10.1385/CBB:41:2:207; Sharma Y, 2007, EXP HEMATOL, V35, P214, DOI 10.1016/j.exphem.2006.10.001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tefferi A, 2011, BLOOD REV, V25, P229, DOI 10.1016/j.blre.2011.06.002; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Tefferi A, 2012, NEW ENGL J MED, V366, P844, DOI 10.1056/NEJMe1115119; Tefferi A, 2011, MAYO CLIN PROC, V86, P1188, DOI 10.4065/mcp.2011.0518; Tefferi A, 2011, NEW ENGL J MED, V365, P1455, DOI 10.1056/NEJMc1109555; TSYGANKOV AY, 1993, STEM CELLS, V11, P371, DOI 10.1002/stem.5530110504; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Xiao WB, 2008, J CLIN INVEST, V118, P924, DOI 10.1172/JCI34013; Yoon SY, 2001, HAEMATOLOGICA, V86, P52; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	38	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59675	10.1371/journal.pone.0059675	http://dx.doi.org/10.1371/journal.pone.0059675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544085	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700045
J	Tan, SY; Lu, L; Li, L; Liu, JX; Oksov, Y; Lu, H; Jiang, SB; Liu, SW				Tan, Suiyi; Lu, Lu; Li, Lin; Liu, Jixiang; Oksov, Yelena; Lu, Hong; Jiang, Shibo; Liu, Shuwen			Polyanionic Candidate Microbicides Accelerate the Formation of Semen-Derived Amyloid Fibrils to Enhance HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLY(SODIUM 4-STYRENE SULFONATE); CELLULOSE SULFATE; POLYSTYRENE SULFONATE; VAGINAL MICROBICIDES; RECTAL MICROBICIDES; SEMINAL PLASMA; DOUBLE-BLIND; IN-VITRO; PREVENTION	Polyanionic candidate microbicides, including cellulose sulfate, carrageenan, PRO 2000, were proven ineffective in preventing HIV-1 transmission and even cellulose sulfate showed increased risk of HIV acquisition in the Phase III efficacy trials. Semen plays critical roles in HIV-1 sexual transmission. Specifically, amyloid fibrils formed by fragments of prostatic acidic phosphatase (PAP) in semen termed semen-derived enhancer of virus infection (SEVI) could drastically enhance HIV-1 infection. Here we investigated the interaction between polyanions and PAP248-286, a prototype peptide of SEVI, to understand the possible cause of polyanionic candidate microbicides to fail in clinical trials. We found anionic polymers could efficiently promote SEVI fibril formation, most likely mediated by the natural electrostatic interaction between polyanions and PAP248-286, as revealed by acid native PAGE and Western blot The overall anti-HIV-1 activity of polyanions in the presence or absence of PAP248-286 or semen was evaluated. In the viral infection assay, the supernatants of polyanions/PAP248-286 or polyanions/semen mixtures containing the free, unbound polyanionic molecules showed a general reduction in antiviral efficacy, while the pellets containing amyloid fibrils formed by the polyanion-bound PAP248-286 showed aggravated enhancement of viral infection. Collectively, from the point of drug-host protein interaction, our study revealed that polyanions facilitate SEVI fibril formation to promote HIV-1 infection, thus highlighting a molecular mechanism underlying the failure of polyanions in clinical trials and the importance of drug-semen interaction in evaluating the anti-HIV-1 efficacy of candidate microbicides.	[Tan, Suiyi; Li, Lin; Jiang, Shibo; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Tan, Suiyi; Lu, Lu; Liu, Jixiang; Oksov, Yelena; Lu, Hong; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Southern Medical University - China; Fudan University; Fudan University; Fudan University; New York Blood Center	Jiang, SB (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	shibojiang@fudan.edu.cn; liusw@smu.edu.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Jiang, Shibo/L-4500-2014; lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; lu, lu/HGA-0894-2022; LI, LI/GVS-5344-2022	Jiang, Shibo/0000-0001-8283-7135; Lu, Lu/0000-0002-2255-0391; Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [81102482, U0832001]; Natural Science Foundation of Guangdong Province [S2011020005207]; National 973 Program [2012CB519001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National 973 Program(National Basic Research Program of China)	This study was supported by grants from the Natural Science Foundation of China (81102482 to S.T. and U0832001 to S.L.), the Natural Science Foundation of Guangdong Province (S2011020005207) to S.L. and the National 973 Program (2012CB519001) to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belec L, 2011, FUTURE MICROBIOL, V6, P731, DOI [10.2217/FMB.11.64, 10.2217/fmb.11.64]; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Bourne N, 1999, J INFECT DIS, V180, P203, DOI 10.1086/314853; Bourne N, 2003, CLIN MICROBIOL INFEC, V9, P816, DOI 10.1046/j.1469-0691.2003.00659.x; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Christensen ND, 2001, ANTIMICROB AGENTS CH, V45, P3427, DOI 10.1128/AAC.45.12.3427-3432.2001; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Herold BC, 2000, J INFECT DIS, V181, P770, DOI 10.1086/315228; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2010, FUTURE MICROBIOL, V5, P527, DOI [10.2217/fmb.10.29, 10.2217/FMB.10.29]; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; Lacey CJ, 2010, INT J STD AIDS, V21, P714, DOI 10.1258/ijsa.2010.010215; Li L, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-37; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; Martellini JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016285; Martellini JA, 2009, FASEB J, V23, P3609, DOI 10.1096/fj.09-131961; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; McGowan I, 2008, SEX TRANSM INFECT, V84, P413, DOI 10.1136/sti.2008.031328; McGowan I, 2008, CURR OPIN HIV AIDS, V3, P593, DOI 10.1097/COH.0b013e32830891cf; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Monsellier E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011363; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Simoes JA, 2002, ANTIMICROB AGENTS CH, V46, P2692, DOI 10.1128/AAC.46.8.2692-2695.2002; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wood H, 2011, PRACTITIONER, V255, P3; Wood Hayley, 2011, Practitioner, V255, P25	51	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59777	10.1371/journal.pone.0059777	http://dx.doi.org/10.1371/journal.pone.0059777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544097	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700057
J	Turner, RM; Bird, SM; Higgins, JPT				Turner, Rebecca M.; Bird, Sheila M.; Higgins, Julian P. T.			The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; SEQUENTIAL-ANALYSIS; SYSTEMATIC-REVIEWS; STATISTICAL TESTS; CLINICAL-TRIALS; POWER; BIAS	Background: Most meta-analyses include data from one or more small studies that, individually, do not have power to detect an intervention effect. The relative influence of adequately powered and underpowered studies in published meta-analyses has not previously been explored. We examine the distribution of power available in studies within meta-analyses published in Cochrane reviews, and investigate the impact of underpowered studies on meta-analysis results. Methods and Findings: For 14,886 meta-analyses of binary outcomes from 1,991 Cochrane reviews, we calculated power per study within each meta-analysis. We defined adequate power as >= 50% power to detect a 30% relative risk reduction. In a subset of 1,107 meta-analyses including 5 or more studies with at least two adequately powered and at least one underpowered, results were compared with and without underpowered studies. In 10,492 (70%) of 14,886 meta-analyses, all included studies were underpowered; only 2,588 (17%) included at least two adequately powered studies. 34% of the meta-analyses themselves were adequately powered. The median of summary relative risks was 0.75 across all meta-analyses (inter-quartile range 0.55 to 0.89). In the subset examined, odds ratios in underpowered studies were 15% lower (95% CI 11% to 18%, P<0.0001) than in adequately powered studies, in meta-analyses of controlled pharmacological trials; and 12% lower (95% CI 7% to 17%, P<0.0001) in meta-analyses of controlled non-pharmacological trials. The standard error of the intervention effect increased by a median of 11% (inter-quartile range -1% to 35%) when underpowered studies were omitted; and between-study heterogeneity tended to decrease. Conclusions: When at least two adequately powered studies are available in meta-analyses reported by Cochrane reviews, underpowered studies often contribute little information, and could be left out if a rapid review of the evidence is required. However, underpowered studies made up the entirety of the evidence in most Cochrane reviews.	[Turner, Rebecca M.; Bird, Sheila M.] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Higgins, Julian P. T.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	MRC Biostatistics Unit; University of Cambridge; University of Bristol; University of York - UK	Turner, RM (corresponding author), Inst Publ Hlth, MRC Biostat Unit, Cambridge, England.	rebecca.turner@mrc-bsu.cam.ac.uk	Higgins, Julian PT/H-4008-2011	Higgins, Julian PT/0000-0002-8323-2514	Medical Research Council [U105285807, U105260794]; MRC [MC_U105260794, MC_U105260558, MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105260558, MC_U105260794, MC_U105285807, UD99999927] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council grants U105285807 and U105260794. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P711, DOI 10.1016/j.jclinepi.2008.09.013; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Guyatt GH, 2008, PLOS MED, V5, P3, DOI 10.1371/journal.pmed.0050004; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kraemer HC, 1998, PSYCHOL METHODS, V3, P23, DOI 10.1037/1082-989X.3.1.23; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Rucker G, 2011, BIOMETRICAL J, V53, P351, DOI 10.1002/bimj.201000151; Shrier I, 2007, CONTEMP CLIN TRIALS, V28, P324, DOI 10.1016/j.cct.2006.11.007; Stanley TD, 2010, AM STAT, V64, P70, DOI 10.1198/tast.2009.08205; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013	25	370	370	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59202	10.1371/journal.pone.0059202	http://dx.doi.org/10.1371/journal.pone.0059202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544056	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700018
J	Bowen, CV; DeBay, D; Ewart, HS; Gallant, P; Gormley, S; Ilenchuk, TT; Iqbal, U; Lutes, T; Martina, M; Mealing, G; Merkley, N; Sperker, S; Moreno, MJ; Rice, C; Syvitski, RT; Stewart, JM				Bowen, Chris V.; DeBay, Drew; Ewart, H. Stephen; Gallant, Pamela; Gormley, Sean; Ilenchuk, T. Toney; Iqbal, Umar; Lutes, Tyler; Martina, Marzia; Mealing, Geoffrey; Merkley, Nadine; Sperker, Sandra; Moreno, Maria J.; Rice, Christopher; Syvitski, Raymond T.; Stewart, John M.			In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin	PLOS ONE			English	Article							CALCIUM-CHANNEL TRPV6; PROSTATE-CANCER; CA2+ CHANNEL; ION-CHANNEL; EXPRESSION; RECEPTOR; GROWTH; MEMBRANE; CAT1; IRON	Soricidin is a 54-amino acid peptide found in the paralytic venom of the northern short-tailed shrew (Blarina brevicauda) and has been found to inhibit the transient receptor potential of vallinoid type 6 (TRPV6) calcium channels. We report that two shorter peptides, SOR-C13 and SOR-C27, derived from the C-terminus of soricidin, are high-affinity antagonists of human TRPV6 channels that are up-regulated in a number of cancers. Herein, we report molecular imaging methods that demonstrate the in vivo diagnostic potential of SOR-C13 and SOR-C27 to target tumor sites in mice bearing ovarian or prostate tumors. Our results suggest that these novel peptides may provide an avenue to deliver diagnostic and therapeutic reagents directly to TRPV6-rich tumors and, as such, have potential applications for a range of carcinomas including ovarian, breast, thyroid, prostate and colon, as well as certain leukemia's and lymphomas.	[Bowen, Chris V.; DeBay, Drew] Natl Res Council Canada, Inst Biodiagnost Atlantic, Neuroimaging Res Lab, Halifax, NS, Canada; [Ewart, H. Stephen; Gallant, Pamela; Merkley, Nadine; Sperker, Sandra; Syvitski, Raymond T.] Natl Res Council Canada, Inst Marine Biosci, Halifax, NS, Canada; [Gormley, Sean; Ilenchuk, T. Toney; Lutes, Tyler; Rice, Christopher; Stewart, John M.] Soricimed Biopharma Inc, Sackville, NB, Canada; [Iqbal, Umar; Martina, Marzia; Mealing, Geoffrey; Moreno, Maria J.] Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Ottawa, ON K1A 0R6, Canada	International Business Machines (IBM); National Research Council Canada; International Business Machines (IBM); National Research Council Canada; National Research Council Canada	Stewart, JM (corresponding author), Soricimed Biopharma Inc, Sackville, NB, Canada.	jstewart@soricimed.com		Stewart, John/0000-0003-3116-4174	National Research Council Industrial Research Assistance Program (IRAP); Atlantic Canada Opportunities Agency (ACOA)	National Research Council Industrial Research Assistance Program (IRAP); Atlantic Canada Opportunities Agency (ACOA)	This work was supported by the National Research Council Industrial Research Assistance Program (IRAP) program (http://www. nrc-cnrc. gc. ca/eng/ irap/index. html) and Atlantic Canada Opportunities Agency (ACOA) (http://www. acoa-apeca. gc. ca/eng/Pages/Home. aspx) of the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ansary D, 2010, FASEB J, V24, P425, DOI 10.1096/fj.09-141481; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Bodding M, 2007, CELL SIGNAL, V19, P617, DOI 10.1016/j.cellsig.2006.08.012; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Clinchy B, 2000, BREAST CANCER RES TR, V61, P217, DOI 10.1023/A:1006494001861; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Howlader N, 2012, SEER CANC STAT REV 1; KIM DG, 1992, MOL CELL BIOL, V12, P3636, DOI 10.1128/MCB.12.8.3636; Kovacs G, 2012, CELL CALCIUM, V52, P468, DOI 10.1016/j.ceca.2012.08.005; Landowski CP, 2011, PHARM RES-DORDR, V28, P322, DOI 10.1007/s11095-010-0249-9; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Mani V, 2006, MAGN RESON MED, V55, P126, DOI 10.1002/mrm.20739; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Nijenhuis T, 2003, PFLUG ARCH EUR J PHY, V446, P401, DOI 10.1007/s00424-003-1038-7; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Rossing MA, 2010, J NATL CANCER I, V102, P222, DOI 10.1093/jnci/djp500; Santoni G, 2011, ADV EXP MED BIOL, V704, P947, DOI 10.1007/978-94-007-0265-3_49; Schwarz EC, 2006, CELL CALCIUM, V39, P163, DOI 10.1016/j.ceca.2005.10.006; Semenova SB, 2009, AM J PHYSIOL-CELL PH, V296, pC1098, DOI 10.1152/ajpcell.00435.2008; Stewart JM, 2006, USPTO. Pat, Patent No. [7,119,168, 7119168]; Stewart JM, 2011, USPTO. Appl, Patent No. [12/886397, 12886397]; Stuber M, 2007, MAGN RESON MED, V58, P1072, DOI 10.1002/mrm.21399; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Zheng DH, 2010, ONCOL REP, V23, P717, DOI 10.3892/or_00000689; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	40	66	70	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58866	10.1371/journal.pone.0058866	http://dx.doi.org/10.1371/journal.pone.0058866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554944	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800040
J	Dumas, P; Jimenez, H; Peignon, C; Wantiez, L; Adjeroud, M				Dumas, Pascal; Jimenez, Haizea; Peignon, Christophe; Wantiez, Laurent; Adjeroud, Mehdi			Small-Scale Habitat Structure Modulates the Effects of No-Take Marine Reserves for Coral Reef Macroinvertebrates	PLOS ONE			English	Article							SPATIAL-PATTERNS; FISH COMMUNITIES; PROTECTED AREAS; NEW-CALEDONIA; FISHERIES; SUSTAINABILITY; BIODIVERSITY; ASSEMBLAGES; RECRUITMENT; SURROGATES	No-take marine reserves are one of the oldest and most versatile tools used across the Pacific for the conservation of reef resources, in particular for invertebrates traditionally targeted by local fishers. Assessing their actual efficiency is still a challenge in complex ecosystems such as coral reefs, where reserve effects are likely to be obscured by high levels of environmental variability. The goal of this study was to investigate the potential interference of small-scale habitat structure on the efficiency of reserves. The spatial distribution of widely harvested macroinvertebrates was surveyed in a large set of protected vs. unprotected stations from eleven reefs located in New Caledonia. Abundance, density and individual size data were collected along random, small-scale (20 x 1 m) transects. Fine habitat typology was derived with a quantitative photographic method using 17 local habitat variables. Marine reserves substantially augmented the local density, size structure and biomass of the target species. Density of Trochus niloticus and Tridacna maxima doubled globally inside the reserve network; average size was greater by 10 to 20% for T. niloticus. We demonstrated that the apparent success of protection could be obscured by marked variations in population structure occurring over short distances, resulting from small-scale heterogeneity in the reef habitat. The efficiency of reserves appeared to be modulated by the availability of suitable habitats at the decimetric scale ("microhabitats") for the considered sessile/low-mobile macroinvertebrate species. Incorporating microhabitat distribution could significantly enhance the efficiency of habitat surrogacy, a valuable approach in the case of conservation targets focusing on endangered or emblematic macroinvertebrate or relatively sedentary fish species	[Dumas, Pascal] IRD, UR CoReUs 2 227, Fisheries Dept Vanuatu, Port Vila, Vanuatu; [Jimenez, Haizea; Peignon, Christophe; Adjeroud, Mehdi] IRD, UR CoReUs 2 227, Noumea, New Caledonia; [Jimenez, Haizea] Smithsonian Environm Res Ctr, Marine Invas Res Lab, Tiburon, CA USA; [Wantiez, Laurent] Univ Nouvelle Caledonie, LIVE, Noumea, New Caledonia	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Smithsonian Institution; Smithsonian Environmental Research Center; Universite Nouvelle Caledonie	Dumas, P (corresponding author), IRD, UR CoReUs 2 227, Fisheries Dept Vanuatu, Port Vila, Vanuatu.	pascal-paul.dumas@ird.fr	Adjeroud, Mehdi/J-6411-2016; Wantiez, Laurent/L-3343-2013	Adjeroud, Mehdi/0000-0002-6825-8759; Wantiez, Laurent/0000-0001-5024-2057; Dumas, Pascal/0000-0001-7369-8989	french PAMPA-LITEAU III programme; IRD (Institut de Recherche pour le developpement)	french PAMPA-LITEAU III programme; IRD (Institut de Recherche pour le developpement)	This study was funded by french PAMPA-LITEAU III programme (http://www.ifremer.fr/pampa) and IRD (Institut de Recherche pour le developpement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrefouet S, 2010, MAR POLLUT BULL, V61, P612, DOI 10.1016/j.marpolbul.2010.06.031; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Andrefouet S., 2004, ATLAS R CIFS CORALLI; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Black R, 2011, MAR FRESHWATER RES, V62, P1318, DOI 10.1071/MF11093; Bour W, 1989, BIOL ECOLOGIE EXPLOI; Bozec YM, 2005, J FISH BIOL, V66, P966, DOI 10.1111/j.0022-1112.2005.00652.x; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Ceccarelli DM, 2011, PACIFIC CONSERVATION, P17; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; David G, 2010, MAR POLLUT BULL, V61, P323, DOI 10.1016/j.marpolbul.2010.06.020; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dumas P, 2007, J EXP MAR BIOL ECOL, V344, P88, DOI 10.1016/j.jembe.2006.12.015; Dumas P, 2010, ENVIRON CONSERV, V37, P364, DOI 10.1017/S0376892910000536; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; Dumas P, 2011, BENITIERS NOUVELLE C; English S., 1997, SURVEY MANUAL TROPIC; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gillet R, 2010, MARINE FISHERY RESOU; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Halpern BS, 2003, ECOL APPL, V13, pS117; Hamel MA, 2010, MAR POLLUT BULL, V60, P1397, DOI 10.1016/j.marpolbul.2010.07.002; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hill JJ, 2004, METHODS ECOLOGICAL M; Jimenez H, 2012, CORAL REEFS, V31, P89, DOI 10.1007/s00338-011-0820-9; Jimenez H, 2011, FISH RES, V108, P195, DOI 10.1016/j.fishres.2010.12.021; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lawrence J.M., 2001, EDIBLE SEA URCHINS B; Lincoln-Smith MP, 2006, CAN J FISH AQUAT SCI, V63, P1251, DOI 10.1139/F06-033; Lubchenco J, 2003, ECOL APPL, V13, pS3; Lucas John S., 1994, Reviews in Fisheries Science, V2, P181; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; MCNEILL SE, 1994, BIODIVERS CONSERV, V3, P586, DOI 10.1007/BF00114203; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Nash W. J., 1993, NEARSHORE MARINE RES, P451; Pakoa K, 2009, STATUS TROCHUS TROCH; Pante E, 2006, AQUAT LIVING RESOUR, V19, P207, DOI 10.1051/alr:2006021; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Pillans S, 2005, MAR ECOL PROG SER, V295, P201, DOI 10.3354/meps295201; Raymakers C, 2003, REV EXPLOITATION TRI; ROBERTS CM, 1993, AMBIO, V22, P363; Stoner AW, 1996, FISH B-NOAA, V94, P551; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; Uthicke S, 2001, CORAL REEFS, V19, P271; Wabnitz CCC, 2010, FRONT ECOL ENVIRON, V8, P124, DOI 10.1890/080109; Wantiez L, 2011, SUIVI TEMPOREL RECIF; Wantiez L, 2011, MODALITES TEMPORELLE; Wantiez L, 2008, REV ECOL-TERRE VIE, V63, P117; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Zuschin M, 2001, CORAL REEFS, V20, P107, DOI 10.1007/s003380100140	66	21	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58998	10.1371/journal.pone.0058998	http://dx.doi.org/10.1371/journal.pone.0058998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554965	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800051
J	Ahrensberg, JM; Fenger-Gron, M; Vedsted, P				Ahrensberg, Jette Moller; Fenger-Gron, Morten; Vedsted, Peter			Use of Primary Care during the Year before Childhood Cancer Diagnosis: A Nationwide Population-Based Matched Comparative Study	PLOS ONE			English	Article							DELAY; SYMPTOMS; INTERVAL; CHILDREN; COHORT	Objective: Childhood cancer is rare and symptoms tend to be unspecific and vague. Using the utilization of health care services as a proxy for symptoms, the present study seeks to determine when early symptoms of childhood cancer are seen in general practice. Methods: A population-based matched comparative study was conducted using nationwide registry data. As cases, all children in Denmark below 16 years of age (N = 1,278) diagnosed with cancer (Jan 2002-Dec 2008) were included. As controls, 10 children per case matched on gender and date of birth (N = 12,780) were randomly selected. The utilization of primary health care services (daytime contacts, out-of-hours contacts and diagnostic procedures) during the year preceding diagnosis/index date was measured for cases and controls. Results: During the six months before diagnosis, children with cancer used primary care more than the control cohort. This excess use grew consistently and steadily towards the time of diagnosis with an IRR = 3.19 (95% CI: 2.99-3.39) (p < 0.0001) during the last three months before diagnosis. Children with Central Nervous System (CNS) tumours had more contacts than other children during the entire study period. The use of practice-based diagnostic tests and the number of out-of-hours contacts began to increase four to five months before cancer diagnosis. Conclusions: The study shows that excess health care use, a proxy for symptoms of childhood cancer, occurs months before the diagnosis is established. Children with lymphoma, bone tumour or other solid tumours had higher consultation rates than the controls in the last five months before diagnosis, whereas children with CNS tumour had higher consultation rates in all twelve months before diagnosis. More knowledge about early symptoms and the diagnostic pathway for childhood cancer would be clinically relevant.	[Ahrensberg, Jette Moller; Fenger-Gron, Morten; Vedsted, Peter] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Ahrensberg, Jette Moller] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Ahrensberg, Jette Moller; Vedsted, Peter] Aarhus Univ, Res Ctr Canc Diag Primary Care, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Ahrensberg, JM (corresponding author), Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark.	jette.ahrensberg@alm.au.dk	Vedsted, Peter/C-2583-2008	Vedsted, Peter/0000-0003-2113-5599; Fenger-Gron, Morten/0000-0002-6354-5871	Child Cancer Foundation; Novo Nordisk foundation; Danish Cancer society; PLU Foundation; Novo Nordisk Fonden [NNF12OC1016030] Funding Source: researchfish	Child Cancer Foundation; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer society(Danish Cancer Society); PLU Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was carried out at The Research Unit for General Practice in Aarhus, Denmark and funded by the Child Cancer Foundation, the Novo Nordisk foundation, the Danish Cancer society and the PLU Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrensberg JM, 2012, ACTA PAEDIATR, V101, P655, DOI 10.1111/j.1651-2227.2012.02625.x; Ansell P, 2010, PEDIATRICS, V125, P112, DOI 10.1542/peds.2009-0254; BROWN PD, 1989, INT J EPIDEMIOL, V18, P546, DOI 10.1093/ije/18.3.546; Buntinx F, 2011, BRIT J GEN PRACT, V61, P43, DOI 10.3399/bjgp11X548974; Dang-Tan T, 2008, PEDIATR BLOOD CANCER, V51, P468, DOI 10.1002/pbc.21600; Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849; Dixon-Woods M, 2001, LANCET, V357, P670, DOI 10.1016/S0140-6736(00)04130-1; Dobrovoljac M, 2002, EUR J PEDIATR, V161, P663, DOI 10.1007/s00431-002-1088-4; Dommett RM, 2012, BRIT J CANCER, V106, P982, DOI 10.1038/bjc.2011.600; Edgeworth J, 1996, ARCH DIS CHILD, V74, P148, DOI 10.1136/adc.74.2.148; FLORES LE, 1986, AM J DIS CHILD, V140, P684, DOI 10.1001/archpedi.1986.02140210082031; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goyal S, 2004, EUR J CANCER, V40, P2280, DOI 10.1016/j.ejca.2004.05.017; Haimi M, 2011, CANCER EPIDEMIOL, V35, P83, DOI 10.1016/j.canep.2010.07.009; Hansen RP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-49; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Olesen F, 2009, BRIT J CANCER, V101, pS5, DOI 10.1038/sj.bjc.6605383; Olivarius ND, 1997, DAN MED BULL, V44, P449; Pedersen CB, 2006, DAN MED BULL, V53, P441; POLLOCK BH, 1991, J PEDIATR-US, V119, P725, DOI 10.1016/S0022-3476(05)80287-2; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Schmiegelow Kjeld, 2006, Ugeskr Laeger, V168, P2373; Storm HH, 1997, DAN MED BULL, V44, P535; Thomsen JL, 2006, FAM PRACT, V23, P407, DOI 10.1093/fampra/cml012; Thulesius H, 2000, ACTA ONCOL, V39, P873, DOI 10.1080/028418600750063640; Vedsted P, 2009, SCAND J PRIM HEALTH, V27, P193, DOI 10.3109/02813430903478623; World Health Organization, INT CLASS DIS ICD	29	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59098	10.1371/journal.pone.0059098	http://dx.doi.org/10.1371/journal.pone.0059098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554980	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500069
J	Bermudez-Brito, M; Munoz-Quezada, S; Gomez-Llorente, C; Matencio, E; Bernal, MJ; Romero, F; Gil, A				Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Matencio, Esther; Bernal, Maria J.; Romero, Fernando; Gil, Angel			Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation	PLOS ONE			English	Article							PROBIOTIC USE; EXPRESSION; LACTOBACILLI; IMMUNITY; TOLL-LIKE-RECEPTOR-2; INDUCTION; RESPONSES; EFFICACY; STRAINS; PROTEIN	Dendritic cells (DCs) constitute the first point of contact between gut commensals and our immune system. Despite growing evidence of the immunomodulatory effects of probiotics, the interactions between the cells of the intestinal immune system and bacteria remain largely unknown. Indeed,, the aim of this work was to determine whether the probiotic Bifidobacterium breve CNCM I-4035 and its cell-free culture supernatant (CFS) have immunomodulatory effects in human intestinal-like dendritic cells (DCs) and how they respond to the pathogenic bacterium Salmonella enterica serovar Typhi, and also to elucidate the molecular mechanisms involved in these interactions. Human DCs were directly challenged with B. breve/CFS, S. typhi or a combination of these stimuli for 4 h. The expression pattern of genes involved in Toll-like receptor (TLR) signaling pathway and cytokine secretion was analyzed. CFS decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with S. typhi. In contrast, the B. breve CNCM I-4035 probiotic strain was a potent inducer of the pro-inflammatory cytokines and chemokines tested, i.e., TNF-alpha, IL-8 and RANTES, as well as anti-inflammatory cytokines including IL-10. CFS restored TGF-beta levels in the presence of Salmonella. Live B. breve and its supernatant enhanced innate immune responses by the activation of TLR signaling pathway. These treatments upregulated TLR9 gene transcription. In addition, CFS was a more potent inducer of TLR9 expression than the probiotic bacteria in the presence of S. typhi. Expression levels of CASP8 and IRAK4 were also increased by CFS, and both treatments induced TOLLIP gene expression. Our results indicate that the probiotic strain B. breve CNCM I-4035 affects the intestinal immune response, whereas its supernatant exerts anti-inflammatory effects mediated by DCs. This supernatant may protect immune system from highly infectious agents such as Salmonella typhi and can down-regulate pro-inflammatory pathways.	[Bermudez-Brito, Miriam; Munoz-Quezada, Sergio; Gomez-Llorente, Carolina; Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain; [Matencio, Esther; Bernal, Maria J.; Romero, Fernando] Hero Grp, Global Ctr Child Nutr Technol, Murcia, Spain	University of Granada	Gil, A (corresponding author), Univ Granada, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Granada, Spain.	agil@ugr.es	Gil, Angel/ABA-7621-2020; Llorente, Carolina Gomez/K-7484-2015; Gil, Angel/L-2275-2014	Gil, Angel/0000-0001-7663-0939; Llorente, Carolina Gomez/0000-0003-3948-1473; Gil, Angel/0000-0001-7663-0939; Bermudez Brito, Miriam/0000-0003-4156-143X	Hero Spain S.A. [3143]; Fundacion General Universidad de Granada Empresa; CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	Hero Spain S.A.; Fundacion General Universidad de Granada Empresa; CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government; Plan Propio of University of Granada	This study was supported by Hero Spain S.A. through a number 3143 contract signed with the Fundacion General Universidad de Granada Empresa and co-sponsored by a CDTI project, a public entity of the Ministry of Economy and Competitiveness of the Spanish Government. CGLL is a recipient of a postdoctoral fellowship of Plan Propio of University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Ayehunie S, 2009, TOXICOLOGY, V264, P1, DOI 10.1016/j.tox.2009.07.021; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; Feng T, 2011, INT IMMUNOPHARMACOL, V11, P589, DOI 10.1016/j.intimp.2010.11.016; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Golowczyc MA, 2007, INT J FOOD MICROBIOL, V118, P264, DOI 10.1016/j.ijfoodmicro.2007.07.042; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hiramatsu Y, 2012, MICROBES INFECT; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Hua MC, 2010, WORLD J GASTROENTERO, V16, P3529, DOI 10.3748/wjg.v16.i28.3529; Huang JS, 2002, DIGEST DIS SCI, V47, P2625, DOI 10.1023/A:1020501202369; Kaji R, 2010, J IMMUNOL, V184, P3505, DOI 10.4049/jimmunol.0901569; Karska-Wysocki B, 2010, MICROBIOL RES, V165, P674, DOI 10.1016/j.micres.2009.11.008; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lavelle EC, 2010, MUCOSAL IMMUNOL, V3, P17, DOI 10.1038/mi.2009.124; Liong MT, 2008, NUTR REV, V66, P192, DOI 10.1111/j.1753-4887.2008.00024.x; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Madsen K, 2006, J CLIN GASTROENTEROL, V40, P232, DOI 10.1097/00004836-200603000-00014; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Munoz-Quezada S, 2013, Br. J. Nutr., V109, pS51, Patent No. 090006; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS63, DOI 10.1017/S0007114512005600; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Pelletier X, 2001, EUR J CLIN NUTR, V55, P509, DOI 10.1038/sj.ejcn.1601169; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Plantinga TS, 2011, CLIN VACCINE IMMUNOL, V18, P621, DOI 10.1128/CVI.00498-10; Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488; Rizzello V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473097; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Verbeek R, 2010, BENEF MICROBES, V1, P109, DOI 10.3920/BM2009.0026; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Weiss G, 2011, CYTOKINE, V56, P520, DOI 10.1016/j.cyto.2011.07.024; Woodard GA, 2009, J GASTROINTEST SURG, V13, P1198, DOI 10.1007/s11605-009-0891-x; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	57	73	76	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59370	10.1371/journal.pone.0059370	http://dx.doi.org/10.1371/journal.pone.0059370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555025	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500086
J	Chiang, NJ; Lin, CI; Liou, JP; Kuo, CC; Chang, CY; Chen, LT; Chang, JY				Chiang, Nai-Jung; Lin, Ching-I; Liou, Jing-Ping; Kuo, Ching-Chuan; Chang, Chi-Yen; Chen, Li-Tzong; Chang, Jang-Yang			A Novel Synthetic Microtubule Inhibitor, MPT0B214 Exhibits Antitumor Activity in Human Tumor Cells through Mitochondria-Dependent Intrinsic Pathway	PLOS ONE			English	Article							HUMAN CANCER-CELLS; TUBULIN-BINDING AGENTS; ANTIMITOTIC ACTIVITY; ANTICANCER DRUGS; PROTEIN-KINASE; CDC25 PROTEIN; IN-VITRO; CYCLIN-B; APOPTOSIS; PHOSPHORYLATION	Agents that interfere with mitotic progression by disturbing microtubule dynamics are commonly used for cancer treatment. Previously, a series of aroylquinolone regioisomers as novel microtubule inhibitors were discovered. One of these new compounds, MPT0B214 inhibited tubulin polymerization through strongly binding to the tubulin's colchicine-binding site and had cytotoxic activity in a variety of human tumor cell lines. After treatment with MPT0B214, KB cells were arrested in the G(2)-M phase before cell death occurred, which were associated with upregulation of cyclin B1, dephosphorylation of Cdc2, phosphorylation of Cdc25C and elevated expression of the mitotic marker MPM-2. Furthermore, the compound induced apoptotic cell death through mitochondria/caspase 9-dependent pathway. Notably, several KB-derived multidrug-resistant cancer cell lines were also sensitive to MPT0B214 treatment. These findings showed that MPT0B214 is a potential compound in the treatment of various malignancies.	[Chiang, Nai-Jung; Lin, Ching-I; Kuo, Ching-Chuan; Chang, Chi-Yen; Chen, Li-Tzong; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chiang, Nai-Jung; Lin, Ching-I; Chen, Li-Tzong; Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol Oncol, Tainan 70428, Taiwan; [Lin, Ching-I] St Martin De Porres Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University	Chang, JY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jychang@nhri.org.tw	Chen, Li-Tzong/D-2071-2010; Chang, Jang-Yang/D-2099-2010; Kuo, Ching-Chuan/C-1201-2010		National Science Council [NSC-101-2325-B-400-007]; Department of Health [DOH101-TD-C-111-004]; National Health Research Institutes, Taiwan, ROC [CA-101-PP-22]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; National Health Research Institutes, Taiwan, ROC(National Health Research Institutes - Taiwan)	This work was supported by grants from National Science Council (NSC-101-2325-B-400-007), Department of Health (DOH101-TD-C-111-004), and National Health Research Institutes (CA-101-PP-22), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; Attard G, 2006, PATHOL BIOL, V54, P72, DOI 10.1016/j.patbio.2005.03.003; BLAGOSKLONNY MV, 1995, CANCER RES, V55, P4623; BOLLAG DM, 1995, CANCER RES, V55, P2325; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; FERGUSON PJ, 1988, CANCER RES, V48, P5956; FINLAY GJ, 1984, ANAL BIOCHEM, V139, P272, DOI 10.1016/0003-2697(84)90002-2; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P1199, DOI 10.1016/S0006-2952(97)00614-X; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Haldar S, 1997, CANCER RES, V57, P229; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hsieh CC, 2010, BIOCHEM PHARMACOL, V79, P1261, DOI 10.1016/j.bcp.2009.12.017; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nien CY, 2010, J MED CHEM, V53, P2309, DOI 10.1021/jm900685y; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tahir SK, 2001, CANCER RES, V61, P5480; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	35	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58953	10.1371/journal.pone.0058953	http://dx.doi.org/10.1371/journal.pone.0058953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554962	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500059
J	Ries, S; Janssen, N; Burle, B; Alario, FX				Ries, Stephanie; Janssen, Niels; Burle, Boris; Alario, F-Xavier			Response-Locked Brain Dynamics of Word Production	PLOS ONE			English	Article							SINGLE NEURON ACTIVITY; TEMPORAL SIGNATURES; LANGUAGE PRODUCTION; PREFRONTAL CORTEX; CORTICAL DYNAMICS; PRECEDING SPEECH; ACTION SELECTION; VERB GENERATION; TIME PRESSURE; PICTURE	The cortical regions involved in the different stages of speech production are relatively well-established, but their spatio-temporal dynamics remain poorly understood. In particular, the available studies have characterized neural events with respect to the onset of the stimulus triggering a verbal response. The core aspect of language production, however, is not perception but action. In this context, the most relevant question may not be how long after a stimulus brain events happen, but rather how long before the production act do they occur. We investigated speech production-related brain activity time-locked to vocal onset, in addition to the common stimulus-locked approach. We report the detailed temporal interplay between medial and left frontal activities occurring shortly before vocal onset. We interpret those as reflections of, respectively, word selection and word production processes. This medial-lateral organization is in line with that described in non-linguistic action control, suggesting that similar processes are at play in word production and non-linguistic action production. This novel view of the brain dynamics underlying word production provides a useful background for future investigations of the spatio-temporal brain dynamics that lead to the production of verbal responses.	[Ries, Stephanie; Janssen, Niels; Burle, Boris; Alario, F-Xavier] Aix Marseille Univ, CNRS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ries, S (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	stephanie.ries@berkeley.edu	ALARIO, F.-Xavier/C-6786-2009; Janssen, Niels/L-2626-2015	ALARIO, F.-Xavier/0000-0002-8627-5034; Janssen, Niels/0000-0001-9770-4458; BURLE, Boris/0000-0001-8179-9034; Ries, Stephanie/0000-0003-0308-0635	Agence Nationale de la Recherche (France) [ANR-07-JCJC-0074]; European Research Council under the European Community's Seventh Framework Program [241077]; MNRT from the Ministere de l'Enseignement et de la Recherche (France); Fyssen foundation; Spanish Ministry of Economy and Competitiveness [RYC-2011-08433]	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); European Research Council under the European Community's Seventh Framework Program(European Research Council (ERC)); MNRT from the Ministere de l'Enseignement et de la Recherche (France); Fyssen foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was supported by grant no. ANR-07-JCJC-0074 from the Agence Nationale de la Recherche (France), by European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013 Grant Agreement no. 241077), by an MNRT grant from the Ministere de l'Enseignement et de la Recherche (France) and by a post-doctoral grant from the Fyssen foundation awarded to Stephanie Ries. Niels Janssen was supported by Grant RYC-2011-08433 from Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Babiloni F, 2001, CLIN NEUROPHYSIOL, V112, P724, DOI 10.1016/S1388-2457(01)00494-1; Baldo JV, 2013, CORTEX, V49, P658, DOI 10.1016/j.cortex.2012.03.001; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; BROOKER BH, 1980, BRAIN LANG, V9, P226, DOI 10.1016/0093-934X(80)90143-1; Burle B, 2004, BRAIN COGNITION, V56, P153, DOI 10.1016/j.bandc.2004.06.004; Carbonnell L, 2004, CLIN NEUROPHYSIOL, V115, P2164, DOI 10.1016/j.clinph.2004.04.012; Chang EF, 2011, J COGNITIVE NEUROSCI, V23, P1437, DOI 10.1162/jocn.2010.21466; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Crosson B, 2001, J COGNITIVE NEUROSCI, V13, P272, DOI 10.1162/089892901564225; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; de Zubicaray GI, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI 10.3758/CABN.9.3.260; DEECKE L, 1986, EXP BRAIN RES, V65, P219; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; Eulitz C, 2000, CLIN NEUROPHYSIOL, V111, P2088, DOI 10.1016/S1388-2457(00)00441-7; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Flinker A, 2010, J NEUROSCI, V30, P16643, DOI 10.1523/JNEUROSCI.1809-10.2010; Galgano J, 2008, NEUROIMAGE, V41, P1313, DOI 10.1016/j.neuroimage.2008.03.019; Ganushchak LY, 2008, NEUROIMAGE, V39, P395, DOI 10.1016/j.neuroimage.2007.09.001; Ganushchak LY, 2006, BRAIN RES, V1125, P104, DOI 10.1016/j.brainres.2006.09.096; Ganushchak LY, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00208; Ganushchak LY, 2009, PSYCHOPHYSIOLOGY, V46, P410, DOI 10.1111/j.1469-8986.2008.00774.x; GEVINS A, 1989, Brain Topography, V2, P37, DOI 10.1007/BF01128842; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Grossman M, 2004, BRAIN, V127, P628, DOI 10.1093/brain/awh075; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hamalainen MS, 1984, TKKKFA599 HELS U TEC; Heim S, 2009, NEUROIMAGE, V48, P616, DOI 10.1016/j.neuroimage.2009.06.044; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; Hulten A, 2009, HUM BRAIN MAPP, V30, P976, DOI 10.1002/hbm.20561; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2011, NEUROIMAGE, V57, P1243, DOI 10.1016/j.neuroimage.2011.05.015; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1186, DOI 10.1016/S1388-2457(01)00543-0; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Laganaro M, 2009, J COGNITIVE NEUROSCI, V21, P1499, DOI 10.1162/jocn.2009.21117; Laganaro M, 2009, CORTEX, V45, P697, DOI 10.1016/j.cortex.2008.09.007; Lau H, 2006, NEUROIMAGE, V29, P446, DOI 10.1016/j.neuroimage.2005.07.050; LAW SK, 1993, ELECTROEN CLIN NEURO, V88, P309, DOI 10.1016/0168-5597(93)90055-T; Llorens A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00375; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; MANAHILOV V, 1992, ELECTROEN CLIN NEURO, V82, P220, DOI 10.1016/0013-4694(92)90171-D; Masaki H, 2001, NEUROREPORT, V12, P1851, DOI 10.1097/00001756-200107030-00018; McArdle JJ, 2009, CLIN NEUROPHYSIOL, V120, P275, DOI 10.1016/j.clinph.2008.10.159; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Mouret I, 2000, J EXP PSYCHOL HUMAN, V26, P1622, DOI 10.1037/0096-1523.26.5.1622; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nunez P.L., 1981, ELECT FIELDS BRAIN; NUNEZ PL, 1994, ELECTROEN CLIN NEURO, V90, P40, DOI 10.1016/0013-4694(94)90112-0; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; Peeva MG, 2010, NEUROIMAGE, V50, P626, DOI 10.1016/j.neuroimage.2009.12.065; PERNIER J, 1988, ELECTROEN CLIN NEURO, V69, P385, DOI 10.1016/0013-4694(88)90009-0; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Ries S, 2011, J COGNITIVE NEUROSCI, V23, P1419, DOI 10.1162/jocn.2010.21467; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schnur TT, 2009, P NATL ACAD SCI USA, V106, P322, DOI 10.1073/pnas.0805874106; Schnur TT, 2006, J MEM LANG, V54, P199, DOI 10.1016/j.jml.2005.10.002; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Snyder HR, 2011, J COGNITIVE NEUROSCI, V23, P3470, DOI 10.1162/jocn_a_00023; Snyder HR, 2010, P NATL ACAD SCI USA, V107, P16483, DOI 10.1073/pnas.1002291107; Soros P, 2003, NEUROIMAGE, V19, P1787, DOI 10.1016/S1053-8119(03)00217-9; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Trebuchon-Da Fonseca A, 2009, BRAIN, V132, P2772, DOI 10.1093/brain/awp083; Tremblay P, 2010, CORTEX, V46, P15, DOI 10.1016/j.cortex.2009.03.003; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P382, DOI 10.1162/jocn.2010.21444; van Turennout M, 1998, SCIENCE, V280, P572, DOI 10.1126/science.280.5363.572; Vidal F, 2003, PSYCHOPHYSIOLOGY, V40, P796, DOI 10.1111/1469-8986.00080; Vidal F, 2011, PSYCHOPHYSIOLOGY, V48, P1242, DOI 10.1111/j.1469-8986.2011.01186.x; Vihla M, 2006, NEUROIMAGE, V33, P732, DOI 10.1016/j.neuroimage.2006.06.040; Vos DM, 2010, NEUROINFORMATICS, V8, P135, DOI [10.1007/s12021-010-9076-8, 10.1007/s12021-010-9071-0]; WOHLERT AB, 1991, J SPEECH HEAR RES, V34, P1387, DOI 10.1044/jshr.3406.1387; WOHLERT AB, 1993, J SPEECH HEAR RES, V36, P897, DOI 10.1044/jshr.3605.897; Yoshida K, 1999, ARCH ORAL BIOL, V44, P183, DOI 10.1016/S0003-9969(98)00122-8; Zhang J, 1997, J NEUROSCI, V17, P2227	93	46	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58197	10.1371/journal.pone.0058197	http://dx.doi.org/10.1371/journal.pone.0058197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554876	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500015
J	Wijsman, LW; de Craen, AJM; Trompet, S; Gussekloo, J; Stott, DJ; Rodondi, N; Welsh, P; Jukema, JW; Westendorp, RGJ; Mooijaart, SP				Wijsman, Liselotte W.; de Craen, Anton J. M.; Trompet, Stella; Gussekloo, Jacobijn; Stott, David J.; Rodondi, Nicolas; Welsh, Paul; Jukema, J. Wouter; Westendorp, Rudi G. J.; Mooijaart, Simon P.			Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age	PLOS ONE			English	Article							CARDIOVASCULAR RISK; ATRIAL-FIBRILLATION; THYROTROPIN CONCENTRATIONS; TOTAL CHOLESTEROL; HYPOTHYROIDISM; DISEASE; MORTALITY; HYPERTHYROIDISM; ASSOCIATION; GUIDELINES	Background: Subclinical thyroid dysfunction has been implicated as a risk factor for cognitive decline in old age, but results are inconsistent. We investigated the association between subclinical thyroid dysfunction and cognitive decline in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Methods: Prospective longitudinal study of men and women aged 70-82 years with pre-existing vascular disease or more than one risk factor to develop this condition (N = 5,154). Participants taking antithyroid medications, thyroid hormone supplementation and/or amiodarone were excluded. Thyroid function was measured at baseline: subclinical hyper- and hypothyroidism were defined as thyroid stimulating hormones (TSH),0.45 mU/L or.4.50 mU/L respectively, with normal levels of free thyroxine (FT4). Cognitive performance was tested at baseline and at four subsequent time points during a mean follow-up of 3 years, using five neuropsychological performance tests. Results: Subclinical hyperthyroidism and hypothyroidism were found in 65 and 161 participants, respectively. We found no consistent association of subclinical hyper-or hypothyroidism with altered cognitive performance compared to euthyroid participants on the individual cognitive tests. Similarly, there was no association with rate of cognitive decline during follow-up. Conclusion: We found no consistent evidence that subclinical hyper-or hypothyroidism contribute to cognitive impairment or decline in old age. Although our data are not in support of treatment of subclinical thyroid dysfunction to prevent cognitive dysfunction in later life, only large randomized controlled trials can provide definitive evidence.	[Wijsman, Liselotte W.; de Craen, Anton J. M.; Trompet, Stella; Westendorp, Rudi G. J.; Mooijaart, Simon P.] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ Med Ctr, Dept Cardiol, Leiden, Netherlands; [Gussekloo, Jacobijn] Leiden Univ Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Stott, David J.] Univ Glasgow, Fac Med, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland; [Rodondi, Nicolas] Univ Bern, Inselhosp, Dept Gen Internal Med, Bern, Switzerland; [Welsh, Paul] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age IEMO, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Glasgow; University of Bern; University Hospital of Bern; University of Glasgow	Mooijaart, SP (corresponding author), Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	s.p.mooijaart@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; Jukema, J. Wouter/ABD-6503-2021; Mooijaart, Simon P./A-5306-2008; Welsh, Paul/H-5249-2019	Gussekloo, Jacobijn/0000-0001-7186-8278; Jukema, J. Wouter/0000-0002-3246-8359; Mooijaart, Simon P./0000-0003-3106-3568; Welsh, Paul/0000-0002-7970-3643; Rodondi, Nicolas/0000-0001-9083-6896	Bristol-Myers Squibb, USA; Swiss National Science Foundation [SNSF 320030-138267]; Netherlands Consortium for Healthy Ageing, The Netherlands	Bristol-Myers Squibb, USA(Bristol-Myers Squibb); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Consortium for Healthy Ageing, The Netherlands(Netherlands Government)	The PROSPER (The Prospective Study of Pravastatin in the Elderly at Risk) study was supported by an investigator initiated grant from Bristol-Myers Squibb, USA, and by a grant from the Swiss National Science Foundation (SNSF 320030-138267, PI: NR). The investigators were financed by the Netherlands Consortium for Healthy Ageing, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; Bensenor IM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-298; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Casserly Ivan P, 2004, Discov Med, V4, P149; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Diez JJ, 2005, J CLIN ENDOCR METAB, V90, P4124, DOI 10.1210/jc.2005-0375; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Hogervorst E, 2008, PSYCHONEUROENDOCRINO, V33, P1013, DOI 10.1016/j.psyneuen.2008.05.008; Houx PJ, 2002, J NEUROL NEUROSUR PS, V73, P385, DOI 10.1136/jnnp.73.4.385; Hueston WJ, 2004, ANN FAM MED, V2, P351, DOI 10.1370/afm.79; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kanaya AM, 2002, ARCH INTERN MED, V162, P773, DOI 10.1001/archinte.162.7.773; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Klubo-Gwiezdzinska J, 2009, ARCH INTERN MED, V169, P1949, DOI 10.1001/archinternmed.2009.415; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Luboshitzky R, 2002, THYROID, V12, P421, DOI 10.1089/105072502760043512; Mooijaart SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023890; Nanchen D, 2012, J CLIN ENDOCR METAB, V97, P852, DOI 10.1210/jc.2011-1978; Packard CJ, 2005, CIRCULATION, V112, P3058, DOI 10.1161/CIRCULATIONAHA.104.526848; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Peeters RP, 2009, J CLIN ENDOCR METAB, V94, P4658, DOI 10.1210/jc.2009-2198; Pinchera A, 2005, THYROID, V15, P1, DOI 10.1089/thy.2005.15.1; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; Stabouli S, 2010, EXPERT REV CARDIOVAS, V8, P1559, DOI [10.1586/erc.10.141, 10.1586/ERC.10.141]; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; Trompet S, 2009, AM J EPIDEMIOL, V170, P1415, DOI 10.1093/aje/kwp294; van Bemmel T, 2006, J HYPERTENS, V24, P287, DOI 10.1097/01.hjh.0000200513.48441.8e; van Boxtel MPJ, 2004, PSYCHONEUROENDOCRINO, V29, P891, DOI 10.1016/j.psyneuen.2003.08.002; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Walsh JP, 2005, CLIN ENDOCRINOL, V63, P670, DOI 10.1111/j.1365-2265.2005.02399.x; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	38	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59199	10.1371/journal.pone.0059199	http://dx.doi.org/10.1371/journal.pone.0059199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554996	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000316252500073
J	Lan, XQ; Rai, P; Chandel, N; Cheng, K; Lederman, R; Saleem, MA; Mathieson, PW; Husain, M; Crosson, JT; Gupta, K; Malhotra, A; Singhal, PC				Lan, Xiqian; Rai, Partab; Chandel, Nirupama; Cheng, Kang; Lederman, Rivka; Saleem, Moin A.; Mathieson, Peter W.; Husain, Mohammad; Crosson, John T.; Gupta, Kalpna; Malhotra, Ashwani; Singhal, Pravin C.			Morphine Induces Albuminuria by Compromising Podocyte Integrity	PLOS ONE			English	Article							OXIDATIVE STRESS; NEPHRIN; PROTEIN; MACROPHAGES; EXPRESSION; APOPTOSIS; INJURY	Morphine has been reported to accelerate the progression of chronic kidney disease. However, whether morphine affects slit diaphragm (SD), the major constituent of glomerular filtration barrier, is still unclear. In the present study, we examined the effect of morphine on glomerular filtration barrier in general and podocyte integrity in particular. Mice were administered either normal saline or morphine for 72 h, then urine samples were collected and kidneys were subsequently isolated for immunohistochemical studies and Western blot. For in vitro studies, human podocytes were treated with morphine and then probed for the molecular markers of slit diaphragm. Morphine-receiving mice displayed a significant increase in albuminuria and showed effacement of podocyte foot processes. In both in vivo and in vitro studies, the expression of synaptopodin, a molecular marker for podocyte integrity, and the slit diaphragm constituting molecules (SDCM), such as nephrin, podocin, and CD2-associated protein (CD2AP), were decreased in morphine-treated podocytes. In vitro studies indicated that morphine modulated podocyte expression of SDCM through opiate mu (MOR) and kappa (KOR) receptors. Since morphine also enhanced podocyte oxidative stress, the latter seems to contribute to decreased SDCM expression. In addition, AKT, p38, and JNK pathways were involved in morphine-induced down regulation of SDCM in human podocytes. These findings demonstrate that morphine has the potential to alter the glomerular filtration barrier by compromising the integrity of podocytes.	[Lan, Xiqian; Rai, Partab; Chandel, Nirupama; Cheng, Kang; Lederman, Rivka; Husain, Mohammad; Malhotra, Ashwani; Singhal, Pravin C.] Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, Great Neck, NY USA; [Saleem, Moin A.; Mathieson, Peter W.] Southmead Hosp, Acad Renal Unit, Bristol, Avon, England; [Crosson, John T.] Univ Minnesota, Sch Med, Hennepin Cty Med Ctr, Dept Lab Med Pathol, Minneapolis, MN 55455 USA; [Gupta, Kalpna] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA	Hofstra University; Northwell Health; Southmead Hospital; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Singhal, PC (corresponding author), Hofstra North Shore LIJ Med Sch, Feinstein Inst Med Res, Renal Mol Res Lab, Great Neck, NY USA.	psinghal@nshs.edu		Husain, Mohammad/0000-0003-3876-8181; Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X	National Institutes of Health, Bethesda, MD [RO1DK084910, RO1DK083931, HL68802, HL103773]; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068802, R01HL103733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083931, R01DK084910] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants RO1DK084910, RO1DK083931 (PCS) and HL68802, HL103773 (KG) from National Institutes of Health, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; BOURGOIGNIE JJ, 1990, KIDNEY INT, V37, P1571, DOI 10.1038/ki.1990.151; Dasgupta N, 2006, DRUG ALCOHOL DEPEN, V82, P135, DOI 10.1016/j.drugalcdep.2005.08.019; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hopfer CJ, 2000, J AM ACAD CHILD PSY, V39, P1316, DOI 10.1097/00004583-200010000-00021; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Husain M, 2009, J BIOL CHEM, V284, P16648, DOI 10.1074/jbc.M109.008482; Ikezumi Y, 2008, BIOCHEM BIOPH RES CO, V376, P706, DOI 10.1016/j.bbrc.2008.09.049; JOHNSON JE, 1987, DRUG ALCOHOL DEPEN, V19, P249, DOI 10.1016/0376-8716(87)90044-5; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Lim AKH, 2009, DIABETOLOGIA, V52, P347, DOI 10.1007/s00125-008-1215-5; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; MacPherson RD, 2000, PHARMACOL THERAPEUT, V88, P163, DOI 10.1016/S0163-7258(00)00090-5; Mao JH, 2006, PEDIATR NEPHROL, V21, P1666, DOI 10.1007/s00467-006-0218-z; Marshall SM, 2007, CURR PHARM DESIGN, V13, P2713, DOI 10.2174/138161207781662957; Mongia A, 2004, KIDNEY INT, V65, P860, DOI 10.1111/j.1523-1755.2004.00464.x; Nielsen DA, 2012, DRUG ALCOHOL DEPEN, V123, pS33, DOI 10.1016/j.drugalcdep.2012.03.026; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Patel J, 2003, AM J PHYSIOL-RENAL, V285, pF861, DOI 10.1152/ajprenal.00134.2003; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Salhan D, 2012, CELL SIGNAL, V24, P734, DOI 10.1016/j.cellsig.2011.11.007; SHARP BM, 1985, ENDOCRINOLOGY, V117, P793, DOI 10.1210/endo-117-2-793; Singhal PC, 1998, KIDNEY INT, V53, P350, DOI 10.1046/j.1523-1755.1998.00758.x; SINGHAL PC, 1994, INFLAMMATION, V18, P293, DOI 10.1007/BF01534270; Singhal PC, 1998, J INVEST MED, V46, P243; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Takano Y, 2007, FEBS LETT, V581, P421, DOI 10.1016/j.febslet.2006.12.051; Tojo A, 2007, EXPERT OPIN THER TAR, V11, P1011, DOI 10.1517/14728222.11.8.1011; Weber ML, 2008, AM J PHYSIOL-RENAL, V294, pF1388, DOI 10.1152/ajprenal.00389.2007; Wen HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021707; Xing Y, 2006, EXP BIOL MED, V231, P585	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e55748	10.1371/journal.pone.0055748	http://dx.doi.org/10.1371/journal.pone.0055748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555556	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900001
J	Tian, M; Zallocchi, M; Wang, WM; Chen, CK; Palczewski, K; Delimont, D; Cosgrove, D; Peng, YW				Tian, Mei; Zallocchi, Marisa; Wang, Weimin; Chen, Ching-Kang; Palczewski, Krzysztof; Delimont, Duane; Cosgrove, Dominic; Peng, You-Wei			Light-Induced Translocation of RGS9-1 and G beta 5L in Mouse Rod Photoreceptors	PLOS ONE			English	Article							GTPASE-ACCELERATING PROTEIN; BETA-SUBUNIT G-BETA-5; ECTOPIC SYNAPTOGENESIS; DARK-ADAPTATION; RETINAL RODS; MICE LACKING; PHOTOTRANSDUCTION; TRANSDUCIN; VERTEBRATE; COMPLEX	The transducin GTPase-accelerating protein complex, which determines the photoresponse duration of photoreceptors, is composed of RGS9-1, G beta 5L and R9AP. Here we report that RGS9-1 and G beta 5L change their distribution in rods during light/dark adaptation. Upon prolonged dark adaptation, RGS9-1 and Gb5L are primarily located in rod inner segments. But very dim-light exposure quickly translocates them to the outer segments. In contrast, their anchor protein R9AP remains in the outer segment at all times. In the dark, G beta 5L's interaction with R9AP decreases significantly and RGS9-1 is phosphorylated at S-475 to a significant degree. Dim light exposure leads to quick de-phosphorylation of RGS9-1. Furthermore, after prolonged dark adaptation, RGS9-1 and transducin G alpha are located in different cellular compartments. These results suggest a previously unappreciated mechanism by which prolonged dark adaptation leads to increased light sensitivity in rods by dissociating RGS9-1 from R9AP and redistributing it to rod inner segments.	[Tian, Mei; Zallocchi, Marisa; Wang, Weimin; Delimont, Duane; Cosgrove, Dominic; Peng, You-Wei] Boys Town Natl Res Hosp, Retinal Neurobiol Lab, Omaha, NE 68131 USA; [Tian, Mei] Chinese Ctr Dis Control & Prevent, Natl Inst Radiol Protect, Beijing, Peoples R China; [Chen, Ching-Kang] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Boys Town National Research Hospital; Chinese Center for Disease Control & Prevention; National Institute for Radiological Protection, Chinese Center for Disease Control & Prevention; Virginia Commonwealth University; Case Western Reserve University	Peng, YW (corresponding author), Boys Town Natl Res Hosp, Retinal Neurobiol Lab, Omaha, NE 68131 USA.	You-wei.peng@boystown.org	Zallocchi, Marisa/HHS-7445-2022		National Institutes of Health (NIH) [P20 RR018788, R01 013811, R01 EY008061, R01 DC04844, R01 DK55000]; tobacco settlement fund from the State of Nebraska; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013811, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004844] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); tobacco settlement fund from the State of Nebraska; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) P20 RR018788 to YWP, NIH R01 013811 to CKC, NIH R01 EY008061 to KP, NIH R01 DC04844, and R01 DK55000 to DC and the tobacco settlement fund from the State of Nebraska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Balasubramanian N, 2001, BIOCHEMISTRY-US, V40, P12619, DOI 10.1021/bi015624b; BARLOW HB, 1964, VISION RES, V4, P47, DOI 10.1016/0042-6989(64)90031-8; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; FARBER DB, 1991, EXP EYE RES, V53, P781, DOI 10.1016/0014-4835(91)90114-T; Fischer T, 2000, P NATL ACAD SCI USA, V97, P4040, DOI 10.1073/pnas.97.8.4040; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hecht S, 1937, PHYSIOL REV, V17, P239, DOI 10.1152/physrev.1937.17.2.239; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hu G, 2001, J BIOL CHEM, V276, P22287, DOI 10.1074/jbc.M011539200; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Krispel CM, 2003, J NEUROSCI, V23, P6965, DOI 10.1523/JNEUROSCI.23-18-06965.2003; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lishko PV, 2002, J BIOL CHEM, V277, P24376, DOI 10.1074/jbc.M203237200; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2003, NEURON, V38, P857, DOI 10.1016/S0896-6273(03)00320-9; Masuho I, 2011, J BIOL CHEM, V286, P21806, DOI 10.1074/jbc.M111.241513; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1991, EXP EYE RES, V53, P773, DOI 10.1016/0014-4835(91)90113-S; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Peng YW, 2003, NEUROSCIENCE, V119, P813, DOI 10.1016/S0306-4522(03)00153-2; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; Sokal I, 2003, J BIOL CHEM, V278, P8316, DOI 10.1074/jbc.M211782200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154	43	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58832	10.1371/journal.pone.0058832	http://dx.doi.org/10.1371/journal.pone.0058832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555598	gold, Green Published			2022-12-27	WOS:000317262200006
J	Basile, LFH; Sato, JR; Alvarenga, MY; Henrique, N; Pasquini, HA; Alfenas, W; Machado, S; Velasques, B; Ribeiro, P; Piedade, R; Anghinah, R; Ramos, RT				Basile, Luis F. H.; Sato, Joao R.; Alvarenga, Milkes Y.; Henrique, Nelson, Jr.; Pasquini, Henrique A.; Alfenas, William; Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto; Anghinah, Renato; Ramos, Renato T.			Lack of Systematic Topographic Difference between Attention and Reasoning Beta Correlates	PLOS ONE			English	Article							BAND OSCILLATIONS; EEG; GENERATION; NETWORK; VARIABILITY; AREAS	Based on previous evidence for individual-specific sets of cortical areas active during simple attention tasks, in this work we intended to perform within individual comparisons of task-induced beta oscillations between visual attention and a reasoning task. Since beta induced oscillations are not time-locked to task events and were first observed by Fourier transforms, in order to analyze the cortical topography of attention induced beta activity, we have previously computed corrected-latency averages based on spontaneous peaks of band-pass filtered epochs. We then used Independent Component Analysis (ICA) only to single out the significant portion of averaged data, above noise levels. In the present work ICA served as the main, exhaustive means for decomposing beta activity in both tasks, using 128-channel EEG data from 24 subjects. Given the previous observed similarity between tasks by visual inspection and by simple descriptive statistics, we now intended another approach: to quantify how much each ICA component obtained in one task could be explained by a linear combination of the topographic patterns from the other task in each individual. Our hypothesis was that the major psychological difference between tasks would not be reflected as important topographic differences within individuals. Results confirmed the high topographic similarity between attention and reasoning beta correlates in that few components in each individual were not satisfactorily explained by the complementary task, and if those could be considered "task-specific", their scalp distribution and estimated cortical sources were not common across subjects. These findings, along with those from fMRI studies preserving individual data and conventional neuropsychological and neurosurgical observations, are discussed in support of a new functional localization hypothesis: individuals use largely different sets of cortical association areas to perform a given task, but those individual sets do not change importantly across tasks that differ in major psychological processes.	[Basile, Luis F. H.; Henrique, Nelson, Jr.; Pasquini, Henrique A.; Ramos, Renato T.] UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil; [Basile, Luis F. H.; Alvarenga, Milkes Y.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Anghinah, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Alvarenga, Milkes Y.; Alfenas, William] Univ Sao Judas Tadeu, Sao Paulo, Brazil; [Sato, Joao R.] Fed Univ ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Sao Judas Tadeu; Universidade Federal do ABC (UFABC)	Basile, LFH (corresponding author), UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil.	lbasile@usp.br	Machado, Sergio/M-9384-2013; Ramos, Renato T/G-1566-2013	Machado, Sergio/0000-0001-8946-8467; Sato, Joao Ricardo/0000-0002-7503-9781				Barbas H, 1992, Adv Neurol, V57, P91; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 1997, INT J PSYCHOPHYSIOL, V27, P29, DOI 10.1016/S0167-8760(97)00784-8; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Basile LFH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015022; Bibbig A, 2002, LONG RANGE SYNCHRONI; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Duffau H, 2012, Adv Tech Stand Neurosurg, V38, P3, DOI 10.1007/978-3-7091-0676-1_1; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Kaminski J, 2012, INT J PSYCHOPHYSIOL, V85, P125, DOI 10.1016/j.ijpsycho.2011.11.006; Kopell N, 2000, GAMMA RHYTHMS BETA R; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Noppency U, 2004, J ANATOMY, V205, P6; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pandya D.N., 1988, P39; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ramirez PM, 2001, ANN NY ACAD SCI, V931, P342; Raven J.C., 1976, COLOURED PROGR MATRI; Santarosa LMC, 1983, EDUC REAL, V1, P7; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59595	10.1371/journal.pone.0059595	http://dx.doi.org/10.1371/journal.pone.0059595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544076	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700036
J	Berglund, K; Birkner, E; Augustine, GJ; Hochgeschwender, U				Berglund, Ken; Birkner, Elisabeth; Augustine, George J.; Hochgeschwender, Ute			Light-Emitting Channelrhodopsins for Combined Optogenetic and Chemical-Genetic Control of Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSGENIC MICE; REMOTE-CONTROL; IN-VIVO; NEURAL ACTIVITY; HIPPOCAMPAL-NEURONS; OPTICAL ACTIVATION; GAUSSIA LUCIFERASE; ION CHANNELS; CELL-TYPE	Manipulation of neuronal activity through genetically targeted actuator molecules is a powerful approach for studying information flow in the brain. In these approaches the genetically targeted component, a receptor or a channel, is activated either by a small molecule (chemical genetics) or by light from a physical source (optogenetics). We developed a hybrid technology that allows control of the same neurons by both optogenetic and chemical genetic means. The approach is based on engineered chimeric fusions of a light-generating Protein (luciferase) to a light-activated ion channel (channelrhodopsin). Ionic currents then can be activated by bioluminescence upon activation of luciferase by its substrate, coelenterazine (CTZ), as well as by external light. In cell lines, expression of the fusion of Gaussia luciferase to Channelrhodopsin-2 yielded photocurrents in response to CTZ. Larger photocurrents were produced by fusing the luciferase to Volvox Channelrhodopsin-1. This version allowed chemical modulation of neuronal activity when expressed in cultured neurons: CTZ treatment shifted neuronal responses to injected currents and sensitized neurons to fire action potentials in response to subthreshold synaptic inputs. These luminescent channelrhodopsins - or luminopsins - preserve the advantages of light-activated ion channels, while extending their capabilities. Our proof-of-principle results suggest that his novel class of tools can be improved and extended in numerous ways.	[Berglund, Ken; Birkner, Elisabeth; Hochgeschwender, Ute] Duke Univ, Dept Neurobiol, Durham, NC 27706 USA; [Birkner, Elisabeth; Hochgeschwender, Ute] Duke Univ, NeuroTransgen Lab, Durham, NC USA; [Augustine, George J.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore; [Augustine, George J.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea	Duke University; Duke University; National University of Singapore; Korea Institute of Science & Technology (KIST)	Hochgeschwender, U (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27706 USA.	ute@neuro.duke.edu	Augustine, George James/J-9228-2013		US National Institutes of Health [P30NS061789]; Duke University; German National Academic Foundation; CRP grant from National Research Foundation of Singapore; World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) (NRF) [WCI 2009-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; German National Academic Foundation; CRP grant from National Research Foundation of Singapore(National Research Foundation, Singapore); World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology of Korea (MEST) (NRF)(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the US National Institutes of Health (P30NS061789), by Duke University, by a fellowship from the German National Academic Foundation to EB, and by a CRP grant from the National Research Foundation of Singapore and by the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (MEST) (NRF Grant Number WCI 2009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Foutz TJ, 2012, J NEUROPHYSIOL, V107, P3235, DOI 10.1152/jn.00501.2011; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grossman N, 2011, IEEE T BIO-MED ENG, V58, P1742, DOI 10.1109/TBME.2011.2114883; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1987, EMBO J, V6, P259, DOI 10.1002/j.1460-2075.1987.tb04748.x; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mancuso JJ, 2011, EXP PHYSIOL, V96, P26, DOI 10.1113/expphysiol.2010.055731; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Miesenbock G, 2011, ANNU REV CELL DEV BI, V27, P301; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; SHIMOMURA O, 1990, BIOCHEM J, V270, P309, DOI 10.1042/bj2700309; Shimomura O., 1985, Symposia of the Society for Experimental Biology, P351; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Teranishi K, 1997, ANAL BIOCHEM, V249, P37, DOI 10.1006/abio.1997.2150; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	70	57	57	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59759	10.1371/journal.pone.0059759	http://dx.doi.org/10.1371/journal.pone.0059759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544095	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700055
J	Fukao, M; Oshima, K; Morita, H; Toh, H; Suda, W; Kim, SW; Suzuki, S; Yakabe, T; Hattori, M; Yajima, N				Fukao, Masanori; Oshima, Kenshiro; Morita, Hidetoshi; Toh, Hidehiro; Suda, Wataru; Kim, Seok-Won; Suzuki, Shigenori; Yakabe, Takafumi; Hattori, Masahira; Yajima, Nobuhiro			Genomic Analysis by Deep Sequencing of the Probiotic Lactobacillus brevis KB290 Harboring Nine Plasmids Reveals Genomic Stability	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; ANTIBIOTIC-RESISTANCE; MATHEMATICAL-MODELS; NUCLEOTIDE-SEQUENCE; IN-VITRO; PLANTARUM; GENE; AGGREGATION	We determined the complete genome sequence of Lactobacillus brevis KB290, a probiotic lactic acid bacterium isolated from a traditional Japanese fermented vegetable. The genome contained a 2,395,134-bp chromosome that housed 2,391 protein-coding genes and nine plasmids that together accounted for 191 protein-coding genes. KB290 contained no virulence factor genes, and several genes related to presumptive cell wall-associated polysaccharide biosynthesis and the stress response were present in L. brevis KB290 but not in the closely related L. brevis ATCC 367. Plasmid-curing experiments revealed that the presence of plasmid pKB290-1 was essential for the strain's gastrointestinal tract tolerance and tendency to aggregate. Using next-generation deep sequencing of current and 18-year-old stock strains to detect low frequency variants, we evaluated genome stability. Deep sequencing of four periodic KB290 culture stocks with more than 1,000-fold coverage revealed 3 mutation sites and 37 minority variation sites, indicating long-term stability and providing a useful method for assessing the stability of industrial bacteria at the nucleotide level.	[Fukao, Masanori; Suzuki, Shigenori; Yakabe, Takafumi; Yajima, Nobuhiro] KAGOME Co Ltd, Res Inst, Nasushiobara, Tochigi, Japan; [Oshima, Kenshiro; Suda, Wataru; Kim, Seok-Won; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa, Japan; [Toh, Hidehiro] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 812, Japan	Kagome Co., Ltd.; University of Tokyo; Azabu University; Kyushu University	Fukao, M (corresponding author), KAGOME Co Ltd, Res Inst, Nasushiobara, Tochigi, Japan.	Masanori_Fukao@kagome.co.jp	Suda, Wataru/AAF-4469-2019; Toh, Yosuke/F-4675-2019; Hattori, Masahira/AAD-3785-2019; Hattori, Masahira/C-6958-2016	Toh, Yosuke/0000-0002-2494-5557; Hattori, Masahira/0000-0001-9467-0344	KAGOME Co. Ltd	KAGOME Co. Ltd	The authors have the following interests. Masanori Fukao, Shigenori Suzuki, Takafumi Yakabe and Nobuhiro Yajima are employed by KAGOME Co. Ltd, the funder of this study and provider of the lactic acid bacteria strain. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Bujnakova D, 2002, J VET MED B, V49, P152, DOI 10.1046/j.1439-0450.2002.00526.x; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; Davis BM, 2009, NUCLEIC ACIDS RES, V37, P5757, DOI 10.1093/nar/gkp568; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Denou E, 2008, J BACTERIOL, V190, P5806, DOI 10.1128/JB.01802-07; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Engelbrektson AL, 2006, FEMS MICROBIOL ECOL, V57, P239, DOI 10.1111/j.1574-6941.2006.00112.x; FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization), 2002, GUID EV PRO IN PRESS; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; Fukao M, 2009, J FOOD PROTECT, V72, P1923, DOI 10.4315/0362-028X-72.9.1923; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jang SH, 2011, ARCH VIROL, V156, P319, DOI 10.1007/s00705-010-0841-7; Jones BV, 2010, GUT MICROBES, V1, P415, DOI 10.4161/gmic.1.6.14087; Kandler O., 1986, BERGEYS MANUAL SYSTE, V2, P1209; Karnezis T, 2002, J BACTERIOL, V184, P4114, DOI 10.1128/JB.184.15.4114-4123.2002; Kishi A, 1996, J AM COLL NUTR, V15, P408; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Lieske JC, 2005, KIDNEY INT, V68, P1244, DOI 10.1111/j.1523-1755.2005.00520.x; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Linsalata M, 2004, HELICOBACTER, V9, P165, DOI 10.1111/j.1083-4389.2004.00214.x; Lorca GL, 2007, BBA-BIOMEMBRANES, V1768, P1342, DOI 10.1016/j.bbamem.2007.02.007; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murakami K, 2012, BIOPSYCHOSOC MED, V6, DOI 10.1186/1751-0759-6-16; Nobuta Y., 2009, International Journal of Probiotics and Prebiotics, V4, P263; Noonpakdee W, 2004, INT J FOOD MICROBIOL, V95, P127, DOI 10.1016/j.ijfoodmicro.2004.01.020; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; RENIERO R, 1992, J GEN MICROBIOL, V138, P763, DOI 10.1099/00221287-138-4-763; Ronka E, 2003, INT J FOOD MICROBIOL, V83, P63, DOI 10.1016/S0168-1605(02)00315-X; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Salminen S, 1993, LACTIC ACID BACTERIA; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schachtsiek M, 2004, APPL ENVIRON MICROB, V70, P7078, DOI 10.1128/AEM.70.12.7078-7085.2004; Serata M, 2012, MICROBIOL-SGM, V158, P953, DOI 10.1099/mic.0.053942-0; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Siezen RJ, 2008, APPL ENVIRON MICROB, V74, P424, DOI 10.1128/AEM.01850-07; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Stasinopoulos SJ, 1999, GLYCOBIOLOGY, V9, P31, DOI 10.1093/glycob/9.1.31; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; van Kranenburg R, 2000, PLASMID, V43, P130, DOI 10.1006/plas.1999.1453; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Ventura M, 2006, APPL ENVIRON MICROB, V72, P3130, DOI 10.1128/AEM.72.5.3130-3146.2006; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Wada T, 2009, MICROBIOL-SGM, V155, P1726, DOI 10.1099/mic.0.022871-0; Wall T, 2007, APPL ENVIRON MICROB, V73, P3924, DOI 10.1128/AEM.01502-06; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Werning ML, 2006, J FOOD PROTECT, V69, P161, DOI 10.4315/0362-028X-69.1.161; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	74	38	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60521	10.1371/journal.pone.0060521	http://dx.doi.org/10.1371/journal.pone.0060521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544154	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700113
J	Li, Q; Bai, HH; Liang, WJ; Xia, JY; Wan, SQ; van der Putten, WH				Li, Qi; Bai, Huahua; Liang, Wenju; Xia, Jianyang; Wan, Shiqiang; van der Putten, Wim H.			Nitrogen Addition and Warming Independently Influence the Belowground Micro-Food Web in a Temperate Steppe	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; SPECIES RICHNESS; SOIL NEMATODES; GLOBAL CHANGE; ELEVATED CO2; PLANT; DEPOSITION; DIVERSITY; CARBON	Climate warming and atmospheric nitrogen (N) deposition are known to influence ecosystem structure and functioning. However, our understanding of the interactive effect of these global changes on ecosystem functioning is relatively limited, especially when it concerns the responses of soils and soil organisms. We conducted a field experiment to study the interactive effects of warming and N addition on soil food web. The experiment was established in 2006 in a temperate steppe in northern China After three to four years (2009-2010), we found that N addition positively affected microbial biomass and negatively influenced trophic group and ecological indices of soil nematodes. However, the warming effects were less obvious, only fungal PLFA showed a decreasing trend under warming. Interestingly, the influence of N addition did not depend on warming. Structural equation modeling analysis suggested that the direct pathway between N addition and soil food web components were more important than the indirect connections through alterations in soil abiotic characters or plant growth. Nitrogen enrichment also affected the soil nematode community indirectly through changes in soil pH and PLFA. We conclude that experimental warming influenced soil food web components of the temperate steppe less than N addition, and there was little influence of warming on N addition effects under these experimental conditions.	[Li, Qi; Bai, Huahua; Liang, Wenju] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Xia, Jianyang; Wan, Shiqiang] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Qi; van der Putten, Wim H.] Netherlands Inst Ecol, Terr Ecol Dept, Wageningen, Netherlands; [Wan, Shiqiang] Henan Univ, State Key Lab Cotton Biol, Sch Life Sci, Henan Key Lab Stress Plant Biol, Kaifeng, Henan, Peoples R China; [van der Putten, Wim H.] Univ Wageningen & Res Ctr, Nematol Lab, Wageningen, Netherlands	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Henan University; Wageningen University & Research	Li, Q (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	liq@iae.ac.cn; liangw@iae.ac.cn	van der Putten, Wim H/C-3707-2011; Xia, Jianyang/S-9499-2019; LI, Qi/N-2673-2017; Wan, Shiqiang/B-5799-2009; Wan, Shiqiang/L-9166-2019; Xia, Jianyang/A-7886-2008; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; LI, Qi/0000-0002-8652-8396; Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; KNAW, NIOO-KNAW/0000-0002-3835-159X	Natural Science Foundation of China [31170484, 30925009]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-QN403]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (31170484 and 30925009) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-QN403). The funders had no role in study desigh, data collection and analysis, decision to publsh, or preparation of the manuscript.	[Anonymous], 2002, CAUSE CORRELATION BI; Antoninka A, 2009, GLOBAL CHANGE BIOL, V15, P914, DOI 10.1111/j.1365-2486.2008.01760.x; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Contosta AR, 2012, BIOGEOCHEMISTRY, DOI [10.1007/s10533-012-9749-6, DOI 10.1007/S10533-012-9749-6]; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; De Boeck HJ, 2008, BIOGEOSCIENCES, V5, P585, DOI 10.5194/bg-5-585-2008; De Deyn GB, 2007, OIKOS, V116, P923, DOI [10.1111/j.2007.0030-1299.15761.x, 10.1111/j.0030-1299.2007.15761.x]; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Eisenhauer N, 2012, GLOBAL CHANGE BIOL, V18, P435, DOI 10.1111/j.1365-2486.2011.02555.x; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Fujimura KE, 2008, ISME J, V2, P105, DOI 10.1038/ismej.2007.89; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grace J.B., 2006, STRUCT EQ MOD NAT; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hattori T., 1988, Reports of the Institute for Agricultural Research, Tohoku University, V37, P23; Hoeksema JD, 2000, PEDOBIOLOGIA, V44, P725, DOI 10.1078/S0031-4056(04)70085-2; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Liang WJ, 2009, SOIL BIOL BIOCHEM, V41, P883, DOI 10.1016/j.soilbio.2008.06.018; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Manning P, 2008, OECOLOGIA, V157, P661, DOI 10.1007/s00442-008-1104-0; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Maraldo K, 2010, PEDOBIOLOGIA, V53, P161, DOI 10.1016/j.pedobi.2009.10.003; Niu SL, 2008, ENVIRON EXP BOT, V63, P91, DOI 10.1016/j.envexpbot.2007.10.016; Oostenbrink M., 1960, NEMATOLOGY; Papanikolaou N, 2010, GLOBAL CHANGE BIOL, V16, P3120, DOI 10.1111/j.1365-2486.2010.02196.x; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schuur EAG, 2007, ECOSYSTEMS, V10, P280, DOI 10.1007/s10021-007-9024-0; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowerby A, 2005, SOIL BIOL BIOCHEM, V37, P1805, DOI 10.1016/j.soilbio.2005.02.023; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Verburg PSJ, 2009, GLOBAL CHANGE BIOL, V15, P888, DOI 10.1111/j.1365-2486.2008.01797.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2003, OIKOS, V102, P45, DOI 10.1034/j.1600-0706.2003.12481.x; Wei CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043384; Weltzin JF, 2003, GLOBAL CHANGE BIOL, V9, P141, DOI 10.1046/j.1365-2486.2003.00571.x; Wu ZT, 2011, ECOSYSTEMS, V14, P1066, DOI 10.1007/s10021-011-9464-4; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015	72	66	78	19	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60441	10.1371/journal.pone.0060441	http://dx.doi.org/10.1371/journal.pone.0060441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544140	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700099
J	Sulzenbruck, S; Heuer, H				Suelzenbrueck, Sandra; Heuer, Herbert			Effective Part-Task Training as Evidence of Distinct Adaptive Processes with Different Time Scales	PLOS ONE			English	Article							INTERNAL-MODELS; INVERSE MODELS; MOTOR; ADAPTATION; TRANSFORMATION; APPROXIMATIONS; MECHANISMS; RESOURCE; MEMORY	For some types of visuo-motor transformations like large visuo-motor rotations or the complex transformation of a sliding first-order lever, distinct adaptive processes have been hypothesized that produce a rapid, discrete approximation of the transformation and a slow, graded fine tuning, respectively. Here we investigate whether part task training of only the second of these processes, namely the fine tuning, transfers to the subsequent performance in a condition with the full transformation of the sliding first-order lever. Therefore, we compared performance of three groups with different practice conditions during transfer to the full transformation. While two groups only practiced the fine tuning without the right left inversion of the lever prior to transfer, a third group practiced the full lever transformation. Our results show a positive, but less than perfect transfer of the isolated practice of the fine tuning on performance with the full transformation. For the fine tuning itself, transfer was not reliably different from being perfect. The observation that the fine tuning can be acquired separately and added to the later adaptation to the left-right inversion of the lever supports the notion that these slow and fast processes progress rather independently. The additional finding that the preceding acquisition of the fine tuning also facilitates the subsequent rapid process could be due to generalized learning-to-learn or to a more precise assignment of movement errors to the process from which they originate.	[Suelzenbrueck, Sandra; Heuer, Herbert] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Sulzenbruck, S (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	suelzenbrueck@ifado.de		Heuer, Herbert/0000-0002-0488-2878; Sulzenbruck, Sandra/0000-0001-9527-8344	Deutsche Forschungsgemeinschaft (DFG) [HE 1187/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by grant HE 1187/16-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Anguera JA, 2012, BEHAV BRAIN RES, V228, P107, DOI 10.1016/j.bbr.2011.11.040; Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Bock O, 2001, EXP BRAIN RES, V138, P359, DOI 10.1007/s002210100704; Bock O, 2005, EXP RES, V160, P259; Davidson PR, 2004, EXP BRAIN RES, V155, P334, DOI 10.1007/s00221-003-1730-z; Davidson PR, 2000, HUM MOVEMENT SCI, V19, P761, DOI 10.1016/S0167-9457(00)00022-1; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Gallagher AG, 1998, ENDOSCOPY, V30, P617, DOI 10.1055/s-2007-1001366; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; Ghez C, 1997, EXP BRAIN RES, V115, P217, DOI 10.1007/PL00005692; Guadagnoli M, 2004, J MOTOR BEHAV, V36, P334; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Heuer H, 2012, NEUROSCIENCE, V207, P137, DOI 10.1016/j.neuroscience.2012.01.035; Heuer H., 1983, BEWEGUNGSLERNEN; HEUER H, 2013, HDB PSYCHOL, V4, P320; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2012, HUM MOVEMENT SCI, V31, P1056, DOI 10.1016/j.humov.2012.01.004; Heuer H, 2012, ERGONOMICS, V55, P1157, DOI 10.1080/00140139.2012.703697; Heuer H, 2009, J EXP PSYCHOL HUMAN, V35, P375, DOI 10.1037/0096-1523.35.2.375; Huang FC, 2012, IEEE T HAPTICS, V5, P356, DOI [10.1109/TOH.2011.52, 10.1109/ToH.2011.52]; Jordan M. I., 1996, HDB PERCEPTION ACTIO, V2, P71, DOI DOI 10.1016/S1874-5822(06)80005-8; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Lee FJ, 2001, COGNITIVE PSYCHOL, V42, P267, DOI 10.1006/cogp.2000.0747; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; Macmillan AIM, 1999, AM J SURG, V177, P274, DOI 10.1016/S0002-9610(99)00016-1; McNay EC, 1998, LEARN MEMORY, V4, P411, DOI 10.1101/lm.4.5.411; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Nakano E, 2002, SYST COMPUT JPN, V33, P814; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sulzenbruck S, 2012, EXP BRAIN RES, V218, P283, DOI 10.1007/s00221-012-3011-1; Sulzenbruck S, 2011, ERGONOMICS, V54, P34, DOI 10.1080/00140139.2010.535023; Sulzenbruck S, 2010, EXP BRAIN RES, V201, P549, DOI 10.1007/s00221-009-2071-3; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; Werner S, 2010, HUM MOVEMENT SCI, V29, P172, DOI 10.1016/j.humov.2010.02.004; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	41	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60196	10.1371/journal.pone.0060196	http://dx.doi.org/10.1371/journal.pone.0060196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544133	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700092
J	Xiang, YQ; Cheng, Y; Li, XT; Li, QL; Xu, JW; Zhang, JY; Liu, Y; Xing, QH; Wang, L; He, L; Zhao, XZ				Xiang, Yuqian; Cheng, Yan; Li, Xiaotian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi			Up-Regulated Expression and Aberrant DNA Methylation of LEP and SH3PXD2A in Pre-Eclampsia	PLOS ONE			English	Article							GENE-EXPRESSION; PROMOTER HYPOMETHYLATION; EPIGENETIC MECHANISMS; PLACENTAL LEPTIN; BREAST-CANCER; FOLIC-ACID; PROTEIN; INVASION; HYPERTENSION; HOMOCYSTEINE	The primary mechanism underlying pre-eclampsia (PE) remains one of the most burning problems in the obstetrics and gynecology. In this study, we performed an expression profiling screen and detected 1312 genes that were differentially expressed (p<0.05 and fold change >1.5) in PE placentas, including LEP and SH3PXD2A. After validating the microarray results, we conducted the quantitative methylation analysis of LEP and SH3PXD2A in preeclamptic (n=16) versus normal placentas (n = 16) Our results showed that many CpG sites close to the transcriptional start site (TSS) of LEP gene were hypomethylated in placentas from pregnancies with PE compared with those of in controls, including the TSS position (p = 0.001), the binding sites of Sp1 (p = 1.57 x 10(-4)), LP1 (p=0.023) and CEBP alpha (p=0.031). Luciferase reporter analysis confirmed the aberrant methylation of LEP promoter and CEBP alpha co-transfection had a role in the regulation of gene expression. Our results indicated the aberrant LEP promoter methylation was involved in the development of PE. We did not find a significant methylation differences between groups in the promoter region of SH3PXD2A, however, a CGI region in the gene body (CGI34) presented a higher methylation in preeclamptic placentas (p = 1.57 x 10(-4)), which might promote the efficiency of gene transcription. We speculated that SH3PXD2A may take part in the pathogenesis of PE through its role in the regulation of trophoblast cell invasion in the period of placenta formation.	[Xiang, Yuqian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Xiang, Yuqian; Li, Qiaoli; Xu, Jiawei; Zhang, Junyu; Liu, Yun; Xing, Qinghe; Wang, Lei; He, Lin; Zhao, Xinzhi] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Cheng, Yan; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	He, L (corresponding author), Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China.	helin@bio-x.cn; xzzhao@fudan.edu.cn	xu, jiawei/GWM-9710-2022; Li, Xiaotian/ABI-3309-2020; Zhang, Junyu/AAF-6658-2019	Li, Xiaotian/0000-0002-2051-4581; Zhang, Junyu/0000-0003-0239-6670	973 Program [2009825606, 2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Natural Science Foundation of China [30800616, 81000256, 81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Rising-Star Program [09QA1400500]; Mingdao Program of Medical Student [MDJH2012027]	973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Rising-Star Program; Mingdao Program of Medical Student	This work was supported by the 973 Program (2009825606, 2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Natural Science Foundation of China (30800616, 81000256, 81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Shanghai Rising-Star Program (09QA1400500) and the Mingdao Program of Medical Student (MDJH2012027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; Guven MA, 2009, HYPERTENS PREGNANCY, V28, P190, DOI 10.1080/10641950802601179; Hennessy A, 1999, J IMMUNOL, V163, P3491; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kang JH, 2011, J HYPERTENS, V29, P928, DOI 10.1097/HJH.0b013e328344a82c; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Knox KS, 2007, MOL HUM REPROD, V13, P251, DOI 10.1093/molehr/gal116; Kulkarni A, 2011, DNA CELL BIOL, V30, P79, DOI 10.1089/dna.2010.1084; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Louwen F, 2012, ONCOTARGET, V3, P759; Makedos Georgios, 2007, Archives of Gynecology and Obstetrics, V275, P121, DOI 10.1007/s00404-006-0223-2; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Mousa AA, 2012, AM J PATHOL, V181, P1455, DOI 10.1016/j.ajpath.2012.06.019; Muller HM, 2004, CLIN CHEM, V50, P1065, DOI 10.1373/clinchem.2003.030387; Nakatsukasa H, 2008, ENDOCR J, V55, P565, DOI 10.1507/endocrj.K07E-136; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; O'Neil JS, 2001, MOL CELL ENDOCRINOL, V176, P67, DOI 10.1016/S0303-7207(01)00473-7; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Ramma W, 2012, ANGIOGENESIS, V15, P333, DOI 10.1007/s10456-012-9261-5; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh Urmila, 2008, J Indian Med Assoc, V106, P503; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Stylli SS, 2012, J CLIN NEUROSCI, V19, P436, DOI 10.1016/j.jocn.2011.11.013; Toft JH, 2008, J MATERN-FETAL NEO M, V21, P267, DOI 10.1080/14767050801924118; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Weaver AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.288pe56; Xiang Y, 2012, MOL HUM REP IN PRESS; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao AM, 2011, MOL HUM REPROD, V17, P199, DOI 10.1093/molehr/gaq092	55	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59753	10.1371/journal.pone.0059753	http://dx.doi.org/10.1371/journal.pone.0059753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544093	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700053
J	Zhou, PY; Liu, X				Zhou, Pingyan; Liu, Xun			Attentional Modulation of Emotional Conflict Processing with Flanker Tasks	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FACIAL EXPRESSIONS; SELECTIVE ATTENTION; NEURAL MECHANISMS; RESOLVE CONFLICT; VISUAL-ATTENTION; STROOP TASK; FACES; ADVANTAGE; AMYGDALA	Emotion processing has been shown to acquire priority by biasing allocation of attentional resources. Aversive images or fearful expressions are processed quickly and automatically. Many existing findings suggested that processing of emotional information was pre-attentive, largely immune from attentional control. Other studies argued that attention gated the processing of emotion. To tackle this controversy, the current study examined whether and to what degrees attention modulated processing of emotion using a stimulus-response-compatibility (SRC) paradigm. We conducted two flanker experiments using color scale faces in neutral expressions or gray scale faces in emotional expressions. We found SRC effects for all three dimensions (color, gender, and emotion) and SRC effects were larger when the conflicts were task relevant than when they were task irrelevant, suggesting that conflict processing of emotion was modulated by attention, similar to those of color and face identity (gender). However, task modulation on color SRC effect was significantly greater than that on gender or emotion SRC effect, indicating that processing of salient information was modulated by attention to a lesser degree than processing of non-emotional stimuli. We proposed that emotion processing can be influenced by attentional control, but at the same time salience of emotional information may bias toward bottom-up processing, rendering less top down modulation than that on non-emotional stimuli.	[Zhou, Pingyan; Liu, Xun] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhou, Pingyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, X (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liux@psych.ac.cn	Liu, Xun/C-2400-2009	Liu, Xun/0000-0003-1366-8926	Chinese Academy of Sciences [Y2CX131003]	Chinese Academy of Sciences(Chinese Academy of Sciences)	International Innovative Team Program of Chinese Academy of Sciences (Grant Y2CX131003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2005, J EXP PSYCHOL GEN, V134, P258, DOI 10.1037/0096-3445.134.2.258; Anderson AK, 2003, J NEUROSCI, V23, P5627; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Baguley T, 2012, BEHAV RES METHODS, V44, P158, DOI 10.3758/s13428-011-0123-7; Beall P, 2008, COGNITION EMOTION, V22, P1613, DOI 10.1080/02699930801940370; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2008, ANN NY ACAD SCI, V1129, P141, DOI 10.1196/annals.1417.016; Calvo MG, 2005, VIS COGN, V12, P13, DOI 10.1080/13506280444000094; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303002002003; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1991, J NEUROSCI, V11, P2383; de Oca BM, 2012, J GEN PSYCHOL, V139, P289, DOI 10.1080/00221309.2012.708681; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Erthal FS, 2005, COGN AFFECT BEHAV NE, V5, P388, DOI 10.3758/CABN.5.4.388; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Fenske MJ, 2006, CURR DIR PSYCHOL SCI, V15, P312, DOI 10.1111/j.1467-8721.2006.00459.x; Fenske MJ, 2004, PSYCHON B REV, V11, P1055, DOI 10.3758/BF03196736; Fenske MJ, 2005, PSYCHOL SCI, V16, P753, DOI 10.1111/j.1467-9280.2005.01609.x; Frank DW, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00116; Franz VH, 2012, PSYCHON B REV, P1; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Gomez-Cuerva J, 2011, PSYCHON B REV, V18, P1057, DOI 10.3758/s13423-011-0170-1; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Hahn S, 2006, ACTA PSYCHOL, V123, P312, DOI 10.1016/j.actpsy.2006.01.008; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Morawetz C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00226; Mothes-Lasch M, 2011, J NEUROSCI, V31, P9594, DOI 10.1523/JNEUROSCI.6665-10.2011; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2003, J NEUROSCI, V23, P3990; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Raymond JE, 2005, J EXP PSYCHOL HUMAN, V31, P1404, DOI 10.1037/0096-1523.31.6.1404; Raymond JE, 2003, PSYCHOL SCI, V14, P537, DOI 10.1046/j.0956-7976.2003.psci_1462.x; Reinholdt-Dunne ML, 2009, BEHAV RES THER, V47, P410, DOI 10.1016/j.brat.2009.01.012; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Richards A, 2004, EMOTION, V4, P275, DOI 10.1037/1528-3542.4.3.275; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Schultheiss OC, 2007, MOTIV EMOTION, V31, P13, DOI 10.1007/s11031-006-9042-9; Shafer AT, 2012, J COGNITIVE NEUROSCI, V24, P1233, DOI 10.1162/jocn_a_00206; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Stenberg G, 1998, COGNITION EMOTION, V12, P755, DOI 10.1080/026999398379420; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	71	10	12	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60548	10.1371/journal.pone.0060548	http://dx.doi.org/10.1371/journal.pone.0060548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544155	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700114
J	Kabir, Z; Daly, S; Clarke, V; Keogan, S; Clancy, L				Kabir, Zubair; Daly, Sean; Clarke, Vanessa; Keogan, Sheila; Clancy, Luke			Smoking Ban and Small-For-Gestational Age Births in Ireland	PLOS ONE			English	Article							MATERNAL SMOKING; PRETERM BIRTH; WEIGHT; EXPOSURE; FETAL; RISK; LEGISLATION; OUTCOMES; WORKERS; HEALTH	Background: Ireland introduced a comprehensive workplace smoke-free legislation in March, 2004. Smoking-related adverse birth outcomes have both health care and societal cost implications. The main aim of this study was to determine the impact of the Irish smoke-free legislation on small-for-gestationa-age (SGA) births. Methods and Findings: We developed a population-based birthweight (BW) percentile curve based on a recent study to compute SGA (BW < 5th percentile) and very SGA (vSGA-BW < 3rd percentile) for each gestational week. Monthly births born between January 1999 and December 2008 were analyzed linking with monthly maternal smoking rates from a large referral maternity university hospital. We ran individual control and CUSUM charts, with bootstrap simulations, to pinpoint the breakpoint for the impact of ban implementation (=April 2004). Monthly SGA rates (%) before and after April 2004 was considered pre and post ban period births, respectively. Autocorrelation was tested using Durbin Watson (DW) statistic. Mixed models using a random intercept and a fixed effect were employed using SAS (v 9.2). A total of 588,997 singleton live-births born between January 1999 and December 2008 were analyzed. vSGA and SGA monthly rates declined from an average of 4.7% to 4.3% and from 6.9% to 6.6% before and after April 2004, respectively. No auto-correlation was detected (DW =similar to 2). Adjusted mixed models indicated a significant decline in both vSGA and SGA rates immediately after the ban [(-5.3%; 95% CI -5.43% to -5.17%, p < 0.0001) and (-0.45%; 95% CI: -0.7% to -0.19%, p < 0.0007)], respectively. Significant gradual effects continued post the ban periods for vSGA and SGA rates, namely, -0.6% (p < 0.0001) and -0.02% (p < 0.0001), respectively. Conclusions: A significant reduction in small-for-gestational birth rates both immediately and sustained over the post-ban period, reinforces the mounting evidence of the positive health effect of a successful comprehensive smoke-free legislation in a vulnerable population group as pregnant women.	[Kabir, Zubair; Clarke, Vanessa; Keogan, Sheila; Clancy, Luke] TobaccoFree Res Inst Ireland, Dublin, Ireland; [Kabir, Zubair] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Daly, Sean] Coombe Women & Infants Univ Hosp, Dublin, Ireland	University College Cork; Trinity College Dublin	Kabir, Z (corresponding author), TobaccoFree Res Inst Ireland, Dublin, Ireland.	z.kabir@ucc.ie	clancy, luke/ABA-1826-2020; Clancy, Luke/O-6597-2019	Clancy, Luke/0000-0003-2407-2263; Kabir, Zubair/0000-0003-1529-004X	Health Research Board of Ireland [PD/2009/34]	Health Research Board of Ireland	Dr. Zubair Kabir has a Career Development Award supported by the Health Research Board of Ireland (PD/2009/34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Ashford KB, 2010, NICOTINE TOB RES, V12, P127, DOI 10.1093/ntr/ntp185; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; Chiolero A, 2005, SWISS MED WKLY, V135, P525; Cnattingius S, 2005, NICOTINE TOB RES S2, V2, pS125; Donnelly JC, 2008, J PERINAT MED, V36, P70, DOI 10.1515/JPM.2008.006; El-Mohandes AAE, 2010, PEDIATRICS, V125, P721, DOI 10.1542/peds.2009-1809; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; Goodman P, 2007, AM J RESP CRIT CARE, V175, P840, DOI 10.1164/rccm.200608-1085OC; IARC, 2004, IARC MON EV CARC RIS, V83; Kabir Z, 2010, ARCH DIS CHILD, V95, P42, DOI 10.1136/adc.2008.155218; Kabir Z, 2009, BJOG-INT J OBSTET GY, V116, P1782, DOI 10.1111/j.1471-0528.2009.02374.x; Kabir Z, 2012, J WOMENS HEALTH, V21, P616, DOI 10.1089/jwh.2012.3695; Khashan AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-36; LIEBERMAN E, 1994, AM J PUBLIC HEALTH, V84, P1127, DOI 10.2105/AJPH.84.7.1127; Mackay DF, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001175; McDonnell-Naughton M, 2012, Ir Med J, V105, P105; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mons U, 2012, TOB CONTROL; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Page RL, 2012, J WOMENS HEALTH, V21, P621, DOI 10.1089/jwh.2011.3305; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Pfarrer C, 1999, LANCET, V354, P303, DOI 10.1016/S0140-6736(99)01676-1; Reeves Shane, 2008, Expert Rev Obstet Gynecol, V3, P719, DOI 10.1586/17474108.3.6.719; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Vielwerth SE, 2007, EARLY HUM DEV, V83, P491, DOI 10.1016/j.earlhumdev.2006.09.010	27	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e57441	10.1371/journal.pone.0057441	http://dx.doi.org/10.1371/journal.pone.0057441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555561	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500004
J	Tumminello, M; Micciche, S; Varho, J; Piilo, J; Mantegna, RN				Tumminello, Michele; Micciche, Salvatore; Varho, Jan; Piilo, Jyrki; Mantegna, Rosario N.			Quantitative Analysis of Gender Stereotypes and Information Aggregation in a National Election	PLOS ONE			English	Article							CANDIDATES	By analyzing a database of a questionnaire answered by a large majority of candidates and elected in a parliamentary election, we quantitatively verify that (i) female candidates on average present political profiles which are more compassionate and more concerned with social welfare issues than male candidates and (ii) the voting procedure acts as a process of information aggregation. Our results show that information aggregation proceeds with at least two distinct paths. In the first case candidates characterize themselves with a political profile aiming to describe the profile of the majority of voters. This is typically the case of candidates of political parties which are competing for the center of the various political dimensions. In the second case, candidates choose a political profile manifesting a clear difference from opposite political profiles endorsed by candidates of a political party positioned at the opposite extreme of some political dimension.	[Tumminello, Michele] Univ Palermo, Dipartimento Sci Stat & Matemat Silvio Vianelli, Palermo, Italy; [Tumminello, Michele] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy; [Varho, Jan; Piilo, Jyrki] Univ Turku, Dept Phys & Astron, Turku, Finland; [Mantegna, Rosario N.] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Mantegna, Rosario N.] Cent European Univ, Dept Econ, Budapest, Hungary	University of Palermo; Carnegie Mellon University; University of Palermo; University of Turku; Central European University; Central European University	Mantegna, RN (corresponding author), Univ Palermo, Dipartimento Fis & Chim, Palermo, Italy.	rn.mantegna@gmail.com	Tumminello, Michele/G-4492-2011; Mantegna, Rosario N/H-3652-2014; Miccichè, Salvatore/B-6575-2008; Piilo, Jyrki/D-3043-2011	Tumminello, Michele/0000-0001-6045-6761; Mantegna, Rosario N/0000-0003-4177-171X; Miccichè, Salvatore/0000-0003-3779-592X; Piilo, Jyrki/0000-0002-5595-873X	Jenny and Antti Wihuri Foundation	Jenny and Antti Wihuri Foundation	JP and JV acknowledge financial support from Jenny and Antti Wihuri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AustenSmith D, 1996, AM POLIT SCI REV, V90, P34, DOI 10.2307/2082796; Easley D, 2010, NETWORKS CROWDS MARK; Feddersen T, 1997, ECONOMETRICA, V65, P1029, DOI 10.2307/2171878; Feddersen T, 1999, P NATL ACAD SCI USA, V96, P10572, DOI 10.1073/pnas.96.19.10572; HUDDY L, 1993, AM J POLIT SCI, V37, P119, DOI 10.2307/2111526; Koch JW, 2000, J POLIT, V62, P414, DOI 10.1111/0022-3816.00019; McDermott ML, 1997, AM J POLIT SCI, V41, P270, DOI 10.2307/2111716; Piketty T, 1999, EUR ECON REV, V43, P791, DOI 10.1016/S0014-2921(98)00094-4; Piketty T, 2000, REV ECON STUD, V67, P169, DOI 10.1111/1467-937X.00126; Razin R, 2003, ECONOMETRICA, V71, P1083, DOI 10.1111/1468-0262.00440; Sanbonmatsu K, 2002, AM J POLIT SCI, V46, P20, DOI 10.2307/3088412; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019	12	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58910	10.1371/journal.pone.0058910	http://dx.doi.org/10.1371/journal.pone.0058910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555606	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500018
J	Zhang, XX; Tang, XX; Zhou, B; Wang, Y				Zhang, Xinxin; Tang, Xuexi; Zhou, Bin; Wang, You			Effects of Decabromodiphenyl Ether (BDE-209) on Inter-Specific Competition between Two Species of Marine Bloom-Forming Microalgae	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; HARMFUL ALGAL BLOOMS; POLYCHLORINATED-BIPHENYLS; CHLOROPLAST ULTRASTRUCTURE; PROROCENTRUM-DONGHAIENSE; DEVELOPMENTAL EXPOSURE; CHEMICAL INTERFERENCE; HETEROSIGMA-AKASHIWO; GROWTH-INHIBITION	Decabromodiphenyl ether (BDE-209), a new kind of persistent organic pollutants, was selected to investigate its influence on population growth and inter-specific competition between two species of marine bloom-forming microalgae, Heterosigma akashiwo and Karenia mikimotoi. (1) BDE-209 showed acute toxic effects on both microalgae and H. akashiwo was more sensitive from view of 96 h-EC50 and the ultrastructure variation. (2) The microalgal population growth patterns in mono-culture were density-dependent and the growth of both species in the normal co-culture was significantly depressed by competition (P<0.05) with different initial biomass ratios. BDE-209 exposure significantly changed the growth. (3) Lotka-Volterra competition model was used to simulate the interaction between the microalgae. BDE-209 exposure broke the competitive balance to make competition gradually shift in favor of H. akashiwo. Results suggested BDE-209 did have toxic effects on either microalgal growth or the inter-specific competition, which was quite different from previous reports. Further exploration of the mechanism is needed.	[Zhang, Xinxin; Tang, Xuexi; Zhou, Bin; Wang, You] Ocean Univ China, Dept Marine Ecol, Coll Marine Life Sci, Qingdao, Peoples R China	Ocean University of China	Wang, Y (corresponding author), Ocean Univ China, Dept Marine Ecol, Coll Marine Life Sci, Qingdao, Peoples R China.	wangyou@ouc.edu.cn			Natural Science Foundation of China [41076066, 31070458]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of China (41076066 and 31070458), www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; APHA A, 1985, STANDARD METHODS EXA; ASPLUND L, 1999, ORGANOHALOGEN COMPD, V40, P351; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Bondada BR, 2000, J AM SOC HORTIC SCI, V125, P553, DOI 10.21273/JASHS.125.5.553; BSEF Bromine Science and Environmental Forum, 2003, MAJ BROM FLAM RET VO; Burreau S, 2004, CHEMOSPHERE, V55, P1043, DOI 10.1016/j.chemosphere.2003.12.018; [蔡恒江 Cai Hengjiang], 2005, [海洋环境科学, Marine Environmental Science], V24, P37; CARBALLEIRA A, 1988, J CHEM ECOL, V14, P1775, DOI 10.1007/BF01014643; Cavender-Bares KK, 2001, LIMNOL OCEANOGR, V46, P778, DOI 10.4319/lo.2001.46.4.0778; Chattopadhyay J, 1996, ECOL MODEL, V84, P287, DOI 10.1016/0304-3800(94)00134-0; Christensen JH, 2001, J ENVIRON MONITOR, V3, P543, DOI 10.1039/b105501c; Christensen JR, 2005, ENVIRON SCI TECHNOL, V39, P6952, DOI 10.1021/es050749f; Covaci A, 2008, ENVIRON SCI TECHNOL, V42, P8654, DOI 10.1021/es8016528; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; European Commission, 2004, UPD RISK ASS BIS PEN; European Commission, 2003, DIPH ETH OCT DER; Gabara B, 2003, PLANT SCI, V164, P507, DOI 10.1016/S0168-9452(02)00447-8; Goodman JE, 2009, REGUL TOXICOL PHARM, V54, P91, DOI 10.1016/j.yrtph.2009.02.006; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HAGER SW, 1968, PRACTICAL MANUAL USE; Hardy M.L., 2000, ORGANOHALOGEN COMPOU, V47, P237; Imai I, 1996, HARMFUL TOXIC ALGAL, P197; IWASA Y, 1998, SURI SEIBUTUGAKU NYU, P352; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P8243, DOI 10.1021/es051551y; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Kallqvist T, 2006, ENVIRON TOXICOL CHEM, V25, P1657, DOI 10.1897/05-424R.1; Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421; Law RJ, 2006, CHEMOSPHERE, V64, P187, DOI 10.1016/j.chemosphere.2005.12.007; Lebeuf M, 2006, ENVIRON SCI TECHNOL, V40, P3211, DOI 10.1021/es0521829; Lema SC, 2007, AQUAT TOXICOL, V82, P296, DOI 10.1016/j.aquatox.2007.03.002; Li A, 2006, ENVIRON SCI TECHNOL, V40, P7528, DOI 10.1021/es0609506; Litchman E, 2001, AM NAT, V157, P170, DOI 10.1086/318628; Madhu NV, 2011, INDIAN J GEO-MAR SCI, V40, P821; [孟范平 MENG Fanping], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P1659; Moller A, 2012, ATMOS ENVIRON, V46, P346, DOI 10.1016/j.atmosenv.2011.09.055; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Moreno-Garrido I, 2000, ECOTOX ENVIRON SAFE, V47, P112, DOI 10.1006/eesa.2000.1953; Mulderij G, 2005, AQUAT ECOL, V39, P11, DOI 10.1007/s10452-004-1021-1; Nakamaru M, 2000, THEOR POPUL BIOL, V57, P131, DOI 10.1006/tpbi.1999.1448; ORIS JT, 1985, AQUAT TOXICOL, V6, P133, DOI 10.1016/0166-445X(85)90012-8; Peng Q, 2009, J RARE EARTH, V27, P304, DOI 10.1016/S1002-0721(08)60238-0; Roy S, 2006, B MATH BIOL, V68, P2303, DOI 10.1007/s11538-006-9109-5; Schecter Arnold, 2006, Toxicological and Environmental Chemistry, V88, P319, DOI 10.1080/02772240600605087; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Sellstrom U, 1999, ORGANOHALOGEN COMPD, V40, P383; Sinkkonen A, 2003, PLANT SOIL, V250, P315, DOI 10.1023/A:1022841503476; Sinkkonen A, 2001, J CHEM ECOL, V27, P1513, DOI 10.1023/A:1010329612753; Sinkkonen Aki, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P225, DOI 10.2201/nonlin.003.02.004; *SIS, 1991, 028106 SS SIS, P17; Sole J, 2005, ECOL MODEL, V183, P373, DOI 10.1016/j.ecolmodel.2004.08.021; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2007, LIMNOECOLOGY, P89; Ter Schure AFH, 2004, ENVIRON SCI TECHNOL, V38, P1282, DOI 10.1021/es0348086; Twiner MJ, 2005, HARMFUL ALGAE, V4, P789, DOI 10.1016/j.hal.2004.12.006; Uchida T, 1999, J EXP MAR BIOL ECOL, V241, P285, DOI 10.1016/S0022-0981(99)00088-X; USEPA (United States Environmental Protection Agency), 2010, EXP ASS POL DIPH ETH, P378; Van den Steen E, 2007, ENVIRON POLLUT, V148, P648, DOI 10.1016/j.envpol.2006.11.017; Van der Ven LTM, 2008, TOXICOL LETT, V179, P6, DOI 10.1016/j.toxlet.2008.03.003; Wang Y, 2008, HARMFUL ALGAE, V7, P65, DOI 10.1016/j.hal.2007.05.005; Wang Y, 2006, J SEA RES, V56, P17, DOI 10.1016/j.seares.2006.04.002; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; *WHO, 1994, 162 WHO; Xie Zhi-hao, 2008, Marine Environmental Science, V27, P462; Xie ZY, 2011, ENVIRON SCI TECHNOL, V45, P1820, DOI 10.1021/es103803t; Yamane K, 2004, PLANT PROD SCI, V7, P435, DOI 10.1626/pps.7.435; Zhang MP, 2010, J PLANT PHYSIOL, V167, P277, DOI 10.1016/j.jplph.2009.09.017; Zhang XX, 2012, MAR ENV SCI IN PRESS; Zhao Xiao-Wei, 2009, Chinese Journal of Plant Ecology, V33, P958, DOI 10.3773/j.issn.1005-264x.2009.05.015; [董云伟 Zhong Yunwei], 2004, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V34, P964; Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105; Zhu L. X, 1983, ELECT MICROSCOPY BIO, P38; Zou YN, 2010, HARMFUL ALGAE, V9, P367, DOI 10.1016/j.hal.2010.01.005	74	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e56084	10.1371/journal.pone.0056084	http://dx.doi.org/10.1371/journal.pone.0056084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555557	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400002
J	Andrews, KA; Modat, M; Macdonald, KE; Yeatman, T; Cardoso, MJ; Leung, KK; Barnes, J; Villemagne, VL; Rowe, CC; Fox, NC; Ourselin, S; Schott, JM				Andrews, K. Abigail; Modat, Marc; Macdonald, Kate E.; Yeatman, Tom; Cardoso, M. Jorge; Leung, Kelvin K.; Barnes, Josephine; Villemagne, Victor L.; Rowe, Christopher C.; Fox, Nick C.; Ourselin, Sebastien; Schott, Jonathan M.		Australian Imaging Biomarkers; Lifestyle Flagship Study Ageing	Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; BIOMARKER SIGNATURE; HIPPOCAMPAL ATROPHY; A-BETA; DISEASE; BRAIN; VOLUME; MRI; DEPOSITION	There is considerable interest in designing therapeutic studies of individuals at risk of Alzheimer disease (AD) to prevent the onset of symptoms. Cortical beta-amyloid plaques, the first stage of AD pathology, can be detected in vivo using positron emission tomography (PET), and several studies have shown that similar to 1/3 of healthy elderly have significant beta-amyloid deposition. Here we assessed whether asymptomatic amyloid-PET-positive controls have increased rates of brain atrophy, which could be harnessed as an outcome measure for AD prevention trials. We assessed 66 control subjects (age = 73.5 +/- 7.3 yrs; MMSE = 29 +/- 1.3) from the Australian Imaging Biomarkers & Lifestyle study who had a baseline Pittsburgh Compound B (PiB) PET scan and two 3T MRI scans similar to 18-months apart. We calculated PET standard uptake value ratios (SUVR), and classified individuals as amyloid-positive/negative. Baseline and 18-month MRI scans were registered, and brain, hippocampal, and ventricular volumes and annualized volume changes calculated. Increasing baseline PiB-PET measures of beta-amyloid load correlated with hippocampal atrophy rate independent of age (p = 0.014). Twenty-two (1/3) were PiB-positive (SUVR>1.40), the remaining 44 PiB-negative (SUVR <= 1.31). Compared to PiB-negatives, PiB-positive individuals were older (76.8 +/- 7.5 vs. 71.7 +/- 7.5, p<0.05) and more were APOE4 positive (63.6% vs. 19.2%, p<0.01) but there were no differences in baseline brain, ventricle or hippocampal volumes, either with or without correction for total intracranial volume, once age and gender were accounted for. The PiB-positive group had greater total hippocampal loss (0.06 +/- 0.08 vs. 0.02 +/- 0.05 ml/yr, p = 0.02), independent of age and gender, with non-significantly higher rates of whole brain (7.1 +/- 9.4 vs. 4.7 +/- 5.5 ml/yr) and ventricular (2.0 +/- 3.0 vs. 1.1 +/- 1.0 ml/yr) change. Based on the observed effect size, recruiting 384 (95% CI 195-1080) amyloid-positive subjects/arm will provide 80% power to detect 25% absolute slowing of hippocampal atrophy rate in an 18-month treatment trial. We conclude that hippocampal atrophy may be a feasible outcome measure for secondary prevention studies in asymptomatic amyloidosis.	[Andrews, K. Abigail; Modat, Marc; Macdonald, Kate E.; Yeatman, Tom; Cardoso, M. Jorge; Leung, Kelvin K.; Barnes, Josephine; Villemagne, Victor L.; Rowe, Christopher C.; Fox, Nick C.; Ourselin, Sebastien; Schott, Jonathan M.] UCL, DRC, London, England; [Andrews, K. Abigail; Modat, Marc; Cardoso, M. Jorge; Leung, Kelvin K.; Ourselin, Sebastien] UCL, CMIC, London, England; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Ctr PET, Heidelberg, Vic, Australia	University of London; University College London; University of London; University College London; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Andrews, KA (corresponding author), UCL, DRC, London, England.	a.andrews@ucl.ac.uk	Barnes, Josesphine/P-5698-2014; Villemagne, Victor/AAC-5406-2019; Schott, Jonathan M/A-9065-2011; Fox, Nick C/B-1319-2009; Fox, Nick C/AAE-1849-2021; Rowe, Christopher/AAX-8748-2021; Ourselin, Sebastien/K-6960-2015; Cardoso, M. Jorge/N-5511-2018	Villemagne, Victor/0000-0002-5832-9875; Schott, Jonathan M/0000-0003-2059-024X; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Ourselin, Sebastien/0000-0002-5694-5340; Cardoso, M. Jorge/0000-0003-1284-2558; Modat, Marc/0000-0002-5277-8530; Barnes, Josephine/0000-0003-3178-025X	National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia; ARUK; Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing; Austin Hospital Medical Research Foundation, Neurosciences Victoria; University of Melbourne; EPSRC; IXICO Ltd; UCLH/UCL NIHR CBRC grant [168]; EPSRC [EP/W046410/1]; MRC (UK) [G0601846 PI]; National Institute on Aging (NIH) USA; UK Alzheimer's Society; Midas image processing software licences; CSIRO; Bayer; Avid Radiopharmaceuticals; GE Healthcare; Astra Zeneca; NHMRC/ADDF; AVID Radiopharmaceuticals Inc; Henry Stewart talks; Alzheimers Research UK [ART-EG2010B-1, ARUK-Network2011-6-ICE] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046410/1, 1031290] Funding Source: researchfish; Medical Research Council [G0601846] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI; MRC [G0601846] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Unit in Dementia(National Institute for Health Research (NIHR)); ARUK(Alzheimer's Research UK (ARUK)); Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing; Austin Hospital Medical Research Foundation, Neurosciences Victoria; University of Melbourne(University of Melbourne); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); IXICO Ltd; UCLH/UCL NIHR CBRC grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging (NIH) USA; UK Alzheimer's Society; Midas image processing software licences; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Bayer(Bayer AG); Avid Radiopharmaceuticals; GE Healthcare(General ElectricGE Healthcare); Astra Zeneca(AstraZeneca); NHMRC/ADDF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AVID Radiopharmaceuticals Inc; Henry Stewart talks; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Institute for Health Research (NIHR) Biomedical Research Unit (http://www.nihr.ac.uk/infrastructure/Pages/infrastructure_biomedical_research_units.aspx) in Dementia based at University College London Hospitals (UCLH), University College London (UCL). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The Dementia Research Centre (DRC) is an Alzheimer's Research UK (ARUK) Coordinating Centre and has also received equipment funded by ARUK (www.alzheimersresearchuk.org). The authors thank the AIBL Study Group (www.aibl.csiro.au) for providing the data for this study, they are supported by the Commonwealth Scientific Industrial Research Organization (CSIRO) Flagship Collaboration Fund through the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship study of Ageing, the Austin Hospital Medical Research Foundation, Neurosciences Victoria, and the University of Melbourne; KA is funded by an EPSRC (www.epsrc.ac.uk) industrial CASE PhD studentship (http://www.epsrc.ac.uk/skills/students/coll/icase/Pages/intro.aspx) co-sponsored by commercial partner IXICO Ltd (www.ixico.com). MM and SO are supported by the UCLH/UCL NIHR CBRC grant 168. MC is supported by EPSRC (EP/W046410/1); NF is an MRC (UK) (www.mrc.ac.uk) Senior Clinical Scientist (Senior Clinical Fellowship No: G0601846 PI), and an NIHR Senior Scientist and also holds grants from the National Institute on Aging (NIH) USA for work on ADNI. JS is a UK HEFCE (www.hefce.ac.uk) Clinical Senior Lecturer and receives grant funding from ARUK and the UK Alzheimer's Society (www.alzheimers.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KA is funded by an EPSRC (www.epsrc.ac.uk) industrial CASE PhD studentship (http://www.epsrc.ac.uk/skills/students/coll/icase/Pages/intro.aspx) co-sponsored by commercial partner IXICO Ltd (www.ixico.com). The DRC holds a patent for QA Box (automated quality assurance for scan acquisition parameters), which may accrue revenue in the future, and currently receives royalties from Midas image processing software licences. NF has provided consultancy to GE Healthcare, Janssen-Cilag, Janssen-Elan pharmaceuticals, AVID Radiopharmaceuticals Inc, Lilly Research Labs, Eisai Inc and Johnson & Johnson; CR holds grants from CSIRO, Bayer, Avid Radiopharmaceuticals, GE Healthcare and Astra Zeneca; VV has provided consultancy to Bayer Healthcare and holds a grant from NHMRC/ADDF; JS receives grant funding from AVID Radiopharmaceuticals Inc and receives royalties from Henry Stewart talks. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Boyes RG, 2008, NEUROIMAGE, V39, P1752, DOI 10.1016/j.neuroimage.2007.10.026; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cardoso MJ, 2011, NEUROIMAGE, V56, P1386, DOI 10.1016/j.neuroimage.2011.02.013; Cardoso MJ, 2013, MED IMAGE IN PRESS; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Chetelat G, 2010, BRAIN, V133, P3349, DOI 10.1093/brain/awq187; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Evans MC, 2010, EUR RADIOL, V20, P674, DOI 10.1007/s00330-009-1581-5; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Lewis EB, 2004, NEUROIMAGE, V23, P75, DOI 10.1016/j.neuroimage.2004.04.030; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schott JM, 2006, J NEUROL, V253, P1147, DOI 10.1007/s00415-006-0173-4; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Strobel G, 2011, ANTIAMYLOID TREATMEN; Tosun D, 2011, BRAIN, V134, P1077, DOI 10.1093/brain/awr044; Vellas B, 2011, PROG NEUROBIOL, V95, P594, DOI 10.1016/j.pneurobio.2011.08.014; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	48	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58816	10.1371/journal.pone.0058816	http://dx.doi.org/10.1371/journal.pone.0058816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554933	Green Published, gold			2022-12-27	WOS:000316409800033
J	Bohte, AE; van Dussen, L; Akkerman, EM; Nederveen, AJ; Sinkus, R; Jansen, PLM; Stoker, J; Hollak, CEM				Bohte, Anneloes E.; van Dussen, Laura; Akkerman, Erik M.; Nederveen, Aart J.; Sinkus, Ralph; Jansen, Peter L. M.; Stoker, Jaap; Hollak, Carla E. M.			Liver Fibrosis in Type I Gaucher Disease: Magnetic Resonance Imaging, Transient Elastography and Parameters of Iron Storage	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; BONE-DISEASE; MANAGEMENT; HEMOCHROMATOSIS; CHITOTRIOSIDASE; GLUCOCEREBROSIDASE; SPLENECTOMY; DEFICIENCY	Long term liver-related complications of type-1 Gaucher disease (GD), a lysosomal storage disorder, include fibrosis and an increased incidence of hepatocellular carcinoma. Splenectomy has been implicated as a risk factor for the development of liver pathology in GD. High ferritin concentrations are a feature of GD and iron storage in Gaucher cells has been described, but iron storage in the liver in relation to liver fibrosis has not been studied. Alternatively, iron storage in GD may be the result of iron supplementation therapy or regular blood transfusions in patients with severe cytopenia. In this pilot study, comprising 14 type-1 GD patients (7 splenectomized, 7 non-splenectomized) and 7 healthy controls, we demonstrate that liver stiffness values, measured by Transient Elastography and MR-Elastography, are significantly higher in splenectomized GD patients when compared with non-splenectomized GD patients (p = 0.03 and p = 0.01, respectively). Liver iron concentration was elevated (>60 +/- 30 mmol/g) in 4 GD patients of whom 3 were splenectomized. No relationship was found between liver stiffness and liver iron concentration. HFE gene mutations were more frequent in splenectomized (6/7) than in non-splenectomized (2/7) participants (p = 0.10). Liver disease appeared more advanced in splenectomized than in non-splenectomized patients. We hypothesize a relationship with excessive hepatic iron accumulation in splenectomized patients. We recommend that all splenectomized patients, especially those with evidence of substantial liver fibrosis undergo regular screening for HCC, according to current guidelines.	[Bohte, Anneloes E.; Akkerman, Erik M.; Nederveen, Aart J.; Stoker, Jaap] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van Dussen, Laura; Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Sinkus, Ralph] Univ Paris Diderot, INSERM, UMR 773, CRB3, Clichy, France; [Jansen, Peter L. M.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam	van Dussen, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.vandussen@amc.uva.nl	Jansen, Peter LM/I-4509-2013; Stoker, Jaap/AAH-7597-2019	Stoker, Jaap/0000-0002-9822-3784; van Dussen, Laura/0000-0002-6539-531X; Sinkus, Ralph/0000-0002-6093-1654; Hollak, Carla/0000-0003-0464-1078				Aguilera B, 2003, J BIOL CHEM, V278, P40911, DOI 10.1074/jbc.M301804200; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; BASSAN R, 1985, AM J HEMATOL, V18, P381, DOI 10.1002/ajh.2830180407; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; Beutler E, 2001, METABOLIC MOL BASES, P3636; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Boursier J, 2012, HEPATOLOGY; BRADY RO, 1974, NEW ENGL J MED, V291, P989, DOI 10.1056/NEJM197411072911901; BREIDENLANGEN CM, 1991, LEBER MAGEN DARM, V21, P126; Brill NE, 1905, AM J MED SCI, V129, P491, DOI 10.1097/00000441-190503000-00014; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2008, J INHERIT METAB DIS, V31, P319, DOI 10.1007/s10545-008-0779-z; de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004; de Fost M, 2008, HAEMATOL-HEMATOL J, V93, P1119, DOI 10.3324/haematol.12651; Deegan PB, 2011, MEDICINE, V90, P52, DOI 10.1097/MD.0b013e3182057be4; Erjavec Z, 1999, ANN ONCOL, V10, P243, DOI 10.1023/A:1008306414822; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Garteiser P, 2012, P INT SOC MAG RESON, V20, P3423; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grebely J, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02627.x; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Hollak CEM, 2012, BRIT J HAEMATOL, V158, P528, DOI 10.1111/j.1365-2141.2012.09175.x; Hughes D, 2007, BRIT J HAEMATOL, V138, P676, DOI 10.1111/j.1365-2141.2007.06701.x; Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076; Krasnewich D, 1998, BLOOD, V91, P3085; Lachmann RH, 2000, QJM-MON J ASSOC PHYS, V93, P237, DOI 10.1093/qjmed/93.4.237; Lee R E, 1982, Prog Clin Biol Res, V95, P177; LEE RE, 1967, AM J MED, V42, P891, DOI 10.1016/0002-9343(67)90070-8; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; LORBER M, 1970, MT SINAI J MED, V37, P404; LORBER M, 1960, ANN INTERN MED, V53, P293, DOI 10.7326/0003-4819-53-2-293; LORBER M, 1967, ACTA HAEMATOL-BASEL, V37, P189, DOI 10.1159/000209069; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; MORGAN M A M, 1983, British Medical Journal, V286, P1864; Nvkc, 2020, PREAN RICHTL LAB MBT; Perel Y, 2002, PEDIATRICS, V109, P1170, DOI 10.1542/peds.109.6.1170; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Poca M, 2011, DIS MARKERS, V31, P147, DOI [10.3233/DMA-2011-0837, 10.1155/2011/537970]; Ponce E, 1997, BLOOD, V90, P43; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Rodrigue SW, 1999, CLIN ORTHOP RELAT R, P201; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schoonhoven A, 2007, CLIN CHIM ACTA, V381, P136, DOI 10.1016/j.cca.2007.02.042; SHOENFELD Y, 1982, ARCH PATHOL LAB MED, V106, P388; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; St Pierre TG, 2005, ANN NY ACAD SCI, V1054, P379, DOI 10.1196/annals.1345.046; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Taddei TH, 2009, AM J HEMATOL, V84, P208, DOI 10.1002/ajh.21362; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wang QB, 2012, HEPATOLOGY; Weisberger James, 2004, Br J Haematol, V124, P696, DOI 10.1046/j.1365-2141.2003.04695.x; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Xu RL, 2005, SEMIN LIVER DIS, V25, P226, DOI 10.1055/s-2005-871201; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Zimran A, 2005, BLOOD CELL MOL DIS, V34, P197, DOI 10.1016/j.bcmd.2005.03.004	58	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57507	10.1371/journal.pone.0057507	http://dx.doi.org/10.1371/journal.pone.0057507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554863	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800008
J	Cristia, A; Dupoux, E; Hakuno, Y; Lloyd-Fox, S; Schuetze, M; Kivits, J; Bergvelt, T; van Gelder, M; Filippin, L; Charron, S; Minagawa-Kawai, Y				Cristia, Alejandrina; Dupoux, Emmanuel; Hakuno, Yoko; Lloyd-Fox, Sarah; Schuetze, Manuela; Kivits, Jose; Bergvelt, Tomas; van Gelder, Marjolijn; Filippin, Luca; Charron, Sylvain; Minagawa-Kawai, Yasuyo			An Online Database of Infant Functional Near InfraRed Spectroscopy Studies: A Community-Augmented Systematic Review	PLOS ONE			English	Review							HEMODYNAMIC-RESPONSES	Until recently, imaging the infant brain was very challenging. Functional Near InfraRed Spectroscopy (fNIRS) is a promising, relatively novel technique, whose use is rapidly expanding. As an emergent field, it is particularly important to share methodological knowledge to ensure replicable and robust results. In this paper, we present a community-augmented database which will facilitate precisely this exchange. We tabulated articles and theses reporting empirical fNIRS research carried out on infants below three years of age along several methodological variables. The resulting spreadsheet has been uploaded in a format allowing individuals to continue adding new results, and download the most recent version of the table. Thus, this database is ideal to carry out systematic reviews. We illustrate its academic utility by focusing on the factors affecting three key variables: infant attrition, the reliability of oxygenated and deoxygenated responses, and signal-to-noise ratios. We then discuss strengths and weaknesses of the DBIfNIRS, and conclude by suggesting a set of simple guidelines aimed to facilitate methodological convergence through the standardization of reports.	[Cristia, Alejandrina; Schuetze, Manuela; Kivits, Jose; Bergvelt, Tomas; van Gelder, Marjolijn] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Dupoux, Emmanuel; Filippin, Luca; Charron, Sylvain] Ecole Hautes Etud Sci Sociales, Lab Sci Cognit & Psycholinguist, Paris, France; [Dupoux, Emmanuel; Filippin, Luca; Charron, Sylvain] Ecole Normale Super, F-75231 Paris, France; [Hakuno, Yoko; Minagawa-Kawai, Yasuyo] Keio Univ, Grad Sch Human Relat, Tokyo, Japan; [Lloyd-Fox, Sarah] Univ London, Ctr Brain & Cognit Dev, London, England; [Minagawa-Kawai, Yasuyo] Ecole Normale Super, Inst Etud Cognit, F-75231 Paris, France	Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Keio University; University of London; Birkbeck University London; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Cristia, A (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	alecristia@gmail.com	Cristia, Alejandrina/H-2768-2019; Lloyd-Fox, Sarah/J-5408-2019	Cristia, Alejandrina/0000-0003-2979-4556; Lloyd-Fox, Sarah/0000-0001-6742-9889; Charron, Sylvain/0000-0001-9511-9693; Dupoux, Emmanuel/0000-0002-7814-2952; Hakuno, Yoko/0000-0001-7309-2733	Ecole de Neurosciences de Paris and Fondation Fyssen; Fondation de France; Medical Research Council [G0701484] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24118508] Funding Source: KAKEN; MRC [G0701484] Funding Source: UKRI	Ecole de Neurosciences de Paris and Fondation Fyssen; Fondation de France(Fondation de France); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AC acknowledges the funding support of Ecole de Neurosciences de Paris and Fondation Fyssen, ED that of Fondation de France, and YH and YMK that of Grant-in-Aid for Scientific Research (B) and Grant-in-Aid for Scientific Research on Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Frederick B, 2012, SHARED NIRS DATA FOR; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Katura T, 2012, INIRS C LOND UK; Kotilahti K, 2010, HUM BRAIN MAPP, V31, P595, DOI 10.1002/hbm.20890; Lloyd-Fox S, 2012, SOC NEUROSCI-UK, V7, P317, DOI 10.1080/17470919.2011.614696; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Meek J, 2002, DEVELOPMENTAL SCI, V5, P371, DOI 10.1111/1467-7687.00376; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; Minagawa-Kawai Y, 2008, DEV NEUROBIOL, V68, P712, DOI 10.1002/dneu.20618; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Obrig H., 2010, FRONT NEUROENERGETIC, V2, P13, DOI DOI 10.3389/FNENE.2010.00013; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Taga G, 2007, NEUROIMAGE, V38, P452, DOI 10.1016/j.neuroimage.2007.07.050	13	38	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58906	10.1371/journal.pone.0058906	http://dx.doi.org/10.1371/journal.pone.0058906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554955	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800046
J	Huxley, RR; Lopez, FL; MacLehose, RF; Eckfeldt, JH; Couper, D; Leiendecker-Foster, C; Hoogeveen, RC; Chen, LY; Soliman, EZ; Agarwal, SK; Alonso, A				Huxley, Rachel R.; Lopez, Faye L.; MacLehose, Richard F.; Eckfeldt, John H.; Couper, David; Leiendecker-Foster, Catherine; Hoogeveen, Ron C.; Chen, Lin Yee; Soliman, Elsayed Z.; Agarwal, Sunil K.; Alonso, Alvaro			Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; CORONARY-ARTERY-DISEASE; MATRIX METALLOPROTEINASES; MYOCARDIAL-INFARCTION; SERUM MATRIX-METALLOPROTEINASE-9; CIRCULATING LEVELS; TISSUE INHIBITORS; HEART-FAILURE; HYPERTENSION; VALIDATION	Background: Previous cross-sectional studies have suggested that biomarkers of extracellular matrix remodelling are associated with atrial fibrillation (AF), but no prospective data have yet been published. Hence, we examine whether plasma matrix metalloproteinases (MMP) and their inhibitors are related to increased risk of incident AF. Methods: We used a case-cohort design in the context of the prospective Atherosclerosis Risk in Communities (ARIC) study. From 13718 eligible men and women free from AF in 1990-92, we selected a stratified random sample of 500 individuals without and 580 with incident AF over a mean follow-up of 11.8 years. Using a weighted proportional hazards regression model, the relationships between MMP-1, MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinase (TIMP)-1, TIMP-2 and C-terminal propeptide of collagen type-I with incident AF were examined after adjusting for confounders. Results: In models adjusted for age, sex and race, all biomarkers were associated with AF, but only the relationship between plasma MMP-9 remained significant in the fully-adjusted model: each one standard deviation increase in MMP-9 was associated with 27% (95% Confidence Interval: 7% to 50%) increase in risk of AF with no evidence of an interaction with race or sex. Individuals with above mean levels of MMP-9 were more likely to be male, white and current smokers. Conclusions: The findings suggest that elevated levels of MMP-9 are independently associated with increased risk of AF. However, given the lack of specificity of MMP-9 to atrial tissue, it remains to be determined whether the observed relationship reflects the impact of atrial fibrosis or more generalized fibrosis on risk of incident AF.	[Huxley, Rachel R.; Lopez, Faye L.; MacLehose, Richard F.; Leiendecker-Foster, Catherine; Chen, Lin Yee; Alonso, Alvaro] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Eckfeldt, John H.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Couper, David; Agarwal, Sunil K.] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Wake Forest University; Wake Forest Baptist Medical Center	Huxley, RR (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	rhuxley@umn.edu	Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013; Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020; Norby, Faye/S-3729-2017	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Chen, Lin/0000-0002-0700-814X; Norby, Faye/0000-0002-1975-0405; Hoogeveen, Ron/0000-0003-2399-4653; Couper, David/0000-0002-4313-9235	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, RC1HL099452]; American Heart Association [09SDG2280087]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055021, N01HC055018, N01HC055019, N01HC055020, N01HC055022, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. This work was additionally supported by the National Heart, Lung, and Blood Institute grant RC1HL099452 and American Heart Association grant 09SDG2280087. There are no relationships with industry to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; [Anonymous], 1989, AM J EPIDEMIOL, V129, P687; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dominguez-Rodriguez A, 2008, ATHEROSCLEROSIS, V196, P365, DOI 10.1016/j.atherosclerosis.2006.11.012; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; ERIKSSON H, 1987, EUR HEART J, V8, P1007, DOI 10.1093/oxfordjournals.eurheartj.a062365; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gai XB, 2010, CLIN CHIM ACTA, V411, P719, DOI 10.1016/j.cca.2010.02.002; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Grodin JL, 2011, VASC MED, V16, P339, DOI 10.1177/1358863X11422110; Jung K, 2008, CLIN CHEM, V54, P772, DOI 10.1373/clinchem.2007.099937; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kallergis EM, 2008, J AM COLL CARDIOL, V52, P211, DOI 10.1016/j.jacc.2008.03.045; Kalogeropoulos AS, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-77; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Nakano Y, 2004, J AM COLL CARDIOL, V43, P818, DOI 10.1016/j.jacc.2003.08.060; Nambi V, 2008, TEX HEART I J, V35, P388; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Selvin E, 2005, DIABETIC MED, V22, P1726, DOI 10.1111/j.1464-5491.2005.01705.x; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Velagaleti RS, 2010, ARTERIOSCL THROM VAS, V30, P2283, DOI 10.1161/ATVBAHA.110.208462; Welsh P, 2008, QJM-INT J MED, V101, P785, DOI 10.1093/qjmed/hcn088; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x	38	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59052	10.1371/journal.pone.0059052	http://dx.doi.org/10.1371/journal.pone.0059052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554968	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800052
J	Renzi, C; Ricciardi, E; Bonino, D; Handjaras, G; Vecchi, T; Pietrini, P				Renzi, Chiara; Ricciardi, Emiliano; Bonino, Daniela; Handjaras, Giacomo; Vecchi, Tomaso; Pietrini, Pietro			The Effects of Visual Control and Distance in Modulating Peripersonal Spatial Representation	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; TOOL USE; REFERENCE FRAMES; HUMAN BRAIN; SPACE; REACH; INTEGRATION; HAND; INFORMATION; ACTIVATION	In the presence of vision, finalized motor acts can trigger spatial remapping, i.e., reference frames transformations to allow for a better interaction with targets. However, it is yet unclear how the peripersonal space is encoded and remapped depending on the availability of visual feedback and on the target position within the individual's reachable space, and which cerebral areas subserve such processes. Here, functional magnetic resonance imaging (fMRI) was used to examine neural activity while healthy young participants performed reach-to-grasp movements with and without visual feedback and at different distances of the target from the effector (near to the hand-about 15 cm from the starting position-vs. far from the hand-about 30 cm from the starting position). Brain response in the superior parietal lobule bilaterally, in the right dorsal premotor cortex, and in the anterior part of the right inferior parietal lobule was significantly greater during visually-guided grasping of targets located at the far distance compared to grasping of targets located near to the hand. In the absence of visual feedback, the inferior parietal lobule exhibited a greater activity during grasping of targets at the near compared to the far distance. Results suggest that in the presence of visual feedback, a visuo-motor circuit integrates visuo-motor information when targets are located farther away. Conversely in the absence of visual feedback, encoding of space may demand multisensory remapping processes, even in the case of more proximal targets.	[Renzi, Chiara; Ricciardi, Emiliano; Bonino, Daniela; Handjaras, Giacomo; Pietrini, Pietro] Univ Pisa, Sch Med, Lab Clin Biochem & Mol Biol, I-56100 Pisa, Italy; [Renzi, Chiara; Vecchi, Tomaso] Univ Pavia, Deptartment Brain & Behav Sci, I-27100 Pavia, Italy; [Ricciardi, Emiliano] Fdn Toscana Gabriele Monasterio CNR Reg Toscana, Pisa, Italy; [Renzi, Chiara; Vecchi, Tomaso] IRCCS Mondino, Brain Connect Ctr, Pavia, Italy; [Pietrini, Pietro] Pisa Univ Hosp, Clin Psychol Branch, Pisa, Italy	University of Pisa; University of Pavia; IRCCS Fondazione Casimiro Mondino; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Ricciardi, E (corresponding author), Univ Pisa, Sch Med, Lab Clin Biochem & Mol Biol, I-56100 Pisa, Italy.	emiliano.ricciardi@bioclinica.unipi.it	Ricciardi, Emiliano/E-6929-2011; Pietrini, Pietro/Z-4202-2019; Renzi, Chiara/AAG-5403-2019	Ricciardi, Emiliano/0000-0002-7178-9534; Renzi, Chiara/0000-0002-3451-0792; Pietrini, Pietro/0000-0002-6768-5556; Handjaras, Giacomo/0000-0001-5677-8434	EU [FP7-ICT-248587]; Italian Ministero dell'Istruzione, dell'Universitae della Ricerca [PRIN2009-2009RC9X8T]; Medical School of the University of Pisa	EU(European Commission); Italian Ministero dell'Istruzione, dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR)); Medical School of the University of Pisa	This research was supported by the EU Grant THE-The Hand Embodied (FP7-ICT-248587) Italian Ministero dell'Istruzione, dell'Universitae della Ricerca (PRIN2009-2009RC9X8T to T.V. and P.P.) and by the Medical School of the University of Pisa (Research Grant to E.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Beurze SM, 2007, J NEUROPHYSIOL, V97, P188, DOI 10.1152/jn.00456.2006; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Brozzoli C, 2010, NEUROPSYCHOLOGIA, V48, P796, DOI 10.1016/j.neuropsychologia.2009.10.009; Brozzoli C., 2011, NEURAL BASES MULTISE; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Brozzoli C, 2009, NEUROREPORT, V20, P913, DOI 10.1097/WNR.0b013e32832c0b9b; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Cardinali L, 2009, BRAIN TOPOGR, V21, P252, DOI 10.1007/s10548-009-0092-7; Carrozzo M, 2002, EXP BRAIN RES, V147, P426, DOI 10.1007/s00221-002-1232-4; CASTIELLO U, 1993, EXP BRAIN RES, V96, P152, DOI 10.1007/BF00230448; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Clavagnier S, 2007, NEUROSCIENTIST, V13, P22, DOI 10.1177/1073858406295688; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; CORRADINI ML, 1992, BIOL CYBERN, V67, P347, DOI 10.1007/BF02414890; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Daprati E, 1997, NEUROPSYCHOLOGIA, V35, P1577, DOI 10.1016/S0028-3932(97)00061-4; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Farne A, 2005, NEUROLOGY, V65, P1754, DOI 10.1212/01.wnl.0000187121.30480.09; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Fiehler K, 2011, NEUROIMAGE, V54, P2401, DOI 10.1016/j.neuroimage.2010.09.080; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Graziano MSA, 2004, HDB MULTISENSORY PRO, P443; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; Heath M, 2006, EXP BRAIN RES, V169, P473, DOI 10.1007/s00221-005-0170-3; Inoue K, 2001, NEUROIMAGE, V14, P1469, DOI 10.1006/nimg.2001.0942; Iriki A, 1996, NEUROREPORT, V7, P2325; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Neppi-Modona M, 2007, CORTEX, V43, P397, DOI 10.1016/S0010-9452(08)70465-9; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; RIZZOLATTI G, 1987, EXP BRAIN RES, V67, P220, DOI 10.1007/BF00269468; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; VALLAR G, 1991, INT J NEUROSCI, V61, P229, DOI 10.3109/00207459108990740; Westwood DA, 2001, EXP BRAIN RES, V141, P166, DOI 10.1007/s002210100865; WING AM, 1986, J MOTOR BEHAV, V18, P245; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59460	10.1371/journal.pone.0059460	http://dx.doi.org/10.1371/journal.pone.0059460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555037	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800094
J	Sierra, JM; Camoez, M; Tubau, F; Gasch, O; Pujol, M; Martin, R; Dominguez, MA				Sierra, Josep M.; Camoez, Mariana; Tubau, Fe; Gasch, Oriol; Pujol, Miquel; Martin, Rogelio; Angeles Dominguez, M.			Low Prevalence of Cfr-Mediated Linezolid Resistance among Methicillin-Resistant Staphylococcus aureus in a Spanish Hospital: Case Report on Linezolid Resistance Acquired during Linezolid Therapy	PLOS ONE			English	Article							GENE; MECHANISM	Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (MRSA). Resistance to linezolid due to the cfr gene is described worldwide. The present study aimed to analyze the prevalence of the cfr-mediated linezolid resistance among MRSA clinical isolates in our area. A very low prevalence of cfr mediated linezolid resistance was found: only one bacteremic isolate out of 2 215 screened isolates. The only linezolid resistant isolate arose in a patient, previously colonized by MRSA, following linezolid therapy. Despite the low rate of resistance in our area, ongoing surveillance is advisable to avoid the spread of linezolid resistance.	[Sierra, Josep M.; Camoez, Mariana; Tubau, Fe; Martin, Rogelio; Angeles Dominguez, M.] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge IDIBELL, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Gasch, Oriol; Pujol, Miquel] Univ Barcelona, Hosp Univ Bellvitge IDIBELL, Dept Pathol & Expt Therapeut, Dept Infect Dis, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Dominguez, MA (corresponding author), Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge IDIBELL, Dept Pathol & Expt Therapeut, Barcelona, Spain.	adominguez@bellvitgehospital.cat	Camoez, Mariana/ACK-3178-2022; Rojo, Miquel Pujol/AAF-5681-2021; Sierra, Josep M/O-3429-2014	Rojo, Miquel Pujol/0000-0002-6475-6208; Sierra, Josep M/0000-0002-0997-5619; Camoez, Mariana/0000-0002-7517-6874; Dominguez, M. Angeles/0000-0003-3107-9586; Gasch, Oriol/0000-0001-8518-458X	Fondo de Investigacion Sanitaria [10/01783]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases	This work was supported by a grant from Fondo de Investigacion Sanitaria (grant number 10/01783) and by Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III co-financed by European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases (grant number REIPI RD06/0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2008, J CLIN MICROBIOL, V46, P892, DOI 10.1128/JCM.01886-07; Besier S, 2008, ANTIMICROB AGENTS CH, V52, P1570, DOI 10.1128/AAC.01098-07; Bozdogan B, 2004, INT J ANTIMICROB AG, V23, P113, DOI 10.1016/j.ijantimicag.2003.11.003; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Jones RN, 2008, DIAGN MICR INFEC DIS, V62, P416, DOI 10.1016/j.diagmicrobio.2008.10.010; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5275, DOI 10.1128/AAC.01032-09; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; de Gopegui ER, 2012, ANTIMICROB AGENTS CH, V56, P2139, DOI 10.1128/AAC.06042-11; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Witte W, 2011, FUTURE MICROBIOL, V6, P925, DOI [10.2217/fmb.11.69, 10.2217/FMB.11.69]	15	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59215	10.1371/journal.pone.0059215	http://dx.doi.org/10.1371/journal.pone.0059215			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554998	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800071
J	Amos, W; Brooks-Pollock, E; Blackwell, R; Driscoll, E; Nelson-Flower, M; Conlan, AJK				Amos, William; Brooks-Pollock, Ellen; Blackwell, Ruth; Driscoll, Erin; Nelson-Flower, Martha; Conlan, Andrew J. K.			Genetic Predisposition to Pass the Standard SICCT Test for Bovine Tuberculosis in British Cattle	PLOS ONE			English	Article							IMMUNE-RESPONSE; MYCOBACTERIUM-BOVIS; CANADIAN HOLSTEINS; SUSCEPTIBILITY; INFECTION; POLYMORPHISMS; RESISTANCE; DISEASE; SKIN	Bovine tuberculosis (bTB) imposes an important financial burden on the British cattle industry, yet despite intense efforts to control its spread, incidence is currently rising. Surveillance for bTB is based on a skin test that measures an immunological response to tuberculin. Cattle that fail the test are classified as "reactors'' and slaughtered. Recent studies have identified genetic markers associated with the reaction of cattle to the tuberculin test. At marker INRA111 a relatively common '22' genotype occurs significantly more frequently in non-reactor cattle. Here we test the possibility that the putative protective '22' genotype does not confer resistance but instead causes cattle that carry it to react less strongly to the prescribed test, and hence avoid slaughter, potentially even though they are infected. We show that, after controlling for age and breed, '22' cattle react less strongly to the immunological challenge and may therefore be less likely to be classified as a reactor. These results highlight the potential discrepancy between infection and test status and imply that the effectiveness of the test-and-slaughter policy may be being compromised by selection for cattle that are genetically predisposed to react less strongly to tuberculin.	[Amos, William; Driscoll, Erin; Nelson-Flower, Martha] Univ Cambridge, Dept Zool, Cambridge, Cambs, England; [Brooks-Pollock, Ellen; Conlan, Andrew J. K.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, Cambs, England; [Blackwell, Ruth] AHVLA, Addlestone, Surrey, England	University of Cambridge; University of Cambridge	Amos, W (corresponding author), Univ Cambridge, Dept Zool, Cambridge, Cambs, England.	w.amos@zoo.cam.ac.uk	Conlan, Andrew/Q-3861-2019	Conlan, Andrew/0000-0002-2593-6353; Nelson-Flower, Martha/0000-0001-6753-9252; Brooks-Pollock, Ellen/0000-0002-5984-4932	DEFRA [SE-3127]; EPSRC; EPSRC [EP/H027270/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H027270/1] Funding Source: researchfish	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AJKC is supported by DEFRA grant SE-3127. EBP is supported by an EPSRC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Bulat-Kardum L, 2006, SCAND J IMMUNOL, V63, P142, DOI 10.1111/j.1365-3083.2005.01694.x; Canty A, 2012, BOOT BOOTSTRAP R S P; Coad M, 2010, VET RES, V41, DOI 10.1051/vetres/2009062; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; DEFRA, 2011, BOV TB ER PROGR ENGL; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; DOWLING D. F., 1955, AUSTRALIAN JOUR AGRIC RES, V6, P776, DOI 10.1071/AR9550776; DOWLING DF, 1964, J AGR SCI-CAMBRIDGE, V62, P307, DOI 10.1017/S0021859600042398; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Gallagher J, 2000, RES VET SCI, V69, P203, DOI 10.1053/rvsc.2000.0422; Goodchild AV, 2001, TUBERCULOSIS, V81, P23, DOI 10.1054/tube.2000.0256; Goodchild T, 2008, MYCOBACTERIUM BOVIS; Green DM, 2007, P ROYAL SOC B, V275, P1001, DOI DOI 10.1098/RSPB.2007.1601; Hine BC, 2012, CAN J VET RES, V76, P149; Hosmer D.W., 2000, ASSESSING FIT MODEL; Jackman S., 2012, PSCL CLASSES METHODS; Jackson CH, 2008, AM STAT, V62, P340, DOI 10.1198/000313008X370843; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; Kleeberg H. H., 1960, Journal of the South African Veterinary Medical Association, V31, P213; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Mitchell AP, 2006, P SOC VET EP PREV ME, P70; R Core Team, 2020, R LANG ENV STAT COMP; Ramirez-Villaescusa AM, 2010, PREV VET MED, V95, P224, DOI 10.1016/j.prevetmed.2010.03.009; Ramirez-Villaescusa AM, 2009, PREV VET MED, V92, P188, DOI 10.1016/j.prevetmed.2009.08.011; Reid JM, 2003, P ROY SOC B-BIOL SCI, V270, P2151, DOI 10.1098/rspb.2003.2480; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P401, DOI 10.3168/jds.2011-4452; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; Venables WN., 2002, MODERN APPL STAT S 4; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58245	10.1371/journal.pone.0058245	http://dx.doi.org/10.1371/journal.pone.0058245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554880	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100095
J	Doi, H; Nishitani, S; Fujisawa, TX; Nagai, T; Kakeyama, M; Maeda, T; Shinohara, K				Doi, Hirokazu; Nishitani, Shota; Fujisawa, Takashi X.; Nagai, Tomoko; Kakeyama, Masaki; Maeda, Takahiro; Shinohara, Kazuyuki			Prenatal Exposure to a Polychlorinated Biphenyl (PCB) Congener Influences Fixation Duration on Biological Motion at 4-Months-Old: A Preliminary Study	PLOS ONE			English	Article							DIOXIN-LIKE COMPOUNDS; POINT-LIGHT; DICHLORODIPHENYL DICHLOROETHENE; DUTCH CHILDREN; HYDROXYLATED METABOLITES; ENVIRONMENTAL EXPOSURE; RISK-ASSESSMENT; YOUNG-CHILDREN; BREAST-MILK; SCHOOL-AGE	Adverse effects of prenatal exposure to polychlorinated biphenyl (PCB) congeners on postnatal brain development have been reported in a number of previous studies. However, few studies have examined the effects of prenatal PCB exposure on early social development. The present study sought to increase understanding of the neurotoxicity of PCBs by examining the relationship between PCB congener concentrations in umbilical cord blood and fixation patterns when observing upright and inverted biological motion (BM) at four-months after birth. The development of the ability to recognize BM stimuli is considered a hallmark of socio-cognitive development. The results revealed a link between dioxin-like PCB #118 concentration and fixation pattern. Specifically, four-month-olds with a low-level of prenatal exposure to PCB #118 exhibited a preference for the upright BM over inverted BM, whereas those with a relatively high-level of exposure did not. This finding supports the proposal that prenatal PCB exposure impairs the development of social functioning, and indicates the importance of congener-specific analysis in the risk analysis of the adverse effects of PCB exposure on the brain development.	[Doi, Hirokazu; Nishitani, Shota; Fujisawa, Takashi X.; Nagai, Tomoko; Shinohara, Kazuyuki] Nagasaki Univ, Dept Neurobiol & Behav, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Kakeyama, Masaki] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch, Tokyo, Japan; [Kakeyama, Masaki] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Maeda, Takahiro] Nagasaki Univ, Dept Isl & Community Med, Isl Med Res Inst, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University; University of Tokyo; University of Tokyo; Nagasaki University	Shinohara, K (corresponding author), Nagasaki Univ, Dept Neurobiol & Behav, Grad Sch Biomed Sci, Nagasaki 852, Japan.	kazuyuki@nagasaki-u.ac.jp	Doi, Hirokazu/AAK-3285-2021; Nishitani, Shota/S-5975-2016; Fujisawa, Takashi/Z-4461-2019	Doi, Hirokazu/0000-0003-0421-2492; Nishitani, Shota/0000-0002-6234-295X; Kakeyama, Masaki/0000-0001-9063-9673	Japan Society for the Promotion of Science (JSPS) [21671002]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (MK; No. 21671002) from the Japan Society for the Promotion of Science (JSPS). http://www.jsps.go.jp/jgrantsinaid/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2000, J ENV HLTH, V73, P8; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; BIRCH E, 1993, J PEDIATR OPHTHALMOL, V30, P33; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005; Cassia VM, 2001, DEVELOPMENTAL SCI, V4, P101; Darvill T, 2000, NEUROTOXICOLOGY, V21, P1029; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Doi H, 2008, PERCEPTION, V37, P1399, DOI 10.1068/p5673; Doi H, 2009, NEUROSCI RES, V64, P317, DOI 10.1016/j.neures.2009.04.002; Endo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050741; Fischer LJ, 1998, TOXICOL SCI, V41, P49; Forns J, 2012, SCI TOTAL ENVIRON, V432, P338, DOI 10.1016/j.scitotenv.2012.06.012; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gladen BC, 2000, J PEDIATR-US, V136, P490, DOI 10.1016/S0022-3476(00)90012-X; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; GLADEN BC, 1991, J PEDIATR-US, V119, P58, DOI 10.1016/S0022-3476(05)81039-X; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; GUO YL, 1995, B ENVIRON CONTAM TOX, V55, P8, DOI 10.1007/BF00212382; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Huisman M, 1995, EARLY HUM DEV, V43, P165, DOI 10.1016/0378-3782(95)01674-0; JACOBSON JL, 1990, J PEDIATR-US, V116, P38, DOI 10.1016/S0022-3476(05)81642-7; JACOBSON JL, 1992, DEV PSYCHOL, V28, P297, DOI 10.1037/0012-1649.28.2.297; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jorissen Joanne, 2007, Adv Neonatal Care, V7, P230; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; KoopmanEsseboom C, 1996, PEDIATRICS, V97, P700; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; Kutsuki A, 2009, INFANT BEHAV DEV, V32, P381, DOI 10.1016/j.infbeh.2009.06.004; Lorber M, 2002, ENVIRON HEALTH PERSP, V110, pA325, DOI 10.1289/ehp.021100325; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Miyake K., 1990, HATTATSU KENKYU, V6, P147; Miyashita C, 2011, ENVIRON RES, V111, P551, DOI 10.1016/j.envres.2011.01.021; Mondloch CJ, 1999, PSYCHOL SCI, V10, P419, DOI 10.1111/1467-9280.00179; Nakai K, 2004, TOHOKU J EXP MED, V202, P227, DOI 10.1620/tjem.202.227; Omura M, 1991, KIDS NYUUYOUJI HATTA; Parham F, 2012, ENVIRON RES, V116, P74, DOI 10.1016/j.envres.2012.04.003; Park HY, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-51; Park JS, 2008, CHEMOSPHERE, V70, P1676, DOI 10.1016/j.chemosphere.2007.07.049; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; ROGAN WJ, 1993, EARLY HUM DEV, V31, P181, DOI 10.1016/0378-3782(93)90194-Y; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sato H, 2010, 30 INT S HAL PERS OR; Schantz SL, 2003, ENVIRON HEALTH PERSP, V111, P357, DOI 10.1289/ehp.5461; SCHWARTZ PM, 1983, AM J PUBLIC HEALTH, V73, P293, DOI 10.2105/AJPH.73.3.293; SEEGAL RF, 1990, TOXICOL APPL PHARM, V106, P136, DOI 10.1016/0041-008X(90)90113-9; SHAIN W, 1991, TOXICOL APPL PHARM, V111, P33, DOI 10.1016/0041-008X(91)90131-W; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Soechitram SD, 2004, ENVIRON HEALTH PERSP, V112, P1208, DOI 10.1289/ehp.6424; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Tatsuta N, 2010, ENVIRON RES, V110, P699; Tatsuta N, 2012, ENVIRON RES, V114, P47, DOI 10.1016/j.envres.2012.02.001; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Turyk ME, 2006, ENVIRON RES, V102, P299, DOI 10.1016/j.envres.2006.01.009; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vreugdenhil HJI, 2004, DEV MED CHILD NEUROL, V46, P398, DOI 10.1017/S0012162204000647; Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593, DOI 10.1289/ehp.021100593; Vreugdenhil HJI, 2002, J PEDIATR-US, V140, P48, DOI 10.1067/mpd.2002.119625; Walkowiak J, 2001, LANCET, V358, P1602, DOI 10.1016/S0140-6736(01)06654-5; White RF, 2011, NEUROTOXICOLOGY, V32, P975, DOI 10.1016/j.neuro.2011.04.001; Winneke G, 2011, J NEUROL SCI, V308, P9, DOI 10.1016/j.jns.2011.05.020; Xu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014552	71	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59196	10.1371/journal.pone.0059196	http://dx.doi.org/10.1371/journal.pone.0059196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555630	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200014
J	Bahar, B; O'Doherty, JV; O'Doherty, AM; Sweeney, T				Bahar, Bojlul; O'Doherty, John V.; O'Doherty, Alan M.; Sweeney, Torres			Chito-Oligosaccharide Inhibits the De-Methylation of a 'CpG' Island within the Leptin (LEP) Promoter during Adipogenesis of 3T3-L1 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELL; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; DNA METHYLATION; OB GENE; OBESITY; REGULATOR	Chito-oligosaccharide (COS) is a natural bioactive compound, which has been shown to suppress lipid metabolic genes and lipid accumulation in differentiating adipocytes. Leptin has been identified as a key regulator of energy homeostasis and is known to be under epigenetic regulation during adipogenesis. Hence, the first objective of this experiment was to compare leptin gene (LEP) expression and leptin secretion during the different stages of adipogenesis and to investigate the effect of COS on, these processes. As COS inhibited LEP expression during adipogenesis, the second aim was to investigate the methylation dynamics of a 'CpG' island in the proximal region of the LEP promoter during adipogenesis and to determine the effect of COS on this process. Mouse 3T3-L1 cells were stimulated to differentiate in the absence or presence of COS and the levels of leptin mRNA and protein were evaluated on days 0, 2,4 and 6 post-induction of differentiation (PID). The extent of de-methylation of six CpG sites was evaluated. LEP mRNA transcript and protein could not be detected on either day OPID or 2PID. In contrast, both were detected on day 4PID (P<0.05) and 6PID (P<0.001) and both were inhibited by COS (P<0.001). Of the six CpG sites analyzed, CpG_52, CpG_62 and CpG_95 became 11.5, 5.0 and 5.0% de-methylated between day 2PID and 6PID, respectively. COS blocked this de-methylation event at CpG_52 (P<0.001), CpG_62 (P<0.01) and CpG_95 (P<0.01) on day 6PID. These data suggest that COS can have an epigenetic effect on differentiating adipocytes, a novel biological function of COS which has potential applications for the manipulation of leptin gene expression adipogenesis, and conditions within the metabolic syndrome spectrum.	[Bahar, Bojlul; O'Doherty, John V.; O'Doherty, Alan M.] Natl Univ Ireland Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Bahar, Bojlul; Sweeney, Torres] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland	University College Dublin; University College Dublin	Sweeney, T (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland.	torres.sweeney@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; O'Doherty, Alan/0000-0001-5071-6793	Sea Change Strategy [MFFRI/07/01]; Marine Institute; Department of Agriculture, Food and the Marine	Sea Change Strategy; Marine Institute; Department of Agriculture, Food and the Marine	This project (Grant-Aid Agreement No. MFFRI/07/01) is carried out under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bahar B, 2011, BRIT J NUTR, V106, P1142, DOI 10.1017/S0007114511001486; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Cho EJ, 2008, J MICROBIOL BIOTECHN, V18, P80; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Enriori PJ, 2006, OBESITY, V14, P254; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo W, 2009, CELL RES, V19, P216, DOI 10.1038/cr.2008.319; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kim KJ, 2010, LIFE SCI, V86, P791, DOI 10.1016/j.lfs.2010.03.010; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kim WK, 2008, ENDOCR J, V55, P827, DOI 10.1507/endocrj.K08E-115; Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645; Lee HW, 2003, BIOL PHARM BULL, V26, P1100; Lee YH, 2004, J LIPID RES, V45, P1162, DOI 10.1194/jlr.D300028-JLR200; Li HX, 2010, J ZHEJIANG UNIV-SC B, V11, P784, DOI 10.1631/jzus.B0900401; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Marroqui L, 2012, J MOL ENDOCRINOL, V49, pR9, DOI 10.1530/JME-12-0025; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Moskalev EA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr213; Nishio Kazuaki, 2008, J Cardiometab Syndr, V3, P200, DOI 10.1111/j.1559-4572.2008.00019.x; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; O'Doherty AM, 2011, DEV BIOL, V356, P411, DOI 10.1016/j.ydbio.2011.05.665; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Salma N, 2006, J MOL ENDOCRINOL, V36, P139, DOI 10.1677/jme.1.01918; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Wu Jing, 2004, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V29, P623; Yokomori N, 2002, DIABETOLOGIA, V45, P140, DOI 10.1007/s125-002-8255-4; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang PL, 2002, ENDOCRINOLOGY, V143, P99, DOI 10.1210/en.143.1.99	45	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60011	10.1371/journal.pone.0060011	http://dx.doi.org/10.1371/journal.pone.0060011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544120	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700079
J	Kaparakis-Liaskos, M; Tate, MD; Price, JD; Pearse, M; Wijburg, OLC				Kaparakis-Liaskos, Maria; Tate, Michelle D.; Price, Jason D.; Pearse, Martin; Wijburg, Odilia L. C.			Increased Antigen Specific T Cell Numbers in the Absence of Altered Migration or Division Rates as a Result of Mucosal Cholera Toxin Administration	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; DENDRITIC CELLS; PRESENTING CELLS; B-SUBUNIT; INTRANASAL IMMUNIZATION; LYMPHOCYTE-RESPONSES; IMMUNE-RESPONSES; TRANSGENIC MICE; FLOW-CYTOMETRY; TH2 CELLS	Cholera toxin (CT) is a mucosal adjuvant capable of inducing strong immune responses to co-administered antigens following oral or intranasal immunization of mice. To date, the direct effect of CT on antigen-specific CD4(+) T cell migration and proliferation profiles in vivo is not well characterized. In this study, the effect of CT on the migration pattern and proliferative responses of adoptively transferred, CD4(+) TCR transgenic T cells in orally or intranasally vaccinated mice, was analyzed by flow cytometry. GFP-expressing or CFSE-labeled OT-II lymphocytes were adoptively transferred to naive C57BL/6 mice, and mice were subsequently vaccinated with OVA with or without CT via the oral or intranasal route. CT did not alter the migration pattern of antigen-specific T cells, regardless of the route of immunization, but increased the number of transgenic CD4(+) T cells in draining lymphoid tissue. This increase in the number of transgenic CD4(+) T cells was not due to cells undergoing more rounds of cellular division in vivo, suggesting that CT may exert an indirect adjuvant effect on CD4(+) T cells. The findings reported here suggest that CT functions as a mucosal adjuvant by increasing the number of antigen specific CD4(+) T cells independent of their migration pattern or kinetics of cellular division.	[Kaparakis-Liaskos, Maria; Price, Jason D.; Wijburg, Odilia L. C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Kaparakis-Liaskos, Maria; Tate, Michelle D.] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Pearse, Martin] CSL Ltd, Parkville, Vic, Australia	University of Melbourne; Monash University; CSL	Wijburg, OLC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	odilia@unimelb.edu.au	Kaparakis-Liaskos, Maria/I-6511-2013; Kaparakis-Liaskos, Maria/R-9321-2019	Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Kaparakis-Liaskos, Maria/0000-0002-8964-4456; Tate, Michelle/0000-0002-0587-5514	National Health and Medical Research Council of Australia (NHMRC); R.D. Wright Career Development Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); R.D. Wright Career Development Award	Grant support was received from the National Health and Medical Research Council of Australia (NHMRC). OLW is a recipient of an R.D. Wright Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alderuccio F, 1995, AUTOIMMUNITY, V21, P215, DOI 10.3109/08916939509008018; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BOWEN JC, 1994, IMMUNOLOGY, V81, P338; Bradley LM, 1996, CURR OPIN IMMUNOL, V8, P312, DOI 10.1016/S0952-7915(96)80118-X; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cong YZ, 1997, J IMMUNOL, V159, P5301; Corthesy-Theulaz IE, 1998, INFECT IMMUN, V66, P581; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; ELSON CO, 1984, J IMMUNOL, V132, P2736; Eriksson K, 2003, INFECT IMMUN, V71, P1740, DOI 10.1128/IAI.71.4.1740-1747.2003; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; FINKELSTEIN RA, 1974, J IMMUNOL, V113, P145; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; HOLMGREN J, 1981, NATURE, V292, P413, DOI 10.1038/292413a0; HOLMGREN J, 1974, J EXP MED, V139, P801, DOI 10.1084/jem.139.4.801; HORNQUIST E, 1993, EUR J IMMUNOL, V23, P2136, DOI 10.1002/eji.1830230914; HORNQVIST E, 1991, INFECT IMMUN, V59, P3630; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jones HP, 2001, J IMMUNOL, V167, P4518, DOI 10.4049/jimmunol.167.8.4518; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kawakami N, 1999, IMMUNOL LETT, V70, P165; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lavelle EC, 2004, J LEUKOCYTE BIOL, V75, P756, DOI 10.1189/jlb.1103534; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; LYCKE N, 1986, IMMUNOLOGY, V59, P301; LYCKE N, 1991, SCAND J IMMUNOL, V33, P691, DOI 10.1111/j.1365-3083.1991.tb02542.x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MARINARO M, 1995, J IMMUNOL, V155, P4621; Martin M, 2001, INFECT IMMUN, V69, P4486, DOI 10.1128/IAI.69.7.4486-4492.2001; NORTHRUP RS, 1972, J INFECT DIS, V125, P672, DOI 10.1093/infdis/125.6.672; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Porgador A, 1998, INFECT IMMUN, V66, P5876, DOI 10.1128/IAI.66.12.5876-5881.1998; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Simmons CP, 1999, J IMMUNOL, V163, P6502; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; SYDORA BC, 1993, INT IMMUNOL, V5, P743, DOI 10.1093/intimm/5.7.743; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Wu HY, 1997, INFECT IMMUN, V65, P227, DOI 10.1128/IAI.65.1.227-235.1997; WU HY, 1993, INFECT IMMUN, V61, P314, DOI 10.1128/IAI.61.1.314-322.1993; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto M, 1999, J IMMUNOL, V162, P7015; Yamamoto M, 2000, J INFECT DIS, V182, P180, DOI 10.1086/315694; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267	55	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59934	10.1371/journal.pone.0059934	http://dx.doi.org/10.1371/journal.pone.0059934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544110	Green Published, gold			2022-12-27	WOS:000317480700070
J	Kumar, NP; Gopinath, V; Sridhar, R; Hanna, LE; Banurekha, VV; Jawahar, MS; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Gopinath, Venugopal; Sridhar, Rathinam; Hanna, Luke E.; Banurekha, Vaithilingam V.; Jawahar, Mohideen S.; Nutman, Thomas B.; Babu, Subash			IL-10 Dependent Suppression of Type 1, Type 2 and Type 17 Cytokines in Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; INTERFERON-GAMMA; INFECTION; IL-23; MACROPHAGES; EXPRESSION; CONTRIBUTE	Background: Although Type 1 cytokine responses are considered protective in pulmonary tuberculosis (PTB), their role as well as those of Type 2, 17 and immunoregulatory cytokines in tuberculous lymphadenitis (TBL) and latent tuberculosis (LTB) have not been well studied. Aim and Methods: To identify cytokine responses associated with pulmonary tuberculosis (TB), TB lymphadenitits and latent TB, we examined mycobacterial antigen-specific immune responses of PTB, TBL and LTB individuals. More specifically, we examined ESAT-6 and CFP-10 induced Type 1, Type 2 and Type 17 cytokine production and their regulation using multiplex ELISA. Results:PTB individuals exhibited a significantly lower baseline as well as antigen-specific production of Type 1 (IFN gamma, TNF alpha and IL-2); Type 2 (IL-4) and Type 17 (IL-17A and IL-17F) cytokines in comparison to both TBL and LTB individuals. TBL individuals exhibited significantly lower antigen-specific IFN gamma responses alone in comparison to LTB individuals. Although, IL-10 levels were not significantly higher, neutralization of IL-10 during antigen stimulation resulted in significantly enhanced production of IFN gamma, IL-4 and IL-17A in PTB individuals, indicating that IL-10 mediates (at least partially) the suppression of cytokine responses in PTB. Conclusion: Pulmonary TB is characterized by an IL-10 dependent antigen-specific suppression of Type 1, Type 2 and Type 17 cytokines, reflecting an important association of these cytokines in the pathogenesis of active TB.	[Kumar, Nathella Pavan; Gopinath, Venugopal; Babu, Subash] NIH, Int Ctr Excellence Res, Chennai, Tamil Nadu, India; [Kumar, Nathella Pavan; Gopinath, Venugopal; Hanna, Luke E.; Banurekha, Vaithilingam V.; Jawahar, Mohideen S.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Chennai, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), NIH, Int Ctr Excellence Res, Chennai, Tamil Nadu, India.	sbabu@mail.nih.gov	Babu, Subash/GXG-4746-2022; Kumar, Nathella Pavan/AAU-2328-2021		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065, ZIAAI000197] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2008, THORAX, V63, P566, DOI 10.1136/thx.2007.092205; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; Holland SM, 2007, IMMUNOL RES, V38, P342, DOI 10.1007/s12026-007-0045-8; Jacobs M, 2007, EUR CYTOKINE NETW, V18, P5; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Pasquinelli V, 2009, J INFECT DIS, V199, P661, DOI 10.1086/596742; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wozniak TM, 2006, INFECT IMMUN, V74, P557, DOI 10.1128/IAI.74.1.557-565.2006; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	34	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59572	10.1371/journal.pone.0059572	http://dx.doi.org/10.1371/journal.pone.0059572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544075	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000317480700035
J	Axelsson-Robertson, R; Loxton, AG; Walzl, G; Ehlers, MM; Kock, MM; Zumla, A; Maeurer, M				Axelsson-Robertson, Rebecca; Loxton, Andre G.; Walzl, Gerhard; Ehlers, Marthie M.; Kock, Marleen M.; Zumla, Alimuddin; Maeurer, Markus			A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+T-Cell Immune Response in South African Patients with Active Tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIMICROBIAL ACTIVITY; PATTERN-RECOGNITION; ANTIGEN; INFECTION; PEPTIDES; STRAINS; CD8(+); DATABASE; ALLELES	We studied major histocompatibility complex (MHC) class I peptide-presentation and nature of the antigen-specific CD8+ T-cell response from South African tuberculosis (TB) patients with active TB. 361 MHC class I binding epitopes were identified from three immunogenic TB proteins (ESAT-6 [Rv3875], Ag85B [Rv1886c], and TB10.4 [Rv0288], including amino acid variations for Rv0288, i.e., A10T, G13D, S27N, and A71S for MHC allotypes common in a South African population (e. g., human leukocyte antigen [HLA]-A*30, B*58, and C*07). Inter-allelic differences were identified regarding the broadness of the peptide-binding capacity. Mapping of frequencies of Mycobacterium tuberculosis (M. tb) antigen-specific CD8+ T-cells using 48 different multimers, including the newly constructed recombinant MHC class I alleles HLA-B* 58: 01 and C*0701, revealed a low frequency of CD8+ T-cell responses directed against a broad panel of co-dominant M. tb epitopes in the peripheral circulation of most patients. The antigen-specific responses were dominated by CD8+ T-cells with a precursor-like phenotype (CD45RA+CCR7+). The data show that the CD8+ T-cell response from patients with pulmonary TB (prior to treatment) is directed against subdominant epitopes derived from secreted and non-secreted M. tb antigens and that variant, natural occurring M. tb Rv0288 ligands, have a profound impact on T-cell recognition.	[Axelsson-Robertson, Rebecca; Maeurer, Markus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Loxton, Andre G.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa; [Loxton, Andre G.; Walzl, Gerhard] Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, MRC Ctr Mol & Cellular Biol,Div Mol Biol & Human, ZA-7600 Stellenbosch, South Africa; [Ehlers, Marthie M.; Kock, Marleen M.] Univ Pretoria, NHLS, Dept Med Microbiol, ZA-0002 Pretoria, South Africa; [Zumla, Alimuddin] UCL, Sch Med, Div Infect & Immun, London W1N 8AA, England; [Maeurer, Markus] Karolinska Inst, Dept Lab Med, Therapeut Immunol TIM, Stockholm, Sweden; [Maeurer, Markus] Karolinska Univ Hosp, CAST, Stockholm, Sweden	Karolinska Institutet; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; University of Pretoria; University of London; University College London; UCL Medical School; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Maeurer, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	markus.maeurer@ki.se	ZUMLA, Alimuddin/ABA-8208-2020; Kock, Martha/ABD-7182-2021; Walzl, Gerhard/N-6371-2016	ZUMLA, Alimuddin/0000-0002-5111-5735; Ehlers, Marthie/0000-0003-2199-6970; Loxton, Andre/0000-0003-0659-9803; Walzl, Gerhard/0000-0003-2487-125X; Maeurer, Markus/0000-0002-8436-8077; Kock, Marleen/0000-0002-1768-9268	EDCTP TB-NEAT study; Soderberg foundation; VR; Vinnova; Karolinska Institutet (KID); DST/NRF; SIDA; HLF (Heart and Lung Foundation, Sweden)	EDCTP TB-NEAT study; Soderberg foundation; VR(Swedish Research Council); Vinnova(Vinnova); Karolinska Institutet (KID); DST/NRF(Department of Science & Technology (India)); SIDA; HLF (Heart and Lung Foundation, Sweden)	The study was funded in part by the EDCTP TB-NEAT study (MM, AZ) and grants from the Soderberg foundation, from VR, SIDA, HLF (Heart and Lung Foundation, Sweden) and Vinnova to MM. RA received a grant from Karolinska Institutet (KID), AGL received an Innovation Postdoctoral fellowship from the DST/NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-41; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anichini A, 1999, J EXP MED, V190, P651, DOI 10.1084/jem.190.5.651; Axelsson-Robertson R, 2011, CLIN VACCINE IMMUNOL, V18, P125, DOI 10.1128/CVI.00302-10; Axelsson-Robertson R, 2010, IMMUNOLOGY, V129, P496, DOI 10.1111/j.1365-2567.2009.03201.x; Bachinsky Margaret M, 2005, Cancer Immun, V5, P6; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2006, J IMMUNOL, V177, P1780, DOI 10.4049/jimmunol.177.3.1780; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Feng CG, 1999, INFECT IMMUN, V67, P3242, DOI 10.1128/IAI.67.7.3242-3247.1999; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gaseitsiwe S, 2010, CLIN VACCINE IMMUNOL, V17, P168, DOI 10.1128/CVI.00208-09; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Hohn H, 2007, SCAND J IMMUNOL, V65, P467, DOI 10.1111/j.1365-3083.2007.01924.x; Hoft DF, 2012, VACCINE; Hohn H, 2003, CLIN EXP IMMUNOL, V131, P102, DOI 10.1046/j.1365-2249.2003.02036.x; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SETTE A, 1994, J IMMUNOL, V153, P5586; Shingler WH, 2008, INT IMMUNOL, V20, P1057, DOI 10.1093/intimm/dxn063; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; WHO, 2011, WHOHTMTB20112016; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yuan Y, 1998, J BIOL CHEM, V273, P21282, DOI 10.1074/jbc.273.33.21282; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	63	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58309	10.1371/journal.pone.0058309	http://dx.doi.org/10.1371/journal.pone.0058309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555576	Green Published, gold			2022-12-27	WOS:000317418500008
J	Baldassarri, D; Grossman, G				Baldassarri, Delia; Grossman, Guy			The Effect of Group Attachment and Social Position on Prosocial Behavior. Evidence from Lab-in-the-Field Experiments	PLOS ONE			English	Article							FOOD-SHARING NETWORKS; COOPERATION; EVOLUTION; FAIRNESS; PREFERENCES; RECIPROCITY; COMMITMENT; ALTRUISM; IDENTITY; LAMALERA	Social life is regulated by norms of fairness that constrain selfish behavior. While a substantial body of scholarship on prosocial behavior has provided evidence of such norms, large inter- and intra-personal variation in prosocial behavior still needs to be explained. The article identifies two social-structural dimensions along which people's generosity varies systematically: group attachment and social position. We conducted lab-in-the-field experiments involving 2,597 members of producer organizations in rural Uganda. Using different variants of the dictator game, we demonstrate that group attachment positively affects prosocial behavior, and that this effect is not simply the by-product of the degree of proximity between individuals. Second, we show that occupying a formal position in an organization or community leads to greater generosity toward in-group members. Taken together, our findings show that prosocial behavior is not an invariant social trait; rather, it varies according to individuals' relative position in the social structure.	[Baldassarri, Delia] NYU, Dept Sociol, New York, NY 10003 USA; [Grossman, Guy] Univ Penn, Dept Polit Sci, Philadelphia, PA 19104 USA	New York University; University of Pennsylvania	Baldassarri, D (corresponding author), NYU, Dept Sociol, New York, NY 10003 USA.	delia.b@nyu.edu	Grossman, Guy/AAF-3940-2019	Grossman, Guy/0000-0002-6980-6390; Baldassarri, Delia/0000-0002-9264-035X	National Science Foundation (NSF) [SES(IOS) - 0924778, SES-0921204]; Princeton Institute for the International and Regional Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Princeton Institute for the International and Regional Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	DB acknowledges support from the National Science Foundation (NSF) Grant SES(IOS) - 0924778 and Princeton Institute for the International and Regional Studies. GG acknowledges support from the NSF Doctoral Dissertation Improvement Grant SES-0921204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida CL, 2010, P NATL ACAD SCI; Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Barr A, 2003, EC J; Bohnet I, 1999, AM ECON REV, V89, P335, DOI 10.1257/aer.89.1.335; Branas-Garza P, 2010, GAME ECON BEHAV, V69, P249, DOI 10.1016/j.geb.2009.10.014; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Campbell, 1976, ETHNOCENTRISM INTERG; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; D'Exelle B, 2010, 5356 IZA; Durkheim E., 1984, DIVISION LABOR SOC; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; EISENSTADT SN, 1980, COMP STUD SOC HIST, V22, P42, DOI 10.1017/S0010417500009154; Ellemers N, 1997, J PERS SOC PSYCHOL, V72, P617, DOI 10.1037/0022-3514.72.3.617; Elster J., 1989, CEMENT SOC; Ermisch J, 2010, J ECON BEHAV ORGAN, V75, P365, DOI 10.1016/j.jebo.2010.05.007; Fearon James D., 1999, DEMOCRACY ACCOUNTABI, P55, DOI DOI 10.1017/CBO9781139175104; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fowler JH, 2007, J POLIT, V69, P813, DOI 10.1111/j.1468-2508.2007.00577.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gintis H., 2005, MORAL SENTIMENTS MAT; Goeree JK, 2010, AM ECON J-MICROECON, V2, P183, DOI 10.1257/mic.2.1.183; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Grossman G, 2012, AM J POLIT SCI, V56, P964, DOI 10.1111/j.1540-5907.2012.00596.x; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Habyarimana J, 2007, AM POLITICAL SCI REV, V101; Habyarimana James, 2009, COETHNICITY DIVERSIT; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hechter M, 2009, AM BEHAV SCI, V53, P279, DOI 10.1177/0002764209338793; Henrich J., 2005, FDN HUMAN SOCIALITY; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Kasper C, 2012, WORKING PAPER; Konow J, 2010, J PUBLIC ECON, V94, P279, DOI 10.1016/j.jpubeco.2009.11.008; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Merton R.K., 1949, SOCIAL THEORY SOCIAL; Nolin DA, 2012, EVOL HUM BEHAV, V33, P334, DOI 10.1016/j.evolhumbehav.2011.11.003; Nolin DA, 2010, HUM NATURE-INT BIOS, V21, P243, DOI 10.1007/s12110-010-9091-3; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 1990, GOVERNING COMMONS EV; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; Portes A, 2011, ANNU REV SOCIOL, V37, P461, DOI 10.1146/annurev-soc-081309-150022; ROTH AE, 1991, AM ECON REV, V81, P1068; Simmel G, 1955, CONICT WEB GROUP AFF; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Weber M., 1978, EC SOC; Whitt S, 2007, AM J POLIT SCI, V51, P655, DOI 10.1111/j.1540-5907.2007.00273.x; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Yamagishi T, 2000, SOC PSYCHOL QUART, V63, P116, DOI 10.2307/2695887	62	43	43	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58750	10.1371/journal.pone.0058750	http://dx.doi.org/10.1371/journal.pone.0058750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555594	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500015
J	Campbell, AG; Campbell, JH; Schwientek, P; Woyke, T; Sczyrba, A; Allman, S; Beall, CJ; Griffen, A; Leys, E; Podar, M				Campbell, Alisha G.; Campbell, James H.; Schwientek, Patrick; Woyke, Tanja; Sczyrba, Alexander; Allman, Steve; Beall, Clifford J.; Griffen, Ann; Leys, Eugene; Podar, Mircea			Multiple Single-Cell Genomes Provide Insight into Functions of Uncultured Deltaproteobacteria in the Human Oral Cavity	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; DESULFOVIBRIO-FAIRFIELDENSIS; OLIGONUCLEOTIDE PROBES; PERIODONTAL-DISEASES; CRYSTAL-STRUCTURE; BIOFILM FORMATION; IV PILI; SEQUENCE; IDENTIFICATION; VIRULENCE	Despite a long history of investigation, many bacteria associated with the human oral cavity have yet to be cultured. Studies that correlate the presence or abundance of uncultured species with oral health or disease highlight the importance of these community members. Thus, we sequenced several single-cell genomic amplicons from Desulfobulbus and Desulfovibrio (class Deltaproteobacteria) to better understand their function within the human oral community and their association with periodontitis, as well as other systemic diseases. Genomic data from oral Desulfobulbus and Desulfovibrio species were compared to other available deltaproteobacterial genomes, including from a subset of host-associated species. While both groups share a large number of genes with other environmental Deltaproteobacteria genomes, they encode a wide array of unique genes that appear to function in survival in a host environment. Many of these genes are similar to virulence and host adaptation factors of known human pathogens, suggesting that the oral Deltaproteobacteria have the potential to play a role in the etiology of periodontal disease.	[Campbell, Alisha G.; Podar, Mircea] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA; [Campbell, Alisha G.; Campbell, James H.; Allman, Steve; Podar, Mircea] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Schwientek, Patrick; Woyke, Tanja; Sczyrba, Alexander] DOE Joint Genome Inst, Walnut Creek, CA USA; [Beall, Clifford J.; Griffen, Ann; Leys, Eugene] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA; [Podar, Mircea] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville	Podar, M (corresponding author), Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA.	podarm@ornl.gov	Allman, Steve L/A-9121-2011; Griffen, Ann/AAC-5999-2019; Podar, Mircea/B-7299-2012; Beall, Clifford/D-1035-2012	Allman, Steve L/0000-0001-6538-7048; Podar, Mircea/0000-0003-2776-0205; Beall, Clifford/0000-0002-2198-9124; Sczyrba, Alexander/0000-0002-4405-3847	National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [R01 HG004857]; National Institute for Dental and Cranial Research (NIDCR) of the NIH [1R56DE021567]; U.S. Department of Energy [DE681 AC05-00OR22725]; U.S. Department of Energy Joint Genome Institute; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE021567] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Dental and Cranial Research (NIDCR) of the NIH; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by grant R01 HG004857 from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) to M.P. and by grant 1R56DE021567 from the National Institute for Dental and Cranial Research (NIDCR) of the NIH to M.P., A.G. and E.L. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE681 AC05-00OR22725. P.S., T.W. and A.S. were supported by the U.S. Department of Energy Joint Genome Institute and the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; AN FY, 1994, PLASMID, V31, P215, DOI 10.1006/plas.1994.1023; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Boopathy R, 2002, CAN J MICROBIOL, V48, P1099, DOI 10.1139/W02-104; Brown CT, 2012, ARXIV12034802QBIOGN; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Casabona MG, 2012, ENV MICROBIOLOGY; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; DANNENBERG S, 1992, ARCH MICROBIOL, V158, P93, DOI 10.1007/BF00245211; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fernandez L, 2004, APPL ENVIRON MICROB, V70, P5199, DOI 10.1128/AEM.70.9.5199-5207.2004; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006; Fuchs BM., 2007, METHODS GEN MOL MICR, V5, P886; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P25, DOI 10.1006/mpat.2000.0365; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004; Langendijk PS, 2000, J CLIN PERIODONTOL, V27, P943, DOI 10.1034/j.1600-051x.2000.027012943.x; Langendijk PS, 2001, INT J SYST EVOL MICR, V51, P1035, DOI 10.1099/00207713-51-3-1035; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; Loubinoux J, 2000, J CLIN MICROBIOL, V38, P1707; Loubinoux J, 2002, ORAL MICROBIOL IMMUN, V17, P321, DOI 10.1034/j.1399-302X.2002.170510.x; Loughlin MF, 2009, MICROB PATHOGENESIS, V46, P53, DOI 10.1016/j.micpath.2008.10.004; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Lucker S, 2007, J MICROBIOL METH, V69, P523, DOI 10.1016/j.mimet.2007.02.009; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Pagani I, 2011, STAND GENOMIC SCI, V4, P100, DOI 10.4056/sigs.1613929; Pimentel JD, 2007, J CLIN MICROBIOL, V45, P2747, DOI 10.1128/JCM.00969-07; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ramirez-Tortosa MC, 2010, NUTR METAB CARDIOVAS, V20, P133, DOI 10.1016/j.numecd.2009.03.003; Reddy M, 2007, J BACTERIOL, V189, P98, DOI 10.1128/JB.01347-06; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Scannapieco FA DA, 2010, DENT CLIN N AM, V54, P18; Seshadri Rekha, 2004, Proceedings of the National Academy of Sciences of the United States of America, V101, P5646, DOI 10.1073/pnas.0307639101; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; Sun H, 2010, STAND GENOMIC SCI, V3, P276, DOI 10.4056/sigs.1243258; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Tamariz J, 2006, J FORENSIC SCI, V51, P790, DOI 10.1111/j.1556-4029.2006.00172.x; TASAKI M, 1993, FEMS MICROBIOL LETT, V106, P259, DOI 10.1111/j.1574-6968.1993.tb05973.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vianna ME, 2008, J BACTERIOL, V190, P3779, DOI 10.1128/JB.01861-07; Wade WG, 2005, INT C SER, V1284, P150; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang RK, 2012, MICROB ECOL, V64, P152, DOI 10.1007/s00248-012-0013-2; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WIDDEL F, 1982, ARCH MICROBIOL, V131, P360, DOI 10.1007/BF00411187; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	83	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59361	10.1371/journal.pone.0059361	http://dx.doi.org/10.1371/journal.pone.0059361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555659	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500034
J	Kim, DH; Park, MH; Choi, YJ; Chung, KW; Park, CH; Jang, EJ; An, HJ; Yu, BP; Chung, HY				Kim, Dae Hyun; Park, Min Hi; Choi, Yeon Ja; Chung, Ki Wung; Park, Chan Hum; Jang, Eun Ji; An, Hye Jin; Yu, Byung Pal; Chung, Hae Young			Molecular Study of Dietary Heptadecane for the Anti-Inflammatory Modulation of NF-kB in the Aged Kidney	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DEPENDENT GENE-TRANSCRIPTION; CALORIE RESTRICTION; OXIDATIVE STRESS; INFLAMMATION HYPOTHESIS; INDUCED APOPTOSIS; RAT-KIDNEY; KINASE; CELLS; SPIRULINA	Heptadecane is a volatile component of Spirulina platensis, and blocks the de novo synthesis of fatty acids and ameliorates several oxidative stress-related diseases. In a redox state disrupted by oxidative stress, pro-inflammatory genes are upregulated by the activation of NF-kB via diverse kinases. Thus, the search and characterization of new substances that modulate NF-kB are lively research topics. In the present study, heptadecane was examined in terms of its ability to suppress inflammatory NF-kB activation via redox-related NIK/IKK and MAPKs pathway in aged rats. In the first part of the study, Fischer 344 rats, aged 9 and 20 months, were administered on average approximately 20 or 40 mg/Kg body weight over 10 days. The potency of heptadecane was investigated by examining its ability to suppress the gene expressions of COX-2 and iNOS (both NF-kappa B-related genes) and reactive species (RS) production in aged kidney tissue. In the second part of the study, YPEN-1 cells (an endothelial cell line) were used to explore the molecular mechanism underlying the anti-inflammatory effect of heptadecane by examining its modulation of NF-kB and NF-kB signal pathway. Results showed that heptadecane exhibited a potent anti-oxidative effect by protecting YPEN-1 cells from tert-butylhydroperoxide induced oxidative stress. Further molecular investigations revealed that heptadecane attenuated RS-induced NF-kB via the NIK/IKK and MAPKs pathways in YPEN-1 cells and aged kidney tissues. Based on these results, we conclude that heptadecane suppresses age-related increases in pro-inflammatory gene expressions by reducing NF-kB activity by upregulating the NIK/IKK and MAPKs pathways induced by RS. These findings provide molecular insight of the mechanisms by which heptadecane exerts its antiinflammatory effect in aged kidney tissues. We conclude that heptadecane suppresses age-related increases in pro-inflammatory gene expressions then travel upstream set by step by reducing NF-kB activity by downregulating the NIK/IKK and MAPKs pathways induced by RS.	[Kim, Dae Hyun; Park, Min Hi; Choi, Yeon Ja; Chung, Ki Wung; Park, Chan Hum; Jang, Eun Ji; An, Hye Jin; Chung, Hae Young] Pusan Natl Univ, Aging Tissue Bank, Coll Pharm, Dept Pharm, Pusan, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Pusan National University; University of Texas System; University of Texas Health San Antonio	Chung, HY (corresponding author), Pusan Natl Univ, Aging Tissue Bank, Coll Pharm, Dept Pharm, Pusan, South Korea.	hyjung@pusan.ac.kr	Sovio, Ulla/H-8532-2019; Viner, Russell M/A-1441-2009; Park, Min Hi/AAL-9880-2020; Hardy, Rebecca/AFR-1989-2022	Sovio, Ulla/0000-0002-0799-1105; Viner, Russell M/0000-0003-3047-2247; 	National Research Foundation of Korea (NRF); Korean government (MEST) [2009-0083538]; MRC [MC_U123092721, MC_U123092720, G1001799] Funding Source: UKRI	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korean government (MEST) (Grant No. 2009-0083538). The authors also take this opportunity to thank the Aging Tissue Bank (Busan, Korea) for supplying research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asima B, 2002, BIOCHEM J, V368, P121; Baichwal V. R., 1997, CURR BIOL, V7, P94; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Carcamo JM, 2002, BIOCHEMISTRY-US, V41, P12995, DOI 10.1021/bi0263210; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Chung HY., 2000, REV CLIN GERONTOL, V10, P207, DOI [DOI 10.1017/S0959259800010327, 10.1017/S0959259800010327]; Darieva Z, 2004, J LEUKOCYTE BIOL, V75, P689, DOI 10.1189/jlb.0603280; Egger T, 2003, BIOCHEM J, V370, P459, DOI 10.1042/BJ20021358; Fish JH, 2001, TISSUE CELL, V33, P189, DOI 10.1054/tice.2001.0170; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Hansen JM, 2004, ANTIOXID REDOX SIGN, V6, P1, DOI 10.1089/152308604771978291; Hatorri M, 1990, DNA CELL BIOL, V9, P777; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2004, ANN RHEUM DIS, V63, P62, DOI 10.1136/ard.2004.028274; Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; King RE, 2005, CHEM-BIOL INTERACT, V151, P143, DOI 10.1016/j.cbi.2004.11.003; Kumiko O, 1998, INT J CANCER, V76, P851; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lin XH, 2010, MOLECULES, V15, P241, DOI 10.3390/molecules15010241; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 2000, METH MOL B, V99, P109; MISHINA M, 1973, AGR BIOL CHEM TOKYO, V37, P863, DOI 10.1080/00021369.1973.10860762; OSAWA T, 1981, AGR BIOL CHEM TOKYO, V45, P735, DOI 10.1080/00021369.1981.10864583; Ozdemir G, 2004, PHYTOTHER RES, V18, P754, DOI 10.1002/ptr.1541; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; SCHMITZ ML, 1995, IMMUNOBIOLOGY, V193, P116, DOI 10.1016/S0171-2985(11)80534-6; Sung B, 2004, J GERONTOL A-BIOL, V59, P997; Wu LC, 2005, J AGR FOOD CHEM, V53, P4207, DOI 10.1021/jf0479517; Yang CM, 2002, CELL SIGNAL, V14, P899, DOI 10.1016/S0898-6568(02)00037-2; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1; YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657	44	91	94	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59316	10.1371/journal.pone.0059316	http://dx.doi.org/10.1371/journal.pone.0059316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555655	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500033
J	Kim, N; Branch, CA; Kim, M; Lipton, ML				Kim, Namhee; Branch, Craig A.; Kim, Mimi; Lipton, Michael L.			Whole Brain Approaches for Identification of Microstructural Abnormalities in Individual Patients: Comparison of Techniques Applied to Mild Traumatic Brain Injury	PLOS ONE			English	Article							DIFFUSION TENSOR IMAGES; WHITE-MATTER INTEGRITY; AXONAL INJURY; FRACTIONAL ANISOTROPY; PERSONALIZED MEDICINE; VOXELWISE ANALYSIS; CORPUS-CALLOSUM; REGISTRATION; BIOMARKERS; PHARMACOGENOMICS	Purpose: Group-wise analyses of DTI in mTBI have demonstrated evidence of traumatic axonal injury (TAI), associated with adverse clinical outcomes. Although mTBI is likely to have a unique spatial pattern in each patient, group analyses implicitly assume that location of injury will be the same across patients. The purpose of this study was to optimize and validate a procedure for analysis of DTI images acquired in individual patients, which could detect inter-individual differences and be applied in the clinical setting, where patients must be assessed as individuals. Materials and Methods: After informed consent and in compliance with HIPAA, 34 mTBI patients and 42 normal subjects underwent 3.0 Tesla DTI. Four voxelwise assessment methods (standard Z-score, "one vs. many" t-test, Family-Wise Error Rate control using pseudo t-distribution, EZ-MAP) for use in individual patients, were applied to each patient's fractional anisotropy (FA) maps and tested for its ability to discriminate patients from controls. Receiver Operating Characteristic (ROC) analyses were used to define optimal thresholds (voxel-level significance and spatial extent) for reliable and robust detection of mTBI pathology. Results: ROC analyses showed EZ-MAP (specificity 71%, sensitivity 71%), "one vs. many" t-test and standard Z-score (sensitivity 65%, specificity 76% for both methods) resulted in a significant area under the curve (AUC) score for discriminating mTBI patients from controls in terms of the total number of abnormal white matter voxels detected while the FWER test was not significant. EZ-MAP is demonstrated to be robust to assumptions of Gaussian behavior and may serve as an alternative to methods that require strict Gaussian assumptions. Conclusion: EZ-MAP provides a robust approach for delineation of regional abnormal anisotropy in individual mTBI patients.	[Kim, Namhee; Branch, Craig A.; Lipton, Michael L.] Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA; [Kim, Namhee; Branch, Craig A.; Lipton, Michael L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Radiol, Bronx, NY USA; [Branch, Craig A.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA; [Kim, Mimi] Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Lipton, Michael L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY USA; [Lipton, Michael L.] Yeshiva Univ, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY USA; [Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Lipton, ML (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu			Dana Foundation; David Mahoney Neuroimaging Program; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS082432]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082432] Funding Source: NIH RePORTER	Dana Foundation; David Mahoney Neuroimaging Program; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The Dana Foundation, David Mahoney Neuroimaging Program and by National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS082432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Becla L, 2011, INT J TECHNOL ASSESS, V27, P118, DOI 10.1017/S026646231100002X; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Curran ME, 2011, PHARMACOGENOMICS, V12, P465, DOI 10.2217/pgs.11.9; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar D, 2011, ANN I SUPER SANITA, V47, P31, DOI 10.4415/ANN_11_01_08; Li C, 2011, CLIN GENET, V79, P403, DOI 10.1111/j.1399-0004.2010.01609.x; Lim KO, 2006, AM J PSYCHIAT, V163, P2008, DOI 10.1176/appi.ajp.163.11.2008; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Patel SA, 2007, J MAGN RESON IMAGING, V26, P552, DOI 10.1002/jmri.21076; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Plas J, 1999, REV NEUROL, V155, P569; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sato Y, 2010, CURR PHARM DESIGN, V16, P2232, DOI 10.2174/138161210791792886; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Viviani R, 2007, HUM BRAIN MAPP, V28, P1075, DOI 10.1002/hbm.20332; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	44	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59382	10.1371/journal.pone.0059382	http://dx.doi.org/10.1371/journal.pone.0059382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555665	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500037
J	Zhang, X; Xu, J; Xiao, WX				Zhang, Xue; Xu, Jin; Xiao, Wang-xin			A New Method for the Discovery of Essential Proteins	PLOS ONE			English	Article							IDENTIFYING ESSENTIAL PROTEINS; ESSENTIAL GENES; NETWORK TOPOLOGY; PPI NETWORK; CENTRALITY; GENOME; INTEGRATION; PREDICTION; IDENTIFICATION; MAP	Background: Experimental methods for the identification of essential proteins are always costly, time-consuming, and laborious. It is a challenging task to find protein essentiality only through experiments. With the development of high throughput technologies, a vast amount of protein-protein interactions are available, which enable the identification of essential proteins from the network level. Many computational methods for such task have been proposed based on the topological properties of protein-protein interaction (PPI) networks. However, the currently available PPI networks for each species are not complete, i.e. false negatives, and very noisy, i.e. high false positives, network topology-based centrality measures are often very sensitive to such noise. Therefore, exploring robust methods for identifying essential proteins would be of great value. Method: In this paper, a new essential protein discovery method, named CoEWC (Co-Expression Weighted by Clustering coefficient), has been proposed. CoEWC is based on the integration of the topological properties of PPI network and the co-expression of interacting proteins. The aim of CoEWC is to capture the common features of essential proteins in both date hubs and party hubs. The performance of CoEWC is validated based on the PPI network of Saccharomyces cerevisiae. Experimental results show that CoEWC significantly outperforms the classical centrality measures, and that it also outperforms PeC, a newly proposed essential protein discovery method which outperforms 15 other centrality measures on the PPI network of Saccharomyces cerevisiae. Especially, when predicting no more than 500 proteins, even more than 50% improvements are obtained by CoEWC over degree centrality (DC), a better centrality measure for identifying protein essentiality. Conclusions: We demonstrate that more robust essential protein discovery method can be developed by integrating the topological properties of PPI network and the co-expression of interacting proteins. The proposed centrality measure, CoEWC, is effective for the discovery of essential proteins.	[Zhang, Xue; Xu, Jin] Peking Univ, Key Lab High Confidence Software Technol, Minist Educ, Beijing 100871, Peoples R China; [Zhang, Xue; Xu, Jin] Peking Univ, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China; [Xiao, Wang-xin] Highway Minist Transport, Res Inst, Beijing, Peoples R China	Peking University; Peking University; Ministry of Transport of the People's Republic of China	Zhang, X (corresponding author), Peking Univ, Key Lab High Confidence Software Technol, Minist Educ, Beijing 100871, Peoples R China.	lindajia03@126.com			National Natural Science Fund [61133010, 61127005]; National Natural Science Foundation of China [50708085, 50978127]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the Key project of National Natural Science Fund (No. 61133010 and No. 61127005) and the National Natural Science Foundation of China (No. 50708085 and No. 50978127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2006, PROTEOMICS, V6, P35, DOI 10.1002/pmic.200500209; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Ning K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-505; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Ren J, 2011, LECT N BIOINFORMAT, V6674, P12, DOI 10.1007/978-3-642-21260-4_6; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Wang H, 2011, LECT N BIOINFORMAT, V6674, P87, DOI 10.1007/978-3-642-21260-4_12; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	39	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58763	10.1371/journal.pone.0058763	http://dx.doi.org/10.1371/journal.pone.0058763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555595	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400011
J	Adaixo, R; Harley, CA; Castro-Rodrigues, AF; Morais-Cabral, JH				Adaixo, Ricardo; Harley, Carol A.; Castro-Rodrigues, Artur F.; Morais-Cabral, Joao H.			Structural Properties of PAS Domains from the KCNH Potassium Channels	PLOS ONE			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; LIGAND-BINDING; HERG; MECHANISM; PROTEIN; EAG	KCNH channels form an important family of voltage gated potassium channels. These channels include a N-terminal Per-Arnt-Sim (PAS) domain with unknown function. In other proteins PAS domains are implicated in cellular responses to environmental queues through small molecule binding or involvement in signaling cascades. To better understand their role we characterized the structural properties of several channel PAS domains. We determined high resolution structures of PAS domains from the mouse EAG (mEAG), drosophila ELK (dELK) and human ERG (hERG) channels and also of the hERG domain without the first nine amino acids. We analyzed these structures for features connected to ligand binding and signaling in other PAS domains. In particular, we have found cavities in the hERG and mEAG structures that share similarities with the ligand binding sites from other PAS domains. These cavities are lined by polar and apolar chemical groups and display potential flexibility in their volume. We have also found that the hydrophobic patch on the domain beta-sheet is a conserved feature and appears to drive the formation of protein-protein contacts. In addition, the structures of the dELK domain and of the truncated hERG domain revealed the presence of N-terminal helices. These helices are equivalent to the helix described in the hERG NMR structures and are known to be important for channel function. Overall, these channel domains retain many of the PAS domain characteristics known to be important for cell signaling.	[Adaixo, Ricardo; Harley, Carol A.; Castro-Rodrigues, Artur F.; Morais-Cabral, Joao H.] Univ Porto, IBMC, P-4100 Oporto, Portugal	Universidade do Porto	Morais-Cabral, JH (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jcabral@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013; Harley, Carol/J-5375-2013	Morais-Cabral, Joao H/0000-0002-4461-9716; Harley, Carol/0000-0003-3610-0604; Rodrigues, Artur/0000-0002-1630-3810	EMBO; FEDER funds through the Operational Competitiveness Program - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-Feder-007427/PTDC/QUI/66171/2006, FCOMP-01-0124-FEDER-0227, FCT Pest-C/SAU/LA0002/2011]; National Institutes of Health [1R01NS081320-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081320] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); FEDER funds through the Operational Competitiveness Program - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by EMBO (installation grant), by FEDER funds through the Operational Competitiveness Program - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-Feder-007427/PTDC/QUI/66171/2006 and FCOMP-01-0124-FEDER-0227(ref: FCT Pest-C/SAU/LA0002/2011) and by National Institutes of Health (1R01NS081320-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaixo R, 2010, ACTA CRYSTALLOGR F, V66, P1056, DOI 10.1107/S1744309110027880; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	42	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59265	10.1371/journal.pone.0059265	http://dx.doi.org/10.1371/journal.pone.0059265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555008	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800077
J	Amali, AA; Sie, L; Winkler, C; Featherstone, M				Amali, Aseervatham Anusha; Sie, Lawrence; Winkler, Christoph; Featherstone, Mark			Zebrafish hoxd4a Acts Upstream of meis1.1 to Direct Vasculogenesis, Angiogenesis and Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; DEFINITIVE HEMATOPOIESIS; HOMEOTIC TRANSFORMATIONS; ENDOTHELIAL LINEAGES; BLOOD; PROTEINS; PBX; LEUKEMOGENESIS; ESTABLISHMENT	Mice lacking the 4th-group paralog Hoxd4 display malformations of the anterior vertebral column, but are viable and fertile. Here, we report that zebrafish embryos having decreased function of the orthologous hoxd4a gene manifest striking perturbations in vasculogenesis, angiogenesis and primitive and definitive hematopoiesis. These defects are preceded by reduced expression of the hemangioblast markers scl1, lmo2 and fli1 within the posterior lateral plate mesoderm (PLM) at 13 hours post fertilization (hpf). Epistasis analysis revealed that hoxd4a acts upstream of meis1.1 but downstream of cdx4 as early as the shield stage in ventral-most mesoderm fated to give rise to hemangioblasts, leading us to propose that loss of hoxd4a function disrupts hemangioblast specification. These findings place hoxd4a high in a genetic hierarchy directing hemangioblast formation downstream of cdx1/cdx4 and upstream of meis1.1. An additional consequence of impaired hoxd4a and meis1.1 expression is the deregulation of multiple Hox genes implicated in vasculogenesis and hematopoiesis which may further contribute to the defects described here. Our results add to evidence implicating key roles for Hox genes in their initial phase of expression early in gastrulation.	[Amali, Aseervatham Anusha; Sie, Lawrence; Featherstone, Mark] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Featherstone, M (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	msfeatherstone@ntu.edu.sg	Winkler, Christoph/G-4822-2012; Featherstone, Mark/E-8057-2010	Featherstone, Mark/0000-0003-1576-046X; Sie, Lawrence/0000-0002-9690-5968; Winkler, Christoph/0000-0003-4688-6241	Ministry of Education, Singapore [T207B3107]; Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore [10/1/22/19/663]	Ministry of Education, Singapore(Ministry of Education, Singapore); Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This project was supported by an Academic Research Fund Tier-2 grant (T207B3107) from the Ministry of Education, Singapore, to CW, and a grant (10/1/22/19/663) from the Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bahrami SB, 2011, CELL ADHES MIGR, V5, P133, DOI 10.4161/cam.5.2.14373; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Charboneau A., 2005, Angiogenesis, V8, P289; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Ciau-Uitz A, 2010, INT J DEV BIOL, V54, P1139, DOI 10.1387/ijdb.093055ac; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; Deschamps J, 1999, INT J DEV BIOL, V43, P635; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; diIorio P, 2007, DEV BIOL, V304, P221, DOI 10.1016/j.ydbio.2006.12.024; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Durston AJ, 2010, GENOMICS, V95, P250, DOI 10.1016/j.ygeno.2009.11.002; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; GAUNT SJ, 1994, DEV DYNAM, V199, P229, DOI 10.1002/aja.1001990307; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Ko KH, 2007, EXP HEMATOL, V35, P465, DOI 10.1016/j.exphem.2006.10.014; Lafontaine CA, 2012, BIOCHEMISTRY; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Magnusson M, 2007, EXP HEMATOL, V35, P1421, DOI 10.1016/j.exphem.2007.05.011; Mamo A, 2006, BLOOD, V108, P622, DOI 10.1182/blood-2005-06-2244; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Minehata K, 2008, BIOCHEM BIOPH RES CO, V374, P647, DOI 10.1016/j.bbrc.2008.07.075; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Nolte C, 2006, DEV BIOL, V299, P582, DOI 10.1016/j.ydbio.2006.08.061; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Prince VE, 1998, DEVELOPMENT, V125, P407; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; THISSE C, 1993, DEVELOPMENT, V119, P1203; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wan XY, 2011, J BIOL CHEM, V286, P33345, DOI 10.1074/jbc.M111.253252; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907	69	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58857	10.1371/journal.pone.0058857	http://dx.doi.org/10.1371/journal.pone.0058857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554940	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800037
J	Brown, AD; Sisneros, JA; Jurasin, T; Nguyen, C; Coffin, AB				Brown, Andrew D.; Sisneros, Joseph A.; Jurasin, Tyler; Nguyen, Chau; Coffin, Allison B.			Differences in Lateral Line Morphology between Hatchery- and Wild-Origin Steelhead	PLOS ONE			English	Article							SALMON; GROWTH; TROUT; REGENERATION; RECEPTION; OTOLITHS; SURVIVAL; FITNESS; ORGANS; WATER	Despite identification of multiple factors mediating salmon survival, significant disparities in survival-to-adulthood among hatchery-versus wild-origin juveniles persist. In the present report, we explore the hypothesis that hatchery-reared juveniles might exhibit morphological defects in vulnerable mechanosensory systems prior to release from the hatchery, potentiating reduced survival after release. Juvenile steelhead (Oncorhynchus mykiss) from two different hatcheries were compared to wild-origin juveniles on several morphological traits including lateral line structure, otolith composition (a proxy for auditory function), and brain weight. Wild juveniles were found to possess significantly more superficial lateral line neuromasts than hatchery-reared juveniles, although the number of hair cells within individual neuromasts was not significantly different across groups. Wild juveniles were also found to possess primarily normal, aragonite-containing otoliths, while hatchery-reared juveniles possessed a high proportion of crystallized (vaterite) otoliths. Finally, wild juveniles were found to have significantly larger brains than hatchery-reared juveniles. These differences together predict reduced sensitivity to biologically important hydrodynamic and acoustic signals from natural biotic (predator, prey, conspecific) and abiotic (turbulent flow, current) sources among hatchery-reared steelhead, in turn predicting reduced survival fitness after release. Physiological and behavioral studies are required to establish the functional significance of these morphological differences.	[Brown, Andrew D.] Washington State Univ, Dept Speech & Hearing Sci, Vancouver, WA USA; [Sisneros, Joseph A.] Washington State Univ, Dept Psychol, Vancouver, WA USA; [Sisneros, Joseph A.] Washington State Univ, Dept Biol, Vancouver, WA USA; [Jurasin, Tyler] Quinault Indian Nat, Dept Fisheries, Taholah, WA USA; [Nguyen, Chau; Coffin, Allison B.] Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA; [Coffin, Allison B.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Vancouver, WA USA	Washington State University; Washington State University; Washington State University; Washington State University; Washington State University	Coffin, AB (corresponding author), Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA.	allison.coffin@wsu.edu	Sisneros, Joseph/AAU-9965-2020	Sisneros, Joseph/0000-0002-3114-773X	Virginia Merrill Bloedel Hearing Research Center; Washington State University Vancouver	Virginia Merrill Bloedel Hearing Research Center; Washington State University Vancouver	This work was supported by a grant from the Virginia Merrill Bloedel Hearing Research Center (http://depts.washington.edu/hearing/) to JAS and by start-up funds from Washington State University Vancouver (http://www.vancouver.wsu.edu/) to ABC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Bonneville Power Administration, 2012, BPA INV FISH WILDL; Bowen CA, 1999, T AM FISH SOC, V128, P929, DOI 10.1577/1548-8659(1999)128<0929:VSIWAS>2.0.CO;2; Brenkman SJ, 2008, NORTHWEST SCI, V82, P91, DOI 10.3955/0029-344X-82.S.I.91; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; Chittenden CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012261; Coombs S., 1988, P553; DeHart M, 2007, COMP SURVIVAL STUDY; Dufourcq P, 2006, MOL CELL NEUROSCI, V33, P180, DOI 10.1016/j.mcn.2006.07.005; Engelmann J, 2002, J COMP PHYSIOL A, V188, P513, DOI 10.1007/s00359-002-0326-6; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P209, DOI 10.1080/00288330.1986.9516145; Groot C., 1995, PHYSL ECOLOGY PACIFI; Haeseker S, 2012, COMP SURV STUD ANN M; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Heard WR, 1995, 154 NPAFC NMFS NOAA; Jonsson N, 2003, J APPL ECOL, V40, P900, DOI 10.1046/j.1365-2664.2003.00851.x; Jorgensen J. M., 1991, CIBA F SYMP, V160, P163; Kalmijn A.J., 1988, P83; Kihslinger RL, 2006, J EXP BIOL, V209, P504, DOI 10.1242/jeb.02019; Kindschi GA, 2009, N AM J AQUACULT, V71, P79, DOI 10.1577/A07-063.1; Kostow K, 2009, REV FISH BIOL FISHER, V19, P9, DOI 10.1007/s11160-008-9087-9; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Larsson S, 2011, ENVIRON BIOL FISH, V92, P361, DOI 10.1007/s10641-011-9846-7; Lu ZM, 1998, HEARING RES, V126, P47, DOI 10.1016/S0378-5955(98)00149-X; MONTGOMERY J, 1995, REV FISH BIOL FISHER, V5, P399, DOI 10.1007/BF01103813; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Montgomery JC, 2003, P ROY SOC B-BIOL SCI, V270, pS195, DOI 10.1098/rsbl.2003.0052; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Montgomery JC, 2002, BRAIN BEHAV EVOLUT, V59, P190, DOI 10.1159/000064906; Oxman DS, 2007, CAN J FISH AQUAT SCI, V64, P1469, DOI 10.1139/F07-106; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ramcharitar J, 2010, J APPL TOXICOL, V30, P536, DOI 10.1002/jat.1523; RAYMOND H L, 1988, North American Journal of Fisheries Management, V8, P1, DOI 10.1577/1548-8675(1988)008<0001:EOHDAF>2.3.CO;2; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; Schellart NAM, 1998, PHYSL FISHES; SIREGAR YI, 1994, ACTA ZOOL-STOCKHOLM, V75, P213, DOI 10.1111/j.1463-6395.1994.tb01209.x; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; Sweeting RM, 2004, REV FISH BIOL FISHER, V14, P361, DOI 10.1007/s11160-005-3793-3; Vladykov V, 1926, LATERAL LINE SYSTE 1; Wark AR, 2010, J EXP BIOL, V213, P108, DOI 10.1242/jeb.031625; Washington Department of Fish and Wildlife, 2002, SALM STOCK INV; Webb J.F., 2008, SPRINGER HDB AUDITOR, V32; WEBER DD, 1976, J FISH BIOL, V9, P217, DOI 10.1111/j.1095-8649.1976.tb04675.x; Wiese FK, 2008, ECOL APPL, V18, P681, DOI 10.1890/06-1825.1	47	29	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59162	10.1371/journal.pone.0059162	http://dx.doi.org/10.1371/journal.pone.0059162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554988	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800063
J	Griffing, SM; Viana, GMR; Mixson-Hayden, T; Sridaran, S; Alam, MT; de Oliveira, AM; Barnwell, JW; Escalante, AA; Povoa, MM; Udhayakumar, V				Griffing, Sean M.; Rachid Viana, Giselle M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Mohammad Tauqeer; de Oliveira, Alexandre Macedo; Barnwell, John W.; Escalante, Ananias A.; Povoa, Marinete Marins; Udhayakumar, Venkatachalam			Historical Shifts in Brazilian P. falciparum Population Structure and Drug Resistance Alleles	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE RESISTANCE; AMAZON REGION; MICROSATELLITE MARKERS; MALARIA; MUTATIONS; DIVERSITY; FIXATION	Previous work suggests that Brazilian Plasmodium falciparum has limited genetic diversity and a history of bottlenecks, multiple reintroductions due to human migration, and clonal expansions. We hypothesized that Brazilian P. falciparum would exhibit clonal structure. We examined isolates collected across two decades from Amapa, Rondonia, and Para state (n = 190). By examining more microsatellites markers on more chromosomes than previous studies, we hoped to define the extent of low diversity, linkage disequilibrium, bottlenecks, population structure, and parasite migration within Brazil. We used retrospective genotyping of samples from the 1980s and 1990s to explore the population genetics of SP resistant dhfr and dhps alleles. We tested an existing hypothesis that the triple mutant dhfr mutations 50R/51I/108N and 51I/108N/164L developed in southern Amazon from a single origin of common or similar parasites. We found that Brazilian P. falciparum had limited genetic diversity and isolation by distance was rejected, which suggests it underwent bottlenecks followed by migration between sites. Unlike Peru, there appeared to be gene flow across the Brazilian Amazon basin. We were unable to divide parasite populations by clonal lineages and pairwise FST were common. Most parasite diversity was found within sites in the Brazilian Amazon, according to AMOVA. Our results challenge the hypothesis that triple mutant alleles arose from a single lineage in the Southern Amazon. SP resistance, at both the double and triple mutant stages, developed twice and potentially in different regions of the Brazilian Amazon. We would have required samples from before the 1980s to describe how SP resistance spread across the basin or describe the complex internal migration of Brazilian parasites after the colonization efforts of past decades. The Brazilian Amazon basin may have sufficient internal migration for drug resistance reported in any particular region to rapidly spread to other parts of basin under similar drug pressure.	[Griffing, Sean M.; Mixson-Hayden, Tonya; Sridaran, Sankar; Alam, Mohammad Tauqeer; de Oliveira, Alexandre Macedo; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Griffing, Sean M.; Mixson-Hayden, Tonya; Alam, Mohammad Tauqeer] Atlanta Res & Educ Fdn, Decatur, GA USA; [Sridaran, Sankar] Assoc Publ Hlth Labs, Silver Spring, MD USA; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Centers for Disease Control & Prevention - USA; Arizona State University; Arizona State University-Tempe	Udhayakumar, V (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30333 USA.	vxu0@cdc.gov	alam, mohammed/GXH-3645-2022; Viana, Giselle/ABF-2920-2020; Povoa, Marinete Marins/C-7039-2017	Viana, Giselle/0000-0003-1771-7211; Povoa, Marinete Marins/0000-0003-3517-2227; Escalante, Ananias/0000-0002-1532-3430	Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center; U.S. Agency for International Development; National Science Foundation; Association of Public Health Laboratories; Atlanta Research and Education Foundation; National Institutes of Health [R01GM084320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center; U.S. Agency for International Development(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF)); Association of Public Health Laboratories; Atlanta Research and Education Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported in part by the Antimicrobial Drug Resistance Working Group, Centers for Disease Control and Prevention, Atlanta Research and Education Foundation, Atlanta VA Medical Center, and the U.S. Agency for International Development-supported Amazon Malaria Initiative. S. Griffing was supported by a National Science Foundation Graduate Research Fellowship. Luke Syphard and Sankar Sridaran were supported by Emerging Infectious Diseases fellowships from the Association of Public Health Laboratories. Andrea M. McCollum, Tonya Mixson-Hayden, Sean Griffing, and Sumiti Vinayak were supported by the Atlanta Research and Education Foundation. A. A. Escalante is supported by grant R01GM084320 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Alecrim MG, 1982, REV INST MED TROP SP, V24, P44; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barata R B, 1998, Rev Panam Salud Publica, V3, P102; Barata R C, 1995, Cad Saude Publica, V11, P128, DOI 10.1590/S0102-311X1995000100019; Conway DJ, 2001, MOL BIOCHEM PARASIT, V115, P145, DOI 10.1016/S0166-6851(01)00278-X; Cornuet JM, 1996, GENETICS, V144, P2001; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Da Silveira LA, 1999, INFECT IMMUN, V67, P5906, DOI 10.1128/IAI.67.11.5906-5916.1999; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; DEANE LM, 1988, AM J TROP MED HYG, V38, P223, DOI 10.4269/ajtmh.1988.38.223; DESOUZA JM, 1992, MEM I OSWALDO CRUZ, V87, P343, DOI 10.1590/S0074-02761992000700058; Durand S, 2007, AM J TROP MED HYG, V76, P614, DOI 10.4269/ajtmh.2007.76.614; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira MU, 1998, AM J TROP MED HYG, V59, P474, DOI 10.4269/ajtmh.1998.59.474; Gadelha P., 1998, Parassitologia (Rome), V40, P159; Griffing S, 2010, ANTIMICROB AGENTS CH, V54, P1572, DOI 10.1128/AAC.01243-09; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hochman G, 2008, CAN BULL MED HIST, V25, P161, DOI 10.3138/cbmh.25.1.161; Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Marques A C, 1986, Rev Bras Malariol Doencas Trop, V38, P51; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2006, J INFECT DIS, V194, P189, DOI 10.1086/504687; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Packard, 2016, HIST GLOBAL HLTH INT; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; SLATKIN M, 1995, GENETICS, V139, P457; Stepan Nancy Leys, 2003, DIS HIST MODERN LATI, P25; Takken W, 2005, WAG UR FRON, V9, P113; Vasconcelos KF, 2000, MEM I OSWALDO CRUZ, V95, P721, DOI 10.1590/S0074-02762000000500020; Vieira PP, 2004, J INFECT DIS, V190, P417, DOI 10.1086/422006; Webb JLA, 2009, STUD ENVIRON HIST, P1; WHO, 1991, CD35INF2 WHO ORG PAN; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P739, DOI 10.1128/AAC.00975-07	43	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58984	10.1371/journal.pone.0058984	http://dx.doi.org/10.1371/journal.pone.0058984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554964	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800050
J	Takashima, O; Tsuruta, F; Kigoshi, Y; Nakamura, S; Kim, J; Katoh, MC; Fukuda, T; Irie, K; Chiba, T				Takashima, Osamu; Tsuruta, Fuminori; Kigoshi, Yu; Nakamura, Shingo; Kim, Jaehyun; Katoh, Megumi C.; Fukuda, Tomomi; Irie, Kenji; Chiba, Tomoki			Brap2 Regulates Temporal Control of NF-kappa B Localization Mediated by Inflammatory Response	PLOS ONE			English	Article							E3 LIGASE COMPLEX; UBIQUITIN-LIGASE; MODIFIER NEDD8; PROTEIN; SYSTEM; CUL1; CONJUGATION; PATHWAY; ATHEROSCLEROSIS; IDENTIFICATION	Nuclear factor-kappaB (NF-kappa B) is critical for the expression of multiple genes involved in inflammatory responses and cellular survival. NF-kappa B is normally sequestered in the cytoplasm through interaction with an inhibitor of NF-kappa B (I kappa B), but inflammatory stimulation induces proteasomal degradation of I kappa B, followed by NF-kappa B nuclear translocation. The degradation of I kappa B is mediated by a SCF (Skp1-Cullin1-F-box protein)-type ubiquitin ligase complex that is post-translationaly modified by a ubiquitin-like molecule Nedd8. In this study, we report that BRCA1-associated protein 2 (Brap2) is a novel Nedd8-binding protein that interacts with SCF complex, and is involved in NF-kappa B translocation following TNF-alpha stimulation. We also found a putative neddylation site in Brap2 associated with NF-kB activity. Our findings suggest that Brap2 is a novel modulator that associates with SCF complex and controls TNF-alpha-induced NF-kappa B nuclear translocation.	[Takashima, Osamu; Tsuruta, Fuminori; Kigoshi, Yu; Nakamura, Shingo; Kim, Jaehyun; Katoh, Megumi C.; Fukuda, Tomomi; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Irie, Kenji] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Chiba, T (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Yasuda Medical Foundation; Grants-in-Aid for Scientific Research [24111504, 23570221, 24570192] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid from Ministry of Education, Science, Sports and Culture of Japan (T.C.) and Yasuda Medical Foundation (T.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Czyzyk J, 2008, J BIOL CHEM, V283, P23004, DOI 10.1074/jbc.M804084200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Koon JC, 2010, J BIOL CHEM, V285, P13437, DOI 10.1074/jbc.M110.107011; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liao YC, 2011, MOL MED, V17, P1065, DOI 10.2119/molmed.2011.00043; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ozaki K, 2009, NAT GENET, V41, P329, DOI 10.1038/ng.326; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Saeki Y, 2004, GENES GENET SYST, V79, P77, DOI 10.1266/ggs.79.77; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	38	15	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58911	10.1371/journal.pone.0058911	http://dx.doi.org/10.1371/journal.pone.0058911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554956	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800047
J	Aleksinskaya, MA; van Faassen, EEH; Nelissen, J; Janssen, BJA; De Mey, JGR; Hanemaaijer, R; Rabelink, T; van Zonneveld, AJ				Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Nelissen, Jelly; Janssen, Ben J. A.; De Mey, Jo G. R.; Hanemaaijer, Roeland; Rabelink, Ton; van Zonneveld, Anton Jan			Identification of Free Nitric Oxide Radicals in Rat Bone Marrow: Implications for Progenitor Cell Mobilization in Hypertension	PLOS ONE			English	Article							SYNTHASE ENHANCER AVE9488; DOCA-SALT; ENDOTHELIAL DYSFUNCTION; NO; ISOFORMS; STEM; EXPRESSION; BIOLOGY; BLOOD	Nitric oxide (NO) has been implicated in matrix metallopeptidase 9 (MMP9)-dependent mobilization of hematopoietic stem and progenitor cells from bone marrow (BM). However, direct measurement of NO in the BM remained elusive due to its low in situ concentration and short lifetime. Using NO spin trapping and electron paramagnetic resonance (EPR) spectroscopy we give the first experimental confirmation of free NO radicals in rodent BM. NO production was quantified and attributed to enzymatic activity of NO synthases (NOS). Although endothelial NOS (eNOS) accounts for most (66%) of basal NO, we identified a significant contribution (23%) from inducible NOS (iNOS). Basal NO levels closely correlate with MMP9 bioavailability in BM of both hypertensive and control rats. Our observations support the hypothesis that inadequate mobilization of BM-derived stem and progenitor cells in hypertension results from impaired NOS/NO/MMP9 signalling in BM, a condition that may be corrected with pharmacological intervention.	[Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Rabelink, Ton; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Aleksinskaya, Marina A.; van Faassen, Ernst E. H.; Rabelink, Ton; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Nelissen, Jelly; Janssen, Ben J. A.; De Mey, Jo G. R.] Maastricht Univ, Dept Pharmacol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Hanemaaijer, Roeland] TNO, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Netherlands Organization Applied Science Research	Aleksinskaya, MA (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	m.a.aleksinskaya@lumc.nl	Rabelink, Ton J./A-5316-2008; van Zonneveld, Anton Jan/D-8060-2018	Rabelink, Ton J./0000-0001-6780-5186; van Zonneveld, Anton Jan/0000-0002-1676-7738; De Mey, Jo G. R./0000-0001-6274-8071	Dutch Top Institute Pharma [T2-108]; Dutch government [FES0908]	Dutch Top Institute Pharma; Dutch government	This research was performed within the framework of project T2-108 of the Dutch Top Institute Pharma and a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2004, TRENDS MOL MED, V10, P421, DOI 10.1016/j.molmed.2004.07.007; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Aicher A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004879; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bae EH, 2009, REGUL PEPTIDES, V157, P76, DOI 10.1016/j.regpep.2009.04.015; Brooks VL, 2006, AM J PHYSIOL-REG I, V291, pR1825, DOI 10.1152/ajpregu.00068.2006; Butler AR, 2001, CHEM COMMUN, P1732, DOI 10.1039/b105460k; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Crabos M, 1997, J MOL CELL CARDIOL, V29, P55, DOI 10.1006/jmcc.1996.0251; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Ergun S, 2011, ANTIOXID REDOX SIGN, V15, P981, DOI 10.1089/ars.2010.3507; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hanemaaijer R, 1998, MATRIX BIOL, V17, P657, DOI 10.1016/S0945-053X(98)90116-0; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Helfrich MH, 1997, J BONE MINER RES, V12, P1108, DOI 10.1359/jbmr.1997.12.7.1108; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Iyer A, 2010, CURR CARDIOL REV, V6, P291, DOI 10.2174/157340310793566109; Johnson FK, 2004, AM J PHYSIOL-HEART C, V286, pH1681, DOI 10.1152/ajpheart.00409.2003; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Kumar S, 2010, CYTOM PART A, V77A, P467, DOI 10.1002/cyto.a.20852; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Rosti V, 2007, HAEMATOLOGICA, V92, P1291, DOI 10.3324/haematol.11455; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Savoia C, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/281240; Suzuki Y, 1997, BBA-GEN SUBJECTS, V1335, P242, DOI 10.1016/S0304-4165(97)00027-5; Taddei S, 2002, J HYPERTENS, V20, P1671, DOI 10.1097/00004872-200209000-00001; van Faassen E., 2007, RADICALS LIFE VARIOU; van Faassen EE, 2008, NITRIC OXIDE-BIOL CH, V18, P279, DOI 10.1016/j.niox.2008.02.003; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; van Zonneveld AJ, 2006, CURR OPIN NEPHROL HY, V15, P167, DOI 10.1097/01.mnh.0000214774.42103.ec; Vanin AF, 2007, CELL MOL LIFE SCI, V64, P96, DOI 10.1007/s00018-006-6374-2; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P71, DOI 10.1016/j.niox.2006.06.009; Vanin Anatoly F., 2007, P383, DOI 10.1016/B978-044452236-8/50018-6; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d	43	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57761	10.1371/journal.pone.0057761	http://dx.doi.org/10.1371/journal.pone.0057761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554866	Green Published, gold			2022-12-27	WOS:000316252500006
J	Allen, JE; Gallant, JN; Dicker, DT; Amin, S; Irby, RB; Sharma, AK; El-Deiry, WS				Allen, Joshua E.; Gallant, Jean-Nicolas; Dicker, David T.; Amin, Shantu; Irby, Rosalyn B.; Sharma, Arun K.; El-Deiry, Wafik S.			The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; ISOTHIOCYANATES; CELLS; ISOSELENOCYANATES; RESISTANCE; APOPTOSIS; MUTATIONS; THERAPY	Phenylbutyl isoselenocyanate (ISC-4) is an Akt inhibitor with demonstrated preclinical efficacy against melanoma and colon cancer. In this study, we sought to improve the clinical utility of ISC-4 by identifying a synergistic combination with FDA-approved anti-cancer therapies, a relevant and appropriate disease setting for testing, and biomarkers of response. We tested the activity of ISC-4 and 19 FDA-approved anticancer agents, alone or in combination, against the SW480 and RKO human colon cancer cell lines. A synergistic interaction with cetuximab was identified and validated in a panel of additional colon cancer cell lines, as well as the kinetics of synergy. ISC-4 in combination with cetuximab synergistically reduced the viability of human colon cancer cells with wild-type but not mutant KRAS genes. Further analysis revealed that the combination therapy cooperatively decreased cell cycle progression, increased caspase-dependent apoptosis, and decreased phospho-Akt in responsive tumor cells. The synergism between ISC-4 and cetuximab was retained independently of acquired resistance to 5-FU in human colon cancer cells. The combination demonstrated synergistic anti-tumor effects in vivo without toxicity and in the face of resistance to 5-FU. These results suggest that combining ISC-4 and cetuximab should be explored in patients with 5-FU-resistant colon cancer harboring wild-type KRAS.	[Allen, Joshua E.; Gallant, Jean-Nicolas; Dicker, David T.; El-Deiry, Wafik S.] Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Lab Translat Oncol & Expt Canc Therapeut, Hershey, PA 17033 USA; [Amin, Shantu; Sharma, Arun K.] Penn State Hershey Canc Inst, Dept Pharmacol, Hershey, PA USA; [Irby, Rosalyn B.] Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	El-Deiry, WS (corresponding author), Penn State Hershey Canc Inst, Dept Med Hematol Oncol, Lab Translat Oncol & Expt Canc Therapeut, Hershey, PA 17033 USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266; Sharma, Arun/0000-0002-7679-7779; Gallant, Jean-Nicolas/0000-0003-4696-2013	Penn State Hershey Cancer Institute; NIH National Cancer Institute [R03-CA143999]; Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R03CA143999] Funding Source: NIH RePORTER	Penn State Hershey Cancer Institute; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to W.S.E.-D. and funds from the Penn State Hershey Cancer Institute, NIH National Cancer Institute grant R03-CA143999 to A. K. S., and the Lung Cancer Research Foundation grant to A. K. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2010, CURR COLORECT CANC R, V6, P212, DOI 10.1007/s11888-010-0069-7; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Faltas B, 2011, J CLIN ONCOL, V29, P2946, DOI 10.1200/JCO.2011.36.6179; Festuccia C, 2008, PROSTATE, V68, P965, DOI 10.1002/pros.20757; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nguyen N, 2011, CANCER PREV RES, V4, P248, DOI 10.1158/1940-6207.CAPR-10-0106; Prewett M, 2007, CLIN CANCER RES, V13, P7432, DOI 10.1158/1078-0432.CCR-07-1768; Sharma A, 2009, CLIN CANCER RES, V15, P1674, DOI 10.1158/1078-0432.CCR-08-2214; Sharma AK, 2011, CLIN CANCER RES, V17, P4474, DOI 10.1158/1078-0432.CCR-10-2370; Sharma AK, 2008, J MED CHEM, V51, P7820, DOI 10.1021/jm800993r; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017	18	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59380	10.1371/journal.pone.0059380	http://dx.doi.org/10.1371/journal.pone.0059380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555026	gold, Green Published			2022-12-27	WOS:000316252500087
J	Jia, LT; Wu, J; Zhang, L; Chen, JM; Zhong, DD; Xu, S; Xie, CG; Cai, JT				Jia, Litao; Wu, Jia; Zhang, Lu; Chen, Jiamin; Zhong, Dandan; Xu, Song; Xie, Chuangao; Cai, Jianting			Restoration of miR-1228*Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE CK2; C-REL; CELL-PROLIFERATION; GENE-EXPRESSION; CARCINOMA; IDENTIFICATION; METASTASIS; ACTIVATION; PHENOTYPE	Dysregulated miRNAs play critical roles during carcinogenesis and cancer progression. In the present study, the function of miR-1228* in regulating cancer progression was investigated in gastric cancer. Decreased expression of miR-1228* was observed in human gastric cancer tissues comparing to normal tissues. Subsequently, the role of miR-1228* was evaluated in vivo using the tumor xenograft model. In this model, miR-1228* overexpression suppressed xenograft tumor formation. Furthermore, we demonstrated miR-1228* negatively regulated NF-kappa B activity in SGC-7901 gastric cancer cells and found that CK2A2 was a target of miR-1228*. Upregulation of miR-1228* decreased the expression of mesenchymal markers and increased the epithelial marker E-cadherin, suggesting its potential role in suppressing epithelial-mesenchymal transition. Collectively, these findings provide the first evidence that miR-1228* plays an important role in regulating gastric cancer growth and suggest that selective restoration of miR-1228* might be beneficial for gastric cancer therapy.	[Jia, Litao; Wu, Jia; Chen, Jiamin; Zhong, Dandan; Xu, Song; Xie, Chuangao; Cai, Jianting] Zhejiang Univ, Dept Gastroenterol, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Lu] Zhejiang Chinese Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Jia, Litao] Tongde Hosp Zhejiang Prov, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University	Cai, JT (corresponding author), Zhejiang Univ, Dept Gastroenterol, Affiliated Hosp 2, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	jiantingcai6757@gmail.com	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022					Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cheng ZX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023752; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fu T, 2009, J PATHOL, V219, P103, DOI 10.1002/path.2590; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kolachala VL, 2010, J BIOL CHEM, V285, P18184, DOI 10.1074/jbc.M109.066555; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Liu JJ, 2003, J BIOL CHEM, V278, P19534, DOI 10.1074/jbc.M212278200; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shi LH, 2009, J BIOL CHEM, V284, P25791, DOI 10.1074/jbc.M109.033993; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Thompson EW, 2008, CLIN EXP METASTAS, V25, P591, DOI 10.1007/s10585-008-9189-8; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang JB, 2010, CANCER LETT, V297, P137, DOI 10.1016/j.canlet.2010.07.018; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Wu LF, 2008, J SURG ONCOL, V97, P439, DOI 10.1002/jso.20952; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yasui W, 2011, PATHOL RES PRACT, V207, P608, DOI 10.1016/j.prp.2011.09.006; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang LR, 2008, FEBS LETT, V582, P1821, DOI 10.1016/j.febslet.2008.04.046; Zhang S, 2012, ONCOGENE, V31, P3607, DOI 10.1038/onc.2011.523; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	55	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58637	10.1371/journal.pone.0058637	http://dx.doi.org/10.1371/journal.pone.0058637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554909	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500035
J	Kamlet, AS; Neumann, CN; Lee, E; Carlin, SM; Moseley, CK; Stephenson, N; Hooker, JM; Ritter, T				Kamlet, Adam S.; Neumann, Constanze N.; Lee, Eunsung; Carlin, Stephen M.; Moseley, Christian K.; Stephenson, Nickeisha; Hooker, Jacob M.; Ritter, Tobias			Application of Palladium-Mediated F-18-Fluorination to PET Radiotracer Development: Overcoming Hurdles to Translation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR MESSENGER-RNA; REDUCTIVE ELIMINATION; CELLULAR-LOCALIZATION; TRANSPORTER BINDING; FLUORINE; LIGANDS; RADIOSYNTHESIS; CITALOPRAM; AGONIST	New chemistry methods for the synthesis of radiolabeled small molecules have the potential to impact clinical positron emission tomography (PET) imaging, if they can be successfully translated. However, progression of modern reactions from the stage of synthetic chemistry development to the preparation of radiotracer doses ready for use in human PET imaging is challenging and rare. Here we describe the process of and the successful translation of a modern palladium-mediated fluorination reaction to non-human primate (NHP) baboon PET imaging-an important milestone on the path to human PET imaging. The method, which transforms [F-18]fluoride into an electrophilic fluorination reagent, provides access to aryl-F-18 bonds that would be challenging to synthesize via conventional radiochemistry methods.	[Kamlet, Adam S.; Neumann, Constanze N.; Lee, Eunsung; Stephenson, Nickeisha; Ritter, Tobias] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Carlin, Stephen M.; Moseley, Christian K.; Hooker, Jacob M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Carlin, Stephen M.; Moseley, Christian K.; Hooker, Jacob M.] Harvard Univ, Sch Med, Charlestown, MA USA; [Hooker, Jacob M.; Ritter, Tobias] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Hooker, JM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	hooker@nmr.mgh.harvard.edu; ritter@chemistry.harvard.edu	Neumann, Constanze/AAL-3918-2020; Ritter, Tobias/AAJ-8703-2021; Stephenson, Nickeisha/AAF-3881-2019; Hooker, Jacob M/P-5716-2018; Lee, Eunsung/F-5308-2013	Neumann, Constanze/0000-0003-1004-1140; Stephenson, Nickeisha/0000-0003-4227-5371; Hooker, Jacob M/0000-0002-9394-7708; Lee, Eunsung/0000-0002-1507-098X	National Institutes of Health (NIH) [GM088237, MH093874, EB013042, S10RR017208, S10RR022976]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022976, S10RR017208, S10RR023385, S10RR026666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH093874] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (NIH) (GM088237, MH093874, EB013042, S10RR017208, and S10RR022976). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Antoni Gunnar, 2008, V185, P177, DOI 10.1007/978-3-540-72718-7_9; Bergman J, 1997, NUCL MED BIOL, V24, P677, DOI 10.1016/S0969-8051(97)00078-4; Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; Cabarcos OM, 1999, J CHEM PHYS, V110, P5, DOI 10.1063/1.478075; Cai LS, 2008, EUR J ORG CHEM, V2008, P2853, DOI 10.1002/ejoc.200800114; Centurion D, 2000, N-S ARCH PHARMACOL, V362, P169, DOI 10.1007/s002100000277; Charette AB, 1998, J AM CHEM SOC, V120, P11943, DOI 10.1021/ja982055v; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; COENEN HH, 1988, EUR J NUCL MED, V14, P80; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Fowler JS, 1997, ACCOUNTS CHEM RES, V30, P181, DOI 10.1021/ar960068c; FOWLER JS, 1982, J LABELLED COMPD RAD, V19, P1634; Furuya T, 2008, CURR OPIN DRUG DISC, V11, P803; Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Hinz R, 2008, J CEREBR BLOOD F MET, V28, P1478, DOI 10.1038/jcbfm.2008.41; Hughes G, 2003, J AM CHEM SOC, V125, P11253, DOI 10.1021/ja0351692; Hummer G, 1996, J PHYS CHEM-US, V100, P1206, DOI 10.1021/jp951011v; Jiang ZJ, 2011, J PHARMACEUT BIOMED, V54, P722, DOI 10.1016/j.jpba.2010.11.004; Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4; Kozikowski AP, 2010, CHEMMEDCHEM, V5, P1221, DOI 10.1002/cmdc.201000186; Landvatter SW, 1998, SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1997, P99; Lee E, 2012, J AM CHEM SOC, V134, P17456, DOI 10.1021/ja3084797; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lopez-Gimenez JF, 2001, SYNAPSE, V42, P12, DOI 10.1002/syn.1095; Luedtke AT, 2007, INORG CHEM, V46, P8496, DOI 10.1021/ic701504z; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Monck NJT, 2008, PROGR MED CHEM, V46, P281, DOI 10.1016/S0079-6468(07)00006-9; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Pandey SC, 1996, ALCOHOL CLIN EXP RES, V20, P1038, DOI 10.1111/j.1530-0277.1996.tb01944.x; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Pinborg LH, 2012, SYNAPSE, V66, P880, DOI 10.1002/syn.21579; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Saulin A, 2012, AMINO ACIDS, V42, P2039, DOI 10.1007/s00726-011-1078-9; Serdons K, 2009, METHODS, V48, P104, DOI 10.1016/j.ymeth.2009.03.010; Serdons K, 2009, J MED CHEM, V52, P1428, DOI 10.1021/jm8013376; Shao X, 2011, J LABELLED COMPD RAD, V54, P292, DOI 10.1002/jlcr.1865; Siuciak JA, 2007, NEUROPHARMACOLOGY, V52, P279, DOI 10.1016/j.neuropharm.2006.07.024; SUEHIRO M, 1991, NUCL MED BIOL, V18, P791; Teare H, 2007, CHEM COMMUN, P2330, DOI 10.1039/b701177f; Teare H, 2010, ANGEW CHEM INT EDIT, V49, P6821, DOI 10.1002/anie.201002310; Wang JL, 2005, CURR TOP MED CHEM, V5, P1053, DOI 10.2174/156802605774297056	49	62	67	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59187	10.1371/journal.pone.0059187	http://dx.doi.org/10.1371/journal.pone.0059187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554994	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500072
J	Webb, EA; O'Reilly, MA; Clayden, JD; Seunarine, KK; Dale, N; Salt, A; Clark, CA; Dattani, MT				Webb, Emma A.; O'Reilly, Michelle A.; Clayden, Jonathan D.; Seunarine, Kiran K.; Dale, Naomi; Salt, Alison; Clark, Chris A.; Dattani, Mehul T.			Reduced Ventral Cingulum Integrity and Increased Behavioral Problems in Children with Isolated Optic Nerve Hypoplasia and Mild to Moderate or No Visual Impairment	PLOS ONE			English	Article							DIFFUSION-TENSOR; WHITE-MATTER; SPATIAL STATISTICS; CORPUS-CALLOSUM; AUTISM; SPECTRUM; ABNORMALITIES; DISORDER; AXONS	Objectives: To assess the prevalence of behavioral problems in children with isolated optic nerve hypoplasia, mild to moderate or no visual impairment, and no developmental delay. To identify white matter abnormalities that may provide neural correlates for any behavioral abnormalities identified. Patients and Methods: Eleven children with isolated optic nerve hypoplasia (mean age 5.9 years) underwent behavioral assessment and brain diffusion tensor imaging, Twenty four controls with isolated short stature (mean age 6.4 years) underwent MRI, 11 of whom also completed behavioral assessments. Fractional anisotropy images were processed using tract-based spatial statistics. Partial correlation between ventral cingulum, corpus callosum and optic radiation fractional anisotropy, and child behavioral checklist scores (controlled for age at scan and sex) was performed. Results: Children with optic nerve hypoplasia had significantly higher scores on the child behavioral checklist (p<0.05) than controls (4 had scores in the clinically significant range). Ventral cingulum, corpus callosum and optic radiation fractional anisotropy were significantly reduced in children with optic nerve hypoplasia. Right ventral cingulum fractional anisotropy correlated with total and externalising child behavioral checklist scores (r = -0.52, p < 0.02, r = -0.46, p < 0.049 respectively). There were no significant correlations between left ventral cingulum, corpus callosum or optic radiation fractional anisotropy and behavioral scores. Conclusions: Our findings suggest that children with optic nerve hypoplasia and mild to moderate or no visual impairment require behavioral assessment to determine the presence of clinically significant behavioral problems. Reduced structural integrity of the ventral cingulum correlated with behavioral scores, suggesting that these white matter abnormalities may be clinically significant. The presence of reduced fractional anisotropy in the optic radiations of children with mild to moderate or no visual impairment raises questions as to the pathogenesis of these changes which will need to be addressed by future studies.	[Webb, Emma A.; Dattani, Mehul T.] Univ Coll London Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [O'Reilly, Michelle A.; Dale, Naomi; Salt, Alison] UCL Inst Child Hlth, Neurosci Unit, London, England; [O'Reilly, Michelle A.; Dale, Naomi; Salt, Alison] Great Ormond St Childrens Hosp, Dev Vis Clin, London, England; [Clayden, Jonathan D.; Seunarine, Kiran K.; Clark, Chris A.] Univ Coll London Inst Child Hlth, Imaging & Biophys Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Dattani, MT (corresponding author), Univ Coll London Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England.	m.dattani@ucl.ac.uk	Clayden, Jonathan D/C-1894-2008	Clayden, Jonathan D/0000-0002-6608-0619; Dale, Naomi/0000-0003-2195-1430	Child Growth Foundation; Novo Nordisk Ltd.; Great Ormond Street Children's Charity; Great Ormond Street Hospital Childrens Charity [V1255] Funding Source: researchfish	Child Growth Foundation; Novo Nordisk Ltd.(Novo Nordisk); Great Ormond Street Children's Charity; Great Ormond Street Hospital Childrens Charity	This study was sponsored by The Child Growth Foundation and an unrestricted educational grant from Novo Nordisk Ltd. EAW and MOR are sponsored by The Child Growth Foundation and an unrestricted educational grant from Novo Nordisk Ltd. MTD is funded by Great Ormond Street Children's Charity. JC, KS, AS, ND and CC have nothing to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Althoff RR, 2010, PSYCHOL ASSESSMENT, V22, P609, DOI 10.1037/a0019699; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Cannistraro PA, 2007, DEPRESS ANXIETY, V24, P440, DOI 10.1002/da.20246; Ek U, 2005, ACTA PAEDIATR, V94, P1421, DOI 10.1080/08035250510037290; Fontenelle Leonardo F, 2009, Top Magn Reson Imaging, V20, P291, DOI 10.1097/RMR.0b013e3181e8f22c; Garcia ML, 2006, J CHILD NEUROL, V21, P949, DOI 10.2310/7010.2006.00241; Hobson RP, 1999, J AUTISM DEV DISORD, V29, P45; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jan J.E., 1977, VISUAL IMPAIRMENT CH; Kelberman D, 2007, PITUITARY, V10, P393, DOI 10.1007/s11102-007-0055-5; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Kumar A, 2009, CEREB CORTEX; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; MARGALITH D, 1984, DEV MED CHILD NEUROL, V26, P311, DOI 10.1111/j.1469-8749.1984.tb04447.x; Nakata Y, 2009, AM J NEURORADIOL, V30, P1142, DOI 10.3174/ajnr.A1527; Parr JR, 2010, DEV MED CHILD NEUROL, V52, P917, DOI 10.1111/j.1469-8749.2010.03664.x; Patel L, 2006, J PEDIATR-US, V148, P85, DOI 10.1016/j.jpeds.2005.07.031; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Reef J, 2011, SOC PSYCH PSYCH EPID, V46, P1233, DOI 10.1007/s00127-010-0297-9; Reef J, 2010, J AM ACAD CHILD PSY, V49, P1117, DOI 10.1016/j.jaac.2010.08.002; Reynell J, 1979, MANUAL REYNELL ZINKI; Salmela MB, 2010, PEDIATR RADIOL, V40, P708, DOI 10.1007/s00247-009-1478-0; Schoth F, 2004, NEURORADIOLOGY, V46, P759, DOI 10.1007/s00234-004-1207-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sonksen PM, 2002, DEV MED CHILD NEUROL, V44, P782; Steinkuller PG, 1999, J AAPOS, V3, P26, DOI 10.1016/S1091-8531(99)70091-1; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Tadic V, 2010, J CHILD PSYCHOL PSYC, V51, P696, DOI 10.1111/j.1469-7610.2009.02200.x; Tirosh E, 1998, INT J REHABIL RES, V21, P63, DOI 10.1097/00004356-199803000-00006; Wang F, 2008, BRIT J PSYCHIAT, V193, P126, DOI 10.1192/bjp.bp.107.048793; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Webb EA, 2010, EUR J HUM GENET, V18, P393, DOI 10.1038/ejhg.2009.125; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wechsler D., 2003, WECHSLER PRESCHOOL P, V4th ed	43	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59048	10.1371/journal.pone.0059048	http://dx.doi.org/10.1371/journal.pone.0059048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554967	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500062
J	Fries, AC; Nolting, JM; Danner, A; Webster, RG; Bowman, AS; Krauss, S; Slemons, RD				Fries, Anthony C.; Nolting, Jacqueline M.; Danner, Angela; Webster, Robert G.; Bowman, Andrew S.; Krauss, Scott; Slemons, Richard D.			Evidence for the Circulation and Inter-Hemispheric Movement of the H14 Subtype Influenza A Virus	PLOS ONE			English	Article							HEMAGGLUTININ; EVOLUTION; GENE; INFECTION; ECOLOGY; H5N1	Three H14 influenza A virus (IAV) isolates recovered in 2010 during routine virus surveillance along the Mississippi Migratory Bird Flyway in Wisconsin, U.S.A. raised questions about the natural history of these rare viruses. These were the first H14 IAV isolates recovered in the Western Hemisphere and the only H14 IAV isolates recovered since the original four isolates in 1982 in Asia. Full length genomic sequencing of the 2010 H14 isolates demonstrated the hemagglutinin (HA) gene from the 1982 and 2010 H14 isolates showed 89.6% nucleotide and 95.6% amino acid similarity and phylogenetic analysis of these viruses placed them with strong support within the H14 subtype lineage. The level of genomic divergence observed between the 1982 and 2010 viruses provides evidence that the H14 HA segment was circulating undetected in hosts and was not maintained in environmental stasis. Further, the evolutionary relationship observed between 1982 H14 and the closely related H4 subtype HA segments were similar to contemporary comparisons suggesting limited adaptive divergence between these sister subtypes. The nonstructural (NS) segment of one 2010 isolate was placed in a NS clade isolated infrequently over the last several decades that includes the NS segment from a previously reported 1982 H14 isolate indicating the existence of an unidentified pool of genomic diversity. An additional neuraminidase reassortment event indicated a recent inter-hemispheric gene flow from Asia into the center of North America. These results demonstrate temporal and spatial gaps in the understanding of IAV natural history. Additionally, the reassortment history of these viruses raises concern for the inter-continental spread of IAVs and the efficacy of current IAV surveillance efforts in detecting genomic diversity of viruses circulating in wild birds.	[Fries, Anthony C.; Nolting, Jacqueline M.; Bowman, Andrew S.; Slemons, Richard D.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Danner, Angela; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	University System of Ohio; Ohio State University; St Jude Children's Research Hospital	Fries, AC (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	fries.41@osu.edu	Bowman, Andrew S/B-4321-2012; Nolting, J/C-4464-2015; Bowman, Andrew/V-5035-2019	Bowman, Andrew S/0000-0002-0738-8453; 	Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS); Centers of Excellence for Influenza Research and Surveillance (CEIRS); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C]	Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS); Centers of Excellence for Influenza Research and Surveillance (CEIRS); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded in part by the Minnesota Center of Excellence for Influenza Research and Surveillance (MCEIRS) with federal funds from the Centers of Excellence for Influenza Research and Surveillance (CEIRS), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN266200700007C. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellrose F. C., 1976, DUCKS GEESE SWANS N; Carrel MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008631; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; KAWAOKA Y, 1990, VIROLOGY, V179, P759, DOI 10.1016/0042-6822(90)90143-F; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; Nolting J, 2012, PLOS CURRENTS INFLUE; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; SLEMONS RD, 1974, AVIAN DIS, V18, P119, DOI 10.2307/1589250; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takekawa JY, 2010, AVIAN BIOL RES, V3, P51, DOI 10.3184/175815510X12737339356701; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	28	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59216	10.1371/journal.pone.0059216	http://dx.doi.org/10.1371/journal.pone.0059216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555632	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200015
J	Condemi, S; Mounier, A; Giunti, P; Lari, M; Caramelli, D; Longo, L				Condemi, Silvana; Mounier, Aurelien; Giunti, Paolo; Lari, Martina; Caramelli, David; Longo, Laura			Possible Interbreeding in Late Italian Neanderthals? New Data from the Mezzena Jaw (Monti Lessini, Verona, Italy)	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; MODERN HUMANS; EUROPE; CHRONOLOGY; MIDDLE; MTDNA; SYSTEMATICS; MANDIBLES; ORNAMENTS; SEQUENCE	In this article we examine the mandible of Riparo Mezzena a Middle Paleolithic rockshelter in the Monti Lessini (NE Italy, Verona) found in 1957 in association with Charentian Mousterian lithic assemblages. Mitochondrial DNA analysis performed on this jaw and on other cranial fragments found at the same stratigraphic level has led to the identification of the only genetically typed Neanderthal of the Italian peninsula and has confirmed through direct dating that it belongs to a late Neanderthal. Our aim here is to re-evaluate the taxonomic affinities of the Mezzena mandible in a wide comparative framework using both comparative morphology and geometric morphometrics. The comparative sample includes mid-Pleistocene fossils, Neanderthals and anatomically modern humans. This study of the Mezzena jaw shows that the chin region is similar to that of other late Neanderthals which display a much more modern morphology with an incipient mental trigone (e.g. Spy 1, La Ferrassie, Saint-Cesaire). In our view, this change in morphology among late Neanderthals supports the hypothesis of anatomical change of late Neanderthals and the hypothesis of a certain degree of interbreeding with AMHs that, as the dating shows, was already present in the European territory. Our observations on the chin of the Mezzena mandible lead us to support a non abrupt phylogenetic transition for this period in Europe.	[Condemi, Silvana; Mounier, Aurelien] Aix Marseille Univ, Sect Nord, Fac Med,CNRS,UMR 7268, EFS ADES Anthropol Bioculturelle Droit Eth & Sant, Marseille, France; [Mounier, Aurelien] Univ Cambridge, Dept Archaeol & Anthropol, Anthropol Div, Leverhulme Ctr Human Evolutionary Studies Biol, Cambridge, England; [Giunti, Paolo] Ist Italiano Preistoria & Protostoria, Florence, Italy; [Lari, Martina; Caramelli, David] Univ Florence, Dipartimento Biol Evoluzionist, Lab Antropol, Unita Antropol Mol Paleogenet, Florence, Italy; [Longo, Laura] Musei Civici Fiorentini, Florence, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; University of Florence	Condemi, S (corresponding author), Aix Marseille Univ, Sect Nord, Fac Med,CNRS,UMR 7268, EFS ADES Anthropol Bioculturelle Droit Eth & Sant, Marseille, France.	silvana.condemi@univ-amu.fr; laura.longo@comune.fi.it	Condemi, Silvana/ABE-2701-2021; Lari, Martina/A-4085-2009	Condemi, Silvana/0000-0002-6516-0879; Caramelli, David/0000-0001-6468-1675; Mounier, Aurelien/0000-0001-9713-7246				Barroso Ruiz C, 2001, SITE MOUSSTERIEN GRO; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BRAUER G, 1990, J HUM EVOL, V19, P789, DOI 10.1016/0047-2484(90)90021-3; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Camps M, 2012, J HUM EVOL, V62, P89, DOI 10.1016/j.jhevol.2011.10.010; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Condemi S., 2001, NEANDERTHALIENS CHAI; Condemi S, 2012, CR PALEVOL, V11, P79, DOI 10.1016/j.crpv.2011.08.004; Cooper A, 2000, SCIENCE, V289, P1139; Corrain C, 1968, MEMORIE MUSEO CIVICO, V16, P97; CreedMiles M, 1996, J HUM EVOL, V30, P147, DOI 10.1006/jhev.1996.0011; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; Davies W., 2001, P PREHIST SOC, V67, P195, DOI [10.1017/S0079497X00001663, DOI 10.1017/S0079497X00001663]; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FRAYER DW, 1992, PREHISTOIRE EUROPEEN, V2, P9; Giunti P, 2011, HUMAN EVOLUTION, P131; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Holliday TW, 2006, NEANDERTHALS REVISIT, P336; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Jankovic I, 2011, VERTEBR PALEOBIOL PA, P299, DOI 10.1007/978-94-007-0492-3_23; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010648; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; Longo L, 2012, QUATERN INT, V259, P102, DOI 10.1016/j.quaint.2011.08.008; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; MARTIN R, 1957, LEHRBUCH ANTHR SYSTE; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P., 1989, HUMAN REVOLUTION BEH; Mounier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018821; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Palma di Cesnola A, 1993, PALEOLITICO SUPERIOR; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Sanchez-Quinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047765; Schwartz JH, 2006, PERIOD BIOL, V108, P389; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SMITH FH, 1989, YEARB PHYS ANTHROPOL, V32, P35; Stefan VH, 1998, J HUM EVOL, V34, P443, DOI 10.1006/jhev.1997.0210; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Trinkaus E, 2011, VERTEBR PALEOBIOL PA, P315, DOI 10.1007/978-94-007-0492-3_24; Trinkaus E, 2011, P NATL ACAD SCI USA, V108, P1267, DOI 10.1073/pnas.1018700108; van Andel T. H., 2003, NEANDERTHALS MODERN; Walker MJ, 2012, QUATERN INT, V259, P7, DOI 10.1016/j.quaint.2011.03.034; Walker MJ, 2010, AM J PHYS ANTHROPOL, V142, P261, DOI 10.1002/ajpa.21223; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wolpoff MH, 1999, SCIENCE, V284, P1774; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2012, DEV QUATER SCI, V16, P35, DOI 10.1016/B978-0-444-53821-5.00004-X	64	25	27	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59781	10.1371/journal.pone.0059781	http://dx.doi.org/10.1371/journal.pone.0059781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124QO	23544098	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700058
J	Fu, M; Song, XX; Yu, ZM; Liu, Y				Fu, Mei; Song, Xiuxian; Yu, Zhiming; Liu, Yun			Responses of Phosphate Transporter Gene and Alkaline Phosphatase in Thalassiosira pseudonana to Phosphine	PLOS ONE			English	Article							MATRIX-BOUND PHOSPHINE; SUPEROXIDE-DISMUTASE; PHOSPHORUS; IDENTIFICATION; EXPRESSION; CLONING; DIATOM; CELLS; PHYTOPLANKTON; ENVIRONMENT	Phosphine, which is released continuously from sediment, can affect the eco-physiological strategies and molecular responses of phytoplankton. To examine the effects of phosphine on phosphorus uptake and utilization in Thalassiosira pseudonana we examined the transcriptional level of the phosphate transporter gene (TpPHO) and the activity of alkaline phosphatase (AKP) in relation to supplement of various concentrations of phosphine. TpPHO expression was markedly promoted by phosphine in both the phosphate-deficient and phosphate-4.1 mu M culture. However, high phosphine concentrations can inhibit TpPHO transcription in the declining growth phase. AKP activity was also higher in the phosphine treatment groups than that of the control. It increased with increasing phosphine concentration in the range of 0 to 0.056 mu M but was inhibited by higher levels of phosphine. These responses revealed that phosphine can affect phosphate uptake and utilization in T. pseudonana. This result was consistent with the effect of phosphine on algal growth, while TpPHO expression and AKP were even more sensitive to phosphine than algal growth. This work provides a basic understanding for further research about how phosphine affects phytoplankton.	[Fu, Mei; Song, Xiuxian; Yu, Zhiming; Liu, Yun] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Fu, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Song, XX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	songxx@qdio.ac.cn		Yu, Zhiming/0000-0003-0377-1129	National Natural Science Foundation of China [30970522]; Funds for Creative Research Groups of China [41121064]; State Key Development Program for Basic Research of China (973 program) [2010CB428706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); State Key Development Program for Basic Research of China (973 program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This work was financially supported by the National Natural Science Foundation of China (30970522), the Funds for Creative Research Groups of China (41121064), and the State Key Development Program for Basic Research of China (973 program) (2010CB428706). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Munoz-Martin MA, 2011, ANAL BIOANAL CHEM, V400, P3573, DOI 10.1007/s00216-011-5017-0; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BOLTER CJ, 1990, PESTIC BIOCHEM PHYS, V36, P52, DOI 10.1016/0048-3575(90)90020-3; BOND EJ, 1969, J STORED PROD RES, V5, P289, DOI 10.1016/0022-474X(69)90002-2; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; CHEFURKA W, 1976, PESTIC BIOCHEM PHYS, V6, P65, DOI 10.1016/0048-3575(76)90010-9; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; DEVAI I, 1988, NATURE, V333, P343, DOI 10.1038/333343a0; DEVAI I, 1995, ORG GEOCHEM, V23, P277, DOI 10.1016/0146-6380(95)00021-6; [牛晓君 Niu Xiaojun], 2003, [湖泊科学, Scientia Limnologica Sinica], V15, P263; Dong B, 1999, PLANT CELL ENVIRON, V22, P1455, DOI 10.1046/j.1365-3040.1999.00500.x; Feng ZH, 2008, MAR POLLUT BULL, V56, P1630, DOI 10.1016/j.marpolbul.2008.05.017; Feng ZH, 2008, CHEMOSPHERE, V73, P519, DOI 10.1016/j.chemosphere.2008.06.018; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; GASSMANN G, 1994, MAR CHEM, V45, P197, DOI 10.1016/0304-4203(94)90003-5; Geng JJ, 2010, INT J ENVIRON AN CH, V90, P737, DOI 10.1080/03067310903013230; Glindemann D, 2005, ECOL ENG, V24, P457, DOI 10.1016/j.ecoleng.2005.01.002; Gonzalez-Gil S, 1998, MAR ECOL PROG SER, V164, P21, DOI 10.3354/meps164021; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hanrahan G, 2005, TALANTA, V66, P435, DOI 10.1016/j.talanta.2004.10.004; Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4; Huang AY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-337; Ivancic I, 2010, MAR ENVIRON RES, V69, P85, DOI 10.1016/j.marenvres.2009.08.004; JANSSON M, 1988, HYDROBIOLOGIA, V170, P177, DOI 10.1007/BF00024904; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lil H, 1998, MAR ECOL PROG SER, V173, P107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu M, 2006, J BIOL CHEM, V281, P13620, DOI 10.1074/jbc.M600523200; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Niu XJ, 2004, SCI TOTAL ENVIRON, V323, P169, DOI 10.1016/j.scitotenv.2003.10.017; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; PETTERSSON K, 1980, ARCH HYDROBIOL, V89, P54; PRICE NR, 1984, J STORED PROD RES, V20, P163, DOI 10.1016/0022-474X(84)90025-0; SINHA RN, 1967, J ECON ENTOMOL, V60, P125, DOI 10.1093/jee/60.1.125; Song XX, 2011, MAR POLLUT BULL, V62, P1744, DOI 10.1016/j.marpolbul.2011.05.025; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; VRBA J, 1993, WATER SCI TECHNOL, V28, P15, DOI 10.2166/wst.1993.0124; WILLSKY GR, 1973, J BACTERIOL, V113, P529, DOI 10.1128/JB.113.2.529-539.1973; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yu ZM, 2003, CHINESE SCI BULL, V48, P31, DOI 10.1360/03tb9006; Zhang BY, 2010, J PHYCOL, V46, P290, DOI 10.1111/j.1529-8817.2009.00801.x	42	13	14	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59770	10.1371/journal.pone.0059770	http://dx.doi.org/10.1371/journal.pone.0059770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544096	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700056
J	Inacio, JM; Marques, S; Nakamura, T; Shinohara, K; Meno, C; Hamada, H; Belo, JA				Inacio, Jose Manuel; Marques, Sara; Nakamura, Tetsuya; Shinohara, Kyosuke; Meno, Chikara; Hamada, Hiroshi; Belo, Jose Antonio			The Dynamic Right-to-Left Translocation of Cerl2 Is Involved in the Regulation and Termination of Nodal Activity in the Mouse Node	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; VERTEBRATE EMBRYO; LATERAL PLATE; CERBERUS-LIKE; FLUID-FLOW; HEART; EXPRESSION; SYMMETRY; ROLES	The determination of left-right body asymmetry in mouse embryos depends on the interplay of molecules In a highly sensitive structure, the node. Here, we show that the localization of Cerl2 protein does not correlate to its mRNA expression pattern, from 3-somite stage onwards. Instead, Cerl2 protein displays a nodal flow-dependent dynamic behavior that controls the activity of Nodal in the node, and the transmission of the laterality information to the left lateral plate mesoderm (LPM). Our results indicate that Cerl2 initially localizes and prevents the activation of Nodal genetic circuitry on the right side of the embryo, and later its right-to-left translocation shutdowns Nodal activity in the node. The consequent prolonged Nodal activity in the node by the absence of Cerl2 affects local Nodal expression and prolongs its expression in the LPM. Simultaneous genetic removal of both Nodal node inhibitors, Cerl2 and Lefty1, sustains even longer and bilateral his LPM expression.	[Inacio, Jose Manuel; Marques, Sara; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal; [Inacio, Jose Manuel; Marques, Sara; Belo, Jose Antonio] Univ Algarve, IBB, Ctr Biomed Mol & Estrutural, Faro, Portugal; [Nakamura, Tetsuya; Shinohara, Kyosuke; Hamada, Hiroshi] Osaka Univ, Dev Genet Grp, Grad Sch Frontier Biosci, Osaka, Japan; [Nakamura, Tetsuya; Shinohara, Kyosuke; Hamada, Hiroshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka, Japan; [Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Fukuoka 812, Japan	Universidade do Algarve; Universidade do Algarve; Osaka University; Japan Science & Technology Agency (JST); Kyushu University	Belo, JA (corresponding author), Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal.	jbelo@ualg.pt	Shinohara, Kyosuke/AAU-2471-2020; Inacio, Jose M/O-1455-2018; Belo, José A. A/F-4444-2012; Hamada, Hiroshi/N-6374-2015	Shinohara, Kyosuke/0000-0002-6350-1684; Inacio, Jose M/0000-0002-9790-8335; Belo, José A. A/0000-0001-7384-0949; Hamada, Hiroshi/0000-0002-7196-5948; Marques, Sara/0000-0001-6784-5612	F.C.T.; IBB/CBME, LA	F.C.T.(Portuguese Foundation for Science and Technology); IBB/CBME, LA	This work was supported by research grants from F.C.T. and from IBB/CBME, LA to J. A. Belo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Belo JA, 2009, INT J DEV BIOL, V53, P1399, DOI 10.1387/ijdb.072297jb; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hojo M, 2007, DEV GROWTH DIFFER, V49, P395, DOI 10.1111/j.1440-169x.2007.00937.x; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Larkins CE, 2012, DEV BIOL, V367, P15, DOI 10.1016/j.ydbio.2012.04.011; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Marques S, 2004, GENE DEV, V18, P2342; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Oki S, 2009, DEVELOPMENT, V136, P3917, DOI 10.1242/dev.039305; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tavares AT, 2007, DEVELOPMENT, V134, P2051, DOI 10.1242/dev.000901; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	33	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60406	10.1371/journal.pone.0060406	http://dx.doi.org/10.1371/journal.pone.0060406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544137	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700096
J	Kwan, A; Hubank, M; Rashid, A; Klein, N; Peters, MJ				Kwan, Antonia; Hubank, Mike; Rashid, Asrar; Klein, Nigel; Peters, Mark J.			Transcriptional Instability during Evolving Sepsis May Limit Biomarker Based Risk Stratification	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; EXPRESSION; THERAPY	Background: Sepsis causes extensive morbidity and mortality in children worldwide. Prompt recognition and timely treatment of sepsis is critical in reducing morbidity and mortality. Genomic approaches are used to discover novel pathways, therapeutic targets and biomarkers. These may facilitate diagnosis and risk stratification to tailor treatment strategies. Objective: To investigate the temporal gene expression during the evolution of sepsis induced multi-organ failure in response to a single organism, Neisseria meningitidis, in previously healthy children. Method: RNA was extracted from serial blood samples (6 time points over 48 hours from presentation) from five critically ill children with meningococcal sepsis. Extracted RNA was hybridized to Affymetrix arrays. The RNA underwent strict quality control and standardized quantitation. Gene expression results were analyzed using GeneSpring software and Ingenuity Pathway Analysis. Result: A marked variability in differential gene expression was observed between time points and between patients revealing dynamic expression changes during the evolution of sepsis. While there was evidence of time-dependent changes in expected gene networks including those involving immune responses and inflammatory pathways, temporal variation was also evident in specific "biomarkers" that have been proposed for diagnostic and risk stratification functions. The extent and nature of this variability was not readily explained by clinical phenotype. Conclusion: This is the first study of its kind detailing extensive expression changes in children during the evolution of sepsis. This highlights a limitation of static or single time point biomarker estimation. Serial estimations or more comprehensive network approaches may be required to optimize risk stratification in complex, time-critical conditions such as evolving sepsis.	[Kwan, Antonia; Klein, Nigel] UCL, Inst Child Hlth, London, England; [Kwan, Antonia] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hubank, Mike] UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London, England; [Rashid, Asrar] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England; [Peters, Mark J.] UCL, Inst Child Hlth, Portex Unit Paediat Crit Care, London, England	University of London; University College London; University of California System; University of California San Francisco; University of London; University College London; Nottingham University Hospital NHS Trust; University of Nottingham; University of London; University College London	Peters, MJ (corresponding author), UCL, Inst Child Hlth, Portex Unit Paediat Crit Care, London, England.	mark.peters@ucl.ac.uk	Peters, Mark/AAD-7518-2019; Hubank, Michael JF/C-1837-2008	Peters, Mark/0000-0003-3653-4808; Hubank, Michael JF/0000-0002-2901-0742; Klein, Nigel/0000-0003-3925-9258; rashid, asrar/0000-0001-6108-9289	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC); NIHR Academic Clinical Fellowship; Higher Education Funding Council for England; Great Ormond Street Children's Charity; For Lucie charity; National Institute for Health Research [ACF-2008-18-032] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC)(National Institute for Health Research (NIHR)); NIHR Academic Clinical Fellowship; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Great Ormond Street Children's Charity; For Lucie charity; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research (NIHR) Biomedical Research Centres (BRC) (http://www.nihr.ac.uk/infrastructure/Page/infrastructure_biomedical_research_centres.aspx), NIHR Academic Clinical Fellowship (http://www.nihrtcc.nhs.uk/intetacatrain/acfs), Higher Education Funding Council for England (http://www.hefce.ac.uk/), Great Ormond Street Children's Charity (http://www.gosh.org/gen/), and For Lucie charity (http://www.forlucie.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Bion J, 2012, LANCET INFECT DIS, V12, P898, DOI 10.1016/S1473-3099(12)70263-3; Booy R, 2002, ARCH DIS CHILD, V87, P560, DOI 10.1136/adc.87.6.560-a; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cornell TT, 2010, PEDIATRICS, V125, P1248, DOI 10.1542/peds.2009-3274; Deasy A, 2010, CURR OPIN INFECT DIS, V23, P255, DOI 10.1097/QCO.0b013e32833939de; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Osuchowski MF, 2009, CRIT CARE MED, V37, P1567, DOI 10.1097/CCM.0b013e31819df06b; Peters Mark J., 2001, Pediatr Crit Care Med, V2, P225, DOI 10.1097/00130478-200107000-00007; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tibby SM, 2002, ARCH DIS CHILD, V87, P559, DOI 10.1136/adc.87.6.559; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2010, CRIT CARE MED, V38, P1955, DOI 10.1097/CCM.0b013e3181eb924f; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08	19	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60501	10.1371/journal.pone.0060501	http://dx.doi.org/10.1371/journal.pone.0060501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544148	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700107
J	O'Hara, A; Howarth, A; Varro, A; Dimaline, R				O'Hara, Adrian; Howarth, Alice; Varro, Andrea; Dimaline, Rod			Role of Proteasome Beta Subunits in Gastrin-Mediated Transcription of Plasminogen Activator Inhibitor-2 and Regenerating Protein1	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER; PLASMINOGEN-ACTIVATOR INHIBITOR-2; MESSENGER-RNA ABUNDANCE; EPITHELIAL-CELLS; NUCLEAR-LOCALIZATION; RESPONSE ELEMENT; GENE-EXPRESSION; AGS CELLS; GASTRIN-CHOLECYSTOKININ(B) RECEPTOR; IN-VITRO	The hormone gastrin physiologically regulates gastric acid secretion and also contributes to maintaining gastric epithelial architecture by regulating expression of genes such as plasminogen activator inhibitor 2 (PAI-2) and regenerating protein 1(Reg1). Here we examine the role of proteasome subunit PSMB1 in the transcriptional regulation of PAI-2 and Reg1 by gastrin, and its subcellular distribution during gastrin stimulation. We used the gastric cancer cell line AGS, permanently transfected with the CCK2 receptor (AGS-GR) to study gastrin stimulated expression of PAI-2 and Reg1 reporter constructs when PSMB1 was knocked down by siRNA. Binding of PSMB1 to the PAI-2 and Reg1 promoters was assessed by chromatin immunoprecipitation (ChIP) assay. Subcellular distribution of PSMB1 was determined by immunocytochemistry and Western Blot. Gastrin robustly increased expression of PAI-2 and Reg1 in AGS-GR cells, but when PSMB1 was knocked down the responses were dramatically reduced. In ChIP assays, following immunoprecipitation of chromatin with a PSMB1 antibody there was a substantial enrichment of DNA from the gastrin responsive regions of the PAI-2 and Reg1 promoters compared with chromatin precipitated with control IgG. In AGS-GR cells stimulated with gastrin there was a significant increase in the ratio of nuclear:cytoplasmic PSMB1 over the same timescale as recruitment of PSMB1 to the PAI-2 and Reg1 promoters seen in ChIP assays. We conclude that PSMB1 is part of the transcriptional machinery required for gastrin stimulated expression of PAI-2 and Reg1, and that its change in subcellular distribution in response to gastrin is consistent with this role.	[O'Hara, Adrian; Howarth, Alice; Varro, Andrea; Dimaline, Rod] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dimaline, R (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	r.dimaline@liv.ac.uk	Varro, Andras/M-2647-2016; O'Hara, Adrian/ABE-7987-2020	O'Hara, Adrian/0000-0003-1837-680X	Wellcome Trust [089059/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by Wellcome Trust (www.wellcome.ac.uk) grant number 089059/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Almeida-Vega S, 2009, AM J PHYSIOL-GASTR L, V296, pG414, DOI 10.1152/ajpgi.90340.2008; Ancha HR, 2007, INT J BIOCHEM CELL B, V39, P2143, DOI 10.1016/j.biocel.2007.06.003; Asahara M, 1996, GASTROENTEROLOGY, V111, P45, DOI 10.1053/gast.1996.v111.pm8698224; Ashcroft FJ, 2004, BIOCHEM J, V381, P397, DOI 10.1042/BJ20031793; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Blackmore CG, 2001, J PHYSIOL-LONDON, V531, P605, DOI 10.1111/j.1469-7793.2001.0605h.x; Catlow K, 2007, J BIOL CHEM, V282, P17069, DOI 10.1074/jbc.M611421200; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; Daulhac L, 1999, J BIOL CHEM, V274, P20657, DOI 10.1074/jbc.274.29.20657; DIMALINE R, 1993, J PHYSIOL-LONDON, V465, P449, DOI 10.1113/jphysiol.1993.sp019686; Dimaline R, 1996, J PHYSIOL-LONDON, V490, P249, DOI 10.1113/jphysiol.1996.sp021140; DIMALINE R, 1993, AM J PHYSIOL, V264, pG583, DOI 10.1152/ajpgi.1993.264.3.G583; Dimaline R, 2007, EXP PHYSIOL, V92, P591, DOI 10.1113/expphysiol.2006.036483; Dockray G, 2005, PFLUG ARCH EUR J PHY, V449, P344, DOI 10.1007/s00424-004-1347-5; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Fukui H, 1998, GASTROENTEROLOGY, V115, P1483, DOI 10.1016/S0016-5085(98)70027-7; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Higham AD, 1999, GASTROENTEROLOGY, V116, P1310, DOI 10.1016/S0016-5085(99)70495-6; Inoue E, 2010, J BIOL CHEM, V285, P25545, DOI 10.1074/jbc.M109.079152; Kazumori H, 2000, GASTROENTEROLOGY, V119, P1610, DOI 10.1053/gast.2000.20262; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; Kim HD, 1999, J CELL PHYSIOL, V180, P97, DOI 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; KRUITHOF EKO, 1987, BLOOD, V69, P460; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Nakamura A, 2006, NEUROSCI LETT, V406, P43, DOI 10.1016/j.neulet.2006.07.050; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Ogiso Y, 2002, CANCER RES, V62, P5008; Pagliocca A, 2002, AM J PHYSIOL-GASTR L, V283, pG292, DOI 10.1152/ajpgi.00056.2002; Pagliocca A, 2008, EXP PHYSIOL, V93, P1174, DOI 10.1113/expphysiol.2008.042648; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Raychowdhury R, 2002, MOL ENDOCRINOL, V16, P2802, DOI 10.1210/me.2001-0292; Raychowdhury R, 2002, BIOCHEM BIOPH RES CO, V297, P1089, DOI 10.1016/S0006-291X(02)02345-8; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399; Varro A, 2002, GASTROENTEROLOGY, V123, P271, DOI 10.1053/gast.2002.34162; Varro A, 2002, GUT, V50, P827, DOI 10.1136/gut.50.6.827; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; WOHLWEND A, 1987, J EXP MED, V165, P320, DOI 10.1084/jem.165.2.320; Wroblewski LE, 2002, BIOCHEM J, V365, P873, DOI 10.1042/BJ20020068	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59913	10.1371/journal.pone.0059913	http://dx.doi.org/10.1371/journal.pone.0059913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544109	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000317480700069
J	Wang, JX; Bartolotti, J; Amaral, LAN; Booth, JR				Wang, Jane X.; Bartolotti, James; Amaral, Luis A. N.; Booth, James R.			Changes in Task-Related Functional Connectivity across Multiple Spatial Scales Are Related to Reading Performance	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; AGE-RELATED-CHANGES; BRAIN CONNECTIVITY; SMALL-WORLD; CHILDREN; FMRI; ORGANIZATION; ACTIVATION; METAANALYSIS; INFORMATION	Reading requires the interaction of a distributed set of cortical areas whose distinct patterns give rise to a wide range of individual skill. However, the nature of these neural interactions and their relation to reading performance are still poorly understood Functional connectivity analyses of fMRI data can be used to characterize the nature of interactivity of distributed brain networks, yet most previous studies have focused on connectivity during task-free (i.e., "resting state") conditions. Here, we report new methods for assessing task related functional connectivity using data-driven graph theoretical methods and describe how large-scale patterns of connectivity relate to individual variability in reading Performance among children. We found that connectivity Patterns of subjects Performing a reading task could be decomposed hierarchically into multiple sub-networks, and we observed stronger long-range interaction between sub-networks in subjects with higher task accuracy. Additionally, we found a network of hub regions known to be critical to reading that displays increased short-range synchronization in higher accuracy subjects. These individual differences in task-related functional connectivity reveal that increased interaction between distant regions, coupled with selective local integration within key regions, is associated with better reading performance. Importantly, we show that task-related neuroimaging data contains far more information than usually extracted via standard univariate analyses - information that can meaningfully relate neural connectivity patterns to cognition and task.	[Wang, Jane X.; Amaral, Luis A. N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Wang, Jane X.; Bartolotti, James; Booth, James R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Wang, Jane X.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Amaral, Luis A. N.] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Amaral, Luis A. N.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Wang, JX (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	janewang@northwestern.edu	Amaral, LAN/A-4980-2008; Amaral, Luis N./C-5485-2009	Amaral, LAN/0000-0002-3762-789X; 	National Institute of Child Health and Human Development [HD042049]; W. M. Keck Foundation (LANA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD042049] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); W. M. Keck Foundation (LANA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (HD042049 to JRB) and the W. M. Keck Foundation (LANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Baayen R. H, 1995, CELEX LEXICAL DATABA; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Bitan T, 2007, HUM BRAIN MAPP, V28, P880, DOI 10.1002/hbm.20313; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bonacich P, 2004, SOC NETWORKS, V26, P331, DOI 10.1016/j.socnet.2004.08.007; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Cao F, 2008, BRAIN LANG, V107, P91, DOI 10.1016/j.bandl.2007.12.009; Cao F, 2010, BRAIN LANG, V114, P80, DOI 10.1016/j.bandl.2009.07.005; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Shaywitz BA, 2007, ANN NEUROL, V61, P363, DOI 10.1002/ana.21093; Sheppard JP, 2012, J COGNITIVE NEUROSCI, V24, P1087, DOI 10.1162/jocn_a_00210; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Zeno S., 1996, ED WORD FREQUENCY GU	62	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59204	10.1371/journal.pone.0059204	http://dx.doi.org/10.1371/journal.pone.0059204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544057	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700019
J	Narumi, S; Matsuo, K; Ishii, T; Tanahashi, Y; Hasegawa, T				Narumi, Satoshi; Matsuo, Kumihiro; Ishii, Tomohiro; Tanahashi, Yusuke; Hasegawa, Tomonobu			Quantitative and Sensitive Detection of GNAS Mutations Causing McCune-Albright Syndrome with Next Generation Sequencing	PLOS ONE			English	Article							FIBROUS DYSPLASIA; DYSFUNCTION	Somatic activating GNAS mutations cause McCune-Albright syndrome (MAS). Owing to low mutation abundance, mutant-specific enrichment procedures, such as the peptide nucleic acid (PNA) method, are required to detect mutations in peripheral blood. Next generation sequencing (NGS) can analyze millions of PCR amplicons independently, thus it is expected to detect low-abundance GNAS mutations quantitatively. In the present study, we aimed to develop an NGS-based method to detect low-abundance somatic GNAS mutations. PCR amplicons encompassing exons 8 and 9 of GNAS, in which most activating mutations occur, were sequenced on the MiSeq instrument. As expected, our NGS-based method could sequence the GNAS locus with very high read depth (approximately 100,000) and low error rate. A serial dilution study with use of cloned mutant and wildtype DNA samples showed a linear correlation between dilution and measured mutation abundance, indicating the reliability of quantification of the mutation. Using the serially diluted samples, the detection limits of three mutation detection methods (the PNA method, NGS, and combinatory use of PNA and NGS [PNA-NGS]) were determined. The lowest detectable mutation abundance was 1% for the PNA method, 0.03% for NGS and 0.01% for PNA-NGS. Finally, we analyzed 16 MAS patient-derived leukocytic DNA samples with the three methods, and compared the mutation detection rate of them. Mutation detection rate of the PNA method, NGS and PNA-NGS in 16 patient-derived peripheral blood samples were 56%, 63% and 75%, respectively. In conclusion, NGS can detect somatic activating GNAS mutations quantitatively and sensitively from peripheral blood samples. At present, the PNA-NGS method is likely the most sensitive method to detect low-abundance GNAS mutation.	[Narumi, Satoshi; Ishii, Tomohiro; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Matsuo, Kumihiro; Tanahashi, Yusuke] Asahikawa Med Univ, Dept Pediat, Sapporo, Hokkaido, Japan	Keio University	Narumi, S (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	sat_naru@hotmail.com	Hasegawa, Tomonobu/L-3331-2013; Ishii, Tomohiro/B-8711-2019	Ishii, Tomohiro/0000-0001-7360-2465	Japan Society for the Promotion of Science [24791087]; Health Science Research Grant for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare, Japan [Jitsuyoka (Nanbyo)-Ippan-014]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Science Research Grant for Research on Applying Health Technology from the Ministry of Health, Labour and Welfare, Japan	This work was supported by the Grant-in-Aid for Young Scientists (B) (24791087) from the Japan Society for the Promotion of Science, and the Health Science Research Grant for Research on Applying Health Technology [Jitsuyoka (Nanbyo)-Ippan-014] from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Candeliere GA, 1997, BONE, V21, P201, DOI 10.1016/S8756-3282(97)00107-5; Hannon TS, 2003, J PEDIATR-US, V142, P532, DOI 10.1067/mpd.2003.153; Kalfa N, 2006, EUR J ENDOCRINOL, V155, P839, DOI 10.1530/eje.1.02301; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SE, 2012, HUM PATHOL, V43, P1234, DOI 10.1016/j.humpath.2011.09.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lumbroso S, 2004, J CLIN ENDOCR METAB, V89, P2107, DOI 10.1210/jc.2003-031225; McCune D, 1936, AM J DIS CHILD, V52, P743; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	16	23	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60525	10.1371/journal.pone.0060525	http://dx.doi.org/10.1371/journal.pone.0060525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536913	gold, Green Published, Green Submitted			2022-12-27	WOS:000317397200061
J	Beaslas, O; Metso, J; Nissila, E; Laurila, PP; Kaiharju, E; Batchu, KC; Kaipiainen, L; Mayranpaa, MI; Yan, D; Gylling, H; Jauhiainen, M; Olkkonen, VM				Beaslas, Olivier; Metso, Jari; Nissila, Eija; Laurila, Pirkka-Pekka; Kaiharju, Essi; Batchu, Krishna Chaithanya; Kaipiainen, Leena; Mayranpaa, Mikko I.; Yan, Daoguang; Gylling, Helena; Jauhiainen, Matti; Olkkonen, Vesa M.			Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism	PLOS ONE			English	Article							OXYSTEROL-BINDING PROTEIN; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ABCA1; EXPRESSION; STEROLS; FAMILY; ER; HYPERCATABOLISM; PURIFICATION; BIOGENESIS	OSBP-related protein 8 (ORP8) encoded by Osbpl8 is an endoplasmic reticulum sterol sensor implicated in cellular lipid metabolism. We generated an Osbpl8(-/-) (KO) C57Bl/6 mouse strain. Wild-type and Osbpl8KO animals at the age of 13-weeks were fed for 5 weeks either chow or high-fat diet, and their plasma lipids/lipoproteins and hepatic lipids were analyzed. The chow-fed Osbpl8KO male mice showed a marked elevation of high-density lipoprotein (HDL) cholesterol (+79%) and phospholipids (+35%), while only minor increase of apolipoprotein A-I (apoA-I) was detected. In chow-fed female KO mice a less prominent increase of HDL cholesterol (+27%) was observed, while on western diet the HDL increment was prominent in both genders. The HDL increase was accompanied by an elevated level of HDL-associated apolipoprotein E in male, but not female KO animals. No differences between genotypes were observed in lecithin: cholesterol acyltransferase (LCAT) or hepatic lipase (HL) activity, or in the fractional catabolic rate of fluorescently labeled mouse HDL injected in chow-diet fed animals. The Osbpl8KO mice of both genders displayed reduced phospholipid transfer protein (PLTP) activity, but only on chow diet. These findings are consistent with a model in which Osbpl8 deficiency results in altered biosynthesis of HDL. Consistent with this hypothesis, ORP8 depleted mouse hepatocytes secreted an increased amount of nascent HDL into the culture medium. In addition to the HDL phenotype, distinct gender-specific alterations in lipid metabolism were detected: Female KO animals on chow diet showed reduced lipoprotein lipase (LPL) activity and increased plasma triglycerides, while the male KO mice displayed elevated plasma cholesterol biosynthetic markers cholestenol, desmosterol, and lathosterol. Moreover, modest gender-specific alterations in the hepatic expression of lipid homeostatic genes were observed. In conclusion, we report the first viable OsbplKO mouse model, demonstrating a HDL elevating effect of Osbpl8 knock-out and additional gender- and/or diet-dependent impacts on lipid metabolism.	[Beaslas, Olivier; Nissila, Eija; Olkkonen, Vesa M.] Minerva Fdn, Helsinki, Finland; [Metso, Jari; Laurila, Pirkka-Pekka; Kaiharju, Essi; Jauhiainen, Matti] Natl Inst Hlth & Welf, Publ Hlth Genom Res Unit, Dept Chron Dis Prevent, Helsinki, Finland; [Metso, Jari; Laurila, Pirkka-Pekka; Kaiharju, Essi; Jauhiainen, Matti] Inst Mol Med Finland FIMM, Helsinki, Finland; [Nissila, Eija; Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Batchu, Krishna Chaithanya] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland; [Kaipiainen, Leena; Gylling, Helena] Univ Helsinki, Div Internal Med, Dept Med, Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; [Mayranpaa, Mikko I.] Univ Helsinki, Cent Hosp, HUSLAB Div Pathol, Meilahti Labs Pathol, Helsinki, Finland; [Yan, Daoguang] Jinan Univ, Dept Biol, Guangzhou, Guangdong, Peoples R China	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Jinan University	Olkkonen, VM (corresponding author), Minerva Fdn, Helsinki, Finland.	vesa.olkkonen@helsinki.fi	Nissila, Eija/AEQ-3909-2022	Nissila, Eija/0000-0002-8089-1266; Olkkonen, Vesa/0000-0001-5553-7997; Mayranpaa, Mikko/0000-0002-0877-9640	Academy of Finland [121457, 132629]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation; EU [202272]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); EU(European Commission)	This study was supported by the Academy of Finland (grants 121457 to VMO and 132629 to MJ) the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, the Liv och Halsa Foundation, the Novo Nordisk Foundation, and the EU FP7 (LipidomicNet, agreement no 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; Anniss AM, 2002, DNA CELL BIOL, V21, P571, DOI 10.1089/104454902320308942; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Calabresi L, 2010, TRENDS CARDIOVAS MED, V20, P50, DOI 10.1016/j.tcm.2010.03.007; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; de Vries Rindert, 2003, Clin Lab, V49, P601; Ehnholm C, 1986, Methods Enzymol, V129, P716; FOLCH J, 1957, J BIOL CHEM, V226, P497; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HUTTUNEN JK, 1975, CLIN CHIM ACTA, V63, P335, DOI 10.1016/0009-8981(75)90055-8; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Jaari S, 2001, COMP BIOCHEM PHYS B, V128, P781, DOI 10.1016/S1096-4959(01)00297-4; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kainu V, 2010, J LIPID RES, V51, P3533, DOI 10.1194/jlr.D009373; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lehto M, 2001, J LIPID RES, V42, P1203; MIETTINEN TA, 1988, J LIPID RES, V29, P43; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Mousley Carl J, 2012, Subcell Biochem, V59, P271, DOI 10.1007/978-94-007-3015-1_9; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Qin SC, 2000, J LIPID RES, V41, P269; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Simonen P, 2008, ATHEROSCLEROSIS, V197, P883, DOI 10.1016/j.atherosclerosis.2007.08.003; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vihervaara T, 2012, BIOCHIMIE; Vihervaara T, 2011, CHEM PHYS LIPIDS, V164, P443, DOI 10.1016/j.chemphyslip.2011.03.002; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yazdanyar A, 2011, CURR ATHEROSCLER REP, V13, P242, DOI 10.1007/s11883-011-0172-5; Yokoyama S, 2006, J ATHEROSCLER THROMB, V13, P1, DOI 10.5551/jat.13.1; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	47	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58856	10.1371/journal.pone.0058856	http://dx.doi.org/10.1371/journal.pone.0058856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554939	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800036
J	Gamble, C; Wolf, A; Sinha, I; Spowart, C; Williamson, P				Gamble, Carrol; Wolf, Andrew; Sinha, Ian; Spowart, Catherine; Williamson, Paula			The Role of Systematic Reviews in Pharmacovigilance Planning and Clinical Trials Authorisation Application: Example from the SLEEPS Trial	PLOS ONE			English	Review							PEDIATRIC INTENSIVE-CARE; CRITICALLY-ILL CHILDREN; LONG-TERM SEDATION; RANDOMIZED CONTROLLED-TRIAL; SEVERE HEAD-INJURY; CARDIAC-SURGERY; MECHANICAL VENTILATION; INTRAVENOUS MIDAZOLAM; NEUROMUSCULAR BLOCKADE; LIVER-TRANSPLANTATION	Background: Adequate sedation is crucial to the management of children requiring assisted ventilation on Paediatric Intensive Care Units (PICU). The evidence-base of randomised controlled trials (RCTs) in this area is small and a trial was planned to compare midazolam and clonidine, two sedatives widely used within PICUs neither of which being licensed for that use. The application to obtain a Clinical Trials Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) required a dossier summarising the safety profiles of each drug and the pharmacovigilance plan for the trial needed to be determined by this information. A systematic review was undertaken to identify reports relating to the safety of each drug. Methodology/Principal Findings: The Summary of Product Characteristics (SmPC) were obtained for each sedative. The MHRA were requested to provide reports relating to the use of each drug as a sedative in children under the age of 16. Medline was searched to identify RCTs, controlled clinical trials, observational studies, case reports and series. 288 abstracts were identified for midazolam and 16 for clonidine with full texts obtained for 80 and 6 articles respectively. Thirty-three studies provided data for midazolam and two for clonidine. The majority of data has come from observational studies and case reports. The MHRA provided details of 10 and 3 reports of suspected adverse drug reactions. Conclusions/Significance: No adverse reactions were identified in addition to those specified within the SmPC for the licensed use of the drugs. Based on this information and the wide spread use of both sedatives in routine practice the pharmacovigilance plan was restricted to adverse reactions. The Clinical Trials Authorisation was granted based on the data presented in the SmPC and the pharmacovigilance plan within the clinical trial protocol restricting collection and reporting to adverse reactions.	[Gamble, Carrol; Spowart, Catherine; Williamson, Paula] Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England; [Wolf, Andrew] Bristol Royal Childrens Hosp, Paediat Intens Care Unit, Bristol, Avon, England; [Sinha, Ian] Alder Hey Childrens NHS Fdn Trust, Resp Unit, Liverpool, Merseyside, England	University of Liverpool; Bristol Royal Hospital For Children; Alder Hey Children's NHS Foundation Trust	Gamble, C (corresponding author), Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England.	c.gamble@liv.ac.uk	Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016	Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636	Medical Research Council, NorthWest Hub for Trials Methodology Research; Carrol Gamble; Ian Sinha; Paula Williamson [G0800792]; Medical Research Council [G0800792] Funding Source: researchfish; MRC [G0800792] Funding Source: UKRI	Medical Research Council, NorthWest Hub for Trials Methodology Research; Carrol Gamble; Ian Sinha; Paula Williamson; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Medical Research Council funded NorthWest Hub for Trials Methodology Research supported contributions from Carrol Gamble, Ian Sinha, and Paula Williamson (grant number G0800792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKENHEAD AR, 1989, LANCET, V2, P704, DOI 10.1016/S0140-6736(89)90770-8; Al-Samsam Rim H, 2005, Pediatr Crit Care Med, V6, P562, DOI 10.1097/01.PCC.0000165561.40986.A6; Ambrose C, 2000, BRIT J ANAESTH, V84, P794, DOI 10.1093/oxfordjournals.bja.a013594; ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; Anand KJS, 2006, PEDIATRICS, V117, pS9, DOI 10.1542/peds.2005-0620C; Anand KJS, 1999, ARCH PEDIAT ADOL MED, V153, P331; ANAND KJS, 1990, ANESTHESIOLOGY, V73, P661, DOI 10.1097/00000542-199010000-00012; Aranda JV, 2005, CLIN THER, V27, P877, DOI 10.1016/j.clinthera.2005.06.019; ARTMAN M, 1983, AM J DIS CHILD, V137, P171, DOI 10.1001/archpedi.1983.02140280063018; Arya V, 2001, Indian Pediatr, V38, P967; BERGMAN I, 1991, J PEDIATR-US, V119, P644, DOI 10.1016/S0022-3476(05)82420-5; Biswas AK, 2005, CLIN TOXICOL, V43, P207, DOI 10.1081/CLT-200053099; Bitar G, 2003, PLAST RECONSTR SURG, V111, P150, DOI 10.1097/01.PRS.0000037756.88297.BC; BOOKER PD, 1986, BRIT J ANAESTH, V58, P1104, DOI 10.1093/bja/58.10.1104; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Marcia LB, 2008, PHARMACOTHERAPY, V28, P51, DOI 10.1592/phco.28.1.51; Carnevale F A, 1997, Intensive Crit Care Nurs, V13, P181, DOI 10.1016/S0964-3397(97)80012-2; Cernaianu AC, 1996, CRIT CARE MED, V24, P222, DOI 10.1097/00003246-199602000-00007; Chamorro C, 1996, CRIT CARE MED, V24, P932, DOI 10.1097/00003246-199606000-00010; Cho Hannah H, 2007, J Intensive Care Med, V22, P173, DOI 10.1177/0885066607299556; Clarke Lorcan, 2007, J Health Serv Res Policy, V12, P101, DOI 10.1258/135581907780279648; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Costa J, 1994, Clin Intensive Care, V5, P17; De Cosmo G, 2005, CURR DRUG TARGETS, V6, P741; DeBerry BB, 2005, PERFUSION-UK, V20, P139, DOI 10.1191/0267659105pf801oa; Deo S, 1994, Eur J Emerg Med, V1, P111; DIRKSEN MSC, 1987, ANAESTH INTENS CARE, V15, P440, DOI 10.1177/0310057X8701500415; Djurberg H, 2002, J CLIN ANESTH, V14, P564, DOI 10.1016/S0952-8180(02)00446-4; Ducharme Celine, 2005, Intensive Crit Care Nurs, V21, P179; DUCHARME MP, 1995, PHARMACOTHERAPY, V15, P665, DOI 10.1002/j.1875-9114.1995.tb02877.x; Easley RB, 2008, CRIT CARE MED, V36, P2479, DOI 10.1097/CCM.0b013e31817c0e07; Enomoto Y, 2006, PEDIATR ANESTH, V16, P1285, DOI 10.1111/j.1460-9592.2006.02008.x; Epstein D, 2007, MOVEMENT DISORD, V22, P712, DOI 10.1002/mds.21260; FLOGEL CM, 1993, ANESTH ANALG, V77, P1207; Fonsmark L, 1999, CRIT CARE MED, V27, P196, DOI 10.1097/00003246-199901000-00052; Franck Linda S, 2004, Intensive Crit Care Nurs, V20, P344, DOI 10.1016/j.iccn.2004.07.008; Goudie AC, 2010, J CLIN EPIDEMIOL, V63, P983, DOI 10.1016/j.jclinepi.2010.01.022; Gruber EM, 2001, ANESTH ANALG, V92, P882; Harte GJ, 1997, J PAEDIATR CHILD H, V33, P335, DOI 10.1111/j.1440-1754.1997.tb01611.x; Hartvig P, 1993, J Cardiothorac Vasc Anesth, V7, P148, DOI 10.1016/1053-0770(93)90207-2; HARTWIG S, 1991, EUR J PEDIATR, V150, P784, DOI 10.1007/BF02026712; Hertzog JH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e30; HICKEY PR, 1992, ANESTH ANALG, V74, P44; HUGHES J, 1994, ACTA PAEDIATR, V83, P1194; Ista E, 2008, CRIT CARE MED, V36, P2427, DOI 10.1097/CCM.0b013e318181600d; Ista E, 2007, INTENS CARE MED, V33, P1396, DOI 10.1007/s00134-007-0696-x; JACQZAIGRAIN E, 1994, LANCET, V344, P646, DOI 10.1016/S0140-6736(94)92085-0; JACQZAIGRAIN E, 1992, EUR J CLIN PHARMACOL, V42, P329; Jenkins IA, 2007, PEDIATR ANESTH, V17, P675, DOI 10.1111/j.1460-9592.2006.02180.x; Jin HS, 2007, J KOREAN MED SCI, V22, P693, DOI 10.3346/jkms.2007.22.4.693; Kadilak PR, 2004, J BURN CARE REHABIL, V25, P262, DOI 10.1097/01.BCR.0000124786.68570.7C; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Koroglu A, 2005, BRIT J ANAESTH, V94, P821, DOI 10.1093/bja/aei119; LAUSSEN PC, 1995, ANESTH ANALG, V80, P1076, DOI 10.1097/00000539-199506000-00002; Lee Y, 2007, ANAESTHESIA, V62, P18, DOI 10.1111/j.1365-2044.2006.04895.x; Lescot T, 2007, NEUROCRIT CARE, V7, P124, DOI 10.1007/s12028-007-0051-7; LLOYDTHOMAS AR, 1986, BRIT J ANAESTH, V58, P1109, DOI 10.1093/bja/58.10.1109; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Lugo RA, 1999, CRIT CARE MED, V27, P417, DOI 10.1097/00003246-199902000-00052; Lyons B, 1996, INTENS CARE MED, V22, P249, DOI 10.1007/BF01712245; Malagon I, 2005, BRIT J ANAESTH, V94, P805, DOI 10.1093/bja/aei142; MRC/DH joint project Clinical Trials Toolkit, 2007, WORK STREAM 6 PHARM; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ng E, 2000, COCHRANE DB SYST REV; NG E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002052; Notterman DA, 1997, CLIN PEDIATR, V36, P449, DOI 10.1177/000992289703600803; Parkinson L, 1997, PAEDIATR ANAESTH, V7, P405, DOI 10.1046/j.1460-9592.1997.d01-109.x; Pepperman ML, 1997, PAEDIATR ANAESTH, V7, P143, DOI 10.1046/j.1460-9592.1997.d01-56.x; Playfor SD, 2000, PAEDIATR ANAESTH, V10, P195, DOI 10.1046/j.1460-9592.2000.00477.x; Playfor SD, 2003, PAEDIATR ANAESTH, V13, P147, DOI 10.1046/j.1460-9592.2003.00989.x; Prause A, 2000, INTENS CARE MED, V26, P1454, DOI 10.1007/s001340000637; Prins SA, 2005, BRIT J ANAESTH, V94, P630, DOI 10.1093/bja/aei104; Rigby-Jones AE, 2007, BRIT J ANAESTH, V99, P252, DOI 10.1093/bja/aem135; ROSEN D A, 1991, Intensive Care Medicine, V17, pS15, DOI 10.1007/BF01731149; Saha AS, 2006, PEDIATR ANESTH, V16, P1063, DOI 10.1111/j.1460-9592.2006.01912.x; Schmidt B, 2006, EUR J CLIN PHARMACOL, V62, P823, DOI 10.1007/s00228-006-0170-7; Searle NR, 1997, CAN J ANAESTH, V44, P629, DOI 10.1007/BF03015447; Shekerdemian L, 1997, ARCH DIS CHILD, V76, P57, DOI 10.1136/adc.76.1.57; SHELLY MP, 1991, EUR J ANAESTH, V8, P21; Sheridan R, 2001, J BURN CARE REHABIL, V22, P150, DOI 10.1097/00004630-200103000-00012; Sheridan RL, 2003, J BURN CARE REHABIL, V24, P356, DOI 10.1097/01.BCR.0000095505.56021.27; Sheridan Robert L., 1994, Journal of Burn Care and Rehabilitation, V15, P515, DOI 10.1097/00004630-199411000-00009; SINCLAIR ME, 1988, INTENS CARE MED, V14, P55, DOI 10.1007/BF00254123; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Somri M, 2007, PEDIATR ANESTH, V17, P1059, DOI 10.1111/j.1460-9592.2007.02278.x; Stewart L, 1999, J NEUROTRAUM, V16, P843, DOI 10.1089/neu.1999.16.843; SURY MRJ, 1989, CRIT CARE MED, V17, P301, DOI 10.1097/00003246-198903000-00027; TANAKA M, 1995, BRIT J ANAESTH, V75, P593, DOI 10.1093/bja/75.5.593; Tanigami H, 1997, ARTIF ORGANS, V21, P21; TOBIAS JD, 1994, PEDIATR CLIN N AM, V41, P1269; Tobias JD, 2000, CRIT CARE MED, V28, P2122, DOI 10.1097/00003246-200006000-00079; TOBIAS JD, 1994, INTENS CARE MED, V20, P504, DOI 10.1007/BF01711905; Tobias JD, 2004, SOUTH MED J, V97, P451, DOI 10.1097/00007611-200405000-00007; Treluyer JM, 2005, J CLIN PHARM THER, V30, P479, DOI 10.1111/j.1365-2710.2005.00678.x; van Alfen-van der Velden AAEM, 2006, BIOL NEONATE, V90, P197, DOI 10.1159/000093489; VANENGELEN BGM, 1993, ANN PHARMACOTHER, V27, P579, DOI 10.1177/106002809302700509; VANSTRAATEN HLM, 1992, DEV PHARMACOL THERAP, V19, P191, DOI 10.1159/000457484; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; Walker J, 2006, J BURN CARE RES, V27, P206, DOI 10.1097/01.BCR.0000200910.76019.CF; Wilson KE, 2003, BRIT J ANAESTH, V91, P850, DOI 10.1093/bja/aeg278; WOLF AR, 1994, LANCET, V344, P628, DOI 10.1016/S0140-6736(94)92077-X; Yaster M, 1996, PEDIATRICS, V98, P135; Yildizdas D, 2004, PEDIATR EMERG CARE, V20, P162, DOI 10.1097/01.pec.0000117922.65522.26	104	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e51787	10.1371/journal.pone.0051787	http://dx.doi.org/10.1371/journal.pone.0051787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554852	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800002
J	Khanicheh, E; Mitterhuber, M; Xu, LF; Haeuselmann, SP; Kuster, GM; Kaufmann, BA				Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.			Noninvasive Ultrasound Molecular Imaging of the Effect of Statins on Endothelial Inflammatory Phenotype in Early Atherosclerosis	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; FAMILIAL HYPERCHOLESTEROLEMIA; CHOLESTEROL LEVELS; P-SELECTIN; PREVENTION; CORONARY; LESIONS; EVENTS; MEN; ROSUVASTATIN	Background/Objectives: Inflammatory changes on the endothelium are responsible for leukocyte recruitment to plaques in atherosclerosis. Noninvasive assessment of treatment-effects on endothelial inflammation may be of use for managing medical therapy and developing novel therapies. We hypothesized that molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) with contrast enhanced ultrasound (CEU) could assess treatment effects on endothelial phenotype in early atherosclerosis. Methods: Mice with atherosclerosis produced by gene deletion of the LDL-receptor and Apobec-1-editing protein were studied. At 12 weeks of age, mice received 8 weeks of regular chow or atorvastatin-enriched chow (10 mg/kg/day). At 20 weeks, CEU molecular imaging for aortic endothelial VCAM-1 expression was performed with VCAM-1-targeted (MBVCAM) and control microbubbles (MBCtr). Aortic wall thickness was assessed with high frequency ultrasound. Histology, immunohistology and Western blot were used to assess plaque burden and VCAM-1 expression. Results: Plaque burden was reduced on histology, and VCAM-1 was reduced on Western blot by atorvastatin, which corresponded to less endothelial expression of VCAM-1 on immunohistology. High frequency ultrasound did not detect differences in aortic wall thickness between groups. In contrast, CEU molecular imaging demonstrated selective signal enhancement for MBVCAM in non-treated animals (MBVCAM 2 +/- 0.3 vs MBCtr 0.7 +/- 0.2, p<0.01), but not in statin-treated animals (MBVCAM 0.8 +/- 0.2 vs MBCtr 1.0 +/- 0.2, p = ns; p<0.01 for the effect of statin on MBVCAM signal). Conclusions: Non-invasive CEU molecular imaging detects the effects of anti-inflammatory treatment on endothelial inflammation in early atherosclerosis. This easily accessible, low-cost technique may be useful in assessing treatment effects in preclinical research and in patients.	[Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.] Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland; [Khanicheh, Elham; Mitterhuber, Martina; Xu, Lifen; Haeuselmann, Stephanie P.; Kuster, Gabriela M.; Kaufmann, Beat A.] Univ Basel Hosp, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Kaufmann, BA (corresponding author), Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland.	kaufmannb@uhbs.ch	Kuster, Gabriela M/AAB-5478-2022; Kaufmann, Beat/AAB-7805-2022	Kuster, Gabriela M/0000-0002-8209-4631; Kaufmann, Beat/0000-0001-6295-3630	Swiss National Science Foundation [SNSF 32323B_123819, 3232B0-141603, SNSF 3232B-111352, 3200B-111353]; University Hospital Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University Hospital Basel	This study was supported by SCORE grants from the Swiss National Science Foundation to Dr. Kaufmann (SNSF 32323B_123819 and 3232B0-141603) and to Dr. Kuster (SNSF 3232B-111352 and 3200B-111353). Dr. Khanicheh is supported by an MD-PhD start up grant from the University Hospital Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustos C, 1998, J AM COLL CARDIOL, V32, P2057, DOI 10.1016/S0735-1097(98)00487-2; Chyu KY, 2011, CARDIOL CLIN, V29, P123, DOI 10.1016/j.ccl.2010.10.003; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Fujimoto S, 2008, J AM COLL CARDIOL, V52, P1847, DOI 10.1016/j.jacc.2008.08.048; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386; Khanicheh E, 2012, J AM SOC ECHOCARDIOG, V25, P460, DOI 10.1016/j.echo.2011.12.016; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Meuwese MC, 2009, J LIPID RES, V50, P148, DOI 10.1194/jlr.P800025-JLR200; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rasmussen LM, 2001, BIOCHEM J, V360, P363, DOI 10.1042/0264-6021:3600363; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sukhova GK, 2002, ARTERIOSCL THROM VAS, V22, P1452, DOI 10.1161/01.ATV.0000030360.72503.56; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	21	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58761	10.1371/journal.pone.0058761	http://dx.doi.org/10.1371/journal.pone.0058761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554922	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800028
J	Oravcova, M; Teska, M; Puta, F; Folk, P; Prevorovsky, M				Oravcova, Martina; Teska, Mikolas; Puta, Frantisek; Folk, Petr; Prevorovsky, Martin			Fission Yeast CSL Proteins Function as Transcription Factors	PLOS ONE			English	Article							RBP-J; NOTCH; SUPPRESSOR; HAIRLESS; BINDING; CELL; VECTORS; EXPRESSION; HOMOLOG; PATHWAY	Background: Transcription factors of the CSL (CBF1/RBP-Jk/Suppressor of Hairless/LAG-1) family are key regulators of metazoan development and function as the effector components of the Notch receptor signalling pathway implicated in various cell fate decisions. CSL proteins recognize specifically the GTG[G/A]AA sequence motif and several mutants compromised in their ability to bind DNA have been reported. In our previous studies we have identified a number of novel putative CSL family members in fungi, organisms lacking the Notch pathway. It is not clear whether these represent genuine CSL family members. Methodology/Principal Findings: Using a combination of in vitro and in vivo approaches we characterized the DNA binding properties of Cbf11 and Cbf12, the antagonistic CSL paralogs from the fission yeast, important for the proper coordination of cell cycle events and the regulation of cell adhesion. We have shown that a mutation of a conserved arginine residue abolishes DNA binding in both CSL paralogs, similar to the situation in mouse. We have also demonstrated the ability of Cbf11 and Cbf12 to activate gene expression in an autologous fission yeast reporter system. Conclusions/Significance: Our results indicate that the fission yeast CSL proteins are indeed genuine family members capable of functioning as transcription factors, and provide support for the ancient evolutionary origin of this important protein family.	[Oravcova, Martina; Teska, Mikolas; Puta, Frantisek; Folk, Petr; Prevorovsky, Martin] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Charles University Prague	Prevorovsky, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	prevorov@natur.cuni.cz	Půta, František/K-6731-2017; Folk, Petr/V-7545-2017; Převorovský, Martin/R-5191-2016	Půta, František/0000-0002-8313-878X; Folk, Petr/0000-0003-3813-7777; Převorovský, Martin/0000-0003-0277-8361	Czech Science Foundation [P305/12/P040]; Czech Ministry of Education, Youth and Sports [UNCE 204013, SVV 265211, MSM0021620858]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded in part by the Czech Science Foundation post-doctoral grant P305/12/P040, projects UNCE 204013 and SVV 265211, and grant number MSM0021620858 of the Czech Ministry of Education, Youth and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Christensen S, 1996, DEVELOPMENT, V122, P1373; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Ehebauer Matthias, 2006, Sci STKE, V2006, pcm7, DOI 10.1126/stke.3642006cm7; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lam LT, 1998, J BIOL CHEM, V273, P24223, DOI 10.1074/jbc.273.37.24223; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Prevorovsky M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-233; Prevorovsky M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023650; Prevorovsky M, 2009, EXP CELL RES, V315, P1533, DOI 10.1016/j.yexcr.2008.12.001; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wells ML, 2012, MOL CELLULAR BIOL; Weng AP, 2004, CURR OPIN GENET DEV, V14, P48, DOI 10.1016/j.gde.2003.11.004	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59435	10.1371/journal.pone.0059435	http://dx.doi.org/10.1371/journal.pone.0059435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555033	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800090
J	Chen, W; Shu, W; Wang, M; Hou, YC; Xia, YY; Xu, WG; Bai, LQ; Nie, SF; Cheng, SM; Xu, YH				Chen, Wei; Shu, Wen; Wang, Min; Hou, Yongchun; Xia, Yinyin; Xu, Weiguo; Bai, Liqiong; Nie, Shaofa; Cheng, Shiming; Xu, Yihua			Pulmonary Tuberculosis Incidence and Risk Factors in Rural Areas of China: A Cohort Study	PLOS ONE			English	Article							RETROSPECTIVE COHORT; PREVALENCE; RECURRENCE; INFECTION; SMOKING; EPIDEMIOLOGY; REINFECTION; CONTACT; INDIA; WOMEN	The incidence of tuberculosis (TB) and its risk factors in China remains unclear. This study examined TB incidence and relative risk factors in rural areas of China. Participants (n = 177,529) were recruited in Xiangtan County (in the central area of China) and in Danyang County (in the eastern area of China) in 2009 and a followed-up study was conducted for one year. The incidence density of pulmonary TB and smear-positive TB were 91.6 (95% CI: 78.7, 106.0) per 100,000 person-year and 36.7 (95% CI: 33.1, 52.4) per 100,000 person-year respectively in Xiangtan, and 47.3 (95% CI: 38.2, 57.5) per 100,000 person-year and 22.7 (95% CI: 16.5, 30.8) per 100,000 person-year in Danyang. The medical history of TB was associated with TB, with the relative risk (RR) of 7.00 (95% CI: 2.76, 17.18) in Xiangtan and that of 31.08 (95% CI: 13.22, 73.10) in Danyang. The association between TB and per capita living space over median was found in Xiangtan, with the RR of 1.86 (95% CI: 1.15, 3.01). No association was found between TB and the insurance status, the contact history with TB, the history of diabetes, smoking, or per capita annual income. The host genetic susceptibility, and social factors such as education and income could be considered in future studies.	[Shu, Wen; Hou, Yongchun; Nie, Shaofa; Xu, Yihua] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Chen, Wei; Xia, Yinyin; Cheng, Shiming] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Wang, Min] Wuhan Hlth Bur, Med Reform Off, Wuhan, Peoples R China; [Xu, Weiguo] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Bai, Liqiong] TB Inst TB Control & Prevent Hunan Prov, Changsha, Hunan, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Cheng, SM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	smcheng@chinatb.org; xuyihua_6@hotmail.com			China's National Science and Technology Major Project [2008ZX10003-008]	China's National Science and Technology Major Project	This work was supported by by China's National Science and Technology Major Project during the Eleventh Five-Year Plan Period (No. 2008ZX10003-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; [Anonymous], 2011, GLOB TUB CONTR; Atre S, 2011, GLOB PUBLIC HEALTH, V6, P56, DOI 10.1080/17441690903334240; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Barry C, 2009, COMMUN DIS INTELL, V33, P304; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; Buff AM, 2010, INT J TUBERC LUNG D, V14, P1347; Cardona PJ, 2010, ARCH IMMUNOL THER EX, V58, P7, DOI 10.1007/s00005-009-0062-5; Crampin AC, 2008, INT J TUBERC LUNG D, V12, P612; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Datiko DG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-348; Dobler CC, 2008, MED J AUSTRALIA, V188, P153, DOI 10.5694/j.1326-5377.2008.tb01558.x; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Gupta Soham, 2011, J Infect Public Health, V4, P140, DOI 10.1016/j.jiph.2011.03.005; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Horie T, 2007, INT J TUBERC LUNG D, V11, P562; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Ling DL, 2011, INT J TUBERC LUNG D, V15, P50; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Viney K, 2011, ASIA-PAC J PUBLIC HE, V23, P86, DOI 10.1177/1010539510390671; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020343; Ziv E, 2001, AM J EPIDEMIOL, V153, P381, DOI 10.1093/aje/153.4.381	32	17	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58171	10.1371/journal.pone.0058171	http://dx.doi.org/10.1371/journal.pone.0058171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554875	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500014
J	Getahun, MN; Olsson, SB; Lavista-Llanos, S; Hansson, BS; Wicher, D				Getahun, Merid N.; Olsson, Shannon B.; Lavista-Llanos, Sofia; Hansson, Bill S.; Wicher, Dieter			Insect Odorant Response Sensitivity Is Tuned by Metabotropically Autoregulated Olfactory Receptors	PLOS ONE			English	Article							PHOSPHOLIPASE-C; DROSOPHILA; NEURONS; GENE; EXPRESSION; EVOLUTION; MECHANISMS; PROTEINS; MAP	Insects possess one of the most exquisitely sensitive olfactory systems in the animal kingdom, consisting of three different types of chemosensory receptors: ionotropic glutamate-like receptors (IRs), gustatory receptors (GRs) and odorant receptors (ORs). Both insect ORs and IRs are ligand-gated ion channels, but ORs possess a unique configuration composed of an odorant-specific protein OrX and a ubiquitous coreceptor (Orco). In addition, these two ionotropic receptors confer different tuning properties for the neurons in which they are expressed. Unlike IRs, neurons expressing ORs are more sensitive and can also be sensitized by sub-threshold concentrations of stimuli. What is the mechanistic basis for these differences in tuning? We show that intrinsic regulation of Orco enhances neuronal response to odorants and sensitizes the ORs. We also demonstrate that inhibition of metabotropic regulation prevents receptor sensitization. Our results indicate that Orco-mediated regulation of OR sensitivity provides tunable ionotropic receptors capable of detecting odors over a wider range of concentrations, providing broadened sensitivity over IRs themselves.	[Getahun, Merid N.; Olsson, Shannon B.; Lavista-Llanos, Sofia; Hansson, Bill S.; Wicher, Dieter] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Max Planck Society	Wicher, D (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	dwicher@ice.mpg.de	Hansson, Bill S/G-2774-2013; Getahun, Merid Negash/ACU-6437-2022	Hansson, Bill S/0000-0002-4811-1223; Getahun, Merid Negash/0000-0001-5902-9236; Olsson, Shannon/0000-0003-4126-7353	Max Planck Society; International Max Planck Research School; iChem (6th Programme of the EU)	Max Planck Society(Max Planck Society); International Max Planck Research School; iChem (6th Programme of the EU)	This study was supported by the Max Planck Society (SLL, BSH, DW), the International Max Planck Research School (MNG), and iChem (6th Programme of the EU; SBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Chatterjee Abhishek, 2009, BMC Physiology, V9, P22, DOI 10.1186/1472-6793-9-22; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dethier V.G, 1947, CHEM INSECT ATTRACTA; Edwards JS, 1997, BRAIN BEHAV EVOLUT, V50, P8, DOI 10.1159/000113317; Getahun MN, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00054; Gomez-Diaz C, 2006, BEHAV GENET, V36, P309, DOI 10.1007/s10519-005-9031-x; Gomez-Diaz C, 2004, BEHAV GENET, V34, P395, DOI 10.1023/B:BEGE.0000023645.02710.fe; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kaissling KE, 2009, BIOL INSPIRED SIGNAL, P170; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Olsson SB, 2011, J NEUROSCI METH, V201, P385, DOI 10.1016/j.jneumeth.2011.08.015; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00048; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	41	53	56	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58889	10.1371/journal.pone.0058889	http://dx.doi.org/10.1371/journal.pone.0058889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554952	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500054
J	Ozdemir, AY; Rom, I; Kovalevich, J; Yen, W; Adiga, R; Dave, RS; Langford, D				Ozdemir, Ahmet Yunus; Rom, Inna; Kovalevich, Jane; Yen, William; Adiga, Radhika; Dave, Rajnish S.; Langford, Dianne			PINCH in the Cellular Stress Response to Tau-Hyperphosphorylation	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; SUBACUTE SCLEROSING-PANENCEPHALITIS; FOCAL ADHESION PROTEIN; PATHOLOGY; TANGLES; CANCER; CHIP; PHOSPHORYLATION; CONTRIBUTES; ACTIVATION	Particularly interesting new cysteine-histidine-rich protein (PINCH) is an adaptor protein that our data have shown is required for neurite extension under stressful conditions. Our previous studies also report that PINCH is recalled by neurons showing decreased levels of synaptodendritic signaling proteins such as MAP2 or synaptophysin in the brains of human immunodeficiency virus (HIV) patients. The current study addressed potential role(s) for PINCH in neurodegenerative diseases. Mass spectrometry predicted the interaction of PINCH with Tau and with members of the heat shock response. Our in vitro data confirmed that PINCH binds to hyperphosphorylated (hp) Tau and to E3 ubiquitin ligase, carboxy-terminus of heat shock-70 interacting protein. Silencing PINCH prior to induction of hp-Tau resulted in more efficient clearance of accumulating hp-Tau, suggesting that PINCH may play a role in stabilizing hp-Tau. Accumulation of hp-Tau is implicated in more than 20 neuropathological diseases including Alzheimer's disease (AD), frontotemporal dementia (FTD), and human immunodeficiency virus encephalitis (HIVE). Analyses of brain tissues from HIVE, AD and FTD patients showed that PINCH is increased and binds to hp-Tau. These studies address a new mechanism by which AD and HIV may intersect and identify PINCH as a contributing factor to the accumulation of hyperphosphorylated Tau.	[Ozdemir, Ahmet Yunus; Rom, Inna; Kovalevich, Jane; Yen, William; Adiga, Radhika; Dave, Rajnish S.; Langford, Dianne] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Langford, D (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	tdl@temple.edu			National Institutes of Health (NIH) National Institute of Mental Health [R01-MH085602]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083506, P30MH092177, U24MH100928, R01MH085602] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	These studies were supported by the National Institutes of Health (NIH) National Institute of Mental Health R01-MH085602 to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2006, ACTA NEUROPATHOL, V111, P529, DOI 10.1007/s00401-006-0037-0; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; DeTure M, 2010, CURR ALZHEIMER RES, V7, P677, DOI 10.2174/156720510793611565; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Holmqvist A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-65; IKEDA K, 1995, NEUROSCI LETT, V194, P133, DOI 10.1016/0304-3940(95)11713-7; Ishii T, 2003, J BIOL CHEM, V278, P26970, DOI 10.1074/jbc.M304113200; Ito S, 2010, MOL BIOL CELL, V21, P4120, DOI 10.1091/mbc.E10-05-0459; Jatiani A, 2011, J NEUROIMMUNE PHARM, V6, P330, DOI 10.1007/s11481-010-9236-5; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Lee VHL, 2011, INT J PHARMACEUT, V415, P1, DOI 10.1016/j.ijpharm.2011.03.035; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Luo WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S7; MCQUAID S, 1994, NEUROPATH APPL NEURO, V20, P103, DOI 10.1111/j.1365-2990.1994.tb01168.x; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Oddo S, 2008, J NEUROSCI, V28, P12163, DOI 10.1523/JNEUROSCI.2464-08.2008; Patrick C, 2011, AM J PATHOL, V178, P1646, DOI 10.1016/j.ajpath.2010.12.033; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Rasband W., 2006, IMAGEJ; Rearden A, 2008, J NEUROSCI RES, V86, P2535, DOI 10.1002/jnr.21701; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Salminen A, 2011, PROG NEUROBIOL, V93, P99, DOI 10.1016/j.pneurobio.2010.10.006; Scaife CL, 2010, HPB, V12, P352, DOI 10.1111/j.1477-2574.2010.00177.x; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stoynova L, 2004, BIOTECHNIQUES, V36, P402, DOI 10.2144/04363BM05; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Wang-Rodriguez J, 2002, CANCER-AM CANCER SOC, V95, P1387, DOI 10.1002/cncr.10878; Wu CY, 1999, J CELL SCI, V112, P4485; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200; Zhang Z, 2010, BRAIN RES, V1345, P176, DOI 10.1016/j.brainres.2010.04.074	44	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58232	10.1371/journal.pone.0058232	http://dx.doi.org/10.1371/journal.pone.0058232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554879	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500018
J	Parker, MJ; Manan, A				Parker, Melissa J.; Manan, Asmaa			Translating Resuscitation Guidelines into Practice: Health Care Provider Attitudes, Preferences and Beliefs Regarding Pediatric Fluid Resuscitation Performance	PLOS ONE			English	Article							CLINICAL-PRACTICE PARAMETERS; FRONT-LINE PARAMEDICS; NEONATAL SEPTIC SHOCK; HEMODYNAMIC SUPPORT; AMERICAN-COLLEGE; AFRICAN CHILDREN; RAPID INFUSION; SEVERE SEPSIS; EQUIPMENT; CATHETERS	Introduction: Children who require fluid resuscitation for the treatment of shock present to tertiary and non-tertiary medical settings. While timely fluid therapy improves survival odds, guidelines are poorly translated into clinical practice. The objective of this study was to characterize the attitudes, preferences and beliefs of health care providers working in acute care settings regarding pediatric fluid resuscitation performance. Methods: A single-centre survey study was conducted at McMaster Children's Hospital from January to May, 2012. The sampling frame (n = 115) included nursing staff, physician staff and subspecialty trainees working in Pediatric Emergency Medicine (PEM) or Pediatric Critical Care Medicine (PCCM). A self-administered questionnaire was developed and assessed for face validity prior to distribution. Eligible participants were invited at 0, 2, and 4 weeks to complete a web-based version of the survey. A follow-up survey administration phase was conducted to improve the response rate. Results: Response rate was 72.2% (83/115), with 83% (68/82) self-identifying as nursing staff and 61% (50/82) as PCCM providers. Resuscitation experience, frequency of shock management, and years in specialty, were similar between PCCM and PEM responders. Physicians and nurses had differing opinions regarding the most effective method to achieve rapid fluid resuscitation in young children presenting in shock (p<0.001). Disagreement also existed regarding the age and size of patients in whom rapid infuser devices, such as the Level-1 Rapid Infuser, should be used (p<0.001). Providers endorsed a number of potential concerns related to the use of rapid infuser devices in children, and only 14% of physicians and 55% of nursing staff felt that they had received adequate training in the use of such devices (p = 0.005). Conclusions: There is a lack of consensus among health care providers regarding how pediatric fluid resuscitation guidelines should be operationalized, supporting a need for further work to define best practices.	[Parker, Melissa J.; Manan, Asmaa] McMaster Childrens Hosp, Dept Pediat, Hamilton, ON, Canada; [Parker, Melissa J.; Manan, Asmaa] McMaster Univ, Hamilton, ON, Canada; [Parker, Melissa J.] Hosp Sick Children, Dept Pediat, Div Emergency Med, Toronto, ON M5G 1X8, Canada; [Parker, Melissa J.] Univ Toronto, Toronto, ON, Canada	McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Parker, MJ (corresponding author), McMaster Childrens Hosp, Dept Pediat, Hamilton, ON, Canada.	parkermj@mcmaster.ca		Parker, Melissa/0000-0002-1052-9296	Canadian Institutes of Health Research [ISU-124114]; McMaster (MAC) new faculty research start-up grant; McMaster Children's Hospital; McMaster University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McMaster (MAC) new faculty research start-up grant; McMaster Children's Hospital; McMaster University	Dr. Parker received funding support in the form of a travel award (ISU-124114) from the Canadian Institutes of Health Research http://www.cihr-irsc.gc.ca/ to attend and present this work at the American Heart Association Resuscitation Science Symposium. Dr. Parker currently holds research funding in the form of a McMaster (MAC) new faculty research start-up grant. Funds from the McMaster (MAC) new faculty research start-up grant were used to support this work and may be used to cover publication costs in relation to this article. The investigators were granted use of the iSURVEY program for one month free of charge ($89 USD value) to support conduct of this investigator-initiated research study. Dr. Parker currently receives salary support from McMaster Children's Hospital and McMaster University. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary GS, 1998, J CLIN ANESTH, V10, P70, DOI 10.1016/S0952-8180(97)00224-9; AEDER MI, 1985, ANN EMERG MED, V14, P307, DOI 10.1016/S0196-0644(85)80092-5; [Anonymous], 2011, PED ADV LIF SUPP PRO, P85; [Anonymous], 2008, ADV TRAUM LIF SUPP D, P55; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2018, ETHICAL CONDUCT RES; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Comunale M, 2000, ANESTHESIA PATIENT S, V15, P41; CROSS GD, 1987, ARCH EMERG MED, V4, P173; DOYLE JT, 1951, J CLIN INVEST, V30, P345, DOI 10.1172/JCI102450; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Ford N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043953; Ford SR, 2011, NEW ENGL J MED, V365, P1348, DOI 10.1056/NEJMc1108712; Gnanalingham MG, 2006, ACTA PAEDIATR, V95, P1677, DOI 10.1080/08035250600763034; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Hilton AK, 2011, CRIT CARE, V15, DOI 10.1186/cc10247; IDRIS AH, 1992, PEDIATR EMERG CARE, V8, P119, DOI 10.1097/00006565-199206000-00001; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Jayanthi NVG, 2006, INJURY, V37, P41, DOI 10.1016/j.injury.2005.09.001; Joyner BL, 2011, NEW ENGL J MED, V365, P1349, DOI 10.1056/NEJMc1108712; Kattwinkel J, 2011, NEONATAL RESUSCITATI; Kissoon N, 2011, NEW ENGL J MED, V365, P1350, DOI 10.1056/NEJMc1108712; Klabunde RE, 2007, CARDIOVASCULAR PHYSL; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; MATEER JR, 1983, ANN EMERG MED, V12, P149, DOI 10.1016/S0196-0644(83)80556-3; Oliveira CF, 2008, PEDIATR EMERG CARE, V24, P810, DOI 10.1097/PEC.0b013e31818e9f3a; Parker Margaret M, 2004, Crit Care Med, V32, pS591, DOI 10.1097/01.CCM.0000145904.97821.0D; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; PHILIP BK, 1983, IEEE T BIO-MED ENG, V30, P702, DOI 10.1109/TBME.1983.325183; Prowle John R, 2012, Crit Care, V16, P436, DOI 10.1186/cc11362; Ranjit Suchitra, 2005, Pediatr Crit Care Med, V6, P412, DOI 10.1097/01.PCC.0000163676.75693.BF; Ribeiro CT, 2011, NEW ENGL J MED, V365, P1348, DOI 10.1056/NEJMc1108712; Roberts K, 2005, EMERG MED J, V22, P572, DOI 10.1136/emj.2004.022533; Roberts K, 2003, RESUSCITATION, V58, P153, DOI 10.1016/S0300-9572(03)00150-3; Smiths Medical, 2010, LEV 1 H 1200 FAST FL; Stoner MJ, 2007, ANN EMERG MED, V50, P601, DOI 10.1016/j.annemergmed.2007.06.482	39	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58282	10.1371/journal.pone.0058282	http://dx.doi.org/10.1371/journal.pone.0058282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554882	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500020
J	Xie, X; Ma, YT; Yang, YN; Li, XM; Ma, X; Fu, ZY; Zheng, YY; Chen, BD; Liu, F				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Zheng, Ying-Ying; Chen, Bang-Dang; Liu, Fen			CYP2C19 Phenotype, Stent Thrombosis, Myocardial Infarction, and Mortality in Patients with Coronary Stent Placement in a Chinese Population	PLOS ONE			English	Article							OF-FUNCTION POLYMORPHISM; CYTOCHROME-P450 2C19-ASTERISK-2 POLYMORPHISM; PLATELET REACTIVITY; CARDIOVASCULAR EVENTS; HEALTHY-SUBJECTS; ARTERY-DISEASE; ANTIPLATELET TREATMENT; CLOPIDOGREL TREATMENT; RESPONSE VARIABILITY; ACTIVE METABOLITE	Background: Several studies have indicated that CYP2C19 loss-of-function polymorphisms have a higher risk of stent thrombosis (ST) after percutaneous coronary interventions (PCIs). However, this association has not been investigated thoroughly in a Chinese population. In this study, we aimed to determine the effect of CYP2C19*2 and CYP2C19*3 loss-of-function polymorphisms on the occurrence of ST and other adverse clinical events in a Chinese population. Methods: We designed a cohort study among 1068 consecutive patients undergoing intracoronary stent implantation after preloading with 600 mg of clopidogrel. CYP2C19*2 and CYP2C19*3 were genotyped by using polymerase chain reaction-restriction fragment length polymorphism analysis. The adverse clinical events recorded were ST, death, myocardial infarction (MI), and bleeding events. The primary end point of the study was the incidence of cumulative ST within 1 year after PCI. The secondary end point was other adverse clinical outcomes 1 year after the procedure. Results: The cumulative 1-year incidence of ST was 0.88% in patients with extensive metabolizers (EMs) (CYP2C19*1/*1 genotype), 4.67% in patients with intermediate metabolizers (IMs) (CYP2C19*1/*2 or *1/*3 genotype), and 10.0% in patients with poor metabolizers (PMs) (CYP2C19*2/*2, *2/*3, or *3/*3 genotype) (P < 0.001). The one-year event-free survival was 97.8% in patients with EMs, 96.5% in patients with IMs, and 92.0% in patients with PMs (P = 0.014). Multivariate analysis confirmed the independent association of CYP2C19 loss-of-function allele carriage with ST (P = 0.009) and total mortality (P < 0.05). Conclusion: PM patients had an increased risk of ST, death, and MI after coronary stent placement in a Chinese population.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Fu, Zhen-Yan; Zheng, Ying-Ying] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		National Natural Science Foundation of China [81160017]; Urumqi City Science and Technology Projects [Y101310008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Urumqi City Science and Technology Projects	This study was funded by the National Natural Science Foundation of China (grant number 81160017) and the Urumqi City Science and Technology Projects (grant number Y101310008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bauer T, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4588; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Caraco Y, 2004, NEW ENGL J MED, V351, P2867, DOI 10.1056/NEJMe048278; Chen M, 2012, ATHEROSCLEROSIS, V220, P168, DOI 10.1016/j.atherosclerosis.2011.04.008; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Fuchshuber-Moraes M, 2011, PHARMACOGENET GENOM, V21, P694, DOI 10.1097/FPC.0b013e328349daba; Galyavich AS, 2012, KARDIOLOGIYA, V52, P20; Giusti B, 2007, PHARMACOGENET GENOM, V17, P1057, DOI 10.1097/FPC.0b013e3282f1b2be; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Luo Y, 2011, J INT MED RES, V39, P2012, DOI 10.1177/147323001103900548; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Montalescot G, 2009, EUR HEART J, V30, P2685, DOI 10.1093/eurheartj/ehp436; Ndrepepa G, 2012, CIRCULATION, V125, P1424, DOI 10.1161/CIRCULATIONAHA.111.060871; Oh IY, 2012, HEART, V98, P139, DOI 10.1136/hrt.2011.227272; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Tang Xiao-Fang, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P617; Tazaki J, 2012, J ATHEROSCLER THROMB, V19, P186, DOI 10.5551/jat.10009; Tello-Montoliu A, 2012, REV ESP CARDIOL, V65, P219, DOI [10.1016/j.rec.2011.07.012, 10.1016/j.recesp.2011.07.013]; Thygesen K, 2007, EUR HEART J, V28, P2525; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Yusuf S, 2001, NEW ENGL J MED, V345, P494	39	18	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59344	10.1371/journal.pone.0059344	http://dx.doi.org/10.1371/journal.pone.0059344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555019	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500082
J	Mastala, Y; Nyangulu, P; Banda, RV; Mhemedi, B; White, SA; Allain, TJ				Mastala, Yamikani; Nyangulu, Phempo; Banda, Rodrick V.; Mhemedi, Bongani; White, Sarah A.; Allain, Theresa J.			Vitamin D Deficiency in Medical Patients at a Central Hospital in Malawi: A Comparison with TB Patients from a Previous Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HYPOVITAMINOSIS D; HEART-FAILURE; DOUBLE-BLIND	Objectives: To determine the prevalence of vitamin D deficiency (VDD) in adult medical, non-tuberculous (non-TB) patients. To investigate associations with VDD. To compare the results with a similar study in TB patients at the same hospital. Design: Cross-sectional sample. Setting: Central hospital in Malawi. Participants: Adult non-TB patients (n = 157), inpatients and outpatients. Outcome Measures: The primary outcome was the prevalence of VDD. Potentially causal associations sought included nutritional status, in/outpatient status, HIV status, anti-retroviral therapy (ART) and, by comparison with a previous study, a diagnosis of tuberculosis (TB). Results: Hypovitaminosis D (<= 75 nmol/L) occurred in 47.8% (75/157) of patients, 16.6% (26/157) of whom had VDD (<= 50 nmol/L). None had severe VDD (<= 25 nmol/L). VDD was found in 22.8% (23/101) of in-patients and 5.4% (3/56) of outpatients. In univariable analysis in-patient status, ART use and low dietary vitamin D were significant predictors of VDD. VDD was less prevalent than in previously studied TB patients in the same hospital (68/161 = 42%). In multivariate analysis of the combined data set from both studies, having TB (OR 3.61, 95% CI 2.02-6.43) and being an in-patient (OR 2.70, 95% CI 1.46-5.01) were significant independent predictors of VDD. Conclusions: About half of adult medical patients without TB have suboptimal vitamin D status, which is more common in in-patients. VDD is much more common in TB patients than non-TB patients, even when other variables are controlled for, suggesting that vitamin D deficiency is associated with TB.	[Mastala, Yamikani; Nyangulu, Phempo; Banda, Rodrick V.; Mhemedi, Bongani; Allain, Theresa J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [White, Sarah A.] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi	Allain, TJ (corresponding author), Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi.	theresa.allain@gmail.com		White, Sarah/0000-0001-5535-8075	College of Medicine	College of Medicine	Dr. Peter Davies made a personal donation to fund the vitamin D assay kits. The College of Medicine provided a small grant for purchase of consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2011, J CARDIOVASC PHARM T, V16, P354, DOI 10.1177/1074248410390214; Allavena C, 2012, J ANTIMICROB CHEMOTH, V67, P2222, DOI 10.1093/jac/dks176; Arabi A, 2010, NAT REV ENDOCRINOL, V6, P550, DOI 10.1038/nrendo.2010.146; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; DAVIES PDO, 1985, TUBERCLE, V66, P301, DOI 10.1016/0041-3879(85)90068-6; Elamin M, 2012, J CLIN ENDOCR METAB, V96, P1931; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Gotsman I, 2012, EUR J HEART FAIL, V14, P357, DOI 10.1093/eurjhf/hfr175; Ho-Pham LT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-306; Holick MF, 2010, ENDOCRIN METAB CLIN, V39, P381, DOI [10.1016/j.rdc.2012.03.013, 10.1016/j.ecl.2010.02.016]; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Martineau AR, 2012, P NUTR SOC, V71, P84, DOI 10.1017/S0029665111003326; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mehmedi B, 2010, INT J TUBERC LUNG D, V15, P408; Michos ED, 2012, NUTRITION, V28, P367, DOI 10.1016/j.nut.2011.10.015; Nansera D, 2011, INT J TUBERC LUNG D, V15, P1522, DOI 10.5588/ijtld.10.0701; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260	24	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59017	10.1371/journal.pone.0059017	http://dx.doi.org/10.1371/journal.pone.0059017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555614	Green Submitted, Green Published, gold			2022-12-27	WOS:000317262200009
J	Nakagami, F; Koriyama, H; Nakagami, H; Osako, MK; Shimamura, M; Kyutoku, M; Miyake, T; Katsuya, T; Rakugi, H; Morishita, R				Nakagami, Futoshi; Koriyama, Hiroshi; Nakagami, Hironori; Osako, Mariana Kiomy; Shimamura, Munehisa; Kyutoku, Mariko; Miyake, Takashi; Katsuya, Tomohiro; Rakugi, Hiromi; Morishita, Ryuichi			Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice	PLOS ONE			English	Article							EXPERIMENTAL RENAL HYPERTENSION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ALZHEIMERS-DISEASE; ACTIVE IMMUNIZATION; BETA PEPTIDE; A-BETA; RENIN; PATHOGENESIS; RATS; IMMUNOGENICITY	Vaccines have been recently developed to treat various diseases such as cancer, rheumatoid arthritis and Alzheimer's disease in addition to infectious diseases. However, before use in the clinical setting, vaccines targeting self-antigens must be demonstrated to be effective and safe, evoking an adequate humoral immune response from B cells while avoiding T cell activation in response to self. Although the vaccine targeting angiotensin II (Ang II) is efficient in rodents and humans, little is known regarding the immunological activation and safety of the vaccine. In this study, we evaluated the efficiency and safety of an Ang II peptide vaccine in mice. Immunization with Ang II conjugated to keyhole limpet hemocyanin (KLH) successfully induced the production of anti-Ang II antibody, which blocked Ang II signaling in human aortic smooth muscle cells. However, Ang II itself did not activate T cells, as assessed by the proliferation and lymphokine production of T cells in immunized mice, whereas KLH activated T cells. In an Ang II-infused model, the non-immunized mice showed high blood pressure (BP), whereas the immunized mice (Ang II-KLH) showed a significant decrease in systolic BP, accompanied by significant reductions in cardiac hypertrophy and fibrosis. Importantly, anti-Ang II antibody titer was not elevated even after the administration of large amounts of Ang II, indicating that Ang II itself boosted antibody production, most likely due to less activation of T cells. In addition, no accumulation of inflammatory cells was observed in immunized mice, because endogenous Ang II would not activate T cells after immunization with Ang II-KLH. Taken together, these data indicate that vaccines targeting Ang II might be effective to decrease high BP and prevent cardiovascular complications without severe side effects.	[Nakagami, Futoshi; Koriyama, Hiroshi; Osako, Mariana Kiomy; Kyutoku, Mariko; Katsuya, Tomohiro; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Nakagami, Futoshi; Koriyama, Hiroshi; Osako, Mariana Kiomy; Rakugi, Hiromi] Osaka Univ, Dept Geriatr Med, Grad Sch Med, Suita, Osaka, Japan; [Nakagami, Hironori; Shimamura, Munehisa; Miyake, Takashi] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Nakagami, H (corresponding author), Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka, Japan.	nakagami@gts.med.osaka-u.ac.jp; morishita@cgt.med.osaka-u.ac.jp	Nakagami, Hironori/GLU-0570-2022; Osako, Mariana Kiomy/AGX-6892-2022; Osako, Mariana/G-2853-2013; Osako, Mariana Kiomy/H-3337-2019	Nakagami, Hironori/0000-0003-4494-3601; Osako, Mariana Kiomy/0000-0002-5021-8433; Rakugi, Hiromi/0000-0001-6508-4338	Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partially supported by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and Adaptive and Seamless Technology Transfer Program (A-step) by from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Brown MT, 2004, ECOL MODEL, V178, P1, DOI 10.1016/j.ecolmodel.2003.12.001; Broytman O, 2004, J NEUROSCI RES, V75, P301, DOI 10.1002/jnr.10876; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Delavallee L, 2010, SWISS MED WKLY, V140, P28, DOI 10.4414/smw.2010.13108; DEODHAR SD, 1964, J EXP MED, V119, P425, DOI 10.1084/jem.119.3.425; Dillman RO, 2011, CANCER BIOTHER RADIO, V26, P1, DOI 10.1089/cbr.2010.0902; Downham MR, 2003, BRIT J CLIN PHARMACO, V56, P505, DOI 10.1046/j.1365-2125.2003.01926.x; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; FRANK MH, 1963, CIRC RES, V12, P241, DOI 10.1161/01.RES.12.3.241; Gardiner SM, 2000, BRIT J PHARMACOL, V129, P1178, DOI 10.1038/sj.bjp.0703178; Gualtierotti R, 2010, AUTOIMMUN REV, V10, P3, DOI 10.1016/j.autrev.2010.09.007; Harding P, 2011, AM J PHYSIOL-HEART C, V300, pH1053, DOI 10.1152/ajpheart.00772.2010; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; HELMER OM, 1958, CIRCULATION, V17, P648, DOI 10.1161/01.CIR.17.4.648; KATZ JI, 1957, CIRC RES, V5, P137, DOI 10.1161/01.RES.5.2.137; MICHEL JB, 1990, CIRCULATION, V81, P1899, DOI 10.1161/01.CIR.81.6.1899; MICHEL JB, 1987, P NATL ACAD SCI USA, V84, P4346, DOI 10.1073/pnas.84.12.4346; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Plescia O J, 1969, Curr Top Microbiol Immunol, V50, P78; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Saito Y, 2006, CIRCULATION, V114, P1177, DOI 10.1161/CIRCULATIONAHA.105.602953; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; SKEGGS LT, 1975, CIRC RES, V37, P715, DOI 10.1161/01.RES.37.6.715; Thomas LJ, 2009, HUM VACCINES, V5, P79, DOI 10.4161/hv.5.2.6521; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; WAKERLIN GE, 1958, CIRCULATION, V17, P653, DOI 10.1161/01.CIR.17.4.653; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Yip HC, 1999, J IMMUNOL, V162, P3942	35	35	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60493	10.1371/journal.pone.0060493	http://dx.doi.org/10.1371/journal.pone.0060493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544146	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700105
J	Wei, T; Ou, B; Li, JB; Zhao, Y; Guo, DS; Zhu, YY; Chen, ZL; Gu, HY; Li, CY; Qin, GJ; Qu, LJ				Wei, Tong; Ou, Bin; Li, Jinbin; Zhao, Yang; Guo, Dongshu; Zhu, Youyong; Chen, Zhangliang; Gu, Hongya; Li, Chengyun; Qin, Genji; Qu, Li-Jia			Transcriptional Profiling of Rice Early Response to Magnaporthe oryzae Identified OsWRKYs as Important Regulators in Rice Blast Resistance	PLOS ONE			English	Article							DISEASE RESISTANCE; FUNCTIONAL-ANALYSIS; PROTEOMIC ANALYSIS; EXPRESSION; DEFENSE; ARABIDOPSIS; GENES; FLAGELLIN; INFECTION; REVEALS	Rice blast disease is a major threat to rice production worldwide, but the mechanisms underlying rice resistance to the causal agent Magnaporthe oryzae remain elusive. Therefore, we carried out a transcriptome study on rice early defense response to M. oryzae. We found that the transcriptional profiles of rice compatible and incompatible interactions with M oryzae were mostly similar, with genes regulated more prominently in the incompatible interactions. The functional analysis showed that the genes involved in signaling and secondary metabolism were extensively up-regulated. In particular, WRKY transcription factor genes were significantly enriched among the up-regulated genes. Overexpressing one of these WRKY genes, OsWRKY47, in transgenic rice plants conferred enhanced resistance against rice blast fungus. Our results revealed the sophisticated transcriptional reprogramming of signaling and metabolic pathways during rice early response to M. oryzae and demonstrated the critical roles of WRKY transcription factors in rice blast resistance.	[Wei, Tong; Ou, Bin; Zhao, Yang; Guo, Dongshu; Chen, Zhangliang; Gu, Hongya; Qin, Genji; Qu, Li-Jia] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Li, Jinbin] Yunnan Acad Agr Sci, Agr Environm & Resources Res Inst, Kunming, Peoples R China; [Zhao, Yang] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhu, Youyong; Li, Chengyun] Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China; [Zhu, Youyong; Li, Chengyun] Yunnan Agr Univ, Key Lab Plant Pathol Yunnan Prov, Kunming, Peoples R China; [Chen, Zhangliang] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China; [Gu, Hongya; Qu, Li-Jia] Natl Plant Gene Res Ctr, Beijing, Peoples R China	Peking University; Yunnan Academy of Agricultural Sciences; China Agricultural University; Yunnan Agricultural University; Yunnan Agricultural University; China Agricultural University	Li, CY (corresponding author), Yunnan Agr Univ, Coll Agron, Kunming, Peoples R China.	chengyun@public.km.yn.cn; qingenji@pku.edu.cn; qulj@pku.edu.cn	Wei, Tong/F-5007-2010	Wei, Tong/0000-0002-2692-7192; Guo, Dongshu/0000-0002-1706-2318	National Transgenic Research Project [2011ZX08009-003-001-003]	National Transgenic Research Project	This work was supported by the National Transgenic Research Project (Grant No. 2011ZX08009-003-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chen YH, 2006, J INTEGR PLANT BIOL, V48, P1084, DOI 10.1111/j.1744-7909.2006.00311.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Delteil A, 2012, MOL PLANT PATHOL, V13, P72, DOI 10.1111/j.1364-3703.2011.00731.x; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Feng JX, 2011, EUR J PLANT PATHOL, V131, P221, DOI 10.1007/s10658-011-9801-7; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gowda M, 2007, PLANT PHYSIOL, V144, P524, DOI 10.1104/pp.107.095653; Hahne F, 2008, USE R, P193, DOI 10.1007/978-0-387-77240-0_13; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kruger WM, 2002, PHYSIOL MOL PLANT P, V61, P41, DOI 10.1016/S0885-5765(02)90415-7; Li JinBin, 2005, Acta Phytophylacica Sinica, V32, P113; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parker D, 2009, PLANT J, V59, P723, DOI 10.1111/j.1365-313X.2009.03912.x; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ryu HS, 2009, PLANT BIOTECHNOL REP, V3, P167, DOI 10.1007/s11816-009-0087-6; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sugano S, 2010, PLANT MOL BIOL, V74, P549, DOI 10.1007/s11103-010-9695-3; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Vergne E, 2007, NEW PHYTOL, V174, P159, DOI 10.1111/j.1469-8137.2007.01971.x; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao Y, 2012, NEW PHYTOL, V195, P450, DOI 10.1111/j.1469-8137.2012.04160.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	72	70	80	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59720	10.1371/journal.pone.0059720	http://dx.doi.org/10.1371/journal.pone.0059720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544090	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700050
J	Verbeke, TJ; Zhang, XL; Henrissat, B; Spicer, V; Rydzak, T; Krokhin, OV; Fristensky, B; Levin, DB; Sparling, R				Verbeke, Tobin J.; Zhang, Xiangli; Henrissat, Bernard; Spicer, Vic; Rydzak, Thomas; Krokhin, Oleg V.; Fristensky, Brian; Levin, David B.; Sparling, Richard			Genomic Evaluation of Thermoanaerobacter spp. for the Construction of Designer Co-Cultures to Improve Lignocellulosic Biofuel Production	PLOS ONE			English	Article							SECONDARY-ALCOHOL DEHYDROGENASE; CLOSTRIDIUM-THERMOCELLUM; ETHANOL-PRODUCTION; THERMOPHILIC BACTERIA; ANAEROBIC THERMOPHILE; SP-NOV.; CELLULOSIC BIOMASS; ESCHERICHIA-COLI; COENZYME-A; COMB-NOV	The microbial production of ethanol from lignocellulosic biomass is a multi-component process that involves biomass hydrolysis, carbohydrate transport and utilization, and finally, the production of ethanol. Strains of the genus Thermoanaerobacter have been studied for decades due to their innate abilities to produce comparatively high ethanol yields from hemicellulose constituent sugars. However, their inability to hydrolyze cellulose, limits their usefulness in lignocellulosic biofuel production. As such, co-culturing Thermoanaerobacter spp. with cellulolytic organisms is a plausible approach to improving lignocellulose conversion efficiencies and yields of biofuels. To evaluate native lignocellulosic ethanol production capacities relative to competing fermentative end-products, comparative genomic analysis of 11 sequenced Thermoanaerobacter strains, including a de novo genome, Thermoanaerobacter thermohydrosulfuricus WC1, was conducted. Analysis was specifically focused on the genomic potential for each strain to address all aspects of ethanol production mentioned through a consolidated bioprocessing approach. Whole genome functional annotation analysis identified three distinct clades within the genus. The genomes of Clade 1 strains encode the fewest extracellular carbohydrate active enzymes and also show the least diversity in terms of lignocellulose relevant carbohydrate utilization pathways. However, these same strains reportedly are capable of directing a higher proportion of their total carbon flux towards ethanol, rather than non-biofuel end-products, than other Thermoanaerobacter strains. Strains in Clade 2 show the greatest diversity in terms of lignocellulose hydrolysis and utilization, but proportionately produce more non-ethanol end-products than Clade 1 strains. Strains in Clade 3, in which T. thermohydrosulfuricus WC1 is included, show mid-range potential for lignocellulose hydrolysis and utilization, but also exhibit extensive divergence from both Clade 1 and Clade 2 strains in terms of cellular energetics. The potential implications regarding strain selection and suitability for industrial ethanol production through a consolidated bioprocessing co-culturing approach are examined throughout the manuscript.	[Verbeke, Tobin J.; Rydzak, Thomas; Sparling, Richard] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Zhang, Xiangli; Fristensky, Brian] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Marseille, France; [Spicer, Vic] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; [Krokhin, Oleg V.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3T 2N2, Canada; [Krokhin, Oleg V.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB R3T 2N2, Canada; [Levin, David B.] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Sparling, R (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	Richard_Sparling@cc.umanitoba.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Rydzak, Thomas/0000-0002-5176-3222; Verbeke, Tobin/0000-0002-0900-3254; Fristensky, Brian/0000-0002-1554-3492; Sparling, Richard/0000-0002-0500-5877	Genome Canada; Natural Sciences and Engineering Research Council [STPGP 365076]; University of Manitoba	Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba	This work was supported by funds provided by a Genome Canada grant titled "Microbial Genomics for Biofuels and Co-Products from Biorefining Processes", the Natural Sciences and Engineering Research Council Strategic Grant (STPGP 365076) and by the University of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aich S, 2007, EVOL BIOINFORM, V3, P333; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bapteste E, 2003, GENE, V318, P185, DOI 10.1016/S0378-1119(03)00797-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENBASSAT A, 1981, J BACTERIOL, V146, P192, DOI 10.1128/JB.146.1.192-199.1981; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Bielen AAM, 2010, FEMS MICROBIOL LETT, V307, P48, DOI 10.1111/j.1574-6968.2010.01957.x; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Breves R, 1997, APPL ENVIRON MICROB, V63, P3902, DOI 10.1128/AEM.63.10.3902-3910.1997; BRYANT FO, 1988, APPL ENVIRON MICROB, V54, P460, DOI 10.1128/AEM.54.2.460-465.1988; BURDETTE D, 1994, BIOCHEM J, V302, P163, DOI 10.1042/bj3020163; Burdette DS, 1996, BIOCHEM J, V316, P115, DOI 10.1042/bj3160115; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; CAYOL JL, 1995, INT J SYST BACTERIOL, V45, P783, DOI 10.1099/00207713-45-4-783; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Cheng JB, 1997, MOL MICROBIOL, V23, P1107, DOI 10.1046/j.1365-2958.1997.2951656.x; Cook GM, 1996, INT J SYST BACTERIOL, V46, P123, DOI 10.1099/00207713-46-1-123; COOK GM, 1994, APPL MICROBIOL BIOT, V41, P84, DOI 10.1007/s002530050111; COOK GM, 1993, APPL ENVIRON MICROB, V59, P2984, DOI 10.1128/AEM.59.9.2984-2990.1993; Cook GM, 2000, EXTREMOPHILES, V4, P279, DOI 10.1007/s007920070014; Das SP, 2012, APPL BIOCHEM BIOTECH, V167, P1475, DOI 10.1007/s12010-012-9618-7; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Demirbas A, 2005, ENERG SOURCE, V27, P327, DOI 10.1080/00908310390266643; Desvaux M, 2006, BIOTECHNOL PROGR, V22, P1229, DOI 10.1021/bp060016e; Erbeznik M, 2004, CURR MICROBIOL, V48, P295, DOI 10.1007/s00284-003-4202-6; Erbeznik M, 1998, CURR MICROBIOL, V37, P295, DOI 10.1007/s002849900381; Fardeau ML, 2004, INT J SYST EVOL MICR, V54, P467, DOI 10.1099/ijs.0.02711-0; FAUDON C, 1995, CURR MICROBIOL, V31, P152, DOI 10.1007/BF00293546; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Furdui C, 2002, BIOCHEMISTRY-US, V41, P9921, DOI 10.1021/bi0257641; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Gavrilov SN, 2003, MICROBIOLOGY+, V72, P132, DOI 10.1023/A:1023299410478; Georgieva TI, 2007, BIOTECHNOL BIOENG, V98, P1161, DOI 10.1002/bit.21536; Gregg D, 1996, APPL BIOCHEM BIOTECH, V57-8, P711, DOI 10.1007/BF02941753; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayashi H, 1999, APPL MICROBIOL BIOT, V51, P348, DOI 10.1007/s002530051401; He Q, 2011, BIORESOURCE TECHNOL, V102, P9586, DOI 10.1016/j.biortech.2011.07.098; He Q, 2009, BIORESOURCE TECHNOL, V100, P5955, DOI 10.1016/j.biortech.2009.06.084; HEINONEN JK, 1988, FEMS MICROBIOL LETT, V52, P205, DOI 10.1016/0378-1097(88)90361-8; Hemme CL, 2011, APPL ENVIRON MICROB, V77, P7998, DOI 10.1128/AEM.05677-11; Holt PJ, 2000, FEMS MICROBIOL LETT, V190, P57, DOI 10.1016/S0378-1097(00)00319-0; Hung KS, 2011, BIOTECHNOL LETT, V33, P1441, DOI 10.1007/s10529-011-0579-7; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Izquierdo JA, 2012, STAND GENOMIC SCI, V6, P104, DOI 10.4056/sigs.2535732; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kozianowski G, 1997, EXTREMOPHILES, V1, P171, DOI 10.1007/s007920050031; Kridelbaugh DM, 2013, BIORESOURCE TECHNOL, V130, P125, DOI 10.1016/j.biortech.2012.12.006; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Krug K, 2011, MOL BIOSYST, V7, P284, DOI 10.1039/c0mb00168f; LAMED R, 1980, J BACTERIOL, V144, P569, DOI 10.1128/JB.144.2.569-578.1980; Larsen L, 1997, ARCH MICROBIOL, V168, P114, DOI 10.1007/s002030050476; LEE YE, 1993, INT J SYST BACTERIOL, V43, P41, DOI 10.1099/00207713-43-1-41; Levin DB, 2006, INT J HYDROGEN ENERG, V31, P1496, DOI 10.1016/j.ijhydene.2006.06.015; Lin L, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-10; Lin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012582; LOVITT RW, 1988, J BACTERIOL, V170, P2809, DOI 10.1128/jb.170.6.2809-2815.1988; LOVITT RW, 1984, APPL ENVIRON MICROB, V48, P171, DOI 10.1128/AEM.48.1.171-177.1984; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; LUTHI E, 1990, APPL ENVIRON MICROB, V56, P1017; Lynd LR, 2008, BIOENERGY, P55; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; LYND LR, 1989, APPL ENVIRON MICROB, V55, P3131, DOI 10.1128/AEM.55.12.3131-3139.1989; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; MAYER MAG, 1995, MICROBIOL-UK, V141, P2891, DOI 10.1099/13500872-141-11-2891; McQueen P, 2012, PROTEOMICS, V12, P1160, DOI 10.1002/pmic.201100425; Mikkelsen MJ, 2007, Patent No. [WO/2007/124607, 2007124607]; MORAG E, 1990, J BACTERIOL, V172, P6098, DOI 10.1128/jb.172.10.6098-6105.1990; Moreira LRS, 2011, ROUTES TO CELLULOSIC ETHANOL, P73, DOI 10.1007/978-0-387-92740-4_6; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Navdaeva V, 2011, BIOCHEMISTRY-US, V50, P1184, DOI 10.1021/bi101721f; NG TK, 1981, APPL ENVIRON MICROB, V41, P1337, DOI 10.1128/AEM.41.6.1337-1343.1981; NG TK, 1982, J BACTERIOL, V150, P1391, DOI 10.1128/JB.150.3.1391-1399.1982; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Onyenwoke RU, 2007, INT J SYST EVOL MICR, V57, P2191, DOI 10.1099/ijs.0.65051-0; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pei JJ, 2011, METAB ENG, V13, P186, DOI 10.1016/j.ymben.2010.12.006; Pei JJ, 2010, METAB ENG, V12, P420, DOI 10.1016/j.ymben.2010.06.001; Piccolo C, 2009, BIOMASS BIOENERG, V33, P478, DOI 10.1016/j.biombioe.2008.08.008; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Podkaminer KK, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-43; Qian Z, 2009, MICROBIOL-SGM, V155, P1717, DOI 10.1099/mic.0.025536-0; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; RAMOS LP, 1993, ENZYME MICROB TECH, V15, P19, DOI 10.1016/0141-0229(93)90111-E; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roh Y, 2002, APPL ENVIRON MICROB, V68, P6013, DOI 10.1128/AEM.68.12.6013-6020.2002; SADDLER JN, 1984, CAN J MICROBIOL, V30, P212, DOI 10.1139/m84-032; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SCHMID U, 1986, SYST APPL MICROBIOL, V8, P80, DOI 10.1016/S0723-2020(86)80153-9; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Shaw AJ, 2011, APPL ENVIRON MICROB, V77, P2534, DOI 10.1128/AEM.01731-10; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Slobodkin AI, 1999, INT J SYST BACTERIOL, V49, P1471, DOI 10.1099/00207713-49-4-1471; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; van de Werken HJG, 2008, APPL ENVIRON MICROB, V74, P6720, DOI 10.1128/AEM.00968-08; Verbeke TJ, 2011, FEMS MICROBIOL ECOL, V78, P473, DOI 10.1111/j.1574-6941.2011.01181.x; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; WIEGEL J, 1985, APPL ENVIRON MICROB, V49, P656, DOI 10.1128/AEM.49.3.656-659.1985; WIEGEL J, 1981, ARCH MICROBIOL, V128, P343, DOI 10.1007/BF00405910; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115, DOI 10.1385/ABAB:115:1-3:1115; Xu CG, 2010, BIORESOURCE TECHNOL, V101, P9560, DOI 10.1016/j.biortech.2010.07.065; Yao S, 2010, APPL MICROBIOL BIOT, V88, P199, DOI 10.1007/s00253-010-2703-3; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; ZEIKUS JG, 1980, J BACTERIOL, V143, P432, DOI 10.1128/JB.143.1.432-440.1980; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YHP, 2005, P NATL ACAD SCI USA, V102, P7321, DOI 10.1073/pnas.0408734102; Zuroff TR, 2012, APPL MICROBIOL BIOT, V93, P1423, DOI 10.1007/s00253-011-3762-9; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0	124	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59362	10.1371/journal.pone.0059362	http://dx.doi.org/10.1371/journal.pone.0059362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555660	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500035
J	Bocedi, A; De Sanctis, G; Ciaccio, C; Tundo, GR; Di Masi, A; Fanali, G; Nicoletti, FP; Fasano, M; Smulevich, G; Ascenzi, P; Coletta, M				Bocedi, Alessio; De Sanctis, Giampiero; Ciaccio, Chiara; Tundo, Grazia R.; Di Masi, Alessandra; Fanali, Gabriella; Nicoletti, Francesco P.; Fasano, Mauro; Smulevich, Giulietta; Ascenzi, Paolo; Coletta, Massimo			Reciprocal Allosteric Modulation of Carbon Monoxide and Warfarin Binding to Ferrous Human Serum Heme-Albumin	PLOS ONE			English	Article							DRUG-BINDING; CRYSTAL-STRUCTURE; LIGAND-BINDING; FATTY-ACIDS; CRYSTALLOGRAPHIC ANALYSIS; ENZYMATIC-PROPERTIES; HUMAN HEMALBUMIN; ATOMIC-STRUCTURE; STRUCTURAL BASIS; NO DISSOCIATION	Human serum albumin (HSA), the most abundant protein in human plasma, could be considered as a prototypic monomeric allosteric protein, since the ligand-dependent conformational adaptability of HSA spreads beyond the immediate proximity of the binding site(s). As a matter of fact, HSA is a major transport protein in the bloodstream and the regulation of the functional allosteric interrelationships between the different binding sites represents a fundamental information for the knowledge of its transport function. Here, kinetics and thermodynamics of the allosteric modulation: (i) of carbon monoxide (CO) binding to ferrous human serum heme-albumin (HSA-heme-Fe(II)) by warfarin (WF), and (ii) of WF binding to HSA-heme-Fe(II) by CO are reported. All data were obtained at pH 7.0 and 25 degrees C. Kinetics of CO and WF binding to the FA1 and FA7 sites of HSA-heme-Fe(II), respectively, follows a multi-exponential behavior (with the same relative percentage for the two ligands). This can be accounted for by the existence of multiple conformations and/or heme-protein axial coordination forms of HSA-heme-Fe(II). The HSA-heme-Fe(II) populations have been characterized by resonance Raman spectroscopy, indicating the coexistence of different species characterized by four-, five-and six-coordination of the heme-Fe atom. As a whole, these results suggest that: (i) upon CO binding a conformational change of HSA-heme-Fe(II) takes place (likely reflecting the displacement of an endogenous ligand by CO), and (ii) CO and/or WF binding brings about a ligand-dependent variation of the HSA-heme-Fe(II) population distribution of the various coordinating species. The detailed thermodynamic and kinetic analysis here reported allows a quantitative description of the mutual allosteric effect of CO and WF binding to HSA-heme-Fe(II).	[Bocedi, Alessio; Ciaccio, Chiara; Tundo, Grazia R.; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [De Sanctis, Giampiero] Univ Camerino, Dept Mol Cellular & Anim Biol, I-62032 Camerino, MC, Italy; [Tundo, Grazia R.; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Di Masi, Alessandra; Ascenzi, Paolo] Univ Roma Tre, Dept Biol & Interdept Lab Electron Microscop, Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Struct & Funct Biol, Busto Arsizio, VA, Italy; [Nicoletti, Francesco P.; Smulevich, Giulietta] Univ Firenze, Dept Chem Ugo Schiff, Sesto Fiorentino, FI, Italy	University of Rome Tor Vergata; University of Camerino; Roma Tre University; University of Insubria; University of Florence	Coletta, M (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.	coletta@seneca.uniroma2.it	di Masi, Alessandra/K-2300-2018; Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015; Fasano, Mauro/A-7100-2008	Fasano, Mauro/0000-0003-0628-5871; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Smulevich, Giulietta/0000-0003-3021-8919; COLETTA, Massimiliano/0000-0002-5489-9467				Adam SS, 2012, ANN INTERN IN PRESS; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V353, P469, DOI 10.1016/j.bbrc.2006.12.041; Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001; Ascenzi P, 2009, IUBMB LIFE, V61, P1118, DOI 10.1002/iub.263; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; Boffi A, 1999, BIOPHYS J, V77, P1143, DOI 10.1016/S0006-3495(99)76965-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabrera-Crespo J, 2000, BIOTECHNOL APPL BIOC, V31, P101, DOI 10.1042/BA19990095; Cao Y, 2012, J BIOL INORG CHEM, V17, P133, DOI 10.1007/s00775-011-0837-0; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHEN RF, 1967, J BIOL CHEM, V242, P173; Chuang VTG, 2002, PHARMACEUT RES, V19, P1458, DOI 10.1023/A:1020496314081; Ciaccio C, 2008, IUBMB LIFE, V60, P112, DOI 10.1002/iub.6; Coletta M, 1996, EUR J BIOCHEM, V235, P49, DOI 10.1111/j.1432-1033.1996.00049.x; COLETTA M, 1985, J BIOL CHEM, V260, P4151; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, FEBS J, V274, P4491, DOI 10.1111/j.1742-4658.2007.05978.x; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Fasano Mauro, 2008, V9, P121; Fitos I, 1999, CHIRALITY, V11, P115, DOI 10.1002/(SICI)1520-636X(1999)11:2<115::AID-CHIR6>3.0.CO;2-R; Fitos I, 2002, CHIRALITY, V14, P442, DOI 10.1002/chir.10113; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gullotta F, 2012, IUBMB LIFE, V64, P378, DOI 10.1002/iub.1015; Gullotta F, 2012, BIOFACTORS, V38, P1, DOI 10.1002/biof.192; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; JANSSEN LHM, 1981, BIOCHIM BIOPHYS ACTA, V669, P244, DOI 10.1016/0005-2795(81)90247-6; Kamal JKA, 2002, J BIOL INORG CHEM, V7, P273, DOI 10.1007/s007750100294; Komatsu T, 2005, J AM CHEM SOC, V127, P15933, DOI 10.1021/ja054819u; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; Minchiotti L, 2008, HUM MUTAT, V29, P1007, DOI 10.1002/humu.20754; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; SOGAMI M, 1968, BIOCHEMISTRY-US, V7, P2172, DOI 10.1021/bi00846a020; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; WILTING J, 1980, J BIOL CHEM, V255, P3032; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	70	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58842	10.1371/journal.pone.0058842	http://dx.doi.org/10.1371/journal.pone.0058842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555601	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400013
J	Kolpas, A; Busch, M; Li, H; Couzin, ID; Petzold, L; Moehlis, J				Kolpas, Allison; Busch, Michael; Li, Hong; Couzin, Iain D.; Petzold, Linda; Moehlis, Jeff			How the Spatial Position of Individuals Affects Their Influence on Swarms: A Numerical Comparison of Two Popular Swarm Dynamics Models	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; SELF-ORGANIZATION; FISH; INFORMATION; SCHOOLS	Schools of fish and flocks of birds are examples of self-organized animal groups that arise through social interactions among individuals. We numerically study two individual-based models, which recent empirical studies have suggested to explain self-organized group animal behavior: (i) a zone-based model where the group communication topology is determined by finite interacting zones of repulsion, attraction, and orientation among individuals; and (ii) a model where the communication topology is described by Delaunay triangulation, which is defined by each individual's Voronoi neighbors. The models include a tunable parameter that controls an individual's relative weighting of attraction and alignment. We perform computational experiments to investigate how effectively simulated groups transfer information in the form of velocity when an individual is perturbed. A cross-correlation function is used to measure the sensitivity of groups to sudden perturbations in the heading of individual members. The results show how relative weighting of attraction and alignment, location of the perturbed individual, population size, and the communication topology affect group structure and response to perturbation. We find that in the Delaunay-based model an individual who is perturbed is capable of triggering a cascade of responses, ultimately leading to the group changing direction. This phenomenon has been seen in self-organized animal groups in both experiments and nature.	[Kolpas, Allison] West Chester Univ Penn, Dept Math, W Chester, PA USA; [Busch, Michael; Petzold, Linda; Moehlis, Jeff] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Li, Hong; Petzold, Linda] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Princeton University	Kolpas, A (corresponding author), West Chester Univ Penn, Dept Math, W Chester, PA USA.	AKolpas@wcupa.edu	Kolpas, Allison/AAG-7071-2020; Couzin, Iain D./Q-6862-2018	Kolpas, Allison/0000-0003-0551-6957; Couzin, Iain D./0000-0001-8556-4558	Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Army Research Office [W911NG-11-1-0385]	Institute for Collaborative Biotechnologies from the U.S. Army Research Office; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Army Research Office	This work was partially supported by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. This work was also supported by National Science Foundation Grant PHY-0848755, Office of Naval Research Award N00014-09-1-1074, and Army Research Office Grant W911NG-11-1-0385 (to IDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AURENHAMMER F, 1991, COMPUT SURV, V23, P345, DOI 10.1145/116873.116880; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Camazine S., 2003, SELF ORG BIOL SYSTEM; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Couzin ID, 2007, NATURE, V445; Driver P. M., 1988, PROTEAN BEHAV BIOL U; Du Q, 1999, SIAM REV, V41, P637, DOI 10.1137/S0036144599352836; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kolpas A, 2008, THESIS U CALIFORNIA; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; Krause J, 2002, LIVING GROUPS; Li H, 2009, CONCURR COMP-PRACT E, V21, P725, DOI 10.1002/cpe.1330; MARTINEZ D R, 1970, Zeitschrift fuer Tierpsychologie, V27, P828; MAY RM, 1979, NATURE, V282, P778, DOI 10.1038/282778a0; NEILL SRS, 1974, J ZOOL, V172, P549, DOI 10.1111/j.1469-7998.1974.tb04385.x; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PARTRIDGE BL, 1982, SCI AM, V246, P114, DOI 10.1038/scientificamerican0682-114; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Radakov D. V., 1973, SCH ECOLOGY FISH; Ristroph L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.194502; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Tunstrom K, 2012, COLLECTIVE IN PRESS; UVAROV BP, 1928, GRASSHOPPERS LOCUSTS; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WITKIN SR, 1977, CONDOR, V79, P490, DOI 10.2307/1367730	36	22	22	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58525	10.1371/journal.pone.0058525	http://dx.doi.org/10.1371/journal.pone.0058525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555585	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400007
J	McAuliffe, E; Daly, M; Kamwendo, F; Masanja, H; Sidat, M; de Pinho, H				McAuliffe, Eilish; Daly, Michael; Kamwendo, Francis; Masanja, Honorati; Sidat, Mohsin; de Pinho, Helen			The Critical Role of Supervision in Retaining Staff in Obstetric Services: A Three Country Study	PLOS ONE			English	Article							HEALTH-WORKERS; MOTIVATION	Millennium Development Goal (MDG) 5 commits us to reducing maternal mortality rates by three quarters and MDG 4 commits us to reducing child mortality by two-thirds between 1990 and 2015. In order to reach these goals, greater access to basic emergency obstetric care (EmOC) as well as comprehensive EmOC which includes safe Caesarean section, is needed.. The limited capacity of health systems to meet demand for obstetric services has led several countries to utilize mid-level cadres as a substitute to more extensively trained and more internationally mobile healthcare workers. Although this does provide greater capacity for service delivery, concern about the performance and motivation of these workers is emerging. We propose that poor leadership characterized by inadequate and unstructured supervision underlies much of the dissatisfaction and turnover that has been shown to exist amongst these mid-level healthcare workers and indeed health workers more generally. To investigate this, we conducted a large-scale survey of 1,561 mid-level cadre healthcare workers (health workers trained for shorter periods to perform specific tasks e. g. clinical officers) delivering obstetric care in Malawi, Tanzania, and Mozambique. Participants indicated the primary supervision method used in their facility and we assessed their job satisfaction and intentions to leave their current workplace. In all three countries we found robust evidence indicating that a formal supervision process predicted high levels of job satisfaction and low intentions to leave. We find no evidence that facility level factors modify the link between supervisory methods and key outcomes. We interpret this evidence as strongly supporting the need to strengthen leadership and implement a framework and mechanism for systematic supportive supervision. This will promote better job satisfaction and improve the retention and performance of obstetric care workers, something which has the potential to improve maternal and neonatal outcomes in the countdown to 2015.	[McAuliffe, Eilish] Univ Dublin, Ctr Global Hlth, Trinity Coll, Dublin, Ireland; [McAuliffe, Eilish] Univ Dublin, Sch Med, Trinity Coll, Dublin, Ireland; [Daly, Michael] Univ Stirling, Sch Management, Stirling FK9 4LA, Scotland; [Kamwendo, Francis] Univ Malawi, Coll Med, Ctr Reprod Hlth, Blantyre, Malawi; [Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Sidat, Mohsin] Eduardo Mondlane Univ, Dept Community Hlth, Fac Med, Maputo, Mozambique; [de Pinho, Helen] Columbia Univ, Averting Maternal Death & Disabil Program, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA	Trinity College Dublin; Trinity College Dublin; University of Stirling; University of Malawi; Ifakara Health Institute; Eduardo Mondlane University; Columbia University	McAuliffe, E (corresponding author), Univ Dublin, Ctr Global Hlth, Trinity Coll, Dublin, Ireland.	eilish.mcauliffe@tcd.ie	Daly, Michael/AAD-7703-2019	Daly, Michael/0000-0003-1557-8326; Sidat, Mohsin/0000-0002-8378-2014; McAuliffe, Eilish/0000-0002-9714-5040	Irish Aid	Irish Aid(CGIAR)	This study is part of the Health Systems Strengthening for Equity study. It was funded by Irish Aid (no grant number assigned) url:www.irishaid.gov.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dmour H., 2002, DIRASAT ADM SCI SERI, V29, P247; [Anonymous], 2002, 4 MAQ USAID; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Awamleh, 2006, MANAGEMENT RES NEWS, V29, P701, DOI [10.1108/01409170610716016, DOI 10.1108/01409170610716016]; Bickel R., 2007, MULTILEVEL ANAL APPL; Bradley S, HUMAN RESOURCE UNPUB; Bradley S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-14; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044484; Cummings GG, 2010, INT J NURS STUD, V47, P363, DOI 10.1016/j.ijnurstu.2009.08.006; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Gerein N, 2006, REPROD HEALTH MATTER, V14, P40, DOI 10.1016/S0968-8080(06)27225-2; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hyrkas Kristiina, 2005, Issues Ment Health Nurs, V26, P531, DOI 10.1080/01612840590931975; Knudsen HK, 2008, J SUBST ABUSE TREAT, V35, P387, DOI 10.1016/j.jsat.2008.02.003; Manafa O, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-65; Martinko M.J., 1982, ACAD MANAGE REV, V7, P195, DOI DOI 10.5465/AMR.1982.4285559; McCord C, 2009, HEALTH AFFAIR, V28, pW876, DOI 10.1377/hlthaff.28.5.w876; Peters DH, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-27; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	22	44	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58415	10.1371/journal.pone.0058415	http://dx.doi.org/10.1371/journal.pone.0058415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555581	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400006
J	Oves, M; Khan, MS; Zaidi, A; Ahmed, AS; Ahmed, F; Ahmad, E; Sherwani, A; Owais, M; Azam, A				Oves, Mohammad; Khan, Mohammad Saghir; Zaidi, Almas; Ahmed, Arham S.; Ahmed, Faheem; Ahmad, Ejaz; Sherwani, Asif; Owais, Mohammad; Azam, Ameer			Antibacterial and Cytotoxic Efficacy of Extracellular Silver Nanoparticles Biofabricated from Chromium Reducing Novel OS4 Strain of Stenotrophomonas maltophilia	PLOS ONE			English	Article							REDUCTASE-MEDIATED SYNTHESIS; BIOLOGICAL SYNTHESIS; CULTURE SUPERNATANT; ASPERGILLUS-NIGER; DRUG-RELEASE; BIOSYNTHESIS; EXTRACTS; KINETICS	Biofabricated metal nanoparticles are generally biocompatible, inexpensive, and ecofriendly, therefore, are used preferably in industries, medical and material science research. Considering the importance of biofabricated materials, we isolated, characterized and identified a novel bacterial strain OS4 of Stenotrophomonas maltophilia (GenBank: JN247637.1). At neutral pH, this Gram negative bacterial strain significantly reduced hexavalent chromium, an important heavy metal contaminant found in the tannery effluents and minings. Subsequently, even at room temperature the supernatant of log phase grown culture of strain OS4 also reduced silver nitrate (AgNO3) to generate nanoparticles (AgNPs). These AgNPs were further characterized by UV-visible, Nanophox particle size analyzer, XRD, SEM and FTIR. As evident from the FTIR data, plausibly the protein components of supernatant caused the reduction of AgNO3. The cuboid and homogenous AgNPs showed a characteristic UV-visible peak at 428 nm with average size of similar to 93 nm. The XRD spectra exhibited the characteristic Bragg peaks of 111, 200, 220 and 311 facets of the face centred cubic symmetry of nanoparticles suggesting that these nanoparticles were crystalline in nature. From the nanoparticle release kinetics data, the rapid release of AgNPs was correlated with the particle size and increasing surface area of the nanoparticles. A highly significant antimicrobial activity against medically important bacteria by the biofabricated AgNPs was also revealed as decline in growth of Staphylococcus aureus (91%), Escherichia coli (69%) and Serratia marcescens (66%) substantially. Additionally, different cytotoxic assays showed no toxicity of AgNPs to liver function, RBCs, splenocytes and HeLa cells, hence these particles were safe to use. Therefore, this novel bacterial strain OS4 is likely to provide broad spectrum benefits for curing chromium polluted sites, for biofabrication of AgNPs and ultimately in the nanoparticle based drug formulation for the treatment of infectious diseases.	[Oves, Mohammad; Khan, Mohammad Saghir; Zaidi, Almas] Aligarh Muslim Univ, Dept Agr Microbiol, Fac Agr Sci, Aligarh, Uttar Pradesh, India; [Ahmed, Arham S.; Azam, Ameer] Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, Aligarh, Uttar Pradesh, India; [Ahmed, Faheem] Changwon Natl Univ, Sch Nano & Adv Mat Engn, Chang Won, South Korea; [Ahmad, Ejaz; Sherwani, Asif; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Azam, Ameer] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21413, Saudi Arabia	Aligarh Muslim University; Aligarh Muslim University; Changwon National University; Aligarh Muslim University; King Abdulaziz University	Oves, M (corresponding author), Aligarh Muslim Univ, Dept Agr Microbiol, Fac Agr Sci, Aligarh, Uttar Pradesh, India.	owais.micro@gmail.com	Ahmed, Faheem/AAS-4175-2021; Ahmed, Faheem/C-5425-2011; Ahmad, Ejaz/L-1506-2013; Ibrahim, Essam Hassan/G-1960-2018; Sherwani, Mohammad Asif/AAQ-2949-2021; Azam, Ameer/C-3346-2011; Azam, Ameer/K-4247-2012; Sherwani, Mohammad/AAR-6089-2021; Oves, Mohammad/J-8804-2015	Ahmed, Faheem/0000-0002-5436-1966; Ahmad, Ejaz/0000-0002-5713-6713; Ibrahim, Essam Hassan/0000-0003-0130-2257; Sherwani, Mohammad Asif/0000-0001-5317-1557; Oves, Mohammad/0000-0002-8513-6155; Mohammad, Owais/0000-0001-7377-7388	Council of Scientific and Industrial Research (CSIR), New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance was provided to M. Oves and E. Ahmad in the form of a Senior Research Fellowship and Research Associateship, respectively, was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India. M. S. Khan, A. Zaidi and A. Azam are Associate Professors in A. M. U., Aligarh. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahemad M, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P393, DOI 10.1007/978-1-4419-7931-5_15; Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1; American Public Health Association (APHA), 1995, STAND METH; Azam A, 2012, INT J NANOMED, V7, P3527, DOI 10.2147/IJN.S29020; Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034; Bryaskova Rayna, 2011, J Chem Biol, V4, P185, DOI 10.1007/s12154-011-0063-9; Chai LY, 2009, J HAZARD MATER, V167, P516, DOI 10.1016/j.jhazmat.2009.01.030; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; Cui H, 2008, J PHYS CHEM C, V112, P11319, DOI 10.1021/jp800749y; Dash S, 2010, ACTA POL PHARM, V67, P217; El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n; Farrel SO, 2000, EXPT BIOCH HANDS ON; Fu MX, 2006, CHINESE J CHEM ENG, V14, P114, DOI 10.1016/S1004-9541(06)60046-3; Fulladosa E, 2006, CHEMOSPHERE, V65, P644, DOI 10.1016/j.chemosphere.2006.01.069; Gade AK, 2008, J BIOBASED MATER BIO, V2, P243, DOI 10.1166/jbmb.2008.401; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Guha H, 2003, CHEMOSPHERE, V52, P175, DOI 10.1016/S0045-6535(03)00104-8; Holt J. G., 1994, BERGEYS MANUAL DETER, P307; Jacob SJP, 2012, COLLOID SURFACE B, V91, P212, DOI 10.1016/j.colsurfb.2011.11.001; Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018; Kalishwaralal K, 2008, MATER LETT, V62, P4411, DOI 10.1016/j.matlet.2008.06.051; Khan MS, 2009, ENVIRON CHEM LETT, V7, P1, DOI 10.1007/s10311-008-0155-0; Khan MS, 2012, TOXICITY HEAVY METAL, P67; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Krishnaraj C, 2012, SPECTROCHIM ACTA A, V93, P95, DOI 10.1016/j.saa.2012.03.002; Kumar A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/29/295606; Kumar CG, 2011, COLLOID SURFACE B, V84, P462, DOI 10.1016/j.colsurfb.2011.01.042; Kumar SA, 2007, BIOTECHNOL LETT, V29, P439, DOI 10.1007/s10529-006-9256-7; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kumar SA, 2007, BIOTECHNOL APPL BIOC, V47, P191, DOI 10.1042/BA20060205; Law N, 2008, APPL ENVIRON MICROB, V74, P7090, DOI 10.1128/AEM.01069-08; LICHTENSTEIN A, 1995, J INORG BIOCHEM, V60, P187, DOI 10.1016/0162-0134(95)00019-K; Loo YY, 2012, INT J NANOMED, V7, P4263, DOI 10.2147/IJN.S33344; Mallick K, 2005, MATER CHEM PHYS, V90, P221, DOI 10.1016/j.matchemphys.2004.10.030; Mourato A, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/546074; Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Priyadarshini S, 2013, COLLOID SURFACE B, V102, P232, DOI 10.1016/j.colsurfb.2012.08.018; Ragunathan R, 2009, INT J NANOTECHNOL AP, V3, P89; Rajkumar M, 2005, CURR MICROBIOL, V50, P266, DOI 10.1007/s00284-005-4470-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005; Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008; Simon-Deckers A, 2009, ENVIRON SCI TECHNOL, V43, P8423, DOI 10.1021/es9016975; Singh S, 2009, NEW J CHEM, V33, P646, DOI 10.1039/b811829a; Smetana AB, 2005, J COLLOID INTERF SCI, V284, P521, DOI 10.1016/j.jcis.2004.10.038; Srivastava S, 2006, SOIL BIOL BIOCHEM, V38, P1904, DOI 10.1016/j.soilbio.2005.12.016; Tao AR, 2008, SMALL, V4, P310, DOI 10.1002/smll.200701295; Tarcan G, 2010, WATER AIR SOIL POLL, V213, P199, DOI 10.1007/s11270-010-0378-0; Thangapandiyan S, 2012, INT J PHARM SCI RES, V3, P1415, DOI 10.13040/IJPSR.0975-8232.3(5).1415-22; Vasimalai N, 2012, J HAZARD MATER, V213, P193, DOI 10.1016/j.jhazmat.2012.01.079; WANG PC, 1990, J BACTERIOL, V172, P1670, DOI 10.1128/jb.172.3.1670-1672.1990; Wani PA, 2007, CURR MICROBIOL, V54, P237, DOI 10.1007/s00284-006-0451-5; Wei XT, 2012, BIORESOURCE TECHNOL, V103, P273, DOI 10.1016/j.biortech.2011.09.118; Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102; YERUSHALMI N, 1994, BBA-BIOMEMBRANES, V1189, P13, DOI 10.1016/0005-2736(94)90274-7; Yu DG, 2007, COLLOID SURFACE B, V59, P171, DOI 10.1016/j.colsurfb.2007.05.007; Zhao J, 2006, NANOMEDICINE-UK, V1, P219, DOI 10.2217/17435889.1.2.219	58	108	111	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59140	10.1371/journal.pone.0059140	http://dx.doi.org/10.1371/journal.pone.0059140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555625	Green Published, gold			2022-12-27	WOS:000316546400023
J	Shen, ZQ; Han, J; Wang, Y; Sahin, O; Zhang, QJ				Shen, Zhangqi; Han, Jing; Wang, Yang; Sahin, Orhan; Zhang, Qijing			The Contribution of ArsB to Arsenic Resistance in Campylobacter jejuni	PLOS ONE			English	Article							ESCHERICHIA-COLI; AS(III) METALLOCHAPERONE; SINORHIZOBIUM-MELILOTI; NUCLEOTIDE-SEQUENCE; REGULATORY PROTEIN; GENOME SEQUENCE; OPERON HOMOLOG; POULTRY LITTER; ANION PUMP; DETOXIFICATION	Arsenic, a toxic metalloid, exists in the natural environment and its organic form is approved for use as a feed additive for animal production. As a major foodborne pathogen of animal origin, Campylobacter is exposed to arsenic selection pressure in the food animal production environments. Previous studies showed that Campylobacter isolates from poultry were highly resistant to arsenic compounds and a 4-gene operon (containing arsP, arsR, arsC, and acr3) was associated with arsenic resistance in Campylobacter. However, this 4-gene operon is only present in some Campylobacter isolates and other arsenic resistance mechanisms in C. jejuni have not been characterized. In this study, we determined the role of several putative arsenic resistance genes including arsB, arsC2, and arsR3 in arsenic resistance in C. jejuni and found that arsB, but not the other two genes, contributes to the resistance to arsenite and arsenate. Inactivation of arsB in C. jejuni resulted in 8- and 4-fold reduction in the MICs of arsenite and arsenate, respectively, and complementation of the arsB mutant restored the MIC of arsenite. Additionally, overexpression of arsB in C. jejuni 11168 resulted in a 16-fold increase in the MIC of arsenite. PCR analysis of C. jejuni isolates from different animals hosts indicated that arsB and acr3 (the 4-gene operon) are widely distributed in various C. jejuni strains, suggesting that Campylobacter requires at least one of the two genes for adaptation to arsenic-containing environments. These results identify ArsB as an alternative mechanism for arsenic resistance in C. jejuni and provide new insights into the adaptive mechanisms of Campylobacter in animal food production environments.	[Shen, Zhangqi; Han, Jing; Wang, Yang; Sahin, Orhan; Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Wang, Yang] China Agr Univ, Coll Vet Med, Dept Pharmacol & Toxicol, Beijing 100094, Peoples R China	Iowa State University; China Agricultural University	Zhang, QJ (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu	Wang, Yang/ABD-5983-2021; Shen, Zhangqi/HCI-5736-2022; Zhang, Qijing/B-7530-2012	Wang, Yang/0000-0002-5928-9377; Shen, Zhangqi/0000-0003-4789-7540; Sahin, Orhan/0000-0003-0262-4581	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grant number R01DK063008 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2011, BIOMETALS, V24, P391, DOI 10.1007/s10534-010-9398-x; Basu A, 2001, MUTAT RES-REV MUTAT, V488, P171, DOI 10.1016/S1383-5742(01)00056-4; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Cai J, 1998, MICROBIOL-SGM, V144, P2705, DOI 10.1099/00221287-144-10-2705; Chapman HD, 2002, POULTRY SCI, V81, P356, DOI 10.1093/ps/81.3.356; CHEN CM, 1986, J BIOL CHEM, V261, P5030; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; FRANCISCO MJDS, 1989, MOL MICROBIOL, V3, P15, DOI 10.1111/j.1365-2958.1989.tb00098.x; Garbarino JR, 2003, ENVIRON SCI TECHNOL, V37, P1509, DOI 10.1021/es026219q; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jackson BP, 2003, J ENVIRON QUAL, V32, P535, DOI 10.2134/jeq2003.0535; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Mattew A, 2006, M2A9 CLSI; Muraoka WT, 2011, J BACTERIOL, V193, P1065, DOI 10.1128/JB.01252-10; Murphy JN, 2009, J BACTERIOL, V191, P6722, DOI 10.1128/JB.00801-09; Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Qin J, 2006, P NATL ACAD SCI USA, V103, P2075, DOI 10.1073/pnas.0506836103; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; ROSENSTEIN R, 1994, MOL GEN GENET, V242, P566, DOI 10.1007/BF00285280; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Saltikov CW, 2003, APPL ENVIRON MICROB, V69, P2800, DOI 10.1128/AEM.69.5.2800-2809.2003; Saltikov CW, 2002, APPL ENVIRON MICROB, V68, P280, DOI 10.1128/AEM.68.1.280-288.2002; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Suzuki K, 1998, APPL ENVIRON MICROB, V64, P411; TISA LS, 1990, J BIOL CHEM, V265, P190; Tuffin IM, 2005, MICROBIOL-SGM, V151, P3027, DOI 10.1099/mic.0.28131-0; Wang LP, 2009, APPL ENVIRON MICROB, V75, P5064, DOI 10.1128/AEM.00149-09; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Wosten MMSM, 1998, J BACTERIOL, V180, P594; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x; WU JH, 1992, J BIOL CHEM, V267, P12570; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Yang JB, 2010, BIOCHEMISTRY-US, V49, P3658, DOI 10.1021/bi100026a; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039; Zhang YB, 2009, ANTON LEEUW INT J G, V96, P161, DOI 10.1007/s10482-009-9313-z	50	16	17	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58894	10.1371/journal.pone.0058894	http://dx.doi.org/10.1371/journal.pone.0058894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554953	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800045
J	Wang, SQ; He, JZ				Wang, Shanquan; He, Jianzhong			Phylogenetically Distinct Bacteria Involve Extensive Dechlorination of Aroclor 1260 in Sediment-Free Cultures	PLOS ONE			English	Article							MICROBIAL REDUCTIVE DECHLORINATION; POLYCHLORINATED BIPHENYL CONGENER; ANAEROBIC MICROORGANISMS; IN-SITU; DEHALOGENATION; IDENTIFICATION; POPULATION; SOILS; META; PCBS	Microbial reductive dechlorination of the persistent polychlorinated biphenyls (PCBs) is attracting much attention in cleanup of the contaminated environment. Nevertheless, most PCB dechlorinating cultures require presence of sediment or sediment substitutes to maintain their dechlorination activities which hinders subsequent bacterial enrichment and isolation processes. The information on enriching sediment-free PCB dechlorinating cultures is still limited. In this study, 18 microcosms established with soils and sediments were screened for their dechlorination activities on a PCB mixture Aroclor 1260. After one year of incubation, 10 out of 18 microcosms showed significant PCB dechlorination with distinct dechlorination patterns (e.g., Process H, N and T classified based on profiles of PCB congeners loss and new congeners formation). Through serial transfers in defined medium, six sediment-free PCB dechlorinating cultures (i.e., CW-4, CG-1, CG-3, CG-4, CG-5 and SG-1) were obtained without amending any sediment or sediment-substitutes. PCB dechlorination Process H was the most frequently observed dechlorination pattern, which was found in four sediment-free cultures (CW-4, CG-3, CG-4 and SG-1). Sediment-free culture CG-5 showed the most extensive PCB dechlorination among the six cultures, which was mediated by Process N, resulting in the accumulation of penta-(e.g., 236-24-CB) and tetra-chlorobiphenyls (tetra-CBs) (e.g., 24-24-CB, 24-25-CB, 24-26-CB and 25-26-CB) via dechlorinating 30.44% hepta-CBs and 59.12% hexa-CBs after three months of incubation. For culture CG-1, dechlorinators mainly attacked double flanked meta-chlorines and partially ortho-chlorines, which might represent a novel dechlorination pattern. Phylogenetic analysis showed distinct affiliation of PCB dechlorinators in the microcosms, including Dehalogenimonas and Dehalococcoides species. This study broadens our knowledge in microbial reductive dechlorination of PCBs, and provides essential information for culturing and stimulating PCB dechlorinators for in situ bioremediation applications.	[Wang, Shanquan; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117548, Singapore.	jianzhong.he@nus.edu.sg	He, Jianzhong/J-2704-2018; WANG, Shanquan/Q-6455-2017	He, Jianzhong/0000-0003-1895-6628; WANG, Shanquan (Alan)/0000-0002-8491-9633; WANG, Shanquan/0000-0002-5880-5894	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project number 102 101 0025 (http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2009, APPL ENVIRON MICROB, V75, P4516, DOI 10.1128/AEM.00102-09; Agency for Toxic Substances and Disease Registry (ATSDR), 2000, TOX PROF POL BIPH UP; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bedard DL, 2006, APPL ENVIRON MICROB, V72, P2460, DOI 10.1128/AEM.72.4.2460-2470.2006; Bedard DL, 2003, DEHALOGENATION: MICROBIAL PROCESSES AND ENVIRONMENTAL APPLICATIONS, P443; Bedard DL, 1996, ENVIRON SCI TECHNOL, V30, P237, DOI 10.1021/es950262e; Bedard DL, 1998, APPL ENVIRON MICROB, V64, P1786; Bedard DL, 2008, ANNU REV MICROBIOL, V62, P253, DOI 10.1146/annurev.micro.62.081307.162733; Bedard DL, 2007, APPL ENVIRON MICROB, V73, P2513, DOI 10.1128/AEM.02909-06; Bedard Donna L., 1997, Environmental Science and Technology, V31, P3308, DOI 10.1021/es9703483; Berkaw M, 1996, APPL ENVIRON MICROB, V62, P2534, DOI 10.1128/AEM.62.7.2534-2539.1996; Beyer A, 2009, REV ENVIRON CONTAM T, V201, P137, DOI 10.1007/978-1-4419-0032-6_5; BOYLE AW, 1993, APPL ENVIRON MICROB, V59, P3027, DOI 10.1128/AEM.59.9.3027-3031.1993; BROWN J F JR, 1984, Northeastern Environmental Science, V3, P167; BROWN JF, 1990, ENVIRON TOXICOL CHEM, V9, P1215, DOI 10.1002/etc.5620091001; BROWN JF, 1987, SCIENCE, V236, P709, DOI 10.1126/science.236.4802.709; Chen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030862; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Chu SG, 2004, ANAL CHEM, V76, P5486, DOI 10.1021/ac049526i; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLE JR, 1994, APPL ENVIRON MICROB, V60, P3536, DOI 10.1128/AEM.60.10.3536-3542.1994; Cutter L, 1998, APPL ENVIRON MICROB, V64, P2966; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; Davis JA, 2007, ENVIRON RES, V105, P67, DOI 10.1016/j.envres.2007.01.013; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Ding C, 2013, APPL ENVIRON MICROB, V79, P1110, DOI 10.1128/AEM.02919-12; Ding C, 2012, MICROB BIOTECHNOL, V5, P347, DOI 10.1111/j.1751-7915.2011.00313.x; Fagervold SK, 2007, APPL ENVIRON MICROB, V73, P3009, DOI 10.1128/AEM.02958-06; Fennell DE, 2004, ENVIRON SCI TECHNOL, V38, P2075, DOI 10.1021/es034989b; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; Gomes HI, 2013, SCI TOTAL ENVIRON, V445, P237, DOI 10.1016/j.scitotenv.2012.11.098; Grimalt JO, 2004, CHEMOSPHERE, V54, P1549, DOI 10.1016/j.chemosphere.2003.09.047; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HartkampCommandeur LCM, 1996, CHEMOSPHERE, V32, P1275, DOI 10.1016/0045-6535(96)00039-2; He JZ, 2006, ENVIRON SCI TECHNOL, V40, P4429, DOI 10.1021/es052508d; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Loffler FE, 1997, APPL ENVIRON MICROB, V63, P2870, DOI 10.1128/AEM.63.7.2870-2875.1997; Loffler FE, 2006, CURR OPIN BIOTECH, V17, P274, DOI 10.1016/j.copbio.2006.05.001; May HD, 2008, APPL ENVIRON MICROB, V74, P2089, DOI 10.1128/AEM.01450-07; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Payne RB, 2011, ENVIRON SCI TECHNOL, V45, P8772, DOI 10.1021/es201553c; QUENSEN JF, 1988, SCIENCE, V242, P752, DOI 10.1126/science.242.4879.752; QUENSEN JF, 1990, APPL ENVIRON MICROB, V56, P2360, DOI 10.1128/AEM.56.8.2360-2369.1990; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Smullen LA, 1993, DEV CUSTOMIZED CONGE, P45; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANDORT HM, 1991, APPL ENVIRON MICROB, V57, P1576, DOI 10.1128/AEM.57.5.1576-1578.1991; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang SQ, 2012, APPL MICROBIOL BIOT, V95, P1305, DOI 10.1007/s00253-012-4251-5; Weber R, 2000, ENVIRON SCI POLLUT R, V15, P363; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; Wu QZ, 2002, APPL ENVIRON MICROB, V68, P807, DOI 10.1128/AEM.68.2.807-812.2002; Wu QZ, 1997, APPL ENVIRON MICROB, V63, P4826, DOI 10.1128/AEM.63.12.4826-4832.1997; Wu QZ, 1998, APPL ENVIRON MICROB, V64, P1052; Wu QZ, 2000, APPL ENVIRON MICROB, V66, P49, DOI 10.1128/AEM.66.1.49-53.2000; Wu QZ, 1997, APPL ENVIRON MICROB, V63, P4818, DOI 10.1128/AEM.63.12.4818-4825.1997; Xing Y, 2005, CHEMOSPHERE, V60, P731, DOI 10.1016/j.chemosphere.2005.05.001; Yan J, 2009, ENVIRON MICROBIOL, V11, P833, DOI 10.1111/j.1462-2920.2008.01804.x; Yan J, 2009, APPL ENVIRON MICROB, V75, P7560, DOI 10.1128/AEM.01938-09; Ye L, 2011, ENVIRON SCI TECHNOL, V45, P7173, DOI 10.1021/es201045e; Yoshida N, 2009, APPL ENVIRON MICROB, V75, P2400, DOI 10.1128/AEM.02112-08; Zanaroli G, 2012, J HAZARD MATER, V209, P449, DOI 10.1016/j.jhazmat.2012.01.042	63	61	62	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59178	10.1371/journal.pone.0059178	http://dx.doi.org/10.1371/journal.pone.0059178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554991	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800066
J	Fasawe, O; Avila, C; Shaffer, N; Schouten, E; Chimbwandira, F; Hoos, D; Nakakeeto, O; De Lay, P				Fasawe, Olufunke; Avila, Carlos; Shaffer, Nathan; Schouten, Erik; Chimbwandira, Frank; Hoos, David; Nakakeeto, Olive; De Lay, Paul			Cost-Effectiveness Analysis of Option B plus for HIV Prevention and Treatment of Mothers and Children in Malawi	PLOS ONE			English	Article							T-CELL COUNT; ANTIRETROVIRAL THERAPY; TRANSMISSION; MORBIDITY; MORTALITY; INFECTION; ADHERENCE; DECLINE; HAART; START	Background: The Ministry of Health in Malawi is implementing a pragmatic and innovative approach for the management of all HIV-infected pregnant women, termed Option B+, which consists of providing life-long antiretroviral treatment, regardless of their CD4 count or clinical stage. Our objective was to determine if Option B+ represents a cost-effective option. Methods: A decision model simulates the disease progression of a cohort of HIV-infected pregnant women receiving prophylaxis and antiretroviral therapy, and estimates the number of paediatric infections averted and maternal life years gained over a ten-year time horizon. We assess the cost-effectiveness from the Ministry of Health perspective while taking into account the practical realities of implementing ART services in Malawi. Results: If implemented as recommended by the World Health Organization, options A, B and B+ are equivalent in preventing new infant infections, yielding cost effectiveness ratios between US$ 37 and US$ 69 per disability adjusted life year averted in children. However, when the three options are compared to the current practice, the provision of antiretroviral therapy to all mothers (Option B+) not only prevents infant infections, but also improves the ten-year survival in mothers more than four-fold. This translates into saving more than 250,000 maternal life years, as compared to mothers receiving only Option A or B, with savings of 153,000 and 172,000 life years respectively. Option B+ also yields favourable incremental cost effectiveness ratios (ICER) of US$ 455 per life year gained over the current practice. Conclusion: In Malawi, Option B+ represents a favorable policy option from a cost-effectiveness perspective to prevent future infant infections, save mothers' lives and reduce orphanhood. Although Option B+ would require more financial resources initially, it would save societal resources in the long-term and represents a strategic option to simplify and integrate HIV services into maternal, newborn and child health programmes.	[Fasawe, Olufunke] SDA Bocconi Sch Management, Econ & Policy Program, Milan, Italy; [Avila, Carlos] Abt Associates Inc, Bethesda, MD 20814 USA; [Shaffer, Nathan] WHO, HIV Dept, PMTCT, CH-1211 Geneva, Switzerland; [Schouten, Erik] Management Sci Hlth, Lilongwe, Malawi; [Chimbwandira, Frank] Minist Hlth, HIV & AIDS Dept, Lilongwe, Malawi; [Hoos, David] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [De Lay, Paul] Joint United Nations Programme HIV AIDS UNAIDS, Geneva, Switzerland	Bocconi University; ABT Associates; World Health Organization; Columbia University; UNAIDS	Avila, C (corresponding author), Abt Associates Inc, Bethesda, MD 20814 USA.	Carlos_Avila@abtassoc.com						[Anonymous], 2011, GUID US ANT AG HIV 1; [Anonymous], 2020, HIGH POSS COST COVID; Athan E, 2010, AIDS, V24, P1887, DOI 10.1097/QAD.0b013e32833b25ed; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Currier JS, 2000, J ACQ IMMUN DEF SYND, V24, P316; Ekouevi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043750; Fox Rushby JA, 2011, HLTH POLICY PLAN, V16, P326; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hirnschall G, 2011, LANCET, V378, P209, DOI 10.1016/S0140-6736(11)60247-X; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Johansson KA, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-3; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; LONGINI IM, 1991, J ACQ IMMUN DEF SYND, V4, P1141; Mauskopf J, 2000, Value Health, V3, P287, DOI 10.1046/j.1524-4733.2000.34006.x; Mauskopf J, 2005, JAIDS-J ACQ IMM DEF, V39, P562; Mauskopf J, 1998, AM J MANAG CARE, V4, P1004; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; McKenna MT, 2007, AM J OBSTET GYNECOL, V197, pS10, DOI 10.1016/j.ajog.2007.02.032; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Health Malawi, 2010, 18 INT AIDS C VIENN; Ministry of Health of Malawi, 2010, Q HIV PROGR REP; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Mussini C, 2011, AIDS, V25, P1041, DOI 10.1097/QAD.0b013e3283463ec5; [National Statistical Office Zomba Malawi ICF Macro Calverton Maryland USA], 2011, MAL DEM HLTH SURV 20; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Sansom SL, 2006, JAIDS-J ACQ IMM DEF, V41, P521, DOI 10.1097/01.qai.0000191286.70331.7b; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Stevens W, 2008, Open AIDS J, V2, P17, DOI 10.2174/1874613600802010017; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2011, OUTL REP 30 YEARS AI; UNAIDS, 2011, EXP GROUP VERT TRANS; UNDP, MILL DEV GOALS 4 5 6; UNICEF, 2010, COTR PROPH HIV EXP H; WHO, 2012, US ANT DRUGS TREAT P; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2010, T PRIC ANT MED HIV D; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2001, COMM MACR HLTH INV H; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	51	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57778	10.1371/journal.pone.0057778	http://dx.doi.org/10.1371/journal.pone.0057778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554867	gold, Green Submitted, Green Published			2022-12-27	WOS:000316252500007
J	Tomita, N; Hattori, T; Itoh, S; Aoyama, E; Yao, M; Yamashiro, T; Takigawa, M				Tomita, Nao; Hattori, Takako; Itoh, Shinsuke; Aoyama, Eriko; Yao, Mayumi; Yamashiro, Takashi; Takigawa, Masaharu			Cartilage-Specific Over-Expression of CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Stimulates Insulin-Like Growth Factor Expression and Bone Growth	PLOS ONE			English	Article							CHONDROCYTE-SPECIFIC GENE; VASCULAR ENDOTHELIAL-CELLS; ANGIOGENESIS IN-VIVO; TRANSGENIC MICE; INTEGRIN ALPHA(V)BETA(3); CONSTITUTIVE ACTIVATION; SKELETAL GROWTH; PROLIFERATION; DIFFERENTIATION; CTGF/HCS24	Previously we showed that CCN family member 2/connective tissue growth factor (CCN2) promotes the proliferation, differentiation, and maturation of growth cartilage cells in vitro. To elucidate the specific role and molecular mechanism of CCN2 in cartilage development in vivo, in the present study we generated transgenic mice overexpressing CCN2 and analyzed them with respect to cartilage and bone development. Transgenic mice were generated expressing a ccn2/lacZ fusion gene in cartilage under the control of the 6 kb-Col2a1-enhancer/promoter. Changes in cartilage and bone development were analyzed histologically and immunohistologically and also by micro CT. Primary chondrocytes as well as limb bud mesenchymal cells were cultured and analyzed for changes in expression of cartilage-related genes, and non-transgenic chondrocytes were treated in culture with recombinant CCN2. Newborn transgenic mice showed extended length of their long bones, increased content of proteoglycans and collagen II accumulation. Micro-CT analysis of transgenic bones indicated increases in bone thickness and mineral density. Chondrocyte proliferation was enhanced in the transgenic cartilage. In in vitro short-term cultures of transgenic chondrocytes, the expression of col2a1, aggrecan and ccn2 genes was substantially enhanced; and in long-term cultures the expression levels of these genes were further enhanced. Also, in vitro chondrogenesis was strongly enhanced. IGF-I and IGF-II mRNA levels were elevated in transgenic chondrocytes, and treatment of non-transgenic chondrocytes with recombinant CCN2 stimulated the expression of these mRNA. The addition of CCN2 to non-transgenic chondrocytes induced the phosphorylation of IGFR, and ccn2-overexpressing chondrocytes showed enhanced phosphorylation of IGFR. Our data indicates that the observed effects of CCN2 may be mediated in part by CCN2-induced overexpression of IGF-I and IGF-II. These findings indicate that CCN2-overexpression in transgenic mice accelerated the endochondral ossification processes, resulting in increased length of their long bones. Our results also indicate the possible involvement of locally enhanced IGF-I or IGF-II in this extended bone growth.	[Tomita, Nao; Hattori, Takako; Itoh, Shinsuke; Yao, Mayumi; Takigawa, Masaharu] Okayama Univ, Sch Dent, Dept Biochem & Mol Dent, Okayama 700, Japan; [Tomita, Nao; Itoh, Shinsuke; Yamashiro, Takashi] Okayama Univ, Sch Dent, Dept Orthodont, Grad Sch Med Dent & Pharmaceut Sci, Okayama 700, Japan; [Aoyama, Eriko; Takigawa, Masaharu] Okayama Univ, Sch Dent, Biodent Res Ctr, Okayama 700, Japan	Okayama University; Okayama University; Okayama University	Hattori, T (corresponding author), Okayama Univ, Sch Dent, Dept Biochem & Mol Dent, Okayama 700, Japan.	hattorit@md.okayama-u.ac.jp; takigawa@md.okayama-u.ac.jp	Yamashiro, Takashi/Y-6411-2019; Yamashiro, Takashi/S-6010-2019	Yamashiro, Takashi/0000-0002-4419-9643	Japan Society for the Promotion of Science; Okayama University; Senri Life Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okayama University; Senri Life Science Foundation	This work was supported by the program Grants-in-Aid for Scientific Research (C) to TH and (S) to MT and Exploratory Research (to MT) from the Japan Society for the Promotion of Science and by internal grants from Okayama University (to TH) and by a grant from Senri Life Science Foundation (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SO, 1983, NATURE, V302, P150, DOI 10.1038/302150a0; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boos N, 1999, J ORTHOPAED RES, V17, P495, DOI 10.1002/jor.1100170406; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Fujisawa T, 2008, OSTEOARTHRITIS CARTI; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hattori T, 1998, BIOCHEM BIOPH RES CO, V245, P679, DOI 10.1006/bbrc.1998.8505; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hoeflich A., 2007, Archives of Physiology and Biochemistry, V113, P142, DOI 10.1080/13813450701531193; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA277; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LUND PK, 1986, J BIOL CHEM, V261, P4539; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SCHMID C, 1995, CELL BIOL INT, V19, P445, DOI 10.1006/cbir.1995.1088; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Shimo T, 1998, J BIOCHEM-TOKYO, V124, P130, DOI 10.1093/oxfordjournals.jbchem.a022071; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Takigawa M, 1997, ENDOCRINOLOGY, V138, P4390, DOI 10.1210/en.138.10.4390; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Takigawa M, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P19, DOI 10.1142/9781860946899_0002; Twigg SM, 2002, ENDOCRINOLOGY, V143, P4907, DOI 10.1210/en.2002-220619; VETTER U, 1985, GROWTH, V49, P229; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103	44	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59226	10.1371/journal.pone.0059226	http://dx.doi.org/10.1371/journal.pone.0059226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555635	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200016
J	Bottino, MC; Rosario, S; Grativol, C; Thiebaut, F; Rojas, CA; Farrineli, L; Hemerly, AS; Ferreira, PCG				Bottino, Mariana Carnavale; Rosario, Sabrina; Grativol, Clicia; Thiebaut, Flavia; Rojas, Cristian Antonio; Farrineli, Laurent; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti			High-Throughput Sequencing of Small RNA Transcriptome Reveals Salt Stress Regulated MicroRNAs in Sugarcane	PLOS ONE			English	Article							GENE-EXPRESSION; COMPUTATIONAL IDENTIFICATION; RESPONSIVE MICRORNAS; ARABIDOPSIS; FAMILY; ROOTS; HOMEOSTASIS; ARGONAUTE1; TARGETS; MIRNAS	Salt stress is a primary cause of crop losses worldwide, and it has been the subject of intense investigation to unravel the complex mechanisms responsible for salinity tolerance. MicroRNA is implicated in many developmental processes and in responses to various abiotic stresses, playing pivotal roles in plant adaptation. Deep sequencing technology was chosen to determine the small RNA transcriptome of Saccharum sp cultivars grown on saline conditions. We constructed four small RNAs libraries prepared from plants grown on hydroponic culture submitted to 170 mM NaCl and harvested after 1 h, 6 hs and 24 hs. Each library was sequenced individually and together generated more than 50 million short reads. Ninety-eight conserved miRNAs and 33 miRNAs* were identified by bioinformatics. Several of the microRNA showed considerable differences of expression in the four libraries. To confirm the results of the bioinformatics-based analysis, we studied the expression of the 10 most abundant miRNAs and 1 miRNA* in Plants treated with 170 mM NaCl and in Plants with a severe treatment of 340 mM NaCl. The results showed that 11 selected miRNAs had higher expression in samples treated with severe salt treatment compared to the mild one. We also investigated the regulation of the same miRNAs in shoots of four cultivars grown on soil treated with 170 mM NaCl. Cultivars could be grouped according to miRNAs expression in response to salt stress. Furthermore, the majority of the predicted target genes had an inverse regulation with their correspondent microRNAs. The targets encode a wide range of proteins, including transcription factors, metabolic enzymes and genes involved in hormone signaling, probably assisting the plants to develop tolerance to salinity. Our work provides insights into the regulatory functions of miRNAs, thereby expanding our knowledge on potential salt-stressed regulated genes.	[Bottino, Mariana Carnavale; Rosario, Sabrina; Grativol, Clicia; Thiebaut, Flavia; Hemerly, Adriana Silva; Gomes Ferreira, Paulo Cavalcanti] Univ Fed Rio de Janeiro, Lab Biol Mol Plantas, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian Antonio] Univ Fed Integracao Latinoamer, Foz Do Iguacu, PR, Brazil; [Farrineli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana	Ferreira, PCG (corresponding author), Univ Fed Rio de Janeiro, Lab Biol Mol Plantas, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.	paulof@bioqmed.ufrj.br	Ferreira, Paulo C G/I-2836-2015; Thiebaut, Flavia/AAU-5318-2021; Thiebaut, Flavia/B-3867-2018; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Thiebaut, Flavia/0000-0002-8833-1722; Rojas, Cristian/0000-0002-9085-6261; Grativol, Clicia/0000-0002-8873-701X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors are grateful to Centro de Tecnologia Canavieira (CTC) for providing plant material from the drought experiment. Research is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Fixacao Biologica de Nitrogenio (INCT), Financiadora de Estudos e Projetos (FINEP), Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Agarwal PK, 2012, MOL BIOTECHNOL; Azevedo R. A., 2011, Tropical Plant Biology, V4, P42, DOI 10.1007/s12042-011-9067-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Esteves BS, 2008, OECOL BRAS, V4, P662, DOI DOI 10.4257/0EC0.2008.1204.06; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; Jeong DH, 2010, METHODS MOL BIOL, V592, P203, DOI 10.1007/978-1-60327-005-2_14; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Lu C, 2010, METHODS MOL BIOL, V592, P107, DOI 10.1007/978-1-60327-005-2_8; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nogueira FTS, 2005, PLANT SCI, V169, P93, DOI 10.1016/j.plantsci.2005.03.008; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pagariya MC, 2012, PLANT SCI, V184, P1, DOI 10.1016/j.plantsci.2011.12.002; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Schreiber L, 1999, J EXP BOT, V50, P1267, DOI 10.1093/jexbot/50.337.1267; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suprasanna P, 2011, SUGAR TECH, V13, P322, DOI 10.1007/s12355-011-0103-3; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Watt DA, 2003, J EXP BOT, V54, P1163, DOI 10.1093/jxb/erg128; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yao DX, 2011, GENOMICS, V98, P47, DOI 10.1016/j.ygeno.2011.04.007; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang DF, 2008, PLANT SCI, V175, P809, DOI 10.1016/j.plantsci.2008.08.002; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang L, 2011, GENOMICS, V98, P460, DOI 10.1016/j.ygeno.2011.08.005; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	57	85	88	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59423	10.1371/journal.pone.0059423	http://dx.doi.org/10.1371/journal.pone.0059423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544066	Green Published, gold			2022-12-27	WOS:000317480700028
J	Chen, MH; Su, TP; Li, CT; Chang, WH; Chen, TJ; Bai, YM				Chen, Mu-Hong; Su, Tung-Ping; Li, Cheng-Ta; Chang, Wen-Han; Chen, Tzeng-Ji; Bai, Ya-Mei			Symptomatic Menopausal Transition Increases the Risk of New-Onset Depressive Disorder in Later Life: A Nationwide Prospective Cohort Study in Taiwan	PLOS ONE			English	Article							MIDLIFE WOMENS HEALTH; CHRONIC HEPATITIS-C; METABOLIC SYNDROME; CARDIOVASCULAR RISK; EARLY POSTMENOPAUSE; ASSOCIATION; HORMONES; MOOD; PREDICTORS; DISEASE	Introduction:The role of the menopausal transition and associated menopausal symptoms in the occurrence of depressive disorders has been discussed and debated for a long time. Most previous clinical studies had limited case samples, and did not control the attributable risk of medical comorbidities. Methods: Patients with a diagnosis of symptomatic menopausal transition and without a psychiatric history were enrolled in 2000 in Taiwan, and compared with age-matched controls (1:4). These subjects were followed to the end of 2010 to investigate the association between symptomatic menopausal transition and new-onset depressive disorder; the effect of medical comorbidities was also assessed. Results: A total of 5,837 women with symptomatic menopausal transition were identified, and compared with 23,348 age-matched controls in 2000. The follow-up showed that symptomatic menopausal transition was an independent risk factor for major depression (hazard ratio[HR]: 2.18, 95%CI: 1.79 similar to 2.65) and any depressive disorder (HR: 2.34, 95%CI: 2.08 similar to 2.63) after adjusting age at enrollment, monthly income, residence location, level of urbanization, and comorbid medical diseases. In addition, medical comorbidities, including cerebrovascular disease (HR: 1.77, 95% CI: 1.52 similar to 2.07), cardiovascular diseases (HR: 1.35, 95% CI: 1.15 similar to 1.57), congestive heart failure (HR: 1.35, 95% CI: 1.04 similar to 1.75), and liver diseases (HR: 1.19, 95% CI: 1.03 similar to 1.36) increased the risk of developing any depressive disorder. Conclusion:Our population cohort study, with the largest study sample and medical record diagnosis thus far, supports an association between symptomatic menopausal transition and depressive disorder in midlife women, and an increased risk of depressive disorder with medical comorbidities.	[Chen, Mu-Hong; Su, Tung-Ping; Li, Cheng-Ta; Chang, Wen-Han; Bai, Ya-Mei] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Su, Tung-Ping; Bai, Ya-Mei] Natl Yang Ming Univ, Coll Med, Dept Psychiat, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Li, Cheng-Ta] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Bai, YM (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	ymbi@mail2000.com.tw	Li, Cheng-Ta/AAI-5759-2021; Chen, TJ/AAH-8430-2021; Chen, MuHong/ACJ-6131-2022	Li, Cheng-Ta/0000-0002-0670-1153; Chen, MuHong/0000-0001-6516-1073	Taipei Veterans General Hospital [V101D-001-1]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The study was supported by a grant from Taipei Veterans General Hospital (V101D-001-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri M, 2012, EUR J NEUROL, V19, P517, DOI 10.1111/j.1468-1331.2011.03583.x; Avis Nancy E., 1994, Annals of Epidemiology, V4, P214; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; Bromberger JT, 2011, PSYCHOL MED, V41, P1879, DOI 10.1017/S003329171100016X; Bromberger JT, 2009, PSYCHOL MED, V39, P55, DOI 10.1017/S0033291708003218; Bromberger JT, 2007, J AFFECT DISORDERS, V103, P267, DOI 10.1016/j.jad.2007.01.034; Bromberger JT, 2010, ARCH GEN PSYCHIAT, V67, P598, DOI 10.1001/archgenpsychiatry.2010.55; Bromberger JT, 2006, EVID-BASED MENT HEAL, V9, P110, DOI 10.1136/ebmh.9.4.110; Carta MG, 2012, J AFFECT DISORDERS, V141, P361, DOI 10.1016/j.jad.2012.03.020; Chae CU, 2011, OBSTET GYN CLIN N AM, V38, P477, DOI 10.1016/j.ogc.2011.05.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Cohen LS, 2006, ARCH GEN PSYCHIAT, V63, P385, DOI 10.1001/archpsyc.63.4.385; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elwing JE, 2006, PSYCHOSOM MED, V68, P563, DOI 10.1097/01.psy.0000221276.17823.df; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Frey Benicio N, 2008, Menopause Int, V14, P123, DOI 10.1258/mi.2008.008019; GOEMAERE S, 1990, J RHEUMATOL, V17, P1620; Graziottin Alessandra, 2009, Menopause Int, V15, P76, DOI 10.1258/mi.2009.009021; GREENDALE GA, 1993, J AM GERIATR SOC, V41, P426, DOI 10.1111/j.1532-5415.1993.tb06953.x; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Janssen I, 2008, ARCH INTERN MED, V168, P1568, DOI 10.1001/archinte.168.14.1568; Kaufert PA, 2008, MATURITAS, V61, P54, DOI 10.1016/j.maturitas.2008.09.009; Kok HS, 2006, J AM COLL CARDIOL, V47, P1976, DOI 10.1016/j.jacc.2005.12.066; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Lin HL, 2013, CLIMACTERIC, V16, P381, DOI 10.3109/13697137.2012.707706; Lisabeth L, 2012, LANCET NEUROL, V11, P82, DOI 10.1016/S1474-4422(11)70269-1; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Marsh W BJ, 2011, N AM MEN SOC 22 ANN; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; Mishra GD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e402; Morrison MF, 2011, ARCH WOMEN MENT HLTH, V14, P375, DOI 10.1007/s00737-011-0231-5; Morrison MF, 2001, BIOL PSYCHIAT, V50, P705, DOI 10.1016/S0006-3223(01)01169-6; National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms, 2005, ANN INTERN MED 1, V142, P1003; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; NIH State of the Science, 2005, NIH CONSENS STATE SC, V22, P1; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Ryan J, 2009, MENOPAUSE, V16, P509, DOI 10.1097/gme.0b013e31818d635f; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; Schmidt PJ, 2009, ANN NY ACAD SCI, V1179, P70, DOI 10.1111/j.1749-6632.2009.04982.x; Schmidt PJ, 2002, PSYCHONEUROENDOCRINO, V27, P907, DOI 10.1016/S0306-4530(02)00004-5; Siseles N, 2010, GYNECOL ENDOCRINOL, V26, P1, DOI 10.3109/09513590903080969; Vesco KK, 2007, CLIMACTERIC, V10, P448, DOI 10.1080/13697130701611267; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; Weinstein AA, 2011, PSYCHOSOMATICS, V52, P127, DOI 10.1016/j.psym.2010.12.019; Wise LA, 2002, J EPIDEMIOL COMMUN H, V56, P851, DOI 10.1136/jech.56.11.851; Woodard GA, 2011, MENOPAUSE, V18, P376, DOI 10.1097/gme.0b013e3181f6480e; Woods NF, 2008, MENOPAUSE, V15, P223, DOI 10.1097/gme.0b013e3181450fc2; Woods NF, 2007, J WOMENS HEALTH, V16, P667, DOI 10.1089/jwh.2006.0138; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Zuidersma M, 2012, PSYCHOL MED, V42, P683, DOI 10.1017/S0033291711001784	52	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59899	10.1371/journal.pone.0059899	http://dx.doi.org/10.1371/journal.pone.0059899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544108	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700068
J	Ferguson, AR; Irvine, KA; Gensel, JC; Nielson, JL; Lin, A; Ly, J; Segal, MR; Ratan, RR; Bresnahan, JC; Beattie, MS				Ferguson, Adam R.; Irvine, Karen-Amanda; Gensel, John C.; Nielson, Jessica L.; Lin, Amity; Ly, Johnathan; Segal, Mark R.; Ratan, Rajiv R.; Bresnahan, Jacqueline C.; Beattie, Michael S.			Derivation of Multivariate Syndromic Outcome Metrics for Consistent Testing across Multiple Models of Cervical Spinal Cord Injury in Rats	PLOS ONE			English	Article							NOGO-66 RECEPTOR ANTAGONIST; DELAYED TRANSPLANTATION; NEUROPROTECTIVE AGENT; LOCOMOTOR RECOVERY; CONTUSION; REASSESSMENT; METHYLPREDNISOLONE; MINOCYCLINE; AXONS; ERYTHROPOIETIN	Spinal cord injury (SCI) and other neurological disorders involve complex biological and functional change characterized preclinical models provide a powerful tool for understanding mechanisms of disease; however managing information produced by experimental models represents a significant challenge for translating findings across research projects and presents a substantial hurdle for translation of novel therapies to humans. In the present work we demonstrate a novel 'syndromic' information-processing approach for capitalizing on heterogeneous data from diverse preclinical models of SCI to discover translational outcomes for therapeutic testing. We first built a large, detailed repository of preclinical outcome data from 10 years of basic research on cervical SCI in rats, and then applied multivariate pattern detection techniques to extract features that are conserved across different injury models. We then applied this translational knowledge to derive a data-driven multivariate metric that provides a common 'ruler' for comparisons of outcomes across different types of injury (NYU/MASCIS weight drop injuries, Infinite Horizons (IH) injuries, and hemisection injuries). The findings revealed that each individual endpoint provides a different view of the SCI syndrome, and that considering any single outcome measure in isolation provides a misleading incomplete view of the SCI syndrome This limitation was overcome by taking a novel multivariate integrative approach for leveraging complex data from Preclinical models of neurological disease to identify therapies that target multiple outcomes. We suggest that applying this syndromic approach provides a roadmap for translating therapies for SCI and other complex neurological diseases.	[Ferguson, Adam R.; Nielson, Jessica L.; Lin, Amity; Ly, Johnathan; Bresnahan, Jacqueline C.; Beattie, Michael S.] Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA 94143 USA; [Irvine, Karen-Amanda] Stanford Univ, Dept Comparat Med, Palo Alto, CA 94304 USA; [Gensel, John C.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Dept Physiol, Lexington, KY USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Ctr Bioinformat & Mol Biostat, San Francisco, CA 94143 USA; [Ratan, Rajiv R.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Cornell Med Res Inst, White Plains, NY USA	University of California System; University of California San Francisco; Stanford University; University of Kentucky; University of California System; University of California San Francisco; Cornell University	Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA 94143 USA.	adam.ferguson@ucsf.edu; michael.beattie@ucsf.edu	Irvine, Karen-amanda/AFG-7716-2022; Irvine, Karen-amanda/AAF-1717-2022	Irvine, Karen-amanda/0000-0001-5259-1824; Irvine, Karen-amanda/0000-0001-5259-1824; , John/0000-0001-8980-108X; Nielson, Jessica/0000-0002-3677-3959; Ferguson, Adam/0000-0001-7102-1608	National Institutes of Health [NS067092, NS069537, NS038079, NS031193, AG032518, F32NS079030]; NYSCoRE [CO19772]; Wings for Life Foundation [WFLUS008/12]; Craig H. Neilsen Foundation [224308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS079030, R01NS067092, R01NS069537, R01NS038079, R01NS031193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032518, P01AG014930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSCoRE; Wings for Life Foundation; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants NS067092 (ARF), NS069537 (ARF), NS038079 (JCB and MSB), NS031193 (MSB and JCB), AG032518 (MSB and JCB), F32NS079030 (JLN); NYSCoRE CO19772 (MSB and JCB); Wings for Life Foundation grant WFLUS008/12 (ARF); and Craig H. Neilsen Foundation Grant 224308 (ARF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN CS, 1991, PHYSIOL BEHAV, V50, P263, DOI 10.1016/0031-9384(91)90065-V; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Biering-Sorensen F, 2011, SPINAL CORD, V49, P60, DOI 10.1038/sc.2010.90; Biering-Sorensen Fin, 2012, Top Spinal Cord Inj Rehabil, V18, P23; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Gensel JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033519; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/neu.2004.21.1795; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; GUADAGNOLI E, 1991, MULTIVAR BEHAV RES, V26, P323, DOI 10.1207/s15327906mbr2602_7; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hastie T, 2009, ELEMENTS STAT LEARNI; Hook MA, 2004, J NEUROTRAUM, V21, P109, DOI 10.1089/089771504772695995; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; KORTH B, 1976, PSYCHOMETRIKA, V41, P531, DOI 10.1007/BF02296973; Lee JHT, 2012, JOVE-J VIS EXP, DOI 10.3791/3313; Li SX, 2003, J NEUROSCI, V23, P4219; Liu Y, 1999, J NEUROSCI, V19, P4370; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Sharp K, 2010, EXP NEUROL; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Young W, 2002, PROG BRAIN RES, V137, P231	64	63	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59712	10.1371/journal.pone.0059712	http://dx.doi.org/10.1371/journal.pone.0059712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544088	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700048
J	Guloksuz, S; Wichers, M; Kenis, G; Russel, MGVM; Wauters, A; Verkerk, R; Arts, B; van Os, J				Guloksuz, Sinan; Wichers, Marieke; Kenis, Gunter; Russel, Maurice G. V. M.; Wauters, Annick; Verkerk, Robert; Arts, Baer; van os, Jim			Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability	PLOS ONE			English	Article							QUALITY-OF-LIFE; INFLAMMATORY-BOWEL-DISEASE; ALPHA THERAPY; CYTOKINES; PATHOPHYSIOLOGY; ASSOCIATION; HYPOTHESIS; SYSTEM; IDO; QUESTIONNAIRE	Crohn's disease (CD) is associated with immune activation and depressive symptoms. This study determines the impact of anti-tumor necrosis factor (TNF)-alpha treatment in CD patients on depressive symptoms and the degree to which tryptophan (TRP) availability and immune markers mediate this effect. Fifteen patients with CD, eligible for anti-TNF-alpha treatment were recruited. Disease activity (Harvey-Bradshaw Index (HBI), Crohn's Disease Activity Index (CDAI)), fatigue (Multidimensional Fatigue Inventory (MFI)), quality of life (Inflammatory Bowel Disease Questionnaire (IBDQ)), symptoms of depression and anxiety (Symptom Checklist (SCL-90), Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HDRS)), immune activation (acute phase proteins (APP)), zinc and TRP availability were assessed before treatment and after 2, 4 and 8 weeks. Anti-TNF-alpha increased IBDQ scores and reduced all depression scores; however only SCL-90 depression scores remained decreased after correction for HBI. Positive APPs decreased, while negative APPs increased after treatment. After correction for HBI, both level and percentage of gamma fraction were associated with SCL-90 depression scores over time. After correction for HBI, patients with current/past depressive disorder displayed higher levels of positive APPs and lower levels of negative APPs and zinc. TRP availability remained invariant over time and there was no association between SCL-90 depression scores and TRP availability. Inflammatory reactions in CD are more evident in patients with comorbid depression, regardless of disease activity. Anti-TNF-alpha treatment in CD reduces depressive symptoms, in part independently of disease activity; there was no evidence that this effect was mediated by immune-induced changes in TRP availability.	[Guloksuz, Sinan; Wichers, Marieke; Kenis, Gunter; Arts, Baer; van os, Jim] Maastricht Univ Med Ctr, EURON, Dept Psychiat & Psychol, Maastricht, Netherlands; [Russel, Maurice G. V. M.] Med Spectrum Twente, Dept Gastroenterol & Hepatol, Enschede, Netherlands; [Wauters, Annick] ZNA Middelheim, Lab Clin Biol, Antwerp, Belgium; [Verkerk, Robert] Univ Antwerp, Med Biochem Lab, Antwerp, Belgium; [van os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Maastricht University Medical Centre (MUMC); Medical Spectrum Twente; ZNA Middelheim Hospital; University of Antwerp; University of London; King's College London	Guloksuz, S (corresponding author), Maastricht Univ Med Ctr, EURON, Dept Psychiat & Psychol, Maastricht, Netherlands.	sguloksuz@yahoo.com	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Guloksuz, Sinan/AAH-1076-2019; Wichers, Marieke/N-6667-2014; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	Guloksuz, Sinan/0000-0002-6626-1874; Wichers, Marieke/0000-0001-5024-9064; van Os, Jim/0000-0002-7245-1586; Verkerk, Robert/0000-0003-3042-3293	European Community [HEALTH-F2-2009-241909]	European Community(European Commission)	Sinan Guloksuz and Jim van Os are supported by the European Community's Seventh Framework Programme under Grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banovic I, 2010, PSYCHOL HEALTH MED, V15, P394, DOI 10.1080/13548501003759155; Banovic I, 2009, J CROHNS COLITIS, V3, P25, DOI 10.1016/j.crohns.2008.10.003; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BOSSCHER RJ, 1986, PSYCHOL REP, V58, P696, DOI 10.2466/pr0.1986.58.3.696; Camara RJA, 2011, INFLAMM BOWEL DIS, V17, P2358, DOI 10.1002/ibd.21623; Capuron L, 2003, BIOL PSYCHIAT, V54, P906, DOI 10.1016/S0006-3223(03)00173-2; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Christmas DM, 2011, NEUROPSYCH DIS TREAT, V7, P431, DOI 10.2147/NDT.S17573; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Cusin C, 2010, CURR CLIN PSYCHIAT, P7, DOI 10.1007/978-1-59745-387-5_2; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HARVEY RF, 1980, LANCET, V1, P514; HELZER JE, 1984, GASTROENTEROLOGY, V86, P324; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Kenis G, 2011, INT J NEUROPSYCHOPH, V14, P247, DOI 10.1017/S1461145710000830; Kurina LM, 2001, J EPIDEMIOL COMMUN H, V55, P716, DOI 10.1136/jech.55.10.716; Kurz K, 2011, AUTOIMMUNITY, V44, P235, DOI 10.3109/08916934.2010.528476; Leonard BE, 2001, PROG NEURO-PSYCHOPH, V25, P767, DOI 10.1016/S0278-5846(01)00155-5; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Lichtenstein GR, 2002, INFLAMM BOWEL DIS, V8, P237, DOI 10.1097/00054725-200207000-00001; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Loftus EV, 2008, AM J GASTROENTEROL, V103, P3132, DOI 10.1111/j.1572-0241.2008.02175.x; Maes M, 1986, Acta Psychiatr Belg, V86, P257; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; MAES M, 1994, PSYCHIAT RES, V54, P143, DOI 10.1016/0165-1781(94)90003-5; Maes M, 1999, J AFFECT DISORDERS, V56, P189, DOI 10.1016/S0165-0327(99)00011-7; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; Maes M, 1996, NEUROPSYCHOPHARMACOL, V15, P243, DOI 10.1016/0893-133X(95)00181-C; Maes M, 1997, EUR ARCH PSY CLIN N, V247, P154, DOI 10.1007/BF03033069; MAES M, 1995, J AFFECT DISORDERS, V34, P61, DOI 10.1016/0165-0327(94)00106-J; Mardini HE, 2004, DIGEST DIS SCI, V49, P492, DOI 10.1023/B:DDAS.0000020509.23162.cc; Miller A. H., 2012, ARCH GEN PSYCHIAT, P1, DOI DOI 10.1001/2013; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Minderhoud IM, 2007, WORLD J GASTROENTERO, V13, P2089, DOI 10.3748/wjg.v13.i14.2089; Mittermaier C, 2004, PSYCHOSOM MED, V66, P79, DOI 10.1097/01.PSY.0000106907.24881.F2; Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X; NORTH CS, 1991, ANN INTERN MED, V114, P381, DOI 10.7326/0003-4819-114-5-381; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Persoons P, 2005, ALIMENT PHARM THER, V22, P101, DOI 10.1111/j.1365-2036.2005.02535.x; Plevy SE, 1997, J IMMUNOL, V159, P6276; Porter RJ, 2005, J AFFECT DISORDERS, V86, P129, DOI 10.1016/j.jad.2004.11.006; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; ROBERTSON DAF, 1989, GUT, V30, P623, DOI 10.1136/gut.30.5.623; Russel MGVM, 1997, DIGESTION, V58, P282, DOI 10.1159/000201455; Savitz J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000643; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sluzewska A, 1996, PSYCHIAT RES, V64, P161, DOI 10.1016/S0165-1781(96)02783-7; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Soczynska JK, 2009, NEUROTOXICOLOGY, V30, P497, DOI 10.1016/j.neuro.2009.03.004; SONG C, 1994, J AFFECT DISORDERS, V30, P283, DOI 10.1016/0165-0327(94)90135-X; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Van Balkom BPJ, 2002, ALIMENT PHARM THER, V16, P1101, DOI 10.1046/j.1365-2036.2002.01268.x; van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9; Van Gool AR, 2003, PHARM WORLD SCI, V25, P11, DOI 10.1023/A:1022449613907; VanHunsel F, 1996, PSYCHIAT RES, V65, P159, DOI 10.1016/S0165-1781(96)03010-7; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Yoshida EM, 1999, CAN J GASTROENTEROL, V13, P65, DOI 10.1155/1999/506915	60	34	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60435	10.1371/journal.pone.0060435	http://dx.doi.org/10.1371/journal.pone.0060435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544139	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700098
J	Schrock, A; Goke, F; Wagner, P; Bode, M; Franzen, A; Braun, M; Huss, S; Agaimy, A; Ihrler, S; Menon, R; Kirsten, R; Kristiansen, G; Bootz, F; Lengerke, C; Perner, S				Schroeck, Andreas; Goeke, Friederike; Wagner, Patrick; Bode, Maike; Franzen, Alina; Braun, Martin; Huss, Sebastian; Agaimy, Abbas; Ihrler, Stephan; Menon, Ropika; Kirsten, Robert; Kristiansen, Glen; Bootz, Friedrich; Lengerke, Claudia; Perner, Sven			Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; GENE AMPLIFICATION; PROTEIN EXPRESSION; SELF-RENEWAL; LUNG; PLURIPOTENCY; FIBROBLASTS; ONCOGENE; OCT3/4; NASAL	Objectives: The transcription factor SOX2 (3q26.3-q27) is an embryonic stem cell factor contributing to the induction of pluripotency in terminally differentiated somatic cells. Recently, amplification of the SOX2 gene locus has been described in squamous cell carcinoma (SCC) of different organ sites. Aim of this study was to investigate amplification and expression status of SOX2 in sinonasal carcinomas and to correlate the results with clinico-pathological data. Materials and Methods: A total of 119 primary tumor samples from the sinonasal region were assessed by fluorescence in-situ hybridization and immunohistochemistry for SOX2 gene amplification and protein expression, respectively. Of these, 59 were SSCs, 18 sinonasal undifferentiated carcinomas (SNUC), 10 carcinomas associated with an inverted papilloma (INVC), 19 adenocarcinomas (AD) and 13 adenoid cystic carcinomas (ACC). Results: SOX2 amplifications were found in subsets of SCCs (37.5%), SNUCs (35.3%), INVCs (37.5%) and ADs (8.3%) but not in ACCs. SOX2 amplification resulted in increased protein expression. Patients with SOX2-amplified sinonasal carcinomas showed a significantly higher rate of tumor recurrences than SOX2 non-amplified tumors. Conclusion:This is the first study assessing SOX2 amplification and expression in a large cohort of sinonasal carcinomas. As opposed to AD and ACC, SOX2 amplifications were detected in more than 1/3 of all SCCs, SNUCs and INVCs. We therefore suggest that SNUCs are molecularly closely related to SCCs and INVCs and that these entities represent a subgroup of sinonasal carcinomas relying on SOX2 acquisition during oncogenesis. SOX2 amplification appears to identify sinonasal carcinomas that are more likely to relapse after primary therapy, suggesting that these patients might benefit from a more aggressive therapy regime.	[Schroeck, Andreas; Bootz, Friedrich] Univ Bonn, Dept Otorhinolaryngol Head & Neck Surg, Bonn, Germany; [Schroeck, Andreas; Goeke, Friederike; Bode, Maike; Franzen, Alina; Braun, Martin; Menon, Ropika; Kirsten, Robert; Perner, Sven] Univ Bonn, Dept Prostate Canc Res, Bonn, Germany; [Goeke, Friederike; Bode, Maike; Franzen, Alina; Braun, Martin; Menon, Ropika; Kirsten, Robert; Kristiansen, Glen; Perner, Sven] Univ Bonn, Inst Pathol, Bonn, Germany; [Wagner, Patrick] Winchester Med Ctr, Winchester, VA USA; [Huss, Sebastian] Univ Cologne, Inst Pathol, Cologne, Germany; [Agaimy, Abbas] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany; [Ihrler, Stephan] Univ Munich, Inst Pathol, Lab Dermatohistol & Oral Pathol, D-80539 Munich, Germany; [Lengerke, Claudia] Univ Tubingen, Med Ctr 2, Tubingen, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Erlangen Nuremberg; University of Munich; Eberhard Karls University of Tubingen	Schrock, A (corresponding author), Univ Bonn, Dept Otorhinolaryngol Head & Neck Surg, Bonn, Germany.	andreas.schroeck@ukb.uni-bonn.de	Wagner, Patrick/AAZ-7790-2021; Lengerke, Claudia/AAV-8745-2021	Lengerke, Claudia/0000-0001-5442-2805	Rudolph-Becker-Foundation; Medical Faculty of the University of Bonn; DFG [PE 1179/4-1, LE 2483/4-1]	Rudolph-Becker-Foundation; Medical Faculty of the University of Bonn; DFG(German Research Foundation (DFG))	This study was supported by a grant of the Rudolph-Becker-Foundation (to SP), by a medical doctoral fellowship of the Medical Faculty of the University of Bonn (to MB) and a grant of the DFG (to SP (#PE 1179/4-1) and CL (#LE 2483/4-1)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; [Anonymous], 2010, CURR PROB CANCER, V34, P304, DOI 10.1016/j.currproblcancer.2010.07.001; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Du LT, 2011, ORAL ONCOL, V47, P709, DOI 10.1016/j.oraloncology.2011.05.017; Dulguerov P, 2001, CANCER-AM CANCER SOC, V92, P3012, DOI 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Guntinas-Lichius O, 2007, EJSO-EUR J SURG ONC, V33, P222, DOI 10.1016/j.ejso.2006.10.033; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Khademi B, 2009, ORAL MAXILLOFAC SURG, V13, P191, DOI 10.1007/s10006-009-0170-8; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011022; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Q, 2009, ANTICANCER RES, V29, P1233; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	28	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59201	10.1371/journal.pone.0059201	http://dx.doi.org/10.1371/journal.pone.0059201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544055	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700017
J	Wierk, JK; Langbehn, A; Kamper, M; Richter, S; Burda, PC; Heussler, VT; Deschermeier, C				Wierk, Jannika Katharina; Langbehn, Annette; Kamper, Maria; Richter, Stefanie; Burda, Paul-Christian; Heussler, Volker Theo; Deschermeier, Christina			Plasmodium berghei MAPK1 Displays Differential and Dynamic Subcellular Localizations during Liver Stage Development	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; PROTEIN-KINASES; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CONTROLS CYTOKINESIS; NUCLEAR IMPORT; CELL-CYCLE; FALCIPARUM; ACTIVATION; ERK; KINETOCHORES	Mitogen-activated protein kinases (MAPKs) regulate key signaling events in eukaryotic cells. In the genomes of protozoan Plasmodium parasites, the causative agents of malaria, two genes encoding kinases with significant homology to other eukaryotic MAPKs have been identified (mapk1, mapk2). In this work, we show that both genes are transcribed during Plasmodium berghei liver stage development, and analyze expression and subcellular localization of the PbMAPK1 protein in liver stage parasites. Live cell imaging of transgenic parasites expressing GFP-tagged PbMAPK1 revealed a nuclear localization of PbMAPK1 in the early schizont stage mediated by nuclear localization signals in the C-terminal domain. In contrast, a distinct localization of PbMAPK1 in comma/ring-shaped structures in proximity to the parasite's nuclei and the invaginating parasite membrane was observed during the cytomere stage of parasite development as well as in immature blood stage schizonts. The PbMAPK1 localization was found to be independent of integrity of a motif putatively involved in ATP binding, integrity of the putative activation motif and the presence of a predicted coiled-coil domain in the C-terminal domain. Although PbMAPK1 knock out parasites showed normal liver stage development, the kinase may still fulfill a dual function in both schizogony and merogony of liver stage parasites regulated by its dynamic and stage-dependent subcellular localization.	[Wierk, Jannika Katharina; Langbehn, Annette; Kamper, Maria; Richter, Stefanie; Deschermeier, Christina] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; [Burda, Paul-Christian; Heussler, Volker Theo] Univ Bern, Inst Cell Biol, Bern, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; University of Bern	Deschermeier, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	descherm@bni-hamburg.de	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Burda, Paul-Christian/0000-0003-0461-4352	MALSIG (Signalling in life cycle stages of malaria parasites); EVIMalaR (European virtual institute of malaria research) EU consortia	MALSIG (Signalling in life cycle stages of malaria parasites); EVIMalaR (European virtual institute of malaria research) EU consortia	The work was supported by the MALSIG (Signalling in life cycle stages of malaria parasites) and the EVIMalaR (European virtual institute of malaria research) EU consortia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe MK, 1999, MOL CELL BIOL, V19, P1301; Arnot DE, 2011, INT J PARASITOL, V41, P71, DOI 10.1016/j.ijpara.2010.07.012; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Deschermeier C, 2012, CELL MICROBIOL, V14, P416, DOI 10.1111/j.1462-5822.2011.01729.x; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Figueiredo LM, 2005, NUCLEIC ACIDS RES, V33, P1111, DOI 10.1093/nar/gki260; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frankel MB, 2009, DNA CELL BIOL, V28, P277, DOI 10.1089/dna.2009.0853; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045; Graeser R, 1997, MOL MICROBIOL, V23, P151, DOI 10.1046/j.1365-2958.1997.2071571.x; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002554; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Helm S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013653; Huang H, 2011, CELL CYCLE, V10, P3519, DOI 10.4161/cc.10.20.17791; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; KUN JFJ, 1995, MOL BIOCHEM PARASIT, V71, P249, DOI 10.1016/0166-6851(94)00047-Q; Lacey MR, 2007, J MOL EVOL, V64, P4, DOI 10.1007/s00239-005-0197-x; Lin DT, 1996, MOL BIOCHEM PARASIT, V78, P67, DOI 10.1016/S0166-6851(96)02608-4; Montagnac G, 2010, NAT CELL BIOL, V12, P308, DOI 10.1038/ncb0410-308; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nivez MP, 2000, MOL BIOCHEM PARASIT, V111, P31, DOI 10.1016/S0166-6851(00)00294-2; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; Rankin KE, 2010, CELL MICROBIOL, V12, P569, DOI 10.1111/j.1462-5822.2010.01454.x; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rodriguez J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002324; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Tuteja R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/461979; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59755	10.1371/journal.pone.0059755	http://dx.doi.org/10.1371/journal.pone.0059755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544094	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700054
J	Manise, M; Holtappels, G; Van Crombruggen, K; Schleich, F; Bachert, C; Louis, R				Manise, Maite; Holtappels, Gabriele; Van Crombruggen, Koen; Schleich, Florence; Bachert, Claus; Louis, Renaud			Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NON-EOSINOPHILIC ASTHMA; SEE VOL. 183; MAST-CELLS; INFLAMMATORY SUBTYPES; PERSISTENT ASTHMA; INTRINSIC ASTHMA; ALLERGIC-ASTHMA; PG. 418; ANTIBODIES	Background: Local IgE production may play a role in asthma pathogenesis. The aim of the study was to assess sputum total IgE and cytokines in asthmatics according to sputum cellular phenotype. Methods: We studied 122 subjects including 22 non atopic healthy subjects, 41 eosinophilic (sputum eosinophils < 3%), 16 neutrophilic (sputum neutrophils <= 76%) and 43 pauci-granulocytic asthmatics (sputum eosinophils,3% and sputum neutrophils <= 76%) recruited from the asthma clinic at CHU Liege. Sputum supernatant total IgE (tIgE) was measured by ImmunoCAP and sputum supernatant cytokines (IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IFN-gamma and TNF-alpha) were measured with the Luminex xMAP Technology by using commercially available Fluorokine MAP kits. Results: After concentrating sputum samples, total IgE was detectable in the majority of subjects. Sputum IgE was raised in asthmatics when compared to healthy subjects. Overall, asthmatics did not significantly differ from healthy subjects with respect to cytokine levels. The eosinophilic asthma phenotype, however, was characterised by raised sputum tIgE, IL-5 and IL-13 compared to healthy subjects (p < 0.001, p < 0.001 and p < 0.05 respectively) and pauci-granulocytic asthma (p < 0.01, p < 0.001 and p < 0.05 respectively) and raised IL-5 compared to neutrophilic asthma (p < 0.01). When patients were classified according to sputum IgE levels, it appeared that IL-5, IL-6, IL-17 and TNF-a sputum supernatant levels were raised in the "IgE high'' asthmatics (IgE >= 0.1 kU/l) when compared to "IgE low'' asthmatics (IgE < 0.1 kU/l). Conclusion: The eosinophilic asthma phenotype was associated with raised sputum IgE and a Th2 cytokine profile. Raised sputum IgE was associated with a heterogeneous cytokine overproduction.	[Manise, Maite; Schleich, Florence; Louis, Renaud] CHU Sart Tilman, Dept Pneumol, GIGA Unit I3Res, B-4000 Liege, Belgium; [Holtappels, Gabriele; Van Crombruggen, Koen; Bachert, Claus] Ghent Univ Hosp, ENT Dept, Upper Airway Res Lab, Ghent, Belgium	University of Liege; Ghent University; Ghent University Hospital	Manise, M (corresponding author), CHU Sart Tilman, Dept Pneumol, GIGA Unit I3Res, B-4000 Liege, Belgium.	mmanise@ulg.ac.be	Bachert, Claus/J-8825-2012		PAI (pole d'attraction interuniversitaire) [P7/30]; Belgian Aireway Study Consortium II; GSK; Astrazeneca; Novartis	PAI (pole d'attraction interuniversitaire); Belgian Aireway Study Consortium II; GSK(GlaxoSmithKline); Astrazeneca(AstraZeneca); Novartis(Novartis)	This work was supported by PAI (pole d'attraction interuniversitaire) grant P7/30: Belgian Aireway Study Consortium II and unrestricted research grants from GSK, Astrazeneca and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Bacharier LB, 2000, J ALLERGY CLIN IMMUN, V105, pS547, DOI 10.1016/S0091-6749(00)90059-9; Bachert C, 2012, J INTERN MED; Bachert C, 2012, J ALLERGY CLIN IMMUN; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Barnes PJ, 2009, CLIN EXP ALLERGY, V39, P1145, DOI 10.1111/j.1365-2222.2009.03298.x; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Berry MA, 2004, J ALLERGY CLIN IMMUN, V114, P1106, DOI 10.1016/j.jaci.2004.08.032; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chiba Y, 2009, AM J RESP CELL MOL, V40, P159, DOI 10.1165/rcmb.2008-0162OC; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Delvaux M, 2004, THORAX, V59, P111, DOI 10.1136/thorax.2003.011130; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Erin EM, 2006, AM J RESP CRIT CARE, V174, P753, DOI 10.1164/rccm.200601-072OC; Erin EM, 2008, AM J RESP CRIT CARE, V177, P132, DOI 10.1164/rccm.200603-311OC; FAHY JV, 1993, AM REV RESPIR DIS, V147, P1126, DOI 10.1164/ajrccm/147.5.1126; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Holgate ST, 2011, EUR RESPIR J, V37, P1352, DOI 10.1183/09031936.00063510; Holgate S, 2009, RESP MED, V103, P1098, DOI 10.1016/j.rmed.2009.03.008; Humbert M, 1996, AM J RESP CRIT CARE, V153, P1931, DOI 10.1164/ajrccm.153.6.8665058; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kamath AV, 2005, THORAX, V60, P529, DOI 10.1136/thx.2005.043182; Kelly MM, 2002, EUR RESPIR J, V20, p24S, DOI 10.1183/09031936.02.00002402; Kowalski ML, 2011, ALLERGY, V66, P32, DOI 10.1111/j.1398-9995.2010.02379.x; Levy F, 1997, INT ARCH ALLERGY IMM, V112, P49, DOI 10.1159/000237431; Louis R, 2011, NONINVASIVE ASSESSME, P113; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mouthuy J, 2011, AM J RESP CRIT CARE, V184, P206, DOI 10.1164/rccm.201009-1434OC; Nahm DH, 1998, CLIN EXP ALLERGY, V28, P686, DOI 10.1046/j.1365-2222.1998.00291.x; O'Byrne PM, 2009, CLIN EXP ALLERGY, V39, P181, DOI 10.1111/j.1365-2222.2008.03172.x; Park SW, 2005, CHEST, V128, P1921, DOI 10.1378/chest.128.4.1921; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pelletier M, 2010, J LEUKOCYTE BIOL, V88, P1163, DOI 10.1189/jlb.0310172; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	48	52	54	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58388	10.1371/journal.pone.0058388	http://dx.doi.org/10.1371/journal.pone.0058388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555579	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500010
J	Chan, PH; Ghosh, B; Lai, HZ; Peng, HL; Mong, KKT; Chen, YC				Chan, Po-Han; Ghosh, Bhaswati; Lai, Hong-Zheng; Peng, Hwei-Ling; Mong, Kwok Kong Tony; Chen, Yu-Chie			Photoluminescent Gold Nanoclusters as Sensing Probes for Uropathogenic Escherichia coli	PLOS ONE			English	Article							NANODOTS; MANNOSE; ADHERENCE	Glycan-bound nanoprobes have been demonstrated as suitable sensing probes for bacteria containing glycan binding sites. In this study, we demonstrated a facile approach for generating glycan-bound gold nanoclusters (AuNCs). The generated AuNCs were used as sensing probes for corresponding target bacteria. Mannose-capped AuNCs (AuNCs@Mann) were generated and used as the model sensors for target bacteria. A one-step synthesis approach was employed to generate AuNCs@Mann. In this approach, an aqueous solution of tetrachloroauric acid and mannoside that functionized with a thiol group (Mann-SH) was stirred at room temperature for 48 h. The mannoside functions as reducing and capping agent. The size of the generated AuNCs@Mann is 1.95 +/- 0.27 nm, whereas the AuNCs with red photoluminescence have a maximum emission wavelength of similar to 630 nm (lambda(excitation) = 375 nm). The synthesis of the AuNCs@Mann was accelerated by microwave heating, which enabled the synthesis of the AuNCs@Mann to complete within 1 h. The generated AuNCs@Mann are capable of selectively binding to the urinary tract infection isolate Escherichia coli J96 containing the mannose binding protein FimH expressed on the type 1 pili. On the basis of the naked eye observation, the limit of detection of the sensing approach is as low as similar to 2 x 10(6) cells/mL.	[Chan, Po-Han; Ghosh, Bhaswati; Lai, Hong-Zheng; Mong, Kwok Kong Tony; Chen, Yu-Chie] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan; [Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Mong, KKT (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan.	tmong@mail.nctu.edu.tw; yuchie@mail.nctu.edu.tw	Ghosh, Bhaswati/GLU-2181-2022; Mong, Kwok-Kong/V-2000-2019		National Science Council of Taiwan [NSC 100-2627-M-009-007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 100-2627-M-009-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett BJ, 1997, AM J MED SCI, V314, P245, DOI 10.1097/00000441-199710000-00007; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; CADDICK S, 1995, TETRAHEDRON, V51, P10403, DOI 10.1016/0040-4020(95)00662-R; Chen WY, 2010, NANOMEDICINE-UK, V5, P755, DOI 10.2217/NNM.10.43; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; Disney MD, 2004, J AM CHEM SOC, V126, P13343, DOI 10.1021/ja047936i; Grunstein D, 2011, J AM CHEM SOC, V133, P13957, DOI 10.1021/ja2036767; Huang CC, 2008, ANAL CHEM, V80, P1497, DOI 10.1021/ac701998f; Huang CC, 2009, ANAL CHEM, V81, P875, DOI 10.1021/ac8010654; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Lin JH, 2010, ANALYST, V135, P104, DOI 10.1039/b916511h; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Rodrigues DF, 2009, BIOFOULING, V25, P401, DOI 10.1080/08927010902833443; Shang L, 2011, NANO TODAY, V6, P401, DOI 10.1016/j.nantod.2011.06.004; Shiang YC, 2011, ANALYST, V136, P1177, DOI 10.1039/c0an00889c; Song YJ, 2011, ADV MATER, V23, P4215, DOI 10.1002/adma.201101853; Sun SH, 2006, ADV MATER, V18, P393, DOI 10.1002/adma.200501464; Tseng YT, 2011, BIOSENS BIOELECTRON, V27, P95, DOI 10.1016/j.bios.2011.06.021; Wen F, 2011, ANAL CHEM, V83, P1193, DOI 10.1021/ac1031447; Wolf Denise M., 2002, OMICS A Journal of Integrative Biology, V6, P91, DOI 10.1089/15362310252780852; Yang W, 2010, BIOMACROMOLECULES, V11, P1840, DOI 10.1021/bm100307d	22	32	32	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58064	10.1371/journal.pone.0058064	http://dx.doi.org/10.1371/journal.pone.0058064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554874	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800010
J	Ou, JX; Bharti, K; Nodari, A; Bertuzzi, S; Arnheiter, H				Ou, Jingxing; Bharti, Kapil; Nodari, Alessandro; Bertuzzi, Stefano; Arnheiter, Heinz			Vax1/2 Genes Counteract Mitf-Induced Respecification of the Retinal Pigment Epithelium	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MITF; EYE DEVELOPMENT; CELL-DIFFERENTIATION; ALAGILLE-SYNDROME; OPTIC VESICLE; NEURAL RETINA; HOMEOBOX GENE; BETA-CATENIN; EXPRESSION; TRANSDIFFERENTIATION	During vertebrate eye development, the transcription factor MITF acts to promote the development of the retinal pigment epithelium (RPE). In embryos with Mitf mutations, the future RPE hyperproliferates and is respecified as retinal tissue but only in a small portion of the dorsal RPE. Using a series of genetic crosses, we show that this spatial restriction of RPE respecification is brought about by persistent expression of the anti-retinogenic ventral homeodomain gene Vax2 in the dorso-proximal and both Vax1 and Vax2 in the ventral RPE. We further show that dorso-proximal RPE respecification in Vax2/Mitf double mutants and dorso-proximal and ventral RPE respecification in Vax1/2/Mitf triple mutants result from increased FGF/MAP kinase signaling. In none of the mutants, however, does the distal RPE show signs of hyperproliferation or respecification, likely due to local JAGGED1/NOTCH signaling. Expression studies and optic vesicle culture experiments also suggest a role for NOTCH signaling within the mutant dorsal RPE domains, where ectopic JAGGED1 expression may partially counteract the effects of FGF/ERK1/2 signaling on RPE respecification. The results indicate the presence of complex interplays between distinct transcription factors and signaling molecules during eye development and show how RPE phenotypes associated with mutations in one gene are modulated by expression changes in other genes.	[Ou, Jingxing; Bharti, Kapil; Nodari, Alessandro; Bertuzzi, Stefano; Arnheiter, Heinz] NINDS, Mammalian Dev Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Ou, JX (corresponding author), NINDS, Mammalian Dev Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	ouj@nei.nih.gov		Arnheiter, Heinz/0000-0003-2537-1134; Bertuzzi, Stefano/0000-0003-4562-3626	Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE [ZIAEY000533, ZIAEY000531] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZZ, 1997, J NEUROSCI, V17, P1425; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; Hallonet M, 1998, DEVELOPMENT, V125, P2599; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Liu H, 2003, DEV DYNAM, V227, P323, DOI 10.1002/dvdy.10315; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McCright B, 2002, DEVELOPMENT, V129, P1075; Mochii M, 1998, DEV BIOL, V193, P47, DOI 10.1006/dbio.1997.8800; Mochii M, 1998, DEV BIOL, V196, P145, DOI 10.1006/dbio.1998.8864; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Ohsaki K, 1999, GENES CELLS, V4, P267, DOI 10.1046/j.1365-2443.1999.00257.x; Ou J, 2008, J PATHOL, V215, P421, DOI 10.1002/path.2371; Ou JX, 2010, INVEST OPHTH VIS SCI, V51, P1415, DOI 10.1167/iovs.09-4023; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PITTACK C, 1991, DEVELOPMENT, V113, P577; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Schouwey K, 2011, ONCOGENE, V30, P313, DOI 10.1038/onc.2010.428; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Tsukiji N, 2009, DEV BIOL, V326, P335, DOI 10.1016/j.ydbio.2008.11.029; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yuan ZR, 1998, HUM MOL GENET, V7, P1363, DOI 10.1093/hmg/7.9.1363; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59247	10.1371/journal.pone.0059247	http://dx.doi.org/10.1371/journal.pone.0059247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555005	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800075
J	Puta, C; Schulz, B; Schoeler, S; Magerl, W; Gabriel, B; Gabriel, HHW; Miltner, WHR; Weiss, T				Puta, Christian; Schulz, Birgit; Schoeler, Saskia; Magerl, Walter; Gabriel, Brunhild; Gabriel, Holger H. W.; Miltner, Wolfgang H. R.; Weiss, Thomas			Somatosensory Abnormalities for Painful and Innocuous Stimuli at the Back and at a Site Distinct from the Region of Pain in Chronic Back Pain Patients	PLOS ONE			English	Article							PARADOXICAL HEAT SENSATION; EVENT-RELATED POTENTIALS; THALAMIC NMDA RECEPTORS; NEUROGENIC HYPERALGESIA; ATTENTIONAL CONTROL; NATURAL-HISTORY; SENSITIZATION; PERCEPTION; MECHANISMS; INTENSITY	Chronic low back pain (CLBP) was shown to be associated with pathophysiological changes at several levels of the sensorimotor system. Changes in sensory thresholds have been reported but complete profiles of Quantitative Sensory Testing (QST) were only rarely obtained in CLBP patients. The aim of the present study was to investigate comprehensive QST profiles in CLBP at the painful site (back) and at a site distinct from their painful region (hand) and to compare these data with similar data in healthy controls. We found increased detection thresholds in CLBP patients compared to healthy controls for all innocuous stimuli at the back and extraterritorial to the painful region at the hand. Additionally, CLBP patients showed decreased pain thresholds at both sites. Importantly, there was no interaction between the investigated site and group, i.e. thresholds were changed both at the affected body site and for the site distinct from the painful region (hand). Our results demonstrate severe, widespread changes in somatosensory sensitivity in CLBP patients. These widespread changes point to alterations at higher levels of the neuraxis or/and to a vulnerability to nociceptive plasticity in CLBP patients.	[Puta, Christian; Schulz, Birgit; Gabriel, Holger H. W.] Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany; [Puta, Christian] Univ Jena, Ctr Interdisciplinary Prevent Dis Related Profess, Jena, Germany; [Schoeler, Saskia; Gabriel, Brunhild; Miltner, Wolfgang H. R.; Weiss, Thomas] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany; [Magerl, Walter] Heidelberg Univ, Ctr Biomed & Med Technol Mannheim CBTM, Mannheim, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruprecht Karls University Heidelberg	Puta, C (corresponding author), Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany.	christian.puta@uni-jena.de	Puta, Christian/P-5562-2014	Puta, Christian/0000-0003-3936-4605	Federal Ministry of Education and Research BMBF [01EC1003B, 01EC1010]	Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	This study was funded by the Federal Ministry of Education and Research BMBF [01EC1003B, 01EC1010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho CMS, 2009, EUR J PAIN, V13, P779, DOI 10.1016/j.ejpain.2008.10.002; APKARIAN AV, 1994, SOMATOSENS MOT RES, V11, P259, DOI 10.3109/08990229409051393; Balague F, 2007, LANCET, V369, P726, DOI 10.1016/S0140-6736(07)60340-7; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blumenstiel K, 2011, CLIN J PAIN, V27, P682, DOI 10.1097/AJP.0b013e3182177654; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Dillmann J, 2000, NEUROSCI LETT, V284, P53, DOI 10.1016/S0304-3940(00)00957-5; EATON SA, 1990, NEUROSCI LETT, V110, P297, DOI 10.1016/0304-3940(90)90863-5; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Franz M, 2012, PAIN, V153, P1687, DOI 10.1016/j.pain.2012.04.029; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; GREEN BG, 1991, SOMATOSENS MOT RES, V8, P301, DOI 10.3109/08990229109144754; Hansen C, 1996, BRAIN, V119, P1729, DOI 10.1093/brain/119.5.1729; Hautzinger M, 1994, BECK DEPRESSIONS INV; HOHMANN C, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/753583; Huge V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002742; Huge V, 2006, PAIN MED, V7, P501, DOI 10.1111/j.1526-4637.2006.00238.x; Jensen IB, 2009, PAIN, V142, P202, DOI 10.1016/j.pain.2008.12.015; Jung K, 2012, EUR J PAIN, V16, P509, DOI 10.1016/j.ejpain.2011.08.006; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kolhekar R, 1997, PAIN, V71, P31, DOI 10.1016/S0304-3959(97)03334-4; Kosek E, 2002, EUR J PAIN, V6, P413, DOI 10.1016/S1090-3801(02)00041-1; Lang PM, 2006, PAIN, V124, P190, DOI 10.1016/j.pain.2006.04.011; Leffler AS, 2000, EUR J PAIN, V4, P57, DOI 10.1053/eujp.1999.0159; Legrain V, 2011, PAIN, V152, P453, DOI 10.1016/j.pain.2010.11.024; Lenz Frederick A, 2004, Suppl Clin Neurophysiol, V57, P50; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; Luoto S, 1999, SPINE, V24, P255, DOI 10.1097/00007632-199902010-00011; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Moriwaki K, 1999, PAIN, V81, P1, DOI 10.1016/S0304-3959(98)00257-7; NATHAN PW, 1960, J NEUROL NEUROSUR PS, V23, P202, DOI 10.1136/jnnp.23.3.202; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; O'Neill S, 2007, EUR J PAIN, V11, P415, DOI 10.1016/j.ejpain.2006.05.009; Pertovaara A, 1998, EXP NEUROL, V149, P193, DOI 10.1006/exnr.1997.6688; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Puta C, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-98; Richter M, 2010, PAIN, V148, P198, DOI 10.1016/j.pain.2009.08.009; ROLAND M, 1983, SPINE, V8, P145, DOI 10.1097/00007632-198303000-00005; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Romero YR, 2013, PAIN, V154, P135, DOI 10.1016/j.pain.2012.10.003; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Taimela S, 1999, SPINE, V24, P1322, DOI 10.1097/00007632-199907010-00009; Treede RD, 2008, EUR J PAIN, V12, P395, DOI 10.1016/j.ejpain.2007.11.008; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; Tsao H, 2010, EUR J PAIN, V14, P832, DOI 10.1016/j.ejpain.2010.01.001; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Weiss T, 2003, NEUROSCI LETT, V340, P135, DOI 10.1016/S0304-3940(03)00103-4	61	45	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58885	10.1371/journal.pone.0058885	http://dx.doi.org/10.1371/journal.pone.0058885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554950	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800044
J	Vehling, S; Oechsle, K; Koch, U; Mehnert, A				Vehling, Sigrun; Oechsle, Karin; Koch, Uwe; Mehnert, Anja			Receiving Palliative Treatment Moderates the Effect of Age and Gender on Demoralization in Patients with Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; PSYCHOLOGICAL DISTRESS; PSYCHOSOMATIC RESEARCH; PSYCHOSOCIAL DISTRESS; DEPRESSIVE SYMPTOMS; DIAGNOSTIC-CRITERIA; SOCIAL SUPPORT; ERROR VARIANCE; CARE	Background: Existential distress is an important factor affecting psychological well-being in cancer patients. We studied occurrence and predictors of demoralization, a syndrome of existential distress, in particular the interaction of age, gender, and curative vs. palliative treatment phase. Methods: A cross-sectional sample of N = 750 patients with different tumor sites was recruited from in-and outpatient treatment facilities. Patients completed the following self-report questionnaires: Demoralization Scale, Patient Health Questionnaire-9, Illness-Specific Social Support Scale Short Version-8, and physical problems list of the NCCN Distress Thermometer. Moderated multiple regression analyses were conducted. Results: We found high demoralization in 15% and moderate demoralization in 8% of the sample. Curative vs. palliative treatment phase moderated the impact of age and gender on demoralization (three-way interaction: b = 1.30, P = 0.2): the effect of age on demoralization was negative for women receiving palliative treatment (b = -2.6, P = 0.2) and positive for men receiving palliative treatment (b = 2.5, P = 0.3). Effects of age and gender were not significant among patients receiving curative treatment. Female gender was associated with higher demoralization among younger patients receiving palliative treatment only. Analyses were controlled for significant effects of the number of physical problems (b = 6.10, P < 0.01) and social support (b = -3.17, P<0.01). Conclusions: Existential distress in terms of demoralization is a relevant problem within the spectrum of cancer-related distress. It is associated with a complex interaction of demographic and medical patient characteristics; existential challenges related to palliative treatment may exacerbate the impact of age-and gender-related vulnerability factors on demoralization. Psychosocial interventions should acknowledge this interaction in order to address the individual nature of existential distress in subgroups of cancer patients.	[Vehling, Sigrun; Koch, Uwe; Mehnert, Anja] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Oechsle, Karin] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol Pneumol, Hamburg, Germany; [Koch, Uwe] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Mehnert, Anja] Univ Med Ctr Leipzig, Div Psychosocial Oncol, Dept Med Psychol & Med Sociol, Leipzig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Vehling, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	s.vehling@uke.de	tan, janie/AAH-9283-2021; Koch, Uwe/A-5825-2009; Mehnert-Theuerkauf, Anja/A-1177-2008; Vehling, Sigrun/AAD-2861-2021	Mehnert-Theuerkauf, Anja/0000-0002-6872-9805; Vehling, Sigrun/0000-0001-9314-4326	German Cancer Aid (Deutsche Krebshilfe) [107465]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was supported by the German Cancer Aid (Deutsche Krebshilfe, Grant number 107465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinis H, 1998, ORGAN RES METHODS, V1, P296, DOI 10.1177/109442819813002; Aiken L. S., 1991, MULTIPLE REGRESSION; ALEXANDER RA, 1994, PSYCHOL BULL, V115, P308, DOI 10.1037/0033-2909.115.2.308; Angelino AF, 2001, SUPPORT CARE CANCER, V9, P344, DOI 10.1007/s005200000195; Arden-Close E, 2008, PSYCHO-ONCOLOGY, V17, P1061, DOI 10.1002/pon.1363; Blank TO, 2008, CANCER-AM CANCER SOC, V112, P2569, DOI 10.1002/cncr.23444; Boscaglia N, 2007, PSYCHO-ONCOL, V16, P189, DOI 10.1002/pon.1044; Breitbart W, 2012, J CLIN ONCOL, V30, P1304, DOI 10.1200/JCO.2011.36.2517; Brothers BM, 2009, PSYCHO-ONCOLOGY, V18, P267, DOI 10.1002/pon.1394; Chochinov HM, 2009, J PAIN SYMPTOM MANAG, V38, P641, DOI 10.1016/j.jpainsymman.2009.04.021; Chochinov HM, 2006, CA-CANCER J CLIN, V56, P84, DOI 10.3322/canjclin.56.2.84; Clarke David M, 2005, World Psychiatry, V4, P96; Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x; Cockram CA, 2009, PSYCHOTHER PSYCHOSOM, V78, P342, DOI 10.1159/000235737; Connor MJ, 2011, NURS INQ, V18, P2, DOI 10.1111/j.1440-1800.2010.00501.x; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; DEFIGUEIREDO JM, 1993, COMPR PSYCHIAT, V34, P308, DOI 10.1016/0010-440X(93)90016-W; Fox J, 2008, APPL REGRESSION ANAL; Giese-Davis J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-441; Grassi L, 2005, PSYCHOTHER PSYCHOSOM, V74, P100, DOI 10.1159/000083168; Grassi L, 2004, PSYCHOSOMATICS, V45, P483, DOI 10.1176/appi.psy.45.6.483; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Jacobsen JC, 2006, INDIAN J PALLIAT CAR, V12, P8, DOI 10.4103/0973-1075.25913; Jacobsen Juliet C, 2007, Prim Care Companion J Clin Psychiatry, V9, P139; Jones JM, 2003, J PSYCHOSOM RES, V55, P411, DOI 10.1016/S0022-3999(03)00526-9; Kissane D, 2009, HDB PSYCHIAT PALLIAT, P324; Kissane DW, 2012, ARCH INTERN MED, V172, P1501, DOI 10.1001/archinternmed.2012.3633; Kissane DW, 2004, J PALLIATIVE CARE, V20, P269, DOI 10.1177/082585970402000402; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Lee CY, 2012, SUPPORT CARE CANCER, V20, P2259, DOI 10.1007/s00520-011-1332-4; Lemay K, 2008, CLIN PSYCHOL REV, V28, P472, DOI 10.1016/j.cpr.2007.07.013; Lo C, 2010, AGEING SOC, V30, P325, DOI 10.1017/S0144686X09990201; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Mehnert A, 2010, EUR J CANCER CARE, V19, P736, DOI 10.1111/j.1365-2354.2009.01117.x; Mehnert A, 2006, PSYCHOTHER PSYCH MED, V56, P462, DOI 10.1055/s-2006-951828; Mehnert A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-70; Mehnert A, 2011, J PAIN SYMPTOM MANAG, V42, P768, DOI 10.1016/j.jpainsymman.2011.02.013; Miller S, 2011, SOC PSYCH PSYCH EPID, V46, P767, DOI 10.1007/s00127-010-0246-7; Monforte-Royo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037117; Mosher CE, 2005, J PSYCHOSOC ONCOL, V23, P101, DOI 10.1300/J077v23n02_07; Nelson CJ, 2009, ONCOLOGIST, V14, P891, DOI 10.1634/theoncologist.2009-0059; Nissim R, 2012, PALLIATIVE MED, V26, P713, DOI 10.1177/0269216311425096; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; REVENSON TA, 1991, SOC SCI MED, V33, P807, DOI 10.1016/0277-9536(91)90385-P; Rodin Gary, 2008, J Am Acad Psychoanal Dyn Psychiatry, V36, P181, DOI 10.1521/jaap.2008.36.1.181; Rodin G, 2009, SOC SCI MED, V68, P562, DOI 10.1016/j.socscimed.2008.10.037; Rosenfeld B, 2004, PSYCHO-ONCOL, V13, P800, DOI 10.1002/pon.797; Ryan D, 2012, PALLIATIVE MED, V26, P162, DOI 10.1177/0269216311399663; Sachs E, 2012, AM J HOSP PALLIAT CA; Scheier MF, 2006, J CLIN ONCOL, V24, P2407, DOI 10.1200/JCO.2005.05.5244; Siegel K, 1999, J PSYCHOSOC ONCOL, V17, P1, DOI 10.1300/J077v17n01_01; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Ullrich A., 2010, KLIN DIAGNOSTIK EVAL, V3, P359; Vehling S, 2011, SUPPORT CARE CANCER, V19, P513, DOI 10.1007/s00520-010-0845-6; Vehling S, 2012, PSYCHO-ONCOLOGY, V21, P54, DOI 10.1002/pon.1866; Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200.19.1.111	57	28	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59417	10.1371/journal.pone.0059417	http://dx.doi.org/10.1371/journal.pone.0059417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZC	23555030	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800088
J	Miguel, RDV; Harvey, SAK; LaFramboise, WA; Reighard, SD; Matthews, DB; Cherpes, TL				Miguel, Rodolfo D. Vicetti; Harvey, Stephen A. K.; LaFramboise, William A.; Reighard, Seth D.; Matthews, Dean B.; Cherpes, Thomas L.			Human Female Genital Tract Infection by the Obligate Intracellular Bacterium Chlamydia trachomatis Elicits Robust Type 2 Immunity	PLOS ONE			English	Article							CELLS; ACTIVATION; EXPRESSION; RECEPTOR; INTERLEUKIN-4; MACROPHAGES; INDUCTION; PROTEIN; TUMORS; WOMEN	While Chlamydia trachomatis infections are frequently asymptomatic, mechanisms that regulate host response to this intracellular Gram-negative bacterium remain undefined. This investigation thus used peripheral blood mononuclear cells and endometrial tissue from women with or without Chlamydia genital tract infection to better define this response. Initial genome-wide microarray analysis revealed highly elevated expression of matrix metalloproteinase 10 and other molecules characteristic of Type 2 immunity (e.g., fibrosis and wound repair) in Chlamydia-infected tissue. This result was corroborated in flow cytometry and immunohistochemistry studies that showed extant upper genital tract Chlamydia infection was associated with increased co-expression of CD200 receptor and CD206 (markers of alternative macrophage activation) by endometrial macrophages as well as increased expression of GATA-3 (the transcription factor regulating T(H)2 differentiation) by endometrial CD4(+) T cells. Also among women with genital tract Chlamydia infection, peripheral CD3(+) CD4(+) and CD3(+) CD4(-) cells that proliferated in response to ex vivo stimulation with inactivated chlamydial antigen secreted significantly more interleukin (IL)-4 than tumor necrosis factor, interferon-gamma, or IL-17; findings that repeated in T cells isolated from these same women 1 and 4 months after infection had been eradicated. Our results thus newly reveal that genital infection by an obligate intracellular bacterium induces polarization towards Type 2 immunity, including Chlamydia-specific T(H)2 development. Based on these findings, we now speculate that Type 2 immunity was selected by evolution as the host response to C. trachomatis in the human female genital tract to control infection and minimize immunopathological damage to vital reproductive structures.	[Miguel, Rodolfo D. Vicetti; Reighard, Seth D.; Matthews, Dean B.; Cherpes, Thomas L.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Harvey, Stephen A. K.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [LaFramboise, William A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cherpes, TL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.	cherpestl@upmc.edu	Miguel, Rodolfo D Vicetti/H-8651-2019	Miguel, Rodolfo D Vicetti/0000-0002-2494-8184; Reighard, Seth/0000-0002-3969-9651	National Institutes of Health [U19AI084024, R01HD072663]; University of Pittsburgh School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from the National Institutes of Health (U19AI084024 and R01HD072663) and the University of Pittsburgh School of Medicine. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, PLOS PATHOG, V11, P375; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Barclay AN, 2002, TRENDS IMMUNOL, V23, P285, DOI 10.1016/S1471-4906(02)02223-8; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cohen CR, 2005, J INFECT DIS, V192, P591, DOI 10.1086/432070; CONCA W, 1994, ARTHRITIS RHEUM, V37, P951, DOI 10.1002/art.1780370626; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hebbar V, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-124; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x; Jardim MJ, 2012, AM J RESP CELL MOL, V47, P536, DOI 10.1165/rcmb.2011-0160OC; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miguel RDV, 2012, MED HYPOTHESES, V79, P713, DOI 10.1016/j.mehy.2012.07.032; Miguel RDV, 2012, AM J REPROD IMMUNOL, V68, P499, DOI 10.1111/aji.12008; Miguel RDV, 2012, J IMMUNOL METHODS, V384, P191, DOI 10.1016/j.jim.2012.07.018; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Soo C, 1999, J CELL BIOCHEM, V74, P1; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tanaka G, 2005, INT IMMUNOL, V17, P797, DOI 10.1093/intimm/dxh260; Taylor BD, 2013, J INFECT DI IN PRESS; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Wang M, 2005, IMMUNOLOGY, V114, P166, DOI 10.1111/j.1365-2567.2005.02094.x; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49	37	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58565	10.1371/journal.pone.0058565	http://dx.doi.org/10.1371/journal.pone.0058565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23555586	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200090
J	Graham, SM; Raboud, J; McClelland, RS; Jaoko, W; Ndinya-Achola, J; Mandaliya, K; Overbaugh, J; Bayoumi, AM				Graham, Susan M.; Raboud, Janet; McClelland, R. Scott; Jaoko, Walter; Ndinya-Achola, Jeckoniah; Mandaliya, Kishor; Overbaugh, Julie; Bayoumi, Ahmed M.			Loss to Follow-Up as a Competing Risk in an Observational Study of HIV-1 Incidence	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CONTRACEPTIVE USE; INFECTION; ACQUISITION; WOMEN; MORTALITY; PROGRAMS; OUTCOMES; DISEASE; MOMBASA	Objective: Conventional survival estimates may be biased if loss to follow-up (LTF) is associated with the outcome of interest. Our goal was to assess whether the association between sexual risk behavior and HIV-1 acquisition changed after accounting for LTF with competing risks regression. Methods: HIV-1-seronegative women who enrolled in a Kenyan sex worker cohort from 1993-2007 were followed prospectively and tested for HIV at monthly clinic visits. Our primary predictor was self-reported sexual risk behavior in the past week, analyzed as a time-dependent covariate. Outcomes included HIV-1 acquisition and LTF. We analyzed the data using Cox proportional hazards regression and competing risks regression, in which LTF was treated as a competing event. Results: A total of 1,513 women contributed 4,150 person-years (py), during which 198 (13.1%) acquired HIV-1 infection (incidence, 4.5 per 100 py) and 969 (64.0%) were LTF (incidence, 23.4 per 100 py). After adjusting for potential confounders, women reporting unprotected sex with multiple partners were less likely to be lost to follow-up (adjusted sub-hazard ratio (aSHR) 0.50, 95% confidence interval (CI) 0.32-0.76, relative to no sexual activity). The risk of HIV-1 acquisition after reporting unprotected sex with multiple partners was similar with Cox regression (adjusted hazard ratio (aHR) 2.41, 95% CI 1.36-4.27) and competing risks regression (aSHR 2.47, 95% CI 1.33-4.58). Conclusions: Unprotected sex with multiple partners was associated with higher HIV-1 acquisition risk, but lower attrition. This differential attrition did not substantially bias Cox regression estimates when compared to competing risks regression results.	[Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan M.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Graham, Susan M.; McClelland, R. Scott; Jaoko, Walter; Ndinya-Achola, Jeckoniah] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Raboud, Janet] Univ Hlth Network, Div Clin Decis Making & Hlth Care, Toronto, ON, Canada; [McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Mandaliya, Kishor] PathCare, Mombasa, Kenya; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Overbaugh, Julie] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Bayoumi, Ahmed M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5B 1W8, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Graham, SM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	grahamsm@u.washington.edu	Jaoko, Walter/AAN-5048-2020; Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686; Jaoko, Walter/0000-0002-7134-6581	National Institutes of Health (NIH) [K23 AI-069990]; Ontario HIV Treatment Network Career Scientist Award; NIH [P01 HD64915, R01 AI38518, R01 AI71794, P30 AI027757]; NIH (National Institute of Allergy and Infectious Diseases (NIAID)); NIH (National Cancer Institute (NCI)); NIH (National Institute of Mental Health (NIMH)); NIH (National Institute on Drug Abuse (NIDA)); NIH (National Institute of Child Health and Human Development (NICHD)); NIH (National Heart, Lung, and Blood Institute (NHLBI)); NIH (National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038518, K23AI069990, R37AI038518, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario HIV Treatment Network Career Scientist Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Institute of Allergy and Infectious Diseases (NIAID)); NIH (National Cancer Institute (NCI))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (National Institute of Mental Health (NIMH)); NIH (National Institute on Drug Abuse (NIDA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (National Institute of Child Health and Human Development (NICHD))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (National Heart, Lung, and Blood Institute (NHLBI))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (National Institute on Aging (NIA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SMG was supported by National Institutes of Health (NIH) grant K23 AI-069990, JR was supported by an Ontario HIV Treatment Network Career Scientist Award, and AMB holds a Chair in Applied Health Services Research from the Canadian Institutes of Health Research and the Ontario Ministry of Health and Long-Term Care. Ongoing support for the Mombasa Cohort includes NIH grants P01 HD64915, R01 AI38518, and R01 AI71794. Additional infrastructure support for the Mombasa Field Site was provided by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chi BH, 2010, AM J EPIDEMIOL, V171, P924, DOI 10.1093/aje/kwq008; Chohan V, 2009, SEX TRANSM INFECT, V85, P489, DOI 10.1136/sti.2009.036103; Cole SR, 2010, AIDS, V24, P2423, DOI 10.1097/QAD.0b013e32833dd0ec; Corbett AM, 2009, PERSPECT SEX REPRO H, V41, P218, DOI 10.1363/4121809; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hoffmann O, 2004, SEX TRANSM INFECT, V80, P69, DOI 10.1136/sti.2004.011908; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Kristman VL, 2005, EUR J EPIDEMIOL, V20, P657, DOI 10.1007/s10654-005-7919-7; Lavreys L, 2004, J INFECT DIS, V189, P303, DOI 10.1086/380974; Lavreys L, 2004, AIDS, V18, P695, DOI 10.1097/00002030-200403050-00017; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; MARTIN HL, 1994, AIDS RES HUM RETROV, V10, pS235; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McClelland RS, 2011, SEX TRANSM DIS, V38, P429, DOI 10.1097/OLQ.0b013e31820369f6; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Richter LM, 2009, EVAL PROGRAM PLANN, V32, P197, DOI 10.1016/j.evalprogplan.2008.12.002; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Tan DHS, 2011, JAIDS-J ACQ IMM DEF, V58, P38, DOI 10.1097/QAI.0b013e3182282cfc; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	35	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59480	10.1371/journal.pone.0059480	http://dx.doi.org/10.1371/journal.pone.0059480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555041	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500090
J	Butler, MI; Stockwell, PA; Black, MA; Day, RC; Lamont, IL; Poulter, RTM				Butler, Margi I.; Stockwell, Peter A.; Black, Michael A.; Day, Robert C.; Lamont, Iain L.; Poulter, Russell T. M.			Pseudomonas syringae pv. actinidiae from Recent Outbreaks of Kiwifruit Bacterial Canker Belong to Different Clones That Originated in China	PLOS ONE			English	Article							MOBILE GENETIC ELEMENTS; CAUSAL AGENT; 1ST REPORT; GENOME; EVOLUTION; SEQUENCE; CHINENSIS; VIRULENCE; ALIGNMENT; TOOLS	A recently emerged plant disease, bacterial canker of kiwifruit (Actinidia deliciosa and A. chinensis), is caused by Pseudomonas syringae pv. actinidiae (PSA). The disease was first reported in China and Japan in the 1980s. A severe outbreak of PSA began in Italy in 2008 and has spread to other European countries. PSA was found in both New Zealand and Chile in 2010. To study the evolution of the pathogen and analyse the transmission of PSA between countries, genomes of strains from China and Japan (where the genus Actinidia is endemic), Italy, New Zealand and Chile were sequenced. The genomes of PSA strains are very similar. However, all strains from New Zealand share several single nucleotide polymorphisms (SNPs) that distinguish them from all other PSA strains. Similarly, all the PSA strains from the 2008 Italian outbreak form a distinct clonal group and those from Chile form a third group. In addition to the rare SNPs present in the core genomes, there is abundant genetic diversity in a genomic island that is part of the accessory genome. The island from several Chinese strains is almost identical to the island present in the New Zealand strains. The island from a different Chinese strain is identical to the island present in the strains from the recent Italian outbreak. The Chilean strains of PSA carry a third variant of this island. These genomic islands are integrative conjugative elements (ICEs). Sequencing of these ICEs provides evidence of three recent horizontal transmissions of ICE from other strains of Pseudomonas syringae to PSA. The analyses of the core genome SNPs and the ICEs, combined with disease history, all support the hypothesis of an independent Chinese origin for both the Italian and the New Zealand outbreaks and suggest the Chilean strains also originate from China.	[Butler, Margi I.; Stockwell, Peter A.; Black, Michael A.; Day, Robert C.; Lamont, Iain L.; Poulter, Russell T. M.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago	Butler, MI (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	margi.butler@otago.ac.nz	Black, Michael/F-1484-2010	Butler, Margi/0000-0001-6863-3961; Black, Michael/0000-0003-1174-6054; Poulter, Russell/0000-0001-5848-646X; Lamont, Iain/0000-0002-7601-6354	(Ministry of Business, Innovation, and Employment) New Zealand Technology Transfer Voucher [PROP-27820-VCH-SEEKAKIWI]; New Zealand Genomics Ltd at Otago University; New Zealand Genomics Ltd at Massey University; New Zealand Genomics Ltd; Seeka Kiwi Fruit Industries	(Ministry of Business, Innovation, and Employment) New Zealand Technology Transfer Voucher; New Zealand Genomics Ltd at Otago University; New Zealand Genomics Ltd at Massey University; New Zealand Genomics Ltd; Seeka Kiwi Fruit Industries	The authors received funding from an Ministry for Primary Industries (now Ministry of Business, Innovation, and Employment.) New Zealand Technology Transfer Voucher awarded to Seeka Kiwifruit Industries (PROP-27820-VCH-SEEKAKIWI) (http://voucher.msi.govt.nz). New Zealand Genomics Ltd (http://www.nzgenomics.co.nz) at Otago University and Massey University subsidised the HiSeq and MiSeq genome sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by New Zealand Genomics Ltd and Seeka Kiwi Fruit Industries. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2011, BACTERIAL CANC KIWIF; [Anonymous], 2011, DETAILS PSEUDOMONAS; Australian Government Department of Agriculture Fisheries and Forestry, 2011, DET AS STRAIN BACT C; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balestra G.M., 2010, NEW DIS REPORTS, V22; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Blakney AJC, 2011, FEMS MICROBIOL ECOL, V77, P546, DOI 10.1111/j.1574-6941.2011.01136.x; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chapman JR, 2012, PHYTOPATHOLOGY, V102, P1034, DOI 10.1094/PHYTO-03-12-0064-R; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Ferrante P, 2009, J PHYTOPATHOL, V157, P768, DOI 10.1111/j.1439-0434.2009.01550.x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Korber B, 2000, HIV SIGNATURE SEQUEN; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Martuza M., 2012, 2012 IEEE 2 PORT M B, P1; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; O'Brien HE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-141; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, TN NUMBER REGISTRY; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, IS FINDER DATABASE; Studholme DJ, 2011, MOL PLANT PATHOL, V12, P829, DOI [10.1111/J.1364-3703.2011.00713.X, 10.1111/j.1364-3703.2011.00713.x]; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; Wang Z., 1992, J SW AGR U; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	46	97	110	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e57464	10.1371/journal.pone.0057464	http://dx.doi.org/10.1371/journal.pone.0057464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23555547	gold, Green Published, Green Submitted			2022-12-27	WOS:000315519000116
J	Bao, SJ; Zhu, LB; Zhuang, Q; Wang, L; Xu, PX; Itoh, K; Holzman, IR; Lin, J				Bao, Sujin; Zhu, Libin; Zhuang, Qiang; Wang, Lucia; Xu, Pin-Xian; Itoh, Keiji; Holzman, Ian R.; Lin, Jing			Distribution Dynamics of Recombinant Lactobacillus in the Gastrointestinal Tract of Neonatal Rats	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NECROTIZING ENTEROCOLITIS; MONITOR LACTOBACILLUS; PROBIOTICS; DELIVERY; INFANTS	One approach to deliver therapeutic agents, especially proteins, to the gastro-intestinal (GI) tract is to use commensal bacteria as a carrier. Germs Lactobacillus is an attractive candidate for use in this approach. However, a system for expressing exogenous proteins at a high level has been lacking in Lactobacillus. Moreover, it will be necessary to introduce the recombinant Lactobacillus into the GI tract, ideally by oral administration. Whether orally administered Lactobacillus can each and reside in the GI tract has not been explored in neonates. In this study, we have examined these issues in neonatal rats. To achieve a high level of protein expression in Lactobacillus, we tested the impact of three promoters and two backbones on protein expression levels using mRFP1, a red fluorescent protein, as a reporter. We found that a combination of an L-lactate dehydrogenase (IdhL) promoter of Lactobacillus sakei with a backbone from pLEM415 yielded the highest level of reporter expression. When this construct was used to transform Lactobacillus case!, Lactobacillus delbrueckii and Lactobacillus acidophilus, high levels of mRFP1 were detected in all these species and colonies of transformed Lactobacillus appeared pink under visible light. To test whether orally administered Lactobacillus can be retained in the GI tract of neonates, we fed the recombinant Lactobacillus casei to neonatal rats. We found that about 3% of the bacteria were retained in the GI tract of the rats at 24 h after oral feeding with more recombinant Lactobacillus in the stomach and small intestine than in the cecum and colon. No mortality was observed throughout this study with Lactobacillus. In contrast, all neonatal rats died within 24 hours after fed with transformed E. coli. Taken together, our results indicate that Lactobacillus has the potential to be used as a vehicle for the delivery of therapeutic agents to neonates.	[Bao, Sujin] St James Sch Med, Bonaire, Netherlands; [Bao, Sujin; Zhu, Libin; Lin, Jing] Wenzhou Med Coll, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Zhuang, Qiang] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Peoples R China; [Wang, Lucia; Xu, Pin-Xian; Itoh, Keiji; Holzman, Ian R.; Lin, Jing] Icahn Sch Med Mt Sinai, New York, NY USA	Wenzhou Medical University; Wenzhou Medical University; Icahn School of Medicine at Mount Sinai	Bao, SJ (corresponding author), St James Sch Med, Bonaire, Netherlands.	baosujin@yahoo.com; jing.lin@mssm.edu	Lin, Jing/I-5293-2019	Lin, Jing/0000-0002-4405-134X	NIH [R03-HD060753]; KMD Foundation [33431-7746]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KMD Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the NIH R03-HD060753 (to J.L.) and the KMD Foundation (2424 N Federal Hwy Ste 454 Boca Raton, Florida 33431-7746) (to S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Duwat P, 1997, J BACTERIOL, V179, P4473, DOI 10.1128/jb.179.14.4473-4479.1997; Fanaroff AA, 2007, AM J OBSTET GYNECOL, V196; Fons M, 1997, PLASMID, V37, P199, DOI 10.1006/plas.1997.1290; Gory L, 2001, FEMS MICROBIOL LETT, V194, P127, DOI 10.1111/j.1574-6968.2001.tb09457.x; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Kelly D, 2011, J Pediatr Gastroenterol Nutr, V53 Suppl 2, pS32; Khani Soghra, 2012, Inflammation & Allergy Drug Targets, V11, P79; Kuwahara A, 2010, J BIOSCI BIOENG, V109, P189, DOI 10.1016/j.jbiosc.2009.08.002; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; MARTEAU P, 1993, FEMS MICROBIOL REV, V12, P207, DOI [10.1016/0168-6445(93)90064-G, 10.1111/j.1574-6976.1993.tb00019.x]; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; THADEPALLI H, 1979, AM J SURG, V138, P845, DOI 10.1016/0002-9610(79)90309-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vanderhoof JA, 2000, J PEDIATR GASTR NUTR, V30, pS34, DOI 10.1097/00005176-200000002-00006; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yu QH, 2007, FEMS MICROBIOL LETT, V275, P207, DOI 10.1111/j.1574-6968.2007.00877.x	24	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60007	10.1371/journal.pone.0060007	http://dx.doi.org/10.1371/journal.pone.0060007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544119	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700078
J	Hinkle, W; Cordell, M; Leibel, R; Rosenbaum, M; Hirsch, J				Hinkle, William; Cordell, Michael; Leibel, Rudy; Rosenbaum, Michael; Hirsch, Joy			Effects of Reduced Weight Maintenance and Leptin Repletion on Functional Connectivity of the Hypothalamus in Obese Humans	PLOS ONE			English	Article							MUSCLE WORK EFFICIENCY; SKELETAL-MUSCLE; RECOMBINANT LEPTIN; NEUROENDOCRINE ADAPTATIONS; PEG-OB; REWARD; PERTURBATION; SATIATION; CIRCUITRY; APPETITE	Treating obesity has proven to be an intractable challenge, in part, due to the difficulty of maintaining reduced weight. In our previous studies of in-patient obese subjects, we have shown that leptin repletion following a 10% or greater weight loss reduces many of the metabolic (decreased energy expenditure, sympathetic nervous system tone, and bioactive thyroid hormones) and behavioral (delayed satiation) changes that favor regain of lost weight. FMRI studies of these same subjects have shown leptin-sensitive increases in activation of the right hypothalamus and reduced activation of the cingulate, medial frontal and parahippocampal gryi, following weight loss, in response to food stimuli. In the present study, we expanded our cohort of in-patient subjects and employed psychophysiological interaction (PPI) analysis to examine changes in the functional connectivity of the right hypothalamus. During reduced-weight maintenance with placebo injections, the functional connectivity of the hypothalamus increased with visual areas and the dorsal anterior cingulate (dorsal ACC) in response to food cues, consistent with higher sensitivity to food. During reduced-weight maintenance with leptin injections, however, the functional connectivity of the right hypothalamus increased with the mid-insula and the central and parietal operculae, suggesting increased coupling with the interoceptive system, and decreased with the orbital frontal cortex, frontal pole and the dorsal ACC, suggesting a down-regulated sensitivity to food. These findings reveal neural mechanisms that may underlie observed changes in sensitivity to food cues in the obese population during reduced-weight maintenance and leptin repletion.	[Hinkle, William; Hirsch, Joy] Columbia Univ, Dept Neurosci, Med Ctr, New York Presbyterian Med Ctr, New York, NY 10027 USA; [Cordell, Michael] Columbia Univ, Inst Human Nutr, Med Ctr, New York Presbyterian Med Ctr, New York, NY 10032 USA; [Leibel, Rudy; Rosenbaum, Michael] Columbia Univ, Dept Pediat, Div Mol Genet, Naomi Berrie Diabet Ctr,Med Ctr,New York Presbyte, New York, NY 10027 USA; [Hirsch, Joy] Columbia Univ, Dept Radiol, Med Ctr, New York Presbyterian Med Ctr, New York, NY USA; [Hirsch, Joy] Columbia Univ, Dept Psychol, Med Ctr, New York Presbyterian Med Ctr, New York, NY 10027 USA; [Hinkle, William; Cordell, Michael; Hirsch, Joy] Columbia Univ, FMRI Res Ctr, Med Ctr, New York Presbyterian Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Hirsch, J (corresponding author), Columbia Univ, Dept Neurosci, Med Ctr, New York Presbyterian Med Ctr, New York, NY 10027 USA.	joy.hirsch@yale.edu		Hirsch, Joy/0000-0002-1418-6489	NIH [DK64473, RR00645]; NIH/National Center for Research Resources [UL1 RR024156]; Department of Defense [W56HZV-04-P-L]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064773, P30DK026687] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	External funding supporting this study came from: NIH grants DK64473 and RR00645 (http://grants.nih.gov/grants/oer.htm), NIH/National Center for Research Resources grant UL1 RR024156 (http://www.nih.gov/about/almanac/organization/NCRR.htm#programs), and Department of Defense grant W56HZV-04-P-L (http://contracting.tacom.army.mil/CFDATA/SOL/SOL01.CFM). Recombinant methionyl human leptin was generously provided by Amylin Pharmaceuticals Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronne Louis J, 2007, Clin Cornerstone, V8, P29, DOI 10.1016/S1098-3597(07)80026-3; Baldwin KM, 2011, AM J PHYSIOL-REG I, V301, pR1259, DOI 10.1152/ajpregu.00397.2011; Binkofski F, 2013, BRAIN LANG, V127, P222, DOI 10.1016/j.bandl.2012.07.007; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Buot A, 2012, REV NEUROL-FRANCE, V168, P569, DOI 10.1016/j.neurol.2012.06.015; Caron E, 2010, J COMP NEUROL, V518, P459, DOI 10.1002/cne.22219; Cornier MA, 2007, AM J CLIN NUTR, V86, P965, DOI 10.1093/ajcn/86.4.965; Cornier MA, 2012, PHYSIOL BEHAV, V105, P1028, DOI 10.1016/j.physbeh.2011.11.023; Cornier MA, 2011, PHYSIOL BEHAV, V104, P608, DOI 10.1016/j.physbeh.2011.04.003; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Frank S, 2011, J CLIN ENDOCR METAB, V96, pE1283, DOI 10.1210/jc.2010-2713; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Hauber W, 2009, CEREB CORTEX, V19, P2240, DOI 10.1093/cercor/bhn241; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hukshorn CJ, 2003, AM J CLIN NUTR, V77, P771, DOI 10.1093/ajcn/77.4.771; Hukshorn CJ, 2003, EUR J ENDOCRINOL, V148, P649, DOI 10.1530/eje.0.1480649; Kampe J, 2009, EUR J NEUROSCI, V30, P415, DOI 10.1111/j.1460-9568.2009.06818.x; Kelly C, 2012, NEUROIMAGE, V61, P1129, DOI 10.1016/j.neuroimage.2012.03.021; Kissileff HR, 2012, AM J CLIN NUTR, V95, P309, DOI 10.3945/ajcn.111.012385; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; Nummenmaa L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031089; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Phelan S, 2005, ARCH INTERN MED, V165, P2430, DOI 10.1001/archinte.165.20.2430-a; Philpot KB, 2005, NEUROSCIENCE, V135, P915, DOI 10.1016/j.neuroscience.2005.06.064; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Rosenbaum M, 2010, BRAIN RES, V1350, P95, DOI 10.1016/j.brainres.2010.05.062; Rothkirch M, 2012, NEUROIMAGE, V62, P1717, DOI 10.1016/j.neuroimage.2012.06.016; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Tsukiura T, 2011, NEUROIMAGE, V54, P653, DOI 10.1016/j.neuroimage.2010.07.046; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Westerterp-Plantenga MS, 1998, INT J OBESITY, V22, P14, DOI 10.1038/sj.ijo.0800538; Westerterp-Plantenga MS, 2001, AM J CLIN NUTR, V74, P426; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281	54	58	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59114	10.1371/journal.pone.0059114	http://dx.doi.org/10.1371/journal.pone.0059114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555620	Green Published, gold			2022-12-27	WOS:000316546400021
J	Ferreira, R; Artali, R; Benoit, A; Gargallo, R; Eritja, R; Ferguson, DM; Sham, YY; Mazzini, S				Ferreira, Ruben; Artali, Roberto; Benoit, Adam; Gargallo, Raimundo; Eritja, Ramon; Ferguson, David M.; Sham, Yuk Y.; Mazzini, Stefania			Structure and Stability of Human Telomeric G-Quadruplex with Preclinical 9-Amino Acridines	PLOS ONE			English	Article							PROXIMAL PROMOTER REGION; FORCE-FIELD; DNA; BINDING; TARGET; RECOGNITION; SELECTIVITY; DYNAMICS; GENE; NMR	G-quadruplexes are higher-order DNA structures formed from guanine-rich sequences, and have been identified as attractive anticancer drug targets. Elucidating the three-dimensional structure of G-quadruplex with 9-amino acridines and the specific interactions involved in binding selectivity are the key to understanding their mechanism of action. Fluorescence titration assays, competitive dialysis and NMR studies have been used to study the binding specificity of 9-amino acridines to DNA. Structural models of the complexes with the telomeric DNA G-quadruplex based on NMR measurements were developed and further examined by molecular dynamics simulations and free energy calculations. Selective binding of 9-amino acridines for G-quadruplex sequences were observed. These compounds bind between A and G-tetrads, involving significant pi-pi interactions and several strong hydrogen bonds. The specific interactions between different moieties of the 9-amino acridines to the DNA were examined and shown to play a significant role in governing the overall stabilities of DNA G-quadruplex complexes. Both 9-amino acridines, with similar binding affinities to the G-quadruplex, were shown to induce different level of structural stabilization through intercalation. This unique property of altering structural stability is likely a contributing factor for affecting telomerase function and, subsequently, the observed differences in the anticancer activities between the two 9-amino acridines.	[Ferreira, Ruben; Eritja, Ramon] CIBER BBN Networking Ctr Bioengn Biomat & Nanomed, IQAC CSIC, Inst Res Biomed, Barcelona, Spain; [Benoit, Adam; Ferguson, David M.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Gargallo, Raimundo] Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Spain; [Sham, Yuk Y.] Univ Minnesota, Acad Hlth Ctr, Ctr Drug Design, Minneapolis, MN USA; [Mazzini, Stefania] Univ Milan, Dept Organ Chem, Dept Food Environm & Nutr Sci DEFENS, Milan, Italy	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Minnesota System; University of Minnesota Twin Cities; University of Barcelona; University of Minnesota System; University of Minnesota Twin Cities; University of Milan	Mazzini, S (corresponding author), Univ Milan, Dept Organ Chem, Dept Food Environm & Nutr Sci DEFENS, Milan, Italy.	stefania.mazzini@unimi.it	Sham, Yuk Y/A-6472-2011; Gargallo, Raimundo/A-6084-2017; Eritja, Ramon/B-5613-2008	Sham, Yuk Y/0000-0003-2601-8930; Gargallo, Raimundo/0000-0001-8716-8356; Eritja, Ramon/0000-0001-5383-9334; Scaglioni, Leonardo/0000-0002-9971-100X; Ferguson, David/0000-0001-6294-8057	Spanish Ministerio de Ciencia e Innovacion MICINN [CTQ2008-00177, CTQ2010-20541]; Generalitat de Catalunya [2009/SGR/208]; EU [MP0802]; University of Milano [PUR09]; MIUR [PRIN09]	Spanish Ministerio de Ciencia e Innovacion MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); EU(European Commission); University of Milano; MIUR(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by grants from Spanish Ministerio de Ciencia e Innovacion MICINN (CTQ2008-00177, CTQ2010-20541), Generalitat de Catalunya, (2009/SGR/208), the EU COST action (MP0802), the University of Milano (PUR09) and by MIUR (Funds PRIN09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimondo P. B., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P219, DOI 10.2174/1568011013354642; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Belmont P, 2007, ANTI-CANCER AGENT ME, V7, P139, DOI 10.2174/187152007780058669; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BORTOLINI R, 1994, APPL MAGN RESON, V7, P71, DOI 10.1007/BF03162548; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Campbell NH, 2009, BIOCHEMISTRY-US, V48, P1675, DOI 10.1021/bi802233v; Cheng MK, 2008, J MED CHEM, V51, P963, DOI 10.1021/jm070587t; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Denny WA, 2002, CURR MED CHEM, V9, P1655; Dyson RM, 1997, ANAL CHIM ACTA, V353, P381, DOI 10.1016/S0003-2670(97)87800-2; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Ferreira R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/489060; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; Frisch M.J., 2016, GAUSSIAN16 REV B01; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goddard T. D., 2004, SPARKY, V3; Goodell JR, 2008, J MED CHEM, V51, P179, DOI 10.1021/jm701228e; Goodell JR, 2006, BIOORGAN MED CHEM, V14, P5467, DOI 10.1016/j.bmc.2006.04.044; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Granotier C, 2005, NUCLEIC ACIDS RES, V33, P4182, DOI 10.1093/nar/gki722; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mazzini S, 2004, ORG BIOMOL CHEM, V2, P505, DOI 10.1039/b312780j; Mazzini S, 1998, J CHEM SOC PERK T 2, P1983, DOI 10.1039/a802350f; Mazzini S, 2010, BIOORGAN MED CHEM, V18, P1497, DOI 10.1016/j.bmc.2010.01.012; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naasani I, 1999, CANCER RES, V59, P4004; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oppegard LM, 2009, EUR J PHARMACOL, V602, P223, DOI 10.1016/j.ejphar.2008.11.044; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Ragazzon P, 2007, METHODS, V43, P313, DOI 10.1016/j.ymeth.2007.08.003; Ragg E, 1998, J CHEM SOC P2, V2, P149; Rao L, 2011, J PHYS CHEM B, V115, P13701, DOI 10.1021/jp207265s; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sponer J, METHODS; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Topcu Z, 2001, J CLIN PHARM THER, V26, P405, DOI 10.1046/j.1365-2710.2001.00368.x; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; WANG Y, 1992, BIOCHEMISTRY-US, V31, P8112, DOI 10.1021/bi00150a002; White EW, 2007, BIOPHYS CHEM, V126, P140, DOI 10.1016/j.bpc.2006.06.006; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0	65	25	26	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57701	10.1371/journal.pone.0057701	http://dx.doi.org/10.1371/journal.pone.0057701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554865	Green Published, gold			2022-12-27	WOS:000316409800009
J	Hansen, R; Berry, SH; Mukhopadhya, I; Thomson, JM; Saunders, KA; Nicholl, CE; Bisset, WM; Loganathan, S; Mahdi, G; Kastner-Cole, D; Barclay, AR; Bishop, J; Flynn, DM; McGrogan, P; Russell, RK; El-Omar, EM; Hold, GL				Hansen, Richard; Berry, Susan H.; Mukhopadhya, Indrani; Thomson, John M.; Saunders, Karin A.; Nicholl, Charlotte E.; Bisset, W. Michael; Loganathan, Sabarinathan; Mahdi, Gamal; Kastner-Cole, Dagmar; Barclay, Andy R.; Bishop, Jon; Flynn, Diana M.; McGrogan, Paraic; Russell, Richard K.; El-Omar, Emad M.; Hold, Georgina L.			The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: The BISCUIT Study	PLOS ONE			English	Article							CAMPYLOBACTER-CONCISUS; CROHNS; DIVERSITY; CHILDREN; ASSOCIATION; IDENTIFICATION; BILE; PCR	Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment. Microaerophilic bacteria can exploit the ecological niche of the intestinal epithelium; Helicobacter and Campylobacter are previously implicated in IBD pathogenesis. We set out to study these and other microaerophilic bacteria in de-novo paediatric IBD. Patients and Methods: 100 children undergoing colonoscopy were recruited including 44 treatment naive de-novo IBD patients and 42 with normal colons. Colonic biopsies were subjected to microaerophilic culture with Gram-negative isolates then identified by sequencing. Biopsies were also PCR screened for the specific microaerophilic bacterial groups: Helicobacteraceae, Campylobacteraceae and Sutterella wadsworthensis. Results: 129 Gram-negative microaerophilic bacterial isolates were identified from 10 genera. The most frequently cultured was S. wadsworthensis (32 distinct isolates). Unusual Campylobacter were isolated from 8 subjects (including 3 C. concisus, 1 C. curvus, 1 C. lari, 1 C. rectus, 3 C. showae). No Helicobacter were cultured. When comparing IBD vs. normal colon control by PCR the prevalence figures were not significantly different (Helicobacter 11% vs. 12%, p = 1.00; Campylobacter 75% vs. 76%, p = 1.00; S. wadsworthensis 82% vs. 71%, p = 0.312). Conclusions: This study offers a comprehensive overview of the microaerophilic microbiota of the paediatric colon including at IBD onset. Campylobacter appear to be surprisingly common, are not more strongly associated with IBD and can be isolated from around 8% of paediatric colonic biopsies. S. wadsworthensis appears to be a common commensal. Helicobacter species are relatively rare in the paediatric colon.	[Hansen, Richard; Berry, Susan H.; Mukhopadhya, Indrani; Thomson, John M.; Saunders, Karin A.; Nicholl, Charlotte E.; El-Omar, Emad M.; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Aberdeen, Scotland; [Hansen, Richard] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Bisset, W. Michael; Loganathan, Sabarinathan; Mahdi, Gamal] Royal Aberdeen Childrens Hosp, Dept Paediat Gastroenterol, Aberdeen, Scotland; [Kastner-Cole, Dagmar] Univ Dundee, Ninewells Hosp & Med Sch, Dept Paediat, Dundee DD1 9SY, Scotland; [Barclay, Andy R.; Bishop, Jon; Flynn, Diana M.; McGrogan, Paraic; Russell, Richard K.] Royal Hosp Sick Children, Dept Paediat Gastroenterol, Glasgow G3 8SJ, Lanark, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Dundee; University of Glasgow	Hold, GL (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Foresterhill, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mukhopadhya, Indrani/K-1113-2019; Hold, Georgina Louise/AAG-9923-2020; El-Omar, Emad/AAT-7780-2021	Mukhopadhya, Indrani/0000-0003-2577-518X; Hold, Georgina Louise/0000-0001-7573-3397; Hansen, Richard/0000-0002-3944-6646; El-Omar, Emad/0000-0002-0011-3924	Chief Scientist Office in Scotland [CAF/08/01]; NHS Research Scotland career fellowship award; Yorkhill IBD fund; Chief Scientist Office [CAF/08/01] Funding Source: researchfish	Chief Scientist Office in Scotland; NHS Research Scotland career fellowship award; Yorkhill IBD fund; Chief Scientist Office	This work was funded by a Clinical Academic Training Fellowship from the Chief Scientist Office in Scotland (CAF/08/01) which also funded the salary of RH. The Royal Hospital for Sick Children, Glasgow IBD team is generously supported by the Catherine McEwan Foundation and the Yorkhill IBD fund. RKR is supported by an NHS Research Scotland career fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SJ, 2003, ALIMENT PHARM THER, V18, P481, DOI 10.1046/j.1365-2036.2003.01703.x; Benach JL, 2012, MBIO, V3, DOI 10.1128/mBio.00019-12; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bohr URM, 2004, J CLIN MICROBIOL, V42, P2766, DOI 10.1128/JCM.42.6.2766-2768.2004; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; ELOMAR E, 1994, GUT, V35, P1385, DOI 10.1136/gut.35.10.1385; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Grehan M, 2004, J CLIN MICROBIOL, V42, P874, DOI 10.1128/JCM.42.2.874-876.2004; Grehan M, 2002, APPL ENVIRON MICROB, V68, P5164, DOI 10.1128/AEM.68.10.5164-5166.2002; Hansen R, 2010, J GASTROENTEROL, V45, P266, DOI 10.1007/s00535-009-0191-y; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Henderson P, 2012, INFLAMM BOWEL DIS, V18, P999, DOI 10.1002/ibd.21797; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Hope B, 2012, ARCH DIS CHILD, V97, P590, DOI 10.1136/archdischild-2011-300651; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaakoush NO, 2010, HELICOBACTER, V15, P549, DOI 10.1111/j.1523-5378.2010.00792.x; Keenan JI, 2010, COLORECTAL DIS, V12, P48, DOI 10.1111/j.1463-1318.2008.01672.x; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kugathasan S, 2007, GUT, V56, P1696, DOI 10.1136/gut.2006.116467; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Laharie D, 2009, ALIMENT PHARM THER, V30, P283, DOI 10.1111/j.1365-2036.2009.04034.x; Lastovica AJ, 2000, J CLIN MICROBIOL, V38, P2798; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2008, HELICOBACTER, V13, P234, DOI 10.1111/j.1523-5378.2008.00607.x; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Martin-de-Carpi J, 2013, INFLAMM BOWEL DIS, V19, P73, DOI 10.1002/ibd.22980; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076; Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Wexler HM, 1996, INT J SYST BACTERIOL, V46, P252, DOI 10.1099/00207713-46-1-252; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zhang L, 2006, J CLIN MICROBIOL, V44, P2276, DOI 10.1128/JCM.02017-05; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	50	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58825	10.1371/journal.pone.0058825	http://dx.doi.org/10.1371/journal.pone.0058825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554935	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000316252500048
J	Khusal, R; Dias, BD; Moodley, K; Penny, C; Reusch, U; Knackmuss, S; Little, M; Weiss, SFT				Khusal, Raksha; Dias, Bianca Da Costa; Moodley, Kiashanee; Penny, Clement; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Weiss, Stefan F. T.			In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37kDa/67kDa Laminin Receptor	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; CELLS; PROTEIN; LUNG; INVOLVEMENT; PROGRESSION; INVASION; COLON; GENE	The 37kDa/67kDa laminin receptor (LRP/LR) is a central receptor mediating interactions between tumour cells and the basement membrane and is thereby a key player in adhesion and invasion, essential processes in metastatic cancer. To affect continued tumour growth, tumours induce angiogenesis for the constant delivery of nutrients and oxygen. This study aims to determine the blocking effect of the anti-LRP/LR specific antibody, W3 on the angiogenic potential of HUVE (human umbilical vein endothelial) cells. Flow cytometric analysis revealed that 97% of HUVE cells display cell surface LRP/LR. An angiogenesis assay was conducted employing HUVE cells seeded on the basement membrane reconstituent Matrigel (TM) supplemented with the pro-angiogenic factor vascular endothelial growth factor (VEGF). Post 18h incubation at 37 degrees C tubular structures, namely tube lengths were assessed. Treatment of established tubular structures with 100 mg/ml anti-LRP/LR specific antibody completely blocked angiogenesis. Our findings suggest a central role of the 37kDa/67kDa LRP/LR in tube formation and recommends anti-LRP/LR specific antibodies as potential therapeutic tools for treatment of tumour angiogenesis.	[Khusal, Raksha; Dias, Bianca Da Costa; Moodley, Kiashanee; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Penny, Clement] Univ Witwatersrand, Dept Internal Med, Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed Therapeut AG, Heidelberg, Germany	University of Witwatersrand; University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	stefan.weiss@wits.ac.za			National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	This work was supported by the National Research Foundation, the Republic of South Africa and the Medical Research Council, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; Ardini E, 2002, CANCER RES, V62, P1321; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Berno V, 2005, ENDOCR-RELAT CANCER, V12, P393, DOI 10.1677/erc.1.00870; Chen ZJ, 2009, J NEURO-ONCOL, V92, P121, DOI 10.1007/s11060-008-9742-y; CIOCE V, 1991, J NATL CANCER I, V83, P29, DOI 10.1093/jnci/83.1.29; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fontanini G, 1997, CLIN CANCER RES, V3, P861; GASPARINI G, 1995, INT J CANCER, V60, P604, DOI 10.1002/ijc.2910600506; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hamid SA, 2003, MICROVASC RES, V66, P159, DOI 10.1016/S0026-2862(03)00054-2; Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45; KLAGSBRUN M, 1991, J CELL BIOCHEM, V47, P199, DOI 10.1002/jcb.240470302; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Moehler TM, 2008, J CELL PHYSIOL, V215, P27, DOI 10.1002/jcp.21285; Moodley K, PLOS ONE IN PRESS; Nadji M, 1999, CANCER-AM CANCER SOC, V85, P432, DOI 10.1002/(SICI)1097-0142(19990115)85:2<432::AID-CNCR22>3.0.CO;2-J; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Pelosi G, 1997, J PATHOL, V183, P62, DOI 10.1002/(SICI)1096-9896(199709)183:1<62::AID-PATH1095>3.0.CO;2-A; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	39	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58888	10.1371/journal.pone.0058888	http://dx.doi.org/10.1371/journal.pone.0058888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554951	Green Published, gold			2022-12-27	WOS:000316252500053
J	Pelzer, ES; Allan, JA; Waterhouse, MA; Ross, T; Beagley, KW; Knox, CL				Pelzer, Elise S.; Allan, John A.; Waterhouse, Mary A.; Ross, Tara; Beagley, Kenneth W.; Knox, Christine L.			Microorganisms within Human Follicular Fluid: Effects on IVF	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; IMMUNODEFICIENCY-VIRUS TYPE-1; STIMULATING-HORMONE BINDING; MICROBIAL-FLORA; EMBRYO-TRANSFER; GARDNERELLA-VAGINALIS; BACTERIAL VAGINOSIS; ENDOMETRIUM; INFERTILITY; RECURRENCE	Our previous study reported microorganisms in human follicular fluid. The objective of this study was to test human follicular fluid for the presence of microorganisms and to correlate these findings with the in vitro fertilization (IVF) outcomes. In this study, 263 paired follicular fluids and vaginal swabs were collected from women undergoing IVF cycles, with various causes for infertility, and were cultured to detect microorganisms. The cause of infertility and the IVF outcomes for each woman were correlated with the microorganisms detected within follicular fluid collected at the time of transvaginal oocyte retrieval. Microorganisms isolated from follicular fluids were classified as: (1) 'colonizers' if microorganisms were detected within the follicular fluid, but not within the vaginal swab (at the time of oocyte retrieval); or (2) 'contaminants' if microorganisms detected in the vagina at the time of oocyte retrieval were also detected within the follicular fluid. The presence of Lactobacillus spp. in ovarian follicular fluids was associated with embryo maturation and transfer. This study revealed microorganisms in follicular fluid itself and that the presence of particular microorganisms has an adverse affect on IVF outcomes as seen by an overall decrease in embryo transfer rates and pregnancy rates in both fertile and infertile women, and live birth rates in women with idiopathic infertility. Follicular fluid microorganisms are a potential cause of adverse pregnancy outcomes in IVF in both infertile women and in fertile women with infertile male partners.	[Pelzer, Elise S.; Beagley, Kenneth W.; Knox, Christine L.] Queensland Univ Technol, Fac Sci & Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Pelzer, Elise S.; Waterhouse, Mary A.] Wesley Hosp, Womens Hlth Lab, Wesley Res Inst, Auchenflower, Qld, Australia; [Allan, John A.; Ross, Tara] Wesley Hosp, Wesley Hosp, Wesley Monash IVF, Auchenflower, Qld, Australia	Queensland University of Technology (QUT); Wesley Hospital; Wesley Hospital	Pelzer, ES (corresponding author), Queensland Univ Technol, Fac Sci & Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	epelzer@wesleyresearch.com.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Pelzer, Elise/0000-0002-9825-7968; Knox, Christine/0000-0003-3997-6812	Wesley Research Institute	Wesley Research Institute	This work was supported by a Wesley Research Institute Grant. Laboratory work was performed in the John and Wendy Thorsen Women's Health Laboratory at the Wesley Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fozan H, 2003, OBSTET GYNECOL, V101, P164, DOI 10.1016/S0029-7844(02)02446-8; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bricou A, 2008, EUR J OBSTET GYN R B, V138, P127, DOI 10.1016/j.ejogrb.2008.01.014; Busacca M, 2009, J MINIM INVAS GYN, V16, P142, DOI 10.1016/j.jmig.2008.12.013; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cottell E, 1996, FERTIL STERIL, V66, P776, DOI 10.1016/S0015-0282(16)58635-X; Debattista Joseph, 2004, Infect Dis Obstet Gynecol, V12, P135, DOI 10.1080/10647440400020703; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; Egbase PE, 1996, HUM REPROD, V11, P1687; Egbase PE, 1999, LANCET, V354, P651, DOI 10.1016/S0140-6736(99)02415-0; Fanchin R, 1998, FERTIL STERIL, V70, P866, DOI 10.1016/S0015-0282(98)00277-5; Fukuda M, 2000, HUM REPROD, V15, P1921, DOI 10.1093/humrep/15.9.1921; GOULET M, 1995, J CLIN MICROBIOL, V33, P2823, DOI 10.1128/JCM.33.11.2823-2825.1995; GURGAN T, 1993, HUM REPROD, V8, P508; Hyman RW, 2012, J ASSIST REPROD GEN, V29, P105, DOI 10.1007/s10815-011-9694-6; Jakobsson Tell, 2008, Ann Clin Microbiol Antimicrob, V7, P14, DOI 10.1186/1476-0711-7-14; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; KLEBANOFF SJ, 1991, J EXP MED, V174, P289, DOI 10.1084/jem.174.1.289; Lan KC, 2010, FERTIL STERIL, V93, P2269, DOI 10.1016/j.fertnstert.2008.12.123; Last RJ., 1984, ANATOMY REGIONAL APP; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; McClure EM, 2009, SEMIN FETAL NEONAT M, V14, P182, DOI 10.1016/j.siny.2009.02.003; MOLLER BR, 1985, J REPROD FERTIL, V73, P237; Moore DE, 2000, FERTIL STERIL, V74, P1118, DOI 10.1016/S0015-0282(00)01624-1; Pelzer ES, 2011, HUM REPROD, V26, P1799, DOI 10.1093/humrep/der108; POTASHNIK G, 1987, BRIT MED J, V294, P219, DOI 10.1136/bmj.294.6566.219; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Sharpe K, 2006, FERTIL STERIL, V86, P11; SLUSS PM, 1983, BIOL REPROD, V29, P335, DOI 10.1095/biolreprod29.2.335; SLUSS PM, 1983, BIOL REPROD, V29, P1105, DOI 10.1095/biolreprod29.5.1105; SLUSS PM, 1994, EUR J ENDOCRINOL, V130, P259, DOI 10.1530/eje.0.1300259; SPENCE MR, 1982, SEX TRANSM DIS, V9, P37, DOI 10.1097/00007435-198201000-00007; Srinivasan S, 2008, INTERDISCIP PERSPECT, V2008; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Sznurkowski Jacek, 2005, Ginekol Pol, V76, P33; Toth A., 2011, Clinical and Experimental Medical Journal, V5, P143; Toth A, 2007, J GYNECOLOGY OBSTET, P7; Vercellini P, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.010; Viniker DA, 1999, HUM REPROD UPDATE, V5, P373, DOI 10.1093/humupd/5.4.373; WIEBOLD JL, 1987, J REPROD FERTIL, V79, P125, DOI 10.1530/jrf.0.0790125; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	45	56	62	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59062	10.1371/journal.pone.0059062	http://dx.doi.org/10.1371/journal.pone.0059062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554970	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500064
J	Stipp, RN; Boisvert, H; Smith, DJ; Hofling, JF; Duncan, MJ; Mattos-Graner, RO				Stipp, Rafael N.; Boisvert, Heike; Smith, Daniel J.; Hoefling, Jose F.; Duncan, Margaret J.; Mattos-Graner, Renata O.			CovR and VicRK Regulate Cell Surface Biogenesis Genes Required for Biofilm Formation in Streptococcus mutans	PLOS ONE			English	Article							GLUCAN-BINDING-PROTEIN; GLUCOSYLTRANSFERASE GTFBC OPERON; SIGNAL-TRANSDUCTION PATHWAY; YYCF RESPONSE REGULATOR; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; ORAL STREPTOCOCCI; MUREIN HYDROLASE; PNEUMONIAE R6; IN-VIVO	The two-component system VicRK and the orphan regulator CovR of Streptococcus mutans co-regulate a group of virulence genes associated with the synthesis of and interaction with extracellular polysaccharides of the biofilm matrix. Knockout mutants of vicK and covR display abnormal cell division and morphology phenotypes, although the gene function defects involved are as yet unknown. Using transcriptomic comparisons between parent strain UA159 with vicK (UAvic) or covR (UAcov) deletion mutants together with electrophoretic motility shift assays (EMSA), we identified genes directly regulated by both VicR and CovR with putative functions in cell wall/surface biogenesis, including gbpB, wapE, smaA, SMU.2146c, and lysM. Deletion mutants of genes regulated by VicR and CovR (wapE, lysM, smaA), or regulated only by VicR (SMU.2146c) or CovR (epsC) promoted significant alterations in biofilm initiation, including increased fragility, defects in microcolony formation, and atypical cell morphology and/or chaining. Significant reductions in mureinolytic activity and/or increases in DNA release during growth were observed in knockout mutants of smaA, wapE, lysM, SMU.2146c and epsC, implying roles in cell wall biogenesis. WapE and lysM mutations also affected cell hydrophobicity and sensitivity to osmotic or oxidative stress. Finally, vicR, covR and VicRK/CovR-targets (gbpB, wapE, smaA, SMU.2146c, lysM, epsC) are up-regulated in UA159 during biofilm initiation, in a sucrose-dependent manner. These data support a model in which VicRK and CovR coordinate cell division and surface biogenesis with the extracellular synthesis of polysaccharides, a process apparently required for formation of structurally stable biofilms in the presence of sucrose.	[Stipp, Rafael N.; Hoefling, Jose F.; Mattos-Graner, Renata O.] Univ Campinas UNICAMP, Dept Oral Diag, Piracicaba Dent Sch, Sao Paulo, Brazil; [Boisvert, Heike; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Smith, Daniel J.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Universidade Estadual de Campinas; Harvard University; Forsyth Institute; Harvard University; Forsyth Institute	Mattos-Graner, RO (corresponding author), Univ Campinas UNICAMP, Dept Oral Diag, Piracicaba Dent Sch, Sao Paulo, Brazil.	rmgraner@fop.unicamp.br	Stipp, Rafael Nobrega/D-4518-2011; Mattos-Graner, Renata O/C-9410-2012	Stipp, Rafael Nobrega/0000-0001-5305-1299; Mattos-Graner, Renata O/0000-0001-8309-8135	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [proc. 07/56100-2, 09/54182-7, proc. 06/55933-8]; National Institutes of Health (NIH) Fogarty award [R03-TW-06324]; CAPES (PNPD);  [R01 DE15931];  [R37 DE06153]; FOGARTY INTERNATIONAL CENTER [R03TW006324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE006153] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institutes of Health (NIH) Fogarty award; CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, proc. 07/56100-2 and 09/54182-7) and the National Institutes of Health (NIH) Fogarty award R03-TW-06324. RNS was supported by FAPESP (proc. 06/55933-8) and CAPES (PNPD, 2010). MJD was supported by R01 DE15931 and R37 DE06153. DJS was supported by R37 DE06153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Catt DM, 2005, J BACTERIOL, V187, P7863, DOI 10.1128/JB.187.22.7863-7865.2005; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; GIBBONS RJ, 1983, INFECT IMMUN, V41, P1190, DOI 10.1128/IAI.41.3.1190-1196.1983; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Li YH, 2001, MICROBIOL-SGM, V147, P2841, DOI 10.1099/00221287-147-10-2841; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Negrini TC, 2012, ORAL DIS, V18, P485, DOI 10.1111/j.1601-0825.2011.01896.x; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Reck M, 2011, J BACTERIOL, V193, P5692, DOI 10.1128/JB.05424-11; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sato Y, 2000, FEMS MICROBIOL LETT, V186, P187, DOI 10.1111/j.1574-6968.2000.tb09102.x; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera DB, 2012, J BACTERIOL, V194, P1307, DOI 10.1128/JB.06071-11; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Shemesh M, 2006, CARBOHYD RES, V341, P2090, DOI 10.1016/j.carres.2006.05.010; Shemesh M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-51; Smith DJ, 2008, CURR TOP MICROBIOL, V319, P131; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Stipp RN, 2008, ORAL MICROBIOL IMMUN, V23, P466, DOI 10.1111/j.1399-302X.2008.00451.x; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; WEXLER DL, 1993, INFECT IMMUN, V61, P1259, DOI 10.1128/IAI.61.4.1259-1267.1993; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07	57	66	68	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58271	10.1371/journal.pone.0058271	http://dx.doi.org/10.1371/journal.pone.0058271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554881	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500019
J	Yu, LJ; Volkert, MR				Yu, Lijian; Volkert, Michael R.			Differential Requirement for SUB1 in Chromosomal and Plasmid Double-Strand DNA Break Repair	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; TRANSCRIPTIONAL ACTIVATION; HOMOLOGOUS RECOMBINATION; HUMAN COACTIVATOR; HUMAN PC4; YEAST; COMPLEX; DAMAGE; GENE	Non homologous end joining (NHEJ) is an important process that repairs double strand DNA breaks (DSBs) in eukaryotic cells. Cells defective in NHEJ are unable to join chromosomal breaks. Two different NHEJ assays are typically used to determine the efficiency of NHEJ. One requires NHEJ of linearized plasmid DNA transformed into the test organism; the other requires NHEJ of a single chromosomal break induced either by HO endonuclease or the I-SceI restriction enzyme. These two assays are generally considered equivalent and rely on the same set of NHEJ genes. PC4 is an abundant DNA binding protein that has been suggested to stimulate NHEJ. Here we tested the role of PC4's yeast homolog SUB1 in repair of DNA double strand breaks using different assays. We found SUB1 is required for NHEJ repair of DSBs in plasmid DNA, but not in chromosomal DNA. Our results suggest that these two assays, while similar are not equivalent and that repair of plasmid DNA requires additional factor(s) that are not required for NHEJ repair of chromosomal double-strand DNA breaks. Possible roles for Sub1 proteins in NHEJ of plasmid DNA are discussed.	[Yu, Lijian; Volkert, Michael R.] Univ Massachusetts, Sch Med, Worcester, MA 01610 USA	University of Massachusetts System; University of Massachusetts Worcester	Volkert, MR (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01610 USA.	michael.volkert@umassmed.edu	yu, lijian/GSE-1701-2022	Volkert, Michael/0000-0002-0045-0912	National Institutes of Health (NIH) [CA100122]; University of Massachusetts Medical School; NATIONAL CANCER INSTITUTE [R01CA100122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are partially funded by National Institutes of Health (NIH) CA100122 and the University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hegde V, 2000, NUCLEIC ACIDS RES, V28, P2779, DOI 10.1093/nar/28.14.2779; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Hiom K, 2010, DNA REPAIR, V9, P1256, DOI 10.1016/j.dnarep.2010.09.018; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Karathanasis E, 2002, GENETICS, V161, P1015; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Monnat RJ, 1999, BIOCHEM BIOPH RES CO, V255, P88, DOI 10.1006/bbrc.1999.0152; Moscariello M, 2010, YEAST, V27, P837, DOI 10.1002/yea.1789; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Tachibana A, 2004, ADV BIOPHYS, V38, P21, DOI 10.1016/S0065-227X(04)80046-7; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van den Bosch M, 2002, BIOL CHEM, V383, P873; van Heemst D, 2004, DNA REPAIR, V3, P43, DOI 10.1016/j.dnarep.2003.09.004; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Westmoreland JW, 2010, DNA REPAIR, V9, P617, DOI 10.1016/j.dnarep.2010.02.008; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Windhofer F, 2008, MUTAT RES-FUND MOL M, V638, P56, DOI 10.1016/j.mrfmmm.2007.08.016; Wu WH, 1999, GENETICS, V153, P643; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	57	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58015	10.1371/journal.pone.0058015	http://dx.doi.org/10.1371/journal.pone.0058015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554872	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500012
J	Tiberio, L; Nascimbeni, R; Villanacci, V; Casella, C; Fra, A; Vezzoli, V; Furlan, L; Meyer, G; Parrinello, G; Baroni, MD; Salerni, B; Schiaffonati, L				Tiberio, Laura; Nascimbeni, Riccardo; Villanacci, Vincenzo; Casella, Claudio; Fra, Anna; Vezzoli, Valeria; Furlan, Lucia; Meyer, Giuliano; Parrinello, Giovanni; Baroni, Maurizio D.; Salerni, Bruno; Schiaffonati, Luisa			The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MINERALOCORTICOID RECEPTOR; ALDOSTERONE; CELLS; EXPRESSION; HYPOXIA; VEGF; TRANSCRIPTION; EPLERENONE; MECHANISMS	Angiogenesis plays a crucial role in tumor growth and progression. Low expression of mineralocorticoid receptor (MR) in several malignant tumors correlates with disease recurrence and overall survival. Previous studies have shown that MR expression is decreased in colorectal cancer (CRC). Here we hypothesize that decreased MR expression can contribute to angiogenesis and poor patient survival in colorectal malignancies. In a cohort of CRC patients, we analyzed tumor MR expression, its correlation with tumor microvascular density and its impact on survival. Subsequently, we interrogated the role of MR in angiogenesis in an in vitro model, based on the colon cancer cell line HCT116, ingenierized to re-express a physiologically controlled MR. In CRC, decreased MR expression was associated with increased microvascular density and poor patient survival. In pchMR transfected HCT116, aldosterone or natural serum steroids largely inhibited mRNA expression levels of both VEGFA and its receptor 2/KDR. In CRC, MR activation may significantly decrease angiogenesis by directly inhibiting dysregulated VEGFA and hypoxia-induced VEGFA mRNA expression. In addition, MR activation attenuates the expression of the VEGF receptor 2/KDR, possibly dampening the activation of a VEGFA/KDR dependent signaling pathway important for the survival of tumor cells under hypoxic conditions.	[Tiberio, Laura; Nascimbeni, Riccardo; Casella, Claudio; Fra, Anna; Parrinello, Giovanni; Salerni, Bruno] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Nascimbeni, Riccardo; Casella, Claudio; Salerni, Bruno] Brescia City Hosp, Unit Gen Surg 1, Brescia, Italy; [Villanacci, Vincenzo] Brescia City Hosp, Dept Pathol, Brescia, Italy; [Vezzoli, Valeria; Meyer, Giuliano] Univ Milan, Dept Biosci, Milan, Italy; [Furlan, Lucia; Schiaffonati, Luisa] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Baroni, Maurizio D.] Univ Padua, Dept Biol, Padua, Italy	University of Brescia; University of Milan; University of Padua; University of Padua	Tiberio, L (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	tiberio@med.unibs.it; mauriziodavide.baroni@unipd.it	Baroni, Maurizio David/AAL-8064-2021; Fra, Annamaria/I-5532-2012; Tiberio, Laura/C-5653-2011	Baroni, Maurizio David/0000-0001-6355-9950; Fra, Annamaria/0000-0002-4327-3004; Tiberio, Laura/0000-0003-0482-9898; Vezzoli, Valeria/0000-0001-6396-7284	Adele and Francesco Lonati Foundation, Brescia, Italy	Adele and Francesco Lonati Foundation, Brescia, Italy	The present study was supported by Adele and Francesco Lonati Foundation, Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergann T, 2009, BIOCHEM BIOPH RES CO, V382, P280, DOI 10.1016/j.bbrc.2009.03.006; Bertrand C, 2010, INT J CANCER, V126, P2847, DOI 10.1002/ijc.25001; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bonvalet JP, 1998, KIDNEY INT, pS49; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Di Fabio F, 2007, J GASTROINTEST SURG, V11, P1521, DOI 10.1007/s11605-007-0234-8; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Duff SE, 2006, EUR J CANCER, V42, P112, DOI 10.1016/j.ejca.2005.09.018; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fujii M, 2012, J STEROID BIOCHEM, V129, P145, DOI 10.1016/j.jsbmb.2011.12.014; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Gomez-Sanchez CE, 2011, STEROIDS, V76, P1541, DOI 10.1016/j.steroids.2011.09.004; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; Grossmann C, 2009, MOL CELL ENDOCRINOL, V308, P53, DOI 10.1016/j.mce.2009.02.005; Hanrahan V, 2003, J PATHOL, V200, P183, DOI 10.1002/path.1339; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; HORISBERGER JD, 1992, HYPERTENSION, V19, P221, DOI 10.1161/01.HYP.19.3.221; Jeong Y, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000378; Keira Sidney Mamoru, 2004, Acta Cir. Bras., V19, P23, DOI 10.1590/S0102-86502004000700006; Kobayashi N, 2006, HYPERTENSION, V47, P671, DOI 10.1161/01.HYP.0000203148.42892.7a; Kobayashi N, 2010, AM J HYPERTENS, V23, P1007, DOI 10.1038/ajh.2010.91; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Latouche C, 2010, ENDOCRINOLOGY, V151, P4467, DOI 10.1210/en.2010-0237; Lombes M, 2000, ANN ENDOCRINOL-PARIS, V61, P41; Meijer OC, 2002, J NEUROENDOCRINOL, V14, P499, DOI 10.1046/j.1365-2826.2002.00795.x; Mihailidou AS, 2005, STEROIDS, V70, P347, DOI 10.1016/j.steroids.2005.02.004; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Oyamada N, 2008, ENDOCRINOLOGY, V149, P3764, DOI 10.1210/en.2007-1770; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Thum T, 2011, EUR HEART J, V32, P1275, DOI 10.1093/eurheartj/ehq254; Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; Vieira SC, 2005, PATHOL RES PRACT, V201, P313, DOI 10.1016/j.prp.2005.01.010; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Zhong H, 1999, CANCER RES, V59, P5830	40	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59410	10.1371/journal.pone.0059410	http://dx.doi.org/10.1371/journal.pone.0059410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555666	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200020
J	Cashion, A; Stanfill, A; Thomas, F; Xu, LJ; Suttee, T; Eason, J; Ensell, M; Homayouni, R				Cashion, Ann; Stanfill, Ansley; Thomas, Fridtjof; Xu, Lijing; Suttee, Thomas; Eason, James; Ensell, Mang; Homayouni, Ramin			Expression Levels of Obesity-Related Genes Are Associated with Weight Change in Kidney Transplant Recipients	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; CARBOXYPEPTIDASE-E; APOLIPOPROTEIN-M; METABOLIC SYNDROME; LEPTIN; GAIN; DOPAMINE; SAMPLES	Background:The aim of this study was to investigate the association of gene expression profiles in subcutaneous adipose tissue with weight change in kidney transplant recipients and to gain insights into the underlying mechanisms of weight gain. Methodology/Principal Findings: A secondary data analysis was done on a subgroup (n=26) of existing clinical and gene expression data from a larger prospective longitudinal study examining factors contributing to weight gain in transplant recipients. Measurements taken included adipose tissue gene expression profiles at time of transplant, baseline and six-month weight, and demographic data. Using multivariate linear regression analysis controlled for race and gender, expression levels of 1553 genes were significantly (p<0.05) associated with weight change. Functional analysis using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes classifications identified metabolic pathways that were enriched in this dataset. Furthermore, GeneIndexer literature mining analysis identified a subset of genes that are highly associated with obesity in the literature and Ingenuity pathway analysis revealed several significant gene networks associated with metabolism and endocrine function. Polymorphisms in several of these genes have previously been linked to obesity. Conclusions/Significance: We have successfully identified a set of molecular pathways that taken together may provide insights into the mechanisms of weight gain in kidney transplant recipients. Future work will be done to determine how these pathways may contribute to weight gain.	[Cashion, Ann; Stanfill, Ansley; Ensell, Mang] Univ Tennessee, Ctr Hlth Sci, Dept Acute & Chron Care, Coll Nursing, Memphis, TN 38163 USA; [Cashion, Ann] NINR, NIH, Bethesda, MD 20892 USA; [Thomas, Fridtjof] Univ Tennessee, Ctr Hlth Sci, Dept Biostat & Epidemiol, Memphis, TN 38163 USA; [Xu, Lijing; Suttee, Thomas; Homayouni, Ramin] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Eason, James] Methodist Univ Hosp Transplant Inst, Memphis, TN USA; [Eason, James] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Transplant Div, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Nursing Research (NINR); University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center	Cashion, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Acute & Chron Care, Coll Nursing, Memphis, TN 38163 USA.	ann.cashion@nih.gov	Homayouni, Ramin/U-2837-2019	Homayouni, Ramin/0000-0003-0186-5076; Stanfill, Ansley/0000-0001-7620-1130; Thomas, Fridtjof/0000-0003-1325-4870	NIH-NINR [USPHS R01 009270, USPHS 009270-0352]; NATIONAL INSTITUTE OF NURSING RESEARCH [ZIANR000030] Funding Source: NIH RePORTER	NIH-NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by NIH-NINR USPHS R01 009270 and NIH-NINR USPHS 009270-0352 (ARRA Summer Research Supplement Funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Bauer F, 2009, AM J CLIN NUTR, V90, P951, DOI 10.3945/ajcn.2009.27781; Baum CL, 2001, JPEN-PARENTER ENTER, V25, P114, DOI 10.1177/0148607101025003114; Cashion AK, 2011, RES NURS HEALTH, V34, P408, DOI 10.1002/nur.20448; Cashion Ann K, 2007, Prog Transplant, V17, P40; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cheung CYY, 2010, J CLIN ENDOCR METAB, V95, P1395, DOI 10.1210/jc.2009-1465; Clunk JM, 2001, AM J KIDNEY DIS, V38, P349, DOI 10.1053/ajkd.2001.26100; Cupples CK, 2012, PROG TRANSPLANT, V22, P62, DOI 10.7182/pit2012888; Dahlman I, 2007, INT J OBESITY, V31, P1629, DOI 10.1038/sj.ijo.0803657; Dolinkova M, 2008, MOL CELL ENDOCRINOL, V291, P63, DOI 10.1016/j.mce.2008.05.001; Dullaart RPF, 2009, CLIN CHIM ACTA, V406, P129, DOI 10.1016/j.cca.2009.06.010; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Elster EA, 2008, CLIN TRANSPLANT, V22, P354, DOI 10.1111/j.1399-0012.2008.00792.x; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Kalra SP, 2008, NUTRITION, V24, P820, DOI 10.1016/j.nut.2008.06.023; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Klimcakova E, 2011, J CLIN ENDOCR METAB, V96, pE73, DOI 10.1210/jc.2010-1575; Korsic Mirko, 2012, Front Biosci (Elite Ed), V4, P2734; Luo Guanghua, 2004, Lipids Health Dis, V3, P21, DOI 10.1186/1476-511X-3-21; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Ooi EMM, 2010, ATHEROSCLEROSIS, V210, P326, DOI 10.1016/j.atherosclerosis.2009.11.024; Patel M G, 1998, J Ren Nutr, V8, P137, DOI 10.1016/S1051-2276(98)90005-X; Pratley RE, 2000, MOL GENET METAB, V70, P19, DOI 10.1006/mgme.2000.2995; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Rodriguez-Acebes S, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-61; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STANLEY BG, 1986, PEPTIDES, V7, P1189; Storey John D, 2003, Methods Mol Biol, V224, P149; USRDS, 2011, ANN DAT REP ATL END; van den Ham ECH, 2003, TRANSPL INT, V16, P300, DOI 10.1111/j.1432-2277.2003.tb00304.x; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Xu N, 2004, J NUTR BIOCHEM, V15, P579, DOI 10.1016/j.jnutbio.2004.03.001; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang HP, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-10	37	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59962	10.1371/journal.pone.0059962	http://dx.doi.org/10.1371/journal.pone.0059962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544116	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700075
J	Harmon-Threatt, AN; Ackerly, DD				Harmon-Threatt, Alexandra N.; Ackerly, David D.			Filtering across Spatial Scales: Phylogeny, Biogeography and Community Structure in Bumble Bees	PLOS ONE			English	Article							PROBOSCIS LENGTH; FUNCTIONAL TRAITS; HYMENOPTERA; DIVERSIFICATION; DISTRIBUTIONS; COEXISTENCE; COMPETITION; RESOURCES; PATTERNS; STRENGTH	Despite the expansion of phylogenetic community analysis to understand community assembly, few studies have used these methods on mobile organisms and it has been suggested the local scales that are typically considered may be too small to represent the community as perceived by organisms with high mobility. Mobility is believed to allow species to mediate competitive interactions quickly and thus highly mobile species may appear randomly assembled in local communities. At larger scales, however, biogeographical processes could cause communities to be either phylogenetically clustered or even. Using phylogenetic community analysis we examined patterns of relatedness and trait similarity in communities of bumble bees (Bombus) across spatial scales comparing: local communities to regional pools, regional communities to continental pools and the continental community to a global species pool. Species composition and data on tongue lengths, a key foraging trait, were used to test patterns of relatedness and trait similarity across scales. Although expected to exhibit limiting similarity, local communities were clustered both phenotypically and phylogenetically. Larger spatial scales were also found to have more phylogenetic clustering but less trait clustering. While patterns of relatedness in mobile species have previously been suggested to exhibit less structure in local communities and to be less clustered than immobile species, we suggest that mobility may actually allow communities to have more similar species that can simply limit direct competition through mobility.	[Harmon-Threatt, Alexandra N.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Harmon-Threatt, Alexandra N.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Washington University (WUSTL)	Harmon-Threatt, AN (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	Aharmont@wustl.edu	Ackerly, David/A-1247-2009	Ackerly, David/0000-0002-1847-7398; Harmon-Threatt, Alexandra/0000-0002-3755-9321	NSF Graduate Research Fellowship Program; National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP)	NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	We Would like to thank the Kremen and Ackerly Labs, and the 2009 Integrative Biology 200B class at University of California Berkeley for comments that improved the manuscript, and acknowledge funding from the NSF Graduate Research Fellowship Program. We would also like to thank Sheila Colla, Amber Tripodi, Rosemary Malfi, Carol Kearns, Richard Hartfeld and Stephen Hendrix for contributing data on bumble bee communities.; This work was funded through a National Science Foundation's Graduate Research Fellowship Program (NSF-GRFP) to Alexandra N. Harmon-Threatt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Begon M, 1996, ECOLOGY INVIDIDUALS; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2011, PHILOS T R SOC B, V366, P2545, DOI 10.1098/rstb.2011.0021; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2008, P ROY SOC B-BIOL SCI, V275, P2031, DOI 10.1098/rspb.2008.0420; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D., 2010, BUMBLEBEES; Graham CH, 2012, ECOLOGY, V93, pS99, DOI 10.1890/11-0493.1; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; HANSKI I, 1982, ANN ZOOL FENN, V19, P319; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1985, ECOLOGY, V66, P198, DOI 10.2307/1941320; HARDER LD, 1982, CAN J ZOOL, V60, P1073, DOI 10.1139/z82-148; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; INOUYE DW, 1977, J NEW YORK ENTOMOL S, V85, P253; JOHNSON RA, 1986, ECOLOGY, V67, P133, DOI 10.2307/1938511; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; MEDLER JOHN T., 1962, ANN ENTOMOL SOC AMER, V55, P212; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MORSE DH, 1977, ANN ENTOMOL SOC AM, V70, P311, DOI 10.1093/aesa/70.3.311; MORSE DH, 1977, SCIENCE, V197, P678, DOI 10.1126/science.197.4304.678; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; PEKKARINEN A, 1984, ANN ENTOMOL FENN, V50, P97; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P577, DOI 10.1111/geb.12026; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Pyke GH, 2012, ENVIRON ENTOMOL, V41, P1332, DOI 10.1603/EN11284; RANTA E, 1980, OIKOS, V35, P298, DOI 10.2307/3544643; RANTA E, 1984, OIKOS, V43, P189, DOI 10.2307/3544768; RANTA E, 1982, OIKOS, V38, P202, DOI 10.2307/3544020; RANTA E, 1983, ANN ENTOMOL FENN, V49, P17; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087	52	29	29	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60446	10.1371/journal.pone.0060446	http://dx.doi.org/10.1371/journal.pone.0060446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544141	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700100
J	Pena-Chilet, M; Ibarrola-Villava, M; Martin-Gonzalez, M; Feito, M; Gomez-Fernandez, C; Planelles, D; Carretero, G; Lluch, A; Nagore, E; Ribas, G				Pena-Chilet, Maria; Ibarrola-Villava, Maider; Martin-Gonzalez, Manuel; Feito, Marta; Gomez-Fernandez, Cristina; Planelles, Dolores; Carretero, Gregorio; Lluch, Ana; Nagore, Eduardo; Ribas, Gloria			rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility	PLOS ONE			English	Article							D-RECEPTOR POLYMORPHISMS; CANCER; RISK; ASSOCIATION; GENES; DETERMINANTS; VDR	Background: Solar radiation should be avoided in melanoma patients. Nevertheless, this is the main means by which the body produces vitamin D. Evidence suggests a protective role against cancer for vitamin D. Since vitamin D performs its function by binding the receptor encoded by the vitamin D-receptor gene (VDR), most studies have focused on polymorphisms (SNPs) within this gene. However, the gene encoding the vitamin D-binding protein (GC) appears in recent studies as a major player in the role of a serum vitamin D level regulator and in Cutaneous Melanoma (CM) predisposition. Methods: We performed a case-control study of 12 polymorphisms on GC and 9 on VDR among 530 cases and 314 controls from Spanish population. Results: We found association between SNP rs12512631, located 3'downstream of GC, and risk of CM that seems to fit a dominant model (OR 1.63 950/0Cl 1.23-2.17 p-value 7x10(-4)). This association remained Bonferroni's correction and after adjustment for potential confounders (p-value 3x10(-3)) and even after increasing the sample size to 1729 individuals (p-value 0.0129). Moreover, we confirmed evidence of an association between CM susceptibility and the linkage disequilibrium block marked by tag-SNP rs222016 (p-value 0.032). This block covers the GC intron 1 region, with probable regulatory functions. Conclusion:To our knowledge, this is the first vitamin D pathway-related polymorphism study in melanoma risk conducted in the Spanish population. Furthermore, we show an association between polymorphisms in GC and melanoma risk, confirming recent studies in different populations.	[Pena-Chilet, Maria; Ibarrola-Villava, Maider; Lluch, Ana; Ribas, Gloria] Hlth Res Inst INCLIVA, Med Oncol & Haematol Unit, Valencia, Spain; [Martin-Gonzalez, Manuel] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain; [Feito, Marta; Gomez-Fernandez, Cristina] La Paz Univ Hosp, Dept Dermatol, Madrid, Spain; [Planelles, Dolores] Ctr Blood Transfus, Lab Histocompatibil Mol Biol, Valencia, Spain; [Carretero, Gregorio] Doctor Negrin Hosp, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Instituto Valenciano De Oncologia	Ribas, G (corresponding author), Hlth Res Inst INCLIVA, Med Oncol & Haematol Unit, Valencia, Spain.	gribasdespuig@gmail.com	PLANELLES, DOLORES/F-2689-2015; PLANELLES, DOLORES/AAS-5437-2020; Ribas-Despuig, Gloria/M-6190-2017; Nagore, Eduardo/Z-2126-2019; Peña-Chilet, Maria/A-8387-2015; Lluch, Ana/R-5493-2019; Ribas, Gloria/K-3379-2013	PLANELLES, DOLORES/0000-0001-6433-4825; PLANELLES, DOLORES/0000-0001-6433-4825; Nagore, Eduardo/0000-0003-3433-8707; Peña-Chilet, Maria/0000-0002-6445-9617; Lluch, Ana/0000-0003-2766-407X; Ribas, Gloria/0000-0001-6883-4130; Ibarrola-Villava, Maider/0000-0003-0946-8075; Bowcock, Anne/0000-0001-8691-9090	National Health System Ministry (Institute Carlos III) [Pl10_0405]; Generalitat Valenciana Conselleria d'Educacio VALi+d program [ACIF/2011/207]; Spanish Ministry of Science and Education [BES-2008-009234]; Spanish Ministry of Health [CP08_00069]	National Health System Ministry (Institute Carlos III); Generalitat Valenciana Conselleria d'Educacio VALi+d program; Spanish Ministry of Science and Education(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This study has been supported by a grant from the National Health System Ministry (Institute Carlos III) Pl10_0405. MPC is funded by the Generalitat Valenciana Conselleria d'Educacio VALi+d program (ACIF/2011/207). MIV is funded by the Spanish Ministry of Science and Education under a FPI grant (BES-2008-009234). GR is funded by the Spanish Ministry of Health (CP08_00069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-385; Bektas-Kayhan K, 2010, IN VIVO, V24, P755; Bishop JAN, 2005, DRUG TODAY, V41, P193, DOI 10.1358/dot.2005.41.3.892524; Chang CK, 2011, J GASTROINTEST CANC; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Davies JR, 2011, CANCER CAUSE CONTROL, V22, P1471, DOI 10.1007/s10552-011-9827-3; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Field S, 2011, MOL ONCOL, V5, P197, DOI 10.1016/j.molonc.2011.01.007; Gapska P, 2009, CANCER EPIDEMIOL, V33, P103, DOI 10.1016/j.canep.2009.06.006; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hibler EA, 2012, CANCER EPIDEM BIOMAR, V21, P368, DOI 10.1158/1055-9965.EPI-11-0916; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Holick MF, 2003, MAYO CLIN PROC, V78, P1457, DOI 10.4065/78.12.1457; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Karami S, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/879362; Kidd LCR, 2005, PROSTATE, V64, P272, DOI 10.1002/pros.20204; Kostner K, 2009, ANTICANCER RES, V29, P3511; Kvaskoff M, 2011, TWIN RES HUM GENET, V14, P422, DOI 10.1375/twin.14.5.422; Laayouni H, 2010, HUM GENET, V127, P455, DOI 10.1007/s00439-010-0798-3; Lurie G, 2011, INT J CANCER, V128, P936, DOI 10.1002/ijc.25403; Mocellin S, 2008, CANCER-AM CANCER SOC, V113, P2398, DOI 10.1002/cncr.23867; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Orlow I, 2011, INT J CANC; Pani MA, 2002, J CLIN ENDOCR METAB, V87, P2564, DOI 10.1210/jc.87.6.2564; Poynter JN, 2010, CANCER EPIDEM BIOMAR, V19, P525, DOI 10.1158/1055-9965.EPI-09-0662; Randerson-Moor JA, 2009, EUR J CANCER, V45, P3271, DOI 10.1016/j.ejca.2009.06.011; Shen LH, 2010, J INT MED RES, V38, P1093, DOI 10.1177/147323001003800337; Smedby KE, 2011, AM J EPIDEMIOL, V173, P48, DOI 10.1093/aje/kwq340; Srinivasan M, 2011, J STEROID BIOCHEM, V123, P30, DOI 10.1016/j.jsbmb.2010.10.002; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0	36	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59607	10.1371/journal.pone.0059607	http://dx.doi.org/10.1371/journal.pone.0059607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544077	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700037
J	Yang, C; Liu, JF; Chai, BS; Fang, Q; Chai, N; Zhao, LY; Xue, YX; Luo, YX; Jian, M; Han, Y; Shi, HS; Lu, L; Wu, P; Wang, JS				Yang, Chang; Liu, Jian-Feng; Chai, Bai-Sheng; Fang, Qin; Chai, Ning; Zhao, Li-Yan; Xue, Yan-Xue; Luo, Yi-Xiao; Jian, Min; Han, Ying; Shi, Hai-Shui; Lu, Lin; Wu, Ping; Wang, Ji-Shi			Stress within a Restricted Time Window Selectively Affects the Persistence of Long-Term Memory	PLOS ONE			English	Article							INDUCED CORTISOL ELEVATIONS; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; SPATIAL MEMORY; FEAR MEMORIES; GLUCOCORTICOID-RECEPTORS; PSYCHOSOCIAL STRESS; DECLARATIVE MEMORY; PROTEIN-SYNTHESIS; LEARNING STRESS	The effects of stress on emotional memory are distinct and depend on the stages of memory. Memory undergoes consolidation and reconsolidation after acquisition and retrieval, respectively. Stress facilitates the consolidation but disrupts the reconsolidation of emotional memory. Previous research on the effects of stress on memory have focused on long-term memory (LTM) formation (tested 24 h later), but the effects of stress on the persistence of LTM (tested at least week later) are unclear. Recent findings indicated that the persistence of LTM requires late-phase protein synthesis in the 1 dorsal hippocampus. The present study investigated the effect of stress (i.e., cold water stress) during the late phase after the acquisition and retrieval of contextual fear memory in rats. We found that stress and corticosterone administration during the late phase (12 h) after acquisition, referred to as late consolidation, selectively enhanced the persistence of LTM, whereas stress during the late phase (12 h) after retrieval, referred to as late reconsolidation, selectively disrupted the restabilized persistence of LTM. Moreover, the effects of stress on the persistence of LTM were blocked by the corticosterone synthesis inhibitor metyrapone, which was administered before stress, suggesting that the glucocorticoid system is involved in the effects of stress on the persistence of LTM. We conclude that stress within a restricted time window after acquisition or retrieval selectively affects the persistence of LTM and depends on the glucocorticoid system.	[Yang, Chang; Chai, Bai-Sheng; Fang, Qin; Wang, Ji-Shi] Affiliated Hosp, Guiyang, Peoples R China; [Yang, Chang; Chai, Bai-Sheng; Fang, Qin; Wang, Ji-Shi] Guiyang Med Univ, Sch Pharm, Guiyang, Peoples R China; [Liu, Jian-Feng; Zhao, Li-Yan; Xue, Yan-Xue; Luo, Yi-Xiao; Jian, Min; Han, Ying; Lu, Lin; Wu, Ping] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Chai, Ning] Hebei Med Univ, Inst Mental Hlth, Shijiazhuang, Peoples R China; [Chai, Ning] Hebei Med Univ, Hebei Brain Ageing & Cognit Neurosci Lab, Shijiazhuang, Peoples R China; [Shi, Hai-Shui] Hebei Med Univ, Basic Med Coll, Dept Biochem & Mol Biol, Shijiazhuang, Peoples R China	Guizhou Medical University; Peking University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Wu, P (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	wuping@bjmu.edu.cn; jswang_yg@yahoo.com	fang, qin/GQA-8223-2022	Liu, Jianfeng/0000-0002-3464-6462	Natural Science Foundation of China [81201032, 91132716, 31070958]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (no. 81201032, 91132716, and 31070958). No additional external funding received for this study. The authors declare that they do not have any conflicts of interest (financial or otherwise) related to the data presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2006, PSYCHONEUROENDOCRINO, V31, P187, DOI 10.1016/j.psyneuen.2005.06.008; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Cai WH, 2006, J NEUROSCI, V26, P9560, DOI 10.1523/JNEUROSCI.2397-06.2006; Costanzi M, 2011, LEARN MEMORY, V18, P508, DOI 10.1101/lm.2175811; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Elzinga BM, 2005, PSYCHIAT RES, V134, P211, DOI 10.1016/j.psychres.2004.11.007; Flavell CR, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1515; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; Izquierdo I, 1998, TRENDS NEUROSCI, V21, P423, DOI 10.1016/S0166-2236(98)01279-X; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; Katche C, 2012, NEUROBIOL LEARN MEM, V98, P220, DOI 10.1016/j.nlm.2012.08.001; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Kindt M, 2013, BIOL PSYCHOL, V92, P43, DOI 10.1016/j.biopsycho.2011.09.016; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Oitzl MS, 1998, BRAIN RES, V797, P159, DOI 10.1016/S0006-8993(98)00387-4; Parfitt GM, 2012, BEHAV NEUROSCI, V126, P729, DOI 10.1037/a0029861; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 1996, PSYCHONEUROENDOCRINO, V21, P681, DOI 10.1016/S0306-4530(96)00028-5; Roozendaal B, 2007, PROG BRAIN RES, V167, P79, DOI 10.1016/S0079-6123(07)67006-X; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Sandi C, 1997, EUR J NEUROSCI, V9, P637, DOI 10.1111/j.1460-9568.1997.tb01412.x; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P44, DOI 10.1016/j.nlm.2008.02.002; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Si JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043973; Smeets T, 2007, BIOL PSYCHOL, V76, P116, DOI 10.1016/j.biopsycho.2007.07.001; Smeets T, 2008, PSYCHONEUROENDOCRINO, V33, P1378, DOI 10.1016/j.psyneuen.2008.07.009; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Xue YX, 2012, SCIENCE, V336, P241, DOI 10.1126/science.1215070; Zhao LY, 2009, PSYCHOPHARMACOLOGY, V203, P599, DOI 10.1007/s00213-008-1406-2	68	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59075	10.1371/journal.pone.0059075	http://dx.doi.org/10.1371/journal.pone.0059075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544051	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700013
J	Zhang, W; Ma, YQ; Wang, Z; Ye, XX; Shui, JF				Zhang, Wei; Ma, Yongqing; Wang, Zhong; Ye, Xiaoxin; Shui, Junfeng			Some Soybean Cultivars Have Ability to Induce Germination of Sunflower Broomrape	PLOS ONE			English	Article							SEED-GERMINATION; PARASITIC WEEDS; OROBANCHE; STRIGA; STRIGOLACTONES; STIMULANTS; PLANTS; RESISTANCE; ALECTROL; GROWTH	Sunflower broomrape is a noxious parasitic weed which has caused severe damage to crop ecosystems. Trap crops can release a mixture of allelochemicals to induce the germination of sunflower broomrape. We studied the allelopathic effects of soybean on sunflower broomrape. Fourteen common soybean cultivars were grown in Pots. Samples were collected from soybean plants and rhizosphere soil at five growth stages (V1, V3, V5, R2, and R4). The allelopathic effects of soybean reached highest at the V3 stage. Methanolic extracts of soybean roots induced higher broomrape germination than methanolic extracts of stems or leaves. The germination rates induced by root extracts (10-fold dilution) were positively correlated with germination rates induced by stem (10-fold dilution) and leaf extracts (10-fold dilution). The broomrape germination rates induced by root extracts were also positively correlated with soybean nodule diameter and dry weight. The results indicated that soybeans could induce sunflower broomrape germination. We conclude that soybean has the potential to be used as a trap crop for sunflower broom rape.	[Zhang, Wei; Ma, Yongqing; Shui, Junfeng] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China; [Ma, Yongqing; Shui, Junfeng] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Zhong; Ye, Xiaoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi Provinc, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Northwest A&F University - China	Ma, YQ (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi Provinc, Peoples R China.	mayongqing@ms.iswc.ac.cn	Ma, Yongqing/M-5616-2017	Ma, Yongqing/0000-0001-7525-9111	National "Twelfth Five-Year Plan" Science and Technology projects [2011BAD31B05]; National Natural Science Foundation [30870403]	National "Twelfth Five-Year Plan" Science and Technology projects; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is supported by the National "Twelfth Five-Year Plan" Science and Technology projects (2011BAD31B05) and National Natural Science Foundation Project (30870403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BD, 2002, CROP PROT, V21, P533, DOI 10.1016/S0261-2194(01)00137-5; Akhtouch B, 2002, PLANT BREEDING, V121, P266, DOI 10.1046/j.1439-0523.2002.00701.x; Al-thahabi SA, 2006, THESIS OREGON STATE; Aly R, 2001, WEED TECHNOL, V15, P306, DOI 10.1614/0890-037X(2001)015[0306:BOCCIS]2.0.CO;2; An M, 2003, ECOL MODEL, V161, P53, DOI 10.1016/S0304-3800(02)00289-2; Botanga CJ, 2003, CROP SCI, V43, P483, DOI 10.2135/cropsci2003.0483; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fernandez-Aparicio M, 2009, ANN BOT-LONDON, V103, P423, DOI 10.1093/aob/mcn236; Foo E, 2011, PLANTA, V234, P1073, DOI 10.1007/s00425-011-1516-7; Joel D. M., 2007, Horticultural Reviews, V33, P267, DOI 10.1002/9780470168011.ch4; Ju Huiyan, 2002, Yingyong Shengtai Xuebao, V13, P723; JuradoExposito M, 1997, J AGR SCI, V129, P307, DOI 10.1017/S0021859697004723; Khanh TD, 2005, CROP PROT, V24, P421, DOI 10.1016/j.cropro.2004.09.020; Kohlen W, 2011, PLANT PHYSIOL, V155, P974, DOI 10.1104/pp.110.164640; Lins RD, 2006, WEED RES, V46, P313, DOI 10.1111/j.1365-3180.2006.00515.x; Ma YQ, 2013, CROP SCI, V53, P260, DOI 10.2135/cropsci2012.03.0197; Ma YQ, 2012, AGRON J, V104, P569, DOI 10.2134/agronj2011.0372; Ma YQ, 2012, SCI CHINA LIFE SCI, V55, P250, DOI 10.1007/s11427-012-4302-2; Ma YQ, 2005, ALLELOPATHY J, V15, P49; MESAGARCIA J, 1985, WEED RES, V25, P129, DOI 10.1111/j.1365-3180.1985.tb00627.x; Nadal S, 2008, CROP PROT, V27, P873, DOI 10.1016/j.cropro.2007.10.009; Odhiambo J. A., 2011, Archives of Phytopathology and Plant Protection, V44, P158, DOI 10.1080/03235400902952194; Olubunmi AA, 2012, AFR J PLANT SCI, V6, P57; PARKER C, 1994, BIOLOGY AND MANAGEMENT OF OROBANCHE, P17; Parker C, 1993, PARASITIC WEEDS WORL; RILEY D, 1969, SOIL SCI SOC AM PRO, V33, P905, DOI 10.2136/sssaj1969.03615995003300060031x; Rubiales D, 2006, EUPHYTICA, V147, P187, DOI 10.1007/s10681-006-7399-1; Rubiales D, 2005, PLANT DIS, V89, P528, DOI 10.1094/PD-89-0528A; Sato D, 2005, BIOSCI BIOTECH BIOCH, V69, P98, DOI 10.1271/bbb.69.98; Wang YY, 2009, ALLELOPATHY J, V24, P103; WHITNEY PJ, 1978, ANN APPL BIOL, V89, P475, DOI 10.1111/j.1744-7348.1978.tb05976.x; Xie X, 2008, PHYTOCHEMISTRY, V69, P427, DOI 10.1016/j.phytochem.2007.07.017; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Yokota T, 1998, PHYTOCHEMISTRY, V49, P1967, DOI 10.1016/S0031-9422(98)00419-1; Yoneyama K., 2006, Natural products for pest management, 226th ACS National Meeting, Anaheim, California, USA, 28 March-1 April 2004, P88; Yoneyama K, 2001, P 7 INT PAR WEED S N, P123	37	12	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59715	10.1371/journal.pone.0059715	http://dx.doi.org/10.1371/journal.pone.0059715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544089	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700049
J	Oravec, GJ; Artino, AR; Hickey, PW				Oravec, Geoffrey J.; Artino, Anthony R., Jr.; Hickey, Patrick W.			Active-Duty Physicians' Perceptions and Satisfaction with Humanitarian Assistance and Disaster Relief Missions: Implications for the Field	PLOS ONE			English	Article							IMPLEMENTATION; RETENTION; PROGRAMS; MILITARY	Background: The United States Department of Defense participates in more than 500 missions every year, including humanitarian assistance and disaster relief, as part of medical stability operations. This study assessed perceptions of active-duty physicians regarding these activities and related these findings to the retention and overall satisfaction of healthcare professionals. Methods and Findings: An Internet-based survey was developed and validated. Of the 667 physicians who responded to the survey, 47% had participated in at least one mission. On a 7-point, Likert-type response scale, physicians reported favorable overall satisfaction with their participation in these missions (mean = 5.74). Perceived benefit was greatest for the United States (mean = 5.56) and self (mean = 5.39) compared to the target population (mean = 4.82). These perceptions were related to participants' intentions to extend their military medical service (total model R-2 =.37), with the strongest predictors being perceived benefit to self (beta =.21, p <.01), the U. S. (beta =.19, p <.01), and satisfaction (beta =.18, p <.05). In addition, Air Force physicians reported higher levels of satisfaction (mean = 6.10) than either Army (mean = 5.27, Cohen's d = 0.75, p <.001) or Navy (mean = 5.60, Cohen's d = 0.46, p <.01) physicians. Conclusions: Military physicians are largely satisfied with humanitarian missions, reporting the greatest benefit of such activities for themselves and the United States. Elucidation of factors that may increase the perceived benefit to the target populations is warranted. Satisfaction and perceived benefits of humanitarian missions were positively correlated with intentions to extend time in service. These findings could inform the larger humanitarian community as well as military medical practices for both recruiting and retaining medical professionals.	[Oravec, Geoffrey J.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Artino, Anthony R., Jr.; Hickey, Patrick W.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Oravec, GJ (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	goravec@usuhs.edu	Artino, Anthony R./A-7475-2009	Artino, Anthony R./0000-0003-2661-7853; Hickey, Patrick/0000-0003-4500-4403				Bjerneld Magdalena, 2004, Disaster Manag Response, V2, P101, DOI 10.1016/j.dmr.2004.08.009; Bjerneld Magdalena, 2006, Disaster Manag Response, V4, P49, DOI 10.1016/j.dmr.2006.01.002; Burkle FM, 2008, LANCET, V371, P189, DOI 10.1016/S0140-6736(08)60118-X; Cohen L., 2019, RES METHODS ED, P245; DoD, 2005, MIL SUPP STAB SEC TR; DoD, 2010, MIL HLTH SUPP STAB O; Drifmeyer J, 2004, MIL MED, V169, P358, DOI 10.7205/MILMED.169.5.358; DSCA, 2009, OV HUM DIS CIV AID F; DSCA, 2010, OV HUM DIS CIV AID O; DSCA, 2011, OV HUM DIS CIV AID O; Gable R.K., 1993, INSTRUMENT DEV AFFEC, V2nd; GAO, 2009, MIL PERS STAT ACC RE; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Licina DJ, 2007, MIL MED, V172, P339, DOI 10.7205/MILMED.172.4.339; Loquercio D., 2006, UNDERSTANDING ADDRES; Lougee D., 2007, DISAM J, V29, P68; Mayhew Barney, 2002, H8MANITARIAN EXCHANG, V22, P26; Mundell BF, 2010, RETENTION MILITARY P; Musa SA, 2008, SOC BEHAV PERSONAL, V36, P407, DOI 10.2224/sbp.2008.36.3.407; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; Reaves EJ, 2008, DISASTER MED PUBLIC, V2, P237, DOI 10.1097/DMP.0b013e31818d4510; Reaves EJ, 2008, DISASTER MED PUBLIC, V2, P230, DOI 10.1097/DMP.0b013e31818d3c80; Stoddard Abby, 2010, STATE HUMANITARIAN S; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	25	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e57814	10.1371/journal.pone.0057814	http://dx.doi.org/10.1371/journal.pone.0057814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555564	gold, Green Published			2022-12-27	WOS:000317418500005
J	Datta, K; Suman, S; Kallakury, BVS; Fornace, AJ				Datta, Kamal; Suman, Shubhankar; Kallakury, Bhaskar V. S.; Fornace, Albert J., Jr.			Heavy Ion Radiation Exposure Triggered Higher Intestinal Tumor Frequency and Greater beta-Catenin Activation than gamma Radiation in APC(Min/+) Mice	PLOS ONE			English	Article							SYNTHASE KINASE 3-BETA; ABERRANT CRYPT FOCI; COLORECTAL-CANCER; CYCLIN D1; DOSE-RATE; EXPRESSION; CELL; DIFFERENTIATION; CARCINOGENESIS; MORTALITY	Risk of colorectal cancer (CRC) after exposure to low linear energy transfer (low-LET) radiation such as c-ray is highlighted by the studies in atom bomb survivors. On the contrary, CRC risk prediction after exposure to high-LET cosmic heavy ion radiation exposure is hindered due to scarcity of in vivo data. Therefore, intestinal tumor frequency, size, cluster, and grade were studied in APC(Min/+) mice (n = 20 per group; 6 to 8 wks old; female) 100 to 110 days after exposure to 1.6 or 4 Gy of heavy ion Fe-56 radiation (energy: 1000 MeV/nucleon) and results were compared to gamma radiation doses of 2 or 5 Gy, which are equitoxic to 1.6 and 4 Gy Fe-56 respectively. Due to relevance of lower doses to radiotherapy treatment fractions and space exploration, we followed 2 Gy gamma and equitoxic 1.6 Gy Fe-56 for comparative analysis of intestinal epithelial cell (IEC) proliferation, differentiation, and beta-catenin signaling pathway alterations between the two radiation types using immunoblot, and immunohistochemistry. Relative to controls and gamma-ray, intestinal tumor frequency and grade was significantly higher after Fe-56 radiation. Additionally, tumor incidence per unit of radiation (per cGy) was also higher after Fe-56 radiation relative to gamma radiation. Staining for phospho-histone H3, indicative of IEC proliferation, was more and alcian blue staining, indicative of IEC differentiation, was less in Fe-56 than gamma irradiated samples. Activation of beta-catenin was more in Fe-56-irradiated tumor-free and tumor-bearing areas of the intestinal tissues. When considered along with higher levels of cyclin D1, we infer that relative to gamma radiation exposure to Fe-56 radiation induced markedly reduced differentiation, and increased proliferative index in IEC resulting in increased intestinal tumors of larger size and grade due to preferentially greater activation of beta-catenin and its downstream effectors.	[Datta, Kamal; Suman, Shubhankar; Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cell Biol, Washington, DC 20057 USA; [Datta, Kamal; Suman, Shubhankar; Fornace, Albert J., Jr.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Kallakury, Bhaskar V. S.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20007 USA; [Fornace, Albert J., Jr.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	Georgetown University; Georgetown University; Georgetown University; King Abdulaziz University	Datta, K (corresponding author), Georgetown Univ, Dept Biochem & Mol & Cell Biol, Washington, DC 20057 USA.	kd257@georgetown.edu; af294@georgetown.edu	Suman, Shubhankar/H-4610-2011; Fornace, Albert/A-7407-2008	Suman, Shubhankar/0000-0002-9197-0461; Fornace, Albert/0000-0001-9695-085X	National Aeronautics and Space Administration (NASA) [NNX07AH70G, NNX09AU95G]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	This study was supported by the National Aeronautics and Space Administration (NASA) grants NNX07AH70G and NNX09AU95G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adler DG, 2005, NAT CLIN PRACT GASTR, V2, P390, DOI 10.1038/ncpgasthep0256; ALPEN EL, 1994, ADV SPACE RES, V14, P573, DOI 10.1016/0273-1177(94)90512-6; ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; Asaithamby A, 2008, RADIAT RES, V169, P437, DOI 10.1667/RR1165.1; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; CRAGLE DL, 1988, AM J IND MED, V14, P379, DOI 10.1002/ajim.4700140404; Cucinotta FA, 1998, RADIAT RES, V150, P115, DOI 10.2307/3579651; Cucinotta FA, 1999, RADIAT ENVIRON BIOPH, V38, P81, DOI 10.1007/s004110050142; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta Francis A, 2003, Gravit Space Biol Bull, V16, P11; Curtis S B, 1989, Adv Space Res, V9, P293, DOI 10.1016/0273-1177(89)90452-3; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Datta K, 2012, INT J RADIAT ONCOL; Datta K, 2012, INT J RADIAT BIOL, V88, P213, DOI 10.3109/09553002.2012.639434; Ding LH, 2005, RADIAT RES, V164, P523, DOI 10.1667/RR3350.1; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Dupree-Ellis E, 2000, AM J EPIDEMIOL, V152, P91, DOI 10.1093/aje/152.1.91; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Ellender M, 2011, INT J RADIAT BIOL, V87, P385, DOI 10.3109/09553002.2011.542542; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Haines J, 2000, GENE CHROMOSOME CANC, V28, P387, DOI 10.1002/1098-2264(200008)28:4<387::AID-GCC4>3.0.CO;2-H; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hamilton SA, 2006, J APPL PHYSIOL, V101, P789, DOI 10.1152/japplphysiol.01078.2005; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hayatsu K, 2009, J PHYS SOC JPN, V78, P149, DOI 10.1143/JPSJS.78SA.149; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; KRONENBERG A, 1994, ADV SPACE RES-SERIES, V14, P339, DOI 10.1016/0273-1177(94)90486-3; KRONENBERG A, 1994, INT J RADIAT BIOL, V66, P603, DOI 10.1080/09553009414551691; KRONENBERG A, 1995, RADIAT ENVIRON BIOPH, V34, P73, DOI 10.1007/BF01275209; LI YQ, 1994, J CELL SCI, V107, P3271; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Luongo C, 1996, GENE CHROMOSOME CANC, V17, P194, DOI 10.1002/1098-2264(199611)17:3<194::AID-GCC2870170302>3.0.CO;2-E; LUONGO C, 1994, CANCER RES, V54, P5947; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Obenaus A, 2008, RADIAT RES, V169, P149, DOI 10.1667/RR1135.1; PAULUS U, 1993, J CELL SCI, V106, P473; Peng Y, 2009, RADIAT RES, V171, P474, DOI 10.1667/RR1547.1; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; REYNOLDS P, 1985, WESTERN J MED, V142, P214; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Setlow RB, 2003, EMBO REP, V4, P1013, DOI 10.1038/sj.embor.7400016; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Suman S, 2012, COLORECTAL CANC PREV, P277, DOI [10.5772/28497, DOI 10.5772/28497]; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trani D, 2010, RADIAT ENVIRON BIOPH, V49, P389, DOI 10.1007/s00411-010-0292-2; Tucker JD, 2004, RADIAT RES, V161, P648, DOI 10.1667/RR3177; ULLRICH RL, 1977, RADIAT RES, V72, P487, DOI 10.2307/3574612; ULLRICH RL, 1976, RADIAT RES, V68, P115, DOI 10.2307/3574539; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wakeford R, 2004, ONCOGENE, V23, P6404, DOI 10.1038/sj.onc.1207896; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1	67	40	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59295	10.1371/journal.pone.0059295	http://dx.doi.org/10.1371/journal.pone.0059295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555653	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400032
J	Egawa, R; Hososhima, S; Hou, XB; Katow, H; Ishizuka, T; Nakamura, H; Yawo, H				Egawa, Ryo; Hososhima, Shoko; Hou, Xubin; Katow, Hidetaka; Ishizuka, Toru; Nakamura, Harukazu; Yawo, Hiromu			Optogenetic Probing and Manipulation of the Calyx-Type Presynaptic Terminal in the Embryonic Chick Ciliary Ganglion	PLOS ONE			English	Article							TRANSMITTER RELEASE; CALCIUM CURRENTS; CA2+ CHANNELS; SYNAPTIC TRANSMISSION; DEVELOPING SYNAPSES; GENE-EXPRESSION; FINE STRUCTURE; PLASTICITY; BRAINBOW; MODEL	The calyx-type synapse of chick ciliary ganglion (CG) has been intensively studied for decades as a model system for the synaptic development, morphology and physiology. Despite recent advances in optogenetics probing and/or manipulation of the elementary steps of the transmitter release such as membrane depolarization and Ca2+ elevation, the current gene-manipulating methods are not suitable for targeting specifically the calyx-type presynaptic terminals. Here, we evaluated a method for manipulating the molecular and functional organization of the presynaptic terminals of this model synapse. We transfected progenitors of the Edinger-Westphal (EW) nucleus neurons with an EGFP expression vector by in ovo electroporation at embryonic day 2 (E2) and examined the CG at E8-14. We found that dozens of the calyx-type presynaptic terminals and axons were selectively labeled with EGFP fluorescence. When a Brainbow construct containing the membrane-tethered fluorescent proteins m-CFP, m-YFP and m-RFP, was introduced together with a Cre expression construct, the color coding of each presynaptic axon facilitated discrimination among inter-tangled projections, particularly during the developmental re-organization period of synaptic connections. With the simultaneous expression of one of the chimeric variants of channelrhodopsins, channelrhodopsin-fast receiver (ChRFR), and R-GECO1, a red-shifted fluorescent Ca2+-sensor, the Ca2+ elevation was optically measured under direct photostimulation of the presynaptic terminal. Although this optically evoked Ca2+ elevation was mostly dependent on the action potential, a significant component remained even in the absence of extracellular Ca2+. It is suggested that the photo-activation of ChRFR facilitated the release of Ca2+ from intracellular Ca2+ stores directly or indirectly. The above system, by facilitating the molecular study of the calyx-type presynaptic terminal, would provide an experimental platform for unveiling the molecular mechanisms underlying the morphology, physiology and development of synapses.	[Egawa, Ryo; Hososhima, Shoko; Hou, Xubin; Katow, Hidetaka; Ishizuka, Toru; Nakamura, Harukazu; Yawo, Hiromu] Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Egawa, Ryo; Hososhima, Shoko; Katow, Hidetaka; Ishizuka, Toru; Nakamura, Harukazu; Yawo, Hiromu] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan; [Egawa, Ryo] Tohoku Univ, Inst Int Adv Res & Educ, Sendai, Miyagi 980, Japan; [Hou, Xubin; Nakamura, Harukazu] Tohoku Univ, Dept Mol Neurobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yawo, Hiromu] Tohoku Univ, Ctr Neurosci, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23115501, 23659105]; Grants-in-Aid for Scientific Research [22570199] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" ( No. 23115501), URL: http://www.meso-neurocircuitry.jp/index_eng.html; Grant-in-Aid for challenging Exploratory Research ( No. 23659105) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, URL: http://www.jsps.go.jp/english/e-grants/grants01. html; Global COE Program (Basic & Translational Research Center for Global Brain Science), MEXT, URL: http://www.med.tohoku.ac.jp/nsgcoe/en/index.html; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), URL: http://www.nibio.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; Card JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021141; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; DEHPOUR AR, 1982, BIOCHEM PHARMACOL, V31, P965, DOI 10.1016/0006-2952(82)90328-8; DELORENZO AJ, 1960, J BIOPHYS BIOCHEM CY, V7, P31, DOI 10.1083/jcb.7.1.31; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; FUJIWARA T, 1989, NEUROSCI LETT, V98, P125, DOI 10.1016/0304-3940(89)90496-5; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Hou XB, 2011, DEV GROWTH DIFFER, V53, P69, DOI 10.1111/j.1440-169X.2010.01229.x; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Kobiler O, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1145; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; LANDMESSER L, 1972, J PHYSIOL-LONDON, V222, P691, DOI 10.1113/jphysiol.1972.sp009822; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MARTIN AR, 1989, NEUROSCI LETT, V105, P14, DOI 10.1016/0304-3940(89)90004-9; MARTIN AR, 1963, J PHYSIOL-LONDON, V168, P443, DOI 10.1113/jphysiol.1963.sp007202; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P1; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P17, DOI 10.1113/jphysiol.1964.sp007500; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mochida S, 2011, NEUROSCI RES, V70, P16, DOI 10.1016/j.neures.2011.03.005; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Odani N, 2008, DEV GROWTH DIFFER, V50, P443, DOI [10.1111/j.1440-169X.2008.01037.x, 10.1111/j.1440-169x.2008.01037.x]; Pan YA, 2011, COLD SPRING HARB PRO, V2011; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Reid CA, 2003, TRENDS NEUROSCI, V26, P683, DOI 10.1016/j.tins.2003.10.003; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Song JW, 2008, J NEUROSCI, V28, P8993, DOI 10.1523/JNEUROSCI.0720-08.2008; STANLEY EF, 1992, CAN J PHYSIOL PHARM, V70, pS73, DOI 10.1139/y92-246; STANLEY EF, 1991, J NEUROSCI, V11, P985; STANLEY EF, 1989, BRAIN RES, V505, P341, DOI 10.1016/0006-8993(89)91465-0; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; TAKAHASHI K, 1965, Z ZELLFORSCH MIK ANA, V67, P835, DOI 10.1007/BF00339304; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wachman ES, 2004, J NEUROSCI, V24, P2877, DOI 10.1523/JNEUROSCI.1660-03.2004; Wan Y, 2009, IEEE T VIS COMPUT GR, V15, P1489, DOI 10.1109/TVCG.2009.118; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Yamashita T, 2012, NEUROSCI RES, V73, P1, DOI 10.1016/j.neures.2012.02.012; YAWO H, 1994, J PHYSIOL-LONDON, V477, P437, DOI 10.1113/jphysiol.1994.sp020205; YAWO H, 1993, J PHYSIOL-LONDON, V460, P153, DOI 10.1113/jphysiol.1993.sp019464; YAWO H, 1993, NATURE, V365, P256, DOI 10.1038/365256a0; YAWO H, 1993, ANN NY ACAD SCI, V707, P379, DOI 10.1111/j.1749-6632.1993.tb38076.x; Yawo H, 1999, J NEUROSCI, V19, P5293; Yawo H., 2012, PATCH CLAMP TECHNIQU, P43; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	72	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59179	10.1371/journal.pone.0059179	http://dx.doi.org/10.1371/journal.pone.0059179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555628	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400024
J	Bashir, IM; Otsyula, N; Awinda, G; Spring, M; Schneider, P; Waitumbi, JN				Bashir, Ismail Mahat; Otsyula, Nekoye; Awinda, George; Spring, Michele; Schneider, Petra; Waitumbi, John Njenga			Comparison of PfHRP-2/pLDH ELISA, qPCR and Microscopy for the Detection of Plasmodium Events and Prediction of Sick Visits during a Malaria Vaccine Study	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; POLYMERASE-CHAIN-REACTION; RAPID DIAGNOSTIC-TESTS; TIME PCR ASSAY; PREGNANT-WOMEN; LACTATE-DEHYDROGENASE; ANTIGEN-DETECTION; FALCIPARUM; BLOOD; TRANSMISSION	Background: Compared to expert malaria microscopy, malaria biomarkers such as Plasmodium falciparum histidine rich protein-2 (PfHRP-2), and PCR provide superior analytical sensitivity and specificity for quantifying malaria parasites infections. This study reports on parasite prevalence, sick visits parasite density and species composition by different diagnostic methods during a phase-I malaria vaccine trial. Methods: Blood samples for microscopy, PfHRP-2 and Plasmodium lactate dehydrogenase (pLDH) ELISAs and real time quantitative PCR (qPCR) were collected during scheduled (n = 298) or sick visits (n = 38) from 30 adults participating in a 112-day vaccine trial. The four methods were used to assess parasite prevalence, as well as parasite density over a 42-day period for patients with clinical episodes. Results: During scheduled visits, qPCR (39.9%, N = 119) and PfHRP-2 ELISA (36.9%, N = 110) detected higher parasite prevalence than pLDH ELISA (16.8%, N = 50) and all methods were more sensitive than microscopy (13.4%, N = 40). All microscopically detected infections contained P. falciparum, as mono-infections (95%) or with P. malariae (5%). By qPCR, 102/119 infections were speciated. P. falciparum predominated either as monoinfections (71.6%), with P. malariae (8.8%), P. ovale (4.9%) or both (3.9%). P. malariae (6.9%) and P. ovale (1.0%) also occurred as co-infections (2.9%). As expected, higher prevalences were detected during sick visits, with prevalences of 65.8% (qPCR), 60.5% (PfHRP-2 ELISA), 21.1% (pLDH ELISA) and 31.6% (microscopy). PfHRP-2 showed biomass build-up that climaxed (1813 +/- 3410 ng/mL SD) at clinical episodes. Conclusion: PfHRP-2 ELISA and qPCR may be needed for accurately quantifying the malaria parasite burden. In addition, qPCR improves parasite speciation, whilst PfHRP-2 ELISA is a potential predictor for clinical disease caused by P. falciparum.	[Bashir, Ismail Mahat; Otsyula, Nekoye; Awinda, George; Waitumbi, John Njenga] Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya; [Bashir, Ismail Mahat; Spring, Michele] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Schneider, Petra] Univ Edinburgh, Inst Evolut, Edinburgh, Midlothian, Scotland; [Schneider, Petra] Univ Edinburgh, Inst Immunol, Edinburgh, Midlothian, Scotland; [Schneider, Petra] Univ Edinburgh, Inst Infect Res, Edinburgh, Midlothian, Scotland	Kenya Medical Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of Edinburgh; University of Edinburgh; University of Edinburgh	Waitumbi, JN (corresponding author), Kenya Govt Med Res Ctr, Walter Reed Project, Kisumu, Kenya.	john.waitumbi@usamru-k.org		Schneider, Petra/0000-0002-2616-237X; BASHIR, ISMAIL MAHAT/0000-0001-5614-2436	US Agency for International Development (USAID); GlaxoSmithKline Biologicals (GSK); US Army Medical and Materiel Research Command (USAMRMC); Office of the Surgeon General, US Army; NERC [NE/I015329/1] Funding Source: UKRI; Natural Environment Research Council [NE/I015329/1] Funding Source: researchfish	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); GlaxoSmithKline Biologicals (GSK)(GlaxoSmithKline); US Army Medical and Materiel Research Command (USAMRMC); Office of the Surgeon General, US Army; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Study Sponsor was the Office of the Surgeon General, US Army. This study was funded by the US Agency for International Development (USAID), with partial support from GlaxoSmithKline Biologicals (GSK) and the US Army Medical and Materiel Research Command (USAMRMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2012, T ROY SOC TROP MED H, V106, P573, DOI 10.1016/j.trstmh.2012.05.001; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Arez AP, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.2.0680161; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; da Rocha JAM, 2008, AM J TROP MED HYG, V78, P872, DOI 10.4269/ajtmh.2008.78.872; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Di Santi Silvia Maria, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P183, DOI 10.1590/S0036-46652004000400002; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Kifude CM, 2008, CLIN VACCINE IMMUNOL, V15, P1012, DOI 10.1128/CVI.00385-07; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Leke RFG, 1999, J CLIN MICROBIOL, V37, P2992, DOI 10.1128/JCM.37.9.2992-2996.1999; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Markus MB, 2012, TRENDS PARASITOL, V28, P39, DOI 10.1016/j.pt.2011.10.005; Martin SK, 2009, AM J TROP MED HYG, V80, P516, DOI 10.4269/ajtmh.2009.80.516; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; MUIRHEADTHOMSON RC, 1954, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.4853.68; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2006, AM J TROP MED HYG, V75, P1205, DOI 10.4269/ajtmh.2006.75.1205; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Oduola AMJ, 1997, EXP PARASITOL, V87, P283, DOI 10.1006/expr.1997.4251; Ohrt C, 2007, KENYA MALAR J, V6, P79; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; PARRA ME, 1991, J CLIN MICROBIOL, V29, P1629, DOI 10.1128/JCM.29.8.1629-1634.1991; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Rubio JM, 1999, J CLIN MICROBIOL, V37, P3260, DOI 10.1128/JCM.37.10.3260-3264.1999; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; Waitumbi JN, 2011, TROP MED INT HEALTH, V16, P786, DOI 10.1111/j.1365-3156.2011.02773.x; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Wernsdorfer Walther H, 2002, Int Marit Health, V53, P7; WHO, 2010, BAS MAL MICR; WHO, 2008, GLOB MAL CONTR EL RE	45	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e56828	10.1371/journal.pone.0056828	http://dx.doi.org/10.1371/journal.pone.0056828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554856	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800004
J	Dubois, V; Delort, L; Billard, H; Vasson, MP; Caldefie-Chezet, F				Dubois, Virginie; Delort, Laetitia; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence			Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies?	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BODY-MASS INDEX; LEPTIN RECEPTOR; ADIPOSE-TISSUE; STIMULATES ANGIOGENESIS; MAMMARY TUMORIGENESIS; UP-REGULATION; ADIPONECTIN; PROLIFERATION; EXPRESSION	Obesity is now considered as a risk factor for breast cancer in postmenopausal women. Adipokine levels are modulated in obesity, and may play a role in carcinogenesis. Moreover, obesity increases risk of cancer mortality. Here, we hypothesized that this increase could be due to a modification in angiogenesis, capital event in the development of metastases, and/or in effectiveness of cancer treatments. To test these assumptions, following a same experimental design and simultaneously the effects of leptin and adiponectin on angiogenesis were investigated, and the impact of hyperleptinemia on anticancer drug effectiveness was measured in physiological and obesity situations. Focusing on angiogenesis, the proliferation of endothelial cells (HUVEC), which expressed leptin and adiponectin receptors, was stimulated by leptin and inhibited by adiponectin. Both adipokines globally reduced apoptosis and caspase activity. Leptin increased migration whereas adiponectin decreased migration, and leptin enhanced the area of the tubes formed by HUVEC cells while adiponectin inhibited their formation. MCF7 and MDA-MB-231 cells treated with leptin secreted more VEGF than untreated cells, whereas adiponectin treatment inhibited VEGF secretion. Finally, MCF7 cells pre-treated with leptin were more invasive than untreated cells. This effect was not reproduced in MDA-MB-231 cells. In the MCF7 breast cancer cell line, leptin could induce cell proliferation and reduced the efficacy of all breast cancer therapies (tamoxifen, 5-fluorouracil, taxol and vinblastin). These results suggest that, in obesity situation, leptin-in contrast to adiponectin - may promote tumor invasion and angiogenesis, leading to metastases 'apparition, and reduce treatment efficacy, which could explain the increased risk of cancer mortality in cases of overweight. The evidence suggests adipokines influence breast cancer issue and could play a significant role, especially in obese patients for which hyperleptinemia, hypoadiponectinemia and increased metastatic potential are described.	[Dubois, Virginie; Delort, Laetitia; Billard, Hermine; Caldefie-Chezet, Florence] Univ Clermont Ferrand 2, Univ Auvergne, UFR Pharm, Lab SVFp, Clermont Ferrand, France; [Delort, Laetitia; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] CRNH Auvergne, ECREIN, INRA, UMR 1019, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Vasson, Marie-Paule; Caldefie-Chezet, Florence] CLARA, Reg Lyon Auvergne, Rhone Alpes, France	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin	Caldefie-Chezet, F (corresponding author), Univ Clermont Ferrand 2, Univ Auvergne, UFR Pharm, Lab SVFp, Clermont Ferrand, France.	florence.caldefie-chezet@udamail.fr	vasson, marie-paule/ABA-2486-2021; FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; delort, laetitia/C-3838-2014		Ligue Contre le Cancer; CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France); French Ministry of Research and Technology	Ligue Contre le Cancer(Ligue nationale contre le cancer); CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France); French Ministry of Research and Technology	This study received financial support from the 'Ligue Contre le Cancer' and from CLARA (Canceropole Lyon Auvergne Rhone-Alpes, France). Virginie Dubois is supported by a fellowship from the French Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; BJORNTORP P, 1991, INT J OBESITY, V15, P67; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; BUSSE R, 1991, BASIC RES CARDIOL, V86, P7; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Chen CC, 2006, BREAST CANCER RES TR, V98, P121, DOI 10.1007/s10549-005-9139-y; Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Fusco R, 2010, ENDOCR-RELAT CANCER, V17, P373, DOI 10.1677/ERC-09-0340; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jiang HP, 2008, BIOCHEM BIOPH RES CO, V368, P1, DOI 10.1016/j.bbrc.2007.04.004; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukanova A, 2006, INT J CANCER, V118, P458, DOI 10.1002/ijc.21354; Marttunen MB, 2000, MATURITAS, V35, P175, DOI 10.1016/S0378-5122(00)00121-3; Masaki Takayuki, 2008, Transl Oncogenomics, V3, P45; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Melen-Mucha Gabriela, 2007, Endokrynol Pol, V58, P2; Nunez NP, 2004, CLIN CANCER RES, V10, P5375, DOI 10.1158/1078-0432.CCR-04-0261; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ozet A, 2001, JPN J CLIN ONCOL, V31, P424, DOI 10.1093/jjco/hye097; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rasband W., 2006, IMAGEJ; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Takahashi Y, 1997, J BIOL CHEM, V272, P12897, DOI 10.1074/jbc.272.20.12897; Umemoto Y, 1997, BLOOD, V90, P3438, DOI 10.1182/blood.V90.9.3438; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	49	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58541	10.1371/journal.pone.0058541	http://dx.doi.org/10.1371/journal.pone.0058541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554900	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800019
J	Lochmann, T; Blanche, TJ; Butts, DA				Lochmann, Timm; Blanche, Timothy J.; Butts, Daniel A.			Construction of Direction Selectivity through Local Energy Computations in Primary Visual Cortex	PLOS ONE			English	Article							CELL RECEPTIVE-FIELDS; 2-DIMENSIONAL SPATIAL STRUCTURE; COMPLEX CELLS; GANGLION-CELLS; MOTION ENERGY; MACAQUE V1; AREA MT; NEURONS; RESPONSES; ORGANIZATION	Despite detailed knowledge about the anatomy and physiology of neurons in primary visual cortex (V1), the large numbers of inputs onto a given V1 neuron make it difficult to relate them to the neuron's functional properties. For example, models of direction selectivity (DS), such as the Energy Model, can successfully describe the computation of phase-invariant DS at a conceptual level, while leaving it unclear how such computations are implemented by cortical circuits. Here, we use statistical modeling to derive a description of DS computation for both simple and complex cells, based on physiologically plausible operations on their inputs. We present a new method that infers the selectivity of a neuron's inputs using extracellular recordings in macaque in the context of random bar stimuli and natural movies in cat. Our results suggest that DS is initially constructed in V1 simple cells through summation and thresholding of non-DS inputs with appropriate spatiotemporal relationships. However, this de novo construction of DS is rare, and a majority of DS simple cells, and all complex cells, appear to receive both excitatory and suppressive inputs that are already DS. For complex cells, these numerous DS inputs typically span a fraction of their overall receptive fields and have similar spatiotemporal tuning but different phase and spatial positions, suggesting an elaboration to the Energy Model that incorporates spatially localized computation. Furthermore, we demonstrate how these computations might be constructed from biologically realizable components, and describe a statistical model consistent with the feed-forward framework suggested by Hubel and Wiesel.	[Lochmann, Timm; Butts, Daniel A.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Lochmann, Timm; Butts, Daniel A.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Blanche, Timothy J.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Blanche, Timothy J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lochmann, T (corresponding author), Tech Univ Berlin, Neural Informat Proc Grp, Berlin, Germany.	lochman@ni.tu-berlin.de	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317	National Science Foundation [IIS-0904430]; National Institutes of Health [5R21NS066260]; Direct For Computer & Info Scie & Enginr [0904430] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066260] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work supported by National Science Foundation IIS-0904430 (TL, DAB) and National Institutes of Health-5R21NS066260 (TJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Bialek W, 2005, FEATURES DIMENSIONS; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Butts DA, 2011, J NEUROSCI, V31, P11313, DOI 10.1523/JNEUROSCI.0434-11.2011; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fitzgerald JD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002249; Freeman J, 2012, ANN M SOC NEUR, P63102; Gerwinn S, 2008, NIPS, V20, P1; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hastie T., 1986, STAT SCI, V1, P297; Hastie T., 2009, UNSUPERVISED LEARNIN; Heess N, 2010, J NEUROSCI, V30, P11300, DOI 10.1523/JNEUROSCI.1271-10.2010; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lau B, 2002, P NATL ACAD SCI USA, V99, P8974, DOI 10.1073/pnas.122173799; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Mante V, 2005, J NEUROPHYSIOL, V94, P788, DOI 10.1152/jn.01094.2004; Martinez LM, 2003, NEUROSCIENTIST, V9, P317, DOI 10.1177/1073858403252732; McFarland J, 2012, ANN M SOC NEUR, P63107; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nishimoto S, 2011, J NEUROSCI, V31, P14551, DOI 10.1523/JNEUROSCI.6801-10.2011; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Park I, 2011, NIPS, V24, P1; Park M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002219; Peterson MR, 2004, J NEUROSCI, V24, P3583, DOI 10.1523/JNEUROSCI.5398-03.2004; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pillow JW, 2006, J VISION, V6, P414, DOI 10.1167/6.4.9; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2003, J NEUROSCI, V23, P5650; Rad KR, 2010, NETWORK-COMP NEURAL, V21, P142, DOI 10.3109/0954898X.2010.532288; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Rust NC, 2010, CURR OPIN NEUROBIOL, V20, P382, DOI 10.1016/j.conb.2010.04.013; Saleem AB, 2008, J VISION, V8, DOI 10.1167/8.13.2; Saul AB, 2005, J NEUROPHYSIOL, V94, P282, DOI 10.1152/jn.00868.2004; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; Touryan J, 2002, J NEUROSCI, V22, P10811; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; Vintch B, 2012, NIPS, P25; Wielaard J, 2006, J NEUROPHYSIOL, V96, P2739, DOI 10.1152/jn.00346.2006	68	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58666	10.1371/journal.pone.0058666	http://dx.doi.org/10.1371/journal.pone.0058666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554913	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800021
J	Tang, QQ; Wu, W; Xu, X; Huang, L; Gao, Q; Chen, HJ; Sun, H; Xia, YK; Sha, JH; Wang, XR; Chen, DZ; Xu, Q				Tang, Qiuqin; Wu, Wei; Xu, Xia; Huang, Lu; Gao, Qiong; Chen, Huijuan; Sun, Hong; Xia, Yankai; Sha, Jiahao; Wang, Xinru; Chen, Daozhen; Xu, Qian			miR-141 Contributes to Fetal Growth Restriction by Regulating PLAG1 Expression	PLOS ONE			English	Article							PLACENTAL DEVELOPMENT; MATERNAL PLASMA; STEM-CELLS; MICRORNAS; INTRAUTERINE; MECHANISMS; DISEASE; MOUSE; IGF2; IDENTIFICATION	Background: Fetal growth restriction (FGR) is an important but poorly understood condition of pregnancy, which results in significant fetal, neonatal and long-term morbidity and mortality. Novel research has suggested that altered miRNA expression in the plasma and placenta is associated with adverse pregnancy. We hypothesized that aberrant expression of microRNA-141 (miR-141) in the placenta is associated with FGR. Additionally, expression levels of predicted target genes of miR-141 were also analyzed in placental tissues of FGR and normal controls. Methodology/Principal Findings: Using quantitative real time PCR, we analyzed the expression level of miR-141 and its target genes in placentas of FGR pregnancies (n = 21) and normal controls (n = 34). Western blot was used to detect the protein expression level of the target genes of miR-141. MiR-141 showed significant up regulation in FGR and significant down regulation of its targets, i.e. E2F transcription factor 3 (E2F3) protein, pleiomorphic adenoma gene 1 (PLAG1) mRNA and protein. Moreover, a positive correlation was found between PLAG1 and insulin-like growth factor 2 (IGF2) expression levels (Spearman r = 0.56, p<0.0001). MiR-141 yields an AUC of 0.83 with 88.5% sensitivity and 71.7% specificity for separating FGR from normal controls. This study indicates that miR-141 may be diagnostically important in FGR. Conclusions/Significance: Our results indicate that aberrant high expression level of miR-141 might play important roles in the pathogenesis of FGR by suppressing E2F3 and PLAG1. We propose that miR-141 may participate in a miR-141-PLAG1-IGF2 network relating to FGR development. These findings may provide new targets via miR-141 in diagnosis and therapy of FGR in the future.	[Tang, Qiuqin; Wu, Wei; Xu, Xia; Huang, Lu; Chen, Huijuan; Xu, Qian] Wuxi Hosp Maternal & Child Hlth Care, Dept Obstet, Wuxi, Peoples R China; [Tang, Qiuqin; Xu, Xia; Gao, Qiong] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Wu, Wei; Xia, Yankai; Sha, Jiahao; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wu, Wei; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Sun, Hong] KULeuven, Dept Microbial & Mol Syst, Louvain, Belgium; [Chen, Daozhen] Wuxi Hosp Maternal & Child Hlth Care, Dept Lab, Wuxi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; KU Leuven	Xu, Q (corresponding author), Wuxi Hosp Maternal & Child Hlth Care, Dept Obstet, Wuxi, Peoples R China.	xxpxq@hotmail.com	Wu, Wei/C-4409-2012; Tang, Qiuqin/X-4817-2019; Wang, Xin/AAN-8435-2021	Wu, Wei/0000-0002-0267-1284; Tang, Qiuqin/0000-0001-9110-9973; Wang, Xin/0000-0002-4457-7376	Key Project of Technology Development of Nanjing Medical University [2012NJMU002]	Key Project of Technology Development of Nanjing Medical University	This work was supported by grants Key Project of Technology Development of Nanjing Medical University (No. 2012NJMU002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Braem CV, 2002, J BIOL CHEM, V277, P19673, DOI 10.1074/jbc.M112112200; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gisselsson D, 2001, AM J PATHOL, V159, P955, DOI 10.1016/S0002-9440(10)61771-3; Hensen K, 2004, DEV GROWTH DIFFER, V46, P459, DOI 10.1111/j.1440-169x.2004.00762.x; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koukoura O, 2011, INT J MOL MED, V28, P481, DOI 10.3892/ijmm.2011.754; Kusinski LC, 2011, PLACENTA, V32, P871, DOI 10.1016/j.placenta.2011.07.086; Lee DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012630; LIEBERMAN E, 1994, AM J PUBLIC HEALTH, V84, P1127, DOI 10.2105/AJPH.84.7.1127; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Liu N, 2010, J MOL CELL BIOL, V2, P333, DOI 10.1093/jmcb/mjq029; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Nardozza LMM, 2012, ARCH GYNECOL OBSTET, V286, P1, DOI 10.1007/s00404-012-2330-6; Matsuyama A, 2011, VIRCHOWS ARCH, V458, P583, DOI 10.1007/s00428-011-1063-4; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mullins E, 2012, AM J REPROD IMMUNOL, V68, P1, DOI 10.1111/j.1600-0897.2012.01132.x; Navarro A, 2010, YONSEI MED J, V51, P622, DOI 10.3349/ymj.2010.51.5.622; NEERHOF MG, 1995, CLIN PERINATOL, V22, P375; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Parisi T, 2007, MOL CELL BIOL, V27, P2283, DOI 10.1128/MCB.01854-06; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Van Dyck F, 2004, J BIOL CHEM, V279, P36121, DOI 10.1074/jbc.M401753200; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zatkova A, 2004, GENE CHROMOSOME CANC, V39, P126, DOI 10.1002/gcc.10307	42	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58737	10.1371/journal.pone.0058737	http://dx.doi.org/10.1371/journal.pone.0058737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554918	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800024
J	Braybrook, SA; Peaucelle, A				Braybrook, Siobhan A.; Peaucelle, Alexis			Mechano-Chemical Aspects of Organ Formation in Arabidopsis thaliana: The Relationship between Auxin and Pectin	PLOS ONE			English	Article							CELL-WALL SYNTHESIS; METHYL-ESTERIFICATION; MECHANICAL-PROPERTIES; GROWTH; EXPANSIN; COLEOPTILE; PHYLLOTAXIS; INITIATION; STIFFNESS; CALCIUM	How instructive signals are translated into robust and predictable changes in growth is a central question in developmental biology. Recently, much interest has centered on the feedback between chemical instructions and mechanical changes for pattern formation in development. In plants, the patterned arrangement of aerial organs, or phyllotaxis, is instructed by the phytohormone auxin; however, it still remains to be seen how auxin is linked, at the apex, to the biochemical and mechanical changes of the cell wall required for organ outgrowth. Here, using Atomic Force Microscopy, we demonstrate that auxin reduces tissue rigidity prior to organ outgrowth in the shoot apex of Arabidopsis thaliana, and that the demethyl-esterification of pectin is necessary for this reduction. We further show that development of functional organs produced by pectin-mediated ectopic wall softening requires auxin signaling. Lastly, we demonstrate that coordinated localization of the auxin transport protein, PIN1, is disrupted in a naked-apex produced by increasing cell wall rigidity. Our data indicates that a feedback loop between the instructive chemical auxin and cell wall mechanics may play a crucial role in phyllotactic patterning.	[Braybrook, Siobhan A.] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Peaucelle, Alexis] Univ Paris Diderot, Lab Matiere & Syst Complexes, UFR Phys, Paris, France; [Peaucelle, Alexis] INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech UMR1318, Versailles, France	University of Bern; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Peaucelle, A (corresponding author), Univ Paris Diderot, Lab Matiere & Syst Complexes, UFR Phys, Paris, France.	Alexis.Peaucelle@versailles.inra.fr		Braybrook, Siobhan/0000-0002-4308-5580	Human Frontiers Science Program; Agence Nationale de la Recherche (ANR) [Blanc 2009 ANR-09-BLAN-0007-02, ANR-10-BLAN-1516 2010]; United States National Science Foundation [OISE-0853105]; Swiss National Science Foundation	Human Frontiers Science Program(Human Frontier Science Program); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); United States National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	AP was funded by the Human Frontiers Science Program, Agence Nationale de la Recherche (ANR) Blanc 2009 ANR-09-BLAN-0007-02 'GrowPec', ANR-10-BLAN-1516 2010 'Mechastem'. SB is funded by a United States National Science Foundation International Research Fellowship (Award No. OISE-0853105) and the Swiss National Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULBAKI AA, 1971, PLANT PHYSIOL, V47, P537, DOI 10.1104/pp.47.4.537; Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; BAKER DB, 1965, PLANT PHYSIOL, V40, P345, DOI 10.1104/pp.40.2.345; BARKLEY GM, 1973, PLANT PHYSIOL, V52, P76, DOI 10.1104/pp.52.1.76; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; BONNER JAMES, 1934, PROTOPLASMA, V21, P406, DOI 10.1007/BF01984529; Braybrook SA, 2012, PLANT SIGNAL BEHAV, V7, P1037, DOI 10.4161/psb.20768; Braybrook SA, 2010, PLANT CELL, V22, P1006, DOI 10.1105/tpc.110.073924; Burgert I., 2007, The expanding cell, P191; Cassereau L, 2012, NAT MATER, V11, P490, DOI 10.1038/nmat3345; Cho A, 2004, SCIENCE, V303, P782, DOI 10.1126/science.303.5659.782; CLELAND R, 1958, PHYSIOL PLANTARUM, V11, P599, DOI 10.1111/j.1399-3054.1958.tb08255.x; CLELAND R, 1956, PLANT PHYSIOL, V31, P350, DOI 10.1104/pp.31.5.350; CLELAND R, 1960, PLANT PHYSIOL, V35, P581, DOI 10.1104/pp.35.5.581; CLELAND R, 1971, ANN REV PLANT PHYSIO, V22, P197, DOI 10.1146/annurev.pp.22.060171.001213; CLELAND R, 1973, P NATL ACAD SCI USA, V70, P3092, DOI 10.1073/pnas.70.11.3092; CLELAND R, 1963, PLANT PHYSIOL, V38, P12, DOI 10.1104/pp.38.1.12; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fernandes AN, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021916; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hayot CM, 2012, J EXP BOT, V63, P2525, DOI 10.1093/jxb/err428; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Heyn ANJ, 1931, MECH ZELLSTRECKUNG; Hofte H, 2012, FRONT PLANT SCI, V3; HOSON T, 1993, J PLANT RES, V106, P369, DOI 10.1007/BF02345982; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kaku T, 2002, PLANT CELL PHYSIOL, V43, P21, DOI 10.1093/pcp/pcf004; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Krupinski P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001560; LINERS F, 1994, PLANTA, V192, P545, DOI 10.1007/BF00203593; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Milani P, 2011, PLANT J, V67, P1116, DOI 10.1111/j.1365-313X.2011.04649.x; Mirabet V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002389; Nakayama N, 2012, CURR BIOL, V22, P1468, DOI 10.1016/j.cub.2012.06.050; OKADA K, 1994, PLANT MOL BIOL, V26, P1357, DOI 10.1007/BF00016480; ORDIN L, 1957, PLANT PHYSIOL, V32, P216, DOI 10.1104/pp.32.3.216; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Peters WS, 2001, PLANT PHYSIOL, V125, P2173, DOI 10.1104/pp.125.4.2173; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Proseus TE, 1999, PLANT PHYSIOL, V119, P775, DOI 10.1104/pp.119.2.775; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; RAY PM, 1965, PLANT PHYSIOL, V40, P353, DOI 10.1104/pp.40.2.353; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reinhardt D, 1998, PLANT CELL, V10, P1427, DOI 10.1105/tpc.10.9.1427; Reinitz J, 2012, NATURE, V482, P464, DOI 10.1038/482464a; Smith RS, 2009, PLANT CELL ENVIRON, V32, P1258, DOI 10.1111/j.1365-3040.2009.01997.x; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Soding H, 1931, JB WISS BOT, V74, P127; Suslov D, 2006, J EXP BOT, V57, P2183, DOI 10.1093/jxb/erj177; TAGAWA T, 1957, PLANT PHYSIOL, V32, P207, DOI 10.1104/pp.32.3.207; TREITEL O, 1946, J COLL SCI IMP U TOK, V1, P327, DOI 10.1016/0095-8522(46)90022-0; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; UHRSTROM I, 1969, PHYSIOL PLANTARUM, V22, P271, DOI 10.1111/j.1399-3054.1969.tb07376.x; Urdy S, 2012, BIOL REV, V87, P786, DOI 10.1111/j.1469-185X.2012.00221.x; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Verbelen JP, 2007, EXPANDING CELL; Zhao QX, 2008, PLANT PHYSIOL, V147, P1874, DOI 10.1104/pp.108.116962	68	154	155	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57813	10.1371/journal.pone.0057813	http://dx.doi.org/10.1371/journal.pone.0057813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554870	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500010
J	Kavanagh, DPJ; Yemm, AI; Zhao, Y; Frampton, J; Kalia, N				Kavanagh, Dean P. J.; Yemm, Adrian I.; Zhao, Yan; Frampton, Jon; Kalia, Neena			Mechanisms of Adhesion and Subsequent Actions of a Haematopoietic Stem Cell Line, HPC-7, in the Injured Murine Intestinal Microcirculation In Vivo	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; BONE-MARROW; TNF-ALPHA; PROGENITOR CELLS; E-SELECTIN; RECRUITMENT; EXPRESSION; BLOOD; SDF-1; INFLAMMATION	Objectives: Although haematopoietic stem cells (HSCs) migrate to injured gut, therapeutic success clinically remains poor. This has been partially attributed to limited local HSC recruitment following systemic injection. Identifying site specific adhesive mechanisms underpinning HSC-endothelial interactions may provide important information on how to enhance their recruitment and thus potentially improve therapeutic efficacy. This study determined (i) the integrins and inflammatory cyto/chemokines governing HSC adhesion to injured gut and muscle (ii) whether pre-treating HSCs with these cyto/chemokines enhanced their adhesion and (iii) whether the degree of HSC adhesion influenced their ability to modulate leukocyte recruitment. Methods: Adhesion of HPC-7, a murine HSC line, to ischaemia-reperfused (IR) injured mouse gut or cremaster muscle was monitored intravitally. Critical adhesion molecules were identified by pre-treating HPC-7 with blocking antibodies to CD18 and CD49d. To identify cyto/chemokines capable of recruiting HPC-7, adhesion was monitored following tissue exposure to TNF-alpha, IL-1 beta or CXCL12. The effects of pre-treating HPC-7 with these cyto/chemokines on surface integrin expression/clustering, adhesion to ICAM-1/VCAM-1 and recruitment in vivo was also investigated. Endogenous leukocyte adhesion following HPC-7 injection was again determined intravitally. Results: IR injury increased HPC-7 adhesion in vivo, with intestinal adhesion dependent upon CD18 and muscle adhesion predominantly relying on CD49d. Only CXCL12 pre-treatment enhanced HPC-7 adhesion within injured gut, likely by increasing CD18 binding to ICAM-1 and/or CD18 surface clustering on HPC-7. Leukocyte adhesion was reduced at 4 hours post-reperfusion, but only when local HPC-7 adhesion was enhanced using CXCL12. Conclusion: This data provides evidence that site-specific molecular mechanisms govern HPC-7 adhesion to injured tissue. Importantly, we show that HPC-7 adhesion is a modulatable event in IR injury and further demonstrate that adhesion instigated by injury alone is not sufficient for mediating anti-inflammatory effects. Enhancing local HSC presence may therefore be essential to realising their clinical potential.	[Kavanagh, Dean P. J.; Yemm, Adrian I.; Zhao, Yan; Kalia, Neena] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Kalia, N (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England.	n.kalia@bham.ac.uk		Yemm, Adrian/0000-0001-9508-5710; KALIA, NEENA/0000-0003-2960-7829	British Heart Foundation [PG/08/043/25067]; Royal Society [12043]; Bardhan Research and Education Trust [09-0675]; British Heart Foundation [PG/11/114/29282] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Royal Society(Royal Society of London); Bardhan Research and Education Trust; British Heart Foundation(British Heart Foundation)	This study was funded by the British Heart Foundation (DK, NK): PG/08/043/25067; The Royal Society (YZ, NK): 12043; Bardhan Research and Education Trust (AY, NK): 09-0675. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Allakhverdi Z, 2012, ALLERGY, V67, P4, DOI 10.1111/j.1398-9995.2011.02703.x; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Chen BP, 1997, IMMUNOL REV, V157, P41, DOI 10.1111/j.1600-065X.1997.tb00972.x; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Esposito E, 2007, J LEUKOCYTE BIOL, V81, P1032, DOI 10.1189/jlb.0706480; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Fukatsu K, 2004, JPEN-PARENTER ENTER, V28, P224, DOI 10.1177/0148607104028004224; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Granick JL, 2012, BONE MARROW RES, DOI 10.1155/2012/165107; Guan YF, 2009, AM J PHYSIOL-GASTR L, V297, pG187, DOI 10.1152/ajpgi.90595.2008; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hiasa K, 2004, CIRCULATION, V109, P2454, DOI 10.1161/01.CIR.0000128213.96779.61; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Katayama Y, 2004, BLOOD, V104, P2020, DOI 10.1182/blood-2003-12-4157; Kavanagh DPJ, 2010, GUT, V59, P79, DOI 10.1136/gut.2008.168054; Kavanagh DP, 2012, CELL TRANSPLANT; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kyriakides C, 2000, J TRAUMA, V48, P32, DOI 10.1097/00005373-200001000-00006; Lundberg AH, 2000, ANN SURG, V231, P213, DOI 10.1097/00000658-200002000-00010; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mejia-Vilet JM, 2007, AM J PHYSIOL-RENAL, V293, pF78, DOI 10.1152/ajprenal.00077.2007; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Oktar BK, 2002, AM J PHYSIOL-GASTR L, V282, pG647, DOI 10.1152/ajpgi.2002.282.4.G647; Orelio C, 2009, HAEMATOL-HEMATOL J, V94, P462, DOI 10.3324/haematol.13728; Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20; Oyama Y, 2005, GASTROENTEROLOGY, V128, P552, DOI 10.1053/j.gastro.2004.11.051; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Playford RJ, 2005, J PATHOL, V205, P417, DOI 10.1002/path.1722; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Santiago B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1900; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Sumpio BE, 2003, HAIMOVICIS VASCULAR, P137; TURNER ML, 1995, STEM CELLS, V13, P311, DOI 10.1002/stem.5530130312; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wyble CW, 1997, J SURG RES, V73, P107, DOI 10.1006/jsre.1997.5207; Yoshida T, 2007, NEUROSCIENCE, V145, P923, DOI 10.1016/j.neuroscience.2006.12.067; Yu T, 2010, AM J PHYSIOL-CELL PH, V299, pC399, DOI 10.1152/ajpcell.00039.2009	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59150	10.1371/journal.pone.0059150	http://dx.doi.org/10.1371/journal.pone.0059150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554986	gold, Green Submitted, Green Published			2022-12-27	WOS:000316252500070
J	Meng, J; Zhu, QH; Zhang, LL; Li, CY; Li, L; She, ZC; Huang, BY; Zhang, GF				Meng, Jie; Zhu, Qihui; Zhang, Linlin; Li, Chunyan; Li, Li; She, Zhicai; Huang, Baoyu; Zhang, Guofan			Genome and Transcriptome Analyses Provide Insight into the Euryhaline Adaptation Mechanism of Crassostrea gigas	PLOS ONE			English	Article							MARKER GENES; OYSTER; SALINITY; EXPRESSION; STRESS; TAURINE; TEMPERATURE; POPULATION; LARVAE; GROWTH	Background: The Pacific oyster, Crassostrea gigas, has developed special mechanisms to regulate its osmotic balance to adapt to fluctuations of salinities in coastal zones. To understand the oyster's euryhaline adaptation, we analyzed salt stress effectors metabolism pathways under different salinities (salt 5, 10, 15, 20, 25, 30 and 40 for 7 days) using transcriptome data, physiology experiment and quantitative real-time PCR. Results: Transcriptome data uncovered 189, 480, 207 and 80 marker genes for monitoring physiology status of oysters and the environment conditions. Three known salt stress effectors (involving ion channels, aquaporins and free amino acids) were examined. The analysis of ion channels and aquaporins indicated that 7 days long-term salt stress inhibited voltage-gated Na+/K+ channel and aquaporin but increased calcium-activated K+ channel and Ca2+ channel. As the most important category of osmotic stress effector, we analyzed the oyster FAAs metabolism pathways (including taurine, glycine, alanine, beta-alanine, proline and arginine) and explained FAAs functional mechanism for oyster low salinity adaptation. FAAs metabolism key enzyme genes displayed expression differentiation in low salinity adapted individuals comparing with control which further indicated that FAAs played important roles for oyster salinity adaptation. A global metabolic pathway analysis (iPath) of oyster expanded genes displayed a co-expansion of FAAs metabolism in C. gigas compared with seven other species, suggesting oyster's powerful ability regarding FAAs metabolism, allowing it to adapt to fluctuating salinities, which may be one important mechanism underlying euryhaline adaption in oyster. Additionally, using transcriptome data analysis, we uncovered salt stress transduction networks in C. gigas. Conclusions: Our results represented oyster salt stress effectors functional mechanisms under salt stress conditions and explained the expansion of FAAs metabolism pathways as the most important effectors for oyster euryhaline adaptation. This study was the first to explain oyster euryhaline adaptation at a genome-wide scale in C. gigas.	[Meng, Jie; Zhu, Qihui; Zhang, Linlin; Li, Chunyan; Li, Li; She, Zhicai; Huang, Baoyu; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Meng, Jie; Zhu, Qihui; Li, Chunyan; She, Zhicai; Huang, Baoyu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	Zhang, Linlin/I-4970-2014; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; li, li/GPX-3938-2022	Zhang, Linlin/0000-0003-0247-7710; 	National Basic Research Program of China (973 Program) [2010CB126402]; National Natural Science Foundation of China [40730845]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126402), the National Natural Science Foundation of China (No. 40730845), National High Technology Research and Development Program (863 program, No. 2012AA10A405), Mollusk Research and Development Center, CARS, Taishan Scholars Climbing Program of Shandong and Oversea Taishan Scholar Program of Shandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DKA, 1999, AFR J ECOL, V37, P424, DOI 10.1046/j.1365-2028.1999.00197.x; Bartol IK, 1999, J EXP MAR BIOL ECOL, V237, P157, DOI 10.1016/S0022-0981(98)00175-0; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; BISHOP SH, 1994, J EXP ZOOL, V268, P151, DOI 10.1002/jez.1402680213; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; BROWN JR, 1988, MAR ECOL PROG SER, V45, P225, DOI 10.3354/meps045225; Chow ML, 2001, PHYSIOL GENOMICS, V5, P99, DOI 10.1152/physiolgenomics.2001.5.2.99; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Duchateau PN, 2001, J LIPID RES, V42, P620; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Gilchrist DG, 1998, ANNU REV PHYTOPATHOL, V36, P393, DOI 10.1146/annurev.phyto.36.1.393; GUNTER G, 1964, ECOLOGY, V45, P181, DOI 10.2307/1937124; Han Q, 2006, BIOCHEM J, V397, P473, DOI 10.1042/BJ20060469; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Heilmayer O, 2008, ESTUAR COAST SHELF S, V79, P179, DOI 10.1016/j.ecss.2008.03.022; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; Hofmann GE, 2007, MAR ECOL PROG SER, V332, P249, DOI 10.3354/meps332249; Hosoi M, 2003, FISHERIES SCI, V69, P395, DOI 10.1046/j.1444-2906.2003.00634.x; Hosoi M, 2007, FISHERIES SCI, V73, P385, DOI 10.1111/j.1444-2906.2007.01346.x; HOYAUX J, 1976, COMP BIOCHEM PHYS A, V53, P361, DOI 10.1016/S0300-9629(76)80157-0; Huang X, 2002, GENETICS, V160, P561; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Laing I, 2002, AQUACULTURE, V205, P171, DOI 10.1016/S0044-8486(01)00663-9; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Luna-Acosta A, 2011, FISH SHELLFISH IMMUN, V31, P795, DOI 10.1016/j.fsi.2011.07.016; Luna-Acosta A, 2011, COMP BIOCHEM PHYS B, V159, P220, DOI 10.1016/j.cbpb.2011.04.009; MACINNES JR, 1979, ARCH ENVIRON CON TOX, V8, P553, DOI 10.1007/BF01055036; MANAHAN DT, 1989, MAR ECOL PROG SER, V53, P247, DOI 10.3354/meps053247; Marom S, 1998, J MEMBRANE BIOL, V161, P105, DOI 10.1007/s002329900318; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Meng XL, 2011, AQUACULTURE, V316, P88, DOI 10.1016/j.aquaculture.2011.03.003; Pauley G B, 1988, FISH WILDLIFE SERVIC, V82, P28; Payn RA, 2009, WATER RESOUR RES, V45; PIERCE SK, 1981, J EXP ZOOL, V215, P247, DOI 10.1002/jez.1402150304; Santoni V, 2003, BIOCHEM J, V373, P289, DOI 10.1042/BJ20030159; SATO K, 1992, J AGR FOOD CHEM, V40, P806, DOI 10.1021/jf00017a019; SHUMWAY SE, 1977, MAR BIOL, V41, P153, DOI 10.1007/BF00394023; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sussarellu R, 2010, MAR GENOM, V3, P133, DOI 10.1016/j.margen.2010.08.005; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takimoto K, 1997, CIRC RES, V81, P533, DOI 10.1161/01.RES.81.4.533; Tirard CT, 1997, COMP BIOCHEM PHYS A, V116, P43, DOI 10.1016/S0300-9629(96)00115-6; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; WELBORN JR, 1995, J EXP BIOL, V198, P1791; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	63	109	121	11	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58563	10.1371/journal.pone.0058563	http://dx.doi.org/10.1371/journal.pone.0058563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554902	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500030
J	Wang, Z; Li, AY; Guo, QH; Zhang, JP; An, Q; Guo, YJ; Chu, L; Weiss, JW; Ji, ES				Wang, Zhuo; Li, Ai-Ying; Guo, Qiu-Hong; Zhang, Jian-Ping; An, Qi; Guo, Ya-jing; Chu, Li; Weiss, J. Woodrow; Ji, En-Sheng			Effects of Cyclic Intermittent Hypoxia on ET-1 Responsiveness and Endothelial Dysfunction of Pulmonary Arteries in Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; NITRIC-OXIDE; INDUCED HYPERTENSION; RENAL VASOCONSTRICTION; CARDIOVASCULAR-DISEASE; BLOOD-VESSELS; RECEPTORS; RELEASE; CELLS; PATHOPHYSIOLOGY	Obstructive sleep apnoea (OSA) is a risk factor for cardiovascular disorders and in some cases is complication of pulmonary hypertension. We simulated OSA by exposing rats to cyclic intermittent hypoxia (CIH) to investigate its effect on pulmonary vascular endothelial dysfunction. Sprague-Dawley Rats were exposed to CIH (FiO(2) 9% for 1 min, repeated every 2 min for 8 h/day, 7 days/wk for 3 wk), and the pulmonary arteries of normoxia and CIH treated rats were analyzed for expression of endothelin-1 (ET-1) and ET receptors by histological, immunohistochemical, RT-PCR and Western Blot analyses, as well as for contractility in response to ET-1. In the pulmonary arteries, ET-1 expression was increased, and ET-1 more potently elicited constriction of the pulmonary artery in CIH rats than in normoxic rats. Exposure to CIH induced marked endothelial cell damage associated with a functional decrease of endothelium-dependent vasodilatation in the pulmonary artery. Compared with normoxic rats, ETA receptor expression was increased in smooth muscle cells of the CIH rats, while the expression of ETB receptors was decreased in endothelial cells. These results demonstrated endothelium-dependent vasodilation was impaired and the vasoconstrictor responsiveness increased by CIH. The increased responsiveness to ET-1 induced by intermittent hypoxia in pulmonary arteries of rats was due to increased expression of ETA receptors predominantly, meanwhile, decreased expression of ETB receptors in the endothelium may also participate in it.	[Wang, Zhuo; An, Qi; Guo, Ya-jing; Ji, En-Sheng] Dept Physiol, Shijiazhuang, Hebei, Peoples R China; [Li, Ai-Ying] Dept Biochem, Shijiazhuang, Hebei, Peoples R China; [Guo, Qiu-Hong; Zhang, Jian-Ping; Chu, Li] Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Weiss, J. Woodrow] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Weiss, JW (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.	jweiss@bidmc.harvard.edu; jejesphy50@gmail.com			National Natural Science Foundation of China [30971195, 81170069]; Hebei Province Natural Science Foundation [C2011206031, C2009001053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Natural Science Foundation(Natural Science Foundation of Hebei Province)	This work was supported by grants from the National Natural Science Foundation of China (numbers 30971195 and 81170069) and the Hebei Province Natural Science Foundation (numbers C2011206031 and C2009001053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahdadi KJ, 2005, HYPERTENSION, V45, P705, DOI 10.1161/01.HYP.0000153794.52852.04; Allahdadi KJ, 2008, AM J PHYSIOL-HEART C, V294, pH920, DOI 10.1152/ajpheart.01264.2007; Bananian Sevag, 2002, Heart Dis, V4, P296, DOI 10.1097/00132580-200209000-00006; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Chakkarwar VA, 2011, VASC PHARMACOL, V55, P163, DOI 10.1016/j.vph.2011.08.215; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Davenport AP, 2002, PHARMACOL REV, V54, P219, DOI 10.1124/pr.54.2.219; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; DORLEANSJUSTE P, 1994, BRIT J PHARMACOL, V113, P1257, DOI 10.1111/j.1476-5381.1994.tb17133.x; Dupuis J, 1998, AM HEART J, V135, P614, DOI 10.1016/S0002-8703(98)70276-5; Flowers MA, 1995, AM J PHYSIOL-HEART C, V269, pH1988, DOI 10.1152/ajpheart.1995.269.6.H1988; FUKURODA T, 1994, BIOCHEM BIOPH RES CO, V199, P1461, DOI 10.1006/bbrc.1994.1395; Gellai M, 1997, PHARMACOLOGY, V55, P299, DOI 10.1159/000139542; Higashi T, 1997, AM J PHYSIOL-LUNG C, V272, pL287, DOI 10.1152/ajplung.1997.272.2.L287; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; HIRATA Y, 1995, CIRCULATION, V91, P1229, DOI 10.1161/01.CIR.91.4.1229; Kanagy NL, 2001, HYPERTENSION, V37, P511, DOI 10.1161/01.HYP.37.2.511; Karkoulias K, 2010, CURR MED CHEM, V17, P1059; Kato M, 2000, CIRCULATION, V102, P2607; Kraiczi H, 2000, J APPL PHYSIOL, V89, P493, DOI 10.1152/jappl.2000.89.2.493; Liu YZ, 2009, J APPL PHYSIOL, V106, P259, DOI 10.1152/japplphysiol.90626.2008; LUSCHER TF, 1991, CIRCULATION, V83, P701, DOI 10.1161/01.CIR.83.2.701; MACLEAN MR, 1994, J CARDIOVASC PHARM, V23, P838, DOI 10.1097/00005344-199405000-00022; MADEDDU P, 1991, CLIN INVEST MED, V14, P600; Marshall JL, 1999, BRIT J PHARMACOL, V128, P809, DOI 10.1038/sj.bjp.0702846; Minchenko A, 2000, MOL CELL BIOCHEM, V208, P53, DOI 10.1023/A:1007042729486; Miyauchi T, 1999, ANNU REV PHYSIOL, V61, P391, DOI 10.1146/annurev.physiol.61.1.391; NAMIKI A, 1992, LIFE SCI, V50, P677, DOI 10.1016/0024-3205(92)90470-A; Phillips BG, 1999, J HYPERTENS, V17, P61, DOI 10.1097/00004872-199917010-00010; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Sajkov D, 2009, PROG CARDIOVASC DIS, V51, P363, DOI 10.1016/j.pcad.2008.06.001; Schiffrin EL, 1999, HYPERTENSION, V34, P876, DOI 10.1161/01.HYP.34.4.876; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Soma S, 1999, AM J RESP CELL MOL, V20, P620, DOI 10.1165/ajrcmb.20.4.3356; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; USHIOFUKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P518, DOI 10.1016/0006-291X(92)91225-F; Weiss JW, 2007, EXP PHYSIOL, V92, P21, DOI 10.1113/expphysiol.2006.035733; Wolk R, 2003, CIRCULATION, V108, P9, DOI 10.1161/01.CIR.0000072346.56728.E4; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhou YB, 2003, AM J PHYSIOL-HEART C, V285, pH2797, DOI 10.1152/ajpheart.00466.2003	43	7	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58078	10.1371/journal.pone.0058078	http://dx.doi.org/10.1371/journal.pone.0058078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23555567	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900078
J	Liu, JB; Wang, J; Luo, F; Wang, ZM; Wang, Y				Liu, Jingbo; Wang, Jun; Luo, Fen; Wang, Zhiming; Wang, Yin			Reconstruction of the Abdominal Vagus Nerve Using Sural Nerve Grafts in Canine Models	PLOS ONE			English	Article							GASTRIC-CANCER SURGERY; RADICAL PROSTATECTOMY; PRESERVING GASTRECTOMY; SUBTOTAL GASTRECTOMY; ERECTILE DYSFUNCTION	Background: Recently, vagus nerve preservation or reconstruction of vagus has received increasing attention. The present study aimed to investigate the feasibility of reconstructing the severed vagal trunk using an autologous sural nerve graft. Methods: Ten adult Beagle dogs were randomly assigned to two groups of five, the nerve grafting group (TG) and the vagal resection group (VG). The gastric secretion and emptying functions in both groups were assessed using Hollander insulin and acetaminophen tests before surgery and three months after surgery. All dogs underwent laparotomy under general anesthesia. In TG group, latency and conduction velocity of the action potential in a vagal trunk were measured, and then nerves of 4 cm long were cut from the abdominal anterior and posterior vagal trunks. Two segments of autologous sural nerve were collected for performing end-to-end anastomoses with the cut ends of vagal trunk (8-0 nylon suture, 3 sutures for each anastomosis). Dogs in VG group only underwent partial resections of the anterior and posterior vagal trunks. Laparotomy was performed in dogs of TG group, and latency and conduction velocity of the action potential in their vagal trunks were measured. The grafted nerve segment was removed, and stained with anti-neurofilament protein and toluidine blue. Results: Latency of the action potential in the vagal trunk was longer after surgery than before surgery in TG group, while the conduction velocity was lower after surgery. The gastric secretion and emptying functions were weaker after surgery in dogs of both groups, but in TG group they were significantly better than in VG group. Anti-neurofilament protein staining and toluidine blue staining showed there were nerve fibers crossing the anastomosis of the vagus and sural nerves in dogs of TG group. Conclusion: Reconstruction of the vagus nerve using the sural nerve is technically feasible.	[Liu, Jingbo] Fudan Univ, Huashan Hosp, Dept Hand Surg, Shanghai 200433, Peoples R China; [Liu, Jingbo] Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Liu, Jingbo] Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China; [Wang, Jun; Luo, Fen; Wang, Zhiming] Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Yin] Fudan Univ, Huashan Hosp, Dept Neuropathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, ZM (corresponding author), Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China.	Luofen1025@126.com; Wzhm824@126.com						Ando H, 2008, ANN SURG, V247, P976, DOI 10.1097/SLA.0b013e31816ffb1c; Ando S, 2008, ANZ J SURG, V78, P172, DOI 10.1111/j.1445-2197.2007.04396.x; Briganti A, 2007, WORLD J UROL, V25, P143, DOI 10.1007/s00345-007-0148-9; Burnett AL, 2003, J UROLOGY, V170, pS31, DOI 10.1097/01.ju.0000075604.60090.60; Davis JW, 2009, EUR UROL, V55, P1135, DOI 10.1016/j.eururo.2008.08.051; Flores-Perez C, 2011, BIOMED CHROMATOGR, V25, P760, DOI 10.1002/bmc.1511; Fukagawa T, 2009, J GASTROINTEST SURG, V13, P886, DOI 10.1007/s11605-009-0832-8; Hagiwara A, 2002, AM J SURG, V183, P692, DOI 10.1016/S0002-9610(02)00854-1; Hanson GR, 2008, CAN J UROL, V15, P3990; Kodama M, 1997, SURG TODAY, V27, P741, DOI 10.1007/BF02384988; Nomura E, 2003, HEPATO-GASTROENTEROL, V50, P2246; Porpiglia F, 2005, BJU INT, V95, P1267, DOI 10.1111/j.1464-410X.2005.05501.x; Sim HG, 2006, UROLOGY, V68, P1290, DOI 10.1016/j.urology.2006.08.1064; Tomita R, 2010, HEPATO-GASTROENTEROL, V57, P984; Wolford Larry M, 2011, Atlas Oral Maxillofac Surg Clin North Am, V19, P91, DOI 10.1016/j.cxom.2010.11.008	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58903	10.1371/journal.pone.0058903	http://dx.doi.org/10.1371/journal.pone.0058903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555604	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900007
J	Sachdev, PS; Lipnicki, DM; Crawford, J; Reppermund, S; Kochan, NA; Trollor, JN; Wen, W; Draper, B; Slavin, MJ; Kang, K; Lux, O; Mather, KA; Brodaty, H				Sachdev, Perminder S.; Lipnicki, Darren M.; Crawford, John; Reppermund, Simone; Kochan, Nicole A.; Trollor, Julian N.; Wen, Wei; Draper, Brian; Slavin, Melissa J.; Kang, Kristan; Lux, Ora; Mather, Karen A.; Brodaty, Henry		Sydney Memory Ageing Study Team	Factors Predicting Reversion from Mild Cognitive Impairment to Normal Cognitive Functioning: A Population-Based Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; SYDNEY MEMORY; BLOOD-PRESSURE; DEMENTIA; DEPRESSION; PREVALENCE; BRAIN; IDENTIFICATION; PROGRESSION; VALIDATION	Introduction: Mild cognitive impairment (MCI) is associated with an increased risk of developing dementia. However, many individuals diagnosed with MCI are found to have reverted to normal cognition on follow-up. This study investigated factors predicting or associated with reversion from MCI to normal cognition. Methods: Our analyses considered 223 participants (48.9% male) aged 71-89 years, drawn from the prospective, population-based Sydney Memory and Ageing Study. All were diagnosed with MCI at baseline and subsequently classified with either normal cognition or repeat diagnosis of MCI after two years (a further 11 participants who progressed from MCI to dementia were excluded). Associations with reversion were investigated for (1) baseline factors that included diagnostic features, personality, neuroimaging, sociodemographics, lifestyle, and physical and mental health; (2) longitudinal change in potentially modifiable factors. Results: There were 66 reverters to normal cognition and 157 non-reverters (stable MCI). Regression analyses identified diagnostic features as most predictive of prognosis, with reversion less likely in participants with multiple-domain MCI (p = 0.011), a moderately or severely impaired cognitive domain (p = 0.002 and p = 0.006), or an informant-based memory complaint (p = 0.031). Reversion was also less likely for participants with arthritis (p = 0.037), but more likely for participants with higher complex mental activity (p = 0.003), greater openness to experience (p = 0.041), better vision (p = 0.014), better smelling ability (p = 0.040), or larger combined volume of the left hippocampus and left amygdala (p<0.040). Reversion was also associated with a larger drop in diastolic blood pressure between baseline and follow-up (p = 0.026). Discussion: Numerous factors are associated with reversion from MCI to normal cognition. Assessing these factors could facilitate more accurate prognosis of individuals with MCI. Participation in cognitively enriching activities and efforts to lower blood pressure might promote reversion.	[Sachdev, Perminder S.; Lipnicki, Darren M.; Crawford, John; Reppermund, Simone; Kochan, Nicole A.; Trollor, Julian N.; Wen, Wei; Draper, Brian; Slavin, Melissa J.; Kang, Kristan; Lux, Ora; Mather, Karen A.; Brodaty, Henry; Sydney Memory Ageing Study Team] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Sachdev, Perminder S.; Kochan, Nicole A.; Wen, Wei; Mather, Karen A.] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia; [Sachdev, Perminder S.; Wen, Wei; Draper, Brian; Slavin, Melissa J.; Brodaty, Henry] Univ New South Wales Med, Sch Psychiat, Primary Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Draper, Brian; Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Sydney, NSW, Australia; [Trollor, Julian N.] Univ New South Wales Med, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Lux, Ora] Prince Wales Hosp, South Eastern Area Lab Serv, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Sachdev, PS (corresponding author), Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia.	p.sachdev@unsw.edu.au	Karen, Mather A/O-9795-2016; Sachdev, Perminder/ABC-1137-2020	Karen, Mather A/0000-0003-4143-8941; Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977	National Health & Medical Research Council of Australia [350833]; Capacity Building Grant [568940]; Eli Lilly; Pfizer; Janssen; Novartis; Sanofi; Medivation	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Capacity Building Grant; Eli Lilly(Eli Lilly); Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Sanofi; Medivation	The study was funded by National Health & Medical Research Council of Australia Program Grant (ID 350833) and Capacity Building Grant (ID568940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Perminder Sachdev has received payment for lectures by Eli Lilly and Pfizer. Henry Brodaty has received payment for lectures by Pfizer, Janssen, and Novartis, is on the Alzheimer's Advisory Boards of these companies and Lunbeck, consults for Wyeth, and has received institutional grants for an Alzheimer's drug trial from Sanofi and Medivation. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Appenzeller S, 2004, METHOD FIND EXP CLIN, V26, P339, DOI 10.1358/mf.2004.26.5.831324; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Australian Bureau of Statistics, 2003, AG AUSTR CENS POUL H; Baars MAE, 2009, DEMENT GERIATR COGN, V27, P173, DOI 10.1159/000200465; Brodaty H, 2012, ALZHEIMERS DEMENT; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Costa PT, 2007, REVISED NEO PERSONAL; Diniz BS, 2009, DEMENT GERIATR COGN, V27, P224, DOI 10.1159/000203346; Dolcos S, 2012, NEUROPSYCHOLOGY, V26, P209, DOI 10.1037/a0026760; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Forlenza OV, 2009, INT PSYCHOGERIATR, V21, P1088, DOI 10.1017/S1041610209990792; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Kochan NA, 2010, AM J GERIAT PSYCHIAT, V18, P711, DOI 10.1097/JGP.0b013e3181d6b6a9; Koepsell TD, 2012, NEUROLOGY, V79, P1591, DOI 10.1212/WNL.0b013e31826e26b7; Kumar R, 2006, INT PSYCHOGERIATR, V18, P471, DOI 10.1017/S1041610205003005; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; Loewenstein DA, 2009, DEMENT GERIATR COGN, V27, P418, DOI 10.1159/000211803; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Nickl-Jockschat T, 2012, BRAIN STRUCT FUNCT, V217, P115, DOI 10.1007/s00429-011-0333-x; Nordlund A, 2010, J NEUROL NEUROSUR PS, V81, P541, DOI 10.1136/jnnp.2008.171066; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Olazaran J, 2011, FAM PRACT, V28, P385, DOI 10.1093/fampra/cmr005; Panza F, 2012, INT J GERIATR PSYCH, V27, P1218, DOI 10.1002/gps.3772; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Razay G, 2009, DEMENT GERIATR COGN, V28, P70, DOI 10.1159/000230877; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie LJ, 2010, AM J ALZHEIMERS DIS, V25, P592, DOI 10.1177/1533317510382286; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sachdev PS, 2012, J AM GERIATR SOC, V60, P24, DOI 10.1111/j.1532-5415.2011.03774.x; Sachdev PS, 2009, AM J GERIAT PSYCHIAT, V17, P175, DOI 10.1097/JGP.0b013e318196a661; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; Wahl HW, 2003, GENERATIONS, V27, P39; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; Wallin K, 2012, J ALZHEIMERS DIS, V31, P669, DOI 10.3233/JAD-2012-111736; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Westervelt HJ, 2008, J CLIN EXP NEUROPSYC, V30, P151, DOI 10.1080/13803390701287408; Wilson RS, 2009, ANN NY ACAD SCI, V1170, P730, DOI 10.1111/j.1749-6632.2009.04013.x; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; WISOTSKY M, 1965, J AM GERIATR SOC, V13, P243, DOI 10.1111/j.1532-5415.1965.tb02672.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	57	101	105	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59649	10.1371/journal.pone.0059649	http://dx.doi.org/10.1371/journal.pone.0059649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544083	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700043
J	Guerrier, G; D'Ortenzio, E				Guerrier, Gilles; D'Ortenzio, Eric			The Jarisch-Herxheimer Reaction in Leptospirosis: A Systematic Review	PLOS ONE			English	Review							BORNE RELAPSING FEVER; PENICILLIN THERAPY; CONTROLLED-TRIAL; DOXYCYCLINE; DISEASE	Background: Leptospirosis is an endemo-epidemic zoonotic disease associated with potentially fatal renal, cardiovascular or pulmonary failure. Recommended treatment includes antibiotics, which may induce a Jarisch-Herxheimer reaction (JHR). Since little information on the importance of this adverse event is available, we performed this review to quantify frequency and impact of JHR in leptospirosis management. Methodology/Principal Findings: This review systematically summarizes the literature on the JHR in leptospirosis. To approach the broader aspects of the subject, articles considering the treatment of leptospirosis, national leptospirosis guidelines and textbook and technical reports of the World Health Organisation were reviewed. Publications describing JHR in leptospirosis are very limited and consist mainly of single case reports and small case series. A single randomized control trial specifically assessed the JHR occurrence, but it has never been systematically investigated in large trials. Not all guidelines and not all literature on leptospirosis mention this reaction which can be fatal. Conclusions/Significance: Although generally assumed to be a rare event, the true prevalence of JHR in leptospirosis is unknown and the awareness of this event is insufficient. All leptospirosis guidelines and local leptospirosis protocols should stress on systematic monitoring for clinical status early after antibiotic administration. Large well designed studies are required to precise the incidence and the impact of JHR as well as the severity and rates between various antibiotics.	[Guerrier, Gilles] Ctr Hosp Territorial, Dept Anesthesie & Reanimat, Noumea, New Caledonia; [D'Ortenzio, Eric] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, Unite Epidemiol Malad Infect, Noumea, New Caledonia		Guerrier, G (corresponding author), Ctr Hosp Territorial, Dept Anesthesie & Reanimat, Noumea, New Caledonia.	guerriergilles@gmail.com		D'Ortenzio, Eric/0000-0002-4527-6209	Institut Pasteur de Nouvelle Caledonie	Institut Pasteur de Nouvelle Caledonie	Institut Pasteur de Nouvelle Caledonie funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HUM LEPT GUID DIAGN; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brett-Major DM, 2012, COCHRANE DATABASE SY, V2; BRYCESON AD, 1972, CLIN SCI, V43, P343, DOI 10.1042/cs0430343; BRYCESON ADM, 1976, J INFECT DIS, V133, P696, DOI 10.1093/infdis/133.6.696; Colle' ge de Maladies Infectieuses et Tropicales, 2012, E PILL MAL INF TROP; Cook GC, 2008, MANSONS TROPICAL DIS, P1161; Costa Everaldo, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P141, DOI 10.1590/S0036-46652003000300005; CROOKS J, 1955, BMJ-BRIT MED J, V1, P885, DOI 10.1136/bmj.1.4918.885; Daher Elizabeth De Francesco, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P327, DOI 10.1590/S0036-46652000000600005; Disease control division Doph Ministry of Health Malaysia, 2011, GUID DIAGN MAN PREV; DOHERTY R. L., 1955, AUSTRALASIAN ANN MED, V4, P53; Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767; Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273; EDWARDS CN, 1988, AM J TROP MED HYG, V39, P388, DOI 10.4269/ajtmh.1988.39.388; EMMANOUILIDES CE, 1994, CLIN INFECT DIS, V18, P1004, DOI 10.1093/clinids/18.6.1004; FAIRBURN AC, 1956, LANCET, V270, P13; Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503; FRIEDLAND JS, 1991, REV INFECT DIS, V13, P207; Gorbach SL, 2004, INFECT DIS, P1469; Guerrant RL, 2011, TROPICAL INFECT DIS, P307; HALL HE, 1951, ANN INTERN MED, V35, P981, DOI 10.7326/0003-4819-35-5-981; Hashimoto T, 2012, J THORAC IMAG, V27, pW24, DOI 10.1097/RTI.0b013e318231535b; Herxheimer K, 1902, DEUT MED WOCHENSCHR, V28, P895, DOI 10.1055/s-0028-1139096; Jarisch A., 1895, WIEN MED WOCHENSCHR, V45, P721; Lau CL, 2012, EMERG INFECT DIS; MACKAY-DICK J, 1957, J R Army Med Corps, V103, P186; Maloy A L, 1998, J Emerg Med, V16, P437, DOI 10.1016/S0736-4679(98)00011-0; Mandell GL, 2009, MANDELL DOUGLAS BENN, P3102; Markham R, 2012, MED J AUSTRALIA, V197, P276, DOI 10.5694/mja11.11175; Marotto PCF, 1997, AM J TROP MED HYG, V56, P307, DOI 10.4269/ajtmh.1997.56.307; Masuda Keita, 2010, Kansenshogaku Zasshi, V84, P59; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696; Munnich D, 1972, Ther Hung, V20, P152; Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652; Panaphut T, 2003, CLIN INFECT DIS, V36, P1507, DOI 10.1086/375226; Philippine College of Physicians, 2011, PHIL CRIT PRACT GUID, P66; Phimda K, 2007, ANTIMICROB AGENTS CH, V51, P3259, DOI 10.1128/AAC.00508-07; Pound MW, 2005, J CLIN PHARM THER, V30, P291, DOI 10.1111/j.1365-2710.2005.00631.x; RUSSELL RWR, 1958, LANCET, V2, P1143; SHENEP JL, 1986, JAMA-J AM MED ASSOC, V256, P388, DOI 10.1001/jama.256.3.388; Spichler A, 2007, AM J TROP MED HYG, V77, P1111, DOI 10.4269/ajtmh.2007.77.1111; Spichler AS, 2008, AM J TROP MED HYG, V79, P911, DOI 10.4269/ajtmh.2008.79.911; Suputtamongkol Y, 2004, CLIN INFECT DIS, V39, P1417, DOI 10.1086/425001; SWIADER L, 1995, PRESSE MED, V24, P1753; Tattevin P, 2003, EUR J CLIN MICROBIOL, V22, P449, DOI 10.1007/s10096-003-0957-8; VAUGHAN C, 1994, POSTGRAD MED J, V70, P118, DOI 10.1136/pgmj.70.820.118; Warrell D.A., 2012, OXFORD TXB MED INFEC, Vfirst; WARRELL DA, 1983, J INFECT DIS, V147, P898, DOI 10.1093/infdis/147.5.898; WATT G, 1988, LANCET, V1, P433; WATT G, 1990, J INFECT DIS, V162, P564, DOI 10.1093/infdis/162.2.564; WINEARLS CG, 1984, Q J MED, V53, P487	53	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59266	10.1371/journal.pone.0059266	http://dx.doi.org/10.1371/journal.pone.0059266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555644	gold, Green Published			2022-12-27	WOS:000317418500029
J	Quinn, EM; Cormican, P; Kenny, EM; Hill, M; Anney, R; Gill, M; Corvin, AP; Morris, DW				Quinn, Emma M.; Cormican, Paul; Kenny, Elaine M.; Hill, Matthew; Anney, Richard; Gill, Michael; Corvin, Aiden P.; Morris, Derek W.			Development of Strategies for SNP Detection in RNA-Seq Data: Application to Lymphoblastoid Cell Lines and Evaluation Using 1000 Genomes Data	PLOS ONE			English	Article							3,000 SHARED CONTROLS; WIDE ASSOCIATION; GENE-EXPRESSION; HUMAN TRANSCRIPTOME; COMMON DISEASES; WHOLE GENOME; IDENTIFICATION; POPULATION; DISCOVERY; GENOTYPES	Next-generation RNA sequencing (RNA-seq) maps and analyzes transcriptomes and generates data on sequence variation in expressed genes. There are few reported studies on analysis strategies to maximize the yield of quality RNA-seq SNP data. We evaluated the performance of different SNP-calling methods following alignment to both genome and transcriptome by applying them to RNA-seq data from a HapMap lymphoblastoid cell line sample and comparing results with sequence variation data from 1000 Genomes. We determined that the best method to achieve high specificity and sensitivity, and greatest number of SNP calls, is to remove duplicate sequence reads after alignment to the genome and to call SNPs using SAMtools. The accuracy of SNP calls is dependent on sequence coverage available. In terms of specificity, 89% of RNA-seq SNPs calls were true variants where coverage is >10X. In terms of sensitivity, at >10X coverage 92% of all expected SNPs in expressed exons could be detected. Overall, the results indicate that RNA-seq SNP data are a very useful by-product of sequence-based transcriptome analysis. If RNA-seq is applied to disease tissue samples and assuming that genes carrying mutations relevant to disease biology are being expressed, a very high proportion of these mutations can be detected.	[Morris, Derek W.] Trinity Coll Dublin, TrinSeq, Dublin, Ireland; Trinity Coll Dublin, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin, Ireland; Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Morris, DW (corresponding author), Trinity Coll Dublin, TrinSeq, Dublin, Ireland.	derek.morris@tcd.ie	Morris, Derek/AAW-8343-2021; Kenny, Elaine/D-1644-2014	Morris, Derek/0000-0002-3413-570X; Anney, Richard/0000-0002-6083-407X; Walters, James/0000-0002-6980-4053; Gill, Michael/0000-0003-0206-5337; Corvin, Aiden/0000-0001-6717-4089; Kenny, Elaine/0000-0003-4676-3436	Science Foundation Ireland (SFI) [SFI/07/RFP/GEN/F327/EC07]; Wellcome Trust	Science Foundation Ireland (SFI)(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	Next generation sequencing was performed in TrinSeq (Trinity Genome Sequencing Laboratory; http://www.medicine.tcd.ie/sequencing), a core facility funded by Science Foundation Ireland (SFI) under Grant No. [SFI/07/RFP/GEN/F327/EC07] to Dr. Morris. Ms. Quinn's PhD studentship is funded by the Wellcome Trust and SFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cirulli ET, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r57; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Herbeck JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006915; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tejero ME, 2008, HEREDITY, V101, P60, DOI 10.1038/hdy.2008.28; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Vidal RO, 2012, GENET MOL BIOL, V35, P331, DOI 10.1590/S1415-47572012000200014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wulff BE, 2011, NAT REV GENET, V12, P81, DOI 10.1038/nrg2915; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	44	92	96	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58815	10.1371/journal.pone.0058815	http://dx.doi.org/10.1371/journal.pone.0058815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555596	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317418500016
J	Mutale, W; Godfrey-Fausset, P; Mwanamwenge, MT; Kasese, N; Chintu, N; Balabanova, D; Spicer, N; Ayles, H				Mutale, Wilbroad; Godfrey-Fausset, Peter; Mwanamwenge, Margaret Tembo; Kasese, Nkatya; Chintu, Namwinga; Balabanova, Dina; Spicer, Neil; Ayles, Helen			Measuring Health System Strengthening: Application of the Balanced Scorecard Approach to Rank the Baseline Performance of Three Rural Districts in Zambia	PLOS ONE			English	Article							INFORMATION BIAS; SELECTION BIAS; CARE; MOTIVATION; RESOURCE	Introduction: There is growing interest in health system performance and recently WHO launched a report on health systems strengthening emphasising the need for close monitoring using system-wide approaches. One recent method is the balanced scorecard system. There is limited application of this method in middle-and low-income countries. This paper applies the concept of balanced scorecard to describe the baseline status of three intervention districts in Zambia. Methodology: The Better Health Outcome through Mentoring and Assessment (BHOMA) project is a randomised step-wedged community intervention that aims to strengthen the health system in three districts in the Republic of Zambia. To assess the baseline status of the participating districts we used a modified balanced scorecard approach following the domains highlighted in the MOH 2011 Strategic Plan. Results: Differences in performance were noted by district and residence. Finance and service delivery domains performed poorly in all study districts. The proportion of the health workers receiving training in the past 12 months was lowest in Kafue (58%) and highest in Luangwa district (77%). Under service capacity, basic equipment and laboratory capacity scores showed major variation, with Kafue and Luangwa having lower scores when compared to Chongwe. The finance domain showed that Kafue and Chongwe had lower scores (44% and 47% respectively). Regression model showed that children's clinical observation scores were negatively correlated with drug availability (coeff -0.40, p = 0.02). Adult clinical observation scores were positively association with adult service satisfaction score (coeff 0.82, p = 0.04) and service readiness (coeff 0.54, p = 0.03). Conclusion: The study applied the balanced scorecard to describe the baseline status of 42 health facilities in three districts of Zambia. Differences in performance were noted by district and residence in most domains with finance and service delivery performing poorly in all study districts. This tool could be valuable in monitoring and evaluation of health systems.	[Mutale, Wilbroad] Univ Zambia, Sch Med, Dept Community Med, Lusaka, Zambia; [Mutale, Wilbroad; Godfrey-Fausset, Peter; Balabanova, Dina; Spicer, Neil; Ayles, Helen] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1E 7HT, England; [Mwanamwenge, Margaret Tembo; Kasese, Nkatya; Ayles, Helen] Univ Zambia, ZAMBART Project, Lusaka, Zambia; [Chintu, Namwinga] Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Fac Publ Hlth & Policy, London WC1E 7HT, England	University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of London; London School of Hygiene & Tropical Medicine	Mutale, W (corresponding author), Univ Zambia, Sch Med, Dept Community Med, Lusaka, Zambia.	wmutale@yahoo.com		Ayles, Helen/0000-0003-4108-2842	Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	The authors thank Doris Duke Charitable Foundation for funding the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Health Policy and Systems Research (AHPSR) and WHO, 2009, SYST THINK HLTH SYST; ASBROEK AHA, 2004, INT J QUAL HEALTH C, V16, P65; Basnet S, 2011, PEDIATRICS, V128, pE986, DOI 10.1542/peds.2010-3657; Edward A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001066; El Turabi A, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-13; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-30; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Gauld R, 2011, HEALTH POLICY, V103, P200, DOI 10.1016/j.healthpol.2011.05.016; Gupta N, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-22; Inamdar S N, 2000, Qual Manag Health Care, V8, P21; Irala RL, 2007, PERFORMANCE MEASUREM; Kabir Z, 2007, HYPERTENSION, V50, pE9, DOI 10.1161/HYPERTENSION.107.092320; KAPLAN RS, 1992, HARVARD BUS REV, V70, P71; Kunz H, 2011, EXPERT SYST APPL, V38, P1947, DOI 10.1016/j.eswa.2010.07.127; Lauer JA, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-19; Law J, 2011, J ADV NURS, V67, P2551, DOI 10.1111/j.1365-2648.2011.05761.x; Leonard KL, 2010, J DEV ECON, V93, P226, DOI 10.1016/j.jdeveco.2009.11.001; Lupi Silvia, 2011, Cost Eff Resour Alloc, V9, P7, DOI 10.1186/1478-7547-9-7; Mbindyo PM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-40; Measham A, 2006, DIS CONTROL PRORITIE; Mutale W, 2012, MEASURING HLTH WORKE; Mutale W, 2012, APPL SYSTEM THINKING; Rabbani F, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-31; Republic of Korea, 2011, ACT PUN CRIM JUR INT; Richardson J, 2003, HEALTH ECON, V12, P355, DOI 10.1002/hec.761; Saiqa Mullick BKaMW, 2001, AGENDA SPECIAL FOCUS, V2005, P124; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Serneels P, 2010, B WORLD HEALTH ORGAN, V88, P342, DOI 10.2471/BLT.09.072728; Spector R, 2000, J CLIN PHARMACOL, V40, P1205; Tripepi G, 2010, NEPHRON CLIN PRACT, V115, pC94, DOI 10.1159/000312871; Turnock B, 2001, AM J PUBLIC HLTH, V91; WHO, 2010, MONITORING BUILDING; World Health Organization, 2007, EV BOD BUS STRENGTH	34	28	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58650	10.1371/journal.pone.0058650	http://dx.doi.org/10.1371/journal.pone.0058650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555590	gold, Green Published, Green Accepted			2022-12-27	WOS:000316546400009
J	Svenningsson, A; Falk, E; Celius, EG; Fuchs, S; Schreiber, K; Berko, S; Sun, J; Penner, IK				Svenningsson, Anders; Falk, Eva; Celius, Elisabeth G.; Fuchs, Siegrid; Schreiber, Karen; Berko, Sara; Sun, Jennifer; Penner, Iris-Katharina		TYNERGY Trial Investigators	Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DEPRESSION; PATHOPHYSIOLOGY; INFLAMMATION	Fatigue is a significant symptom in multiple sclerosis (MS) patients. First-generation disease modifying therapies (DMTs) are at best moderately effective to improve fatigue. Observations from small cohorts have indicated that natalizumab, an antibody targeting VLA-4, may reduce MS-related fatigue. The TYNERGY study aimed to further evaluate the effects of natalizumab treatment on MS-related fatigue. In this one-armed clinical trial including 195 MS patients, natalizumab was prescribed in a real-life setting, and a validated questionnaire, the Fatigue Scale for Motor and Cognitive functions (FSMC), was used both before and after 12 months of treatment to evaluate a possible change in the fatigue experienced by the patients. In the treated cohort all measured variables, that is, fatigue score, quality of life, sleepiness, depression, cognition, and disability progression were improved from baseline (all p values<0.0001). Walking speed as measured by the six-minute walk-test also increased at month 12 (p = 0.0016). All patients were aware of the nature of the treatment agent, and of the study outcomes. Conclusion: Natalizumab, as used in a real-life setting, might improve MS-related fatigue based on the results from this one-armed un-controlled stud. Also other parameters related to patients' quality of life seemed to improve with natalizumab treatment.	[Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Svenningsson, Anders] Univ Hosp Northern Sweden, Umea, Sweden; [Falk, Eva; Berko, Sara] BiogenIdec Sweden AB, Upplands Vasby, Sweden; [Celius, Elisabeth G.] Oslo Univ Hosp, Dept Neurol, Ulleval, Norway; [Fuchs, Siegrid] Graz Univ, Dept Neurol, Graz, Austria; [Schreiber, Karen] Rigshosp, Dept Neurol, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Sun, Jennifer] BiogenIdec Global Med Affairs, Boston, MA USA; [Penner, Iris-Katharina] Univ Basel, Dept Cognit Psychol & Methodol, Basel, Switzerland	Umea University; University of Oslo; University of Graz; Rigshospitalet; University of Copenhagen; University of Basel	Svenningsson, A (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	anders.svenningsson@neuro.umu.se	Celius, Elisabeth Gulowsen/S-1387-2019; Myhr, Kjell-Morten/H-1528-2018	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Myhr, Kjell-Morten/0000-0002-0980-510X; Lycke, Jan/0000-0002-7891-8466; Penner, Iris-Katharina/0000-0002-6746-1034; Svenningsson, Anders/0000-0003-0663-2220				Amato MP, 2012, EXPERT OPIN PHARMACO, V13, P207, DOI 10.1517/14656566.2012.647767; Bakshi R, 2000, MULT SCLER, V6, P181, DOI 10.1177/135245850000600308; Bergamaschi R, 1997, FUNCT NEUROL, V12, P247; Chandler S, 1997, J NEUROIMMUNOL, V72, P155, DOI 10.1016/S0165-5728(96)00179-8; Comi G, 2001, J NEUROL, V248, P174, DOI 10.1007/s004150170222; Elbers RG, 2012, QUAL LIFE RES, V21, P925, DOI 10.1007/s11136-011-0009-2; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Flachenecker P, 2004, MULT SCLER J, V10, P165, DOI 10.1191/1352458504ms991oa; Gold SM, 2011, J NEUROL NEUROSUR PS, V82, P814, DOI 10.1136/jnnp.2010.230029; Gold SM, 2009, IMMUNOL ALLERGY CLIN, V29, P309, DOI 10.1016/j.iac.2009.02.008; Heesen C, 2006, J NEUROL NEUROSUR PS, V77, P34, DOI 10.1136/jnnp.2005.065805; Iaffaldano P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035843; Krupp LB, 2003, CNS DRUGS, V17, P225, DOI 10.2165/00023210-200317040-00002; Melanson M, 2010, INT J NEUROSCI, V120, P631, DOI 10.3109/00207454.2010.511732; Metz LM, 2004, J NEUROL NEUROSUR PS, V75, P1045, DOI 10.1136/jnnp.2002.007724; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Patti F, 2011, MULT SCLER J, V17, P991, DOI 10.1177/1352458511401943; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Penner IK, 2009, MULT SCLER J, V15, P1509, DOI 10.1177/1352458509348519; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Putzki N, 2009, J NEUROL SCI, V285, P109, DOI 10.1016/j.jns.2009.06.004; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Whitaker JN, 1997, MULTIPLE SCLEROSIS C, P3; Wood B, 2013, MULT SCLER J, V19, P217, DOI 10.1177/1352458512450351; Yaldizli O, 2011, J NEUROL, V258, P2199, DOI 10.1007/s00415-011-6091-0; Yildiz M, 2011, EUR NEUROL, V65, P231, DOI 10.1159/000324028; Ziemssen T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-67	31	69	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58643	10.1371/journal.pone.0058643	http://dx.doi.org/10.1371/journal.pone.0058643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555589	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400008
J	Webster, NL; Zufferey, C; Pane, JA; Coulson, BS				Webster, Nicole L.; Zufferey, Christel; Pane, Jessica A.; Coulson, Barbara S.			Alteration of the Thymic T Cell Repertoire by Rotavirus Infection Is Associated with Delayed Type 1 Diabetes Development in Non-Obese Diabetic Mice	PLOS ONE			English	Article							SMALL-INTESTINAL MUCOSA; PANCREATIC LYMPH-NODES; INTRAEPITHELIAL LYMPHOCYTES; COXSACKIEVIRUS-B4 INFECTION; B7 FAMILY; ONSET; EXPRESSION; MOUSE; AUTOIMMUNITY; PATHOGENESIS	Rotaviruses are implicated as a viral trigger for the acceleration of type 1 diabetes in children. Infection of adult non-obese diabetic (NOD) mice with rotavirus strain RRV accelerates diabetes development, whereas RRV infection in infant NOD mice delays diabetes onset. In this study of infant mice, RRV titers and lymphocyte populations in the intestine, mesenteric lymph nodes (MLN) and thymus of NOD mice were compared with those in diabetes-resistant BALB/c and C57BL/6 mice. Enhanced intestinal RRV infection occurred in NOD mice compared with the other mouse strains. This was associated with increases in the frequency of CD8 alpha beta TCR alpha beta intraepithelial lymphocytes, and their PD-L1 expression. Virus spread to the MLN and T cell numbers there also were greatest in NOD mice. Thymic RRV infection is shown here in all mouse strains, often in combination with alterations in T cell ontogeny. Infection lowered thymocyte numbers in infant NOD and C57BL/6 mice, whereas thymocyte production was unaltered overall in infant BALB/c mice. In the NOD mouse thymus, effector CD4(+) T cell numbers were reduced by infection, whereas regulatory T cell numbers were maintained. It is proposed that maintenance of thymic regulatory T cell numbers may contribute to the increased suppression of inflammatory T cells in response to a strong stimulus observed in pancreatic lymph nodes of adult mice infected as infants. These findings show that rotavirus replication is enhanced in diabetes-prone mice, and provide evidence that thymic T cell alterations may contribute to the delayed diabetes onset following RRV infection.	[Webster, Nicole L.; Zufferey, Christel; Pane, Jessica A.; Coulson, Barbara S.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne	Coulson, BS (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	barbarac@unimelb.edu.au	Neil, Jessica/GLS-0700-2022	Coulson, Barbara/0000-0002-2110-8147; , Jessica/0000-0003-2824-3701	Juvenile Diabetes Research Foundation [27-2011-281]; National Health and Medical Research Council of Australia [509008, 350253, 628319]; University of Melbourne [600667]; Swiss National Science Foundation [PBBEP3 128392]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Juvenile Diabetes Research Foundation Award 27-2011-281 (B.S.C.), together with Project Grant 509008 and Senior Research Fellowships 350253 and 628319 (B.S.C.) from the National Health and Medical Research Council of Australia. N.W. was supported by Early Career Researcher Grant 600667 from The University of Melbourne and C.Z. received a Fellowship for Prospective Researchers from the Swiss National Science Foundation (#PBBEP3 128392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; Bharhani MS, 2007, INT IMMUNOL, V19, P567, DOI 10.1093/intimm/dxm022; Binda E, 2009, J IMMUNOL METHODS, V344, P26, DOI 10.1016/j.jim.2009.02.006; Blutt SE, 2006, J VIROL, V80, P6702, DOI 10.1128/JVI.00329-06; Brilot F, 2008, J MED VIROL, V80, P659, DOI 10.1002/jmv.21016; Buesa J, 1999, VIROLOGY, V257, P424, DOI 10.1006/viro.1999.9646; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; CHATTERJEE NK, 1992, J MED VIROL, V38, P124, DOI 10.1002/jmv.1890380210; COULSON BS, 1985, J VIROL, V54, P14, DOI 10.1128/JVI.54.1.14-20.1985; COULSON BS, 1991, J VIROL, V65, P5968, DOI 10.1128/JVI.65.11.5968-5974.1991; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; CUFF CF, 1993, EUR J IMMUNOL, V23, P1333, DOI 10.1002/eji.1830230622; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Dong HD, 1999, NAT MED, V5, P1365; Feuerer M, 2007, P NATL ACAD SCI USA, V104, P18181, DOI 10.1073/pnas.0708899104; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Fujiura Y, 1996, J IMMUNOL, V156, P2710; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Graham KL, 2008, J VIROL, V82, P6139, DOI 10.1128/JVI.00597-08; Graham KL, 2007, J VIROL, V81, P6446, DOI 10.1128/JVI.00205-07; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; HANAFUSA T, 1994, DIABETES RES CLIN PR, V24, pS307, DOI 10.1016/0168-8227(94)90267-4; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Honeyman MC, 2000, DIABETES, V49, P1319, DOI 10.2337/diabetes.49.8.1319; Jaidane H, 2012, CLIN EXP IMMUNOL, V168, P39, DOI 10.1111/j.1365-2249.2011.04558.x; Jaidane H, 2012, J VIROL, V86, P11151, DOI 10.1128/JVI.00726-12; Jaimes MC, 2005, J VIROL, V79, P4568, DOI 10.1128/JVI.79.8.4568-4579.2005; Jeker LT, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007807; Johansson-Lindbom B, 2007, IMMUNOL REV, V215, P226, DOI 10.1111/j.1600-065X.2006.00482.x; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Kwon H, 2005, J AUTOIMMUN, V24, P11, DOI 10.1016/j.jaut.2004.10.002; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Londrigan SL, 2000, J GEN VIROL, V81, P2203, DOI 10.1099/0022-1317-81-9-2203; Lozanoska-Ochser B, 2009, CLIN EXP IMMUNOL, V157, P119, DOI 10.1111/j.1365-2249.2009.03940.x; Lundqvist C, 1996, J IMMUNOL, V157, P1926; Maclaren N, 1999, J AUTOIMMUN, V12, P279, DOI 10.1006/jaut.1999.0281; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; Muller S, 2000, J IMMUNOL, V164, P1986, DOI 10.4049/jimmunol.164.4.1986; OFFIT PA, 1991, J VIROL, V65, P1318, DOI 10.1128/JVI.65.3.1318-1324.1991; ONODERA T, 1991, THYMUS, V18, P95; PARSONS KR, 1993, VET IMMUNOL IMMUNOP, V39, P355, DOI 10.1016/0165-2427(93)90067-E; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Solomon M, 2004, ADV IMMUNOL, V84, P239, DOI 10.1016/S0065-2776(04)84007-0; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; TerSteege JCA, 1997, DEV IMMUNOL, V5, P121, DOI 10.1155/1997/34891; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wetzel JD, 2006, J VIROL, V80, P3078, DOI 10.1128/JVI.80.6.3078-3082.2006; Wu AJ, 2002, P NATL ACAD SCI USA, V99, P12287, DOI 10.1073/pnas.172382999; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59182	10.1371/journal.pone.0059182	http://dx.doi.org/10.1371/journal.pone.0059182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554993	gold, Green Published			2022-12-27	WOS:000316409800068
J	Aissani, B; Wiener, H; Zhang, K				Aissani, Brahim; Wiener, Howard; Zhang, Kui			Multiple Hits for the Association of Uterine Fibroids on Human Chromosome 1q43	PLOS ONE			English	Article							RENAL-CELL CANCER; FUMARATE-HYDRATASE; PROSTATE-CANCER; ULTRASOUND EVIDENCE; PHOSPHOLIPASE-D; BODY-FAT; LEIOMYOMAS; MUTATIONS; GENE; FH	Uterine leiomyomas (or fibroids) are the most common tumors in women of reproductive age. Early studies of two familial cancer syndromes, the multiple cutaneous and uterine leiomyomatosis (MCUL1), and the hereditary leiomyomatosis and renal cell cancer (HLRCC), implicated FH, a gene on chromosome 1q43 encoding the tricarboxylic acid cycle fumarate hydratase enzyme. The role of this metabolic housekeeping gene in tumorigenesis is still a matter of debate and pseudohypoxia has been suggested as a pathological mechanism. Inactivating FH mutations have rarely been observed in the nonsyndromic and common form of fibroids; however, loss of heterozygosity across FH appeared as a significant event in the pathogenesis of a subset of these tumors. To assess the role of FH and the linked genes in nonsyndromic uterine fibroids, we explored a two-megabase interval spanning FH in the NIEHS Uterine fibroid study, a cross-sectional study of fibroids in 1152 premenopausal women. Association mapping with a dense set of single nucleotide polymorphisms revealed several peaks of association (p = 10(-2)-8.10(-5)) with the risk and/or growth of fibroids. In particular, genes encoding factors suspected (cytosolic FH) or known (EXO1 - exonuclease 1) to be involved in DNA mismatch repair emerged as candidate susceptibility genes whereas those acting in the autophagy/apoptosis (MAP1LC3C - microtubule-associated protein) or signal transduction (RGS7 - Regulator of G-protein and PLD5- Phospoholipase D) appeared to affect tumor growth. Furthermore, body mass index, a suspected confounder altered significantly but unpredictably the association with the candidate genes in the African and European American populations, suggesting the presence of a major obesity gene in the studied region. With the high potential for occult tumors in common conditions such as fibroids, validation of our data in family-based studies is needed.	[Aissani, Brahim; Wiener, Howard] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA; [Zhang, Kui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Aissani, B (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA.	baissani@uab.edu			National Institute of Child and Health Development (NIH-NICHD) [R01-HD064398]; National Institute for Environmental and Health Science (NIH-NIEHS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064398] Funding Source: NIH RePORTER	National Institute of Child and Health Development (NIH-NICHD); National Institute for Environmental and Health Science (NIH-NIEHS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grant R01-HD064398 to BA from the National Institute of Child and Health Development (NIH-NICHD) and National Institute for Environmental and Health Science (NIH-NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissani B, 2012, CONFOUNDING LINKAGE; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Alam NA, 2001, AM J HUM GENET, V68, P1264, DOI 10.1086/320124; Andersen J, 1996, SEMIN REPROD ENDOCR, V14, P269, DOI 10.1055/s-2007-1016336; Ashrafian H, 2010, CANCER RES, V70, P9153, DOI 10.1158/0008-5472.CAN-10-1949; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 1998, AM J EPIDEMIOL, V147, pS90; Baird DD, 2007, AM J EPIDEMIOL, V165, P157, DOI 10.1093/aje/kwj363; Barker KT, 2002, BRIT J CANCER, V87, P446, DOI 10.1038/sj.bjc.6600502; Barry KH, 2011, AM J EPIDEMIOL, V173, P404, DOI 10.1093/aje/kwq360; Bayley JP, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-20; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bolderson E., 2009, NUCL ACIDS RES; Cancel-Tassin G, 2001, EUR J HUM GENET, V9, P135, DOI 10.1038/sj.ejhg.5200592; Cha PC, 2011, NAT GENET, V43, P447, DOI 10.1038/ng.805; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Dunson DB, 2002, BIOMETRICS, V58, P71, DOI 10.1111/j.0006-341X.2002.00071.x; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Foster DA, 2003, MOL CANCER RES, V1, P789; Gross KL, 2004, GENE CHROMOSOME CANC, V41, P183, DOI 10.1002/gcc.20079; Haiman Christopher A., 2008, V141, P37; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1; Kurbanova M Kh, 1989, Genetika, V25, P1122; Lehtonen R, 2004, AM J PATHOL, V164, P17, DOI 10.1016/S0002-9440(10)63091-X; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; McCauley JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-266; O'Flaherty L, 2010, HUM MOL GENET, V19, P3844, DOI 10.1093/hmg/ddq305; Pithukpakorn M, 2006, J MED GENET, V43, P755, DOI 10.1136/jmg.2006.041087; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Raimundo N, 2008, BBA-MOL BASIS DIS, V1782, P287, DOI 10.1016/j.bbadis.2008.01.008; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schwartz SM, 2000, ENVIRON HEALTH PERSP, V108, P821, DOI 10.2307/3454313; Singh B, 2006, BIOCHEM BIOPH RES CO, V346, P911, DOI 10.1016/j.bbrc.2006.05.188; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Sudarshan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021037; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Ukkola O, 2002, J CLIN ENDOCR METAB, V87, P3708, DOI 10.1210/jc.87.8.3708; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Xu ZL, 2007, BIOINFORMATICS, V23, P3254, DOI 10.1093/bioinformatics/btm426; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	47	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58399	10.1371/journal.pone.0058399	http://dx.doi.org/10.1371/journal.pone.0058399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23555580	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400024
J	Cai, YJ; Wang, WS; Yang, Y; Sun, LH; Teitelbaum, DH; Yang, H				Cai, Yu-Jiao; Wang, Wen-Sheng; Yang, Yang; Sun, Li-Hua; Teitelbaum, Daniel H.; Yang, Hua			Up-Regulation of Intestinal Epithelial Cell Derived IL-7 Expression by Keratinocyte Growth Factor through STAT1/IRF-1, IRF-2 Pathway	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; II TRANSACTIVATOR CIITA; JAK-STAT PATHWAYS; GENE-EXPRESSION; ADMINISTRATION ALTERS; DEVELOPMENT SUGGESTS; IFN-GAMMA; T-CELLS; IN-VIVO; INTERLEUKIN-7	Background: Epithelial cells(EC)-derived interleukin-7 (IL-7) plays a crucial role in control of development and homeostasis of neighboring intraepithelial lymphocytes (IEL), and keratinocyte growth factor (KGF) exerts protective effects on intestinal epithelial cells and up-regulates EC-derived IL-7 expression through KGFR pathway. This study was to further investigate the molecular mechanism involved in the regulation of IL-7 expression by KGF in the intestine. Methods: Intestinal epithelial cells (LoVo cells) and adult C57BL/6J mice were treated with KGF. Epithelial cell proliferation was studied by flow cytometry for BrdU-incorporation and by immunohistochemistry for PCNA staining. Western blot was used to detect the changes of expression of P-Tyr-STAT1, STAT1, and IL-7 by inhibiting STAT1. Alterations of nuclear extracts and total proteins of IRF-1, IRF-2 and IL-7 following IRF-1 and IRF-2 RNA interference with KGF treatment were also measured with western blot. Moreover, IL-7 mRNA expressions were also detected by Real-time PCR and IL-7 protein level in culture supernatants was measured by enzyme linked immunosorbent assay(ELISA). Results: KGF administration significantly increased LoVo cell proliferation and also increased intestinal wet weight, villus height, crypt depth and crypt cell proliferation in mice. KGF treatment led to increased levels of P-Tyr-STAT1, RAPA and AG490 both blocked P-Tyr-STAT1 and IL-7 expression in LoVo cells. IRF-1 and IRF-2 expression in vivo and in vitro were also up-regulated by KGF, and IL-7 expression was decreased after IRF-1 and IRF-2 expression was silenced by interfering RNA, respectively. Conclusion: KGF could up-regulate IL-7 expression through the STAT1/IRF-1, IRF-2 signaling pathway, which is a new insight in potential effects of KGF on the intestinal mucosal immune system.	[Cai, Yu-Jiao; Wang, Wen-Sheng; Yang, Yang; Sun, Li-Hua; Yang, Hua] Third Mil Med Univ, Dept Gen Surg, Xinqiao Hosp, Chongqing, Peoples R China; [Teitelbaum, Daniel H.; Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Yang, H (corresponding author), Third Mil Med Univ, Dept Gen Surg, Xinqiao Hosp, Chongqing, Peoples R China.	huayang@tmmu.edu.cn			National Natural Science Foundation of China [30973113, 81020108023, 81000830]; Chongqing Science and Technology Commission International Key Collaboration Project [CSTC 201110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission International Key Collaboration Project	This study was supported by the National Natural Science Foundation of China (No. 30973113 to H.Y.; No. 81020108023 to H.Y.; No. 81000830 to Y.J.C.), and the Chongqing Science and Technology Commission International Key Collaboration Project (CSTC 201110008 to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane Y, 1997, J IMMUNOL, V158, P5393; BILENKER M, 1995, DIGEST DIS SCI, V40, P1744, DOI 10.1007/BF02212696; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; BRAZZELL RK, 1991, INVEST OPHTH VIS SCI, V32, P336; Cai YJ, 2012, INT J CLIN EXP PATHO, V5, P569; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Erickson M, 2002, BLOOD, V100, P3269, DOI 10.1182/blood-2002-04-1036; Farrell CL, 1998, CANCER RES, V58, P933; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Geiselhart LA, 2001, J IMMUNOL, V166, P3019, DOI 10.4049/jimmunol.166.5.3019; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Liang QW, 1998, INVEST OPHTH VIS SCI, V39, P1329; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Min DL, 2002, BLOOD, V99, P4592, DOI 10.1182/blood.V99.12.4592; Monteleone G, 1998, GUT, V43, P620, DOI 10.1136/gut.43.5.620; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; Munro H.N., 1969, MAMMALIAN PROTEIN ME, P465; Nepomuceno RR, 2003, CANCER RES, V63, P4472; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Verschuren MCM, 1996, J IMMUNOL, V156, P3806; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Wu SL, 2005, CANCER-AM CANCER SOC, V103, P1054, DOI 10.1002/cncr.20869; Yang H, 2005, CYTOKINE, V31, P419, DOI 10.1016/j.cyto.2005.06.014; Yang H, 2004, J IMMUNOL, V172, P4151, DOI 10.4049/jimmunol.172.7.4151; Zhao M, 2007, MOL IMMUNOL, V44, P2923, DOI 10.1016/j.molimm.2007.01.009; ZLOTNIK A, 1995, CURR OPIN IMMUNOL, V7, P206, DOI 10.1016/0952-7915(95)80005-0	37	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58647	10.1371/journal.pone.0058647	http://dx.doi.org/10.1371/journal.pone.0058647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554911	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500037
J	Dufour, J; Pommier, A; Alves, G; De Boussac, H; Lours-Calet, C; Volle, DH; Lobaccaro, JMA; Baron, S				Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere			Lack of Liver X Receptors Leads to Cell Proliferation in a Model of Mouse Dorsal Prostate Epithelial Cell	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CANCER-CELLS; HUMAN HEALTH; LXR-ALPHA; MICE; CHOLESTEROL; EXPRESSION; ANDROGEN; GROWTH; PROGRESSION	Recent studies underline the implication of Liver X Receptors (LXRs) in several prostate diseases such as benign prostatic hyperplasia (BPH) and prostate cancer. In order to understand the molecular mechanisms involved, we derived epithelial cells from dorsal prostate (MPECs) of wild type (WT) or Lxr alpha beta-/- mice. In the WT MPECs, our results show that LXR activation reduces proliferation and correlates with the modification of the AKT-survival pathway. Moreover, LXRs regulate lipid homeostasis with the regulation of Abca1, Abcg1 and Idol, and, in a lesser extent, Srebp1, Fas and Acc. Conversely cells derived from Lxr alpha beta-/- mice show a higher basal phosphorylation and consequently activation of the survival/proliferation transduction pathways AKT and MAPK. Altogether, our data point out that the cell model we developed allows deciphering the molecular mechanisms inducing the cell cycle arrest. Besides, we show that activated LXRs regulate AKT and MAPK transduction pathways and demonstrate that LXRs could be good pharmacological targets in prostate disease such as cancer.	[Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] CNRS, UMR GReD 6293, Aubiere, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] INSERM, UMR GReD 1103, Aubiere, France; [Dufour, Julie; Pommier, Aurelien; Alves, Georges; De Boussac, Hugues; Lours-Calet, Corinne; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Baron, S (corresponding author), Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France.	Silvere.BARON@univ-bpclermont.fr	LOBACCARO, Jean-Marc/L-6151-2015; Lobaccaro, Jean-Marc/Q-3926-2019; Volle, David H/P-6155-2014	Lobaccaro, Jean-Marc/0000-0001-9890-2392; Volle, David H/0000-0003-0843-0550	Association de Recherche sur les Tumeurs Prostatiques; Ligue contre le Cancer (Allier committee); Fondation pour la Recherche Medicale (FRM); Fondation BNP-Paribas; Association pour la Recherche contre le Cancer (ARC); Canceropole Lyon Rhone-alpes Auvergne (CLARA); MNERT; ARC; Region Auvergne program; Region Auvergne "Nouveau Chercheur" program	Association de Recherche sur les Tumeurs Prostatiques; Ligue contre le Cancer (Allier committee); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation BNP-Paribas; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Canceropole Lyon Rhone-alpes Auvergne (CLARA); MNERT; ARC(Australian Research Council); Region Auvergne program(Region Auvergne-Rhone-Alpes); Region Auvergne "Nouveau Chercheur" program(Region Auvergne-Rhone-Alpes)	This study was supported by research grants from Association de Recherche sur les Tumeurs Prostatiques, Ligue contre le Cancer (Allier committee), Fondation pour la Recherche Medicale (FRM), Fondation BNP-Paribas, Association pour la Recherche contre le Cancer (ARC) and Canceropole Lyon Rhone-alpes Auvergne (CLARA). A. Pommier and J. Dufour were funded by MNERT and ARC grants. G. Alves was funded by Region Auvergne program. H. De Boussac was funded by Region Auvergne "Nouveau Chercheur" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Berquin IM, 2005, J BIOL CHEM, V280, P36442, DOI 10.1074/jbc.M504945200; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dufour J, 2012, CURR OPIN PHARMACOL, V12, P724, DOI 10.1016/j.coph.2012.06.012; Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106; MANIN M, 1992, ENDOCRINOLOGY, V131, P2378, DOI 10.1210/en.131.5.2378; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rossi S, 2003, MOL CANCER RES, V1, P707; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Viennois E, 2012, ENDOCRINOLOGY, V153, P3211, DOI 10.1210/en.2011-1996; Viennois E, 2012, MOL CELL ENDOCRINOL, V351, P129, DOI 10.1016/j.mce.2011.08.036; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853	23	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58876	10.1371/journal.pone.0058876	http://dx.doi.org/10.1371/journal.pone.0058876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554947	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500052
J	Esposito, A; Campana, L; Palmisano, A; De Cobelli, F; Canu, T; Santarella, F; Colantoni, C; Monno, A; Vezzoli, M; Pezzetti, G; Manfredi, AA; Rovere-Querini, P; Del Maschio, A				Esposito, Antonio; Campana, Lara; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Santarella, Francesco; Colantoni, Caterina; Monno, Antonella; Vezzoli, Michela; Pezzetti, Giulio; Manfredi, Angelo A.; Rovere-Querini, Patrizia; Del Maschio, Alessandro			Magnetic Resonance Imaging at 7T Reveals Common Events in Age-Related Sarcopenia and in the Homeostatic Response to Muscle Sterile Injury	PLOS ONE			English	Article							SKELETAL-MUSCLE; FIBER TRACKING; HUMAN CALF; DIFFUSION; DAMAGE; MICE; REGENERATION; RELAXATION; T2	Skeletal muscle remodeling in response to various noxae physiologically includes structural changes and inflammatory events. The possibility to study those phenomena in-vivo has been hampered by the lack of validated imaging tools. In our study, we have relied on multiparametric magnetic resonance imaging for quantitative monitoring of muscle changes in mice experiencing age-related sarcopenia or active regeneration after sterile acute injury of tibialis anterior muscle induced by cardiotoxin (CTX) injection. The extent of myofibrils' necrosis, leukocyte infiltration, and regeneration have been evaluated and compared with parameters from magnetic resonance imaging: T2-mapping (T2 relaxation time; T2-rt), diffusion-tensor imaging (fractional anisotropy, F. A.) and diffusion weighted imaging (apparent diffusion coefficient, ADC). Inflammatory leukocytes within the perimysium and heterogeneous size of fibers characterized aged muscles. They displayed significantly increased T2-rt (P<0.05) and F. A. (P<0.05) compared with young muscles. After acute damage T2-rt increased in otherwise healthy young muscles with a peak at day 3, followed by a progressive decrease to basal values. F. A. dropped 24 hours after injury and afterward increased above the basal level in the regenerated muscle (from day 7 to day 15) returning to the basal value at the end of the follow up period. The ADC displayed opposite kinetics. T2-rt positively correlated with the number of infiltrating leucocytes retrieved by immunomagnetic bead sorting from the tissue (r = 0.92) and with the damage/infiltration score (r = 0.88) while F. A. correlated with the extent of tissue regeneration evaluated at various time points after injury (r = 0.88). Our results indicate that multiparametric MRI is a sensitive and informative tool for monitoring inflammatory and structural muscle changes in living experimental animals; particularly, it allows identifying the increase of T2-rt and F. A. as common events reflecting inflammatory infiltration and muscle regeneration in the transient response of the tissue to acute injury and in the persistent adaptation to aging.	[Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Colantoni, Caterina; Pezzetti, Giulio; Del Maschio, Alessandro] Ist Sci San Raffaele, Dept Radiol, I-20132 Milan, Italy; [Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Canu, Tamara; Colantoni, Caterina; Pezzetti, Giulio; Del Maschio, Alessandro] Ist Sci San Raffaele, Preclin MR & US Facil, Expt Imaging Ctr, I-20132 Milan, Italy; [Esposito, Antonio; Palmisano, Anna; De Cobelli, Francesco; Santarella, Francesco; Colantoni, Caterina; Vezzoli, Michela; Manfredi, Angelo A.; Del Maschio, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Campana, Lara; Santarella, Francesco; Monno, Antonella; Vezzoli, Michela; Rovere-Querini, Patrizia] Ist Sci San Raffaele, Div Regenerat Med Stem Cell & Gene Therapy, Innate Immun & Tissue Remodeling Unit, I-20132 Milan, Italy; [Manfredi, Angelo A.] Ist Sci San Raffaele, Div Regenerat Med Stem Cell & Gene Therapy, Autoimmun & Vasc Inflammat Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Esposito, A (corresponding author), Ist Sci San Raffaele, Dept Radiol, I-20132 Milan, Italy.	esposito.antonio@hsr.it	Tamara, Canu/ABG-8524-2020; Esposito, Antonio/AAZ-7967-2020; Colantoni, Caterina/AAC-1624-2019; DE COBELLI, Francesco/AAC-6488-2022; Manfredi, Angelo A./C-7018-2014; Rovere-Querini, Patrizia/J-2340-2012; Vezzoli, Michela/AAN-7355-2020; Palmisano, Anna/AAN-3242-2020; Campana, Lara/AAI-9372-2020; Esposito, Antonio/K-5088-2018	Tamara, Canu/0000-0002-4589-9377; Esposito, Antonio/0000-0002-1170-6266; DE COBELLI, Francesco/0000-0003-4014-3711; Manfredi, Angelo A./0000-0001-8370-6970; Palmisano, Anna/0000-0002-1564-2060; Campana, Lara/0000-0003-1805-4755; Esposito, Antonio/0000-0002-1170-6266; Santarella, Francesco/0000-0002-4941-0014; Colantoni, Caterina/0000-0002-2622-1691	Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS); Italian Ministry of Health (Ricerca Finalizzata); Association Francaise contre les Myopathies [15440]; Ministero dell'Istruzione, dell'Universita' e della Ricerca	Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Health (Fondo per gli Investimenti della Ricerca di Base-IDEAS to PRQ and Ricerca Finalizzata to AAM and PRQ), by the Association Francaise contre les Myopathies (Grant 15440 to PRQ), and by the Ministero dell'Istruzione, dell'Universita' e della Ricerca (to AAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027283; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Collins-Hooper H, 2012, STEM CELLS, V30, P1182, DOI 10.1002/stem.1088; Curiel RV, 2009, ANN NY ACAD SCI, V1154, P101, DOI 10.1111/j.1749-6632.2009.04386.x; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Fearon KCH, 2011, NEW ENGL J MED, V365, P565, DOI 10.1056/NEJMcibr1106880; Fleckenstein JL, 1996, SKELETAL MUSCLE EVAL; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Holt LJ, 2012, FASEB J, V26, P3658, DOI 10.1096/fj.11-199349; Jia Y, 2012, FASEB J, V26, P2847, DOI 10.1096/fj.11-196618; Julienne CM, 2012, J CACHEXIA SARCOPENI, V3, P265, DOI 10.1007/s13539-012-0071-9; Loerakker S, 2011, MAGN RESON MED, V66, P528, DOI 10.1002/mrm.22801; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; Mammen AL, 2011, NAT REV NEUROL, V7, P343, DOI 10.1038/nrneurol.2011.63; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Matthews GDK, 2011, ANN NY ACAD SCI, V1237, P95, DOI 10.1111/j.1749-6632.2011.06236.x; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; Paylor B, 2011, CURR TOP DEV BIOL, V96, P139, DOI 10.1016/B978-0-12-385940-2.00006-1; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Saupe N, 2008, INVEST RADIOL, V43, P612, DOI 10.1097/RLI.0b013e31817e909f; Schwenzer NF, 2009, NMR BIOMED, V22, P1047, DOI 10.1002/nbm.1409; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Wishnia A, 2001, NEUROMUSCULAR DISORD, V11, P50, DOI 10.1016/S0960-8966(00)00164-4	29	37	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59308	10.1371/journal.pone.0059308	http://dx.doi.org/10.1371/journal.pone.0059308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555016	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500079
J	Wright, HL; Thomas, HB; Moots, RJ; Edwards, SW				Wright, Helen L.; Thomas, Huw B.; Moots, Robert J.; Edwards, Steven W.			RNA-Seq Reveals Activation of Both Common and Cytokine-Specific Pathways following Neutrophil Priming	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; SYNOVIAL-FLUID; KAPPA-B; TNF-ALPHA; INFLAMMATORY STIMULI; GM-CSF; APOPTOSIS; NECROSIS	Neutrophils are central to the pathology of inflammatory diseases, where they can damage host tissue through release of reactive oxygen metabolites and proteases, and drive inflammation via secretion of cytokines and chemokines. Many cytokines, such as those generated during inflammation, can induce a similar "primed" phenotype in neutrophils, but it is unknown if different cytokines utilise common or cytokine-specific pathways to induce these functional changes. Here, we describe the transcriptomic changes induced in control human neutrophils during priming in vitro with pro-inflammatory cytokines (TNF-alpha and GM-CSF) using RNA-seq. Priming led to the rapid expression of a common set of transcripts for cytokines, chemokines and cell surface receptors (CXCL1, CXCL2, IL1A, IL1B, IL1RA, ICAM1). However, 580 genes were differentially regulated by TNF-alpha and GM-CSF treatment, and of these 58 were directly implicated in the control of apoptosis. While these two cytokines both delayed apoptosis, they induced changes in expression of different pro-and antiapoptotic genes. Bioinformatics analysis predicted that these genes were regulated via differential activation of transcription factors by TNF-alpha and GM-CSF and these predictions were confirmed using functional assays: inhibition of NF-kappa B signalling abrogated the protective effect of TNF-alpha (but not that of GM-CSF) on neutrophil apoptosis, whereas inhibition of JAK/STAT signalling abrogated the anti-apoptotic effect of GM-CSF, but not that of TNF-alpha (p<0.05). These data provide the first characterisation of the human neutrophil transcriptome following GM-CSF and TNF-alpha priming, and demonstrate the utility of this approach to define functional changes in neutrophils following cytokine exposure. This may provide an important, new approach to define the molecular properties of neutrophils after in vivo activation during inflammation.	[Wright, Helen L.; Thomas, Huw B.; Edwards, Steven W.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Moots, Robert J.] Univ Liverpool, Univ Hosp Aintree, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Edwards, SW (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	s.w.edwards@liv.ac.uk	Wright, Helen/O-2555-2019; Moots, Robert/AAM-8091-2020	Wright, Helen/0000-0003-0442-3134; Thomas, Huw/0000-0002-3576-0291; Edwards, Steven/0000-0002-7074-0552; Thomas, Huw/0000-0001-9626-9706	Arthritis Research UK [19437]; BBSRC [BB/H016163/1]; Versus Arthritis [19437] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	Funding came from Arthritis Research UK, Grant No. 19437 http://www.arthritisresearchuk.org/, BBSRC Grant No. BB/H016163/1, http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEAULIEU AD, 1994, ARTHRITIS RHEUM, V37, P855, DOI 10.1002/art.1780370613; Belostocki K, 2005, CLIN IMMUNOL, V117, P78, DOI 10.1016/j.clim.2005.07.001; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Cross A, 2008, BLOOD, V111, P878, DOI 10.1182/blood-2007-05-087833; de Kleijn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038255; den Broeder AA, 2003, J RHEUMATOL, V30, P232; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Edwards Steven W., 1996, Methods (Orlando), V9, P563, DOI 10.1006/meth.1996.0064; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Fortin CF, 2007, BIOGERONTOLOGY, V8, P173, DOI 10.1007/s10522-006-9067-1; Fossati G, 2002, ARTHRITIS RHEUM, V46, P1351, DOI 10.1002/art.10230; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Hatano Y, 1999, ANN RHEUM DIS, V58, P297, DOI 10.1136/ard.58.5.297; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030244; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Kettritz R, 2004, J BIOL CHEM, V279, P2657, DOI 10.1074/jbc.M309778200; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Krebs DL, 2000, J CELL SCI, V113, P2813; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Midgley A, 2009, ARTHRITIS RHEUM, V60, P2390, DOI 10.1002/art.24634; Momohara S, 1997, CLIN RHEUMATOL, V16, P133, DOI 10.1007/BF02247841; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moulding DA, 1999, J LEUKOCYTE BIOL, V65, P875, DOI 10.1002/jlb.65.6.875; Naylor EJ, 2007, AM J RESP CELL MOL, V37, P135, DOI 10.1165/rcmb.2006-0375OC; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SOPATA I, 1995, RHEUMATOL INT, V15, P9, DOI 10.1007/BF00286763; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wilhelm BT, 2011, BLOOD, V117, pE27, DOI 10.1182/blood-2010-07-293332; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wong SH, 2009, RHEUMATOLOGY, V48, P39, DOI 10.1093/rheumatology/ken412; Wright HL, 2012, RHEUMATOLOGY, V51, P451, DOI 10.1093/rheumatology/ker338; Wright HL, 2011, ANN RHEUM DIS, V70, P537, DOI 10.1136/ard.2010.138065; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zhang XQ, 2004, J LEUKOCYTE BIOL, V75, P358, DOI 10.1189/jlb.0903412	55	69	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58598	10.1371/journal.pone.0058598	http://dx.doi.org/10.1371/journal.pone.0058598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554905	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100128
J	Cormier, F; Monjanel, H; Fabre, C; Billot, K; Sapharikas, E; Chereau, F; Bordereaux, D; Molina, TJ; Avet-Loiseau, H; Baud, V				Cormier, Francoise; Monjanel, Helene; Fabre, Claire; Billot, Katy; Sapharikas, Elene; Chereau, Fanny; Bordereaux, Didier; Molina, Thierry J.; Avet-Loiseau, Herve; Baud, Veronique			Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; MARROW STROMAL CELLS; BONE-MARROW; EXPRESSION; MECHANISMS; LYMPHOMA; ADHESION; PATHWAY; TARGET; CANCER	The NF-kappa B family of transcription factors has emerged as a key player in the pathogenesis of multiple myeloma (MM). NF-kappa B is activated by at least two major signaling pathways. The classical pathway results in the activation of mainly RelA containing dimers, whereas the alternative pathway leads to the activation of RelB/p52 and RelB/p50 heterodimers. Activating mutations in regulators of the alternative pathway have been identified in 17% of MM patients. However, the status of RelB activation per se and its role in the regulation of cell survival in MM has not been investigated. Here, we reveal that 40% of newly diagnosed MM patients have a constitutive RelB DNA-binding activity in CD138(+) tumor cells, and we show an association with increased expression of a subset of anti-apoptotic NF-kappa B target genes, such as cIAP2. Furthermore, we demonstrate that RelB exerts a crucial anti-apoptotic activity in MM cells. Our findings indicate that RelB activation is key for promoting MM cell survival through the upregulation of anti-apoptotic proteins. Altogether, our study provides the framework for the development of new molecules targeting RelB in the treatment of MM.	[Cormier, Francoise; Monjanel, Helene; Billot, Katy; Sapharikas, Elene; Chereau, Fanny; Bordereaux, Didier; Baud, Veronique] Inst Cochin Genet Mol, U1016, INSERM, F-75014 Paris, France; [Cormier, Francoise; Monjanel, Helene; Billot, Katy; Sapharikas, Elene; Chereau, Fanny; Bordereaux, Didier; Baud, Veronique] CNRS, UMR8104, Paris, France; [Cormier, Francoise; Monjanel, Helene; Billot, Katy; Sapharikas, Elene; Chereau, Fanny; Bordereaux, Didier; Baud, Veronique] Univ Paris 05, Paris, France; [Monjanel, Helene] CHU Tours, Serv Hematol & Therapie Cellulaire, Tours, France; [Fabre, Claire] Inst Curie, Dept Med Oncol, Paris, France; [Molina, Thierry J.] Hop Hotel Dieu, Dept Pathol, F-75181 Paris, France; [Avet-Loiseau, Herve] CHU Nantes, Hematol Lab, F-44035 Nantes 01, France; [Avet-Loiseau, Herve] Ctr Hosp Univ, Unite Genom Myelome, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU de Toulouse	Baud, V (corresponding author), Inst Cochin Genet Mol, U1016, INSERM, F-75014 Paris, France.	veronique.baud@inserm.fr	Baud, Veronique/F-7699-2013; Molina, Thierry/ABA-5214-2020; Baud, Veronique/AAL-3950-2020; Avet-Loiseau, Herve/P-8872-2014	Baud, Veronique/0000-0002-4090-718X; Molina, Thierry/0000-0002-3929-9754; Baud, Veronique/0000-0002-4090-718X; Avet-Loiseau, Herve/0000-0002-3050-0140; Cormier, Francoise/0000-0002-6904-5122	Agence Nationale pour la Recherche (ANR); Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-de-France; Association CANCEN (Tours, France); Ministere de la Recherche et des Technologies; Societe Francaise d'Hematologie	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Association CANCEN (Tours, France); Ministere de la Recherche et des Technologies; Societe Francaise d'Hematologie	This work was supported by grants to V.B. from Agence Nationale pour la Recherche (ANR), Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-de-France, research fellowship from Association CANCEN (Tours, France) (H.M.), and doctoral fellowships from Ministere de la Recherche et des Technologies and Societe Francaise d'Hematologie (F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hideshima T, 2009, BLOOD, V113, P5228, DOI 10.1182/blood-2008-06-161505; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jacque E, 2013, ONCOGENE, V32, P2661, DOI 10.1038/onc.2012.282; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Landowski TH, 2003, ONCOGENE, V22, P2417, DOI 10.1038/sj.onc.1206315; Laubach J, 2011, ANNU REV MED, V62, P249, DOI 10.1146/annurev-med-070209-175325; Li ZW, 2008, CURR OPIN HEMATOL, V15, P391, DOI 10.1097/MOH.0b013e328302c7f4; Lwin T, 2007, LEUKEMIA, V21, P1521, DOI 10.1038/sj.leu.2404723; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Maier HJ, 2003, J BIOL CHEM, V278, P39242, DOI 10.1074/jbc.M301521200; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Natoli G, 2006, CELL DEATH DIFFER, V13, P693, DOI 10.1038/sj.cdd.4401880; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schwarzer R, 2012, LEUKEMIA, V26, P806, DOI 10.1038/leu.2011.265; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004	50	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59127	10.1371/journal.pone.0059127	http://dx.doi.org/10.1371/journal.pone.0059127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555623	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200012
J	Rammohan, A; Iqbal, K; Awofeso, N				Rammohan, Anu; Iqbal, Kazi; Awofeso, Niyi			Reducing Neonatal Mortality in India: Critical Role of Access to Emergency Obstetric Care	PLOS ONE			English	Article							CHILD-MORTALITY; UTTAR-PRADESH; CASH TRANSFER; RURAL INDIA; DEATHS; MANAGEMENT; FERTILITY; SURVIVAL; TRIAL	Background: Neonatal mortality currently accounts for 41% of all global deaths among children below five years. Despite recording a 33% decline in neonatal deaths between 2000 and 2009, about 900,000 neonates died in India in 2009. The decline in neonatal mortality is slower than in the post-neonatal period, and neonatal mortality rates have increased as a proportion of under-five mortality rates. Neonatal mortality rates are higher among rural dwellers of India, who make up at least two-thirds of India's population. Identifying the factors influencing neonatal mortality will significantly improve child survival outcomes in India. Methods:Our analysis is based on household data from the nationally representative 2008 Indian District Level Household Survey (DLHS-3). We use probit regression techniques to analyse the links between neonatal mortality at the household level and households' access to health facilities. The probability of the child dying in the first month of birth is our dependent variable. Results: We found that 80% of neonatal deaths occurred within the first week of birth, and that the probability of neonatal mortality is significantly lower when the child's village is closer to the district hospital (DH), suggesting the critical importance of specialist hospital care in the prevention of newborn deaths. Neonatal deaths were lower in regions where emergency obstetric care was available at the District Hospitals. We also found that parental schooling and household wealth status improved neonatal survival outcomes. Conclusions: Addressing the main causes of neonatal deaths in India - preterm deliveries, asphyxia, and sepsis - requires adequacy of specialised workforce and facilities for delivery and neonatal intensive care and easy access by mothers and neonates. The slow decline in neonatal death rates reflects a limited attention to factors which contribute to neonatal deaths. The suboptimal quality and coverage of Emergency Obstetric Care facilities in India require urgent attention.	[Rammohan, Anu; Iqbal, Kazi] Univ Western Australia, Sch Business, Discipline Econ, Perth, WA 6009, Australia; [Awofeso, Niyi] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Awofeso, Niyi] Univ New S Wales, Sch Publ Hlth, Sydney, NSW, Australia	University of Western Australia; University of Western Australia; University of New South Wales Sydney	Awofeso, N (corresponding author), Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia.	niyi.awofeso@uwa.edu.au	Iqbal, Kazi/ABB-9409-2020; Awofeso, Niyi/J-4705-2019	Iqbal, Kazi/0000-0001-8161-4079; Rammohan, Anu/0000-0002-9062-4508	Australian Research Council	Australian Research Council(Australian Research Council)	Anu Rammohan gratefully acknowledges funding from Australian Research Council Discovery Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INDIA INFRASTRUCTURE; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhalotra S, 2008, J ECONOMETRICS, V143, P274, DOI 10.1016/j.jeconom.2007.10.005; Bhargava A, 2003, J ECONOMETRICS, V112, P225, DOI 10.1016/S0304-4076(02)00162-8; Chaturvedi S, 2012, BMC P S1, V6, P01, DOI DOI 10.1186/1753-6561-6-S1-O1; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Jehan K, 2012, REPROD HEALTH MATTER, V20, P142, DOI 10.1016/S0968-8080(12)39609-2; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Maitra P, 2008, J HEALTH ECON, V27, P690, DOI 10.1016/j.jhealeco.2007.09.005; McClure EM, 2007, INT J GYNECOL OBSTET, V96, P139, DOI 10.1016/j.ijgo.2006.10.010; Ministry of Health and Family Welfare, 2011, B RUR HLTH STAT IND; Ministry of Health and Family Welfare, 2011, IND PUBL HLTH STAND; Mori R, 2007, PEDIATR INT, V49, P452, DOI 10.1111/j.1442-200X.2007.02393.x; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Post M, 1997, PREVENTING MATERNAL; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Rasaily R, 2008, INDIAN PEDIATR, V45, P991; van der Klaauw B, 2011, J POPUL ECON, V24, P601, DOI 10.1007/s00148-009-0290-3; Wagstaff A, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7982-0; World Health Organization, 2009, EM OBST CAR HDB; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	26	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57244	10.1371/journal.pone.0057244	http://dx.doi.org/10.1371/journal.pone.0057244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544038	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700001
J	Wilson, N; Nghiem, N; Mhurchu, CN; Eyles, H; Baker, MG; Blakely, T				Wilson, Nick; Nhung Nghiem; Mhurchu, Cliona Ni; Eyles, Helen; Baker, Michael G.; Blakely, Tony			Foods and Dietary Patterns That Are Healthy, Low-Cost, and Environmentally Sustainable: A Case Study of Optimization Modeling for New Zealand	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; RISK-FACTORS; METAANALYSIS; SECURITY; COHORT; CONSUMPTION; PREVENTION	Objective: Global health challenges include non-communicable disease burdens, ensuring food security in the context of rising food prices, and environmental constraints around food production, e.g., greenhouse gas [GHG] emissions. We therefore aimed to consider optimized solutions to the mix of food items in daily diets for a developed country population: New Zealand (NZ). Methods: We conducted scenario development and linear programming to model 16 diets (some with uncertainty). Data inputs included nutrients in foods, food prices, food wastage and food-specific GHG emissions. Findings: This study identified daily dietary patterns that met key nutrient requirements for as little as a median of NZ$ 3.17 per day (US$ 2.41/d) (95% simulation interval [SI]=NZ$ 2.86 to 3.50/d). Diets that included "more familiar meals" for New Zealanders, increased the cost. The optimized diets also had low GHG emission profiles compared with the estimate for the 'typical NZ diet e.g., 1.62 kg CO(2)e/d for one scenario (95%SI=1.39 to 1.85 kg CO(2)e) compared with 10.1 kg CO(2)e/d, respectively. All of the optimized low-cost and low-GHG dietary patterns had likely health advantages over the current NZ dietary pattern, i.e., lower cardiovascular disease and cancer risk. Conclusions: We identified optimal foods and dietary patterns that would lower the risk of non-communicable diseases at low cost and with low greenhouse gas emission profiles. These results could help guide central and local government decisions around which foods to focus policies on. That is which foods are most suitable for: food taxes (additions and exemptions); healthy food vouchers and subsidies; and for increased use by public institutions involved in food preparation.	[Wilson, Nick; Nhung Nghiem; Baker, Michael G.; Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand; [Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand	University of Otago; University of Auckland	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, Wellington Sout, New Zealand.	nick.wilson@otago.ac.nz		Ni Mhurchu, Cliona/0000-0002-1144-9167; Nghiem, Nhung/0000-0003-0078-4549; Blakely, Tony/0000-0002-6995-4369	Health Research Council of New Zealand [10/248]; Heart Foundation of New Zealand [1380, 1463]	Health Research Council of New Zealand(Health Research Council of New Zealand); Heart Foundation of New Zealand	This project was part of the BODE3 Program which receives funding support from the Health Research Council of New Zealand (Project number 10/248). CNM holds the Heart Foundation of New Zealand Senior Fellowship (Grant 1380). HE holds a Heart Foundation of New Zealand Research Fellowship (Grant 1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Aune D, 2011, BMJ-BRIT MED J, V343, pd6617; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Carter KN, 2011, SOC SCI MED, V72, P1463, DOI 10.1016/j.socscimed.2011.03.009; Carter KN, 2010, AUST NZ J PUBL HEAL, V34, P602, DOI 10.1111/j.1753-6405.2010.00615.x; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Drewnowski A, 2011, J AM COLL NUTR, V30, p422S, DOI 10.1080/07315724.2011.10719986; Elliot P, 2007, SODIUM INTAKES WORLD; Faber J, 2012, BEHAV CLIMATE CHANGE; Garnett T., 2008, COOKING STORM FOOD G; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; Human Nutrition University of Otago, FOOD COST SURV; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Macdiarmid JI, 2012, P NUTR SOC; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Marmot M, 2010, FAIR SOC HLTH LIVES; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; McLean RM, 2011, NEW ZEAL MED J, V124, P68; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Metzgar M, 2011, NUTR RES, V31, P444, DOI 10.1016/j.nutres.2011.05.008; MHURCHU CN, 2007, NZ MED J, V120, pU2388; Ministry for the Environment (MfE), 2010, NZ GREENH GAS INV 19; Morris JN, 2000, J EPIDEMIOL COMMUN H, V54, P885, DOI 10.1136/jech.54.12.885; Morton SMB., 2012, GROWING NZ LONGITUDI; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NHMRC and MOH, 2006, NUTR REF VAL AUSTR N; NHS England, 2010, CARB EM NHS ENGL CAR; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Parnell WR, 2001, NEW ZEAL MED J, V114, P141; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Rush E, 2007, ASIA PAC J CLIN NUTR, V16, P448; Saunders C., 2006, Research Report - Agribusiness & Economics Research Unit, Lincoln University; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Smedman A, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5170; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Statistics New Zealand, 2011, FOOD PRIC IND 2011; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Thow AM, 2011, PUBLIC HEALTH NUTR, V14, P176, DOI 10.1017/S1368980010002053; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Wilson N, 2012, B WORLD HEALTH ORGAN, V90, P88, DOI 10.2471/BLT.11.091470; Wilson Nick, 2007, N Z Med J, V120, pU2665; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST; Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713	56	93	93	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59648	10.1371/journal.pone.0059648	http://dx.doi.org/10.1371/journal.pone.0059648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544082	gold, Green Published			2022-12-27	WOS:000317480700042
J	Torralbo, A; Walther, DB; Chai, B; Caddigan, E; Fei-Fei, L; Beck, DM				Torralbo, Ana; Walther, Dirk B.; Chai, Barry; Caddigan, Eamon; Fei-Fei, Li; Beck, Diane M.			Good Exemplars of Natural Scene Categories Elicit Clearer Patterns than Bad Exemplars but Not Greater BOLD Activity	PLOS ONE			English	Article							REPRESENTATIONS; MEMORY; RECOGNITION	Within the range of images that we might categorize as a "beach'', for example, some will be more representative of that category than others. Here we first confirmed that humans could categorize "good'' exemplars better than "bad'' exemplars of six scene categories and then explored whether brain regions previously implicated in natural scene categorization showed a similar sensitivity to how well an image exemplifies a category. In a behavioral experiment participants were more accurate and faster at categorizing good than bad exemplars of natural scenes. In an fMRI experiment participants passively viewed blocks of good or bad exemplars from the same six categories. A multi-voxel pattern classifier trained to discriminate among category blocks showed higher decoding accuracy for good than bad exemplars in the PPA, RSC and V1. This difference in decoding accuracy cannot be explained by differences in overall BOLD signal, as average BOLD activity was either equivalent or higher for bad than good scenes in these areas. These results provide further evidence that V1, RSC and the PPA not only contain information relevant for natural scene categorization, but their activity patterns mirror the fundamentally graded nature of human categories. Analysis of the image statistics of our good and bad exemplars shows that variability in low-level features and image structure is higher among bad than good exemplars. A simulation of our neuroimaging experiment suggests that such a difference in variance could account for the observed differences in decoding accuracy. These results are consistent with both low-level models of scene categorization and models that build categories around a prototype.	[Torralbo, Ana] UCL, Inst Cognit Neurosci, London, England; [Walther, Dirk B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Chai, Barry; Fei-Fei, Li] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Caddigan, Eamon] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; [Beck, Diane M.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Beck, Diane M.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA	University of London; University College London; University System of Ohio; Ohio State University; Stanford University; University of California System; University of California Santa Barbara; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Torralbo, A (corresponding author), UCL, Inst Cognit Neurosci, London, England.	a.torralbo@ucl.ac.uk	Beck, Diane M/F-7536-2010	Beck, Diane M/0000-0001-9802-5828	NIH [1 R01 EY019429]; Beckman Postdoctoral Fellowship; Microsoft Research New Faculty Fellowship; Frank Moss Gift Fund; NATIONAL EYE INSTITUTE [R01EY019429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Postdoctoral Fellowship; Microsoft Research New Faculty Fellowship(Microsoft); Frank Moss Gift Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH grant 1 R01 EY019429 (LFF, DMB, DBW), a Beckman Postdoctoral Fellowship (DBW), a Microsoft Research New Faculty Fellowship (LFF) and the Frank Moss Gift Fund (LFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2000, MED RAD DIA IMG, P369; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chai B, 2009, P NEUR INF PROC SYS; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ehinger KA, 2011, P 33 ANN C COGN SCI; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Li FF, 2005, VIS COGN, V12, P893, DOI 10.1080/13506280444000571; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Park S, 2011, J NEUROSCI, V31, P1333, DOI 10.1523/JNEUROSCI.3885-10.2011; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; ROSCH E, 1976, J EXP PSYCHOL HUMAN, V2, P491, DOI 10.1037/0096-1523.2.4.491; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; Schneider KA, 2004, J NEUROSCI, V24, P8975, DOI 10.1523/JNEUROSCI.2413-04.2004; STANDING L, 1970, PSYCHON SCI, V19, P73, DOI 10.3758/BF03337426; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; Vogel J, 2007, INT J COMPUT VISION, V72, P133, DOI 10.1007/s11263-006-8614-1; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009; Yao B, 2009, P NEUR INF PROC SYS	38	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58594	10.1371/journal.pone.0058594	http://dx.doi.org/10.1371/journal.pone.0058594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555588	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500013
J	Daniels, DR; Turner, MS				Daniels, D. Robert; Turner, Matthew S.			Islands of Conformational Stability for Filopodia	PLOS ONE			English	Article							ACROSOMAL PROCESS; POLYMER	Filopodia are long, thin protrusions formed when bundles of fibers grow outwardly from a cell surface while remaining closed in a membrane tube. We study the subtle issue of the mechanical stability of such filopodia and how this depends on the deformation of the membrane that arises when the fiber bundle adopts a helical configuration. We calculate the ground state conformation of such filopodia, taking into account the steric interaction between the membrane and the enclosed semiflexible fiber bundle. For typical filopodia we find that a minimum number of fibers is required for filopodium stability. Our calculation elucidates how experimentally observed filopodia can obviate the classical Euler buckling condition and remain stable up to several tens of mm. We briefly discuss how experimental observation of the results obtained in this work for the helical-like deformations of enclosing membrane tubes in filopodia could possibly be observed in the acrosomal reactions of the sea cucumber Thyone, and the horseshoe crab Limulus. Any realistic future theories for filopodium stability are likely to rely on an accurate treatment of such steric effects, as analysed in this work.	[Daniels, D. Robert] Swansea Univ, Multidisciplinary Nanotechnol Ctr, Coll Engn, Swansea, W Glam, Wales; [Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Turner, Matthew S.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England	Swansea University; University of Warwick; University of Warwick	Daniels, DR (corresponding author), Swansea Univ, Multidisciplinary Nanotechnol Ctr, Coll Engn, Swansea, W Glam, Wales.	d.r.daniels@swansea.ac.uk	Turner, Matthew/D-1121-2011	Turner, Matthew/0000-0002-3441-678X	EPSRC [EP/I005439/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005439/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Boal D, 2001, MECH CELL; Bray D., 1992, CELL MOVEMENTS; BRIEHL RW, 1995, J MOL BIOL, V245, P710, DOI 10.1006/jmbi.1994.0057; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Daniels DR, 2010, BIOPHYS J, V98, P1139, DOI 10.1016/j.bpj.2009.11.053; Daniels DR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238101; Daniels DR, 2004, J CHEM PHYS, V121, P7401, DOI 10.1063/1.1794551; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; DEROSIER D, 1980, J MOL BIOL, V137, P375, DOI 10.1016/0022-2836(80)90163-1; Fournier JB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018103; Fygenson DK, 1997, PHYS REV LETT, V79, P4497, DOI 10.1103/PhysRevLett.79.4497; Hannezo E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.018101; Hu YF, 2008, BIOPHYS J, V94, P1428, DOI 10.1529/biophysj.107.117473; Marenduzzo D, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283102; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Morrison G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011924; Nelson D, 1989, STAT MECH MEMBRANES; Pronk S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258102; Safran S. A., 1994, STAT THERMODYNAMICS; Santangelo CD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061501; TILNEY LG, 1982, J CELL BIOL, V93, P820, DOI 10.1083/jcb.93.3.820; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8	24	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59010	10.1371/journal.pone.0059010	http://dx.doi.org/10.1371/journal.pone.0059010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555612	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400018
J	Houssaini, A; Assoumou, L; Miller, V; Calvez, V; Marcelin, AG; Flandre, P				Houssaini, Allal; Assoumou, Lambert; Miller, Veronica; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe			Scoring Methods for Building Genotypic Scores: An Application to Didanosine Resistance in a Large Derivation Set	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY PHENOTYPE; VIROLOGICAL RESPONSE; HIV-1 RESISTANCE; PROTEASE; VALIDATION; PREDICTION; MORTALITY; RITONAVIR; PATTERNS; THERAPY	Background: Several attempts have been made to determine HIV-1 resistance from genotype resistance testing. We compare scoring methods for building weighted genotyping scores and commonly used systems to determine whether the virus of a HIV-infected patient is resistant. Methods and Principal Findings: Three statistical methods (linear discriminant analysis, support vector machine and logistic regression) are used to determine the weight of mutations involved in HIV resistance. We compared these weighted scores with known interpretation systems (ANRS, REGA and Stanford HIV-db) to classify patients as resistant or not. Our methodology is illustrated on the Forum for Collaborative HIV Research didanosine database (N = 1453). The database was divided into four samples according to the country of enrolment (France, USA/Canada, Italy and Spain/UK/Switzerland). The total sample and the four country-based samples allow external validation (one sample is used to estimate a score and the other samples are used to validate it). We used the observed precision to compare the performance of newly derived scores with other interpretation systems. Our results show that newly derived scores performed better than or similar to existing interpretation systems, even with external validation sets. No difference was found between the three methods investigated. Our analysis identified four new mutations associated with didanosine resistance: D123S, Q207K, H208Y and K223Q. Conclusions: We explored the potential of three statistical methods to construct weighted scores for didanosine resistance. Our proposed scores performed at least as well as already existing interpretation systems and previously unrecognized didanosine-resistance associated mutations were identified. This approach could be used for building scores of genotypic resistance to other antiretroviral drugs.	[Houssaini, Allal; Assoumou, Lambert; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe] INSERM, U943, Paris, France; [Houssaini, Allal; Assoumou, Lambert; Calvez, Vincent; Marcelin, Anne-Genevieve; Flandre, Philippe] Univ Paris 06, UMR S 943, Paris, France; [Miller, Veronica] George Washington Univ, Washington, DC USA; [Marcelin, Anne-Genevieve] Grp Hosp Pitie Salpetriere, Virol Lab, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Houssaini, A (corresponding author), INSERM, U943, Paris, France.	ahoussaini@ccde.chups.jussieu.fr	Flandre, Philippe/N-6314-2017; Marcelin, Anne-Genevieve/D-8272-2014	Flandre, Philippe/0000-0002-2612-3522; Marcelin, Anne-Genevieve/0000-0003-4808-8999	SIDACTION [FJC-1/AO20-2/09]; European Community [223131]; French Agence National de Recherches sur le Sida et les hepatites virales (ANRS); Association de Recherche en Virologie en Dermatologie (ARVD)	SIDACTION; European Community(European Commission); French Agence National de Recherches sur le Sida et les hepatites virales (ANRS); Association de Recherche en Virologie en Dermatologie (ARVD)	AH is grateful for the financial support of SIDACTION in the form of a PhD fellowship (Grant FJC-1/AO20-2/09). This work was supported by the European Community Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (Grant agreement no. 223131), the French Agence National de Recherches sur le Sida et les hepatites virales (ANRS) and the Association de Recherche en Virologie en Dermatologie (ARVD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, WILEY SERIES PROBABI, DOI 10.1002/0471249688; Altmann A, 2007, ANTIVIR THER, V12, P169; Assoumou L, 2008, J INFECT DIS, V198, P470, DOI 10.1086/590156; Assoumou L, 2010, J ANTIMICROB CHEMOTH, V65, P752, DOI 10.1093/jac/dkq034; Assoumou L, 2010, AIDS, V24, P365, DOI 10.1097/QAD.0b013e32833338ba; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Cozzi-Lepri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025665; De Luca A, 2011, ANTIVIR THER, V16, P489, DOI 10.3851/IMP1799; Descamps D, 2009, J ANTIMICROB CHEMOTH, V63, P585, DOI 10.1093/jac/dkn544; DiRienzo AG, 2003, STAT MED, V22, P2785, DOI 10.1002/sim.1516; Draghici S, 2003, BIOINFORMATICS, V19, P98, DOI 10.1093/bioinformatics/19.1.98; Frentz D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011505; Grant RM, 1996, CURR OPIN INFECT DIS, V9, P7, DOI 10.1097/00001432-199602000-00003; Houssaaini A, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/478467; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kandathil AJ, 2009, AIDS RES HUM RETROV, V25, P315, DOI 10.1089/aid.2008.0177; Kijak G H, 2003, HIV Med, V4, P72, DOI 10.1046/j.1468-1293.2003.00131.x; King MS, 2007, ANTIMICROB AGENTS CH, V51, P3067, DOI 10.1128/AAC.00388-07; Larder B, 2007, ANTIVIR THER, V12, P15; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Marcelin AG, 2005, ANTIMICROB AGENTS CH, V49, P1739, DOI 10.1128/AAC.49.5.1739-1744.2005; Marcelin AG, 2008, ANTIMICROB AGENTS CH, V52, P3237, DOI 10.1128/AAC.00133-08; Masquelier B, 2008, J ANTIMICROB CHEMOTH, V61, P1362, DOI 10.1093/jac/dkn127; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Ravela J, 2003, JAIDS-J ACQ IMM DEF, V33, P8, DOI 10.1097/00126334-200305010-00002; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Sevin AD, 2000, J INFECT DIS, V182, P59, DOI 10.1086/315673; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Sinisi SE, 2007, STAT APPL GENET MOL, V6; Vapnik V., 1998, STAT LEARNING THEORY; Vella S, 1995, J ACQ IMMUN DEF SYND, V10, pS20; Vora S, 2006, AIDS, V20, P35, DOI 10.1097/01.aids.0000196179.11293.fc; Wang K, 2004, ANTIVIR THER, V9, P343; Zazzi M, 2011, HIV MED, V12, P211, DOI 10.1111/j.1468-1293.2010.00871.x	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59014	10.1371/journal.pone.0059014	http://dx.doi.org/10.1371/journal.pone.0059014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555613	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400019
J	Chamaille-Jammes, S; Mtare, G; Makuwe, E; Fritz, H				Chamaille-Jammes, Simon; Mtare, Godfrey; Makuwe, Edwin; Fritz, Herve			African Elephants Adjust Speed in Response to Surface-Water Constraint on Foraging during the Dry-Season	PLOS ONE			English	Article							ANIMAL MOVEMENT; DENSITY; SAVANNA; HETEROGENEITY	Most organisms need to acquire various resources to survive and reproduce. Individuals should adjust their behavior to make optimal use of the landscape and limit the costs of trade-offs emerging from the use of these resources. Here we study how African elephants Loxodonta africana travel to foraging places between regular visits to waterholes. Elephant herds were tracked using GPS collars during two consecutive dry seasons in Hwange National Park, Zimbabwe. We segmented each individual movement track at each visit to water to define foraging trips, and then used trip-level statistics to build an understanding of movement strategies. Travel speed within these individually-consistent movement bouts was also analyzed to understand if speed was better linked to distance to water or progression in the trip over time. We found that elephants went further from water when drinking less often, which could result from a trade-off between drinking and foraging in less depleted, far from water, places. Speed increased towards the beginning and the end of the trips, and was also greater than observed during the wet season, suggesting that elephants were trying to save time. Numerous short trips traveled at greater speed, particularly when commuting to a different waterhole, was tentatively explained by the inability to drink at specific waterholes due to intra-specific interference. Unexpectedly elephants did not always minimize travel time by drinking at the closest waterhole, but the extra distance traveled remained never more than a few kilometers. Our results show how individuals may adjust movement behavior to deal with resource trade-offs at the landscape scale. We also highlight how behavioral context, here progression in the trip, may be more important than spatial context, here distance to water, in explaining animal movement patterns.	[Chamaille-Jammes, Simon] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Mtare, Godfrey; Makuwe, Edwin] Hwange Natl Pk, Zimbabwe Parks & Wildlife Management Author, Sci Serv, Hwange, Zimbabwe; [Fritz, Herve] CNRS, Lab Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Chamaille-Jammes, S (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France.	simon.chamaille@cefe.cnrs.fr	Fritz, Herve/D-1729-2014; Chamaillé-Jammes, Simon/B-3833-2009	Fritz, Herve/0000-0002-7106-3661; Chamaillé-Jammes, Simon/0000-0003-0505-6620	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-08-BLAN-0022, ANR-11-CEPL-003]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was partially funded by the "Centre National de la Recherche Scientifique'' and grants ANR-08-BLAN-0022 and ANR-11-CEPL-003 from the "Agence Nationale de la Recherche''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2012, LME4 LINEAR MIXED EF; BOVET P, 1991, ANIM BEHAV, V42, P57, DOI 10.1016/S0003-3472(05)80605-0; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Chamaille-Jammes S, 2006, INT J REMOTE SENS, V27, P5185, DOI 10.1080/01431160600702392; Chamaille-Jammes S, 2007, J TROP ECOL, V23, P725, DOI 10.1017/S0266467407004531; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chamaille-Jammes S, 2009, ECOGRAPHY, V32, P871, DOI 10.1111/j.1600-0587.2009.05785.x; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; McClintock BT, 2012, ECOL MONOGR, V82, P335, DOI 10.1890/11-0326.1; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; O'Connor TG, 2007, BIOL CONSERV, V136, P329, DOI 10.1016/j.biocon.2006.12.014; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; R Core Team, 2012, R LANG ENV STAT COMP; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x	23	39	40	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59164	10.1371/journal.pone.0059164	http://dx.doi.org/10.1371/journal.pone.0059164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554989	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800064
J	Ostrowski, SR; Berg, RMG; Windelov, NA; Meyer, MAS; Plovsing, RR; Moller, K; Johansson, PI				Ostrowski, Sisse R.; Berg, Ronan M. G.; Windelov, Nis A.; Meyer, Martin A. S.; Plovsing, Ronni R.; Moller, Kirsten; Johansson, Par I.			Discrepant Fibrinolytic Response in Plasma and Whole Blood during Experimental Endotoxemia in Healthy Volunteers	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE-PLASMINOGEN ACTIVATOR; ABDOMINAL AORTIC-ANEURYSM; CRITICALLY-ILL PATIENTS; MULTIPLE ORGAN FAILURE; PROTEIN-C; ENDOTHELIAL GLYCOCALYX; ACUTE COAGULOPATHY; ROTATION THROMBELASTOGRAPHY; PLATELET-FUNCTION	Background: Sepsis induces early activation of coagulation and fibrinolysis followed by late fibrinolytic shutdown and progressive endothelial damage. The aim of the present study was to investigate and compare the functional hemostatic response in whole blood and plasma during experimental human endotoxemia by the platelet function analyzer, Multiplate and by standard and modified thrombelastography (TEG). Methods: Prospective physiologic study of nine healthy male volunteers undergoing endotoxemia by means of a 4-hour infusion of E. coli lipopolysaccharide (LPS, 0.5 ng/kg/hour), with blood sampled at baseline and at 4 h and 6 h. Physiological and standard biochemical data and coagulation tests, TEG (whole blood: TEG, heparinase-TEG, Functional Fibrinogen; plasma: TEG +/- tissue-type plasminogen activator (tPA)) and Multiplate (TRAPtest, ADPtest, ASPItest, COLtest) were recorded. Mixed models with Tukey post hoc tests and correlations were applied. Results: Endotoxemia induced acute SIRS with increased HR, temperature, WBC, CRP and procalcitonin and decreased blood pressure. It also induced a hemostatic response with platelet consumption and reduced APTT while INR increased (all p<0.05). Platelet aggregation decreased (all tests, p<0.05), whereas TEG whole blood clot firmness increased (G, p = 0.05). Furthermore, during endotoxemia (4 h), whole blood fibrinolysis increased (clot lysis time (CLT), p<0.001) and Functional Fibrinogen clot strength decreased (p = 0.049). After endotoxemia (6 h), whole blood fibrinolysis was reduced (CLT, p<0.05). In contrast to findings in whole blood, the plasma fibrin clot became progressively more resistant towards tPA-induced fibrinolysis at both 4 h and 6 h (p<0.001). Conclusions: Endotoxemia induced a hemostatic response with reduced primary but enhanced secondary hemostasis, enhanced early fibrinolysis and fibrinogen consumption followed by downregulation of fibrinolysis, with a discrepant fibrinolytic response in plasma and whole blood. The finding that blood cells are critically involved in the vasculo-fibrinolytic response to acute inflammation is important given that disturbances in the vascular system contribute significantly to morbidity and mortality in critically ill patients.	[Ostrowski, Sisse R.; Meyer, Martin A. S.; Johansson, Par I.] Rigshosp, Transfus Med Sect, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Berg, Ronan M. G.; Moller, Kirsten] Rigshosp, Dept Infect Dis, Sect M7641, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Windelov, Nis A.] Rigshosp, Ctr Head & Orthoped, Dept Anesthesia, DK-2100 Copenhagen, Denmark; [Plovsing, Ronni R.] Rigshosp, Dept Anesthesia, Sect 4131, Intens Care Unit, DK-2100 Copenhagen, Denmark; [Moller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Neurointens Care Unit, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Health Science Center Houston	Ostrowski, SR (corresponding author), Rigshosp, Transfus Med Sect, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark.	sisse.ostrowski@gmail.com	Plovsing, Ronni Thermann Reitz/A-7233-2014; Johansson, Pär I/P-9283-2015; Johansson, Pär/GQB-1032-2022; Ostrowski, Sisse R/E-7423-2011; Meyer, Martin A. S./J-2951-2013; Moller, Kirsten/A-4751-2009	Johansson, Pär I/0000-0001-9778-5964; Johansson, Pär/0000-0001-9778-5964; Ostrowski, Sisse R/0000-0001-5288-3851; Meyer, Martin A. S./0000-0002-6312-2457; Moller, Kirsten/0000-0003-3058-1072; Berg, Ronan/0000-0002-5757-9506	Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich; Foundation of 1870; Toyota Foundation; Christian Larsen and Judge Ella Larsen's grant; Classen Trust Jubilee Foundation; P. Carl Petersen Foundation; University Hospital Rigshospitalet; Faculty of Health Sciences, University of Copenhagen; Danish Council for Independent Research - Medical Sciences; Commission of the European Communities [223576 - MYOAGE]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]	Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich; Foundation of 1870; Toyota Foundation; Christian Larsen and Judge Ella Larsen's grant; Classen Trust Jubilee Foundation; P. Carl Petersen Foundation; University Hospital Rigshospitalet; Faculty of Health Sciences, University of Copenhagen; Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Commission of the European Communities(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by The Foundation of Merchant Jakob Ehrenreich and Grete Ehrenreich, The Foundation of 1870, The Toyota Foundation, Christian Larsen and Judge Ella Larsen's grant, The Classen Trust Jubilee Foundation, The P. Carl Petersen Foundation, University Hospital Rigshospitalet, and the Faculty of Health Sciences, University of Copenhagen. The study was further supported by the Danish Council for Independent Research - Medical Sciences, the Commission of the European Communities (grant agreement number 223576 - MYOAGE). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant number 09-067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam DJ, 2004, ANN VASC SURG, V18, P572, DOI 10.1007/s10016-004-0087-5; Adamzik M, 2011, SHOCK, V35, P339, DOI 10.1097/SHK.0b013e318204bff6; Adamzik M, 2010, CRIT CARE, V14, DOI 10.1186/cc9284; Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Agarwal S, 2008, LIVER TRANSPLANT, V14, P855, DOI 10.1002/lt.21437; Alt E, 2004, CLIN HEMORHEOL MICRO, V30, P107; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137; Berg RMG, 2012, AM J PHYSIOL-REG I, V303, pR1127, DOI 10.1152/ajpregu.00242.2012; BRADBURY AW, 1995, J VASC SURG, V21, P484, DOI 10.1016/S0741-5214(95)70291-1; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Carroll RC, 2009, TRANSL RES, V154, P34, DOI 10.1016/j.trsl.2009.04.001; Chakroun T, 2006, THROMB HAEMOSTASIS, V95, P822, DOI 10.1160/TH05-07-0500; Cicala C, 1997, LIFE SCI, V60, pL31; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; COWAN DH, 1976, JAMA-J AM MED ASSOC, V235, P1230, DOI 10.1001/jama.235.12.1230; CRYER PE, 1980, NEW ENGL J MED, V303, P436; Daudel F, 2009, CRIT CARE, V13, DOI 10.1186/cc7765; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Dirkmann D, 2012, ANESTH ANALG, V114, P1182, DOI 10.1213/ANE.0b013e31823b6683; Dong HP, 2010, KAOHSIUNG J MED SCI, V26, P584, DOI 10.1016/S1607-551X(10)70090-5; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Eralp O, 2011, J VET INTERN MED, V25, P524, DOI 10.1111/j.1939-1676.2011.0698.x; Esmon CT, 2004, CRIT CARE MED, V32, pS219, DOI 10.1097/01.CCM.0000127036.27343.48; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Frith D, 2012, CURR OPIN CRIT CARE, V18, P631, DOI 10.1097/MCC.0b013e3283599ab9; Gando S, 2007, THROMB RES, V120, P87, DOI 10.1016/j.thromres.2006.07.009; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Goerlinger K, 2007, TRANSFUS MED HEMOTH, V34, P396, DOI 10.1159/000109642; Gonano C, 2006, CRIT CARE, V10, DOI 10.1186/cc5098; Grant HW, 1997, PEDIATR SURG INT, V12, P289, DOI 10.1007/s003830050133; HAWKEY CM, 1975, BRIT J HAEMATOL, V29, P377, DOI 10.1111/j.1365-2141.1975.tb01835.x; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2008, BRIT J HAEMATOL, V143, P559, DOI 10.1111/j.1365-2141.2008.07379.x; Johansson PI, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-45; Johansson PI, 2008, TRANSFUSION, V48, P2377, DOI 10.1111/j.1537-2995.2008.01846.x; Johansson PI, 2010, BLOOD COAGUL FIBRIN, V21, P168, DOI 10.1097/MBC.0b013e3283367882; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Khurana S, 1997, J LAB CLIN MED, V130, P401, DOI 10.1016/S0022-2143(97)90040-8; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Kristova Viera, 1993, Acta Physiologica Hungarica, V81, P363; Lacroix R, 2012, HAEMATOL-HEMATOL J, V97, P1864, DOI 10.3324/haematol.2012.066167; Leemann H, 2010, J TRAUMA, V69, P1403, DOI 10.1097/TA.0b013e3181faaa25; Leslie M, 2010, SCIENCE, V328, P562, DOI 10.1126/science.328.5978.562; Levi M, 2008, SEMIN THROMB HEMOST, V34, P417, DOI 10.1055/s-0028-1092871; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; MAKHMUDOV RM, 1985, COR VASA, V27, P456; Mesters RM, 2000, CRIT CARE MED, V28, P2209, DOI 10.1097/00003246-200007000-00005; Morel O, 2009, HAEMATOL-HEMATOL J, V94, P313, DOI 10.3324/haematol.2009.003657; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2005.00602.x; Nydam TL, 2011, J TRAUMA, V70, P401, DOI 10.1097/TA.0b013e31820b5c85; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Ostrowski SR, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-64; Ostrowski SR, 2011, MED HYPOTHESES, V77, P798, DOI 10.1016/j.mehy.2011.07.040; Ostrowski SR, 2012, J CRIT CARE; Raivio P, 2007, J THORAC CARDIOV SUR, V133, P44, DOI 10.1016/j.jtcvs.2006.10.003; Raza I, 2012, J THROMB HAEMOST, P10; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Salim A, 2009, J TRAUMA, V66, P1349, DOI 10.1097/TA.0b013e318191b8af; Schochl H, 2012, RESUSCITATION, P10; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Sefrin P, 1987, Prog Clin Biol Res, V236A, P477; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Senzolo M, 2007, BLOOD COAGUL FIBRIN, V18, P227, DOI 10.1097/MBC.0b013e328010bd3d; Sharma P, 2010, AM J CLIN PATHOL, V134, P97, DOI 10.1309/AJCPPZ4J6CAFYDVM; Sivula M, 2009, BLOOD COAGUL FIBRIN, V20, P419, DOI 10.1097/MBC.0b013e32832a76e1; Spiel AO, 2006, J THROMB HAEMOST, V4, P411, DOI 10.1111/j.1538-7836.2006.01715.x; Spiel AO, 2012, CLIN SCI LOND; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Taudorf S, 2007, CLIN VACCINE IMMUNOL, V14, P250, DOI 10.1128/CVI.00380-06; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsai HJ, 2012, BLOOD COAGUL FIBRIN, V23, P118, DOI 10.1097/MBC.0b013e32834ee170; Ueno H, 2002, CRIT CARE MED, V30, P2242, DOI 10.1097/00003246-200210000-00011; vanderPoll T, 1997, J EXP MED, V185, P1143, DOI 10.1084/jem.185.6.1143; Velik-Salchner C, 2009, BLOOD COAGUL FIBRIN, V20, P41, DOI 10.1097/MBC.0b013e32831be9ad; VENDSALU A, 1960, ACTA PHYSIOL SCAND, V49, P1; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Wohner N, 2011, ARTERIOSCL THROM VAS, V31, P2306, DOI 10.1161/ATVBAHA.111.229088; Woth G, 2011, J THROMB THROMBOLYS, V31, P6, DOI 10.1007/s11239-010-0486-0; Xing K, 2012, CRIT CARE, V16, DOI 10.1186/cc11145; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Zambruni A, 2004, SCAND J GASTROENTERO, V39, P830, DOI 10.1080/00365520410004433	100	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59368	10.1371/journal.pone.0059368	http://dx.doi.org/10.1371/journal.pone.0059368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555024	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800085
J	Qiu, HB; Zhang, LY; Ren, C; Zeng, ZL; Wu, WJ; Luo, HY; Zhou, ZW; Xu, RH				Qiu, Hai-bo; Zhang, Li-yi; Ren, Chao; Zeng, Zhao-lei; Wu, Wen-jing; Luo, Hui-yan; Zhou, Zhi-wei; Xu, Rui-hua			Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							LIVER-INTESTINE-CADHERIN; EXPRESSION; CDX2; ACTIVATION; METAPLASIA; PEPTIDE; RISK	Purpose: Gastric cancer remains one of the leading causes of cancer death worldwide. Patients usually present late with local invasion or metastasis, for which there are no effective therapies available. Following previous studies that identified the adhesion molecule Cadherin-17(CDH17) as a potential marker for gastric carcinoma, we performed proof-of-principle studies to develop rational therapeutic approaches targeting CDH17 for treating this disease. Methods: Immunohistochemistry was used to study the expression of CDH17 in 156 gastric carcinomas, and the relationship between survival and CDH17 expression was studied by multivariate analyses. The effect of RNA interference-mediated knockdown of CDH17 on proliferation of gastric carcinoma cell lines was examined in vitro and in vivo, as well as the effects on downstream signaling by immunoblotting. Results: CDH17 was consistently up-regulated in human gastric cancers, and overall survival in patients with CDH17 upregulation was poorer than in those without expression of this gene (5 yrs overall survival rate 29.0% vs. 45.0%, P < 0.01). Functional assays demonstrated that CDH17 knockdown inhibited cell proliferation, adhesion, migration, invasion, clonogenicity and induce G0/G1 arrest. In mice, shRNA-mediated CDH17 knockdown markedly inhibits tumor growth; intratumoral injection of CDH17 shRNAs results in significant antitumor effects on transplanted tumor models. The antitumor mechanisms underlying CDH17 inhibition involve inactivation of Wnt/beta-catenin signaling. Conclusion: Our results identify CDH17 as a biomarker of gastric carcinoma and attractive therapeutic target for this aggressive malignancy.	[Qiu, Hai-bo; Ren, Chao; Zeng, Zhao-lei; Wu, Wen-jing; Luo, Hui-yan; Zhou, Zhi-wei; Xu, Rui-hua] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Qiu, Hai-bo; Ren, Chao; Zeng, Zhao-lei; Wu, Wen-jing; Luo, Hui-yan; Xu, Rui-hua] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Qiu, Hai-bo; Zhou, Zhi-wei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Li-yi] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Qiu, Hai-bo] Dana Farber Canc Inst, Div Surg Oncol, Boston, MA 02115 USA; [Qiu, Hai-bo] Harvard Univ, Sch Med, Boston, MA USA	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Xu, RH (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xurh@sysucc.org.cn	Xu, Rui-Hua/AAW-4766-2021; xu, rui/GRX-5734-2022; 骆, 卉妍/GWR-3383-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299	National Natural Science Foundation [30672408]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (30672408 to RHX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P1302; Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Cao ZA, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-11; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Ge J, 2008, CLIN ONCOL-UK, V20, P275, DOI 10.1016/j.clon.2008.01.013; Gessner R, 2000, ANN NY ACAD SCI, V915, P136; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Ito R, 2005, VIRCHOWS ARCH, V447, P717, DOI 10.1007/s00428-005-0015-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Ko S, 2005, J PATHOL, V205, P615, DOI 10.1002/path.1741; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Lev N, 2007, J MOL BIOL, V374, P220, DOI 10.1016/j.jmb.2007.09.008; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Marrelli D, 2005, ANN SURG, V241, P247, DOI 10.1097/01.sla.0000152019.14741.97; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Park SS, 2007, ANN SURG ONCOL, V14, P94, DOI 10.1245/s10434-006-9114-9; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Sobin LH, 2002, TNM CLASSIFICATION M, V6th; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang XQ, 2006, CLIN CANCER RES, V12, P5248, DOI 10.1158/1078-0432.CCR-06-0558	29	29	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e56959	10.1371/journal.pone.0056959	http://dx.doi.org/10.1371/journal.pone.0056959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554857	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800005
J	Tseng, CM; Chen, YT; Ou, SM; Hsiao, YH; Li, SY; Wang, SJ; Yang, AC; Chen, TJ; Perng, DW				Tseng, Ching-Min; Chen, Yung-Tai; Ou, Shuo-Ming; Hsiao, Yi-Han; Li, Szu-Yuan; Wang, Shuu-Jiun; Yang, Albert C.; Chen, Tzeng-Ji; Perng, Diahn-Warng			The Effect of Cold Temperature on Increased Exacerbation of Chronic Obstructive Pulmonary Disease: A Nationwide Study	PLOS ONE			English	Article							FLUTICASONE PROPIONATE; COPD EXACERBATIONS; MORTALITY; RISK; INFLUENZA; SALMETEROL; SYMPTOMS; MODERATE; WEATHER; ENGLAND	Background: Seasonal variations in the acute exacerbation of chronic obstructive pulmonary disease (COPD) have been reported. However, the influence of air temperature and other meteorological factors on COPD exacerbation remains unclear. Methods: National Health Insurance registry data from January 1, 1999 to December 1, 2009 and meteorological variables from the Taiwan Central Weather Bureau for the same period were analyzed. A case-crossover study design was used to investigate the association between COPD exacerbation and meteorological variables. Results: A total of 16,254 cases who suffered from COPD exacerbation were enrolled. We found that a 1 degrees C decrease in air temperature was associated with a 0.8% increase in the exacerbation rate on event-days (95% confidence interval (CI), 1.015-1.138, p = 0.015). With a 5 degrees C decrease in mean temperature, the cold temperature (28-day average temperature) had a long-term effect on the exacerbation of COPD (odds ratio (OR), 1.106, 95% CI 1.063-1.152, p < 0.001). In addition, elderly patients and those who did not receive inhaled medication tended to suffer an exacerbation when the mean temperature dropped 5 degrees C. Higher barometric pressure, more hours of sunshine, and lower humidity were associated with an increase in COPD exacerbation. Conclusions: This study demonstrated the effect of cold temperatures on the COPD exacerbation rate. Elderly patients and those without inhaled medicine before the exacerbation event were affected significantly by lower mean temperatures. A more comprehensive program to prevent cold stress in COPD patients may lead to a reduction in the exacerbations rate of COPD.	[Tseng, Ching-Min; Hsiao, Yi-Han; Perng, Diahn-Warng] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Yung-Tai] Taipei City Hosp, Dept Med, Heping Fuyou Branch, Taipei, Taiwan; [Chen, Yung-Tai; Ou, Shuo-Ming; Li, Szu-Yuan] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Li, Szu-Yuan] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Wang, Shuu-Jiun; Yang, Albert C.; Chen, Tzeng-Ji; Perng, Diahn-Warng] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Perng, DW (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	dwperng@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021	Yang, Albert Chih-Chieh/0000-0003-2794-9649	Taipei Veterans General Hospital [V100B-030, V101D-001-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	Research was funded by the Taipei Veterans General Hospital research grant V100B-030 and V101D-001-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Donaldson GC, 2012, CHEST, V141, P94, DOI 10.1378/chest.11-0281; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Ferrari U, 2012, INT J BIOMETEOROL, V56, P137, DOI 10.1007/s00484-011-0405-x; Greenberg SB, 2000, AM J RESP CRIT CARE, V162, P167, DOI 10.1164/ajrccm.162.1.9911019; Hak E, 1998, J EPIDEMIOL COMMUN H, V52, P120, DOI 10.1136/jech.52.2.120; Holmer I, 2000, Int J Circumpolar Health, V59, P267; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jenkins CR, 2012, EUR RESPIR J, V39, P38, DOI 10.1183/09031936.00194610; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Koskela HO, 1996, CHEST, V110, P632, DOI 10.1378/chest.110.3.632; Liao CM, 2009, INT J INFECT DIS, V13, P589, DOI 10.1016/j.ijid.2008.09.019; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; Lindemann J, 2008, LARYNGOSCOPE, V118, P1472, DOI 10.1097/MLG.0b013e3181758174; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MANN M, 1993, CHEST, V103, P1369, DOI 10.1378/chest.103.5.1369; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Navidi W, 2002, EPIDEMIOLOGY, V13, P100, DOI 10.1097/00001648-200201000-00016; Rea H, 2010, RESP MED, V104, P525, DOI 10.1016/j.rmed.2009.12.016; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; Upshur REG, 2006, EPIDEMIOL INFECT, V134, P1174, DOI 10.1017/S0950268806006236; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Williams R, 1996, CRIT CARE MED, V24, P1920, DOI 10.1097/00003246-199611000-00025; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011	34	71	75	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57066	10.1371/journal.pone.0057066	http://dx.doi.org/10.1371/journal.pone.0057066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554858	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800006
J	Xing, XK; Ma, XT; Hart, MM; Wang, AR; Guo, SX				Xing, Xiaoke; Ma, Xueting; Hart, Miranda M.; Wang, Airong; Guo, Shunxing			Genetic Diversity and Evolution of Chinese Traditional Medicinal Fungus Polyporus umbellatus (Polyporales, Basidiomycota)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; POLYMORPHISM; SCLEROTIUM; REVEALS; RDNA; DNA	Background: Polyporus umbellatus is an important medicinal fungus distributed throughout most area of China. Its wide distribution may have resulted in substantial intraspecific genetic diversity for the fungus, potentially creating variation in its medical value. To date, we know little about the intraspecific genetic diversity of P. umbellatus. Methodology/Principal Findings: The objective of this research was to assess genetic differences of P. umbellatus from geographically diverse regions of China based on nrDNA ITS and 28S rRNA (LSU, large subunit) sequences. Significant sequence variations in the ITS and LSU sequences were detected. All sclerotial samples were clustered into four clades based on phylogenetic analysis of ITS, LSU and a combined data set of both regions. Heterogeneity of ITS and LSU sequences was detected in 5 and 7 samples respectively. All clone sequences clustered into the same clade except for one LSU clone sequences (from Henan province) which clustered into two clades (Clade I and Clade II). Significant genetic divergence in P. umbellatus was observed and the genetic diversification was greater among sclerotial samples from Shaanxi, Henan and Gansu provinces than among other provinces. Polymorphism of ITS and LSU sequences indicated that in China, P. umbellatus may spread from a center (Shaanxi, Henan and Gansu province) to other regions. Conclusions/Significance: We found sclerotial samples of P. umbellatus contained levels of intraspecific genetic diversity. These findings suggested that P. umbellatus populations in Shaanxi, Henan and Gansu are important resources of genetic diversity and should be conserved accordingly.	[Xing, Xiaoke; Ma, Xueting; Wang, Airong; Guo, Shunxing] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xing, Xiaoke; Ma, Xueting; Wang, Airong; Guo, Shunxing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hart, Miranda M.] Univ British Columbia Okanagan, Kelowna, BC, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of British Columbia; University of British Columbia Okanagan	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	guosx2000@yahoo.com.cn	Hart, Miranda m/D-1562-2011		National Natural Sciences Foundation of China [30830117, 30901013]; International Science and Technology Cooperation Projects of China [2011DFA31260]; Specialized Research Fund for the Doctoral Program of Higher Education [20091106110003]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Projects of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was financially supported by the National Natural Sciences Foundation of China (No. 30830117 and No. 30901013), the International Science and Technology Cooperation Projects of China (No. 2011DFA31260) and Specialized Research Fund for the Doctoral Program of Higher Education (20091106110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PHARM PEOPL REP CHIN, V1; Binder M, 2002, MOL PHYLOGENET EVOL, V22, P76, DOI 10.1006/mpev.2001.1043; Dai YC, 1996, ANN BOT FENN, V33, P153; Dai YC, 2012, MYCOSCIENCE, V53, P49, DOI 10.1007/s10267-011-0134-3; Dai YC, 2009, INT J MED MUSHROOMS, V11, P287, DOI 10.1615/IntJMedMushr.v11.i3.80; Dai YuCheng, 2010, Mycosystema, V29, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Hibbett David S., 1992, Transactions of the Mycological Society of Japan, V33, P533; Hughes KW, 1999, MYCOLOGIA, V91, P978, DOI 10.2307/3761628; Imazeki R, 1989, COLORED ILLUSTRATION, VII; Ko KS, 2002, MYCOTAXON, V82, P315; Kruger D., 2004, Feddes Repertorium, V115, P530, DOI 10.1002/fedr.200311052; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J.Y., 1988, COLORED KOREAN MUSHR; Li, 2008, MODERN CHINESE MED, V10, P43; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu K, 2009, ACTA EDULIS FUNGI, V16, P11; Liu Zhijun, 2001, Journal of Herbal Pharmacotherapy, V1, P25, DOI 10.1080/J157v01n03_03; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; MIYAZAKI T, 1973, CHEM PHARM BULL, V21, P2545; NUNEZ M, 1995, SYNOPSIS FUNGORUM, V10; Okabe I, 2003, MYCOL RES, V107, P164, DOI 10.1017/S0953756203007160; Pannecoucque J, 2009, MYCOLOGIA, V101, P26, DOI 10.3852/08-084; Shen Q, 2002, MYCOLOGIA, V94, P472, DOI 10.2307/3761781; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Sun Y, 2008, BIOORG MED CHEM LETT, V18, P3417, DOI 10.1016/j.bmcl.2008.04.008; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vasaitis R, 2009, MYCOL RES, V113, P326, DOI 10.1016/j.mycres.2008.11.009; VILGALYS R, 1990, Journal of Bacteriology, V172, P4238; Wang QM, 2008, APPL ENVIRON MICROB, V74, P2604, DOI 10.1128/AEM.02223-07; White T. J., 1990, RCR PROTOCOLS GUIDE; Xu JT, 1997, MED MYCOLOGY CHINA; Yang Li-juan, 2004, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V20, P234; Yao L, 2006, GUIDELINES GOOD AGR; Yuan D, 2004, BIOL PHARM BULL, V27, P867, DOI 10.1248/bpb.27.867; Zeng Xing, 2011, Chinese Journal of Immunology, V27, P414; Zhao YY, 2009, J ETHNOPHARMACOL, V126, P184, DOI 10.1016/j.jep.2009.07.033	40	6	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58807	10.1371/journal.pone.0058807	http://dx.doi.org/10.1371/journal.pone.0058807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554929	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800031
J	Neo, ML; Erftemeijer, PLA; van Beek, JKL; van Maren, DS; Teo, SLM; Todd, PA				Neo, Mei Lin; Erftemeijer, Paul L. A.; van Beek, Jan K. L.; van Maren, Dirk S.; Teo, Serena L-M.; Todd, Peter A.			Recruitment constraints in Singapore's fluted giant clam (Tridacna squamosa) population-A dispersal model approach	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE INVERTEBRATE; GENETIC-STRUCTURE; BENTHIC INVERTEBRATES; STOCK ENHANCEMENT; LARVAL TRANSPORT; CONNECTIVITY; RESTOCKING; CROCEA; SETTLEMENT	Recruitment constraints on Singapore's dwindling fluted giant clam, Tridacna squamosa, population were studied by modelling fertilisation, larval transport, and settlement using real-time hydrodynamic forcing combined with knowledge of spawning characteristics, larval development, behaviour, and settlement cues. Larval transport was simulated using a finite-volume advection-diffusion model coupled to a three-dimensional hydrodynamic model. Three recruitment constraint hypotheses were tested: 1) there is limited connectivity between Singapore's reefs and other reefs in the region, 2) there is limited exchange within Singapore's Southern Islands, and 3) there exist low-density constraints to fertilisation efficacy (component Allee effects). Results showed that connectivity among giant clam populations was primarily determined by residual hydrodynamic flows and spawning time, with greatest chances of successful settlement occurring when spawning and subsequent larval dispersal coincided with the period of lowest residual flow. Simulations suggested poor larval transport from reefs located along the Peninsular Malaysia to Singapore, probably due to strong surface currents between the Andaman Sea and South China Sea combined with a major land barrier disrupting larval movement among reefs. The model, however, predicted offshore coral reefs to the southeast of Singapore (Bintan and Batam) may represent a significant source of larvae. Larval exchange within Singapore's Southern Islands varied substantially depending on the locations of source and sink reefs as well as spawning time; but all simulations resulted in low settler densities (2.1-68.6 settled individuals per 10,000 m(2)). Poor fertilisation rates predicted by the model indicate that the low density and scattered distribution of the remaining T. squamosa in Singapore are likely to significantly inhibit any natural recovery of local stocks.	[Neo, Mei Lin; Todd, Peter A.] Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore; [Neo, Mei Lin; Teo, Serena L-M.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore; [Erftemeijer, Paul L. A.] Sinclair Knight Merz, Perth, WA, Australia; [Erftemeijer, Paul L. A.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [van Beek, Jan K. L.; van Maren, Dirk S.] Deltares, Delft, Netherlands	National University of Singapore; National University of Singapore; University of Western Australia; Deltares	Todd, PA (corresponding author), Natl Univ Singapore, Dept Biol Sci, Expt Marine Ecol Lab, Singapore 117548, Singapore.	dbspat@nus.edu.sg	van Maren, Dirk Sebastiaan/AAG-8759-2019; Todd, Peter A/H-8410-2012; Erftemeijer, Paul/U-7485-2018	van Beek, Jan/0000-0002-4019-7202; Neo, Mei Lin/0000-0002-0141-8164; Erftemeijer, Paul/0000-0002-2904-7422	Building with Nature Singapore Supportive Modelling project [1201442.002]; National Parks Board's Coastal & Marine Environment [R-154-000-504-490]; Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2) [R-264-001-001-272]	Building with Nature Singapore Supportive Modelling project; National Parks Board's Coastal & Marine Environment; Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2)	The research presented in this work was carried out as part of the Building with Nature Singapore Supportive Modelling project (1201442.002). This study was also supported by the National Parks Board's Coastal & Marine Environment grant number R-154-000-504-490 and Singapore-Delft Water Alliance's Marine & Coastal Research Programme (Theme 2) grant number R-264-001-001-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T. J. H., 1988, ACIAR MONOGRAPH, P78; Alcala A.C., 1986, Silliman Journal, V33, P45; Alcazar S.N., 1986, Silliman Journal, V33, P65; Arnold WS, 2008, REV FISH SCI, V16, P65, DOI 10.1080/10641260701678140; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Bell JD, 2005, ADV MAR BIOL, V49, P1, DOI 10.1016/S0065-2881(05)49001.X; Bell JD, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P437; Bell JD, 2006, FISH RES, V80, P1, DOI 10.1016/j.fishres.2006.03.008; BENZIE JAH, 1992, CORAL REEFS, V11, P135, DOI 10.1007/BF00255467; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bolle LJ, 2009, MAR ECOL PROG SER, V390, P195, DOI 10.3354/meps08177; Botsford LW, 2003, ECOL APPL, V13, pS25; BRALEY R D, 1987, Micronesica, V20, P215; BRALEY RD, 1984, CORAL REEFS, V3, P221, DOI 10.1007/BF00288258; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; CHIA FS, 1984, CAN J ZOOL, V62, P1205, DOI 10.1139/z84-176; Chou LM, 2004, HYDROBIOLOGIA, V515, P91, DOI 10.1023/B:HYDR.0000027321.23230.2f; Copland J. W., 1988, AUSTR CTR INT AGR RE, V9; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; DENNY MW, 1989, AM NAT, V117, P838; Deredec Anne, 2007, Ecoscience, V14, P440, DOI 10.2980/1195-6860(2007)14[440:IOTAEF]2.0.CO;2; DiNitto D, 2010, GO FLOW FIELD MODELL, P137; Ellis S., 1998, CTR TROPICAL SUBTROP, V130; Erftemeijer PLA, 2008, MAR ECOL PROG SER, V358, P115, DOI 10.3354/meps07304; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; FITT WK, 1984, AQUACULTURE, V39, P181, DOI 10.1016/0044-8486(84)90265-5; FITT WK, 1981, BIOL BULL, V161, P213, DOI 10.2307/1540800; Gascoigne J, 2004, MAR ECOL PROG SER, V269, P49, DOI 10.3354/meps269049; Gerritsen H, 2009, P 8 INT C HYDR CHIL; Goh N.K.C., 1992, 3 ASEAN SCI TECHN WE, P55; Gomez ED, 2006, FISH RES, V80, P46, DOI 10.1016/j.fishres.2006.03.017; Green A, 1999, CORAL REEFS, V18, P205, DOI 10.1007/s003380050183; Guest JR, 2008, AQUAT CONSERV, V18, P570, DOI 10.1002/aqc.888; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; GWYTHER J, 1981, AQUACULTURE, V24, P197, DOI 10.1016/0044-8486(81)90057-0; Hadfield MG, 2004, BIOL BULL-US, V207, P28, DOI 10.2307/1543626; Han L, 2008, J EXP MAR BIOL ECOL, V359, P77, DOI 10.1016/j.jembe.2008.02.021; Heslinga G.A., 1990, GIANT CLAM FARMING; HESLINGA GA, 1987, BIOSCIENCE, V37, P332, DOI 10.2307/1310689; Hobday AJ, 2001, REV FISH BIOL FISHER, V10, P493; Huang DW, 2007, J EXP MAR BIOL ECOL, V342, P269, DOI 10.1016/j.jembe.2006.10.051; Huang DW, 2009, RAFFLES B ZOOL, P69; JAMESON SC, 1976, PAC SCI, V30, P219; Knights AM, 2006, MAR ECOL PROG SER, V326, P167, DOI 10.3354/meps326167; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; LABARBERA M, 1974, MAR BIOL, V25, P233, DOI 10.1007/BF00394969; Latama Gunarto, 1995, Phuket Marine Biological Center Special Publication, V15, P79; Launder B.E., 1972, MATH MODELS TURBULEN; Leendertse J. J., 1987, 3 DIMENSIONAL ALTERN; Lesser GR, 2004, COAST ENG, V51, P883, DOI 10.1016/j.coastaleng.2004.07.014; Liao PC, 2007, CONSERV GENET, V8, P89, DOI 10.1007/s10592-006-9151-8; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Luijendijk AP, 2001, THESIS DELFT U TECHN; Manuel JL, 1997, J PLANKTON RES, V19, P1929, DOI 10.1093/plankt/19.12.1929; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Morgan LE, 2001, LOW WAKE FI, V17, P667; MUNRO PE, 1983, COMP BIOCHEM PHYS C, V74, P219, DOI 10.1016/0742-8413(83)90177-9; Munro PE, 1993, ICLARM C P, V39; Nash W.J., 1988, ACIAR Monograph Series, P89; Neo M.L., 2011, Nature in Singapore, V4, P157; Neo ML, 2012, RAFFLES B ZOOL, P67; Neo ML, 2012, AQUAT BIOL, V14, P265, DOI 10.3354/ab00400; Neo ML, 2011, J ETHOL, V29, P85, DOI 10.1007/s10164-010-0226-0; Neo ML, 2011, J EXP MAR BIOL ECOL, V397, P21, DOI 10.1016/j.jembe.2010.11.008; Neo ML, 2009, HYDROBIOLOGIA, V625, P83, DOI 10.1007/s10750-008-9698-0; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; Nuryanto A, 2007, HAYATI J BIOSCI, V14, P162, DOI DOI 10.4308/HJB.14.4.162; Ooi SK, 2009, P 23 IAHR C VANC 9 1; Palumbi SR, 2003, ECOL APPL, V13, pS146; PEARSON RG, 1991, AUST J MAR FRESH RES, V42, P241; Postma L., 1994, DELWAQ USERS MANUAL; Purchon R. D., 1954, Bulletin of the Raffles Museum Singapore, V25, P47; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; Riddle AM, 1996, J MARINE SYST, V8, P133, DOI 10.1016/0924-7963(96)00003-6; Roegner GC, 2000, J PLANKTON RES, V22, P1779, DOI 10.1093/plankt/22.9.1779; Roelvink JA, 1994, HYDROINFORMATICS, P451; SCHELTEMA RS, 1988, BIOL BULL, V174, P145, DOI 10.2307/1541781; Shanks AL, 2003, ECOL APPL, V13, pS159; STELLING GS, 1994, INT J NUMER METH FL, V18, P915, DOI 10.1002/fld.1650181003; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tan Aileen Shau-Hwai, 2001, Phuket Marine Biological Center Special Publication, V25, P349; Tan ASH, 1998, PHUKET MAR BIOL CTR, V18, P107; Thia-Eng C, 2000, MAR POLLUT BULL, V41, P160, DOI 10.1016/S0025-326X(00)00108-9; Todd Peter A., 2008, Tentacle, V16, P24; van Maren DS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007615; van Maren DS, 2011, 1201442002ZKS; WADA S. K., 1954, JAPANESE JOUR ZOOL, V11, P273; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Young Craig M., 1995, P249; Zhang Z, 2007, ATMOS ENVIRON, V41, P5236, DOI 10.1016/j.atmosenv.2006.05.086	94	22	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58819	10.1371/journal.pone.0058819	http://dx.doi.org/10.1371/journal.pone.0058819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23555597	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200116
J	Larsen, MT; Hother, C; Hager, M; Pedersen, CC; Theilgaard-Monch, K; Borregaard, N; Cowland, JB				Larsen, Maria T.; Hother, Christoffer; Hager, Mattias; Pedersen, Corinna C.; Theilgaard-Monch, Kim; Borregaard, Niels; Cowland, Jack B.			MicroRNA Profiling in Human Neutrophils during Bone Marrow Granulopoiesis and In Vivo Exudation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DOWN-REGULATION; DIFFERENTIATION; EXPRESSION; CELLS; GRANULOCYTES; PROGRESSION; TRANSITION; INDUCTION; MECHANISM	The purpose of this study was to describe the microRNA (miRNA) expression profiles of neutrophils and their precursors from the initiation of granulopoiesis in the bone marrow to extravasation and accumulation in skin windows. We analyzed three different cell populations from human bone marrow, polymorphonuclear neutrophil (PMNs) from peripheral blood, and extravasated PMNs from skin windows using the Affymetrix 2.0 platform. Our data reveal 135 miRNAs differentially regulated during bone marrow granulopoiesis. The majority is differentially regulated between the myeloblast/promyelocyte (MB/PM) and myelocyte/metamyelocyte (MC/MM) stages of development. These 135 miRNAs were divided into six clusters according to the pattern of their expression. Several miRNAs demonstrate a pronounced increase or reduction at the transition between MB/PM and MC/MM, which is associated with cell cycle arrest and the initiation of terminal differentiation. Seven miRNAs are differentially up-regulated between peripheral blood PMNs and extravasated PMNs and only one of these (miR-132) is also differentially regulated during granulopoiesis. The study indicates that several different miRNAs participate in the regulation of normal granulopoiesis and that miRNAs might also regulate activities of extravasated neutrophils. The data present the miRNA profiles during the development and activation of the neutrophil granulocyte in healthy humans and thus serves as a reference for further research of normal and malignant granulocytic development.	[Larsen, Maria T.; Hager, Mattias; Pedersen, Corinna C.; Theilgaard-Monch, Kim; Borregaard, Niels; Cowland, Jack B.] Univ Copenhagen, Dept Hematol, Natl Univ Hosp, Granulocyte Res Lab, Copenhagen, Denmark; [Hother, Christoffer] Univ Copenhagen, Dept Hematol, Natl Univ Hosp, Epigenome Res Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Cowland, JB (corresponding author), Univ Copenhagen, Dept Hematol, Natl Univ Hosp, Granulocyte Res Lab, Copenhagen, Denmark.	jack.cowland@regionh.dk		Cowland, Jack Bernard/0000-0002-7429-5388; Theilgaard-Monch, Kim/0000-0002-4239-4939	Danish Cancer Society; Lundbeck foundation; Danish Medical Research Council; Brochner Mortensen foundation; Lundbeck Foundation [R17-2007-1726] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1015986] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Lundbeck foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brochner Mortensen foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from The Danish Cancer Society, Lundbeck foundation, Danish Medical Research Council, and The Brochner Mortensen foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Hager M, 2011, BLOOD, V118, P6649, DOI 10.1182/blood-2011-03-339978; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Lekstrom-Himes JA, 2001, STEM CELLS, V19, P125, DOI 10.1634/stemcells.19-2-125; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Merkerova MD, 2011, EUR J HUM GENET, V19, P313, DOI 10.1038/ejhg.2010.209; Mora-Jensen H, 2011, J LEUKOCYTE BIOL, V90, P629, DOI 10.1189/jlb.0311123; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Sun SM, 2011, BRIT J HAEMATOL, V155, P395, DOI 10.1111/j.1365-2141.2011.08682.x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Theilgaard-Monch K, 2006, CURR OPIN IMMUNOL, V18, P54, DOI 10.1016/j.coi.2005.11.010; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang HJ, 2012, SHOCK, V37, P263, DOI 10.1097/SHK.0b013e318241baf8; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	50	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58454	10.1371/journal.pone.0058454	http://dx.doi.org/10.1371/journal.pone.0058454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554893	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500025
J	Zhang, Q; Zhang, SF; Wang, CX; Gao, X; Zhou, Y; Zhou, H; Wang, AX; Wu, JW; Bian, LH; Wu, SL; Zhao, XQ				Zhang, Qian; Zhang, Shufeng; Wang, Chunxue; Gao, Xiang; Zhou, Yong; Zhou, Heng; Wang, Anxin; Wu, Jianwei; Bian, Liheng; Wu, Shouling; Zhao, Xingquan			Ideal Cardiovascular Health Metrics on the Prevalence of Asymptomatic Intracranial Artery Stenosis: A Cross-Sectional Study	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER; RISK-FACTORS; CEREBRAL ATHEROSCLEROSIS; OCCLUSIVE LESIONS; CHINESE PATIENTS; STROKE RISK; BODY-WEIGHT; MORTALITY; DISEASE; GENDER	Background and Purpose: Intracranial Artery Stenosis (ICAS) is one of the most common causes of ischemic stroke in Asia. Previous studies have shown the number of ideal cardiovascular health (CVH) metrics was associated with lower risk of stroke. This study aimed to investigate the relationship between ideal CVH metrics and prevalence of ICAS. Methods: A random sample of 5,412 participants (selected from Kailuan Study as a reference population) aged 40 years or older (40.10% women), free of stroke, transient ischemic attack, and coronary disease, were enrolled in the Asymptomatic Polyvascular Abnormalities Community study from 2010 to 2011. We collected information on the seven CVH metrics (including smoking, body mass index, dietary intake, physical activity, blood pressure, total cholesterol and fasting blood glucose); and assessed ICAS by transcranial Doppler. The relationship between the ideal CVH metrics and prevalence of ICAS was analyzed using the multivariate logistic regression. Results: After adjusting for age, sex, and other potential confounders, the adjusted odds ratios(95% confidence interval) for ICAS were 0.76(0.58-0.99), 0.55(0.43-0.72), 0.49(0.37-0.65), 0.43(0.31-0.61), and 0.36(0.22-0.62), respectively, for those having 2, 3, 4, 5, and 6-7 ideal CVH metrics compared with those having 0-1 ideal metric(p-trend<0.0001). Similar inverse associations were observed in different age and gender groups (all p-trends<0.05). Conclusion: We found a clear gradient relationship between the number of ideal CVH metrics and lower prevalence of ICAS in a Chinese population, which supports the importance of ideal health behaviors and factors in the prevention of ICAS.	[Zhang, Qian; Zhang, Shufeng; Wang, Chunxue; Zhou, Yong; Zhou, Heng; Wang, Anxin; Wu, Jianwei; Bian, Liheng; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Qian] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Cell Transplantat, Beijing, Peoples R China; [Zhang, Shufeng] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Gao, Xiang] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wu, Shouling] Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Wu, SL (corresponding author), Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; zxq@vip.163.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; , Xiang/0000-0003-2617-6509	Ministry of Science and Technology; Ministry of Health of the People's Republic of China [2008BAI52B03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China	This study is performed as a collaborative study supported by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. The Grant number is 2008BAI52B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Bae HJ, 2007, CEREBROVASC DIS, V24, P355, DOI 10.1159/000106982; Bambs C, 2011, FUTUR CARDIOL, V7, P447, DOI [10.2217/fca.11.38, 10.2217/FCA.11.38]; Boddu DB, 2011, J NEUROIMAGING, V21, pe34, DOI 10.1111/j.1552-6569.2009.00412.x; de Kleijn MJJ, 2002, AM J EPIDEMIOL, V155, P339, DOI 10.1093/aje/155.4.339; Dong C, 2012, CIRCULATION; Duggirala R, 1996, STROKE, V27, P833, DOI 10.1161/01.STR.27.5.833; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; FLORA GC, 1968, CIRCULATION, V38, P859, DOI 10.1161/01.CIR.38.5.859; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Gomez CR, 2001, ARCH NEUROL-CHICAGO, V58, P1687, DOI 10.1001/archneur.58.10.1687; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; INGALL TJ, 1991, ARCH NEUROL-CHICAGO, V48, P687, DOI 10.1001/archneur.1991.00530190033011; ITOH T, 1993, STROKE, V24, P1192, DOI 10.1161/01.STR.24.8.1192; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Kublickiene K, 2008, PHARMACOL REP, V60, P49; Li H, 2003, J CLIN NEUROSCI, V10, P30, DOI 10.1016/S0967-5868(02)00264-3; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Miller AA, 2007, STROKE, V38, P2142, DOI 10.1161/STROKEAHA.106.477406; Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29; Qureshi AI, 2009, ANN NEUROL, V66, P730, DOI 10.1002/ana.21768; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Segura T, 2001, NEUROLOGY, V56, P497, DOI 10.1212/WNL.56.4.497; Siddiq F, 2012, NEUROEPIDEMIOLOGY, V38, P148, DOI 10.1159/000335498; Suwanwela Nijasri C., 2006, Journal of the Medical Association of Thailand, V89, P2021; Uehara T, 2005, EUR J NEUROL, V12, P218, DOI 10.1111/j.1468-1331.2004.00959.x; Uehara T, 1998, CEREBROVASC DIS, V8, P267, DOI 10.1159/000015864; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Wu S, 2012, CIRC CARDIOVASC QUAL; Yoo JH, 1998, STROKE, V29, P2478, DOI 10.1161/01.STR.29.12.2478; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang YQ, 2012, NEUROL RES, V34, P359, DOI 10.1179/1743132812Y.0000000024; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	45	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58923	10.1371/journal.pone.0058923	http://dx.doi.org/10.1371/journal.pone.0058923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554958	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500057
J	Moreno, JC; Pizarro, L; Fuentes, P; Handford, M; Cifuentes, V; Stange, C				Moreno, Juan Camilo; Pizarro, Lorena; Fuentes, Paulina; Handford, Michael; Cifuentes, Victor; Stange, Claudia			Levels of Lycopene beta-Cyclase 1 Modulate Carotenoid Gene Expression and Accumulation in Daucus carota	PLOS ONE			English	Article							PHYTOENE SYNTHASE; EPSILON-CYCLASE; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHETIC-PATHWAY; ARABIDOPSIS-THALIANA; STRUCTURAL GENES; TOMATO REVEALS; CLONING; DESATURASE; ENZYME	Plant carotenoids are synthesized and accumulated in plastids through a highly regulated pathway. Lycopene beta-cyclase (LCYB) is a key enzyme involved directly in the synthesis of alpha-carotene and beta-carotene through the cyclization of lycopene. Carotenoids are produced in both carrot (Daucus carota) leaves and reserve roots, and high amounts of alpha-carotene and beta-carotene accumulate in the latter. In some plant models, the presence of different isoforms of carotenogenic genes is associated with an organ-specific function. D. carota harbors two Lcyb genes, of which DcLcyb1 is expressed in leaves and storage roots during carrot development, correlating with an increase in carotenoid levels. In this work, we show that DcLCYB1 is localized in the plastid and that it is a functional enzyme, as demonstrated by heterologous complementation in Escherichia coli and over expression and post transcriptional gene silencing in carrot. Transgenic plants with higher or reduced levels of DcLcyb1 had incremented or reduced levels of chlorophyll, total carotenoids and beta-carotene in leaves and in the storage roots, respectively. In addition, changes in the expression of DcLcyb1 are accompanied by a modulation in the expression of key endogenous carotenogenic genes. Our results indicate that DcLcyb1 does not possess an organ specific function and modulate carotenoid gene expression and accumulation in carrot leaves and storage roots.	[Moreno, Juan Camilo; Pizarro, Lorena; Fuentes, Paulina; Handford, Michael; Stange, Claudia] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Moreno, Juan Camilo; Fuentes, Paulina] Max Planck Inst Mol Pflanzenphysiol, Potsdam, Germany; [Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Chile	Universidad de Chile; Max Planck Society; Universidad de Chile	Stange, C (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	cstange@uchile.cl	Handford, Michael/C-6127-2012; Stange, Claudia/H-7411-2013	Stange, Claudia/0000-0002-2265-0472; Pizarro, Lorena/0000-0001-5954-5839; Handford, Michael/0000-0003-0969-3192; Moreno Beltran, Juan Camilo/0000-0001-9722-5262	Chilean grant [FONDEF D10I1022]	Chilean grant	This work was funded by the Chilean grant FONDEF D10I1022. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Alquezar B, 2009, J EXP BOT, V60, P1783, DOI 10.1093/jxb/erp048; Ampomah-Dwamena C, 2009, J EXP BOT, V60, P3765, DOI 10.1093/jxb/erp218; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Bang H, 2007, MOL BREEDING, V20, P63, DOI 10.1007/s11032-006-9076-4; Baranska M, 2006, PLANTA, V224, P1028, DOI 10.1007/s00425-006-0289-x; BEYER P, 1991, J BIOL CHEM, V266, P17072; Blas AL, 2010, PLANT PHYSIOL, V152, P2013, DOI 10.1104/pp.109.152298; Bollag W, 1996, FASEB J, V10, P938, DOI 10.1096/fasebj.10.9.8801175; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Bouvier F, 1996, J BIOL CHEM, V271, P28861, DOI 10.1074/jbc.271.46.28861; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Briton G, 2008, CAROTENOIDS HDB; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Britton G., 2008, CAROTENOIDS HDB; Chaudhary N, 2010, MOL GENET GENOMICS, V283, P13, DOI 10.1007/s00438-009-0495-x; Chen WP, 2002, PLANT CELL REP, V20, P929, DOI 10.1007/s00299-001-0419-7; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Conti A, 2004, PLANT CELL PHYSIOL, V45, P445, DOI 10.1093/pcp/pch052; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Cunningham FX, 2002, PURE APPL CHEM, V74, P1409, DOI 10.1351/pac200274081409; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Dong HL, 2007, CELL RES, V17, P458, DOI 10.1038/cr.2007.37; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fuentes P, 2012, PLANT MOL BIOL, V79, P47, DOI 10.1007/s11103-012-9893-2; Giorio G, 2007, TRANSGENIC RES, V16, P15, DOI 10.1007/s11248-006-9025-3; Hable WE, 1998, MOL GEN GENET, V257, P167; Handford M, 2012, MOL PLANT, V5, P1263, DOI 10.1093/mp/sss074; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hornero-Mendez D, 2002, FEBS LETT, V515, P133, DOI 10.1016/S0014-5793(02)02453-5; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; HUGUENEY P, 1995, PLANT J, V8, P417, DOI 10.1046/j.1365-313X.1995.08030417.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Matthews PD, 2003, J EXP BOT, V54, P2215, DOI 10.1093/jxb/erg235; Mendes-Pinto MM, 2009, ARCH BIOCHEM BIOPHYS, V483, P236, DOI 10.1016/j.abb.2009.01.008; Nelson JL, 2003, J NUTR, V133, P3117, DOI 10.1093/jn/133.10.3117; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Pecker I, 1996, PLANT MOL BIOL, V30, P807, DOI 10.1007/BF00019013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogson B, 1996, PLANT PHYSIOL, V111, P109; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Romer S, 2005, PLANTA, V221, P305, DOI 10.1007/s00425-005-1533-5; Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Rosati C, 2000, PLANT J, V24, P413, DOI 10.1046/j.1365-313x.2000.00880.x; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Simkin AJ, 2003, Z NATURFORSCH C, V58, P371; Singh M, 2003, PLANT CELL, V15, P874, DOI 10.1105/tpc.010249; Skelton RL, 2006, CELL RES, V16, P731, DOI 10.1038/sj.cr.7310081; Stange C, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P77; Stange C, 2008, BIOL RES, V41, P289, DOI [10.4067/S0716-97602008000300006, /S0716-97602008000300006]; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Van Norman JM, 2007, PLANT J, V49, P619, DOI 10.1111/j.1365-313X.2006.02982.x; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Woitsch S, 2003, PLANT PHYSIOL, V132, P1508, DOI 10.1104/pp.102.019364; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453	72	60	68	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58144	10.1371/journal.pone.0058144	http://dx.doi.org/10.1371/journal.pone.0058144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555569	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900003
J	Turner, NA; Moake, J				Turner, Nancy A.; Moake, Joel			Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR MULTIMERS; FACTOR-H; ATYPICAL HUS; FACTOR-B; PATHWAY; PROTEINS; BINDING; MUTATIONS; ADAMTS-13	Background: Vascular endothelial cells (ECs) express and release protein components of the complement pathways, as well as secreting and anchoring ultra-large von Willebrand factor (ULVWF) multimers in long string-like structures that initiate platelet adhesion during hemostasis and thrombosis. The alternative complement pathway (AP) is an important non-antibody-requiring host defense system. Thrombotic microangiopathies can be associated with defective regulation of the AP (atypical hemolytic-uremic syndrome) or with inadequate cleavage by ADAMTS-13 of ULVWF multimeric strings secreted by/anchored to ECs (thrombotic thrombocytopenic purpura). Our goal was to determine if EC-anchored ULVWF strings caused the assembly and activation of AP components, thereby linking two essential defense mechanisms. Methodology/Principal Findings: We quantified gene expression of these complement components in cultured human umbilical vein endothelial cells (HUVECs) by real-time PCR: C3 and C5; complement factor (CF) B, CFD, CFP, CFH and CFI of the AP; and C4 of the classical and lectin (but not alternative) complement pathways. We used fluorescent microscopy, monospecific antibodies against complement components, fluorescent secondary antibodies, and the analysis of > 150 images to quantify the attachment of HUVEC-released complement proteins to ULVWF strings secreted by, and anchored to, the HUVECs (under conditions of ADAMTS-13 inhibition). We found that HUVEC-released C4 did not attach to ULVWF strings, ruling out activation of the classical and lectin pathways by the strings. In contrast, C3, FB, FD, FP and C5, FH and FI attached to ULVWF strings in quantitative patterns consistent with assembly of the AP components into active complexes. This was verified when non-functional FB blocked the formation of AP C3 convertase complexes (C3bBb) on ULVWF strings. Conclusions/Significance: AP components are assembled and activated on EC-secreted/anchored ULVWF multimeric strings. Our findings provide one possible molecular mechanism for clinical linkage between different types of thrombotic and complement-mediated disorders.	[Turner, Nancy A.; Moake, Joel] Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Turner, NA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	nturner@rice.edu			Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund	Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund	This work was supported by grants from the Mary R. Gibson Foundation and the Mabel and Everett Hinkson Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategui-Garrido C, 2008, AM J KIDNEY DIS, V52, P171, DOI 10.1053/j.ajkd.2008.01.026; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bongrazio M, 2003, MOL IMMUNOL, V39, P669, DOI 10.1016/S0161-5890(02)00215-8; BROOIMANS RA, 1990, J IMMUNOL, V144, P3835; Chapin J, 2012, BRIT J HAEMATOL, V157, P772, DOI 10.1111/j.1365-2141.2012.09084.x; CHAPITIS J, 1978, J IMMUNOL, V120, P1768; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; FEARON DT, 1973, J EXP MED, V138, P1305, DOI 10.1084/jem.138.6.1305; Feng SJ, 2013, BRIT J HAEMATOL, V160, P404, DOI 10.1111/bjh.12112; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Gandhi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021621; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; KINOSHITA T, 1988, J IMMUNOL, V141, P3895; Klegeris A, 2000, BRAIN RES, V871, P1, DOI 10.1016/S0006-8993(00)02253-8; Langeggen H, 2001, APMIS, V109, P73, DOI 10.1111/j.1600-0463.2001.tb00016.x; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; Law SKA, 1997, PROTEIN SCI, V6, P263; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Maga TK, 2010, HUM MUTAT, V31, pE1445, DOI 10.1002/humu.21256; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Morgan BP, 1999, COMPLEMENT REGULATOR, p[59, 121]; NAGASAWA S, 1977, P NATL ACAD SCI USA, V74, P2998, DOI 10.1073/pnas.74.7.2998; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195; Pangburn MK, 2008, VACCINE, V26, pI15, DOI 10.1016/j.vaccine.2008.11.023; PANGBURN MK, 1986, J IMMUNOL, V136, P2216; Patschan Daniel, 2011, J Med Case Rep, V5, P598, DOI 10.1186/1752-1947-5-598; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; Rawal N, 2001, J IMMUNOL, V166, P2635, DOI 10.4049/jimmunol.166.4.2635; Reti M, 2012, J THROMB HAEMOST, V10, P791, DOI 10.1111/j.1538-7836.2012.04674.x; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; SCHREIBER RD, 1978, P NATL ACAD SCI USA, V75, P3948, DOI 10.1073/pnas.75.8.3948; Turner N, 2006, J THROMB HAEMOST, V4, P1396, DOI 10.1111/j.1538-7836.2006.01959.x; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Turner N, 2012, SEMIN THROMB HEMOST, V38, P38, DOI 10.1055/s-0031-1300950; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; ZICCARDI RJ, 1981, J IMMUNOL, V126, P1769	45	79	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59372	10.1371/journal.pone.0059372	http://dx.doi.org/10.1371/journal.pone.0059372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555663	Green Published, gold			2022-12-27	WOS:000317263900012
J	Furuta, M; Kozaki, K; Tanimoto, K; Tanaka, S; Arii, S; Shimamura, T; Niida, A; Miyano, S; Inazawa, J				Furuta, Mayuko; Kozaki, Ken-ichi; Tanimoto, Kousuke; Tanaka, Shinji; Arii, Shigeki; Shimamura, Teppei; Niida, Atsushi; Miyano, Satoru; Inazawa, Johji			The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma	PLOS ONE			English	Article							ONCOGENE ADDICTION; MICRORNA GENES; CANCER; TRANSITION; EXPRESSION; SIGNATURES	MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression and commonly deregulated carcinogenesis. To explore functionally crucial tumor-suppressive (TS)-miRNAs in hepatocellular carcinoma (HCC), we performed integrative function- and expression-based screenings of TS-miRNAs in six HCC cell lines. The screenings identified seven miRNAs, which showed growth-suppressive activities through the overexpression of each miRNA and were endogenously downregulated in HCC cell lines. Further expression analyses using a large panel of HCC cell lines and primary tumors demonstrated four miRNAs, miR-101, -195, -378 and -497, as candidate TS-miRNAs frequently silenced in HCCs. Among them, two clustered miRNAs miR-195 and miR-497 showed significant growth-suppressive activity with induction of G1 arrest. Comprehensive exploration of their targets using Argonute2-immunoprecipitation-deep-sequencing (Ago2-IP-seq) and genome-wide expression profiling after their overexpression followed by pathway analysis, revealed a significant enrichment of cell cycle regulators. Among the candidates, we successfully identified CCNE1, CDC25A, CCND3, CDK4, and BTRC as direct targets for miR-497 and rniR-195. Moreover, target genes frequently upregulated in HCC in a tumor-specific manner, such as CDK6, CCNE1, CDC25A and CDK4, showed an inverse correlation in the expression of miR-195 and miR-497, and their targets. These results suggest the molecular pathway regulating cell cycle progression to be integrally altered by downregulation of miR-195 and miR-497 expression, leading to the aberrant cell proliferation in hepatocarcinogenesis.	[Furuta, Mayuko; Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Tokyo, Japan; [Furuta, Mayuko; Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Sch Biomed Sci, Tokyo, Japan; [Furuta, Mayuko; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Global Ctr Excellence GCOE Program Int Res Ctr Mo, Tokyo, Japan; [Kozaki, Ken-ichi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Therapeut Genom, Tokyo, Japan; [Kozaki, Ken-ichi; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Grad Sch Med, Genome Lab, Tokyo, Japan; [Tanaka, Shinji; Arii, Shigeki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Furuta, Mayuko] Univ Tokyo, Japan Soc Promot Sci, Inst Med Sci, Tokyo, Japan; [Shimamura, Teppei; Niida, Atsushi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science; University of Tokyo; University of Tokyo	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Tokyo, Japan.	johinaz.cgen@mri.tmd.ac.jp	Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X; Miyano, Satoru/0000-0002-1753-6616; Shimamura, Teppei/0000-0003-2994-872X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	Grant-in-Aid for Scientific Research (A), (B), (C), and JSPS Fellows, and Scientific Research on Priority Areas and Innovative Areas, and a Global Center of Excellence (GCOE) Program for International Research Center for Molecular Science in Tooth and Bone Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Health and Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare, Japan; a grant from the New Energy and Industrial Technology Development Organization (NEDO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Matsumura S, 2012, CLIN CANCER RES, V18, P3541, DOI 10.1158/1078-0432.CCR-11-1007; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	33	125	131	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60155	10.1371/journal.pone.0060155	http://dx.doi.org/10.1371/journal.pone.0060155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544130	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700089
J	Jakobsen, H; Bojer, MS; Marinus, MG; Xu, T; Struve, C; Krogfelt, KA; Lobner-Olesen, A				Jakobsen, Henrik; Bojer, Martin S.; Marinus, Martin G.; Xu, Tao; Struve, Carsten; Krogfelt, Karen A.; Lobner-Olesen, Anders			The Alkaloid Compound Harmane Increases the Lifespan of Caenorhabditis elegans during Bacterial Infection, by Modulating the Nematode's Innate Immune Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; WORM; MAP	The nematode Caenorhabditis elegans has in recent years been proven to be a powerful in vivo model for testing antimicrobial compounds. We report here that the alkaloid compound Harmane (2-methyl-beta-carboline) increases the lifespan of nematodes infected with a human pathogen, the Shiga toxin-producing Escherichia coli O157:H7 strain EDL933 and several other bacterial pathogens. This was shown to be unrelated to the weak antibiotic effect of Harmane. Using GFP-expressing E coli EDL933, we showed that Harmane does not lower the colonization burden in the nematodes. We also found that the expression of the putative immune effector gene F35E12.5 was up-regulated in response to Harmane treatment. This indicates that Harmane stimulates the innate immune response of the nematode; thereby increasing its lifespan during bacterial infection. Expression of F35E12.5 is predominantly regulated through the p38 MAPK pathway; however, intriguingly the lifespan extension resulting from Harmane was higher in p38 MAPK-deficient nematodes. This indicates that Harmane has a complex effect on the innate immune system of C. elegans. Harmane could therefore be a useful tool in the further research into C. elegans immunity. Since the innate immunity of C. elegans has a high degree of evolutionary conservation, drugs such as Harmane could also be possible alternatives to classic antibiotics. The C. elegans model could prove to be useful for selection and development of such drugs.	[Jakobsen, Henrik; Bojer, Martin S.] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Jakobsen, Henrik; Bojer, Martin S.; Struve, Carsten; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Marinus, Martin G.; Xu, Tao] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Lobner-Olesen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Roskilde University; Statens Serum Institut; University of Massachusetts System; University of Massachusetts Worcester; University of Copenhagen	Lobner-Olesen, A (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	lobner@bio.ku.dk	Løbner-Olesen, Anders/K-4344-2014; Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018	Løbner-Olesen, Anders/0000-0002-0344-6417; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Bojer, Martin Saxtorph/0000-0002-8488-9593	Basic and Clinical Microbiology (BCM) program (Roskilde University); Danish Council for Strategic Research; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Basic and Clinical Microbiology (BCM) program (Roskilde University); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HJ and MSB were both partially supported by the Basic and Clinical Microbiology (BCM) program (Roskilde University). KAK and ALO are members of the Danish Centre for Antibiotic Research and Development (DanCARD) supported by the Danish Council for Strategic Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kim F. Rewitz and Julie L. Hentze from University of Copenhagen for use of equipment and for assistance with the qRT-PCR experiments. We also thank Hong Cao and the University of Massachusetts Medical School Small Molecule Screening Core Facility for their help in the two-hybrid screen. The C. elegans strains used in this study Were obtained from the Caenorhabditis Genetics Center (CGC), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Bojer MS, 2012, MICROBES INFECT, V14, P1034, DOI 10.1016/j.micinf.2012.06.002; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Marsh EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016839; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733; Reza V. R. M., 2007, Journal of Pharmacology and Toxicology, V2, P677; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Stiernagle Theresa, 2006, WormBook, P1; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183	25	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60519	10.1371/journal.pone.0060519	http://dx.doi.org/10.1371/journal.pone.0060519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544153	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700112
J	Tian, JC; Wang, XP; Long, LP; Romeis, J; Naranjo, SE; Hellmich, RL; Wang, P; Earle, ED; Shelton, AM				Tian, Jun-Ce; Wang, Xiang-Ping; Long, Li-Ping; Romeis, Joerg; Naranjo, Steven E.; Hellmich, Richard L.; Wang, Ping; Earle, Elizabeth D.; Shelton, Anthony M.			Bt Crops Producing Cry1Ac, Cry2Ab and Cry1F Do Not Harm the Green Lacewing, Chrysoperla rufilabris	PLOS ONE			English	Article							TRANSGENIC INSECTICIDAL CROPS; BACILLUS-THURINGIENSIS; NATURAL ENEMIES; METAANALYSIS RESPONSE; BIOLOGICAL-CONTROL; DIAMONDBACK MOTH; TRICHOPLUSIA-NI; CABBAGE-LOOPER; RESISTANCE; PLANTS	The biological control function provided by natural enemies is regarded as a protection goal that should not be harmed by. he application of any new pest management tool. Plants producing Cry proteins from the bacterium, Bacillus thuringiensis (Bt), have become a major tactic for controlling pest Lepidoptera on cotton and maize and risk assessment studies are needed to ensure they do not harm important natural enemies. However, using Cry protein susceptible hosts as prey often compromises such studies. To avoid this problem we utilized pest Lepidoptera, cabbage looper (Trichoplusia ni) and fall armyworm (Spodoptera frugiperda), that were resistant to Cry1Ac produced in Bt broccoli (T. ni), Cry1Ac/Cry2Ab produced in Bt cotton (T ni), and Cry1F produced in Bt maize (S. frugiperda). Larvae of these species were fed Bt plants or non-Bt plants and then exposed to predaceous larvae of the green lacewing Chrysoperla rufilabris. Fitness parameters (larval survival, development time, fecundity and egg hatch) of C. rufilabris were assessed over two generations. There were no differences in any of the fitness parameters regardless if C. rufilabris consumed prey (71 ni or S. frugiperda) that had consumed Bt or non-plants. Additional studies confirmed that the prey contained bioactive Cry proteins when they were consumed by the predator. These studies confirm that Cry1Ac, Cry2Ab and Cry1F do not pose a hazard to the important predator C. rufilabris. This study also demonstrates the power of using resistant hosts when assessing the risk of genetically modified plants on non-target organisms.	[Tian, Jun-Ce; Wang, Xiang-Ping; Long, Li-Ping; Wang, Ping; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Tian, Jun-Ce] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiang-Ping] Yangtze Univ, Coll Agr, Jinzhou, Hubei, Peoples R China; [Long, Li-Ping] Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Guangxi, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Naranjo, Steven E.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ USA; [Hellmich, Richard L.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Hellmich, Richard L.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Earle, Elizabeth D.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	Cornell University; Zhejiang Academy of Agricultural Sciences; Yangtze University; Guangxi Academy of Agricultural Sciences; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; United States Department of Agriculture (USDA); Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Cornell University	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu	JunCe, Tian/F-6931-2013; Tian, Jun-Ce/M-6947-2019; Romeis, Joerg/J-5360-2013	JunCe, Tian/0000-0001-7870-7127; Tian, Jun-Ce/0000-0001-7870-7127; Romeis, Joerg/0000-0003-3652-8360	USDA National Institute of Food and Agriculture [2010-33522-21772]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant No. 2010-33522-21772 from the USDA National Institute of Food and Agriculture. (http://www.csrees.usda.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Ferry N, 2006, TRANSGENIC RES, V15, P501, DOI 10.1007/s11248-006-0021-4; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Iracheta MM, 2000, J INVERTEBR PATHOL, V76, P70, DOI 10.1006/jipa.2000.4946; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; McEwen PK, 2001, LACEWINGS CROP ENV; METZ TD, 1995, MOL BREEDING, V1, P309, DOI 10.1007/BF01248408; Naranjo SE, 2009, CAB REV PERSPECTIVES, P11; Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J., 2008, INTEGRATION INSECT R; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; SAS Institute, 2001, P US MAN VERS 6; Schuler TH, 2004, J INSECT PHYSIOL, V50, P435, DOI 10.1016/j.jinsphys.2004.03.001; Schwartz PH, 1985, AGR HDB USDA, V589, P329; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shelton AM, 2012, ENVIRON ENTOMOL, V41, P1047, DOI 10.1603/EN11238a; Shelton AM, 2009, ENVIRON ENTOMOL, V38, P1533, DOI 10.1603/022.038.0603; Shelton AM, 2009, TRANSGENIC RES, V18, P317, DOI 10.1007/s11248-009-9260-5; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sutherland D.W.S., 1984, U S Department of Agriculture Technical Bulletin, P1; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; Torres JB, 2006, ENTOMOL EXP APPL, V120, P11, DOI 10.1111/j.1570-7458.2006.00422.x; van Lenteren JC, 2012, BIOCONTROL, V57, P1, DOI 10.1007/s10526-011-9395-1	36	42	43	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60125	10.1371/journal.pone.0060125	http://dx.doi.org/10.1371/journal.pone.0060125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544126	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700085
J	Sahu, G; Bera, AK				Sahu, Giriraj; Bera, Amal Kanti			Contribution of Intracellular Calcium and pH in Ischemic Uncoupling of Cardiac Gap Junction Channels Formed of Connexins 43, 40, and 45: A Critical Function of C-Terminal Domain	PLOS ONE			English	Article							VOLTAGE-DEPENDENCE; GATING PROPERTIES; CALMODULIN; EXPRESSION; CELL; HEMICHANNELS; CONDUCTANCE; INHIBITION; NEURONS; BINDING	Ischemia is known to inhibit gap junction (GJ) mediated intercellular communication. However the detail mechanisms of this inhibition are largely unknown. In the present study, we determined the vulnerability of different cardiac GJ channels formed of connexins (Cxs) 43, 40, and 45 to simulated ischemia, by creating oxygen glucose deprived (OGD) condition. 5 minutes of OGD decreased the junctional conductance (Gj) of Cx43, Cx40 and Cx45 by 53 +/- 3%, 64 +/- 1% and 85 +/- 2% respectively. Reduction of G(j) was prevented completely by restricting the change of both intracellular calcium ([Ca2+](i)) and pH (pH(i)) with potassium phosphate buffer. Clamping of either [Ca2+](i) or pH(i), through BAPTA (2 mM) or HEPES (80 mM) respectively, offered partial resistance to ischemic uncoupling. Anti-calmodulin antibody attenuated the uncoupling of Cx43 and Cx45 significantly but not of Cx40. Furthermore, OGD could reduce only 26 +/- 2% of G(j) in C-terminus (CT) truncated Cx43 (Cx43-Delta 257). Tethering CT of Cx43 to the CT-truncated Cx40 (Cx40-Delta 249), and Cx45 (Cx45-Delta 272) helped to resist OGD mediated uncoupling. Moreover, CT domain played a significant role in determining the junction current density and plaque diameter. Our results suggest; OGD mediated uncoupling of G(j) channels is primarily due to elevated [Ca2+](i) and acidic pH(i), though the latter contributes more. Among Cx43, Cx40 and Cx45, Cx43 is the most resistant to OGD while Cx45 is the most sensitive one. CT of Cx43 has major necessary elements for OGD induced uncoupling and it can complement CT of Cx40 and Cx45.	[Sahu, Giriraj; Bera, Amal Kanti] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Bera, AK (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	amal@iitm.ac.in	Sahu, Giriraj/GXF-2849-2022	Sahu, Giriraj/0000-0001-6566-9563; Bera, Amal Kanti/0000-0003-0362-5578	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Cascio WE, 2005, J ELECTROCARDIOL, V38, P55, DOI 10.1016/j.jelectrocard.2005.06.019; Chandrasekhar A, 2012, CELL BIOCHEM FUNCT, V30, P89, DOI 10.1002/cbf.2794; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; Choi BH, 2007, NEUROSCI LETT, V412, P118, DOI 10.1016/j.neulet.2006.11.015; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dhein S, 2006, ADV CARDIOL, V42, P198, DOI 10.1159/000092570; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Francis R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026379; GarciaDorado D, 1997, CIRCULATION, V96, P3579; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; He DS, 1999, P NATL ACAD SCI USA, V96, P6495, DOI 10.1073/pnas.96.11.6495; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lurtz MM, 2007, AM J PHYSIOL-CELL PH, V293, pC1806, DOI 10.1152/ajpcell.00630.2006; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Maass K, 2009, CARDIOVASC RES, V84, P361, DOI 10.1093/cvr/cvp250; Mao AJ, 2000, J BIOL CHEM, V275, P34407, DOI 10.1074/jbc.M003917200; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; Miura T, 2010, AM J PHYSIOL-HEART C, V298, pH1115, DOI 10.1152/ajpheart.00879.2009; Moreno AP, 2004, CARDIOVASC RES, V62, P276, DOI 10.1016/j.cardiores.2004.03.003; Nicholson BJ, 2003, J CELL SCI, V116, P4479, DOI 10.1242/jcs.00821; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 1996, PFLUG ARCH EUR J PHY, V431, P379, DOI 10.1007/BF02207275; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Revilla A, 1999, BIOPHYS J, V77, P1374, DOI 10.1016/S0006-3495(99)76986-9; RUBIN JB, 1992, P NATL ACAD SCI USA, V89, P3820, DOI 10.1073/pnas.89.9.3820; Schulz R, 2007, HEART FAIL REV, V12, P261, DOI 10.1007/s10741-007-9032-3; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Swain SM, 2012, STEM CELL RES, V9, P59, DOI 10.1016/j.scr.2012.04.005; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; von Maltzahn J, 2009, EUR J CELL BIOL, V88, P481, DOI 10.1016/j.ejcb.2009.04.004; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; WELSH MJ, 1982, SCIENCE, V216, P642, DOI 10.1126/science.6280283; WHITE RL, 1990, J GEN PHYSIOL, V95, P1061, DOI 10.1085/jgp.95.6.1061; Xu Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1548, DOI 10.1152/ajpcell.00319.2011; ZHANG L, 1993, J NEUROPHYSIOL, V69, P118, DOI 10.1152/jn.1993.69.1.118	47	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60506	10.1371/journal.pone.0060506	http://dx.doi.org/10.1371/journal.pone.0060506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536911	Green Submitted, gold, Green Published			2022-12-27	WOS:000317397200059
J	Hu, SH; Xu, DR; Peterson, B; Wang, QD; He, XF; Hu, JB; Xu, XJ; Wei, N; Long, D; Huang, ML; Zhou, WH; Xu, WJ; Zhang, MM; Xu, Y				Hu, Shaohua; Xu, Dongrong; Peterson, Bradley; Wang, Qidong; He, Xiaofu; Hu, Jianbo; Xu, Xiaojun; Wei, Ning; Long, Dan; Huang, Manli; Zhou, Weihua; Xu, Weijuan; Zhang, Minming; Xu, Yi			Association of Cerebral Networks in Resting State with Sexual Preference of Homosexual Men: A Study of Regional Homogeneity and Functional Connectivity	PLOS ONE			English	Article							HETEROSEXUAL MEN; BRAIN RESPONSE; MOTOR CORTEX; DEFAULT MODE; VISUAL AREA; ORIENTATION; ROTATION; WOMEN; LANGUAGE; FMRI	Recent imaging studies have shown that brain morphology and neural activity during sexual arousal differ between homosexual and heterosexual men. However, functional differences in neural networks at the resting state is unknown. The study is to characterize the association of homosexual preference with measures of regional homogeneity and functional connectivity in the resting state. Participants were 26 healthy homosexual men and 26 age-matched healthy heterosexual men in whom we collected echo planar magnetic resonance imaging data in the resting state. The sexual orientation was evaluated using the Kinsey Scale. We first assessed group differences in regional homogeneity and then, taking the identified differences as seed regions, we compared groups in measures of functional connectivity from those seeds. The behavioral significances of the differences in regional homogeneity and functional connectivity were assessed by examining their associations with Kinsey Scores. Homosexual participants showed significantly reduced regional homogeneity in the left inferior occipital gyrus, right middle occipital gyrus, right superior occipital gyrus, left cuneus, right precuneus, and increased regional homogeneity in rectal gyrus, bilateral midbrain, and left temporal lobe. Regional homogeneity correlated positively with Kinsey scores in the left inferior occipital gyrus. The homosexual group also showed reduced functional connectivity between left middle temporal gyrus, left supra-marginal gyrus, right cuneus and the seed region, i.e. left inferior occipital gyrus. Additionly, the connection between the left inferior occipital gyrus and right thalamus correlated positively with Kinsey scores. These differences in regional homogeneity and functional connectivity may contribute to a better understanding of the neural basis of male sexual orientation.	[Hu, Shaohua; Hu, Jianbo; Wei, Ning; Huang, Manli; Zhou, Weihua; Xu, Weijuan; Xu, Yi] Zhejiang Univ, Coll Med, Dept Mental Hlth, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Dongrong; Peterson, Bradley; He, Xiaofu] Columbia Univ, Dept Psychiat, MRI Unit, New York, NY USA; [Xu, Dongrong; Peterson, Bradley; He, Xiaofu] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Wang, Qidong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xiaojun; Long, Dan; Zhang, Minming] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; New York State Psychiatry Institute; Zhejiang University; Zhejiang University	Xu, Y (corresponding author), Zhejiang Univ, Coll Med, Dept Mental Hlth, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	xuyi61@yahoo.com.cn	Hu, Shaohua/I-3336-2019	Hu, Shaohua/0000-0003-0570-670X	Ministry of Science and Technology of the People's Republic of China [2010CB833905]; National Natural Science Foundation of China [81101013]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (2010CB833905), www.nsfc.gov.cn; and the National Natural Science Foundation of China (81101013), www.most.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Demonet J. F., 1993, Human Brain Mapping, V1, P39, DOI 10.1002/hbm.460010105; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Ecuyer-Dab I, 2004, COGNITION, V91, P221, DOI 10.1016/j.cognition.2003.09.007; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gazzaniga, 2002, COGNITIVE NEUROSCIEN; GLADUE BA, 1984, SCIENCE, V225, P1496, DOI 10.1126/science.6089349; Halpern Diane F, 2007, Psychol Sci Public Interest, V8, P1, DOI 10.1111/j.1529-1006.2007.00032.x; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HAMPSON E, 1992, P357; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Hubrich-Ungureanu P, 2002, NEUROSCI LETT, V319, P91, DOI 10.1016/S0304-3940(01)02566-6; Joseph R, 2000, ARCH SEX BEHAV, V29, P35, DOI 10.1023/A:1001834404611; Jozet-Alves C, 2008, P ROY SOC B-BIOL SCI, V275, P2049, DOI 10.1098/rspb.2008.0501; Kansaku K, 2000, CEREB CORTEX, V10, P866, DOI 10.1093/cercor/10.9.866; Kendall M., 1990, CORRELATION METHODS; Kimura D, 1999, SEX COGNITION, P164; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Liu Y, 2011, NATURE, V472, P95, DOI 10.1038/nature09822; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MCCORMICK CM, 1991, PSYCHONEUROENDOCRINO, V16, P459, DOI 10.1016/0306-4530(91)90030-W; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Ponseti J, 2009, J SEX MED, V6, P1628, DOI 10.1111/j.1743-6109.2009.01233.x; Rahman Q, 2003, NEUROPSYCHOLOGY, V17, P25, DOI 10.1037/0894-4105.17.1.25; Rahman Q, 2004, BEHAV NEUROSCI, V118, P243, DOI 10.1037/0735-7044.118.1.243; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Safron A, 2007, BEHAV NEUROSCI, V121, P237, DOI 10.1037/0735-7044.121.2.237; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shen LM, 1999, HUM BRAIN MAPP, V8, P60, DOI 10.1002/(SICI)1097-0193(1999)8:1<60::AID-HBM5>3.0.CO;2-6; SWAAB DF, 1992, HORM RES, V38, P51, DOI 10.1159/000182597; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wegesin DJ, 1998, ARCH SEX BEHAV, V27, P91, DOI 10.1023/A:1018661925976; Wegesin DJ, 1998, BRAIN COGNITION, V36, P73, DOI 10.1006/brcg.1997.0964; Windischberger C, 2003, NEUROIMAGE, V20, P225, DOI 10.1016/S1053-8119(03)00235-0; Witelson SF, 2008, ARCH SEX BEHAV, V37, P857, DOI 10.1007/s10508-007-9276-y; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zeki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015802	52	19	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59426	10.1371/journal.pone.0059426	http://dx.doi.org/10.1371/journal.pone.0059426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555670	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400039
J	De la Fuente, IM; Cortes, JM; Pelta, DA; Veguillas, J				De la Fuente, Ildefonso M.; Cortes, Jesus M.; Pelta, David A.; Veguillas, Juan			Attractor Metabolic Networks	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; BIOCHEMICAL OSCILLATIONS; NEURAL-NETWORKS; KINETIC-MODEL; SLIME-MOLD; ORGANIZATION; DYNAMICS; BEHAVIOR; FAMILIARITY; ORGANELLES	Background: The experimental observations and numerical studies with dissipative metabolic networks have shown that cellular enzymatic activity self-organizes spontaneously leading to the emergence of a Systemic Metabolic Structure in the cell, characterized by a set of different enzymatic reactions always locked into active states (metabolic core) while the rest of the catalytic processes are only intermittently active. This global metabolic structure was verified for Escherichia coli, Helicobacter pylori and Saccharomyces cerevisiae, and it seems to be a common key feature to all cellular organisms. In concordance with these observations, the cell can be considered a complex metabolic network which mainly integrates a large ensemble of self-organized multienzymatic complexes interconnected by substrate fluxes and regulatory signals, where multiple autonomous oscillatory and quasi-stationary catalytic patterns simultaneously emerge. The network adjusts the internal metabolic activities to the external change by means of flux plasticity and structural plasticity. Methodology/Principal Findings: In order to research the systemic mechanisms involved in the regulation of the cellular enzymatic activity we have studied different catalytic activities of a dissipative metabolic network under different external stimuli. The emergent biochemical data have been analysed using statistical mechanic tools, studying some macroscopic properties such as the global information and the energy of the system. We have also obtained an equivalent Hopfield network using a Boltzmann machine. Our main result shows that the dissipative metabolic network can behave as an attractor metabolic network. Conclusions/Significance: We have found that the systemic enzymatic activities are governed by attractors with capacity to store functional metabolic patterns which can be correctly recovered from specific input stimuli. The network attractors regulate the catalytic patterns, modify the efficiency in the connection between the multienzymatic complexes, and stably retain these modifications. Here for the first time, we have introduced the general concept of attractor metabolic network, in which this dynamic behavior is observed.	[De la Fuente, Ildefonso M.; Cortes, Jesus M.; Veguillas, Juan] BioCruces Hlth Res Inst, Quantitat Biomed Unit, Baracaldo, Basque Country, Spain; [De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.] Univ Basque Country, EHU UPV, Dept Math, Leioa, Basque Country, Spain; [Cortes, Jesus M.] Ikerbasque Basque Fdn Sci, Bilbao, Basque Country, Spain; [Pelta, David A.] Univ Granada, Dept Comp Sci & Artificial Intelligence, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Basque Country; Basque Foundation for Science; University of Granada	De la Fuente, IM (corresponding author), BioCruces Hlth Res Inst, Quantitat Biomed Unit, Baracaldo, Basque Country, Spain.	mtpmadei@ehu.es	Pelta, David/B-6978-2008; Cortes, Jesus/D-9949-2012; Pelta, David A./ABG-9763-2020	Cortes, Jesus/0000-0002-9059-8194; Pelta Mochcovsky, David Alejandro/0000-0002-7653-1452; De la Fuente, Ildefonso/0000-0001-6548-7583	Junta de Andalucia Proyecto de Excelencia [P09FQM-4682]; UPV/EHU [US11/13]; Spanish Ministry of Economy and Competitiveness [TIN2011-27696-C02-01]; Ikerbasque, The Basque Foundation for Science	Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); UPV/EHU; Spanish Ministry of Economy and Competitiveness(Spanish Government); Ikerbasque, The Basque Foundation for Science	Funding provided by Junta de Andalucia Proyecto de Excelencia P09FQM-4682 and the University-Society grant US11/13 of the UPV/EHU. DAP acknowledges support from project TIN2011-27696-C02-01, Spanish Ministry of Economy and Competitiveness. JMC is supported by Ikerbasque, The Basque Foundation for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Albrecht E, 1998, P NATL ACAD SCI USA, V95, P5039, DOI 10.1073/pnas.95.9.5039; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Amit Daniel J., 1992, MODELING BRAIN FUNCT; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; Ashlock D, 2006, EVOLUTIONARY COMPUTA; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Bonner JT, 2010, P NATL ACAD SCI USA, V107, P5267, DOI 10.1073/pnas.1000861107; Boyd S., 2004, CONVEX OPTIMIZATION; Bremer H, 1996, ESCHERICHIA COLI SAL; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; Cormen T., 2009, INTRO ALGORITHMS; Cortes JM, 2010, NEURAL COMPUT, V22, P448, DOI 10.1162/neco.2009.12-08-921; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030162; De la Fuente IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027224; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; De la Fuente IM, 1998, FRACTALS, V6, P95, DOI 10.1142/S0218348X98000110; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; De La Fuente IM, 1998, B MATH BIOL, V60, P689; De la Fuentea IM, 1999, J BIOL SYST, V7, P113, DOI 10.1142/S0218339099000103; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE IM, 1995, BIOSYSTEMS, V35, P1, DOI 10.1016/0303-2647(94)01473-K; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Glick BS, 2007, NAT CELL BIOL, V9, P130, DOI 10.1038/ncb0207-130; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Gough J, 2009, EUROPEAN SPACE AGENC, V3, P43; Greve A, 2010, HIPPOCAMPUS, V20, P235, DOI 10.1002/hipo.20606; Greve A, 2009, BIOL CYBERN, V100, P11, DOI 10.1007/s00422-008-0275-4; Hertz JA, 2018, INTRO THEORY NEURAL; Hinton G.E., 2007, SCHOLARPEDIA, V2, P1668, DOI 10.4249/scholarpedia.1668; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jennings HS, 1905, BEHAV LOWER ORGANISM; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kappen HJ, 1998, NEURAL COMPUT, V10, P1137, DOI 10.1162/089976698300017386; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Kass L, 1996, J PHOTOCH PHOTOBIO B, V35, P105, DOI 10.1016/1011-1344(96)07301-0; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; Kessler D, 1982, CELL BIOL PHYS DIDYM; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353, DOI 10.1109/TC.1972.5008975; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Latty T, 2011, P ROY SOC B-BIOL SCI, V278, P539, DOI 10.1098/rspb.2010.1624; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Marro J., 1999, NONEQUILIBRIUM PHASE, DOI 10.1017/CBO9780511524288; de la Fuente IM, 2010, INT J MOL SCI, V11, P3540, DOI 10.3390/ijms11093540; Marwan W, 2010, SCIENCE, V327, P419, DOI 10.1126/science.1185570; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Miyaji T., 2008, INT J PURE APPL MATH, V47, P353; Mogilevskaya E, 2006, J BIOL PHYS, V32, P245, DOI 10.1007/s10867-006-9015-y; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2004, BIOPHYS CHEM, V107, P1, DOI 10.1016/S0301-4622(03)00189-3; Nakagaki T, 2001, RES MICROBIOL, V152, P767, DOI 10.1016/S0923-2508(01)01259-1; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; Nakagaki T, 2008, SOFT MATTER, V4, P57, DOI 10.1039/b706317m; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pang CNI, 2008, PROTEOMICS, V8, P425, DOI 10.1002/pmic.200700801; Peretto P., 1992, INTRO MODELING NEURA; Pershin YV, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021926; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Russell PJ, 2002, IGENETICS, P16; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Shirakawa T, 2007, BIOPHYS CHEM, V128, P253, DOI 10.1016/j.bpc.2007.04.010; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Stein LD, 2004, NATURE, V431, P915, DOI 10.1038/431915a; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Thomas MC, 2006, ELEMENTS INFORM THEO; Tsuda S, 2007, BIOSYSTEMS, V87, P215, DOI 10.1016/j.biosystems.2006.09.016; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; UEDA T, 1986, EXP CELL RES, V162, P486, DOI 10.1016/0014-4827(86)90352-6; Van Bogelen RA, 1996, ESCHERICHIA COLI SAL; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	104	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58284	10.1371/journal.pone.0058284	http://dx.doi.org/10.1371/journal.pone.0058284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554883	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800011
J	Lee, KM; Ahn, KH				Lee, Kyoung-Min; Ahn, Kyung-Ha			The Frontal Eye Fields Limit the Capacity of Visual Short-Term Memory in Rhesus Monkeys	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; INTRAPARIETAL SULCUS; NEURAL ACTIVITY; INACTIVATION; ATTENTION; RESOURCES; STORAGE; TARGET; SHIFTS	The frontal eye fields (FEF) in rhesus monkeys have been implicated in visual short-term memory (VSTM) as well as control of visual attention. Here we examined the importance of the area in the VSTM capacity and the relationship between VSTM and attention, using the chemical inactivation technique and multi-target saccade tasks with or without the need of target-location memory. During FEF inactivation, serial saccades to targets defined by color contrast were unaffected, but saccades relying on short-term memory were impaired when the target count was at the capacity limit of VSTM. The memory impairment was specific to the FEF-coded retinotopic locations, and subject to competition among targets distributed across visual fields. These results together suggest that the FEF plays a crucial role during the entry of information into VSTM, by enabling attention deployment on targets to be remembered. In this view, the memory capacity results from the limited availability of attentional resources provided by FEF: The FEF can concurrently maintain only a limited number of activations to register the targets into memory. When lesions render part of the area unavailable for activation, the number would decrease, further reducing the capacity of VSTM.	[Lee, Kyoung-Min; Ahn, Kyung-Ha] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital	Lee, KM (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	kminlee@snu.ac.kr			National Research Foundation of Republic of Korea [800-20100003, 800-20110005]	National Research Foundation of Republic of Korea(National Research Foundation of Korea)	Supported by a grant from the National Research Foundation of Republic of Korea (Grants No. 800-20100003 and 800-20110005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Alvarez GA, 2012, J VISION, V12, DOI 10.1167/12.5.9; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, 2009, SCIENCE, V323, DOI 10.1126/science.1166478; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Elmore LC, 2011, CURR BIOL, V21, P975, DOI 10.1016/j.cub.2011.04.031; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Harrison A, 2010, CEREB CORTEX, V20, P2478, DOI 10.1093/cercor/bhp314; Heyselaar E, 2011, J VISION, V11, DOI 10.1167/11.3.11; Inoue M, 2004, CEREB CORTEX, V14, P106, DOI 10.1093/cercor/bhg109; Keller EL, 2008, J NEUROPHYSIOL, V100, P2726, DOI 10.1152/jn.90673.2008; Lara AH, 2012, J VISION, V12, DOI 10.1167/12.3.13; Lee KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039886; Lu ZL, 2005, P NATL ACAD SCI USA, V102, P1797, DOI 10.1073/pnas.0408402102; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Offen S, 2010, J VISION, V10, DOI 10.1167/10.11.28; Pisella L, 2004, NEUROSCI BIOBEHAV R, V28, P181, DOI 10.1016/j.neubiorev.2004.03.003; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Umemoto A, 2010, COGNITION, V117, P69, DOI 10.1016/j.cognition.2010.07.001; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wardak C, 2010, CEREB CORTEX, V20, P2464, DOI 10.1093/cercor/bhp315; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Wright AA, 2007, J EXP ANAL BEHAV, V88, P405, DOI 10.1901/jeab.2007.88-405; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	45	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59606	10.1371/journal.pone.0059606	http://dx.doi.org/10.1371/journal.pone.0059606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555049	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800105
J	Li, YX; Wang, XY; Zheng, HY; Wang, CY; Minvielle, S; Magrangeas, F; Avet-Loiseau, H; Shah, PK; Zhang, Y; Munshi, NC; Li, C				Li, Yingxiang; Wang, Xujun; Zheng, Haiyang; Wang, Chengyang; Minvielle, Stephane; Magrangeas, Florence; Avet-Loiseau, Herve; Shah, Parantu K.; Zhang, Yong; Munshi, Nikhil C.; Li, Cheng			Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles	PLOS ONE			English	Article							PROBE LEVEL; ABNORMALITIES; PATHOGENESIS; PREDICTION; ANEUPLOIDY; PROGNOSIS	Multiple myeloma (MM) is a cancer of antibody-making plasma cells. It frequently harbors alterations in DNA and chromosome copy numbers, and can be divided into two major subtypes, hyperdiploid (HMM) and non-hyperdiploid multiple myeloma (NHMM). The two subtypes have different survival prognosis, possibly due to different but converging paths to oncogenesis. Existing methods for identifying the two subtypes are fluorescence in situ hybridization (FISH) and copy number microarrays, with increased cost and sample requirements. We hypothesize that chromosome alterations have their imprint in gene expression through dosage effect. Using five MM expression datasets that have HMM status measured by FISH and copy number microarrays, we have developed and validated a K-nearest-neighbor method to classify MM into HMM and NHMM based on gene expression profiles. Classification accuracy for test datasets ranges from 0.83 to 0.88. This classification will enable researchers to study differences and commonalities of the two MM subtypes in disease biology and prognosis using expression datasets without need for additional subtype measurements. Our study also supports the advantages of using cancer specific characteristics in feature design and pooling multiple rounds of classification results to improve accuracy. We provide R source code and processed datasets at www.ChengLiLab.org/software.	[Li, Yingxiang; Wang, Xujun; Zheng, Haiyang; Wang, Chengyang; Zhang, Yong; Li, Cheng] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Minvielle, Stephane; Magrangeas, Florence; Avet-Loiseau, Herve] Univ Nantes, Unite Mixte Genom Canc, Ctr Hosp Univ Nantes, Inserm UMR892,CNRS 6299, Nantes, France; [Shah, Parantu K.; Li, Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Shah, Parantu K.; Li, Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Munshi, Nikhil C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Munshi, Nikhil C.] Harvard Univ, Sch Med, Boston, MA USA; [Munshi, Nikhil C.] Boston VA Healthcare Syst, Boston, MA USA	Tongji University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Li, C (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China.	lch3000@gmail.com	Munshi, Nikhil/ABE-2338-2021; Zhang, Yong/B-4838-2011; Magrangeas, Florence/L-3080-2015; Minvielle, Stéphane/K-8251-2015; Avet-Loiseau, Herve/P-8872-2014	Zhang, Yong/0000-0001-6316-2734; Avet-Loiseau, Herve/0000-0002-3050-0140; Minvielle, Stephane/0000-0003-1389-312X; wang, xujun/0000-0002-7152-611X; Magrangeas, Florencce/0000-0002-5031-3748	National Basic Research Program of China (973 Program) [2010CB944904]; National Institutes of Health (NIH) [R01 GM077122]; NIH [RO1-124929, PO1-155258, P50-100007, PO1-78378]; Dept. of Veterans Affairs Merit Review Awards; Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development Award; French National Research Agency [R08079NS]; NATIONAL CANCER INSTITUTE [P50CA100707, P01CA155258, P01CA078378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs Merit Review Awards(US Department of Veterans Affairs); Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development Award; French National Research Agency(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China (973 Program; No. 2010CB944904) (YL, XW, HZ, CW, YZ) and National Institutes of Health (NIH) R01 GM077122 (CL). This work was also supported in part by NIH grants RO1-124929, PO1-155258, P50-100007 and PO1-78378 to NCM and CL and from the Dept. of Veterans Affairs Merit Review Awards to NCM. PKS was supported by Claudia Adams Barr Program in Innovative Basic Cancer Research and the Multiple Myeloma Career Development Award. SM and FM were supported by French National Research Agency, Grant R08079NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2007, BRIT J HAEMATOL, V136, P565, DOI 10.1111/j.1365-2141.2006.06467.x; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Avet-Loiseau H, 2009, J CLIN ONCOL, V27, P4585, DOI 10.1200/JCO.2008.20.6136; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Chng WJ, 2006, GENE CHROMOSOME CANC, V45, P1111, DOI 10.1002/gcc.20375; Debes-Marun CS, 2003, LEUKEMIA, V17, P427, DOI 10.1038/sj.leu.2402797; Fassas ABT, 2002, BRIT J HAEMATOL, V118, P1041, DOI 10.1046/j.1365-2141.2002.03757.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Mohamed AN, 2007, AM J HEMATOL, V82, P1080, DOI 10.1002/ajh.20998; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ripley BD, 2008, PATTERN RECOGNITION; Smadja NV, 1998, LEUKEMIA, V12, P960, DOI 10.1038/sj.leu.2401041; Venebles WN, 1994, MODERN APPL STAT S P; Zhou YM, 2012, BLOOD, V119, pE148, DOI 10.1182/blood-2011-10-388702	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58809	10.1371/journal.pone.0058809	http://dx.doi.org/10.1371/journal.pone.0058809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554930	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800032
J	Vuilleumier, PH; Besson, M; Desmeules, J; Arendt-Nielsen, L; Curatolo, M				Vuilleumier, Pascal H.; Besson, Marie; Desmeules, Jules; Arendt-Nielsen, Lars; Curatolo, Michele			Evaluation of Anti-Hyperalgesic and Analgesic Effects of Two Benzodiazepines in Human Experimental Pain: A Randomized Placebo-Controlled Study	PLOS ONE			English	Article							HEALTHY-VOLUNTEERS; INTRADERMAL CAPSAICIN; ALLODYNIA; CLONAZEPAM; CLOBAZAM; CANNABIS; MODELS	Background and Aims: Compounds that act on GABA-receptors produce anti-hyperalgesia in animal models, but little is known on their effects in humans. The aim of this study was to explore the potential usefulness of GABA-agonism for the control of pain in humans. Two agonists at the benzodiazepine-binding site of GABA(A)-receptors (clobazam and clonazepam) were studied using multiple experimental pain tests. Positive results would support further investigation of GABA agonism for the control of clinical pain. Methods: In a randomized double-blind crossover design, 16 healthy male volunteers received clobazam 20 mg, clonazepam 1 mg and tolterodine 1 mg (active placebo). The area of static hyperalgesia after intradermal capsaicin injection was the primary endpoint. Secondary endpoints were: area of dynamic hyperalgesia, response to von Frey hair stimulation, pressure pain thresholds, conditioned pain modulation, cutaneous and intramuscular electrical pain thresholds (1, 5 and 20 repeated stimulation), and pain during cuff algometry. Results: For the primary endpoint, an increase in the area of static hyperalgesia was observed after administration of placebo (p<0.001), but not after clobazam and clonazepam. Results suggestive for an anti-hyperalgesic effect of the benzodiazepines were obtained with all three intramuscular pain models and with cuff algometry. No effect could be detected with the other pain models employed. Conclusions: Collectively, the results are suggestive for a possible anti-hyperalgesic effect of drugs acting at the GABA(A)-receptors in humans, particularly in models of secondary hyperalgesia and deep pain. The findings are not conclusive, but support further clinical research on pain modulation by GABAergic drugs. Because of the partial results, future research should focus on compounds acting selectively on subunits of the GABA complex, which may allow the achievement of higher receptor occupancy than unselective drugs. Our data also provide information on the most suitable experimental models for future investigation of GABAergic compounds.	[Vuilleumier, Pascal H.; Curatolo, Michele] Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Besson, Marie; Desmeules, Jules] Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Arendt-Nielsen, Lars; Curatolo, Michele] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark	University of Bern; University Hospital of Bern; University of Geneva; Aalborg University	Curatolo, M (corresponding author), Univ Hosp Bern, Inselspital, Univ Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	Michele.Curatolo@insel.ch	Curatolo, Michele/A-5859-2011; Besson, Marie/AAG-3253-2019; Arendt-Nielsen, Lars/T-4885-2018	Curatolo, Michele/0000-0003-4130-6826; Arendt-Nielsen, Lars/0000-0003-0892-1579; Vuilleumier, Pascal/0000-0002-9286-6797	Swiss National Science Foundation [SPUM 33CM30-124117]; Scientific Funds of the University Department of Anesthesiology and Pain Therapy of the University of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Scientific Funds of the University Department of Anesthesiology and Pain Therapy of the University of Bern	The study was funded by the Swiss National Science Foundation (SPUM 33CM30-124117) and the Scientific Funds of the University Department of Anesthesiology and Pain Therapy of the University of Bern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2000, EUR J APPL PHYSIOL, V81, P165, DOI 10.1007/s004210050026; CHITOUR D, 1982, BRAIN RES, V236, P329, DOI 10.1016/0006-8993(82)90718-1; Corrigan R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009486.pub2; Curatolo M, 2000, BRIT J ANAESTH, V85, P529, DOI 10.1093/bja/85.4.529; Curatolo Michele, 2006, Phys Med Rehabil Clin N Am, V17, P287, DOI 10.1016/j.pmr.2005.12.010; de Hass SL, 2007, J PSYCHOPHARMACOL, V21, P374, DOI 10.1177/0269881106072343; Di Lio A, 2011, NEUROPHARMACOLOGY, V60, P626, DOI 10.1016/j.neuropharm.2010.11.026; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Gazerani P, 2007, J OROFAC PAIN, V21, P289; Ge HY, 2004, PAIN, V110, P72, DOI 10.1016/j.pain.2004.03.005; Gottrup H, 2004, ANESTHESIOLOGY, V101, P1400; HINDMARCH I, 1980, BRIT J CLIN PHARMACO, V10, P189, DOI 10.1111/j.1365-2125.1980.tb01745.x; Ho KM, 2008, ANAESTH INTENS CARE, V36, P365, DOI 10.1177/0310057X0803600307; Huge H, 2003, J PAIN SYMPTOM MANAG, V26, P1073, DOI 10.1016/j.jpainsymman.2003.09.005; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Knabl J, 2009, PAIN, V141, P233, DOI 10.1016/j.pain.2008.10.015; Kraft B, 2008, ANESTHESIOLOGY, V109, P101, DOI 10.1097/ALN.0b013e31817881e1; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Neziri AY, 2011, PAIN, V152, P1146, DOI 10.1016/j.pain.2011.01.047; Nilvebrant L, 1997, LIFE SCI, V60, P1129, DOI 10.1016/S0024-3205(97)00057-X; Polianskis R, 2002, PAIN, V100, P19, DOI 10.1016/S0304-3959(02)00162-8; Poyhia R, 2006, CLIN J PAIN, V22, P32; PULLAR T, 1987, BRIT J CLIN PHARMACO, V24, P793, DOI 10.1111/j.1365-2125.1987.tb03247.x; Reichl S, 2011, PAIN; Riss J, 2008, ACTA NEUROL SCAND, V118, P69, DOI 10.1111/j.1600-0404.2008.01004.x; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Scanlon GC, 2006, J INVEST MED, V54, P238, DOI 10.2310/6650.2006.05046; Staahl C, 2009, BRIT J CLIN PHARMACO, V68, P322, DOI 10.1111/j.1365-2125.2009.03433.x; Staahl C, 2009, BRIT J CLIN PHARMACO, V68, P149, DOI 10.1111/j.1365-2125.2009.03456.x; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; VANDERMEYDEN CH, 1989, EUR J CLIN PHARMACOL, V37, P365, DOI 10.1007/BF00558501; Wallace M, 2007, ANESTHESIOLOGY, V107, P785, DOI 10.1097/01.anes.0000286986.92475.b7; Wallace MS, 2002, ANESTH ANALG, V95, P973, DOI 10.1097/00000539-200210000-00034; Wallace MS, 2002, J CLIN PHARMACOL, V42, P70, DOI 10.1177/0091270002042001008; Wang H, 2008, J PAIN, V9, P1088, DOI 10.1016/j.jpain.2008.05.013; Whitwam JG, 1995, ACTA ANAESTH SCAND, V39, P3, DOI 10.1111/j.1399-6576.1995.tb04374.x; Wiffen P, 2005, COCHRANE DB SYST REV, V20; WILDIN JD, 1990, BRIT J CLIN PHARMACO, V29, P169, DOI 10.1111/j.1365-2125.1990.tb03616.x; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2	42	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e43896	10.1371/journal.pone.0043896	http://dx.doi.org/10.1371/journal.pone.0043896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554851	Green Published, gold			2022-12-27	WOS:000316409800001
J	Kuprys, PV; Davis, SM; Hauer, TM; Meltser, M; Tzfati, Y; Kirk, KE				Kuprys, Paulius V.; Davis, Shaun M.; Hauer, Tyler M.; Meltser, Max; Tzfati, Yehuda; Kirk, Karen E.			Identification of Telomerase RNAs from Filamentous Fungi Reveals Conservation with Vertebrates and Yeasts	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; TEMPLATE BOUNDARY DEFINITION; SECONDARY STRUCTURE; ASPERGILLUS-NIDULANS; REVERSE-TRANSCRIPTASE; BUDDING YEAST; TRIPLE-HELIX; SEQUENCE; BINDING; TETRAHYMENA	Telomeres are the nucleoprotein complexes at eukaryotic chromosomal ends. Telomeric DNA is synthesized by the ribonucleoprotein telomerase, which comprises a telomerase reverse transcriptase (TERT) and a telomerase RNA (TER). TER contains a template for telomeric DNA synthesis. Filamentous fungi possess extremely short and tightly regulated telomeres. Although TERT is well conserved between most organisms, TER is highly divergent and thus difficult to identify. In order to identify the TER sequence, we used the unusually long telomeric repeat sequence of Aspergillus oryzae together with reverse-transcription-PCR and identified a transcribed sequence that contains the potential template within a region predicted to be single stranded. We report the discovery of TERs from twelve other related filamentous fungi using comparative genomic analysis. These TERs exhibited strong conservation with the vertebrate template sequence, and two of these potentially use the identical template as humans. We demonstrate the existence of important processing elements required for the maturation of yeast TERs such as an Sm site, a 5' splice site and a branch point, within the newly identified TER sequences. RNA folding programs applied to the TER sequences show the presence of secondary structures necessary for telomerase activity, such as a yeast-like template boundary, pseudoknot, and a vertebrate-like three-way junction. These telomerase RNAs identified from filamentous fungi display conserved structural elements from both yeast and vertebrate TERs. These findings not only provide insights into the structure and evolution of a complex RNA but also provide molecular tools to further study telomere dynamics in filamentous fungi.	[Kuprys, Paulius V.; Davis, Shaun M.; Hauer, Tyler M.; Meltser, Max; Kirk, Karen E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Tzfati, Yehuda] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Tzfati, Y (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	tzfati@cc.huji.ac.il; kirk@lakeforest.edu		Tzfati, Yehuda/0000-0001-7720-435X	National Science Foundation [MCB 0950957]; United States-Israel Binational Science Foundation [2009204]	National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by a National Science Foundation grant MCB 0950957 (www.nsf.gov) to Karen E. Kirk and a United States-Israel Binational Science Foundation grant 2009204 (http://www.bsf.org.il) to Yehuda Tzfati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; AUTEXIER C, 1994, GENE DEV, V8, P563, DOI 10.1101/gad.8.5.563; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Bhattacharyya A, 1997, NUCLEIC ACIDS RES, V25, P1426, DOI 10.1093/nar/25.7.1426; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blackburn EH, 2011, COLD SPRING HARBOR P, V3; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Brown Y, 2007, NUCLEIC ACIDS RES, V35, P6280, DOI 10.1093/nar/gkm713; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; Chapon C, 1997, RNA, V3, P1337; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Cifuentes-Rojas C, 2011, P NATL ACAD SCI USA, V108, P73, DOI 10.1073/pnas.1013021107; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gavory G, 2002, NUCLEIC ACIDS RES, V30, P4470, DOI 10.1093/nar/gkf575; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; JONES MH, 1990, EMBO J, V9, P2555, DOI 10.1002/j.1460-2075.1990.tb07436.x; Kabaha MA, 2008, MOL CELL BIOL, V28, P1875, DOI 10.1128/MCB.01683-07; Kachouri-Lafond R, 2009, FEBS LETT, V583, P3605, DOI 10.1016/j.febslet.2009.10.034; Koering CE, 2000, NUCLEIC ACIDS RES, V28, P2519, DOI 10.1093/nar/28.13.2519; Kusumoto KI, 2003, APPL MICROBIOL BIOT, V61, P247, DOI 10.1007/s00253-002-1193-3; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; Liu F, 2012, RNA, V18, P973, DOI 10.1261/rna.030924.111; LIU ZP, 1991, GENE DEV, V5, P49, DOI 10.1101/gad.5.1.49; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; McCormickGraham M, 1996, MOL CELL BIOL, V16, P1871; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Moon IK, 2007, FRONT BIOSCI, V12, P4595, DOI 10.2741/2412; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Payne GA, 2006, MED MYCOL, V44, pS9, DOI 10.1080/13693780600835716; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Qi XD, 2013, NUCLEIC ACIDS RES, V41, P450, DOI 10.1093/nar/gks980; Qi XD, 2012, EMBO J, V31, P150, DOI 10.1038/emboj.2011.363; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Sato A, 2011, DNA RES, V18, P165, DOI 10.1093/dnares/dsr009; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Takahashi T, 2006, BIOSCI BIOTECH BIOCH, V70, P135, DOI 10.1271/bbb.70.135; Tang W, 2012, NATURE, V484, P260, DOI 10.1038/nature10924; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Tzfati Y, 2003, GENE DEV, V17, P1779, DOI 10.1101/gad.1099403; Tzfati Y, 2012, TELOMERASES CHEM BIO; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Underwood DH, 2004, MOL CELL BIOL, V24, P912, DOI 10.1128/MCB.24.2.912-923.2004; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wang ZR, 2009, MOL CELL BIOL, V29, P5389, DOI 10.1128/MCB.00528-09; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wortman JR, 2009, FUNGAL GENET BIOL, V46, pS2, DOI 10.1016/j.fgb.2008.12.003; Ye AJ, 2002, INT J SYST EVOL MICR, V52, P2297, DOI 10.1099/00207713-52-6-2297; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58661	10.1371/journal.pone.0058661	http://dx.doi.org/10.1371/journal.pone.0058661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23555591	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400045
J	Leinonen, JV; Emanuelov, AK; Platt, Y; Helman, Y; Feinberg, Y; Lotan, C; Beeri, R				Leinonen, Jussi V.; Emanuelov, Avishag K.; Platt, Yardanna; Helman, Yaron; Feinberg, Yael; Lotan, Chaim; Beeri, Ronen			Left Atrial Appendages from Adult Hearts Contain a Reservoir of Diverse Cardiac Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; PRESSURE-OVERLOAD; THERAPY; CARDIOMYOCYTES; REGENERATION; MULTIPOTENT; EXPRESSION; DISEASE; ORIGIN	Aims: There is strong evidence supporting the claim that endogenous cardiac progenitor cells (CPCs) are key players in cardiac regeneration, but the anatomic source and phenotype of the master cardiac progenitors remains uncertain. Our aim was to investigate the different cardiac stem cell populations in the left atrial appendage (LAA) and their fates. Methods and Results: We investigated the CPC content and profile of adult murine LAAs using immunohistochemistry and flow cytometry. We demonstrate that the LAA contains a large number of CPCs relative to other areas of the heart, representing over 20% of the total cell number. We grew two distinct CPC populations from the LAA by varying the degree of proteolysis. These differed by their histological location, surface marker profiles and growth dynamics. Specifically, CD45(pos) cells grew with milder proteolysis, while CD45(neg) cells grew mainly with more intense proteolysis. Both cell types could be induced to differentiate into cells with cardiomyocyte markers and organelles, albeit by different protocols. Many CD45(pos) cells expressed CD45 initially and rapidly lost its expression while differentiating. Conclusions: Our results demonstrate that the left atrial appendage plays a role as a reservoir of multiple types of progenitor cells in murine adult hearts. Two different types of CPCs were isolated, differing in their epicardial-myocardial localization. Considering studies demonstrating layer-specific origins of different cardiac progenitor cells, our findings may shed light on possible pathways to study and utilize the diversity of endogenous progenitor cells in the adult heart.	[Leinonen, Jussi V.; Emanuelov, Avishag K.; Platt, Yardanna; Helman, Yaron; Feinberg, Yael; Lotan, Chaim; Beeri, Ronen] Hadassah Hebrew Univ Med Ctr, Inst Heart, Cardiovasc Res Ctr, Jerusalem, Israel	Hebrew University of Jerusalem	Beeri, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Inst Heart, Cardiovasc Res Ctr, Jerusalem, Israel.	rbeeri@hadassah.org.il	Beeri, Ronen/A-4035-2009	Beeri, Ronen/0000-0002-8014-0702	US-Israel Binational Science Foundation [2005250]; NIH/NHLBI [R01HL072265]; Finnish Foundation for Cardiovascular Research, Helsinki, Finland; Foundation of Jorma and Martha Sihvola, Lahti, Finland; USAID's American Schools and Hospitals Abroad (ASHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072265] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Finnish Foundation for Cardiovascular Research, Helsinki, Finland; Foundation of Jorma and Martha Sihvola, Lahti, Finland; USAID's American Schools and Hospitals Abroad (ASHA)(United States Agency for International Development (USAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant 2005250, from the US-Israel Binational Science Foundation (www.BSF.org.il) and grant R01HL072265 from NIH/NHLBI (to Dr Beeri- sub contract)(www.nhlbi.nih.gov). Dr Leinonen was supported by a grant from Finnish Foundation for Cardiovascular Research, Helsinki, Finland (www.sydantutkimussaatio.fi)and Foundation of Jorma and Martha Sihvola, Lahti, Finland (no website). Program for upgrading the Flow Cytometry laboratory in the Core Research Facility of the Hebrew University of Jerusalem was supported by a grant from USAID's American Schools and Hospitals Abroad (ASHA)(www.usaid.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Douglas YL, 2006, AM J CARDIOL, V97, P662, DOI 10.1016/j.amjcard.2005.11.019; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Gambini E, 2011, CARDIOVASC RES, V89, P362, DOI 10.1093/cvr/cvq292; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pouly J, 2008, J THORAC CARDIOV SUR, V135, P673, DOI 10.1016/j.jtcvs.2007.10.024; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rosenblatt-Velin N, 2012, FASEB J, V26, P229, DOI 10.1096/fj.11-189605; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; VLIEGEN HW, 1991, EUR HEART J, V12, P488, DOI 10.1093/oxfordjournals.eurheartj.a059928; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	34	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59228	10.1371/journal.pone.0059228	http://dx.doi.org/10.1371/journal.pone.0059228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555001	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500074
J	Natividad, KDT; Junankar, SR; Redzwan, NM; Nair, R; Wirasinha, RC; King, C; Brink, R; Swarbrick, A; Batten, M				Natividad, Karlo D. T.; Junankar, Simon R.; Redzwan, Norhanani Mohd; Nair, Radhika; Wirasinha, Rushika C.; King, Cecile; Brink, Robert; Swarbrick, Alexander; Batten, Marcel			Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors	PLOS ONE			English	Article							REGULATORY T-CELLS; CUTTING EDGE; COMPLETE REGRESSION; ADAPTIVE IMMUNITY; TH1 RESPONSES; IL-27; ANTITUMOR; BIOLOGY; BET; CARCINOGENESIS	Interleukin-27 (IL-27) is a pleiotropic cytokine but its immunosuppressive effects predominate during many in vivo immunological challenges. Despite this, evidence from tumor cell line transfer models suggested that IL-27 could promote immune responses in the tumor context. However, the role of IL-27 in immunity against tumors that develop in situ and in tumor immunosurveillance remain undefined. In this study, we demonstrate that tumor development and growth are accelerated in IL-27 receptor alpha (Il27ra)-deficient mice. Enhanced tumor growth in both carcinogen-induced fibrosarcoma and oncogene-driven mammary carcinoma was associated with decreased interferon-gamma production by CD4 and CD8 T cells and increased numbers of regulatory T-cells (T-reg). This is the first study to show that IL-27 promotes protective immune responses against endogenous tumors, which is critical as the basis for future development of an IL-27 based therapeutic agent.	[Natividad, Karlo D. T.; Redzwan, Norhanani Mohd; Wirasinha, Rushika C.; King, Cecile; Brink, Robert; Batten, Marcel] Garvan Inst Med Res, Immunol Dis Div, Sydney, NSW, Australia; [Junankar, Simon R.; Nair, Radhika; Swarbrick, Alexander] Garvan Inst Med Res, Canc Div, Sydney, NSW, Australia; [King, Cecile; Brink, Robert; Swarbrick, Alexander; Batten, Marcel] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney	Batten, M (corresponding author), Garvan Inst Med Res, Immunol Dis Div, Sydney, NSW, Australia.	m.batten@garvan.org.au	Junankar, Simon/B-7677-2019; Swarbrick, Alexander/E-6107-2010; Brink, Robert/B-7910-2010; Junankar, Simon/O-2009-2019; King, Cecile/Q-9794-2019	Swarbrick, Alexander/0000-0002-3051-5676; Brink, Robert/0000-0002-9586-3655; Junankar, Simon/0000-0002-3965-8278; King, Cecile/0000-0003-2193-2563; Mohd Redzwan, Norhanani/0000-0002-5710-4009; Nair, Radhika/0000-0002-6585-3384; Batten, Marcel/0000-0002-3726-3790; Wirasinha, Rushika/0000-0002-2839-2697	National Health and Medical Research Council, Australia [APP1031277]; Cancer Institute New South Wales [08ECF110]; National Breast Cancer Foundation Australia	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; National Breast Cancer Foundation Australia	M.B. is the recipient of a Career Development Fellowship (APP1031277) from the National Health and Medical Research Council (http://www.nhmrc.gov.au/), Australia. This work was also supported by an Early Career Fellowship (M. B.; 08ECF110) from the Cancer Institute New South Wales (http://www.cancerinstitute.org.au/). A. S. is the recipient of an Early Career Fellowship from the National Breast Cancer Foundation Australia (http://www.nbcf.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, J IMMUNOL, V172, P4672, DOI 10.4049/jimmunol.172.8.4672; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Elkord E, 2010, EXPERT OPIN BIOL TH, V10, P1573, DOI 10.1517/14712598.2010.529126; Emtage PCR, 1999, HUM GENE THER, V10, P697, DOI 10.1089/10430349950018463; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Huber M, 2008, INT IMMUNOL, V20, P223, DOI 10.1093/intimm/dxm139; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Putzer BM, 1998, HUM GENE THER, V9, P707, DOI 10.1089/hum.1998.9.5-707; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ruffell B, 2010, CYTOKINE GROWTH F R, V21, P3, DOI 10.1016/j.cytogfr.2009.11.002; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schreiber TH, 2009, BRIT J CANCER, V101, P381, DOI 10.1038/sj.bjc.6605198; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Shinozaki Y, 2009, INT J CANCER, V124, P1372, DOI 10.1002/ijc.24107; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tao YP, 2012, J CANC RES CLIN ONCO; Teng MWL, 2010, CANCER RES, V70, P7800, DOI 10.1158/0008-5472.CAN-10-1681; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	50	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57469	10.1371/journal.pone.0057469	http://dx.doi.org/10.1371/journal.pone.0057469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554861	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500003
J	Chan, CS; Jungreis, I; Kellis, M				Chan, Clara S.; Jungreis, Irwin; Kellis, Manolis			Heterologous Stop Codon Readthrough of Metazoan Readthrough Candidates in Yeast	PLOS ONE			English	Article							LUCIFERASE ASSAY SYSTEM; TRANSLATION TERMINATION; DOWNSTREAM; EFFICIENCY; PSI+	Recent analysis of genomic signatures in mammals, flies, and worms indicates that functional translational stop codon readthrough is considerably more abundant in metazoa than previously recognized, but this analysis provides only limited clues about the function or mechanism of readthrough. If an mRNA known to be read through in one species is also read through in another, perhaps these questions can be studied in a simpler setting. With this end in mind, we have investigated whether some of the readthrough genes in human, fly, and worm also exhibit readthrough when expressed in S. cerevisiae. We found that readthrough was highest in a gene with a post stop hexamer known to trigger readthrough, while other metazoan readthrough genes exhibit borderline readthrough in S. cerevisiae.	[Chan, Clara S.] MIT, Dept Biol, Cambridge, MA USA; [Jungreis, Irwin; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kellis, M (corresponding author), MIT, CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630	NIH [5U54HG004555-03]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH 5U54HG004555-03, which is described here: http://projectreporter.nih.gov/project_info_description.cfm?aid = 7685458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Cimino PA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002423; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; McNabb DS, 2005, EUKARYOT CELL, V4, P1539, DOI 10.1128/EC.4.9.1539-1549.2005; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2012, COMMUNICATION; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991	18	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59450	10.1371/journal.pone.0059450	http://dx.doi.org/10.1371/journal.pone.0059450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544069	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700030
J	Eraud, C; Riviere, M; Lormee, H; Fox, JW; Ducamp, JJ; Boutin, JM				Eraud, Cyril; Riviere, Marcel; Lormee, Herve; Fox, James W.; Ducamp, Jean-Jacques; Boutin, Jean-Marie			Migration Routes and Staging Areas of Trans-Saharan Turtle Doves Appraised from Light-Level Geolocators	PLOS ONE			English	Article							STREPTOPELIA-TURTUR; POPULATION-DYNAMICS; SONGBIRD MIGRATION; BREEDING ECOLOGY; LESSER KESTRELS; SURVIVAL RATES; TRACKING; CICONIA; LONG; MOVEMENTS	The identification of migration routes, wintering grounds and stopover sites are crucial issues for the understanding of the Palearctic-African bird migration system as well as for the development of relevant conservation strategies for trans-Saharan migrants. Using miniaturized light-level geolocators we report a comprehensive and detailed year round track of a granivorous trans-Saharan migrant, the European Turtle Dove (Streptopelia turtur). From five recovered loggers, our data provide new insights on migratory journeys and winter destinations of Turtle Doves originating from a breeding population in Western France. Data confirm that Turtle Doves wintered in West Africa. The main wintering area encompassed Western Mali the Inner Delta Niger and the Malian/Mauritanian border. Some individuals also extended their wintering ranges over North Guinea, North-West of Burkina Faso and the Ivory-Coast Our results reveal that all individuals did not spend the winter period at a single location; some of them experienced a clear eastward shift of several hundred kilometres. We also found evidence for a loop migration pattern, with a post-breeding migration flyway lying west of the spring route. Finally, we found that on their way back to breeding grounds Turtle Doves needed to refuel after crossing the Sahara desert. Contrary to previous suggestions, our data reveal that birds used stopover sites for several weeks presumably in Morocco and North Algeria. This later finding is a crucial issue for future conservation strategies because environmental conditions on these staging areas might play a pivotal role in population dynamics of this declining species.	[Eraud, Cyril; Lormee, Herve; Boutin, Jean-Marie] Off Natl Chasse & Faune Sauvage, Villiers En Bois, France; [Riviere, Marcel] Maisonneuve, St Pierre Doleron, France; [Fox, James W.] Migrate Technol Ltd, Cambridge, England; [Ducamp, Jean-Jacques] CNRS, UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Eraud, C (corresponding author), Off Natl Chasse & Faune Sauvage, Villiers En Bois, France.	cyril.eraud@oncfs.gouv.fr			Office National de la Chasse et de la Faune Sauvage	Office National de la Chasse et de la Faune Sauvage	This work was funded by the Office National de la Chasse et de la Faune Sauvage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer NJ., 2002, MIGRATION ATLAS MOVE, P420; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Alerstam T, 2007, PLOS BIOL, V5, P1656, DOI 10.1371/journal.pbio.0050197; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; BAIRLEIN F, 1985, OECOLOGIA, V66, P141, DOI 10.1007/BF00378566; Bairlein F, 2012, BIOL LETT; Bairlein Franz, 2009, Ringing & Migration, V24, P162; Barbraud C, 1999, IBIS, V141, P469, DOI 10.1111/j.1474-919X.1999.tb04416.x; BIEBACH H, 1986, OECOLOGIA, V69, P370, DOI 10.1007/BF00377059; BirdLife International, 2012, SPEC FACTSH STREPT T; Browne SJ, 2005, BIRD STUDY, V52, P1, DOI 10.1080/00063650509461368; Browne SJ, 2004, IBIS, V146, P125, DOI 10.1111/j.1474-919X.2004.00235.x; Catry I, 2011, IBIS, V153, P154, DOI 10.1111/j.1474-919X.2010.01073.x; Cramp S, 1985, BIRDS W PALEARCTIC, V4; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; EI Mastour A, 1988, B MENS O N C, V127, P43; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Eraud C, 2009, IBIS, V151, P186, DOI 10.1111/j.1474-919X.2008.00876.x; Eraud C, 2011, CONDOR, V113, P150, DOI 10.1525/cond.2011.090141; EVANS TR, 1994, WILSON BULL, V106, P154; FOX J. W., 2009, BAS GEOLOCATOR UNPUB; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; Jarry G., 1991, HIVERNAGE TOURTERELL; Jarry G, 1994, STATUT BIOL TOURTERE; KANYAMIBWA S, 1990, IBIS, V132, P27, DOI 10.1111/j.1474-919X.1990.tb01013.x; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Klaassen RHG, 2011, BIOL LETTERS, V7, P833, DOI 10.1098/rsbl.2011.0343; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Mainguy J, 2002, CONDOR, V104, P156, DOI 10.1650/0010-5422(2002)104[0156:ABCARE]2.0.CO;2; MOLLER AP, 1989, J ANIM ECOL, V58, P1051, DOI 10.2307/5141; MOREL G, 1973, Terre et la Vie, V27, P523; MOREL G J, 1988, Alauda, V56, P85; Morel M.Y., 1987, Malimbus, V9, P23; MOREL M-Y, 1986, Alauda, V54, P121; MOREL M-Y, 1985, Alauda, V53, P100; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Payevsky V.A, 2006, ENTOMOL REV, V86, P82, DOI [10.1134/S001387380610006X, DOI 10.1134/S001387380610006X]; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Risely K, 2010, 599 BTO; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Strandberg R, 2010, BIOL LETTERS, V6, P297, DOI 10.1098/rsbl.2009.0785; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; SZEP T, 1995, IBIS, V137, P162, DOI 10.1111/j.1474-919X.1995.tb03235.x; Thevenot M, 2003, BRIT ORNITHOLOGIST U, V20; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilson R.P., 1992, P131; Woodrey Mark S., 2005, U S Forest Service General Technical Report PSW, V191, P653; Zwarts L., 2009, LIVING EDGE WETLANDS	62	25	26	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59396	10.1371/journal.pone.0059396	http://dx.doi.org/10.1371/journal.pone.0059396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544064	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700026
J	Hughes, AD; Park, C; Davies, J; Francis, D; Thom, SAM; Mayet, J; Parker, KH				Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil; Parker, Kim H.			Limitations of Augmentation Index in the Assessment of Wave Reflection in Normotensive Healthy Individuals	PLOS ONE			English	Article							BLOOD-PRESSURE; ARTERIAL STIFFNESS; INTENSITY ANALYSIS; INPUT IMPEDANCE; AGE; VELOCITY; PULSE; MEN; METAANALYSIS; WOMEN	Objectives: Augmentation index (AIx) is widely used as a measure of wave reflection. We compared the relationship between AIx and age, height and sex with 'gold standard' measures of wave reflection derived from measurements of pressure and flow to establish how well AIx measures wave reflection. Materials and Methods:Measurements of carotid pressure and flow velocity were made in the carotid artery of 65 healthy normotensive individuals (age 21-78 yr; 43 male) and pulse wave analysis, wave intensity analysis and wave separation was performed; waveforms were classified into type A, B or C. AIx, the time of the first shoulder (T-s), wave reflection index (WRI) and the ratio of backward to forward pressure (P-b/P-f) were calculated. Results: AIx did not correlate with log WRI or P-b/P-f. When AIx was restricted to positive values AIx and log WRI were positively correlated (r = 0.33; p = 0.04). In contrast log WRI and P-b/P-f were closely correlated (r = 0.66; p<0.001). There was no correlation between the T-s and the timing of P-b or the reflected wave identified by wave intensity analysis. Wave intensity analysis showed that the morphology of type C waveforms (negative AIx) was principally due to a forward travelling (re-reflected) decompression wave in mid-systole. AIx correlated positively with age, inversely with height and was higher in women. In contrast log WRI and P-b/P-f showed negative associations with age, were unrelated to height and did not differ significantly by gender. Conclusions: AIx has serious limitations as a measure of wave reflection. Negative AIx values derived from Type C waves should not be used as estimates of wave reflection magnitude.	[Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England; [Hughes, Alun D.; Park, Chloe; Davies, Justin; Francis, Darrel; Thom, Simon A. McG; Mayet, Jamil] Imperial Coll Healthcare NHS Trust, London, England; [Parker, Kim H.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London; Imperial College London; Imperial College London	Hughes, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England.	a.hughes@imperial.ac.uk	Hughes, Alun David/N-3781-2013	Hughes, Alun David/0000-0001-5432-5271; Park, Chloe/0000-0001-8302-7484; Thom, Simon/0000-0002-3020-1351	British Heart Foundation; Wellcome Trust; Biomedical Research Centre Award; BHF Research Centre Excellence Award; British Heart Foundation [FS/10/38/28268, PG/08/103/26133] Funding Source: researchfish; National Institute for Health Research [CL-2006-21-003(1)] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre Award; BHF Research Centre Excellence Award; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported in part by grants from the British Heart Foundation and the Wellcome Trust. A Hughes, J Mayet and S Thom received support from a Biomedical Research Centre Award to Imperial NHS Healthcare Trust and a BHF Research Centre Excellence Award to Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksi AJ, 2009, J AM COLL CARDIOL, V54, P2087, DOI 10.1016/j.jacc.2009.06.049; Davies JE, 2006, AM J PHYSIOL-HEART C, V290, pH878, DOI 10.1152/ajpheart.00751.2005; Davies JE, 2010, AM J PHYSIOL-HEART C, V298, pH580, DOI 10.1152/ajpheart.00875.2009; Hughes AD, 2009, MED BIOL ENG COMPUT, V47, P207, DOI 10.1007/s11517-009-0444-1; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P94; KELLY R, 1989, CIRCULATION, V80, P1652, DOI 10.1161/01.CIR.80.6.1652; Khir AW, 2001, J BIOMECH, V34, P1145, DOI 10.1016/S0021-9290(01)00076-8; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; London GM, 1996, KIDNEY INT, V50, P600, DOI 10.1038/ki.1996.355; Manisty C, 2010, J AM COLL CARDIOL, V56, P24, DOI 10.1016/j.jacc.2010.03.030; Manisty CH, 2009, HYPERTENSION, V54, P724, DOI 10.1161/HYPERTENSIONAHA.108.125740; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Brien, 1996, Blood Press Monit, V1, P55; PARKER KH, 1990, J BIOMECH ENG-T ASME, V112, P322, DOI 10.1115/1.2891191; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P175, DOI 10.1007/s11517-009-0439-y; Segers P, 2007, PHYSIOL MEAS, V28, P1045, DOI 10.1088/0967-3334/28/9/006; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; TAKAZAWA K, 1995, HYPERTENSION, V26, P520, DOI 10.1161/01.HYP.26.3.520; Trachet B, 2010, ANN BIOMED ENG, V38, P876, DOI 10.1007/s10439-010-9945-1; van Trijp MJCA, 2004, EUR J CLIN INVEST, V34, P825, DOI 10.1111/j.1365-2362.2004.01433.x; Verbeke F, 2011, HYPERTENSION, V58, P833, DOI 10.1161/HYPERTENSIONAHA.111.176594; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Zambanini A, 2005, AM J PHYSIOL-HEART C, V289, pH270, DOI 10.1152/ajpheart.00636.2003; Zambanini A, 2002, COMPUT CARDIOL, V29, P717, DOI 10.1109/CIC.2002.1166873	31	79	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59371	10.1371/journal.pone.0059371	http://dx.doi.org/10.1371/journal.pone.0059371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544061	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700023
J	Prabhakara, S; Khedkar, S; Shambat, SM; Srinivasan, R; Basu, A; Norrby-Teglund, A; Seshasayee, ASN; Arakere, G				Prabhakara, Sushma; Khedkar, Supriya; Shambat, Srikanth Mairpady; Srinivasan, Rajalakshmi; Basu, Atanu; Norrby-Teglund, Anna; Seshasayee, Aswin Sai Narain; Arakere, Gayathri			Genome Sequencing Unveils a Novel Sea Enterotoxin-Carrying PVL Phage in Staphylococcus aureus ST772 from India	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; GENE-EXPRESSION DATA; STRAINS; IDENTIFICATION; PATHOGENESIS; RESISTANCE; DIVERSITY; EMERGENCE; EVOLUTION; LINEAGES	Staphylococcus aureus is a major human pathogen, first recognized as a leading cause of hospital-acquired infections. Community-associated S. aureus (CA-SA) pose a greater threat due to increase in severity of infection and disease among children and healthy adults. CA-SA strains in India are genetically diverse, among which is the sequence type (ST) 772, which has now spread to Australia, Europe and Japan. Towards understanding the genetic characteristics of ST772, we obtained draft genome sequences of five relevant clinical isolates and studied the properties of their PVL-carrying prophages, whose presence is a defining hallmark of CA-SA. We show that this is a novel prophage, which carries the structural genes of the hlb-carrying prophage and includes the sea enterotoxin. This architecture probably emerged early within the ST772 lineage, at least in India. The sea gene, unique to ST772 PVL, despite having promoter sequence characteristics typical of low expression, appears to be highly expressed during early phase of growth in laboratory conditions. We speculate that this might be a consequence of its novel sequence context. The crippled nature of the hlb-converting prophage in ST772. suggests that widespread mobility of the sea enterotoxin might be a selective force behind its 'transfer' to the PVL prophage. Wild type ST772 strains induced strong proliferative responses as well as high cytotoxic activity against neutrophils, likely mediated by superantigen SEA and the PVL toxin respectively. Both proliferation and cytotoxicity were markedly reduced in a cured ST772 strain indicating the impact of the phage on virulence. The presence of SEA alongside he genes for the immune system-modulating PVL toxin may contribute to the success and virulence of ST772.	[Prabhakara, Sushma; Arakere, Gayathri] Indian Inst Sci, Soc Innovat & Dev, Bengaluru, India; [Khedkar, Supriya; Srinivasan, Rajalakshmi; Seshasayee, Aswin Sai Narain] GKVK, TIER, Natl Ctr Biol Sci, Bengaluru, India; [Basu, Atanu] Natl Inst Virol, Pune, Maharashtra, India; [Shambat, Srikanth Mairpady; Norrby-Teglund, Anna] Karolinska Inst, Karolinska Univ Hosp, Ctr Infect Med F59, Stockholm, Sweden	Indian Institute of Science (IISC) - Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Karolinska Institutet; Karolinska University Hospital	Seshasayee, ASN (corresponding author), GKVK, TIER, Natl Ctr Biol Sci, Bengaluru, India.	aswin@ncbs.res.in; gayathri.arakere@gmail.com		Srinivasan, Rajalakshmi/0000-0003-4020-2339; Mairpady Shambat, Srikanth/0000-0002-0527-3978; , Supriya/0000-0001-6606-2202	Council for Scientific & Industrial Research (CSIR), India [09/860(0122)/2011-EMR-I]; NCBS core budget; Department of Science and Technology, Government of India [SR/S2/RJN-49/2010]; Department of Biotechnology [BT/IN/New Indigo/16/GA/2010]; Swedish International Development Agency	Council for Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); NCBS core budget; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology; Swedish International Development Agency	SP is a junior research fellow under BT/IN/New Indigo/16/GA/2010. SK is supported by fellowship [09/860(0122)/2011-EMR-I] from the Council for Scientific & Industrial Research (CSIR), India. ASNS is funded by the NCBS core budget and the Ramanujan Fellowship (SR/S2/RJN-49/2010) from the Department of Science and Technology, Government of India. GA is funded by Department of Biotechnology (BT/IN/New Indigo/16/GA/2010) and Swedish International Development Agency funding to ANT and GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2008, JPN J INFECT DIS, V61, P393; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Boakes E, 2012, J CLIN MICROBIOL, V50, P1773, DOI 10.1128/JCM.06421-11; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Cao R, 2012, APPL ENVIRON MICROB, V78, P4942, DOI 10.1128/AEM.00803-12; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Dauwalder O, 2006, J LEUKOCYTE BIOL, V80, P753, DOI 10.1189/jlb.0306232; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Graves SF, 2012, J LEUKOCYTE BIOL, V92, P361, DOI 10.1189/jlb.1111575; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; Nadig S, 2012, CLIN OPHTHALMOL, V6, P165, DOI 10.2147/OPTH.S23878; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Neela Vasanthakumari, 2009, Int J Infect Dis, V13, pe131, DOI 10.1016/j.ijid.2008.07.009; Nguyen HM, 2010, J IMMUNOL METHODS, V356, P1, DOI 10.1016/j.jim.2010.03.005; Otter JA, 2010, CLIN MICROBIOL INFEC, V16, P68, DOI 10.1111/j.1469-0691.2009.02925.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Prabhakara S, 2012, J BACTERIOL, V194, P3727, DOI 10.1128/JB.00480-12; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Raphae IL, 2004, NUCLEIC ACIDS RES, V32, P45; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; Schelin J, 2011, VIRULENCE, V2, P580, DOI 10.4161/viru.2.6.18122; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Tong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037212; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wirtz C, 2009, MICROBIOL-SGM, V155, P3491, DOI 10.1099/mic.0.032466-0; Yamaguchi T, 2012, JPN J INFECT DIS, V65, P175; Yoong P, 2012, INFECT IMMUN, V80, P2894, DOI 10.1128/IAI.06360-11; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang M, 2011, FEMS MICROBIOL LETT, V323, P20, DOI 10.1111/j.1574-6968.2011.02355.x	46	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60013	10.1371/journal.pone.0060013	http://dx.doi.org/10.1371/journal.pone.0060013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544121	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000317480700080
J	Romon, M; Perez-Guzman, MD; Jimenez-Rabadan, P; Esteso, MC; Garcia-Alvarez, O; Maroto-Morales, A; Anel-Lopez, L; Soler, AJ; Fernandez-Santos, MR; Garde, JJ				Romon, Manuel; Dolores Perez-Guzman, M.; Jimenez-Rabadan, Pilar; Esteso, Milagros C.; Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Anel-Lopez, Luis; Soler, Ana J.; Rocio Fernandez-Santos, M.; Julian Garde, J.			Sperm Cell Population Dynamics in Ram Semen during the Cryopreservation Process	PLOS ONE			English	Article							ACROSOMAL INTEGRITY; MORPHOMETRIC SUBPOPULATIONS; HEAD MORPHOMETRY; MEMBRANE-CHANGES; FROZEN STORAGE; VIABILITY; BOAR; SPERMATOZOA; EJACULATE; IDENTIFICATION	Background:Sperm cryopreservation has become an indispensable tool in biology. Initially, studies were aimed towards the development of efficient freezing protocols in different species that would allow for an efficient storage of semen samples for long periods of time, ensuring its viability. Nowadays, it is widely known that an important individual component exists in the cryoresistance of semen, and efforts are aimed at identifying those sperm characteristics that may allow us to predict this cryoresistance. This knowledge would lead, ultimately, to the design of optimized freezing protocols for the sperm characteristics of each male. Methodology/Principal Findings: We have evaluated the changes that occur in the sperm head dimensions throughout the cryopreservation process. We have found three different patterns of response, each of one related to a different sperm quality at thawing. We have been able to characterize males based on these patterns. For each male, its pattern remained constant among different ejaculates. This latter would imply that males always respond in the same way to freezing, giving even more importance to this sperm feature. Conclusions/Significance:Changes in the sperm head during cryopreservation process have resulted useful to identify the ability of semen of males for freezing. We suggest that analyses of these response patterns would represent an important tool to characterize the cryoresistance of males when implemented within breeding programs. We also propose follow-up experiments to examine the outcomes of the use of different freezing protocols depending on the pattern of response of males.	[Romon, Manuel; Dolores Perez-Guzman, M.; Jimenez-Rabadan, Pilar] Junta Comunidades Castilla La Mancha, CERSYRA, Valdepenas, Spain; [Esteso, Milagros C.] INIA, Dpto Reprod Anim, Madrid, Spain; [Garcia-Alvarez, Olga; Maroto-Morales, Alejandro; Anel-Lopez, Luis; Soler, Ana J.; Rocio Fernandez-Santos, M.; Julian Garde, J.] SaBio CSIC UCLM JCCM, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Romon, M (corresponding author), Junta Comunidades Castilla La Mancha, CERSYRA, Valdepenas, Spain.	mramon@jccm.es	Soler, Ana Josefa/AAB-1024-2020; Fernandez, Manuel Ramon/B-5755-2014; López-Brea, José Julián Garde/AAE-5894-2019; ANEL-LÓPEZ, LUIS/AAP-2438-2020; Soler, Ana Josefa/M-8209-2013; Garde, Julian J/O-5607-2015; Esteso, Milagros C/K-7895-2014; Fernández-Santos, Maria Rocío/H-1522-2018; Anel-Lopez, Luis/K-6546-2017; garcia-alvarez, olga/L-4424-2014; garcia-alvarez, olga/AAM-5128-2020	Soler, Ana Josefa/0000-0002-6429-5157; Fernandez, Manuel Ramon/0000-0003-4179-9894; López-Brea, José Julián Garde/0000-0002-3667-6518; ANEL-LÓPEZ, LUIS/0000-0001-7179-5742; Soler, Ana Josefa/0000-0002-6429-5157; Garde, Julian J/0000-0002-3667-6518; Esteso, Milagros C/0000-0002-8963-5736; Fernández-Santos, Maria Rocío/0000-0002-3359-1623; Anel-Lopez, Luis/0000-0001-7179-5742; garcia-alvarez, olga/0000-0003-4310-0557; garcia-alvarez, olga/0000-0003-4310-0557	Education and Science Council of Castilla-La Mancha [PCC08-0105-8042]; DOC-INIA program	Education and Science Council of Castilla-La Mancha; DOC-INIA program	This work was supported by the Education and Science Council of Castilla-La Mancha (PCC08-0105-8042). Manuel Ramon was supported by the DOC-INIA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2008, THERIOGENOLOGY, V70, P1498, DOI 10.1016/j.theriogenology.2008.06.097; ARMITAGE WJ, 1986, CRYOBIOLOGY, V23, P116, DOI 10.1016/0011-2240(86)90002-7; Arruda RP, 2002, THERIOGENOLOGY, V58, P253; Benson JD, 2012, THERIOGENOLOGY, V78, P1682, DOI 10.1016/j.theriogenology.2012.06.007; Curry MR, 2000, CRYOBIOLOGY, V41, P167, DOI 10.1006/cryo.2000.2277; Esteso MC, 2003, REPROD DOMEST ANIM, V41, P241; FISER PS, 1989, CRYOBIOLOGY, V26, P64, DOI 10.1016/0011-2240(89)90033-3; Garcia-Alvarez O, 2009, THERIOGENOLOGY, V72, P160, DOI 10.1016/j.theriogenology.2009.02.002; Gravance CG, 2009, ANIM REPROD SCI, V114, P81, DOI 10.1016/j.anireprosci.2008.09.014; Gravance CG, 1998, J ANDROL, V19, P704; HAMMERSTEDT RH, 1990, J ANDROL, V11, P73; Hernandez M, 2006, INT J ANDROL, V29, P583, DOI 10.1111/j.1365-2605.2006.00699.x; Hidalgo M, 2007, ANIM REPROD SCI, V100, P61, DOI 10.1016/j.anireprosci.2006.07.003; Holt WV, 2000, THERIOGENOLOGY, V53, P47, DOI 10.1016/S0093-691X(99)00239-3; Januskauskas A, 2003, THERIOGENOLOGY, V60, P743, DOI 10.1016/S0093-691X(03)00050-5; Maroto-Morales A, 2010, THERIOGENOLOGY, V73, P437, DOI 10.1016/j.theriogenology.2009.10.003; Martin G, 2004, BIOL REPROD, V71, P28, DOI 10.1095/biolreprod.103.024281; Martinez-Pastor F, 2005, BIOL REPROD, V72, P316, DOI 10.1095/biolreprod.104.032730; Martinez-Pastor F, 2010, REPROD DOMEST ANIM, V45, P67, DOI 10.1111/j.1439-0531.2010.01622.x; MAZUR P, 1989, CRYOBIOLOGY, V26, P1, DOI 10.1016/0011-2240(89)90030-8; Nunez-Martinez I, 2007, ZYGOTE, V15, P257, DOI 10.1017/S0967199407004248; Pena AI, 2003, THERIOGENOLOGY, V59, P1725, DOI 10.1016/S0093-691X(02)01233-5; Pena AI, 2001, J REP FER S, P371; Pena FJ, 2005, J ANDROL, V26, P716, DOI 10.2164/jandrol.05030; Pena FJ, 2004, ZYGOTE, V12, P117, DOI 10.1017/S096719940400262X; Petrunkina AM, 2004, REPRODUCTION, V128, P829, DOI 10.1530/rep.1.00296; QUINN PJ, 1989, J BIOENERG BIOMEMBR, V21, P3, DOI 10.1007/BF00762209; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramon M, 2012, THERIOGENOLOGY, V77, P1661, DOI 10.1016/j.theriogenology.2011.12.011; Rijsselaere T, 2004, THERIOGENOLOGY, V62, P1292, DOI 10.1016/j.theriogenology.2004.01.005; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; SALAMON S, 1995, ANIM REPROD SCI, V38, P1, DOI 10.1016/0378-4320(94)01328-J; SALAMON S, 1995, ANIM REPROD SCI, V37, P185, DOI 10.1016/0378-4320(94)01327-I; Sancho S, 2007, REPRODUCTION, V134, P111, DOI 10.1530/REP-07-0118; SCHNEIDER U, 1984, THERIOGENOLOGY, V21, P68, DOI 10.1016/0093-691X(84)90307-8; Soler AJ, 2003, J ANDROL, V24, P746; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Thomas CA, 1997, BIOL REPROD, V56, P991, DOI 10.1095/biolreprod56.4.991; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Thurston LM, 2002, CRYOLETTERS, V23, P255; Thurston LM, 2001, J ANDROL, V22, P382	41	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59189	10.1371/journal.pone.0059189	http://dx.doi.org/10.1371/journal.pone.0059189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544054	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700016
J	Kofod-Olsen, E; Moller, JML; Schleimann, MH; Bundgaard, B; Bak, RO; Oster, B; Mikkelsen, JG; Hupp, T; Hollsberg, P				Kofod-Olsen, Emil; Moller, Janni M. L.; Schleimann, Mariane H.; Bundgaard, Bettina; Bak, Rasmus O.; Oster, Bodil; Mikkelsen, Jacob G.; Hupp, Ted; Hollsberg, Per			Inhibition of p53-Dependent, but Not p53-Independent, Cell Death by U19 Protein from Human Herpesvirus 6B	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS; HUMAN-HERPESVIRUS-6 INFECTION; INDEPENDENT MANNER; IE2-86 PROTEIN; DNA-DAMAGE; T-CELLS; IN-VIVO; P53; APOPTOSIS; EXPRESSION	Infection with human herpesvirus (HHV)-6B alters cell cycle progression and stabilizes tumor suppressor protein p53. In this study, we have analyzed the activity of p53 after stimulation with p53-dependent and -independent DNA damaging agents during HHV-6B infection. Microarray analysis, Western blotting and confocal microscopy demonstrated that HHV-6B-infected cells were resistant to p53-dependent arrest and cell death after gamma irradiation in both permissive and non-permissive cell lines. In contrast, HHV-6B-infected cells died normally through p53-independet DNA damage induced by UV radiation. Moreover, we identified a viral protein involved in inhibition of p53 during HHV-6B-infection. The protein product from the U19 ORF was able to inhibit p53-dependent signaling following gamma irradiation in a manner similar to that observed during infection. Similar to HHV-6B infection, overexpression of U19 failed to rescue the cells from p53-independent death induced by UV radiation. Hence, infection with HHV-6B specifically blocks DNA damage-induced cell death associated with p53 without inhibiting the p53-independent cell death response. This block in p53 function can in part be ascribed to the activities of the viral U19 protein.	[Kofod-Olsen, Emil; Moller, Janni M. L.; Schleimann, Mariane H.; Bundgaard, Bettina; Bak, Rasmus O.; Oster, Bodil; Mikkelsen, Jacob G.; Hollsberg, Per] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Oster, Bodil; Hupp, Ted] Univ Edinburgh, Inst Genet & Mol Med, Canc Res UK p53 Signal Transduct Labs, Edinburgh, Midlothian, Scotland	Aarhus University; University of Edinburgh	Hollsberg, P (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ph@microbiology.au.dk	Bak, Rasmus O./AAH-9748-2021	Bak, Rasmus O./0000-0002-7383-0297; Mikkelsen, Jacob Giehm/0000-0002-1322-3209; Schleimann, Mariane/0000-0001-5147-9523	Doctor Sofus Carl Emil Friis and wife Olga Doris Friis's foundation; Lundbeck Foundation; Aarhus University AU Ideas program	Doctor Sofus Carl Emil Friis and wife Olga Doris Friis's foundation; Lundbeck Foundation(Lundbeckfonden); Aarhus University AU Ideas program	This work was supported by grants from Doctor Sofus Carl Emil Friis and wife Olga Doris Friis's foundation, the Lundbeck Foundation, and the Aarhus University AU Ideas program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Boutell C, 2004, J VIROL, V78, P8068, DOI 10.1128/JVI.78.15.8068-8077.2004; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Casavant NC, 2006, J VIROL, V80, P8390, DOI 10.1128/JVI.00505-06; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen ZP, 2007, J BIOL CHEM, V282, P29284, DOI 10.1074/jbc.M705349200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Fotheringham J, 2007, PLOS MED, V4, P848, DOI 10.1371/journal.pmed.0040180; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Gong XW, 2010, FEBS LETT, V584, P4711, DOI 10.1016/j.febslet.2010.10.057; Hall CB, 2008, PEDIATRICS, V122, P513, DOI 10.1542/peds.2007-2838; Hannemann H, 2009, J VIROL, V83, P4316, DOI 10.1128/JVI.02075-08; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Hwang ES, 2009, J VIROL, V83, P12388, DOI 10.1128/JVI.00304-09; Kofod-Olsen E, 2008, J GEN VIROL, V89, P106, DOI 10.1099/vir.0.83224-0; Kofod-Olsen E, 2012, J VIROL, V86, P11483, DOI 10.1128/JVI.00847-12; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; LI Y, 1994, ONCOGENE, V9, P2261; Luppi M, 1999, J VIROL, V73, P754, DOI 10.1128/JVI.73.1.754-759.1999; MINOWADA J, 1972, J NATL CANCER I, V49, P891; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OKAN I, 1995, ONCOGENE, V11, P1027; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; Oster B, 2008, J GEN VIROL, V89, P87, DOI 10.1099/vir.0.83136-0; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2002, J VIROL, V76, P7578, DOI 10.1128/JVI.76.15.7578-7586.2002; Oster B, 2006, J CLIN VIROL, V37, pS63, DOI 10.1016/S1386-6532(06)70014-2; Schleimann MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007457; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Takemoto M, 2005, J VIROL, V79, P13037, DOI 10.1128/JVI.79.20.13037-13046.2005; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WARD KN, 1993, J MED VIROL, V39, P131, DOI 10.1002/jmv.1890390209; YAMANISHI K, 1988, LANCET, V1, P1065; Yamashita Nobuko, 2005, Herpes, V12, P46; YOSHIKAWA T, 1991, BLOOD, V78, P1381; Zhang ZG, 2006, J VIROL, V80, P3833, DOI 10.1128/JVI.80.8.3833-3843.2006	46	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59223	10.1371/journal.pone.0059223	http://dx.doi.org/10.1371/journal.pone.0059223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555634	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500026
J	House, MJ; Gan, EK; Adams, LA; Ayonrinde, OT; Bangma, SJ; Bhathal, PS; Olynyk, JK; St Pierre, TG				House, Michael J.; Gan, Eng K.; Adams, Leon A.; Ayonrinde, Oyekoya T.; Bangma, Sander J.; Bhathal, Prithi S.; Olynyk, John K.; St Pierre, Tim G.			Diagnostic Performance of a Rapid Magnetic Resonance Imaging Method of Measuring Hepatic Steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GRADIENT-ECHO; NONINVASIVE MEASUREMENT; QUANTIFICATION; SPECTROSCOPY; MRI; MACROSTEATOSIS; VALIDATION; EXPERIENCE; ACCURACY	Objectives: Hepatic steatosis is associated with an increased risk of developing serious liver disease and other clinical sequelae of the metabolic syndrome. However, visual estimates of steatosis from histological sections of biopsy samples are subjective and reliant on an invasive procedure with associated risks. The aim of this study was to test the ability of a rapid, routinely available, magnetic resonance imaging (MRI) method to diagnose clinically relevant grades of hepatic steatosis in a cohort of patients with diverse liver diseases. Materials and Methods: Fifty-nine patients with a range of liver diseases underwent liver biopsy and MRI. Hepatic steatosis was quantified firstly using an opposed-phase, in-phase gradient echo, single breath-hold MRI methodology and secondly, using liver biopsy with visual estimation by a histopathologist and by computer-assisted morphometric image analysis. The area under the receiver operating characteristic (ROC) curve was used to assess the diagnostic performance of the MRI method against the biopsy observations. Results: The MRI approach had high sensitivity and specificity at all hepatic steatosis thresholds. Areas under ROC curves were 0.962, 0.993, and 0.972 at thresholds of 5%, 33%, and 66% liver fat, respectively. MRI measurements were strongly associated with visual (r(2) = 0.83) and computer-assisted morphometric (r(2) = 0.84) estimates of hepatic steatosis from histological specimens. Conclusions: This MRI approach, using a conventional, rapid, gradient echo method, has high sensitivity and specificity for diagnosing liver fat at all grades of steatosis in a cohort with a range of liver diseases.	[House, Michael J.; St Pierre, Tim G.] Univ Western Australia, Sch Phys, Crawley, Australia; [Gan, Eng K.; Adams, Leon A.; Ayonrinde, Oyekoya T.; Olynyk, John K.] Univ Western Australia, Sch Med & Pharmacol, Crawley, Australia; [Gan, Eng K.; Ayonrinde, Oyekoya T.; Olynyk, John K.] Fremantle Hosp, Dept Gastroenterol, Fremantle, WA, Australia; [Adams, Leon A.] Sir Charles Gairdner Hosp, Liver Transplant Unit, Nedlands, WA 6009, Australia; [Bangma, Sander J.] Resonance Hlth Ltd, Claremont, CA USA; [Bhathal, Prithi S.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Ayonrinde, Oyekoya T.; Olynyk, John K.] Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Olynyk, John K.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Melbourne; Curtin University; Murdoch University	House, MJ (corresponding author), Univ Western Australia, Sch Phys, Crawley, Australia.	michael.house@uwa.edu.au	House, Michael/B-6477-2008	House, Michael/0000-0002-1752-6274; AYONRINDE, OYEKOYA/0000-0002-0598-151X; St Pierre, Tim/0000-0003-4682-4972; Olynyk, John/0000-0003-0417-3411	National Health & Medical Research Council of Australia Practitioner Fellowship [1042370]	National Health & Medical Research Council of Australia Practitioner Fellowship	John K. Olynyk is the recipient of a National Health & Medical Research Council of Australia Practitioner Fellowship (1042370). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl M, 2008, RADIOLOGY, V249, P160, DOI 10.1148/radiol.2491071375; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BRIX G, 1993, MAGN RESON IMAGING, V11, P977, DOI 10.1016/0730-725X(93)90217-2; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Cesbron-Metivier E, 2010, EUR J GASTROEN HEPAT, V22, P973, DOI 10.1097/MEG.0b013e32833775fb; Cho CS, 2008, J AM COLL SURGEONS, V206, P480, DOI 10.1016/j.jamcollsurg.2007.08.020; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; d'Assignies G, 2011, EUR RADIOL, V21, P301, DOI 10.1007/s00330-010-1941-1; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Hatta T, 2010, J GASTROENTEROL, V45, P1263, DOI 10.1007/s00535-010-0277-6; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Joe E, 2012, J MAGN RESON IMAGING, V36, P1124, DOI 10.1002/jmri.23738; Kang BK, 2012, INVEST RADIOL, V47, P368, DOI 10.1097/RLI.0b013e31824baff3; Kim SH, 2006, RADIOLOGY, V240, P116, DOI 10.1148/radiol.2393042218; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KUHN JP, 2011, RADIOLOGY, V46, P783, DOI DOI 10.1097/RLI.0B013E31822B124C; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Mennesson N, 2009, J COMPUT ASSIST TOMO, V33, P672, DOI 10.1097/RCT.0b013e318199d883; Pilleul F, 2005, GASTROEN CLIN BIOL, V29, P1143, DOI 10.1016/S0399-8320(05)82179-7; Qayyum A, 2005, RADIOLOGY, V237, P507, DOI 10.1148/radiol.2372040539; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Rinella ME, 2003, LIVER TRANSPLANT, V9, P851, DOI 10.1053/jlts.2003.50153; Roldan-Valadez E, 2010, J HEPATOL, V53, P732, DOI 10.1016/j.jhep.2010.04.018; Schuchmann S, 2007, EUR J RADIOL, V62, P416, DOI 10.1016/j.ejrad.2006.12.009; Siegel CA, 2005, CLEV CLIN J MED, V72, P199, DOI 10.3949/ccjm.72.3.199; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; St Pierre TG, 2010, BLOOD, V116, P852; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Westphalen ACA, 2007, RADIOLOGY, V242, P450, DOI 10.1148/radiol.2422052024	37	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59287	10.1371/journal.pone.0059287	http://dx.doi.org/10.1371/journal.pone.0059287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555650	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400031
J	Marshall, C; Richards, M; McBryde, E				Marshall, Caroline; Richards, Michael; McBryde, Emma			Do Active Surveillance and Contact Precautions Reduce MRSA Acquisition? A Prospective Interrupted Time Series	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE-UNIT; HOSPITAL OUTBREAK; TRANSMISSION; INFECTION; COLONIZATION; INTERVENTION; MODEL; ENTEROCOCCI; IMPACT	Background: Consensus for methicillin-resistant Staphylococcus aureus (MRSA) control has still not been reached. We hypothesised that use of rapid MRSA detection followed by contact precautions and single room isolation would reduce MRSA acquisition. Methods: This study was a pre-planned prospective interrupted time series comparing rapid PCR detection and use of long sleeved gowns and gloves (contact precautions) plus single room isolation or cohorting of MRSA colonised patients with a control group. The study took place in a medical-surgical intensive care unit of a tertiary adult hospital between May 21st 2007 and September 21st 2009. The primary outcome was the rate of MRSA acquisition. A segmented regression analysis was performed to determine the trend in MRSA acquisition rates before and after the intervention. Findings: The rate of MRSA acquisition was 18.5 per 1000 at risk patient days in the control phase and 7.9 per 1000 at-risk patient days in the intervention phase, with an adjusted hazard ratio 0.39 (95% CI 0.24 to 0.62). Segmented regression analysis showed a decline in MRSA acquisition of 7% per month in the intervention phase, (95% CI 1.9% to 12.8% reduction) which was a significant change in slope compared with the control phase. Secondary analysis found prior exposure to anaerobically active antibiotics and colonization pressure were associated with increased acquisition risk. Conclusion: Contact precautions with single room isolation or cohorting were associated with a 60% reduction in MRSA acquisition. While this study was a quasi-experimental design, many measures were taken to strengthen the study, such as accounting for differences in colonisation pressure, hand hygiene compliance and individual risk factors across the groups, and confining the study to one centre to reduce variation in transmission. Use of two research nurses may limit its generalisability to units in which this level of support is available.	[Marshall, Caroline] Univ Melbourne, Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic, Australia; Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Marshall, C (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic, Australia.	caroline.marshall@mh.org.au	McBryde, Emma/D-2220-2018	McBryde, Emma/0000-0002-9570-9172; Marshall, Caroline/0000-0001-5901-2004; Richards, Michael/0000-0002-7380-6852	National Health and Medical Research Council of Australia [454495]; Victorian Department of Human Services; Sylvia and Charles Viertel Charitable Foundation; Victor Hurley Medical Research Fund	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Human Services; Sylvia and Charles Viertel Charitable Foundation; Victor Hurley Medical Research Fund	This study was supported by grants from the National Health and Medical Research Council of Australia, http://www.nhmrc.gov.au/ (Project Grant number 454495); the Victorian Department of Human Services, http://www.health.vic.gov.au/ (Public Health Research Project award); a Sylvia and Charles Viertel Charitable Foundation Clinical Investigatorship, www.anz.com/anztrustees; and a Victor Hurley Medical Research Fund Grant-in-Aid. The authors thank Becton Dickinson for supplying the swabs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao AO, 2011, INFECT CONT HOSP EP, V32, P481, DOI 10.1086/659403; Ballard SA, 2005, ANTIMICROB AGENTS CH, V49, P1688, DOI 10.1128/AAC.49.5.1688-1694.2005; Bishop EJ, 2006, J CLIN MICROBIOL, V44, P2904, DOI 10.1128/JCM.02211-05; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Cooper B S, 2003, Health Technol Assess, V7, P1; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Ferguson J, 2002, AUST INF CONTROL, V7, P8; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Gurieva T, 2012, CLIN INFECT DIS, V54, P1618, DOI 10.1093/cid/cis272; Harbarth S, 2000, J HOSP INFECT, V46, P43, DOI 10.1053/jhin.2000.0798; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Harrington G, 2007, INFECT CONT HOSP EP, V28, P837, DOI 10.1086/518844; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jernigan JA, 1996, AM J EPIDEMIOL, V143, P496, DOI 10.1093/oxfordjournals.aje.a008770; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kirkland KB, 2009, CLIN INFECT DIS, V48, P766, DOI 10.1086/597090; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lee AS, 2011, INFECT DIS CLIN N AM, V25, P155, DOI 10.1016/j.idc.2010.11.002; Marshall C, 2003, INFECT CONT HOSP EP, V24, P322, DOI 10.1086/502215; Marshall C, 2009, INFECT CONT HOSP EP, V30, P125, DOI 10.1086/593967; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Wang J., 2010, Healthcare Infection, V15, P115, DOI 10.1071/HI10021; Wenzel RP, 2008, INFECT CONT HOSP EP, V29, P1012, DOI 10.1086/593120	32	30	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58112	10.1371/journal.pone.0058112	http://dx.doi.org/10.1371/journal.pone.0058112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555568	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000316546400005
J	Chapman, BB; Hegg, A; Ljungberg, P				Chapman, Ben B.; Hegg, Alexander; Ljungberg, Peter			Sex and the Syndrome: Individual and Population Consistency in Behaviour in Rock Pool Prawn Palaemon elegans	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; COD GADUS-MORHUA; ANIMAL PERSONALITIES; POECILIA-RETICULATA; SOCIAL-CONTEXT; BOLDNESS; ADSPERSUS; SQUILLA; DIFFERENTIATION; CONSEQUENCES	Animal personality has been widely documented across a range of species. The concept of personality is composed of individual behavioural consistency across time and between situations, and also behavioural trait correlations known as behavioural syndromes. Whilst many studies have now investigated the stability of individual personality traits, few have analysed the stability over time of entire behavioural syndromes. Here we present data from a behavioural study of rock pool prawns. We show that prawns are temporally consistent in a range of behaviours, including activity, exploration and boldness, and also that a behavioural syndrome is evident in this population. We find correlations between many behavioural traits (activity, boldness, shoaling and exploration). In addition, behavioural syndrome structure was consistent over time. Finally, few studies have explicitly studied the role of sex differences in personality traits, behavioural consistency and syndrome structure. We report behavioural differences between male and female prawns but no differences in patterns of consistency. Our study adds to the growing literature on animal personality, and provides evidence showing that syndromes themselves can exhibit temporal consistency.	[Chapman, Ben B.; Hegg, Alexander; Ljungberg, Peter] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Skane, Sweden	Lund University	Chapman, BB (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Skane, Sweden.	ben.chapman@biol.lu.se		Ljungberg, Peter/0000-0003-1168-4375	EU; Anna and Edwin Berger Foundation	EU(European Commission); Anna and Edwin Berger Foundation	BBC was funded by an EU FP7 Marie Curie fellowship. Financial support was provided from Anna and Edwin Berger Foundation to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2012, ECOLOGY LETT; [Anonymous], 2010, R LANG ENV STAT COMP; Bell A, 2012, BEHAV ECOLOGY; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BERGLUND A, 1981, OECOLOGIA, V49, P300, DOI 10.1007/BF00347589; BERGLUND A, 1980, HOLARCTIC ECOL, V3, P111; BERGLUND A, 1981, OIKOS, V36, P158, DOI 10.2307/3544440; BERGLUND A, 1983, MAR BIOL, V77, P49, DOI 10.1007/BF00393209; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Buss A. H., 1988, PERSONALITY EVOLUTIO; Chapman BB, 2008, ANIM BEHAV, V76, P923, DOI 10.1016/j.anbehav.2008.03.022; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chapman BB, 2009, BEHAV ECOL SOCIOBIOL, V63, P1757, DOI 10.1007/s00265-009-0796-4; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Evans SR, 2007, ANIM BEHAV, V74, P1691, DOI 10.1016/j.anbehav.2007.03.017; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Ioannou CC, 2009, BIOL LETTERS, V5, P191, DOI 10.1098/rsbl.2008.0758; Johnson JC, 2007, ANIM BEHAV, V74, P1131, DOI 10.1016/j.anbehav.2007.02.006; Krause J, 2002, LIVING GROUPS; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Ljungberg P, 2012, MARINE BIOL; Ljungberg P, 2012, MAR ECOL PROG SER, V466, P215, DOI 10.3354/meps09932; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Moen FE, 2009, DJURLIV HAVET NORDEU; Mowles SL, 2012, BEHAV ECOL SOCIOBIOL, V66, P1087, DOI 10.1007/s00265-012-1359-7; Persson A, 2012, MAR ECOL PROG SER, V456, P245, DOI 10.3354/meps09705; Persson M, 2008, MAR ECOL PROG SER, V371, P203, DOI 10.3354/meps07674; Piyapong C, 2010, BEHAV ECOL, V21, P3, DOI 10.1093/beheco/arp142; Pruitt JN, 2012, AM NAT, V179, P217, DOI 10.1086/663680; Pruitt JN, 2009, ANIM BEHAV, V78, P175, DOI 10.1016/j.anbehav.2009.04.016; RIECHERT SE, 1993, ANIM BEHAV, V46, P669, DOI 10.1006/anbe.1993.1243; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	46	22	22	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59437	10.1371/journal.pone.0059437	http://dx.doi.org/10.1371/journal.pone.0059437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555034	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800091
J	Denoeud-Ndam, L; Fourcade, C; Ogouyemi-Hounto, A; Azon-Kouanou, A; d'Almeida, M; Azondekon, A; Alao, MJ; Dossou-Gbete, V; Afangnihoun, A; Girard, PM; Cot, M; Zannou, DM				Denoeud-Ndam, Lise; Fourcade, Camille; Ogouyemi-Hounto, Aurore; Azon-Kouanou, Angele; d'Almeida, Marcelline; Azondekon, Alain; Alao, Marouf J.; Dossou-Gbete, Veronique; Afangnihoun, Aldric; Girard, Pierre-Marie; Cot, Michel; Zannou, Djimon-Marcel			Predictive Factors of Plasma HIV Suppression during Pregnancy: A Prospective Cohort Study in Benin	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; RNA VIRAL LOAD; RISK-FACTORS; BIRTH-WEIGHT; SOUTH-AFRICA; WOMEN; MALARIA; PREVENTION	Objective: To investigate the factors associated with HIV1 RNA plasma viral load (pVL) below 40 copies/mL at the third trimester of pregnancy, as part of prevention of mother-to-child transmission (PMTCT) in Benin. Design: Sub study of the PACOME clinical trial of malaria prophylaxis in HIV-infected pregnant women, conducted before and after the implementation of the WHO 2009 revised guidelines for PMTCT. Methods: HIV-infected women were enrolled in the second trimester of pregnancy. Socio-economic characteristics, HIV history, clinical and biological characteristics were recorded. Malaria prevention and PMTCT involving antiretroviral therapy (ART) for mothers and infants were provided. Logistic regression helped identifying factors associated with virologic suppression at the end of pregnancy. Results: Overall 217 third trimester pVLs were available, and 71% showed undetectability. Virologic suppression was more frequent in women enrolled after the change in PMTCT recommendations, advising to start ART at 14 weeks instead of 28 weeks of pregnancy. In multivariate analysis, Fon ethnic group (the predominant ethnic group in the study area), regular job, first and second pregnancy, higher baseline pVL and impaired adherence to ART were negative factors whereas higher weight, higher antenatal care attendance and longer ART duration were favorable factors to achieve virologic suppression. Conclusions: This study provides more evidence that ART has to be initiated before the last trimester of pregnancy to achieve an undetectable pVL before delivery. In Benin, new recommendations supporting early initiation were well implemented and, together with a high antenatal care attendance, led to high rate of virologic control.	[Denoeud-Ndam, Lise; Fourcade, Camille; Cot, Michel] Inst Rech Dev, UMR 216, Paris, France; [Denoeud-Ndam, Lise; Fourcade, Camille; Cot, Michel] Univ Paris 05, Paris, France; [Ogouyemi-Hounto, Aurore] Programme Natl Lutte Sida, Lab Natl Reference, Cotonou, Benin; [Azon-Kouanou, Angele; Zannou, Djimon-Marcel] Ctr Natl Hosp Univ Hubert Koutoukou Maga, Ctr Traitement Ambulatoire, Cotonou, Benin; [d'Almeida, Marcelline] Ctr Natl Hosp Univ Hubert Koutoukou Maga, Serv Pediat, Cotonou, Benin; [Azondekon, Alain] Hop Instruct Armees, Serv Pediat, Cotonou, Benin; [Alao, Marouf J.] Hop Mere & Enfant Lagune, Serv Pediat, Cotonou, Benin; [Dossou-Gbete, Veronique] Clin Louis Pasteur, Porto Novo, Benin; [Afangnihoun, Aldric] Hop Zone Suru Lere, Ctr Traitement Ambulatoire, Cotonou, Benin; [Girard, Pierre-Marie] Hop St Antoine, Serv Malad Infect & Trop, F-75571 Paris, France; [Girard, Pierre-Marie] Univ Paris 06, Paris, France; [Zannou, Djimon-Marcel] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Abomey Calavi	Denoeud-Ndam, L (corresponding author), Inst Rech Dev, UMR 216, Paris, France.	lisedenoeud@yahoo.fr; camillefourcade@gmail.com	Cot, Michel/E-7633-2011	Cot, Michel/0000-0003-3014-4294; DENOEUD-NDAM, Lise/0000-0002-9482-1461	Sidaction [AI19-3-01528]	Sidaction	This study was funded by Sidaction (grant number AI19-3-01528). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Becquet R, 2011, LANCET INFECT DIS, V11, P154, DOI 10.1016/S1473-3099(10)70299-1; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Brahmbhatt H, 2008, JAIDS-J ACQ IMM DEF, V47, P472, DOI 10.1097/QAI.0b013e318162afe0; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Cowan FA, 2008, AIDS, V22, P193, DOI 10.1097/QAD.0b013e3282f2a939; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Denoeud L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-27; Denoeud-Ndam L, 2012, JAIDS-J ACQ IMM DEF, V61, P64, DOI 10.1097/QAI.0b013e3182615a58; Duri K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-176; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Fawzi W, 2001, AIDS, V15, P1157, DOI 10.1097/00002030-200106150-00011; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Izzo I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-124; Jourdain G, 2007, J INFECT DIS, V196, P1629, DOI 10.1086/522009; Kahn JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031316; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V30, P316, DOI [10.1097/01.QAI.0000014767.47046.C8, 10.1097/00126334-200207010-00008]; Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Read PJ, 2012, AIDS, V26, P1095, DOI 10.1097/QAD.0b013e3283536a6c; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; UNAIDS, 2012, UNAIDSJC2417E; WHO, 2012, US ANT DRUGS TREAT P; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zijenah LS, 2004, AIDS, V18, P273, DOI 10.1097/00002030-200401230-00017	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59446	10.1371/journal.pone.0059446	http://dx.doi.org/10.1371/journal.pone.0059446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555035	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800092
J	Belachew, T; Lindstrom, D; Gebremariam, A; Hogan, D; Lachat, C; Huybregts, L; Kolsteren, P				Belachew, Tefera; Lindstrom, David; Gebremariam, Abebe; Hogan, Dennis; Lachat, Carl; Huybregts, Lieven; Kolsteren, Patrick			Food Insecurity, Food Based Coping Strategies and Suboptimal Dietary Practices of Adolescents in Jimma Zone Southwest Ethiopia	PLOS ONE			English	Article							ANIMAL SOURCE FOODS; URBAN-RURAL DIFFERENCES; NUTRITIONAL-STATUS; FREQUENCY QUESTIONNAIRE; INTRAHOUSEHOLD ALLOCATION; NUTRIENT ADEQUACY; DIVERSITY SCORES; GENDER BIAS; CHILDREN; CONSUMPTION	Despite the high prevalence of adolescent food insecurity in Ethiopia, there is no study which documented its association with suboptimal dietary practices. The objective of this study is to determine the association between adolescent food insecurity and dietary practices. We used data on 2084 adolescents in the age group of 13-17 years involved in the first round survey of the five year longitudinal family study in Southwest Ethiopia. Adolescents were selected using residence stratified random sampling methods. Food insecurity was measured using scales validated in developing countries. Dietary practices were measured using dietary diversity score, food variety score and frequency of consuming animal source food. Multivariable regression models were used to compare dietary behaviors by food security status after controlling for socio-demographic and economic covariates. Food insecure adolescents had low dietary diversity score (P<0.001), low mean food variety score (P<0.001) and low frequency of consuming animal source foods (P<0.001). After adjusting for other variables in a multivariable logistic regression model, adolescent food insecurity (P<0.001) and rural residence (P<0.001) were negatively associated with the likelihood of having a diversified diet (P<0.001) and frequency of consuming animal source foods, while a high household income tertile was positively associated. Similarly, multivariable linear regression model showed that adolescent food insecurity was negatively associated with food variety score, while residence in semi-urban areas (P<0.001), in urban areas (P<0.001) and high household income tertile (P = 0.013) were positively associated. Girls were less likely to have diversified diet (P = 0.001) compared with boys. Our findings suggest that food insecurity has negative consequence on optimal dietary intake of adolescents. Food security interventions should look into ways of targeting adolescents to mitigate these dietary consequences and provide alternative strategies to improve dietary quality of adolescents in Southwest Ethiopia.	[Belachew, Tefera; Gebremariam, Abebe] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia; [Belachew, Tefera; Lachat, Carl; Huybregts, Lieven; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Lindstrom, David; Hogan, Dennis] Brown Univ, Dept Sociol, Providence, RI 02912 USA; [Lachat, Carl; Kolsteren, Patrick] Inst Trop Med, Nutr & Child Hlth Unit, Dept Publ Hlth, B-2000 Antwerp, Belgium	Jimma University; Ghent University; Brown University; Institute of Tropical Medicine (ITM)	Belachew, T (corresponding author), Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia.	teferabelachew@gmail.com	Belachew, Tefera/AAO-5877-2020; lachat, carl/AAH-9764-2020; Huybregts, Lieven/B-9578-2009	lachat, carl/0000-0002-1389-8855; Huybregts, Lieven/0000-0002-3068-2853	Packard Foundation; Campton Foundation; National Institute of Health; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Campton Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Jimma Longitudinal Family Survey of Youth was funded by the Packard Foundation, Campton Foundation, National Institute of Health and National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2010, J HEALTH POPUL NUTR, V28, P86; ALARCON JA, 1991, ARCH LATINOAM NUTR, V41, P327; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Ayele Z, 2003, J NUTR, V133, p3981S, DOI 10.1093/jn/133.11.3981S; Azadbakht L, 2005, EUR J CLIN NUTR, V59, P1233, DOI 10.1038/sj.ejcn.1602234; Becquey E, 2010, J NUTR, V140, P2233, DOI 10.3945/jn.110.125716; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; Belachew T, 2011, PEDIATRICS, V127, pE398, DOI 10.1542/peds.2010-0944; Belachew T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-29; Belsky DW, 2010, AM J EPIDEMIOL, V172, P809, DOI 10.1093/aje/kwq201; Bernal J, 2012, J NUTR, V142, P1343, DOI 10.3945/jn.112.158063; Brinkman HJ, 2010, J NUTR, V140, p153S, DOI 10.3945/jn.109.110767; Christian P, 2010, J NUTR, V140, p177S, DOI 10.3945/jn.109.111708; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Cohen M. J., 2009, HUMAN SETTLEMENTS WO, V2; Cook JT, 2008, ANN NY ACAD SCI, V1136, P193, DOI 10.1196/annals.1425.001; Daniels MC, 2009, EUR J CLIN NUTR, V63, P199, DOI 10.1038/sj.ejcn.1602927; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Duffy P, 2009, J NUTR EDUC BEHAV, V41, P414, DOI 10.1016/j.jneb.2008.09.002; Federal Democratic Republic of Ethiopia Ministry of Health, 2003, AD REPR HLTH EXT PAC; Federal Ministry of Health, 2008, NAT NUTR PROGR ETH P; Federal Ministry of Health, 2008, NAT NUTR STRAT ETH; Food and Agriculture Organization (FAO), 2010, STATE FOOD INSECURIT; Fram MS, 2011, J NUTR, V141, P1114, DOI 10.3945/jn.110.135988; Frongillo EA, 2006, J NUTR, V136, P1409; FRONGILLO EA, 1993, J NUTR, V123, P189; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hadley C, 2009, ANN ANTHROPL PRACT, V32, P77, DOI 10.1111/j.1556-4797.2009.01029.x; Hamelin AM, 1999, J NUTR, V129, p525S, DOI 10.1093/jn/129.2.525S; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Ibrahim H., 2009, Pakistan Journal of Nutrition, V8, P810; Jackson M, 2002, PUBLIC HEALTH NUTR, V5, P281, DOI 10.1079/PHN2002262; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kant AK, 1997, NUTR RES, V17, P1443, DOI 10.1016/S0271-5317(97)00135-8; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kuku O, 2011, FOOD POLICY, V36, P311, DOI 10.1016/j.foodpol.2010.11.029; Larsen CS, 2003, J NUTR, V133, p3893S, DOI 10.1093/jn/133.11.3893S; Leyna GH, 2010, PUBLIC HEALTH NUTR, V13, P1438, DOI 10.1017/S1368980010000327; Mammen S, 2009, SOC INDIC RES, V92, P151, DOI 10.1007/s11205-008-9294-8; Marshall TA, 2001, J NUTR, V131, P2192, DOI 10.1093/jn/131.8.2192; Maxwell D., 2003, COPING STRATEGIES IN; Melgar-Quinonez HR, 2006, J NUTR, V136, P1431, DOI 10.1093/jn/136.5.1431S; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Mulugeta A, 2009, ETHIOP J HEALTH DEV, V23, P5; Nanama S, 2012, FOOD POLICY, V37, P217, DOI 10.1016/j.foodpol.2012.02.006; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Norhasmah S Jr, 2010, Malays J Nutr, V16, P39; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Oldewage-Theron WH, 2010, S AFR J CLIN NUTR, V23, P149; Onyango AW, 2003, COMP BIOCHEM PHYS A, V136, P61, DOI 10.1016/S1095-6433(03)00071-0; Pan Y, 2008, J AM DIET ASSOC, V108, P276, DOI 10.1016/j.jada.2007.10.049; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Rodriguez MM, 2002, PUBLIC HEALTH NUTR, V5, P691, DOI 10.1079/PHN2002333; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Sanogo I., 2009, HUMANITARIAN EXCHANG; SENAUER B, 1988, AM J AGR ECON, V70, P170, DOI 10.2307/1241987; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Speedy AW, 2003, J NUTR, V133, p4048S, DOI 10.1093/jn/133.11.4048S; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Teufel NI, 1997, AM J CLIN NUTR, V65, P1173; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Torheim LE, 2003, EUR J CLIN NUTR, V57, P1283, DOI 10.1038/sj.ejcn.1601686; US Deparment of Agriculture Human Nutrition Information Service, 2005, HOM GARD B; Webb Patrick, 2006, J Nutr, V136, p1404S; WFP & UNICEF, 2009, SUMM FOOD SEC VULN S; Woodward DR, 2000, ECOL FOOD NUTR, V39, P271, DOI 10.1080/03670244.2000.9991619	73	51	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57643	10.1371/journal.pone.0057643	http://dx.doi.org/10.1371/journal.pone.0057643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554864	Green Published, gold			2022-12-27	WOS:000316252500005
J	Carlson, KJ; Jashashvili, T; Houghton, K; Westaway, MC; Patel, BA				Carlson, Kristian J.; Jashashvili, Tea; Houghton, Kimberley; Westaway, Michael C.; Patel, Biren A.			Joint Loads in Marsupial Ankles Reflect Habitual Bipedalism versus Quadrupedalism	PLOS ONE			English	Article							SUBCHONDRAL BONE; TERRESTRIAL LOCOMOTION; APPARENT DENSITY; FORELIMB KINEMATICS; ARBOREAL LOCOMOTION; COMPLIANT WALKING; MAYULESTES-FEROX; ENERGETIC COST; HAND POSTURES; PAPIO-ANUBIS	Joint surfaces of limb bones are loaded in compression by reaction forces generated from body weight and musculotendon complexes bridging them. In general, joints of eutherian mammals have regions of high radiodensity subchondral bone that are better at resisting compressive forces than low radiodensity subchondral bone. Identifying similar form-function relationships between subchondral radiodensity distribution and joint load distribution within the marsupial postcranium, in addition to providing a richer understanding of marsupial functional morphology, can serve as a phylogenetic control in evaluating analogous relationships within eutherian mammals. Where commonalities are established across phylogenetic borders, unifying principles in mammalian physiology, morphology, and behavior can be identified. Here, we assess subchondral radiodensity patterns in distal tibiae of several marsupial taxa characterized by different habitual activities (e. g., locomotion). Computed tomography scanning, maximum intensity projection maps, and pixel counting were used to quantify radiodensity in 41 distal tibiae of bipedal (5 species), arboreal quadrupedal (4 species), and terrestrial quadrupedal (5 species) marsupials. Bipeds (Macropus and Wallabia) exhibit more expansive areas of high radiodensity in the distal tibia than arboreal (Dendrolagus, Phascolarctos, and Trichosurus) or terrestrial quadrupeds (Sarcophilus, Thylacinus, Lasiorhinus, and Vombatus), which may reflect the former carrying body weight only through the hind limbs. Arboreal quadrupeds exhibit smallest areas of high radiodensity, though they differ non-significantly from terrestrial quadrupeds. This could indicate slightly more compliant gaits by arboreal quadrupeds compared to terrestrial quadrupeds. The observed radiodensity patterns in marsupial tibiae, though their statistical differences disappear when controlling for phylogeny, corroborate previously documented patterns in primates and xenarthrans, potentially reflecting inferred limb use during habitual activities such as locomotion. Despite the complex nature of factors contributing to joint loads, broad observance of these patterns across joints and across a variety of taxa suggests that subchondral radiodensity can be used as a unifying form-function principle within Mammalia.	[Carlson, Kristian J.; Jashashvili, Tea; Houghton, Kimberley] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Jashashvili, Tea] Georgian Natl Museum, Dept Geol & Paleontol, Tbilisi, Georgia; [Westaway, Michael C.] Queensland Museum, Cultures & Hist Program, Brisbane, Qld 4101, Australia; [Patel, Biren A.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Witwatersrand; Indiana University System; Indiana University Bloomington; Queensland Museum; University of Southern California	Carlson, KJ (corresponding author), Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa.	kristian.carlson@wits.ac.za	Patel, Biren/B-8373-2016		African Origins Platform of the Department of Science and Technology (South Africa); National Research Foundation of South Africa; University of the Witwatersrand	African Origins Platform of the Department of Science and Technology (South Africa); National Research Foundation of South Africa(National Research Foundation - South Africa); University of the Witwatersrand	Funding for the project was provided by the African Origins Platform of the Department of Science and Technology (South Africa), the National Research Foundation of South Africa, and the University of the Witwatersrand. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Bassarova M, 2009, J MAMM EVOL, V16, P1, DOI 10.1007/s10914-008-9093-7; BAUDINETTE RV, 1994, AUST J ZOOL, V42, P103, DOI 10.1071/ZO9940103; BAUDINETTE RV, 1992, AM J PHYSIOL, V262, pR771, DOI 10.1152/ajpregu.1992.262.5.R771; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; Bennett MB, 2000, PHYSIOL BIOCHEM ZOOL, V73, P726, DOI 10.1086/318110; BIEWENER AA, 1995, J EXP BIOL, V198, P1829; Biewener AA., 2003, ANIMAL LOCOMOTION; Byron CD, 2004, J ZOOL, V263, P101, DOI 10.1017/S0952836904004935; Carlson KJ, 2005, J ZOOL, V266, P261, DOI 10.1017/S0952836905006874; Carlson KJ, 2006, J ANAT, V208, P659, DOI 10.1111/j.1469-7580.2006.00555.x; Carlson KJ, 2010, AM J PHYS ANTHROPOL, V142, P273, DOI 10.1002/ajpa.21224; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; CURREY J, 1984, AM ZOOL, V24, P5; Daley MA, 2010, BIOL LETTERS, V6, P418, DOI 10.1098/rsbl.2010.0175; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; Eckstein F, 1999, ANAT EMBRYOL, V199, P85, DOI 10.1007/s004290050212; FARLEY CT, 1993, J EXP BIOL, V185, P71; GARLAND T, 1988, J ZOOL, V215, P505, DOI 10.1111/j.1469-7998.1988.tb02856.x; Herzog W, 2003, LANGENBECK ARCH SURG, V388, P305, DOI 10.1007/s00423-003-0402-6; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; Jones C, 2010, FIELD GUIDE AUSTR MA; Kram R, 1998, COMP BIOCHEM PHYS B, V120, P41, DOI 10.1016/S0305-0491(98)00022-4; Lammers AR, 2004, J EXP BIOL, V207, P4325, DOI 10.1242/jeb.01231; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; McGowan CR, 2008, COMP BIOCHEM PHYS A, V150, P151, DOI 10.1016/j.cbpa.2006.06.018; McGowan CP, 2005, J EXP BIOL, V208, P41, DOI 10.1242/jeb.01305; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; MULLERGERBL M, 1992, J BONE MINER RES, V7, pS411; Nowak MG, 2010, AM J PHYS ANTHROPOL, V142, P180, DOI 10.1002/ajpa.21210; Patel BA, 2008, BIOL LETTERS, V4, P486, DOI 10.1098/rsbl.2008.0297; Patel BA, 2007, J HUM EVOL, V52, P130, DOI 10.1016/j.jhevol.2006.08.007; Patel BA, 2012, J EXP BIOL, V215, P115, DOI 10.1242/jeb.063107; Patel BA, 2010, INT J PRIMATOL, V31, P191, DOI 10.1007/s10764-010-9394-6; Patel BA, 2010, ANAT REC, V293, P710, DOI 10.1002/ar.21128; Patel BA, 2010, AM J PHYS ANTHROPOL, V141, P222, DOI 10.1002/ajpa.21138; Patel BA, 2009, AM J PHYS ANTHROPOL, V140, P92, DOI 10.1002/ajpa.21039; Polk JD, 2008, ANAT REC, V291, P293, DOI 10.1002/ar.20653; PRIDMORE PA, 1992, J MORPHOL, V211, P137, DOI 10.1002/jmor.1052110203; RADIN EL, 1970, J BONE JOINT SURG AM, VA 52, P444, DOI 10.2106/00004623-197052030-00004; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Schmitt D, 1999, J ZOOL, V248, P149, DOI 10.1017/S0952836999006020; Schmitt D, 2004, J HUM EVOL, V46, P239, DOI 10.1016/j.jhevol.2003.11.008; Schmitt D, 2002, AM J PHYS ANTHROPOL, V118, P231, DOI 10.1002/ajpa.10048; Shapiro LJ, 2012, J EXP BIOL, V215, P480, DOI 10.1242/jeb.062588; Stevens NJ, 2006, J EXP ZOOL PART A, V305A, P953, DOI 10.1002/jez.a.336; Su A, 2011, THESIS STONY BROOK U; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Szalay FS, 2006, EVOLUTIONARY HIST MA; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x	57	9	9	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58811	10.1371/journal.pone.0058811	http://dx.doi.org/10.1371/journal.pone.0058811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554931	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500045
J	Pendleton, C; Li, Q; Chesler, DA; Yuan, K; Guerrero-Cazares, H; Quinones-Hinojosa, A				Pendleton, Courtney; Li, Qian; Chesler, David A.; Yuan, Kristy; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo			Mesenchymal Stem Cells Derived from Adipose Tissue vs Bone Marrow: In Vitro Comparison of Their Tropism towards Gliomas	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; CELLULAR VEHICLES; PROGENITOR CELLS; STROMAL CELLS; BRAIN-TUMORS; DELIVERY; TRANSFORMATION; RESISTANCE; SURVIVAL; THERAPY	Introduction: Glioblastoma is the most common primary malignant brain tumor, and is refractory to surgical resection, radiation, and chemotherapy. Human mesenchymal stem cells (hMSC) may be harvested from bone marrow (BMSC) and adipose (AMSC) tissue. These cells are a promising avenue of investigation for the delivery of adjuvant therapies. Despite extensive research into putative mechanisms for the tumor tropism of MSCs, there remains no direct comparison of the efficacy and specificity of AMSC and BMSC tropism towards glioma. Methods: Under an IRB-approved protocol, intraoperative human Adipose MSCs (hAMSCs) were established and characterized for cell surface markers of mesenchymal stem cell origin in conjunction with the potential for tri-lineage differentiation (adipogenic, chondrogenic, and osteogenic). Validated experimental hAMSCs were compared to commercially derived hBMSCs (Lonza) and hAMSCs (Invitrogen) for growth responsiveness and glioma tropism in response to glioma conditioned media obtained from primary glioma neurosphere cultures. Results: Commercial and primary culture AMSCs and commercial BMSCs demonstrated no statistically significant difference in their migration towards glioma conditioned media in vitro. There was statistically significant difference in the proliferation rate of both commercial AMSCs and BMSCs as compared to primary culture AMSCs, suggesting primary cultures have a slower growth rate than commercially available cell lines. Conclusions: Adipose- and bone marrow-derived mesenchymal stem cells have similar in vitro glioma tropism. Given the well-documented ability to harvest larger numbers of AMSCs under local anesthesia, adipose tissue may provide a more efficient source of MSCs for research and clinical applications, while minimizing patient morbidity during cell harvesting.	[Quinones-Hinojosa, Alfredo] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Quinones-Hinojosa, A (corresponding author), Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21205 USA.	aquinon2@jhmi.edu		Guerrero-Cazares, Hugo/0000-0003-1307-719X; Li, Qian/0000-0003-0359-5604	National Institutes of Health; Maryland Stem Cells Research Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cells Research Fund	This study was funded by the National Institutes of Health and the Maryland Stem Cells Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BERNSTEIN JJ, 1995, NEUROSURGERY, V36, P124, DOI 10.1227/00006123-199501000-00016; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cavarretta I. T., 2009, MOL THER; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Covas DT, 2003, BRAZ J MED BIOL RES, V36, P1179, DOI 10.1590/S0100-879X2003000900006; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dembinski JL, 2009, CANC GENE THER; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6; Huang Q, 2009, CANC GENE THER; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kerkis I, 2011, TISSUE ENG B; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lamfers M, 2009, CANCER LETT, V274, P78, DOI 10.1016/j.canlet.2008.08.035; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Momin Eric N., 2010, Current Immunology Reviews, V6, P137; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Rodriguez-Lozano FJ, 2011, INT ENDOD J, V44, P800, DOI 10.1111/j.1365-2591.2011.01877.x; Roger M, 2011, M S-MED SCI, V27, P234, DOI 10.1051/medsci/2011273234; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Sakariassen PO, 2007, NEOPLASIA, V9, P882, DOI 10.1593/neo.07658; Song F, 2012, J CANCER RES CLIN, V138, P347, DOI 10.1007/s00432-011-1104-z; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Sun XL, 2011, CANCER LETT, V312, P168, DOI 10.1016/j.canlet.2011.07.035; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Tyler MA, 2009, GENE THER, V16, P262, DOI 10.1038/gt.2008.165; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Xu Feng, 2007, Neurosci Bull, V23, P363, DOI 10.1007/s12264-007-0054-6; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Yuan XP, 2006, CANCER RES, V66, P2630, DOI 10.1158/0008-5472.CAN-05-1682; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	48	90	92	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58198	10.1371/journal.pone.0058198	http://dx.doi.org/10.1371/journal.pone.0058198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554877	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500016
J	Walters, RG; Coin, LJM; Ruokonen, A; de Smith, AJ; Moustafa, JSES; Jacquemont, S; Elliott, P; Esko, T; Hartikainen, AL; Laitinen, J; Mannik, K; Martinet, D; Meyre, D; Nauck, M; Schurmann, C; Sladek, R; Thorleifsson, G; Thorsteinsdottir, U; Valsesia, A; Waeber, G; Zufferey, F; Balkau, B; Pattou, F; Metspalu, A; Volzke, H; Vollenweider, P; Stefansson, K; Jarvelin, MR; Beckmann, JS; Froguel, P; Blakemore, AIF				Walters, Robin G.; Coin, Lachlan J. M.; Ruokonen, Aimo; de Smith, Adam J.; Moustafa, Julia S. El-Sayed; Jacquemont, Sebastien; Elliott, Paul; Esko, Tonu; Hartikainen, Anna-Liisa; Laitinen, Jaana; Maennik, Katrin; Martinet, Danielle; Meyre, David; Nauck, Matthias; Schurmann, Claudia; Sladek, Rob; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Valsesia, Armand; Waeber, Gerard; Zufferey, Flore; Balkau, Beverley; Pattou, Francois; Metspalu, Andres; Voelzke, Henry; Vollenweider, Peter; Stefansson, Kari; Jarvelin, Marjo-Riitta; Beckmann, Jacques S.; Froguel, Philippe; Blakemore, Alexandra I. F.			Rare Genomic Structural Variants in Complex Disease: Lessons from the Replication of Associations with Obesity	PLOS ONE			English	Article							COPY NUMBER VARIATION; CIRCULAR BINARY SEGMENTATION; HIDDEN-MARKOV MODEL; WIDE ASSOCIATION; CHILDHOOD OBESITY; EARLY-ONSET; LOCI; DELETIONS; EXTREME; COHORT	The limited ability of common variants to account for the genetic contribution to complex disease has prompted searches for rare variants of large effect, to partly explain the 'missing heritability'. Analyses of genome-wide genotyping data have identified genomic structural variants (GSVs) as a source of such rare causal variants. Recent studies have reported multiple GSV loci associated with risk of obesity. We attempted to replicate these associations by similar analysis of two familial-obesity case-control cohorts and a population cohort, and detected GSVs at 11 out of 18 loci, at frequencies similar to those previously reported. Based on their reported frequencies and effect sizes (OR >= 25), we had sufficient statistical power to detect the large majority (80%) of genuine associations at these loci. However, only one obesity association was replicated. Deletion of a 220 kb region on chromosome 16p11.2 has a carrier population frequency of 2x10(-4) (95% confidence interval [9.6x10(-5)-3.1x10(-4)]); accounts overall for 0.5% [0.19%-0.82%] of severe childhood obesity cases (P=3.8x10(-10); odds ratio = 25.0 [9.9-60.6]); and results in a mean body mass index (BMI) increase of 5.8 kg.m(-2) [1.8-10.3] in adults from the general population. We also attempted replication using BMI as a quantitative trait in our population cohort; associations with BMI at or near nominal significance were detected at two further loci near KIF2B and within FOXP2, but these did not survive correction for multiple testing. These findings emphasise several issues of importance when conducting rare GSV association, including the need for careful cohort selection and replication strategy, accurate GSV identification, and appropriate correction for multiple testing and/or control of false discovery rate. Moreover, they highlight the potential difficulty in replicating rare CNV associations across different populations. Nevertheless, we show that such studies are potentially valuable for the identification of variants making an appreciable contribution to complex disease.	[Walters, Robin G.; Coin, Lachlan J. M.; de Smith, Adam J.; Moustafa, Julia S. El-Sayed; Froguel, Philippe; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Walters, Robin G.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Walters, Robin G.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Coin, Lachlan J. M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Ruokonen, Aimo] Oulu Univ Hosp, Oulu, Finland; [de Smith, Adam J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jacquemont, Sebastien; Martinet, Danielle; Zufferey, Flore; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA, Ctr Environm & Hlth, London, England; [Esko, Tonu; Maennik, Katrin; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Sci Obstet & Gynecol, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Maennik, Katrin] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Meyre, David; Froguel, Philippe] Inst Pasteur, CNRS 8199, Inst Biol, F-59019 Lille, France; [Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Nauck, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Schurmann, Claudia] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Sladek, Rob] McGill Univ, Montreal, PQ, Canada; [Sladek, Rob] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Sladek, Rob] McGill Univ, Dept Med & Human Genet, Montreal, PQ, Canada; [Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Valsesia, Armand; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Valsesia, Armand] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Valsesia, Armand] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Balkau, Beverley] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Pattou, Francois] INSERM, U859, F-59045 Lille, France; [Pattou, Francois] Univ Lille Nord France, CHU Lille, Lille, France; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse & Serv, Oulu, Finland; [Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Sect Invest Med, London, England	Imperial College London; University of Oxford; University of Oxford; University of Queensland; University of Oulu; University of Oulu; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; Imperial College London; University of Tartu; University of Tartu; University of Oulu; Finnish Institute of Occupational Health; University of Lausanne; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; McMaster University; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; McGill University; McGill University; University of Iceland; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Ernst Moritz Arndt Universitat Greifswald; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London	Froguel, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England.	p.froguel@imperial.ac.uk; a.blakemore@imperial.ac.uk	Sladek, Robert/R-2391-2019; Walters, Robin G/E-6069-2010; Coin, Lachlan JM/A-9001-2014; Colaus, PsyColaus/K-6607-2013; Coin, Lachlan/O-4976-2019; Pattou, Francois/O-6151-2017; Beckmann, Jacques S/A-9772-2008; FROGUEL, Philippe/O-6799-2017; Blakemore, Alexandra I F/D-2253-2009; Stefansson, Kari/AAE-7187-2019; Schurmann, Claudia/L-1204-2016; Jacquemont, Sebastien/AAS-5060-2021; Meyre, David/D-7315-2011	Sladek, Robert/0000-0002-2730-1204; Walters, Robin G/0000-0002-9179-0321; Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Pattou, Francois/0000-0001-8388-3766; Beckmann, Jacques S/0000-0002-9741-1900; FROGUEL, Philippe/0000-0003-2972-0784; Blakemore, Alexandra I F/0000-0003-0661-564X; Schurmann, Claudia/0000-0003-4158-9192; Jacquemont, Sebastien/0000-0001-6838-8767; Meyre, David/0000-0003-4850-7444; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Valsesia, Armand/0000-0003-0746-9664; Esko, Tonu/0000-0003-1982-6569; Waeber, Gerard/0000-0003-4193-788X; de Smith, Adam/0000-0003-4880-7543; Elliott, Paul/0000-0002-7511-5684; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654	Imperial College Department of Medicine PhD studentship; MRC [G1002084, G0801056] Funding Source: UKRI; Diabetes UK [08/0003775] Funding Source: researchfish; Medical Research Council [G1002084, G0801056, G0801056B] Funding Source: researchfish	Imperial College Department of Medicine PhD studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The NFBC authors thank Prof. Paula Rantakallio (launch of NFBC1966 and initial data collection), Ms Sarianna Vaara (data collection), Ms Tuula Ylitalo (administration), Mr Markku Koiranen (data management), Ms Outi Tornwall and Ms Minttu Jussila (DNA biobanking). We acknowledge the contribution of Prof. Vincent Mooser to the CoLaus study. The CoLaus authors thank Yolande Barreau, Mathieu Firmann, Vladimir Mayor, Anne-Lise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey, and Sylvie Mermoud for data collection. The SHIP authors are grateful to the contribution of Anja Wiechert and Astrid Petersmann in generating the genetic data. JSe-SM was supported by an Imperial College Department of Medicine PhD studentship.	Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bonnefond A, 2012, NAT GENET; Bouatia-Naji N, 2008, OBESITY, V16, P1471, DOI 10.1038/oby.2008.209; Chen XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012185; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Froguel P, 2008, NEW ENGL J MED, V359, P891, DOI 10.1056/NEJMp0805396; Glessner JT, 2010, AM J HUM GENET, V87, P661, DOI 10.1016/j.ajhg.2010.09.014; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Holder JL, 2000, HUM MOL GENET, V9, P101; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jarick I, 2010, HUMAN MOL GENETICS; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-330; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829; R Development Core Team, 2005, R LANG ENV STAT COMP; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sampson JN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-68; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stutzmann F, 2009, DIABETOLOGIA, V52, pS104; Tang T, 2009, J BIOL CHEM; Traurig M, 2009, DIABETES, V58, P1682, DOI 10.2337/db09-0028; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; Valsesia A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-241; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2010, DIABETES, V59, P2690, DOI 10.2337/db10-0192; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhai GJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002025; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	58	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58048	10.1371/journal.pone.0058048	http://dx.doi.org/10.1371/journal.pone.0058048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554873	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500013
J	Zimmerman, MW; Homanics, GE; Lazo, JS				Zimmerman, Mark W.; Homanics, Gregg E.; Lazo, John S.			Targeted Deletion of the Metastasis-Associated Phosphatase Ptp4a3 (PRL-3) Suppresses Murine Colon Cancer	PLOS ONE			English	Article							TYROSINE PHOSPHATASE; MUTANT MICE; MOUSE MODEL; EXPRESSION; CARCINOGENESIS; INVASION; PROTEIN; 1,2-DIMETHYLHYDRAZINE; TUMORS; BETA	Ptp4a3 (commonly known as PRL-3) is an enigmatic member of the Ptp4a family of prenylated protein tyrosine phosphatases that are highly expressed in many human cancers. Despite strong correlations with tumor metastasis and poor patient prognosis, there is very limited understanding of this gene family's role in malignancy. Therefore, we created a gene-targeted murine knockout model for Ptp4a3, the most widely studied Ptp4a family member. Mice deficient for Ptp4a3 were grossly normal. Fewer homozygous-null males were observed at weaning, however, and they maintained a decreased body mass. Although Ptp4a3 is normally associated with late-stage cancer and metastasis, we observed increased Ptp4a3 expression in the colon of wildtype mice immediately following treatment with the carcinogen azoxymethane. To investigate the role of Ptp4a3 in malignancy, we used the most commonly studied murine colitis-associated colon cancer model. Wildtype mice treated with azoxymethane and dextran sodium sulfate developed approximately 7-10 tumors per mouse in the distal colon. The resulting tumor tissue had 4-fold more Ptp4a3 mRNA relative to normal colon epithelium and increased PTP4A3 protein. Ptp4a3-null mice developed 50% fewer colon tumors than wildtype mice after exposure to azoxymethane and dextran sodium sulfate. Tumors from the Ptp4a3-null mice had elevated levels of both IGF1R beta and c-MYC compared to tumors replete with Ptp4a3, suggesting an enhanced cell signaling pathway engagement in the absence of the phosphatase. These results provide the first definitive evidence implicating Ptp4a3 in colon tumorigenesis and highlight the potential value of the phosphatase as a therapeutic target for early stage malignant disease.	[Zimmerman, Mark W.; Homanics, Gregg E.; Lazo, John S.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Homanics, Gregg E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Lazo, John S.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia	Lazo, JS (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	lazo@virginia.edu		Homanics, Gregg/0000-0003-3641-8153	National Institutes of Health [AA10422, F31AA019597A]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010422, R37AA010422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This was funded by National Institutes of Health grant AA10422 and fellowship F31AA019597A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; De Robertis M., 2011, J CARCINOG, V10; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Dong Y, 2012, AKT J BIOL IN PRESS; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Goo K, 2006, CANCER RES, V66, P9625, DOI 10.1158/0008-5472.CAN-06-0726; Guda K, 2003, MOL CARCINOGEN, V37, P51, DOI 10.1002/mc.10120; Guzinska-Ustymowicz K, 2011, ANTI-CANCER AGENT ME, V11, P99, DOI 10.2174/187152011794941145; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kohno H, 2005, CANCER SCI, V96, P69, DOI 10.1111/j.1349-7006.2005.00020.x; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; OTOOLE SM, 1993, CANCER RES, V53, P3895; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Zhao WB, 2008, INT J MOL MED, V22, P187, DOI 10.3892/ijmm_00000007; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	30	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58300	10.1371/journal.pone.0058300	http://dx.doi.org/10.1371/journal.pone.0058300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555575	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000317262200004
J	Bevacqua, S; Cerasti, E; Falcone, R; Cervelloni, M; Brunamonti, E; Ferraina, S; Genovesio, A				Bevacqua, Sara; Cerasti, Erika; Falcone, Rossella; Cervelloni, Milena; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo			Macaque Monkeys Can Learn Token Values from Human Models through Vicarious Reward	PLOS ONE			English	Article							CEBUS-APELLA; CAPUCHIN MONKEYS; RHESUS-MONKEYS; IMITATION; PRIMATES; CUES	Monkeys can learn the symbolic meaning of tokens, and exchange them to get a reward. Monkeys can also learn the symbolic value of a token by observing conspecifics but it is not clear if they can learn passively by observing other actors e.g., humans. To answer this question, we tested two monkeys in a token exchange paradigm in three experiments. Monkeys learned token values through observation of human models exchanging them. We used, after a phase of object familiarization, different sets of tokens. One token of each set was rewarded with a bit of apple. Other tokens had zero value neutral tokens). Each token was presented only in one set. During the observation phase, monkeys watched the human model exchange tokens and watched them consume rewards (vicarious rewards). In the test phase, the monkeys were asked to exchange one of the tokens for food reward. Sets of three tokens were used in the first experiment and sets of two tokens were used in the second and third experiments. The valuable token was presented with different probabilities in the observation phase during the first and second experiments in which the monkeys exchanged the valuable token more frequently than any of the neutral tokens. The third experiments examined the effect of unequal probabilities. Our results support the view that monkeys can learn from non-conspecific actors through vicarious reward, even a symbolic task like the token-exchange task.	[Bevacqua, Sara; Cerasti, Erika; Falcone, Rossella; Cervelloni, Milena; Brunamonti, Emiliano; Ferraina, Stefano; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy	Sapienza University Rome	Genovesio, A (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	aldo.genovesio@uniroma1.it	ferraina, stefano/M-5230-2018	ferraina, stefano/0000-0001-6100-2438; FALCONE, ROSSELLA/0000-0001-5068-2984; Genovesio, Aldo/0000-0003-2521-143X; Brunamonti, Emiliano/0000-0002-5119-6950	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie [P288/09]	'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie	This work was supported by the 'Sapienza' University of Rome, Ricerca dell'Ateneo Federato di Scienze delle Politiche Pubbliche e Sanitarie (Protocol number: P288/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; [Anonymous], 1956, LEARNING INSTINCT AN; Bandura Albert, 1977, SOCIAL LEARNING THEO; Bourjade M, 2012, ANIM COGN, V15, P783, DOI 10.1007/s10071-012-0502-1; Brosnan SF, 2005, PRIMATES, V46, P173, DOI 10.1007/s10329-005-0125-0; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Davis KM, 2011, J COMP PSYCHOL, V125, P404, DOI 10.1037/a0024784; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Evans TA, 2010, J COMP PSYCHOL, V124, P369, DOI 10.1037/a0019855; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040283; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kohts N, 1935, SCI MEMOIRS MUSCUM D; Kumashiro M, 2003, INT J PSYCHOPHYSIOL, V50, P81, DOI 10.1016/S0167-8760(03)00126-0; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Meunier M, 2007, NEUROBIOL LEARN MEM, V88, P243, DOI 10.1016/j.nlm.2007.04.015; Miklosi A, 1999, BIOL REV, V74, P347, DOI 10.1017/S000632319900537X; Monfardini E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00127; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Pele M, 2010, ANIM COGN, V13, P745, DOI 10.1007/s10071-010-0325-x; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; Spence KW, 1937, PSYCHOL BULL, V34, P806, DOI 10.1037/h0061498; Westergaard GC, 2004, ANIM COGN, V7, P19, DOI 10.1007/s10071-003-0181-z; Westergaard Gregory Charles, 1998, Animal Cognition, V1, P101, DOI 10.1007/s100710050014; Wolfe JB., 1936, COMP PSYCHOL MONOGR, V12, P72; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004; ZENTALL TR, 1972, SCIENCE, V178, P1220, DOI 10.1126/science.178.4066.1220	32	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59961	10.1371/journal.pone.0059961	http://dx.doi.org/10.1371/journal.pone.0059961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544115	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700074
J	Greenway, KT; LeGresley, EB; Pinto, BM				Greenway, Kyle T.; LeGresley, Eric B.; Pinto, B. Mario			The Influence of 150-Cavity Binders on the Dynamics of Influenza A Neuraminidases as Revealed by Molecular Dynamics Simulations and Combined Clustering	PLOS ONE			English	Article							BINDING; N1; OSELTAMIVIR; INHIBITORS; DESIGN	Neuraminidase inhibitors are the main pharmaceutical agents employed for treatments of influenza infections. The neuraminidase structures typically exhibit a 150-cavity, an exposed pocket that is adjacent to the catalytic site. This site offers promising additional contact points for improving potency of existing pharmaceuticals, as well as generating entirely new candidate inhibitors. Several inhibitors based on known compounds and designed to interact with 150 cavity residues have been reported. However, the dynamics of any of these inhibitors remains unstudied and their viability remains unknown. This work reports the outcome of long-term, all-atom molecular dynamics simulations of four such inhibitors, along with three standard inhibitors for comparison. Each is studied in complex with four representative neuraminidase structures, which are also simulated in the absence of ligands for comparison, resulting in a total simulation time of 9.6 mu s. Our results demonstrate that standard inhibitors characteristically reduce the mobility of these dynamic proteins, while the 150-binders do not, instead giving rise to many unique conformations. We further describe an improved RMSD-based clustering technique that isolates these conformations - the structures of which are provided to facilitate future molecular docking studies - and reveals their interdependence. We find that this approach confers many advantages over previously described techniques, and the implications for rational drug design are discussed.	[Greenway, Kyle T.; LeGresley, Eric B.; Pinto, B. Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Pinto, BM (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	bpinto@sfu.ca		Greenway, Kyle/0000-0002-7829-493X; LeGresley, Eric/0000-0002-5286-5693	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	KTG received a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). BMP received funding from the same organization. All calculations were performed with the resources of Compute Canada (https://computecanada.ca/index.php/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2007, J AM CHEM SOC, V129, P7764, DOI 10.1021/ja0723535; Amaro RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1390; [Anonymous], PYMOL MOL GRAPH SYST; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Du J, 2012, DRUG DISCOV TODAY, V17, P1111, DOI 10.1016/j.drudis.2012.06.002; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Garcia-Sosa AT, 2008, J CHEM INF MODEL, V48, P2074, DOI 10.1021/ci800242z; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jefferson T, 2011, COCHRANE DB SYST REV, V2011; Kar P, 2012, J PHYS CHEM B, V116, P6137, DOI 10.1021/jp3022612; Lawrenz M, 2010, PROTEINS, V78, P2523, DOI 10.1002/prot.22761; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li Y, 2009, J MOL GRAPH MODEL, V28, P203, DOI 10.1016/j.jmgm.2009.07.001; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; Park JW, 2010, EUR J MED CHEM, V45, P536, DOI 10.1016/j.ejmech.2009.10.040; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rudrawar S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1114; Rungrotmongkol T, 2009, ANTIVIR RES, V82, P51, DOI 10.1016/j.antiviral.2009.01.008; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Scalmani G., 2016, GAUSSIAN 09; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Udommaneethanakit T, 2009, J CHEM INF MODEL, V49, P2323, DOI 10.1021/ci900277r; Vavricka CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002249; Venkatramani L, 2006, J MOL BIOL, V356, P651, DOI 10.1016/j.jmb.2005.11.061; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wen WH, 2010, BIOORGAN MED CHEM, V18, P4074, DOI 10.1016/j.bmc.2010.04.010; Ye DJ, 2012, EUR J MED CHEM, V54, P764, DOI 10.1016/j.ejmech.2012.06.033	37	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59873	10.1371/journal.pone.0059873	http://dx.doi.org/10.1371/journal.pone.0059873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544106	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700066
J	Jaakkonen, T; Kari, A; Forsman, JT				Jaakkonen, Tuomo; Kari, Annemari; Forsman, Jukka T.			Flycatchers Copy Conspecifics in Nest-Site Selection but Neither Personal Experience nor Frequency of Tutors Have an Effect	PLOS ONE			English	Article							BREEDING HABITAT SELECTION; PUBLIC INFORMATION; INVESTMENT DECISIONS; COLLARED FLYCATCHER; ADAPTIVE USE; FITNESS; CHIMPANZEES; COMPETITOR; PREFERENCE; EVOLUTION	Using the behavior of others in guiding one's own behavior is a common strategy in animals. The prevailing theory predicts that young age and the inexperience of an individual are expected to increase the probability of adopting the behaviors of others. Also, the most common behavior in the population should be copied. Here, we tested the above predictions by examining social information use in the selection of nest-site features with a field experiment using a wild cavity nesting bird, the collared flycatcher (Ficedula albicollis). We used an experimental design in which geometric symbols depict nest-site features. By manipulating the apparent symbol choices of early settled individuals and monitoring the choices of later arriving birds, we can study social information use without bias from learned or innate Preferences. Flycatchers were found to use social information in the selection of nest site features, with about 60% of the population preferring the manipulated conspecific choices. However, age and experience as explanatory factors suggested by the social information use theory did not explain the choices. The present result, in concert with earlier similar experiments, implies that flycatchers may in some situations rely more on iriterspecific information in the selection of nest-site characteristics.	[Jaakkonen, Tuomo; Kari, Annemari; Forsman, Jukka T.] Univ Oulu, Dept Biol, Oulu, Finland	University of Oulu	Jaakkonen, T (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	tuomo.jaakkonen@oulu.fi; jukka.forsman@oulu.fi			Academy of Finland [122665, 125720]; Ella and Georg Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Ella and Georg Ehrnrooth Foundation	This work was funded by the Academy of Finland (project numbers 122665 and 125720) and Ella and Georg Ehrnrooth Foundation (May 2011, May 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; ALATALO RV, 1982, BIRD BEHAV, V4, P42, DOI 10.3727/015613882791560576; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Coolen I, 2003, P ROY SOC B-BIOL SCI, V270, P2413, DOI 10.1098/rspb.2003.2525; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 1999, J ANIM ECOL, V68, P1193, DOI 10.1046/j.1365-2656.1999.00362.x; Dubois F, 2012, P ROY SOC B-BIOL SCI, V279, P1977, DOI 10.1098/rspb.2011.2342; Forsman JT, 2002, P ROY SOC B-BIOL SCI, V269, P1619, DOI 10.1098/rspb.2002.2065; Forsman JT, 2008, BEHAV ECOL, V19, P539, DOI 10.1093/beheco/arn005; Forsman JT, 2012, BIOL LETTERS, V8, P341, DOI 10.1098/rsbl.2011.0970; Forsman JT, 2011, ANIM BEHAV, V81, P879, DOI 10.1016/j.anbehav.2011.01.029; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Laland KN, 1998, BEHAV ECOL, V9, P493, DOI 10.1093/beheco/9.5.493; Laland KN, 2004, LEARN BEHAV, V32, P4; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martin TE, 1996, NATURE, V380, P338, DOI 10.1038/380338a0; Morand-Ferron J, 2011, P ROY SOC B-BIOL SCI, V278, P1223, DOI 10.1098/rspb.2010.1769; Nordell SE, 1998, ECOL LETT, V1, P74; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Seppanen JT, 2007, CURR BIOL, V17, P1248, DOI 10.1016/j.cub.2007.06.034; Seppanen JT, 2011, P ROY SOC B-BIOL SCI, V278, P1736, DOI 10.1098/rspb.2010.1610; Svensson L., 1992, IDENTIFICATION GUIDE; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Venables W., 2013, MODERN APPL STAT S, V53, P86; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Zuberbuhler K, 2000, P ROY SOC B-BIOL SCI, V267, P713, DOI 10.1098/rspb.2000.1061	33	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60395	10.1371/journal.pone.0060395	http://dx.doi.org/10.1371/journal.pone.0060395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544136	gold, Green Published			2022-12-27	WOS:000317480700095
J	Sheard, JM; Ash, S; Mellick, GD; Silburn, PA; Kerr, GK				Sheard, Jamie M.; Ash, Susan; Mellick, George D.; Silburn, Peter A.; Kerr, Graham K.			Markers of Disease Severity Are Associated with Malnutrition in Parkinson's Disease	PLOS ONE			English	Article							BODY-COMPOSITION; OLDER-ADULTS; NUTRITIONAL-STATUS; WEIGHT-LOSS; HOME; RISK; CARE; INTERVENTION; PROGRESSION; PREVALENCE	Objective: In Parkinson's disease (PD), commonly reported risk factors for malnutrition in other populations commonly occur. Few studies have explored which of these factors are of particular importance in malnutrition in PD. The aim was to identify the determinants of nutritional status in people with Parkinson's disease (PWP). Methods: Community-dwelling PWP (>18 years) were recruited (n=125; 73M/52F; Mdn 70 years). Self-report assessments included Beck's Depression Inventory (BDI), Spielberger Trait Anxiety Inventory (STAI), Scales for Outcomes in Parkinson's disease - Autonomic (SCOPA-AUT), Modified Constipation Assessment Scale (MCAS) and Freezing of Gait Questionnaire (FOG-Q). Information about age, PD duration, medications, co-morbid conditions and living situation was obtained. Addenbrooke's Cognitive Examination (ACE-R), Unified Parkinson's Disease Rating Scale (UPDRS) II and UPDRS III were performed. Nutritional status was assessed using the Subjective Global Assessment (SGA) as part of the scored Patient-Generated Subjective Global Assessment (PG-SGA). Results: Nineteen (15%) were malnourished (SGA-B). Median PG-SGA score was 3. More of the malnourished were elderly (84% vs. 71%) and had more severe disease (H&Y: 21% vs. 5%). UPDRS II and UPDRS III scores and levodopa equivalent daily dose (LEDD)/body weight(mg/kg) were significantly higher in the malnourished (Mdn 18 vs. 15; 20 vs. 15; 10.1 vs. 7.6 respectively). Regression analyses revealed older age at diagnosis, higher LEDD/body weight (mg/kg), greater UPDRS III score, lower STAI score and higher BDI score as significant predictors of malnutrition (SGA-B). Living alone and higher BDI and UPDRS III scores were significant predictors of a higher log-adjusted PG-SGA score. Conclusions: In this sample of PWP, the rate of malnutrition was higher than that previously reported in the general community. Nutrition screening should occur regularly in those with more severe disease and depression. Community support should be provided to PWP living alone. Dopaminergic medication should be reviewed with body weight changes.	[Sheard, Jamie M.; Ash, Susan; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Sheard, Jamie M.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [Mellick, George D.] Griffith Univ, Australia Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; University of Queensland	Sheard, JM (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	jamie.sheard@qut.edu.au	Ash, Susan/I-9664-2012; Mellick, George D./A-7650-2010	Ash, Susan/0000-0003-2078-7560; Mellick, George D./0000-0002-7211-4651; Sheard, Jamie/0000-0002-1730-4831; Kerr, Graham/0000-0002-1008-256X	Parkinson's Queensland, Inc.	Parkinson's Queensland, Inc.	Parkinson's Queensland, Inc. (http://parkinsons-qld.org.au/) provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did advertise the study in their newsletter and on their website for the purpose of recruiting participants.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; [Anonymous], 2009, NUTR DIET, V66, pS1; Arabia G, 2002, NEUROL SCI, V23, pS53, DOI 10.1007/s100720200066; Bachmann CG, 2009, EUR J NEUROL, V16, P895, DOI 10.1111/j.1468-1331.2009.02617.x; Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Buchanan RJ, 2002, PARKINSONISM RELAT D, V8, P369, DOI 10.1016/S1353-8020(02)00004-4; Campbell KL, 2008, AM J KIDNEY DIS, V51, P748, DOI 10.1053/j.ajkd.2007.12.015; Campbell KL, 2007, J RENAL NUTR, V17, P189, DOI 10.1053/j.jrn.2006.12.005; Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dissanayaka NNW, 2011, J AFFECT DISORDERS, V132, P82, DOI 10.1016/j.jad.2011.01.021; EDWARDS LL, 1991, MOVEMENT DISORD, V6, P151, DOI 10.1002/mds.870060211; Elia M, 2005, NUTRITION, V21, P1100, DOI 10.1016/j.nut.2005.03.005; Encarnacion EV, 2008, EUR NEUROL, V60, P57, DOI 10.1159/000131893; Endevelt R, 2011, J NUTR HEALTH AGING, V15, P624, DOI 10.1007/s12603-011-0074-9; Evatt ML, 2009, MOVEMENT DISORD, V24, P635, DOI 10.1002/mds.22260; Guest JF, 2011, CLIN NUTR, V30, P422, DOI 10.1016/j.clnu.2011.02.002; Johansson Y, 2009, J CLIN NURS, V18, P1354, DOI 10.1111/j.1365-2702.2008.02552.x; Laky B, 2008, AM J CLIN NUTR, V87, P1678, DOI 10.1093/ajcn/87.6.1678; Landi F, 2012, J NUTR HEALTH AGING, V16, P79, DOI 10.1007/s12603-011-0064-y; Leggo M, 2008, NUTR DIET, V65, P162, DOI 10.1111/j.1747-0080.2008.00239.x; Loewdalt B, 2006, GERONTOLOGY, V52, P160, DOI 10.1159/000091825; Mamhidir AG, 2006, J NUTR HEALTH AGING, V10, P255; Miller M., 2000, Australian Journal of Nutrition and Dietetics, V57, P152; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; Pai MK, 2011, BIOMED RES-INDIA, V22, P120; Parker BA, 2004, MECH AGEING DEV, V125, P859, DOI 10.1016/j.mad.2004.05.006; Poewe W, 2007, J NEUROL, V254, P49, DOI 10.1007/s00415-007-5008-4; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704; Saka B, 2010, CLIN NUTR, V29, P745, DOI 10.1016/j.clnu.2010.04.006; SCOTT DM, 2009, DRUG TOP, V153, P40; Sharma JC, 2010, PARKINSONISM RELAT D, V16, P490, DOI 10.1016/j.parkreldis.2010.06.003; Sharma JC, 2006, PARKINSONISM RELAT D, V12, P499, DOI 10.1016/j.parkreldis.2006.07.002; Shatenstein B, 2001, J GERONTOL A-BIOL, V56, pM483, DOI 10.1093/gerona/56.8.M483; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053290; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Thomas P, 2003, J Nutr Health Aging, V7, P166; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; van der Marck MA, 2012, PARKINSONISM RELAT D, V18, P263, DOI 10.1016/j.parkreldis.2011.10.016; Verbaan D, 2007, NEUROLOGY, V69, P333, DOI 10.1212/01.wnl.0000266593.50534.e8; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009	47	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57986	10.1371/journal.pone.0057986	http://dx.doi.org/10.1371/journal.pone.0057986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544041	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700004
J	Velo, P; Leiras, R; Canedo, A				Velo, Patricia; Leiras, Roberto; Canedo, Antonio			Electrophysiological Study of Supraspinal Input and Spinal Output of Cat's Subnucleus Reticularis Dorsalis (SRD) Neurons	PLOS ONE			English	Article							PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; ADJACENT CUNEATE NUCLEUS; DESCENDING PROJECTIONS; EFFERENT PROJECTIONS; BRAIN-STEM; RETICULOSPINAL NEURONS; NOCICEPTIVE NEURONS; CONDUCTION-VELOCITY; RAT; HORN	This work addressed the study of subnucleus reticularis dorsalis (SRD) neurons in relation to their supraspinal input and the spinal terminating sites of their descending axons. SRD extracellular unitary recordings from anesthetized cats aimed to specifically test, 1) the rostrocaudal segmental level reached by axons of spinally projecting (SPr) neurons collateralizing or not to or through the ipsilateral nucleus reticularis gigantocellularis (NRGc), 2) whether SPr fibers bifurcate to the thalamus, and 3) the effects exerted on SRD cells by electrically stimulating the locus coeruleus, the periaqueductal grey, the nucleus raphe magnus, and the mesencephalic locomotor region. From a total of 191 SPr fibers tested to cervical 2 (Ce2), thoracic 5 (Th5) and lumbar5 (Lu5) stimulation, 81 ended between Ce2 and Th5 with 39 of them branching to or through the NRGc; 21/49 terminating between Th5 and Lu5 collateralized to or through the same nucleus, as did 34/61 reaching Lu5. The mean antidromic conduction velocity of SPr fibers slowed in the more proximal segments and increased with terminating distance along the cord. None of the 110 axons tested sent collaterals to the thalamus; instead thalamic stimulation induced long-latency polysynaptic responses in most cells but also short-latency, presumed monosynaptic, in 7.9% of the tested neurons (18/227). Antidromic and orthodromic spikes were elicited from the locus coeruleus and nucleus raphe magnus, but exclusively orthodromic responses were observed following stimulation of the periaqueductal gray or mesencephalic locomotor region. The results suggest that information from pain-and-motor-related supraspinal structures converge on SRD cells that through SPr axons having conduction velocities tuned to their length may affect rostral and caudal spinal cord neurons at fixed delays, both directly and in parallel through different descending systems. The SRD will thus play a dual functional role by simultaneously regulating dorsal horn ascending noxious information and pain-related motor responses.	[Velo, Patricia; Leiras, Roberto; Canedo, Antonio] Fac Med, Dept Physiol, Santiago De Compostela, Spain		Canedo, A (corresponding author), Fac Med, Dept Physiol, Santiago De Compostela, Spain.	antonio.canedo@usc.es		Canedo, Antonio/0000-0002-1728-3954; Leiras, Roberto/0000-0001-7232-2904	Spanish Ministerio de Ciencia y Tecnologia [BFU2009-12803]; Xunta de Galicia [09CSA010208PR]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	Work supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (BFU2009-12803) and the Xunta de Galicia (09CSA010208PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1993, NEUROSCIENCE, V55, P1093, DOI 10.1016/0306-4522(93)90323-8; Almeida A, 2000, EUR J PAIN, V4, P373, DOI 10.1053/eujp.2000.0193; Almeida A, 1997, EUR J NEUROSCI, V9, P686, DOI 10.1111/j.1460-9568.1997.tb01417.x; ALMEIDA A, 1995, NEUROREPORT, V6, P1245, DOI 10.1097/00001756-199506090-00004; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P286, DOI 10.1016/0304-3940(87)90311-9; BASBAUM AI, 1979, J COMP NEUROL, V187, P513, DOI 10.1002/cne.901870304; BASBAUM AI, 1978, J COMP NEUROL, V178, P209, DOI 10.1002/cne.901780203; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BERNARD JF, 1990, NEUROSCI LETT, V116, P257, DOI 10.1016/0304-3940(90)90083-L; BOBILLIER P, 1976, BRAIN RES, V113, P449, DOI 10.1016/0006-8993(76)90050-0; BOWSHER D, 1968, J NEUROPHYSIOL, V31, P288, DOI 10.1152/jn.1968.31.2.288; BRINDLEY GS, 1980, J NEUROL NEUROSUR PS, V43, P1083, DOI 10.1136/jnnp.43.12.1083; BURTON H, 1968, Brain Research, V11, P357, DOI 10.1016/0006-8993(68)90031-0; CAMERON AA, 1995, J COMP NEUROL, V351, P585, DOI 10.1002/cne.903510408; Canedo A, 1997, PROG NEUROBIOL, V51, P287, DOI 10.1016/S0301-0082(96)00058-5; CANEDO A, 1993, J PHYSIOL-LONDON, V463, P475, DOI 10.1113/jphysiol.1993.sp019606; Canedo A, 2000, EUR J NEUROSCI, V12, P2515, DOI 10.1046/j.1460-9568.2000.00107.x; CASEY K L, 1971, International Journal of Neuroscience, V2, P29, DOI 10.3109/00207457109146990; CASEY KL, 1989, BRAIN RES, V501, P150, DOI 10.1016/0006-8993(89)91036-6; CASEY KL, 1969, EXP NEUROL, V25, P35, DOI 10.1016/0014-4886(69)90070-3; CHAN SHH, 1979, EXP NEUROL, V66, P356, DOI 10.1016/0014-4886(79)90086-4; Chomiak T, 2008, J NEUROPHYSIOL, V100, P327, DOI 10.1152/jn.90392.2008; Chomiak T, 2007, J PHYSIOL-LONDON, V579, P403, DOI 10.1113/jphysiol.2006.124057; CLOUGH JFM, 1968, J PHYSIOL-LONDON, V198, P167, DOI 10.1113/jphysiol.1968.sp008599; DARIANSM.I, 1965, J NEUROPHYSIOL, V28, P682, DOI 10.1152/jn.1965.28.4.682; Davies PW, 1968, MED PHYSL, V2, P1073; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; ECCLES JC, 1975, J NEUROPHYSIOL, V38, P513, DOI 10.1152/jn.1975.38.3.513; FIELDS HL, 1978, ANNU REV PHYSIOL, V40, P217, DOI 10.1146/annurev.ph.40.030178.001245; Fujino Y, 1996, BRAIN RES, V715, P225, DOI 10.1016/0006-8993(96)00019-4; FUNG SJ, 1987, ARCH ITAL BIOL, V125, P171; GARCIARILL E, 1987, BRAIN RES, V411, P13, DOI 10.1016/0006-8993(87)90676-7; GRILL WM, 1995, IEEE ENG MED BIOL, V14, P375, DOI 10.1109/51.395310; Hermann DM, 1997, J CHEM NEUROANAT, V13, P1, DOI 10.1016/S0891-0618(97)00019-7; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; HOCKFIELD S, 1978, BRAIN RES, V139, P333, DOI 10.1016/0006-8993(78)90933-2; HOLSTEGE G, 1982, PROG BRAIN RES, V57, P145, DOI 10.1016/S0079-6123(08)64128-X; HUNT CC, 1954, J GEN PHYSIOL, V38, P117, DOI 10.1085/jgp.38.1.117; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P597, DOI 10.1113/jphysiol.1972.sp009817; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; Kuncel AM, 2004, CLIN NEUROPHYSIOL, V115, P2431, DOI 10.1016/j.clinph.2004.05.031; Kuwabara N, 2000, BRAIN RES, V878, P79, DOI 10.1016/S0006-8993(00)02695-0; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leiras R, 2010, J NEUROSCI, V30, P15383, DOI 10.1523/JNEUROSCI.2193-10.2010; Leite-Almeida H, 2006, NEUROSCIENCE, V140, P577, DOI 10.1016/j.neuroscience.2006.02.022; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; MANCIA M, 1974, BRAIN RES, V69, P297, DOI 10.1016/0006-8993(74)90008-0; MARTIN GF, 1988, NEUROSCIENCE, V25, P87, DOI 10.1016/0306-4522(88)90008-5; MATSUYAMA K, 1988, BRAIN RES, V460, P124, DOI 10.1016/0006-8993(88)91212-7; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; Monconduit L, 2002, EUR J NEUROSCI, V16, P937, DOI 10.1046/j.1460-9568.2002.02148.x; Morgan MM, 1996, PAIN, V66, P307, DOI 10.1016/0304-3959(96)03061-8; Morgan MM, 1999, NEUROSCIENCE, V88, P489, DOI 10.1016/S0306-4522(98)00238-3; Nauta WJH, 1958, RETICULAR FORMATION, P3; PEARL GS, 1980, BRAIN RES BULL, V5, P203, DOI 10.1016/0361-9230(80)90194-X; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; PETERSON BW, 1975, EXP BRAIN RES, V23, P333; Peterson BW, 1980, RETICULAR FORMATION, P171; Peterson BW, 1984, BRAIN STEM CONTROL S, P141; Raboisson P, 1996, J COMP NEUROL, V367, P503, DOI 10.1002/(SICI)1096-9861(19960415)367:4<503::AID-CNE3>3.0.CO;2-8; RAPOPORT S, 1977, J PHYSIOL-LONDON, V272, P367, DOI 10.1113/jphysiol.1977.sp012049; RINDOS AJ, 1984, EXP NEUROL, V86, P208, DOI 10.1016/0014-4886(84)90182-1; ROWE MJ, 1968, J PHYSIOL-LONDON, V196, P19, DOI 10.1113/jphysiol.1968.sp008491; SANDKUHLER J, 1984, BRAIN RES, V305, P67, DOI 10.1016/0006-8993(84)91120-X; Scheibel ME, 1958, RETICULAR FORMATION, P31; SHIGENAGA Y, 1983, BRAIN RES, V277, P201, DOI 10.1016/0006-8993(83)90928-9; SHIZGAL P, 1991, BEHAV BRAIN RES, V42, P151, DOI 10.1016/S0166-4328(05)80006-3; SIEGEL JM, 1979, BRAIN RES REV, V1, P69, DOI 10.1016/0165-0173(79)90017-1; Soto C, 2011, J PHYSIOL-LONDON, V589, P4383, DOI 10.1113/jphysiol.2011.212464; Soto-Sanchez C, 2008, PAIN, V140, P190, DOI 10.1016/j.pain.2008.08.007; STEEVES JD, 1984, BRAIN RES, V307, P263, DOI 10.1016/0006-8993(84)90480-3; TAKAHASHI K, 1967, J NEUROPHYSIOL, V30, P22, DOI 10.1152/jn.1967.30.1.22; TAVARES I, 1994, EXP BRAIN RES, V99, P455; TSUKAHARA N, 1967, EXP BRAIN RES, V4, P18; TSUMOTO T, 1972, BRAIN RES, V44, P666, DOI 10.1016/0006-8993(72)90332-0; UDO M, 1970, J NEUROPHYSIOL, V33, P227, DOI 10.1152/jn.1970.33.2.227; VALVERDE F, 1961, J COMP NEUROL, V116, P71, DOI 10.1002/cne.901160105; Velo P, 2010, 2010 NEUR M PLANN; VERTES RP, 1986, NEUROSCIENCE, V19, P873, DOI 10.1016/0306-4522(86)90305-2; VILLANUEVA L, 1989, J NEUROPHYSIOL, V61, P391, DOI 10.1152/jn.1989.61.2.391; VILLANUEVA L, 1988, J NEUROPHYSIOL, V60, P980, DOI 10.1152/jn.1988.60.3.980; Villanueva L, 1998, J COMP NEUROL, V390, P133; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; VILLANUEVA L, 1995, J COMP NEUROL, V352, P11, DOI 10.1002/cne.903520103; Villanueva Luis, 1995, Biological Research, V28, P113; WALTZER R, 1984, BRAIN RES, V293, P153, DOI 10.1016/0006-8993(84)91462-8; WATT DGD, 1976, J NEUROPHYSIOL, V39, P1375, DOI 10.1152/jn.1976.39.6.1375; WAXMAN SG, 1977, PROG NEUROBIOL, V8, P297, DOI 10.1016/0301-0082(77)90009-0; Winer JA, 2002, HEARING RES, V168, P181, DOI 10.1016/S0378-5955(02)00489-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	92	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60686	10.1371/journal.pone.0060686	http://dx.doi.org/10.1371/journal.pone.0060686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544161	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700120
J	Bispo, NA; Culleton, R; Silva, LA; Cravo, P				Bispo, Nadlla Alves; Culleton, Richard; Silva, Lourival Almeida; Cravo, Pedro			A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS; ISOXYL; NITROXOLINE; RESISTANCE; INHIBITORS; MECHANISMS; MALARIA	Most of the drugs in use against Plasmodium falciparum share similar modes of action and, consequently, there is a need to identify alternative potential drug targets. Here, we focus on the apicoplast, a malarial plastid-like organelle of algal source which evolved through secondary endosymbiosis. We undertake a systematic in silico target-based identification approach for detecting drugs already approved for clinical use in humans that may be able to interfere with the P. falciparum apicoplast. The P. falciparum genome database GeneDB was used to compile a list of approximate to 600 proteins containing apicoplast signal peptides. Each of these proteins was treated as a potential drug target and its predicted sequence was used to interrogate three different freely available databases (Therapeutic Target Database, DrugBank and STITCH3.1) that provide synoptic data on drugs and their primary or putative drug targets. We were able to identify several drugs that are expected to interact with forty-seven (47) peptides predicted to be involved in the biology of the P. falciparum apicoplast. Fifteen (15) of these putative targets are predicted to have affinity to drugs that are already approved for clinical use but have never been evaluated against malaria parasites. We suggest that some of these drugs should be experimentally tested and/or serve as leads for engineering new antimalarials.	[Bispo, Nadlla Alves; Silva, Lourival Almeida; Cravo, Pedro] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Culleton, Richard] Nagasaki Univ, Malaria Unit, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Cravo, Pedro] Univ Nova Lisboa, Ctr Malaria & Doencas Trop LA, IHMT, P-1200 Lisbon, Portugal	Universidade Federal de Goias; Nagasaki University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Cravo, P (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.	pedrovcravo@gmail.com	Cravo, Pedro/AET-0639-2022; Cravo, Pedro VL/G-3532-2012; Culleton, Richard/H-8327-2014	Cravo, Pedro/0000-0003-1675-4504; Cravo, Pedro VL/0000-0003-1675-4504; SILVA, LOURIVAL DE ALMEIDA/0000-0003-0774-0960; Culleton, Richard/0000-0001-8808-5771	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/PVE of Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/PVE of Brazil	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/PVE of Brazil (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MALARIA PARASITE MET; [Anonymous], PLASM FALC GEN DAT; Archer S, 1974, Prog Drug Res, V18, P15; BERGOGNEBEREZIN E, 1987, PATHOL BIOL, V35, P873; Botte CY, 2012, CHEM REV, V112, P1269, DOI 10.1021/cr200258w; Friedman R, 2009, CHEMMEDCHEM, V4, P1317, DOI 10.1002/cmdc.200900078; Galhaup I, 1989, Acta Derm Venereol Suppl (Stockh), V143, P75; JENSEN SL, 1992, DIGEST DIS, V10, P153, DOI 10.1159/000171353; Johnson RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020633; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Le Bras J, 2003, FUND CLIN PHARMACOL, V17, P147, DOI 10.1046/j.1472-8206.2003.00164.x; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; PELLETIER C, 1995, ANTIMICROB AGENTS CH, V39, P707, DOI 10.1128/AAC.39.3.707; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; REES WDW, 1991, AM J MED, V91, pS58, DOI 10.1016/0002-9343(91)90452-4; SCHEIBEL LW, 1981, MOL PHARMACOL, V20, P218; SHEKHAR KC, 1991, DRUGS, V42, P379, DOI 10.2165/00003495-199142030-00004; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; *TDR TARG, TDR TARG DAT; Umeda T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00009; Wang CC, 2010, AAPS PHARMSCITECH, V11, P538, DOI 10.1208/s12249-010-9415-y; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wiesner J, 2008, CURR PHARM DESIGN, V14, P855, DOI 10.2174/138161208784041105; WILSON RJM, 1994, INFECT AGENT DIS, V3, P29; Woodrow CJ, 2006, CELL MOL LIFE SCI, V63, P1586, DOI 10.1007/s00018-006-6071-1; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	33	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59288	10.1371/journal.pone.0059288	http://dx.doi.org/10.1371/journal.pone.0059288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555651	Green Published, gold			2022-12-27	WOS:000317418500032
J	Choi, Y; Hur, CG; Park, T				Choi, Youngshim; Hur, Cheol-Goo; Park, Taesun			Induction of Olfaction and Cancer-Related Genes in Mice Fed a High-Fat Diet as Assessed through the Mode-of-Action by Network Identification Analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; GROWTH-FACTOR; EXPRESSION ANALYSIS; ODORANT RECEPTORS; PROTEIN-KINASE; OBESE SUBJECTS; CELL-CYCLE; INSULIN; RISK	The pathophysiological mechanisms underlying the development of obesity and metabolic diseases are not well understood. To gain more insight into the genetic mediators associated with the onset and progression of diet-induced obesity and metabolic diseases, we studied the molecular changes in response to a high-fat diet (HFD) by using a mode-of-action by network identification (MNI) analysis. Oligo DNA microarray analysis was performed on visceral and subcutaneous adipose tissues and muscles of male C57BL/6N mice fed a normal diet or HFD for 2, 4, 8, and 12 weeks. Each of these data was queried against the MNI algorithm, and the lists of top 5 highly ranked genes and gene ontology (GO)-annotated pathways that were significantly overrepresented among the 100 highest ranked genes at each time point in the 3 different tissues of mice fed the HFD were considered in the present study. The 40 highest ranked genes identified by MNI analysis at each time point in the different tissues of mice with diet-induced obesity were subjected to clustering based on their temporal patterns. On the basis of the above-mentioned results, we investigated the sequential induction of distinct olfactory receptors and the stimulation of cancer-related genes during the development of obesity in both adipose tissues and muscles. The top 5 genes recognized using the MNI analysis at each time point and gene cluster identified based on their temporal patterns in the peripheral tissues of mice provided novel and often surprising insights into the potential genetic mediators for obesity progression.	[Choi, Youngshim; Park, Taesun] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea; [Hur, Cheol-Goo] Korea Res Inst Biosci & Biotechnol, Plant Syst Engn Res Ctr, Taejon, South Korea	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, T (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Seoul 120749, South Korea.	tspark@yonsei.ac.kr		Park, Taesun/0000-0002-9752-9407	National Research Foundation of Korea (NRF); Korean government (MEST) [2012-0000643]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012-0000643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2011, CANCER LETT, V300, P1, DOI 10.1016/j.canlet.2010.09.008; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Chen LY, 2002, J IMMUNOL, V169, P3934, DOI 10.4049/jimmunol.169.7.3934; Chen PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000092; Chen QZ, 2009, J LEUKOCYTE BIOL, V85, P539, DOI 10.1189/jlb.0308219; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser MM, 2005, CANCER RES, V65, P6228, DOI 10.1158/0008-5472.CAN-05-0650; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gloyn AL, 2002, DIABETOLOGIA, V45, P580, DOI 10.1007/s00125-002-0779-8; Guo FJ, 2010, WORLD J GASTROENTERO, V16, P1465, DOI 10.3748/wjg.v16.i12.1465; Hsu KL, 2006, NAT CHEM BIOL, V2, P153, DOI 10.1038/nchembio767; Hu C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-3; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kelley JR, 2003, ANTICANCER RES, V23, P2007; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lyon RC, 2009, CHEM-BIOL INTERACT, V178, P283, DOI 10.1016/j.cbi.2008.10.025; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Mejia A, 2009, EXPERT REV MOL DIAGN, V9, P777, DOI [10.1586/erm.09.67, 10.1586/ERM.09.67]; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Munoz-Alonso MJ, 2000, J BIOL CHEM, V275, P32406, DOI 10.1074/jbc.M000841200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Oesterreich S, 2003, J CELL BIOCHEM, V90, P653, DOI 10.1002/jcb.10685; Ostrakhovitch EA, 2010, BREAST CANCER RES TR, V119, P773, DOI 10.1007/s10549-009-0372-7; Palouzier-Paulignan B, 2012, CHEM SENSES; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Richardson BE, 2004, OBES SURG, V14, P967, DOI 10.1381/0960892041719617; Richardson BE, 2012, OBES SURG, V22, P283, DOI 10.1007/s11695-011-0487-x; RUGGERI BA, 1989, CANCER RES, V49, P4130; Saydah SH, 2003, CANCER EPIDEM BIOMAR, V12, P412; Seeman T, 2010, PEDIATR NEPHROL, V25, P2375, DOI 10.1007/s00467-010-1591-1; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Sorensen CS, 2010, CELL CYCLE, V9, P450, DOI 10.4161/cc.9.3.10513; Soukas A, 2000, GENE DEV, V14, P963; Storey John D, 2003, Methods Mol Biol, V224, P149; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Xing HM, 2006, NAT PROTOC, V1, P2551, DOI 10.1038/nprot.2006.300; Xu JY, 2011, J GASTROEN HEPATOL, V26, P700, DOI 10.1111/j.1440-1746.2010.06563.x; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	58	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e56610	10.1371/journal.pone.0056610	http://dx.doi.org/10.1371/journal.pone.0056610			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555558	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500003
J	Zarski, JP; Sturm, N; Guechot, J; Zafrani, ES; Vaubourdolle, M; Thoret, S; Margier, J; David-Tchouda, S; Bosson, JL				Zarski, Jean-Pierre; Sturm, Nathalie; Guechot, Jerome; Zafrani, Elie-Serge; Vaubourdolle, Michel; Thoret, Sophie; Margier, Jennifer; David-Tchouda, Sandra; Bosson, Jean-Luc			Contribution of the ELFG Test in Algorithms of Non-Invasive Markers towards the Diagnosis of Significant Fibrosis in Chronic Hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; III PROCOLLAGEN; SERUM MARKERS; STIFFNESS; ACCURACY; BIOPSY	Background and Aims: We aimed to determine the best algorithms for the diagnosis of significant fibrosis in chronic hepatitis C (CHC) patients using all available parameters and tests. Patients and Methods: We used the database from our study of 507 patients with histologically proven CHC in which fibrosis was evaluated by liver biopsy (Metavir) and tests: Fibrometer (R), FibrotestH (R), Hepascore (R), Apri, ELFG, MP3, Forn's, hyaluronic acid, tissue inhibitor of metalloproteinase- 1 (TIMP1), MMP1, collagen IV and when possible Fibroscan (TM). For the first test we used 90% negative predictive value to exclude patients with F <= 1, next an induction algorithm was applied giving the best tests with at least 80% positive predictive value for the diagnosis of F >= 2. The algorithms were computed using the R Software C4.5 program to select the best tests and cut- offs. The algorithm was automatically induced without premises on the part of the investigators. We also examined the inter- observer variations after independent review of liver biopsies by two pathologists. A medico- economic analysis compared the screening strategies with liver biopsy. Results: In "intention to diagnose" the best algorithms for F >= 2 were Fibrometer (R), Fibrotest (R), or Hepascore (R) in first intention with the ELFG score in second intention for indeterminate cases. The percentage of avoided biopsies varied between 50% (Fibrotest (R) or Fibrometer (R)+ELFG) and 51% (Hepascore (R)+ELFG). In "per-analysis" Fibroscan (TM)+ELFG avoided liver biopsy in 55% of cases. The diagnostic performance of these screening strategies was statistically superior to the usual combinations (Fibrometer (R) or Fibrotest (R)+Fibroscan (TM)) and was cost effective. We note that the consensual review of liver biopsies between the two pathologists was mainly in favor of F1 (64- 69%). Conclusion: The ELFG test could replace Fibroscan in most currently used algorithms for the diagnosis of significant fibrosis including for those patients for whom Fibroscan (TM) is unusable.	[Zarski, Jean-Pierre] Grenoble Univ Hosp, Hepatogastroenterol Clin, DIGIDUNE Pole, Grenoble, France; [Zarski, Jean-Pierre; Sturm, Nathalie] Inst Albert Bonniot, INSERM UJF U823 IAPC Unit, Grenoble, France; [Sturm, Nathalie] Grenoble Univ Hosp, Dept Pathol Anat & Cytol, Grenoble, France; [Guechot, Jerome; Vaubourdolle, Michel] St Antoine Hosp, Assistance Publ Hop Paris, Biochem Lab A, Paris, France; [Zafrani, Elie-Serge] Paris Est Creteil Univ, Dept Pathol, Henri Mondor Hosp Ctr, Assistance Publ Hop Paris, Creteil, France; [Thoret, Sophie; Margier, Jennifer; Bosson, Jean-Luc] Grenoble Univ Hosp, UJF Grenoble CNRS Clin Res Centre Inserm TIMC IMA, Grenoble, France; [David-Tchouda, Sandra] Grenoble Univ Hosp, Med Econ Unit, Clin Res Adm, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Zarski, JP (corresponding author), Grenoble Univ Hosp, Hepatogastroenterol Clin, DIGIDUNE Pole, Grenoble, France.	JPZarski@chu-grenoble.fr	david-tchouda, Sandra/M-6383-2014; Margier, Jennifer/GXG-0266-2022; bosson, jean-luc/AAP-5163-2020; STURM, Nathalie/L-8844-2013	bosson, jean-luc/0000-0003-0967-6026; 	ANRS (French Agency for Research on AIDS and Viral Hepatitis) [HCEP 23]	ANRS (French Agency for Research on AIDS and Viral Hepatitis)	The ANRS (French Agency for Research on AIDS and Viral Hepatitis) funded the main study (HCEP 23) (http://www. anrs. fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bourliere M, 2006, J VIRAL HEPATITIS, V13, P659, DOI 10.1111/j.1365-2893.2006.00736.x; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Guechot J, 1996, CLIN CHEM, V42, P558; Haute Autorite de Sante (HAS) France, 2006, METH ASS HEP FIBR CH; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Poynard T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003857; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2012, ALIMENT PHARM THER, V35, P92, DOI 10.1111/j.1365-2036.2011.04897.x; Sebastiani G, 2009, WORLD J GASTROENTERO, V15, P2190, DOI 10.3748/wjg.15.2190; Tsutsumi M, 1996, ALCOHOL CLIN EXP RES, V20, P1512, DOI 10.1111/j.1530-0277.1996.tb01692.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	24	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59088	10.1371/journal.pone.0059088	http://dx.doi.org/10.1371/journal.pone.0059088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555619	gold, Green Published, Green Submitted			2022-12-27	WOS:000316546400020
J	Koido, S; Homma, S; Okamoto, M; Namiki, Y; Takakura, K; Takahara, A; Odahara, S; Tsukinaga, S; Yukawa, T; Mitobe, J; Matsudaira, H; Nagatsuma, K; Uchiyama, K; Kajihara, M; Arihiro, S; Imazu, H; Arakawa, H; Kan, S; Komita, H; Ito, M; Ohkusa, T; Gong, JL; Tajiri, H				Koido, Shigeo; Homma, Sadamu; Okamoto, Masato; Namiki, Yoshihisa; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Arihiro, Seiji; Imazu, Hiroo; Arakawa, Hiroshi; Kan, Shin; Komita, Hideo; Ito, Masaki; Ohkusa, Toshifumi; Gong, Jianlin; Tajiri, Hisao			Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; STREPTOCOCCAL PREPARATION; COLORECTAL-CANCER; TUMOR-CELLS; PSK; ACTIVATION; THERAPY; CD4(+); OK-432; MICE	Induction of antitumor immunity by dendritic cell (DC)-tumor fusion cells (DC/tumor) can be modulated by their activation status. In this study, to address optimal status of DC/tumor to induce efficient antigen-specific cytotoxic T lymphocytes (CTLs), we have created various types of DC/tumor: 1) un-activated DC/tumor; 2) penicillin-killed Streptococcus pyogenes (OK-432; TLR4 agonist)-activated DC/tumor; 3) protein-bound polysaccharides isolated from Coriolus versicolor (PSK; TLR2 agonist)-activated DC/tumor; and 4) Combined OK-432- and PSK-activated DC/tumor. Moreover, we assessed the effects of TGF-beta 1 derived from DC/tumor on the induction of MUC1-specific CTLs. Combined TLR2- and TLR4-activated DC/tumor overcame immune-suppressive effect of TGF-beta 1 in comparison to those single activated or un-activated DC/tumor as demonstrated by: 1) up-regulation of MHC class II and CD86 expression on DC/tumor; 2) increased fusion efficiency; 3) increased production of fusions derived IL-12p70; 4) activation of CD4(+) and CD8(+) T cells that produce high levels of IFN-gamma; 5) augmented induction of CTL activity specific for MUC1; and 6) superior efficacy in inhibiting CD4(+)CD25(+)Foxp3(+) T cell generation. However, DC/tumor-derived TGF-beta 1 reduced the efficacy of DC/tumor vaccine in vitro. Incorporating combined TLRs-activation and TGF-beta 1-blockade of DC/tumor may enhance the effectiveness of DC/tumor-based cancer vaccines and have the potential applicability to the field of adoptive immunotherapy.	[Koido, Shigeo; Takakura, Kazuki; Takahara, Akitaka; Odahara, Shunichi; Tsukinaga, Shintaro; Yukawa, Toyokazu; Mitobe, Jimi; Matsudaira, Hiroshi; Nagatsuma, Keisuke; Uchiyama, Kan; Kajihara, Mikio; Arihiro, Seiji; Arakawa, Hiroshi; Komita, Hideo; Ohkusa, Toshifumi; Tajiri, Hisao] Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Koido, Shigeo; Namiki, Yoshihisa] Jikei Univ, Sch Med, Inst Clin Med & Res, Tokyo, Japan; [Koido, Shigeo; Homma, Sadamu; Kan, Shin; Komita, Hideo; Ito, Masaki] Jikei Univ, Sch Med, Dept Oncol, Inst DNA Med, Tokyo, Japan; [Okamoto, Masato] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Imazu, Hiroo; Arakawa, Hiroshi] Jikei Univ, Sch Med, Dept Endoscopy, Tokyo, Japan; [Gong, Jianlin] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Jikei University; Jikei University; Jikei University; Keio University; Jikei University; Boston University	Koido, S (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	shigeo_koido@jikei.ac.jp	大草, 敏史/HGD-2376-2022	Gong, Jianlin/0000-0003-0910-014X	Ministry of Education, Cultures, Sports, Science and Technology of Japan; Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research [25463119] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Promotion of Cancer Research; Mitsui Life Social Welfare Foundation; Japan Medical Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Cultures, Sports, Science and Technology of Japan, the Foundation for Promotion of Cancer Research, Mitsui Life Social Welfare Foundation, Grant in-Aid of the Japan Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani V, 2007, CANCER RES, V67, P10519, DOI 10.1158/0008-5472.CAN-07-0079; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Harada M, 1997, INT J CANCER, V70, P362, DOI 10.1002/(SICI)1097-0215(19970127)70:3<362::AID-IJC19>3.0.CO;2-H; Huang A, 2003, CLIN EXP IMMUNOL, V134, P270, DOI 10.1046/j.1365-2249.2003.02295.x; INGE TH, 1992, CANCER RES, V52, P1386; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Koido S, 2007, J IMMUNOL, V179, P4874, DOI 10.4049/jimmunol.179.7.4874; Koido S, 2013, ANTICANCER RES, V33, P347; Koido S, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/516768; Koido S, 2010, CLIN IMMUNOL, V135, P384, DOI 10.1016/j.clim.2010.02.003; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Lu HL, 2011, CLIN CANCER RES, V17, P6742, DOI 10.1158/1078-0432.CCR-11-1142; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Mou HB, 2011, TRANSPL P, V43, P2049, DOI 10.1016/j.transproceed.2011.02.054; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Shibata M, 2002, CANCER INVEST, V20, P166, DOI 10.1081/CNV-120001142; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tamagawa K, 2012, LANGENBECK ARCH SURG, V397, P475, DOI 10.1007/s00423-011-0896-2; TANAKA N, 1994, CANCER, V74, P3097, DOI 10.1002/1097-0142(19941215)74:12<3097::AID-CNCR2820741206>3.0.CO;2-P; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669	22	22	25	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59280	10.1371/journal.pone.0059280	http://dx.doi.org/10.1371/journal.pone.0059280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555011	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800079
J	Maazi, H; Singh, AK; Speak, AO; Lombardi, V; Lam, J; Khoo, B; Inn, KS; Sharpe, AH; Jung, JU; Akbari, O				Maazi, Hadi; Singh, Abinav K.; Speak, Anneliese O.; Lombardi, Vincent; Lam, Jonathan; Khoo, Bryant; Inn, Kyung Soo; Sharpe, Arlene H.; Jung, Jae U.; Akbari, Omid			Lack of PD-L1 Expression by iNKT Cells Improves the Course of Influenza A Infection	PLOS ONE			English	Article							INVARIANT NKT CELLS; CD8(+) T-CELLS; NATURAL-KILLER; REGULATORY T; IMMUNE-RESPONSES; INTERFERON-GAMMA; GENE-EXPRESSION; VIRUS-INFECTION; IFN-ALPHA/BETA; B7 FAMILY	There is evidence indicating that invariant Natural Killer T (iNKT) cells play an important role in defense against influenza A virus (IAV). However, the effect of inhibitory receptor, programmed death-1 (PD-1), and its ligands, programmed death ligand (PD-L) 1 and 2 on iNKT cells in protection against IAV remains to be elucidated. Here we investigated the effects of these co-stimulatory molecules on iNKT cells in the response to influenza. We discovered that compare to the wild type, PD-L1 deficient mice show reduced sensitivity to IAV infection as evident by reduced weight loss, decreased pulmonary inflammation and cellular infiltration. In contrast, PD-L2 deficient mice showed augmented weight loss, pulmonary inflammation and cellular infiltration compare to the wild type mice after influenza infection. Adoptive transfer of iNKT cells from wild type, PD-L1 or PD-L2 deficient mice into iNKT cell deficient mice recapitulated these findings. Interestingly, in our transfer system PD-L1(-/-)-derived iNKT cells produced high levels of interferon-gamma whereas PD-L2(-/-)-derived iNKT cells produced high amounts of interleukin-4 and 13 suggesting a role for these cytokines in sensitivity to influenza. We identified that PD-L1 negatively regulates the frequency of iNKT cell subsets in the lungs of IAV infected mice. Altogether, these results demonstrate that lack of PD-L1 expression by iNKT cells reduces the sensitivity to IAV and that the presence of PD-L2 is important for dampening the deleterious inflammatory responses after IAV infection. Our findings potentially have clinical implications for developing new therapies for influenza.	[Maazi, Hadi; Singh, Abinav K.; Speak, Anneliese O.; Lombardi, Vincent; Lam, Jonathan; Khoo, Bryant; Inn, Kyung Soo; Jung, Jae U.; Akbari, Omid] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Southern California; Harvard University; Harvard Medical School	Akbari, O (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.	akbari@usc.edu	Inn, Kyung-Soo/AAJ-4118-2020	Maazi, Hadi/0000-0002-8979-3769; Speak, Anneliese/0000-0003-4890-4685	National Institutes of Health [R01 AI066020]; Senior Research Training Fellowship from the American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Research Training Fellowship from the American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health R01 AI066020 grant (to O.A.) and a Senior Research Training Fellowship from the American Lung Association (to V.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bocek P, 2004, J EXP MED, V199, P1619, DOI 10.1084/jem.20032014; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Dong HD, 1999, NAT MED, V5, P1365; Droebner K, 2008, VACCINE, V26, P6965, DOI 10.1016/j.vaccine.2008.09.051; Dulgerian LR, 2011, IMMUNOLOGY, V133, P29, DOI 10.1111/j.1365-2567.2011.03406.x; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kerzerho J, 2012, J ALLERGY CLIN IMMUN; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Liang SC, 2006, EUR J IMMUNOL, V36, P58, DOI 10.1002/eji.200535458; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; MURPHY BR, 1973, J INFECT DIS, V128, P488, DOI 10.1093/infdis/128.4.488; Paget C, 2011, J IMMUNOL, V186, P5590, DOI 10.4049/jimmunol.1002348; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Ronni T, 1997, J IMMUNOL, V158, P2363; Sareneva T, 1998, J IMMUNOL, V160, P6032; Singh AK, 2011, ALLERGY, V66, P155, DOI 10.1111/j.1398-9995.2010.02458.x; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Tessmer MS, 2009, EXPERT OPIN THER TAR, V13, P153, DOI [10.1517/14712590802653601 , 10.1517/14712590802653601]; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Van Dommelen SLH, 2004, IMMUNOL CELL BIOL, V82, P332, DOI 10.1111/j.0818-9641.2004.01261.x; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59599	10.1371/journal.pone.0059599	http://dx.doi.org/10.1371/journal.pone.0059599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555047	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800103
J	Singh, P; Saxena, R; Srinivas, G; Pande, G; Chattopadhyay, A				Singh, Pushpendra; Saxena, Roopali; Srinivas, Gunda; Pande, Gopal; Chattopadhyay, Amitabha			Cholesterol Biosynthesis and Homeostasis in Regulation of the Cell Cycle	PLOS ONE			English	Article							SEROTONIN(1A) RECEPTOR; MEMBRANE CHOLESTEROL; SIGNALING PATHWAY; DNA-SYNTHESIS; INHIBITION; MEVALONATE; GROWTH; ORGANIZATION; REQUIREMENT; PROGRESSION	The cell cycle is a ubiquitous, multi-step process that is essential for growth and proliferation of cells. The role of membrane lipids in cell cycle regulation is not explored well, although a large number of cytoplasmic and nuclear regulators have been identified. We focus in this work on the role of membrane cholesterol in cell cycle regulation. In particular, we have explored the stringency of the requirement of cholesterol in the regulation of cell cycle progression. For this purpose, we utilized distal and proximal inhibitors of cholesterol biosynthesis, and monitored their effect on cell cycle progression. We show that cholesterol content increases in S phase and inhibition of cholesterol biosynthesis results in cell cycle arrest in G1 phase under certain conditions. Interestingly, G1 arrest mediated by cholesterol biosynthesis inhibitors could be reversed upon metabolic replenishment of cholesterol. Importantly, our results show that the requirement of cholesterol for G1 to S transition is absolute, and even immediate biosynthetic precursors of cholesterol, differing with cholesterol merely in a double bond, could not replace cholesterol for reversing the cell cycle arrest. These results are useful in the context of diseases, such as cancer and Alzheimer's disease, that are associated with impaired cholesterol biosynthesis and homeostasis.	[Singh, Pushpendra; Saxena, Roopali; Srinivas, Gunda; Pande, Gopal; Chattopadhyay, Amitabha] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pande, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	gpande@ccmb.res.in; amit@ccmb.res.in		Gunda, Srinivas/0000-0003-2053-2330; Pande, Gopal/0000-0002-0730-1389	Council of Scientific and Industrial Research; Department of Science and Technology, Government of India; Jawaharlal Nehru Centre for Advanced Scientific Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Council of Scientific and Industrial Research and Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.S. thanks Jawaharlal Nehru Centre for Advanced Scientific Research for the award of a Research Fellowship. R. S. thanks the Council of Scientific and Industrial Research for the award of a Research Fellowship. A. C. is an Adjunct Professor at the Special Centre for Molecular Medicine of Jawaharlal Nehru University (New Delhi, India) and Indian Institute of Science Education and Research (Mohali, India), and Honorary Professor of the Jawaharlal Nehru Centre for Advanced Scientific Research (Bangalore, India). A. C. gratefully acknowledges J.C. Bose Fellowship (Department of Science and Technology, Govt. of India). We thank Md. Jafurulla for help in organizing the manuscript and members of A.C.'s laboratory for critically reading the manuscript.	Amundson DM, 1999, J BIOCHEM BIOPH METH, V38, P43, DOI 10.1016/S0165-022X(98)00036-0; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; Brown AJ, 2007, CLIN EXP PHARMACOL P, V34, P135, DOI 10.1111/j.1440-1681.2007.04565.x; BROWN MS, 1974, J BIOL CHEM, V249, P7306; CHAKRABARTI R, 1991, J BIOL CHEM, V266, P12216; Chauhan NB, 2003, J LIPID RES, V44, P2019, DOI 10.1194/jlr.R300010-JLR200; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; CHEN HW, 1974, NATURE, V251, P419, DOI 10.1038/251419a0; Chevy F, 2002, J LIPID RES, V43, P1192, DOI 10.1194/jlr.M200082-JLR200; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; DVORNIK D, 1963, J AM CHEM SOC, V85, P3309, DOI 10.1021/ja00903a066; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gimpl G, 2002, PROG BRAIN RES, V139, P43; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hawk MA, 1996, CANCER LETT, V109, P217, DOI 10.1016/S0304-3835(96)04465-5; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Kennady PK, 2004, CYTOM PART A, V62A, P97, DOI 10.1002/cyto.a.20091; KEYOMARSI K, 1991, CANCER RES, V51, P3602; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LANGAN TJ, 1987, J NEUROCHEM, V49, P513, DOI 10.1111/j.1471-4159.1987.tb02894.x; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; Menge T, 2005, NAT REV NEUROSCI, V6, P325, DOI 10.1038/nrn1652; NARISAWA T, 1994, CARCINOGENESIS, V15, P2045, DOI 10.1093/carcin/15.9.2045; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Paila YD, 2008, BBA-BIOMEMBRANES, V1778, P1508, DOI 10.1016/j.bbamem.2008.03.002; Paila YD, 2010, SUBCELL BIOCHEM, V51, P439, DOI 10.1007/978-90-481-8622-8_16; Pande G, 1996, CYTOMETRY, V24, P55, DOI 10.1002/(SICI)1097-0320(19960501)24:1<55::AID-CYTO7>3.0.CO;2-H; Papakostas GI, 2004, EUR NEUROPSYCHOPHARM, V14, P135, DOI 10.1016/S0924-977X(03)00099-3; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Porter FD, 2008, EUR J HUM GENET, V16, P535, DOI 10.1038/ejhg.2008.10; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; QUESNEYHUNEEUS V, 1983, J BIOL CHEM, V258, P378; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Sanchez-Wandelmer J, 2010, NEUROSCIENCE, V167, P143, DOI 10.1016/j.neuroscience.2010.01.051; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shrivastava S, 2010, BIOCHEMISTRY-US, V49, P5426, DOI 10.1021/bi100276b; Singh P, 2007, BIOCHEM BIOPH RES CO, V358, P495, DOI 10.1016/j.bbrc.2007.04.135; Singh P, 2009, BBA-BIOMEMBRANES, V1788, P2169, DOI 10.1016/j.bbamem.2009.07.004; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Suarez Y, 2005, BBA-MOL CELL BIOL L, V1734, P203, DOI 10.1016/j.bbalip.2005.02.003; SUMI S, 1992, GASTROENTEROLOGY, V103, P982, DOI 10.1016/0016-5085(92)90032-T; Thibault A, 1996, CLIN CANCER RES, V2, P483; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005	57	70	72	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58833	10.1371/journal.pone.0058833	http://dx.doi.org/10.1371/journal.pone.0058833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554937	gold, Green Published			2022-12-27	WOS:000316409800035
J	Zellin, M; Conci, M; von Muhlenen, A; Muller, HJ				Zellin, Martina; Conci, Markus; von Muehlenen, Adrian; Mueller, Hermann J.			Here Today, Gone Tomorrow - Adaptation to Change in Memory-Guided Visual Search	PLOS ONE			English	Article							SPATIAL CONTEXT; IMPLICIT; EXPLICIT	Visual search for a target object can be facilitated by the repeated presentation of an invariant configuration of nontargets ('contextual cueing'). Here, we tested adaptation of learned contextual associations after a sudden, but permanent, relocation of the target. After an initial learning phase targets were relocated within their invariant contexts and repeatedly presented at new locations, before they returned to the initial locations. Contextual cueing for relocated targets was neither observed after numerous presentations nor after insertion of an overnight break. Further experiments investigated whether learning of additional, previously unseen context-target configurations is comparable to adaptation of existing contextual associations to change. In contrast to the lack of adaptation to changed target locations, contextual cueing developed for additional invariant configurations under identical training conditions. Moreover, across all experiments, presenting relocated targets or additional contexts did not interfere with contextual cueing of initially learned invariant configurations. Overall, the adaptation of contextual memory to changed target locations was severely constrained and unsuccessful in comparison to learning of an additional set of contexts, which suggests that contextual cueing facilitates search for only one repeated target location.	[Zellin, Martina; Conci, Markus; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [von Muehlenen, Adrian] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England	University of Munich; University of Warwick	Zellin, M (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	martina.zellin@psy.lmu.de		von Muhlenen, Adrian/0000-0001-8338-8554	Deutsche Forschungsgemeinschaft (DFG) [CO 1002/1-1, FOR 480]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de) project grants (CO 1002/1-1; FOR 480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00012; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Anderson M. C., 1996, MEMORY, P237, DOI DOI 10.1016/B978-012102570-0/50010-0; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Beesley T, 2010, Q J EXP PSYCHOL, V63, P108, DOI 10.1080/17470210902831767; Brady TF, 2007, J EXP PSYCHOL HUMAN, V33, P798, DOI 10.1037/0096-1523.33.4.798; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Conci M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00409; Conci M, 2012, VIS COGN, V20, P746, DOI 10.1080/13506285.2012.694376; Conci M, 2011, PSYCHOL RES-PSYCH FO, V75, P279, DOI 10.1007/s00426-010-0306-3; Conci M, 2009, ATTEN PERCEPT PSYCHO, V71, P1514, DOI 10.3758/APP.71.7.1514; Gebhart AL, 2009, COGNITIVE SCI, V33, P1087, DOI 10.1111/j.1551-6709.2009.01041.x; Geyer T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00272; Ghilardi MF, 2009, J NEUROPHYSIOL, V101, P2218, DOI 10.1152/jn.01138.2007; Jiang YH, 2005, PSYCHON B REV, V12, P524, DOI 10.3758/BF03193799; Junge JA, 2007, VIS COGN, V15, P1, DOI 10.1080/13506280600859706; Kunar MA, 2011, ATTEN PERCEPT PSYCHO, V73, P2077, DOI 10.3758/s13414-011-0164-0; Lleras A, 2004, SPATIAL VISION, V17, P465, DOI 10.1163/1568568041920113; Luhmann CC, 2011, VIS COGN, V19, P846, DOI 10.1080/13506285.2011.586653; Makovski T, 2010, Q J EXP PSYCHOL, V63, P216, DOI 10.1080/17470210903281590; Manginelli AA, 2009, PSYCHOL RES-PSYCH FO, V73, P212, DOI 10.1007/s00426-008-0211-1; Mednick SC, 2009, VISION RES, V49, P2557, DOI 10.1016/j.visres.2009.04.011; Ogawa H, 2006, PSYCHON B REV, V13, P543, DOI 10.3758/BF03193883; Olson IR, 2001, BRAIN, V124, P1417, DOI 10.1093/brain/124.7.1417; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sanchez DJ, 2012, J EXP PSYCHOL HUMAN, V38, P439, DOI 10.1037/a0026347; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; Smyth AC, 2008, MEM COGNITION, V36, P403, DOI 10.3758/MC.36.2.403; Stephan MA, 2009, EXP BRAIN RES, V196, P253, DOI 10.1007/s00221-009-1845-y; Tseng P, 2011, PERCEPTION, V40, P822, DOI 10.1068/p6833; Tunney RJ, 2003, EXP PSYCHOL, V50, P124, DOI 10.1026//1618-3169.50.2.124; van Asselen M, 2009, ATTEN PERCEPT PSYCHO, V71, P76, DOI 10.3758/APP.71.1.76; van den Bos E, 2010, PSYCHOL RES-PSYCH FO, V74, P138, DOI 10.1007/s00426-009-0227-1; Westerberg CE, 2011, NEUROPSYCHOLOGIA, V49, P3439, DOI 10.1016/j.neuropsychologia.2011.08.019; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Zellin M, 2011, ATTEN PERCEPT PSYCHO, V73, P2065, DOI 10.3758/s13414-011-0175-x	42	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59466	10.1371/journal.pone.0059466	http://dx.doi.org/10.1371/journal.pone.0059466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZC	23555038	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000316409800095
J	Xiao, HB; Qin, X; Ping, D; Zuo, KQ				Xiao, Hongbing; Qin, Xiong; Ping, Ding; Zuo, Keqiang			Inhibition of Rho and Rac Geranylgeranylation by Atorvastatin Is Critical for Preservation of Endothelial Junction Integrity	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; BARRIER INTEGRITY; CELL INVASION; SIMVASTATIN; PERMEABILITY; PROTEIN; GTPASES; ACTIVATION; KINASE	Background: Small GTPases (guanosine triphosphate, GTP) are involved in many critical cellular processes, including inflammation, proliferation, and migration. GTP loading and isoprenylation are two important post-translational modifications of small GTPases, and are critical for their normal function. In this study, we investigated the role of post-translational modifications of small GTPases in regulating endothelial cell inflammatory responses and junctional integrity. Methods and Results: Confluent human umbilical vein endothelial cell (HUVECs) treated with atorvastatin demonstrated significantly decreased lipopolysaccharide (LPS)-mediated IL-6 and IL-8 generation. The inhibitory effect of atorvastatin (Atorva) was attenuated by co-treatment with 100 mu M mevalonate (MVA) or 10 mu M geranylgeranyl pyrophosphate (GGPP), but not by 10 mu M farnesyl pyrophosphate (FPP). Atorvastatin treatment of HUVECs produced a time-dependent increase in GTP loading of all Rho GTPases, and induced the translocation of small Rho GTPases from the cellular membrane to the cytosol, which was reversed by 100 mu M MVA and 10 mu M GGPP, but not by 10 mu M FPP. Atorvastatin significantly attenuated thrombin-induced HUVECs permeability, increased VE-cadherin targeting to cell junctions, and preserved junction integrity. These effects were partially reversed by GGPP but not by FPP, indicating that geranylgeranylation of small GTPases plays a major role in regulating endothelial junction integrity. Silencing of small GTPases showed that Rho and Rac, but not Cdc42, play central role in HUVECs junction integrity. Conclusions: In conclusion, our studies show that post-translational modification of small GTPases plays a vital role in regulating endothelial inflammatory response and endothelial junction integrity. Atorvastatin increased GTP loading and inhibited isoprenylation of small GTPases, accompanied by reduced inflammatory response and preserved cellular junction integrity.	[Xiao, Hongbing; Ping, Ding; Zuo, Keqiang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai 200092, Peoples R China; [Qin, Xiong] Tongji Univ, Shanghai Peoples Hosp 10, Dept Cardiothorac Surg, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Xiao, HB (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai 200092, Peoples R China.	xhb63@yahoo.cn			National Natural Scientific Foundation of China [NSFC-81270133, NSFC-30872116]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Scientific Foundation of China (NSFC-81270133 and NSFC-30872116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacova B, 2010, J PHYSIOL PHARMACOL, V61, P717; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Chen WG, 2010, J CELL BIOCHEM, V110, P718, DOI 10.1002/jcb.22582; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Ishibashi Toshiyuki, 2011, Nihon Rinsho, V69, P79; Jacobson JR, 2005, AM J PHYSIOL-LUNG C, V288, pL1026, DOI 10.1152/ajplung.00354.2004; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kato T, 2004, BBA-MOL BASIS DIS, V1689, P267, DOI 10.1016/j.bbadis.2004.04.006; Kowluru RA, 2009, BIOCHEM BIOPH RES CO, V387, P461, DOI 10.1016/j.bbrc.2009.07.038; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Mital S, 2000, AM J PHYSIOL-HEART C, V279, pH2649, DOI 10.1152/ajpheart.2000.279.6.H2649; Morofuji Y, 2010, CELL MOL NEUROBIOL, V30, P727, DOI 10.1007/s10571-010-9497-9; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Shivanna M, 2010, J OCUL PHARMACOL TH, V26, P1, DOI 10.1089/jop.2009.0025; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Sugden PH, 2000, TRENDS CARDIOVAS MED, V10, P1, DOI 10.1016/S1050-1738(00)00038-4; Tafazoli F, 2003, INFECT IMMUN, V71, P872, DOI 10.1128/IAI.71.2.872-881.2003; Vecchione C, 2002, CIRC RES, V91, P173, DOI 10.1161/01.RES.0000028004.76218.B8; Wei HM, 2005, FEBS LETT, V579, P1272, DOI 10.1016/j.febslet.2005.01.020; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xu HS, 2006, AM J PHYSIOL-RENAL, V291, pF995, DOI 10.1152/ajprenal.00092.2006; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527	33	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59233	10.1371/journal.pone.0059233	http://dx.doi.org/10.1371/journal.pone.0059233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23555637	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200138
J	Zhong, CX; Liu, HC; Jiang, LY; Zhang, W; Yao, F				Zhong, Chenxi; Liu, Hongcheng; Jiang, Liyan; Zhang, Wei; Yao, Feng			Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							QUALITY-OF-LIFE; PEMETREXED MAINTENANCE THERAPY; COMBINATION CHEMOTHERAPY; PHASE-III; CISPLATIN; SURVIVAL; MULTICENTER; STATISTICS; DOCETAXEL; MITOMYCIN	Background: The use of chemotherapy has been proposed to increase the effectiveness of best supportive care (BSC) in patients with non-small cell lung cancer (NSCLC). Previous trials reported inconsistent findings regarding the efficacy and safety of chemotherapy on overall survival (OS) and treatment-related mortality. We performed a systematic review and meta-analysis to evaluate the effects of chemotherapy plus BSC versus BSC alone on survival of patients with NSCLC. Methodology and Principal Findings: We systematically searched PubMed, EmBase, and the Cochrane Central Register of Controlled Trials for relevant literature. All eligible studies included patients with NSCLC who had received chemotherapy and BSC or BSC alone. All eligible studies measured at least 1 of the following outcomes: OS or treatment-related mortality. Overall, patients that received chemotherapy plus BSC had significant longer OS than those that received BSC alone (HR, 0.76; 95%CI, 0.69-0.84; P<0.001). Additionally, chemotherapy plus BSC as compared to BSC alone resulted in a 28% RR reduction (95%CI: 12-40; P = 0.001) in 6-month mortality, 11% RR reduction (95%CI: 8-15; P<0.001) in 12-month mortality, and 5% RR reduction (95%CI: 1-8; P = 0.02) in 2-year mortality. Toxicity was greater in patients that received chemotherapy plus BSC. Conclusion/Significance: Chemotherapy plus BSC increased the OS and reduced the 6-month, 12-month, and 2-year mortality of NSCLC patients.	[Zhong, Chenxi; Yao, Feng] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China; [Liu, Hongcheng] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai 200092, Peoples R China; [Jiang, Liyan; Zhang, Wei] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University	Liu, HC (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai 200092, Peoples R China.	shlhc@hotmail.com; yaofeng6796678@gmail.com		Yao, Feng/0000-0002-9635-9581				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; AISNER J, 1981, CANCER TREAT REP, V65, P979; Anderson H, 2000, BRIT J CANCER, V83, P447, DOI 10.1054/bjoc.2000.1307; Baggstrom MQ, 2007, J THORAC ONCOL, V2, P845, DOI 10.1097/JTO.0b013e31814617a2; Belani CP, 2012, J THORAC ONCOL, V7, P567, DOI 10.1097/JTO.0b013e31823d4f9d; CARTEI G, 1993, JNCI-J NATL CANCER I, V85, P794, DOI 10.1093/jnci/85.10.794; CELLERINO R, 1991, J CLIN ONCOL, V9, P1453, DOI 10.1200/JCO.1991.9.8.1453; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Cohen MH, 2010, ONCOLOGIST, V15, P1352, DOI 10.1634/theoncologist.2010-0224; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Dancey J, 2004, LUNG CANCER-J IASLC, V43, P183, DOI 10.1016/j.lungcan.2003.09.001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GANZ PA, 1989, CANCER, V63, P1271, DOI 10.1002/1097-0142(19890401)63:7<1271::AID-CNCR2820630707>3.0.CO;2-6; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Helsing M, 1998, EUR J CANCER, V34, P1036, DOI 10.1016/S0959-8049(97)10122-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOFFMAN PC, 1983, SEMIN ONCOL, V10, P111; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KAASA S, 1991, CANCER, V67, P2443, DOI 10.1002/1097-0142(19910515)67:10<2443::AID-CNCR2820671008>3.0.CO;2-K; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Non-Small Cell Lung Cancer Collaborative Group, 2010, COCHRANE DB SYST REV, V5; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Ranson M, 2000, JNCI-J NATL CANCER I, V92, P1074, DOI 10.1093/jnci/92.13.1074; RAPP E, 1988, J CLIN ONCOL, V6, P633, DOI 10.1200/JCO.1988.6.4.633; Roszkowski K, 2000, LUNG CANCER-J IASLC, V27, P145, DOI 10.1016/S0169-5002(00)00094-5; Rudd R, 1991, RESP DIS PRACTICE, V7, P12; Shepherd FA, 1999, SEMIN ONCOL, V26, P3; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; SOUHAMI R, 1985, THORAX, V40, P641, DOI 10.1136/thx.40.9.641; Spiro SG, 2004, THORAX, V59, P828, DOI 10.1136/thx.2003.020164; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; WOODS RL, 1990, BRIT J CANCER, V61, P608, DOI 10.1038/bjc.1990.135	36	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58466	10.1371/journal.pone.0058466	http://dx.doi.org/10.1371/journal.pone.0058466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23555583	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200071
J	Bucci, M; Cantalupo, A; Vellecco, V; Panza, E; Monti, MC; Zampella, A; Ianaro, A; Cirino, G				Bucci, Mariarosaria; Cantalupo, Anna; Vellecco, Valentina; Panza, Elisabetta; Monti, Maria Chiara; Zampella, Angela; Ianaro, Angela; Cirino, Giuseppe			Perthamide C Inhibits eNOS and iNOS Expression and Has Immunomodulating Activity In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARRAGEENAN-INDUCED EDEMA; THEONELLA-SWINHOEI; INFLAMMATION; CYCLOPEPTIDES; ACTIVATION; MICE	Here we have characterized perthamide C, a cyclopeptide from a Solomon Lithistid sponge Theonella swinhoei, which displays an anti-inflammatory/immunomodulatory activity. The study has been performed using the carragenan-induced mouse paw edema that displays an early (0-6 h) and a late phase (24-96 h). Perthamide C significantly inhibits neutrophils infiltration in tissue both in the early and late phases. This effect was coupled to a reduced expression of the endothelial nitric oxide synthase (eNOS) in the early phase while cyclooxygenase-1 and 2 (COX-1, COX-2), and inducible NOS (iNOS) expression were unaffected. In the late phase perthamide C reduced expression of both NOS isoforms without affecting COXs expression. This peculiar selectivity toward the two enzymes deputed to produce NO lead us to investigate on a possible action of perthamide C on lymphocytes infiltration and activation. We found that perthamide C inhibited the proliferation of peripheral lymphocytes, and that this effect was secondary to its metabolic activation in vivo. Indeed, in vitro perthamide C did not inhibit proliferation as opposite to its metabolite perthamide H. In conclusion, perthamide C selectively interferes with NO generation triggered by either eNOS or iNOS without affecting either COX-1 or COX-2. This in turn leads to modulation of the inflammatory response through a reduction of vascular permeability, neutrophil infiltration as well as lymphocyte proliferation.	[Bucci, Mariarosaria; Cantalupo, Anna; Vellecco, Valentina; Panza, Elisabetta; Ianaro, Angela; Cirino, Giuseppe] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Monti, Maria Chiara] Univ Salerno, Dept Biomed & Pharmaceut Sci, Fisciano, SA, Italy; [Zampella, Angela] Univ Naples Federico II, Dept Nat Prod Chem, Naples, Italy	University of Naples Federico II; University of Salerno; University of Naples Federico II	Ianaro, A (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	ianaro@unina.it	Monti, Maria Chiara/A-4105-2011; ianaro, angela/ABC-2713-2020	Monti, Maria Chiara/0000-0002-1337-2909; Vellecco, Valentina/0000-0002-5674-9112; Cirino, Giuseppe/0000-0003-3954-4083; Zampella, Angela/0000-0002-6170-279X	Italian Ministry of Scientific Research	Italian Ministry of Scientific Research(Ministry of Education, Universities and Research (MIUR))	The research was supported by the Italian Ministry of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C A, 1999, Dermatol Online J, V5, P7; Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Burkard I, 2005, J CHROMATOGR B, V826, P147, DOI 10.1016/j.jchromb.2005.08.016; Festa C, 2012, TETRAHEDRON, V68, P2851, DOI 10.1016/j.tet.2012.01.097; Festa C, 2011, TETRAHEDRON, V67, P7780, DOI 10.1016/j.tet.2011.07.077; Festa C, 2011, ORG LETT, V13, P1532, DOI 10.1021/ol200221n; Festa C, 2011, J MED CHEM, V54, P401, DOI 10.1021/jm100968b; Festa C, 2009, TETRAHEDRON, V65, P10424, DOI 10.1016/j.tet.2009.10.026; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ianaro A, 1998, N-S ARCH PHARMACOL, V358, P489, DOI 10.1007/PL00005282; IANARO A, 1994, IMMUNOLOGY, V82, P370; IANARO A, 1995, IMMUNOLOGY, V84, P8; Alcaraz MJ, 2006, CURR OPIN INVEST DR, V7, P974; Margarucci L, 2012, MOL BIOSYST, V8, P1412, DOI 10.1039/c2mb05507d; Niedbala W, 2006, ANN RHEUM DIS, V65, P37, DOI 10.1136/ard.2006.058446; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Sepe V, 2011, J MED CHEM, V54, P4590, DOI 10.1021/jm200241s; Sepe V, 2010, TETRAHEDRON, V66, P7520, DOI 10.1016/j.tet.2010.07.060	18	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57801	10.1371/journal.pone.0057801	http://dx.doi.org/10.1371/journal.pone.0057801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554869	gold, Green Submitted, Green Published			2022-12-27	WOS:000316252500009
J	Trigas, P; Panitsa, M; Tsiftsis, S				Trigas, Panayiotis; Panitsa, Maria; Tsiftsis, Spyros			Elevational Gradient of Vascular Plant Species Richness and Endemism in Crete - The Effect of Post-Isolation Mountain Uplift on a Continental Island System	PLOS ONE			English	Article							SMALL MAMMAL DIVERSITY; ALTITUDINAL GRADIENT; RAPOPORTS RULE; GEOMETRIC CONSTRAINTS; DISTRIBUTION PATTERNS; LATE MIOCENE; HUMAN IMPACT; SCALE; AREA; GREECE	Understanding diversity patterns along environmental gradients and their underlying mechanisms is a major topic in current biodiversity research. In this study, we investigate for the first time elevational patterns of vascular plant species richness and endemism on a long-isolated continental island (Crete) that has experienced extensive post-isolation mountain uplift. We used all available data on distribution and elevational ranges of the Cretan plants to interpolate their presence between minimum and maximum elevations in 100-m elevational intervals, along the entire elevational gradient of Crete (0-2400 m). We evaluate the influence of elevation, area, mid-domain effect, elevational Rapoport effect and the post-isolation mountain uplift on plant species richness and endemism elevational patterns. Furthermore, we test the influence of the island condition and the post-isolation mountain uplift to the elevational range sizes of the Cretan plants, using the Peloponnese as a continental control area. Total species richness monotonically decreases with increasing elevation, while endemic species richness has a unimodal response to elevation showing a peak at mid-elevation intervals. Area alone explains a significant amount of variation in species richness along the elevational gradient. Mid-domain effect is not the underlying mechanism of the elevational gradient of plant species richness in Crete, and Rapoport's rule only partly explains the observed patterns. Our results are largely congruent with the post-isolation uplift of the Cretan mountains and their colonization mainly by the available lowland vascular plant species, as high-elevation specialists are almost lacking from the Cretan flora. The increase in the proportion of Cretan endemics with increasing elevation can only be regarded as a result of diversification processes towards Cretan mountains (especially mid-elevation areas), supported by elevation-driven ecological isolation. Cretan plants have experienced elevational range expansion compared to the continental control area, as a result of ecological release triggered by increased species impoverishment with increasing elevation.	[Trigas, Panayiotis] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece; [Panitsa, Maria] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Tsiftsis, Spyros] Aristotle Univ Thessaloniki, Sch Biol, Dept Bot, GR-54006 Thessaloniki, Greece	Agricultural University of Athens; University of Ioannina; Aristotle University of Thessaloniki	Trigas, P (corresponding author), Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece.	trigas@aua.gr	Tsiftsis, Spyros/Y-7700-2019; Panitsa, Maria/S-4814-2019	Tsiftsis, Spyros/0000-0002-3389-9089; Panitsa, Maria/0000-0003-2388-3400				Acharya BK, 2011, ACTA OECOL, V37, P329, DOI 10.1016/j.actao.2011.03.005; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; [Anonymous], 2004, ISLAND ECOLOGY; Atherden MA, 1999, HOLOCENE, V9, P183, DOI 10.1191/095968399673523574; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Baniya CB, 2012, FOLIA GEOBOT, V47, P135, DOI 10.1007/s12224-011-9113-x; Berry P. E., 1995, FLORA VENEZUELAN GUA, V1, P161; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bittkau C, 2005, MOL ECOL, V14, P4065, DOI 10.1111/j.1365-294X.2005.02725.x; Bohling N., 2003, GRAMINEAE POACEAE FL; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Cellinese N, 2009, J BIOGEOGR, V36, P1253, DOI 10.1111/j.1365-2699.2008.02077.x; Chatzaki M, 2005, J BIOGEOGR, V32, P813, DOI 10.1111/j.1365-2699.2004.01189.x; Chilton L, 2008, FLORA CRETE S2; CHILTON L, 1997, FLORA CRETE S; Colwell R.K., 2006, RANGEMODEL MONTE CAR; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2008, ECOGRAPHY, V31, P4, DOI 10.1111/j.2008.0906-7590.05347.x; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; D'Agata C.D.C., 2009, BOCCONEA, V23, P301; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Dermitzakis M.D., 1991, Accademia Nazionale dei Lincei Atti Convegni Lincei (Rome), V85, P263; Dermitzakis MD, 1981, ANN GEOL PAYS HELL, V30, P245; DIAMOND JM, 1973, SCIENCE, V179, P759, DOI 10.1126/science.179.4075.759; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Efstratiou N., 2005, DID FARMING REACH EU, P143; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Fassoulas C, 2005, B GEOLOGICAL SOC GRE, V37, P201; Fauquette S, 1998, PALAEOGEOGR PALAEOCL, V144, P183, DOI 10.1016/S0031-0182(98)00083-2; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Ganas A, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005599; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Georgiakakis P, 2010, HYSTRIX, V21, P43; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; GREUTER W, 1971, Boissiera, V19, P329; Greuter W., 1972, Taxonomy phytogeography and evolution., P161; Greuter W., 1979, PLANTS ISLANDS, P87; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2006, J BIOGEOGR, V33, P1838, DOI 10.1111/j.1365-2699.2006.01554.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hulme P. E., 2008, Plant invasions: human perception, ecological impacts and management, P39; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kallimanis AS, 2011, ACTA OECOL, V37, P65, DOI 10.1016/j.actao.2010.11.008; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; Keeley S. C., 2011, The biology of island floras, P57; Kerr JT, 1999, GLOBAL ECOL BIOGEOGR, V8, P47, DOI 10.1046/j.1365-2699.1999.00315.x; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2000, PLANT ECOL, V149, P181, DOI 10.1023/A:1026500710274; Kessler M, 2011, GLOBAL ECOL BIOGEOGR, V20, P868, DOI 10.1111/j.1466-8238.2011.00653.x; Kluge J, 2006, DIVERS DISTRIB, V12, P535, DOI 10.1111/j.1366-9516.2006.00231.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lymberakis P, 2003, CRUSTACEANA MONOGR, V2, P217; Lymberakis P, 2003, THESIS U ATHENS, P233; LYRINTZIS G, 1995, LAND DEGRAD REHABIL, V6, P79, DOI 10.1002/ldr.3400060203; MAC ARTHUR ROBERT H., 1967; Major J., 1988, ANAL BIOGEOGRAPHY, P117, DOI DOI 10.1007/978-94-009-0435-4; MAYR E, 1976, P NATL ACAD SCI USA, V73, P1765, DOI 10.1073/pnas.73.5.1765; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Meulenkamp J. E., 1985, GEOLOGICAL EVOLUTION, P307; MEULENKAMP JE, 1988, TECTONOPHYSICS, V146, P203, DOI 10.1016/0040-1951(88)90091-1; MEULENKAMP JE, 1994, TECTONOPHYSICS, V234, P53, DOI 10.1016/0040-1951(94)90204-6; MEULENKAMP JE, 1971, OPERA BOT, V30, P5; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Panitsa M, 2010, ACTA OECOL, V36, P431, DOI 10.1016/j.actao.2010.04.004; Papanastasis V. P. S., 2002, J MEDITERR ECOL, V3, P53; Parmakelis A, 2005, EVOLUTION, V59, P991; Poulakakis N, 2005, MOL ECOL, V14, P2433, DOI 10.1111/j.1365-294X.2005.02588.x; Press J. R., 1993, FLORA CRETAN AREA AN; Prodon R, 2002, ECOLOGY, V83, P1294, DOI 10.2307/3071944; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenweig ML, 1997, SPECIES DIVERSITY SP; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sauer J, 2011, THESIS U HAMBURG GER; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Steinbauer MJ, 2013, ACTA OECOL, V47, P52, DOI 10.1016/j.actao.2012.11.004; Steinbauer MJ, 2012, ECOGRAPHY, V35, P23, DOI 10.1111/j.1600-0587.2011.07064.x; Steinbauer MJ, 2010, ERDKUNDE, V64, P57, DOI 10.3112/erdkunde.2010.01.05; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; STRID A, 1986, P ROY SOC EDINB B, V89, P59, DOI 10.1017/S0269727000008903; Strid A, 1997, FLORA HELLENICA, V1; Trichas A, 1996, THESIS U CRETE; Trigas P, 2012, FOLIA GEOBOT, V47, P421, DOI 10.1007/s12224-012-9130-4; Vardinoyannis K, 1994, THESIS U ATHENS GREE; Velona A, 2010, MOL PHYLOGENET EVOL, V56, P1051, DOI 10.1016/j.ympev.2010.04.037; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willerslev E, 2002, ECOGRAPHY, V25, P109, DOI 10.1034/j.1600-0587.2002.250113.x; Willinghofer S, 2012, PLANT ECOL, V213, P407, DOI 10.1007/s11258-011-9986-z; Zachariasse WJ, 2008, GEOL SOC AM BULL, V120, P976, DOI 10.1130/B26175.1; Zhang DC, 2009, BIODIVERS CONSERV, V18, P699, DOI 10.1007/s10531-008-9534-x; Zidianakis G, 2007, GEODIVERSITAS, V29, P351; [No title captured]	108	78	84	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59425	10.1371/journal.pone.0059425	http://dx.doi.org/10.1371/journal.pone.0059425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555031	gold, Green Submitted, Green Published			2022-12-27	WOS:000316252500089
J	Wu, XL; Yang, DY; Zhao, YS; Lu, CY; Wang, Y				Wu, Xingli; Yang, Dingyou; Zhao, Yusheng; Lu, Caiyi; Wang, Yu			Effectiveness of Percutaneous Coronary Intervention within 12 Hours to 28 Days of ST-Elevation Myocardial Infarction in a Real-World Chinese Population	PLOS ONE			English	Article							PRIMARY ANGIOPLASTY; AMERICAN-COLLEGE; ELDERLY-PATIENTS; OUTCOMES; REVASCULARIZATION; MORTALITY; THERAPY; GENDER; TRENDS; IMPACT	Objectives: Percutaneous coronary intervention(PCI) for ST-elevation myocardial infarction (STEMI) has been widely accepted for patient who come within 12 hours, but for those who come to the hospital late (12 hours to 28 days) the long-term data and possible predictors are limited regarding 'hard' endpoints in 'real world'. Methods: The registry data of all 5523 consecutive patients admitted due to an incident STEMI (12 hours to 28 days) in our center were analyzed. Patients were divided into 3 age groups (age < 65; age = 65-74; age >= 75) and two therapeutic groups including conservative and PCI group. The primary endpoints included 30-day mortality and 1-year mortality. Results: The clinical characteristics include female gender; history of diabetes mellitus, previous myocardial infarction, cerebral vascular disease, chronic renal failure, atrial fibrillation, hypertension, anemia, gastric bleeding; presentation of ventricular tachycardia/ventricular fibrillation, pneumonia, heart failure, multiple organ failure and cardiogenic shock. The ratio of all the above factors increased with the age getting older (all p < 0.05), while that of the PCI decreased significantly with ageing (53.9%, 36.3% and 21.7%). Except hypertension, all the other factors were less seen in the PCI group than in the conservative group (p < 0.01). Pooled estimates, based on type of therapy and age groups, PCI resulted in significantly lower 30-day and 1-year mortality. Cox analysis showed the positive predictors for 30 days and 1 year mortality were heart failure, cerebral vascular disease, chronic renal failure, ventricular tachycardia/ventricular fibrillation, age, female, gastric intestinal bleeding, cardiogenic shock, multiple organ failure, while PCI was a negative predictor. ROCs analysis showed AUCs were always higher for PCI group. Conclusions: The elderly have more comorbidities and higher rates of mortality, mandating thorough evaluation before acceptance for PCI. PCI between 12 hours to 28 days in all ages of patients including the elderly with STEMI is significantly more effective than conservative therapy.	[Wu, Xingli; Zhao, Yusheng; Lu, Caiyi; Wang, Yu] China PLA Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China; [Yang, Dingyou] China PLA Gen Hosp, Dept Tradit Chinese Med, Affiliate Hosp 1, Beijing, Peoples R China		Wu, XL (corresponding author), China PLA Gen Hosp, Inst Geriatr Cardiol, Beijing, Peoples R China.	WXL301@yahoo.com						Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Balzi D, 2008, INTERN EMERG MED, V3, P109, DOI 10.1007/s11739-008-0090-x; Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4; Benamer H, 2011, EUROINTERVENTION, V6, P1073, DOI 10.4244/EIJV6I9A187; Buchholz J, 2008, HERZ, V33, P148, DOI 10.1007/s00059-008-3119-z; Bufe A, 2010, J WOMENS HEALTH, V19, P471, DOI 10.1089/jwh.2009.1371; Busk M, 2009, EUR HEART J, V30, P1322, DOI 10.1093/eurheartj/ehp113; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; de Labriolle A, 2007, CARDIOVASC REVASCULA, V8, P90, DOI 10.1016/j.carrev.2006.12.002; Deyell MW, 2011, ARCH INTERN MED, V171, P1636, DOI 10.1001/archinternmed.2011.315; Eagle Kim A, 2004, Circulation, V110, P1168, DOI 10.1161/01.CIR.0000138790.14877.7D; Ergelen M, 2009, ACTA CARDIOL, V64, P729, DOI 10.2143/AC.64.6.2044735; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hillis LD, 2006, NEW ENGL J MED, V355, P2475, DOI 10.1056/NEJMe068251; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keeley EC, 2004, ANN INTERN MED, V141, P298, DOI 10.7326/0003-4819-141-4-200408170-00010; Kiemeneij F, 2001, J AM COLL CARDIOL, V37, P1598, DOI 10.1016/S0735-1097(01)01207-4; Klein LW, 2002, J AM COLL CARDIOL, V40, P394, DOI 10.1016/S0735-1097(02)01992-7; Kuch B, 2011, INT J CARDIOL, V149, P205, DOI 10.1016/j.ijcard.2010.01.010; Lazzeri C, 2012, HEART VESSELS, V27, P370, DOI 10.1007/s00380-011-0169-6; Lefering R, 2002, LANGENBECK ARCH SURG, V387, P14, DOI 10.1007/s00423-001-0269-3; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lin CJ, 2011, INT HEART J, V52, P153, DOI 10.1536/ihj.52.153; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mehta RH, 2009, JAMA-J AM MED ASSOC, V301, P1779, DOI 10.1001/jama.2009.600; Nash MC, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-69; Nazici GE, 2009, ANGIOLOGY, V60, P67, DOI 10.1177/0003319708314248; Newell MC, 2011, AM HEART J, V161, P664, DOI 10.1016/j.ahj.2010.12.018; Norhammar A, 2010, EUROINTERVENTION, V5, P891, DOI 10.4244/; Peterson ED, 2004, AM HEART J, V148, P486, DOI 10.1016/j.ahj.2004.03.039; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rasoul S, 2009, CORONARY ARTERY DIS, V20, P415, DOI 10.1097/MCA.0b013e32832e5c4c; Saltzman AJ, 2011, JACC-CARDIOVASC INTE, V4, P1011, DOI 10.1016/j.jcin.2011.06.012; Shelton RJ, 2010, AM HEART J, V159, P956, DOI 10.1016/j.ahj.2010.02.026; Shivaraju A, 2011, AM HEART J, V162, P1062, DOI 10.1016/j.ahj.2011.09.009; Sutton AGC, 2005, HEART, V91, P339, DOI 10.1136/hrt.2003.021691; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Thompson RC, 1996, CLIN GERIATR MED, V12, P181, DOI 10.1016/S0749-0690(18)30252-0; Ting HH, 2006, ANN INTERN MED, V145, P610, DOI 10.7326/0003-4819-145-8-200610170-00010; Tsujita K, 2010, AM J CARDIOL, V105, P1385, DOI 10.1016/j.amjcard.2010.01.001; Valente S, 2008, CIRC J, V72, P67, DOI 10.1253/circj.72.67; Wijeysundera HC, 2010, ANN INTERN MED, V152, P370, DOI 10.7326/0003-4819-152-6-201003160-00007; Yan BP, 2007, CATHETER CARDIO INTE, V70, P928, DOI 10.1002/ccd.21303; Yip HK, 2004, CHEST, V126, P38, DOI 10.1378/chest.126.1.38; Zeymer U, 2005, DEUT MED WOCHENSCHR, V130, P633, DOI 10.1055/s-2005-865072	49	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58382	10.1371/journal.pone.0058382	http://dx.doi.org/10.1371/journal.pone.0058382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554888	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500022
J	Goli, S; Doshi, R; Perianayagam, A				Goli, Srinivas; Doshi, Riddhi; Perianayagam, Arokiasamy			Pathways of Economic Inequalities in Maternal and Child Health in Urban India: A Decomposition Analysis	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; URBANIZATION; DETERMINANTS; POVERTY; CITIES; CASTE	Background/Objective: Children and women comprise vulnerable populations in terms of health and are gravely affected by the impact of economic inequalities through multi-dimensional channels. Urban areas are believed to have better socioeconomic and maternal and child health indicators than rural areas. This perception leads to the implementation of health policies ignorant of intra-urban health inequalities. Therefore, the objective of this study is to explain the pathways of economic inequalities in maternal and child health indicators among the urban population of India. Methods: Using data from the third wave of the National Family Health Survey (NFHS, 2005-06), this study calculated relative contribution of socioeconomic factors to inequalities in key maternal and child health indicators such as antenatal check-ups (ANCs), institutional deliveries, proportion of children with complete immunization, proportion of underweight children, and Infant Mortality Rate (IMR). Along with regular CI estimates, this study applied widely used regression-based Inequality Decomposition model proposed by Wagstaff and colleagues. Results: The CI estimates show considerable economic inequalities in women with less than 3 ANCs (CI = -0.3501), institutional delivery (CI = -0.3214), children without fully immunization (CI = -0.18340), underweight children (CI = -0.19420), and infant deaths (CI = -0.15596). Results of the decomposition model reveal that illiteracy among women and her partner, poor economic status, and mass media exposure are the critical factors contributing to economic inequalities in maternal and child health indicators. The residuals in all the decomposition models are very less; this implies that the above mentioned factors explained maximum inequalities in maternal and child health of urban population in India. Conclusion: Findings suggest that illiteracy among women and her partner, poor economic status, and mass media exposure are the critical pathways through which economic factors operate on inequalities in maternal and child health outcomes in urban India.	[Goli, Srinivas; Perianayagam, Arokiasamy] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Doshi, Riddhi] Parkview Hlth, Ft Wayne, IN USA	International Institute for Population Sciences	Goli, S (corresponding author), Int Inst Populat Sci, Mumbai, Maharashtra, India.	sirispeaks2u@gmail.com	Goli, Srinivas/J-7238-2012; Perianayagam, Arokiasamy/AAT-4147-2020	Goli, Srinivas/0000-0002-8481-484X; Perianayagam, Arokiasamy/0000-0001-8698-217X				Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Agarwal S, 2005, INDIAN PEDIATR, V42, P233; Agarwal S., 2007, DEMOGR INDIA, V36, P121; Agarwal S, 2005, INDIAN J PUBLIC HLTH, V39, P1; Agarwal S, 2011, ENVIRON URBAN, V23, P13, DOI 10.1177/0956247811398589; [Anonymous], 2008, ANAL HLTH EQUITY USI; ATKINSON SJ, 1993, ENVIRON URBAN, V5, P146, DOI 10.1177/095624789300500212; Bergel EE, 1955, URBAN SOCIOLOGY; Beshers JM, 1962, URBAN SOCIAL STRUCTU; Bhasin Reena, 2001, URBAN POVERTY URBANI; Brockerhoff M, 1998, POPUL DEV REV, V24, P75, DOI 10.2307/2808123; Chattopadhyay A., 2005, DEMOGRAPHY INDIA, V34, P299; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Faghihzadeh S, 2010, MED J ISLAM REPUB IR, V24, P175; Fotso Jean-Christophe, 2006, Int J Equity Health, V5, P9, DOI 10.1186/1475-9276-5-9; Gakidou EE, 2000, B WORLD HEALTH ORGAN, V78, P42; Goli S, 2011, CITIES, V28, P461, DOI 10.1016/j.cities.2011.05.006; Government of India, 2008, URB HLTH MI IN PRESS; HARPHAM T, 1994, SOC SCI MED, V39, P233, DOI 10.1016/0277-9536(94)90332-8; HARPHAM T, 1991, World Health Statistics Quarterly, V44, P62; Hazarika I, 2010, J URBAN HEALTH, V87, P264, DOI 10.1007/s11524-009-9421-0; IIPS and Macro Internationals, 2009, LIVING HLTH CONDITIO; International Institute for Population Sciences (IIPS), 2008, NATL FAMILY HLTH SUR; Jorgenson AK, 2012, J WORLD SYST RES, V18, P103, DOI 10.5195/JWSR.2012.483; kanitkar T., 2002, ECON POLIT WEEKLY, V37, P5086; Khan Zulfia, 2012, Indian J Community Med, V37, P50, DOI 10.4103/0970-0218.94027; Kopparty S.N.M, 1994, SOCIAL INEQUALITY HL; Kundu A., 1983, SOC SCI, V11, P37; Macbeth H., 2002, HUMAN POPULATION DYN; Montgomery MR, 2009, POPUL B, V64; Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Office of RGI, 2011, MAT CHILD MORT TOT F; Pradhan J, 2010, HEALTH POLICY, V98, P114, DOI 10.1016/j.healthpol.2010.05.010; PRESTON SH, 1979, POPUL DEV REV, V5, P195, DOI 10.2307/1971823; RGI and Census Commissioner, 2001, CENS IND; RGI and Census Commissioner, 2011, PROV CENS IND; RGI (Registrar General and Census Commissioner of India), 2006, POP PROJ IND STAT 20; Siddiqui I H., 2009, DELHI SULTANATE URBA; Speybroeck N, 2010, INT J PUBLIC HEALTH, V55, P347, DOI 10.1007/s00038-009-0105-z; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Timaus IM., 1995, HLTH TRANSIT REV, V5, P163; UNDESA, 2018, STESASERA420 UNDESA, DOI [10.4054/demres.2005.12.9, DOI 10.4054/DEMRES.2005.12.9]; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Weeks JR, 2005, 25 INT POP C; WHO, 2008, IN AR KILL PEOPL GRA; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; World Bank, 2015, LEVERAGING URBANIZAT	50	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58573	10.1371/journal.pone.0058573	http://dx.doi.org/10.1371/journal.pone.0058573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	121SG	23555587	Green Submitted, gold, Green Published			2022-12-27	WOS:000317263900006
J	Zhu, H; Qian, J; Wang, WQ; Yan, Q; Xu, Y; Jiang, Y; Zhang, L; Lu, FQ; Hu, WT; Zhang, X; Wang, FH; Sun, XD				Zhu, Hong; Qian, Jin; Wang, Wenqiu; Yan, Quan; Xu, Ying; Jiang, Yuan; Zhang, Lei; Lu, Fengqing; Hu, Weiting; Zhang, Xi; Wang, Fenghua; Sun, Xiaodong			RNA Interference of GADD153 Protects Photoreceptors from Endoplasmic Reticulum Stress-Mediated Apoptosis after Retinal Detachment	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; CHOP GADD153; EXPERIMENTAL-MODEL; PROAPOPTOTIC BAX; CELL-DEATH; RAT MODEL; ACTIVATION; EXPRESSION; DYSFUNCTION; INHIBITION	Background: Apoptosis of photoreceptors plays a critical role in the vision loss caused by retinal detachment (RD). Pharmacologic inhibition of photoreceptor cell death may prevent RD. This study investigated the role of GADD153 that participates in endoplasmic reticulum (ER) stress-mediated apoptosis of photoreceptor cells after RD. Methods: Retinal detachment was created in Wistar rats by subretinal injection of hyaluronic acid. The rats were then randomly divided into four groups: normal control group, RD group, GADD153 RNAi group and vehicle group. RNA interference of GADD153 was performed using short hairpin RNA (shRNA). Expressions of GADD153 mRNA and protein were examined by RT-PCR and Western blotting analysis, respectively. GADD153 protein distribution in the retinal cells was observed using immunofluorescence confocal laser scanning microscopy. Apoptosis of retinal cells was determined by TdT-mediated fluorescein-16-dUTP nick-end labeling (TUNEL) assay. Results: Lentivirus GADD153 shRNA with the most effective silencing effect was chosen for in vivo animal study and was successfully delivered into the retinal tissues. GADD153 mRNA and protein expressions in GADD153 RNAi group were significantly lower than those in the RD group. Silencing of GADD153 by RNAi protected photoreceptors from ER stress-induced apoptosis. Conclusion: ER stress-mediated pathway is involved in photoreceptor cell apoptosis after RD. GADD153 is a key regulatory molecule regulating ER-stress pathways and plays a crucial role in the apoptosis of photoreceptor cells after RD.	[Zhu, Hong; Qian, Jin; Wang, Wenqiu; Yan, Quan; Xu, Ying; Jiang, Yuan; Zhang, Lei; Lu, Fengqing; Hu, Weiting; Zhang, Xi; Wang, Fenghua; Sun, Xiaodong] Shanghai Jiao Tong Univ, Eye Res Inst, Dept Ophthalmol, Sch Med,Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Zhu, Hong] Shanghai Jiao Tong Univ, Peoples Hosp 3, Dept Ophthalmol, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Xi; Sun, Xiaodong] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai 200030, Peoples R China; [Wang, Fenghua] Shanghai Key Lab Fundus Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, FH (corresponding author), Shanghai Jiao Tong Univ, Eye Res Inst, Dept Ophthalmol, Sch Med,Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	sighiris@gmail.com; xdsun@sjtu.edu.cn	XU, Ying/T-1446-2019	XU, Ying/0000-0002-3793-7716	National Basic Research Program (973 Program) [2011CB707506]; National Natural Science Foundation of China [30973259, 81100678, 81271030]; Shanghai Key Basic Research Grant [11JC141601]; Shanghai Scholar Leadship Grant [12XD1404100]; Shanghai Medical Research Grant [114119a7000]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Grant; Shanghai Scholar Leadship Grant; Shanghai Medical Research Grant	This work was supported by the National Basic Research Program (973 Program, 2011CB707506), National Natural Science Foundation of China (30973259, 81100678 and 81271030), Shanghai Key Basic Research Grant (11JC141601), Shanghai Scholar Leadship Grant (12XD1404100) and Shanghai Medical Research Grant (114119a7000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011025; An DS, 2003, HUM GENE THER, V14, P1207, DOI 10.1089/104303403322168037; BARONE MV, 1994, GENE DEV, V8, P453, DOI 10.1101/gad.8.4.453; Besirli CG, 2010, INVEST OPHTH VIS SCI, V51, P2177, DOI 10.1167/iovs.09-4439; Chen G, 2007, J NEUROSCI RES, V85, P1674, DOI 10.1002/jnr.21292; Eigeldinger-Berthou S, 2012, RETINA-J RET VIT DIS, V32, P617, DOI 10.1097/IAE.0b013e31821e2070; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Kayama M, 2011, AM J PATHOL, V178, P1080, DOI 10.1016/j.ajpath.2010.11.072; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Lei B, 2009, MOL VIS, V15, P1374; Lewis GP, 2009, INVEST OPHTH VIS SCI, V50, P4429, DOI 10.1167/iovs.09-3445; Liu H, 2010, EYE, V24, P137, DOI 10.1038/eye.2009.20; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mockel A, 2012, J BIOL CHEM, V287, P37483, DOI 10.1074/jbc.M112.386821; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Nakazawa T, 2006, MOL VIS, V12, P867; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Shimazaki H, 2011, INVEST OPHTH VIS SCI, V52, P7289, DOI 10.1167/iovs.11-7983; ShyongAb MP, 2008, VISION RES, V48, P2394, DOI 10.1016/j.visres.2008.07.017; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xie Z, 2012, EYE, V26, P144, DOI 10.1038/eye.2011.254; Zacks DN, 2007, ARCH OPHTHALMOL-CHIC, V125, P1389, DOI 10.1001/archopht.125.10.1389; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zhang D, 2007, CELL DEATH DIFFER, V14, P703, DOI 10.1038/sj.cdd.4402072; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	38	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59339	10.1371/journal.pone.0059339	http://dx.doi.org/10.1371/journal.pone.0059339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555658	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900011
J	Cusimano, MD; Cho, N; Amin, K; Shirazi, M; McFaull, SR; Do, MT; Wong, MC; Russell, K				Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; McFaull, Steven R.; Do, Minh T.; Wong, Matthew C.; Russell, Kelly			Mechanisms of Team-Sport-Related Brain Injuries in Children 5 to 19 Years Old: Opportunities for Prevention	PLOS ONE			English	Article							HEAD-INJURIES; ICE HOCKEY; BODY-CHECKING; SOCCER; EPIDEMIOLOGY; CONCUSSIONS; AGREEMENT; RISK	Background: There is a gap in knowledge about the mechanisms of sports-related brain injuries. The objective of this study was to determine the mechanisms of brain injuries among children and youth participating in team sports. Methods: We conducted a retrospective case series of brain injuries suffered by children participating in team sports. The Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) database was searched for brain injury cases among 5-19 year-olds playing ice hockey, soccer, American football (football), basketball, baseball, or rugby between 1990 and 2009. Mechanisms of injury were classified as "struck by player,'' "struck by object,'' "struck by sport implement,'' "struck surface,'' and "other.'' A descriptive analysis was performed. Results: There were 12,799 brain injuries related to six team sports (16.2% of all brain injuries registered in CHIRPP). Males represented 81% of injuries and the mean age was 13.2 years. Ice hockey accounted for the greatest number of brain injuries (44.3%), followed by soccer (19.0%) and football (12.9%). In ice hockey, rugby, and basketball, striking another player was the most common injury mechanism. Football, basketball, and soccer also demonstrated high proportions of injuries due to contact with an object (e.g., post) among younger players. In baseball, a common mechanism in the 5-9 year-old group was being hit with a bat as a result of standing too close to the batter (26.1% males, 28.3% females). Interpretation: Many sports-related brain injury mechanisms are preventable. The results suggest that further efforts aimed at universal rule changes, safer playing environments, and the education of coaches, players, and parents should be targeted in maximizing prevention of sport-related brain injury using a multifaceted approach.	[Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; Wong, Matthew C.; Russell, Kelly] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [McFaull, Steven R.; Do, Minh T.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Public Health Agency of Canada	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research [TIR-103946]	Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.cihr-irsc.gc.ca/e/193.html	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Canadian Fitness & Lifestyle Research Institute, 2011, GETT KIDS ACT 2010 P; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cusimano Michael D, 2011, Open Med, V5, pe57; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hassan A, 2009, CAN J CARDIOL, V25, P207, DOI 10.1016/S0828-282X(09)70062-5; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kang J., 2012, INT J INJ CONTROL SA, P1; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Statistics Canada, 2010, AGE SEX; Turk EE, 2008, BRIT J SPORT MED, V42, P604, DOI 10.1136/bjsm.2007.038505; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	25	38	38	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58868	10.1371/journal.pone.0058868	http://dx.doi.org/10.1371/journal.pone.0058868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555602	Green Published, gold			2022-12-27	WOS:000317262200007
J	Shimada, M; Abe, S; Takahashi, T; Shiozaki, K; Okuda, M; Mizukami, H; Klinman, DM; Ozawa, K; Okuda, K				Shimada, Masaru; Abe, Shinya; Takahashi, Toru; Shiozaki, Kazumasa; Okuda, Mitsue; Mizukami, Hiroaki; Klinman, Dennis M.; Ozawa, Keiya; Okuda, Kenji			Prophylaxis and Treatment of Alzheimer's Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein	PLOS ONE			English	Article							PHASE-I TRIAL; TRANSGENIC MICE; MOUSE MODEL; A-BETA(42) IMMUNIZATION; IMMUNE-RESPONSE; MEMORY DEFICITS; SKELETAL-MUSCLE; BRAIN DELIVERY; GENE DELIVERY; VIRAL VECTOR	We previously reported on a monoclonal antibody (mAb) that targeted amyloid beta (A beta) protein. Repeated injection of that mAb reduced the accumulation of A beta protein in the brain of human A beta transgenic mice (Tg2576). In the present study, cDNA encoding the heavy and light chains of this mAb were subcloned into an adeno-associated virus type 1 (AAV) vector with a 2A/furin adapter. A single intramuscular injection of 3.0x10(10) viral genome of these AAV vectors into C57BL/6 mice generated serum anti-A beta Ab levels up to 0.3 mg/ml. Anti-A beta Ab levels in excess of 0.1 mg/ml were maintained for up to 64 weeks. The effect of AAV administration on A beta levels in vivo was examined. A significant decrease in A beta levels in the brain of Tg2576 mice treated at 5 months (prophylactic) or 10 months (therapeutic) of age was observed. These results support the use of AAV vector encoding anti-A beta Ab for the prevention and treatment of Alzheimer's disease.	[Shimada, Masaru; Abe, Shinya; Takahashi, Toru; Okuda, Kenji] Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan; [Shiozaki, Kazumasa] Yokohama City Univ, Dept Psychiat, Yokohama, Kanagawa 232, Japan; [Okuda, Mitsue] Okuda Dent Clin, Yokohama, Kanagawa, Japan; [Mizukami, Hiroaki; Ozawa, Keiya] Jichi Med Sch, Ctr Mol Med, Div Genet Therapeut, Mibu, Tochigi, Japan; [Klinman, Dennis M.] NCI, Expt Immunol Lab, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA	Yokohama City University; Yokohama City University; Jichi Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Okuda, K (corresponding author), Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan.	kokuda@chojuken.net	Mizukami, Hiroaki/D-7674-2013	Mizukami, Hiroaki/0000-0001-8954-874X; Shimada, Masaru/0000-0002-5271-4238	Ministry of Education, Science, Sports, Culture of Japan; Ministry of Health and Welfare of Japan; NATIONAL CANCER INSTITUTE [ZIABC010852] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports, Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant-in-aid for the Ministry of Education, Science, Sports, Culture of Japan, and the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Black RS, 2010, ALZ DIS ASSOC DIS, V24, P198, DOI 10.1097/WAD.0b013e3181c53b00; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chackerian B, 2006, VACCINE, V24, P6321, DOI 10.1016/j.vaccine.2006.05.059; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Chu J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-1; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Farlow MR, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt39; Feng X, 2004, FRONT BIOSCI-LANDMRK, V9, P1540, DOI 10.2741/1323; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fleisher AS, 2012, NEUROBIOL AGING; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Karlnoski RA, 2008, J NEUROIMMUNE PHARM, V3, P187, DOI 10.1007/s11481-008-9114-6; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; McCarron MO, 2004, LANCET NEUROL, V3, P484, DOI 10.1016/S1474-4422(04)00825-7; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104; Okada T, 2005, HUM GENE THER, V16, P1212, DOI 10.1089/hum.2005.16.1212; Okura Y, 2006, P NATL ACAD SCI USA, V103, P9619, DOI 10.1073/pnas.0600966103; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Ryan DA, 2010, MOL THER, V18, P1471, DOI 10.1038/mt.2010.111; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Shoji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030302; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sudol KL, 2009, MOL THER, V17, P2031, DOI 10.1038/mt.2009.174; Takuma H, 2008, NEUROREPORT, V19, P615, DOI 10.1097/WNR.0b013e3282fb78c4; Tamura Y, 2005, NEUROBIOL DIS, V20, P541, DOI 10.1016/j.nbd.2005.04.007; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Xin KQ, 2001, HUM GENE THER, V12, P1047, DOI 10.1089/104303401750214276; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	51	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e57606	10.1371/journal.pone.0057606	http://dx.doi.org/10.1371/journal.pone.0057606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555563	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200002
J	Verma, S; Ronsard, L; Kapoor, R; Banerjea, AC				Verma, Sachin; Ronsard, Larance; Kapoor, Richa; Banerjea, Akhil C.			Genetic Characterization of Natural Variants of Vpu from HIV-1 Infected Individuals from Northern India and Their Impact on Virus Release and Cell Death	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUBTYPE-B VPU; TYPE-1 HIV-1; BETA-TRCP; TRANSMEMBRANE DOMAIN; PROTEIN; DEGRADATION; APOPTOSIS; REGION; IDENTIFICATION	Background: Genetic studies reveal that vpu is one of the most variable regions in HIV-1 genome. Functional studies have been carried out mostly with Vpu derived from laboratory adapted subtype B pNL 4-3 virus. The rationale of this study was to characterize genetic variations that are present in the vpu gene from HIV-1 infected individuals from North-India (Punjab/Haryana) and determine their functional relevance. Methods: Functionally intact vpu gene variants were PCR amplified from genomic DNA of HIV-1 infected individuals. These variants were then subjected to genetic analysis and unique representative variants were cloned under CMV promoter containing expression vector as well as into pNL 4-3 HIV-1 virus for intracellular expression studies. These variants were characterized with respect to their ability to promote virus release as well as cell death. Results: Based on phylogenetic analysis and extensive polymorphisms with respect to consensus Vpu B and C, we were able to arbitrarily assign variants into two major groups (B and C). The group B variants always showed significantly higher virus release activity and exhibited moderate levels of cell death. On the other hand, group C variants displayed lower virus release activity but greater cell death potential. Interestingly, Vpu variants with a natural S61A mutation showed greater intracellular stability. These variants also exhibited significant reduction in their intracellular ubiquitination and caused greater virus release. Another group C variant that possessed a non-functional beta-TrcP binding motif due to two critical serine residues (S52 and S56) being substituted with isoleucine residues, showed reduced virus release activity but modest cytotoxic activity. Conclusions: The natural variations exhibited by our Vpu variants involve extensive polymorphism characterized by substitution and deletions that contribute toward positive selection. We identified two major groups and an extremely rare b-TrcP binding motif mutant that show widely varying biological activities with potential implications for conferring subtype-specific pathogenesis.	[Verma, Sachin; Ronsard, Larance; Kapoor, Richa; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Banerjea, AC (corresponding author), Natl Inst Immunol, Virol Lab, New Delhi 110067, India.	akhil@nii.res.in	Ronsard, Larance/H-2731-2019; Verma, Sachin/AGZ-1331-2022	Ronsard, Larance/0000-0002-5307-1940; Verma, Sachin/0000-0002-7447-0537	Department of Biotechnology [BT/PR8322/Med/14/1245/2006]; Indian Council of Medical Research, Government of India [HIV/50/142/9/2011-ECD-II]; NII, New Delhi	Department of Biotechnology; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); NII, New Delhi	The financial support for the work was provided by Department of Biotechnology (Grant # BT/PR8322/Med/14/1245/2006) and Indian Council of Medical Research (Grant # HIV/50/142/9/2011-ECD-II), Government of India to ACB and NII, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; Cornall A, 2010, J VIROL METHODS, V165, P90, DOI 10.1016/j.jviromet.2010.01.010; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Hill MS, 2008, VIROLOGY, V371, P86, DOI 10.1016/j.virol.2007.09.015; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Jens T, 2001, AIDS RES HUM RETROV, V8, P775; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Lee CN, 2000, J CLIN MICROBIOL, V38, P2468, DOI 10.1128/JCM.38.7.2468-2474.2000; Lv MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020890; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; MATSUDA Z, 1988, P NATL ACAD SCI USA, V85, P6968, DOI 10.1073/pnas.85.18.6968; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Paul M, 1998, J VIROL, V72, P1270, DOI 10.1128/JVI.72.2.1270-1279.1998; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; WAINHOBSON S, 1993, CURR OPIN GENET DEV, V3, P878, DOI 10.1016/0959-437X(93)90008-D; Yang SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-78; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	39	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59283	10.1371/journal.pone.0059283	http://dx.doi.org/10.1371/journal.pone.0059283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555649	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200017
J	Granada, AE; Bordyugov, G; Kramer, A; Herzel, H				Granada, Adrian E.; Bordyugov, Grigory; Kramer, Achim; Herzel, Hanspeter			Human Chronotypes from a Theoretical Perspective	PLOS ONE			English	Article							PHASE-RESPONSE CURVE; CIRCADIAN PACEMAKER; ENTRAINMENT; PERIOD; DYNAMICS; CLOCK; MODEL; STIMULI; SYSTEM; RHYTHM	The endogenous circadian timing system has evolved to synchronize an organism to Periodically recurring environmental conditions. Those external time cues are called Zeitgebers: When entrained by a Zeitgeber, the intrinsic oscillator adopts a fixed Phase relation psi to the Zeitgeber Here, we systematically study how the phase of entrainment depends on clock and Zitgeber properties. We combine numerical simulations of amplitude-phase models with predictions from analytically tractable models. In this way we derive relations between the Phase of entrainment psi to the mismatch between the endogenous and Zeitgeber period, the Zeitgeber strength,and the range of entrainment. A core result is "180 degrees rule" asserting that the phase psi varies over a range of about 180 degrees within the entrainment range. The 180 degrees rule implies that clocks with a narrow entrainment range ("strong oscillators") exhibit quite flexible entrainment phases. We argue that this high sensitivity of the entrainment phase contributes to the wide range of human chronotypes.	[Granada, Adrian E.; Bordyugov, Grigory; Herzel, Hanspeter] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herzel, H (corresponding author), Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany.	h.herzel@biologie.hu-berlin.de	Granada, Adrian/AAR-3743-2020	Granada, Adrian/0000-0003-0537-9091; Kramer, Achim/0000-0001-9671-6078	BMBF (BCCN) [01GQ1001C]; DFG [SFB 618, SPP 1395, GRK 1742]	BMBF (BCCN)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	The authors thank the BMBF (BCCN, grant 01GQ1001C) and the DFG (SFB 618, SPP 1395, GRK 1742) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Beersma DGM, 2009, J BIOL RHYTHM, V24, P153, DOI 10.1177/0748730408330196; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Comas M, 2006, J BIOL RHYTHM, V21, P362, DOI 10.1177/0748730406292446; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DAAN S, 1975, OECOLOGIA, V18, P269, DOI 10.1007/BF00345851; Duffing G., 1918, ZAMM Z ANGEW MATH ME; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Geier F, 2005, J BIOL RHYTHM, V20, P83, DOI 10.1177/0748730404269309; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Granada A, 2009, METHOD ENZYMOL, V454, P1, DOI 10.1016/S0076-6879(08)03801-9; Granada AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007057; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; GUEVARA MR, 1981, SCIENCE, V214, P1350, DOI 10.1126/science.7313693; Harada T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.088301; HOFFMANN K, 1969, Z VERGL PHYSIOL, V62, P93, DOI 10.1007/BF00298045; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pittendrigh C., 1981, BIOL RHYTHMS, P95, DOI DOI 10.1007/978-1-4615-6552-9_7; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Remi J, 2010, J BIOL RHYTHM, V25, P318, DOI 10.1177/0748730410379081; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T., 2012, INTERNAL TIME; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Westermark PO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000580; WEVER R, 1964, KYBERNETIK, V2, P127, DOI 10.1007/BF00306797; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	43	65	65	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59464	10.1371/journal.pone.0059464	http://dx.doi.org/10.1371/journal.pone.0059464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544070	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700031
J	Kano, F; Tomonaga, M				Kano, Fumihiro; Tomonaga, Masaki			Head-Mounted Eye Tracking of a Chimpanzee under Naturalistic Conditions	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; OBJECT-CHOICE TASKS; PAN-TROGLODYTES; PONGO-PYGMAEUS; MOVEMENTS; HUMANS; MONKEYS; FACES; STRATEGIES	This study offers a new method for examining the bodily, manual, and eye movements of a chimpanzee at the micro-level. A female chimpanzee wore a lightweight head-mounted eye tracker (60 Hz) on her head while engaging in daily interactions with the human experimenter. The eye tracker recorded her eye movements accurately while the chimpanzee freely moved her head, hands, and body. Three video cameras recorded the bodily and manual movements of the chimpanzee from multiple angles. We examined how the chimpanzee viewed the experimenter in this interactive setting and how the eye movements were related to the ongoing interactive contexts and actions. We prepared two experimentally defined contexts in each session: a face-to-face greeting phase upon the appearance of the experimenter in the experimental room, and a subsequent face-to-face task phase that included manual gestures and fruit rewards. Overall, the general viewing pattern of the chimpanzee, measured in terms of duration of individual fixations, length of individual saccades, and total viewing duration of the experimenter's face/body, was very similar to that observed in previous eye-tracking studies that used non-interactive situations, despite the differences in the experimental settings. However, the chimpanzee viewed the experimenter and the scene objects differently depending on the ongoing context and actions. The chimpanzee viewed the experimenter's face and body during the greeting phase, but viewed the experimenter's face and hands as well as the fruit reward during the task phase. These differences can be explained by the differential bodily/manual actions produced by the chimpanzee and the experimenter during each experimental phase (i.e., greeting gestures, task cueing). Additionally, the chimpanzee's viewing pattern varied depending on the identity of the experimenter (i.e., the chimpanzee's prior experience with the experimenter). These methods and results offer new possibilities for examining the natural gaze behavior of chimpanzees.	[Kano, Fumihiro; Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Kano, Fumihiro] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Kano, F (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	fkanou@pri.kyoto-u.ac.jp		Kano, Fumihiro/0000-0003-4534-6630	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [16002001, 19300091, 20002001, 212299]; JSPS/MEXT global COE programs [D07, A06]; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS/MEXT global COE programs; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by the Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Japan Grants-in-Aid for Scientific Research (nos. 16002001, 19300091, 20002001, 212299) and the JSPS/MEXT global COE programs (D07 and A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1996, BEHAV PROCESS, V37, P47; Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; Hashiya K, 1997, JPN PSYCHOL RES, V39, P182, DOI 10.1111/1468-5884.00052; Hattori Y, 2010, BIOL LETTERS, V6, P610, DOI 10.1098/rsbl.2010.0120; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kano F, 2011, ANIM COGN, V14, P879, DOI 10.1007/s10071-011-0422-5; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; LAND M, 1995, NATURE, V377, P339, DOI 10.1038/377339a0; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Myowa-Yamakoshi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1695; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Peignot P, 1999, J COMP PSYCHOL, V113, P253, DOI 10.1037/0735-7036.113.3.253; Pelz JB, 2001, VISION RES, V41, P3587, DOI 10.1016/S0042-6989(01)00245-0; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Ruiz April, 2009, Animal Cognition, V12, P427, DOI 10.1007/s10071-008-0202-z; Shepherd SV, 2010, CURR BIOL, V20, P649, DOI 10.1016/j.cub.2010.02.032; Shepherd SV, 2006, METHODS, V38, P185, DOI 10.1016/j.ymeth.2005.12.003; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tomonaga M, 2010, MIND CHIMPANZEE ECOL; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Turano KA, 2003, VISION RES, V43, P333, DOI 10.1016/S0042-6989(02)00498-4; Williams FJ, 2011, J NEUROSCI METH, V194, P259, DOI 10.1016/j.jneumeth.2010.10.022	44	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59785	10.1371/journal.pone.0059785	http://dx.doi.org/10.1371/journal.pone.0059785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544099	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700059
J	Lamers, RP; Cavallari, JF; Burrows, LL				Lamers, Ryan P.; Cavallari, Joseph F.; Burrows, Lori L.			The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA beta N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN; MEXA-MEXB-OPRM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; LACTAMASE INDUCTION; BILE-SALTS; PUMPS; SYSTEM	Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump inhibitors (EPIs) with pump substrates is under exploration to overcome efflux-mediated multidrug resistance. Phenylalanine-arginine beta-naphthylamide (PA beta N) is a well-studied EPI that is routinely combined with. fluoroquinolone antibiotics, but few studies have assessed its utility in combination with beta-lactam antibiotics. The initial goal of this study was to assess the efficacy of beta-lactams in combination with PA beta N against the opportunistic pathogen pseudomoneas aeruginosa. PA beta N reduced the minimal inhibitory concentrations (MICs) of several beta-lactam antibiotics against P. aeruginosa; however, the susceptibility changes were not due entirely to efflux inhibition. Upon PA beta N treatment, intracellular levels of the chromosomally-encoded AmpC beta-lactamase that inactivates beta-lactam antibiotics were significantly reduced and AmpC levels in supernatants correspondingly increased, potentially due to perrneabilization of the outer membrane. PP PA beta N treatment caused a significant increase in uptake of 8-anilino-1-naphthylenesulfonic acid, a fluorescent hydrophobic probe, and sensitized P aeruginosa to bulky antibiotics (e.g. vancomycin) that are normally incapable of crossing the outer membrane, as well as to detergent-like bile salts. Supplementation of growth media with magnesium to stabilize the outer membrane increased MICs in the presence of PA beta N and restored resistance to vancomycin. Thus, PAN permeabilizes bacterial membranes in a concentration-dependent manner at levels below those typically used in combination studies, and this additional mode of action should be considered when using PA beta N as a control for efflux studies.	[Lamers, Ryan P.; Cavallari, Joseph F.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	burrowl@mcmaster.ca			Canada-UK Partnership on Antibiotic Resistance [114045]; Michael G. DeGroote Fellowship in Basic Biomedical Science	Canada-UK Partnership on Antibiotic Resistance; Michael G. DeGroote Fellowship in Basic Biomedical Science	This study was funded by a Canada-UK Partnership on Antibiotic Resistance-114045 award to LLB. RPL is the recipient of the Michael G. DeGroote Fellowship in Basic Biomedical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askoura M, 2011, LIBYAN J MED, V6, DOI [10.3402/Ijm.v6i0.5870, DOI 10.3402/IJM.V6I0.5870]; Balemans W, 2012, ANTIMICROB AGENTS CH, V56, P4131, DOI 10.1128/AAC.00273-12; Beadle BM, 2001, PROTEIN SCI, V10, P1254, DOI 10.1110/ps.52001; Drusano GL, 2012, ANTIMICROB AGENTS CH, V56, P231, DOI 10.1128/AAC.05252-11; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Kus JV, 2011, J BACTERIOL, V193, P4509, DOI 10.1128/JB.00200-11; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Li XZ, 2000, J ANTIMICROB CHEMOTH, V45, P433, DOI 10.1093/jac/45.4.433; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Lomovskaya O, 2006, BIOCHEM PHARMACOL, V71, P910, DOI 10.1016/j.bcp.2005.12.008; Lomovskaya O, 2001, J MOL MICROB BIOTECH, V3, P225; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018547; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Mulet X, 2011, ANTIMICROB AGENTS CH, V55, P4560, DOI 10.1128/AAC.00519-11; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1998, DRUG RESIST UPDATE, V1, P93, DOI 10.1016/S1368-7646(98)80023-X; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; Schweizer HP, 2012, EXPERT OPIN DRUG DIS, V7, P633, DOI 10.1517/17460441.2012.688949; Srikumar R, 1999, J ANTIMICROB CHEMOTH, V44, P537, DOI 10.1093/jac/44.4.537; Stickland HG, 2010, J PROTEOME RES, V9, P2957, DOI 10.1021/pr9011415; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suzuki H, 2003, ANAL SCI, V19, P1239, DOI 10.2116/analsci.19.1239; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zechini B., 2009, DRUG DISCOVERY, V4, P37; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000	39	166	168	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60666	10.1371/journal.pone.0060666	http://dx.doi.org/10.1371/journal.pone.0060666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544160	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700119
J	Nauta, AC; Grova, M; Montoro, DT; Zimmermann, A; Tsai, M; Gurtner, GC; Galli, SJ; Longaker, MT				Nauta, Allison C.; Grova, Monica; Montoro, Daniel T.; Zimmermann, Andrew; Tsai, Mindy; Gurtner, Geoffrey C.; Galli, Stephen J.; Longaker, Michael T.			Evidence That Mast Cells Are Not Required for Healing of Splinted Cutaneous Excisional Wounds in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FIBROBLAST PROLIFERATION; GENE-EXPRESSION; PROMOTION; NUMBERS; LOCUS; MODEL	Wound healing is a complex biological process involving the interaction of many cell types to replace lost or damaged tissue. Although the biology of wound healing has been extensively investigated, few studies have focused on the role of mast cells. In this study, we investigated the possible role of mast cells in wound healing by analyzing aspects of cutaneous excisional wound healing in three types of genetically mast cell-deficient mice. We found that C57BL/6-Kit(W-sh/W-sh), WBB6F(1)-Kit(W/W-v), and Cpa3-Cre; Mcl-1(fl/fl) mice re-epithelialized splinted excisional skin wounds at rates very similar to those in the corresponding wild type or control mice. Furthermore, at the time of closure, scars were similar in the genetically mast cell-deficient mice and the corresponding wild type or control mice in both quantity of collagen deposition and maturity of collagen fibers, as evaluated by Masson's Trichrome and Picro-Sirius red staining. These data indicate that mast cells do not play a significant non-redundant role in these features of the healing of splinted full thickness excisional cutaneous wounds in mice.	[Nauta, Allison C.; Grova, Monica; Montoro, Daniel T.; Zimmermann, Andrew; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Nauta, Allison C.] Oregon Hlth & Sci Univ, Dept Surg, Div Plast & Reconstruct Surg, Portland, OR 97201 USA; [Grova, Monica] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Oregon Health & Science University; University of California System; University of California San Francisco; Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu; longaker@stanford.edu		Tsai, Mindy/0000-0002-8421-4721; Montoro, Daniel/0000-0002-6222-2149	Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; United States Public Health Service [AI23990, AI070813, CA72074]; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER	Hagey Laboratory for Pediatric Regenerative Medicine; Oak Foundation; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the Hagey Laboratory for Pediatric Regenerative Medicine and the Oak Foundation, as well as United States Public Health Service grants (to S.J.G.) AI23990, AI070813 and CA72074 for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Bradding P, 1996, CLIN EXP ALLERGY, V26, P13, DOI 10.1111/j.1365-2222.1996.tb00051.x; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; CHERVENI.PA, 1969, J CELL PHYSIOL, V73, P25, DOI 10.1002/jcp.1040730104; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Coneely J, 2010, J SURG RES, V164, pE73, DOI 10.1016/j.jss.2010.04.035; Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x; Foley TT, 2011, PLAST RECONSTR SURG, V127, P1478, DOI 10.1097/PRS.0b013e318208d0bb; Gailit J, 2001, J INVEST DERMATOL, V117, P1113, DOI 10.1046/j.1523-1747.2001.15211.x; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; GALLI SJ, 1987, BLOOD, V69, P1661; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Iba Y, 2004, INT IMMUNOPHARMACOL, V4, P1873, DOI 10.1016/j.intimp.2004.08.009; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kendall JC, 1997, J ALLERGY CLIN IMMUN, V99, P113; KISCHER CW, 1972, TEX REP BIOL MED, V30, P327; KITAMURA Y, 1978, BLOOD, V52, P447; Kohyama T, 2010, MOL CELL BIOCHEM, V337, P77, DOI 10.1007/s11010-009-0287-y; Kulka M, 2009, J LEUKOCYTE BIOL, V86, P1217, DOI 10.1189/jlb.0908517; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; NAKANO T, 1989, BLOOD, V74, P1552; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; RUSSELL JD, 1977, J CELL PHYSIOL, V93, P389, DOI 10.1002/jcp.1040930310; Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Szpaderska AM, 2003, J INVEST DERMATOL, V120, P1130, DOI 10.1046/j.1523-1747.2003.12253.x; TONO T, 1992, BLOOD, V80, P1448; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wilgus TA, 2012, J INVEST DERMATOL, V132, P493, DOI 10.1038/jid.2011.343; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Wong VW, 2011, FASEB J, V25, P4498, DOI 10.1096/fj.10-178087; Wulff BC, 2012, J INVEST DERMATOL, V132, P458, DOI 10.1038/jid.2011.324; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803; Younan GJ, 2011, PLAST RECONSTR SURG, V128, p649E, DOI 10.1097/PRS.0b013e318230c55d; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391	48	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59167	10.1371/journal.pone.0059167	http://dx.doi.org/10.1371/journal.pone.0059167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544053	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700015
J	Sebek, P; Altman, J; Platek, M; Cizek, L				Sebek, Pavel; Altman, Jan; Platek, Michal; Cizek, Lukas			Is Active Management the Key to the Conservation of Saproxylic Biodiversity? Pollarding Promotes the Formation of Tree Hollows	PLOS ONE			English	Article							TRADITIONAL LAND-USE; OSMODERMA-EREMITA; COLEOPTERA; FOREST; PREFERENCES; WOODLANDS; ABUNDANCE; DYNAMICS; BEETLES	Trees with hollows are key features sustaining biodiversity in wooded landscapes. They host rich assemblages of often highly specialised organisms. Hollow trees, however, have become rare and localised in Europe. Many of the associated biota is thus declining or endangered. The challenge of its conservation, therefore, is to safeguard the presence of hollow trees in sufficient numbers. Populations of numerous species associated with tree hollows and dead wood are often found in habitats that were formed by formerly common traditional silvicultural practices such as coppicing, pollarding or pasture. Although it has been occasionally mentioned that such practices increase the formation of hollows and the availability of often sun-exposed dead wood, their effect has never been quantified. Our study examined the hollow incidence in pollard and non-pollard (unmanaged) willows and the effect of pollarding on incremental growth rate by tree ring analysis. The probability of hollow occurrence was substantially higher in pollard than in non-pollard trees. Young pollards, especially, form hollows much more often than non-pollards; for instance, in trees of 50 cm DBH, the probability of hollow ocurrence was similar to 0.75 in pollards, but only similar to 0.3 in non-pollards. No difference in growth rate was found. Pollarding thus leads to the rapid formation of tree hollows, a habitat usually associated with old trees. It is therefore potentially a very important tool in the restoration of saproxylic habitats and conservation of hollow-dependent fauna. If applied along e.g. roads and watercourses, pollarding could also be used to increase landscape connectivity for saproxylic organisms. In reserves where pollarding was formerly practiced, its restoration would be necessary to prevent loss of saproxylic biodiversity. Our results point to the importance of active management measures for maintaining availability, and spatial and temporal continuity of deadwood microhabitats.	[Sebek, Pavel; Platek, Michal; Cizek, Lukas] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Sebek, Pavel; Altman, Jan; Platek, Michal; Cizek, Lukas] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Altman, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Sebek, P (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	pav.sebek@gmail.com	Sebek, Pavel/O-4522-2017; Cizek, Lukas/G-7905-2014; Altman, Jan/B-4305-2015; Cizek, Lukas/K-7111-2015; Sebek, Pavel/AAC-9599-2021	Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Sebek, Pavel/0000-0003-3341-4771	Czech Science Foundation [P504/12/1952]; Technology Agency of the Czech Republic [TA02021501]; Grant Agency of University of South Bohemia [145/2010/P]; project Biodiversity of Forest Ecosystems [CZ.1.07/2.3.00/20.0064]; European Social Fund; state budget of the Czech Republic	Czech Science Foundation(Grant Agency of the Czech Republic); Technology Agency of the Czech Republic; Grant Agency of University of South Bohemia; project Biodiversity of Forest Ecosystems; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	The study and its authors were supported by the Czech Science Foundation (P504/12/1952; http://www.gacr.cz), the Technology Agency of the Czech Republic (TA02021501; http://www.tacr.cz), Grant Agency of University of South Bohemia (145/2010/P; http://www.jcu.cz/research/gaju), and the project Biodiversity of Forest Ecosystems (CZ.1.07/2.3.00/20.0064; http://biodiverzita.pri.jcu.cz) co-financed by the European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2012, EUR J ENTOMOL, V109, P553, DOI 10.14411/eje.2012.069; Alexander KNA, 1998, ECOLOGICAL HISTORY OF EUROPEAN FORESTS, P73; Alexander KNA, 2008, LANDSC ARCHACOL ECOL, V7, P12; Alexander KNA, 2012, SAPROXYLIC BEETLES E, P7; ALLEN A W, 1990, Northern Journal of Applied Forestry, V7, P179; Altman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055770; Ball IR, 1999, FOREST ECOL MANAG, V123, P179, DOI 10.1016/S0378-1127(99)00026-2; Biodiversity and Pollards, 2012, BIOD POLL; Butler J, 2010, LANDSC ARCHACOL ECOL, V8, P54, DOI [10.1007/978-94-007-6159-9_25, DOI 10.1007/978-94-007-6159-9_25]; Castro Alberto, 2012, Munibe (Ciencias Naturales - Natur Zientziak), V60, P77; Chiari S, 2013, INSECT CONSERV DIVER, V6, P309, DOI 10.1111/j.1752-4598.2012.00215.x; Dryad, 2013, INT DIG RESP; Dubois GF, 2009, LANDSCAPE URBAN PLAN, V91, P152, DOI 10.1016/j.landurbplan.2008.12.009; Fan ZF, 2004, FOREST ECOL MANAG, V193, P399, DOI 10.1016/j.foreco.2004.02.008; Fan ZF, 2003, FOREST ECOL MANAG, V179, P231, DOI 10.1016/S0378-1127(02)00522-4; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gouix N, 2011, THESIS U P M CURIE P; Gouix N, 2012, BIODIVERS CONSERV, V21, P421, DOI 10.1007/s10531-011-0190-1; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hauck D, 2006, INVENTARIZACE STORMU; Hedin J, 2008, BIODIVERS CONSERV, V17, P675, DOI 10.1007/s10531-007-9299-7; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jansson N, 2009, BIODIVERS CONSERV, V18, P3891, DOI 10.1007/s10531-009-9687-2; Jonsson MT, 2011, APPL VEG SCI, V14, P120, DOI 10.1111/j.1654-109X.2010.01096.x; Koch AJ, 2008, FOREST ECOL MANAG, V255, P674, DOI 10.1016/j.foreco.2007.09.042; Kohler F, 2000, TOTHOLZKAFER NATURWA; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Leppik E, 2011, LICHENOLOGIST, V43, P257, DOI 10.1017/S002428291100003X; Lequet A, 2012, ROSALIE ALPES ROSALI; Lush M, 2005, ENGLISH NATURE RES R; Mansion D, 2010, TRONGES ARBRE PAYSAN; Moe B, 1997, PLANT ECOL, V129, P157, DOI 10.1023/A:1009720132726; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Oleksa A, 2007, POL J ECOL, V55, P315; PACKHAM JR, 1992, FUNCTIONAL ECOLOGY W; Parviainen J, 2000, FORESTRY, V73, P107, DOI 10.1093/forestry/73.2.107; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; R Core Team, 2018, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Ranius T., 2005, Animal Biodiversity and Conservation, V28, P1; Ranius T., 2002, Animal Biodiversity and Conservation, V25, P53; Ranius T, 2002, BIODIVERS CONSERV, V11, P931, DOI 10.1023/A:1015364020043; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Read H. J., 1996, INC P M HOST CORP LO; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; Rozas V, 2004, FOREST ECOL MANAG, V195, P205, DOI 10.1016/j.foreco.2004.02.058; Schweingruber F. H., 1996, Tree rings and environment: dendroecology.; SCIEM, 2012, PERS AN SYST TREER R; Sebek P., 2012, SAPROXYLIC BEETLES E, P67; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Spitzer L, 2008, BIOL CONSERV, V141, P827, DOI 10.1016/j.biocon.2008.01.005; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Thomas P, 2000, TREES THEIR NATURAL, P230; Thomas PA, 2007, ECOLOGY OF WOODLANDS AND FORESTS: DESCRIPTION, DYNAMICS AND DIVERSITY, P1, DOI 10.1017/CBO9780511805578; Todarello P, 2007, P LINN SOC N S W, V128, P1; Vandekerkhove K, 2011, SILVA FENN, V45, P909, DOI 10.14214/sf.78; Vera F. W. M., 2000, Grazing ecology and forest history, DOI 10.1079/9780851994420.0000; Vignon V, 2003, P 2 PAN EUR C SAPR B, P36; Vignon V, 2006, PIQUE PRUNE HIST SAU; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Vuidot A, 2011, BIOL CONSERV, V144, P441, DOI 10.1016/j.biocon.2010.09.030; Whitehead P.F., 2003, P 2 PAN EUR C SAPR B, P1; Zmihorski M, 2009, FOLIA ZOOL, V58, P207	64	73	76	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60456	10.1371/journal.pone.0060456	http://dx.doi.org/10.1371/journal.pone.0060456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544142	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700101
J	Yao, XH; Nguyen, HK; Nyomba, BLG				Yao, Xing-Hai; Nguyen, Hoa K.; Nyomba, B. L. Gregoire			Prenatal Ethanol Exposure Causes Glucose Intolerance with Increased Hepatic Gluconeogenesis and Histone Deacetylases in Adult Rat Offspring: Reversal by Tauroursodeoxycholic Acid	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; INSULIN-RESISTANCE; ALCOHOL EXPOSURE; MOUSE MODEL; EXPRESSION; DIFFERENTIATION; ACETYLATION; DEGRADATION; SUPPRESSION	Prenatal ethanol exposure results in increased glucose production in adult rat offspring and this may involve modulation of protein acetylation by cellular stress. We used adult male offspring of dams given ethanol during gestation days 1-7 (early), 8-14 (mid) and 15-21 (late) compared with those from control dams. A group of ethanol offspring was treated with tauroursodeoxycholic acid (TUDCA) for 3 weeks. We determined gluconeogenesis, phosphoenolpyruvate carboxykinase PEPCK) glucose-6-phosphatase, hepatic free radicals, histone deacetylases (HDAC), acetylated foxo1, acetylated PEPCK, and C/EBP homologous protein as a marker of endoplasmic reticulum stress. prenatal ethanol during either of the 3 weeks of pregnancy increased gluconeogenesis, gluconeogenic genes, oxidative and endoplasmic reticulum stresses, sirtuin-2 and HDAC3, 4, 5, and 7 in adult offspring. Conversely, prenatal ethanol reduced acetylation of foxo1 and PEPCK. Treatment of adult ethanol offspring with TUDCA reversed all these abnormalities. Thus, prenatal exposure of rats to ethanol results in long lasting oxidative and endoplasmic reticulum stresses explaining increased expression of gluconeogenic genes and HDAC proteins which, by deacetylating foxo1 and PEPCK, contribute to increased gluconeogenesis. These anomalies occurred regardless of the time of ethanol exposure during pregnancy, including early embryogenesis. As these anomalies were reversed by treatment of the adult offspring with TUDCA, this compound has therapeutic potentials in the treatment of glucose intolerance associated with prenatal ethanol exposure.	[Yao, Xing-Hai; Nyomba, B. L. Gregoire] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Nguyen, Hoa K.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Nyomba, BLG (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	bnyomba@cc.umanitoba.ca		Nyomba, B. L. Gregoire/0000-0001-9472-607X	Canadian Diabetes Association	Canadian Diabetes Association	This work was supported by the Canadian Diabetes Association (www.Diabetes.Ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2011, ALCOHOL CLIN EXP RES, V35, P1550, DOI 10.1111/j.1530-0277.2011.01492.x; Barr M, 2000, ENVIRON HEALTH PERSP, V108, P569, DOI 10.2307/3454548; Batta Kiran, 2007, Subcell Biochem, V41, P193; Berger E, 2011, BIOCHEM BIOPH RES CO, V409, P610, DOI 10.1016/j.bbrc.2011.05.043; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; CASTELLS S, 1981, DEV PHARMACOL THERAP, V3, P232, DOI 10.1159/000457447; Chen L, 2005, J APPL PHYSIOL, V99, P528, DOI 10.1152/japplphysiol.01098.2004; Chen L, 2004, J APPL PHYSIOL, V96, P167, DOI 10.1152/japplphysiol.00751.2003; Chen L, 2003, ENDOCRINOLOGY, V144, P500, DOI 10.1210/en.2002-220623; Cohen-Kerem R, 2003, NEUROTOXICOL TERATOL, V25, P1, DOI 10.1016/S0892-0362(02)00324-0; Dembele K, 2006, AM J PHYSIOL-REG I, V291, pR796, DOI 10.1152/ajpregu.00633.2005; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Elton CW, 2002, J ENDOCRINOL, V173, P63, DOI 10.1677/joe.0.1730063; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fofana B, 2010, PROTEOMICS, V10, P417, DOI 10.1002/pmic.200800969; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Grucza RA, 2010, ARCH GEN PSYCHIAT, V67, P1301, DOI 10.1001/archgenpsychiatry.2010.155; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kaminen-Ahola N, 2010, BIRTH DEFECTS RES A, V88, P818, DOI 10.1002/bdra.20729; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Nguyen KH, 2012, ALCOHOL, V46, P89, DOI 10.1016/j.alcohol.2011.04.001; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Nammi S, 2007, AM J PHYSIOL-REG I, V292, pR1101, DOI 10.1152/ajpregu.00255.2006; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oiso H, 2011, BIOCHEM BIOPH RES CO, V404, P166, DOI 10.1016/j.bbrc.2010.11.086; Pennington JS, 2002, ALCOHOL CLIN EXP RES, V26, P848, DOI 10.1097/00000374-200206000-00015; Rabbani B, 2012, GENE, V503, P215, DOI 10.1016/j.gene.2012.04.080; Rodrigues CMP, 2003, BIOCHEMISTRY-US, V42, P3070, DOI 10.1021/bi026979d; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Yao XH, 2006, J APPL PHYSIOL, V100, P642, DOI 10.1152/japplphysiol.01115.2005; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Yao XH, 2007, AM J PHYSIOL-REG I, V292, pR1926, DOI 10.1152/ajpregu.00822.2006; Young TK, 2002, ARCH PEDIAT ADOL MED, V156, P651, DOI 10.1001/archpedi.156.7.651; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	48	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59680	10.1371/journal.pone.0059680	http://dx.doi.org/10.1371/journal.pone.0059680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544086	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700046
J	Adamson, A; Ghoreschi, K; Rittler, M; Chen, Q; Sun, HW; Vahedi, G; Kanno, Y; Stetler-Stevenson, WG; O'Shea, JJ; Laurence, A				Adamson, Adewole; Ghoreschi, Kamran; Rittler, Matthew; Chen, Qian; Sun, Hong-Wei; Vahedi, Golnaz; Kanno, Yuka; Stetler-Stevenson, William G.; O'Shea, John J.; Laurence, Arian			Tissue Inhibitor of Metalloproteinase 1 Is Preferentially Expressed in Th1 and Th17 T-Helper Cell Subsets and Is a Direct Stat Target Gene	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MULTIPLE-SCLEROSIS; TGF-BETA; CYTOKINE; DIFFERENTIATION; T(H)17; TIMP-1; IL-17; MECHANISMS; PHENOTYPE	CD4(+) T helper (Th) cells differentiate into distinct effector subsets that are critical for host defense, but are also implicated in the pathogenesis of autoimmune disorders. Thelper17 (Th17) cells in particular are emerging as important drivers of multiple diseases including psoriasis, spondyloarthropathy and multiple sclerosis. To gain insight into the function of Th17 cells, we performed transcriptional profiling in hopes of elucidating products not previously recognized as being functionally relevant in these T cells. Herein, we demonstrate that tissue inhibitor of metalloproteinase 1 (TIMP1), a secreted protein with pleiotropic effects on cellular growth, survival and integrity of the extracellular matrix, is preferentially produced by Th17 and Th1 cells. We further show that Th1 and Th17 cell TIMP1 regulation follows separate mechanisms with a requirement for STAT4 in the former and STAT3 in the latter. Finally, we demonstrate that when restricted to T cells, expression of TIMP1 promotes neuropathology in experimental allergic encephalomyelitis.	[Adamson, Adewole; Ghoreschi, Kamran; Sun, Hong-Wei; Vahedi, Golnaz; Kanno, Yuka; O'Shea, John J.; Laurence, Arian] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Rittler, Matthew; Stetler-Stevenson, William G.] NCI, Radiat Oncol Branch, Bethesda, MD 20892 USA; [Chen, Qian] Huazhong Univ Sci & Technol, Tongji Med Coll, Div Gastroenterol, Dept Internal Med, Wuhan, Hubei Province, Peoples R China; [Adamson, Adewole] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Ghoreschi, Kamran] Univ Tubingen, Dept Dermatol, Univ Med Ctr, Tubingen, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Huazhong University of Science & Technology; Harvard University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Laurence, A (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	laurencea@mail.nih.gov	Stetler-Stevenson, William/AAE-3501-2020; Laurence, Arian/A-8770-2009; Kanno, Yuka/B-5802-2013; Stetler-Stevenson, William G/H-6956-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Stetler-Stevenson, William G/0000-0002-5500-5808; Ghoreschi, Kamran/0000-0002-5526-7517	National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIHAR041173] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by intramural funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. AA was supported by the National Institutes of Health Clinical Research Training Program, a public-private partnership between the Foundation for the National Institutes of Health and Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Althoff GEM, 2010, AM J PATHOL, V177, P840, DOI 10.2353/ajpath.2010.090918; Annunziato F, 2011, CYTOKINE, V56, P112, DOI 10.1016/j.cyto.2011.06.009; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Birkedal-Hansen H, 2008, CURR PROTOC CELL BIO; Burkhardt J, 2009, J RHEUMATOL, V36, P2149, DOI 10.3899/jrheum.090059; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; CLARK IM, 1993, ARTHRITIS RHEUM, V36, P372, DOI 10.1002/art.1780360313; Crocker M, 2011, NEURO-ONCOLOGY, V13, P99, DOI 10.1093/neuonc/noq170; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hoey T, 2003, EMBO J, V22, P4237, DOI 10.1093/emboj/cdg393; Holten-Andersen MN, 2002, CLIN CANCER RES, V8, P156; Kohem CL, 1996, ARTHRITIS RHEUM, V39, P844, DOI 10.1002/art.1780390518; Kouwenhoven M, 2001, J AUTOIMMUN, V16, P463, DOI 10.1006/jaut.2001.0505; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Meijer MJW, 2007, WORLD J GASTROENTERO, V13, P2960, DOI 10.3748/wjg.v13.i21.2960; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Toft-Hansen H, 2004, J IMMUNOL, V173, P5209, DOI 10.4049/jimmunol.173.8.5209; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yoshiji H, 1998, INT J CANCER, V75, P81, DOI 10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J; Young-Min SA, 2001, ANN RHEUM DIS, V60, P846; Zhou JH, 2005, J VIROL, V79, P4764, DOI 10.1128/JVI.79.8.4764-4773.2005; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59367	10.1371/journal.pone.0059367	http://dx.doi.org/10.1371/journal.pone.0059367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555662	gold, Green Published, Green Submitted			2022-12-27	WOS:000317418500036
J	Bhagwat, SR; Chandrashekar, DS; Kakar, R; Davuluri, S; Bajpai, AK; Nayak, S; Bhutada, S; Acharya, K; Sachdeva, G				Bhagwat, Sonali R.; Chandrashekar, Darshan S.; Kakar, Ruchi; Davuluri, Sravanthi; Bajpai, Akhilesh K.; Nayak, Sumeet; Bhutada, Sumit; Acharya, Kshitish; Sachdeva, Geetanjali			Endometrial Receptivity: A Revisit to Functional Genomics Studies on Human Endometrium and Creation of HGEx-ERdb	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; IMPLANTATION; TROPHOBLAST; ADHESION; THROMBOSPONDIN-1; ATTACHMENT; EPITHELIUM; SURFACE; WINDOW	Background: Endometrium acquires structural and functional competence for embryo implantation only during the receptive phase of menstrual cycle in fertile women. Sizeable data are available to indicate that this ability is acquired by modulation in the expression of several genes/gene products. However, there exists little consensus on the identity, number of expressed/not-detected genes and their pattern of expression (up or down regulation). Methods: Literature search was carried out to retrieve the data on endometrial expression of genes/proteins in various conditions. Data were compiled to generate a comprehensive database, Human Gene Expression Endometrial Receptivity database (HGEx-ERdb). The database was used to identify the Receptivity Associated Genes (RAGs) which display the similar pattern of expression across different investigations. Transcript levels of select RAGs encoding cell adhesion proteins were compared between two human endometrial epithelial cell lines; RL95-2 and HEC-1-A by quantitative real time polymerase chain reaction (q-RT-PCR). Further select RAGs were investigated for their expression in pre-receptive (n = 4) and receptive phase (n = 4) human endometrial tissues by immunohistochemical studies. JAr spheroid attachment assays were carried out to assess the functional significance of two RAGs. Results: HGEx-ERdb (http://resource.ibab.ac.in/HGEx-ERdb/) helped identification of 179 RAGs, of which 151 genes were consistently expressed and upregulated and 28 consistently not-detected and downregulated in receptive phase as compared to pre-receptive phase. q-RT-PCR confirmed significantly higher (p<0.005) expression of Thrombospondin1 (THBS1), CD36 and Mucin 16 transcripts, in RL95-2 as compared to HEC-1-A. Further, the pretreatment with antibodies against CD36 and COMP led to a reduction in the percentage of JAr spheroids attached to RL95-2. Immunohistochemical studies demonstrated significantly higher (p<0.05) expression of endometrial THBS1, Cartilage Oligomeric Matrix Protein (COMP) and CD36 in the receptive phase as compared to pre-receptive phase human endometrial tissues. Conclusion: HGEx-ERdb is a catalogue of 19,285 genes, reported for their expression in human endometrium. Further 179 genes were identified as the RAGs. Expression analysis of some RAGs validated the utility of approach employed in creation of HGEx-ERdb. Studies aimed towards defining the specific functions of RAGs and their potential networks may yield relevant information about the major 'nodes' which regulate endometrial receptivity.	[Bhagwat, Sonali R.; Kakar, Ruchi; Nayak, Sumeet; Bhutada, Sumit; Sachdeva, Geetanjali] Natl Inst Res Reprod Hlth, Primate Biol Dept, Bombay, Maharashtra, India; [Chandrashekar, Darshan S.; Davuluri, Sravanthi; Bajpai, Akhilesh K.; Acharya, Kshitish] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Sachdeva, G (corresponding author), Natl Inst Res Reprod Hlth, Primate Biol Dept, Bombay, Maharashtra, India.	sachdevag@nirrh.res.in	Nayak, Sumeet/AAF-7143-2021; Bhutada, Sumit/CAG-8918-2022	Nayak, Sumeet/0000-0002-3326-6484; Bhutada, Sumit/0000-0002-5274-5122	Indian Council of Medical Research and Department of Biotechnology, Government of India; centre of excellence scheme for IBAB from DEITY, Government of India; Shodhaka Life Sciences Pvt. Ltd., Bengaluru	Indian Council of Medical Research and Department of Biotechnology, Government of India(Indian Council of Medical Research (ICMR)Department of Biotechnology (DBT) India); centre of excellence scheme for IBAB from DEITY, Government of India; Shodhaka Life Sciences Pvt. Ltd., Bengaluru	The reserach project was funded by Indian Council of Medical Research and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate the help extended by Ms. Krutika Phalnikar, in cell line maintenance. The authors also thank Dr Lalita Savardekar for providing the endometrial tissue sections for the study no. 140/2007. DC was supported under the centre of excellence scheme for IBAB from DEITY, Government of India, while AKB and SD were supported by Shodhaka Life Sciences Pvt. Ltd. (www.shodhaka.com), Bengaluru.	Aboussahoud W, 2010, HUM REPROD, V25, P2217, DOI 10.1093/humrep/deq185; Acharya KK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-467; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; [Anonymous], NUCL ACIDS RES, V38, pD331; APLIN JD, 1994, ANN NY ACAD SCI, V734, P103, DOI 10.1111/j.1749-6632.1994.tb21739.x; Aplin JD, 1998, GLYCOBIOLOGY, V8, P269, DOI 10.1093/glycob/8.3.269; Bajpai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036776; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Casals G, 2008, REPROD BIOMED ONLINE, V16, P808, DOI 10.1016/S1472-6483(10)60146-0; Casals G, 2010, REPROD BIOMED ONLINE, V21, P349, DOI 10.1016/j.rbmo.2010.04.012; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; DeLoia JA, 1998, HUM REPROD, V13, P2902, DOI 10.1093/humrep/13.10.2902; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; GRUMMER R, 1994, PLACENTA, V15, P411, DOI 10.1016/0143-4004(94)90008-6; Hohn HP, 2000, MOL REPROD DEV, V57, P135; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kawano Y, 2005, FERTIL STERIL, V83, P1056, DOI 10.1016/j.fertnstert.2004.09.035; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Martin J, 2002, J REPROD IMMUNOL, V55, P131, DOI 10.1016/S0165-0378(01)00140-1; Mirkin S, 2005, HUM REPROD, V20, P2104, DOI 10.1093/humrep/dei051; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Ponnampalam AP, 2004, MOL HUM REPROD, V10, P879, DOI 10.1093/molehr/gah121; Punyadeera C, 2005, CELL MOL LIFE SCI, V62, P239, DOI 10.1007/s00018-004-4435-y; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Serafini PC, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-30; Sharkey AM, 2003, BEST PRACT RES CL OB, V17, P289, DOI 10.1016/S1521-6934(02)00130-X; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Tapia A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-14; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	40	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58419	10.1371/journal.pone.0058419	http://dx.doi.org/10.1371/journal.pone.0058419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555582	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500011
J	McKay, GJ; Savage, DA; Patterson, CC; Lewis, G; McKnight, AJ; Maxwell, AP				McKay, Gareth J.; Savage, David A.; Patterson, Christopher C.; Lewis, Gareth; McKnight, Amy Jayne; Maxwell, Alexander P.		Warren 3UK GoKinD Study Grp	Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; LIPID PROFILES; SERUM-LIPIDS; CETP GENE; LOCI; RISK; CHOLESTEROL; PROGRESSION	Type 1 diabetes (T1D) increases risk of the development of microvascular complications and cardiovascular disease (CVD). Dyslipidemia is a common risk factor in the pathogenesis of both CVD and diabetic nephropathy (DN), with CVD identified as the primary cause of death in patients with DN. In light of this commonality, we assessed single nucleotide polymorphisms (SNPs) in thirty-seven key genetic loci previously associated with dyslipidemia in a T1D cohort using a case-control design. SNPs (n = 53) were genotyped using Sequenom in 1467 individuals with T1D (718 cases with proteinuric nephropathy and 749 controls without nephropathy i.e. normal albumin excretion). Cases and controls were white and recruited from the UK and Ireland. Association analyses were performed using PLINK to compare allele frequencies in cases and controls. In a sensitivity analysis, samples from control individuals with reduced renal function (estimated glomerular filtration rate, 60 ml/min/1.73 m(2)) were excluded. Correction for multiple testing was performed by permutation testing. A total of 1394 samples passed quality control filters. Following regression analysis adjusted by collection center, gender, duration of diabetes, and average HbA1c, two SNPs were significantly associated with DN. rs4420638 in the APOC1 region (odds ratio [OR] = 1.51; confidence intervals [CI]: 1.19-1.91; P = 0.001) and rs1532624 in CETP (OR = 0.82; CI: 0.69-0.99; P = 0.034); rs4420638 was also significantly associated in a sensitivity analysis (P = 0.016) together with rs7679 (P = 0.027). However, no association was significant following correction for multiple testing. Subgroup analysis of end-stage renal disease status failed to reveal any association. Our results suggest common variants associated with dyslipidemia are not strongly associated with DN in T1D among white individuals. Our findings, cannot entirely exclude these key genes which are central to the process of dyslipidemia, from involvement in DN pathogenesis as our study had limited power to detect variants of small effect size. Analysis in larger independent cohorts is required.	[McKay, Gareth J.; Lewis, Gareth; McKnight, Amy Jayne; Maxwell, Alexander P.] Queens Univ Belfast, Ctr Publ Hlth, Nephrol Res Grp, Belfast, Antrim, North Ireland; [Savage, David A.] Belfast Hlth & Social Care Trust, Belfast City Hosp, Histocompatibil & Immunogenet Lab, Belfast, Antrim, North Ireland; [Patterson, Christopher C.] Queens Univ Belfast, Ctr Publ Hlth, Cardiovasc Epidemiol & Publ Hlth Res Grp, Belfast, Antrim, North Ireland	Queens University Belfast; Belfast City Hospital; Queens University Belfast	McKay, GJ (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Nephrol Res Grp, Belfast, Antrim, North Ireland.	g.j.mckay@qub.ac.uk	McKnight, Amy Jayne/ABF-4492-2020; McKay, Gareth/AAZ-2601-2020	McKnight, Amy Jayne/0000-0002-7482-709X; McKay, Gareth/0000-0001-8197-6280; Maxwell, Alexander P./0000-0002-6110-7253	Diabetes UK; Juvenile Diabetes Research Foundation; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI	Diabetes UK(Diabetes UK); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Public Health Agency; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Warren 3/UK GoKinD Study Group was jointly funded by Diabetes UK and the Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Danesh FR, 2004, FASEB J, V18, P805, DOI 10.1096/fj.03-0839rev; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Dullaart RPF, 2008, PHARMACOGENOMICS, V9, P747, DOI 10.2217/14622416.9.6.747; Durrington PN, 1999, BEST PRACT RES CL EN, V13, P265, DOI 10.1053/beem.1999.0019; Ginsberg HN, 2006, J CLIN ENDOCR METAB, V91, P383, DOI 10.1210/jc.2005-2084; Groop PH, 1996, DIABETES, V45, P974, DOI 10.2337/diabetes.45.7.974; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Heeringa P, 2002, CURR OPIN NEPHROL HY, V11, P287, DOI 10.1097/00041552-200205000-00004; Igl W, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000798; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; JONES SL, 1989, BRIT MED J, V298, P487, DOI 10.1136/bmj.298.6672.487; Kamanna VS, 1998, HISTOL HISTOPATHOL, V13, P169, DOI 10.14670/HH-13.169; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kavanagh D, 2011, DIABETOLOGIA, V54, P334, DOI 10.1007/s00125-010-1978-3; Keane WF, 2000, KIDNEY INT, V57, pS27, DOI 10.1046/j.1523-1755.2000.07503.x; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; LAGROST L, 1993, ARTERIOSCLER THROMB, V13, P815, DOI 10.1161/01.ATV.13.6.815; Lahiry P, 2010, J LIPID RES, V51, P843, DOI 10.1194/jlr.P002014; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1994, NEW ENGL J MED, V330, P152; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Marcovecchio ML, 2009, DIABETES CARE, V32, P658, DOI 10.2337/dc08-1641; Mattock MB, 2001, DIABETIC MED, V18, P59, DOI 10.1046/j.1464-5491.2001.00411.x; McKnight AJ, 2009, NEPHROL DIAL TRANSPL, V24, P2473, DOI 10.1093/ndt/gfp015; Molitch ME, 2006, CLIN J AM SOC NEPHRO, V1, P1090, DOI 10.2215/CJN.00780306; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; MULEC H, 1993, AM J KIDNEY DIS, V22, P196, DOI 10.1016/S0272-6386(12)70186-5; Nishida Y, 1997, AM J KIDNEY DIS, V29, P919, DOI 10.1016/S0272-6386(97)90467-4; O'Brien T, 1998, MAYO CLIN PROC, V73, P969, DOI 10.4065/73.10.969; PARVING HH, 1989, BRIT MED J, V299, P230, DOI 10.1136/bmj.299.6693.230; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; SAWICKI PT, 1994, DIABETES CARE, V17, P126, DOI 10.2337/diacare.17.2.126; Solano Maria P, 2006, Cardiol Rev, V14, P125, DOI 10.1097/01.crd.0000188034.76283.5e; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Teran-Garcia M, 2008, ATHEROSCLEROSIS, V196, P455, DOI 10.1016/j.atherosclerosis.2006.12.005; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas MC, 2006, DIABETES CARE, V29, P317, DOI 10.2337/diacare.29.02.06.dc05-0809; Tolonen N, 2008, DIABETOLOGIA, V51, P12, DOI 10.1007/s00125-007-0858-y; Tuomilehto J, 1998, DIABETOLOGIA, V41, P784, DOI 10.1007/s001250050988; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; WATTS GF, 1989, DIABETIC MED, V6, P25, DOI 10.1111/j.1464-5491.1989.tb01134.x; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	54	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58472	10.1371/journal.pone.0058472	http://dx.doi.org/10.1371/journal.pone.0058472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555584	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500012
J	Tiller, D; Russ, M; Greiser, KH; Nuding, S; Ebelt, H; Kluttig, A; Kors, JA; Thiery, J; Bruegel, M; Haerting, J; Werdan, K				Tiller, Daniel; Russ, Martin; Greiser, Karin Halina; Nuding, Sebastian; Ebelt, Henning; Kluttig, Alexander; Kors, Jan A.; Thiery, Joachim; Bruegel, Mathias; Haerting, Johannes; Werdan, Karl			Prevalence of Symptomatic Heart Failure with Reduced and with Normal Ejection Fraction in an Elderly General Population-The CARLA Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; EUROPEAN-SOCIETY; RISK-FACTORS; DIASTOLIC DYSFUNCTION; NATRIURETIC PEPTIDE; DISEASE; TRENDS; ECHOCARDIOGRAPHY; RECOMMENDATIONS; EPIDEMIOLOGY	Background/Objectives: Chronic heart failure (CHF) is one of the most important public health concerns in the industrialized world having increasing incidence and prevalence. Although there are several studies describing the prevalence of heart failure with reduced ejection fraction (HFREF) and heart failure with normal ejection fraction (HFNEF) in selected populations, there are few data regarding the prevalence and the determinants of symptomatic heart failure in the general population. Methods: Cross-sectional data of a population-based German sample (1,779 subjects aged 45-83 years) were analyzed to determine the prevalence and determinants of chronic SHF and HFNEF defined according to the European Society of Cardiology using symptoms, echocardiography and serum NT-proBNP. Prevalence was age-standardized to the German population as of December 31st, 2005. Results: The overall age-standardized prevalence of symptomatic CHF was 7.7% (95%CI 6.0-9.8) for men and 9.0% (95% CI 7.0-11.5) for women. The prevalence of CHF strongly increased with age from 3.0% among 45-54-year-old subjects to 22.0% among 75-83-year-old subjects. Symptomatic HFREF could be shown in 48% (n = 78), symptomatic HFNEF in 52% (n = 85) of subjects with CHF. The age-standardized prevalence of HFREF was 3.8 % (95%CI 2.4-5.8) for women and 4.6 % (95%CI 3.6-6.3) for men. The age-standardized prevalence of HFNEF for women and men was 5.1 % (95%CI 3.8-7.0) and 3.0 % (95%CI 2.1-4.5), respectively. Persons with CHF were more likely to have hypertension (PR = 3.4; 95%CI 1.6-7.3) or to have had a previous myocardial infarction (PR = 2.5, 95%CI 1.8-3.5). Conclusion: The prevalence of symptomatic CHF appears high in this population compared with other studies. While more women were affected by HFNEF than men, more male subjects suffered from HFREF. The high prevalence of symptomatic CHF seems likely to be mainly due to the high prevalence of cardiovascular risk factors in this population.	[Tiller, Daniel; Greiser, Karin Halina; Kluttig, Alexander; Haerting, Johannes] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany; [Russ, Martin; Nuding, Sebastian; Ebelt, Henning; Werdan, Karl] Univ Halle Wittenberg, Univ Clin Halle Saale, Dept Med 3, D-06108 Halle, Germany; [Greiser, Karin Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Kors, Jan A.] Erasmus Univ, Dept Med Informat, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Thiery, Joachim; Bruegel, Mathias] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Erasmus University Rotterdam; Erasmus MC; Leipzig University	Tiller, D (corresponding author), Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany.	daniel.tiller@medizin.uni-halle.de	Russ, Martin/V-8221-2019		Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Federal Employment Office; Ministry of Education and Cultural Affairs of Saxony-Anhalt	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg(German Research Foundation (DFG)); Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Federal Employment Office; Ministry of Education and Cultural Affairs of Saxony-Anhalt	This study was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the Collaborative Research Center 598 "Heart failure in the elderly-cellular mechanisms and therapy" at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; by a grant of the Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; by the Federal Employment Office; and by the Ministry of Education and Cultural Affairs of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, BRIT MED J, V313, P1448; Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Azevedo A, 2007, EUR J HEART FAIL, V9, P391, DOI 10.1016/j.ejheart.2006.10.017; de Sa DDC, 2010, HEART, V96, P528, DOI 10.1136/hrt.2009.177980; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fay MP, 1997, STAT MED, V16, P791; Gaasch WH, 2004, ANNU REV MED, V55, P373, DOI 10.1146/annurev.med.55.091902.104417; Goetze JP, 2006, EUR HEART J, V27, P3004, DOI 10.1093/eurheartj/ehl406; Gorelik O, 2009, CLIN RES CARDIOL, V98, P224, DOI 10.1007/s00392-009-0746-1; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Hoes A. W., 1998, European Heart Journal, V19, pL2; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Kalsch H, 2010, CLIN RES CARDIOL, V99, P175, DOI 10.1007/s00392-009-0104-3; Kannel W B, 2000, Heart Fail Rev, V5, P167; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Le Jemtel TH, 2007, J AM COLL CARDIOL, V49, P171, DOI 10.1016/j.jacc.2006.08.046; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Luers C, 2010, CLIN RES CARDIOL, V99, P217, DOI 10.1007/s00392-009-0108-z; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; MATTIASSON I, 1990, BRIT MED J, V301, P461, DOI 10.1136/bmj.301.6750.461; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKelvie RS, 2010, J CARD FAIL, V16, P128, DOI 10.1016/j.cardfail.2009.09.007; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Moebus S, 2008, DTSCH ARZTEBL INT, V105, P207, DOI 10.3238/artzebl.2008.0207; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Muller-Nordhorn J, 2004, J EPIDEMIOL COMMUN H, V58, P481, DOI 10.1136/jech.2003.013367; Naimi AI, 2009, CIRCULATION, V119, pE305; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Prineas R., 1982, MINNESOTA CODE MANUA; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Task FM, 2012, EUR HEART J; Tehrani Faramarz, 2010, Clin Cardiol, V33, pE1, DOI 10.1002/clc.20615; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Volzke H, 2006, DTSCH ARZTEBL, V103	47	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59225	10.1371/journal.pone.0059225	http://dx.doi.org/10.1371/journal.pone.0059225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555000	Green Published, gold			2022-12-27	WOS:000316409800073
J	Yang, HQ; Liu, L; Shin, HD; Li, JH; Du, GC; Chen, J				Yang, Haiquan; Liu, Long; Shin, Hyun-dong; Li, Jianghua; Du, Guocheng; Chen, Jian			Structure-Guided Systems-Level Engineering of Oxidation-Prone Methionine Residues in Catalytic Domain of an Alkaline alpha-Amylase from Alkalimonas amylolytica for Significant Improvement of Both Oxidative Stability and Catalytic Efficiency	PLOS ONE			English	Article							PROTEIN THERMAL-STABILITY; HYDROGEN-BONDS; SALT BRIDGE; BACILLUS; PURIFICATION; REPLACEMENT; RESISTANCE; STRAIN	High oxidative stability and catalytic efficiency are required for the alkaline alpha-amylases to keep the enzymatic performance under the harsh conditions in detergent industries. In this work, we attempted to significantly improve both the oxidative stability and catalytic efficiency of an alkaline alpha-amylase from Alkalimonas amylolytica by engineering the five oxidation-prone methionine residues around the catalytic domain via a systematic approach. Specifically, based on the tertiary structure analysis, five methionines (Met 145, Met 214, Met 229, Met 247 and Met 317) were individually substituted with oxidation-resistant threonine, isoleucine and alaline, respectively. Among the created 15 mutants, 7 mutants M145A, M145I, M214A, M229A, M229T, M247T and M317I showed significantly enhanced oxidative stability or catalytic efficiency. In previous work, we found that the replacement of M247 with leucine could significantly improve the oxidative stability. Thus, these 8 positive mutants (M145A, M145I, M214A, M229A, M229T, M247T, M247L and M317I) were used to conduct the second round of combinational mutations. Among the constructed 85 mutants (25 two-point mutants, 36 three-point mutants, 16 four-point mutants and 8 five-point mutants), the mutant M145I-214A-229T-247T-317I showed a 5.4-fold increase in oxidative stability and a 3.0-fold increase in catalytic efficiency. Interestingly, the specific activity, alkaline stability and thermal stability of this mutant were also increased. The increase of salt bridge and hydrogen bonds around the catalytic domain contributed to the significantly improved catalytic efficiency and stability, as revealed by the three-dimensional structure model of wild-type alkaline alpha-amylase and its mutant M145I-214A-229T-247T-317I. With the significantly improved oxidative stability and catalytic efficiency, the mutant M145I-214A-229T-247T-317I has a great potential as a detergent additive, and this structure-guided systems engineering strategy may be useful for the protein engineering of the other microbial enzymes to fulfill industrial requirements.	[Yang, Haiquan; Liu, Long; Li, Jianghua; Du, Guocheng] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Yang, Haiquan; Liu, Long; Li, Jianghua; Du, Guocheng] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Chen, Jian] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology; Jiangnan University	Liu, L (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China.	longliu@jiangnan.edu.cn; jchen@jiangnan.edu.cn	li, jianghua/GXG-4735-2022		Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project [111-2-06]; National High Technology Research and Development Program of China (863 Program) [2012AA022202]; 973 Program [2012CB720806]	Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China)	This work was financially supported by Priority Academic Program Development of Jiangsu Higher Education Institutions, the 111 Project (111-2-06), National High Technology Research and Development Program of China (863 Program, 2012AA022202), and 973 Program (2012CB720806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo Rodriguez V, 2006, ELECTRON J BIOTECHN, V9, P0717; BROSNAN MP, 1992, EUR J BIOCHEM, V203, P225, DOI 10.1111/j.1432-1033.1992.tb19850.x; FUWA H, 1954, J BIOCHEM-TOKYO, V41, P583, DOI 10.1093/oxfordjournals.jbchem.a126476; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gumpena R, 2012, PROTEIN SCI, V21, P727, DOI 10.1002/pro.2060; GUO H, 1994, J PHYS CHEM-US, V98, P7104, DOI 10.1021/j100080a002; Hagihara H, 2001, APPL ENVIRON MICROB, V67, P1744, DOI 10.1128/AEM.67.4.1744-1750.2001; Hagihara H, 2001, EUR J BIOCHEM, V268, P3974, DOI 10.1046/j.1432-1327.2001.02308.x; Khemakhem B, 2009, BIOTECHNOL BIOENG, V102, P380, DOI 10.1002/bit.22083; KIM TU, 1995, APPL ENVIRON MICROB, V61, P3105, DOI 10.1128/AEM.61.8.3105-3112.1995; Kurosawa K, 2006, APPL ENVIRON MICROB, V72, P71, DOI 10.1128/AEM.72.1.71-77.2006; Lin LL, 2003, CURR MICROBIOL, V46, P211, DOI 10.1007/s00284-002-3846-y; Liu YH, 2008, APPL MICROBIOL BIOT, V80, P795, DOI 10.1007/s00253-008-1580-5; Murakami S, 2008, ENZYME MICROB TECH, V43, P321, DOI 10.1016/j.enzmictec.2008.05.006; Russell GL, 2002, J SURFACTANTS DETERG, V5, P5, DOI 10.1007/s11743-002-0198-9; Tan TC, 2008, J MOL BIOL, V378, P852, DOI 10.1016/j.jmb.2008.02.041; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang Nan, 2006, Biotechnology Journal, V1, P1258, DOI 10.1002/biot.200600098; Yang HQ, 2012, BIOTECHNOL PROGR, V28, P1271, DOI 10.1002/btpr.1611; Yang HQ, 2012, APPL ENVIRON MICROB, V78, P7519, DOI 10.1128/AEM.01307-12	25	10	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e57403	10.1371/journal.pone.0057403	http://dx.doi.org/10.1371/journal.pone.0057403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554859	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800007
J	Bhathena, J; Martoni, C; Kulamarva, A; Tomaro-Duchesneau, C; Malhotra, M; Paul, A; Urbanska, AM; Prakash, S				Bhathena, Jasmine; Martoni, Christopher; Kulamarva, Arun; Tomaro-Duchesneau, Catherine; Malhotra, Meenakshi; Paul, Arghya; Urbanska, Aleksandra Malgorzata; Prakash, Satya			Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters	PLOS ONE			English	Article							FERULIC ACID; INSULIN-RESISTANCE; GUT-MICROBIOTA; ESTERASE; CELLS; INFLAMMATION; ABSORPTION; MECHANISMS; INTESTINE; RELEASE	The beneficial effect of a microencapsulated feruloyl esterase producing Lactobacillus fermentum ATCC 11976 formulation for use in non-alcoholic fatty liver disease (NAFLD) was investigated. For which Bio F1B Golden Syrian hamsters were fed a methionine deficient/choline devoid diet to induce non-alcoholic fatty liver disease. Results, for the first time, show significant clinical benefits in experimental animals. Examination of lipids show that concentrations of hepatic free cholesterol, esterified cholesterol, triglycerides and phospholipids were significantly lowered in treated animals. In addition, serum total cholesterol, triglycerides, uric acid and insulin resistance were found to decrease in treated animals. Liver histology evaluations showed reduced fat deposits. Western blot analysis shows significant differences in expression levels of key liver enzymes in treated animals. In conclusion, these findings suggest the excellent potential of using an oral probiotic formulation to ameliorate NAFLD.	[Prakash, Satya] McGill Univ, Dept Biomed Engn, Fac Med, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada; McGill Univ, Fac Med, Artificial Cells & Organs Res Ctr, Montreal, PQ, Canada	McGill University; McGill University	Prakash, S (corresponding author), McGill Univ, Dept Biomed Engn, Fac Med, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada.	satya.prakash@mcgill.ca	Paul, Arghya/AAT-4155-2020; Tomaro-Duchesneau, Catherine/H-2839-2019	Paul, Arghya/0000-0003-4788-0378; Tomaro-Duchesneau, Catherine/0000-0001-5811-3268; /0000-0002-4902-2353	Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) by Micropharma, Montreal, Canada [205811]; Canadian Institutes of Health Research (CIHR); Canada Graduate Scholarship from NSERC; Alexander Graham Bell Canada Graduate Scholarship from NSERC; FRSQ Doctoral Award; Post Graduate Scholarship from NSERC	Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) by Micropharma, Montreal, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Graduate Scholarship from NSERC; Alexander Graham Bell Canada Graduate Scholarship from NSERC; FRSQ Doctoral Award; Post Graduate Scholarship from NSERC	The authors would like to acknowledge support by grants from the Natural Science and Engineering Research Council (NSERC): Idea to Innovation (I2I) Grant supported by Micropharma, Montreal, Canada (Grant # 205811) (to SP), a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) (to JB), a Canada Graduate Scholarship from NSERC (to CM), an Alexander Graham Bell Canada Graduate Scholarship from NSERC (to AK, CTD and AP), a FRSQ Doctoral Award (to MM) and a Post Graduate Scholarship from NSERC (to AMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mukdsi MCA, 2012, LETT APPL MICROBIOL, V54, P18, DOI 10.1111/j.1472-765X.2011.03166.x; Adam A, 2002, J NUTR, V132, P1962, DOI 10.1093/jn/132.7.1962; Andreasen MF, 2001, FREE RADICAL BIO MED, V31, P304, DOI 10.1016/S0891-5849(01)00585-8; Anstee Quentin M, 2011, BMJ, V343, pd3897, DOI 10.1136/bmj.d3897; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; Bhathena J, 2008, BIOTECHNOL APPL BIOC, V50, P1, DOI 10.1042/BA20070007; Bhathena J, 2007, APPL MICROBIOL BIOT, V75, P1023, DOI 10.1007/s00253-007-0908-x; Bhathena J, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S6-006; Bhathena J, 2011, DIABETES METAB SYNDR, V4, P195, DOI 10.2147/DMSO.S18435; Bookman ID, 2006, LIVER INT, V26, P566, DOI 10.1111/j.1478-3231.2006.01256.x; Buchanan CJ, 1996, J SCI FOOD AGR, V71, P459, DOI 10.1002/(SICI)1097-0010(199608)71:4&lt;459::AID-JSFA602&gt;3.0.CO;2-H; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS39; de Roos B, 2005, FASEB J, V19, P1746, DOI 10.1096/fj.05-3953fje; Delaney B, 2003, J NUTR, V133, P468, DOI 10.1093/jn/133.2.468; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667; Gill HS, 2004, POSTGRAD MED J, V80, P516, DOI 10.1136/pgmj.2003.008664; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Iacono A, 2011, J NUTR BIOCHEM, V22, P699, DOI 10.1016/j.jnutbio.2010.10.002; Jones ML, 2013, EXPERT OPIN BIOL THE; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Lee RG, 2000, J LIPID RES, V41, P1991; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liang KH, 2003, KIDNEY INT, V64, P192, DOI 10.1046/j.1523-1755.2003.00041.x; Lirussi F, 2007, COCHRANE DB SYST REV, V1; Loguercio C, 2005, J CLIN GASTROENTEROL, V39, P540, DOI 10.1097/01.mcg.0000165671.25272.0f; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Ng DS, 2004, REV ENDOCR METAB DIS, V5, P311, DOI 10.1023/B:REMD.0000045102.70521.af; Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161; Prakash S, 1996, NAT MED, V2, P883, DOI 10.1038/nm0896-883; Prakash S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/981214; Reid AA, 2005, J MICROENCAPSUL, V22, P603, DOI 10.1080/02652040500162840; Saha S, 2012, EXPERT OPIN BIOL TH, V12, P1207, DOI 10.1517/14712598.2012.693474; Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006; Tomaro-Duchesneau C., 2012, International Journal of Probiotics and Prebiotics, V7, P23; Tomaro-Duchesneau C, 2013, J PHARMACEUTICS, V2013, DOI 10.1155/2013/103527; Tomaro-Duchesneau C, 2012, PHARMACEUTICALS, V5, P236, DOI 10.3390/ph5020236; Wende G, 1997, J SCI FOOD AGR, V73, P296, DOI 10.1002/(SICI)1097-0010(199703)73:3&lt;296::AID-JSFA737&gt;3.0.CO;2-0; Yamasaki Tomoyuki, 2008, Nihon Rinsho, V66, P766; Yan E, 2007, NUTR REV, V65, P376, DOI [10.1301/nr.2007.aug.376-384, 10.1111/j.1753-4887.2007.tb00315.x]; Zhao Z, 2003, J AGR FOOD CHEM, V51, P5534, DOI 10.1021/jf034455u; Zvenigorodskaia L A, 2010, Eksp Klin Gastroenterol, P25	45	29	32	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58394	10.1371/journal.pone.0058394	http://dx.doi.org/10.1371/journal.pone.0058394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554890	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500023
J	Dijkstra, JA; Buckman, KL; Ward, D; Evans, DW; Dionne, M; Chen, CY				Dijkstra, Jennifer A.; Buckman, Kate L.; Ward, Darren; Evans, David W.; Dionne, Michele; Chen, Celia Y.			Experimental and Natural Warming Elevates Mercury Concentrations in Estuarine Fish	PLOS ONE			English	Article							MICROBIAL SULFATE REDUCTION; FUNDULUS-HETEROCLITUS L; SALT-MARSH; METHYLMERCURY PRODUCTION; REDUCING BACTERIA; MARINE ECOSYSTEMS; CLIMATE-CHANGE; GUT CONTENTS; FOOD WEBS; TEMPERATURE	Marine food webs are the most important link between the global contaminant, methylmercury (MeHg), and human exposure through consumption of seafood. Warming temperatures may increase human exposure to MeHg, a potent neurotoxin, by increasing MeHg production as well as bioaccumulation and trophic transfer through marine food webs. Studies of the effects of temperature on MeHg bioaccumulation are rare and no study has specifically related temperature to MeHg fate by linking laboratory experiments with natural field manipulations in coastal ecosystems. We performed laboratory and field experiments on MeHg accumulation under varying temperature regimes using the killifish, Fundulus heteroclitus. Temperature treatments were established in salt pools on a coastal salt marsh using a natural temperature gradient where killifish fed on natural food sources. Temperatures were manipulated across a wider range in laboratory experiments with killifish exposed to MeHg enriched food. In both laboratory microcosms and field mesocosms, MeHg concentrations in killifish significantly increased at elevated temperatures. Moreover, in field experiments, other ancillary variables (salinity, MeHg in sediment, etc.) did not relate to MeHg bioaccumulation. Modeling of laboratory experimental results suggested increases in metabolic rate as a driving factor. The elevated temperatures we tested are consistent with predicted trends in climate warming, and indicate that in the absence of confounding factors, warmer sea surface temperatures could result in greater in bioaccumulation of MeHg in fish, and consequently, increased human exposure.	[Dijkstra, Jennifer A.; Dionne, Michele] Wells Natl Estuarine Res Reserve, Wells, ME 04090 USA; [Buckman, Kate L.; Chen, Celia Y.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Ward, Darren] Humboldt State Univ, Fisheries Biol Dept, Arcata, CA 95521 USA; [Evans, David W.] NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA	Dartmouth College; California State University System; California State Polytechnic University, Humboldt; National Oceanic Atmospheric Admin (NOAA) - USA	Dijkstra, JA (corresponding author), Wells Natl Estuarine Res Reserve, Wells, ME 04090 USA.	jdijkstra@ccom.unh.edu			NIEHS (NIH) [P42 ES007373]; Maine Sea Grant [DV-08-017]; George and Eleanor Ford Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	NIEHS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Maine Sea Grant; George and Eleanor Ford Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this research was provided by NIEHS (NIH #P42 ES007373) and Maine Sea Grant (#DV-08-017). Funding for J. A. Dijkstra was provided by the George and Eleanor Ford Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2012, ESTUAR COAST, V35, P743, DOI 10.1007/s12237-011-9471-x; Al-Raei AM, 2009, OCEAN DYNAM, V59, P351, DOI 10.1007/s10236-009-0186-5; ALLEN EA, 1994, ESTUARIES, V17, P462, DOI 10.2307/1352676; [Anonymous], 2007, PHYS SCI BAS CONTR W; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Bloom NS, 1997, FRESEN J ANAL CHEM, V358, P371, DOI 10.1007/s002160050432; Breitburg DL, 1999, LIMNOL OCEANOGR, V44, P837, DOI 10.4319/lo.1999.44.3_part_2.0837; Carrie J, 2010, ENVIRON SCI TECHNOL, V44, P316, DOI 10.1021/es902582y; Chen C, 2008, ECOHEALTH, V5, P399, DOI 10.1007/s10393-008-0201-1; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CY, 2005, ENVIRON SCI TECHNOL, V39, P115, DOI 10.1021/es0403007; Cherkasov AS, 2007, J THERM BIOL, V32, P162, DOI 10.1016/j.jtherbio.2007.01.005; Chetelat J, 2009, GLOBAL CHANGE BIOL, V15, P706, DOI 10.1111/j.1365-2486.2008.01729.x; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; COMPEAU GC, 1987, APPL ENVIRON MICROB, V53, P261, DOI 10.1128/AEM.53.2.261-265.1987; Compeau GC, 1994, APPL ENVIRON MICROB, V48, P1203; Dijkstra JA, 2011, GLOBAL CHANGE BIOL, V17, P2360, DOI 10.1111/j.1365-2486.2010.02371.x; Driscoll CT, 2012, ENVIRON RES, V119, P118, DOI 10.1016/j.envres.2012.05.002; Dutton J, 2011, ENVIRON TOXICOL CHEM, V30, P2107, DOI 10.1002/etc.600; Eagles-Smith CA, 2009, ENVIRON SCI TECHNOL, V43, P8658, DOI 10.1021/es901400c; FERNANDEZDELGADO C, 1989, ESTUAR COAST SHELF S, V29, P573, DOI 10.1016/0272-7714(89)90011-5; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; FRITZ ES, 1975, CAN J ZOOL, V53, P361, DOI 10.1139/z75-047; Frohne T, 2012, BIOGEOSCIENCES, V9, P493, DOI 10.5194/bg-9-493-2012; GILMOUR CC, 1992, ENVIRON SCI TECHNOL, V26, P2281, DOI 10.1021/es00035a029; Hall BD, 2008, ENVIRON POLLUT, V154, P124, DOI 10.1016/j.envpol.2007.12.017; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, ENVIRON SCI TECHNOL, V38, P1487, DOI 10.1021/es034528q; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Jackson B, 2009, ENVIRON SCI TECHNOL, V43, P2463, DOI 10.1021/es802656p; Karimi R, 2007, P NATL ACAD SCI USA, V104, P7477, DOI 10.1073/pnas.0611261104; Kneib RT, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P267; Leung KMY, 2000, J MAR BIOL ASSOC UK, V80, P647, DOI 10.1017/S0025315400002472; MacKenzie RA, 2008, MAR ECOL PROG SER, V368, P217, DOI 10.3354/meps07560; Madon SP, 2001, ECOL MODEL, V136, P149, DOI 10.1016/S0304-3800(00)00416-6; Martinez-Cortizas A, 1999, SCIENCE, V284, P939, DOI 10.1126/science.284.5416.939; Marvin-DiPasquale MC, 2003, ENVIRON GEOL, V43, P260, DOI 10.1007/s00254-002-0623-y; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1998, MAR CHEM, V61, P37, DOI 10.1016/S0304-4203(98)00006-1; McMahon KW, 2005, ESTUARIES, V28, P966, DOI 10.1007/BF02696024; MEREDITH WH, 1979, ESTUAR COAST MAR SCI, V8, P99, DOI 10.1016/0302-3524(79)90066-5; Modassir, 2000, ASIAN FISH SCI, V13, P335; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Nordlie FG, 2003, REV FISH BIOL FISHER, V13, P281, DOI 10.1023/B:RFBF.0000033050.51699.84; Pallud C, 2006, GEOCHIM COSMOCHIM AC, V70, P1148, DOI 10.1016/j.gca.2005.11.002; Pickhardt PC, 2002, P NATL ACAD SCI USA, V99, P4419, DOI 10.1073/pnas.072531099; Roman HA, 2011, ENVIRON HEALTH PERSP, V119, P607, DOI 10.1289/ehp.1003012; Sanz-Lazaro C, 2011, ECOL APPL, V21, P2664, DOI 10.1890/10-2219.1; Scheuhammer AM, 1998, ENVIRON TOXICOL CHEM, V17, P191, DOI 10.1002/etc.5620170208; Shanley JB, 2005, ECOTOXICOLOGY, V14, P125, DOI 10.1007/s10646-004-6264-z; Sheffield PE, 2011, ENVIRON HEALTH PERSP, V119, P291, DOI 10.1289/ehp.1002233; Skyllberg U, 2007, AMBIO, V36, P437, DOI 10.1579/0044-7447(2007)36[437:NMPAAB]2.0.CO;2; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003425; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2011, ANAL METHODS-UK, V3, P1143, DOI 10.1039/c0ay00528b; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Trombulak SC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020574; Trudel M, 2001, ECOL APPL, V11, P517, DOI 10.1890/1051-0761(2001)011[0517:PMCIFU]2.0.CO;2; Tsui MTK, 2006, ENVIRON SCI TECHNOL, V40, P4025, DOI 10.1021/es052377g; Tsui MTK, 2004, AQUAT TOXICOL, V70, P245, DOI 10.1016/j.aquatox.2004.09.006; Ullrich SM, 2001, CRIT REV ENV SCI TEC, V31, P241, DOI 10.1080/20016491089226; US Environmental Protection Agency, 1998, MERC SOL SOL THERM D; Wainright SC, 2000, MAR ECOL PROG SER, V200, P77, DOI 10.3354/meps200077; Wang R, 2011, ENVIRON TOXICOL CHEM, V30, P2142, DOI 10.1002/etc.604; Ward DM, 2010, ANN NY ACAD SCI, V1195, P62, DOI 10.1111/j.1749-6632.2010.05456.x; Ward DM, 2010, T AM FISH SOC, V139, P1, DOI 10.1577/T09-032.1; Ward DM, 2010, ENVIRON SCI TECHNOL, V44, P3245, DOI 10.1021/es902639a; Weinstein MP, 2000, T AM FISH SOC, V129, P797, DOI 10.1577/1548-8659(2000)129<0797:TROTSM>2.3.CO;2	74	66	68	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58401	10.1371/journal.pone.0058401	http://dx.doi.org/10.1371/journal.pone.0058401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554891	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500024
J	Gingo, MR; Balasubramani, GK; Kingsley, L; Rinaldo, CR; Alden, CB; Detels, R; Greenblatt, RM; Hessol, NA; Holman, S; Huang, L; Kleerup, EC; Phair, J; Sutton, SH; Seaberg, EC; Margolick, JB; Wisniewski, SR; Morris, A				Gingo, Matthew R.; Balasubramani, G. K.; Kingsley, Lawrence; Rinaldo, Charles R., Jr.; Alden, Christine B.; Detels, Roger; Greenblatt, Ruth M.; Hessol, Nancy A.; Holman, Susan; Huang, Laurence; Kleerup, Eric C.; Phair, John; Sutton, Sarah H.; Seaberg, Eric C.; Margolick, Joseph B.; Wisniewski, Stephen R.; Morris, Alison			The Impact of HAART on the Respiratory Complications of HIV Infection: Longitudinal Trends in the MACS andWIHS Cohorts	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; LUNG-CANCER; PULMONARY COMPLICATIONS; UNITED-STATES; RISK; ERA; SMOKING; DISEASE; HEALTH	Objective: To review the incidence of respiratory conditions and their effect on mortality in HIV-infected and uninfected individuals prior to and during the era of highly active antiretroviral therapy (HAART). Design: Two large observational cohorts of HIV-infected and HIV-uninfected men (Multicenter AIDS Cohort Study [MACS]) and women (Women's Interagency HIV Study [WIHS]), followed since 1984 and 1994, respectively. Methods: Adjusted odds or hazards ratios for incident respiratory infections or non-infectious respiratory diagnoses, respectively, in HIV-infected compared to HIV-uninfected individuals in both the pre-HAART (MACS only) and HAART eras; and adjusted Cox proportional hazard ratios for mortality in HIV-infected persons with lung disease during the HAART era. Results: Compared to HIV-uninfected participants, HIV-infected individuals had more incident respiratory infections both pre-HAART (MACS, odds ratio [adjusted-OR], 2.4; 95% confidence interval [CI], 2.2-2.7; p<0.001) and after HAART availability (MACS, adjusted-OR, 1.5; 95% CI 1.3-1.7; p<0.001; WIHS adjusted-OR, 2.2; 95% CI 1.8-2.7; p<0.001). Chronic obstructive pulmonary disease was more common in MACS HIV-infected vs. HIV-uninfected participants pre-HAART (hazard ratio [adjusted-HR] 2.9; 95% CI, 1.02-8.4; p=0.046). After HAART availability, non-infectious lung diseases were not significantly more common in HIV-infected participants in either MACS or WIHS participants. HIV-infected participants in the HAART era with respiratory infections had an increased risk of death compared to those without infections (MACS adjusted-HR, 1.5; 95% CI, 1.3-1.7; p<0.001; WIHS adjusted-HR, 1.9; 95% CI, 1.5-2.4; p<0.001). Conclusion: HIV infection remained a significant risk for infectious respiratory diseases after the introduction of HAART, and infectious respiratory diseases were associated with an increased risk of mortality.	[Gingo, Matthew R.; Morris, Alison] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Balasubramani, G. K.; Kingsley, Lawrence; Wisniewski, Stephen R.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Kingsley, Lawrence; Rinaldo, Charles R., Jr.] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Rinaldo, Charles R., Jr.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Alden, Christine B.] Johns Hopkins Univ, WIHS Data Management & Anal Ctr, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Greenblatt, Ruth M.; Hessol, Nancy A.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.; Hessol, Nancy A.; Huang, Laurence] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Holman, Susan] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Kleerup, Eric C.] Univ Calif San Francisco, Dept Med, David Geffen Sch Med, San Francisco, CA USA; [Phair, John; Sutton, Sarah H.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Seaberg, Eric C.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Margolick, Joseph B.] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Morris, Alison] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California San Francisco; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morris, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA.	morrisa@upmc.edu	Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021; Gingo, Matthew/K-7203-2013	Huang, Laurence/0000-0003-3888-2195; Wisniewski, Stephen/0000-0002-3877-9860; Kingsley, Lawrence/0000-0002-7000-8556; Goundappa K, Balasubramani/0000-0001-7221-1825	National Institutes of Health (NIH) [T32 HL007563, K23 HL108697, R01 HL090339, HL083461]; National Institute of Allergy and Infectious Diseases [UO1-AI35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; National Cancer Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL108697, T32HL007563, R01HL090339, R01HL083461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, U01AI042590, U01AI034989, U01AI034993, U01AI035043, U01AI035039, U01AI034994, U01AI031834, U01AI035004, U01AI035040, U01AI035042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Sources of support: National Institutes of Health (NIH) T32 HL007563 and K23 HL108697 (MG); R01 HL090339 and HL083461 (AM); Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) with centers (Principal Investigators) at the Johns Hopkins Bloomberg School of Public Health (Joseph B. Margolick, Lisa P. Jacobson), Howard Brown Health Center, Feinberg School of Medicine, Northwestern University, and Cook County Bureau of Health Services (John P. Phair, Steven M. Wolinsky), University of California, Los Angeles (Roger Detels), and University of Pittsburgh (Charles R. Rinaldo, Lawrence Kingsley). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. Website located at http://www. statepi. jhsph. edu/ macs/macs. html. Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington, DC, Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardice GM, 2003, BRIT J CANCER, V89, P505, DOI 10.1038/sj.bjc.6601139; Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Balbi B, 2010, EUR RESPIR J, V35, P231, DOI 10.1183/09031936.00189309; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bower M, 2003, AIDS, V17, P371, DOI 10.1097/00002030-200302140-00011; Celli BR, 2005, AM J MED, V118, P1364, DOI 10.1016/j.amjmed.2005.06.041; Chaturvedi AK, 2007, AIDS, V21, P207, DOI 10.1097/QAD.0b013e3280118fca; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029; Crothers K, 2007, J GEN INTERN MED, V22, P749, DOI 10.1007/s11606-007-0158-8; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; D'Jaen GA, 2010, CLIN LUNG CANCER, V11, P396, DOI 10.3816/CLC.2010.n.051; Dal Maso L, 2003, AIDS, V17, P2117, DOI 10.1097/00002030-200309260-00013; DHHS/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV infection, GUID US ANT AG HIV I; Diggle P, 1994, ANAL LONGITUDINAL DA, VXI, P253; Dufour V, 2004, LUNG, V182, P331, DOI 10.1007/s00408-004-2513-4; Engels EA, 2006, J CLIN ONCOL, V24, P1383, DOI 10.1200/JCO.2005.03.4413; Engsig FN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-272; Foster SB, 2008, J ALLERGY CLIN IMMUN, V122, P159, DOI 10.1016/j.jaci.2008.04.043; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gingo MR, 2012, J ALLERGY CLIN IMMUN, V129, P708, DOI 10.1016/j.jaci.2011.11.015; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Grubb JR, 2006, AIDS, V20, P1095, DOI 10.1097/01.aids.0000226949.64600.f9; Gutin F, 2009, ANN ALLERG ASTHMA IM, V102, P438, DOI 10.1016/S1081-1206(10)60518-2; Hardin JW, 2003, GEN ESTIMATING EQUAT, VXIII, P222; Hariri S, 2007, CLIN MICROBIOL REV, V20, P478, DOI 10.1128/CMR.00006-07; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Hessol NA, 2004, JAIDS-J ACQ IMM DEF, V36, P978, DOI 10.1097/00126334-200408010-00013; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Johannessen A, 2005, INT J TUBERC LUNG D, V9, P926; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Maurice E., 2005, Morbidity and Mortality Weekly Report, V54, P1121; MCKENZIE R, 1991, MEDICINE, V70, P326, DOI 10.1097/00005792-199109000-00004; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; MURRAY JF, 1987, AM REV RESPIR DIS, V135, P504; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Phelps RM, 2001, INT J CANCER, V94, P753, DOI 10.1002/ijc.1528; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Seaberg EC, 2011, CANCER, V116, P5507; Shiels MS, 2010, JAIDS-J ACQ IMM DEF, V55, P510, DOI 10.1097/QAI.0b013e3181f53783; Sigel K, 2012, AIDS, V26, P1017, DOI 10.1097/QAD.0b013e328352d1ad; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Takahashi TU, 2003, RESPIROLOGY, V8, P504, DOI 10.1046/j.1440-1843.2003.00501.x; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292	51	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58812	10.1371/journal.pone.0058812	http://dx.doi.org/10.1371/journal.pone.0058812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554932	Green Published, Green Accepted, gold			2022-12-27	WOS:000316252500046
J	Plaut, RD; Mocca, CP; Prabhakara, R; Merkel, TJ; Stibitz, S				Plaut, Roger D.; Mocca, Christopher P.; Prabhakara, Ranjani; Merkel, Tod J.; Stibitz, Scott			Stably Luminescent Staphylococcus aureus Clinical Strains for Use in Bioluminescent Imaging	PLOS ONE			English	Article							METHICILLIN-RESISTANT; MOUSE MODEL; IN-VIVO; VIRULENCE; SEQUENCE; GENOME; GENE; REPLACEMENT; EVOLUTION; INFECTION	In vivo bioluminescent imaging permits the visualization of bacteria in live animals, allowing researchers to monitor, both temporally and spatially, the progression of infection in each animal. We sought to engineer stably luminescent clinical strains of Staphylococcus aureus, with the goal of using such strains in mouse models. The gram-positive shuttle vector pMAD was used as the backbone for an integration plasmid. A chloramphenicol resistance gene, a modified lux operon from Photorhabdus luminescens, and approximately 650 bp of homology to the chromosome of the USA300 S. aureus strain NRS384 were added, generating plasmid pRP1195. Electroporation into strain RN4220 followed by temperature shift led to integration of pRP1195 into the chromosome. The integrated plasmid was transferred to clinical strains by phage transduction. Luminescent strains displayed no in vitro growth defects. Moreover, luminescence was stable in vitro after three rounds of subculture over 48 hours of growth in the absence of antibiotics. Mice were infected with a luminescent strain of NRS384 in skin and intravenous models. In a mouse skin model, luminescent bacteria were present in lesions that formed and cleared over the course of several days, and in an intravenous model, bacteria inoculated in the mouse tail vein were observed spreading to multiple tissues. No statistically significant difference in virulence was observed between NRS384 and the luminescent strain in either infection model. These preliminary data suggest that this luminescent USA300 strain is suitable for use in mouse models. Similar strains were engineered using other sequenced clinical strains. Because these strains are stably luminescent, they should prove useful in animal models of infection.	[Plaut, Roger D.; Mocca, Christopher P.; Prabhakara, Ranjani; Merkel, Tod J.; Stibitz, Scott] US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Plaut, RD (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	Roger.Plaut@fda.hhs.gov	Plaut, Roger D./B-2340-2013	Plaut, Roger D./0000-0002-0883-972X	Food and Drug Administration Medical Countermeasures Initiative; National Institute of Allergy and Infectious Diseases/National Institutes of Health [HHSN272200700055C]	Food and Drug Administration Medical Countermeasures Initiative; National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Stanley Kim was supported by the Food and Drug Administration Medical Countermeasures Initiative. Strain NRS384 was obtained through the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA; www.narsa.net) Program, supported under National Institute of Allergy and Infectious Diseases/National Institutes of Health Contract No. HHSN272200700055C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Christie GE, 2010, VIROLOGY, V407, P381, DOI 10.1016/j.virol.2010.08.036; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; GRAY GS, 1983, MOL BIOL EVOL, V1, P57; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Loving CL, 2009, INFECT IMMUN, V77, P255, DOI 10.1128/IAI.00633-08; McNamara Peter J., 2008, P89; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Steinhuber A, 2008, INT J MED MICROBIOL, V298, P599, DOI 10.1016/j.ijmm.2007.09.008	22	57	59	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59232	10.1371/journal.pone.0059232	http://dx.doi.org/10.1371/journal.pone.0059232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555002	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500075
J	Shu, CL; Jing-Yang-Lai; Su, LC; Chuu, CP; Fukui, Y				Shu, Chung-Li; Jing-Yang-Lai; Su, Liang-Cheng; Chuu, Chih-Pin; Fukui, Yasuhisa			SWAP-70: A New Type of Oncogene	PLOS ONE			English	Article								SWAP-70 is a protein that has been suggested to be involved in regulation of actin rearrangement. Having discovered that an artificially-derived mutant of SWAP-70 can transform mouse embryo fibroblasts, we searched for naturally-occurring mutations in the SWAP-70 gene, finding listings for several on the Web at www.sanger.ac.uk/genetics/CGP/cosmic/, including three mutations found in ovarian cancers. (The number of such mutations has now reached 13 out of 228 tumors). We created expression vectors for the mutant SWAP-70 proteins and introduced these into NIH3T3 cells. The cells expressing the mutant SWAP-70 constructs exhibited faster growth than the parental or wild-type SWAP-70-expressing cells. In most instances, cells that are able to grow in soft agar will form tumors in nude mice. While SWAP-70-transformed cells grew in soft agar, they failed to form tumors in nude mice. This result implies that transformation by the SWAP-70 mutants is unique. The cells bearing the mutant SWAP-70 genes were sensitive to nutrient starvation, supporting the idea that they are transformed cells. However, they failed to pile up and demonstrated contact inhibition, unlike most normal transformed cells. Upon expression of human SWAP-70 genes, MEK1 was activated. This activation appeared to contribute to the saturation density of the cells. As SWAP-70 has been shown to be the last protein to receive signals from cytokines, it is likely that there is a putative feedback signaling pathway, and that disorder of this signaling pathway can transform cells. Accordingly, this may explain why SWAP-70-transformed cells have different characteristics than most transformed cells.	[Shu, Chung-Li; Jing-Yang-Lai; Su, Liang-Cheng; Chuu, Chih-Pin; Fukui, Yasuhisa] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Fukui, Y (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town, Miaoli County, Taiwan.	990412@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010		National Health Research Institute [01A1-CSPP04-014]; National Science Council Taiwan [101-2300-B-400-015]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This paper is supported by a grant from National Health Research Institute 01A1-CSPP04-014 and from National Science Council Taiwan 101-2300-B-400-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Fukui Y, 2007, BIOCHEM BIOPH RES CO, V356, P512, DOI 10.1016/j.bbrc.2007.03.011; Fukui Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014180; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1	8	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59245	10.1371/journal.pone.0059245	http://dx.doi.org/10.1371/journal.pone.0059245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555004	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500076
J	Gabrielli, F; Salvi, R; Garulli, C; Kalogris, C; Arima, S; Tardella, L; Monaci, P; Pupa, SM; Tagliabue, E; Montani, M; Quaglino, E; Stramucci, L; Curcio, C; Marchini, C; Amici, A				Gabrielli, Federico; Salvi, Roberto; Garulli, Chiara; Kalogris, Cristina; Arima, Serena; Tardella, Luca; Monaci, Paolo; Pupa, Serenella M.; Tagliabue, Elda; Montani, Maura; Quaglino, Elena; Stramucci, Lorenzo; Curcio, Claudia; Marchini, Cristina; Amici, Augusto			Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD)	PLOS ONE			English	Article							DNA VACCINATION; BREAST-CANCER; PROTECTIVE IMMUNITY; MAMMARY CARCINOMAS; WILD-TYPE; T-CELL; ANTIBODY; ELECTROPORATION; REGION; TUMORS	We developed a new phage-display based approach, the Large Fragment Phage Display (LFPD), that can be used for mapping conformational epitopes on target molecules of immunological interest. LFPD uses a simplified and more effective phage-display approach in which only a limited set of larger fragments (about 100 aa in length) are expressed on the phage surface. Using the human HER2 oncoprotein as a target, we identified novel B-cell conformational epitopes. The same homologous epitopes were also detected in rat HER2 and all corresponded to the epitopes predicted by computational analysis (PEPITO software), showing that LFPD gives reproducible and accurate results. Interestingly, these newly identified HER2 epitopes seem to be crucial for an effective immune response against HER2-overexpressing breast cancers and might help discriminating between metastatic breast cancer and early breast cancer patients. Overall, the results obtained in this study demonstrated the utility of LFPD and its potential application to the detection of conformational epitopes on many other molecules of interest, as well as, the development of new and potentially more effective B-cell conformational epitopes based vaccines.	[Gabrielli, Federico; Garulli, Chiara; Kalogris, Cristina; Monaci, Paolo; Montani, Maura; Marchini, Cristina; Amici, Augusto] Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, MC, Italy; [Salvi, Roberto] Univ Lille 2, Fac Med, Lille, France; [Arima, Serena] Univ Roma La Sapienza, Dept Methods & Models Econ Terr & Finance, Rome, Italy; [Tardella, Luca] Univ Roma La Sapienza, Dept Stat Sci, Rome, Italy; [Pupa, Serenella M.; Tagliabue, Elda] Fdn IRCCS, Ist Nazl Tumori, AmadeoLab, Mol Targeting Unit,Dept Expt Oncol & Mol Med, Milan, Italy; [Quaglino, Elena] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Stramucci, Lorenzo; Curcio, Claudia] Univ G DAnnunzio, Aging Res Ctr, Chieti, Italy	University of Camerino; Universite de Lille - ISITE; Universite de Lille; Sapienza University Rome; Sapienza University Rome; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; G d'Annunzio University of Chieti-Pescara	Marchini, C (corresponding author), Univ Camerino, Dept Biosci & Biotechnol, I-62032 Camerino, MC, Italy.	cristina.marchini@unicam.it; augusto.amici@unicam.it	Curcio, Claudia/AAB-3638-2019; Stramucci, Lorenzo/I-2561-2018; Pupa, Serenella/K-6388-2016; Tagliabue, Elda/B-9377-2017	Stramucci, Lorenzo/0000-0001-9839-2441; Pupa, Serenella/0000-0002-4592-6830; Tagliabue, Elda/0000-0001-9877-2903; Amici, Augusto/0000-0002-4634-1500; Marchini, Cristina/0000-0001-7692-8428; TARDELLA, Luca/0000-0002-5703-3909; Garulli, Chiara/0000-0002-5292-2336; Quaglino, Elena/0000-0002-8151-9124; CURCIO, Claudia/0000-0001-5306-4399	Italian Association for Cancer Research (AIRC) [IG11889]; Italian Ministry for the Universities and Research	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for the Universities and Research	The experimental data herein were obtained through grants from the Italian Association for Cancer Research (AIRC, IG11889) and the Italian Ministry for the Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici A, 2000, GENE THER, V7, P703, DOI 10.1038/sj.gt.3301151; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Curcio C, 2003, J CLIN INVEST, V111, P1161, DOI 10.1172/JCI200317426; DISIS ML, 1994, CANCER RES, V54, P16; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jacob JB, 2010, CANCER RES, V70, P119, DOI 10.1158/0008-5472.CAN-09-2554; Jiang BH, 2005, J BIOL CHEM, V280, P4656, DOI 10.1074/jbc.M411047200; LIN TM, 1981, J CLIN MICROBIOL, V13, P646, DOI 10.1128/JCM.13.4.646-651.1981; Nagata Y, 1997, J IMMUNOL, V159, P1336; Orlandi R, 1997, BIOL CHEM, V378, P1387, DOI 10.1515/bchm.1997.378.11.1387; Peoples GE, 2005, J CLIN ONCOL, V23, P7536, DOI 10.1200/JCO.2005.03.047; Quaglino E, 2004, CANCER RES, V64, P2858, DOI 10.1158/0008-5472.CAN-03-2962; Quaglino E, 2010, CANCER RES, V70, P2604, DOI 10.1158/0008-5472.CAN-09-2548; Rolla S, 2008, HUM GENE THER, V19, P229, DOI 10.1089/hum.2006.196; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spadaro M, 2005, CLIN CANCER RES, V11, P1941, DOI 10.1158/1078-0432.CCR-04-1873; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Yip YL, 2001, J IMMUNOL, V166, P5271, DOI 10.4049/jimmunol.166.8.5271	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58358	10.1371/journal.pone.0058358	http://dx.doi.org/10.1371/journal.pone.0058358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555577	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200005
J	Braem, MGM; Voorhuis, M; Van der Schouw, YT; Peeters, PHM; Schouten, LJ; Eijkemans, MJC; Broekmans, FJ; Onland-Moretl, NC				Braem, Marieke G. M.; Voorhuis, Marlies; Van der Schouw, Yvonne T.; Peeters, Petra H. M.; Schouten, Leo J.; Eijkemans, Marinus J. C.; Broekmans, Frank J.; Onland-Moret, N. Charlotte			Interactions between Genetic Variants in AMH and AMHR2 May Modify Age at Natural Menopause	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; RISK-FACTORS; CANCER; LOCI; ASSOCIATION; DESIGN; COHORT; WOMEN	The onset of menopause has important implications on women's fertility and health. We previously identified genetic variants in genes involved in initial follicle recruitment as potential modifiers of age at natural menopause. The objective of this study was to extend our previous study, by searching for pairwise interactions between tagging single nucleotide polymorphisms (tSNPs) in the 5 genes previously selected (AMH, AMHR2, BMP15, FOXL2, GDF9). We performed a cross-sectional study among 3445 women with a natural menopause participating in the Prospect-EPIC study, a population-based prospective cohort study, initiated between 1993 and 1997. Based on the model-based multifactor dimensionality reduction (MB-MDR) test with a permutation-based maxT correction for multiple testing, we found a statistically significant interaction between rs10407022 in AMH and rs11170547 in AMHR2 (p = 0.019) associated with age at natural menopause. Rs10407022 did not have a statistically significant main effect. However, rs10407022 is an eQTL SNP that has been shown to influence mRNA expression levels in lymphoblastoid cell lines. This study provides additional insights into the genetic background of age at natural menopause and suggests a role of the AMH signaling pathway in the onset of natural menopause. However, these results remain suggestive and replication by independent studies is necessary	[Braem, Marieke G. M.; Voorhuis, Marlies; Van der Schouw, Yvonne T.; Peeters, Petra H. M.; Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Voorhuis, Marlies; Broekmans, Frank J.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Schouten, Leo J.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Biostat & Res Support, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Utrecht University; Utrecht University Medical Center	Braem, MGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	M.G.M.Braem@umcutrecht.nl	Onland-Moret, N. Charlotte/G-9185-2011; Schouten, Leo J/AAB-2275-2019; van der Schouw, Yvonne T./F-8327-2014; Schouten, Leo J/G-3713-2012	Onland-Moret, N. Charlotte/0000-0002-2360-913X; Schouten, Leo J/0000-0003-3361-7560; van der Schouw, Yvonne T./0000-0002-4605-435X; 	Dutch Cancer Society [UU2008-4267]; Dutch Organisation for Scientific Research (NOW) [92003575]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Organisation for Scientific Research (NOW)	MGMB and NCO-M are financially supported by the Dutch Cancer Society (UU2008-4267). MV is financially supported by a grant from the Dutch Organisation for Scientific Research (NOW, project 92003575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, World Health Organ Tech Rep Ser, V866, P1; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Freeman EW, 2012, J CLIN ENDOCR METAB, V97, P1673, DOI 10.1210/jc.2011-3032; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; John JMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029594; Kevenaar ME, 2007, HUM REPROD, V22, P2382, DOI 10.1093/humrep/dem176; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Moore JH, 2010, ADV GENET, V72, P101, DOI [10.1016/B978-0-12-380862-2.00005-9, 10.1016/S0065-2660(10)72005-8]; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Voorhuis M, 2011, J CLIN ENDOCR METAB, V96, pE473, DOI 10.1210/jc.2010-1799; Williams RBH, 2007, GENOME RES, V17, P1707, DOI 10.1101/gr.6981507	24	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59819	10.1371/journal.pone.0059819	http://dx.doi.org/10.1371/journal.pone.0059819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544102	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700062
J	Domke, GM; Woodall, CW; Walters, BF; Smith, JE				Domke, Grant M.; Woodall, Christopher W.; Walters, Brian F.; Smith, James E.			From Models to Measurements: Comparing Downed Dead Wood Carbon Stock Estimates in the US Forest Inventory	PLOS ONE			English	Article							OLD-GROWTH FORESTS; UNITED-STATES; TREE DEATH; DEBRIS; VALIDATION; DYNAMICS; HARVEST; FIELD	The inventory and monitoring of coarse woody debris (CWD) carbon (C) stocks is an essential component of any comprehensive National Greenhouse Gas Inventory (NGHGI) Due to the expense and difficulty associated with conducting field inventories of CWD pools, CWDC stocks are often modeled as a function of more commonly measured stand attributes such as live tree C density. In order to assess potential benefits of adopting a field-based inventory of CWD C stocks in lieu of the current model-based approach a national inventory of downed dead wood C across the U S was compared to estimates calculated from models associated with the U.S.'s NGHGI and used in the USDA Forest Service, Forest Inventory and Analysis program. The model-based population estimate of C stocks for CWD (i.e., pieces and slash piles) in the conterminous U.S. was 9 percent (145.1 Tg) greater than the field-based estimate. The relatively small absolute difference was driven by contrasting results for each CWD component. The model-based population estimate of C stocks from CWD pieces was 17 percent (230.3 Tg) greater than the field based estimate, while the model-based estimate of C stocks from CWD slash piles was 27 percent (85.2 Tg) smaller than the field-based estimate. In general, models overestimated the C density per-unit-area from slash piles early in stand development and underestimated the C density from CWD pieces in young stands. This resulted in significant differences in CWD C stocks by region and ownership. The disparity in estimates across spatial scales illustrates the complexity in estimating CWD C in a NGHGI. Based on the results of this study, it is suggested that the U.S. adopt field-based estimates of CWD C stocks as a component of its NGHGI to both reduce the uncertainty within the inventory and improve the sensitivity to potential management and climate change events.	[Domke, Grant M.; Woodall, Christopher W.; Walters, Brian F.] US Forest Serv, USDA, No Res Stn, St Paul, MN USA; [Smith, James E.] US Forest Serv, USDA, No Res Stn, Durham, NH USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Domke, GM (corresponding author), US Forest Serv, USDA, No Res Stn, St Paul, MN USA.	gmdomke@fs.fed.us		Woodall, Christopher/0000-0001-8076-6214; Walters, Brian/0000-0001-7408-9704; Domke, Grant/0000-0003-0485-0355				[Anonymous], 2008, NRS29 USDA FOR SERV; [Anonymous], 2011, NRS88 USDA FOR SERV; Arseneault J, 2012, CAN J FOREST RES, V42, P1467, DOI [10.1139/X2012-054, 10.1139/x2012-054]; Bechtold WA, 2005, USDA GEN TECH REP, DOI 10.1371/journal.pone.0044795; Bigler C, 2011, CAN J FOREST RES, V41, P331, DOI 10.1139/X10-217; Bradford J, 2009, CAN J FOREST RES, V39, P802, DOI 10.1139/X09-010; Bull E.L., 1997, PNWGTR391 USDA FOR S; Chojnacky D.C., 2002, ENVIRON POLLUT, V116, P25; COVINGTON WW, 1984, FOREST SCI, V30, P183; Domke GM, 2012, FOREST ECOL MANAG, V270, P108, DOI 10.1016/j.foreco.2012.01.022; Domke GM, 2012, BIOMASS BIOENERG, V36, P141, DOI 10.1016/j.biombioe.2011.10.035; Domke Grant M, 2011, Carbon Balance Manag, V6, P14, DOI 10.1186/1750-0680-6-14; EPA, 2012, 430R12001 US EPA; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Forest Carbon Portal, 2012, FOR CARB PROJ INV; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Fraver S, 2002, CAN J FOREST RES, V32, P2094, DOI 10.1139/X02-131; Hagan JM, 1999, J FOREST, V97, P6; Hardy CC, 1996, PNW364 USDA FOR SERV; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hatfield MA, 2010, THESIS U MINNESOTA S; Heath L.S., 2010, NRS67 USDA FOR SERV; Hoover CM, 2012, FOREST ECOL MANAG, V266, P108, DOI 10.1016/j.foreco.2011.11.010; Intergovernmental Panel on Climate Change, 2003, GOOD PRACTICE GUIDAN; Marcot BG, 2010, FOREST SCI, V56, P391; Maser C., 1979, U S Department of Agriculture Agriculture Handbook, P78; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robert E, 2012, CAN J FOREST RES, V42, P1446, DOI [10.1139/X2012-085, 10.1139/x2012-085]; Robinson AP, 2005, TREE PHYSIOL, V25, P903, DOI 10.1093/treephys/25.7.903; Robinson AP, 2004, ECOL MODEL, V176, P349, DOI 10.1016/j.ecolmodel.2004.01.013; Rollins MG, 2004, ECOL APPL, V14, P75, DOI 10.1890/02-5145; Sample A, 2007, PINCHOT LETT, V11, P1; Smith J.E., 2006, METHODS CALCULATING; Smith JE, 2004, J FOREST, V102, P25; Spetich MA, 1999, FOREST SCI, V45, P302; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; US Environmental Protection Agency, 2013, INV US GREE IN PRESS; USDA Forest Service, 2013, FOR INV AN NAT PROGR; Vanclay JK, 1997, ECOL MODEL, V98, P1, DOI 10.1016/S0304-3800(96)01932-1; Wear DN, 2002, J FOREST, V100, P6; Westfall JA, 2013, CLIMATIC CH IN PRESS; Woodall CW, 2008, FOREST ECOL MANAG, V256, P221, DOI 10.1016/j.foreco.2008.04.003; Woodall C.W., 2008, NRS22 USDA FOR SERV; Woodall C.W., 2010, NRS61 USDA FOR SERV; Woodall CW, 2012, FOREST ECOL MANAG, V269, P1, DOI 10.1016/j.foreco.2011.12.041; Woodall CW, 2012, FORESTRY, V85, P125, DOI 10.1093/forestry/cpr065; Woodall CW, 2009, ENVIRON MANAGE, V44, P624, DOI 10.1007/s00267-009-9358-9; Woodall CW, 2012, J FOREST, V110, P113; Woudenberg S.W., 2010, RMRSGTR245 USDA FOR; Zhou XH, 2005, BIOSTATISTICS, V6, P187, DOI 10.1093/biostatistics/kxi002	50	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59949	10.1371/journal.pone.0059949	http://dx.doi.org/10.1371/journal.pone.0059949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544112	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700071
J	Nakamura, S; Takizawa, H; Shimazawa, M; Hashimoto, Y; Sugitani, S; Tsuruma, K; Hara, H				Nakamura, Shinsuke; Takizawa, Haruka; Shimazawa, Masamitsu; Hashimoto, Yuhei; Sugitani, Sou; Tsuruma, Kazuhiro; Hara, Hideaki			Mild Endoplasmic Reticulum Stress Promotes Retinal Neovascularization via Induction of BiP/GRP78	PLOS ONE			English	Article							ANCHORED T-CADHERIN; ANTI-VEGF THERAPY; MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; PROTEIN GRP78; GROWTH-FACTOR; ACTIVATION; RECEPTOR; SURFACE; MECHANISMS	Endoplasmic reticulum (ER) stress occurs as a result of accumulation of unfolded or misfolded proteins in the ER and is involved in the mechanisms of various diseases, such as cancer and neurodegeneration. The goal of the present study was to clarify the relationship between ER stress and pathological neovascularization in the retina. Proliferation and migration of human retinal microvascular endothelial cells (HRMEC) were assessed in the presence of ER stress inducers, such as tunicamycin and thapsigargin. The expression of ER chaperone immunoglobulin heavy-chain binding protein (BiP), known as Grp78, was evaluated by real time RT-PCR, immunostaining, and Western blotting. Tunicamycin or thapsigargin was injected into the intravitreal body of oxygen-induced retinopathy (OIR) model mice at postnatal day 14 (P14) and retinal neovascularization was quantified at P17. The expression and localization of BiP in the retina was also evaluated in the OIR model. Exposure to tunicamycin and thapsigargin increased the proliferation and migration of HRMEC. Tunicamycin enhanced the expression of BiP in HRMEC at both the mRNA level and at the protein level on the cell surface, and increased the formation of a BiP/T-cadherin immunocomplex. In OIR model mice, retinal neovascularization was accelerated by treatments with ER stress inducers. BiP was particularly observed in the pathological vasculature and retinal microvascular endothelial cells, and the increase of BiP expression was correlated with retinal neovascularization. In conclusion, ER stress may contribute to the formation of abnormal vasculature in the retina via BiP complexation with T-cadherin, which then promotes endothelial cell proliferation and migration.	[Nakamura, Shinsuke; Takizawa, Haruka; Shimazawa, Masamitsu; Hashimoto, Yuhei; Sugitani, Sou; Tsuruma, Kazuhiro; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Gifu Pharmaceutical University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu pharmaceutical University	Gifu pharmaceutical University	Funding was provided by Gifu pharmaceutical University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2011, FREE RADICAL RES, V45, P1083, DOI 10.3109/10715762.2011.595408; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; BARINAGA M, 1995, SCIENCE, V267, P452, DOI 10.1126/science.7824943; Bhattacharjee G, 2005, ARTERIOSCL THROM VAS, V25, P1737, DOI 10.1161/01.ATV.0000173419.31242.56; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chikaraishi Y, 2007, EXP EYE RES, V84, P529, DOI 10.1016/j.exer.2006.11.007; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Arevalo JF, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/584238; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Horster R, 2011, GRAEF ARCH CLIN EXP, V249, P645, DOI 10.1007/s00417-010-1588-2; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Ivanov D, 2004, EXP CELL RES, V293, P207, DOI 10.1016/j.yexcr.2003.09.030; Jardeleza MSR, 2009, SEMIN OPHTHALMOL, V24, P87, DOI 10.1080/08820530902800330; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li B, 2008, MOL VIS, V14, P1122; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Muether PS, 2011, GRAEF ARCH CLIN EXP, V249, P633, DOI 10.1007/s00417-010-1520-9; Nakamura S, 2011, CURR NEUROVASC RES, V8, P25, DOI 10.2174/156720211794520224; Nakamura S, 2011, ARTERIOSCL THROM VAS, V31, P1041, DOI 10.1161/ATVBAHA.111.223594; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Philippova M, 2005, FASEB J, V19, P588, DOI 10.1096/fj.04-2430fje; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Romano MR, 2009, EUR J OPHTHALMOL, V19, P618, DOI 10.1177/112067210901900416; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Sogawa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011945; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Tripathi RC, 1998, OPHTHALMOLOGY, V105, P232, DOI 10.1016/S0161-6420(98)92782-8; Tsuruma K, 2010, J NEUROCHEM, V113, P1545, DOI 10.1111/j.1471-4159.2010.06724.x; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008	45	35	40	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60517	10.1371/journal.pone.0060517	http://dx.doi.org/10.1371/journal.pone.0060517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544152	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700111
J	Roth, MS; Fan, TY; Deheyn, DD				Roth, Melissa S.; Fan, Tung-Yung; Deheyn, Dimitri D.			Life History Changes in Coral Fluorescence and the Effects of Light Intensity on Larval Physiology and Settlement in Seriatopora hystrix	PLOS ONE			English	Article							REEF-BUILDING CORALS; GFP-LIKE PROTEINS; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; CENSUS TECHNIQUES; GENE-EXPRESSION; SOUTHERN TAIWAN; PLANULA LARVAE; UV-RADIATION; RED-SEA	Fluorescence is common in both coral adult and larval stages, and is produced by fluorescent proteins that absorb higher energy light and emit lower energy light. This study investigated the changes of coral fluorescence in different life histo stages and the effects of parental light environment on larval fluorescence, larval endosymbiotic dinoflagellate abundance, larval size and settlement in the brooding coral Seriatopora hystrix. Data showed that coral fluorescence changed during development from green in larvae to cyan in adult colonies. In larvae, two green fluorescent proteins (GFPs) co-occur where the peak emission of one GFP overlaps with the peak excitation of the second GFP allowing the potential for energy transfer. Coral larvae showed great variation in GFP fluorescence, dinoflagellate abundance, and size. There was no obvious relationship between green fluorescence intensity and dirioflagellate abundance, green fluorescence intensity and larval size, or dinoflagellate abundance and larval size. Larvae of parents from high and low light treatments showed similar green fluorescence intensity, yet small but significant differences in size, dinoflagellate abundance, and settlement. The large variation in larval physiology combined with subtle effects of parental environment on larval characteristics seem to indicate that even though adult corals produce larvae with a wide range of physiological capacities, these larvae can still show small preferences for settling in similar habitats as their parents. These data highlight the importance of environmental conditions at the onset of life history and parent colony effects on coral larvae.	[Roth, Melissa S.; Deheyn, Dimitri D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolut, Pingtung, Taiwan	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Roth, MS (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA.	Melissa.S.Roth@gmail.com		Roth, Melissa/0000-0001-7389-5982	National Science Foundation East Asia and Pacific Summer Institutes; National Science Council in Taiwan; Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program [FA9550-07-1-0027]	National Science Foundation East Asia and Pacific Summer Institutes; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by a National Science Foundation East Asia and Pacific Summer Institutes (MSR); the National Science Council in Taiwan (MSR); the Air Force Office of Scientific Research Biomimetics, Biomaterials, and Biointerfacial Sciences program (grant # FA9550-07-1-0027; DDD). Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the Air Force Office of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Apprill AM, 2007, CORAL REEFS, V26, P387, DOI 10.1007/s00338-007-0209-y; Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Baker A, 1995, ULTRAVIOLET RAD CORA, P149; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; D'Angelo C, 2008, MAR ECOL PROG SER, V364, P97, DOI 10.3354/meps07588; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fan TY, 2002, ZOOL STUD, V41, P288; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Gaither MR, 2010, J EXP MAR BIOL ECOL, V386, P45, DOI 10.1016/j.jembe.2010.02.003; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Kawaguti S., 1969, Micronesica, V5, P313; Kawaguti S, 1944, CONTR PALAO TROP BIO, V2, P616; Kenkel CD, 2011, P ROY SOC B-BIOL SCI, V278, P2691, DOI 10.1098/rspb.2010.2344; Kuffner IB, 2001, MAR ECOL PROG SER, V217, P251, DOI 10.3354/meps217251; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; Meng PJ, 2008, ENVIRON POLLUT, V156, P67, DOI 10.1016/j.envpol.2007.12.039; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; Padilla-Gamino JL, 2013, CORAL REEFS, V32, P137, DOI 10.1007/s00338-012-0957-1; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Permata WD, 2000, MAR ECOL PROG SER, V200, P191, DOI 10.3354/meps200191; Piniak GA, 2005, CORAL REEFS, V24, P496, DOI 10.1007/s00338-005-0495-1; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Roth M. S., 2007, BIOL CORALS DEV FUND, P95; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; TITLYANOV EA, 1991, SYMBIOSIS, V10, P249; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vermeij MJA, 2002, PHOTOSYNTHETICA, V40, P423, DOI 10.1023/A:1022635327172; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron JEN, 1976, MONOGRAPH SER AUST I, V1, P59; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Wilkinson C, 2008, STATUS CORAL REEFS W; Zar JH, 1999, BIOSTATISTICAL ANAL	61	29	29	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59476	10.1371/journal.pone.0059476	http://dx.doi.org/10.1371/journal.pone.0059476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544072	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700032
J	Hamilton, EJ; Martin, N; Makepeace, A; Sillars, BA; Davis, WA; Davis, TME				Hamilton, Emma J.; Martin, Natalie; Makepeace, Ashley; Sillars, Brett A.; Davis, Wendy A.; Davis, Timothy M. E.			Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study0	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ACQUIRED PNEUMONIA; GLYCEMIC CONTROL; POSTMENOPAUSAL WOMEN; COMMON INFECTIONS; WESTERN-AUSTRALIA; PRIMARY-CARE; RISK; POPULATION; BACTEREMIA	Background: The few studies that have examined the relationship between diabetes and bacterial infections have utilized administrative databases and/or have had limited/incomplete data including recognized infection risk factors. The aim of this study was to determine the incidence and associates of bacterial infection severe enough to require hospitalization in well-characterized community-based patients with type 2 diabetes. Methods and Findings: We studied a cohort of 1,294 patients (mean +/- SD age 64.1 +/- 11.3 years) from the longitudinal observational Fremantle Diabetes Study Phase I (FDS1) and 5,156 age-, gender-and zip-code-matched non-diabetic controls. The main outcome measure was incident hospitalization for bacterial infection as principal diagnosis between 1993 and 2010. We also examined differences in statin use in 52 FDS1 pairs hospitalized with pneumonia (cases) or a contemporaneous non-infection-related cause (controls). During 12.0 +/- 5.4 years of follow-up, 251 (19.4%) patients were hospitalized on 368 occasions for infection (23.7/1,000 patient-years). This was more than double the rate in matched controls (incident rate ratio (IRR) (95% CI), 2.13 (1.88-2.42), P < 0.001). IRRs for pneumonia, cellulitis, and septicemia/bacteremia were 1.86 (1.55-2.21), 2.45 (1.92-3.12), and 2.08 (1.41-3.04), respectively (P < 0.001). Among the diabetic patients, older age, male sex, prior recent infection-related hospitalization, obesity, albuminuria, retinopathy and Aboriginal ethnicity were baseline variables independently associated with risk of first hospitalization with any infection (P <= 0.005). After adjustment for these variables, baseline statin treatment was not significant (hazard ratio (95% CI), 0.70 (0.39-1.25), P = 0.22). Statin use at hospitalization for pneumonia among the case-control pairs was similar (23.1% vs. 13.5%, P = 0.27). Conclusions: The risk of severe infection is increased among type 2 diabetic patients and is not reduced by statin therapy. There are a number of other easily-accessible sociodemographic and clinical variables that could be used to optimize infection-related education, prevention and management in type 2 diabetes.	[Hamilton, Emma J.; Makepeace, Ashley] Fremantle Hosp, Dept Endocrinol & Diabet, Fremantle, WA, Australia; [Martin, Natalie] Fremantle Hosp, Dept Geriatr Med, Fremantle, WA, Australia; [Makepeace, Ashley; Sillars, Brett A.; Davis, Wendy A.; Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Davis, TME (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA, Australia.	tim.davis@uwa.edu.au	Davis, Timothy ME/M-5144-2014	Davis, Wendy/0000-0002-5709-8235; Hamilton, Emma/0000-0003-1617-6353; Davis, Timothy/0000-0003-0749-7411	Raine Foundation, University of Western Australia; National Health and Medical Research Council of Australia	Raine Foundation, University of Western Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Fremantle Diabetes Study Phase I was supported by the Raine Foundation, University of Western Australia. TMED is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Barcia AM, 2005, CLIN INFECT DIS, V41, pS498, DOI 10.1086/432005; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; Chua D, 2007, ANN PHARMACOTHER, V41, P647, DOI 10.1345/aph.1H550; Davis TM, 2013, INT J EPIDEMIOL; Davis TME, 2000, DIABETIC MED, V17, P667, DOI 10.1046/j.1464-5491.2000.00359.x; Davis TME, 2005, J DIABETES COMPLICAT, V19, P259, DOI 10.1016/j.jdiacomp.2005.03.003; Davis TME, 2004, DIABETOLOGIA, V47, P395, DOI 10.1007/s00125-004-1344-4; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Game F, 2010, NAT REV ENDOCRINOL, V6, P43, DOI 10.1038/nrendo.2009.243; Gorter KJ, 2010, FAM PRACT, V27, P379, DOI 10.1093/fampra/cmq026; Guvener M, 2002, ENDOCR J, V49, P531, DOI 10.1507/endocrj.49.531; Hirji I, 2012, J DIABETES COMPLICAT; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Hounsom L, 2011, POSTGRAD MED J, V87, P757, DOI 10.1136/pgmj.2010.116616; Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730; Jacups SP, 2011, VACCINE, V29, P5386, DOI 10.1016/j.vaccine.2011.05.082; Jamsen E, 2012, J BONE JOINT SURG AM, V94, pe1011; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Karunajeewa H, 2005, DIABETOLOGIA, V48, P1288, DOI 10.1007/s00125-005-1794-3; Kish TD, 2010, AM J GERIATR PHARMAC, V8, P485, DOI 10.1016/S1543-5946(10)80002-9; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Laupland KB, 2011, INFECTION, V39, P405, DOI 10.1007/s15010-011-0149-x; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Lepper PM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3397; Magliano DJ, 2012, EUR J ENDOCRINOL, V167, P589, DOI 10.1530/EJE-12-0053; Mancuso P, 2012, PULM PHARM THER; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mongardon N, 2012, CRIT CARE, V16, DOI 10.1186/cc11471; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Myint PK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001030; PATEL MS, 1991, MED J AUSTRALIA, V155, P218, DOI 10.5694/j.1326-5377.1991.tb142224.x; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Stapleton A, 2002, AM J MED, V113, p80S; Thomsen RW, 2011, J INFECTION, V63, P8, DOI 10.1016/j.jinf.2011.05.013; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; THORNTON GF, 1971, MED CLIN N AM, V55, P931, DOI 10.1016/S0025-7125(16)32487-7; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; WALTERS DP, 1992, DIABETIC MED, V9, P354, DOI 10.1111/j.1464-5491.1992.tb01796.x; WHEAT LJ, 1980, DIABETES CARE, V3, P187, DOI 10.2337/diacare.3.1.187; Williams P, 1997, INT J EPIDEMIOL, V26, P797, DOI 10.1093/ije/26.4.797	51	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60502	10.1371/journal.pone.0060502	http://dx.doi.org/10.1371/journal.pone.0060502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536910	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200058
J	Harada, H; Yamashita, Y; Misumi, K; Tsubokawa, N; Nakao, J; Matsutani, J; Yamasaki, M; Ohkawachi, T; Taniyama, K				Harada, Hiroaki; Yamashita, Yoshinori; Misumi, Keizo; Tsubokawa, Norifumi; Nakao, Junichi; Matsutani, Junko; Yamasaki, Miyako; Ohkawachi, Tomomi; Taniyama, Kiyomi			Multidisciplinary Team-Based Approach for Comprehensive Preoperative Pulmonary Rehabilitation Including Intensive Nutritional Support for Lung Cancer Patients	PLOS ONE			English	Article							RESECTION; SUPPLEMENTATION; PHYSIOTHERAPY; MORBIDITY; DISEASE; SURGERY; PROTEIN; MUSCLE	Background: To decrease the risk of postoperative complication, improving general and pulmonary conditioning preoperatively should be considered essential for patients scheduled to undergo lung surgery. Objective: The aim of this study is to develop a short-term beneficial program of preoperative pulmonary rehabilitation for lung cancer patients. Methods: From June 2009, comprehensive preoperative pulmonary rehabilitation (CHPR) including intensive nutritional support was performed prospectively using a multidisciplinary team-based approach. Postoperative complication rate and the transitions of pulmonary function in CHPR were compared with historical data of conventional preoperative pulmonary rehabilitation (CVPR) conducted since June 2006. The study population was limited to patients who underwent standard lobectomy. Results: Postoperative complication rate in the CVPR (n = 29) and CHPR (n = 21) were 48.3% and 28.6% (p = 0.2428), respectively. Those in patients with Charlson Comorbidity Index scores >= 2 were 68.8% (n = 16) and 27.3% (n = 11), respectively (p = 0.0341) and those in patients with preoperative risk score in Estimation of Physiologic Ability and Surgical Stress scores >0.3 were 57.9% (n = 19) and 21.4% (n = 14), respectively (p = 0.0362). Vital capacities of pre- and post intervention before surgery in the CHPR group were 2.63 +/- 0.65 L and 2.75 +/- 0.63 L (p = 0.0043), respectively; however, their transition in the CVPR group was not statistically significant (p = 0.6815). Forced expiratory volumes in one second of pre- and post intervention before surgery in the CHPR group were 1.73 +/- 0.46 L and 1.87 +/- 0.46 L (p = 0.0012), respectively; however, their transition in the CVPR group was not statistically significant (p = 0.6424). Conclusions: CHPR appeared to be a beneficial and effective short-term preoperative rehabilitation protocol, especially in patients with poor preoperative conditions.	[Harada, Hiroaki; Yamashita, Yoshinori; Tsubokawa, Norifumi] Natl Hosp Org, Kure Med Ctr, Dept Resp Surg, Kure, Japan; [Harada, Hiroaki; Yamashita, Yoshinori; Tsubokawa, Norifumi; Nakao, Junichi; Matsutani, Junko; Yamasaki, Miyako; Ohkawachi, Tomomi; Taniyama, Kiyomi] Chugoku Canc Ctr, Kure, Japan; [Harada, Hiroaki; Yamashita, Yoshinori; Taniyama, Kiyomi] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Kure, Japan; [Harada, Hiroaki; Misumi, Keizo] Hiroshima Univ, Grad Sch Biomed Sci, Res Inst Radiat Biol & Med, Dept Surg Oncol, Hiroshima, Japan; [Nakao, Junichi; Matsutani, Junko; Yamasaki, Miyako] Natl Hosp Org, Kure Med Ctr, Dept Rehabil, Kure, Japan; [Ohkawachi, Tomomi] Natl Hosp Org, Kure Med Ctr, Dept Nutr, Kure, Japan	Hiroshima University	Harada, H (corresponding author), Natl Hosp Org, Kure Med Ctr, Dept Resp Surg, Kure, Japan.	haradah@kure-nh.go.jp						Aquilani R, 2004, AM J CARDIOL, V93, p21A, DOI 10.1016/j.amjcard.2003.11.005; Benzo R, 2011, LUNG CANCER, V74, P441, DOI 10.1016/j.lungcan.2011.05.011; Bobbio A, 2008, EUR J CARDIO-THORAC, V33, P95, DOI 10.1016/j.ejcts.2007.10.003; Boelens PG, 2001, J NUTR, V131, p2569S, DOI 10.1093/jn/131.9.2569S; Cesario A, 2007, LUNG CANCER, V57, P118, DOI 10.1016/j.lungcan.2007.03.022; Choudry HA, 2006, J NUTR, V136, p314S, DOI 10.1093/jn/136.1.314S; Colice GL, 2007, CHEST, V132, p161S, DOI 10.1378/chest.07-1359; Dominguez-Ventura A, 2007, EUR J CARDIO-THORAC, V32, P370, DOI 10.1016/j.ejcts.2007.04.002; Engelen MPKJ, 2007, AM J CLIN NUTR, V85, P431, DOI 10.1093/ajcn/85.2.431; Engelen MPKJ, 2000, AM J CLIN NUTR, V72, P1480; Fountain SW, 2001, THORAX, V56, P89; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gany F, 2011, J ONCOL PRACT, V7, P31, DOI 10.1200/JOP.2010.000036; Gregg JR, 2011, J UROLOGY, V185, P90, DOI 10.1016/j.juro.2010.09.021; Guo R, 2006, EUR RESPIR J, V28, P330, DOI 10.1183/09031936.06.00119905; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; Jones LW, 2007, CANCER-AM CANCER SOC, V110, P590, DOI 10.1002/cncr.22830; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Melloul Emanuel, 2008, Interact Cardiovasc Thorac Surg, V7, P986, DOI 10.1510/icvts.2008.182279; Morgan TM, 2011, EUR UROL, V59, P923, DOI 10.1016/j.eururo.2011.01.034; Nagarajan K, 2011, INTERACT CARDIOV TH, V13, P300, DOI 10.1510/icvts.2010.264507; Nici Linda, 2008, Thorac Surg Clin, V18, P39, DOI 10.1016/j.thorsurg.2007.10.003; Niewoehner DE, 2010, NEW ENGL J MED, V362, P1407, DOI 10.1056/NEJMcp0912556; Novoa N, 2011, EUR J CARDIO-THORAC, V40, P130, DOI 10.1016/j.ejcts.2010.11.028; Steiner MC, 2003, THORAX, V58, P745, DOI 10.1136/thorax.58.9.745; van Meerbeeck J P, 2005, Ned Tijdschr Geneeskd, V149, P72; Varela G, 2006, EUR J CARDIO-THORAC, V29, P216, DOI 10.1016/j.ejcts.2005.11.002; Wang CY, 2007, EUR J CARDIO-THORAC, V32, P877, DOI 10.1016/j.ejcts.2007.09.008; Wang XY, 2003, WORLD J GASTROENTERO, V9, P599, DOI 10.3748/wjg.v9.i3.599; Weiner P, 1997, J THORAC CARDIOV SUR, V113, P552, DOI 10.1016/S0022-5223(97)70370-2; Yamashita S, 2004, EUR SURG RES, V36, P249, DOI 10.1159/000078860; YOUNG LH, 1991, J CLIN INVEST, V87, P554, DOI 10.1172/JCI115030; Zemanova M, 2012, J BUON, V17, P310	33	31	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59566	10.1371/journal.pone.0059566	http://dx.doi.org/10.1371/journal.pone.0059566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555043	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800099
J	Li, J; Zhao, L; He, X; Zeng, YJ; Dai, SS				Li, Jun; Zhao, Li; He, Xie; Zeng, Yi-Jun; Dai, Shuang-Shuang			Sinomenine Protects against Lipopolysaccharide-Induced Acute Lung Injury in Mice via Adenosine A(2A) Receptor Signaling	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; ALKALOID SINOMENINE; CYTOKINE EXPRESSION; MAST-CELLS; IN-VIVO; ACTIVATION; INFLAMMATION; NEUTROPHILS	Sinomenine (SIN) is a bioactive alkaloid extracted from the Chinese medicinal plant Sinomenium acutum, which is widely used in the clinical treatment of rheumatoid arthritis (RA). However, its role in acute lung injury (ALI) is unclear. In this study, we investigate the role of SIN in lipopolysaccharide (LPS)-induced ALI in mice. After ALI, lung water content and histological signs of pulmonary injury were attenuated, whereas the PaO2/FIO2 (P/F) ratios were elevated significantly in the mice pretreated with SIN. Additionally, SIN markedly inhibited inflammatory cytokine TNF-alpha and IL-1 beta expression levels as well as neutrophil infiltration in the lung tissues of the mice. Microarray analysis and real-time PCR showed that SIN treatment upregulated adenosine A(2A) receptor (A(2A)R) expression, and the protective effect of SIN was abolished in A(2A)R knockout mice. Further investigation in isolated mouse neutrophils confirmed the upregulation of A(2A)R by SIN and showed that A(2A)R-cAMP-PKA signaling was involved in the anti-inflammatory effect of SIN. Taken together, these findings demonstrate an A(2A)R-associated anti-inflammatory effect and the protective role of SIN in ALI, which suggests a potential novel approach to treat ALI.	[Li, Jun] Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China; [Zhao, Li; He, Xie; Zeng, Yi-Jun; Dai, Shuang-Shuang] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Dai, SS (corresponding author), Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China.	tmmubiodss@yahoo.com.cn			National Natural Science Foundation of China [81172817]; Natural Science Foundation of Chongqing, China [CSTC2009BB5317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (81172817), Natural Science Foundation of Chongqing, China (CSTC2009BB5317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Allen-Gipson DS, 2006, AM J PHYSIOL-LUNG C, V290, pL849, DOI 10.1152/ajplung.00373.2005; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bonneau O, 2006, AM J PHYSIOL-LUNG C, V290, pL1036, DOI 10.1152/ajplung.00422.2005; Bshesh K, 2002, J LEUKOCYTE BIOL, V72, P1027; Candinas D, 1996, TRANSPLANTATION, V62, P1855, DOI 10.1097/00007890-199612270-00030; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cheng Y, 2009, INT IMMUNOPHARMACOL, V9, P894, DOI 10.1016/j.intimp.2009.03.014; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Ellman PI, 2008, J SURG RES, V149, P3, DOI 10.1016/j.jss.2007.08.008; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Folkesson HG, 2012, AM J PHYSIOL-LUNG C, V303, pL259, DOI 10.1152/ajplung.00395.2011; Gazoni LM, 2008, J THORAC CARDIOV SUR, V135, P156, DOI 10.1016/j.jtcvs.2007.08.041; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Heyn J, 2012, SHOCK, V37, P156, DOI 10.1097/SHK.0b013e31823f16bc; HOJO H, 1985, J IMMUNOPHARMACOL, V7, P33, DOI 10.3109/08923978509026467; Huang J, 2007, J ETHNOPHARMACOL, V114, P180, DOI 10.1016/j.jep.2007.07.036; Kim HM, 2000, J ETHNOPHARMACOL, V70, P135, DOI 10.1016/S0378-8741(99)00160-9; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; KONDO Y, 1994, BIOCHEM PHARMACOL, V48, P1050, DOI 10.1016/0006-2952(94)90378-6; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219; LIU L, 1994, ARZNEIMITTEL-FORSCH, V44-2, P1223; LIU L, 1994, INT J IMMUNOPHARMACO, V16, P685, DOI 10.1016/0192-0561(94)90142-2; Liu LA, 1996, INT J IMMUNOPHARMACO, V18, P529, DOI 10.1016/S0192-0561(96)00025-2; Lukashev D, 2004, J IMMUNOL, V173, P21, DOI 10.4049/jimmunol.173.1.21; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Mark W, 2003, TRANSPLANTATION, V75, P940, DOI 10.1097/01.TP.0000056610.22062.03; Martin TR, 2002, J CLIN INVEST, V110, P1603, DOI 10.1172/JCI200217302; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Nadeem A, 2007, AM J PHYSIOL-LUNG C, V292, pL1335, DOI 10.1152/ajplung.00416.2006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Reece TB, 2005, J THORAC CARDIOV SUR, V129, P1137, DOI 10.1016/j.jtcvs.2004.11.042; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sharma AK, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-58; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Vieregge B, 1999, PLANTA MED, V65, P80, DOI 10.1055/s-2006-960446; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wang Y, 2005, J ETHNOPHARMACOL, V98, P37, DOI 10.1016/j.jep.2004.12.022; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu RQ, 2006, CRIT CARE MED, V34, P1273, DOI 10.1097/01.CCM.0000208437.93725.18; YAMASAKI H, 1976, ACTA MED OKAYAMA, V30, P1; Zhao Y, 2007, INT IMMUNOPHARMACOL, V7, P637, DOI 10.1016/j.intimp.2007.01.007; Zhong H, 2003, J IMMUNOL, V171, P338, DOI 10.4049/jimmunol.171.1.338	50	26	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59257	10.1371/journal.pone.0059257	http://dx.doi.org/10.1371/journal.pone.0059257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555007	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800076
J	Li, X; Zhang, TC; Qiao, Q; Ren, ZM; Zhao, JY; Yonezawa, T; Hasegawa, M; Crabbe, MJC; Li, JQ; Zhong, Y				Li, Xi; Zhang, Ti-Cao; Qiao, Qin; Ren, Zhumei; Zhao, Jiayuan; Yonezawa, Takahiro; Hasegawa, Masami; Crabbe, M. James C.; Li, Jianqiang; Zhong, Yang			Complete Chloroplast Genome Sequence of Holoparasite Cistanche deserticola (Orobanchaceae) Reveals Gene Loss and Horizontal Gene Transfer from Its Host Haloxylon ammodendron (Chenopodiaceae)	PLOS ONE			English	Article							PLASTID GENOME; TRANSFER-RNA; SECONDARY STRUCTURE; FLOWERING PLANTS; DNA; EVOLUTION; DISINTEGRATION; RECOMBINATION; POLYMORPHISM; TRANSCRIPTS	Background: The central function of chloroplasts is to carry out photosynthesis, and its gene content and structure are highly conserved across land plants. Parasitic plants, which have reduced photosynthetic ability, suffer gene losses from the chloroplast (cp) genome accompanied by the relaxation of selective constraints. Compared with the rapid rise in the number of cp genome sequences of photosynthetic organisms, there are limited data sets from parasitic plants. Principal Findings/Significance: Here we report the complete sequence of the cp genome of Cistanche deserticola, a holoparasitic desert species belonging to the family Orobanchaceae. The cp genome of C. deserticola is greatly reduced both in size (102,657 bp) and in gene content, indicating that all genes required for photosynthesis suffer from gene loss and pseudogenization, except for psbM. The striking difference from other holoparasitic plants is that it retains almost a full set of tRNA genes, and it has lower dN/dS for most genes than another close holoparasitic plant, E. virginiana, suggesting that Cistanche deserticola has undergone fewer losses, either due to a reduced level of holoparasitism, or to a recent switch to this life history. We also found that the rpoC2 gene was present in two copies within C. deserticola. Its own copy has much shortened and turned out to be a pseudogene. Another copy, which was not located in its cp genome, was a homolog of the host plant, Haloxylon ammodendron (Chenopodiaceae), suggesting that it was acquired from its host via a horizontal gene transfer.	[Li, Xi; Zhang, Ti-Cao; Qiao, Qin; Zhao, Jiayuan; Yonezawa, Takahiro; Hasegawa, Masami; Zhong, Yang] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China; [Ren, Zhumei] Shanxi Univ, Coll Life Sci & Technol, Taiyuan, Peoples R China; [Crabbe, M. James C.] Univ Bedfordshire, Inst Biomed Environm Sci & Technol, Fac Creat Arts Technol & Sci, Luton, Beds, England; [Li, Jianqiang] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China; [Zhong, Yang] Tibet Univ, Inst Biodivers Sci & Geobiol, Lhasa, Peoples R China	Fudan University; Shanxi University; University of Bedfordshire; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Tibet University	Li, JQ (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Peoples R China.	jianqiangl@hotmail.com; yangzhong@fudan.edu.cn	Zhang, Ticao/AHB-1915-2022	Zhang, Ticao/0000-0002-8578-6131; Qiao, Qin/0000-0003-2085-6853; Yonezawa, Takahiro/0000-0002-0012-1887	National Science Foundation of China [30925004, 91131901, 31070197]; China Postdoctoral Science Foundation [20100480550, 2011M500538]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the National Science Foundation of China [30925004, 91131901 to Zhong Y; 31070197 to Li JQ]; and China Postdoctoral Science Foundation [20100480550, 2011M500538 to Zhang TC and Qiao Q]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Asakura Y, 2006, PLANT PHYSIOL, V142, P1656, DOI 10.1104/pp.106.088096; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cai ZQ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-77; Carlsson J, 2007, THEOR APPL GENET, V115, P627, DOI 10.1007/s00122-007-0593-2; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E; Grivet D, 2001, MOL ECOL NOTES, V1, P345, DOI 10.1046/j.1471-8278.2001.00107.x; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haddrill PR, 2008, BIOL LETTERS, V4, P758, DOI 10.1098/rsbl.2008.0376; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; HESS WR, 1994, MOL GEN GENET, V242, P305, DOI 10.1007/BF00280420; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim DH, 2006, CURR GENET, V49, P59, DOI 10.1007/s00294-005-0032-3; Koulintchenko M, 2003, EMBO J, V22, P1245, DOI 10.1093/emboj/cdg128; Krause K, 2008, CURR GENET, V54, P111, DOI 10.1007/s00294-008-0208-8; Krause K, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P79, DOI 10.1007/978-3-642-22380-8_4; Krause K, 2011, PLANTA, V234, P647, DOI 10.1007/s00425-011-1494-9; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LW, 2002, J ETHNOPHARMACOL, V83, P177, DOI 10.1016/S0378-8741(02)00147-2; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Nickrent DL, 2003, PARASITIC PLANT CONN; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Olmstead RG, 2001, AM J BOT, V88, P348, DOI 10.2307/2657024; Olson LE, 2002, MOL BIOL EVOL, V19, P93, DOI 10.1093/oxfordjournals.molbev.a003987; Oxelman B, 2005, TAXON, V54, P411, DOI 10.2307/25065369; Park JM, 2007, MOL PHYLOGENET EVOL, V43, P974, DOI 10.1016/j.ympev.2006.10.011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinones V, 1996, PLANT MOL BIOL, V31, P937, DOI 10.1007/BF00019483; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SHIMADA H, 1991, NUCLEIC ACIDS RES, V19, P983, DOI 10.1093/nar/19.5.983; Swofford DL., 2003, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tobe K, 2000, AUST J BOT, V48, P455, DOI 10.1071/BT99013; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Wakasugi T, 1998, PLANT MOL BIOL REP, V16, P231, DOI 10.1023/A:1007564209282; Wang Xiang-yan, 2009, Zhongguo Yaolixue Tongbao, V25, P787; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Wolfe AD, 2005, FOLIA GEOBOT, V40, P115, DOI 10.1007/BF02803229; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Woloszynska M, 2004, PLANT MOL BIOL, V56, P811, DOI 10.1007/s11103-004-5183-y; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zhang Z.-Y., 1990, FLORA REIPUBLICAE PO, V69, P69; Zoschke R, 2010, P NATL ACAD SCI USA, V107, P3245, DOI 10.1073/pnas.0909400107	68	73	73	7	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58747	10.1371/journal.pone.0058747	http://dx.doi.org/10.1371/journal.pone.0058747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554920	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800026
J	Sarrafpour, B; Swain, M; Li, Q; Zoellner, H				Sarrafpour, Babak; Swain, Michael; Li, Qing; Zoellner, Hans			Tooth Eruption Results from Bone Remodelling Driven by Bite Forces Sensed by Soft Tissue Dental Follicles: A Finite Element Analysis	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; GENE-EXPRESSION; STRESS-ANALYSIS; CRANIOFACIAL GROWTH; STRAIN DISTRIBUTION; ENDOTHELIAL-CELLS; MANDIBULAR BONE; MUSCLE-ACTIVITY; PART I; RAT	Intermittent tongue, lip and cheek forces influence precise tooth position, so we here examine the possibility that tissue remodelling driven by functional bite-force-induced jaw-strain accounts for tooth eruption. Notably, although a separate true 'eruptive force' is widely assumed, there is little direct evidence for such a force. We constructed a three dimensional finite element model from axial computerized tomography of an 8 year old child mandible containing 12 erupted and 8 unerupted teeth. Tissues modelled included: cortical bone, cancellous bone, soft tissue dental follicle, periodontal ligament, enamel, dentine, pulp and articular cartilage. Strain and hydrostatic stress during incisive and unilateral molar bite force were modelled, with force applied via medial and lateral pterygoid, temporalis, masseter and digastric muscles. Strain was maximal in the soft tissue follicle as opposed to surrounding bone, consistent with follicle as an effective mechanosensor. Initial numerical analysis of dental follicle soft tissue overlying crowns and beneath the roots of unerupted teeth was of volume and hydrostatic stress. To numerically evaluate biological significance of differing hydrostatic stress levels normalized for variable finite element volume, 'biological response units' in Nmm were defined and calculated by multiplication of hydrostatic stress and volume for each finite element. Graphical representations revealed similar overall responses for individual teeth regardless if incisive or right molar bite force was studied. There was general compression in the soft tissues over crowns of most unerupted teeth, and general tension in the soft tissues beneath roots. Not conforming to this pattern were the unerupted second molars, which do not erupt at this developmental stage. Data support a new hypothesis for tooth eruption, in which the follicular soft tissues detect bite-force-induced bone-strain, and direct bone remodelling at the inner surface of the surrounding bony crypt, with the effect of enabling tooth eruption into the mouth.	[Sarrafpour, Babak; Zoellner, Hans] Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent, Westmead, NSW 2145, Australia; [Swain, Michael] Univ Sydney, Fac Dent, Biomat Sci Unit, Westmead, NSW 2145, Australia; [Li, Qing] Univ Sydney, Fac Engn, Sch Aerosp Mech & Mech Engn, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney	Sarrafpour, B (corresponding author), Univ Sydney, Westmead Hosp, Dept Oral Pathol & Oral Med, Cellular & Mol Pathol Res Unit,Fac Dent, Westmead, NSW 2145, Australia.	babak.sarrafpour@sydney.edu.au	Swain, Michael V/J-7266-2017; Li, Qing/B-3422-2009; Zoellner, Hans/GWQ-7168-2022	Li, Qing/0000-0002-7930-2145; Swain, Michael/0000-0002-8801-8656; Zoellner, Hans/0000-0003-4804-2464	Australian Dental Research Fund	Australian Dental Research Fund	No direct funding was obtained for this work, which was supported solely from internal departmental funds. However, the authors acknowledge the support of the Australian Dental Research Fund for separate related work. The internal university funding resources used to fund the current work were available without any role of the University administration in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBS JH, 1984, EXP NEUROL, V85, P469, DOI 10.1016/0014-4886(84)90024-4; Ainamo J, 1976, ERUPTION OCCLUSION T, P97; Al-Sukhun J, 2007, J BIOMED MATER RES A, V80A, P247, DOI 10.1002/jbm.a.30881; AVERY JK, 2001, ORAL DEV HISTOLOGY; BEERTSEN W, 1974, ARCH ORAL BIOL, V19, P1087, DOI 10.1016/0003-9969(74)90235-0; BERKOVIT.BK, 1969, ARCH ORAL BIOL, V14, P771, DOI 10.1016/0003-9969(69)90168-X; Berkovitz B K, 1990, Dent Update, V17, P206; Carrion JB, 2009, INT J PERIODONT REST, V29, P333; Bolitho C, 2007, J VASC RES, V44, P313, DOI 10.1159/000101777; Bourauel C, 2000, J Orofac Orthop, V61, P266, DOI 10.1007/s000560050012; BURNMURDOCH RA, 1981, ARCH ORAL BIOL, V26, P939, DOI 10.1016/0003-9969(81)90155-2; CAHILL DR, 1980, J ORAL PATHOL MED, V9, P189, DOI 10.1111/j.1600-0714.1980.tb00377.x; Carpenter RD, 2008, BIOMECH MODEL MECHAN, V7, P227, DOI 10.1007/s10237-007-0087-9; Carpenter RD, 2010, BIOMECH MODEL MECHAN, V9, P317, DOI 10.1007/s10237-009-0178-x; Chen DC, 2000, J DENT, V28, P583, DOI 10.1016/S0300-5712(00)00041-5; COMPAGNON D, 1991, J PROSTHET DENT, V66, P29, DOI 10.1016/0022-3913(91)90347-Y; Daegling DJ, 2009, AM J PHYS ANTHROPOL, V138, P306, DOI 10.1002/ajpa.20929; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; Field C, 2008, ARCH ORAL BIOL, V53, P1129, DOI 10.1016/j.archoralbio.2008.06.013; Field C, 2012, J DENT, V40, P48, DOI 10.1016/j.jdent.2011.10.003; Field C, 2010, J BIOMECH, V43, P1771, DOI 10.1016/j.jbiomech.2010.02.016; Field C, 2009, AM J ORTHOD DENTOFAC, V135, P174, DOI 10.1016/j.ajodo.2007.03.032; Fragiskos FD, 2007, ORAL SURG; Frost H. M., 1964, PLAST RECONSTR SURG, V33, P196; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; GAENGLER P, 1983, J PERIODONTAL RES, V18, P86, DOI 10.1111/j.1600-0765.1983.tb00339.x; Garat JA, 2005, J PERIODONTAL RES, V40, P441, DOI 10.1111/j.1600-0765.2005.00809.x; GARNER LD, 1973, J DENT RES, V52, P698, DOI 10.1177/00220345730520041001; Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251; Groning F, 2012, ANAT REC, V295, P853, DOI 10.1002/ar.22455; Groning F, 2011, AM J PHYS ANTHROPOL, V144, P593, DOI 10.1002/ajpa.21447; Hammond AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029121; HART RT, 1992, J BIOMECH, V25, P261, DOI 10.1016/0021-9290(92)90025-V; HELLSING E, 1987, AM J ORTHOD DENTOFAC, V91, P286, DOI 10.1016/0889-5406(87)90168-5; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; HYLANDER WL, 1984, AM J PHYS ANTHROPOL, V64, P1, DOI 10.1002/ajpa.1330640102; Ichim I, 2007, DENT MATER, V23, P1553, DOI 10.1016/j.dental.2007.02.003; Ichim I, 2007, ARCH ORAL BIOL, V52, P465, DOI 10.1016/j.archoralbio.2006.10.020; Kamegai T, 2005, EUR J ORTHODONT, V27, P53, DOI 10.1093/ejo/cjh090; Kang YG, 2010, J DENT RES, V89, P1444, DOI 10.1177/0022034510378521; KATONA TR, 1987, ARCH ORAL BIOL, V32, P367, DOI 10.1016/0003-9969(87)90093-8; Katona TR, 2001, AM J ORTHOD DENTOFAC, V120, P263, DOI 10.1067/mod.2001.116086; KILIARIDIS S, 1995, ACTA ODONTOL SCAND, V53, P196, DOI 10.3109/00016359509005972; Kishen A, 2007, DENT MATER, V23, P1296, DOI 10.1016/j.dental.2006.11.018; KORIOTH TWP, 1994, J DENT RES, V73, P56, DOI 10.1177/00220345940730010801; KORIOTH TWP, 1992, AM J PHYS ANTHROPOL, V88, P69, DOI 10.1002/ajpa.1330880107; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; Lee SS, 2010, INT J LEGAL MED, V124, P659, DOI 10.1007/s00414-010-0513-x; Li W, 2004, BIOMATERIALS, V25, P4987, DOI 10.1016/j.biomaterials.2004.01.010; Lin D, 2010, J BIOMECH, V43, P287, DOI 10.1016/j.jbiomech.2009.08.024; Lin D, 2009, J MECH BEHAV BIOMED, V2, P410, DOI 10.1016/j.jmbbm.2008.11.007; Liu D, 2005, EUR J ORAL SCI, V113, P404, DOI 10.1111/j.1600-0722.2005.00245.x; Liu DW, 2006, EUR J ORAL SCI, V114, P42, DOI 10.1111/j.1600-0722.2006.00283.x; Lucero JC, 1999, J ACOUST SOC AM, V106, P2834, DOI 10.1121/1.428108; MARKS SC, 1984, ARCH ORAL BIOL, V29, P311, DOI 10.1016/0003-9969(84)90105-5; McCollum M, 2001, J ANAT, V199, P153, DOI 10.1046/j.1469-7580.2001.19910153.x; Mellal A, 2004, CLIN ORAL IMPLAN RES, V15, P239, DOI 10.1111/j.1600-0501.2004.01000.x; Miles TS, 2007, ARCH ORAL BIOL, V52, P347, DOI 10.1016/j.archoralbio.2006.12.017; Nelson S.J., 2010, WHEELERS DENT ANATOM, V9th; Nilforoushan D, 2009, ANGLE ORTHOD, V79, P502, DOI 10.2319/050808-252.1; Ohshima H, 2005, ARCH ORAL BIOL, V50, P153, DOI 10.1016/j.archoralbio.2004.09.008; OLUWASANMI JO, 1976, PLAST RECONSTR SURG, V57, P342, DOI 10.1097/00006534-197603000-00011; PERERA KAS, 1981, J ANAT, V133, P281; POSEN AL, 1972, ANGLE ORTHOD, V42, P285; PROFFIT WR, 1978, ANGLE ORTHOD, V48, P175; Reitan K, 1960, AM J ORTHOD DENTOFAC, V46, P881, DOI [10.1016/0002-9416(60)90091-9, DOI 10.1016/0002-9416(60)90091-9]; Roberts W E, 1999, J Indiana Dent Assoc, V78, P24; Romanes GJ., 1983, CUNNINGHAMS MANUAL P, V14th; Saifuddin M, 2003, J ORAL REHABIL, V30, P578, DOI 10.1046/j.1365-2842.2003.00991.x; Sarrafpour B, 2012, ARCH ORAL BIOL, V57, P1070, DOI 10.1016/j.archoralbio.2012.05.001; Shapira Y, 2011, AM J ORTHOD DENTOFAC, V139, P563, DOI 10.1016/j.ajodo.2009.02.033; SIMARDSAVOIE S, 1976, AM J ORTHOD DENTOFAC, V70, P304, DOI 10.1016/0002-9416(76)90336-5; Sloten JV, 1998, P I MECH ENG H, V212, P489, DOI 10.1243/0954411981534240; STEEDLE JR, 1985, AM J ORTHOD DENTOFAC, V87, P56, DOI 10.1016/0002-9416(85)90174-5; Tanaka E, 2001, INT J ORAL MAX SURG, V30, P421, DOI 10.1054/ijom.2001.0132; TENCATE AR, 1976, AM J ORTHOD DENTOFAC, V69, P155; Topouzelis N, 2010, DENT TRAUMATOL, V26, P335, DOI 10.1111/j.1600-9657.2010.00915.x; Tseng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019171; vanEijden TMGJ, 1997, ANAT REC, V248, P464; VANHASSE.HJ, 1972, ARCH ORAL BIOL, V17, P183, DOI 10.1016/0003-9969(72)90146-X; Vollmer D, 2000, J CRANIO MAXILL SURG, V28, P91, DOI 10.1054/jcms.2000.0125; Waters K, 1987, SIGGRAPH COMPUTER GR, V21, P17; WILLIAMS KR, 1984, BIOMATERIALS, V5, P347, DOI 10.1016/0142-9612(84)90033-4; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wise GE, 2004, EUR J ORAL SCI, V112, P439, DOI 10.1111/j.1600-0722.2004.00156.x; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Wise GE, 2003, J DENT RES, V82, P298, DOI 10.1177/154405910308200411; Wolff J, 1892, GESETZ TRANSFORMATIO; Wu JP, 2011, DNA CELL BIOL, V30, P865, DOI 10.1089/dna.2010.1139; Yao SM, 2007, ARCH ORAL BIOL, V52, P228, DOI 10.1016/j.archoralbio.2006.10.008; Yao SM, 2004, ARCH ORAL BIOL, V49, P451, DOI 10.1016/j.archoralbio.2004.01.009; Zoellner H, 1999, MICROVASC RES, V57, P162, DOI 10.1006/mvre.1998.2126; ZOELLNER H, 1993, LYMPHOKINE CYTOK RES, V12, P93	94	46	56	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58803	10.1371/journal.pone.0058803	http://dx.doi.org/10.1371/journal.pone.0058803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554928	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800030
J	Song, Y; Rubio, A; Jayaswal, RK; Silverman, JA; Wilkinson, BJ				Song, Yang; Rubio, Aileen; Jayaswal, Radheshyam K.; Silverman, Jared A.; Wilkinson, Brian J.			Additional Routes to Staphylococcus aureus Daptomycin Resistance as Revealed by Comparative Genome Sequencing, Transcriptional Profiling, and Phenotypic Studies	PLOS ONE			English	Article							REDUCED VANCOMYCIN SUSCEPTIBILITY; CATIONIC ANTIMICROBIAL PEPTIDES; PLATELET MICROBICIDAL PROTEIN; WALL TEICHOIC-ACID; METHICILLIN-RESISTANT; CELL-WALL; POLYNUCLEOTIDE PHOSPHORYLASE; DECREASED SUSCEPTIBILITY; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE	Daptomycin is an extensively used anti-staphylococcal agent due to the rise in methicillin-resistant Staphylococcus aureus, but the mechanism(s) of resistance is poorly understood. Comparative genome sequencing, transcriptomics, ultrastructure, and cell envelope studies were carried out on two relatively higher level (4 and 8 mu g/ml(-1)) laboratory-derived daptomycin-resistant strains (strains CB1541 and CB1540 respectively) compared to their parent strain (CB1118; MW2). Several mutations were found in the strains. Both strains had the same mutations in the two-component system genes waIK and agrA. In strain CB1540 mutations were also detected in the ribose phosphate pyrophosphokinase (prs) and polyribonucleotide nucleotidyltransferase genes (pnpA), a hypothetical protein gene, and in an intergenic region. In strain CB1541 there were mutations in clpP, an ATP-dependent protease, and two different hypothetical protein genes. The strain CB1540 transcriptome was characterized by upregulation of cap (capsule) operon genes, genes involved in the accumulation of the compatible solute glycine betaine, ure genes of the urease operon, and mscL encoding a mechanosensitive chanel. Downregulated genes included smpB, femAB and femH involved in the formation of the pentaglycine interpeptide bridge, genes involved in protein synthesis and fermentation, and spa encoding protein A. Genes altered in their expression common to both transcriptomes included some involved in glycine betaine accumulation, mscL, ure genes, femH, spa and smpB. However, the CB1541 transcriptome was further characterized by upregulation of various heat shock chaperone and protease genes, consistent with a mutation in clpP, and lytM and sceD. Both strains showed slow growth, and strongly decreased autolytic activity that appeared to be mainly due to decreased autolysin production. In contrast to previous common findings, we did not find any mutations in phospholipid biosynthesis genes, and it appears there are multiple pathways to and factors in daptomycin resistance.	[Song, Yang; Jayaswal, Radheshyam K.; Wilkinson, Brian J.] Illinois State Univ, Sch Biol Sci, Microbiol Grp, Normal, IL 61761 USA; [Rubio, Aileen; Silverman, Jared A.] Cubist Pharmaceut Inc, Lexington, MA USA	Illinois State University	Wilkinson, BJ (corresponding author), Illinois State Univ, Sch Biol Sci, Microbiol Grp, Normal, IL 61761 USA.	bjwilkin@ilstu.edu	song, yang/P-1033-2015		Cubist Inc.; National Institutes of Health [IR15AI084006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI084006] Funding Source: NIH RePORTER	Cubist Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by a grant from Cubist Inc. (http://cubist.com/). Additional funding for this study has come from National Institutes of Health grant IR15AI084006 to BJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Arakawa T, 1991, ADV COMP ENV PHYSL, V1 9, P226; Awano N, 2008, J BACTERIOL, V190, P5924, DOI 10.1128/JB.00500-08; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Chuard C, 1997, J ANTIMICROB CHEMOTH, V39, P603, DOI 10.1093/jac/39.5.603; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P428, DOI 10.1128/AAC.50.2.428-438.2006; Davis AO, 2005, J APPL MICROBIOL, V98, P364, DOI 10.1111/j.1365-2672.2004.02460.x; De Lay N, 2011, RNA, V17, P1172, DOI 10.1261/rna.2531211; DEBONO M, 1988, J ANTIBIOT, V41, P1093, DOI 10.7164/antibiotics.41.1093; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; ELIOPOULOS GM, 1985, ANTIMICROB AGENTS CH, V27, P357, DOI 10.1128/AAC.27.3.357; Fischer A, 2011, J ANTIMICROB CHEMOTH, V10, P1093; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Fujimoto DF, 1998, J BACTERIOL, V180, P3724, DOI 10.1128/JB.180.14.3724-3726.1998; GRAHAM JE, 1992, J BACTERIOL, V174, P2711, DOI 10.1128/jb.174.8.2711-2716.1992; GUSTAFSON JE, 1992, ANTIMICROB AGENTS CH, V36, P566, DOI 10.1128/AAC.36.3.566; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hanawa-Suetsugu K, 2002, NUCLEIC ACIDS RES, V30, P1620, DOI 10.1093/nar/30.7.1620; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Ho SW, 2008, EUR BIOPHYS J BIOPHY, V37, P421, DOI 10.1007/s00249-007-0227-2; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Julian K, 2007, ANTIMICROB AGENTS CH, V51, P3445, DOI 10.1128/AAC.00559-07; Kaatz GW, 2006, INT J ANTIMICROB AG, V28, P280, DOI 10.1016/j.ijantimicag.2006.05.030; KAENJAK A, 1993, J BACTERIOL, V175, P2400, DOI 10.1128/JB.175.8.2400-2406.1993; Koehl JL, 2004, ANTIMICROB AGENTS CH, V48, P3749, DOI 10.1128/AAC.48.10.3749-3757.2004; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Ledala N, 2006, INT J ANTIMICROB AG, V27, P518, DOI 10.1016/j.ijantimicag.2006.03.008; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McGillivray SM, 2012, ANTIMICROB AGENTS CH, V56, P1854, DOI 10.1128/AAC.05131-11; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P6192, DOI 10.1128/AAC.01525-12; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Mishra NN, 2012, J INFECT DIS, V206, P1160, DOI 10.1093/infdis/jis482; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mishra NN, 2012, INT J MICROBIOL, DOI [10.1155/2012/683450, DOI 10.1155/2012/683450]; Morikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P385, DOI 10.1006/bbrc.2001.5774; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Oku Y, 2004, MICROBIOL-SGM, V150, P45, DOI 10.1099/mic.0.26706-0; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Pardo Lorena, 2009, Int J Microbiol, V2009, P472126, DOI 10.1155/2009/472126; Patel D, 2011, INT J ANTIMICROB AG, V38, P442, DOI 10.1016/j.ijantimicag.2011.06.010; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Pfeltz R. F., 2004, Current Drug Targets - Infectious Disorders, V4, P273, DOI 10.2174/1568005043340470; Pillai SK, 2007, ANTIMICROB AGENTS CH, V51, P2223, DOI 10.1128/AAC.00202-07; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; QORONFLEH MW, 1986, ANTIMICROB AGENTS CH, V29, P250, DOI 10.1128/AAC.29.2.250; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Rubio A, 2011, ANTIMICROB AGENTS CH, V55, P364, DOI 10.1128/AAC.00429-10; Sader HS, 2006, ANTIMICROB AGENTS CH, V50, P2330, DOI 10.1128/AAC.01491-05; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Shimizu Y, 2002, FEBS LETT, V514, P74, DOI 10.1016/S0014-5793(02)02333-5; Shoji M, 2011, ANTIMICROB AGENTS CH, V55, P3870, DOI 10.1128/AAC.01563-10; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Silverman JA, 2001, ANTIMICROB AGENTS CH, V45, P1799, DOI 10.1128/AAC.45.6.1799-1802.2001; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Staubitz P, 2004, FEMS MICROBIOL LETT, V231, P67, DOI 10.1016/S0378-1097(03)00921-2; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; Tsuji BT, 2007, ANTIMICROB AGENTS CH, V51, P1089, DOI 10.1128/AAC.00671-06; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; VIJARANAKUL U, 1995, J BACTERIOL, V177, P5116, DOI 10.1128/jb.177.17.5116-5121.1995; Vikram HR, 2005, J CLIN MICROBIOL, V43, P5384, DOI 10.1128/JCM.43.10.5384-5387.2005; Wilkinson Brian J., 2005, Current Medicinal Chemistry - Anti-Infective Agents, V4, P259, DOI 10.2174/1568012054368119; Wootton M, 2006, ANTIMICROB AGENTS CH, V50, P4195, DOI 10.1128/AAC.00678-06; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3161, DOI 10.1128/AAC.00487-10; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhu K, 2005, MICROBIOL-SGM, V151, P615, DOI 10.1099/mic.0.27634-0	92	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58469	10.1371/journal.pone.0058469	http://dx.doi.org/10.1371/journal.pone.0058469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554895	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800017
J	Yang, ZZ; Grote, DM; Ziesmer, SC; Xiu, B; Yates, NR; Secreto, FJ; Hodge, LS; Witzig, TE; Novak, AJ; Ansell, SM				Yang, Zhi-Zhang; Grote, Deanna M.; Ziesmer, Steven C.; Xiu, Bing; Yates, Nicole R.; Secreto, Frank J.; Hodge, Lucy S.; Witzig, Thomas E.; Novak, Anne J.; Ansell, Stephen M.			Soluble and Membrane-Bound TGF-beta-Mediated Regulation of Intratumoral T Cell Differentiation and Function in B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; DEPENDENT MECHANISM; IMMUNE-RESPONSES; FOXP3 EXPRESSION; BINDING-PROTEIN; IN-VIVO; TGF-BETA-1; RECEPTOR; SURFACE	While the effect of TGF-beta on malignant B cells in non-Hodgkin lymphoma (NHL) has been previously evaluated, studies to specifically define the role of TGF-beta in tumor immunity in B-cell NHL are limited. We found that soluble TGF-beta, secreted by both lymphoma cells and intratumoral T cells, is present in the serum of patients with B-cell NHL. Soluble TGF-beta promoted regulatory T (T-reg) cells by enhancing expression of Foxp3 in CD4(+) T cells and suppressed effector helper T (T-H) cells by inhibiting expression of IFN-gamma and IL-17. Blockade of the IL-2 signaling pathway diminished the effect of soluble TGF-b on T cell differentiation. Furthermore, we found that membrane-bound TGF-beta is expressed specifically on the surface of malignant B cells in B-cell NHL. TGF-beta was able to bind to the surface of lymphoma B cells through an interaction with heparan sulfate (HS) but not through the TGF-beta receptor. We showed that pretreatment of lymphoma B cells with TGF-beta significantly inhibits the proliferation and cytokine production of intratumoral T cells. Taken together, these results suggest that tumor-associated soluble and membrane-bound TGF-beta are involved in the regulation of intratumoral T cell differentiation and function in B-cell NHL.	[Yang, Zhi-Zhang; Grote, Deanna M.; Ziesmer, Steven C.; Yates, Nicole R.; Secreto, Frank J.; Hodge, Lucy S.; Witzig, Thomas E.; Novak, Anne J.; Ansell, Stephen M.] Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA; [Xiu, Bing] Tongji Univ, Tongji Hosp, Dept Hematol, Shanghai 200092, Peoples R China	Mayo Clinic; Tongji University	Yang, ZZ (corresponding author), Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA.	yang.zhizhang@mayo.edu; ansell.stephen@mayo.edu			National Institutes of Health [CA92104, CA97274]; Lymphoma Research Foundation; Leukemia & Lymphoma Society; Predolin Foundation; NATIONAL CANCER INSTITUTE [P50CA097274, R01CA092104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Predolin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA92104 and CA97274 from the National Institutes of Health, the Lymphoma Research Foundation, the Leukemia & Lymphoma Society and the Predolin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Ahn YO, 2009, J IMMUNOL, V182, P6114, DOI 10.4049/jimmunol.0803725; Baker K, 2008, INT J CANCER, V122, P1695, DOI 10.1002/ijc.23312; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Bright JJ, 1997, J IMMUNOL, V159, P175; BUTZOW R, 1993, J CELL BIOL, V122, P721, DOI 10.1083/jcb.122.3.721; CHANG H, 1995, LEUKEMIA LYMPHOMA, V19, P165, DOI 10.3109/10428199509059672; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Chung JS, 2011, BLOOD, V117, P3382, DOI 10.1182/blood-2010-08-302034; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Das L, 2008, J IMMUNOL, V180, P1490, DOI 10.4049/jimmunol.180.3.1490; DELMISTRO A, 1994, LEUKEMIA, V8, P1214; FISCHER P, 1988, BLOOD, V72, P234; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Foster AE, 2008, J IMMUNOTHER, V31, P500, DOI 10.1097/CJI.0b013e318177092b; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Han SH, 1998, J PHARMACOL EXP THER, V287, P1105; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; McKarns SC, 2000, IMMUNOPHARMACOLOGY, V48, P101, DOI 10.1016/S0162-3109(00)00183-1; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Piek E, 1997, J CELL PHYSIOL, V173, P447, DOI 10.1002/(SICI)1097-4652(199712)173:3<447::AID-JCP17>3.0.CO;2-8; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SING GK, 1990, CELL GROWTH DIFFER, V1, P549; TWEEDDALE ME, 1987, BLOOD, V69, P1307; Vega JL, 2010, OCUL IMMUNOL INFLAMM, V18, P459, DOI 10.3109/09273948.2010.509532; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xie YF, 2009, CANCER RES, V69, P7756, DOI 10.1158/0008-5472.CAN-09-0496; Yamada Y, 2010, INVEST OPHTH VIS SCI, V51, P2548, DOI 10.1167/iovs.09-4233; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	48	36	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59456	10.1371/journal.pone.0059456	http://dx.doi.org/10.1371/journal.pone.0059456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555036	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800093
J	Heel, T; Vogel, GF; Lammirato, A; Schneider, R; Auer, B				Heel, Thomas; Vogel, Georg F.; Lammirato, Andrea; Schneider, Rainer; Auer, Bernhard			FlgM as a Secretion Moiety for the Development of an Inducible Type III Secretion System	PLOS ONE			English	Article							FLAGELLAR GENE-EXPRESSION; ANTI-SIGMA FACTOR; ESCHERICHIA-COLI; TRANSCRIPTIONAL CONTROL; SALMONELLA-TYPHIMURIUM; REGULATORY SYSTEM; TRANSPOSON TN7; MESSENGER-RNA; ACTIVATOR; COMPLEX	Regulation and assembly of the flagellar type III secretion system is one of the most investigated and best understood regulational cascades in molecular biology. Depending on the host organism, flagellar morphogenesis requires the interplay of more than 50 genes. Direct secretion of heterologous proteins to the supernatant is appealing due to protection against cellular proteases and simplified downstream processing. As Escherichia coli currently remains the predominant host organism used for recombinant prokaryotic protein expression, the generation of a strain that exhibits inducible flagellar secretion would be highly desirable for biotechnological applications. Here, we report the first engineered Escherichia coli mutant strain featuring flagellar morphogenesis upon addition of an external inducer. Using FlgM as a sensor for direct secretion in combination with this novel strain may represent a potent tool for significant improvements in future engineering of an inducible type III secretion for heterologous proteins.	[Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Austrian Ctr Ind Biotechnol, Graz, Austria; [Heel, Thomas; Schneider, Rainer; Auer, Bernhard] Univ Innsbruck, Ctr Mol Biosci CMBI, A-6020 Innsbruck, Austria; [Vogel, Georg F.] Med Univ Innsbruck, Div Histol & Embryol, A-6020 Innsbruck, Austria; [Lammirato, Andrea] Med Univ Innsbruck, Div Cell Biol, A-6020 Innsbruck, Austria	University of Innsbruck; Austrian Centre of Industrial Biotechnology; University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Heel, T (corresponding author), Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria.	Thomash@caltech.edu		Vogel, Georg-Friedrich/0000-0002-2515-4490	Austrian Ministry of Economics and Labor, the federal state of Vienna; Austrian Ministry of Economics and Labor, the federal state of Tyrol; Sandoz GmbH; Boehringer Ingelheim Austria GmbH; Austrian government	Austrian Ministry of Economics and Labor, the federal state of Vienna; Austrian Ministry of Economics and Labor, the federal state of Tyrol; Sandoz GmbH; Boehringer Ingelheim Austria GmbH(Boehringer Ingelheim); Austrian government	The present work was performed within the Austrian Center of Industrial Biotechnology (ACIB), a competence center funded by the Austrian Ministry of Economics and Labor, the federal states of Vienna and Tyrol and by its industrial partners Sandoz GmbH and Boehringer Ingelheim Austria GmbH. The funders had no role in the study design data collection and analysis, decision to publish, or preparation of the manuscript.; The Austrian Center for Industrial Biotechnology is a research center, which is financed partly by the Austrian government and by industry partners. Thomas Heel was an employee of this research center. The research program is decided in a scientific steering committee in which universities (as representatives of the government) and the companies are represented. The outcome of the research can be used by the industrial partners, however, they can also decide to give the results free for publication, which they did in this case. So the authors can declare that, "This does not alter their adherence to all the PLOS ONE policies on sharing data and materials."	Aizawa SI, 1996, MOL MICROBIOL, V19, P1, DOI 10.1046/j.1365-2958.1996.344874.x; Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Aldridge PD, 2006, GENE DEV, V20, P2315, DOI 10.1101/gad.380406; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; GAY NJ, 1986, BIOCHEM J, V234, P111, DOI 10.1042/bj2340111; Georgiou G, 2005, CURR OPIN BIOTECH, V16, P538, DOI 10.1016/j.copbio.2005.07.008; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GRINGAUZ E, 1988, J BACTERIOL, V170, P2832, DOI 10.1128/jb.170.6.2832-2840.1988; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; Ide N, 1999, GENES GENET SYST, V74, P113, DOI 10.1266/ggs.74.113; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Karlinsey JE, 2000, CELL, V102, P487, DOI 10.1016/S0092-8674(00)00053-2; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, J BACTERIOL, V176, P3598, DOI 10.1128/JB.176.12.3598-3605.1994; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Lloyd SA, 2001, TRENDS MICROBIOL, V9, P367, DOI 10.1016/S0966-842X(01)02100-X; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Majander K, 2005, NAT BIOTECHNOL, V23, P475, DOI 10.1038/nbt1077; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Minamino T, 2004, J MOL MICROB BIOTECH, V7, P5, DOI 10.1159/000077865; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Siegele DA, 2010, FEMS MICROBIOL LETT, V309, P94, DOI 10.1111/j.1574-6968.2010.02021.x; Singer HM, 2012, MBIO, V3, DOI 10.1128/mBio.00115-12; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Wozniak CE, 2008, J MOL BIOL, V379, P936, DOI 10.1016/j.jmb.2008.04.043; Wozniak CE, 2009, J BACTERIOL, V191, P1498, DOI 10.1128/JB.01177-08; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59034	10.1371/journal.pone.0059034	http://dx.doi.org/10.1371/journal.pone.0059034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554966	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500061
J	Jin, M; Jusiak, B; Bai, ZL; Mardon, G				Jin, Meng; Jusiak, Barbara; Bai, Zengliang; Mardon, Graeme			Eyes Absent Tyrosine Phosphatase Activity Is Not Required for Drosophila Development or Survival	PLOS ONE			English	Article							BRANCHIOOTORENAL SYNDROME; GENETIC-CONTROL; CELL-SURVIVAL; HUMAN HOMOLOG; PROTEIN; EYA; MUTATIONS; ACTIVATION; REVEALS; EXPRESSION	Eyes absent (Eya) is an evolutionarily conserved transcriptional coactivator and protein phosphatase that regulates multiple developmental processes throughout the metazoans. Drosophila eya is necessary for survival as well as for the formation of the adult eye. Eya contains a tyrosine phosphatase domain, and mutations altering presumptive active-site residues lead to strongly reduced activities in ectopic eye induction, in vivo genetic rescue using the Gal4-UAS system, and in vitro phosphatase assays. However, these mutations have not been analyzed during normal development with the correct levels, timing, and patterns of endogenous eya expression. To investigate whether the tyrosine phosphatase activity of Eya plays a role in Drosophila survival or normal eye formation, we generated three eya genomic rescue (eyaGR) constructs that alter key active-site residues and tested them in vivo. In striking contrast to previous studies, all eyaGR constructs fully restore eye formation as well as viability in an eya null mutant background. We conclude that the tyrosine phosphatase activity of Eya is not required for normal eye development or survival in Drosophila. Our study suggests the need for a re-evaluation of the mechanism of Eya action and underscores the importance of studying genes in their native context.	[Jin, Meng; Bai, Zengliang] Shandong Univ, Lab Dev Immunol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Jusiak, Barbara; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jin, Meng; Mardon, Graeme] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA	Shandong University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bai, ZL (corresponding author), Shandong Univ, Lab Dev Immunol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	zengliangbai@sdu.edu.cn; gmardon@bcm.edu	Jin, Meng/AAI-7085-2020	Jin, Meng/0000-0002-1525-0876; /0000-0001-6439-0456	Retina Research Foundation; National Eye Institute [R01 EY011232]; Chinese Scholarship Council; NEI/NIH [EY-002520]; China Scholarship Council (CSC); NATIONAL EYE INSTITUTE [R01EY011232, P30EY002520] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chinese Scholarship Council(China Scholarship Council); NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Retina Research Foundation, National Eye Institute grant R01 EY011232 (GM), the Chinese Scholarship Council (MJ), and the NEI/NIH Core Grant for Vision Research EY-002520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Nele Haelterman for ERG technical assistance, Ilaria Rebay for providing the ro-lacZ<SUP>tau</SUP> fly stock and Georg Halder for comments on the manuscript. MJ thanks the China Scholarship Council (CSC) for financial support.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Bui QT, 2000, GENETICS, V155, P709; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jusiak B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050776; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pepple KL, 2007, GENETICS, V175, P125, DOI 10.1534/genetics.106.065680; Petersen N.S., 1990, Advances in Genetics, V28, P275; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Tadjuidje E., 2012, CELL MOL LIFE SCI; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Zhang L, 2005, CANCER RES, V65, P925; Zimmerman JE, 1997, GENOME RES, V7, P128, DOI 10.1101/gr.7.2.128	43	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58818	10.1371/journal.pone.0058818	http://dx.doi.org/10.1371/journal.pone.0058818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554934	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500047
J	Yang, BK; Ma, CC; Chen, ZS; Yi, WN; McNutt, MA; Wang, Y; Korteweg, C; Gu, J				Yang, Baokai; Ma, Changchun; Chen, Zhengshan; Yi, Weining; McNutt, Michael A.; Wang, Yun; Korteweg, Christine; Gu, Jiang			Correlation of Immunoglobulin G Expression and Histological Subtype and Stage in Breast Cancer	PLOS ONE			English	Article							CHAIN CONSTANT-REGION; KAPPA-LIGHT-CHAIN; DUCTAL CARCINOMA; CELL-LINES; JAPANESE WOMEN; RISK-FACTORS; PLASMA IGA; IN-SITU; TUMORS; PREVENTION	Introduction: Recently, growing evidence indicates that immunoglobulins (Igs) are not only produced by mature B lymphocytes or plasma cells, but also by various normal cells types at immune privileged sites and neoplasm, including breast cancer. However, the association of breast cancer derived IgG with genesis and development of the disease has not yet been established. Methods: In this study we examined the expression of IgG in 186 breast cancers, 20 benign breast lesions and 30 normal breast tissues. Both immunohistochemistry with antibodies to Ig kappa (immunoglobulin G kappa light chain) and Ig gamma (immunoglobulin G heavy chain) and in situ hybridization with an antisense probe to IgG1 heavy chain constant region gene were performed. Various clinicopathological features were also analyzed. Results: We found that IgG is specifically expressed in human breast cancer cells. Both infiltrating ductal carcinoma and infiltrating lobular carcinoma had significantly greater numbers of Ig kappa and Ig gamma positive cancer cells as compared with medullary carcinoma, carcinoma in situ, and benign lesions (all p<0.05). In addition, IgG expression was correlated with breast cancer histological subtypes (p<0.01) and AJCC stages (p<0.05), with more abundance of IgG expression in more malignant histological subtypes or in more advanced stage of the disease. Conclusions: IgG expression in breast cancer cells is correlated with malignancy and AJCC stages of the cancers. This suggests that breast cancer derived IgG may be associated with genesis, development and prognosis of the cancer.	[Yang, Baokai; Chen, Zhengshan; McNutt, Michael A.; Wang, Yun; Gu, Jiang] Peking Beijing Univ, Dept Pathol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China; [Ma, Changchun; Chen, Zhengshan; Korteweg, Christine; Gu, Jiang] Shantou Univ, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Dept Pathol & Pathophysiol, Coll Med, Shantou, Peoples R China; [Ma, Changchun] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China; [Yi, Weining] Peking Beijing Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Wang, Yun] NIMH, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA	Peking University; Shantou University; Shantou University; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Gu, J (corresponding author), Peking Beijing Univ, Dept Pathol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020	Gu, Jiang/0000-0002-0706-8329	Li Fu Educational Foundation; 111 project of the Ministry of Education, China [B07001]; National Natural Science Foundation of China [81030033, 30971150]; Science and Technology Funding of Shantou [186]	Li Fu Educational Foundation; 111 project of the Ministry of Education, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Funding of Shantou	This work was supported by the Li Fu Educational Foundation, 111 project of the Ministry of Education, China (No. B07001), the National Natural Science Foundation of China (Nos. 81030033 and 30971150 to J.G.) and the Science and Technology Funding of Shantou (No. 186 to C. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WHO CLASSIFICATION T; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Chu JS, 1998, CANCER LETT, V131, P145, DOI 10.1016/S0304-3835(98)00118-9; Cowan WK, 2000, J CLIN PATHOL, V53, P140, DOI 10.1136/jcp.53.2.140; Edhemovic I, 2001, EUR J SURG ONCOL, V27, P545, DOI 10.1053/ejso.2001.1134; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gu J., 1997, ANAL MORPHOLOGY THEO; Heimann R, 2000, CANCER RES, V60, P298; Hoff ER, 2002, AM J CLIN PATHOL, V117, P916, DOI 10.1309/4NTU-N6K4-F8JF-EWRX; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Lee G., 2012, AM J IMMUNOL, V8, P101, DOI [10.3844/ajisp.2012.101.116, DOI 10.3844/AJISP.2012.101.116]; Lee G, 2009, CANCER BIOMARK, V5, P177, DOI 10.3233/CBM-2009-0102; Lee G, 2009, CANCER BIOL THER, V8, P161, DOI 10.4161/cbt.8.2.7117; Lee G, 2008, CANCER BIOL THER, V7, P2007, DOI 10.4161/cbt.7.12.6984; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Lonning PE, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm260; Ma C, 2013, CURRENT MOL IN PRESS, V13; Molland JG, 2004, BREAST, V13, P389, DOI 10.1016/j.breast.2004.03.004; Pedersen L, 1995, EUR J CANCER, V31A, P2289, DOI 10.1016/0959-8049(95)00408-4; PETTINGALE KW, 1977, BRIT J CANCER, V36, P550, DOI 10.1038/bjc.1977.230; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pierce E, 1998, J CLIN PATHOL-MOL PA, V51, P90, DOI 10.1136/mp.51.2.90; Qiu XY, 2003, CANCER RES, V63, P6488; Rivenbark AG, 2012, EXP MOL PATHOL, V93, P391, DOI 10.1016/j.yexmp.2012.10.018; ROYDS JA, 1993, J NATL CANCER I, V85, P727, DOI 10.1093/jnci/85.9.727; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Shiao YH, 2000, CANCER EPIDEM BIOMAR, V9, P631; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Singletary SE, 2006, CA-CANCER J CLIN, V56, P37, DOI 10.3322/canjclin.56.1.37; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; WANG DY, 1977, EUR J CANCER, V13, P1405, DOI 10.1016/0014-2964(77)90153-0; WANG DY, 1979, CANCER, V44, P492, DOI 10.1002/1097-0142(197908)44:2<492::AID-CNCR2820440219>3.0.CO;2-V; WANG DY, 1977, CANCER, V39, P2190, DOI 10.1002/1097-0142(197705)39:5<2190::AID-CNCR2820390536>3.0.CO;2-C; WELLINGS SR, 1973, J NATL CANCER I, V50, P1111, DOI 10.1093/jnci/50.5.1111; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zhang LY, 2012, HUM PATHOL, V43, P423, DOI 10.1016/j.humpath.2011.05.020; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zhou JH, 2004, CELL MOL IMMUNOL, V1, P247	43	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58706	10.1371/journal.pone.0058706	http://dx.doi.org/10.1371/journal.pone.0058706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554916	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500040
J	Chu, HT; Hsiao, WWL; Tsao, TTH; Hsu, DF; Chen, CC; Lee, SA; Kao, CY				Chu, Hsueh-Ting; Hsiao, William W. L.; Tsao, Theresa T. H.; Hsu, D. Frank; Chen, Chaur-Chin; Lee, Sheng-An; Kao, Cheng-Yan			SeqEntropy: Genome-Wide Assessment of Repeats for Short Read Sequencing	PLOS ONE			English	Article							ASSEMBLIES; MAP; DNA	Background: Recent studies on genome assembly from short-read sequencing data reported the limitation of this technology to reconstruct the entire genome even at very high depth coverage. We investigated the limitation from the perspective of information theory to evaluate the effect of repeats on short-read genome assembly using idealized (error-free) reads at different lengths. Methodology/Principal Findings: We define a metric H-(k) to be the entropy of sequencing reads at a read length k and use the relative loss of entropy Delta H-(k) to measure the impact of repeats for the reconstruction of whole-genome from sequences of length k. In our experiments, we found that entropy loss correlates well with de-novo assembly coverage of a genome, and a score of Delta H-(k)>1% indicates a severe loss in genome reconstruction fidelity. The minimal read lengths to achieve Delta H-(k)<1% are different for various organisms and are independent of the genome size. For example, in order to meet the threshold of Delta H-(k)<1%, a read length of 60 bp is needed for the sequencing of human genome (3.2 10(9) bp) and 320 bp for the sequencing of fruit fly (1.8 x 10(8) bp). We also calculated the Delta H-(k) scores for 2725 prokaryotic chromosomes and plasmids at several read lengths. Our results indicate that the levels of repeats in different genomes are diverse and the entropy of sequencing reads provides a measurement for the repeat structures. Conclusions/Significance:The proposed entropy-based measurement, which can be calculated in seconds to minutes in most cases, provides a rapid quantitative evaluation on the limitation of idealized short-read genome sequencing. Moreover, the calculation can be parallelized to scale up to large euakryotic genomes. This approach may be useful to tune the sequencing parameters to achieve better genome assemblies when a closely related genome is already available.	[Chu, Hsueh-Ting] Asia Univ, Dept Biomed informat, Taichung, Taiwan; [Chu, Hsueh-Ting] Asia Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Hsiao, William W. L.] British Columbia Publ Hlth Microbiol & Reference, Vancouver, BC, Canada; [Hsiao, William W. L.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [Hsiao, William W. L.] Univ British Columbia, Lab Med, Vancouver, BC V5Z 1M9, Canada; [Tsao, Theresa T. H.; Kao, Cheng-Yan] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Hsu, D. Frank] Fordham Univ, Dept Comp & Informat Sci, New York, NY 10023 USA; [Chen, Chaur-Chin] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Lee, Sheng-An] Kainan Univ, Dept Informat Management, Tao Yuan, Taiwan	Asia University Taiwan; Asia University Taiwan; University of British Columbia; University of British Columbia; National Taiwan University; Fordham University; National Tsing Hua University; Nan Kai University Technology	Lee, SA (corresponding author), Kainan Univ, Dept Informat Management, Tao Yuan, Taiwan.	shengan@gmail.com; cykao@csie.ntu.edu.tw						Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bischof DF, 2006, GENOMICS, V88, P633, DOI 10.1016/j.ygeno.2006.06.018; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brown Jr J, 2006, GENOMES; Cerveau N, 2011, GENOME BIOL EVOL, V3, P1175, DOI 10.1093/gbe/evr096; Cho NH, 2007, P NATL ACAD SCI USA, V104, P7981, DOI 10.1073/pnas.0611553104; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Schneider T. D., 1995, INFORM THEORY PRIMER; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Tammi MT, 2002, BIOINFORMATICS, V18, P379, DOI 10.1093/bioinformatics/18.3.379; Wetzel J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-95; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	21	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59484	10.1371/journal.pone.0059484	http://dx.doi.org/10.1371/journal.pone.0059484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544073	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700033
J	Ruan, WJ; Unsain, N; Desbarats, J; Fon, EA; Barker, PA				Ruan, Wenjing; Unsain, Nicolas; Desbarats, Julie; Fon, Edward A.; Barker, Philip A.			Wengen, the Sole Tumour Necrosis Factor Receptor in Drosophila, Collaborates with Moesin to Control Photoreceptor Axon Targeting during Development	PLOS ONE			English	Article							VISUAL-SYSTEM; PRONEURAL GENES; TNF SUPERFAMILY; NEURITE GROWTH; NOGO RECEPTOR; PROTEIN; EIGER; CELL; FLAMINGO; PATHWAY	Photoreceptor neurons (R cells) in the Drosophila eye define a map of visual space by connecting to targets in distinct layers of the optic lobe, with R1-6 cells connecting to the lamina (the first optic ganglion) and R7 and R8 cells connecting to the medulla (the second optic ganglion). Here, we show that Wengen (Wgn) directly binds Moesin (Moe) through a cytosolic membrane proximal domain and this interaction is important for mediating two distinct aspects of axonal targeting. First, we show that loss of wgn or moe function disrupts cell autonomous R8 axon targeting. Second, we report that wgn or moe mutants show defects in R2-R5 targeting that result from disruption of non-cell autonomous effects, which are secondary to the cell autonomous R8 phenotype. Thus, these studies reveal that the Wgn-Moe signaling cascade plays a key role in photoreceptor target field innervations through cell autonomous and non cell autonomous mechanisms.	[Ruan, Wenjing; Unsain, Nicolas; Desbarats, Julie; Fon, Edward A.; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	ted.fon@mcgill.ca; phil.barker@mcgill.ca	Unsain, Nicolas/AGZ-4095-2022	Desbarats, Julie/0000-0002-2495-7152	Canadian Institutes of Health Research [204868, 224928]; National Sciences and Engineering Research Council of Canada [231901]; Parkinson Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson Society	This work was supported by independent grants to E.A.F (204868) and P.A.B. (224928) from the Canadian Institutes of Health Research and the National Sciences and Engineering Research Council of Canada to P.A.B.(231901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lindsay Osso for help With quantification, Drs. Yong Rao (McGill University), Pejmun Haghighi (McGill University), Xiaohang Yang (National University of Singapore) and Hugo Bellen (Baylor College of Medicine) who generously provided materials used in this study. W.J.R. is recipient of a Parkinson Society Canada fellowship and E.A.F is an FRSQ Chercheur Boursier Senior Clinical Fellow. P.A.B is an FRSQ Chercheur National and is a James McGill Scholar.	Babcock DT, 2011, CURR BIOL, V21, P1525, DOI 10.1016/j.cub.2011.08.020; Babcock Daniel T, 2009, Commun Integr Biol, V2, P517; Ben-Zvi A, 2007, J NEUROSCI, V27, P13000, DOI 10.1523/JNEUROSCI.3373-07.2007; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Hakeda-Suzuki S, 2011, NAT NEUROSCI, V14, P314, DOI 10.1038/nn.2756; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Meinertzhagen Ian A., 1993, P1363; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Ruan WJ, 2008, MOL BIOL CELL, V19, P3192, DOI 10.1091/mbc.E08-02-0161; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tomasi T, 2008, NEURON, V57, P691, DOI 10.1016/j.neuron.2008.01.012; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Wang H, 2006, SHOCK, V25, P25, DOI 10.1097/00024382-200606001-00075; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	43	5	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60091	10.1371/journal.pone.0060091	http://dx.doi.org/10.1371/journal.pone.0060091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544124	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700083
J	Stollar, V; Mensah, V; Adams, S; Li, ML				Stollar, Victor; Mensah, Virginia; Adams, Sandra; Li, Mei-Ling			Evolution of Sindbis Virus with a Low-Methionine-Resistant Phenotype Is Dependent Both on a Pre-Existing Mutation and on the Methionine Concentration in the Medium	PLOS ONE			English	Article							RNA-POLYMERASE; MUTANT; METHYLTRANSFERASE; REPLICATION; EXPRESSION; FIDELITY; ENCODES; CLONES; CELLS; NSP1	SVIm21 is a mutant of Sindbis virus which was isolated by serial passage of virus in mosquito cells maintained in low-methionine medium; it therefore has a low-methionine-resistant (LMR) Phenotype. This Phenotype requires mutations at nts 319 and 321; these mutations result in Arg to Leu and Ser to Cys changes at positions 87 and 88 respectively in the viral methyl transferase, nsP1. To better understand the genesis of SVIm21, we carried out serial passages of viruses having only one of these amino acid changes, but in mosquito cells maintained in normal methionine-medium. Whether the Passage was begun with SV319 or with SV321, the dominant virus population which emerged always acquired the second SVIm21 amino acid change. However, when the Passage was begun with virus having neither the nt 319 or the nt321 mutation, even after many Passages neither of these mutations. was seen in the passaged virus population. Virus with the LMR phenotype emerged earlier when the virus encoded a wild type RDRP. (Passage 4) rather than the mutant RDRP encoded by SVpzf (passage 7). When the methionine concentration in the medium of mosquito cells was increased to 250 mu M, more than 20 passages were required until the LMR phenotype predominated. Competition experiments were carried out to compare the relative fitness of SVIm21, SVwt, SV319 and SV321 to each other. Our results indicated that SVIm21 was dominant to SVwt, as well as to both SV319 and SV321. However, SV319 and SV321 were able to co-exist with SVwt implying that in these mixed infection the presence of SVwt inhibited the emergence of SVIm21. Finally, our experiments highlight how a virus population by mutation and selection can adapt to the intracellular concentration of a simple metabolite, S-adenosylmethionine.	[Stollar, Victor; Mensah, Virginia; Li, Mei-Ling] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Stollar, Victor] Canc Inst New Jersey, New Brunswick, NJ USA; [Adams, Sandra] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Montclair State University	Li, ML (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	lime@umdnj.edu			NIH/NIAID Public Health Service [AI-49273, AI-070728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049273, R01AI070728] Funding Source: NIH RePORTER	NIH/NIAID Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID Public Health Service grants AI-49273 and AI-070728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Delgado T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002866; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Domingo E, 2007, FIELDS VIROLOGY, P389; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; DURBIN RK, 1985, VIROLOGY, V144, P529, DOI 10.1016/0042-6822(85)90294-6; Heyduk E, 2003, ANAL BIOCHEM, V316, P1, DOI 10.1016/S0003-2697(03)00004-6; Lemm JA, 1998, J VIROL, V72, P6546, DOI 10.1128/JVI.72.8.6546-6553.1998; Lin YH, 2000, VIROLOGY, V272, P61, DOI 10.1006/viro.2000.0329; MI S, 1990, VIROLOGY, V178, P429, DOI 10.1016/0042-6822(90)90340-W; MI S, 1989, VIROLOGY, V170, P385, DOI 10.1016/0042-6822(89)90429-7; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; SARVER N, 1977, VIROLOGY, V80, P390, DOI 10.1016/S0042-6822(77)80014-7; SCHEIDEL LM, 1989, VIROLOGY, V173, P408, DOI 10.1016/0042-6822(89)90553-9; Sitole LJ, 2013, MOL BIOSYST, V9, P18, DOI 10.1039/c2mb25318f	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60504	10.1371/journal.pone.0060504	http://dx.doi.org/10.1371/journal.pone.0060504			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544150	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700109
J	Lan, Q; Cawthon, R; Gao, YT; Hu, W; Hosgood, HD; Barone-Adesi, F; Ji, BT; Bassig, B; Chow, WH; Shu, XO; Cai, QY; Xiang, YB; Berndt, S; Kim, C; Chanock, S; Zheng, W; Rothman, N				Lan, Qing; Cawthon, Richard; Gao, Yutang; Hu, Wei; Hosgood, H. Dean, III; Barone-Adesi, Francesco; Ji, Bu-Tian; Bassig, Bryan; Chow, Wong-Ho; Shu, Xiaoou; Cai, Qiuyin; Xiang, Yongbin; Berndt, Sonja; Kim, Christopher; Chanock, Stephen; Zheng, Wei; Rothman, Nathaniel			Longer Telomere Length in Peripheral White Blood Cells Is Associated with Risk of Lung Cancer and the rs2736100 (CLPTM1L-TERT) Polymorphism in a Prospective Cohort Study among Women in China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLEX QUANTITATIVE PCR; SUSCEPTIBILITY LOCI; DNA-REPAIR; VARIANTS; 5P15.33; CHEMOTHERAPY; LYMPHOMA; BIOLOGY; HEALTH	A recent genome-wide association study of lung cancer among never-smoking females in Asia demonstrated that the rs2736100 polymorphism in the TERT-CLPTM1L locus on chromosome 5p15.33 was strongly and significantly associated with risk of adenocarcinoma of the lung. The telomerase gene TERT is a reverse transcriptase that is critical for telomere replication and stabilization by controlling telomere length. We previously found that longer telomere length measured in peripheral white blood cell DNA was associated with increased risk of lung cancer in a prospective cohort study of smoking males in Finland. To follow up on this finding, we carried out a nested case-control study of 215 female lung cancer cases and 215 female controls, 94% of whom were never-smokers, in the prospective Shanghai Women's Health Study cohort. There was a dose-response relationship between tertiles of telomere length and risk of lung cancer (odds ratio (OR), 95% confidence interval [CI]: 1.0, 1.4 [0.8-2.5], and 2.2 [1.2-4.0], respectively; P trend = 0.003). Further, the association was unchanged by the length of time from blood collection to case diagnosis. In addition, the rs2736100 G allele, which we previously have shown to be associated with risk of lung cancer in this cohort, was significantly associated with longer telomere length in these same study subjects (P trend = 0.030). Our findings suggest that individuals with longer telomere length in peripheral white blood cells may have an increased risk of lung cancer, but require replication in additional prospective cohorts and populations.	[Lan, Qing; Hu, Wei; Hosgood, H. Dean, III; Barone-Adesi, Francesco; Ji, Bu-Tian; Bassig, Bryan; Chow, Wong-Ho; Berndt, Sonja; Kim, Christopher; Chanock, Stephen; Rothman, Nathaniel] NCI, NIH, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Cawthon, Richard] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Gao, Yutang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Shu, Xiaoou; Cai, Qiuyin; Xiang, Yongbin; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Shu, Xiaoou; Cai, Qiuyin; Xiang, Yongbin; Zheng, Wei] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Shanghai Jiao Tong University; Vanderbilt University; Vanderbilt University	Lan, Q (corresponding author), NCI, NIH, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	qingl@mail.nih.gov	zhang, weihua/GXV-1334-2022; Gao, Y./GWZ-3665-2022; wei, hu/GXW-2391-2022; Berndt, Sonja I/J-8423-2016; Zheng, Wei/O-3351-2013; Gao, Yu/HGE-1937-2022; Barone-Adesi, Francesco/ABG-1580-2020; gao, yi/HCI-8298-2022	Zheng, Wei/0000-0003-1226-070X; Barone-Adesi, Francesco/0000-0003-1550-436X	National Cancer Institute (Bethesda, MD); NATIONAL CANCER INSTITUTE [ZIACP010123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005007] Funding Source: NIH RePORTER	National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by intramural funds from the National Cancer Institute (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Ducray C, 1999, ONCOGENE, V18, P4211, DOI 10.1038/sj.onc.1202797; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fu XY, 2012, EUR J CANCER, V48, P1014, DOI 10.1016/j.ejca.2012.02.066; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Hosgood HD, 2009, LUNG CANCER, V66, P157, DOI 10.1016/j.lungcan.2009.02.005; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025774; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lee JJ, 2003, ANN HEMATOL, V82, P492, DOI 10.1007/s00277-003-0691-4; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Mirabello L, 2011, INT J MOL EPIDEMIOL, V2, P19; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Schroder CP, 2001, BRIT J CANCER, V84, P1348, DOI 10.1054/bjoc.2001.1803; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shen J, 2012, BREAST CANCER RES TR, V134, P393, DOI 10.1007/s10549-012-2058-9; Shen M, 2011, LUNG CANCER, V73, P133, DOI 10.1016/j.lungcan.2010.11.009; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	41	90	92	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59230	10.1371/journal.pone.0059230	http://dx.doi.org/10.1371/journal.pone.0059230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555636	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000317418500027
J	Liu, ZQ; Chen, DC; Sheng, L; Liu, AY				Liu, Zhenqiu; Chen, Dechang; Sheng, Li; Liu, Amy Y.			Class Prediction and Feature Selection with Linear Optimization for Metagenomic Count Data	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; DNA-SEQUENCES	The amount of metagenomic data is growing rapidly while the computational methods for metagenome analysis are still in their infancy. It is important to develop novel statistical learning tools for the prediction of associations between bacterial communities and disease phenotypes and for the detection of differentially abundant features. In this study, we presented a novel statistical learning method for simultaneous association prediction and feature selection with metagenomic samples from two or multiple treatment populations on the basis of count data. We developed a linear programming based support vector machine with L-1 and joint L-1,L-infinity penalties for binary and multiclass classifications with metagenomic count data (metalinprog). We evaluated the performance of our method on several real and simulation datasets. The proposed method can simultaneously identify features and predict classes with the metagenomic count data.	[Liu, Zhenqiu] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Chen, Dechang] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Sheng, Li] Drexel Univ, Dept Math, Philadelphia, PA 19104 USA; [Liu, Amy Y.] Brown Univ, Dept Appl Math, Providence, RI 02912 USA	University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA; Drexel University; Brown University	Liu, ZQ (corresponding author), Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	zliu@umm.edu			National Science Foundation (NSF) [ADT-1220747, CCF-0729080]; National Cancer Institute [1R03CA133899]; NATIONAL CANCER INSTITUTE [R03CA133899] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Science Foundation (NSF) grant ADT-1220747, the 1R03CA133899 grant from National Cancer Institute, and the NSF CCF-0729080 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jeiroudi G, 2009, J OPTIMIZ THEORY APP, V141, P231, DOI 10.1007/s10957-008-9500-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026624; Antonov AV, 2004, BIOINFORMATICS, V20, P3284, DOI 10.1093/bioinformatics/bth376; Antonov AV, 2004, BIOINFORMATICS, V20, P644, DOI 10.1093/bioinformatics/btg462; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bergamaschi L, 2004, COMPUT OPTIM APPL, V28, P149, DOI 10.1023/B:COAP.0000026882.34332.1b; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dagliyan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014579; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Huson D, 2007, GENOME RES, V17; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Knights D., 2010, FEMS MICROBIOL REV, DOI [10.1111/j.1574-6976, DOI 10.1111/J.1574-6976]; Liu ZQ, 2011, BIOINFORMATICS, V27, P3242, DOI 10.1093/bioinformatics/btr547; Liu ZQ, 2010, IEEE ACM T COMPUT BI, V7, P100, DOI 10.1109/TCBB.2008.17; Lozupone C, 2010, ISME J, V5, DOI DOI 10.1128/AEM.01541-09; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Mohammed MH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S4; NAGARSENKER PB, 1984, BIOMETRIKA, V71, P405; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quattoni A, 2009, P 26 ANN INT C MACH; Rosen G, 2010, BIOINFORMATICS, V27; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt M, 2008, P C COMP VIS PATT RE; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; Tropp J, 2006, SIGNAL PROCESS, V86; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tzahor S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-229; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Zheng Hao, 2010, Journal of Bioinformatics and Computational Biology, V8, P995, DOI 10.1142/S0219720010005051	40	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e53253	10.1371/journal.pone.0053253	http://dx.doi.org/10.1371/journal.pone.0053253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555553	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500001
J	Babur, BK; Ghanavi, P; Levett, P; Lott, WB; Klein, T; Cooper-White, JJ; Crawford, R; Doran, MR				Babur, Betul Kul; Ghanavi, Parisa; Levett, Peter; Lott, William B.; Klein, Travis; Cooper-White, Justin J.; Crawford, Ross; Doran, Michael R.			The Interplay between Chondrocyte Redifferentiation Pellet Size and Oxygen Concentration	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; MICROCARRIERS ENHANCES REDIFFERENTIATION; FORMATION IN-VITRO; HYALURONIC-ACID; CARTILAGE DEFECTS; STROMAL CELLS; KNEE; IMPLANTATION; CULTURES	Chondrocytes dedifferentiate during ex vivo expansion on 2-dimensional surfaces. Aggregation of the expanded cells into 3-dimensional pellets, in the presence of induction factors, facilitates their redifferentiation and restoration of the chondrogenic phenotype. Typically 1x10(5)-5x10(5) chondrocytes are aggregated, resulting in "macro" pellets having diameters ranging from 1-2 mm. These macropellets are commonly used to study redifferentiation, and recently macropellets of autologous chondrocytes have been implanted directly into articular cartilage defects to facilitate their repair. However, diffusion of metabolites over the 1-2 mm pellet length-scales is inefficient, resulting in radial tissue heterogeneity. Herein we demonstrate that the aggregation of 2x10(5) human chondrocytes into micropellets of 166 cells each, rather than into larger single macropellets, enhances chondrogenic redifferentiation. In this study, we describe the development of a cost effective fabrication strategy to manufacture a microwell surface for the large-scale production of micropellets. The thousands of micropellets were manufactured using the microwell platform, which is an array of 360x360 mu m microwells cast into polydimethylsiloxane (PDMS), that has been surface modified with an electrostatic multilayer of hyaluronic acid and chitosan to enhance micropellet formation. Such surface modification was essential to prevent chondrocyte spreading on the PDMS. Sulfated glycosaminoglycan (sGAG) production and collagen II gene expression in chondrocyte micropellets increased significantly relative to macropellet controls, and redifferentiation was enhanced in both macro and micropellets with the provision of a hypoxic atmosphere (2% O-2). Once micropellet formation had been optimized, we demonstrated that micropellets could be assembled into larger cartilage tissues. Our results indicate that micropellet amalgamation efficiency is inversely related to the time cultured as discreet microtissues. In summary, we describe a micropellet production platform that represents an efficient tool for studying chondrocyte redifferentiation and demonstrate that the micropellets could be assembled into larger tissues, potentially useful in cartilage defect repair.	[Babur, Betul Kul; Ghanavi, Parisa; Lott, William B.; Doran, Michael R.] Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia; [Babur, Betul Kul; Ghanavi, Parisa; Lott, William B.; Doran, Michael R.] Translat Res Inst, Brisbane, Qld, Australia; [Levett, Peter; Klein, Travis; Crawford, Ross] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld, Australia; [Doran, Michael R.] Mater Med Res Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland; Mater Research	Doran, MR (corresponding author), Queensland Univ Technol, Fac Hlth, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.	michael.doran@qut.edu.au	Klein, Travis/J-1117-2012; Lott, William/J-1062-2012	Klein, Travis/0000-0002-6669-7766; Lott, William/0000-0001-7118-7560; Crawford, Ross/0000-0001-6079-1316; Cooper-White, Justin/0000-0002-1920-8229; Doran, Michael/0000-0001-5876-4757	Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies	Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies	This study was funded by the Australian National Health and Medical Research Council (NHMRC), Perpetual Philanthropies, and a generous donation from Mr. James Carruthers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderer U, 2002, J BONE MINER RES, V17, P1420, DOI 10.1359/jbmr.2002.17.8.1420; Banu N, 2007, J BIOMED MATER RES A, V80A, P257, DOI 10.1002/jbm.a.30931; Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Boeuf S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt31; Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cameron HU, 1997, CAN J SURG, V40, P114; Cao Z, 2012, BIOTECHNOL LETT, V34, P1151, DOI 10.1007/s10529-012-0884-9; Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021; Cherubino P, 2003, J Orthop Surg (Hong Kong), V11, P10; Cook MM, 2012, TISSUE ENG PART C-ME, V18, P319, DOI [10.1089/ten.tec.2011.0159, 10.1089/ten.TEC.2011.0159]; Coyle CH, 2009, J ORTHOP RES, V27, P793, DOI 10.1002/jor.20816; Croucher LJ, 2000, BBA-MOL BASIS DIS, V1502, P297, DOI 10.1016/S0925-4439(00)00055-7; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Doran MR, 2010, TISSUE ENG PART C-ME, V16, P407, DOI [10.1089/ten.tec.2009.0367, 10.1089/ten.TEC.2009.0367]; Doran MR, 2010, BIOMATERIALS, V31, P5137, DOI 10.1016/j.biomaterials.2010.03.015; Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]; Fu YQ, 2009, J VAC SCI TECHNOL B, V27, P1520, DOI 10.1116/1.3065991; Gillogly SD, 1998, J ORTHOP SPORT PHYS, V28, P241, DOI 10.2519/jospt.1998.28.4.241; Giovannini S, 2010, EUR CELLS MATER, V20, P245; Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154; Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008; Haasper C, 2009, KNEE SURG SPORT TR A, V17, P1384, DOI 10.1007/s00167-009-0791-3; Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Hsieh-Bonassera ND, 2009, TISSUE ENG PT A, V15, P3513, DOI [10.1089/ten.tea.2008.0628, 10.1089/ten.TEA.2008.0628]; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Kabiri M, 2012, BIOCHEM BIOPH RES CO, V419, P142, DOI 10.1016/j.bbrc.2012.01.017; Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI 10.1089/ten.TEB.2008.0563; Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256; Liebman J., 2001, CURRENT PROTOCOLS PH; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lutzner J, 2009, NAT REV RHEUMATOL, V5, P309, DOI 10.1038/nrrheum.2009.88; Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9; Malda J, 2003, TISSUE ENG, V9, P939, DOI 10.1089/107632703322495583; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Perrot S, 1996, DRUGS, V52, P21, DOI 10.2165/00003495-199600523-00005; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Siebold R, 2011, KNEE SURG SPORT TR A, V19, P2036, DOI 10.1007/s00167-011-1505-1; Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004; Tan GK, 2010, BIOMATERIALS, V31, P6104, DOI 10.1016/j.biomaterials.2010.04.018; Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117; Teixeira LSM, 2012, EUR CELLS MATER, V23, P387, DOI 10.22203/eCM.v023a30; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Van Assche D, 2010, KNEE SURG SPORT TR A, V18, P486, DOI 10.1007/s00167-009-0955-1; Vavken P, 2010, OSTEOARTHR CARTILAGE, V18, P857, DOI 10.1016/j.joca.2010.03.005; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yen CN, 2008, BIOTECHNOL PROGR, V24, P452, DOI 10.1021/bp0702828	50	59	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58865	10.1371/journal.pone.0058865	http://dx.doi.org/10.1371/journal.pone.0058865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554943	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800039
J	Huette, S; Kello, CT; Rhodes, T; Spivey, MJ				Huette, Stephanie; Kello, Christopher T.; Rhodes, Theo; Spivey, Michael J.			Drawing from Memory: Hand-Eye Coordination at Multiple Scales	PLOS ONE			English	Article							VISUAL-IMAGERY; MOVEMENTS	Eyes move to gather visual information for the purpose of guiding behavior. This guidance takes the form of perceptual-motor interactions on short timescales for behaviors like locomotion and hand-eye coordination. More complex behaviors require perceptual-motor interactions on longer timescales mediated by memory, such as navigation, or designing and building artifacts. In the present study, the task of sketching images of natural scenes from memory was used to examine and compare perceptual-motor interactions on shorter and longer timescales. Eye and pen trajectories were found to be coordinated in time on shorter timescales during drawing, and also on longer timescales spanning study and drawing periods. The latter type of coordination was found by developing a purely spatial analysis that yielded measures of similarity between images, eye trajectories, and pen trajectories. These results challenge the notion that coordination only unfolds on short timescales. Rather, the task of drawing from memory evokes perceptual-motor encodings of visual images that preserve coarse-grained spatial information over relatively long timescales as well.	[Huette, Stephanie; Kello, Christopher T.; Spivey, Michael J.] Univ Calif Merced, Merced, CA 95340 USA; [Rhodes, Theo] SUNY Coll Oswego, Dept Psychol, Oswego, NY 13126 USA	University of California System; University of California Merced; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego	Huette, S (corresponding author), Univ Calif Merced, Merced, CA 95340 USA.	shuette@ucmerced.edu			NSF [1031903]	NSF(National Science Foundation (NSF))	This work was supported by NSF award 1031903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aks D.J., 2002, NONLINEAR DYNAMICS P, V6, P1, DOI 10.1023/A:1012222601935; ALLAN DW, 1966, PR INST ELECTR ELECT, V54, P221, DOI 10.1109/PROC.1966.4634; ANTROBUS JS, 1964, J ABNORM SOC PSYCH, V69, P244, DOI 10.1037/h0041846; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; Cagli RC, 2008, IEEE INT CONF ROBOT, P1582; Cagli RC, 2007, LECT NOTES COMPUT SC, V4729, P161; Coen-Cagli R, 2009, VISION RES, V49, P810, DOI 10.1016/j.visres.2009.02.016; FINKE RA, 1983, J EXP PSYCHOL LEARN, V9, P398, DOI 10.1037/0278-7393.9.3.398; Foulsham T, 2012, J EXPT PSYCHOL GEN; Gibson JJ, 1979, ECOLOGICAL APPROACH, Vxiv; Gowen E, 2006, HUM MOVEMENT SCI, V25, P568, DOI 10.1016/j.humov.2006.06.005; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hayhoe M., 2003, J VISION, V3; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land M., 2009, LOOKING ACTING VISIO; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Shelhamer M, 2003, J NEUROPHYSIOL, V90, P2763, DOI 10.1152/jn.00478.2003; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Struzik ZR, 1999, LECT NOTES ARTIF INT, V1704, P12; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; ZIKMUND V, 1966, STUD PSYCHOL, V8, P254	32	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58464	10.1371/journal.pone.0058464	http://dx.doi.org/10.1371/journal.pone.0058464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZC	23554894	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800016
J	Jensen, HA; Styskal, LE; Tasseff, R; Bunaciu, RP; Congleton, J; Varner, JD; Yen, A				Jensen, Holly A.; Styskal, Lauren E.; Tasseff, Ryan; Bunaciu, Rodica P.; Congleton, Johanna; Varner, Jeffrey D.; Yen, Andrew			The Src-Family Kinase Inhibitor PP2 Rescues Inducible Differentiation Events in Emergent Retinoic Acid-Resistant Myeloblastic Leukemia Cells	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; LIGAND-BINDING DOMAIN; HL-60 CELLS; PHOSPHORYLATION SITES; MYELOID-LEUKEMIA; RECEPTOR-ALPHA; PROTEIN-KINASE; RAF-1 KINASE; C-RAF; ACTIVATION	Retinoic acid is an embryonic morphogen and dietary factor that demonstrates chemotherapeutic efficacy in inducing maturation in leukemia cells. Using HL60 model human myeloid leukemia cells, where all-trans retinoic acid (RA) induces granulocytic differentiation, we developed two emergent RA-resistant HL60 cell lines which are characterized by loss of RA-inducible G1/G0 arrest, CD11b expression, inducible oxidative metabolism and p47(phox) expression. However, RA-treated RA-resistant HL60 continue to exhibit sustained MEK/ERK activation, and one of the two sequentially emergent resistant lines retains RA-inducible CD38 expression. Other signaling events that define the wild-type (WT) response are compromised, including c-Raf phosphorylation and increased expression of c-Cbl, Vav1, and the Src-family kinases (SFKs) Lyn and Fgr. As shown previously in WT HL60 cells, we found that the SFK inhibitor PP2 significantly increases G1/G0 cell cycle arrest, CD38 and CD11b expression, c-Raf phosphorylation and expression of the aforementioned regulators in RA-resistant HL60. The resistant cells were potentially incapable of developing inducible oxidative metabolism. These results motivate the concept that RA resistance can occur in steps, wherein growth arrest and other differentiation events may be recovered in both emergent lines. Investigating the mechanistic anomalies in resistant cell lines is of therapeutic significance and helps to mechanistically understand the response to retinoic acid's biological effects in WT HL60 cells.	[Jensen, Holly A.; Tasseff, Ryan; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA; [Styskal, Lauren E.] Cornell Univ, Dept Biol Engn, Ithaca, NY USA; [Bunaciu, Rodica P.; Congleton, Johanna; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA	Cornell University; Cornell University; Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	National Institutes of Health (NIH) [CA033505, CA152870]; NYSTEM New York State Department of Health; National Science Foundation CAREER (NSF) [CBET-0846876]; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0846876] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM New York State Department of Health; National Science Foundation CAREER (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the National Institutes of Health (NIH) (R01 # CA033505 and CA152870) and a NYSTEM New York State Department of Health grant to Andrew Yen. The authors acknowledge the gracious financial support of the National Science Foundation CAREER (NSF # CBET-0846876) to Jeffrey Varner for support of H.A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bertagnolo V, 2004, CELL SIGNAL, V16, P423, DOI 10.1016/j.cellsig.2003.09.013; Bertagnolo V, 2005, EXP CELL RES, V306, P56, DOI 10.1016/j.yexcr.2004.12.001; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; COLLINS SJ, 1987, BLOOD, V70, P1233; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; DE LUCA LM, 1991, FASEB J, V5, P2924; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dore BT, 1996, LEUKEMIA RES, V20, P761, DOI 10.1016/0145-2126(96)00043-4; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FONTANA JA, 1981, P NATL ACAD SCI-BIOL, V78, P3863, DOI 10.1073/pnas.78.6.3863; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Kobayashi T, 2001, REDOX REP, V6, P27, DOI 10.1179/135100001101536003; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Lee M, 2004, J BIOL CHEM, V279, P48692, DOI 10.1074/jbc.M403132200; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; Li ZP, 2006, BIOCHEM BIOPH RES CO, V341, P363, DOI 10.1016/j.bbrc.2005.12.193; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mehta K, 1997, BLOOD, V89, P3607, DOI 10.1182/blood.V89.10.3607.3607_3607_3614; Miranda MB, 2007, MOL CANCER THER, V6, P3081, DOI 10.1158/1535-7163.MCT-07-0514; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Opavsky MA, 2002, J CLIN INVEST, V109, P1561, DOI 10.1172/JCI200213971; Pandolfi PP, 2007, ACUTE PROMYELOCYTIC; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; ROBERTSON KA, 1992, BLOOD, V80, P1885; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Yamaguchi K, 2005, CANCER CHEMOTH PHARM, V56, P585, DOI 10.1007/s00280-005-1030-3; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; YEN A, 1987, CANCER RES, V47, P129; Yen A, 1998, CANCER RES, V58, P3163; Zumaquero E, 2010, EXP CELL RES, V316, P2692, DOI 10.1016/j.yexcr.2010.05.032	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58621	10.1371/journal.pone.0058621	http://dx.doi.org/10.1371/journal.pone.0058621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554907	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800020
J	Mayo, C; de los Santos, LF; Kruse, J; Blackwell, CR; McLemore, LB; Pafundi, D; Stoker, J; Herman, M				Mayo, Charles; de los Santos, Luis Fong; Kruse, Jon; Blackwell, Charles R.; McLemore, Luke B.; Pafundi, Deanna; Stoker, Joshua; Herman, Michael			Report on Use of a Methodology for Commissioning and Quality Assurance of a VMAT System	PLOS ONE			English	Article							PASSING RATES; RAPIDARC; QA; DOSIMETRY; DELIVERY	Introduction: Results of use of methodology for VMAT commissioning and quality assurance, utilizing both control point tests and dosimetric measurements are presented. Methods and Materials: A generalizable, phantom measurement approach is used to characterize the accuracy of the measurement system. Correction for angular response of the measurement system and inclusion of couch structures are used to characterize the full range gantry angles desirable for clinical plans. A dose based daily QA measurement approach is defined. Results: Agreement in the static vs. VMAT picket fence control point test was better than 0.5 mm. Control point tests varying gantry rotation speed, leaf speed and dose rate, demonstrated agreement with predicted values better than 1%. Angular dependence of the MatriXX array, varied over a range of 0.94-1.06, with respect to the calibration condition. Phantom measurements demonstrated central axis dose accuracy for un-modulated four field box plans was >= 2.5% vs. 1% with and without angular correction respectively with better results for VMAT (0.4%) vs. IMRT (1.6%) plans. Daily QA results demonstrated average agreement all three chambers within 0.4% over 9 month period with no false positives at a 3% threshold. Discussion: The methodology described is simple in design and characterizes both the inherit limitations of the measurement system as well at the dose based measurements that may be directly related to patient plan QA.	[Mayo, Charles; de los Santos, Luis Fong; Kruse, Jon; Blackwell, Charles R.; McLemore, Luke B.; Pafundi, Deanna; Stoker, Joshua; Herman, Michael] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	Mayo Clinic	Mayo, C (corresponding author), Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA.	mayo.charles@mayo.edu		Stoker, Joshua/0000-0002-0486-1495				Bedford JL, 2009, INT J RADIAT ONCOL, V73, P537, DOI 10.1016/j.ijrobp.2008.08.055; Chandraraj V, 2011, J APPL CLIN MED PHYS, V12, P338, DOI 10.1120/jacmp.v12i2.3367; Clivio A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-129; Dobler B, 2011, RADIOTHER ONCOL, V99, P86, DOI 10.1016/j.radonc.2011.01.024; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Gloi AM, 2011, J APPL CLIN MED PHYS, V12, P39, DOI 10.1120/jacmp.v12i2.3251; Iftimia I, 2010, J APPL CLIN MED PHYS, V11, P130, DOI 10.1120/jacmp.v11i4.3164; Klein EE, 2009, MED PHYS, V36, P4197, DOI 10.1118/1.3190392; Kruse JJ, 2010, MED PHYS, V37, P2516, DOI 10.1118/1.3425781; Ling CC, 2008, INT J RADIAT ONCOL, V72, P575, DOI 10.1016/j.ijrobp.2008.05.060; Masi L, 2011, MED PHYS, V38, P612, DOI 10.1118/1.3533900; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Palta JR, 2003, INTENSITY MODULATED, V29, P593; Van Esch A, 2011, MED PHYS, V38, P5146, DOI 10.1118/1.3622672; Zhen HM, 2011, MED PHYS, V38, P5477, DOI 10.1118/1.3633904	15	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58877	10.1371/journal.pone.0058877	http://dx.doi.org/10.1371/journal.pone.0058877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554948	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800042
J	Nayak, RC; Keshava, S; Esmon, CT; Pendurthi, UR; Rao, LVM				Nayak, Ramesh C.; Keshava, Shiva; Esmon, Charles T.; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Rab GTPases Regulate Endothelial Cell Protein C Receptor-Mediated Endocytosis and Trafficking of Factor VIIa	PLOS ONE			English	Article							RECYCLING ENDOSOME; PATHWAY; BINDING; FUSION; COMPARTMENT; INHIBITION; DISEASE; GTP	Recent studies have established that factor VIIa (FVIIa) binds to the endothelial cell protein C receptor (EPCR). FVIIa binding to EPCR may promote the endocytosis of this receptor/ligand complex. Rab GTPases are known to play a crucial role in the endocytic and exocytic pathways of receptors or receptor/ligand complexes. The present study was undertaken to investigate the role of Rab GTPases in the intracellular trafficking of EPCR and FVIIa. CHO-EPCR cells and human umbilical vein endothelial cells (HUVEC) were transduced with recombinant adenoviral vectors to express wild-type, constitutively active, or dominant negative mutant of various Rab GTPases. Cells were exposed to FVIIa conjugated with AF488 fluorescent probe (AF488-FVIIa), and intracellular trafficking of FVIIa, EPCR, and Rab proteins was evaluated by immunofluorescence confocal microscopy. In cells expressing wild-type or constitutively active Rab4A, internalized AF488-FVIIa accumulated in early/sorting endosomes and its entry into the recycling endosomal compartment (REC) was inhibited. Expression of constitutively active Rab5A induced large endosomal structures beneath the plasma membrane where EPCR and FVIIa accumulated. Dominant negative Rab5A inhibited the endocytosis of EPCR-FVIIa. Expression of constitutively active Rab11 resulted in retention of accumulated AF488-FVIIa in the REC, whereas expression of a dominant negative form of Rab11 led to accumulation of internalized FVIIa in the cytoplasm and prevented entry of internalized FVIIa into the REC. Expression of dominant negative Rab11 also inhibited the transport of FVIIa across the endothelium. Overall our data show that Rab GTPases regulate the internalization and intracellular trafficking of EPCR-FVIIa.	[Nayak, Ramesh C.; Keshava, Shiva; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma Med Res Fdn, Coagulat Biol Lab, Oklahoma City, OK USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Rao, LVM (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Vijay.Rao@uthct.edu		Nayak, Ramesh/0000-0002-3206-8152	National Institutes of Health [HL58869, HL107483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107483, R01HL058869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL58869 and HL107483 to LVMR from the National Institutes of Health. CTE is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Clark CA, 2012, J THROMB HAEMOST, V10, P2383, DOI 10.1111/j.1538-7836.2012.04917.x; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Etzion S, 2010, J MOL CELL CARDIOL, V49, P931, DOI 10.1016/j.yjmcc.2010.08.011; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Ginsberg SD, 2010, J ALZHEIMERS DIS, V22, P631, DOI 10.3233/JAD-2010-101080; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Hou QS, 2008, CANCER RES, V68, P4623, DOI 10.1158/0008-5472.CAN-07-5870; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Laszik Z, 1997, CIRCULATION, V96, P3633; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; LI GP, 1993, J BIOL CHEM, V268, P24475; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; MERESSE S, 1995, J CELL SCI, V108, P3349; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Regan LM, 1996, J BIOL CHEM, V271, P17499, DOI 10.1074/jbc.271.29.17499; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roberts RL, 1999, J CELL SCI, V112, P3667; Rosenfeld JL, 2002, RECEPTOR CHANNEL, V8, P87, DOI 10.1080/10606820212398; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sen P, 2011, BLOOD, V118, P2635, DOI 10.1182/blood-2011-05-354571; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	42	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59304	10.1371/journal.pone.0059304	http://dx.doi.org/10.1371/journal.pone.0059304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555015	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800083
J	Blanken, MO; Koffijberg, H; Nibbelke, EE; Rovers, MM; Bont, L				Blanken, Maarten O.; Koffijberg, Hendrik; Nibbelke, Elisabeth E.; Rovers, Maroeska M.; Bont, Louis		Dutch RSV Neonatal Network	Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study	PLOS ONE			English	Article							WEEKS GESTATIONAL-AGE; 35 COMPLETED WEEKS; RISK-SCORING TOOL; PREMATURE-INFANTS; COST-EFFECTIVENESS; PREDICT HOSPITALIZATION; YOUNG-CHILDREN; INFECTION; PROPHYLAXIS; BORN	Objectives: This study aimed to update and validate a prediction rule for respiratory syncytial virus (RSV) hospitalization in preterm infants 33-35 weeks gestational age (WGA). Study Design: The RISK study consisted of 2 multicenter prospective birth cohorts in 41 hospitals. Risk factors were assessed at birth among healthy preterm infants 33-35 WGA. All hospitalizations for respiratory tract infection were screened for proven RSV infection by immunofluorescence or polymerase chain reaction. Multivariate logistic regression analysis was used to update an existing prediction model in the derivation cohort (n = 1,227). In the validation cohort (n = 1,194), predicted versus actual RSV hospitalization rates were compared to determine validity of the model. Results: RSV hospitalization risk in both cohorts was comparable (5.7% versus 4.9%). In the derivation cohort, a prediction rule to determine probability of RSV hospitalization was developed using 4 predictors: family atopy (OR 1.9; 95% CI, 1.1-3.2), birth period (OR 2.6; 1.6-4.2), breastfeeding (OR 1.7; 1.0-2.7) and siblings or daycare attendance (OR 4.7; 1.7-13.1). The model showed good discrimination (c-statistic 0.703; 0.64-0.76, 0.702 after bootstrapping). External validation showed good discrimination and calibration (c-statistic 0.678; 0.61-0.74). Conclusions: Our prospectively validated prediction rule identifies infants at increased RSV hospitalization risk, who may benefit from targeted preventive interventions. This prediction rule can facilitate country-specific, cost-effective use of RSV prophylaxis in late preterm infants.	[Blanken, Maarten O.; Nibbelke, Elisabeth E.; Bont, Louis] Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands; [Koffijberg, Hendrik] Univ Med Ctr, Dept Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol, Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen Med Ctr, Dept Biostat & HTA, Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen Med Ctr, Dept Operating Rooms, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bont, L (corresponding author), Univ Med Ctr, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands.	l.bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Blanken, Maarten O./0000-0003-4065-7368; Koffijberg, Hendrik/0000-0002-1753-0652	Abbott; Netherlands Organization for Health Research and Development (ZonMw), NWO-AGIKO [920-035-89]; Abbott International	Abbott(Abbott Laboratories); Netherlands Organization for Health Research and Development (ZonMw), NWO-AGIKO; Abbott International(Abbott Laboratories)	This investigator driven study was funded by Abbott. This study is an investigator driven study, which means generation of the study hypothesis, study design, data collection, analysis and interpretation, decision to publish and the preparation of the manuscript were performed independently by the researchers. No honorarium, grant or other form of payment was given to anyone to produce the manuscript. Netherlands Organization for Health Research and Development (ZonMw), NWO-AGIKO grant 920-035-89 (M.O. Blanken). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This investigator driven study was funded by Abbott. Dr. Bont has received fees for lectures and advisory activities from Abbott International; the other authors indicated they have no financial relationships relevant to this article to disclose. The authors hereby state they have no Abbott employment or consultancy to declare and no patents, products in development or marketed products related to Abbott to disclose. The authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Bos JM, 2007, VACCINE, V25, P6922, DOI 10.1016/j.vaccine.2007.07.006; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Carbonell-Estrany Xavier, 2004, Pediatr Infect Dis J, V23, pS193, DOI 10.1097/01.inf.0000144664.31888.53; Carbonell-Estrany X, 2010, J PERINAT MED, V38, P411, DOI [10.1515/JPM.2010.074, 10.1515/jpm.2010.074]; Carbonell-Estrany Xavier, 2009, Paediatr Respir Rev, V10 Suppl 1, P12, DOI 10.1016/S1526-0542(09)70006-5; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Doering G, 2006, PEDIATR INFECT DIS J, V25, P1188, DOI 10.1097/01.inf.0000246978.58565.b5; ElHassan NO, 2006, ARCH PEDIAT ADOL MED, V160, P1070, DOI 10.1001/archpedi.160.10.1070; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Ferrero F, 2012, PEDIATR INFECT DIS J, V31, P628, DOI 10.1097/INF.0b013e31825670f2; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houben ML, 2011, PEDIATRICS, V127, P35, DOI 10.1542/peds.2010-0581; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; Krilov LR, 2009, PEDIATRICS, V124, P1682, DOI 10.1542/peds.2009-2681; Lanari M, 2002, PEDIATR PULM, V33, P458, DOI 10.1002/ppul.10047; Lanctot KL, 2008, CURR MED RES OPIN, V24, P3223, DOI [10.1185/03007990802484234, 10.1185/03007990802484234 ]; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Lenney W, 2009, EUR RESPIR J, V34, P531, DOI 10.1183/09031936.00166508; Meissner HC, 2009, PEDIATRICS, V124, P1676, DOI 10.1542/peds.2009-2346; Nuijten M, 2009, J MED EC; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Paes B, 2009, CURR MED RES OPIN, V25, P1585, DOI 10.1185/03007990902929112; Prescott WA, 2010, PHARMACOECONOMICS, V28, P279, DOI 10.2165/11531860-000000000-00000; Resch B, 2012, PEDIATR INFECT DIS J, V31, pE1, DOI 10.1097/INF.0b013e318235455b; Rietveld E, 2004, PEDIATR INFECT DIS J, V23, P523, DOI 10.1097/01.inf.0000129690.35341.8d; Sampalis JS, 2008, MED DECIS MAKING, V28, P471, DOI 10.1177/0272989X08315238; Simoes EAF, 2011, J MATERN-FETAL NEO M, V24, P152, DOI 10.3109/14767058.2010.482610; Simoes EAF, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-78; Sinha A, 2003, PEDIATRICS, V112, pE303, DOI 10.1542/peds.112.4.e303; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Stensballe LG, 2010, PEDIATR INFECT DIS J, V29, P374, DOI 10.1097/INF.0b013e3181c810da; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2006, J CLIN ONCOL, V24, P4277, DOI 10.1200/JCO.2005.05.0658; Wang D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15050; Wang D, 2008, HLTH TECHNOL ASSESS, V12; Weisman LE, 2003, PEDIATR INFECT DIS J, V22, pS33, DOI 10.1097/00006454-200302001-00005; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0	42	41	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59161	10.1371/journal.pone.0059161	http://dx.doi.org/10.1371/journal.pone.0059161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554987	gold, Green Published			2022-12-27	WOS:000316252500071
J	Messner, B; Kern, J; Wiedemann, D; Schwaiger, S; Turkcan, A; Ploner, C; Trockenbacher, A; Aumayr, K; Bonaros, N; Laufer, G; Stuppner, H; Untergasser, G; Bernhard, D				Messner, Barbara; Kern, Johann; Wiedemann, Dominik; Schwaiger, Stefan; Tuerkcan, Adrian; Ploner, Christian; Trockenbacher, Alexander; Aumayr, Klaus; Bonaros, Nikolaos; Laufer, Guenther; Stuppner, Hermann; Untergasser, Gerold; Bernhard, David			5-Methoxyleoligin, a Lignan from Edelweiss, Stimulates CYP26B1-Dependent Angiogenesis In Vitro and Induces Arteriogenesis in Infarcted Rat Hearts In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR; LEONTOPODIUM-ALPINUM; INTIMAL HYPERPLASIA; MAJOR LIGNAN; MECHANISMS; LEOLIGIN; CADMIUM	Background: Insufficient angiogenesis and arteriogenesis in cardiac tissue after myocardial infarction (MI) is a significant factor hampering the functional recovery of the heart. To overcome this problem we screened for compounds capable of stimulating angiogenesis, and herein investigate the most active molecule, 5-Methoxyleoligin (5ML), in detail. Methods and Results: 5ML potently stimulated endothelial tube formation, angiogenic sprouting, and angiogenesis in a chicken chorioallantoic membrane assay. Further, microarray- and knock down-based analyses revealed that 5ML induces angiogenesis by upregulation of CYP26B1. In an in vivo rat MI model 5ML potently increased the number of arterioles in the peri-infarction and infarction area, reduced myocardial muscle loss, and led to a significant increase in LV function (plus 21% 28 days after MI). Conclusion: The present study shows that 5ML induces CYP26B1-dependent angiogenesis in vitro, and arteriogenesis in vivo. Whether or not CYP26B1 is relevant for in vivo arteriogenesis is not clear at the moment. Importantly, 5ML-induced arteriogenesis in vivo makes the compound even more interesting for a post MI therapy. 5ML may constitute the first low molecular weight compound leading to an improvement of myocardial function after MI.	[Messner, Barbara; Wiedemann, Dominik; Tuerkcan, Adrian; Laufer, Guenther; Bernhard, David] Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria; [Kern, Johann; Untergasser, Gerold] Med Univ Innsbruck, Div Internal Med 5, A-6020 Innsbruck, Austria; [Wiedemann, Dominik; Bonaros, Nikolaos; Bernhard, David] Med Univ Innsbruck, Cardiac Surg Res Lab, Dept Cardiac Surg, A-6020 Innsbruck, Austria; [Schwaiger, Stefan; Stuppner, Hermann] Univ Innsbruck, Inst Pharm Pharmacognosy, A-6020 Innsbruck, Austria; [Ploner, Christian] Med Univ Innsbruck, Dept Plast & Reconstruct Surg, A-6020 Innsbruck, Austria; [Trockenbacher, Alexander] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Aumayr, Klaus] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; Medical University of Innsbruck; Medical University of Innsbruck; University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna	Bernhard, D (corresponding author), Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria.	David.Bernhard@i-med.ac.at	Messner, Barbara/GLS-8150-2022; Bonaros, Nikolaos/N-7236-2017; Wiedemann, Dominik/AAH-2649-2020; Schwaiger, Stefan/W-8296-2019	Messner, Barbara/0000-0001-8331-6497; Bonaros, Nikolaos/0000-0002-7656-5812; Wiedemann, Dominik/0000-0002-2055-8293; Schwaiger, Stefan/0000-0002-3731-7349; Bernhard, David/0000-0002-2383-6607; Ploner, Christian/0000-0002-0313-2960; Turkcan, Adrian/0000-0002-9750-1690	TWF ("Tiroler Zukunftsstiftung"); Austrain Science Fund (FWF) [DNTI S10703]; Austrian National Bank [14745, 14590]	TWF ("Tiroler Zukunftsstiftung"); Austrain Science Fund (FWF); Austrian National Bank	This project was supported by the TWF ("Tiroler Zukunftsstiftung"), the Austrain Science Fund (FWF; DNTI S10703, the Austrian National Bank Project 14745 to D. B. and also by the Austrian National Bank Project 14590 to B. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhard D, 2006, ARTERIOSCL THROM VAS, V26, P833, DOI 10.1161/01.ATV.0000205616.70614.e5; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; Coats AJS, 2011, INT J CARDIOL, V153, P239, DOI 10.1016/j.ijcard.2011.10.119; Dobner MJ, 2004, PLANTA MED, V70, P502, DOI 10.1055/s-2004-827148; Duwensee K, 2011, ATHEROSCLEROSIS, V219, P109, DOI 10.1016/j.atherosclerosis.2011.07.023; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Henderson B, 2008, ATHEROSCLEROSIS, V201, P298, DOI 10.1016/j.atherosclerosis.2008.02.022; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Korff T, 1999, J CELL SCI, V112, P3249; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Pieske B, 2004, EUR HEART J SUPPL, V6, pD66, DOI 10.1016/j.ehjsup.2004.05.019; Reisinger U, 2009, CARDIOVASC RES, V82, P542, DOI 10.1093/cvr/cvp059; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SASAYAMA S, 1992, CIRCULATION, V85, P1197, DOI 10.1161/01.CIR.85.3.1197; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schwaiger S, 2004, PLANTA MED, V70, P978, DOI 10.1055/s-2004-832625; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zeller I, 2010, ARTERIOSCL THROM VAS, V30, P1733, DOI 10.1161/ATVBAHA.110.211011	29	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58342	10.1371/journal.pone.0058342	http://dx.doi.org/10.1371/journal.pone.0058342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554885	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500021
J	Moore, HM; Bai, BY; Matilainen, O; Colis, L; Peltonen, K; Laiho, M				Moore, Henna M.; Bai, Baoyan; Matilainen, Olli; Colis, Laureen; Peltonen, Karita; Laiho, Marikki			Proteasome Activity Influences UV-Mediated Subnuclear Localization Changes of NPM	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; RIBOSOMAL-PROTEINS; UBIQUITIN; NUCLEOLUS; P53; BIOGENESIS; DAMAGE; RECOGNITION; DEGRADATION; COMPONENTS	UV damage activates cellular stress signaling pathways, causes DNA helix distortions and inhibits transcription by RNA polymerases I and II. In particular, the nucleolus, which is the site of RNA polymerase I transcription and ribosome biogenesis, disintegrates following UV damage. The disintegration is characterized by reorganization of the subnucleolar structures and change of localization of many nucleolar proteins. Here we have queried the basis of localization change of nucleophosmin (NPM), a nucleolar granular component protein, which is increasingly detected in the nucleoplasm following UV radiation. Using photobleaching experiments of NPM-fluorescent fusion protein in live human cells we show that NPM mobility increases after UV damage. However, we show that the increase in NPM nucleoplasmic abundance after UV is independent of UV-activated cellular stress and DNA damage signaling pathways. Unexpectedly, we find that proteasome activity affects NPM redistribution. NPM nucleolar expression was maintained when the UV-treated cells were exposed to proteasome inhibitors or when the expression of proteasome subunits was inhibited using RNAi. However, there was no evidence of increased NPM turnover in the UV damaged cells, or that ubiquitin or ubiquitin recycling affected NPM localization. These findings suggest that proteasome activity couples to nucleolar protein localizations in UV damage stress.	[Moore, Henna M.; Matilainen, Olli; Peltonen, Karita; Laiho, Marikki] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland; [Bai, Baoyan; Colis, Laureen; Laiho, Marikki] Johns Hopkins Univ Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Bai, Baoyan; Colis, Laureen; Laiho, Marikki] Johns Hopkins Univ Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA	University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Laiho, M (corresponding author), Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland.	mlaiho1@jhmi.edu		Peltonen, Karita Dolores/0000-0002-3063-451X; Matilainen, Olli/0000-0001-9939-4828	Academy of Finland [251307]; Finnish Cancer Organisations; K. Albin Johanssons stiftelse; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Ida Montin Foundation	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; K. Albin Johanssons stiftelse; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Ida Montin Foundation	This work was funded by Academy of Finland (grant no. 251307), Finnish Cancer Organisations, K. Albin Johanssons stiftelse, Magnus Ehrnrooth Foundation, The Maud Kuistila Memorial Foundation, and The Ida Montin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Bancaud Aurelien, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top90; Beryink S, 2007, DNA REPAIR, V6, P1231, DOI 10.1016/j.dnarep.2007.01.012; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Boyd MT, 2011, J CELL BIOL, V194, P689, DOI 10.1083/jcb.201105143; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Cornish T, 2008, ARCH PATHOL LAB MED, V132, P856; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lo D, 2012, J BIOL CHEM, V287, P10013, DOI 10.1074/jbc.M111.335141; Louvet E, 2005, EXP CELL RES, V304, P457, DOI 10.1016/j.yexcr.2004.11.018; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Scharf A, 2007, HISTOCHEM CELL BIOL, V127, P591, DOI 10.1007/s00418-006-0266-2; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shcherbik Natalia, 2010, Genes Cancer, V1, P681; Stark LA, 2009, EMBO REP, V10, P35, DOI 10.1038/embor.2008.230; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	59	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59096	10.1371/journal.pone.0059096	http://dx.doi.org/10.1371/journal.pone.0059096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554979	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500068
J	Park, MH; Sovio, U; Viner, RM; Hardy, RJ; Kinra, S				Park, Min Hae; Sovio, Ulla; Viner, Russell M.; Hardy, Rebecca J.; Kinra, Sanjay			Overweight in Childhood, Adolescence and Adulthood and Cardiovascular Risk in Later Life: Pooled Analysis of Three British Birth Cohorts	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; FETAL ORIGINS; DISEASE RISK; FOLLOW-UP; OBESITY; WEIGHT; HEALTH; CHILDREN; PROFILE	Background: Overweight and obesity in adulthood are established risk factors for adverse cardiovascular outcomes, but the contribution of overweight in childhood to later cardiovascular risk is less clear. Evidence for a direct effect of childhood overweight would highlight early life as an important target for cardiovascular disease prevention. The aim of this study was to assess whether overweight and obesity in childhood and adolescence contribute to excess cardiovascular risk in adults. Methods and findings: Data from three British birth cohorts, born in 1946, 1958 and 1970, were pooled for analysis (n = 11,447). Individuals were categorised, based on body mass index (BMI), as being of normal weight or overweight/obese in childhood, adolescence and adulthood. Eight patterns of overweight were defined according to weight status at these three stages. Logistic regression models were fitted to assess the associations of patterns of overweight with self-reported type 2 diabetes, hypertension, and coronary heart disease (CHD) in adulthood (34-53 years). Compared to cohort members who were never overweight, those who were obese in adulthood had increased risk of all outcomes. For type 2 diabetes, the odds ratio was higher for obese adults who were also overweight or obese in childhood and adolescence (OR 12.6; 95% CI 6.6 to 24.0) than for those who were obese in adulthood only (OR 5.5; 95% CI 3.4 to 8.8). There was no such effect of child or adolescent overweight on hypertension. For CHD, there was weak evidence of increased risk among those with overweight in childhood. The main limitations of this study concern the use of self-reported outcomes and the generalisability of findings to contemporary child populations. Conclusions: Type 2 diabetes and to a lesser extent CHD risk may be affected by overweight at all stages of life, while hypertension risk is associated more strongly with weight status in adulthood.	[Park, Min Hae; Sovio, Ulla; Kinra, Sanjay] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Viner, Russell M.] UCL Inst Child Hlth, Dept Gen & Adolescent Paediat, London, England; [Hardy, Rebecca J.] UCL, Inst Epidemiol & Hlth Care, MRC, Unit Lifelong Hlth & Ageing, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	Park, MH (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England.	minhae.park@lshtm.ac.uk	Sovio, Ulla/H-8532-2019; Viner, Russell M/A-1441-2009; Park, Min Hi/AAL-9880-2020; Hardy, Rebecca/AFR-1989-2022	Sovio, Ulla/0000-0002-0799-1105; Viner, Russell M/0000-0003-3047-2247; 	ESRC; MRC Unit for Lifelong Health and Ageing, UK; Economic and Research Council, UK; MRC [MC_U123092721, MC_U123092720, G1001799] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC Unit for Lifelong Health and Ageing, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Research Council, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Min Hae Park was funded by an ESRC 1+3 PhD studentship at the time that the research was conducted. The NSHD is funded by the MRC Unit for Lifelong Health and Ageing, UK. The National Child Development Study and the 1970 British Cohort Study are funded by the Economic and Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Forouhi NG, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.01.003; Gatineau M, 2011, OBESITY AND ETHNICIT; Hannon TS, 2005, PEDIATRICS, V116, P473, DOI 10.1542/peds.2004-2536; Hardy R, 2004, INT J EPIDEMIOL, V33, P121, DOI 10.1093/ije/dyh027; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley R, 2006, INT J EPIDEMIOL, V35, P1025, DOI 10.1093/ije/dyl058; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P1405, DOI 10.1093/aje/kwm028; Leveille SG, 2005, AM J PUBLIC HEALTH, V95, P1607, DOI 10.2105/AJPH.2004.060418; Li L, 2007, J HYPERTENS, V25, P1215, DOI 10.1097/HJH.0b013e3280f3c01a; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reinehr T, 2004, PEDIATRICS, V114, P1569, DOI 10.1542/peds.2003-0649-F; Reinehr T, 2006, AM J CLIN NUTR, V84, P490, DOI 10.1093/ajcn/84.3.490; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Tilling K, 2011, INT J EPIDEMIOL, V40, P250, DOI 10.1093/ije/dyq233; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Weiss R, 2005, BEST PRACT RES CL EN, V19, P405, DOI 10.1016/j.beem.2005.04.009; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wills AK, 2010, J HYPERTENS, V28, P679, DOI 10.1097/HJH.0b013e328335de7b; World Health Organization, 2007, ICD 10; World Health Organization, 2006, BMI CLASSIFICATION; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0	39	91	94	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70684	10.1371/journal.pone.0070684	http://dx.doi.org/10.1371/journal.pone.0070684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23555655	Green Published, gold, Green Accepted			2022-12-27	WOS:000322167900138
J	Bell, AV				Bell, Adrian Viliami			Evolutionary Thinking in Microeconomic Models: Prestige Bias and Market Bubbles	PLOS ONE			English	Article							CULTURAL-DIVERSITY; BEHAVIOR; TRANSMISSION	Evolutionary models broadly support a number of social learning strategies likely important in economic behavior. Using a simple model of price dynamics, I show how prestige bias, or copying of famed (and likely successful) individual, influences price equilibria and investor disposition in a way that exacerbates or creates market bubbles. I discuss how integrating the social learning and demographic forces important in cultural evolution with economic models provides a fruitful line of inquiry into real-world behavior.	Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Bell, AV (corresponding author), Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA.	adrian.bell@anthro.utah.edu						Alesina A, 2005, J ECON LIT, V43, P762, DOI 10.1257/002205105774431243; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Asch SE, 1956, PSYCHOL MONOGR, V70, P70; Blanchard OJ, 1982, BUBBLES RATIONAL EXP, P295; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 1993, RATIONALITY IMITATIO, P131; Boyd R, 2009, J THEOR BIOL, V257, P331, DOI 10.1016/j.jtbi.2008.12.007; Calvo GA, 2000, CONTAGION GLOBALIZAT; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Collins P.W., 1965, MAN CULTURE ANIMALS, V78; Dass N, 2008, REV FINANC STUD, V21, P51, DOI 10.1093/rfs/hhm033; DeMarzo PM, 2008, REV FINANC STUD, V21, P19, DOI 10.1093/rfs/hhm032; Edwards S, 2000, WORLD ECON, V23, P873, DOI 10.1111/1467-9701.00307; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Ferraro PJ, 2007, ECON INQ, V45, P217, DOI 10.1111/j.1465-7295.2006.00013.x; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Foley William A., 1986, PAPUAN LANGUAGES NEW; Grin F, 2006, EC CONSIDERATIONS LA; HANNAN MT, 1981, AM SOCIOL REV, V46, P19, DOI 10.2307/2095024; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Horner V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010625; Jones EL, 2000, CASE SHARED WORLD LA; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mitchell WC, 1923, BUSINESS CYDES; Nisbett R., 1996, NEW DIRECTIONS SOCIA; Ostrom E, 2005, UNDERSTANDING INSTITUTIONAL DIVERSITY, P1; Ottaviano GIP, 2006, J ECON GEOGR, V6, P9, DOI 10.1093/jeg/lbi002; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; Richerson PJ., 2005, NOT GENES ALONE CULT; Salamon S, 1984, ETHNIC ORIGIN EXPLAN, V1; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59805	10.1371/journal.pone.0059805	http://dx.doi.org/10.1371/journal.pone.0059805			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544100	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700060
J	Martin, S; Harper, CB; May, LM; Coulson, EJ; Meunier, FA; Osborne, SL				Martin, Sally; Harper, Callista B.; May, Linda M.; Coulson, Elizabeth J.; Meunier, Frederic A.; Osborne, Shona L.			Inhibition of PIKfyve by YM-201636 Dysregulates Autophagy and Leads to Apoptosis-Independent Neuronal Cell Death	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; CAUSES NEURODEGENERATION; ENDOCYTOSED RECEPTORS; NERVOUS-SYSTEM; PROTEIN; MATURATION; PI(3,5)P-2; TRANSPORT; VAC14; MICE	The lipid phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2), synthesised by PIKfyve, regulates a number of intracellular membrane trafficking pathways. Genetic alteration of the PIKfyve complex, leading to even a mild reduction in PtdIns(3,5)P-2 results in marked neurodegeneration via an uncharacterised mechanism. In the present study we have shown that selectively inhibiting PIKfyve activity, using YM-201636, significantly reduces the survival of primary mouse hippocampal neurons in culture. YM-201636 treatment promoted vacuolation of endolysosomal membranes followed by apoptosis-independent cell death. Many vacuoles contained intravacuolar membranes and inclusions reminiscent of autolysosomes. Accordingly, YM-201636 treatment increased the level of the autophagosomal marker protein LC3-II, an effect that was potentiated by inhibition of lysosomal proteases, suggesting that alterations in autophagy could be a contributing factor to neuronal cell death.	[Martin, Sally; Harper, Callista B.; May, Linda M.; Coulson, Elizabeth J.; Meunier, Frederic A.; Osborne, Shona L.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.meunier@uq.edu.au; s.osborne@uq.edu.au	Osborne, Shona/C-8290-2009; Martin, Sally/A-7150-2010; Coulson, Elizabeth J./C-8766-2009; Meunier, Frederic A/C-8161-2009	Martin, Sally/0000-0001-9294-5404; Coulson, Elizabeth J./0000-0003-3783-6197; Meunier, Frederic A/0000-0001-6400-1107; Osborne, Shona/0000-0002-7012-9278	National Health and Medical Research Council Australia [631418]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia (S.L.O grant number 631418). F.A.M. and E.J.C. are Research Fellows of the National Health and Medical Research Council Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2010, J ORG CHEM, V75, P3541, DOI 10.1021/jo100393c; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kajta M, 2006, BRAIN RES, V1116, P64, DOI 10.1016/j.brainres.2006.07.105; Kerr MC, 2010, EMBO J, V29, P1331, DOI 10.1038/emboj.2010.28; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Osborne SL, 2008, J BIOL CHEM, V283, P2804, DOI 10.1074/jbc.M704856200; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2012, AM J PHYSIOL-CELL PH, V303, pC436, DOI 10.1152/ajpcell.00105.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; Tsuruta F, 2009, J CELL BIOL, V187, P279, DOI 10.1083/jcb.200903028; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wen PJ, 2011, PROG LIPID RES, V50, P52, DOI 10.1016/j.plipres.2010.08.001; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zhang YL, 2012, EMBO J, V31, P3442, DOI 10.1038/emboj.2012.200	43	60	62	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60152	10.1371/journal.pone.0060152	http://dx.doi.org/10.1371/journal.pone.0060152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544129	Green Published, gold			2022-12-27	WOS:000317480700088
J	van Raan, AFJ				van Raan, Anthony F. J.			Universities Scale Like Cities	PLOS ONE			English	Article							BIBLIOMETRIC STATISTICAL PROPERTIES; CUMULATIVE ADVANTAGE; SCIENCE; RULES	Recent studies of urban scaling show that important socioeconomic city characteristics such as wealth and innovation capacity exhibit a nonlinear, particularly a power law scaling with population size. These nonlinear effects are common to all cities, with similar power law exponents. These findings mean that the larger the city, the more disproportionally they are places of wealth and innovation. Local properties of cities cause a deviation from the expected behavior as predicted by the power law scaling. In this paper we demonstrate that universities show a similar behavior as cities in the distribution of the 'gross university income' in terms of total number of citations over 'size in terms of total number of publications. Moreover, the power law exponents for university scaling are comparable to those for urban scaling. We find that deviations from the expected behavior can indeed be explained by specific local properties of universities, particularly the field specific composition of a university, and its quality in terms of field normalized citation impact. By studying both the set of the 500 largest universities worldwide and a specific subset of these 500 universities -the top-100 European universities- we are also able to distinguish between properties of universities with as well as without selection of one specific local property, the quality of a university in terms of its average field-normalized citation impact. It also reveals an interesting observation concerning the working of a crucial property in networked systems, preferential attachment.	Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	van Raan, AFJ (corresponding author), Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.	vanraan@cwts.leidenuniv.nl		van Raan, Anthony/0000-0001-8980-5937	Leiden University	Leiden University	This work is part of the institute's research theme Science Systems funded by Leiden University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bonitz M, 2005, SCIENTOMETRICS, V64, P375, DOI 10.1007/s11192-005-0256-5; Jamtveit B, 2009, P NATL ACAD SCI USA, V106, P13160, DOI 10.1073/pnas.0903190106; Katz JS, 2005, MEAS-INTERDISCIP RES, V3, P24, DOI 10.1207/s15366359mea0301_3; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Katz JS., 2000, SCI PUBL POLICY, V27, P23, DOI [DOI 10.3152/147154300781782156, 10.3152/147154300781782156]; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P408, DOI 10.1002/asi.20284; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P565, DOI 10.1002/asi.20765; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P461, DOI 10.1002/asi.20761; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P1919, DOI 10.1002/asi.20389; van Raan AFJ, 2011, SCIENTOMETRICS, V88, P495, DOI 10.1007/s11192-011-0382-1; van Raan T, 2011, NATURE, V469, P34, DOI 10.1038/469034a; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708	22	29	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59384	10.1371/journal.pone.0059384	http://dx.doi.org/10.1371/journal.pone.0059384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544062	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700024
J	Masszi, G; Horvath, EM; Tarszabo, R; Benko, R; Novak, A; Buday, A; Tokes, AM; Nadasy, GL; Hamar, P; Benyo, Z; Varbiro, S				Masszi, Gabriella; Horvath, Eszter Maria; Tarszabo, Robert; Benko, Rita; Novak, Agnes; Buday, Anna; Tokes, Anna-Maria; Nadasy, Gyorgy L.; Hamar, Peter; Benyo, Zoltan; Varbiro, Szabolcs			Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; POLY(ADP-RIBOSE) POLYMERASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; HEART-FAILURE; CELL-DEATH; ACTIVATION; WOMEN; ESTROGEN; INHIBITION	Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism and insulin resistance, both of which have been connected to atherosclerosis. Indeed, an increased risk of clinical manifestations of arterial vascular diseases has been described in PCOS. On the other hand endothelial dysfunction can be detected early on, before atherosclerosis develops. Thus we assumed that vascular dysfunction is also related directly to the hormonal imbalance rather than to its metabolic consequences. To detect early functional changes, we applied a novel rodent model of PCOS: rats were either sham operated or hyperandrogenism was achieved by implanting subcutaneous pellets of dihydrotestosterone (DHT). After ten weeks, myograph measurements were performed on isolated aortic rings. Previously we described an increased contractility to norepinephrine (NE). Here we found a reduced immediate relaxation to estradiol treatment in pre-contracted aortic rings from hyperandrogenic rats. Although the administration of vitamin D-3 along with DHT reduced responsiveness to NE, it did not restore relaxation to estradiol. Poly-(ADP-ribose) polymerase (PARP) activity was assessed by poly-ADP-ribose immunostaining. Increased PAR staining in ovaries and circulating leukocytes from DHT rats showed enhanced DNA damage, which was reduced by concomitant vitamin D-3 treatment. Surprisingly, PAR staining was reduced in both the endothelium and vascular smooth muscle cells of the aorta rings from hyperandrogenic rats. Thus in the early phase of PCOS, vascular tone is already shifted towards vasoconstriction, characterized by reduced vasorelaxation and vascular dysfunction is concomitant with altered PARP activity. Based on our findings, PARP inhibitors might have a future perspective in restoring metabolic disorders in PCOS.	[Masszi, Gabriella; Novak, Agnes] Bajcsy Zsilinszky Hosp, Cardiol Unit, Budapest, Hungary; [Horvath, Eszter Maria; Benko, Rita; Benyo, Zoltan] Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1085 Budapest, Hungary; [Nadasy, Gyorgy L.; Varbiro, Szabolcs] Semmelweis Univ, Dept Obstet Gynecol 32, H-1085 Budapest, Hungary; [Tarszabo, Robert; Buday, Anna; Hamar, Peter] Semmelweis Univ, Dept Pathophysiol, H-1085 Budapest, Hungary; [Tokes, Anna-Maria] Semmelweis Univ, Dept Pathol, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University	Masszi, G (corresponding author), Bajcsy Zsilinszky Hosp, Cardiol Unit, Budapest, Hungary.	gmasszi@bni.hu; varbiroszabolcs@gmail.com	Horvath, Eszter/I-9128-2017; Benko, Rita/I-9646-2017; Tokes, Anna-Maria/S-5713-2017	Horvath, Eszter/0000-0002-0517-1269; Benko, Rita/0000-0001-7740-9128; Tokes, Anna-Maria/0000-0002-9581-7536; Varbiro, Szabolcs/0000-0002-7109-6906; Benyo, Zoltan/0000-0001-6015-0359	European Foundation; Hungarian NIH [ALAP1-01298/2009, K81972, NF69278]; Scientific Healthcare Council (ETT) [427/2009]; Hungarian National Developmental Agency (NFU) [TAMOP 4.2.1/B-09/1/KMR-2010-001]; Hungarian Society of Hypertension; National Grants of the Hungarian Government Fund; Hungarian Academy of Sciences	European Foundation(European Science Foundation (ESF)); Hungarian NIH; Scientific Healthcare Council (ETT); Hungarian National Developmental Agency (NFU); Hungarian Society of Hypertension; National Grants of the Hungarian Government Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by a Servier Grant from the European Foundation for the Study of Diabetes as well as by grants from the Hungarian NIH (ALAP1-01298/2009), Scientific Healthcare Council (ETT) (427/2009) and the Hungarian National Developmental Agency (NFU) (TAMOP 4.2.1/B-09/1/KMR-2010-001). This study was sponsored by a research grant of the Hungarian Society of Hypertension, and National Grants of the Hungarian Government Fund, Hungarian NIH (K81972, NF69278). Eszter M. Horvath was supported by the Janos Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Clinical Endocrinologists, 2005, POS STAT MET CARD CO, V11; Andersen HL, 1999, BRIT J PHARMACOL, V126, P159, DOI 10.1038/sj.bjp.0702289; Ardabili HR, 2012, NUTR RES, V32, P195, DOI 10.1016/j.nutres.2012.02.001; Buday A, 2010, AM J PHYSIOL-HEART C, V299, pH386, DOI 10.1152/ajpheart.01042.2009; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Cignarella A, 2001, MED RES REV, V21, P171, DOI 10.1002/1098-1128(200103)21:2<171::AID-MED1005>3.0.CO;2-4; de Groot PCM, 2011, HUM REPROD UPDATE, V17, P495, DOI 10.1093/humupd/dmr001; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Firouzabadi Raziah dehghani, 2012, Complement Ther Clin Pract, V18, P85, DOI 10.1016/j.ctcp.2012.01.005; Horvath EM, 2009, DIABETOLOGIA, V52, P952, DOI 10.1007/s00125-009-1304-0; Horvath EM, 2011, METHODS MOL BIOL, V780, P267, DOI 10.1007/978-1-61779-270-0_16; Jog NR, 2009, J IMMUNOL, V182, P7297, DOI 10.4049/jimmunol.0803565; Kravariti M, 2005, J CLIN ENDOCR METAB, V90, P5088, DOI 10.1210/jc.2005-0151; Lakhani K, 2000, CLIN SCI, V98, P661, DOI 10.1042/cs0980661; Li M, 2008, AM J PHYSIOL-HEART C, V294, pH2444, DOI 10.1152/ajpheart.01121.2007; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Mabley JG, 2007, INT J MOL MED, V19, P947; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Miller VM, 2010, WOMENS HEALTH, V6, P737, DOI [10.2217/whe.10.53, 10.2217/WHE.10.53]; Molnar A, 2006, MOL MED, V12, P143, DOI 10.2119/2006-00043.Molnar; Morrow DA, 2009, J THROMB THROMBOLYS, V27, P359, DOI 10.1007/s11239-008-0230-1; New G, 2000, CORONARY ARTERY DIS, V11, P253, DOI 10.1097/00019501-200005000-00008; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Perez Torres I, 2007, LIFE SCI, V80, P2170, DOI 10.1016/j.lfs.2007.04.006; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; Przybylski R, 2010, NUTR METAB CARDIOVAS, V20, P641, DOI 10.1016/j.numecd.2009.07.009; Puurunen J, 2011, J CLIN ENDOCR METAB, V96, P1827, DOI 10.1210/jc.2011-0039; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Toth-Zsamboki E, 2006, MOL MED, V12, P221, DOI 10.2119/2006-00055.Toth-Zsamboki; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Virag Laszlo, 2005, Current Vascular Pharmacology, V3, P209, DOI 10.2174/1570161054368625; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Xu ZR, 2010, EUR J PHARMACOL, V643, P254, DOI 10.1016/j.ejphar.2010.06.039; Yao L, 2008, INT J CARDIOL, V123, P366, DOI 10.1016/j.ijcard.2007.06.069; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012	40	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e55589	10.1371/journal.pone.0055589	http://dx.doi.org/10.1371/journal.pone.0055589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555555	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317418500002
J	Davis, A; Major, RE; Taylor, CE				Davis, Adrian; Major, Richard E.; Taylor, Charlotte E.			Housing Shortages in Urban Regions: Aggressive Interactions at Tree Hollows in Forest Remnants	PLOS ONE			English	Article							HOLE-NESTING PASSERINES; VERTEBRATE FAUNA; BREEDING BIOLOGY; BIRD COMMUNITIES; PALM COCKATOOS; BEARING TREES; FIRE REGIMES; AVAILABILITY; URBANIZATION; COMPETITION	Urbanisation typically results in a reduction of hollow-bearing trees and an increase in the density of particularly species, potentially resulting in an increased level of competition as cavity-nesting species compete for a limited resource. To improve understanding of hollow usage between urban cavity-nesting species in Australia, particularly parrots, we investigated how the hollow-using assemblage, visitation rate, diversity and number of interactions varied between hollows within urban remnant forest and continuous forest. Motion-activated video cameras were installed, via roped access to the canopy, and hollow usage was monitored at 61 hollows over a two-year period. Tree hollows within urban remnants had a significantly different assemblage of visitors to those in continuous forest as well as a higher rate of visitation than hollows within continuous forest, with the rainbow lorikeet making significantly more visitations than any other taxa. Hollows within urban remnants were characterised by significantly higher usage rates and significantly more aggressive interactions than hollows within continuous forest, with parrots responsible for almost all interactions. Within urban remnants, high rates of hollow visitation and both interspecific and intraspecific interactions observed at tree hollows suggest the number of available optimal hollows may be limiting. Understanding the usage of urban remnant hollows by wildlife, as well as the role of parrots as a potential flagship for the conservation of tree-hollows, is vital to prevent a decrease in the diversity of urban fauna, particularly as other less competitive species risk being outcompeted by abundant native species.	[Davis, Adrian; Taylor, Charlotte E.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Major, Richard E.] Australian Museum, Sydney, NSW 2000, Australia	University of Sydney; Australian Museum	Davis, A (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	adrian.davis@sydney.edu.au		Major, Richard/0000-0002-1334-9864	Winifred Violet Scott Charitable Trust	Winifred Violet Scott Charitable Trust	Funding provided by the Winifred Violet Scott Charitable Trust (http://www.thetrustcompany.com.au/philanthropy/funding/documents/DiscretionaryTrustGuidelines-WVScott.pdf). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KEH, 2007, J ORNITHOL, V148, pS425, DOI 10.1007/s10336-007-0166-9; Beissinger SR, 1998, ANIM BEHAV, V55, P21, DOI 10.1006/anbe.1997.0576; BROWN JL, 1969, WILSON BULL, V81, P293; Burgin S, 2007, PARROTS SYDNEY REGIO; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cockle K, 2011, BIOTROPICA, V43, P228, DOI 10.1111/j.1744-7429.2010.00661.x; Cockle KL, 2010, BIOL CONSERV, V143, P2851, DOI 10.1016/j.biocon.2010.08.002; Collins L, 2012, BIOL CONSERV, V149, P23, DOI 10.1016/j.biocon.2012.01.065; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Davis A, 2012, LANDSCAPE URBAN PLAN, V106, P191, DOI 10.1016/j.landurbplan.2012.03.005; Dixon MD, 2012, URBAN ECOSYST, V15, P683, DOI 10.1007/s11252-011-0219-y; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gill AM, 1996, FOREST ECOL MANAG, V85, P261, DOI 10.1016/S0378-1127(96)03763-2; Goldingay RL, 2009, WILDLIFE RES, V36, P394, DOI 10.1071/WR08172; Grarock K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040622; GUSTAFSSON L, 1988, IBIS, V130, P11, DOI 10.1111/j.1474-919X.1988.tb00951.x; Harper MJ, 2005, WILDLIFE RES, V32, P509, DOI 10.1071/WR04106; Harper MJ, 2005, BIOL CONSERV, V122, P181, DOI 10.1016/j.biocon.2004.07.003; Heinsohn R, 2003, AUST J ZOOL, V51, P81, DOI 10.1071/ZO02003; Higgins PJ, 1999, HDB AUSTR NZ ANTARCT, V4; INIONS GB, 1989, AUST WILDLIFE RES, V16, P449; Keith D. A., 2006, OCEAN SHORES DESERT; Koch A, 2008, WILDLIFE RES, V35, P727, DOI 10.1071/WR08007; Krebs EA, 1998, AUST J ZOOL, V46, P119, DOI 10.1071/ZO97040; Lohmus A, 2005, ACTA OECOL, V27, P125, DOI 10.1016/j.actao.2004.11.001; Lowe KA, 2011, J ORNITHOL, V152, P909, DOI 10.1007/s10336-011-0674-5; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Major RE, 2010, EMU, V110, P92, DOI 10.1071/MU09058; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Martin JM, 2007, WILDLIFE RES, V34, P319, DOI 10.1071/WR07005; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Murphy S, 2003, J ZOOL, V261, P327, DOI 10.1017/S0952836903004175; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Remm J, 2008, ACTA ORNITHOL, V43, P83, DOI 10.3161/000164508X345365; Renton K, 2004, CONDOR, V106, P354, DOI 10.1650/7388; Salinas-Melgoza A, 2009, CONDOR, V111, P305, DOI 10.1525/cond.2009.090017; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; SAUNDERS DA, 1979, AUST WILDLIFE RES, V6, P205, DOI 10.1071/WR9790205; SAUNDERS DA, 1982, AUST WILDLIFE RES, V9, P541; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith KW, 2006, ANN ZOOL FENN, V43, P177; Strubbe D, 2007, ECOGRAPHY, V30, P578, DOI 10.1111/j.0906-7590.2007.05096.x; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Terho M, 2008, FORESTRY, V81, P151, DOI 10.1093/forestry/cpn002; van der Ree R, 2005, ANIM CONSERV, V8, P309, DOI 10.1017/S1367943005002258; Walker JS, 2005, BIRD CONSERV INT, V15, P347, DOI 10.1017/S0959270905000638; WALTMAN JR, 1992, WILSON BULL, V104, P65; Waterhouse R. D., 1997, Corella, V21, P17; WENNER AS, 1984, J FIELD ORNITHOL, V55, P214	52	22	30	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59332	10.1371/journal.pone.0059332	http://dx.doi.org/10.1371/journal.pone.0059332			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555657	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400035
J	Choudhary, R; Baturin, D; Fosmire, S; Freed, B; Porter, CC				Choudhary, Rashmi; Baturin, Dmitry; Fosmire, Susan; Freed, Brian; Porter, Christopher C.			Knockdown of HPRT for Selection of Genetically Modified Human Hematopoietic Progenitor Cells	PLOS ONE			English	Article							RESISTANT BONE-MARROW; IN-VIVO SELECTION; GENE-THERAPY; LENTIVIRAL VECTOR; MEDIATED TRANSFER; RETROVIRUS; MDR1; IMMUNODEFICIENCY; TRANSPLANTATION; CHEMOTHERAPY	The inability to obtain sufficient numbers of transduced cells remains a limitation in gene therapy. One strategy to address this limitation is in vivo pharmacologic selection of transduced cells. We have previously shown that knockdown of HPRT using lentiviral delivered shRNA facilitates efficient selection of transduced murine hematopoietic progenitor cells (HPC) using 6-thioguanine (6TG). Herein, we now extend these studies to human HPC. We tested multiple shRNA constructs in human derived cell lines and identified the optimal shRNA sequence for knockdown of HPRT and 6TG resistance. We then tested this vector in human umbilical cord blood derived HPC in vitro and in NOD/SCID recipients. Knockdown of HPRT effectively provided resistance to 6TG in vitro. 6TG treatment of mice resulted in increased percentages of transduced human CD45(+) cells in the peripheral blood and in the spleen in particular, in both myeloid and lymphoid compartments. 6TG treatment of secondary recipients resulted in higher percentages of transduced human cells in the bone marrow, confirming selection from the progeny of long-term repopulating HPCs. However, the extent of selection of cells in the bone marrow at the doses of 6TG tested and the toxicity of higher doses, suggest that this strategy may be limited to selection of more committed progenitor cells. Together, these data suggest that human HPC can be programmed to be resistant to purine analogs, but that HPRT knockdown/6TG-based selection may not be robust enough for in vivo selection.	[Choudhary, Rashmi; Baturin, Dmitry; Fosmire, Susan; Porter, Christopher C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Freed, Brian] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Freed, Brian] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Porter, CC (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.	chris.porter@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	United States National Heart Lung and Blood Institute [HL094921]; NATIONAL CANCER INSTITUTE [T32CA082086, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094921] Funding Source: NIH RePORTER	United States National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a research grant to CCP from the United States National Heart Lung and Blood Institute (HL094921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Adair JE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003425; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; COREY CA, 1990, BLOOD, V75, P337; Cowan KH, 1999, CLIN CANCER RES, V5, P1619; Davis BM, 2000, BLOOD, V95, P3078; Erlichman C, 2001, CANC CHEMOTHERAPY BI, P67; Giordano FA, 2011, HUM GENE THER, V22, P697, DOI 10.1089/hum.2010.088; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacke K, 2012, EXP HEMATOL, V40, P3, DOI 10.1016/j.exphem.2011.09.009; Hesdorffer C, 1998, J CLIN ONCOL, V16, P165, DOI 10.1200/JCO.1998.16.1.165; Hildinger M, 1998, HUM GENE THER, V9, P33, DOI 10.1089/hum.1998.9.1-33; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Masunaga Y, 2007, ANN PHARMACOTHER, V41, P21, DOI 10.1345/aph.1H219; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Maze R, 1996, P NATL ACAD SCI USA, V93, P206, DOI 10.1073/pnas.93.1.206; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Pedersen-Bjergaard J, 2002, BLOOD, V99, P1909, DOI 10.1182/blood.V99.6.1909; Porter CC, 2008, BLOOD, V112, P4466, DOI 10.1182/blood-2008-03-146571; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; SORRENTINO BP, 1992, SCIENCE, V257, P99, DOI 10.1126/science.1352414; Warlick CA, 2002, J PHARMACOL EXP THER, V300, P50, DOI 10.1124/jpet.300.1.50; WILLIAMS DA, 1987, J EXP MED, V166, P210, DOI 10.1084/jem.166.1.210; Zielske SP, 2003, J CLIN INVEST, V112, P1561, DOI 10.1172/JCI200317922	32	6	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59594	10.1371/journal.pone.0059594	http://dx.doi.org/10.1371/journal.pone.0059594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555045	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800101
J	Durif, CMF; Browman, HI; Phillips, JB; Skiftesvik, AB; Vollestad, LA; Stockhausen, HH				Durif, Caroline M. F.; Browman, Howard I.; Phillips, John B.; Skiftesvik, Anne Berit; Vollestad, L. Asbjorn; Stockhausen, Hans H.			Magnetic Compass Orientation in the European Eel	PLOS ONE			English	Article							RED-SPOTTED NEWT; ANGUILLA-ANGUILLA; SILVER EELS; ENVIRONMENTAL-FACTORS; AMERICAN EELS; SPAWNING MIGRATION; JAPONICA; ROSTRATA; RESPONSES	European eel migrate from freshwater or coastal habitats throughout Europe to their spawning grounds in the Sargasso Sea. However, their route (similar to 6000 km) and orientation mechanisms are unknown. Several attempts have been made to prove the existence of magnetoreception in Anguilla sp., but none of these studies have demonstrated magnetic compass orientation in earth-strength magnetic field intensities. We tested eels in four altered magnetic field conditions where magnetic North was set at geographic North, South, East, or West. Eels oriented in a manner that was related to the tank in which they were housed before the test. At lower temperature (under 12 degrees C), their orientation relative to magnetic North corresponded to the direction of their displacement from the holding tank. At higher temperatures (12-17 degrees C), eels showed bimodal orientation along an axis perpendicular to the axis of their displacement. These temperature-related shifts in orientation may be linked to the changes in behavior that occur between the warm season (during which eels are foraging) and the colder fall and winter (during which eels undertake their migrations). These observations support the conclusion that 1. eels have a magnetic compass, and 2. they use this sense to orient in a direction that they have registered moments before they are displaced. The adaptive advantage of having a magnetic compass and learning the direction in which they have been displaced becomes clear when set in the context of the eel's seaward migration. For example, if their migration is halted or blocked, as it is the case when environmental conditions become unfavorable or when they encounter a barrier, eels would be able to resume their movements along their old bearing when conditions become favorable again or when they pass by the barrier.	[Durif, Caroline M. F.; Browman, Howard I.; Skiftesvik, Anne Berit] Austevoll Res Stn, Inst Marine Res, Storebo, Norway; [Phillips, John B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Vollestad, L. Asbjorn] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Stockhausen, Hans H.] Inst Marine Res, N-5024 Bergen, Norway	Institute of Marine Research - Norway; Virginia Polytechnic Institute & State University; University of Oslo; Institute of Marine Research - Norway	Durif, CMF (corresponding author), Austevoll Res Stn, Inst Marine Res, Storebo, Norway.	caroline.durif@imr.no	Browman, Howard/B-4441-2009; Browman, Howard/CAA-2802-2022; Vøllestad, Leif Asbjørn/H-7305-2019; Durif, Caroline/A-6406-2011; Skiftesvik, Anne Berit/M-1266-2013	Browman, Howard/0000-0002-6282-7316; Browman, Howard/0000-0002-6282-7316; Vøllestad, Leif Asbjørn/0000-0002-9389-7982; Skiftesvik, Anne Berit/0000-0002-7754-5661	Research Council of Norway [NFR] [159222]; University of Oslo; Norwegian Institute of Marine Research; Norwegian Institute of Marine Research: Sensory biology and behaviour project; Fine scale interactions in the plankton	Research Council of Norway [NFR](Research Council of Norway); University of Oslo; Norwegian Institute of Marine Research; Norwegian Institute of Marine Research: Sensory biology and behaviour project; Fine scale interactions in the plankton	This study was funded by the Research Council of Norway [NFR grant number 159222], The University of Oslo and the Norwegian Institute of Marine Research. CMFD, HIB, ABS, and HS were supported by the Norwegian Institute of Marine Research: Sensory biology and behaviour project and Fine scale interactions in the plankton in support of trophodynamic models project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; Baras E, 1998, HYDROBIOLOGIA, V372, P187, DOI 10.1023/A:1017072213791; Batschelet, 1981, CIRCULAR STAT BIOL; Branover G. G., 1971, J ICHTHYOL+, V11, P608; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; Deutschlander ME, 1999, NATURE, V400, P324, DOI 10.1038/22450; Deutschlander ME, 2000, COPEIA, P413; Diego-Rasilla FJ, 2007, ETHOLOGY, V113, P474, DOI 10.1111/j.1439-0310.2007.01334.x; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; Durif C, 2002, AM FISH S S, V33, P343; Durif CMF, 2008, FISHERIES MANAG ECOL, V15, P127, DOI 10.1111/j.1365-2400.2008.00593.x; Durif CMF, 2008, AQUAT LIVING RESOUR, V21, P163, DOI 10.1051/alr:2008031; FERGUSON DE, 1966, BEHAVIOUR, V26, P105, DOI 10.1163/156853966X00047; Freake MJ, 2002, COPEIA, P466; Hart V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051100; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Hellinger J, 2009, J COMP PHYSIOL A, V195, P873, DOI 10.1007/s00359-009-0466-z; Jellyman DJ, 1996, NEW ZEAL J MAR FRESH, V30, P171; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; KARLSSON L, 1985, HELGOLANDER MEERESUN, V39, P71, DOI 10.1007/BF01997522; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2005, FISHERIES SCI, V71, P101, DOI 10.1111/j.1444-2906.2005.00936.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; Phillips JB, 2006, ANIMAL SPATIAL COGNI; Phillips JB, 2010, J EXP BIOL, V213, P3247, DOI 10.1242/jeb.020792; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; ROMMEL SA, 1973, J FISH RES BOARD CAN, V30, P657, DOI 10.1139/f73-114; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; SOUZA JJ, 1988, COMP BIOCHEM PHYS A, V90, P57, DOI 10.1016/0300-9629(88)91005-5; Tabeke A, 2012, SCI REPORTS, V2, P1; Tesch F.-W., 1992, Ecology of Freshwater Fish, V1, P52, DOI 10.1111/j.1600-0633.1992.tb00007.x; Tesch F-W., 2003, EEL; TESCH FW, 1974, HELGOLAND WISS MEER, V26, P382, DOI 10.1007/BF01627623; TESCH FW, 1991, MEERESFORSCHUNG, V33, P183; VOLLESTAD LA, 1986, CAN J FISH AQUAT SCI, V43, P1909, DOI 10.1139/f86-236; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1986, NATURWISSENSCHAFTEN, V73, P12, DOI 10.1007/BF01168800; Watene EM, 2002, AM FISH S S, V33, P295; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Westin L, 1977, Contributions Asko Lab., VNo. 17, P1; White EM, 1997, J FISH BIOL, V50, P1104, DOI 10.1006/jfbi.1996.0383; ZIMMERMAN MA, 1975, HELGOLAND WISS MEER, V27, P175, DOI 10.1007/BF01611805	50	47	48	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59212	10.1371/journal.pone.0059212	http://dx.doi.org/10.1371/journal.pone.0059212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554997	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000316409800070
J	Feng, Y; Johnston, RN; Liu, GR; Liu, SL				Feng, Ye; Johnston, Randal N.; Liu, Gui-Rong; Liu, Shu-Lin			Genomic Comparison between Salmonella Gallinarum and Pullorum: Differential Pseudogene Formation under Common Host Restriction	PLOS ONE			English	Article							ENTERICA SEROVAR PULLORUM; MAXIMUM-LIKELIHOOD; EVOLUTIONARY; SEQUENCE; TYPHI; ADAPTATION; PARATYPHI; CHOLERAESUIS	Background: Salmonella serovars Enteritidis and Gallinarum are closely related, but their host ranges are very different: the former is host-promiscuous and the latter can infect poultry only. Comparison of their genomic sequences reveals that Gallinarum has undergone much more extensive degradation than Enteritidis. This phenomenon has also been observed in other host restricted Salmonella serovars, such as Typhi and Paratyphi A. The serovar Gallinarum can be further split into two biovars: Gallinarum and Pullorum, which take poultry as their common host but cause distinct diseases, with the former eliciting typhoid and the latter being a dysentery agent. Genomic comparison of the two pathogens, with a focus on pseudogenes, would provide insights into the evolutionary processes that might have facilitated the formation of host-restricted Salmonella pathogens. Methodologies/Principal Findings: We sequenced the complete genome of Pullorum strains and made comparison with Gallinarum and other Salmonella lineages. The gene contents of Gallinarum and Pullorum were highly similar, but their pseudogene compositions differed considerably. About one fourth of pseudogenes had the same inactivation mutations in Gallinarum and Pullorum but these genes remained intact in Enteritidis, suggesting that the ancestral Gallinarum may have already been restricted to poultry. On the other hand, the remaining pseudogenes were either in the same genes but with different inactivation sites or unique to Gallinarum or Pullorum, reflecting unnecessary functions in infecting poultry. Conclusions: Our results support the hypothesis that the divergence between Gallinarum and Pullorum was initiated and facilitated by host restriction. Formation of pseudogenes instead of gene deletion is the major form of genomic degradation. Given the short divergence history of Gallinarum and Pullorum, the effect of host restriction on genomic degradation is huge and rapid, and such effect seems to be continuing to work. The pseudogenes may reflect the unnecessary functions for Salmonella within the poultry host.	[Feng, Ye; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China; [Johnston, Randal N.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; University of Calgary; University of Calgary	Liu, SL (corresponding author), Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China.	slliu@ucalgary.ca	Johnston, Randal/B-9247-2009	RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	National Science Foundation of China [NSFC81201248, NSFC30970119, 81030029, 81271786]; National Natural Science Foundation of China [NSFC30970078]; Natural Science Foundation of Heilongjiang Province of China; Harbin Medical University; National Institutes of Health of United States of America [NSFC-NIH 81161120416]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20092307110001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Harbin Medical University; National Institutes of Health of United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by a grant from the National Science Foundation of China (NSFC81201248) to YF; a grant of National Natural Science Foundation of China (NSFC30970078) and a grant of Natural Science Foundation of Heilongjiang Province of China to GRL; and a start-up grant from Harbin Medical University, grants of the National Natural Science Foundation of China (NSFC30970119, 81030029, 81271786), a grant of the National Natural Science Foundation of China and National Institutes of Health of United States of America (NSFC-NIH 81161120416), and a Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP, 20092307110001) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Feng Y, 2012, J PROTEOME RES; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Gong J, 2007, GENOMICS, V90, P542, DOI 10.1016/j.ygeno.2007.06.009; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	24	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59427	10.1371/journal.pone.0059427	http://dx.doi.org/10.1371/journal.pone.0059427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555032	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800089
J	McKinley, ET; Ayers, GD; Smith, RA; Saleh, SA; Zhao, P; Washington, MK; Coffey, RJ; Manning, HC				McKinley, Eliot T.; Ayers, Gregory D.; Smith, R. Adam; Saleh, Samir A.; Zhao, Ping; Washington, Mary Kay; Coffey, Robert J.; Manning, H. Charles			Limits of [F-18]-FLT PET as a Biomarker of Proliferation in Oncology	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COLORECTAL-CANCER; IN-VIVO; CELLULAR PROLIFERATION; IMAGING PROLIFERATION; BREAST-CANCER; F-18-FLT PET; KINETIC-ANALYSIS; THORACIC TUMORS; BRAIN-TUMORS	Background: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantifying response to personalized medicine in oncology. An emerging approach to assess tumor proliferation utilizes the positron emission tomography (PET) tracer 3'-deoxy-3'[F-18]-fluorothymidine, [F-18]-FLT. Though several studies have associated serial changes in [F-18]-FLT-PET with elements of therapeutic response, the degree to which [F-18]-FLT-PET quantitatively reflects proliferative index has been continuously debated for more that a decade. The goal of this study was to elucidate quantitative relationships between [F-18]-FLT-PET and cellular metrics of proliferation in treatment naive human cell line xenografts commonly employed in cancer research. Methods and Findings: [F-18]-FLT-PET was conducted in human cancer xenograft-bearing mice. Quantitative relationships between PET, thymidine kinase 1 (TK1) protein levels and immunostaining for proliferation markers (Ki67, TK1, PCNA) were evaluated using imaging-matched tumor specimens. Overall, we determined that [F-18]-FLT-PET reflects TK1 protein levels, yet the cell cycle specificity of TK1 expression and the extent to which tumors utilize thymidine salvage for DNA synthesis decouple [F-18]-FLT-PET data from standard estimates of proliferative index. Conclusions: Our findings illustrate that [F-18]-FLT-PET reflects tumor proliferation as a function of thymidine salvage pathway utilization. Unlike more general proliferation markers, such as Ki67, [F-18]-FLT PET reflects proliferative indices to variable and potentially unreliable extents. [F-18]-FLT-PET cannot discriminate moderately proliferative, thymidine salvage-driven tumors from those of high proliferative index that rely primarily upon de novo thymidine synthesis. Accordingly, the magnitude of [F-18]-FLT uptake should not be considered a surrogate of proliferative index. These data rationalize the diversity of [F-18]-FLT-PET correlative results previously reported and suggest future best-practices when [F-18]-FLT-PET is employed in oncology.	[McKinley, Eliot T.; Smith, R. Adam; Saleh, Samir A.; Zhao, Ping; Manning, H. Charles] Vanderbilt Univ, Med Ctr, VUIIS, Nashville, TN 37235 USA; [McKinley, Eliot T.; Manning, H. Charles] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Ayers, Gregory D.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Washington, Mary Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Washington, Mary Kay; Coffey, Robert J.] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN USA; [Washington, Mary Kay; Coffey, Robert J.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Program Chem & Phys Biol, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, VUIIS, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu			National Cancer Institute [R01 CA140628, RC1 CA145138, K25 CA127349, P50 CA128323, P50 CA95103, U24 CA126588]; Kleberg Foundation [5P30 DK058404, S10 RR17858];  [R25 CA136440]; NATIONAL CANCER INSTITUTE [R01CA140628, RC1CA145138, P50CA128323, R25CA136440, U24CA126588, P50CA095103, K25CA127349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by grants from the National Cancer Institute: R01 CA140628, RC1 CA145138, K25 CA127349, P50 CA128323, P50 CA95103, U24 CA126588, The Kleberg Foundation, 5P30 DK058404, and S10 RR17858. E. T. McKinley was supported by a training grant in imaging science R25 CA136440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barthel H, 2003, CANCER RES, V63, P3791; Brockenbrough JS, J NUCL MED, V52, P1181; Buck AK, 2002, CANCER RES, V62, P3331; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen W, 2005, J NUCL MED, V46, P945; Choi SJ, 2005, EUR J NUCL MED MOL I, V32, P653, DOI 10.1007/s00259-004-1742-3; Cobben DCP, 2003, CANCER RES, V63, P8558; Dittmann H, 2003, EUR J NUCL MED MOL I, V30, P1407, DOI 10.1007/s00259-003-1257-3; DY DY, 1992, CANCER RES, V52, P917; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Grierson JR, 2000, NUCL MED BIOL, V27, P143, DOI 10.1016/S0969-8051(99)00104-3; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; Kim SJ, 2008, J NUCL MED, V49, P2057, DOI 10.2967/jnumed.108.053215; Krieger-Hinck N, 2006, ANTICANCER RES, V26, P3467; Li W, J CHROMATOGR B, V879, P2963; Mankoff DA, 2007, CLIN CANCER RES, V13, P3460, DOI 10.1158/1078-0432.CCR-07-0074; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; McKinley ET, ANN NUCL MED; Moroz MA, CLIN CANC RES, V17, P1099; Muzi M, 2005, J NUCL MED, V46, P371; Muzi M, 2006, J NUCL MED, V47, P1612; Muzic RF, 2001, J NUCL MED, V42, P636; OLIVE M, 1993, IN VITRO CELL DEV-AN, V29A, P239; Reinhardt MJ, 1997, J NUCL MED, V38, P280; Schwartz JL, 2003, J NUCL MED, V44, P2027; Shah C, 2009, CLIN CANCER RES, V15, P4712, DOI 10.1158/1078-0432.CCR-08-2635; Shields AF, 1998, J NUCL MED, V39, P1757; Shields AF, 1996, J NUCL MED, V37, P290; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8; van Westreenen HL, 2005, J NUCL MED, V46, P400; Wagner M, 2003, CANCER RES, V63, P2681; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang H, 2009, J NUCL MED, V50, P1857, DOI 10.2967/jnumed.109.064238; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Yamamoto Y, 2009, NUCL MED COMMUN, V30, P841, DOI 10.1097/MNM.0b013e328330294d; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393; Zhang CC, CLIN CANC RES	42	74	75	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58938	10.1371/journal.pone.0058938	http://dx.doi.org/10.1371/journal.pone.0058938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554961	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800049
J	Mu, J; Pang, Q; Guo, YH; Chen, JG; Zeng, W; Huang, YJ; Zhang, J; Feng, B				Mu, Jiao; Pang, Qi; Guo, Yan-Hong; Chen, Ji-Gang; Zeng, Wei; Huang, Yong-Jun; Zhang, Jun; Feng, Bing			Functional Implications of MicroRNA-215 in TGF-beta 1-Induced Phenotypic Transition of Mesangial Cells by Targeting CTNNBIP1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INDUCED COLLAGEN EXPRESSION; DIABETIC-NEPHROPATHY; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CRYPTOSPORIDIUM-PARVUM; RENAL-DISEASE; CATENIN; KIDNEY; ACTIVATION	Mesangial cell (MC) phenotypic transition is crucial for the progression of diabetic nephropathy. A major stimulus mediating high glucose-induced MC phenotypic transition is TGF-beta 1. Our current study focuses on microRNA-215 (miR-215) and investigates its role in TGF-beta 1-mediated MC phenotypic transition. Using real-time quantitative PCR (qRT-PCR) and northern blotting, we determined that the miR-192/215 family is dramatically upregulated under diabetic conditions both in vitro and in vivo. Gain-and loss-of-function approaches demonstrated that miR-215 inhibition significantly inhibited TGF-beta 1-induced mouse mesangial cell (MMC) phenotypic transition, whereas miR-215 upregulation promoted MMC phenotypic transition. Interestingly, these changes were not detected in cells that were treated with TGF-beta 1 and miR-192 mimics or inhibitors. These results suggest that miR-215 participates in TGF-beta 1-induced MMC phenotypic transition. Luciferase reporter assays were used to identify whether catenin-beta interacting protein 1 (CTNNBIP1) is a direct target of miR-215, which was predicted by bioinformatic analysis. Mechanistic studies revealed that CTNNBIP1 suppresses Wnt/beta-catenin signaling and that miR-215 promotes beta-catenin activation and upregulates alpha-SMA and fibronectin expression in TGF-beta 1-treated MMCs by targeting CTNNBIP1. In addition, in vivo miR-215 silencing with a specific antagomir significantly increased CTNNBIP1 protein expression, resulting in reduced beta-catenin activity and decreased alpha-SMA and fibronectin expression in db/db mouse kidney glomeruli. Taken together, our findings indicate that miR-215 plays an essential role in MC phenotypic transition by regulating the CTNNBIP1/beta-catenin pathway, which is related to the pathogenesis of diabetic nephropathy.	[Feng, Bing] Third Mil Med Univ, Inst Nephrol Chongqing, Xinqiao Hosp, Chongqing, Peoples R China; Third Mil Med Univ, Dept Nephrol, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Feng, B (corresponding author), Third Mil Med Univ, Inst Nephrol Chongqing, Xinqiao Hosp, Chongqing, Peoples R China.	fxb1359462@163.com			National Natural Science Foundation of China [31100927, 30900690]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from two National Natural Science Foundation of China: No.31100927 and No.30900690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; Amrouche L, 2011, M S-MED SCI, V27, P398, DOI 10.1051/medsci/2011274016; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; FLOEGE J, 1992, CLIN INVESTIGATOR, V70, P857; Fogo AB, 1999, EXP NEPHROL, V7, P147; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Herrera GA, 2006, ULTRASTRUCT PATHOL, V30, P471, DOI 10.1080/01913120600932594; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kaucsar T, 2010, ADV DRUG DELIVER REV, V62, P1390, DOI 10.1016/j.addr.2010.10.003; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kim TH, 2011, TOHOKU J EXP MED, V223, P45, DOI 10.1620/tjem.223.45; Kim YS, 2003, KIDNEY INT, V64, P1702, DOI 10.1046/j.1523-1755.2003.00286.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Li WT, 2011, DIGEST LIVER DIS, V43, P559, DOI 10.1016/j.dld.2011.02.016; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu Z, 2012, ARCH DERMATOL RES, V304, P195, DOI 10.1007/s00403-011-1178-0; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lussier CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012378; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Mishra R, 2008, ARTERIOSCL THROM VAS, V28, P541, DOI 10.1161/ATVBAHA.107.157339; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Saal S, 2009, CURR OPIN NEPHROL HY, V18, P317, DOI 10.1097/MNH.0b013e32832c9da2; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Stow JL, 2004, AM J PHYSIOL-CELL PH, V286, pC745, DOI 10.1152/ajpcell.00563.2003; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tago K, 2000, GENE DEV, V14, P1741; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	64	65	70	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58622	10.1371/journal.pone.0058622	http://dx.doi.org/10.1371/journal.pone.0058622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554908	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500034
J	Wada, K; Smith, DR				Wada, Koji; Smith, Derek R.			Influenza Vaccination Uptake among the Working Age Population of Japan: Results from a National Cross-Sectional Survey	PLOS ONE			English	Article							INEQUALITIES	Background: Influenza vaccination rates among Japanese people of working age (20-69 years) is currently suboptimal, and the reasons for this have not been clearly elucidated. This study examined factors associated with vaccination intention among the working age population in Japan during September 2011, one-month prior to influenza vaccination becoming available. Methodology/Principal Findings: A web-based survey of intention to be vaccinated against influenza in the coming season was undertaken among 3,129 Japanese aged 20 to 69 years. Multinomial logistic regression analysis was used to explore the associations between vaccination intent and other variables. Influenza vaccination intent was associated with having been vaccinated in the previous year (Odds Ratio (OR): 3.81; 95% Confidence Interval (CI): 3.75-3.86), the number of children per household (one compared with zero; OR: 1.37; 95% CI: 1.11-1.65), and household income ($50,000 to <$100,000 compared with $0 to <$ 50,000; OR: 1.30; 95% CI: 1.07-1.54). Smoking was inversely associated with influenza vaccine uptake (current smokers compared with non-smokers; OR: 0.79; 95% CI: 0.61-0.98). A history of either the survey respondent or a household member having being medically diagnosed with influenza in the previous year was not statistically associated with future influenza vaccination intent. Conclusions/Significance: Overall, this suggests that intention to be vaccinated among working age Japanese is associated with a past history of influenza vaccination, having children, and the household's income. As such, consideration of these factors should now form the cornerstone of strategies to encourage increased uptake of vaccination against influenza in future years.	[Wada, Koji] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Ourimbah, Australia	Kitasato University; University of Newcastle	Wada, K (corresponding author), Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan.	kwada-sgy@umin.ac.jp	Smith, Derek/F-4844-2010	Smith, Derek/0000-0002-8202-2523	Ministry of Education, Culture, Sports, Science and Technology, Japan [23790705]; Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) (23790705) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and partly funded by a Health Labour Sciences Research Grant from the Ministry of Health, Labour, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2012, Ann Intern Med, V156, P211, DOI 10.7326/0003-4819-156-3-201202070-00388; Armstrong K, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(00)00263-4; Bagdure D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015173; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Hirota Y, 2008, VACCINE, V26, P6451, DOI 10.1016/j.vaccine.2008.06.042; Hirotsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031519; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Hothersall EJ, 2012, PRIM CARE RESP J, V21, P302, DOI 10.4104/pcrj.2012.00056; Janks M, 2012, INFLUENZA RES TREAT, V2012, DOI DOI 10.1155/2012/182565; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Nicholson KG, 1999, EPIDEMIOL INFECT, V123, P103, DOI 10.1017/S095026889900271X; Nobuhara H, 2007, J HLTH WELFARE STAT, V54, P44; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Plans-Rubio Pedro, 2007, Int J Chron Obstruct Pulmon Dis, V2, P41, DOI 10.2147/copd.2007.2.1.41; Rachiotis G, 2010, EUROSURVEILLANCE, V15, P8; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Smith DR, 2009, PUBLIC HEALTH, V123, P196, DOI 10.1016/j.puhe.2008.12.003; SteelFisher Gillian K, 2010, N Engl J Med, V362, pe65, DOI 10.1056/NEJMp1005102; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; Wada K, 2011, PANDEMIC H1N1 2009 J; Wada K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1065; Yi SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018893	27	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59272	10.1371/journal.pone.0059272	http://dx.doi.org/10.1371/journal.pone.0059272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23555010	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500078
J	Liu, HY; Quampah, A; Chen, JH; Li, JR; Huang, ZR; He, QL; Zhu, SJ; Shi, CH				Liu, Haiying; Quampah, Alfred; Chen, Jinhong; Li, Jinrong; Huang, Zhuangrong; He, Qiuling; Zhu, Shuijin; Shi, Chunhai			QTL Mapping Based on Different Genetic Systems for Essential Amino Acid Contents in Cottonseeds in Different Environments	PLOS ONE			English	Article							UPLAND COTTON; TRAITS; IDENTIFICATION; POPULATION; GOSSYPIUM; ENDOSPERM; QUALITY; RICE; L.	Cottonseeds are rich in various essential amino acids. However, the inheritance of them at molecular level are still not defined across various genetic systems. In the present study, using a newly developed mapping model that can analyze the embryo and maternal main effects as well as QTL x environment interaction effects on quantitative quality trait loci (QTLs) in cottonseeds, a study on QTL located in the tetraploid embryo and tetraploid maternal plant genomes for essential amino acid contents in cottonseeds under different environments was carried out, using the immortal F-2 (IF2) populations from a set of 188 recombinant inbred lines derived from an intraspecific hybrid cross of two upland cotton germplasms HS46 and MARKCBUCAG8US-1-88 as experimental materials. The results showed a total of 35 QTLs associated with these quality traits in cottonseeds. Nineteen QTLs were subsequently mapped on chromosome 5, 6 and 8 in sub-A genome and chromosome 15, 18, 22 and 23 in sub-D genome. Eighteen QTLs were also found having QTL x environment (QE) interaction effects. The genetic main effects from QTLs located on chromosomes in the embryo and maternal plant genomes and their QE effects in different environments were all important for these essential amino acids in cottonseeds. The results suggested that the influence of environmental factors on the expression of some QTLs located in different genetic systems should be considered when improving for these amino acids. This study can serve as the foundation for the improvement of these essential amino acids in cottonseeds.	[Liu, Haiying; Quampah, Alfred; Chen, Jinhong; Li, Jinrong; Huang, Zhuangrong; He, Qiuling; Zhu, Shuijin; Shi, Chunhai] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, SJ (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	shjzhu@zju.edu.cn; chhshi@zju.edu.cn	Huang, Zhuangrong/AAV-2846-2020	Huang, Zhuangrong/0000-0002-9145-5582	National Basic Research Program (973 program) [2010CB126006]; National High Technology Research and Development Program of China [2011AA10A102]	National Basic Research Program (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The project is support by the National Basic Research Program (973 program. No: 2010CB126006) and the National High Technology Research and Development Program of China (2011AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AMINO ACIDS ANIMAL N; Ashokkumar K., 2011, INT RES J PLANT SCI, V2; Cai YF, 2010, AGRON SUSTAIN DEV, V30, P181, DOI 10.1051/agro/2008024; Cherry J. P., 1978, 1978 Proceedings Beltwide Cotton Production Research Conferences. Jan. 9-11, 1978, Dallas, Texas (Brown, J.M. (Editor))., P47; Doerge RW, 1996, GENETICS, V142, P285; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gutierrez OA, 2006, NAT COTT COUNC BELTW, P826; Huang ZR, 2011, SPECTROSC SPECT ANAL, V31, P2692, DOI 10.3964/j.issn.1000-0593(2011)10-2692-05; JI D, 1988, Acta Agronomica Sinica, V14, P1; Ji DF, 1985, ACTA AGR U ZHENJIANG, V11, P257; Jiang C, 2000, THEOR APPL GENET, V100, P409, DOI 10.1007/s001220050054; KHATTAB AH, 1977, J AGR SCI, V88, P55, DOI 10.1017/S0021859600033761; Kohel RJ, 1978, 187 USDA ARSS; McCouch S. R., 1997, NEWLETT, V14, P11; MEREDITH WR, 1978, CROP SCI, V18, P577, DOI 10.2135/cropsci1978.0011183X001800040013x; OBrien RD, 2005, BAILEYS IND OIL FAT; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shi CH, 2009, CROP PASTURE SCI, V60, P295, DOI 10.1071/CP08234; Song XL, 2007, SEED SCI RES, V17, P243, DOI 10.1017/S0960258507834957; Sun QA, 2010, MOL BIOL REP, V37, P3319, DOI 10.1007/s11033-009-9918-3; Sun S. K., 1987, Scientia Agricultura Sinica, V20, P12; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Wu J, 2000, NAT COTT COUNC BELTW; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu JX, 2004, EUPHYTICA, V140, P171, DOI 10.1007/s10681-004-2897-5; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Ye ZH, 2003, EUPHYTICA, V129, P183, DOI 10.1023/A:1021974901501; Zheng X, 2008, THEOR APPL GENET, V116, P335, DOI 10.1007/s00122-007-0671-5	29	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e57531	10.1371/journal.pone.0057531	http://dx.doi.org/10.1371/journal.pone.0057531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555562	Green Submitted, Green Published, gold			2022-12-27	WOS:000317263900002
J	Braeckman, U; Vanaverbeke, J; Vincx, M; van Oevelen, D; Soetaert, K				Braeckman, Ulrike; Vanaverbeke, Jan; Vincx, Magda; van Oevelen, Dick; Soetaert, Karline			Meiofauna Metabolism in Suboxic Sediments: Currently Overestimated	PLOS ONE			English	Article							DEEP-SEA NEMATODES; VERTICAL-DISTRIBUTION; RESPIRATION RATES; MARINE NEMATODE; OXYGEN; FORAMINIFERA; BACTERIA; MARGIN; PHYTOPLANKTON; TEMPERATURE	Oxygen is recognized as a structuring factor of metazoan communities in marine sediments. The importance of oxygen as a controlling factor on meiofauna (32 mu m-1 mm in size) respiration rates is however less clear. Typically, respiration rates are measured under oxic conditions, after which these rates are used in food web studies to quantify the role of meiofauna in sediment carbon turnover. Sediment oxygen concentration ([O-2]) is generally far from saturated, implying that (1) current estimates of the role of meiofauna in carbon cycling may be biased and (2) meiofaunal organisms need strategies to survive in oxygen-stressed environments. Two main survival strategies are often hypothesized: 1) frequent migration to oxic layers and 2) morphological adaptation. To evaluate these hypotheses, we (1) used a model of oxygen turnover in the meiofauna body as a function of ambient [O-2], and (2) performed respiration measurements at a range of [O-2] conditions. The oxygen turnover model predicts a tight coupling between ambient [O-2] and meiofauna body [O-2] with oxygen within the body being consumed in seconds. This fast turnover favors long and slender organisms in sediments with low ambient [O-2] but even then frequent migration between suboxic and oxic layers is for most organisms not a viable strategy to alleviate oxygen limitation. Respiration rates of all measured meiofauna organisms slowed down in response to decreasing ambient [O-2], with Nematoda displaying the highest metabolic sensitivity for declining [O-2] followed by Foraminifera and juvenile Gastropoda. Ostracoda showed a behavioral stress response when ambient [O-2] reached a critical level. Reduced respiration at low ambient [O-2] implies that meiofauna in natural, i.e. suboxic, sediments must have a lower metabolism than inferred from earlier respiration rates conducted under oxic conditions. The implications of these findings are discussed for the contribution of meiofauna to carbon cycling in marine sediments.	[Braeckman, Ulrike; Vanaverbeke, Jan; Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [van Oevelen, Dick; Soetaert, Karline] Royal Netherlands Inst Sea Res NIOZ Yerseke, Yerseke, Netherlands	Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Braeckman, U (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	ulrike.braeckman@ugent.be	Braeckman, Ulrike/AAJ-4801-2021; Soetaert, Karline E/A-9839-2011	Soetaert, Karline E/0000-0003-4603-7100; Braeckman, Ulrike/0000-0002-7558-6363	FWO [G.0033.11]; Special Research Fund of Ghent University [BOF-GOA 01GA1911W]	FWO(FWO); Special Research Fund of Ghent University(Ghent University)	The first author is funded by FWO project nr G.0033.11. Additional funding was provided by the Special Research Fund of Ghent University (BOF-GOA 01GA1911W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R.C., 1988, SCOPE, V33, P301; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; ATKINSON HJ, 1975, J EXP BIOL, V62, P1; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; CALOW P, 1977, J ANIM ECOL, V46, P765, DOI 10.2307/3639; CULLEN DJ, 1973, NATURE, V242, P323, DOI 10.1038/242323a0; DEBOVEE F, 1987, CAH BIOL MAR, V28, P367; DEBOVEE F, 1993, MAR ECOL-P S Z N I, V14, P159; Epping E, 2002, PROG OCEANOGR, V52, P399, DOI 10.1016/S0079-6611(02)00017-4; FENCHEL T, 1975, OECOLOGIA, V20, P1, DOI 10.1007/BF00364318; Franco MA, 2008, J EXP MAR BIOL ECOL, V362, P1, DOI 10.1016/j.jembe.2008.04.010; Franco MD, 2010, MAR ECOL-EVOL PERSP, V31, P276, DOI 10.1111/j.1439-0485.2009.00319.x; Frenzel P, 2005, PALAEOGEOGR PALAEOCL, V225, P68, DOI 10.1016/j.palaeo.2004.02.051; GERLACH SA, 1971, OECOLOGIA, V6, P176, DOI 10.1007/BF00345719; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; GOLDSTEIN ST, 1993, MICROPALEONTOLOGY, V39, P53, DOI 10.2307/1485974; Goldstein ST, 1995, MAR MICROPALEONTOL, V26, P17, DOI 10.1016/0377-8398(95)00006-2; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; HENDELBERG M, 1993, OPHELIA, V37, P83, DOI 10.1080/00785326.1993.10429909; HERMAN PMJ, 1984, HYDROBIOLOGIA, V118, P21, DOI 10.1007/BF00031784; Higgins R.P., 1988, P1; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; Jahn A, 1996, MAR ECOL PROG SER, V142, P215, DOI 10.3354/meps142215; MAHAUT ML, 1995, DEEP-SEA RES PT I, V42, P1575, DOI 10.1016/0967-0637(95)00070-M; Modig H, 1998, J EXP MAR BIOL ECOL, V229, P133, DOI 10.1016/S0022-0981(98)00043-4; Moens T, 2000, MAR ECOL PROG SER, V205, P185, DOI 10.3354/meps205185; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P137, DOI 10.1016/S0022-0981(99)00114-8; Moens T, 1999, MAR BIOL, V134, P585, DOI 10.1007/s002270050573; Moens T, 1999, J MAR BIOL ASSOC UK, V79, P1017, DOI 10.1017/S0025315499001253; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; MOODLEY L, 1992, BIOL BULL, V183, P94, DOI 10.2307/1542410; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Moodley L, 2000, OPHELIA, V53, P203, DOI 10.1080/00785326.2000.10409450; Moodley L, 2008, J EXP MAR BIOL ECOL, V357, P41, DOI 10.1016/j.jembe.2007.12.025; Newell RC., 1979, BIOL INTERTIDAL ANIM; Nicol J, 1967, INT REV GESAMTEN HYD, V53; OTT J, 1973, Netherlands Journal of Sea Research, V7, P233, DOI 10.1016/0077-7579(73)90047-1; Pasotti F, 2012, POLAR BIOL, P1; POWELL E, 1989, J MAR RES, V47, P887, DOI 10.1357/002224089785076082; Pozzato L, J SEA RES UNPUB; REISE K, 1979, MAR BIOL, V54, P225, DOI 10.1007/BF00395785; Reise K., 1985, TIDAL FLAT ECOLOGY E, V54, P119; SOETAERT K, 1994, ESTUAR COAST SHELF S, V39, P367, DOI 10.1006/ecss.1994.1070; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soetaert K, 2009, FME FLEXIBLE MODELLI; Soetaert K., 2009, PRACTICAL GUIDE ECOL; Steyaert M, 2007, J EXP MAR BIOL ECOL, V345, P175, DOI 10.1016/j.jembe.2007.03.001; Steyaert M, 2005, HYDROBIOLOGIA, V540, P217, DOI 10.1007/s10750-004-7145-4; Steyaert M, 2001, MAR ECOL PROG SER, V224, P299, DOI 10.3354/meps224299; Steyaert M, 2003, THESIS GHENT U GHENT; WARWICK RM, 1981, OECOLOGIA, V51, P318, DOI 10.1007/BF00540900; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wetzel MA, 2001, COAST EST S, V58, P165; WIESER W, 1960, LIMNOL OCEANOGR, V5, P121, DOI 10.4319/lo.1960.5.2.0121; WIESER W, 1974, Marine Biology (Berlin), V26, P235, DOI 10.1007/BF00389254; WIESER W, 1977, J EXP MAR BIOL ECOL, V26, P97, DOI 10.1016/0022-0981(77)90082-X; WIESER W, 1961, LIMNOL OCEANOGR, V6, P262, DOI 10.4319/lo.1961.6.3.0262	58	30	31	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59289	10.1371/journal.pone.0059289	http://dx.doi.org/10.1371/journal.pone.0059289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555652	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200018
J	El-Desoky, GE; Bashandy, SA; Alhazza, IM; Al-Othman, ZA; Aboul-Soud, MAM; Yusuf, K				El-Desoky, Gaber E.; Bashandy, Samir A.; Alhazza, Ibrahim M.; Al-Othman, Zeid A.; Aboul-Soud, Mourad A. M.; Yusuf, Kareem			Improvement of Mercuric Chloride-Induced Testis Injuries and Sperm Quality Deteriorations by Spirulina platensis in Rats	PLOS ONE			English	Article							ASCORBIC-ACID; VITAMIN-E; SERUM TESTOSTERONE; LIPID-PEROXIDATION; OXIDATIVE STRESS; METHYL MERCURY; C-PHYCOCYANIN; IN-VIVO; GLUTATHIONE; SUPPLEMENTATION	The present study was undertaken to investigate the protective effect of the filamentous cyanobacterium Spirulina platensis (S. platensis) on mercury (II) chloride (HgCl2)-induced oxidative damages and histopathological alterations in the testis of Wistar albino rats. The animals were divided into four equal groups, i) control, ii) HgCl2, iii) S. platensis and iv) combination of HgCl2+S. platensis. Oxidative stress, induced by a single dose of HgCl2 (5 mg/kg, bw; subcutaneously, s.c.), substantially decreased (P<0.01) the activity level of testicular key enzymatic antioxidant biomarkers (superoxide dismutase, SOD; catalase, CAT and glutathione peroxidase, GPx), oxidative stress makers (blood hydroperoxide; testicular reduced glutathione, GSH and malondialdehyde, MDA), and testicular mercury levels. Moreover, HgCl2 administration resulted in a significant (P<0.01) increase in the number of sperms with abnormal morphology and decrease in epididymal sperm count, motility, plasma testosterone level and testicular cholesterol. Furthermore, HgCl2 exposure induced histopathological changes to the testis including morphological alterations of the seminiferous tubules, and degeneration and dissociation of spermatogenic cells. Notably, oral pretreatment of animals with Spirulina (300 mg/kg, bw) lowered the extent of the observed HgCl2-mediated toxicity, whereby significantly reducing the resulting lipid peroxidation products, mercury accumulation in the testis, histopathological changes of the testes and spermatozoal abnormalities. In parallel, the pretreatment with Spirulina also completely reverted the observed Hg-Cl-2-induced inhibition in enzymatic activities of antioxidant biomarkers (SOD, CAT and GPx) back to control levels. The pretreatment of rats with S. platensis significantly recovered the observed HgCl2-mediated decrease in the weight of accessory sex organs. Taken together, our findings clearly highlight the role of S. platensis as a protective modulator of HgCl2-induced testicular injuries and suggest some therapeutic potential in mammals. Further investigation of therapeutic strategies employing Spirulina against heavy metals toxicity in humans is therefore warranted.	[El-Desoky, Gaber E.; Al-Othman, Zeid A.; Yusuf, Kareem] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia; [Bashandy, Samir A.; Alhazza, Ibrahim M.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Bashandy, Samir A.] Natl Res Ctr, Dept Pharmacol, Cairo, Egypt; [El-Desoky, Gaber E.; Aboul-Soud, Mourad A. M.] Cairo Univ, Dept Biochem, Fac Agr, Giza, Egypt; [Aboul-Soud, Mourad A. M.] King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; King Saud University	El-Desoky, GE (corresponding author), King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia.	eldesokyg@yahoo.com	ALOthman, Zeid A./E-7333-2014; Aboul-Soud, Mourad/F-8111-2010; ALHAZZA, IBRAHIM MOHAMMAD/ABB-9996-2021; Mahmoud, Kareem Youssif/ABD-6953-2020	ALOthman, Zeid A./0000-0001-9970-2480; Aboul-Soud, Mourad/0000-0001-9395-0563; Yusuf, Kareem/0000-0002-7127-8750; bashandy, samir/0000-0001-5701-0320	King Saud University [RGP-VPP-130]	King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No RGP-VPP-130. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2011, J TOXICOL SCI, V36, P285; Aebi H, 1984, Methods Enzymol, V105, P121; Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; Al-Attar AM, 2011, SAUDI J BIOL SCI, V18, P63, DOI 10.1016/j.sjbs.2010.10.004; Al-Othman AM, 2011, AFR J PHARM PHARMACO, V5, P1263; Allouche L, 2009, EXP TOXICOL PATHOL, V61, P503, DOI 10.1016/j.etp.2008.12.003; ANDERSON MB, 1992, REPROD TOXICOL, V6, P41; ASADA K, 1974, AGR BIOL CHEM TOKYO, V38, P471, DOI 10.1080/00021369.1974.10861178; BARKLEY MS, 1977, HORM BEHAV, V8, P208, DOI 10.1016/0018-506X(77)90038-1; Bhat VB, 2000, BIOCHEM BIOPH RES CO, V275, P20, DOI 10.1006/bbrc.2000.3270; Boujbiha MA, 2009, REPROD TOXICOL, V28, P81, DOI 10.1016/j.reprotox.2009.03.011; Chamorro G, 1996, PHYTOTHER RES, V10, P28, DOI 10.1002/(SICI)1099-1573(199602)10:1&lt;28::AID-PTR768&gt;3.0.CO;2-A; Cohen Z, 1997, SPIRULINA PLATENSIS, P175; DELAMIRANDE E, 1992, J ANDROL, V13, P368; Diemer T, 2003, ENDOCRINOLOGY, V144, P2882, DOI 10.1210/en.2002-0090; Ekstrand J, 1998, EUR J ORAL SCI, V106, P678, DOI 10.1046/j.0909-8836.1998.eos10602ii03.x; El-Demerdash FM, 2001, J ENVIRON SCI HEAL B, V36, P489, DOI 10.1081/PFC-100104191; da Silva DAF, 2011, REPROD TOXICOL, V31, P431, DOI 10.1016/j.reprotox.2011.01.002; Garg Madhu C., 2005, Indian Journal of Experimental Biology, V43, P177; GERSTER H, 1993, INT J VITAM NUTR RES, V63, P93; Gey KF, 1998, BIOFACTORS, V7, P113, DOI 10.1002/biof.5520070115; Gunn S, 1970, TESTIS, V111, P378; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; InSug O, 1997, TOXICOLOGY, V124, P211, DOI 10.1016/S0300-483X(97)00153-4; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Karadeniz A, 2008, PHYTOTHER RES, V22, P1506, DOI 10.1002/ptr.2522; Kaur P, 2006, NEUROTOXICOLOGY, V27, P492, DOI 10.1016/j.neuro.2006.01.010; KECK C, 1993, REPROD TOXICOL, V7, P469, DOI 10.1016/0890-6238(93)90092-L; Khan AT, 2004, FOOD CHEM TOXICOL, V42, P571, DOI 10.1016/j.fct.2003.10.018; Kistanova E., 2009, Biotechnology in Animal Husbandry, V25, P547; KROMIDAS L, 1990, TOXICOL LETT, V51, P67, DOI 10.1016/0378-4274(90)90226-C; LORSCHEIDER FL, 1995, FASEB J, V9, P504, DOI 10.1096/fasebj.9.7.7737458; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Luxia AS, 1996, MUTAGENESIS, V17, P2395; Mathur N., 2010, J BIOL SCI, V10, P396, DOI [10.3923/jbs.2010.396.404, DOI 10.3923/JBS.2010.396.404]; Mazo V. K., 2004, Voprosy Pitaniya, V73, P45; Mcvey MJ, 2008, FOOD CHEM TOXICOL, V46, P270, DOI 10.1016/j.fct.2007.08.004; MOHAMED MK, 1987, PHARMACOL TOXICOL, V60, P29, DOI 10.1111/j.1600-0773.1987.tb01715.x; Mohammadi S., 2008, Medical Journal of Reproduction & Infertility, V9, P229; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; NAGASAWA H, 1989, In Vivo (Attiki), V3, P79; Narayana K, 2005, MUTAT RES-GEN TOX EN, V588, P28, DOI 10.1016/j.mrgentox.2005.08.012; Narayana K, 2002, MUTAT RES-GEN TOX EN, V513, P193, DOI 10.1016/S1383-5718(01)00308-4; Nogueira CW, 2003, TOXICOLOGY, V184, P85, DOI 10.1016/S0300-483X(02)00575-9; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park EJ, 2007, TOXICOL IN VITRO, V21, P789, DOI 10.1016/j.tiv.2007.01.019; Peixoto NC, 2003, TOXICOL LETT, V146, P17, DOI 10.1016/j.toxlet.2003.08.006; Peter C, 2008, PHYTOTHER RES, V22, P627; Popescu HI, 1978, BMJ-BRIT MED J, V1, P23; Rao MV, 2008, TOXICOL IN VITRO, V22, P935, DOI 10.1016/j.tiv.2008.01.014; RAO MV, 1989, ENDOCRINOL EXP, V23, P55; Rao MV, 2001, REPROD TOXICOL, V15, P705, DOI 10.1016/S0890-6238(01)00183-6; Romay C, 1998, INFLAMM RES, V47, P36, DOI 10.1007/s000110050256; Salazar M, 1998, J ETHNOPHARMACOL, V62, P235, DOI 10.1016/S0378-8741(98)00080-4; Salazar M, 1996, FOOD CHEM TOXICOL, V34, P353, DOI 10.1016/0278-6915(96)00000-2; Saxena Preeti Suman, 2004, Indian Journal of Experimental Biology, V42, P998; Sharma MK, 2007, FOOD CHEM TOXICOL, V45, P2412, DOI 10.1016/j.fct.2007.06.023; Shinyashiki M, 1998, BRAIN RES, V798, P147, DOI 10.1016/S0006-8993(98)00400-4; Simsek N, 2009, J HAZARD MATER, V164, P1304, DOI 10.1016/j.jhazmat.2008.09.041; Sonmez M, 2005, THERIOGENOLOGY, V63, P2063, DOI 10.1016/j.theriogenology.2004.10.003; Steinberger E, 1975, Curr Top Mol Endocrinol, V2, P337; Su L, 2008, ECOTOX ENVIRON SAFE, V70, P483, DOI 10.1016/j.ecoenv.2007.05.018; Torres-Duran PV, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-33; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; VACHHRAJANI K D, 1988, Journal of Reproductive Biology and Comparative Endocrinology, V8, P97; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Yousef MI, 2003, ANIM REPROD SCI, V76, P99, DOI 10.1016/S0378-4320(02)00226-9; Zlatki S, 1953, PRACTICAL CLIN BIOCH	69	81	86	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59177	10.1371/journal.pone.0059177	http://dx.doi.org/10.1371/journal.pone.0059177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555627	Green Submitted, gold, Green Published			2022-12-27	WOS:000317262200013
J	Beer, LA; Wang, H; Tang, HY; Cao, ZJ; Chang-Wong, T; Tanyi, JL; Zhang, RG; Liu, Q; Speicher, DW				Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Tanyi, Janos L.; Zhang, Rugang; Liu, Qin; Speicher, David W.			Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera	PLOS ONE			English	Article							CANCER-CELLS; PROTEOMIC ANALYSIS; PLASMA; MARKERS; COMPLEX; CARCINOMAS; STRATEGY	The most cancer-specific biomarkers in blood are likely to be proteins shed directly by the tumor rather than less specific inflammatory or other host responses. The use of xenograft mouse models together with in-depth proteorne analysis for identification of human proteins in the mouse blood is an under-utilized strategy that can clearly identify proteins shed by the tumor. In the current study, 268 human proteins shed into mouse blood from human OVCAR-3 serous tumors were identified based upon human vs. mouse species differences using a four-dimensional plasma proteome fractionation strategy. A multi-step prioritization and verification strategy was subsequently developed to efficiently select some of the most promising biomarkers from this large number of candidates. A key step was parallel analysis of human proteins detected in the tumor supernatant, because substantially greater sequence coverage for many of the human proteins initially detected in the xenograft mouse plasma confirmed assignments as tumor derived human proteins. Verification of candidate biomarkers in patient sera was facilitated by in-depth, label-free quantitative comparisons of serum pools from patients with ovarian cancer and benign ovarian tumors. The only proteins that advanced to multiple reaction monitoring (MRM) assay development were those that exhibited increases in ovarian cancer patients compared with benign tumor controls. MRM assays were facilely developed for all 11 novel biomarker candidates selected by this process and analysis of larger pools of patient sera suggested that all 11 proteins are promising candidate biomarkers that should be further evaluated on individual patient blood samples.	[Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Liu, Qin; Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA USA; [Beer, Lynn A.; Wang, Huan; Tang, Hsin-Yao; Cao, Zhijun; Chang-Wong, Tony; Liu, Qin; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Tanyi, Janos L.] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Zhang, Rugang] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; The Wistar Institute	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA USA.	speicher@wistar.org	Cao, Zhijun/T-2981-2019; cao, zhijun/F-4776-2012	Cao, Zhijun/0000-0001-5429-484X; Tang, Hsin-Yao/0000-0003-1838-018X	National Institutes of Health (NIH) [CA131582, CA010813]; Reproductive Scientist Development Program, NIH [5K12HD00849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA163377, R01CA131582] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reproductive Scientist Development Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA131582 to DWS and an institutional grant to The Wistar Institute, National Cancer Institute (NCI) Cancer Core Grant CA010813), and by the Reproductive Scientist Development Program, NIH grant 5K12HD00849 to JLT (www.nih.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011137; Andersen JD, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-21; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Beer LA, 2011, J PROTEOME RES, V10, P1126, DOI 10.1021/pr1008866; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Faca VM, 2009, CANCER RES, V69, P728, DOI 10.1158/0008-5472.CAN-08-3087; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; Hellstrom I, 2003, CANCER RES, V63, P3695; Heubner M, 2011, GYNECOL ONCOL, V120, P233, DOI 10.1016/j.ygyno.2010.10.014; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; JACOBS I, 1989, HUM REPROD, V4, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Pitteri SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007916; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Su AI, 2001, CANCER RES, V61, P7388; Tang HY, 2012, J PROTEOME RES, V11, P678, DOI 10.1021/pr200603h; Tang HY, 2005, EXPERT REV PROTEOMIC, V2, P295, DOI 10.1586/14789450.2.3.295; Tang HY, 2005, PROTEOMICS, V5, P3329, DOI 10.1002/pmic.200401275; Tchagang AB, 2008, MOL CANCER THER, V7, P27, DOI 10.1158/1535-7163.MCT-07-0565; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang H, 2011, J PROTEOME RES, V10, P4993, DOI 10.1021/pr200464c; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; WOOLAS RP, 1993, JNCI-J NATL CANCER I, V85, P1748, DOI 10.1093/jnci/85.21.1748; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yue Wen, 2004, Ai Zheng, V23, P141; Zhang Y, 2012, PROTEOMICS, V12, P1883, DOI 10.1002/pmic.201100654; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193; Zuo X, 2001, ELECTROPHORESIS, V22, P1603, DOI 10.1002/1522-2683(200105)22:9<1603::AID-ELPS1603>3.0.CO;2-I	40	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60129	10.1371/journal.pone.0060129	http://dx.doi.org/10.1371/journal.pone.0060129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544127	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700086
J	Kalani, A; Mohan, A; Godbole, MM; Bhatia, E; Gupta, A; Sharma, RK; Tiwari, S				Kalani, Anuradha; Mohan, Aradhana; Godbole, Madan M.; Bhatia, Eesh; Gupta, Amit; Sharma, Raj Kumar; Tiwari, Swasti			Wilm's Tumor-1 Protein Levels in Urinary Exosomes from Diabetic Patients with or without Proteinuria	PLOS ONE			English	Article							PODOCYTE; DISEASE; BIOMARKERS; PROTEOMICS; EXCRETION; HEALTH; SERUM	Background: Podocyte injury is an early feature of diabetic nephropathy (DN). Recently, urinary exosomal Wilm's tumor-1 protein (WT1), shed by renal epithelial cells, has been proposed as a novel biomarker for podocyte injury. However, its usefulness as biomarker for early diabetic nephropathy has not been verified yet. We investigated urinary exosomal WT1 in type-1 diabetic patients to confirm its role as a non-invasive biomarker for predicting early renal function decline. Methods:The expression of WT1 protein in urinary exosomes from spot urine samples of type-1 diabetes mellitus patients (n=48) and healthy controls (n=25) were analyzed. Patients were divided based on their urinary albumin excretion, ACR (mg/g creatinine) into non- proteinuria group (ACR<30 mg/g, n=30) and proteinuria group (ACR>30 mg/g, n=18). Regression analysis was used to assess the association between urinary exosomal levels of WT1 with parameters for renal function. Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic performance of exosomal WT-1. Results: WT1 protein was detected in 33 out of 48 diabetic patients and in only 1 healthy control. The levels of urinary exosomal WT1 protein is significantly higher (p = 0.001) in patients with proteinuria than in those without proteinuria. In addition, all the patients with proteinuria but only half of the patients without proteinuria were positive for exosomal WT1. We found that the level of exosomal WT1 were associated with a significant increase in urine protein-to-creatinine ratio, albumin-to-creatinine ratio, and serum creatinine as well as a decline in eGFR. Furthermore, patients exhibiting WT1-positive urinary exosomes had decreased renal function compared to WT1-negative patients. ROC analysis shows that WT-1 effectively predict GFR<60 ml. min-1/1.73 m(2). Conclusion: The predominant presence of WT1 protein in urinary exosomes of diabetic patients and increase in its expression level with decline in renal function suggest that it could be useful as early non-invasive marker for diabetic nephropathy.	[Kalani, Anuradha; Mohan, Aradhana; Godbole, Madan M.; Tiwari, Swasti] Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India; [Godbole, Madan M.; Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India; [Gupta, Amit; Sharma, Raj Kumar] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nephrol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Tiwari, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Mol Med & Biotechnol, Lucknow, Uttar Pradesh, India.	tiwaris@sgpgi.ac.in	Kalani, Anuradha/GYE-2711-2022		SGPGI- Intramural research grant; Department of Science and Technology, Government of India [SR/FR/LS-143/2010]; University Grant Commission, India [F 2-89/98]; Department of Biotechnology, India	SGPGI- Intramural research grant; Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grant Commission, India(University Grants Commission, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by SGPGI- Intramural research grant and the Department of Science and Technology, Government of India (SR/FR/LS-143/2010) grant to ST. AM was supported by a Junior Research Fellowship from University Grant Commission, India (F 2-89/98; SA I). AK was supported by a Research Associate Fellowship from Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramham K, 2009, QJM-INT J MED, V102, P523, DOI 10.1093/qjmed/hcp071; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hu J, 2009, CLIN EXP HYPERTENS, V31, P49, DOI 10.1080/10641960802409788; Kubo K, 1999, EUR J CLIN INVEST, V29, P824; Lee H, 2012, PEDIATR NEPHROL, V27, P317, DOI 10.1007/s00467-011-2035-2; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lezaic V, 2010, J MED BIOCHEM, V29, P288, DOI 10.2478/v10011-010-0046-3; Marshall SM, 2004, POSTGRAD MED J, V80, P624, DOI 10.1136/pgmj.2004.021287; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Woredekal Yalemzewd, 2008, Pediatr Endocrinol Rev, V5 Suppl 4, P999; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yadav I, 2011, Indian J Nephrol, V21, P219, DOI 10.4103/0971-4065.85479; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	25	97	110	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60177	10.1371/journal.pone.0060177	http://dx.doi.org/10.1371/journal.pone.0060177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544132	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700091
J	Verhoeven, TJ; Nolte, JW; Maal, TJJ; Berge, SJ; Becking, AG				Verhoeven, Tim J.; Nolte, Jitske W.; Maal, Thomas J. J.; Berge, Stefaan J.; Becking, Alfred G.			Unilateral Condylar Hyperplasia: A 3-Dimensional Quantification of Asymmetry	PLOS ONE			English	Article							FACIAL ASYMMETRY	Purpose: Objective quantifications of facial asymmetry in patients with Unilateral Condylar Hyperplasia (UCH) have not yet been described in literature. The aim of this study was to objectively quantify soft-tissue asymmetry in patients with UCH and to compare the findings with a control group using a new method. Material and Methods:Thirty 3D photographs of patients diagnosed with UCH were compared with 30 3D photographs of healthy controls. As UCH presents particularly in the mandible, a new method was used to isolate the lower part of the face to evaluate asymmetry of this part separately. The new method was validated by two observers using 3D photographs of five patients and five controls. Results: A significant difference (0.79 mm) between patients and controls whole face asymmetry was found. lntra- and inter-observer differences of 0.011 mm (-0.034-0.011) and 0.017 mm (-0.007-0.042) respectively were found. These differences are irrelevant in clinical practice. Conclusion: After objective quantification, a significant difference was identified in soft-tissue asymmetry between patients with UCH and controls. The method used to isolate mandibular asymmetry was found to be valid and a suitable tool to evaluate facial asymmetry.	[Verhoeven, Tim J.; Maal, Thomas J. J.; Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Nolte, Jitske W.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands; [Nolte, Jitske W.] Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Becking, Alfred G.] Emma Children Hosp Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands	Radboud University Nijmegen; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Verhoeven, TJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.	t.verhoeven@mka.umcn.nl	Bergé, S.J./H-8011-2014; Becking, Alfred G/G-9420-2016; Verhoeven, Tim/P-6916-2018; Maal, Thomas JJ/L-4497-2015; Berge, Stefaan/AAP-3708-2020	Becking, Alfred G/0000-0002-6371-4671; Maal, Thomas JJ/0000-0002-1702-4733; 				BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bochnen C, 2007, P 5 INT C 3 D DIG IM; Chia MS., 2008, ORTHO UPDATE, V1, P44, DOI DOI 10.12968/ortu.2008.1.2.44; De Groeve P, 2001, LECT NOTES COMPUTER, V2208, P991; EGYEDI P, 1969, Australian Dental Journal, V14, P12; FERRARIO VF, 1994, J ORAL MAXIL SURG, V52, P1126, DOI 10.1016/0278-2391(94)90528-2; GRAY RJM, 1990, INT J ORAL MAX SURG, V19, P65, DOI 10.1016/S0901-5027(05)80196-1; Hajeer Mohammad Y, 2002, Int J Adult Orthodon Orthognath Surg, V17, P318; Hwang HS, 2007, AM J ORTHOD DENTOFAC, V132, DOI 10.1016/j.ajodo.2007.01.017; IANNETTI G, 1989, ORAL SURG ORAL MED O, V68, P673, DOI 10.1016/0030-4220(89)90154-0; Jones RHB, 2012, J ORAL MAXIL SURG, V70, P1413, DOI 10.1016/j.joms.2011.03.047; Kaban LB, 2009, J CRANIOFAC SURG, V20, P622, DOI 10.1097/SCS.0b013e318195249c; Kau CH, 2007, INT J MED ROBOT COMP, V3, P97, DOI 10.1002/rcs.141; Maal TJJ, 2008, INT J ORAL MAX SURG, V37, P641, DOI 10.1016/j.ijom.2008.04.012; Maal TJJ, 2011, INT J ORAL MAX SURG, V40, P1252, DOI 10.1016/j.ijom.2011.02.033; Maal TJJ, 2010, J ORAL MAXIL SURG, V68, P2391, DOI 10.1016/j.joms.2009.10.017; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023; Nitzan DW, 2008, J ORAL MAXIL SURG, V66, P312, DOI 10.1016/j.joms.2007.08.046; OBWEGESER HL, 1986, J MAXILLOFAC SURG, V14, P183, DOI 10.1016/S0301-0503(86)80290-9; Plooij JM, 2009, INT J ORAL MAX SURG, V38, P267, DOI 10.1016/j.ijom.2008.12.009; Primozic J, 2011, EUROPEAN J ORTHODONT, V350, P7; Primozic J, 2009, EUR J ORTHODONT, V31, P352, DOI 10.1093/ejo/cjp041; Saridin CP, 2011, INT J ORAL MAX SURG, V40, P11, DOI 10.1016/j.ijom.2010.09.015; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL, P320; Verhoeven TJ, 2013, INT J ORAL MAX SURG, V42, P19, DOI 10.1016/j.ijom.2012.05.036; Villanueva-Alcojol L, 2011, J ORAL MAXIL SURG, V69, P447, DOI 10.1016/j.joms.2010.04.025	26	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59391	10.1371/journal.pone.0059391	http://dx.doi.org/10.1371/journal.pone.0059391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544063	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700025
J	Kurpios, NA; Girgis-Gabardo, A; Hallett, RM; Rogers, S; Gludish, DW; Kockeritz, L; Woodgett, J; Cardiff, R; Hassell, JA				Kurpios, Natasza A.; Girgis-Gabardo, Adele; Hallett, Robin M.; Rogers, Stephen; Gludish, David W.; Kockeritz, Lisa; Woodgett, James; Cardiff, Robert; Hassell, John A.			Single Unpurified Breast Tumor-Initiating Cells from Multiple Mouse Models Efficiently Elicit Tumors in Immune-Competent Hosts	PLOS ONE			English	Article							CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; MAMMARY-TUMORS; METASTATIC-DISEASE; NEU PROTOONCOGENE; CLONAL EVOLUTION; PROGENITOR CELLS; TRANSGENIC MICE; IN-VITRO; IDENTIFICATION	The tumor-initiating cell (TIC) frequency of bulk tumor cell populations is one of the criteria used to distinguish malignancies that follow the cancer stem cell model from those that do not. However, tumor-initiating cell frequencies may be influenced by experimental conditions and the extent to which tumors have progressed, parameters that are not always addressed in studies of these cells. We employed limiting dilution cell transplantation of minimally manipulated tumor cells from mammary tumors of several transgenic mouse models to determine their tumor-initiating cell frequency. We determined whether the tumors that formed following tumor cell transplantation phenocopied the primary tumors from which they were isolated and whether they could be serially transplanted. Finally we investigated whether propagating primary tumor cells in different tissue culture conditions affected their resident tumor-initiating cell frequency. We found that tumor-initiating cells comprised between 15% and 50% of the bulk tumor cell population in multiple independent mammary tumors from three different transgenic mouse models of breast cancer. Culture of primary mammary tumor cells in chemically-defined, serum-free medium as non-adherent tumorspheres preserved TIC frequency to levels similar to that of the primary tumors from which they were established. By contrast, propagating the primary tumor cells in serum-containing medium as adherent populations resulted in a several thousand-fold reduction in their tumor-initiating cell fraction. Our findings suggest that experimental conditions, including the sensitivity of the transplantation assay, can dramatically affect estimates of tumor initiating cell frequency. Moreover, conditional on cell culture conditions, the tumor-initiating cell fraction of bulk mouse mammary tumor cell preparations can either be maintained at high or low frequency in vitro thus permitting comparative studies of tumorigenic and non-tumorigenic cancer cells.	[Kurpios, Natasza A.; Girgis-Gabardo, Adele; Hallett, Robin M.; Rogers, Stephen; Gludish, David W.; Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON, Canada; [Kockeritz, Lisa; Woodgett, James] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Cardiff, Robert] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA	McMaster University; University of Toronto; University of California System; University of California Davis	Hassell, JA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON, Canada.	hassell@mcmaster.ca	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797; Gludish, David/0000-0002-3537-4585	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation (Ontario); Canadian Stem Cell Network	Canadian Breast Cancer Research Alliance; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation (Ontario); Canadian Stem Cell Network	The authors' research was supported by grants from the Canadian Breast Cancer Research Alliance, the Ontario Institute for Cancer Research, the Canadian Breast Cancer Foundation (Ontario) and the Canadian Stem Cell Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cardiff RD, 2001, VET PATHOL, V38, P357, DOI 10.1354/vp.38-4-357; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; DEOME KB, 1959, CANCER RES, V19, P515; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondratyev M, 2012, ONCOGENE, V31, P93, DOI 10.1038/onc.2011.212; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Maglione JE, 2004, MOL CANCER THER, V3, P941; Maglione JE, 2001, CANCER RES, V61, P8298; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; PULLAN S, 1996, EPITHELIAL CELL CULT; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smalley MJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1513, DOI 10.1177/002215549904701203; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vaillant F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2851; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	57	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58151	10.1371/journal.pone.0058151	http://dx.doi.org/10.1371/journal.pone.0058151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555570	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500006
J	Nishimura, S; Nagata, N; Shimbo, T; Asayama, N; Akiyama, J; Ohmagari, N; Yazaki, H; Oka, S; Uemura, N				Nishimura, So; Nagata, Naoyoshi; Shimbo, Takuro; Asayama, Naoki; Akiyama, Junichi; Ohmagari, Norio; Yazaki, Hirohisa; Oka, Shinichi; Uemura, Naomi			Factors Associated with Esophageal Candidiasis and Its Endoscopic Severity in the Era of Antiretroviral Therapy	PLOS ONE			English	Article							INFECTED PATIENTS; RISK-FACTORS; DIAGNOSIS; MANAGEMENT; SYMPTOMS; DISEASE	Background: Candidia esophagitis (CE) is an AIDS-defining condition, usually occurring in individuals with low CD4 counts of < 200 cells/mu L. Endoscopy is a valuable definitive diagnostic method for CE but may not be indicated for asymptomatic patients or for those with high CD4 counts or without oral candidiasis. This study assessed such patients to clarify the factors associated with CE and its severity on endoscopy in the highly active antiretroviral therapy (HAART) era. Methodology/Principal Findings: A total of 733 HIV-infected patients who underwent upper gastrointestinal (GI) endoscopy were analyzed. Sexual behavior, CD4(+) count, HIV-RNA viral load (VL), history of HAART, GI symptoms, GI diseases, and oral candidiasis were assessed. Endoscopic severity of CE was classified as mild (Kodsi's grade I/II) or severe (grade III/IV). Of the 733 subjects, 62 (8.46%) were diagnosed with CE (mild, n = 33; severe, n = 29). Of them, 56.5% (35/62) had no GI symptoms, 30.6% (19/62) had CD4 + >= 200 cells/mu L, and 55.3% (21/38) had no oral candidiasis. Univariate analysis found lower CD4(+) counts, higher HIV VL, and no history of HAART to be significantly associated with CE. With lower CD4(+) counts and higher HIV VL, CE occurrence increased significantly (P < 0.01 for trend in odds). Multivariate analysis showed low CD4(+) counts and high HIV VL to be independently associated with CE. Of the severe CE patients, 55.2% (16/29) had no GI symptoms and 44.4% (8/18) had no oral candidiasis. Median CD4(+) counts in severe cases were significantly lower than in mild cases (27 vs. 80; P = 0.04). Conclusions: Low CD4(+) counts and high HIV VL were found to be factors associated with CE, and advanced immunosuppression was associated with the development of severity. Endoscopy is useful as it can detect CE, even severe CE, in patients without GI symptoms, those with high CD4 counts, and those without oral candidiasis.	[Nishimura, So; Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan; [Nagata, Naoyoshi; Asayama, Naoki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Res Inst, Dept Clin Res & Informat, Tokyo, Japan; [Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dept Infect Dis, Tokyo, Japan; [Yazaki, Hirohisa; Oka, Shinichi] Natl Ctr Global Hlth & Med, Div AIDS Clin Ctr ACC, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Oka, Shinichi/0000-0002-9283-2167	Medicine for Ministry of Health; Labour and Welfare; Health and Labour Sciences Research Grants; Research on Clinical Trials' Infrastructure Development; National Center for Global Health and Medicine	Medicine for Ministry of Health; Labour and Welfare; Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Research on Clinical Trials' Infrastructure Development; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was partly supported by Medicine for Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Research on Clinical Trials' Infrastructure Development and grants for research and development in National Center for Global Health and Medicine. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTINORI A, 1995, ENDOSCOPY, V27, P371, DOI 10.1055/s-2007-1005716; BAEHR PH, 1994, GASTROENTEROLOGY, V106, P509, DOI 10.1016/0016-5085(94)90613-0; BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567; ERAS P, 1972, MEDICINE, V51, P367, DOI 10.1097/00005792-197209000-00002; Gaissert HA, 1999, ANN THORAC SURG, V67, P231, DOI 10.1016/S0003-4975(98)01144-8; Kanzaki R, 2009, SURG TODAY, V39, P972, DOI 10.1007/s00595-009-3958-0; KODSI BE, 1976, GASTROENTEROLOGY, V71, P715; LOPEZDUPLA M, 1992, AM J GASTROENTEROL, V87, P1771; Manfredi R, 2007, BRAZ J INFECT DIS, V11, P605, DOI 10.1590/S1413-86702007000600016; Martinez AC, 2000, EUR J CLIN MICROBIOL, V19, P96; Mimidis K, 2005, INT J CLIN PRACT, V59, P210, DOI [10.1111/j.1742-1241.2004.00249.x, 10.1111/j.1368-5031.2004.00249.x]; Monkemuller KE, 2005, DIGEST DIS SCI, V50, P230, DOI 10.1007/s10620-005-1587-z; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; PORRO GB, 1989, AM J GASTROENTEROL, V84, P143; ROLSTON KVI, 1992, ARCH INTERN MED, V152, P881, DOI 10.1001/archinte.1992.00400160161040; Werneck-Silva AL, 2009, WORLD J GASTROENTERO, V15, P1050, DOI 10.3748/wjg.15.1050; WHEELER RR, 1987, REV INFECT DIS, V9, P88; Wilcox CM, 1996, GASTROENTEROLOGY, V110, P1803, DOI 10.1053/gast.1996.v110.pm8964406; Wilcox CM, 1996, DIGEST DIS SCI, V41, P1337, DOI 10.1007/BF02088557; Yakoob A, 2003, WORLD J GASTROENTERO, V9, P2328; YOUNG JA, 1985, J CLIN PATHOL, V38, P293, DOI 10.1136/jcp.38.3.293	22	13	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58217	10.1371/journal.pone.0058217	http://dx.doi.org/10.1371/journal.pone.0058217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555571	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500007
J	Bendik, NF; Morrison, TA; Gluesenkamp, AG; Sanders, MS; O'Donnell, LJ				Bendik, Nathan F.; Morrison, Thomas A.; Gluesenkamp, Andrew G.; Sanders, Mark S.; O'Donnell, Lisa J.			Computer-Assisted Photo Identification Outperforms Visible Implant Elastomers in an Endangered Salamander, Eurycea tonkawae	PLOS ONE			English	Article							CAPTURE-RECAPTURE; PHOTOGRAPHIC IDENTIFICATION; CENTRAL TEXAS; PLETHODONTIDAE; TYPHLOMOLGE; RECOGNITION; TECHNOLOGY; NEOTENES; SURVIVAL; ECOLOGY	Despite recognition that nearly one-third of the 6300 amphibian species are threatened with extinction, our understanding of the general ecology and population status of many amphibians is relatively poor. A widely-used method for monitoring amphibians involves injecting captured individuals with unique combinations of colored visible implant elastomer (VIE). We compared VIE identification to a less-invasive method - computer-assisted photographic identification (photoID) - in endangered Jollyville Plateau salamanders (Eurycea tonkawae), a species with a known range limited to eight stream drainages in central Texas. We based photoID on the unique pigmentation patterns on the dorsal head region of 1215 individual salamanders using identification software Wild-ID. We compared the performance of photoID methods to VIEs using both 'high-quality' and 'low-quality' images, which were taken using two different camera types and technologies. For high-quality images, the photoID method had a false rejection rate of 0.76% compared to 1.90% for VIEs. Using a comparable dataset of lower-quality images, the false rejection rate was much higher (15.9%). Photo matching scores were negatively correlated with time between captures, suggesting that evolving natural marks could increase misidentification rates in longer term capture-recapture studies. Our study demonstrates the utility of large-scale capture-recapture using photo identification methods for Eurycea and other species with stable natural marks that can be reliably photographed.	[Bendik, Nathan F.] City Austin, Watershed Protect Dept, Austin, TX USA; [Morrison, Thomas A.] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Gluesenkamp, Andrew G.] Texas Parks & Wildlife Dept, Austin, TX 78744 USA; [Sanders, Mark S.; O'Donnell, Lisa J.] City Austin, Balcones Canyonlands Preserve, Austin, TX USA	University of Wyoming	Bendik, NF (corresponding author), City Austin, Watershed Protect Dept, Austin, TX USA.	nathan.bendik@austintexas.gov		Bendik, Nathan/0000-0001-8897-1722	City of Austin	City of Austin	Work was primarily funded by the City of Austin, through staff time and purchase of materials. This includes the City of Austin Balcones Canyonland Preserve and Watershed Protection Department. The Texas Parks and Wildlife Department also provided staff assistance with this project. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (with the exception of the authors and acknowledged individuals).	Amstrup S.C., 2010, HDB CAPTURE RECAPTUR; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Bailey Larissa L., 2004, Herpetological Review, V35, P38; Bendik NF, 2013, J ZOOL, V290, P35, DOI 10.1111/jzo.12009; Biagas TD, 2012, SOUTHWEST NAT, V57, P162, DOI 10.1894/0038-4909-57.2.162; Bolger DT, 2012, METHODS ECOL EVOL, V3, P813, DOI 10.1111/j.2041-210X.2012.00212.x; Bowles BD, 2006, HYDROBIOLOGIA, V553, P111, DOI 10.1007/s10750-005-5440-0; BRUCE RC, 1976, COPEIA, P242; Campbell TS, 2009, APPL HERPETOL, V6, P247, DOI 10.1163/157075409X420042; Chippindale PT, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P193; Chippindale PT, 2000, HERPETOL MONOGR, V14, P1, DOI 10.2307/1467045; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; Clemen Guenter, 2009, Vertebrate Zoology, V59, P157; Davis TM, 2001, J HERPETOL, V35, P217, DOI 10.2307/1566111; Emerson E. T., 1905, Pap Boston Soc, Vxxxii, P43; FERNANDEZ PJ, 1988, COPEIA, P928, DOI 10.2307/1445716; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Grant EHC, 2008, J WILDLIFE MANAGE, V72, P1247, DOI 10.2193/2007-183; Hastings KK, 2008, J MAMMAL, V89, P1201, DOI 10.1644/07-MAMM-A-151.1; Hillis DM, 2001, HERPETOLOGICA, V57, P266; Jain AK, 2007, NATURE, V449, P38, DOI 10.1038/449038a; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; KEZER J, 1952, COPEIA, P234, DOI 10.2307/1439269; Knox CD, 2012, NZ J ECOLOGY, V37, P7; Link WA, 2010, BIOMETRICS, V66, P178, DOI 10.1111/j.1541-0420.2009.01244.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lukacs PM, 2005, J WILDLIFE MANAGE, V69, P396, DOI 10.2193/0022-541X(2005)069<0396:EPSFDC>2.0.CO;2; McMahon C, 2005, AMBIO, V34, P426, DOI 10.1639/0044-7447(2005)034[0426:HIATSA]2.0.CO;2; Morrison TA, 2012, J ANIM ECOL, V81, P543, DOI 10.1111/j.1365-2656.2011.01941.x; Morrison TA, 2011, METHODS ECOL EVOL, V2, P454, DOI 10.1111/j.2041-210X.2011.00106.x; Phillips CT, 2009, N AM J FISH MANAGE, V29, P529, DOI 10.1577/M08-138.1; Pierce BA, 2010, SOUTHWEST NAT, V55, P291, DOI 10.1894/WL-30.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Sacchi R, 2010, AMPHIBIA-REPTILIA, V31, P489, DOI 10.1163/017353710X521546; SEVER DM, 1985, HERPETOLOGICA, V41, P71; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sweet S.S., 1984, Copeia, V1984, P428, DOI 10.2307/1445201; SWEET SS, 1982, HERPETOLOGICA, V38, P430; TUPA DD, 1976, TEX J SCI, V27, P179; U.S. Fish and Wildlife Service, 2012, FED REGISTER, V77, P50767; Wake D.B., 1966, MEMOIRS SO CALIFORNI, V4, P1; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	45	58	62	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59424	10.1371/journal.pone.0059424	http://dx.doi.org/10.1371/journal.pone.0059424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555669	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000316546400038
J	Jaramillo, VDA; Vargas, WA; Sukno, SA; Thon, MR				Armijos Jaramillo, Vinicio Danilo; Alberto Vargas, Walter; Ana Sukno, Serenella; Thon, Michael R.			Horizontal Transfer of a Subtilisin Gene from Plants into an Ancestor of the Plant Pathogenic Fungal Genus Colletotrichum	PLOS ONE			English	Article							MONOCOT-DICOT DIVERGENCE; SERINE PROTEASES; CELL-DEATH; PROTEIN; SUBTILASES; GENOME; FAMILY; PURIFICATION; PHYLOGENIES; EVOLUTION	The genus Colletotrichum contains a large number of phytopathogenic fungi that produce enormous economic losses around the world. The effect of horizontal gene transfer (HGT) has not been studied yet in these organisms. Inter-Kingdom HGT into fungal genomes has been reported in the past but knowledge about the HGT between plants and fungi is particularly limited. We describe a gene in the genome of several species of the genus Colletotrichum with a strong resemblance to subtilisins typically found in plant genomes. Subtilisins are an important group of serine proteases, widely distributed in all of the kingdoms of life. Our hypothesis is that the gene was acquired by Colletotrichum spp. through (HGT) from plants to a Colletotrichum ancestor. We provide evidence to support this hypothesis in the form of phylogenetic analyses as well as a characterization of the similarity of the subtilisin at the primary, secondary and tertiary structural levels. The remarkable level of structural conservation of Colletotrichum plant-like subtilisin (CPLS) with plant subtilisins and the differences with the rest of Colletotrichum subtilisins suggests the possibility of molecular mimicry. Our phylogenetic analysis indicates that the HGT event would have occurred approximately 150-155 million years ago, after the divergence of the Colletotrichum lineage from other fungi. Gene expression analysis shows that the gene is modulated during the infection of maize by C. graminicola suggesting that it has a role in plant disease. Furthermore, the upregulation of the CPLS coincides with the downregulation of several plant genes encoding subtilisins. Based on the known roles of subtilisins in plant pathogenic fungi and the gene expression pattern that we observed, we postulate that the CPLSs have an important role in plant infection.	[Armijos Jaramillo, Vinicio Danilo; Alberto Vargas, Walter; Ana Sukno, Serenella; Thon, Michael R.] Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Genet & Microbiol, Villamayor, Spain	University of Salamanca	Thon, MR (corresponding author), Univ Salamanca, Ctr Hispano Luso Invest Agr, Dept Genet & Microbiol, Villamayor, Spain.	mthon@usal.es	Armijos-Jaramillo, Vinicio Danilo/Q-4988-2019; Thon, Michael/M-9463-2014; Sukno, Serenella A/K-1449-2014; Sukno, Serenella/T-5919-2019	Armijos-Jaramillo, Vinicio Danilo/0000-0003-2965-2515; Thon, Michael/0000-0002-7225-7003; Sukno, Serenella A/0000-0003-3248-6490; Sukno, Serenella/0000-0003-3248-6490	Ministerio de Ciencia e Innovacion (MICINN) of Spain [AGL2011-29446, AGL2012-34139]; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador; Juan de la Cierva Program [JCI-2009-05364]	Ministerio de Ciencia e Innovacion (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador; Juan de la Cierva Program	This research was supported by funds from the Ministerio de Ciencia e Innovacion (MICINN) of Spain (grants AGL2011-29446 and AGL2012-34139). VDAJ was supported by a graduate fellowship from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion of Ecuador. W.A.V was supported by a fellowship from the Juan de la Cierva Program (JCI-2009-05364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Broad Institute of Harvard and MIT, COLL SEQ PROJ; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; BRYAN P, 1995, BIOCHEMISTRY-US, V34, P10310, DOI 10.1021/bi00032a026; Bryant MK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-168; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; Drummond AJ, 2011, GENEIOUS V5 5; Dunasevsky YE, 2007, BIOCHEMISTRY-MOSCOW+, V72, P345, DOI 10.1134/S0006297907030145; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gogarten JP, 2003, CURR BIOL, V13, pR53, DOI 10.1016/S0960-9822(02)01426-4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heuer Holger, 2007, Environmental Biosafety Research, V6, P3, DOI 10.1051/ebr:2007034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; Jorda L, 1999, J BIOL CHEM, V274, P2360, DOI 10.1074/jbc.274.4.2360; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim SE, 2012, J MICROBIOL BIOTECHN, V22, P563, DOI 10.4014/jmb.1110.10066; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Mi H, 2009, NUCLEIC ACIDS RES, V38, pD204, DOI DOI 10.1093/NAR/GKP1019; Muszewska A, 2011, MOL BIOL EVOL, V28, P3395, DOI 10.1093/molbev/msr176; Nakagawa M, 2010, J BIOL CHEM, V285, P29797, DOI 10.1074/jbc.M109.083162; Nembaware V, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-10; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OHTA Y, 1990, MOL MICROBIOL, V4, P295, DOI 10.1111/j.1365-2958.1990.tb00596.x; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Pearce G, 2010, P NATL ACAD SCI USA, V107, P14921, DOI 10.1073/pnas.1007568107; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy PV, 1996, PLANT PHYSIOL, V111, P1209, DOI 10.1104/pp.111.4.1209; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Rolland T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006515; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose R, 2010, PLANT SIGNAL BEHAV, V5, P180, DOI 10.4161/psb.5.2.11069; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Saeki K, 2000, BIOCHEM BIOPH RES CO, V279, P313, DOI 10.1006/bbrc.2000.3931; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrodinger L., 2020, PYMOL; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takano Yoshitaka, 2004, Journal of General Plant Pathology, V70, P390, DOI 10.1007/s10327-004-0147-2; Takeda N, 2009, PLANT J, V58, P766, DOI 10.1111/j.1365-313X.2009.03824.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Techtmann SM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00132; Tiburcio RA, 2010, J MOL EVOL, V70, P85, DOI 10.1007/s00239-009-9311-9; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0	89	23	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59078	10.1371/journal.pone.0059078	http://dx.doi.org/10.1371/journal.pone.0059078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554975	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800056
J	Gouba, N; Raoult, D; Drancourt, M				Gouba, Nina; Raoult, Didier; Drancourt, Michel			Plant and Fungal Diversity in Gut Microbiota as Revealed by Molecular and Culture Investigations	PLOS ONE			English	Article							DNA EXTRACTION METHODS; IDENTIFICATION; PCR; WATER; ASPERGILLUS; PATHOGENS; BACTERIAL; STARTER; ECOLOGY; CHEESE	Background: Few studies describing eukaryotic communities in the human gut microbiota have been published. The objective of this study was to investigate comprehensively the repertoire of plant and fungal species in the gut microbiota of an obese patient. Methodology/Principal Findings: A stool specimen was collected from a 27-year-old Caucasian woman with a body mass index of 48.9 who was living in Marseille, France. Plant and fungal species were identified using a PCR-based method incorporating 25 primer pairs specific for each eukaryotic phylum and universal eukaryotic primers targeting 18S rRNA, internal transcribed spacer (ITS) and a chloroplast gene. The PCR products amplified using these primers were cloned and sequenced. Three different culture media were used to isolate fungi, and these cultured fungi were further identified by ITS sequencing. A total of 37 eukaryotic species were identified, including a Diatoms (Blastocystis sp.) species, 18 plant species from the Streptophyta phylum and 18 fungal species from the Ascomycota, Basidiomycota and Chytridiocomycota phyla. Cultures yielded 16 fungal species, while PCR-sequencing identified 7 fungal species. Of these 7 species of fungi, 5 were also identified by culture. Twenty-one eukaryotic species were discovered for the first time in human gut microbiota, including 8 fungi (Aspergillus flavipes, Beauveria bassiana, Isaria farinosa, Penicillium brevicompactum, Penicillium dipodomyicola, Penicillium camemberti, Climacocystis sp. and Malassezia restricta). Many fungal species apparently originated from food, as did 11 plant species. However, four plant species (Atractylodes japonica, Fibraurea tinctoria, Angelica anomala, Mitella nuda) are used as medicinal plants. Conclusions/Significance: Investigating the eukaryotic components of gut microbiota may help us to understand their role in human health.	[Gouba, Nina; Raoult, Didier; Drancourt, Michel] Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, UMR63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	michel.drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Abdullahi I, 2005, APPL MICROBIOL BIOT, V68, P368, DOI 10.1007/s00253-005-1952-z; Asefa DT, 2009, INT J FOOD MICROBIOL, V128, P435, DOI 10.1016/j.ijfoodmicro.2008.09.024; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Bragulat MR, 2008, LETT APPL MICROBIOL, V47, P286, DOI 10.1111/j.1472-765X.2008.02422.x; Callahan HA, 2002, J EUKARYOT MICROBIOL, V49, P119, DOI 10.1111/j.1550-7408.2002.tb00354.x; Santos HLC, 2010, PARASITOL RES, V106, P883, DOI 10.1007/s00436-010-1728-y; Chabchoub N, 2009, AM J TROP MED HYG, V80, P24, DOI 10.4269/ajtmh.2009.80.24; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Desquesnes M, 2001, INT J PARASITOL, V31, P610, DOI 10.1016/S0020-7519(01)00161-8; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Dopheide A, 2008, APPL ENVIRON MICROB, V74, P1740, DOI 10.1128/AEM.01438-07; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Giraud F, 2010, INT J FOOD MICROBIOL, V137, P204, DOI 10.1016/j.ijfoodmicro.2009.11.014; Goerges S, 2008, APPL ENVIRON MICROB, V74, P2210, DOI 10.1128/AEM.01663-07; Griffiths LJ, 2006, J MED MICROBIOL, V55, P1187, DOI 10.1099/jmm.0.46510-0; Hayes DC, 2003, J VET DIAGN INVEST, V15, P390, DOI 10.1177/104063870301500417; Hong MH, 2010, ARCH PHARM RES, V33, P843, DOI 10.1007/s12272-010-0606-6; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Kabli Saleh A, 2007, MET ENV ARID LAND AG, V18, P87; Khatib R, 2001, MYCOSES, V44, P151, DOI 10.1046/j.1439-0507.2001.00639.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klich MA, 2009, TOXICOL IND HEALTH, V25, P657, DOI 10.1177/0748233709348271; Kolisko M, 2010, ENVIRON MICROBIOL, V12, P2700, DOI 10.1111/j.1462-2920.2010.02239.x; Kuiper MW, 2006, APPL ENVIRON MICROB, V72, P5750, DOI 10.1128/AEM.00085-06; Kullberg BJ, 2002, EUR J MED RES, V7, P183; Lee YW, 2011, ANN DERMATOL, V23, P156, DOI 10.5021/ad.2011.23.2.156; LEEMING JP, 1987, J CLIN MICROBIOL, V25, P2017, DOI 10.1128/JCM.25.10.2017-2019.1987; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li Q, 2012, DESALIN WATER TREAT, V43, P43, DOI 10.1080/19443994.2012.672197; Lin SJ, 2006, APPL ENVIRON MICROB, V72, P5626, DOI 10.1128/AEM.00586-06; Mirhendi H, 2005, J MICROBIOL METH, V61, P281, DOI 10.1016/j.mimet.2004.11.016; Muellner AN, 2001, INT J SYST EVOL MICR, V51, P783; Nam YD, 2008, J MICROBIOL, V46, P491, DOI 10.1007/s12275-008-0199-7; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Pandey PK, 2012, J BIOSCIENCES, V37, P221, DOI 10.1007/s12038-012-9197-3; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Pounder JI, 2007, J CLIN MICROBIOL, V45, P568, DOI 10.1128/JCM.01684-06; Provan J, 2004, EUR J PHYCOL, V39, P43, DOI 10.1080/09670260310001636668; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rodriguez A, 2012, INT J FOOD MICROBIOL, V155, P10, DOI 10.1016/j.ijfoodmicro.2012.01.007; Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Senapin S, 2011, AQUACULT INT, V19, P693, DOI 10.1007/s10499-010-9384-x; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sonjak S, 2011, FOOD MICROBIOL, V28, P373, DOI 10.1016/j.fm.2010.09.007; Stensvold CR, 2011, TRENDS PARASITOL, V27, P53, DOI 10.1016/j.pt.2010.11.005; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Valdez JG, 2009, PLANT PATHOL, V58, P352, DOI 10.1111/j.1365-3059.2008.01960.x; Westwood Greg S, 2005, Clin Mol Allergy, V3, P1, DOI 10.1186/1476-7961-3-1; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wright SG, 2012, INFECT DIS CLIN N AM, V26, P323, DOI 10.1016/j.idc.2012.03.009; Yim SM, 2010, ANN DERMATOL, V22, P41, DOI 10.5021/ad.2010.22.1.41	64	59	64	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59474	10.1371/journal.pone.0059474	http://dx.doi.org/10.1371/journal.pone.0059474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555039	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800096
J	Pan, Q; Ju, ZH; Huang, JM; Zhang, Y; Qi, C; Gao, Q; Zhou, L; Li, QL; Wang, LL; Zhong, JF; Liu, M; Wang, CF				Pan, Qing; Ju, Zhihua; Huang, Jinming; Zhang, Yan; Qi, Chao; Gao, Qin; Zhou, Lei; Li, Qiuling; Wang, Lingling; Zhong, Jifeng; Liu, Mei; Wang, Changfa			PLCz Functional Haplotypes Modulating Promoter Transcriptional Activity Are Associated with Semen Quality Traits in Chinese Holstein Bulls	PLOS ONE			English	Article							PHOSPHOLIPASE-C-ZETA; SINGLE-NUCLEOTIDE POLYMORPHISMS; OSCILLATION-INDUCING ACTIVITY; CANDIDATE GENE MARKERS; GROWTH-HORMONE GENE; CA2+ OSCILLATIONS; SPERM QUALITY; INOSITOL 1,4,5-TRISPHOSPHATE; EGG ACTIVATION; BINDING LECTIN	The sperm-specific phospholipase C zeta (PLCz) is a candidate sperm-borne oocyte-activating factor that triggers a characteristic series of physiological stimuli via cytoplasmic Ca2+ oscillations during fertilization. The molecular mechanisms involved in the regulation of PLCz gene expression remain largely unknown. To explore the genetic variations in the 5'-flanking region of the PLCz gene and their common haplotypes in Chinese Holstein bulls, as well as to determine whether these variations affect bovine semen quality traits and transcriptional activity, DNA samples were collected from Chinese Holstein bulls and sequenced for the identification of genetic variants in the 59-flanking region of PLCz. Two genetic variants were identified, and their haplotypic profiles were constructed. The two novel genetic variations (g. 2456 G>A and g. +65 T>C) were genotyped in 424 normal Chinese Holstein bulls. Bioinformatics analysis revealed that both loci are in transcription factor binding sites of the core promoter region. The association studies revealed that the two genetic variations and their haplotype combinations significantly affected semen quality traits. Using serially truncated constructs of the bovine PLCz promoters and the luciferase reporter, we found that a 726 bp (-641 nt to +112 nt) fragment constitutes the core promoter region. Furthermore, four haplotypes, H1H1 (GTGT), H2H2 (GCGC), H3H3 (ATAT), and H4H4 (ACAC), were significantly associated with semen quality traits and successfully transfected into MLTC-1 cell lines. The luciferase reporter assay showed that the different haplotypes exhibited distinct promoter activities. Maximal promoter activity was demonstrated by the H2H2 haplotypes, as compared with the other haplotypes. To the best of our knowledge, this study is the first report on genetic variants and their respective haplotypes in the 5'-flanking region of PLCz gene that can influence the semen quality of Chinese Holstein bulls as well as contribute to the transcriptional activity of the PLCz promoter.	[Pan, Qing; Ju, Zhihua; Huang, Jinming; Zhang, Yan; Qi, Chao; Gao, Qin; Zhou, Lei; Li, Qiuling; Wang, Lingling; Zhong, Jifeng; Wang, Changfa] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Peoples R China; [Pan, Qing; Liu, Mei] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Shandong Academy of Agricultural Sciences; Nanjing Normal University	Liu, M (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	meiliunj@163.com; wcf1967@yahoo.com.cn			National Science and Technology Pillar Program during the 12th Five-Year Plan of China [2011BAD19B04]; Modern Agro-industry Technology Research System [CARS-37]; State Major Project of Transgenic [2011ZX08007-004]; Well-bred Program of Shandong Province [2012LZ10-06]; Key Scientific and Technological Project of Shandong Province [2009GG20002033]	National Science and Technology Pillar Program during the 12th Five-Year Plan of China; Modern Agro-industry Technology Research System; State Major Project of Transgenic; Well-bred Program of Shandong Province; Key Scientific and Technological Project of Shandong Province	This work was partially supported by grants the National Science and Technology Pillar Program during the 12th Five-Year Plan of China (Grant no. 2011BAD19B04), the Modern Agro-industry Technology Research System (Grant no. CARS-37), State Major Project of Transgenic (2011ZX08007-004), the Well-bred Program of Shandong Province (Grant no. 2012LZ10-06), and the Key Scientific and Technological Project of Shandong Province (Grant no. 2009GG20002033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford-Guaus SJ, 2011, BIOL REPROD, V85, P78, DOI 10.1095/biolreprod.110.089466; Brind S, 2000, DEV BIOL, V223, P251, DOI 10.1006/dbio.2000.9728; Capparelli R, 2008, IMMUNOGENETICS, V60, P157, DOI 10.1007/s00251-008-0284-4; Coward K, 2005, REPRODUCTION, V130, P157, DOI 10.1530/rep.1.00707; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Daghigh-Kia H., 2007, THESIS U BONN BONN, P135; Dai LS, 2009, ANIM REPROD SCI, V114, P14, DOI 10.1016/j.anireprosci.2008.08.021; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Fujimoto S, 2004, DEV BIOL, V274, P370, DOI 10.1016/j.ydbio.2004.07.025; Gorbai A, 2009, AFR J MICROBIOL RES, V3, P809; Gorbani A, 2009, AFR J BIOTECHNOL, V8, P4811; Gredler B, 2007, REPROD DOMEST ANIM, V42, P326, DOI 10.1111/j.1439-0531.2006.00778.x; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Huang SY, 2002, ANIM REPROD SCI, V70, P99, DOI 10.1016/S0378-4320(01)00202-0; Ito M, 2008, BIOL REPROD, V78, P1081, DOI 10.1095/biolreprod.108.067801; Jellerette T, 2000, DEV BIOL, V223, P238, DOI 10.1006/dbio.2000.9675; Jones KT, 2000, DEV BIOL, V225, P1, DOI 10.1006/dbio.2000.9826; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; Ju ZH, 2012, DNA CELL BIOL, V31, P1038, DOI 10.1089/dna.2011.1555; Kaewmala K, 2012, REPROD DOMEST ANIM, V47, P213, DOI 10.1111/j.1439-0531.2011.01831.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kealey CG, 2006, J ANIM SCI, V84, P283, DOI 10.2527/2006.842283x; Knott JG, 2005, BIOL REPROD, V72, P992, DOI 10.1095/biolreprod.104.036244; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Lin CL, 2006, ANIM REPROD SCI, V92, P349, DOI 10.1016/j.anireprosci.2005.05.023; Liu XY, 2012, AFR J MICROBIOL RES, V6, P594, DOI 10.5897/AJMR11.1429; Liu XY, 2011, ANIM REPROD SCI, V129, P14, DOI 10.1016/j.anireprosci.2011.10.003; Long AD, 1999, GENOME RES, V9, P720; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Mathevon M, 1998, J DAIRY SCI, V81, P3321, DOI 10.3168/jds.S0022-0302(98)75898-9; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Ohl DA, 2008, UROL CLIN N AM, V35, P211, DOI 10.1016/j.ucl.2008.01.014; Parmentier I, 1999, DOMEST ANIM ENDOCRIN, V17, P139, DOI 10.1016/S0739-7240(99)00031-4; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; TAMULI MK, 1994, ANIM REPROD SCI, V35, P247, DOI 10.1016/0378-4320(94)90040-X; Wang PQ, 2011, GENET MOL RES, V10, P731, DOI 10.4238/vol10-2gmr1091; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wimmers K, 2005, ANIM GENET, V36, P152, DOI 10.1111/j.1365-2052.2005.01267.x; Wu H, 2001, BIOL REPROD, V64, P1338, DOI 10.1095/biolreprod64.5.1338; Yang WC, 2011, MOL BIOL REP, V38, P3411, DOI 10.1007/s11033-010-0450-2; Yoneda A, 2006, REPRODUCTION, V132, P393, DOI 10.1530/rep.1.01018; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942; Yoon SY, 2007, REPRODUCTION, V134, P695, DOI 10.1530/REP-07-0259; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021	49	20	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58795	10.1371/journal.pone.0058795	http://dx.doi.org/10.1371/journal.pone.0058795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554927	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800029
J	Yang, DH; Kang, JH; Park, YB; Park, YJ; Oh, HS; Kim, SB				Yang, Dong Hoon; Kang, Ji Hoon; Park, Young Bae; Park, Young Jae; Oh, Hwan Sup; Kim, Seoung Bum			Association Rule Mining and Network Analysis in Oriental Medicine	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; KNOWLEDGE DISCOVERY	Extracting useful and meaningful patterns from large volumes of text data is of growing importance. In the present study we analyze vast amounts of prescription data, generated from the book of oriental medicine to identify the relationships between the symptoms and the associated medicines used to treat these symptoms. The oriental medicine book used in this study (called Bangyakhappyeon) contains a large number of prescriptions to treat about 54 categorized symptoms and lists the corresponding herbal materials. We used an association rule algorithm combined with network analysis and found useful and informative relationships between the symptoms and medicines.	[Yang, Dong Hoon; Park, Young Bae; Park, Young Jae] Kyung Hee Univ, Dept Biofunct Med & Diagnost, Seoul, South Korea; [Kang, Ji Hoon; Kim, Seoung Bum] Korea Univ, Sch Ind Management Engn, Seoul, South Korea; [Oh, Hwan Sup] Kyung Hee Univ, Dept Human Informat Oriental Med, Interdisciplinary Programs, Yongin, Gyeonggi Do, South Korea; [Oh, Hwan Sup] Kyung Hee Univ, Dept Mech Engn, Yongin, Gyeonggi Do, South Korea	Kyung Hee University; Korea University; Kyung Hee University; Kyung Hee University	Kim, SB (corresponding author), Korea Univ, Sch Ind Management Engn, Seoul, South Korea.	sbkim1@korea.ac.kr			Brain Korea 21	Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was support in part by Brain Korea 21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R., 1994, P 20 INT C VER LARG, P487; Cao CG, 2004, ARTIF INTELL MED, V32, P3, DOI 10.1016/j.artmed.2004.01.015; Fayyad U, 1996, AI MAG, V17, P37; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Fu X, 2012, CHINESE J INTEGRATIV, P1; Hong CD, 2001, J ALTERN COMPLEM MED, V7, pS33; Hunyadi Daniel, 2011, European Computing Conference. Proceedings of the European Computing Conference (ECC '11), P376; Jang ES, 2007, KOREAN J OREINTAL ME, V13, P143; Jiang Y, 2003, WORLD SCI TECHNOL MO, V5, P33; 홍대기, 2011, [Journal of Korean Medicine, 대한한의학회지], V32, P56; Li C, 2004, LECT NOTES COMPUT SC, V3289, P246; Li S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S6; Memon N, 2010, DAT AMINING SOCIAL N; Riondato M, 2012, MACHINE LEARNING KNO, P5; Shang E., 2010, WORLD SCI TECHNOLOGY, V12, P377; Tan P., 2006, INTRO DATA MINING; Witten IH, 2011, MOR KAUF D, P1; [姚美村 Yao Meicun], 2002, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V25, P48; Zhou XZ, 2010, J BIOMED INFORM, V43, P650, DOI 10.1016/j.jbi.2010.01.002; Zhou XZ, 2005, LECT NOTES COMPUT SC, V3735, P396	21	33	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59241	10.1371/journal.pone.0059241	http://dx.doi.org/10.1371/journal.pone.0059241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555003	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800074
J	Hackman, DA; Betancourt, LM; Brodsky, NL; Kobrin, L; Hurt, H; Farah, MJ				Hackman, Daniel A.; Betancourt, Laura M.; Brodsky, Nancy L.; Kobrin, Lara; Hurt, Hallam; Farah, Martha J.			Selective Impact of Early Parental Responsivity on Adolescent Stress Reactivity	PLOS ONE			English	Article							CORTISOL RESPONSES; SALIVARY CORTISOL; ADRENOCORTICAL REACTIVITY; HPA AXIS; CHILDREN; ENVIRONMENT; VIOLENCE; SENSITIVITY; EXPOSURE; INFANTS	Research in animals has shown that early life experience, particularly parenting behaviors, influences later-life stress reactivity. Despite the tremendous relevance of this finding to human development and brain function, it has not been tested prospectively in humans. In this study two aspects of parenting were measured at age 4 in a sample of healthy, low socioeconomic status, African American children, and stress reactivity was measured in the same children 11-14 years later using a modified version of the Trier Social Stress Test (n = 55). Salivary cortisol was measured before, during and after the stressor and data were analyzed using piecewise hierarchical linear modeling. Parental responsivity, independent of the use of physical discipline, was positively related to cortisol reactivity. Effects were independent of subjective appraisals of the stressor and were also independent of other environmental risk factors and current psychosocial functioning. Therefore this study demonstrates in a novel and precise fashion that early childhood parental responsivity prospectively and independently predicts stress reactivity in adolescence.	[Hackman, Daniel A.; Kobrin, Lara; Farah, Martha J.] Univ Penn, Dept Psychol, Ctr Neurosci & Soc, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA; [Betancourt, Laura M.; Brodsky, Nancy L.; Hurt, Hallam] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia	Hackman, DA (corresponding author), Univ Penn, Dept Psychol, Ctr Neurosci & Soc, Ctr Cognit Neurosci, 3815 Walnut St, Philadelphia, PA 19104 USA.	hackmanda@upmc.edu		Hackman, Daniel/0000-0002-6968-5701	National Institute of Child Health and Human Development [R01-HD055689]; National Institute on Drug Abuse [R01-DA14129]; National Center for Research Resources [ULI-RR-024134]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055689] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014129] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the following grants: R01-HD055689 (National Institute of Child Health and Human Development), R01-DA14129 (National Institute on Drug Abuse), and ULI-RR-024134 (National Center for Research Resources). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Aiken L. S., 1991, MULTIPLE REGRESSION; Albers EM, 2008, J CHILD PSYCHOL PSYC, V49, P97, DOI 10.1111/j.1469-7610.2007.01818.x; Alink LRA, 2008, DEV PSYCHOBIOL, V50, P427, DOI 10.1002/dev.20300; Beck AT, 1996, PSYCHOL ASSESS; Bento SP, 2010, PSYCHONEUROENDOCRINO, V35, P944, DOI 10.1016/j.psyneuen.2009.12.003; Bernard K, 2010, DEV PSYCHOL, V46, P1771, DOI 10.1037/a0020660; Betancourt LM, 2011, NEUROTOXICOL TERATOL, V33, P36, DOI 10.1016/j.ntt.2010.08.004; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Blair C, 2008, DEV PSYCHOL, V44, P1095, DOI 10.1037/0012-1649.44.4.1095; Brotman LM, 2007, ARCH GEN PSYCHIAT, V64, P1172, DOI 10.1001/archpsyc.64.10.1172; Bugental DB, 2003, HORM BEHAV, V43, P237, DOI 10.1016/S0018-506X(02)00008-9; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Caldwell B., 1984, HOME OBSERVATION MEA; Carpenter LL, 2007, BIOL PSYCHIAT, V62, P1080, DOI 10.1016/j.biopsych.2007.05.002; Childs E, 2006, PSYCHOPHYSIOLOGY, V43, P366, DOI 10.1111/j.1469-8986.2006.00414.x; Chong RY, 2008, PSYCHONEUROENDOCRINO, V33, P246, DOI 10.1016/j.psyneuen.2007.10.014; Coplan JD, 2001, BIOL PSYCHIAT, V50, P200, DOI 10.1016/S0006-3223(01)01175-1; Cummings E. Mark, 2020, DEV PSYCHOPATHOL; Davies PT, 2011, DEV PSYCHOPATHOL, V23, P801, DOI 10.1017/S0954579411000319; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dozier M, 2008, DEV PSYCHOPATHOL, V20, P845, DOI 10.1017/S0954579408000400; Ellis BJ, 2008, CURR DIR PSYCHOL SCI, V17, P183, DOI 10.1111/j.1467-8721.2008.00571.x; Endler NS., 1999, COPING INVENTORY STR, V2; Engert V, 2010, J PSYCHIATR NEUROSCI, V35, P370, DOI 10.1503/jpn.100022; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fisher PA, 2012, INT J BEHAV DEV, V36, P29, DOI 10.1177/0165025411406863; Grant KA, 2009, DEV PSYCHOBIOL, V51, P625, DOI 10.1002/dev.20397; Gump BB, 2009, DEV PSYCHOPATHOL, V21, P207, DOI 10.1017/S0954579409000133; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gunnar MR, 2009, PSYCHONEUROENDOCRINO, V34, P953, DOI 10.1016/j.psyneuen.2009.02.010; Gunnar MR, 1996, DEV PSYCHOBIOL, V29, P191, DOI 10.1002/(SICI)1098-2302(199604)29:3<191::AID-DEV1>3.3.CO;2-T; Hackman DA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00277; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hastings PD, 2011, DEV PSYCHOBIOL, V53, P694, DOI 10.1002/dev.20545; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Hibel LC, 2006, HORM BEHAV, V50, P293, DOI 10.1016/j.yhbeh.2006.03.014; Hibel LC, 2011, DEV PSYCHOPATHOL, V23, P689, DOI 10.1017/S0954579411000010; HURT H, 1995, J DEV BEHAV PEDIATR, V16, P29, DOI 10.1097/00004703-199502000-00005; Hurt H, 2001, ARCH PEDIAT ADOL MED, V155, P1351, DOI 10.1001/archpedi.155.12.1351; Hurt H, 2009, NEUROTOXICOL TERATOL, V31, P334, DOI 10.1016/j.ntt.2009.08.002; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; Llabre MM, 2001, PSYCHOPHYSIOLOGY, V38, P951, DOI 10.1111/1469-8986.3860951; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Luecken LJ, 2009, HORM BEHAV, V55, P412, DOI 10.1016/j.yhbeh.2008.12.007; Luecken LJ, 2004, CLIN PSYCHOL REV, V24, P171, DOI 10.1016/j.cpr.2004.01.003; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Mueller A, 2011, NEUROPSYCHOPHARMACOL, V36, P1332, DOI 10.1038/npp.2011.11; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; O'Neal CR, 2010, CHILD DEV, V81, P290, DOI 10.1111/j.1467-8624.2009.01395.x; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Raudenbush SW, 2004, HLM 6 WINDOWS; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; RICHTERS JE, 1993, PSYCHIATRY, V56, P7; Rohleder N, 2006, INT J PSYCHOPHYSIOL, V59, P236, DOI 10.1016/j.ijpsycho.2005.10.012; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; SPANGLER G, 1993, CHILD DEV, V64, P1439, DOI 10.2307/1131544; Steptoe A, 2009, PSYCHONEUROENDOCRINO, V34, P273, DOI 10.1016/j.psyneuen.2008.09.006; Sturge-Apple ML, 2012, DEV PSYCHOL, V48, P237, DOI 10.1037/a0025419; Sturge-Apple ML, 2009, J FAM PSYCHOL, V23, P215, DOI 10.1037/a0014198; Taylor SE, 2004, J PERS, V72, P1365, DOI 10.1111/j.1467-6494.2004.00300.x; Tyrka AR, 2008, BIOL PSYCHIAT, V63, P1147, DOI 10.1016/j.biopsych.2008.01.011; Van Cauter E, 2007, HORM RES, V67, P2, DOI 10.1159/000097543; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Welberg L, 2006, PSYCHONEUROENDOCRINO, V31, P553, DOI 10.1016/j.psyneuen.2005.11.011; WORK W C, 1990, Journal of Primary Prevention, V11, P3, DOI 10.1007/BF01324858; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008; Zhang TY, 2006, BIOL PSYCHOL, V73, P72, DOI 10.1016/j.biopsycho.2006.01.009; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625	74	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58250	10.1371/journal.pone.0058250	http://dx.doi.org/10.1371/journal.pone.0058250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23555573	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200047
J	Duran, C; Chien, LT; Hartzell, HC				Duran, Charity; Chien, Li-Ting; Hartzell, H. Criss			Drosophila Bestrophin-1 Currents Are Regulated by Phosphorylation via a CaMKII Dependent Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-II; CL-CHANNELS; CHLORIDE CHANNELS; ANION CHANNELS; CELL-VOLUME; CALCIUM; INHIBITOR	Cell swelling induced by hypo-osmotic stress results in activation of volume-regulated anion channels (VRAC) that drive a compensatory regulatory volume decrease. We have previously shown that the Best1 gene in Drosophila encodes a VRAC that is also activated by increases in intracellular Ca2+. The role of Best1 as a VRAC has recently been independently confirmed by the Clapham lab in an unbiased RNAi screen. Although dBest1 is clearly a volume-regulated channel, its mechanisms of regulation remain unknown. Here we investigate Drosophila Best1 (dBest1) regulation using the Drosophila S2 cell model system. Because dBest1 activates slowly after establishing whole-cell recording, we tested the hypothesis that the channel is activated by phosphorylation. Two experiments indicate that phosphorylation is required for dBest1 activation: nonspecific protein kinase inhibitors or intracellular perfusion with the non-hydrolyzable ATP analog AMP-PNP dramatically reduce the amplitude of dBest1 currents. Furthermore, intracellular perfusion with ATP-gamma-S augments channel activation. The kinase responsible for dBest1 activation is likely Ca2+/calmodulin dependent kinase II (CaMKII), because specific inhibitors of this kinase dramatically inhibit dBest1 current activation. Neither specific PKA inhibitors nor inactive control inhibitors have effects on dBest1currents. Our results demonstrate that dBest1 currents are regulated by phosphorylation via a CaMKII dependent mechanism.	[Hartzell, H. Criss] Emory Univ Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA	Emory University; Emory University	Hartzell, HC (corresponding author), Emory Univ Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	criss.hartzell@emory.edu			National Institutes of Health (NIH) [EYO14852, GM60448]; National Eye Institute (NEI) [5T32EY007092-25]; NATIONAL EYE INSTITUTE [R01EY014852, T32EY007092, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) EYO14852, GM60448, and National Eye Institute (NEI) training grant 5T32EY007092-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; de Tassigny AD, 2003, FUND CLIN PHARMACOL, V17, P539, DOI 10.1046/j.1472-8206.2003.00197.x; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; HOLEVINSKY KO, 1994, J MEMBRANE BIOL, V140, P13; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; Stotz S, 2012, BIOPHYS J, DOI [10.1016/j.bpj.2011.11.2999 ed. 550a, DOI 10.1016/J.BPJ.2011.11.2999ED.550A]; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; Xiao QH, 2009, J PHYSIOL-LONDON, V587, P4379, DOI 10.1113/jphysiol.2009.176800; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	22	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58875	10.1371/journal.pone.0058875	http://dx.doi.org/10.1371/journal.pone.0058875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554946	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500051
J	Jezbera, J; Jezberova, J; Kasalicky, V; Simek, K; Hahn, MW				Jezbera, Jan; Jezberova, Jitka; Kasalicky, Vojtech; Simek, Karel; Hahn, Martin W.			Patterns of Limnohabitans Microdiversity across a Large Set of Freshwater Habitats as Revealed by Reverse Line Blot Hybridization	PLOS ONE			English	Article							COMMUNITY COMPOSITION; BACTERIA; LAKE; ASYMBIOTICUS; BIOGEOGRAPHY; TEMPERATE; RESERVOIR; UBIQUITY; RIVERS; RATES	Among abundant freshwater Betaproteobacteria, only few groups are considered to be of central ecological importance. One of them is the well-studied genus Limnohabitans and mainly its R-BT subcluster, investigated previously mainly by fluorescence in situ hybridization methods. We designed, based on sequences from a large Limnohabitans culture collection, 18 RLBH (Reverse Line Blot Hybridization) probes specific for different groups within the genus Limnohabitans by targeting diagnostic sequences on their 16 S-23 S rRNA ITS regions. The developed probes covered in sum 92% of the available isolates. This set of probes was applied to environmental DNA originating from 161 different European standing freshwater habitats to reveal the microdiversity (intra-genus) patterns of the Limnohabitans genus along a pH gradient. Investigated habitats differed in various physicochemical parameters, and represented a very broad range of standing freshwater habitats. The Limnohabitans microdiversity, assessed as number of RLBH-defined groups detected, increased significantly along the gradient of rising pH of habitats. 14 out of 18 probes returned detection signals that allowed predictions on the distribution of distinct Limnohabitans groups. Most probe-defined Limnohabitans groups showed preferences for alkaline habitats, one for acidic, and some seemed to lack preferences. Complete niche-separation was indicated for some of the probe-targeted groups. Moreover, bimodal distributions observed for some groups of Limnohabitans, suggested further niche separation between genotypes within the same probe-defined group. Statistical analyses suggested that different environmental parameters such as pH, conductivity, oxygen and altitude influenced the distribution of distinct groups. The results of our study do not support the hypothesis that the wide ecological distribution of Limnohabitans bacteria in standing freshwater habitats results from generalist adaptations of these bacteria. Instead, our observations suggest that the genus Limnohabitans, as well as its R-BT subgroup, represent ecologically heterogeneous taxa, which underwent pronounced ecological diversification.	[Jezbera, Jan; Jezberova, Jitka; Kasalicky, Vojtech; Simek, Karel] ASCR, Ctr Biol, Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Jezbera, J (corresponding author), ASCR, Ctr Biol, Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic.	jezbera@hbu.cas.cz	Simek, Karel/F-8930-2014; Šimek, Karel/AAB-1956-2021; Hahn, Martin W./B-9998-2008; Kasalicky, Vojtech/F-8578-2014; Jezberova, Jitka/G-1024-2014; Jezbera, Jan/B-5657-2015; Kasalicky, Vojtech/AAC-2903-2021	Šimek, Karel/0000-0002-7058-9063; Hahn, Martin W./0000-0003-0501-2556; Kasalicky, Vojtech/0000-0002-9132-8321; Jezberova, Jitka/0000-0001-5000-9319; Kasalicky, Vojtech/0000-0002-9132-8321	Czech Grant Agency [P504/10/0566, EEF/10/E011]	Czech Grant Agency(Grant Agency of the Czech Republic)	This study was financially supported by the Czech Grant Agency projects P504/10/0566 and EEF/10/E011 awarded to Jan Jezbera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Crump BC, 2005, LIMNOL OCEANOGR, V50, P1718, DOI 10.4319/lo.2005.50.6.1718; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P1358, DOI 10.1099/ijs.0.013292-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P766, DOI 10.1128/AEM.71.2.766-773.2005; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; HANSKI I, 1997, METAPOPULATION BIOL; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jezbera J, 2005, FEMS MICROBIOL ECOL, V52, P351, DOI 10.1016/j.femsec.2004.12.001; Jezbera J, 2012, FEMS MICROBIOL ECOL, V81, P467, DOI 10.1111/j.1574-6941.2012.01372.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Jezberova J, 2010, ENVIRON MICROBIOL, V12, P658, DOI 10.1111/j.1462-2920.2009.02106.x; Kasalicky V, 2013, PLOS ONE IN PRESS; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liao PC, 2007, MICROB ECOL, V54, P497, DOI 10.1007/s00248-007-9217-2; Lindstrom ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025883; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2010, APPL ENVIRON MICROB, V76, P3762, DOI 10.1128/AEM.00774-10; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; TERBRAAK CJF, 1998, CANOCO WINDOWS VERSI; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141; Zwart G, 2003, APPL ENVIRON MICROB, V69, P5875, DOI 10.1128/AEM.69.10.5875-5883.2003	32	31	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58527	10.1371/journal.pone.0058527	http://dx.doi.org/10.1371/journal.pone.0058527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554898	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500028
J	Turturro, MV; Christenson, MC; Larson, JC; Young, DA; Brey, EM; Papavasiliou, G				Turturro, Michael V.; Christenson, Megan C.; Larson, Jeffery C.; Young, Daniel A.; Brey, Eric M.; Papavasiliou, Georgia			MMP-Sensitive PEG Diacrylate Hydrogels with Spatial Variations in Matrix Properties Stimulate Directional Vascular Sprout Formation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIRECTED CELL-MIGRATION; COVALENTLY IMMOBILIZED GRADIENTS; VEGF; MUSCLE; SCAFFOLDS; ANGIOGENESIS; ORGANIZATION; DEGRADATION; FIBRONECTIN	The spatial presentation of immobilized extracellular matrix (ECM) cues and matrix mechanical properties play an important role in directed and guided cell behavior and neovascularization. The goal of this work was to explore whether gradients of elastic modulus, immobilized matrix metalloproteinase (MMP)-sensitivity, and YRGDS cell adhesion ligands are capable of directing 3D vascular sprout formation in tissue engineered scaffolds. PEGDA hydrogels were engineered with mechanical and biofunctional gradients using perfusion-based frontal photopolymerization (PBFP). Bulk photopolymerized hydrogels with uniform mechanical properties, degradation, and immobilized biofunctionality served as controls. Gradient hydrogels exhibited an 80.4% decrease in elastic modulus and a 56.2% decrease in immobilized YRGDS. PBFP hydrogels also demonstrated gradients in hydrogel degradation with degradation times ranging from 10-12 hours in the more crosslinked regions to 4-6 hours in less crosslinked regions. An in vitro model of neovascularization, composed of co-culture aggregates of endothelial and smooth muscle cells, was used to evaluate the effect of these gradients on vascular sprout formation. Aggregate invasion in gradient hydrogels occurred bi-directionally with sprout alignment observed in the direction parallel to the gradient while control hydrogels with homogeneous properties resulted in uniform invasion. In PBFP gradient hydrogels, aggregate sprout length was found to be twice as long in the direction parallel to the gradient as compared to the perpendicular direction after three weeks in culture. This directionality was found to be more prominent in gradient regions of increased stiffness, crosslinked MMP-sensitive peptide presentation, and immobilized YRGDS concentration.	[Turturro, Michael V.; Christenson, Megan C.; Larson, Jeffery C.; Young, Daniel A.; Brey, Eric M.; Papavasiliou, Georgia] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA	Illinois Institute of Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Papavasiliou, G (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	papavasiliou@iit.edu	Young, Daniel/F-9652-2017; Papavailiou, Georgia/D-2645-2014	Young, Daniel/0000-0003-1214-9577; Papavailiou, Georgia/0000-0002-6730-7360	Searle Funds at the Chicago Community Trust; National Institutes of Health [R21HL094916]; Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094916] Funding Source: NIH RePORTER	Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the CBC-UIC Research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium, for their help with performing mass spectroscopy on our synthesized peptides. The authors would also like to acknowledge the laboratory of Professor David Venerus in the department of Chemical and Biological Engineering at the Illinois Institute of Technology for providing access for mechanical testing of our samples. Finally the authors thank Dr. Howard Greisler (Edward Hines Jr. VA Hospital, Hines, Illinois) for his stimulating discussions and input during the early phases of this work.; This work was supported by National Institutes of Health (Grant No. R21HL094916) and the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Borselli C, 2007, J BIOMED MATER RES A, V80A, P297, DOI 10.1002/jbm.a.30896; Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332; Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046; Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n; Cai KY, 2009, COLLOID SURFACE B, V72, P230, DOI 10.1016/j.colsurfb.2009.04.008; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761; DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020; DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021; Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Guarnieri D, 2008, MACROMOL SYMP, V266, P36, DOI 10.1002/masy.200850607; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057; Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381; Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x; Mac Gabhann F, 2007, J APPL PHYSIOL, V102, P722, DOI 10.1152/japplphysiol.00800.2006; Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574; Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002; Papavasiliou G, 2010, J INVEST MED, V58, P838, DOI 10.231/JIM.0b013e3181f18e38; Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016; Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061; Porter AM, 2011, BIOMACROMOLECULES, V12, P242, DOI 10.1021/bm101220b; Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Smith JT, 2006, EXP CELL RES, V312, P2424, DOI 10.1016/j.yexcr.2006.04.005; Smith JT, 2009, COMB CHEM HIGH T SCR, V12, P598, DOI 10.2174/138620709788681871; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turturro MV, 2012, J BIOMAT SCI-POLYM E, V23, P917, DOI 10.1163/092050611X566450; Wallace CS, 2007, AM J PHYSIOL-HEART C, V293, pH1978, DOI 10.1152/ajpheart.00618.2007; Wang Z, 2012, J MATER SCI-MATER M, V14, P14; West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje	46	55	60	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58897	10.1371/journal.pone.0058897	http://dx.doi.org/10.1371/journal.pone.0058897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554954	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500055
J	Kozhevnikov, M; Elliott, J; Shephard, J; Gramann, K				Kozhevnikov, Maria; Elliott, James; Shephard, Jennifer; Gramann, Klaus			Neurocognitive and Somatic Components of Temperature Increases during g-Tummo Meditation: Legend and Reality	PLOS ONE			English	Article							BODY-TEMPERATURE; ALPHA OSCILLATIONS; INHIBITION; ATTENTION; BIOFEEDBACK; HYPOTHESIS; RETENTION; IMAGERY; CORTEX; MEMORY	Stories of g-tummo meditators mysteriously able to dry wet sheets wrapped around their naked bodies during a frigid Himalayan ceremony have intrigued scholars and laypersons alike for a century. Study 1 was conducted in remote monasteries of eastern Tibet with expert meditators performing g-tummo practices while their axillary temperature and electroencephalographic (EEG) activity were measured. Study 2 was conducted with Western participants (a non-meditator control group) instructed to use the somatic component of the g-tummo practice (vase breathing) without utilization of meditative visualization. Reliable increases in axillary temperature from normal to slight or moderate fever zone (up to 38.3 degrees C) were observed among meditators only during the Forceful Breath type of g-tummo meditation accompanied by increases in alpha, beta, and gamma power. The magnitude of the temperature increases significantly correlated with the increases in alpha power during Forceful Breath meditation. The findings indicate that there are two factors affecting temperature increase. The first is the somatic component which causes thermogenesis, while the second is the neurocognitive component (meditative visualization) that aids in sustaining temperature increases for longer periods. Without meditative visualization, both meditators and non-meditators were capable of using the Forceful Breath vase breathing only for a limited time, resulting in limited temperature increases in the range of normal body temperature. Overall, the results suggest that specific aspects of the g-tummo technique might help non-meditators learn how to regulate their body temperature, which has implications for improving health and regulating cognitive performance.	[Kozhevnikov, Maria; Elliott, James] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Kozhevnikov, Maria] Harvard Univ, Sch Med, Dept Radiol, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Elliott, James] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Shephard, Jennifer] Harvard Univ, Div Social Sci, Cambridge, MA 02138 USA; [Gramann, Klaus] Berlin Inst Technol, D Berlin, Germany; [Gramann, Klaus] Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA	National University of Singapore; Harvard University; University of California System; University of California Santa Barbara; Harvard University; Technical University of Berlin; University of California System; University of California San Diego	Kozhevnikov, M (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	psymaria@nus.edu.sg	Gramann, Klaus/AAD-7313-2019	Gramann, Klaus/0000-0003-2673-1832	National University of Singapore	National University of Singapore(National University of Singapore)	This research was supported by the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas LI, 2001, NEUROSCI LETT, V310, P57, DOI 10.1016/S0304-3940(01)02094-8; BENSON H, 1982, NATURE, V295, P234, DOI 10.1038/295234a0; BENSON H, 1990, BEHAV MED, V16, P90, DOI 10.1080/08964289.1990.9934596; BIRD EI, 1980, BIOFEEDBACK SELF-REG, V5, P283, DOI 10.1007/BF00998604; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; CAMPBELL SS, 1995, SLEEP, V18, P408, DOI 10.1093/sleep/18.6.408; Colquhoun WP, 1985, HOURS WORK TEMPORAL, P253; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Cromie WJ, 2002, MEDITATION CHANGES T; David-Neel Alexandra., 1971, MAGIC MYSTERY TIBET; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Erickson CA, 1996, EXP BRAIN RES, V107, P348; Evans-Wentz W. Y., 2002, TIBETAN YOGA SECRET; Govinda Lama Anagarika, 1988, WAY WHITE CLOUDS; HOLLAND RL, 1985, J APPL PHYSIOL, V59, P1823, DOI 10.1152/jappl.1985.59.6.1823; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kelly G, 2006, ALTERN MED REV, V11, P278; Kiebel SJ, 2005, HUM BRAIN MAPP, V26, P170, DOI 10.1002/hbm.20153; KING NJ, 1981, BEHAV THER, V12, P263, DOI 10.1016/S0005-7894(81)80077-9; KLEITMAN N, 1950, J APPL PHYSIOL, V3, P309, DOI 10.1152/jappl.1950.3.6.309; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kluger MJ, 1996, INFECT DIS CLIN N AM, V10, P1, DOI 10.1016/S0891-5520(05)70282-8; Lee LH, 1996, J DEV BEHAV PEDIATR, V17, P323, DOI 10.1097/00004703-199610000-00006; Levine W., 1996, CONTROL HDB; Lindsley G, 1999, CHRONOBIOL INT, V16, P69, DOI 10.3109/07420529908998713; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; MACKOWIAK PA, 1994, ANN INTERN MED, V120, P1037, DOI 10.7326/0003-4819-120-12-199406150-00010; Masino SA, 2000, NEUROSCIENCE, V101, P907, DOI 10.1016/S0306-4522(00)00431-0; McGuik J, 1998, CONT HYPNOSIS, V15, P101; Moore LE, 1996, AM J CLIN HYPN, V39, P97; Mullin G. H., 1996, TSONGKHAPAS 6 YOGAS; Mullin G. H., 1997, READINGS 6 YOGAS NAR; Nise Norman S., 2008, CONTROL SYSTEMS ENG; Rowe-Horwege RW, 2006, ENCY MED DEV INSTRUM; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Serra D, 2012, CLIN J ONCOL NURS, V16, P617, DOI 10.1188/12.CJON.617-623; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; TAUB E, 1976, BIOFEEDBACK SELF-REG, V1, P147, DOI 10.1007/BF00998583; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; WILLERMAN L, 1976, PERCEPT MOTOR SKILL, V43, P995, DOI 10.2466/pms.1976.43.3.995; Worden MS, 2000, J NEUROSCI, V20; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002	45	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58244	10.1371/journal.pone.0058244	http://dx.doi.org/10.1371/journal.pone.0058244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555572	Green Published, gold			2022-12-27	WOS:000317263900004
J	Ahmad, A; Crupi, R; Campolo, M; Genovese, T; Esposito, E; Cuzzocrea, S				Ahmad, Akbar; Crupi, Rosalia; Campolo, Michela; Genovese, Tiziana; Esposito, Emanuela; Cuzzocrea, Salvatore			Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; TOLL-LIKE RECEPTORS; SPINAL-CORD-INJURY; NF-KAPPA-B; EXPRESSION; NEUROPROTECTION; ACTIVATION; SYSTEM; INHIBITION; RELEASE	Background: Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to neuronal damage and behavioral impairment. Toll-like receptors (TLRs) are signaling receptors in the innate immune system, although emerging evidence indicates their role in brain injury. We have therefore investigated the role played by TLR4 signaling pathway in the development of mechanisms of secondary inflammatory process in traumatic brain injury (TBI) differ in mice that lack a functional TLR4 signaling pathway. Methods/Principal Findings: Controlled cortical impact injury was performed on TLR4 knockout (KO) mice (C57BL/10ScNJ) and wild-type (WT) mice (C57BL/10ScNJ). TBI outcome was evaluated by determination of infarct volume and assessment of neurological scores. Brains were collected at 24 h after TBI. When compared to WT mice, TLR4 KO mice had lower infarct volumes and better outcomes in neurological and behavioral tests (evaluated by EBST and rotarod test). Mice that lacked TLR4 had minor expression of TBI-induced GFAP, Chymase, Tryptase, IL-1 beta, iNOS, PARP and Nitrotyrosine mediators implicated in brain damage. The translocation of expression of p-JNK, I kappa B-alpha and NF-kappa B pathway were also lower in brains from TLR4 KO mice. When compared to WT mice, resulted in significant augmentation of all the above described parameters. In addition, apoptosis levels in TLR4 KO mice had minor expression of Bax while on the contrary with Bcl-2. Conclusions/Significance: Our results clearly demonstrated that absence of TLR4 reduces the development of neuroinflammation, tissues injury events associated with brain trauma and may play a neuroprotective role in TBI in mice.	[Ahmad, Akbar; Crupi, Rosalia; Campolo, Michela; Genovese, Tiziana; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Manchester, Lancs, England	University of Messina; University of Manchester	Cuzzocrea, S (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy.	salvator@unime.it	AHMAD, AKBAR/D-6621-2013; Crupi, Rosalia/U-4364-2019; Campolo, Michela/K-6432-2016	AHMAD, AKBAR/0000-0003-4341-0352; Crupi, Rosalia/0000-0002-7629-3132; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690; Esposito, Emanuela/0000-0002-2663-6387; GENOVESE, Tiziana/0000-0002-3335-7327; Ahmad, Akbar/0000-0003-1841-9670	Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy	Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy	Funding provided by the Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine, Messina, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bar-Peled O, 1999, J NEUROSCI RES, V55, P542, DOI 10.1002/(SICI)1097-4547(19990301)55:5<542::AID-JNR2>3.0.CO;2-7; Barcia C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002977; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Cao GD, 2002, J NEUROSCI, V22, P5423; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Chvatal A, 2007, J NEUROSCI RES, V85, P260, DOI 10.1002/jnr.21113; Cuzzocrea S, 2001, SHOCK, V16, P51, DOI 10.1097/00024382-200116010-00010; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; GORDON JR, 1991, J EXP MED, V174, P103, DOI 10.1084/jem.174.1.103; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Hwang D, 2001, FASEB J, V15, P2556, DOI 10.1096/fj.01-0432com; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; KOWNATZKI E, 1982, MOL IMMUNOL, V19, P1297, DOI 10.1016/0161-5890(82)90296-6; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee JY, 2005, BIOCHEM PHARMACOL, V70, P1231, DOI 10.1016/j.bcp.2005.07.020; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Sirin BH, 2002, ACTA CARDIOL, V57, P279, DOI 10.2143/AC.57.4.2005427; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Trendelenburg G, 2008, J CEREBR BLOOD F MET, V28, P867, DOI 10.1038/sj.jcbfm.9600609; Vanzani MC, 2005, MEDICINA-BUENOS AIRE, V65, P213; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	88	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e57208	10.1371/journal.pone.0057208	http://dx.doi.org/10.1371/journal.pone.0057208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555560	gold, Green Published, Green Submitted			2022-12-27	WOS:000317262200001
J	Lobo, J; Bettencourt, LMA; Strumsky, D; West, GB				Lobo, Jose; Bettencourt, Luis M. A.; Strumsky, Deborah; West, Geoffrey B.			Urban Scaling and the Production Function for Cities	PLOS ONE			English	Article							AGGLOMERATION ECONOMIES; CITY; DETERMINANTS; LOCALIZATION; RETURNS; GROWTH	The factors that account for the differences in the economic productivity of urban areas have remained difficult to measure and identify unambiguously. Here we show that a microscopic derivation of urban scaling relations for economic quantities vs. population, obtained from the consideration of social and infrastructural properties common to all cities, implies an effective model of economic output in the form of a Cobb-Douglas type production function. As a result we derive a new expression for the Total Factor Productivity (TFP) of urban areas, which is the standard measure of economic productivity per unit of aggregate production factors (labor and capital). Using these results we empirically demonstrate that there is a systematic dependence of urban productivity on city population size, resulting from the mismatch between the size dependence of wages and labor, so that in contemporary US cities productivity increases by about 11% with each doubling of their population. Moreover, deviations from the average scale dependence of economic output, capturing the effect of local factors, including history and other local contingencies, also manifest surprising regularities. Although, productivity is maximized by the combination of high wages and low labor input, high productivity cities show invariably high wages and high levels of employment relative to their size expectation. Conversely, low productivity cities show both low wages and employment. These results shed new light on the microscopic processes that underlie urban economic productivity, explain the emergence of effective aggregate urban economic output models in terms of labor and capital inputs and may inform the development of economic theory related to growth.	[Lobo, Jose] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA	Arizona State University; Arizona State University-Tempe; The Santa Fe Institute; University of North Carolina; University of North Carolina Charlotte	Lobo, J (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	jose.lobo@asu.edu	Bettencourt, Luis/R-9861-2019; Strumsky, Deborah/F-5795-2013		Rockefeller Foundation; James S. McDonnell Foundation [220020195]; National Science Foundation [103522]; John Templeton Foundation [15705]	Rockefeller Foundation; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation	This research was partially supported by the Rockefeller Foundation, the James S. McDonnell Foundation (grant no. 220020195), the National Science Foundation (grant no. 103522), the John Templeton Foundation (grant no. 15705) and by a gift from the Bryan J. and June B. Zwan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JR, 2012, J REGIONAL SCI, V52, P562, DOI 10.1111/j.1467-9787.2011.00742.x; Barenblatt IG, 2003, SCALING; BATTY M, 1976, ENVIRON PLANN A, V8, P189, DOI 10.1068/a080189; Beaudry C, 2009, RES POLICY, V38, P318, DOI 10.1016/j.respol.2008.11.010; Bettencourt L. M. A., 2013, 1301004 SANT FE I; Bettencourt LMA, 2012, 1209014 SANT FE I; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Blumenthal P, 2009, URBAN STUD, V46, P605, DOI 10.1177/0042098008100997; CARLINO GA, 1979, J REGIONAL SCI, V19, P363, DOI 10.1111/j.1467-9787.1979.tb00601.x; Combes PP, 2011, J ECON GEOGR, V11, P253, DOI 10.1093/jeg/lbq038; Drennan M, 2002, URBAN STUD, V39, P1129, DOI 10.1080/00420980220135527; Florida R, 2008, J ECON GEOGR, V8, P615, DOI 10.1093/jeg/lbn023; GLAESER EL, 1995, J MONETARY ECON, V36, P117, DOI 10.1016/0304-3932(95)01206-2; GLAESER EL, 1992, J POLIT ECON, V100, P1126, DOI 10.1086/261856; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Henderson JV, 1988, URBAN DEV THEORY FAC; Jones CI, 2010, AM ECON J-MACROECON, V2, P224, DOI 10.1257/mac.2.1.224; Knudsen B, 2008, ANN ASSOC AM GEOGR, V98, P461, DOI 10.1080/00045600701851150; Lobo J, 1999, GROWTH CHANGE, V30, P106, DOI 10.1111/0017-4815.00106; Lobo J, 2002, URBAN STUD, V39, P529, DOI 10.1080/00420980220112810; MOOMAW RL, 1988, URBAN STUD, V25, P150, DOI 10.1080/00420988820080201; MOOMAW RL, 1981, Q J ECON, V96, P675, DOI 10.2307/1880747; Ortman SG, 2013, 1301001 SANT FE I; OSullivan Arthur., 2011, URBAN EC, V8th; Puga D, 2010, J REGIONAL SCI, V50, P203, DOI 10.1111/j.1467-9787.2009.00657.x; RAUCH JE, 1993, J URBAN ECON, V34, P380, DOI 10.1006/juec.1993.1042; Rosenthal SS, 2001, J URBAN ECON, V50, P191, DOI 10.1006/juec.2001.2230; SEGAL D, 1976, REV ECON STAT, V58, P339, DOI 10.2307/1924956; SHAIKH A, 1974, REV ECON STAT, V56, P115, DOI 10.2307/1927538; SHEFER D, 1973, J REGIONAL SCI, V13, P55, DOI 10.1111/j.1467-9787.1973.tb00377.x; SOLOW RM, 1957, REV ECON STAT, V39, P312, DOI 10.2307/1926047; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; Thisse, 2004, HDB REGIONAL URBAN E, P2063, DOI [10.1016/S1574-0080(04)80005-1, DOI 10.1016/S1574-0080(04)80005-1]; USLANER EM, 1976, AM J POLIT SCI, V20, P125, DOI 10.2307/2110513	36	92	94	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58407	10.1371/journal.pone.0058407	http://dx.doi.org/10.1371/journal.pone.0058407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544042	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700005
J	Zheng, MM; Zhang, ZF; Bemis, K; Belch, AR; Pilarski, LM; Shively, JE; Kirshner, J				Zheng, Mary M.; Zhang, Zhifang; Bemis, Kyle; Belch, Andrew R.; Pilarski, Linda M.; Shively, John E.; Kirshner, Julia			The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma	PLOS ONE			English	Article							CHRONIC INFLAMMATION; T-CELLS; IL-7; PROFILES; CANCER; PROLIFERATION; MECHANISMS; SURVIVAL; INCREASE; RECEPTOR	Multiple myeloma (MM) is an incurable bone marrow malignancy of the B cell lineage. Utilizing multiplex Luminex technology we measured levels of 25 cytokines in the plasma of normal donors (n=177), those with monoclonal gammopathy of undetermined significance (n=8), and MM patients (n=55) with either active disease, on treatment, or in remission. The cytokine levels were compared between normal donors and MM patients as well as between various phases of MM, and discriminant analysis was used to create a predictive classification model based on the differentially expressed cytokines. Evaluating age- and gender dependence of cytokine expression, we determined that with age there is a shift toward a pro-inflammatory environment. Moreover, we observed a strong gender bias in cytokine expression. However, the profile of differentially expressed cytokines was heavily skewed toward an anti-inflammatory, pro-tumorigenic response in patients with MM. Significantly, our predictive model placed all patients in remission in the same category as those with active disease. Thus, our study demonstrates that the homeostasis of systemic cytokines is not restored when MM patients enter remission, suggesting that once an individual has cancer, the microenvironent is permanently altered and the system is primed for a relapse.	[Zheng, Mary M.; Kirshner, Julia] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zhang, Zhifang; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Div Immunol, Duarte, CA 91010 USA; [Bemis, Kyle] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Belch, Andrew R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Pilarski, Linda M.] Univ Alberta, Dept Med Oncol, Edmonton, AB, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; City of Hope; Beckman Research Institute of City of Hope; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alberta; University of Alberta; University of Alberta	Kirshner, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	jkirshne@purdue.edu			Canadian Institutes of Health Research; Alberta Cancer Board Research Initiatives Program; Indiana Clinical and Translational Sciences Institute; Project Development Teams (PDT) pilot grants from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000006]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Board Research Initiatives Program; Indiana Clinical and Translational Sciences Institute; Project Development Teams (PDT) pilot grants from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award	This work was funded by grants from the Canadian Institutes of Health Research and the Alberta Cancer Board Research Initiatives Program. The mass spectrometry analysis was funded by the Indiana Clinical and Translational Sciences Institute funded, in part by the Project Development Teams (PDT) pilot grants (Grant # TR000006) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataille R, 1997, HEMATOL ONCOL CLIN N, V11, P349, DOI 10.1016/S0889-8588(05)70435-4; Bikker A, 2012, RHEUMATOLOGY, V51, P996, DOI 10.1093/rheumatology/ker448; Bonafe M, 2012, BIOESSAYS, V34, P40, DOI 10.1002/bies.201100104; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chipeta J, 1998, CELL IMMUNOL, V183, P149, DOI 10.1006/cimm.1998.1244; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; Forsey RJ, 2003, MECH AGEING DEV, V124, P487, DOI 10.1016/S0047-6374(03)00025-3; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Frassanito MA, 2001, CLIN EXP IMMUNOL, V125, P190, DOI 10.1046/j.1365-2249.2001.01582.x; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Kikuchi K, 2008, J IMMUNOL, V181, P383, DOI 10.4049/jimmunol.181.1.383; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirshner J, 2008, BLOOD, V112, P2935, DOI 10.1182/blood-2008-02-142430; KLEIN B, 1992, HEMATOL ONCOL CLIN N, V6, P273, DOI 10.1016/S0889-8588(18)30344-7; Kowalska M, 2011, MED ONCOL, V28, P194, DOI 10.1007/s12032-009-9403-9; Kroning H, 1997, ACTA HAEMATOL-BASEL, V98, P116; Krueger C, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-88; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; LU ZY, 1995, STEM CELLS, V13, P28; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Matsui W, 2012, BIOL BLOOD MARROW TR, V18, pS27, DOI 10.1016/j.bbmt.2011.10.036; Morley JE, 2004, J GERONTOL A-BIOL, V59, P924; Nevala WK, 2009, CLIN CANCER RES, V15, P1931, DOI 10.1158/1078-0432.CCR-08-1980; Nitsche A, 2003, STEM CELLS, V21, P236, DOI 10.1634/stemcells.21-2-236; Nucci M, 2009, CLIN INFECT DIS, V49, P1211, DOI 10.1086/605664; Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; Salazar-Onfray F, 1999, MED ONCOL, V16, P86, DOI 10.1007/BF02785841; Sartono E, 1997, J INFECT DIS, V175, P1276, DOI 10.1086/593701; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Yu WG, 1996, INT IMMUNOL, V8, P855, DOI 10.1093/intimm/8.6.855; Zhang Xiu-Lian, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P930	45	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58504	10.1371/journal.pone.0058504	http://dx.doi.org/10.1371/journal.pone.0058504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544044	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700007
J	Glozier, N; Christensen, H; Naismith, S; Cockayne, N; Donkin, L; Neal, B; Mackinnon, A; Hickie, I				Glozier, Nicholas; Christensen, Helen; Naismith, Sharon; Cockayne, Nicole; Donkin, Liesje; Neal, Bruce; Mackinnon, Andrew; Hickie, Ian			Internet-Delivered Cognitive Behavioural Therapy for Adults with Mild to Moderate Depression and High Cardiovascular Disease Risks: A Randomised Attention-Controlled Trial	PLOS ONE			English	Article							SUBTHRESHOLD DEPRESSION; HEALTH; POPULATION; VALIDITY; INTERVENTIONS; ANXIETY; PEOPLE	Background and Aim: Mild to moderate depression is common in those with cardiovascular disease and undertreated. We aimed to evaluate the effectiveness of internet-delivered Cognitive Behaviour Therapy (iCBT) on depressive symptom severity and adherence to medical advice and lifestyle interventions in adults with mild to moderate depression and high cardiovascular disease (CVD) risks. Methods: Randomised double-blind, 12 week attention-controlled trial comparing an iCBT programme (E-couch) with an internet-delivered attention control health information package (HealthWatch, n = 282). The primary outcome was depression symptom level on the nine-item Patient Health Questionnaire (PHQ-9) (trial registration: ACTRN12610000085077). Results: 487/562 (88%) participants completed the endpoint assessment. 383/562 (70%) were currently treated for cardiovascular disease and 314/562 (56%) had at least one other comorbid condition. In ITT analysis of 562 participants iCBT produced a greater decline in the mean PHQ-9 score compared to the attention control of 1.06 (95% CI: 0.23-1.89) points, with differences between the two arms increasing over the intervention period (time by treatment effect interaction p = .012). There were also larger improvements in adherence (2.16 points; 95% CI: 0.33-3.99), reductions in anxiety (0.96 points; 95% CI: 0.19-1.73), and a greater proportion engaging in beneficial physical activity (Odds Ratio 1.91, 95% CI: 1.01-3.61) in the iCBT participants but no effect upon disability, or walking time/day. There were no withdrawals due to study related adverse events. Conclusions: In people with mild to moderate depression and high levels of CVD risk factors, a freely accessible iCBT programme (http://www.ecouch.anu.edu.au) produced a small, but robust, improvement in depressive symptoms, adherence and some health behaviours. Trial Registration: Australian and New Zealand Clinical Trials Registry ACTRN12610000085077	[Glozier, Nicholas; Naismith, Sharon; Cockayne, Nicole; Donkin, Liesje; Hickie, Ian] Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Christensen, Helen] Black Dog Inst, Sydney, NSW, Australia; [Neal, Bruce] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Mackinnon, Andrew] Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia	University of Sydney; Black Dog Institute; George Institute for Global Health; University of Sydney; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	Glozier, N (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	nick.glozier@sydney.edu.au	Hickie, Ian B/K-8975-2015; Christensen, Helen/F-5053-2012	Hickie, Ian B/0000-0001-8832-9895; Christensen, Helen/0000-0003-0435-2065; Donkin, Liesje/0000-0002-0457-8788; Neal, Bruce/0000-0002-0490-7465; Mackinnon, Andrew/0000-0003-0831-9801; Naismith, Sharon/0000-0001-9076-2778; Glozier, Nick/0000-0002-0476-9146	Cardiovascular Disease and Depression Strategic Research Program [G08S 4048]; National Heart Foundation of Australia; beyondblue: the national depression initiative	Cardiovascular Disease and Depression Strategic Research Program; National Heart Foundation of Australia(National Heart Foundation of Australia); beyondblue: the national depression initiative	This trial was funded by the Cardiovascular Disease and Depression Strategic Research Program (No. G08S 4048) funded by the National Heart Foundation of Australia (http://www.heartfoundation.org.au) and beyondblue: the national depression initiative (http: www.beyondblue.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Christensen H, 2009, J MED INTERNET RES, V11, P2; Christensen H, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.1.e3; Cockayne NL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-10; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79; Donkin L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.100; Donkin L, 2012, J MED INTERNET RES, V14, P262, DOI 10.2196/jmir.2100; Donkin L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1772; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Griffiths KM, 2007, AUST J RURAL HEALTH, V15, P81, DOI 10.1111/j.1440-1584.2007.00859.x; Jorm AF, 2002, MED J AUSTRALIA, V176, pS84; Kelley K, 2007, J STAT SOFTW, V20, P1; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Mackinnon A, 2008, BRIT J PSYCHIAT, V192, P130, DOI 10.1192/bjp.bp.106.032078; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Collaborating Centre for Mental Health, 2009, NICE CLIN GUID; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; Peterson AM, 2003, AM J HEALTH-SYST PH, V60, P657, DOI 10.1093/ajhp/60.7.657; Powell J, 2013, J MED INTERNET RES, V15, P2, DOI 10.2196/jmir.2240; Rieckmann N, 2006, J AM COLL CARDIOL, V48, P2218, DOI 10.1016/j.jacc.2006.07.063; Spek V, 2008, PSYCHOL MED, V38, P635, DOI 10.1017/S0033291707002590; Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Whalley B, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002902.pub3, 10.1002/14651858.CD002902]; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	38	61	63	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59139	10.1371/journal.pone.0059139	http://dx.doi.org/10.1371/journal.pone.0059139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555624	Green Published, gold			2022-12-27	WOS:000317418500022
J	Iranzo, EC; Traba, J; Acebes, P; Gonzalez, BA; Mata, C; Estades, CF; Malo, JE				Iranzo, Esperanza C.; Traba, Juan; Acebes, Pablo; Gonzalez, Benito A.; Mata, Cristina; Estades, Cristian F.; Malo, Juan E.			Niche Segregation between Wild and Domestic Herbivores in Chilean Patagonia	PLOS ONE			English	Article							GUANACOS LAMA-GUANICOE; HABITAT USE; MONTE DESERT; COMPETITION; LIVESTOCK; RANGE; SHEEP; POPULATION; MECHANISMS; EROSION	Competition arises when two co-occuring species share a limiting resource. Potential for competition is higher when species have coexisted for a short time, as it is the case for herbivores and livestock introduced in natural systems. Sheep, introduced in the late 19th century in Patagonia, bear a great resemblance in size and diet to the guanaco, the main native herbivore in Patagonia. In such circumstances, it could be expected that the two species compete and one of them could be displaced. We investigated spatial overlap and habitat selection by coexisting sheep and guanaco in winter and in summer. Additionally, we studied habitat selection of the guanaco in a control situation free from sheep, both in summer and winter. We also determined overlap between species in areas with different intensity of use (named preferred and marginal areas) in order to further detect the potential level of competition in the case of overlapping. Guanaco and sheep showed significantly different habitat preferences through all seasons, in spite of their spatial overlap at landscape scale. Additionally, the habitat used by guanaco was similar regardless of the presence or absence of livestock, which further indicates that sheep is not displacing guanaco where they coexist. These results suggest that habitat segregation between guanaco and sheep is due to a differential habitat selection and not to a competitive displacement process. Therefore, the potential for competition is considered low, contrary to what has been previously observed, although this could be a density-dependent result.	[Iranzo, Esperanza C.; Traba, Juan; Acebes, Pablo; Mata, Cristina; Malo, Juan E.] Univ Autonoma Madrid, Fac Ciencias, Dept Ecol, Terr Ecol Grp TEG, E-28049 Madrid, Spain; [Gonzalez, Benito A.; Estades, Cristian F.] Univ Chile, Dept Manejo Recursos Forestales, Fac Ciencias Forestales & Conservac Nat, Santiago, Chile	Autonomous University of Madrid; Universidad de Chile	Iranzo, EC (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Ecol, Terr Ecol Grp TEG, E-28049 Madrid, Spain.	esperanza.iranzo@uam.es	Mata, Cristina/ABF-1169-2021; Acebes, Pablo/L-6444-2014; Arrazola, Juan Esteban Malo/Q-4819-2019; Estades, Cristian F/A-5221-2008; Iranzo, Esperanza/W-1256-2019; Malo, Juan E/K-8305-2014; Traba, Juan/D-9191-2012; González, Benito/I-9570-2014; González, Benito/H-5189-2013	Mata, Cristina/0000-0002-6206-1015; Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Estades, Cristian F/0000-0002-4479-7774; Iranzo, Esperanza/0000-0001-9411-8437; Malo, Juan E/0000-0002-6033-5035; Traba, Juan/0000-0001-6326-8942; González, Benito/0000-0001-8201-8789; Acebes Vives, Pablo/0000-0003-1880-7841; Gonzalez, Benito/0000-0002-0039-5722	Interuniversity Cooperation Program from Agencia Espanola de Cooperacion Internacional para el Desarrollo [A/016431/08, A/024945/09]; Remedinal-2 research network [S/2009/AMB1783]; Universidad de Chile; FPU grant from Ministerio de Educacion Cultura y Deporte (Gobierno de 329 Espana)	Interuniversity Cooperation Program from Agencia Espanola de Cooperacion Internacional para el Desarrollo; Remedinal-2 research network; Universidad de Chile; FPU grant from Ministerio de Educacion Cultura y Deporte (Gobierno de 329 Espana)	This research was funded by an Interuniversity Cooperation Program from Agencia Espanola de Cooperacion Internacional para el Desarrollo (A/016431/08 and A/024945/09). Partial support for UAM researchers is provided by the Remedinal-2 research network (S/2009/AMB1783) and by Universidad de Chile. E. C. Iranzo is funded by a FPU grant from Ministerio de Educacion Cultura y Deporte (Gobierno de 329 Espana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes P, 2012, J ARID ENVIRON, V77, P39, DOI 10.1016/j.jaridenv.2011.09.003; Acebes P, 2009, 10 INT MAMM C MEND A; Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Adler PB, 2005, ECOL APPL, V15, P774, DOI 10.1890/04-0231; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Bailey Derek W., 2008, V23, P7; Baldi B, 2008, IUCN RED LIST THREAT; Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; Bank MS, 2003, BIOL CONSERV, V112, P427, DOI 10.1016/S0006-3207(02)00342-7; Bonino N., 1991, Turrialba, V41, P452; Borgnia M, 2008, J ARID ENVIRON, V72, P2150, DOI 10.1016/j.jaridenv.2008.07.012; Chartier MP, 2006, RANGELAND ECOL MANAG, V59, P616, DOI 10.2111/06-009R.1; Cimino L, 2003, J ZOOL, V261, P299, DOI 10.1017/S0952836903004229; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; ESRI, COMPL INT SYST; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; Kutt AS, 2012, ANIM CONSERV, V15, P416, DOI 10.1111/j.1469-1795.2012.00530.x; Mishra C, 2004, J APPL ECOL, V41, P344, DOI 10.1111/j.0021-8901.2004.00885.x; Mishra C, 2002, ANIM CONSERV, V5, P251, DOI 10.1017/S1367943002002305; Namgail T, 2007, ECOL RES, V22, P25, DOI 10.1007/s11284-006-0015-y; Ortega IM, 1995, REV CHIL HIST NAT, V61, P209; Ovejero RJA, 2011, EUR J WILDLIFE RES, V57, P1007, DOI 10.1007/s10344-011-0511-4; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Pisano E., 1974, ANALES I PATAGONIA, P59; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Puig S, 2001, J ARID ENVIRON, V47, P291, DOI 10.1006/jare.2000.0677; Putman R. J., 1996, COMPETITION RESOURCE; RAEDEKE KJ, 1982, TURRIALBA, V32, P309; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Esteban RS, 2012, AGROFOREST SYST, V85, P397, DOI 10.1007/s10457-011-9430-3; SORIANO A, 1986, INTERCIENCIA, V11, P77; Sosa RA, 2005, EUR J WILDLIFE RES, V51, P207, DOI 10.1007/s10344-005-0105-0; Soto N, 2010, DISTRIBUCION ABUNDAN; StatSoft Inc, 2014, STATISTICA DAT AN SO; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Von Thuangen J., 2010, PASTORALISM, V1, P274; Wiens JA, 1989, ECOLOGY BIRDS COMMUN, V1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	48	26	27	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59326	10.1371/journal.pone.0059326	http://dx.doi.org/10.1371/journal.pone.0059326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555656	Green Submitted, gold, Green Published			2022-12-27	WOS:000316546400034
J	Rowzee, AM; Perez-Riveros, PJ; Zheng, CY; Krygowski, S; Baum, BJ; Cawley, NX				Rowzee, Anne M.; Perez-Riveros, Paola J.; Zheng, Changyu; Krygowski, Sarah; Baum, Bruce J.; Cawley, Niamh X.			Expression and Secretion of Human Proinsulin-B10 from Mouse Salivary Glands: Implications for the Treatment of Type I Diabetes Mellitus	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; INSULIN-RECEPTOR ISOFORM; CARBOXYPEPTIDASE-E; CELL LINE; MUTANT PROINSULIN; EPITHELIAL-CELLS; SKELETAL-MUSCLE; MICE; THERAPY; HYPERPROINSULINEMIA	Adenovirus (Ad) mediated expression of therapeutic proteins from salivary glands can result in the delivery of biologically active proteins into the circulation where they impart their physiological function. In recent years, Ad vector delivery to salivary glands (SGs) has emerged as a viable option for gene therapy. Here, we engineered a variant of human proinsulin (hProinsulin-B10) into an Ad vector and demonstrated its ability to transduce cell lines, and express a bioactive protein that induces the phosphorylation of AKT, a key insulin signaling molecule. We also examined its expression in mice following delivery of the vector to the parotid gland (PTG), the submandibular gland (SMG) or to the liver via the tail vein and assessed transgenic protein expression and vector containment for each delivery method. In all cases, hProinsulin-B10 was expressed and secreted into the circulation. Lower levels of circulating hProinsulin-B10 were obtained from the PTG while higher levels were obtained from the tail vein and the SMG; however, vector particle containment was best when delivered to the SMG. Expression of hProinsulin-B10 in the SMG of chemically induced diabetic mice prevented excessive hyperglycemia observed in untreated mice. These results demonstrate that hProinsulin-B10 can be expressed and secreted into the circulation from SGs and can function physiologically in vivo. The ability to remediate a diabetic phenotype in a model of type 1 diabetes mellitus is the first step in an effort that may lead to a possible therapy for diabetes.	[Rowzee, Anne M.; Perez-Riveros, Paola J.; Zheng, Changyu; Krygowski, Sarah; Baum, Bruce J.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Cawley, Niamh X.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cawley, NX (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	cawleyn@mail.nih.gov			Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen J, 2011, HUM GENE THER, V22, P84, DOI 10.1089/hum.2010.097; Adriaansen J, 2008, HUM GENE THER, V19, P1021, DOI 10.1089/hum.2008.079; Baum B, 2012, P NATL ACAD IN PRESS; Baum BJ, 2010, ORAL ONCOL, V46, P4, DOI 10.1016/j.oraloncology.2009.09.004; BAVENHOLM P, 1995, CIRCULATION, V92, P1422, DOI 10.1161/01.CIR.92.6.1422; BROWN AM, 1989, J ORAL PATHOL MED, V18, P206, DOI 10.1111/j.1600-0714.1989.tb00764.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burkhardt BR, 2005, FEBS LETT, V579, P5759, DOI 10.1016/j.febslet.2005.09.060; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Cawley NX, 2003, ENDOCRINOLOGY, V144, P292, DOI 10.1210/en.2002-220588; CHAN SJ, 1987, P NATL ACAD SCI USA, V84, P2194, DOI 10.1073/pnas.84.8.2194; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Cotrim Ana P, 2006, Dent Clin North Am, V50, P157, DOI 10.1016/j.cden.2005.11.002; Cotrim AP, 2006, DENT CLIN N AM, V50, pvii; GABBAY KH, 1976, NEW ENGL J MED, V294, P911, DOI 10.1056/NEJM197604222941701; GROSS DJ, 1989, P NATL ACAD SCI USA, V86, P4107, DOI 10.1073/pnas.86.11.4107; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; He X, 1998, GENE THER, V5, P537, DOI 10.1038/sj.gt.3300622; Hermann LS, 1999, DIABETES OBES METAB, V1, P227, DOI 10.1046/j.1463-1326.1999.00034.x; Hsu PYJ, 2005, J GENE MED, V7, P1311, DOI 10.1002/jgm.779; Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223, DOI 10.1152/ajpendo.1999.276.2.E223; Kumar M, 2007, GENE THER, V14, P162, DOI 10.1038/sj.gt.3302836; LAZARUS N R, 1970, Journal of Clinical Investigation, V49, P487, DOI 10.1172/JCI106258; Malaguarnera R, 2012, ENDOCRINOLOGY, V153, P2152, DOI 10.1210/en.2011-1843; Marcovina S, 2007, CLIN CHEM, V53, P711, DOI 10.1373/clinchem.2006.082214; Martinenghi S, 2002, GENE THER, V9, P1429, DOI 10.1038/sj.gt.3301804; MASTRANGELI A, 1994, AM J PHYSIOL, V266, pG1146, DOI 10.1152/ajpgi.1994.266.6.G1146; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Oh TK, 2006, DIABETES RES CLIN PR, V71, P233, DOI 10.1016/j.diabres.2005.08.005; Perez P, 2010, INT J BIOCHEM CELL B, V42, P773, DOI 10.1016/j.biocel.2010.02.012; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Ren B, 2007, DIABETOLOGIA, V50, P1910, DOI 10.1007/s00125-007-0722-0; Roder ME, 1996, J CLIN ENDOCR METAB, V81, P1634, DOI 10.1210/jc.81.4.1634; Rowzee AM, 2009, ENDOCRINOLOGY, V150, P3611, DOI 10.1210/en.2008-1473; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Shaw JAM, 2002, J ENDOCRINOL, V172, P653, DOI 10.1677/joe.0.1720653; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Steiner DF, 1996, DIABETES METAB, V22, P94; STOLL RW, 1971, ENDOCRINOLOGY, V88, P714, DOI 10.1210/endo-88-3-714; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Voutetakis A, 2010, ENDOCRINOLOGY, V151, P4566, DOI 10.1210/en.2010-0193; Yudkin JS, 2002, DIABETOLOGIA, V45, P327, DOI 10.1007/s00125-001-0756-7; Zheng CY, 2008, MOL THER, V16, P1089, DOI 10.1038/mt.2008.56; Zheng CY, 2010, J GENE MED, V12, P3, DOI 10.1002/jgm.1416; Zheng CY, 2005, MOL THER, V12, P528, DOI 10.1016/j.ymthe.2005.03.008	48	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59222	10.1371/journal.pone.0059222	http://dx.doi.org/10.1371/journal.pone.0059222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554999	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800072
J	Samanta, T; Roymahapatra, G; Porto, WF; Seth, S; Ghorai, S; Saha, S; Sengupta, J; Franco, OL; Dinda, J; Mandal, SM				Samanta, Tapastaru; Roymahapatra, Gourisankar; Porto, William F.; Seth, Saikat; Ghorai, Sudipta; Saha, Suman; Sengupta, Jayangshu; Franco, Octavio L.; Dinda, Joydev; Mandal, Santi M.			N, N '-Olefin Functionalized Bis-Imidazolium Gold(I) Salt Is an Efficient Candidate to Control Keratitis-Associated Eye Infection	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; HETEROCYCLIC CARBENES; COMPLEXES; RESISTANCE	Keratitis treatment has become more complicated due to the emergence of bacterial or fungal pathogens with enhanced antibiotic resistance. The pharmaceutical applications of N-heterocyclic carbene complexes have received remarkable attention due to their antimicrobial properties. In this paper, the new precursor, 3,3'-(p-phenylenedimethylene) bis{1-(2-methyl-allyl) imidazolium} bromide (1a) and its analogous PF6 salt (1b) were synthesized. Furthermore, silver(I) and gold(I) - N-heterocyclic carbene (NHC) complexes [Ag2LBr2/Au2LBr2; 2a/3a], [(Ag2L2)(PF6)(2)/(Au2L2)(PF6) 2; 2b/3b] were developed from their corresponding ligands. All compounds were screened for their antimicrobial activities against multiple keratitis-associated human eye pathogens, including bacteria and fungi. Complexes 2a and 3a showed highest activity, and the effectiveness of 3a was also studied, focusing eradication of pathogen biofilm. Furthermore, the structures of 1a, 2a and 3b were determined using single crystal X-ray analysis, 2b and 3a were optimized theoretically. The mechanism of action of 3a was evaluated by scanning electron microscopy and docking experiments, suggesting that its target is the cell membrane. In summary, 3a may be helpful in developing antimicrobial therapies in patients suffering from keratitis-associated eye infections caused by multidrug-resistant pathogens.	[Samanta, Tapastaru; Roymahapatra, Gourisankar; Dinda, Joydev] Haldia Inst Technol, Sch Appl Sci, Haldia, W Bengal, India; [Mandal, Santi M.] Indian Inst Technol, Ctr Res Facil, Kharagpur 721302, W Bengal, India; [Porto, William F.; Franco, Octavio L.] Posgrad Ciencias Genom & Biotecnol UCB, Ctr Anal Prot & Bioquim, Brasilia, DF, Brazil; [Seth, Saikat; Ghorai, Sudipta] Egra Sarada Sashibhusan Mahavidyalaya, Mugberia Gangadhar Coll, Midnapore, W Bengal, India; [Saha, Suman; Sengupta, Jayangshu] Priyamvada Birla Aravind Eye Hosp, Kolkata, W Bengal, India	Haldia Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Mandal, SM (corresponding author), Indian Inst Technol, Ctr Res Facil, Kharagpur 721302, W Bengal, India.	mandalsm@gmail.com	Mandal, Santi M./AAF-7156-2020; Roymahapatra, Gourisankar/AAC-7585-2020; SAHA, SUMAN/GLS-7922-2022; Seth, Saikat Kumar/H-4122-2013; Franco, Octavio L/T-3020-2017; Dinda, Joydev/M-7432-2017; Dinda, Joydev/AHA-1483-2022	Roymahapatra, Gourisankar/0000-0002-8018-5206; Seth, Saikat Kumar/0000-0003-4904-6926; Dinda, Joydev/0000-0002-8780-6300; Franco, Octavio/0000-0001-9546-0525; Mandal, Santi M/0000-0002-0119-7138; Porto, William/0000-0002-4739-8250				[Anonymous], 2004, GAUSSIAN 03 REVISION; Arulmozhiraja S, 2002, J PHYS CHEM A, V106, P1765, DOI 10.1021/jp013558h; Barnes NA, 2011, DALTON T, V40, P1743, DOI 10.1039/c0dt01014f; BERNERSPRICE SJ, 1986, CANCER RES, V46, P5486; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; CLSI, 2007, M100S17 CLSI; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Hahn EF, 2007, J ORGANOMET CHEM, V692, P4630, DOI 10.1016/j.jorganchem.2007.04.025; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; Hindi KM, 2009, CHEM REV, V109, P3859, DOI 10.1021/cr800500u; Huang W, 2007, J ORGANOMET CHEM, V692, P3804, DOI 10.1016/j.jorganchem.2007.05.019; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Knapp AR, 2010, INORG CHIM ACTA, V364, P125, DOI 10.1016/j.ica.2010.08.008; Lillo V, 2007, CHEM COMMUN, P3380, DOI 10.1039/b705197b; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Mandal SM, 2012, J CELL BIOCHEM, V113, P184, DOI 10.1002/jcb.23343; Mellon M., 2001, HOGGING IT ESTIMATES; Mitchell BM, 2007, INVEST OPHTH VIS SCI, V48, P774, DOI 10.1167/iovs.06-0793; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Ozdemir I, 2004, APPL ORGANOMET CHEM, V18, P318, DOI 10.1002/aoc.668; Parthasarathi R, 2003, J PHYS CHEM A, V107, P10346, DOI 10.1021/jp035620b; Platania CBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044316; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Roymahapatra G, 2012, CURR MED CHEM, V19, P4184, DOI 10.2174/092986712802430090; Saha Suman, 2009, Oman J Ophthalmol, V2, P114, DOI 10.4103/0974-620X.57310; Sahu K, 2009, J PHOTOCH PHOTOBIO B, V96, P9, DOI 10.1016/j.jphotobiol.2009.03.008; Schuster O, 2009, CHEM REV, V109, P3445, DOI 10.1021/cr8005087; Sengupta J, 2012, J INFECT CHEMOTHER, V18, P698, DOI 10.1007/s10156-012-0398-3; Sheldrick GM, 1997, SHELX76 PROGRAMME RE; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Willcox MDP, 2011, CLIN EXP OPTOM, V94, P161, DOI 10.1111/j.1444-0938.2010.00536.x	31	49	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58346	10.1371/journal.pone.0058346	http://dx.doi.org/10.1371/journal.pone.0058346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554886	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800013
J	Wang, HF; Xiao, B; Wang, MY; Shao, MA				Wang, Huifang; Xiao, Bo; Wang, Mingyu; Shao, Ming'an			Modeling the Soil Water Retention Curves of Soil-Gravel Mixtures with Regression Method on the Loess Plateau of China	PLOS ONE			English	Article							PEDOTRANSFER FUNCTIONS; HYDRAULIC-PROPERTIES; COARSE FRAGMENTS; ROCK FRAGMENTS; STONY SOILS; CONDUCTIVITY; CENTRIFUGE; VALIDITY	Soil water retention parameters are critical to quantify flow and solute transport in vadose zone, while the presence of rock fragments remarkably increases their variability. Therefore a novel method for determining water retention parameters of soil-gravel mixtures is required. The procedure to generate such a model is based firstly on the determination of the quantitative relationship between the content of rock fragments and the effective saturation of soil-gravel mixtures, and then on the integration of this relationship with former analytical equations of water retention curves (WRCs). In order to find such relationships, laboratory experiments were conducted to determine WRCs of soil-gravel mixtures obtained with a clay loam soil mixed with shale clasts or pebbles in three size groups with various gravel contents. Data showed that the effective saturation of the soil-gravel mixtures with the same kind of gravels within one size group had a linear relation with gravel contents, and had a power relation with the bulk density of samples at any pressure head. Revised formulas for water retention properties of the soil-gravel mixtures are proposed to establish the water retention curved surface models of the power-linear functions and power functions. The analysis of the parameters obtained by regression and validation of the empirical models showed that they were acceptable by using either the measured data of separate gravel size group or those of all the three gravel size groups having a large size range. Furthermore, the regression parameters of the curved surfaces for the soil-gravel mixtures with a large range of gravel content could be determined from the water retention data of the soil-gravel mixtures with two representative gravel contents or bulk densities. Such revised water retention models are potentially applicable in regional or large scale field investigations of significantly heterogeneous media, where various gravel sizes and different gravel contents are present.	[Wang, Huifang; Xiao, Bo] Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China; [Wang, Huifang; Wang, Mingyu] Chinese Acad Sci, Grad Univ, Ctr Water Syst Secur, Beijing, Peoples R China; [Wang, Huifang; Xiao, Bo; Shao, Ming'an] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Beijing Academy of Agriculture & Forestry; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Xiao, B (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China.	xiaoboxb@gmail.com	Xiao, Bo/F-9722-2013	Xiao, Bo/0000-0002-9544-4207	Natural Science Foundation of China [50479063, 41001156]; Program of Hundreds of Talents of Chinese Academy of Sciences [99T3005WA2]; Key National Science & Technology Water Project [2009ZX07212-003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Hundreds of Talents of Chinese Academy of Sciences; Key National Science & Technology Water Project	This study was funded by Natural Science Foundation of China (No. 50479063 and 41001156), by the Program of Hundreds of Talents of Chinese Academy of Sciences (99T3005WA2), and by The Key National Science & Technology Water Project (No. 2009ZX07212-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittelli M, 2009, SOIL SCI SOC AM J, V73, P1453, DOI 10.2136/sssaj2008.0082; Bouma J, 1989, ADV SOIL SCI, V9, P225; BOUWER H, 1984, GROUND WATER, V22, P696, DOI 10.1111/j.1745-6584.1984.tb01438.x; Brooks R., 1964, HYDROLOGY PAPERS COL, V3, P3; Brouwer J, 2000, SOIL SCI SOC AM J, V64, P1603, DOI 10.2136/sssaj2000.6451603x; Cornelis WM, 2001, SOIL SCI SOC AM J, V65, P638, DOI 10.2136/sssaj2001.653638x; Cousin I, 2003, CATENA, V53, P97, DOI 10.1016/S0341-8162(03)00037-7; Cuniglio R, 2009, GEODERMA, V148, P375, DOI 10.1016/j.geoderma.2008.11.005; Dann R, 2009, VADOSE ZONE J, V8, P651, DOI 10.2136/vzj2008.0174; Das B.M., 2010, GEOTECHNICAL ENG HDB; Fies JC, 2002, EUR J SOIL SCI, V53, P95, DOI 10.1046/j.1365-2389.2002.00431.x; GARDNER WH, 1986, AGRONOMY, V9, P493, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C21; HANSON CT, 1979, SOIL SCI SOC AM J, V43, P819, DOI 10.2136/sssaj1979.03615995004300040044x; Indrawan IGB, 2006, ENG GEOL, V82, P154, DOI 10.1016/j.enggeo.2005.10.003; Ippisch O, 2006, ADV WATER RESOUR, V29, P1780, DOI 10.1016/j.advwatres.2005.12.011; Khaleel R, 1997, WATER RESOUR RES, V33, P1875, DOI 10.1029/97WR01068; Khanzode RM, 2002, CAN GEOTECH J, V39, P1209, DOI 10.1139/T02-060; Klute A., 1986, METHODS SOIL ANAL 1; Li YS, 1981, SOILS, V4, P143, DOI [10. 13758/j. cnki. tr. 1981. 04. 007, DOI 10.13758/J.CNKI.TR.1981.04.007]; Ma DH, 2008, EUR J SOIL SCI, V59, P950, DOI 10.1111/j.1365-2389.2008.01055.x; Mace A, 1998, GROUND WATER, V36, P465, DOI 10.1111/j.1745-6584.1998.tb02818.x; Margesin R, 2005, DETERMINATION CHEM P, P47; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Minasny B, 1999, GEODERMA, V93, P225, DOI 10.1016/S0016-7061(99)00061-0; NIELSEN DR, 1986, WATER RESOUR RES, V22, P89, DOI DOI 10.1029/WR022I09SP0089S; Omuto CT, 2009, GEODERMA, V149, P235, DOI 10.1016/j.geoderma.2008.12.001; Pachepsky Y, 2001, SOIL SCI SOC AM J, V65, P460, DOI 10.2136/sssaj2001.652460x; Patil NG, 2012, J IRRIG DRAIN ENG, V138, P177, DOI 10.1061/(ASCE)IR.1943-4774.0000375; Phillips JD, 2005, EARTH SURF PROC LAND, V30, P429, DOI 10.1002/esp.1152; POESEN J, 1994, CATENA, V23, P1, DOI 10.1016/0341-8162(94)90050-7; Puhlmann H, 2012, J PLANT NUTR SOIL SC, V175, P221, DOI 10.1002/jpln.201100139; RAVINA I, 1984, SOIL SCI SOC AM J, V48, P736, DOI 10.2136/sssaj1984.03615995004800040008x; Reatto A, 2008, SOIL SCI SOC AM J, V72, P1547, DOI 10.2136/sssaj2007.0355N; Sauer TJ, 2002, SOIL SCI SOC AM J, V66, P1947, DOI 10.2136/sssaj2002.1947; Scheinost AC, 1997, GEODERMA, V78, P129, DOI 10.1016/S0016-7061(97)00046-3; Smagin AV, 2012, EURASIAN SOIL SCI+, V45, P416, DOI 10.1134/S1064229312040126; van Genuchten MT, 1987, DOCUMENTED COMPUTE 2; van Genuchten MT, 1987, DOCUMENTED COMPUTE 1; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vereecken H, 2007, VADOSE ZONE J, V6, P1, DOI 10.2136/vzj2006.0055; Vogel T, 2000, ADV WATER RESOUR, V24, P133, DOI 10.1016/S0309-1708(00)00037-3	41	11	11	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59475	10.1371/journal.pone.0059475	http://dx.doi.org/10.1371/journal.pone.0059475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555040	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800097
J	Walsh, MP; Duncan, B; Larabee, S; Krauss, A; Davis, JPE; Cui, YZ; Kim, SY; Guimond, M; Bachovchin, W; Fry, TJ				Walsh, Meghaan P.; Duncan, Brynn; Larabee, Shannon; Krauss, Aviva; Davis, Jessica P. E.; Cui, Yongzhi; Kim, Su Young; Guimond, Martin; Bachovchin, William; Fry, Terry J.			Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; DIPEPTIDYL PEPTIDASE-IV; PHASE-II TRIAL; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; SMALL-MOLECULE; CANCER; IMMUNOSURVEILLANCE; CHEMOTHERAPY; TALABOSTAT	Although tumors naturally prime adaptive immune responses, tolerance may limit the capacity to control progression and can compromise effectiveness of immune-based therapies for cancer. Post-proline cleaving enzymes (PPCE) modulate protein function through N-terminal dipeptide cleavage and inhibition of these enzymes has been shown to have antitumor activity. We investigated the mechanism by which Val-boroPro, a boronic dipeptide that inhibits post-proline cleaving enzymes, mediates tumor regression and tested whether this agent could serve as a novel immune adjuvant to dendritic cell vaccines in two different murine syngeneic murine tumors. In mice challenged with MB49, which expresses the HY antigen complex, T cell responses primed by the tumor with and without Val-boroPro were measured using interferon gamma ELISPOT. Antibody depletion and gene-deficient mice were used to establish the immune cell subsets required for tumor regression. We demonstrate that Val-boroPro mediates tumor eradication by accelerating the expansion of tumor-specific T cells. Interestingly, T cells primed by tumor during Val-boroPro treatment demonstrate increased capacity to reject tumors following adoptive transfer without further treatment of the recipient. Val-boroPro -mediated tumor regression requires dendritic cells and is associated with enhanced trafficking of dendritic cells to tumor draining lymph nodes. Finally, dendritic cell vaccination combined with Val-boroPro treatment results in complete regression of established tumors. Our findings demonstrate that Val-boroPro has antitumor activity and a novel mechanism of action that involves more robust DC trafficking with earlier priming of T cells. Finally, we show that Val-boroPro has potent adjuvant properties resulting in an effective therapeutic vaccine.	[Walsh, Meghaan P.; Duncan, Brynn; Larabee, Shannon; Krauss, Aviva; Davis, Jessica P. E.; Cui, Yongzhi; Kim, Su Young; Fry, Terry J.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guimond, Martin] Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Bachovchin, William] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Biochem, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universite de Montreal; Tufts University	Fry, TJ (corresponding author), NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	fryt@mail.nih.gov	william.bachovchin@tufts.edu/AAA-3538-2022	Larabee, Shannon/0000-0003-4308-3099; Duncan, Brynn/0000-0003-2739-9712	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011295] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V370, P22, DOI 10.1016/j.bbrc.2008.02.145; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eager RM, 2009, CLIN ONCOL-UK, V21, P464, DOI 10.1016/j.clon.2009.04.007; Eager RM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-263; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fry TJ, 2009, CANCER IMMUNOL IMMUN, V58, P1257, DOI 10.1007/s00262-008-0638-7; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gerner MY, 2008, J IMMUNOL, V181, P155, DOI 10.4049/jimmunol.181.1.155; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Ghiringhelli F, 2007, CURR OPIN IMMUNOL, V19, P224, DOI 10.1016/j.coi.2007.02.003; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Jones B, 2003, BLOOD, V102, P1641, DOI 10.1182/blood-2003-01-0208; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kusmartsev S, 2009, NAT REV UROL, V6, P540, DOI 10.1038/nrurol.2009.177; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Meadors JL, 2011, PEDIATR BLOOD CANCER, V57, P921, DOI 10.1002/pbc.23048; Meany H, 2010, JNCI-J NATL CANCER I, V102, P909, DOI 10.1093/jnci/djq174; Melchionda F, 2005, J CLIN INVEST, V115, P1177, DOI 10.1172/JCI200523134; Melchionda F, 2004, J IMMUNOTHER, V27, P329, DOI 10.1097/00002371-200409000-00001; Mele DA, 2011, EUR J IMMUNOL, V41, P1583, DOI 10.1002/eji.201041157; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Nemunaitis J, 2006, CANCER INVEST, V24, P553, DOI 10.1080/07357900600894732; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Pennisi A, 2009, BRIT J HAEMATOL, V145, P775, DOI 10.1111/j.1365-2141.2009.07696.x; Peters A, 2010, AM J MED, V123, pS28, DOI 10.1016/j.amjmed.2009.12.007; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Van Damme J, 1999, Chem Immunol, V72, P42, DOI 10.1159/000058725; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Weigel BJ, 2003, CLIN CANCER RES, V9, P3105; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	52	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58860	10.1371/journal.pone.0058860	http://dx.doi.org/10.1371/journal.pone.0058860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554941	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500050
J	Sarris, PF; Trantas, EA; Baltrus, DA; Bull, CT; Wechter, WP; Yan, SC; Ververidis, F; Almeida, NF; Jones, CD; Dangl, JL; Panopoulos, NJ; Vinatzer, BA; Goumas, DE				Sarris, Panagiotis F.; Trantas, Emmanouil A.; Baltrus, David A.; Bull, Carolee T.; Wechter, William Patrick; Yan, Shuangchun; Ververidis, Filippos; Almeida, Nalvo F.; Jones, Corbin D.; Dangl, Jeffery L.; Panopoulos, Nickolas J.; Vinatzer, Boris A.; Goumas, Dimitrios E.			Comparative Genomics of Multiple Strains of Pseudomonas cannabina pv. alisalensis, a Potential Model Pathogen of Both Monocots and Dicots	PLOS ONE			English	Article							VI SECRETION SYSTEMS; BACTERIAL-BLIGHT; 1ST REPORT; III SECRETION; SEQUENCE ALIGNMENT; FUNCTIONAL SCREEN; CAUSAL AGENT; SYRINGAE; VIRULENCE; MACULICOLA	Comparative genomics of closely related pathogens that differ in host range can provide insights into mechanisms of host-pathogen interactions and host adaptation. Furthermore, sequencing of multiple strains with the same host range reveals information concerning pathogen diversity and the molecular basis of virulence. Here we present a comparative analysis of draft genome sequences for four strains of Pseudomonas cannabina pathovar alisalensis (Pcal), which is pathogenic on a range of monocotyledonous and dicotyledonous plants. These draft genome sequences provide a foundation for understanding host range evolution across the monocot-dicot divide. Like other phytopathogenic pseudomonads, Pcal strains harboured a hrp/hrc gene cluster that codes for a type III secretion system. Phylogenetic analysis based on the hrp/hrc cluster genes/proteins, suggests localized recombination and functional divergence within the hrp/hrc cluster. Despite significant conservation of overall genetic content across Pcal genomes, comparison of type III effector repertoires reinforced previous molecular data suggesting the existence of two distinct lineages within this pathovar. Furthermore, all Pcal strains analyzed harbored two distinct genomic islands predicted to code for type VI secretion systems (T6SSs). While one of these systems was orthologous to known P. syringae T6SSs, the other more closely resembled a T6SS found within P. aeruginosa. In summary, our study provides a foundation to unravel Pcal adaptation to both monocot and dicot hosts and provides genetic insights into the mechanisms underlying pathogenicity.	[Sarris, Panagiotis F.; Trantas, Emmanouil A.; Ververidis, Filippos; Goumas, Dimitrios E.] Technol Educ Inst Crete, Sch Agr Technol, Dept Plant Sci, Iraklion, Greece; [Sarris, Panagiotis F.; Panopoulos, Nickolas J.] Univ Crete, Dept Biol, Iraklion, Greece; [Baltrus, David A.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Bull, Carolee T.] ARS, USDA, Salinas, CA USA; [Wechter, William Patrick] ARS, USDA, Charleston, SC USA; [Yan, Shuangchun; Vinatzer, Boris A.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Sch Comp, Mato Grosso, Brazil; [Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC USA; [Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Panopoulos, Nickolas J.] Univ Crete, Iraklion, Greece; [Panopoulos, Nickolas J.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Hellenic Mediterranean University; University of Crete; University of Arizona; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University; Universidade Federal de Mato Grosso do Sul; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Crete; University of California System; University of California Berkeley	Sarris, PF (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	sarrispanos@science.agrool.gr	Trantas, Emmanouil/AAM-2974-2021; Almeida, Nalvo/B-5856-2012; Sarris, Panagiotis F./N-9978-2015; Ververidis, Filippos/AAH-9553-2019	Baltrus, David/0000-0002-5166-9551; Ververidis, Filippos/0000-0002-3104-6103; Trantas, Emmanouil/0000-0001-7536-101X; Yan, Shuangchun/0000-0002-9924-283X; Bull, Carolee/0000-0002-2592-407X; Almeida, Nalvo/0000-0001-5615-1746; Sarris, Panagiotis/0000-0001-7000-8997	National Science Foundation [IOS 0746501]; FUNDECT [TO-0096/2012, TO 0096/12]; CNPq [474814/2010-6, 305503/2010-3]; University of Arizona; National Institutes of Health (NIH) [GM082279-03, 1-R01-GM066025]; University Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082279, R01GM066025] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0746501] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Arizona; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	B.A.V. (Department of Plant Pathology, Physiology, and Weed Science at Virginia Tech) was supported by the National Science Foundation (award IOS 0746501). N.F.A. (School of Computing at the Federal University of Mato Grosso do Sul) was supported by FUNDECT TO-0096/2012, CNPq grant 474814/2010-6. D.A.B. was supported by startup funds from the University of Arizona as well as an National Institutes of Health (NIH) Ruth Kirschstein NRSA postdoctoral fellowship GM082279-03, J.L.D and C.D.J were supported by NIH grant 1-R01-GM066025 and by the University Cancer Research Fund which support to the UNC High-Throughput Sequencing Facility. NFA was funded by Fundect TO 0096/12 and CNPq 305503/2010-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Bull CT, 2011, PLANT DIS, V95, P1027, DOI 10.1094/PDIS-11-10-0804; Bull CT, 2010, PLANT DIS, V94, P1375, DOI 10.1094/PDIS-07-10-0538; Bull CT, 2009, PLANT DIS, V93, P109, DOI 10.1094/PDIS-93-1-0109A; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Bull CT, 2010, SYST APPL MICROBIOL, V33, P105, DOI 10.1016/j.syapm.2010.02.001; Bull CT, 2004, PLANT DIS, V88, P1384, DOI 10.1094/PDIS.2004.88.12.1384A; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cintas NA, 2002, PLANT DIS, V86, P992, DOI 10.1094/PDIS.2002.86.8.921A; Cintas NA, 2000, RAPPINI BACTERIAL BL, pS15; Cui JP, 2002, PLANT PHYSIOL, V129, P551, DOI 10.1104/pp.010815; Cunnac S, 2009, CURR OPIN MICROBIOL, V12, P53, DOI 10.1016/j.mib.2008.12.003; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Guttman DS, 2006, MOL BIOL EVOL, V23, P2342, DOI 10.1093/molbev/msl103; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Haapalainen M, 2012, J BACTERIOL; Hendrickson EL, 2000, J BACTERIOL, V182, P3498, DOI 10.1128/JB.182.12.3498-3507.2000; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Inoue Yasuhiro, 2006, Journal of General Plant Pathology, V72, P26, DOI 10.1007/s10327-005-0252-x; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Keinath AP, 2006, PLANT DIS, V90, P683, DOI 10.1094/PD-90-0683C; Koike ST, 2007, PLANT DIS, V91, P112, DOI 10.1094/PD-91-0112C; Koike ST, 2006, PLANT DIS, V90, P1551, DOI 10.1094/PD-90-1551B; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mauzey SJ, 2011, PLANT DIS, V95, P71, DOI 10.1094/PDIS-09-10-0642; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Naum M, 2009, MICROBIOL-SGM, V155, P3187, DOI 10.1099/mic.0.029892-0; Preston GM, 2004, PSEUDOMONAS, VOL 2: VIRULENCE AND GENE REGULATION, P181; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Rubio I, 2012, PLANT DIS, V96, P904, DOI 10.1094/PDIS-01-12-0043-PDN; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sarris PF, 2011, INFECT GENET EVOL, V11, P1352, DOI 10.1016/j.meegid.2011.04.029; Sarris PF, 2011, MOL PLANT MICROBE IN, V24, P907, DOI 10.1094/MPMI-01-11-0010; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Sarris PF, 2010, NEW DIS REPORTS, V22; Sarris PF, 2012, PLANT PATHOL; Sohn KH, 2012, J BACTERIOL, V194, P3733, DOI 10.1128/JB.00567-12; Souza RC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-172; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; SUTIC D., 1959, Phytopathologische Zeitschrift, V34, P307; Tampakaki AP, 2010, ANN REV PHYTOPATHOL; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegli S, 2011, GENES-BASEL, V2, P957, DOI 10.3390/genes2040957; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; WILLIAMS PAUL H., 1966, PLANT DIS REPORTER, V50, P192; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	69	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59366	10.1371/journal.pone.0059366	http://dx.doi.org/10.1371/journal.pone.0059366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555661	Green Published, Green Submitted, gold			2022-12-27	WOS:000317262200019
J	Debarnot, U; Piolino, P; Baron, JC; Guillot, A				Debarnot, Ursula; Piolino, Pascale; Baron, Jean-Claude; Guillot, Aymeric			Mental Rotation: Effects of Gender, Training and Sleep Consolidation	PLOS ONE			English	Article							MOTOR MEMORY CONSOLIDATION; SEX-DIFFERENCES; SPATIAL ABILITIES; DAYTIME NAPS; REM-SLEEP; PERFORMANCE; SKILL; IMAGERY; IMPROVEMENT; ACTIVATION	A wide range of experimental studies have provided evidence that a night of sleep contributes to memory consolidation. Mental rotation (MR) skill is characterized by fundamental aspect of both cognitive and motor abilities which can be improved within practice sessions, but little is known about the effect of consolidation after MR practice. In the present study, we investigated the effect of MR training and the following corresponding day- and sleep-related time consolidations in taking into account the well-established gender difference in MR. Forty participants (20 women) practiced a computerized version of the Vandenberg and Kuse MR task. Performance was evaluated before MR training, as well as prior to, and after a night of sleep or a similar daytime interval. Data showed that while men outperformed women during the pre-training test, brief MR practice was sufficient for women to achieve equivalent performance. Only participants subjected to a night of sleep were found to enhance MR performance during the retest, independently of gender. These results provide first evidence that a night of sleep facilitates MR performance compared with spending a similar daytime interval regardless gender of the participants. Since MR is known to involve motor processes, the present data might contribute to schedule relevant mental practice interventions for fruitful applications in rehabilitation and motor learning processes.	[Debarnot, Ursula; Piolino, Pascale; Baron, Jean-Claude] Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France; [Debarnot, Ursula; Piolino, Pascale] Inst Psychol, Lab Memoire & Cognit, Boulogne Billancourt, France; [Debarnot, Ursula; Guillot, Aymeric] Univ Lyon 1, Ctr Rech & Innovat Sport, EA 647, F-69622 Villeurbanne, France; [Debarnot, Ursula] Inst Psychol, Lab Neuropsychol & Vieillissement, Boulogne, France; [Piolino, Pascale; Guillot, Aymeric] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Debarnot, U (corresponding author), Univ Paris 05, Ctr Psychiat & Neurosci, INSERM, UMR S894, Paris, France.	Ursula.debarnot@gmail.com	Piolino, pascale/F-8075-2014	Piolino, pascale/0000-0002-7787-924X; baron, jean-claude/0000-0002-5264-2588				Agniel A, 1987, PROTOCOLE EVALUATION; Amorim MA, 2006, J EXP PSYCHOL GEN, V135, P327, DOI 10.1037/0096-3445.135.3.327; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Brown RM, 2007, J NEUROSCI, V27, P10468, DOI 10.1523/JNEUROSCI.2799-07.2007; Buhry L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/203462; Butler T, 2006, NEUROIMAGE, V32, P445, DOI 10.1016/j.neuroimage.2006.03.030; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clements-Stephens AM, 2009, NEUROSCI LETT, V449, P155, DOI 10.1016/j.neulet.2008.10.094; Colom R, 2007, COGN NEUROPSYCHOL, V24, P867, DOI 10.1080/02643290701781557; CORBALLIS MC, 1982, J EXP PSYCHOL HUMAN, V8, P215, DOI 10.1037/0096-1523.8.2.215; Curtze C, 2010, EXP BRAIN RES, V201, P527, DOI 10.1007/s00221-009-2067-z; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; Debarnot U, ARCH ITALIE IN PRESS; Debarnot U, 2011, COGN AFFECT BEHAV NE, V11, P541, DOI 10.3758/s13415-011-0052-z; Debarnot U, 2010, BRAIN COGNITION, V74, P52, DOI 10.1016/j.bandc.2010.06.004; Debarnot U, 2009, SLEEP, V32, P1559, DOI 10.1093/sleep/32.12.1559; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Eisenegger C, 2007, EUR J NEUROSCI, V25, P1240, DOI 10.1111/j.1460-9568.2007.05354.x; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gaab N, 2004, NEUROREPORT, V15, P731, DOI 10.1097/00001756-200403220-00032; Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006; Guillot A, 2007, ADV HEALTH SCI EDUC, V12, P491, DOI 10.1007/s10459-006-9021-7; Harris IM, 2002, NEUROPSYCHOLOGY, V16, P524, DOI 10.1037//0894-4105.16.4.524; Heil M, 2008, Q J EXP PSYCHOL, V61, P683, DOI 10.1080/17470210701822967; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoppe C, 2012, BRAIN COGNITION, V78, P14, DOI 10.1016/j.bandc.2011.10.008; Hoyek N, 2009, TEACH LEARN MED, V21, P201, DOI 10.1080/10401330903014178; Jausovec N, 2012, INTELLIGENCE, V40, P151, DOI 10.1016/j.intell.2012.01.005; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Jordan K, 2010, J INDIVID DIFFER, V31, P83, DOI 10.1027/1614-0001/a000015; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kass SJ, 1998, HUM PERFORM, V11, P337, DOI 10.1207/s15327043hup1104_3; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Linn MC, 1986, PSYCHOL GENDER ADV M, P67; Lizarraga MLSD, 2003, SEX ROLES, V49, P277; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2004, Bull Mem Acad R Med Belg, V159, P167; Marusan M., 2006, P 3 CENTR EUR MULT V, P77; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Peters M, 2008, BRAIN COGNITION, V66, P260, DOI 10.1016/j.bandc.2007.09.003; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Peters Michael, 2005, Brain Cogn, V57, P176, DOI 10.1016/j.bandc.2004.08.052; Podzebenko K, 2005, J COGNITIVE NEUROSCI, V17, P24, DOI 10.1162/0898929052879996; Prime DJ, 2010, J COGNITIVE NEUROSCI, V22, P2437, DOI 10.1162/jocn.2009.21337; Robertson EM, 2012, CURR BIOL, V22, pR66, DOI 10.1016/j.cub.2011.11.051; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Rose F.D., 1998, VIRTUAL ENV CLIN PSY; Semrud-Clikeman M, 2012, INT J NEUROSCI; Semrud-Clikeman M, 2012, INT J NEUROSCI, V122, P590, DOI 10.3109/00207454.2012.693999; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Stransky D, 2010, J EXP PSYCHOL-APPL, V16, P349, DOI 10.1037/a0021702; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wang B, 2009, J ZHEJIANG UNIV-SC B, V10, P536, DOI 10.1631/jzus.B0820384; Warrington EK., 1991, VISUAL OBJECT SPACE; Wexler M, 1998, COGNITION, V68, P77, DOI 10.1016/S0010-0277(98)00032-8; Willingham DB, 1999, PSYCHOL SCI, V10, P531, DOI 10.1111/1467-9280.00201; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	82	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60296	10.1371/journal.pone.0060296	http://dx.doi.org/10.1371/journal.pone.0060296			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544134	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700093
J	Lei, RL; Chen, HS; Huang, BY; Chen, YC; Chen, PKT; Lee, HY; Chang, CW; Wu, CL				Lei, Ruoh-Lih; Chen, Huey-Shys; Huang, Bao-Yuan; Chen, Yueh-Chih; Chen, Philip Kuo-Ting; Lee, Huei-Ying; Chang, Chi-Wen; Wu, Chih-Lung			Population-Based Study of Birth Prevalence and Factors Associated with Cleft Lip and/or Palate in Taiwan 2002-2009	PLOS ONE			English	Article							PSYCHOSOCIAL ADJUSTMENT; CHILDREN	Background: Facial cleft deformities, including cleft lip with or without cleft palate (CL/P) and cleft palate (CP), are common congenital birth anomalies, especially in Asia. This study aimed to analyze the prevalence of CL/P and CP and to identify associated factors in Taiwan. Methods: This population-based epidemiological study retrospectively analyzed birth data obtained from the Department of Health in Taiwan for years 2002-2009. Frequency distribution, percentages and related predictors were investigated, and findings were presented by types of cleft deformities. Logistic regression analysis was performed to identify factors associated with cleft deformities. Results: Overall prevalence of cleft deformities among 1,705,192 births was 0.1% for CL/P and 0.04% for CP over the 8-year study period. Higher prevalence of CL/P or CP was observed with multiple pregnancies, being male for CL/P, being female for CP, gestational age <= 37 weeks and lower birth weight (<1.5 kg). Both CL/P and CP were significantly associated with gestational age < 37 weeks and birth weight < 1.5 kg (all P < 0.0001). CL/P was significantly associated with multiple parities (P = 0.0004-0.002). Male newborns and female newborns were significantly associated with CL/P and CP, respectively (both P < 0.0001). Conclusions: Overall prevalence for congenital cleft deformities in study subjects was 0.1%, in keeping with high rates in Asia. Results suggest the need for awareness and early identification of those at high risk for cleft deformities, including newborns with gestational age < 37 weeks, weighing < 1.5 kg at birth and women with multiple parities, as a potential strategy to counter long-term adverse effects on speech and language in this population.	[Lei, Ruoh-Lih; Chen, Yueh-Chih; Lee, Huei-Ying] HungKuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Chen, Huey-Shys] Univ Toledo, Coll Nursing, Nursing Practice Program, Dept Hlth Promot Outcomes Syst & Policy, Toledo, OH 43606 USA; [Huang, Bao-Yuan] Cent Taiwan Univ Sci & Technol, Dept Childhood Educ & Enterprise Management, Taichung, Taiwan; [Chen, Philip Kuo-Ting] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Ctr, Tao Yuan, Taiwan; [Lee, Huei-Ying] Kaohsiung Med Univ, Coll Nursing, Dept Nursing, Kaohsiung, Taiwan; [Chang, Chi-Wen] Chang Gung Univ, Coll Med, Dept Nursing, Tao Yuan, Taiwan; [Wu, Chih-Lung] Chung Shan Med Univ, Sch Med, Chung Shan Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan	Hungkuang University; University System of Ohio; University of Toledo; Central Taiwan University Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lei, RL (corresponding author), HungKuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan.	lilylei@sunrise.hk.edu.tw	Lei, Ruoh Lih/AAJ-4179-2020		HungKuang - Mednur Research [HK-MNRC-99-8]	HungKuang - Mednur Research	This study was supported by grants HungKuang - Mednur Research (HK-MNRC-99-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Omari F, 2004, CLEFT PALATE-CRAN J, V41, P609, DOI 10.1597/03-034.1; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; Basseri B, 2011, PLAST RECONSTR SURG, V127, P1255, DOI 10.1097/PRS.0b013e3182043af6; DAS SK, 1995, SOUTHERN MED J, V88, P437, DOI 10.1097/00007611-199504000-00011; Department of Health Executive Yuan, LIST REL INF IT; Gregg TA, 2008, CLEFT PALATE-CRAN J, V45, P141, DOI 10.1597/06-045.1; Hunt O, 2005, EUR J ORTHODONT, V27, P274, DOI 10.1093/ejo/cji004; Hutchinson K, 2011, CLEFT PALATE-CRAN J, V48, P497, DOI 10.1597/09-046; Jagomagi Triin, 2010, Stomatologija, V12, P105; Kim S, 2002, J KOREAN MED SCI, V17, P49, DOI 10.3346/jkms.2002.17.1.49; Liou JD, 2011, INT J GYNECOL OBSTET, V113, P211, DOI 10.1016/j.ijgo.2010.12.016; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; Merritt Linda, 2005, Adv Neonatal Care, V5, P64, DOI 10.1016/j.adnc.2004.12.006; Messer LC, 2010, ANN EPIDEMIOL, V20, P32, DOI 10.1016/j.annepidem.2009.09.006; Mossey P A, 2011, Adv Dent Res, V23, P247, DOI 10.1177/0022034511402083; Patil SB, 2011, PLAST RECONSTR SURG, V127, P327, DOI 10.1097/PRS.0b013e3181f95b9c; Pope AW, 2005, CLEFT PALATE-CRAN J, V42, P556, DOI 10.1597/04-066R.1; Pope AW, 2005, CLEFT PALATE-CRAN J, V42, P349, DOI 10.1597/04-043R.1; Rozendaal AM, 2011, ARCH DIS CHILD-FETAL, V96, pF212, DOI 10.1136/adc.2010.193599; TYAN ML, 1982, P SOC EXP BIOL MED, V171, P41, DOI 10.3181/00379727-171-41474; Wang W, 2009, PAEDIATR PERINAT EP, V23, P310, DOI 10.1111/j.1365-3016.2009.01025.x; Wang ZR, 2000, TRACING PROGRAM REGI; WHO, 2008, WHO REP	23	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58690	10.1371/journal.pone.0058690	http://dx.doi.org/10.1371/journal.pone.0058690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555592	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500014
J	Sotnikov, I; Veremeyko, T; Starossom, SC; Barteneva, N; Weiner, HL; Ponomarev, ED				Sotnikov, Ilya; Veremeyko, Tatyana; Starossom, Sarah C.; Barteneva, Natalia; Weiner, Howard L.; Ponomarev, Eugene D.			Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICROVASCULAR ENDOTHELIAL-CELLS; SIALIC-ACID; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; PERTUSSIS TOXIN; ISCHEMIC-STROKE; SPINAL-CORD; GANGLIOSIDES; BLOOD	Platelets respond to vascular damage and contribute to inflammation, but their role in the neurodegenerative diseases is unknown. We found that the systemic administration of brain lipid rafts induced a massive platelet activation and degranulation resulting in a life-threatening anaphylactic-like response in mice. Platelets were engaged by the sialated glycosphingolipids (gangliosides) integrated in the rigid structures of astroglial and neuronal lipid rafts. The brain-abundant gangliosides GT1b and GQ1b were specifically recognized by the platelets and this recognition involved multiple receptors with P-selectin (CD62P) playing the central role. During the neuroinflammation, platelets accumulated in the central nervous system parenchyma, acquired an activated phenotype and secreted proinflammatory factors, thereby triggering immune response cascades. This study determines a new role of platelets which directly recognize a neuronal damage and communicate with the cells of the immune system in the pathogenesis of neurodegenerative diseases.	[Sotnikov, Ilya; Veremeyko, Tatyana; Starossom, Sarah C.; Weiner, Howard L.; Ponomarev, Eugene D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Sotnikov, Ilya] Emory Univ, Sch Med, Div Neonatal Perinatal Med, Atlanta, GA USA; [Barteneva, Natalia] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Ponomarev, Eugene D.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Emory University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Chinese University of Hong Kong	Weiner, HL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu; eponomarev@cuhk.edu.hk	Barteneva, Natalie/V-3826-2019; Barteneva, Natasha/B-9094-2017; Ponomarev, Eugene D./K-1546-2013	Barteneva, Natalie/0000-0002-8109-1754; Ponomarev, Eugene D./0000-0002-0871-8522; Sotnikov, ILya/0000-0001-9968-2803; Starossom, Sarah/0000-0001-7935-9910	 [R01 NS071039-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported in part by R01 NS071039-01A1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Armstrong RC, 1998, METHODS, V16, P282, DOI 10.1006/meth.1998.0685; BAKRY N, 1991, J PHARMACOL EXP THER, V258, P830; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; CANANZI AR, 1987, ACTA NEUROL SCAND, V76, P79, DOI 10.1111/j.1600-0404.1987.tb03550.x; CHEN M, 1995, BIOCHEM BIOPH RES CO, V213, P96, DOI 10.1006/bbrc.1995.2103; CHRONOS NAF, 1993, CIRCULATION, V88, P2035, DOI 10.1161/01.CIR.88.5.2035; Ciabattoni G, 2007, NEUROBIOL AGING, V28, P336, DOI 10.1016/j.neurobiolaging.2005.12.011; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; DIBIASE A, 1990, NEUROCHEM RES, V15, P519, DOI 10.1007/BF00966210; Erpenbeck L, 2010, BLOOD, V115, P3427, DOI 10.1182/blood-2009-10-247296; Feng D, 1998, INT ARCH ALLERGY IMM, V116, P188, DOI 10.1159/000023944; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Gaglia MA, 2010, AM HEART J, V160, P595, DOI 10.1016/j.ahj.2010.06.007; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; GORE PJ, 1986, BIOCHIM BIOPHYS ACTA, V876, P36, DOI 10.1016/0005-2760(86)90315-2; Gresele P, 1998, J CLIN INVEST, V101, P667, DOI 10.1172/JCI575; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; Jabbar AA, 2006, PEDIATR BLOOD CANCER, V46, P292, DOI 10.1002/pbc.20326; Jain S, 2010, ARTERIOSCL THROM VAS, V30, P2362, DOI 10.1161/ATVBAHA.110.207514; Jirouskova M, 2007, J THROMB HAEMOST, V5, P661, DOI 10.1111/j.1538-7836.2007.02407.x; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KIJIMASUDA I, 1988, CANCER RES, V48, P3728; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; LEDEEN RW, 1978, J SUPRAMOL STR CELL, V8, P1, DOI 10.1002/jss.400080102; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lian TS, 1997, PHARMACEUT RES, V14, P1309, DOI 10.1023/A:1012195932724; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Lu CM, 2008, J NEUROSCI RES, V86, P2624, DOI 10.1002/jnr.21716; Mandic R, 2002, THROMB RES, V106, P137, DOI 10.1016/S0049-3848(02)00087-7; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MAZUROV AV, 1988, BIOCHIM BIOPHYS ACTA, V968, P167, DOI 10.1016/0167-4889(88)90004-3; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; McNicol Archibald, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P99, DOI 10.2174/187152908784533739; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; MUNOZ JJ, 1987, INFECT IMMUN, V55, P1004, DOI 10.1128/IAI.55.4.1004-1008.1987; Nutikka A, 2003, GLYCOCONJUGATE J, V20, P33, DOI 10.1023/B:GLYC.0000016740.69726.fb; Ohba M, 2004, ORAL MICROBIOL IMMUN, V19, P26, DOI 10.1046/j.0902-0055.2002.00107.x; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Qi F, 2008, TRANSPLANTATION, V86, P1267, DOI 10.1097/TP.0b013e318188d433; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Rapoport E, 2003, BIOORG MED CHEM LETT, V13, P675, DOI 10.1016/S0960-894X(02)00998-8; Saito M, 2000, ARCH BIOCHEM BIOPHYS, V376, P371, DOI 10.1006/abbi.2000.1729; Sato C, 2002, J BIOL CHEM, V277, P45299, DOI 10.1074/jbc.M206046200; Seidel G, 2011, INT J MED MICROBIOL, V301, P204, DOI 10.1016/j.ijmm.2010.08.018; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Sevush S, 1998, ARCH NEUROL-CHICAGO, V55, P530, DOI 10.1001/archneur.55.4.530; Sheremata WA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-27; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; STENBERG PE, 1991, J CELL PHYSIOL, V147, P7, DOI 10.1002/jcp.1041470103; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tonra JR, 2001, J COMP NEUROL, V430, P131; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; VOMEL T, 1985, ARCH GERONTOL GERIAT, V4, P125, DOI 10.1016/0167-4943(85)90026-3; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Wen FQ, 1999, ARTERIOSCL THROM VAS, V19, P519, DOI 10.1161/01.ATV.19.3.519; Weyrich AS, 2003, J THROMB HAEMOST, V1, P1897, DOI 10.1046/j.1538-7836.2003.00304.x; Wilhelm I, 2011, ACTA NEUROBIOL EXP, V71, P113; WRIGHT HP, 1965, LANCET, V2, P1109; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yoshida A, 2002, BRIT J PHARMACOL, V137, P146, DOI 10.1038/sj.bjp.0704852; Zibitsker DE, 1961, J SCI ARTICLES BYELO, P143; Zucker-Franklin D, 2000, AM J PATHOL, V157, P69, DOI 10.1016/S0002-9440(10)64518-X	86	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58979	10.1371/journal.pone.0058979	http://dx.doi.org/10.1371/journal.pone.0058979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555611	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500019
J	Rivas-Santiago, B; Castaneda-Delgado, JE; Santiago, CER; Waldbrook, M; Gonzalez-Curiel, I; Leon-Contreras, JC; Enciso-Moreno, JA; del Villar, V; Mendez-Ramos, J; Hancock, REW; Hernandez-Pando, R				Rivas-Santiago, Bruno; Castaneda-Delgado, Julio E.; Rivas Santiago, Cesar E.; Waldbrook, Matt; Gonzalez-Curiel, Irma; Leon-Contreras, Juan C.; Antonio Enciso-Moreno, Jose; del Villar, Victor; Mendez-Ramos, Jazmin; Hancock, Robert E. W.; Hernandez-Pando, Rogelio			Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models	PLOS ONE			English	Article							HUMAN NEUTROPHIL PEPTIDE-1; PULMONARY TUBERCULOSIS; ANTIMICROBIAL PEPTIDES; BACTERIAL-INFECTIONS; BETA-DEFENSINS; INDUCTION; KINETICS; IMMUNITY; CELLS	Tuberculosis is an ongoing threat to global health, especially with the emergence of multi drug-resistant (MDR) and extremely drug-resistant strains that are motivating the search for new treatment strategies. One potential strategy is immunotherapy using Innate Defence Regulator (IDR) peptides that selectively modulate innate immunity, enhancing chemokine induction and cell recruitment while suppressing potentially harmful inflammatory responses. IDR peptides possess only modest antimicrobial activity but have profound immunomodulatory functions that appear to be influential in resolving animal model infections. The IDR peptides HH2, 1018 and 1002 were tested for their activity against two M. tuberculosis strains, one drug-sensitive and the other MDR in both in vitro and in vivo models. All peptides showed no cytotoxic activity and only modest direct antimicrobial activity versus M. tuberculosis (MIC of 15-30 mu g/ml). Nevertheless peptides HH2 and 1018 reduced bacillary loads in animal models with both the virulent drug susceptible H37Rv strain and an MDR isolate and, especially 1018 led to a considerable reduction in lung inflammation as revealed by decreased pneumonia. These results indicate that IDR peptides have potential as a novel immunotherapy against TB.	[Rivas-Santiago, Bruno; Castaneda-Delgado, Julio E.; Gonzalez-Curiel, Irma; Antonio Enciso-Moreno, Jose] Mexican Inst Social Secur IMSS, Med Res Unit Zacatecas, Zacatecas, Mexico; [Rivas Santiago, Cesar E.; del Villar, Victor; Mendez-Ramos, Jazmin] Natl Inst Med Sci & Nutr Salvador Zubiran, Expt Pathol Sect, Mexico City, DF, Mexico; [Rivas Santiago, Cesar E.; Leon-Contreras, Juan C.; Hernandez-Pando, Rogelio] UMDNJ Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA; [Castaneda-Delgado, Julio E.; Gonzalez-Curiel, Irma] Autonomous Univ San Luis Potosi, Dept Immunol, Sch Med, San Luis Potosi, Mexico; [Waldbrook, Matt; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada	Instituto Mexicano del Seguro Social; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidad Autonoma de San Luis Potosi; University of British Columbia	Hernandez-Pando, R (corresponding author), UMDNJ Sch Publ Hlth, Dept Environm & Occupat Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA.	rhdezpando@hotmail.com	Rivas-Santiago, Cesar/L-8627-2019; Hancock, Robert E. W./E-1145-2013; Delgado, Julio Enrique Castañeda/AAL-1946-2020; Rivas-Santiago, Bruno/AAJ-1885-2020; Gonzalez, Irma/G-8490-2019	Rivas-Santiago, Cesar/0000-0002-0504-2299; Hancock, Robert E. W./0000-0001-5989-8503; Delgado, Julio Enrique Castañeda/0000-0003-2124-2036; Rivas-Santiago, Bruno/0000-0002-1521-1519; Gonzalez, Irma/0000-0002-0044-9196; Hernandez-Pando, Rogelio/0000-0003-1292-3833	Foundation of the National Institutes of Health; Canadian Institutes for Health Research; Mexican Institute for Social Security-IMSS [FIS/IMSS/PROT/G10/832]; CONACyT [84456]	Foundation of the National Institutes of Health; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Mexican Institute for Social Security-IMSS; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	REWH funding from the Grand Challenges in Global Health Research program through the Foundation of the National Institutes of Health and the Canadian Institutes for Health Research. REWH holds a Canada Research Chair in antimicrobials and genomics, BRS acknowledges the Mexican Institute for Social Security-IMSS grant project FIS/IMSS/PROT/G10/832. RHP holds the grant project CONACyT (contract: 84456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; [Anonymous], 2012, GLOBAL TUBERCULOSIS; Ashitani J, 2001, CHEST, V119, P1131, DOI 10.1378/chest.119.4.1131; Castaneda-Delgado J, 2010, CLIN EXP IMMUNOL, V161, P542, DOI 10.1111/j.1365-2249.2010.04199.x; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; Kindrachuk J, 2009, VACCINE, V27, P4662, DOI 10.1016/j.vaccine.2009.05.094; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Luna-Herrera J, 2003, EUR J CLIN MICROBIOL, V22, P21, DOI 10.1007/s10096-002-0855-5; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; PANDO RH, 1997, IMMUNOLOGY, V90, P507; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; Rivas-Santiago B, 2009, INFECT IMMUN, V77, P4690, DOI 10.1128/IAI.01515-08; Rivas-Santiago CE, 2011, CLIN EXP IMMUNOL, V164, P80, DOI 10.1111/j.1365-2249.2010.04313.x; Schmidtchen A, 2012, J INNATE IMMUN, V4, P325, DOI 10.1159/000339249; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Sharma S, 2001, ANTIMICROB AGENTS CH, V45, P639, DOI 10.1128/AAC.45.2.639-640.2001; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007	24	86	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59119	10.1371/journal.pone.0059119	http://dx.doi.org/10.1371/journal.pone.0059119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555622	Green Published, gold			2022-12-27	WOS:000316546400022
J	Rokic, MB; Stojilkovic, SS; Vavra, V; Kuzyk, P; Tvrdonova, V; Zemkova, H				Rokic, Milos B.; Stojilkovic, Stanko S.; Vavra, Vojtech; Kuzyk, Pavlo; Tvrdonova, Vendula; Zemkova, Hana			Multiple Roles of the Extracellular Vestibule Amino Acid Residues in the Function of the Rat P2X4 Receptor	PLOS ONE			English	Article							HUMAN P2X(1) RECEPTORS; GATED ION CHANNELS; ATP-BINDING-SITE; TRANSMEMBRANE SEGMENTS; AGONIST BINDING; LATERAL PORTALS; IDENTIFICATION; PORE; MODULATION; ACTIVATION	The binding of ATP to trimeric P2X receptors (P2XR) causes an enlargement of the receptor extracellular vestibule, leading to opening of the cation-selective transmembrane pore, but specific roles of vestibule amino acid residues in receptor activation have not been evaluated systematically. In this study, alanine or cysteine scanning mutagenesis of V47-V61 and F324-N338 sequences of rat P2X4R revealed that V49, Y54, Q55, F324, and G325 mutants were poorly responsive to ATP and trafficking was only affected by the V49 mutation. The Y54F and Y54W mutations, but not the Y54L mutation, rescued receptor function, suggesting that an aromatic residue is important at this position. Furthermore, the Y54A and Y54C receptor function was partially rescued by ivermectin, a positive allosteric modulator of P2X4R, suggesting a rightward shift in the potency of ATP to activate P2X4R. The Q55T, Q55N, Q55E, and Q55K mutations resulted in non-responsive receptors and only the Q55E mutant was ivermectin-sensitive. The F324L, F324Y, and F324W mutations also rescued receptor function partially or completely, ivermectin action on channel gating was preserved in all mutants, and changes in ATP responsiveness correlated with the hydrophobicity and side chain volume of the substituent. The G325P mutant had a normal response to ATP, suggesting that G325 is a flexible hinge. A topological analysis revealed that the G325 and F324 residues disrupt a beta-sheet upon ATP binding. These results indicate multiple roles of the extracellular vestibule amino acid residues in the P2X4R function: the V49 residue is important for receptor trafficking to plasma membrane, the Y54 and Q55 residues play a critical role in channel gating and the F324 and G325 residues are critical for vestibule widening.	[Rokic, Milos B.; Vavra, Vojtech; Kuzyk, Pavlo; Tvrdonova, Vendula; Zemkova, Hana] Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic; [Rokic, Milos B.; Tvrdonova, Vendula] Charles Univ Prague, Fac Sci, Dept Anim Physiol, Prague, Czech Republic; [Stojilkovic, Stanko S.] NICHHD, Sect Cellular Signaling, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rokic, MB (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Cellular & Mol Neuroendocrinol, Prague, Czech Republic.	rokic@biomed.cas.cz	Stillerova (Tvrdonova), Vendula/G-3060-2014; ROKIC, MILOS/O-7204-2014; Zemkova, Hana/C-1844-2012; Vavra, Vojtech/C-1857-2012	Stillerova (Tvrdonova), Vendula/0000-0001-5295-2837; ROKIC, MILOS/0000-0002-9148-2716; Zemkova, Hana/0000-0001-5219-8563; 	Internal Grant Agency of Academy of Sciences [IAA500110910]; Grant Agency of the Czech Republic [P304/12/G069]; Grant Agency of Charles University [3446/2011]; Academy of Sciences of the Czech Republic [AVOZ 50110509, RVO 67985823]; Intramural Research Program of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000195] Funding Source: NIH RePORTER	Internal Grant Agency of Academy of Sciences; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Intramural Research Program of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Internal Grant Agency of Academy of Sciences (Grant No. IAA500110910), the Grant Agency of the Czech Republic (P304/12/G069), Grant Agency of Charles University (3446/2011), the Academy of Sciences of the Czech Republic (Research Project No. AVOZ 50110509 and RVO 67985823), and the Intramural Research Program of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Das M, 2012, J AM CHEM SOC, V134, P16536, DOI 10.1021/ja308110t; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Friday SC, 2008, J NEUROCHEM, V105, P1264, DOI 10.1111/j.1471-4159.2008.05228.x; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Inoue K, 2004, J PHARMACOL SCI, V94, P112, DOI 10.1254/jphs.94.112; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jindrichova M, 2009, J NEUROCHEM, V109, P923, DOI 10.1111/j.1471-4159.2009.06021.x; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Li CY, 2000, NEUROSCI LETT, V295, P77, DOI 10.1016/S0304-3940(00)01586-X; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Lorca RA, 2011, EUR J NEUROSCI, V33, P1175, DOI 10.1111/j.1460-9568.2010.07589.x; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Popova M, 2010, J NEUROCHEM, V112, P307, DOI 10.1111/j.1471-4159.2009.06460.x; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2006, J NEUROCHEM, V96, P843, DOI 10.1111/j.1471-4159.2005.03593.x; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2012, J BIOL CHEM, V287, P7594, DOI 10.1074/jbc.M111.322461; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Stojilkovic SS, 2010, CELL MOL NEUROBIOL, V30, P1251, DOI 10.1007/s10571-010-9568-y; Stojilkovic SS, 2009, TRENDS ENDOCRIN MET, V20, P460, DOI 10.1016/j.tem.2009.05.005; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vavra V, 2011, NEUROSCIENCE, V188, P1, DOI 10.1016/j.neuroscience.2011.04.067; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200	52	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59411	10.1371/journal.pone.0059411	http://dx.doi.org/10.1371/journal.pone.0059411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555667	gold, Green Submitted, Green Published			2022-12-27	WOS:000316546400037
J	Kelly, S; Maini, PK				Kelly, Steven; Maini, Philip K.			DendroBLAST: Approximate Phylogenetic Trees in the Absence of Multiple Sequence Alignments	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; BAYESIAN-INFERENCE; PROTEIN SEQUENCES; DATABASE; GAPS; ALGORITHMS; SUPERTREES; ACCURACY; FAMILIES	The rapidly growing availability of genome information has created considerable demand for both fast and accurate phylogenetic inference algorithms. We present a novel method called DendroBLAST for reconstructing phylogenetic dendrograms/trees from protein sequences using BLAST. This method differs from other methods by incorporating a simple model of sequence evolution to test the effect of introducing sequence changes on the reliability of the bipartitions in the inferred tree. Using realistic simulated sequence data we demonstrate that this method produces phylogenetic trees that are more accurate than other commonly-used distance based methods though not as accurate as maximum likelihood methods from good quality multiple sequence alignments. In addition to tests on simulated data, we use DendroBLAST to generate input trees for a supertree reconstruction of the phylogeny of the Archaea. This independent analysis produces an approximate phylogeny of the Archaea that has both high precision and recall when compared to previously published analysis of the same dataset using conventional methods. Taken together these results demonstrate that approximate phylogenetic trees can be produced in the absence of multiple sequence alignments, and we propose that these trees will provide a platform for improving and informing downstream bioinformatic analysis. A web implementation of the DendroBLAST method is freely available for use at http://www.dendroblast.com/.	[Kelly, Steven] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Math Inst, Ctr Math Biol, Oxford, England; [Kelly, Steven; Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; University of Oxford; University of Oxford	Kelly, S (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	steven.kelly@plants.ox.ac.uk	Kelly, Steven/F-7237-2011	Kelly, Steven/0000-0001-8583-5362	Biotechnology and Biological Sciences Research Council [BB/D020190/1]; BBSRC [BB/D020190/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council through BB/D020190/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cantarel BL, 2006, MOL BIOL EVOL, V23, P2090, DOI 10.1093/molbev/msl080; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dwivedi B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-211; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian R, 2010, NUCLEIC ACIDS RES, V38, pW29, DOI 10.1093/nar/gkq298; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Holland B, 2007, SYST BIOL, V56, P57, DOI 10.1080/10635150601167013; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kelly S, 2010, PHILOS T R SOC LON B; Kriventseva EV, 2003, NUCLEIC ACIDS RES, V31, P388, DOI 10.1093/nar/gkg035; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Liu K, 2009, SCIENCE, V324, P1561, DOI 10.1126/science.1171243; Liu XM, 2011, J THEOR BIOL, V284, P106, DOI 10.1016/j.jtbi.2011.06.020; Loewenstein Y, 2008, BIOINFORMATICS, V24, pI41, DOI 10.1093/bioinformatics/btn174; Novak A, 2008, BIOINFORMATICS, V24, P2403, DOI 10.1093/bioinformatics/btn457; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Piaggio-Talice R., 2004, COMPU BIOL, P173; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Walter R., 1976, PRINCIPLES MATH ANAL; Yona G, 2000, NUCLEIC ACIDS RES, V28, P49, DOI 10.1093/nar/28.1.49	41	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58537	10.1371/journal.pone.0058537	http://dx.doi.org/10.1371/journal.pone.0058537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554899	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800018
J	Qin, YF; Chen, MJ; Wu, W; Xu, B; Tang, R; Chen, XJ; Du, GZ; Lu, CC; Meeker, JD; Zhou, ZM; Xia, YK; Wang, XR				Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Meeker, John D.; Zhou, Zuomin; Xia, Yankai; Wang, Xinru			Interactions between Urinary 4-tert-Octylphenol Levels and Metabolism Enzyme Gene Variants on Idiopathic Male Infertility	PLOS ONE			English	Article							BISPHENOL-A; DRINKING-WATER; IN-VITRO; POLYMORPHISMS; EXPOSURE; 4-N-OCTYLPHENOL; SUSCEPTIBILITY; CHLOROPHENOL; ASSOCIATION; OCTYLPHENOL	Octylphenol (OP) and Trichlorophenol (TCP) act as endocrine disruptors and have effects on male reproductive function. We studied the interactions between 4-tert-Octylphenol (4-t-OP), 4-n-Octylphenol (4-n-OP), 2,3,4-Trichlorophenol (2,3,4-TCP), 2,4,5-Trichlorophenol (2,4,5-TCP) urinary exposure levels and polymorphisms in selected xenobiotic metabolism enzyme genes among 589 idiopathic male infertile patients and 396 controls in a Han-Chinese population. Ultra high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to measure alkylphenols and chlorophenols in urine. Polymorphisms were genotyped using the SNPstream platform and the Taqman method. Among four phenols that were detected, we found that only exposure to 4-t-OP increased the risk of male infertility (P-trend = 1.70 x 10(-7)). The strongest interaction was between 4-t-OP and rs4918758 in CYP2C9 (P-inter = 6.05 x 10(-7)). It presented a significant monotonic increase in risk estimates for male infertility with increasing 4-t-OP exposure levels among men with TC/CC genotype (low level compared with non-exposed, odds ratio (OR) = 2.26, 95% confidence intervals (CI) = 1.06, 4.83; high level compared with non-exposed, OR = 9.22, 95% CI = 2.78, 30.59), but no associations observed among men with TT genotype. We also found interactions between 4-t-OP and rs4986894 in CYP2C19, and between rs1048943 in CYP1A1, on male infertile risk (P-inter = 8.09 x 10(-7), P-inter = 3.73 x 10(-4), respectively). We observed notable interactions between 4-t-OP exposure and metabolism enzyme gene polymorphisms on idiopathic infertility in Han-Chinese men.	[Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Zhou, Zuomin; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qin, Yufeng; Chen, Minjian; Wu, Wei; Xu, Bin; Tang, Rong; Chen, Xiaojiao; Du, Guizhen; Lu, Chuncheng; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	Nanjing Medical University; Nanjing Medical University; University of Michigan System; University of Michigan	Xia, YK (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yankaixia@njmu.edu.cn; xrwang@njmu.edu.cn	Wu, Wei/C-4409-2012; Wang, Xin/AAN-8435-2021	Wu, Wei/0000-0002-0267-1284; Wang, Xin/0000-0002-4457-7376; Meeker, John/0000-0001-8357-5085; qin, yufeng/0000-0002-3947-7610	National Basic Research Program of China (973 Program) [2012CBA01306, 2009CB941703]; National Natural Science Foundation of China [81072328]; Key Project of National Natural Science Foundation [30930079]; Key Project of MOE [211063]; Program for Postgraduates Research Innovation in University of Jiangsu Province [CXZZ12-0600]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of MOE; Program for Postgraduates Research Innovation in University of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported in part by National Basic Research Program of China (973 Program, 2012CBA01306, 2009CB941703); National Natural Science Foundation of China (81072328); The Key Project of National Natural Science Foundation (30930079); The Key Project of MOE (211063). The Program for Postgraduates Research Innovation in University of Jiangsu Province (CXZZ12-0600). Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul Y, 2008, REPROD TOXICOL, V25, P67, DOI 10.1016/j.reprotox.2007.10.007; Barry KH, 2011, ENVIRON HEALTH PERSP, V119, P1726, DOI 10.1289/ehp.1103454; Blake CA, 2004, REPROD TOXICOL, V18, P43, DOI 10.1016/j.reprotox.2003.09.003; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Boockfor FR, 1997, BIOL REPROD, V57, P267, DOI 10.1095/biolreprod57.2.267; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David A, 2009, MAR POLLUT BULL, V58, P953, DOI 10.1016/j.marpolbul.2009.04.021; Denomme GA, 2005, TRANSFUSION, V45, P660, DOI 10.1111/j.1537-2995.2005.04365.x; Feng QZ, 2009, J HAZARD MATER, V167, P282, DOI 10.1016/j.jhazmat.2008.12.115; Fuortes L, 1997, AM J IND MED, V31, P445, DOI 10.1002/(SICI)1097-0274(199704)31:4&lt;445::AID-AJIM11&gt;3.0.CO;2-#; Gregory M, 2009, J TOXICOL ENV HEAL A, V72, P1553, DOI 10.1080/15287390903232434; Guengerich FP, 2001, MUTAT RES-REV MUTAT, V488, P195, DOI 10.1016/S1383-5742(01)00059-X; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; Hawker DW, 2011, WATER RES, V45, P768, DOI 10.1016/j.watres.2010.08.053; Hirvonen A, 1999, ENVIRON HEALTH PERSP, V107, P37, DOI 10.2307/3434470; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Isidori M, 2006, CHEMOSPHERE, V64, P135, DOI 10.1016/j.chemosphere.2005.10.047; Ji GX, 2012, FREE RADICAL BIO MED, V52, P775, DOI 10.1016/j.freeradbiomed.2011.11.032; Ji GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013145; Kim SK, 2007, ENVIRON TOXICOL, V22, P449, DOI 10.1002/tox.20280; Kisselev P, 2005, CANCER RES, V65, P2972, DOI 10.1158/0008-5472.CAN-04-3543; Lampi P, 2000, EUR J EPIDEMIOL, V16, P245, DOI 10.1023/A:1007622317866; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Ma YB, 2011, TOXICOLOGY, V282, P146, DOI 10.1016/j.tox.2011.01.024; Miners J, 2002, PHARMACOGENETICS, V12, P91, DOI 10.1097/00008571-200203000-00002; Mirabelli MC, 2000, AM J IND MED, V37, P532, DOI 10.1002/(SICI)1097-0274(200005)37:5&lt;532::AID-AJIM9&gt;3.0.CO;2-A; Niwa T, 2002, BIOL PHARM BULL, V25, P235, DOI 10.1248/bpb.25.235; Nomura S, 2008, LIFE SCI, V83, P223, DOI 10.1016/j.lfs.2008.06.009; Pedersen SN, 1999, SCI TOTAL ENVIRON, V233, P89, DOI 10.1016/S0048-9697(99)00182-5; Routledge EJ, 1997, J BIOL CHEM, V272, P3280, DOI 10.1074/jbc.272.6.3280; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sumpter JP, 1998, TOXICOL LETT, V103, P337, DOI 10.1016/S0378-4274(98)00328-2; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Turesky RJ, 2004, CURR DRUG METAB, V5, P169, DOI 10.2174/1389200043489036; WHITE E, 1994, JNCI-J NATL CANCER I, V86, P505, DOI 10.1093/jnci/86.7.505; Xia YK, 2008, FERTIL STERIL, V89, P1743, DOI 10.1016/j.fertnstert.2007.05.049; Ying GG, 2006, ENVIRON INT, V32, P417, DOI 10.1016/j.envint.2005.07.004	40	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59398	10.1371/journal.pone.0059398	http://dx.doi.org/10.1371/journal.pone.0059398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555028	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800086
J	Verreault, M; Weppler, SA; Stegeman, A; Warburton, C; Strutt, D; Masin, D; Bally, MB				Verreault, Maite; Weppler, Sherry A.; Stegeman, Amelia; Warburton, Corinna; Strutt, Dita; Masin, Dana; Bally, Marcel B.			Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-B/AKT; PHASE-II TRIAL; INTEGRIN-LINKED KINASE; HIGH-GRADE GLIOMAS; FACTOR RECEPTOR; MAMMALIAN TARGET; C-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; MOTIF PHOSPHORYLATION	The PI3K/AKT/mTOR pathway is commonly over activated in glioblastoma (GBM), and Rictor was shown to be an important regulator downstream of this pathway. EGFR overexpression is also frequently found in GBM tumors, and both EGFR and Rictor are associated with increased proliferation, invasion, metastasis and poor prognosis. This research evaluated in vitro and in vivo whether the combined silencing of EGFR and Rictor would result in therapeutic benefits. The therapeutic potential of targeting these proteins in combination with conventional agents with proven activity in GBM patients was also assessed. In vitro validation studies were carried out using siRNA-based gene silencing methods in a panel of three commercially available human GBM cell lines, including two PTEN mutant lines (U251MG and U118MG) and one PTEN-wild type line (LN229). The impact of EGFR and/or Rictor silencing on cell migration and sensitivity to chemotherapeutic drugs in vitro was determined. In vivo validation of these studies was focused on EGFR and/or Rictor silencing achieved using doxycycline-inducible shRNA-expressing U251MG cells implanted orthotopically in Rag2M mice brains. Target silencing, tumor size and tumor cell proliferation were assessed by quantification of immunohistofluorescence-stained markers. siRNA-mediated silencing of EGFR and Rictor reduced U251MG cell migration and increased sensitivity of the cells to irinotecan, temozolomide and vincristine. In LN229, co-silencing of EGFR and Rictor resulted in reduced cell migration, and increased sensitivity to vincristine and temozolomide. In U118MG, silencing of Rictor alone was sufficient to increase this line's sensitivity to vincristine and temozolomide. In vivo, while the silencing of EGFR or Rictor alone had no significant effect on U251MG tumor growth, silencing of EGFR and Rictor together resulted in a complete eradication of tumors. These data suggest that the combined silencing of EGFR and Rictor should be an effective means of treating GBM.	[Verreault, Maite] Hop La Pitie Salpetriere, Brain & Bone Marrow Inst Res Ctr, Paris, France; [Weppler, Sherry A.; Stegeman, Amelia; Warburton, Corinna; Strutt, Dita; Masin, Dana; Bally, Marcel B.] British Columbia Canc Agcy, Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Verreault, M (corresponding author), Hop La Pitie Salpetriere, Brain & Bone Marrow Inst Res Ctr, Paris, France.	maiteverreault@gmail.com; mbally@bccrc.ca	Verreault, Maite/AAZ-3637-2020	Verreault, Maite/0000-0001-6708-7698; Bally, Marcel/0000-0002-1994-4787	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The research described in this original paper was supported by grant funding from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014; Albert Ladislau, 2009, Cancer Genomics & Proteomics, V6, P255; Allen C, 2006, CANCER RES, V66, P11840, DOI 10.1158/0008-5472.CAN-06-1200; Arao T, 2006, INT J CANCER, V118, P483, DOI 10.1002/ijc.21340; Arwert E, 2007, CANCER RES, V67, P7335, DOI 10.1158/0008-5472.CAN-07-0077; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Boado Ruben J, 2005, NeuroRx, V2, P139, DOI 10.1602/neurorx.2.1.139; Brandes AA, 2004, J CLIN ONCOL, V22, P4779, DOI 10.1200/JCO.2004.06.181; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chakravarti A, 2002, CANCER RES, V62, P200; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Cho KK, 1999, INT J DEV NEUROSCI, V17, P447, DOI 10.1016/S0736-5748(99)00054-4; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; de Groot JF, 2008, J NEURO-ONCOL, V90, P89, DOI 10.1007/s11060-008-9637-y; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Fan QW, 2003, CANCER RES, V63, P8930; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franceschi E, 2007, BRIT J CANCER, V96, P1047, DOI 10.1038/sj.bjc.6603669; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grill J, 2001, CLIN CANCER RES, V7, P641; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gulati N, 2009, INT J ONCOL, V35, P731, DOI 10.3892/ijo_00000386; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang PH, 2009, SCI SIGNAL, V2; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Kappelle AC, 2001, NEUROLOGY, V56, P118, DOI 10.1212/WNL.56.1.118; Karpel-Massler G, 2009, MOL CANCER RES, V7, P1000, DOI 10.1158/1541-7786.MCR-08-0479; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kreisl TN, 2009, J NEURO-ONCOL, V92, P99, DOI 10.1007/s11060-008-9741-z; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lassman Andrew B, 2004, Curr Neurol Neurosci Rep, V4, P228, DOI 10.1007/s11910-004-0043-3; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li XY, 2011, J NEURO-ONCOL, V103, P453, DOI 10.1007/s11060-010-0424-1; Liu JM, 2008, ADV THER, V25, P389, DOI 10.1007/s12325-008-0050-x; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Nakamura JL, 2007, EXPERT OPIN THER TAR, V11, P463, DOI 10.1517/14728222.11.4.463; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Rao RD, 2005, NEOPLASIA, V7, P921, DOI 10.1593/neo.05361; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sanchez-Martin M, 2008, CURR STEM CELL RES T, V3, P197, DOI 10.2174/157488808785740370; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sathornsumetee S, 2006, EXPERT REV ANTICANC, V6, P1087, DOI 10.1586/14737140.6.7.1087; Saydam O, 2005, MOL THER, V12, P803, DOI 10.1016/j.ymthe.2005.07.534; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tian XX, 1998, NEUROPATH APPL NEURO, V24, P389; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Turner CD, 2002, NEURO-ONCOLOGY, V4, P102, DOI 10.1093/neuonc/4.2.109; Verreault M, 2011, ANTICANCER RES, V31, P2161; Verreault M, 2009, OLIGONUCLEOTIDES, V19, P129, DOI 10.1089/oli.2008.0157; Vollmann A, 2006, INT J ONCOL, V28, P1531; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Yung WKA, 2010, NEURO-ONCOLOGY, V12, P1061, DOI 10.1093/neuonc/noq072; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	94	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59597	10.1371/journal.pone.0059597	http://dx.doi.org/10.1371/journal.pone.0059597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555046	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800102
J	Delfino, KR; Rodriguez-Zas, SL				Delfino, Kristin R.; Rodriguez-Zas, Sandra L.			Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; C-MYC; ALTERED EXPRESSION; DNA METHYLATION; CELL-SURVIVAL; GROWTH; BETA; OVEREXPRESSION; PROGRESSION; RESISTANCE	The identification of reliable transcriptome biomarkers requires the simultaneous consideration of regulatory and target elements including microRNAs (miRNAs), transcription factors (TFs), and target genes. A novel approach that integrates multivariate survival analysis, feature selection, and regulatory network visualization was used to identify reliable biomarkers of ovarian cancer survival and recurrence. Expression profiles of 799 miRNAs, 17,814 TFs and target genes and cohort clinical records on 272 patients diagnosed with ovarian cancer were simultaneously considered and results were validated on an independent group of 146 patients. Three miRNAs (hsa-miR-16, hsa-miR-22*, and ebv-miR-BHRF1-2*) were associated with both ovarian cancer survival and recurrence and 27 miRNAs were associated with either one hazard. Two miRNAs (hsa-miR-521 and hsa-miR-497) were cohort-dependent, while 28 were cohort-independent. This study confirmed 19 miRNAs previously associated with ovarian cancer and identified two miRNAs that have previously been associated with other cancer types. In total, the expression of 838 and 734 target genes and 12 and eight TFs were associated (FDR-adjusted Pvalue <0.05) with ovarian cancer survival and recurrence, respectively. Functional analysis highlighted the association between cellular and nucleotide metabolic processes and ovarian cancer. The more direct connections and higher centrality of the miRNAs, TFs and target genes in the survival network studied suggest that network-based approaches to prognosticate or predict ovarian cancer survival may be more effective than those for ovarian cancer recurrence. This study demonstrated the feasibility to infer reliable miRNA-TF-target gene networks associated with survival and recurrence of ovarian cancer based on the simultaneous analysis of co-expression profiles and consideration of the clinical characteristics of the patients.	[Delfino, Kristin R.; Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Dept Stat, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	rodrgzzs@illinois.edu		Rodriguez-Zas, Sandra/0000-0003-1122-4758	NCI [1R03CA143975]; NIH/NIDA [R21DA027548]; NCI/NHGRI TCGA DAC (NIH/NHGRI) [1988]; NATIONAL CANCER INSTITUTE [R03CA143975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCI/NHGRI TCGA DAC (NIH/NHGRI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The support of NCI (Grant Number: 1R03CA143975) to SRZ and KRD, NIH/NIDA (Grant Number: R21DA027548) to SRZ, and NCI/NHGRI TCGA DAC (NIH/NHGRI Project Number: 1988) to SRZ are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azawi D, 2008, ONCOGENE, V27, P3021, DOI 10.1038/sj.onc.1210964; Azuma T, 2000, J HUM GENET, V45, P192, DOI 10.1007/s100380050210; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Chen CH, 2005, INT J GYNECOL CANCER, V15, P878, DOI 10.1111/j.1525-1438.2005.00150.x; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen X, CANC RES, V72, P2294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Dahiya N, 2010, ENDOCR-RELAT CANCER, V17, pF77, DOI 10.1677/ERC-09-0203; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Delfino KR, 2011, CANCER GENOM PROTEOM, V8, P173; Delfino KR, 2010, NEUROPEPTIDES, V44, P31, DOI 10.1016/j.npep.2009.11.002; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dodson H, 2011, WOMEN VARIANTS CLOCK; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Filippova GN, 2002, CANCER RES, V62, P48; Fox J., 2002, R S PLUS COMPANION A; Gao ZJ, 2011, CLIN CANCER RES, V17, P1065, DOI 10.1158/1078-0432.CCR-10-1644; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Heckman CA, 2006, ONCOGENE, V25, P888, DOI 10.1038/sj.onc.1209127; Hiranuma C, 2004, INT J MOL MED, V13, P413; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Inan S, 2006, HISTOL HISTOPATHOL, V21, P1055, DOI 10.14670/HH-21.1055; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kobayashi D, 2002, ANTICANCER RES, V22, P3963; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Li AJ, 2003, AM J OBSTET GYNECOL, V189, P22, DOI 10.1067/mob.2003.328; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Lurie G, 2009, CANCER CAUSE CONTROL, V20, P47, DOI 10.1007/s10552-008-9216-8; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mayr D, 2008, PATHOL RES PRACT, V204, P823, DOI 10.1016/j.prp.2008.07.009; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Miles Gregory D, 2012, BMC Res Notes, V5, P164, DOI 10.1186/1756-0500-5-164; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Nakagawa M, 2007, ONCOL REP, V18, P769; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ohuchida K, 2012, ANN SURG ONCOL, V19, P2394, DOI 10.1245/s10434-012-2252-3; Schaubel DE, 2007, BIOMETRICAL J, V49, P719, DOI 10.1002/bimj.200610349; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]; Smith BJ, 2007, BEEHIVE SUITE TOOLS; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; von Gruenigen VE, 2010, J PAIN SYMPTOM MANAG, V39, P839, DOI 10.1016/j.jpainsymman.2009.09.022; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Wisman GBA, 2003, INT J ONCOL, V23, P1451; Wu M, 2012, BRIEF BIOINFORM, V13, P150, DOI 10.1093/bib/bbr029; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhou X, 2012, ONCOL REP, V27, P447, DOI 10.3892/or.2011.1482; ZOREFSHANI E, 1994, J CANCER RES CLIN, V120, P717, DOI 10.1007/BF01194269	72	59	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58608	10.1371/journal.pone.0058608	http://dx.doi.org/10.1371/journal.pone.0058608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554906	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500033
J	Mishra, DK; Wu, YY; Sarkissyan, M; Sarkissyan, S; Chen, ZJ; Shang, XY; Ong, M; Heber, D; Koeffler, HP; Vadgama, JV				Mishra, Dhruva K.; Wu, Yanyuan; Sarkissyan, Marianna; Sarkissyan, Suren; Chen, Zujian; Shang, Xiying; Ong, May; Heber, David; Koeffler, H. Phillip; Vadgama, Jaydutt V.			Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women	PLOS ONE			English	Article							PROSTATE-CANCER; D SUPPLEMENTATION; D PATHWAY; RISK; POPULATION; ASSOCIATION; INSENSITIVITY; HAPLOTYPES; VARIANTS	Background: Vitamin D plays a role in cancer development and acts through the vitamin D receptor (VDR). Although African-Americans have the lowest levels of serum vitamin D, there is a dearth of information on VDR gene polymorphisms and breast cancer among African-Americans and Hispanics. This study examines whether VDR gene polymorphisms are associated with breast cancer in these cohorts. Methods: Blood was collected from 232 breast cancer patients (Cases) and 349 non-cancer subjects (Controls). Genotyping for four polymorphic variants of VDR (FokI, BsmI, TaqI and ApaI) was performed using the PCR-RFLP method. Results: An increased association of the VDR-Fok1 f allele with breast cancer was observed in African-Americans (OR = 1.9, p = 0.07). Furthermore, the FbTA, FbtA and fbtA haplotypes were associated with breast cancer among African-Americans (p < 0.05). Latinas were more likely to have the VDR-ApaI alleles (Aa or aa) (p = 0.008). The VDR-ApaI aa genotype was significantly associated with poorly-differentiated breast tumors (p = 0.04) in combined Cases. Kaplan-Meier survival analysis showed decreased 5-year disease-free-survival (DFS) in breast cancer patients who had the VDR-Fok1 FF genotype (p<0.05). The Cox regression with multivariate analysis revealed the independent predictor value of the VDR-FokI polymorphism for DFS. The other three variants of VDR (BsmI, TaqI and ApaI) were not associated with disease outcome. Conclusions: VDR haplotypes are associated with breast cancer in African-Americans, but not in Hispanic/Latinas. The VDR-FokI FF genotype is linked with poor prognosis in African-American women with breast cancer.	[Mishra, Dhruva K.; Wu, Yanyuan; Sarkissyan, Marianna; Sarkissyan, Suren; Chen, Zujian; Shang, Xiying; Ong, May; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, Div Canc Res & Training, Ctr Eliminate Canc Hlth Dispar, Dept Internal Med, Los Angeles, CA 90059 USA; [Wu, Yanyuan; Heber, David; Vadgama, Jaydutt V.] David Geffen UCLA Sch Med, Los Angeles, CA USA; [Wu, Yanyuan; Heber, David; Vadgama, Jaydutt V.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Hematol & Oncol, Sch Med, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Natl Canc Inst Singapore, Singapore 117548, Singapore	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore	Vadgama, JV (corresponding author), Charles R Drew Univ Med & Sci, Div Canc Res & Training, Ctr Eliminate Canc Hlth Dispar, Dept Internal Med, 1621 E 120th St, Los Angeles, CA 90059 USA.	jayvadgama@cdrewu.edu		Mishra, Dhruva/0000-0001-8651-005X	National Institutes of Health(NIH)/NCI [U56CA101599-01, CA15083-25S3, U54CA14393]; NIH/NIDDK [R25DK067015-01]; Department of Defense (BCRP) [BC043180]; NATIONAL CANCER INSTITUTE [U54CA143931, P30CA015083, U56CA101599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK067015] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000103] Funding Source: NIH RePORTER	National Institutes of Health(NIH)/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense (BCRP)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health(NIH)/NCI (Grant numbers U56CA101599-01; CA15083-25S3; U54CA14393); NIH/NIDDK (Grant number R25DK067015-01); Department of Defense (BCRP) (Grant number BC043180) - to JVV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1994; Abedin SA, 2006, ANTICANCER RES, V26, P2557; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Banwell CM, 2004, J STEROID BIOCHEM, V89-90, P245, DOI 10.1016/j.jsbmb.2004.03.081; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barroso E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-385; Bretherton-Watt D, 2001, BRIT J CANCER, V85, P171, DOI 10.1054/bjoc.2001.1864; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Buyru N, 2003, EXP MOL MED, V35, P550, DOI 10.1038/emm.2003.72; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6&lt;723::AID-IJC4&gt;3.0.CO;2-3; Dunning AM, 1999, CARCINOGENESIS, V20, P2131, DOI 10.1093/carcin/20.11.2131; Engel LS, 2012, CANCER EPIDEM BIOMAR, V21, P1856, DOI 10.1158/1055-9965.EPI-12-0551; Gapska P, 2009, BREAST CANCER RES TR, V115, P629, DOI 10.1007/s10549-008-0107-1; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Hefler LA, 2004, CANCER, V101, P264, DOI 10.1002/cncr.20361; Ingles SA, 2000, CANCER CAUSE CONTROL, V11, P25, DOI 10.1023/A:1008979417618; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Marik R, 2010, CANCER BIOL THER, V10, P44, DOI 10.4161/cbt.10.1.11994; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mishra DK, 2005, UROL INT, V74, P315, DOI 10.1159/000084429; Mohr SB, 2012, DERM-ENDOCRINOL, V4, P152, DOI 10.4161/derm.20449; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Raimondi S, 2009, CARCINOGENESIS, V30, P1170, DOI 10.1093/carcin/bgp103; Rodriquez S, 2012, HARDY WEINBERG EQUIL; Rollison DE, 2012, BREAST CANCER RES TR, V132, P683, DOI 10.1007/s10549-011-1885-4; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; VandeVord PJ, 2006, BREAST CANCER RES TR, V100, P103, DOI 10.1007/s10549-006-9228-6; Xu Y, 2003, CANCER EPIDEM BIOMAR, V12, P23; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162	37	65	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57967	10.1371/journal.pone.0057967	http://dx.doi.org/10.1371/journal.pone.0057967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554871	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500011
J	Shao, LJ; Zhou, ZS; Cai, Y; Castro, P; Dakhov, O; Shi, P; Bai, YX; Ji, HX; Shen, WH; Wang, JH				Shao, Longjiang; Zhou, Zhansong; Cai, Yi; Castro, Patricia; Dakhov, Olga; Shi, Ping; Bai, Yaoxia; Ji, Huixiang; Shen, Wenhao; Wang, Jianghua			Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-kappa B Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; SIGNALING PATHWAYS; IKK-EPSILON; P65 SUBUNIT; NUDE-MICE; GOD VINE; PHOSPHORYLATION; PROGRESSION; ACTIVATION; KINASE	The TMPRSS2/ERG (T/E) fusion gene is present in the majority of all prostate cancers (PCa). We have shown previously that NF-kappa B signaling is highly activated in these T/E fusion expressing cells via phosphorylation of NF-kB p65 Ser536 (p536). We therefore hypothesize that targeting NF-kB signaling may be an efficacious approach for the subgroup of PCas that carry T/E fusions. Celastrol is a well known NF-kB inhibitor, and thus may inhibit T/E fusion expressing PCa cell growth. We therefore evaluated Celastrol's effects in vitro and in vivo in VCaP cells, which express the T/E fusion gene. VCaP cells were treated with different concentrations of Celastrol and growth inhibition and target expression were evaluated. To test its ability to inhibit growth in vivo, 0.5 mg/kg Celastrol was used to treat mice bearing subcutaneous VCaP xenograft tumors. Our results show Celastrol can significantly inhibit the growth of T/E fusion expressing PCa cells both in vitro and in vivo through targeting three critical signaling pathways: AR, ERG and NF-kB in these cells. When mice received 0.5 mg/kg Celastrol for 4 times/week, significant growth inhibition was seen with no obvious toxicity or significant weight loss. Therefore, Celastrol is a promising candidate drug for T/E fusion expressing PCa. Our findings provide a novel strategy for the targeted therapy which may benefit the more than half of PCa patients who have T/E fusion expressing PCas.	[Shao, Longjiang; Cai, Yi; Castro, Patricia; Dakhov, Olga; Wang, Jianghua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shao, Longjiang; Cai, Yi; Castro, Patricia; Dakhov, Olga; Wang, Jianghua] Michael E DeBakey Dept Vet Affairs Med Ctr, Houston, TX USA; [Zhou, Zhansong; Shi, Ping; Bai, Yaoxia; Ji, Huixiang; Shen, Wenhao] South West Hosp, Dept Urol, Chongqing, Peoples R China	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Army Medical University	Wang, JH (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	jwang1@bcm.edu	Castro, Patricia/AAN-3032-2021	Castro, Patricia/0000-0001-5286-8037	Department of Defense Prostate Cancer Research program [DOD W81XWH-08-1-0055]; NCI; Duncan Cancer Center Human Tissue and Pathology Core [NCI: P30CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research program(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Duncan Cancer Center Human Tissue and Pathology Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Prostate Cancer Research program (DOD W81XWH-08-1-0055; JW) and the NCI to the Dan L. Duncan Cancer Center Human Tissue and Pathology Core (NCI: P30CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Goldstein AS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002169; Guo HR, 2011, INTEGR CANCER THER, V10, P127, DOI 10.1177/1534735410387599; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hishikawa K, 2001, Nihon Yakurigaku Zasshi, V118, P197; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Huang YL, 2012, ANTI-CANCER DRUG, V23, P515, DOI 10.1097/CAD.0b013e3283514b68; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kannaiyan R, 2011, APOPTOSIS; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Morita T, 2010, AM J HYPERTENS, V23, P821, DOI 10.1038/ajh.2010.87; Paimela T, 2011, PHARM RES; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Seo SI, 2009, APMIS, V117, P623, DOI 10.1111/j.1600-0463.2009.02506.x; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tamaki K, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/278958; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang J, 2010, CANC RES; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang WW, 2008, J CHROMATOGR B, V863, P163, DOI 10.1016/j.jchromb.2007.11.044; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhu H, 2010, CANCER LETT, V297, P155, DOI 10.1016/j.canlet.2010.04.030; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	50	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58391	10.1371/journal.pone.0058391	http://dx.doi.org/10.1371/journal.pone.0058391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23554889	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100115
J	Morrison, SD; Rashidi, V; Banushi, VH; Barbhaiya, NJ; Gashi, VH; Sarnquist, C; Maldonado, Y; Harxhi, A				Morrison, Shane D.; Rashidi, Vania; Banushi, Vilson H.; Barbhaiya, Namrata J.; Gashi, Valbona H.; Sarnquist, Clea; Maldonado, Yvonne; Harxhi, Arjan			Cultural Adaptation of a Survey to Assess Medical Providers' Knowledge of and Attitudes towards HIV/AIDS in Albania	PLOS ONE			English	Article							HIV; KAPPA; CARE; PHYSICIANS; AGREEMENT; RISK	Though the HIV/AIDS epidemic in Southeastern Europe is one of low reported prevalence, numerous studies have described the pervasiveness of medical providers' lack of knowledge of HIV/AIDS in the Balkans. This study sought to culturally adapt an instrument to assess medical providers' knowledge of and attitudes towards HIV/AIDS in Albania. Cultural adaptation was completed through development of a survey from previously validated instruments, translation of the survey into Albanian, blinded back translation, expert committee review of the draft instrument, focus group pre-testing with community- and University Hospital Center of Tirana-based physicians and nurses, and test-retest reliability testing. Blinded back translation of the instrument supported the initial translation with slight changes to the idiomatic and conceptual equivalences. Focus group pre-testing generally supported the instrument, yet some experiential and idiomatic changes were implemented. Based on unweighted kappa and/or prevalence adjusted bias adjusted kappa (PABAK), 20 of the 43 questions were deemed statistically significant at kappa and/or PABAK >= 0.5, while 12 others did not cross zero on the 95% confidence interval for kappa, indicating their probable significance. Subsequently, an instrument to assess medical providers' knowledge of and attitudes toward HIV/AIDS for an Albanian population was developed which can be expanded within Albania and potentially to other countries within the Balkans, which have an Albanian-speaking population.	[Morrison, Shane D.; Sarnquist, Clea; Maldonado, Yvonne] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Rashidi, Vania; Barbhaiya, Namrata J.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Banushi, Vilson H.; Gashi, Valbona H.; Harxhi, Arjan] Univ Tirana, Fac Med, Dept Infect Dis, Tirana, Albania	Stanford University; Stanford University; University of Tirana (UT)	Morrison, SD (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	shanem@stanford.edu; bonniem@stanford.edu		Morrison, Shane/0000-0003-3868-3532; Harxhi, Arjan/0000-0001-8518-7377	Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship; Infectious Diseases Society of America; Stanford University Goodrich Traveling Medical Scholars grant	Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship; Infectious Diseases Society of America; Stanford University Goodrich Traveling Medical Scholars grant	Funding for this study was provided by the Center for East Europe and Eurasia Studies at Stanford University Summer Research Fellowship, Medical Scholars Grant from the Infectious Diseases Society of America, and the Stanford University Goodrich Traveling Medical Scholars grant to Shane D. Morrison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2003, ADHERENCE LONG TERM; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bino S, 2006, ALBANIA BEHAV BIOL S; Boulle A, 2007, SEX TRANSM INFECT, V83, P503, DOI 10.1136/sti.2007.027748; Brachman P, 1996, ARCH INTERN MED, V156, P761, DOI 10.1001/archinte.156.7.761; Brusaferro S, 1997, Med Lav, V88, P495; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599; Devroey D, 2003, AIDS, V17, P641, DOI 10.1097/01.aids.0000050848.71999.52; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Grudens-Schuck N, 2004, FOCUS GROUP FUNDAMEN; GUILLEMIN F, 1995, SCAND J RHEUMATOL, V24, P61, DOI 10.3109/03009749509099285; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; HARXHI A, 2002, RAPID ASSESSMENT RES; International Organization for Migration, 2007, REP ALB MIGR PROF; Jovic-Vranes A, 2006, OCCUP MED-OXFORD, V56, P275, DOI 10.1093/occmed/kql019; Kocic Biljana, 2008, Central European Journal of Public Health, V16, P134; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lohrer H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-134; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Mann Jonathan M, 1994, Health Hum Rights, V1, P6; Ministry of Health Kenya, 2004, ADH ANT THER AD GUID; Ministry of Health (Republic of Albania), 2003, LETS KEEP ALB LOW HI; Ministry of Health (Republic of Albania), 2012, NAT STRAT P IN PRESS; Ministry of Health (Republic of Albania), 2007, ALB COUNTR PROGR REP; Morrison SD, 2011, CENT EUR J PUBL HEAL, V19, P91, DOI 10.21101/cejph.a3644; Quach L, 2005, AIDS PATIENT CARE ST, V19, P335, DOI 10.1089/apc.2005.19.335; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Stepanoya E, 2004, 15 INT C AIDS BANGK; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; The World Bank, 2008, ALB KEY IND; TIRELLI U, 1991, BRIT MED J, V303, P582, DOI 10.1136/bmj.303.6802.582; UNAIDS, 1999, UN AIDS EP UPD; UNAIDS, 2011, UNAIDS DAT TABL; UNAIDS, 2010, GLOB REP UNAIDS REP; *UNAIDS WHO, 2007, 2007 AIDS EP UPD; UNAIDS/World Health Organization, 2009, FACT SHEET GLOB HIV; UNAIDS/World Health Organization, 2007, FACT SHEET HIV AIDS; UNICEF, 2004, RAP ASS RESP TIR; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2008, EP HIV AIDS 2008 UPD	45	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59816	10.1371/journal.pone.0059816	http://dx.doi.org/10.1371/journal.pone.0059816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544101	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700061
J	Thonnard, M; Charland-Verville, V; Bredart, S; Dehon, H; Ledoux, D; Laureys, S; Vanhaudenhuyse, A				Thonnard, Marie; Charland-Verville, Vanessa; Bredart, Serge; Dehon, Hedwige; Ledoux, Didier; Laureys, Steven; Vanhaudenhuyse, Audrey			Characteristics of Near-Death Experiences Memories as Compared to Real and Imagined Events Memories	PLOS ONE			English	Article							OF-BODY EXPERIENCE; PHENOMENAL CHARACTERISTICS; FALSE MEMORIES; BRAIN	Since the dawn of time, Near-Death Experiences NDEs) have intrigued and, nowadays, are still not fully explained. Since reports of NDEs are proposed to be imagined events, and since memories of imagined events have, on average, fewer phenomenological characteristics than real events memories, we here compared phenomenological characteristics of NDEs reports with memories of imagined and real events. We included three groups of coma survivors (8 patients with NDE as defined by the Greyson NDE scale, 6 patients without NDE but with memories of their coma, 7 patients without memories of their coma) and a group of 18 age-matched healthy volunteers. Five types of memories were assessed using Memory Characteristics Questionnaire (MCQ - Johnson et al., 1988): target memories (NDE for NDE memory group, coma memory for coma memory group, and first childhood memory for no memory and control groups), old and recent real event memories and old and recent imagined event memories. Since NDEs are known to have high emotional content, participants were requested to choose the most emotionally salient memories for both real and imagined recent and old event memories. Results showed that, in NDE memories group, NDE memories have more characteristics than memories of imagined and real events (p<0.02). NDE memories contain more self-referential and emotional information and have better clarity than memories of coma (all ps<0.02). The present study showed that NDE memories contained more characteristics than real event memories and coma memories. Thus, this suggests that they cannot be considered as imagined event memories. On the contrary, their physiological origins could lead them to be really perceived although not lived in the reality. Further work needed to better understand this phenomenon.	[Thonnard, Marie; Charland-Verville, Vanessa; Bredart, Serge; Ledoux, Didier; Laureys, Steven; Vanhaudenhuyse, Audrey] Univ Liege, Univ Hosp Liege, Dept Neurol, Cyclotron Res Ctr,Coma Sci Grp, Liege, Belgium; [Bredart, Serge; Dehon, Hedwige] Univ Liege, Cognit & Behav Neurosci Ctr, Liege, Belgium	University of Liege; University of Liege	Laureys, S (corresponding author), Univ Liege, Univ Hosp Liege, Dept Neurol, Cyclotron Res Ctr,Coma Sci Grp, Liege, Belgium.	steven.laureys@ulg.ac.be	Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/A-3349-2011; Ledoux, Didier/ABA-8401-2021; Laureys, Steven/AAN-2097-2021	Ledoux, Didier/0000-0002-9314-6564; Laureys, Steven/0000-0002-3096-3807; Bredart, Serge/0000-0002-2250-5603	University and University Hospital of Liege; Belgian National Funds for Scientific Research (FRS-FNRS); European Commission; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC 06/11-340]; Foundation Medicale Reine Elisabeth; Public Utility Foundation "Universite Europeenne du Travail" and "Fondazione Europea di Ricerca Biomedica"	University and University Hospital of Liege; Belgian National Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; Foundation Medicale Reine Elisabeth; Public Utility Foundation "Universite Europeenne du Travail" and "Fondazione Europea di Ricerca Biomedica"	This research was funded by the University and University Hospital of Liege, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Commission (COST, DISCOS, MINDBRIDGE, DECODER), the James McDonnell Foundation, the Mind Science Foundation, the French Speaking Community Concerted Research Action (ARC 06/11-340), the Foundation Medicale Reine Elisabeth and the Public Utility Foundation "Universite Europeenne du Travail" and "Fondazione Europea di Ricerca Biomedica". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore S., 1993, DYING LIVE SCI NEAR; Blackmore Susan, 1993, DYING LIVE NEAR DEAT; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P303, DOI 10.1016/B978-0-12-374168-4.00023-X; CONWAY MA, 1995, Q J EXP PSYCHOL-A, V48, P125, DOI 10.1080/14640749508401380; CONWAY MA, 1994, MEM COGNITION, V22, P326, DOI 10.3758/BF03200860; D'Argembeau A, 2008, MEMORY, V16, P538, DOI 10.1080/09658210802010463; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; French CC, 2005, PROG BRAIN RES, V150, P351, DOI 10.1016/S0079-6123(05)50025-6; French CC, 2001, LANCET, V358, P2010, DOI 10.1016/S0140-6736(01)07133-1; Greyson B, 2000, VARIETIES OF ANOMALOUS EXPERIENCE: EXAMINING THE SCIENTIFIC EVIDENCE, P315, DOI 10.1037/10371-010; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B, 1997, J NERV MENT DIS, V185, P327, DOI 10.1097/00005053-199705000-00007; HASHTROUDI S, 1990, PSYCHOL AGING, V5, P119, DOI 10.1037/0882-7974.5.1.119; Hoepner R, 2012, J NEUROLOGY; Hoepner R, 2012, EPILEPSY BEHAV, V23, P360, DOI 10.1016/j.yebeh.2012.01.010; JENNETT B, 1972, LANCET, V1, P734; JOHNSON MK, 1988, J EXP PSYCHOL GEN, V117, P371, DOI 10.1037/0096-3445.117.4.371; JOHNSON MK, 1988, MEM COGNITION, V16, P337, DOI 10.3758/BF03197044; Moody R.A., 1975, LIFE LIFE; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Potts M., 2002, J NEAR DEATH STUDIES, V20, P233, DOI [10.1023/A:1015210902730, DOI 10.1023/A:1015210902730]; Schaefer A, 2005, MEMORY, V13, P148, DOI 10.1080/09658210344000648; Slade P. D., 1988, SENSORY DECEPTION SC; Strange D, 2008, MEMORY, V16, P475, DOI 10.1080/09658210802059049	26	41	41	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57620	10.1371/journal.pone.0057620	http://dx.doi.org/10.1371/journal.pone.0057620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544039	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700002
J	Webb, H; Lanfear, R; Hamill, J; Foley, WJ; Kulheim, C				Webb, Hamish; Lanfear, Robert; Hamill, John; Foley, William J.; Kuelheim, Carsten			The Yield of Essential Oils in Melaleuca alternifolia (Myrtaceae) Is Regulated through Transcript Abundance of Genes in the MEP Pathway	PLOS ONE			English	Article							METHYLERYTHRITOL PHOSPHATE PATHWAYS; TEA TREE OIL; ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; AUSTRALIAN MYRTACEAE; PLASTIDIAL PATHWAYS; EUCALYPTUS-GLOBULUS; HIGHER-PLANTS; ARABIDOPSIS; 1-DEOXY-D-XYLULOSE	Medicinal tea tree (Melaleuca alternifolia) leaves contain large amounts of an essential oil, dominated by monoterpenes. Several enzymes of the chloroplastic methylerythritol phosphate (MEP) pathway are hypothesised to act as bottlenecks to the production of monoterpenes. We investigated, whether transcript abundance of genes encoding for enzymes of the MEP pathway were correlated with foliar terpenes in M. alternifolia using a population of 48 individuals that ranged in their oil concentration from 39-122 mg.g DM-1. Our study shows that most genes in the MEP pathway are co-regulated and that the expression of multiple genes within the MEP pathway is correlated with oil yield. Using multiple regression analysis, variation in expression of MEP pathway genes explained 87% of variation in foliar monoterpene concentrations. The data also suggest that sesquiterpenes in M. alternifolia are syrithesised, at least in part, from isopentenyl pyrophosphate originating from the plastid via the MEP pathway.	[Webb, Hamish; Lanfear, Robert; Foley, William J.; Kuelheim, Carsten] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Webb, Hamish; Hamill, John] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Australian National University; Monash University	Kulheim, C (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	carsten.kulheim@anu.edu.au	Lanfear, Robert/A-2022-2010; Kulheim, Carsten/AAR-2734-2021; Foley, William J/C-8069-2009; Kulheim, Carsten/F-4720-2010	Lanfear, Robert/0000-0002-1140-2596; Foley, William J/0000-0001-8587-1814; Kulheim, Carsten/0000-0002-0798-3324	Australian Research Council [LP110100184]; Australian Tea Tree Industry Association (ATTIA); Rural Industries Research and Development Corporation	Australian Research Council(Australian Research Council); Australian Tea Tree Industry Association (ATTIA); Rural Industries Research and Development Corporation	The work was funded by an Australian Research Council Linkage grant to W.J.F. (LP110100184) with the active partnership of the Australian Tea Tree Industry Association (ATTIA) and a supplementary grant from the Rural Industries Research and Development Corporation. The funders had no role is study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Battilana J, 2009, THEOR APPL GENET, V118, P653, DOI 10.1007/s00122-008-0927-8; Besser K, 2009, PLANT PHYSIOL, V149, P499, DOI 10.1104/pp.108.126276; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Butcher PA, 1996, NEW FOREST, V11, P31; BUTCHER PA, 1994, BIOCHEM SYST ECOL, V22, P419, DOI 10.1016/0305-1978(94)90033-7; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Crawley MJ, 2005, STAT INTRO USING R; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Doran JC, 2006, AUST J EXP AGR, V46, P1521, DOI 10.1071/Ea05205; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Fernandez M, 2010, TREES-STRUCT FUNCT, V24, P1109, DOI 10.1007/s00468-010-0483-0; HANOVER JW, 1966, HEREDITY, V21, P73, DOI 10.1038/hdy.1966.5; Hart PH, 2000, INFLAMM RES, V49, P619, DOI 10.1007/s000110050639; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Homer LE, 2000, BIOCHEM SYST ECOL, V28, P367, DOI 10.1016/S0305-1978(99)00071-X; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Kasahara H, 2004, J BIOL CHEM, V279, P14049, DOI 10.1074/jbc.M314195200; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; Keszei A, 2008, AUST J BOT, V56, P197, DOI 10.1071/BT07146; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; List S, 1995, AUST J BOT, V43, P629, DOI 10.1071/BT9950629; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; R Core Team, 2020, R LANG ENV STAT COMP; Russell MF, 2003, PHYTOCHEMISTRY, V62, P683, DOI 10.1016/S0031-9422(02)00607-6; Skorupinska-Tudek K, 2008, J BIOL CHEM, V283, P21024, DOI 10.1074/jbc.M706069200; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Stein M, 2002, NIST MASS SPECTRAL S; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Venables WN., 2002, MODERN APPL STAT S 4; Wildung M, 2005, TRANSGENIC RES, V14, P365, DOI 10.1007/s11248-005-5475-2; Xie Z, 2008, PLANT J, V54, P349, DOI 10.1111/j.1365-313X.2008.03429.x; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	42	28	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60631	10.1371/journal.pone.0060631	http://dx.doi.org/10.1371/journal.pone.0060631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544156	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700115
J	Groen, Y; Tucha, O; Wijers, AA; Althaus, M				Groen, Yvonne; Tucha, Oliver; Wijers, Albertus A.; Althaus, Monika			Processing of Continuously Provided Punishment and Reward in Children with ADHD and the Modulating Effects of Stimulant Medication: An ERP Study	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; DIAGNOSTIC INTERVIEW; RESPONSE COST; HEART-RATE; FEEDBACK; DEFICIT; HYPERACTIVITY	Objectives: Current models of ADHD suggest abnormal reward and punishment sensitivity, but the exact mechanisms are unclear. This study aims to investigate effects of continuous reward and punishment on the processing of performance feedback in children with ADHD and the modulating effects of stimulant medication. Methods: 15 Methylphenidate (Mph)-treated and 15 Mph-free children of the ADHD-combined type and 17 control children performed a selective attention task with three feedback conditions: no-feedback, gain and loss. Event Related Potentials (ERPs) time-locked to feedback and errors were computed. Results: All groups performed more accurately with gain and loss than without feedback. Feedback-related ERPs demonstrated no group differences in the feedback P2, but an enhanced late positive potential (LPP) to feedback stimuli (both gains and losses) for Mph-free children with ADHD compared to controls. Feedback-related ERPs in Mph-treated children with ADHD were similar to controls. Correlational analyses in the ADHD groups revealed that the severity of inattention problems correlated negatively with the feedback P2 amplitude and positively with the LPP to losses and omitted gains. Conclusions: The early selective attention for rewarding and punishing feedback was relatively intact in children with ADHD, but the late feedback processing was deviant (increased feedback LPP). This may explain the often observed positive effects of continuous reinforcement on performance and behaviour in children with ADHD. However, these group findings cannot be generalised to all individuals with the ADHD, because the feedback-related ERPs were associated with the severity of the inattention problems. Children with ADHD-combined type with more inattention problems showed both deviant early attentional selection of feedback stimuli, and deviant late processing of non-reward and punishment.	[Groen, Yvonne; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Wijers, Albertus A.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Althaus, Monika] Univ Groningen, Univ Med Ctr Groningen, Dept Child & Adolescent Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Groen, Y (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	y.groen@rug.nl	Tucha, Oliver/AAD-1403-2019	Groen, Yvonne/0000-0002-7242-0317	Protestants Christelijke Kinderuitzending (PCK)	Protestants Christelijke Kinderuitzending (PCK)	This work was supported by a gift from the Protestants Christelijke Kinderuitzending (PCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Carlson CL, 2000, COGNITIVE THER RES, V24, P87, DOI 10.1023/A:1005455009154; Carlson CL, 2000, J CONSULT CLIN PSYCH, V68, P73, DOI 10.1037/0022-006X.68.1.73; Conners C.K, 1990, MANUAL CONNERSRATING; Conners CK, 1999, PEDIATR CLIN N AM, V46, P857, DOI 10.1016/S0031-3955(05)70159-0; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Davies PL, 2004, DEV NEUROPSYCHOL, V25, P355, DOI 10.1207/s15326942dn2503_6; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075; Ferdinand RF, 1998, DUTCH DIAGNOSTIC INT; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Groen Y, 2009, BIOL PSYCHOL, V82, P45, DOI 10.1016/j.biopsycho.2009.05.004; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, NEUROPSYCHOLOGIA, V46, P2234, DOI 10.1016/j.neuropsychologia.2008.02.011; Huang-Pollock CL, 2012, J ABNORM PSYCHOL, V121, P360, DOI 10.1037/a0027205; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J ABNORM CHILD PSYCH, V36, P445, DOI 10.1007/s10802-007-9190-8; Luman M, 2007, J CHILD PSYCHOL PSYC, V48, P890, DOI 10.1111/j.1469-7610.2007.01769.x; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; PATTERSON CM, 1993, PSYCHOL REV, V100, P716, DOI 10.1037/0033-295X.100.4.716; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Shiels K, 2010, CLIN PSYCHOL REV, V30, P951, DOI 10.1016/j.cpr.2010.06.010; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Tucha L, 2009, J ATTENTION DISORDER, V12; Van der Molen MW, 2003, J CHILD PSYCHOL PSYC, V43, P1; van Meel CS, 2011, J CHILD PSYCHOL PSYC, V52, P942, DOI 10.1111/j.1469-7610.2010.02352.x; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; Van Strien, 2003, DUTCH HANDEDNESS INV; Warreyn P., 2003, VRAGENLIJST SOCIALE; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x	61	15	15	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59240	10.1371/journal.pone.0059240	http://dx.doi.org/10.1371/journal.pone.0059240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555639	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400026
J	Logan, TT; Villapol, S; Symes, AJ				Logan, Trevor T.; Villapol, Sonia; Symes, Aviva J.			TGF-beta Superfamily Gene Expression and Induction of the Runx1 Transcription Factor in Adult Neurogenic Regions after Brain Injury	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; NEURAL STEM-CELLS; ENHANCED HIPPOCAMPAL NEUROGENESIS; TRANSFORMING GROWTH-FACTOR-BETA-1; NEURONAL DIFFERENTIATION; INCREASES NEUROGENESIS; SUBVENTRICULAR ZONE; COGNITIVE RECOVERY; PROGENITOR CELLS; ANALYSIS REVEALS	Traumatic brain injury (TBI) increases neurogenesis in the forebrain subventricular zone (SVZ) and the hippocampal dentate gyrus (DG). Transforming growth factor-beta (TGF-beta) superfamily cytokines are important regulators of adult neurogenesis, but their involvement in the regulation of this process after brain injury is unclear. We subjected adult mice to controlled cortical impact (CCI) injury, and isolated RNA from the SVZ and DG at different post-injury time points. qPCR array analysis showed that cortical injury caused significant alterations in the mRNA expression of components and targets of the TGF-beta, BMP, and activin signaling pathways in the SVZ and DG after injury, suggesting that these pathways could regulate post-injury neurogenesis. In both neurogenic regions, the injury also induced expression of Runt-related transcription factor-1 (Runx1), which can interact with intracellular TGF-beta Smad signaling pathways. CCI injury strongly induced Runx1 expression in activated and proliferating microglial cells throughout the neurogenic regions. Runx1 protein was also expressed in a subset of Nestin-and GFAP-expressing putative neural stem or progenitor cells in the DG and SVZ after injury. In the DG only, these Runx1+ progenitors proliferated. Our data suggest potential roles for Runx1 in the processes of microglial cell activation and proliferation and in neural stem cell proliferation after TBI.	[Logan, Trevor T.; Villapol, Sonia; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Logan, Trevor T.; Villapol, Sonia; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu	Symes, Aviva J/S-7471-2016; Villapol, Sonia/D-1949-2014	Symes, Aviva J/0000-0003-2557-9939; Villapol, Sonia/0000-0002-6174-4113	Center for Neuroscience and Regenerative Medicine [300604 11.0 60855]	Center for Neuroscience and Regenerative Medicine(United States Department of Defense)	This project was funded by the Center for Neuroscience and Regenerative Medicine (grant no: 300604 11.0 60855), http://www.usuhs.mil/cnrm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Beck K, 2012, CELL TISSUE RES, V347, P187, DOI 10.1007/s00441-011-1228-0; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bonnert TP, 2006, EUR J NEUROSCI, V24, P661, DOI 10.1111/j.1460-9568.2006.04912.x; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Florio P, 2007, ADV CLIN CHEM, V43, P117, DOI 10.1016/S0065-2423(06)43004-3; Franklin K., 2007, MOUSE BRAIN STEREOTA; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Fujita Y, 2001, BIOCHEM BIOPH RES CO, V281, P1248, DOI 10.1006/bbrc.2001.4513; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Ginhoux F, 2011, M S-MED SCI, V27, P719, DOI 10.1051/medsci/2011278013; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Goings GE, 2006, GLIA, V54, P329, DOI 10.1002/glia.20381; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hultman K, 2010, J NEUROSCI RES, V88, P2441, DOI 10.1002/jnr.22412; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Jakubowiak A, 2000, J BIOL CHEM, V275, P40282, DOI 10.1074/jbc.C000485200; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kobayashi A, 2012, MOL CELL NEUROSCI, V49, P23, DOI 10.1016/j.mcn.2011.08.009; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Li LY, 2012, J MOL NEUROSCI; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Mahmood A, 2012, EXP NEUROL; Mathieu P, 2010, NEUROIMMUNOMODULAT, V17, P200, DOI 10.1159/000258723; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Nakagawa M, 2011, BLOOD, V118, P6626, DOI 10.1182/blood-2010-12-326710; Okuda T, 2000, MOL CELL BIOL, V20, P319, DOI 10.1128/MCB.20.1.319-328.2000; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Russo I, 2011, J NEUROCHEM, V116, P947, DOI 10.1111/j.1471-4159.2010.07168.x; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Stifani N, 2008, P NATL ACAD SCI USA, V105, P6451, DOI 10.1073/pnas.0711299105; Strom DK, 2000, J BIOL CHEM, V275, P3438, DOI 10.1074/jbc.275.5.3438; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Swiers G, 2010, INT J DEV BIOL, V54, P1151, DOI 10.1387/ijdb.103106gs; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Tjarnlund-Wolf A, 2012, STROKE, V43, P2833, DOI 10.1161/STROKEAHA.111.622217; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Wang Y, 2010, J MOL NEUROSCI, V41, P383, DOI 10.1007/s12031-010-9329-x; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Xiong Y, 2010, DISCOV MED, V10, P434; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yun SJ, 2002, MOL BRAIN RES, V107, P57, DOI 10.1016/S0169-328X(02)00447-3; Zagami CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013944; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	78	67	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59250	10.1371/journal.pone.0059250	http://dx.doi.org/10.1371/journal.pone.0059250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555640	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400027
J	Lau, MT; So, WK; Leung, PCK				Lau, Man-Tat; So, Wai-Kin; Leung, Peter C. K.			Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR SNAIL; REPRESSES E-CADHERIN; MESENCHYMAL TRANSFORMATION; TUMOR-CELLS; MAMMALIAN TARGET; GENE-EXPRESSION; CARCINOMA-CELLS; PATHWAY; PROGRESSION	Fibroblast growth factor 2 (FGF2) is produced by ovarian cancer cells and it has been suggested to play an important role in tumor progression. In this study, we report that FGF2 treatment down-regulated E-cadherin by up-regulating its transcriptional repressors, Slug and ZEB1, in human ovarian cancer cells. The pharmacological inhibition of phosphatidylinositol-3-kinase (PI3K), mammalian target of rapamycin (mTOR), and MEK suggests that both PI3K/Akt/mTOR and MAPK/ERK signaling are required for FGF2-induced E-cadherin down-regulation. Moreover, FGF2 up-regulated Slug and ZEB1 expression via the PI3K/Akt/mTOR and MAPK/ERK signaling pathways, respectively. Finally, FGF2-induced cell invasion was abolished by the inhibition of the PI3K/Akt/mTOR and MAPK/ERK pathways, and the forced expression of E-cadherin diminished the intrinsic invasiveness of ovarian cancer cells as well as the FGF2-induced cell invasion. This study demonstrates a novel mechanism in which FGF2 down-regulates E-cadherin expression through the activation of PI3K/Akt/mTOR and MAPK/ERK signaling, and the up-regulation of Slug and ZEB1 in human ovarian cancer cells.	[Lau, Man-Tat; So, Wai-Kin; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada.	peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research to PCKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DPJ, 1997, CLIN CANCER RES, V3, P1579; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Billottet C, 2004, MOL BIOL CELL, V15, P4725, DOI 10.1091/mbc.E04-04-0336; Blair KJ, 2011, OTOL NEUROTOL, V32, P308, DOI 10.1097/MAO.0b013e318206fc3d; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; CRICKARD K, 1994, GYNECOL ONCOL, V55, P277, DOI 10.1006/gyno.1994.1290; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; DIBLASIO AM, 1993, AM J OBSTET GYNECOL, V169, P1517, DOI 10.1016/0002-9378(93)90428-L; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; El-Hariry I, 2001, BRIT J CANCER, V84, P1656, DOI 10.1054/bjoc.2001.1813; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Elloul S, 2010, CLIN EXP METASTAS, V27, P161, DOI 10.1007/s10585-010-9315-2; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fujimoto J, 1997, EUR J GYNAECOL ONCOL, V18, P349; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GRAFF JR, 1995, CANCER RES, V55, P5195; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hatziapostolou M, 2006, J BIOL CHEM, V281, P32217, DOI 10.1074/jbc.M607104200; HENNIG G, 1995, ONCOGENE, V11, P475; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Kurrey NK, 2005, GYNECOL ONCOL, V97, P155, DOI 10.1016/j.ygyno.2004.12.043; Lau MT, 2011, ONCOGENE, V30, P2753, DOI 10.1038/onc.2011.6; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li T, 2010, PHARM BIOL, V48, P161, DOI 10.3109/13880200903062630; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Luo J, 1999, CANCER RES, V59, P3552; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Obermair A, 1998, CANCER LETT, V130, P69, DOI 10.1016/S0304-3835(98)00119-0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Sako A, 2003, J SURG RES, V115, P113, DOI 10.1016/S0022-4804(03)00307-X; Salgado R., 2004, Angiogenesis, V7, P29, DOI 10.1023/B:AGEN.0000037331.14489.0b; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Secord AA, 2007, GYNECOL ONCOL, V106, P221, DOI 10.1016/j.ygyno.2007.03.021; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Van der Poel HG, 2004, J UROLOGY, V172, P1333, DOI 10.1097/01.ju.0000138829.97838.19; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wu C, 2008, DIFFERENTIATION, V76, P193, DOI 10.1111/j.1432-0436.2007.00193.x; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu JC, 2008, EXP CELL RES, V314, P421, DOI 10.1016/j.yexcr.2007.10.002; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3	68	77	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59083	10.1371/journal.pone.0059083	http://dx.doi.org/10.1371/journal.pone.0059083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554977	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800057
J	Milan-Lobo, L; Enquist, J; van Rijn, RM; Whistler, JL				Milan-Lobo, Laura; Enquist, Johan; van Rijn, Richard M.; Whistler, Jennifer L.			Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MORPHINE-TOLERANCE; PHYSICAL-DEPENDENCE; REDUCES TOLERANCE; DELTA; MU; TRAFFICKING; ANALGESIA; OPIATE; PAIN	Delta (DOR) and mu opioid receptors (MOR) can complex as heteromers, conferring functional properties in agonist binding, signaling and trafficking that can differ markedly from their homomeric counterparts. Because of these differences, DOR/MOR heteromers may be a novel therapeutic target in the treatment of pain. However, there are currently no ligands selective for DOR/MOR heteromers, and, consequently, their role in nociception remains unknown. In this study, we used a pharmacological opioid cocktail that selectively activates and stabilizes the DOR/MOR heteromer at the cell surface by blocking its endocytosis to assess its role in antinociception. We found that mice treated chronically with this drug cocktail showed a significant right shift in the ED50 for opioid-mediated analgesia, while mice treated with a drug that promotes degradation of the heteromer did not. Furthermore, promoting degradation of the DOR/MOR heteromer after the right shift in the ED50 had occurred, or blocking signal transduction from the stabilized DOR/MOR heteromer, shifted the ED50 for analgesia back to the left. Taken together, these data suggest an anti-analgesic role for the DOR/MOR heteromer in pain. In conclusion, antagonists selective for DOR/MOR heteromer could provide an avenue for alleviating reduced analgesic response during chronic pain treatment.	[Milan-Lobo, Laura; Enquist, Johan; van Rijn, Richard M.; Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, Emeryville, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	jwhistler@gallo.ucsf.edu	van Rijn, Richard M./I-8790-2019	van Rijn, Richard M./0000-0002-9957-1633	Austrian Science Fund (FWF) [J2967-B09]; European Molecular Biology Organization (EMBO) [ALTF1229-2006]; Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH) [DA015232, DA019958, AA020539]; State of California through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA020539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019958, R01DA015232] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH); State of California through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by a Schrodinger fellowship from the Austrian Science Fund (FWF) (J2967-B09 to LML), a European Molecular Biology Organization (EMBO) long term fellowship (ALTF1229-2006 to JE), Foundation for Alcohol Research-ABMRF (RMVR), National Institutes of Health (NIH) grants DA015232, DA019958 (both to JLW) and AA020539 (RMVR), and by funds provided by the State of California for medical research through the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID EE, 1991, J PHARMACOL EXP THER, V258, P299; Abul-Husn NS, 2007, BRIT J PHARMACOL, V151, P877, DOI 10.1038/sj.bjp.0707277; Arttamangkul S, 2008, MOL PHARMACOL, V74, P972, DOI 10.1124/mol.108.048512; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Dykstra LA, 2002, PSYCHOPHARMACOLOGY, V163, P420, DOI 10.1007/s00213-002-1100-8; Fan T, 2005, J BIOL CHEM, V280, P38478, DOI 10.1074/jbc.M505644200; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; FUNDYTUS ME, 1995, EUR J PHARMACOL, V286, P105, DOI 10.1016/0014-2999(95)00554-X; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gomes I, 2011, MOL PHARMACOL, V79, P1044, DOI 10.1124/mol.110.070847; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Hasbi A, 2007, BIOCHEMISTRY-US, V46, P12997, DOI 10.1021/bi701436w; He L, 2005, CURR BIOL, V15, P1028, DOI 10.1016/j.cub.2005.04.052; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hepburn MJ, 1997, J PHARMACOL EXP THER, V281, P1350; Kabli N, 2010, BRIT J PHARMACOL, V161, P1122, DOI 10.1111/j.1476-5381.2010.00944.x; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kest B, 1996, BRAIN RES BULL, V39, P185, DOI 10.1016/0361-9230(95)02092-6; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McNaull B, 2007, EUR J PHARMACOL, V560, P132, DOI 10.1016/j.ejphar.2006.12.013; Mercadante S, 2001, J CLIN ONCOL, V19, P2898, DOI 10.1200/JCO.2001.19.11.2898; Mercadante S, 2009, J PAIN SYMPTOM MANAG, V37, P632, DOI 10.1016/j.jpainsymman.2007.12.024; Milan-Lobo L, 2011, J PHARMACOL EXP THER, V337, P868, DOI 10.1124/jpet.111.179093; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Stevenson GW, 2003, J PHARMACOL EXP THER, V307, P1054, DOI 10.1124/jpet.103.056515; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang HB, 2010, P NATL ACAD SCI USA, V107, P13117, DOI 10.1073/pnas.1008382107; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	40	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58362	10.1371/journal.pone.0058362	http://dx.doi.org/10.1371/journal.pone.0058362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554887	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800014
J	Monroy, PLC; Grefte, S; Kuijpers-Jagtman, AM; Helmich, MPAC; Ulrich, DJO; Von den Hoff, JW; Wagener, FADTG				Monroy, Paola L. Carvajal; Grefte, Sander; Kuijpers-Jagtman, Anne M.; Helmich, Maria P. A. C.; Ulrich, Dietmar J. O.; Von den Hoff, Johannes W.; Wagener, Frank A. D. T. G.			A Rat Model for Muscle Regeneration in the Soft Palate	PLOS ONE			English	Article							LEVATOR VELI-PALATINI; ADULT SKELETAL-MUSCLE; CLEFT-PALATE; SATELLITE CELLS; EUSTACHIAN-TUBE; VELOPHARYNGEAL INSUFFICIENCY; CHILDREN BORN; MICE LACKING; STEM-CELL; DIFFERENTIATION	Background: Children with a cleft in the soft palate have difficulties with speech, swallowing, and sucking. Despite successful surgical repositioning of the muscles, optimal function is often not achieved. Scar formation and defective regeneration may hamper the functional recovery of the muscles after cleft palate repair. Therefore, the aim of this study is to investigate the anatomy and histology of the soft palate in rats, and to establish an in vivo model for muscle regeneration after surgical injury. Methods: Fourteen adult male Sprague Dawley rats were divided into four groups. Groups 1 (n = 4) and 2 (n = 2) were used to investigate the anatomy and histology of the soft palate, respectively. Group 3 (n = 6) was used for surgical wounding of the soft palate, and group 4 (n = 2) was used as unwounded control group. The wounds (1 mm) were evaluated by (immuno) histochemistry (AZAN staining, Pax7, MyoD, MyoG, MyHC, and ASMA) after 7 days. Results: The present study shows that the anatomy and histology of the soft palate muscles of the rat is largely comparable with that in humans. All wounds showed clinical evidence of healing after 7 days. AZAN staining demonstrated extensive collagen deposition in the wound area, and initial regeneration of muscle fibers and salivary glands. Proliferating and differentiating satellite cells were identified in the wound area by antibody staining. Conclusions: This model is the first, suitable for studying muscle regeneration in the rat soft palate, and allows the development of novel adjuvant strategies to promote muscle regeneration after cleft palate surgery.	[Monroy, Paola L. Carvajal; Kuijpers-Jagtman, Anne M.; Von den Hoff, Johannes W.; Wagener, Frank A. D. T. G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Grefte, Sander; Helmich, Maria P. A. C.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Ulrich, Dietmar J. O.] Radboud Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Von den Hoff, JW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	h.vondenhoff@dent.umcn.nl	Ulrich, D.J.O./H-8099-2014; Wagener, Frank/O-6225-2014; Von den Hoff, Johannes W/L-8762-2015; Kuijpers-Jagtman, Anne Marie/A-9413-2008	Wagener, Frank/0000-0003-4837-1559; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090	The Netherlands Organization for Scientific Research (NWO) [017.009.009]	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was partly funded by a Mosaic grant (017.009.009) from The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALBIIN N, 1983, ANAT REC, V207, P513, DOI 10.1002/ar.1092070313; Andersson EM, 2010, CLEFT PALATE-CRAN J, V47, P335, DOI 10.1597/07-230.1; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bae YC, 2002, ANN PLAS SURG, V48, P359, DOI 10.1097/00000637-200204000-00004; BOORMAN JG, 1985, BRIT J PLAST SURG, V38, P333, DOI 10.1016/0007-1226(85)90237-1; Braithwaite F, 1968, Br J Plast Surg, V21, P60, DOI 10.1016/S0007-1226(68)80087-6; Calzolari E, 2007, AM J MED GENET A, V143A, P528, DOI 10.1002/ajmg.a.31447; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Danoviz ME, 2012, METHODS MOL BIOL, V798, P21, DOI 10.1007/978-1-61779-343-1_2; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; FARA M, 1970, PLAST RECONSTR SURG, V46, P488; Fukushima K, 2001, AM J SPORT MED, V29, P394, DOI 10.1177/03635465010290040201; FURUSAWA K, 1991, BRAIN RES BULL, V26, P599, DOI 10.1016/0361-9230(91)90101-O; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Grefte S, 2010, REGEN MED, V5, P737, DOI 10.2217/RME.10.69; Grefte S, 2010, MED SCI SPORT EXER, V42, P813, DOI 10.1249/MSS.0b013e3181beeb52; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Huang MHS, 1997, PLAST RECONSTR SURG, V100, P833, DOI 10.1097/00006534-199709001-00003; Huang MHS, 1998, PLAST RECONSTR SURG, V101, P613, DOI 10.1097/00006534-199803000-00007; Hwang K, 2009, J CRANIOFAC SURG, V20, P1591, DOI 10.1097/SCS.0b013e3181b0dbb2; Inman DS, 2005, BRIT J PLAST SURG, V58, P1051, DOI 10.1016/j.bjps.2005.05.019; Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606; Kelly RG, 2010, EXP CELL RES, V316, P3034, DOI 10.1016/j.yexcr.2010.04.029; Kirschner RE, 1999, PLAST RECONSTR SURG, V104, P1998, DOI 10.1097/00006534-199912000-00009; Koo SH, 2001, PLAST RECONSTR SURG, V108, P938, DOI 10.1097/00006534-200109150-00018; Kuehn DP, 2003, AM J SPEECH-LANG PAT, V12, P103, DOI 10.1044/1058-0360(2003/056); Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Marrinan EM, 1998, CLEFT PALATE-CRAN J, V35, P95, DOI 10.1597/1545-1569(1998)035<0095:VFINCP>2.3.CO;2; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Monroy PLC, 2012, TISSUE ENG PART B-RE, V18, P468, DOI [10.1089/ten.TEB.2012.0049, 10.1089/ten.teb.2012.0049]; Moon JB, 1998, CLEFT PALATE-CRAN J, V35, P419, DOI 10.1597/1545-1569(1998)035<0419:MFTDIT>2.3.CO;2; Morris H L, 1973, Cleft Palate J, V10, P62; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Mulder JJS, 1999, ANN OTO RHINOL LARYN, V108, P277, DOI 10.1177/000348949910800311; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Persson C, 2002, CLEFT PALATE-CRAN J, V39, P397, DOI 10.1597/1545-1569(2002)039<0397:SOIICP>2.0.CO;2; Phua YS, 2008, CLEFT PALATE-CRAN J, V45, P172, DOI 10.1597/06-205.1; RINTALA AE, 1995, BRIT J ORAL MAX SURG, V33, P295, DOI 10.1016/0266-4356(95)90040-3; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780; YAMAOKA M, 1992, CLEFT PALATE-CRAN J, V29, P271, DOI 10.1597/1545-1569(1992)029<0271:MSDITL>2.3.CO;2; Yasuda K, 2003, BRAIN RES, V968, P80, DOI 10.1016/S0006-8993(02)04273-7; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	57	22	22	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59193	10.1371/journal.pone.0059193	http://dx.doi.org/10.1371/journal.pone.0059193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554995	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800069
J	Zhang, XJ; Hao, LL; Meng, LJ; Liu, ML; Zhao, LN; Hu, F; Ding, CB; Wang, Y; He, BL; Pan, YX; Fang, W; Chen, J; Hu, SN; Jia, MC				Zhang, Xiujun; Hao, Lili; Meng, Lijun; Liu, Meiling; Zhao, Lina; Hu, Fen; Ding, Cunbao; Wang, Yang; He, Baoling; Pan, Yuxin; Fang, Wei; Chen, Jing; Hu, Songnian; Jia, Mengchun			Digital Gene Expression Tag Profiling Analysis of the Gene Expression Patterns Regulating the Early Stage of Mouse Spermatogenesis	PLOS ONE			English	Article							CELL JUNCTION DYNAMICS; RHO GTPASES; SERTOLI; TESTIS; PATHWAY; AP-1; ACTIVATION; APOPTOSIS; ONTOLOGY; KINASE	Detailed characterization of the gene expression patterns in spermatogonia and primary spermatocytes is critical to understand the processes which occur prior to meiosis during normal spermatogenesis. The genome-wide expression profiles of mouse type B spermatogonia and primary spermatocytes were investigated using the Solexa/Illumina digital gene expression (DGE) system, a tag based high-throughput transcriptome sequencing method, and the developmental processes which occur during early spermatogenesis were systematically analyzed. Gene expression patterns vary significantly between mouse type B spermatogonia and primary spermatocytes. The functional analysis revealed that genes related to junction assembly, regulation of the actin cytoskeleton and pluripotency were most significantly differently expressed. Pathway analysis indicated that the Wnt non-canonical signaling pathway played a central role and interacted with the actin filament organization pathway during the development of spermatogonia. This study provides a foundation for further analysis of the gene expression patterns and signaling pathways which regulate the molecular mechanisms of early spermatogenesis.	[Zhang, Xiujun; Zhao, Lina; Hu, Fen; Ding, Cunbao; Wang, Yang; He, Baoling; Pan, Yuxin; Fang, Wei; Chen, Jing] Hebei United Univ, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Zhang, Xiujun; Liu, Meiling; Jia, Mengchun] Natl Res Inst Family Planning, Dept Reprod Endocrinol, Beijing, Peoples R China; [Hao, Lili; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Meng, Lijun] Tangshan Coll, Dept Environm & Chem Engn, Tangshan, Hebei, Peoples R China	North China University of Science & Technology; National Research Institute for Family Planning - China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Hu, SN (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	husn@big.ac.cn; mengchunjia@163.com	meng, li/GVT-2063-2022; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [81170616, 81072093, 30671092]; Natural Science Foundation of Hebei Province [C2009001260, C2012401039]; Scientific and Technical Supporting Programs of Hebei Province [10276109D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Scientific and Technical Supporting Programs of Hebei Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81170616; 81072093; 30671092), the Natural Science Foundation of Hebei Province (C2009001260; C2012401039) and the Scientific and Technical Supporting Programs of Hebei Province (No. 10276109D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Anderson DH, 2006, PROG LIPID RES, V45, P102, DOI 10.1016/j.plipres.2005.12.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; BUSH J, 1993, GENE, V136, P61, DOI 10.1016/0378-1119(93)90448-C; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chu DS, 2013, ADV EXP MED BIOL, V757, P171, DOI 10.1007/978-1-4614-4015-4_7; Cory AT, 2007, MOL REPROD DEV, V74, P1491, DOI 10.1002/mrd.20722; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Guttman JA, 2004, BIOL REPROD, V70, P805, DOI 10.1095/biolreprod.103.022723; Habas R, 2006, METHOD ENZYMOL, V406, P500, DOI 10.1016/S0076-6879(06)06038-1; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ishida-Takagishi M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1861; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Li Michelle Wm, 2011, Spermatogenesis, V1, P123, DOI 10.4161/spmg.1.2.16393; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Lui WY, 2009, J MOL ENDOCRINOL, V43, P43, DOI 10.1677/JME-08-0174; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Mezzacappa Courtney, 2012, Methods Mol Biol, V839, P119, DOI 10.1007/978-1-61779-510-7_10; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossi P, 2004, GENE EXPR PATTERNS, V4, P267, DOI 10.1016/j.modgep.2003.11.003; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Siu ER, 2009, P NATL ACAD SCI USA, V106, P9298, DOI 10.1073/pnas.0813113106; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Ward KK, 2012, CLIN EXP METASTASIS; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Wong EW, 2012, FASEB J; Xiao X, 2013, HUM REPROD UPDATE; Xiao Y, 2007, CANCER BIOL THER, V6, P1044, DOI 10.4161/cbt.6.7.4317; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	46	19	20	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58680	10.1371/journal.pone.0058680	http://dx.doi.org/10.1371/journal.pone.0058680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554914	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800022
J	Vittori, M; Rozman, A; Grdadolnik, J; Novak, U; Strus, J				Vittori, Milos; Rozman, Alenka; Grdadolnik, Joze; Novak, Urban; Strus, Jasna			Mineral Deposition in Bacteria-Filled and Bacteria-Free Calcium Bodies in the Crustacean Hyloniscus riparius (Isopoda: Oniscidea)	PLOS ONE			English	Article							TITANETHES-ALBUS CRUSTACEA; PORCELLIO-SCABER; TERRESTRIAL ISOPODS; RAMAN-SPECTROSCOPY; CARBONATE; TRANSPORT; STORAGE; CUTICLE; ULTRASTRUCTURE; MORPHOLOGY	Crustacean calcium bodies are epithelial sacs which contain a mineralized matrix. The objectives of this study were to describe the microscopic anatomy of calcium bodies in the terrestrial isopod Hyloniscus riparius and to establish whether they undergo molt-related structural changes. We performed 3D reconstruction of the calcium bodies from paraffin sections and analyzed their structure with light and electron microscopy. In addition, we analyzed the chemical composition of their mineralized matrices with micro-Raman spectroscopy. Two pairs of these organs are present in H. riparius. One pair is filled with bacteria while the other pair is not. In non-molting animals, the bacteria-filled calcium bodies contain apatite crystals and the bacteria-free calcium bodies enclose CaCO3-containing concretions with little organic matrix. During preparation for molt, an additional matrix layer is deposited in both pairs of calcium bodies. In the bacteria-filled calcium bodies it contains a mixture of calcium carbonate and calcium phosphate, whereas only calcium carbonate is present in bacteria-free calcium bodies. After ecdysis, all mineral components in bacteria-free calcium bodies and the additional matrix layer in bacteria-filled calcium bodies are completely resorbed. During calcium resorption, the apical surface of the calcium body epithelium is deeply folded and electron dense granules are present in spaces between epithelial cells. Our results indicate that the presence of bacteria might be linked to calcium phosphate mineralization. Calcium bodies likely provide a source of calcium and potentially phosphate for the mineralization of the new cuticle after molt. Unlike other terrestrial isopods, H. riparius does not form sternal CaCO3 deposits and the bacteria-free calcium bodies might functionally replace them in this species.	[Vittori, Milos; Rozman, Alenka; Strus, Jasna] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Grdadolnik, Joze; Novak, Urban] Natl Inst Chem, Ljubljana, Slovenia; [Grdadolnik, Joze] Ctr Excellence, EN FIST, Ljubljana, Slovenia	University of Ljubljana; National Institute of Chemistry - Slovenia	Vittori, M (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	milos.vittori@gmail.com	Strus, Jasna/I-4376-2019	Grdadolnik, Joze/0000-0002-0312-168X	Slovenian Research Agency (ARRS) [1000-09-310037]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Slovenian Research Agency (ARRS), grant No 1000-09-310037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva-Tal A, 2011, P NATL ACAD SCI USA, V108, P14763, DOI 10.1073/pnas.1102608108; Rivadeneyra MA, 2010, ISME J, V4, P922, DOI 10.1038/ismej.2010.17; Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0; Becker A, 2003, DALTON T, P551, DOI 10.1039/b210529b; Bentov S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1839; Billen J, 2000, ARTHROPOD STRUCT DEV, V29, P259, DOI 10.1016/S1467-8039(00)00029-3; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Frost RL, 2012, J RAMAN SPECTROSC, V43, P571, DOI 10.1002/jrs.3063; Gal JY, 1996, TALANTA, V43, P1497, DOI 10.1016/0039-9140(96)01925-X; Glotzner J, 2000, ARTHROPOD STRUCT DEV, V29, P241, DOI 10.1016/S1467-8039(00)00030-X; GRAF F, 1985, CELL TISSUE RES, V242, P83; GREENAWAY P, 1991, ACTA ZOOL-STOCKHOLM, V72, P29, DOI 10.1111/j.1463-6395.1991.tb00313.x; Hild S, 2008, J STRUCT BIOL, V163, P100, DOI 10.1016/j.jsb.2008.04.010; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; HIRSCHLER A, 1990, FEMS MICROBIOL ECOL, V73, P211, DOI 10.1016/0378-1097(90)90732-6; Kazanci M, 2006, CALCIFIED TISSUE INT, V79, P354, DOI 10.1007/s00223-006-0011-9; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Mehely LV, 1932, STUDIA ZOOL, V2, P103; Neues F, 2007, CRYSTENGCOMM, V9, P1245, DOI 10.1039/b710789g; Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; ROER R, 1984, AM ZOOL, V24, P893; Rosch P, 2005, APPL ENVIRON MICROB, V71, P1626, DOI 10.1128/AEM.71.3.1626-1637.2005; RUTT HN, 1974, J PHYS C SOLID STATE, V7, P4522, DOI 10.1088/0022-3719/7/24/015; Schmidt Christian, 2008, Arthropod Systematics & Phylogeny, V66, P191; Seidl B, 2011, J STRUCT BIOL, V174, P512, DOI 10.1016/j.jsb.2011.03.005; Simcic T, 2010, MAR FRESHW BEHAV PHY, V43, P149, DOI 10.1080/10236244.2010.483052; STEEL CGH, 1993, CAN J ZOOL, V71, P4, DOI 10.1139/z93-002; Strus J, 2001, CRUSTACEAN ISS, V13, P343; Tas AC, 2009, J AM CERAM SOC, V92, P2907, DOI 10.1111/j.1551-2916.2009.03351.x; Tlili MM, 2002, J RAMAN SPECTROSC, V33, P10, DOI 10.1002/jrs.806; VERHOEFF K. W., 1926, [MITTEIL BULGARISCHEN ENT GES], V3, P135; Vittori M, 2012, J STRUCT BIOL, V180, P216, DOI 10.1016/j.jsb.2012.05.014; Vittori M, 2012, ZOOKEYS, P23, DOI 10.3897/zookeys.176.2285; Wehrmeister U, 2010, J RAMAN SPECTROSC, V41, P193, DOI 10.1002/jrs.2438; Welch SA, 2002, GEOMICROBIOL J, V19, P343, DOI 10.1080/01490450290098414; Zidar P, 1998, CRUSTACEANA, V71, P646, DOI 10.1163/156854098X00644; Ziegler A, 2003, CRUSTACEANA MONOGR, V2, P299; Ziegler A, 2005, MICRON, V36, P137, DOI 10.1016/j.micron.2004.09.006; Ziegler A, 2002, CELL CALCIUM, V31, P307, DOI 10.1016/S0143-4160(02)00060-X; Ziegler A, 1997, ZOOMORPHOLOGY, V117, P181, DOI 10.1007/s004350050043; Ziegler A, 1996, CELL TISSUE RES, V284, P459, DOI 10.1007/s004410050606	47	6	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58968	10.1371/journal.pone.0058968	http://dx.doi.org/10.1371/journal.pone.0058968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554963	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500060
J	Wang, YP; Cheng, ML; Zhang, BF; Nie, F; Jiang, HM				Wang, Yuping; Cheng, Mingliang; Zhang, Baofang; Nie, Fei; Jiang, Hongmei			Dietary Supplementation of Blueberry Juice Enhances Hepatic Expression of Metallothionein and Attenuates Liver Fibrosis in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED DNA; INJURY; OXYGEN; MICE; PROANTHOCYANIDIN; STEATOSIS; PROTEIN; LEAVES; DAMAGE	Aim: To investigate the effect of blueberry juice intake on rat liver fibrosis and its influence on hepatic antioxidant defense. Methods: Rabbiteye blueberry was used to prepare fresh juice to feed rats by daily gastric gavage. Dan-shao-hua-xian capsule (DSHX) was used as a positive control for liver fibrosis protection. Liver fibrosis was induced in male Sprague-Dawley rats by subcutaneous injection of CCl4 and feeding a high-lipid/low-protein diet for 8 weeks. Hepatic fibrosis was evaluated by Masson staining. The expression of alpha-smooth muscle actin (alpha-SMA) and collagen III (Col III) were determined by immunohistochemical techniques. The activities of superoxide dismutase (SOD) and malondialdehyde (MDA) in liver homogenates were determined. Metallothionein (MT) expression was detected by real-time RT-PCR and immunohistochemical techniques. Results: Blueberry juice consumption significantly attenuates CCl4-induced rat hepatic fibrosis, which was associated with elevated expression of metallothionein (MT), increased SOD activity, reduced oxidative stress, and decreased levels of alpha-SMA and Col III in the liver. Conclusion: Our study suggests that dietary supplementation of blueberry juice can augment antioxidative capability of the liver presumably via stimulating MT expression and SOD activity, which in turn promotes HSC inactivation and thus decreases extracellular matrix collagen accumulation in the liver, and thereby alleviating hepatic fibrosis.	[Wang, Yuping; Jiang, Hongmei] Guiyang Med Coll, Dept Clin Microbiol & Immunol, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China; [Cheng, Mingliang; Zhang, Baofang] Guiyang Med Coll, Dept Infect Dis, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China; [Nie, Fei] Guizhou Acad Sci, Guiyang, Guizhou Provinc, Peoples R China	Guizhou Medical University; Guizhou Medical University	Cheng, ML (corresponding author), Guiyang Med Coll, Dept Infect Dis, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China.	chengml@21cn.com			Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization [ZY[2012]3017]; Foundation of the Governor of Guizhou Province [[2012] 44]; National Foundation for Educational Teams of China [[2009]12]	Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization; Foundation of the Governor of Guizhou Province; National Foundation for Educational Teams of China	This study was supported by a grant from the Department of Science and Technology of Guizhou Province for Traditional Chinese Medicine Modernization (Grant No. ZY[2012]3017), a grant from the Foundation of the Governor of Guizhou Province ([2012] 44), and a grant from the National Foundation for Educational Teams of China ([2009]12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2000, J BIOL CHEM, V275, P38957, DOI 10.1074/jbc.C000593200; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Carrera G, 2003, AM J GASTROENTEROL, V98, P1142; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Cherian MG, 2006, EXP BIOL MED, V231, P138; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Eum WS, 2004, FREE RADICAL BIO MED, V37, P339, DOI 10.1016/j.freeradbiomed.2004.04.036; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Geng Xiao-Xia, 2004, Hepatobiliary Pancreat Dis Int, V3, P558; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang YC, 2004, MOL THER, V10, P1130, DOI 10.1016/j.ymthe.2004.08.011; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Koh M, 2001, B KOREAN CHEM SOC, V22, P362; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Ming LC, 2008, HEPATIC FIBROSIS, P3; Nachman-Clewner M, 2008, INVEST OPHTH VIS SCI, V49, P3207, DOI 10.1167/iovs.07-1039; Osman N, 2007, DIGEST LIVER DIS, V39, P849, DOI 10.1016/j.dld.2007.06.001; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Prior RL, 2000, J AOAC INT, V83, P950; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Tahan G, 2007, DIGEST DIS SCI, V52, P3348, DOI 10.1007/s10620-006-9717-9; Tahan V, 2004, J PINEAL RES, V37, P78, DOI 10.1111/j.1600-079X.2004.00137.x; Takami Y, 2010, HEPATOL RES, V40, P337, DOI 10.1111/j.1872-034X.2009.00589.x; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Wang YD, 2000, WORLD J GASTRONET S3, V6, P73; Wang YP, 2010, ZHONG HUA YI XUE ZA, V9, P2504; Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657; Wang YP, 2010, HEPATOB PANCREAT DIS, V9, P164; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Yang Q, 2005, WORLD J GASTROENTERO, V11, P4953, DOI 10.3748/wjg.v11.i32.4953	35	26	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58659	10.1371/journal.pone.0058659	http://dx.doi.org/10.1371/journal.pone.0058659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554912	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500038
J	Yang, ZX; Han, ZB; Ji, YR; Wang, YW; Liang, L; Chi, Y; Yang, SG; Li, LN; Luo, WF; Li, JP; Chen, DD; Du, WJ; Cao, XC; Zhuo, GS; Wang, T; Han, ZC				Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Liang, Lu; Chi, Ying; Yang, Shao Guang; Li, Li Na; Luo, Wei Feng; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Cao, Xiao Cang; Zhuo, Guang Sheng; Wang, Tao; Han, Zhong Chao			CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; UMBILICAL-CORD; HUMAN PLACENTA; IFN-GAMMA; ADHESION MOLECULE-1; ADIPOSE-TISSUE; TNF-ALPHA; EXPRESSION; TOLERANCE	Mesenchymal stem cells (MSCs) reside in almost all of the body tissues, where they undergo self-renewal and multi-lineage differentiation. MSCs derived from different tissues share many similarities but also show some differences in term of biological properties. We aim to search for significant differences among various sources of MSCs and to explore their implications in physiopathology and clinical translation. We compared the phenotype and biological properties among different MSCs isolated from human term placental chorionic villi (CV), umbilical cord (UC), adult bone marrow (BM) and adipose (AD). We found that CD106 (VCAM-1) was expressed highest on the CV-MSCs, moderately on BM-MSCs, lightly on UC-MSCs and absent on AD-MSCs. CV-MSCs also showed unique immune-associated gene expression and immunomodulation. We thus separated CD106(+) cells and CD106(-) cells from CV-MSCs and compared their biological activities. Both two subpopulations were capable of osteogenic and adipogenic differentiation while CD106(+) CV-MSCs were more effective to modulate T helper subsets but possessed decreased colony formation capacity. In addition, CD106(+) CV-MSCs expressed more cytokines than CD106(-) CV-MSCs. These data demonstrate that CD106 identifies a subpopulation of CV-MSCs with unique immunoregulatory activity and reveal a previously unrecognized mechanism underlying immunomodulation of MSCs.	[Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Yang, Zhou Xin; Han, Zhi-Bo; Ji, Yue Ru; Wang, You Wei; Chi, Ying; Yang, Shao Guang; Li, Jian Ping; Chen, Dan Dan; Du, Wen Jing; Han, Zhong Chao] Peking Union Med Coll, Tianjin, Peoples R China; [Wang, You Wei; Liang, Lu; Han, Zhong Chao] Natl Engn Res Ctr Cell Prod, Tianjin, Peoples R China; [Han, Zhi-Bo; Liang, Lu; Zhuo, Guang Sheng; Wang, Tao] Beijing Inst Hlth & Stem Cells, Beijing, Peoples R China; [Li, Li Na; Luo, Wei Feng] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Cao, Xiao Cang] Tianjin Med Univ, Tianjin Med Univ Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jinan University; Tianjin Medical University	Han, ZC (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	hanzhongchao@hotmail.com	Li, Jianping/Q-1618-2019; Wang, Youwei/M-4544-2019; Han, Zhong Chao/D-7157-2016; Chen, Dan/GRY-2691-2022; Li, Jianping/U-6806-2017; Du, Weiting/C-9971-2014	Han, Zhong Chao/0000-0002-2687-7682; Chen, Dan/0000-0002-1570-9034; cao, xiaocang/0000-0001-8376-3481	863 project [2011AA020118]; 973 program of China from the Ministry Science & Technology of China [2011 CB964800, 2011CB964802]	863 project(National High Technology Research and Development Program of China); 973 program of China from the Ministry Science & Technology of China	This study was supported by the 863 project (Grant no. 2011AA020118) and the 973 program of China 2011 CB964800 (Grant no. 2011CB964802) from the Ministry Science & Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Bernardo ME, 2007, CONNECT TISSUE RES, V48, P132, DOI 10.1080/03008200701228464; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Cesario A, 2011, CURR MED CHEM, V18, P2263, DOI 0929-8673/11 $58.00+.00; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; KWEE L, 1995, DEVELOPMENT, V121, P489; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Liu M, 2010, PLATELETS, V21, P199, DOI 10.3109/09537101003602483; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; MATTSSON R, 1991, J REPROD IMMUNOL, V19, P115, DOI 10.1016/0165-0378(91)90012-F; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Paulesu L, 2008, EVOL DEV, V10, P778, DOI 10.1111/j.1525-142X.2008.00292.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; SIMMONS PJ, 1992, BLOOD, V80, P388; Simon C, 1998, FERTIL STERIL, V70, P896, DOI 10.1016/S0015-0282(98)00275-1; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; TERRANOVA PF, 1995, P SOC EXP BIOL MED, V209, P325; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vacchio MS, 2005, J IMMUNOL, V174, P4657, DOI 10.4049/jimmunol.174.8.4657; Wang D, 2010, EXP CELL RES, V316, P2414, DOI 10.1016/j.yexcr.2010.04.018; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	49	100	109	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59354	10.1371/journal.pone.0059354	http://dx.doi.org/10.1371/journal.pone.0059354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555021	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500083
J	Kuo, LC; Chen, SW; Lin, CJ; Lin, WJ; Lin, SC; Su, FC				Kuo, Li-Chieh; Chen, Shih-Wei; Lin, Chien-Ju; Lin, Wei-Jr; Lin, Sheng-Che; Su, Fong-Chin			The Force Synergy of Human Digits in Static and Dynamic Cylindrical Grasps	PLOS ONE			English	Article							MULTI-FINGER TASKS; QUANTITATIVE-ANALYSIS; MOTOR VARIABILITY; PRECISION GRIP; COORDINATION; OBJECT; HAND; MANIPULATION	This study explores the force synergy of human digits in both static and dynamic cylindrical grasping conditions. The patterns of digit force distribution, error compensation, and the relationships among digit forces are examined to quantify he synergetic patterns and coordination of multi-finger movements. This study recruited 24 healthy participants to perform cylindrical grasps using a glass simulator under normal grasping and one-finger restricted conditions. Parameters such as the grasping force, patterns of digit force distribution, and the force coefficient of variation are determined. Correlation coefficients and principal component analysis (PCA) are used to estimate the synergy strength under the dynamic grasping condition. Specific distribution patterns of digit forces are identified for various conditions. The compensation of adjacent fingers for the force in the normal direction of an absent finger agrees with the principle of error compensation. For digit forces in anti-gravity directions, the distribution patterns vary significantly by participant. The forces exerted by the thumb are closely related to those exerted by other fingers under all conditions. The index-middle and middle ring finger pairs demonstrate a significant relationship. The PCA results show that the normal forces of digits are highly coordinated. This study reveals that normal force synergy exists under both static and dynamic cylindrical grasping conditions.	[Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan; [Chen, Shih-Wei; Lin, Wei-Jr; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Chien-Ju; Lin, Wei-Jr; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Lin, Sheng-Che] Natl Cheng Kung Univ, Sect Plast Surg, Dept Surg, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021; Lin, Chien-Ju/AAP-5725-2020	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Lin, Chien-Ju/0000-0001-9571-8610; Kuo, Li-Chieh/0000-0002-5644-655X	National Health Research Institute of Taiwan [NHRI-EX100-10040EI]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institute of Taiwan under grant NHRI-EX100-10040EI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib M.A., 1985, EXP BRAIN RES S, V10, P111, DOI DOI 10.1007/978-3-642-70105-4_; Baud-Bovy G, 2001, J NEUROPHYSIOL, V86, P604, DOI 10.1152/jn.2001.86.2.604; Bernstein N, 1967, COORDINATION REGULAT; Braido P, 2004, HUM MOVEMENT SCI, V22, P661, DOI 10.1016/j.humov.2003.10.001; Burstedt MKO, 1999, J NEUROPHYSIOL, V82, P2393, DOI 10.1152/jn.1999.82.5.2393; de Freitas PB, 2008, J HUM KINET, V20, P37; de Freitas PB, 2008, NEUROSCI LETT, V434, P234; Gorniak S, 2009, EXP BRAIN RES, V194, P1, DOI 10.1007/s00221-008-1663-7; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kim SW, 2008, HUM MOVEMENT SCI, V27, P408, DOI 10.1016/j.humov.2007.08.005; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Latash ML, 2001, EXP BRAIN RES, V141, P153, DOI 10.1007/s002210100861; Latash ML, 2008, SYNERGY; Li S, 2003, EXP BRAIN RES, V150, P230, DOI 10.1007/s00221-003-1449-x; Li ZM, 2002, ERGONOMICS, V45, P425, DOI 10.1080/00140130210129673; Li ZM, 2007, J BIOMECH, V40, P502, DOI 10.1016/j.jbiomech.2006.02.019; MacKenzie C. L., 1994, THE GRASPING HAND; MAH CD, 1994, J MOTOR BEHAV, V26, P83, DOI 10.1080/00222895.1994.9941664; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Martin JR, 2009, EXP BRAIN RES, V192, P293, DOI 10.1007/s00221-008-1615-2; Quaine F, 2011, INT J SPORTS MED, V32, P49, DOI 10.1055/s-0030-1267230; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Scholz JP, 2002, BIOL CYBERN, V86, P29, DOI 10.1007/s004220100279; Sun Y, 2011, EXP BRAIN RES, V209, P571, DOI 10.1007/s00221-011-2590-6; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; Weiss EJ, 2004, J NEUROPHYSIOL, V92, P523, DOI 10.1152/jn.01265.2003; Winges SA, 2004, J NEUROPHYSIOL, V92, P3210, DOI 10.1152/jn.00516.2004; Zatsiorsky VM, 2003, EXP BRAIN RES, V148, P77, DOI 10.1007/s00221-002-1278-3; Zatsiorsky VM, 1998, BIOL CYBERN, V79, P139, DOI 10.1007/s004220050466; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zhang W, 2008, J NEUROPHYSIOL, V99, P500, DOI 10.1152/jn.01029.2007	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60509	10.1371/journal.pone.0060509	http://dx.doi.org/10.1371/journal.pone.0060509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544151	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700110
J	Morton, PK; Schemerhorn, BJ				Morton, Philip K.; Schemerhorn, Brandon J.			Population Structure and the Colonization Route of One of the Oldest North American Invasive Insects: Stories from the Worn Road of the Hessian Fly, Mayetiola destructor (Say)	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; GENE CONFERRING RESISTANCE; COMPUTER-PROGRAM; DIPTERA; WHEAT; CECIDOMYIIDAE; BOTTLENECK; VIRULENCE; VH13	An integral part to understanding the biology of an invasive species is determining its origin, particularly in pest species. As one of the oldest known invasive species, the goals of this study were to evaluate the evidence of a westward expansion of Hessian fly into North America, from a potential singular introduction event, and the population genetic structure of current populations. Levels of genetic diversity and population structure in the Hessian fly were compared across North America Europe, North Africa, Western Asia, and New Zealand. Furthermore, Old World populations were evaluated as possible sources of introduction. We tested diversity and population structure by examining 18 microsatellite loci with coverage across all four Hessian fly chromosomes. Neither genetic diversity nor population genetic structure provided evidence of a westward movement from a single introduction in North America. Introduced populations in North America did not show identity or assignment to any Old World population, likely indicating a multiple introduction scenario with subsequent gene flow between populations. Diversity and selection were assessed on a chromosomal level, with no differences in diversity or selection between chromosomes or between native and introduced populations.	[Morton, Philip K.; Schemerhorn, Brandon J.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Schemerhorn, Brandon J.] USDA ARS, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA)	Morton, PK (corresponding author), Univ Oklahoma, Biol Stn, Kingston, OK 73019 USA.	pmorton@ou.edu		Schemerhorn, Brandon/0000-0003-0247-478X	United States Department of Agriculture [USDA-ARS CRIS 3602-22000-14D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture grant USDA-ARS CRIS 3602-22000-14D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; BLACK WC, 1990, J HERED, V81, P331, DOI 10.1093/oxfordjournals.jhered.a110998; Bray AM, 2011, BIOL INVASIONS, V13, P2869, DOI 10.1007/s10530-011-9970-5; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Coombs JA, 2007, CREATE 1 0 SOFTWARE; Cornuet JM, 1996, GENETICS, V144, P2001; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; El Bouhssini M, 2001, B ENTOMOL RES, V91, P327; Fitch A, 1847, AM Q J AGR SCI, V4, P244; Formusoh ES, 1996, ANN ENTOMOL SOC AM, V89, P428, DOI 10.1093/aesa/89.3.428; Foster JE, 1986, BULLETIN, V502; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; GALLUN RL, 1978, ANN ENTOMOL SOC AM, V71, P481, DOI 10.1093/aesa/71.4.481; GALLUN RL, 1977, ANN NY ACAD SCI, V287, P223, DOI 10.1111/j.1749-6632.1977.tb34241.x; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Harris MO, 2006, ANN ENTOMOL SOC AM, V99, P305, DOI 10.1603/0013-8746(2006)099[0305:VHFDCL]2.0.CO;2; HATCHETT JH, 1970, ANN ENTOMOL SOC AM, V63, P1400, DOI 10.1093/aesa/63.5.1400; Jakobsson M, 2007, CLUMPP CLUSTER MATCH; Johnson AJ, 2004, ANN ENTOMOL SOC AM, V97, P940, DOI 10.1603/0013-8746(2004)097[0940:AFAOMD]2.0.CO;2; Johnson AJ, 2012, B ENTOMOL RES; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Martin-Sanchez JA, 2003, THEOR APPL GENET, V106, P1248, DOI 10.1007/s00122-002-1182-z; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Morton PK, 2011, ENVIRON ENTOMOL, V40, P1303, DOI 10.1603/EN10244; Packard AS, 1880, B US ENTOMOLOGICAL C; Packard CM, 1928, USDA B, V81; Patterson F. L., 1973, Proceedings of the fourth international wheat genetics symposium. Pests., P445; Pauly P. J., 2002, ENV HIST, V7, P377; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prestidge R.A., 1987, Proceedings of New Zealand Weed and Pest Control Conference, V40, P226; Pritchard JK, 2004, DOCUMENTATION STRUCT; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Ratcliffe R.H., 1997, NEW DEV ENTOMOLOGY, P47; Rider SD, 2002, GENOME, V45, P812, DOI [10.1139/G02-047, 10.1139/g02-047]; Rosenberg N, 2004, MOL ECOL, V4, P127; Sardesai N, 2005, THEOR APPL GENET, V111, P1167, DOI 10.1007/s00122-005-0048-6; Schemerhorn BJ, 2009, J HERED, V100, P790, DOI 10.1093/jhered/esp045; Schulte SJ, 1999, GENOME, V42, P821, DOI 10.1139/gen-42-5-821; STUART JJ, 1988, J HERED, V79, P184, DOI 10.1093/oxfordjournals.jhered.a110490; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Williams CE, 2003, THEOR APPL GENET, V107, P1516, DOI 10.1007/s00122-003-1393-y; Withers TM, 1995, P NZ PLAN P, V48, P165, DOI 10.30843/nzpp.1995.48.11548; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; ZEISS MR, 1993, J AGR ENTOMOL, V10, P107	57	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59833	10.1371/journal.pone.0059833	http://dx.doi.org/10.1371/journal.pone.0059833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544103	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700063
J	Rao, T; Ruiz-Gomez, G; Hill, TA; Hoang, HN; Fairlie, DP; Mason, JM				Rao, Tara; Ruiz-Gomez, Gloria; Hill, Timothy A.; Hoang, Huy N.; Fairlie, David P.; Mason, Jody M.			Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1	PLOS ONE			English	Article							HYDROGEN-BOND-SURROGATE; SHORT ALPHA-HELICES; TRANSCRIPTION FACTORS; LEUCINE-ZIPPER; STAPLED P53; DESIGN; INHIBITION; STABILITY; SELECTION; ENERGY	Protein-based therapeutics feature large interacting surfaces. Protein folding endows structural stability to localised surface epitopes, imparting high affinity and target specificity upon interactions with binding partners. However, short synthetic peptides with sequences corresponding to such protein epitopes are unstructured in water and promiscuously bind to proteins with low affinity and specificity. Here we combine structural stability and target specificity of proteins, with low cost and rapid synthesis of small molecules, towards meeting the significant challenge of binding coiled coil proteins in transcriptional regulation. By iteratively truncating a Jun-based peptide from 37 to 22 residues, strategically incorporating i -> i+4 helix-inducing constraints, and positioning unnatural amino acids, we have produced short, water-stable, a-helical peptides that bind cFos. A three-dimensional NMR-derived structure for one peptide (24) confirmed a highly stable alpha-helix which was resistant to proteolytic degradation in serum. These short structured peptides are entropically pre-organized for binding with high affinity and specificity to cFos, a key component of the oncogenic transcriptional regulator Activator Protein-1 (AP-1). They competitively antagonized the cJun-cFos coiled-coil interaction. Truncating a Jun-based peptide from 37 to 22 residues decreased the binding enthalpy for cJun by similar to 9 kcal/mol, but this was compensated by increased conformational entropy (T Delta S <= 7.5 kcal/mol). This study demonstrates that rational design of short peptides constrained by alpha-helical cyclic pentapeptide modules is able to retain parental high helicity, as well as high affinity and specificity for cFos. These are important steps towards small antagonists of the cJun-cFos interaction that mediates gene transcription in cancer and inflammatory diseases.	[Rao, Tara; Mason, Jody M.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Ruiz-Gomez, Gloria; Hill, Timothy A.; Hoang, Huy N.; Fairlie, David P.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld, Australia	University of Essex; University of Queensland	Mason, JM (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	jmason@essex.ac.uk	Mason, Jody/W-8204-2019; Mason, Jody/A-9329-2011; Hill, Timothy A/C-9670-2017; Fairlie, David P/F-8865-2014; Hoang, Huy N/I-6357-2015	Mason, Jody/0000-0002-4118-1958; Mason, Jody/0000-0002-4118-1958; Hill, Timothy A/0000-0001-9727-9930; Fairlie, David P/0000-0002-7856-8566; Hoang, Huy N/0000-0002-7124-6097	Wellcome Trust [WT090184MA]; Cancer Research UK [DBB3800]; Australian Research Council [FF668733, DP00770936]; National Health and Medical Research Council [511194, APP1028423, APP1027369]; ARC Federation; NHMRC; Cancer Research UK [11738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Federation(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	JMM gratefully acknowledges support from the Wellcome Trust (WT090184MA) and Cancer Research UK for a career establishment award (DBB3800). DPF acknowledges the Australian Research Council (FF668733, DP00770936) and National Health and Medical Research Council (511194, APP1028423, APP1027369) for grant support and for ARC Federation and NHMRC Senior Principal Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; Aud D, 2006, NAT CLIN PRACT RHEUM, V2, P434, DOI 10.1038/ncprheum0222; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bullock BN, 2011, J AM CHEM SOC, V133, P14220, DOI 10.1021/ja206074j; Chapman RN, 2004, J AM CHEM SOC, V126, P12252, DOI 10.1021/ja0466659; Chapman R, 2008, BIOCHEMISTRY-US, V47, P4189, DOI 10.1021/bi800136m; Crooks RO, 2011, J BIOL CHEM, V286, P29470, DOI 10.1074/jbc.M111.221267; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fairlie DP, 1998, CURR MED CHEM, V5, P29; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Fuchs SM, 2006, CELL MOL LIFE SCI, V63, P1819, DOI 10.1007/s00018-006-6170-z; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guarracino DA, 2011, BIOPOLYMERS, V95, P1, DOI 10.1002/bip.21546; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Henchey LK, 2010, J AM CHEM SOC, V132, P941, DOI 10.1021/ja9082864; Ibarra-Molero B, 2001, BIOCHEMISTRY-US, V40, P719, DOI 10.1021/bi001438e; Johnson LM, 2011, J AM CHEM SOC, V133, P10038, DOI 10.1021/ja203358t; Judice JK, 1997, P NATL ACAD SCI USA, V94, P13426, DOI 10.1073/pnas.94.25.13426; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kim YW, 2009, BIOORG MED CHEM LETT, V19, P2533, DOI 10.1016/j.bmcl.2009.03.022; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Kutchukian PS, 2009, J AM CHEM SOC, V131, P4622, DOI 10.1021/ja805037p; Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136; Libermann TA, 2006, CURR GENE THER, V6, P17, DOI 10.2174/156652306775515501; Liu J, 2008, J AM CHEM SOC, V130, P4334, DOI 10.1021/ja077704u; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mason JM, 2009, BIOCHEMISTRY-US, V48, P10380, DOI 10.1021/bi901401e; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; PACE CN, 1988, J BIOL CHEM, V263, P11820; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Seebach D, 2008, ACCOUNTS CHEM RES, V41, P1366, DOI 10.1021/ar700263g; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Shepherd NE, 2004, ANGEW CHEM INT EDIT, V43, P2687, DOI 10.1002/anie.200352659; Shepherd NE, 2006, J AM CHEM SOC, V128, P13284, DOI 10.1021/ja064058a; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang D, 2008, ANGEW CHEM INT EDIT, V47, P1879, DOI 10.1002/anie.200704227; Wang DY, 2006, ORG BIOMOL CHEM, V4, P4074, DOI 10.1039/b612891b; Wang D, 2006, J AM CHEM SOC, V128, P9248, DOI 10.1021/ja062710w; Wang DY, 2005, ANGEW CHEM INT EDIT, V44, P6525, DOI 10.1002/anie.200501603; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	58	38	39	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59415	10.1371/journal.pone.0059415	http://dx.doi.org/10.1371/journal.pone.0059415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544065	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000317480700027
J	Rastrick, SPS; Whiteley, NM				Rastrick, Samuel P. S.; Whiteley, Nia M.			Influence of Natural Thermal Gradients on Whole Animal Rates of Protein Synthesis in Marine Gammarid Amphipods	PLOS ONE			English	Article							NORTHWESTERN ATLANTIC; SYNTHESIS CAPACITIES; METABOLIC COST; LIFE-HISTORY; TEMPERATURE; TURNOVER; GROWTH; LIMPET; ADAPTATION; CRUSTACEAN	Although temperature is known to have an important effect on protein synthesis rates and growth in aquatic ectotherms held in the laboratory, little is known about the effects of thermal gradients on natural populations in the field. To address this issue we determined whole-animal fractional rates of protein synthesis (k(s)) in four dominant species of gammarid amphipods with different distributions along the coasts of Western Europe from arctic to temperate latitudes. Up to three populations of each species were collected in the summer and k(s) measured within 48 h. Summer k(s) values were relatively high in the temperate species, Gammarus locusta, from Portugal (48 degrees N) and Wales (53 degrees N) and were maintained across latitudes by the conservation of translational efficiency. In sharp contrast, summer k(s). remained remarkably low in the boreal/temperate species G. duebeni from Wales, Scotland (58 degrees N) and Tromso (70 degrees N), probably as a temporary energy saving strategy to ensure survival in rapidly fluctuating environments of the high intertidal. Values for k(s) increased in acclimated G. duebeni from Scotland and Tromso showing a lack of compensation with latitude. In the subarctic/boreal species, G. oceanicus, summer k(s) remained unchanged in Scotland and Tromso but fell significantly in Svalbard (79 degrees N) at 5 degrees C, despite a slight increase in RNA content. At 79 degrees N, mean k(s) was 4.5 times higher in the circumpolar species G. setosus than in G. oceanicus due to a doubling in RNA content. The relationship between whole-animal protein synthesis rates and natural thermal gradients is complex, varies between species and appears to be associated with local temperatures and their variability, as well as changes in other environmental factors.	[Rastrick, Samuel P. S.; Whiteley, Nia M.] Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales	Bangor University	Whiteley, NM (corresponding author), Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	n.m.whiteley@bangor.ac.uk	Rastrick, Sam/C-3027-2013		NERC [NER/S/A/2005/13424]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a NERC studentship to SPS Rastrick (NER/S/A/2005/13424). http://www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHFORD AJ, 1986, J BIOL CHEM, V261, P4059; Bedulina DS, 2010, COMP BIOCHEM PHYS B, V155, P413, DOI 10.1016/j.cbpb.2010.01.004; BREY T, 1993, ANTARCT SCI, V5, P253, DOI 10.1017/S0954102093000343; Brooks SJ, 2003, COMP BIOCHEM PHYS A, V135, P527, DOI 10.1016/S1095-6433(03)00111-9; BULNHEIM HP, 1979, OECOLOGIA, V44, P80, DOI 10.1007/BF00346402; Conceicao LEC, 1997, FISH PHYSIOL BIOCHEM, V16, P291, DOI 10.1023/A:1007751130768; Costa FO, 2009, SYST BIODIVERS, V7, P365, DOI 10.1017/S1477200009990120; Costa F. O. C. M. H, 2000, POL ARCH HYDROBIOL, V47, P541; Costa FO, 2004, MAR ECOL PROG SER, V277, P197, DOI 10.3354/meps277197; DEFUR PL, 1983, BIOL BULL, V165, P582, DOI 10.2307/1541467; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; FENCHEL TM, 1979, OIKOS, V33, P316, DOI 10.2307/3544008; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Fraser KPP, 2007, J EXP BIOL, V210, P2691, DOI 10.1242/jeb.003715; Fraser KPP, 2002, J EXP BIOL, V205, P3077; Garlick PJ, 1980, BIOCHEM J, V192, P47; Gaston KJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P179, DOI 10.1046/j.1466-822x.2001.00225.x; Hawkins AJS, 1987, FUNCT ECOL, V1, P339, DOI 10.2307/2389790; Hawkins AJS, 1999, AM ZOOL, V39, P401; HAWKINS AJS, 1989, PHYSIOL ZOOL, V62, P745, DOI 10.1086/physzool.62.3.30157925; HAWKINS AJS, 1991, FUNCT ECOL, V5, P222, DOI 10.2307/2389260; HOULIHAN DF, 1990, PHYSIOL ZOOL, V63, P735, DOI 10.1086/physzool.63.4.30158174; Ikko N V, 2010, Dokl Biol Sci, V431, P149; Intanai I, 2009, COMP BIOCHEM PHYS A, V152, P372, DOI 10.1016/j.cbpa.2008.11.006; Klekowski R.Z., 1990, ATLAS MARINE FAUNA 1, V2; LITTLE C, 1989, J MOLLUS STUD, V55, P273, DOI 10.1093/mollus/55.2.273; Marsh AG, 2001, SCIENCE, V291, P1950, DOI 10.1126/science.1056341; McCarthy Ian D., 1997, Society for Experimental Biology Seminar Series, V61, P51; MCCARTHY ID, 1994, P ROY SOC B-BIOL SCI, V257, P141, DOI 10.1098/rspb.1994.0107; McCleary SJ, 2006, THESIS BANGOR U; Mente E, 2002, J EXP BIOL, V205, P3107; Pantin CFA, 1934, J EXP BIOL, V11, P11; PARRY GD, 1978, J ANIM ECOL, V47, P351, DOI 10.2307/3788; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Place SP, 2004, AM J PHYSIOL-REG I, V287, pR429, DOI 10.1152/ajpregu.00223.2004; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2005, SCI MAR, V69, P271; PREEDY VR, 1988, BIOCHEM J, V250, P179, DOI 10.1042/bj2500179; Rastrick SPS, 2011, PHYSIOL BIOCHEM ZOOL, V84, P154, DOI 10.1086/658857; Robertson RF, 2001, J EXP MAR BIOL ECOL, V262, P113, DOI 10.1016/S0022-0981(01)00286-6; Robertson RF, 2001, POLAR BIOL, V24, P677; SAINTE-MARIE B, 1991, HYDROBIOLOGIA, V223, P189, DOI 10.1007/BF00047641; Shatilina ZM, 2011, J THERM BIOL, V36, P142, DOI 10.1016/j.jtherbio.2010.12.008; SKADSHEIM A, 1989, J EXP MAR BIOL ECOL, V127, P25, DOI 10.1016/0022-0981(89)90207-4; STEELE DH, 1974, CAN J ZOOL, V52, P1115, DOI 10.1139/z74-149; STEELE VJ, 1970, CAN J ZOOLOG, V48, P659, DOI 10.1139/z70-124; Storch D, 2005, J EXP BIOL, V208, P2409, DOI 10.1242/jeb.01632; Storch D, 2003, J COMP PHYSIOL B, V173, P611, DOI 10.1007/s00360-003-0371-7; Tomos A.D., 1994, PLANT CELL BIOL A PR, P297; Vader W, 1977, CRUSTACEANA S, V4, P192; WATERLOW JC, 1995, ANNU REV NUTR, V15, P57, DOI 10.1146/annurev.nu.15.070195.000421; Weslawski Jan Marcin, 2002, Polish Polar Research, V23, P253; Weslawski Jan Marcin, 2010, Marine Biodiversity, V40, P123, DOI 10.1007/s12526-010-0038-z; Whiteley N, 2005, PHYSIOL BIOCHEM ZOOL, V78, P227, DOI 10.1086/427054; Whiteley NM, 2011, J EXP MAR BIOL ECOL, V400, P70, DOI 10.1016/j.jembe.2011.02.027; Whiteley N.M., 2009, PROTEIN BIOSYNTHESIS, P249; Whiteley NM, 1996, AM J PHYSIOL-REG I, V271, pR1295, DOI 10.1152/ajpregu.1996.271.5.R1295; Wright, 1995, NITROGEN METABOLISM	59	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60050	10.1371/journal.pone.0060050	http://dx.doi.org/10.1371/journal.pone.0060050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544122	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700081
J	DellaValle, B; Staalsoe, T; Kurtzhals, JAL; Hempel, C				DellaValle, Brian; Staalsoe, Trine; Kurtzhals, Jorgen Anders Lindholm; Hempel, Casper			Investigation of Hydrogen Sulfide Gas as a Treatment against P. falciparum, Murine Cerebral Malaria, and the Importance of Thiolation State in the Development of Cerebral Malaria	PLOS ONE			English	Article							CYTOCHROME-C OXIDASE; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; CARBON-MONOXIDE; NITRIC-OXIDE; PATHOGENESIS; INHIBITION; PROTECTION; TRANSPORT; INSIGHTS	Introduction: Cerebral malaria (CM) is a potentially fatal cerebrovascular disease of complex pathogenesis caused by Plasmodium falciparum. Hydrogen sulfide (HS) is a physiological gas, similar to nitric oxide and carbon monoxide, involved in cellular metabolism, vascular tension, inflammation, and cell death. HS treatment has shown promising results as a therapy for cardio-and neuro-pathology. This study investigates the effects of fast (NaHS) and slow (GYY4137) HS-releasing drugs on the growth and metabolism of P. falciparum and the development of P. berghei ANKA CM. Moreover, we investigate the role of free plasma thiols and cell surface thiols in the pathogenesis of CM. Methods: P. falciparum was cultured in vitro with varying doses of HS releasing drugs compared with artesunate. Growth and metabolism were quantified. C57Bl/6 mice were infected with P. berghei ANKA and were treated with varying doses and regimes of HS-releasing drugs. Free plasma thiols and cell surface thiols were quantified in CM mice and age-matched healthy controls. Results: HS-releasing drugs significantly and dose-dependently inhibited P. falciparum growth and metabolism. Treatment of CM did not affect P. berghei growth, or development of CM. Interestingly, CM was associated with lower free plasma thiols, reduced leukocyte+erythrocyte cell surface thiols (infection day 3), and markedly (5-fold) increased platelet cell surface thiols (infection day 7). Conclusions: HS inhibits P. falciparum growth and metabolism in vitro. Reduction in free plasma thiols, cell surface thiols and a marked increase in platelet cell surface thiols are associated with development of CM. HS drugs were not effective in vivo against murine CM.	[DellaValle, Brian; Staalsoe, Trine; Kurtzhals, Jorgen Anders Lindholm; Hempel, Casper] Univ Copenhagen Hosp, Ctr Med Parasitol, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [DellaValle, Brian; Staalsoe, Trine; Kurtzhals, Jorgen Anders Lindholm; Hempel, Casper] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	DellaValle, B (corresponding author), Univ Copenhagen Hosp, Ctr Med Parasitol, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.	briandellavalle@gmail.com	Hempel, Casper/ABE-7065-2020; Kurtzhals, Jorgen/Y-3799-2019; Hempel, Casper/C-9511-2013	Hempel, Casper/0000-0002-9816-4673; Kurtzhals, Jorgen/0000-0003-2760-8713; Hempel, Casper/0000-0002-9816-4673; DellaValle, Brian/0000-0002-1427-8244; Staalso, Trine/0000-0002-7259-9425	University of Copenhagen; Novo Nordisk; Novo Nordisk Foundation; Augustinusfonden; Dagmar Marshalls fond	University of Copenhagen; Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinusfonden; Dagmar Marshalls fond	This work was supported by University of Copenhagen, Novo Nordisk, Novo Nordisk Foundation, Augustinusfonden, Dagmar Marshalls fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskar R, 2011, EUR J PHARMACOL, V656, P5, DOI 10.1016/j.ejphar.2011.01.052; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Chillemi R, 2004, CLIN CHIM ACTA, V348, P113, DOI 10.1016/j.cccn.2004.05.007; Cox D, 2010, CELL MOL LIFE SCI, V67, P557, DOI 10.1007/s00018-009-0211-3; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Essex DW, 2004, ANTIOXID REDOX SIGN, V6, P736, DOI 10.1089/1523086041361622; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Hein-Kristensen L, 2010, SCAND J IMMUNOL, V72, P302, DOI 10.1111/j.1365-3083.2010.02431.x; Hein-Kristensen L, 2009, EXP PARASITOL, V123, P152, DOI 10.1016/j.exppara.2009.06.010; Hempel C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-216; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; Kida K, 2011, ANTIOXID REDOX SIGN, V15, P343, DOI 10.1089/ars.2010.3671; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lu M, 2012, ANTIOXID REDOX SIGN, V17, P849, DOI 10.1089/ars.2011.4507; Marutani E, 2012, J BIOL CHEM; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Mitchell AJ, 2005, INFECT IMMUN, V73, P5645, DOI 10.1128/IAI.73.9.5645-5653.2005; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; NICHOLLS P, 1975, BIOCHEM SOC T, V3, P316, DOI 10.1042/bst0030316; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; Predmore BL, 2010, J CARDIOVASC TRANSL, V3, P487, DOI 10.1007/s12265-010-9201-y; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robinson A, 2006, BRIT J HAEMATOL, V132, P339, DOI 10.1111/j.1365-2141.2005.05878.x; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; Sarfo BY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-69; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Xuan AG, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-202; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zanini GM, 2012, J NEUROIMMUNE PHARM, V7, P477, DOI 10.1007/s11481-012-9343-6	55	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59271	10.1371/journal.pone.0059271	http://dx.doi.org/10.1371/journal.pone.0059271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555646	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500030
J	Firmino, J; Tinevez, JY; Knust, E				Firmino, Joao; Tinevez, Jean-Yves; Knust, Elisabeth			Crumbs Affects Protein Dynamics in Anterior Regions of the Developing Drosophila Embryo	PLOS ONE			English	Article							YELLOW FLUORESCENT PROTEIN; EPITHELIAL-CELLS; MITOTIC DOMAINS; APICAL MEMBRANE; GENE-EXPRESSION; POLARITY; INTERCALATION; MORPHOGENESIS; ELONGATION; MATURATION	Maintenance of apico-basal polarity is essential for epithelial integrity and requires particular reinforcement during tissue morphogenesis, when cells are reorganised, undergo shape changes and remodel their junctions. It is well established that epithelial integrity during morphogenetic processes depends on the dynamic exchange of adherens junction components, but our knowledge on the dynamics of other proteins and their dynamics during these processes is still limited. The early Drosophila embryo is an ideal system to study membrane dynamics during morphogenesis. Here, morphogenetic activities differ along the anterior-posterior axis, with the extending germband showing a high degree of epithelial remodelling. We developed a Fluorescence Recovery After Photobleaching (FRAP) assay with a higher temporal resolution, which allowed the distinction between a fast and a slow component of recovery of membrane proteins during the germband extension stage. We show for the first time that the recovery kinetics of a general membrane marker, SpiderGFP, differs in the anterior and posterior parts of the embryo, which correlates well with the different morphogenetic activities of the respective embryonic regions. Interestingly, absence of crumbs, a polarity regulator essential for epithelial integrity in the Drosophila embryo, decreases the fast component of SpiderGFP and of the apical marker Stranded at Second-Venus specifically in the anterior region. We suggest that the defects in kinetics observed in crumbs mutant embryos are the first signs of tissue instability in this region, explaining the earlier breakdown of the head epidermis in comparison to that of the trunk, and that diffusion in the plasma membrane is affected by the absence of Crumbs.	[Firmino, Joao; Tinevez, Jean-Yves; Knust, Elisabeth] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Knust, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	knust@mpi-cbg.de	Tinevez, Jean-Yves/E-8398-2012; Knust, Elisabeth/B-4338-2017; Tinevez, Jean-Yves/L-7581-2015; Tinevez, Jean-Yves/O-4551-2019	Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718	Max-Planck Society	Max-Planck Society(Max Planck Society)	Funding provided by the Max-Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2011, J CELL BIOL, V193, P455, DOI 10.1083/jcb.201011018; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Castanon I, 2011, CURR OPIN CELL BIOL, V23, P697, DOI 10.1016/j.ceb.2011.09.009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Costa Michael, 1993, P425; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; FOE VE, 1989, DEVELOPMENT, V107, P1; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Grawe F, 1996, DEVELOPMENT, V122, P951; HARTENSTEIN V, 1994, DEV BIOL, V165, P480, DOI 10.1006/dbio.1994.1269; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hildick KL, 2012, JOVE-J VIS EXP, DOI 10.3791/3747; Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muschalik N, 2011, J CELL SCI, V124, P3715, DOI 10.1242/jcs.091223; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Richard M, 2009, EUR J CELL BIOL, V88, P765, DOI 10.1016/j.ejcb.2009.07.006; Roberts DB, 1986, DROSOPHILA PRACTICAL, Vxix; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Vincent J P, 1997, Methods Mol Biol, V62, P385; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2008, SEMIN CELL DEV BIOL, V19, P263, DOI 10.1016/j.semcdb.2008.01.005	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58839	10.1371/journal.pone.0058839	http://dx.doi.org/10.1371/journal.pone.0058839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555600	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400012
J	Owada, S; Shimoda, Y; Tsuchihara, K; Esumi, H				Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu			Critical Role of H2O2 Generated by NOX4 during Cellular Response under Glucose Deprivation	PLOS ONE			English	Article							TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; PYRVINIUM PAMOATE; INDUCED APOPTOSIS; ACTIVATION; PROTEIN; CELLS; AKT; INVOLVEMENT; PATHWAY	Glucose is the most efficient energy source, and various cancer cells depend on glycolysis for energy production. For maintenance of survival and proliferation, glucose sensing and adaptation to poor nutritional circumstances must be well organized in cancer cells. While the glucose sensing machinery has been well studied in yeasts, the molecular mechanism of glucose sensing in mammalian cells remains to be elucidated. We have reported glucose deprivation rapidly induces AKT phosphorylation through PI3K activation. We assumed that regulation of AKT is relevant to glucose sensing and further investigated the underlying mechanisms. In this study, AKT phosphorylation under glucose deprivation was inhibited by galactose and fructose, but induced by 2-deoxyglucose (2-DG). Both 2-DG treatment and glucose deprivation were found to induce AKT phosphorylation in HepG2 cells. These findings suggested that glucose transporter may not be involved in the sensing of glucose and induction of AKT phosphorylation, and that downstream metabolic events may have important roles. A variety of metabolic stresses reportedly induce the production of reactive oxygen species (ROS). In the present study, glucose deprivation was found to induce intracellular hydrogen peroxide (H2O2) production in HepG2 cells. N-acetylcysteine (NAC), an antioxidant reagent, reduced both the increase in cellular H2O2 levels and AKT phosphorylation induced by glucose deprivation. These results strongly suggest that the glucose deprivation-induced increase of H2O2 in the cells mediated the AKT phosphorylation. RNA interference of NOX4, but not of NOX5, completely suppressed the glucose deprivation-induced AKT phosphorylation as well as increase of the intracellular levels of ROS, whereas exogenous H2O2 could still induce AKT phosphorylation in the NOX4-knockdown cells. In this study, we demonstrated that the ROS generated by NOX4 are involved in the intracellular adaptive responses by recognizing metabolic flux.	[Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Owada, Satoshi; Shimoda, Yuko; Tsuchihara, Katsuya; Esumi, Hiroyasu] Natl Canc Ctr Hosp East, Canc Physiol Project, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan	University of Tokyo; National Cancer Center - Japan	Esumi, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	hesumi@ncc.go.jp			Ministry of Health, Labour and Welfare Japan [H22-3ji taigann-ippann-033]	Ministry of Health, Labour and Welfare Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare Japan [H22-3ji taigann-ippann-033 to HE] (http://www.mhlw.go.jp/english/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Brown JM, 1998, CANCER RES, V58, P1408; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CRANE RK, 1954, J BIOL CHEM, V210, P597; Esposito F, 2003, J BIOL CHEM, V278, P20828, DOI 10.1074/jbc.M211841200; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guo M, 2000, BIOCHEM PHARMACOL, V60, P635, DOI 10.1016/S0006-2952(00)00379-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Inazuka F, 2012, J BIOL CHEM, V287, P16379, DOI 10.1074/jbc.M111.302687; Izuishi K, 2000, CANCER RES, V60, P6201; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Kim HJ, 2011, FREE RADICAL BIO MED, V50, P1039, DOI 10.1016/j.freeradbiomed.2011.01.014; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; LESS JR, 1991, CANCER RES, V51, P265; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Nomura M, 2001, J BIOL CHEM, V276, P25558, DOI 10.1074/jbc.M101164200; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; TOWER DB, 1958, J NEUROCHEM, V3, P185, DOI 10.1111/j.1471-4159.1958.tb12625.x; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	37	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e56628	10.1371/journal.pone.0056628	http://dx.doi.org/10.1371/journal.pone.0056628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555559	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400003
J	Zhang, MM; Ji, W; Pei, LY; Wang, W; Chen, T; Wang, W; Li, H; Zhang, T; Wu, SX; Li, YQ				Zhang, Ming-Ming; Ji, Wei; Pei, Li-Yu; Wang, Wen; Chen, Tao; Wang, Wei; Li, Hui; Zhang, Ting; Wu, Sheng-Xi; Li, Yun-Qing			Acute Colitis Induces Neurokinin 1 Receptor Internalization in the Rat Lumbosacral Spinal Cord	PLOS ONE			English	Article							SUBSTANCE-P RECEPTOR; DORSAL-HORN NEURONS; NOXIOUS VISCERAL STIMULUS; PRIMARY SENSORY NEURONS; LAMINA-I; C-FOS; PROJECTION NEURONS; PRIMARY AFFERENTS; URINARY-BLADDER; THERMAL STIMULI	Substance P (SP) and its receptor, the neurokinin 1 receptor (NK1R), play important roles in transmitting and regulating somatosensory nociceptive information. However, their roles in visceral nociceptive transmission and regulation remain to be elucidated. In the previous study, moderate SP immunoreactive (SP-ir) terminals and NK1R-ir neurons were observed in the dorsal commissural nucleus (DCN) of the lumbosacral spinal cord. Thus we hypothesized that the SP-NK1R system is involved in visceral pain transmission and control within the DCN. The acute visceral pain behaviors, the colon histological changes and the temporal and spatial changes of NK1R-ir structures and Fos expression in the neurons of the DCN were observed in rats following lower colon instillation with 5% formalin. The formalin instillation induced significant acute colitis as revealed by the histological changes in the colon. NK1R internalization in the DCN was obvious at 8 min. It reached a peak (75.3%) at 30 min, began to decrease at 90 min (58.1%) and finally reached the minimum (19.7%) at 3 h after instillation. Meanwhile, formalin instillation induced a biphasic visceral pain response as well as a strong expression of Fos protein in the nuclei of neurons in the DCN. Finally, intrathecal treatment with the NK1R antagonist L732138 attenuated the NK1R internalization, Fos expression and visceral nociceptive responses. The present results suggest that the visceral nociceptive information arising from inflamed pelvic organs, such as the lower colon, might be mediated by the NK1R-ir neurons in the DCN of the lumbosacral spinal cord.	[Zhang, Ming-Ming; Ji, Wei; Pei, Li-Yu; Wang, Wen; Chen, Tao; Wang, Wei; Li, Hui; Zhang, Ting; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China; [Zhang, Ming-Ming; Ji, Wei; Pei, Li-Yu; Wang, Wen; Chen, Tao; Wang, Wei; Li, Hui; Zhang, Ting; Wu, Sheng-Xi; Li, Yun-Qing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Ji, Wei; Pei, Li-Yu] Navy Gen Hosp Peoples Liberat Army, Dept Orthoped, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Wu, SX (corresponding author), Fourth Mil Med Univ, Dept Anat, Xian 710032, Peoples R China.	shengxi@fmmu.edu.cn; deptanat@fmmu.edu.cn		Feng, Jingchen/0000-0001-5166-2141	National Natural Science Foundation of China [30771133, 30971123, 31010103909]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30771133, 30971123, 31010103909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 1997, J NEUROSCI, V17, P8049; Adelson D, 2009, NEUROSCIENCE, V161, P538, DOI 10.1016/j.neuroscience.2009.03.058; Allen BJ, 1997, J NEUROSCI, V17, P5921; Badie-Mahdavi H, 2001, EUR J NEUROSCI, V14, P426, DOI 10.1046/j.0953-816x.2001.01656.x; Bai L, 2012, J NEW MAT ELECTR SYS, V15, P15; Birder LA, 1998, SOMATOSENS MOT RES, V15, P5; Bradesi S, 2006, GASTROENTEROLOGY, V130, P1729, DOI 10.1053/j.gastro.2006.01.037; Cahill CM, 2002, PAIN, V95, P277, DOI 10.1016/S0304-3959(01)00410-9; Castillo C, 2011, NEUROSCIENCE, V177, P308, DOI 10.1016/j.neuroscience.2010.12.040; Chen W, 2010, NEUROSCIENCE, V166, P924, DOI 10.1016/j.neuroscience.2010.01.009; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Gamboa-Esteves FO, 2004, J CHEM NEUROANAT, V27, P251, DOI 10.1016/j.jchemneu.2004.04.001; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Greenwood-Van Meerveld B, 2003, PHARMACOL BIOCHEM BE, V74, P1005, DOI 10.1016/S0091-3057(03)00032-7; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Honore P, 2002, J PAIN, V3, P3, DOI 10.1054/jpai.2002.27001; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; Hossen MA, 2003, INT IMMUNOPHARMACOL, V3, P1563, DOI 10.1016/S1567-5769(03)00009-2; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Laird JMA, 2000, NEUROSCIENCE, V98, P345, DOI 10.1016/S0306-4522(00)00148-2; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Lee K, 2011, EUR J PHARM, V667, P169; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; Lu Y, 2000, J NEUROSCI METH, V100, P71, DOI 10.1016/S0165-0270(00)00232-6; LU Y, 1995, NEUROSCI LETT, V198, P139, DOI 10.1016/0304-3940(95)11991-5; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MANTYH PW, 1995, P NATL ACAD SCI USA, V92, P2622, DOI 10.1073/pnas.92.7.2622; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Marvizon JCG, 2003, NEUROSCIENCE, V118, P535, DOI 10.1016/S0306-4522(02)00977-6; MIAMPAMBA M, 1994, PAIN, V57, P327, DOI 10.1016/0304-3959(94)90008-6; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; Munglani R, 1995, PROG BRAIN RES, V104, P283; Munoz Miguel, 2010, Cancers (Basel), V2, P611, DOI 10.3390/cancers2020611; NADELHAFT I, 1984, J COMP NEUROL, V226, P238, DOI 10.1002/cne.902260207; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; Palecek J, 2003, PAIN, V104, P249, DOI 10.1016/S0304-3959(03)00013-7; Palecek J, 2003, NEUROSCIENCE, V116, P565, DOI 10.1016/S0306-4522(02)00660-7; Southwell BR, 1998, NEUROSCIENCE, V87, P925, DOI 10.1016/S0306-4522(98)00176-6; Todd AJ, 2005, NEUROSCIENCE, V131, P209, DOI 10.1016/j.neuroscience.2004.11.001; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; Wang XR, 2002, BRAIN RES, V944, P239, DOI 10.1016/S0006-8993(02)02918-9; Wesselmann U, 1998, NEUROSCI LETT, V246, P73, DOI 10.1016/S0304-3940(98)00234-1; Wu ZZ, 2004, BRAIN RES, V1010, P117, DOI 10.1016/j.brainres.2004.03.010; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006	46	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59234	10.1371/journal.pone.0059234	http://dx.doi.org/10.1371/journal.pone.0059234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555638	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400025
J	Leman, SC; House, L; Maiti, D; Endert, A; North, C				Leman, Scotland C.; House, Leanna; Maiti, Dipayan; Endert, Alex; North, Chris			Visual to Parametric Interaction (V2PI)	PLOS ONE			English	Article								Typical data visualizations result from linear pipelines that start by characterizing data using a model or algorithm to reduce the dimension and summarize structure, and end by displaying the data in a reduced dimensional form. Sensemaking may take place at the end of the pipeline when users have an opportunity to observe, digest, and internalize any information displayed. However, some visualizations mask meaningful data structures when model or algorithm constraints (e. g., parameter specifications) contradict information in the data. Yet, due to the linearity of the pipeline, users do not have a natural means to adjust the displays. In this paper, we present a framework for creating dynamic data displays that rely on both mechanistic data summaries and expert judgement. The key is that we develop both the theory and methods of a new human-data interaction to which we refer as "Visual to Parametric Interaction" (V2PI). With V2PI, the pipeline becomes bidirectional in that users are embedded in the pipeline; users learn from visualizations and the visualizations adjust to expert judgement. We demonstrate the utility of V2PI and a bi-directional pipeline with two examples.	[Leman, Scotland C.; House, Leanna; Maiti, Dipayan] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA; [Endert, Alex; North, Chris] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	House, L (corresponding author), Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA.	lhouse@vt.edu			National Science Foundation, Computer and Communications Foundations [0937071]; Direct For Computer & Info Scie & Enginr [0937071] Funding Source: National Science Foundation	National Science Foundation, Computer and Communications Foundations(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation, Computer and Communications Foundations, #0937071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abowd G. D., 1991, People and Computers VI. Proceedings of the HCI '91 Conference, P73; Andrews N. O., 2007, TECHNICAL REPORT; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Buja A, 1998, J COMPUTATIONAL GRAP, V5, P78; Card SK, 1999, INFORM VISUALIZATION; Carroll JD, 1970, PSYCHOMETRIKA, V35, P238, DOI DOI 10.1007/BF02310791; Endert A., 2011, 2011 IEEE Conference on Visual Analytics Science and Technology, P121, DOI 10.1109/VAST.2011.6102449; Hastie T., 2008, ELEMENTS STAT LEARNI; House L, 2012, TECHNICAL REPORT; Icke I., 2009, TECHNICAL REPORT; Jeong DH, 2009, COMPUT GRAPH FORUM, V28, P767, DOI 10.1111/j.1467-8659.2009.01475.x; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Keim D, 2008, VISUAL DATA MINING T, P767; Keim DA, 2002, IEEE T VIS COMPUT GR, V8, P1, DOI 10.1109/2945.981847; Koren Y, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P121, DOI 10.1109/INFVIS.2003.1249017; Kruskal JB, 1978, SAGE U PAPER SERIES, V48, P07; Lederberg J, 1989, EXCITEMENT FASCINATI; Mordecai A., 1976, NONLINEAR PROGRAMMIN; Myers B., 2000, ACM Transactions on Computer-Human Interaction, V7, P3, DOI 10.1145/344949.344959; Norman D. A., 1990, DESIGN EVERYDAY THIN; Pak Chung W, 2004, P IEEE S INF VIS INF; Pike WA, 2009, INFORM VISUALIZATION, V5, P78; Pirolli P., 2005, P 2005 INT C INT AN; Schiffman SS, 1981, INTRO MULTIDIMENSION; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Thomas J. J., 2005, ILLUMINATING PATH; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; TORGERSON W, 1958, THEORY METHODS SCALI	28	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e50474	10.1371/journal.pone.0050474	http://dx.doi.org/10.1371/journal.pone.0050474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23555552	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600001
J	Yang, XH; Gong, Y; Tang, YF; Li, HF; He, Q; Gower, L; Liaw, L; Friesel, RE				Yang, Xuehui; Gong, Yan; Tang, Yuefeng; Li, Hongfang; He, Qing; Gower, Lindsey; Liaw, Lucy; Friesel, Robert E.			Spry1 and Spry4 Differentially Regulate Human Aortic Smooth Muscle Cell Phenotype via Akt/FoxO/Myocardin Signaling	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOTHELIAL-CELLS; SPROUTY PROTEINS; ERK ACTIVATION; GROWTH; MYOCARDIN; PROLIFERATION; INHIBITION; PATHWAY; OVEREXPRESSION	Background: Changes in the vascular smooth muscle cell (VSMC) contractile phenotype occur in pathological states such as restenosis and atherosclerosis. Multiple cytokines, signaling through receptor tyrosine kinases (RTK) and PI3K/Akt and MAPK/ERK pathways, regulate these phenotypic transitions. The Spry proteins are feedback modulators of RTK signaling, but their specific roles in VSMC have not been established. Methodology/Principal Findings: Here, we report for the first time that Spry1, but not Spry4, is required for maintaining the differentiated state of human VSMC in vitro. While Spry1 is a known MAPK/ERK inhibitor in many cell types, we found that Spry1 has little effect on MAPK/ERK signaling but increases and maintains Akt activation in VSMC. Sustained Akt signaling is required for VSMC marker expression in vitro, while ERK signaling negatively modulates Akt activation and VSMC marker gene expression. Spry4, which antagonizes both MAPK/ERK and Akt signaling, suppresses VSMC differentiation marker gene expression. We show using siRNA knockdown and ChIP assays that FoxO3a, a downstream target of PI3K/Akt signaling, represses myocardin promoter activity, and that Spry1 increases, while Spry4 decreases myocardin mRNA levels. Conclusions: Together, these data indicate that Spry1 and Spry4 have opposing roles in VSMC phenotypic modulation, and Spry1 maintains the VSMC differentiation phenotype in vitro in part through an Akt/FoxO/myocardin pathway.	[Yang, Xuehui; Gong, Yan; Tang, Yuefeng; He, Qing; Gower, Lindsey; Liaw, Lucy; Friesel, Robert E.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Gong, Yan; Tang, Yuefeng; He, Qing; Liaw, Lucy; Friesel, Robert E.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Li, Hongfang] Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou 730000, Peoples R China	Maine Medical Center; University of Maine System; University of Maine Orono; Lanzhou University	Yang, XH (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.	yangx@mmc.org; friesr@mmc.org		Gong, Yan/0000-0002-4805-0459	National Institutes of Health [R01 HL065301, P30RR030927/P30GM103392, R01 Hl070865, P20RR181789/P20GM103465]; Founders Affiliate of the American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR030927] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070865, R01HL109652, R01HL065301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P20GM103465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Founders Affiliate of the American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 HL065301 and P30RR030927/P30GM103392 (confocal microscopy, DNA sequencing, and viral vector cores) RF, PI, R01 Hl070865 to LL, and P20RR181789/P20GM103465 (cell phenotyping core) to DM Wojchowski, PI, and institutional support from the Maine Medical Center. YG is the recipient of a predoctoral fellowship award from the Founders Affiliate of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Chen PY, 2009, J BIOL CHEM, V284, P15980, DOI 10.1074/jbc.M809399200; COOK CL, 1994, CIRC RES, V74, P189, DOI 10.1161/01.RES.74.2.189; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; OBRIEN ER, 1993, CIRC RES, V73, P223, DOI 10.1161/01.RES.73.2.223; Owens Gary K, 2007, Novartis Found Symp, V283, P174; OWENS GK, 1986, J BIOL CHEM, V261, P3373; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozaki K, 2005, J CELL SCI, V118, P5861, DOI 10.1242/jcs.02711; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Sathyanarayana P, 2012, BLOOD, V119, P5522, DOI 10.1182/blood-2011-11-392571; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yang XH, 2008, DEV BIOL, V321, P64, DOI 10.1016/j.ydbio.2008.05.555; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	35	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58746	10.1371/journal.pone.0058746	http://dx.doi.org/10.1371/journal.pone.0058746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554919	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800025
J	Cullen, TM; Ryan, MJ; Schroder-Adams, C; Currie, PJ; Kobayashi, Y				Cullen, Thomas M.; Ryan, Michael J.; Schroeder-Adams, Claudia; Currie, Philip J.; Kobayashi, Yoshitsugu			An Ornithomimid (Dinosauria) Bonebed from the Late Cretaceous of Alberta, with Implications for the Behavior, Classification, and Stratigraphy of North American Ornithomimids	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; SOUTHERN ALBERTA; PARK FORMATION; SEDIMENTOLOGY; TAPHONOMY; CANADA	Bonebeds can provide a wealth of anatomical, taphonomic, and ontogenetic information about the specimens preserved within them, and can provide evidence for inferred behavior. The material described here represents the first known bonebed of ornithomimids in North America, and the fourth record of an ornithomimosaur bonebed in the world. Partial skeletons representing three individuals are preserved in this assemblage, each comprising primarily portions of the posterior postcrania (pelvis, hind limbs and tail). All three individuals are morphologically similar, although one is larger in overall size. Given the stratigraphic position of the site, and the morphology of the postcrania, the preserved material represents a taxon from the clade containing Ornithomimus and Struthiomimus. Pedal ungual morphology is examined and found to be too variable to be useful in distinguishing these species taxonomically. This site provides additional evidence of gregarious behavior in ornithomimids and the first probable record of that behavior in North American forms.	[Cullen, Thomas M.; Ryan, Michael J.; Schroeder-Adams, Claudia] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [Ryan, Michael J.] Cleveland Museum Nat Hist, Dept Vertebrate Paleontol, Cleveland, OH USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Kobayashi, Yoshitsugu] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido, Japan	Carleton University; Cleveland Museum of Natural History; University of Alberta; Hokkaido University	Cullen, TM (corresponding author), Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada.	thomas_cullen@carleton.ca	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Cullen, Thomas/0000-0002-4261-1323; Schroder-Adams, Claudia/0000-0002-0245-2559				Allain R, 2011, J VERTEBRATE PALCONT, V2011, P46; Coria RA, 2006, GEODIVERSITAS, V28, P71; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie PJ, 2010, CAN J EARTH SCI, V47, P1277, DOI 10.1139/E10-072; Currie PJ, 2005, LIFE O PAST, P313; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; DODSON P, 1971, PALAEOGEOGR PALAEOCL, V10, P21, DOI 10.1016/0031-0182(71)90044-7; Dodson P, 1978, SYST ZOOL, V24, P37; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2002, C CAN SOC PETR GEOL; Eberth DA, 2012, CAN J EARTH SCI, V49, P1053, DOI 10.1139/E2012-035; Eberth DA, 2010, CAN J EARTH SCI, V47, P1119, DOI 10.1139/E10-045; Eberth David A., 2007, P103; Fiorillo A.R., 1988, U WYOMING CONTRIBUTI, V26, P57; Goloboff P, 2008, CLADISTICS, V24, P91; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Kobayashi Y, 2006, J VERTEBR PALEONTOL, V26, p86A; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Makovicky P.J., 2009, P ROYAL SOC B, V277, P211; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Mathews JC, 2009, J VERTEBR PALEONTOL, V29, P286, DOI 10.1080/02724634.2009.10010382; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Parks W. A., 1933, University of Toronto Studies Geological Series, VNo. 34, P3; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P375, DOI 10.1139/e72-031; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Smith D., 1990, Journal of Vertebrate Paleontology, V10, P255; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; Xu L, 2011, CRETACEOUS RES, V32, P213, DOI 10.1016/j.cretres.2010.12.004	35	28	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58853	10.1371/journal.pone.0058853	http://dx.doi.org/10.1371/journal.pone.0058853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554938	gold, Green Published			2022-12-27	WOS:000316252500049
J	Kahabuka, C; Kvale, G; Hinderaker, SG				Kahabuka, Catherine; Kvale, Gunnar; Hinderaker, Sven Gudmund			Care-Seeking and Management of Common Childhood Illnesses in Tanzania - Results from the 2010 Demographic and Health Survey	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; RURAL TANZANIA; ZINC SUPPLEMENTATION; MALARIA TREATMENT; CHILDREN; FACILITIES; MORTALITY; SERVICES; DISTRICT; QUALITY	Background: Malaria, pneumonia and diarrhoea continue to kill millions of children in Africa despite the available and effective treatments. Correct diagnosis and prompt treatment with effective drugs at the first option consulted for child care is crucial for preventing severe disease and death from these illnesses. Using the 2010 Demographic and Health Survey data, the present study aims to assess care-seeking and management of suspected malaria, pneumonia and diarrhoea at various health care facilities in Tanzania. Methods: We analyzed data for 8176 children born within a 5 years period preceding the survey. The information was collected by interviewing 5519 women aged 15-49 years in 10,300 households selected from 475 sample points throughout Tanzania. Results: The most common first option for child care was PHC facilities (54.8%), followed by private pharmacies (23.4%). These were more commonly utilized in rural compared to urban areas: 61.2% versus 34.5% for PHC facilities, and 26.5% versus 17.7% for pharmacies. Women in urban areas and those with higher level of education more commonly utilized higher level hospitals and private facilities as their first option for child care. Only one in four children with fever had received a blood test during the illness with lowest proportion being reported among children solely attended at PHC facilities. Use of abandoned antimalarial drugs for the treatment of suspected malaria was also observed in public health facilities and antibiotics use for diarrhoea treatment was high (49.0%). Conclusions: PHC facilities and pharmacies most commonly provided sub-optimal care. These facilities were more commonly utilized as the first option for child care in rural areas and among the poor and non-educated families. These are groups with the highest child mortality, which calls for interventions' targeting improvement of care at these facilities to further reduce child mortality from treatable illnesses in Tanzania.	[Kahabuka, Catherine; Kvale, Gunnar; Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway	University of Bergen	Kahabuka, C (corresponding author), Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway.	cka083@cih.uib.no			Norwegian Government through Quota program	Norwegian Government through Quota program	The study is part of PhD training that is funded by the Norwegian Government through Quota program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], 1994, SAFE MOTHER, P1; Audo MO, 2006, E AFRI MED J, V82; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boonstra E, 2005, INT J QUAL HEALTH C, V17, P221, DOI 10.1093/intqhc/mzi020; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Damrongmanee Alisara, 2007, Journal of the Medical Association of Thailand, V90, P513; Dutta P, 2000, J TROP PEDIATRICS, V46, P259, DOI 10.1093/tropej/46.5.259; Eriksen J, 2007, TROP MED INT HEALTH, V12, P52, DOI 10.1111/j.1365-3156.2006.01753.x; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kahabuka C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-315; Kahabuka C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-219; Kahabuka C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-158; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Leonard KL, 2007, HEALTH AFFAIR, V26, pW380, DOI 10.1377/hlthaff.26.3.w380; Leonard KL, 2002, J AFR ECON, V11, P441, DOI 10.1093/jae/11.4.441; Low A, 2001, INT J HEALTH PLAN M, V16, P243, DOI 10.1002/hpm.628; Mamdani M, 2004, REPROD HEALTH MATTER, V12, P138, DOI 10.1016/S0968-8080(04)24135-0; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mazumder S, 2010, B WORLD HEALTH ORGAN, V88, P754, DOI 10.2471/BLT.10.075986; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; MEASURE DHS, 2012, DESCR DEM HLTH SURV; Measure DHS, 2012, MEAS DHS DEM HLTH SU; Ministry of health and Welfare - United Republic of Tanzania, 2007, PRIM HLTH SERV DEV P; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Nsimba SED, 2005, J CLIN PHARM THER, V30, P515, DOI 10.1111/j.1365-2710.2005.00645.x; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Slutsker L, 1996, AM J TROP MED HYG, V55, P77, DOI 10.4269/ajtmh.1996.55.77; SNYDER JD, 1982, B WORLD HEALTH ORGAN, V60, P605; Swiss Agency for Development and Cooperation, 2003, VIEWS POOR PERSP RUR; Thandrayen K, 2010, S AFR J CHILD HEALTH, V4, P73; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; Turck D, 2003, J PEDIATR GASTR NUTR, V37, P22, DOI 10.1097/00005176-200307000-00004; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF and World Health Organization, 2009, DIARRH WHY CHILDR ST; United Republic Of Tanzania - National Bureau of Statistics (NBS), 2004, DEM HLTH SURV; United Republic Of Tanzania - National Bureau of Statistics (NBS), 2010, TANZ DEM HLTH SURV T; USAID UNICEF WHO, 2005, DIARRH TREATM GUID I; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; World Health Organization, 2011, WORLD HLTH STAT 2011; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	44	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58789	10.1371/journal.pone.0058789	http://dx.doi.org/10.1371/journal.pone.0058789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554926	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500044
J	McCarthy, CB; Santini, MS; Pimenta, PFP; Diambra, LA				McCarthy, Christina B.; Soledad Santini, Maria; Pimenta, Paulo F. P.; Diambra, Luis A.			First Comparative Transcriptomic Analysis of Wild Adult Male and Female Lutzomyia longipalpis, Vector of Visceral Leishmaniasis	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PERMETHRIN INDUCES OVEREXPRESSION; DROSOPHILA ACTIN GENES; PERITROPHIC MATRIX; CUTANEOUS LEISHMANIASIS; INSECTICIDE RESISTANCE; FUNCTIONAL GENOMICS; MOLECULAR-CLONING; RNA INTERFERENCE; MISMATCH REPAIR	Leishmaniasis is a vector-borne disease with a complex epidemiology and ecology. Visceral leishmaniasis (VL) is its most severe clinical form as it results in death if not treated. In Latin America VL is caused by the protist parasite Leishmania infantum (syn. chagasi) and transmitted by Lutzomyia longipalpis. This phlebotomine sand fly is only found in the New World, from Mexico to Argentina. However, due to deforestation, migration and urbanisation, among others, VL in Latin America is undergoing an evident geographic expansion as well as dramatic changes in its transmission patterns. In this context, the first VL outbreak was recently reported in Argentina, which has already caused 7 deaths and 83 reported cases. Insect vector transcriptomic analyses enable the identification of molecules involved in the insect's biology and vector-parasite interaction. Previous studies on laboratory reared Lu. longipalpis have provided a descriptive repertoire of gene expression in the whole insect, midgut, salivary gland and male reproductive organs. Nevertheless, the study of wild specimens would contribute a unique insight into the development of novel bioinsecticides. Given the recent VL outbreak in Argentina and the compelling need to develop appropriate control strategies, this study focused on wild male and female Lu. longipalpis from an Argentine endemic (Posadas, Misiones) and a Brazilian non-endemic (Lapinha Cave, Minas Gerais) VL location. In this study, total RNA was extracted from the sand flies, submitted to sequence independent amplification and high-throughput pyrosequencing. This is the first time an unbiased and comprehensive transcriptomic approach has been used to analyse an infectious disease vector in its natural environment. Transcripts identified in the sand flies showed characteristic profiles which correlated with the environment of origin and with taxa previously identified in these same specimens. Among these, various genes represented putative targets for vector control via RNA interference (RNAi).	[McCarthy, Christina B.; Diambra, Luis A.] Univ Nacl La Plata, Ctr Reg Estudios Genom, Fac Ciencias Exactas, Buenos Aires, DF, Argentina; [McCarthy, Christina B.] Univ Nacl Noroeste Prov Buenos Aires, Dept Informat & Tecnol, Buenos Aires, DF, Argentina; [Soledad Santini, Maria] Minist Salud, Ctr Nacl Diagnost & Invest Endemoepidemias, Adm Nacl Labs, Buenos Aires, DF, Argentina; [Soledad Santini, Maria] Minist Salud, Inst Salud, Buenos Aires, DF, Argentina; [Pimenta, Paulo F. P.] Fundacao Oswaldo Cruz FIOCRUZ, Lab Med Entomol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil	National University of La Plata; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Fundacao Oswaldo Cruz	McCarthy, CB (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genom, Fac Ciencias Exactas, Buenos Aires, DF, Argentina.	mccarthychristina@gmail.com	Pimenta, Paulo/AAH-1502-2020; L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; McCarthy, Christina Beryl/0000-0001-9725-5285	Fundacion Bunge y Born grant [FBBEI5/08]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT PRH 112]	Fundacion Bunge y Born grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This research was supported by a Fundacion Bunge y Born grant (FBBEI5/08) and an Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grant (PICT PRH 112) to CBM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alemany C, 2000, BBA-MOL CELL RES, V1495, P319, DOI 10.1016/S0167-4889(99)00159-7; Alexander B, 2009, TROP MED INT HEALTH, V14, P1272, DOI 10.1111/j.1365-3156.2009.02371.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P365; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Azevedo RVDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034495; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho-Abreu IV, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000901; Coy MR, 2012, J APPL ENTOMOL, DOI DOI 10.1111/J/1439-0418.2012.01713.X; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Craig NL., 2002, MOBILE DNA-UK; Cummins SF, 2009, INT J DEV BIOL, V53, P1081, DOI 10.1387/ijdb.082791sc; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Danielli A, 2003, J BIOL CHEM, V278, P4184, DOI 10.1074/jbc.M208187200; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dougherty M.J., 1991, Parassitologia (Rome), V33, P185; Eickbush T.H., 2002, MOBILE DNA-UK, V2, P1111, DOI [10.1128/9781555817954.ch49, DOI 10.1128/9781555817954.CH49]; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Fisher R, 1970, STATISTICAL METHODS, P96; FREEMAN BA, 1982, LAB INVEST, V47, P412; FYRBERG EA, 1983, CELL, V33, P115, DOI 10.1016/0092-8674(83)90340-9; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Ganko EW, 2003, MOL BIOL EVOL, V20, P1925, DOI 10.1093/molbev/msg200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gochfeld M, 1997, ENVIRON HEALTH PERSP, V105, P817, DOI 10.1289/ehp.97105s4817; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; IARC, 1987, ARS ARS COMP GROUP 1; Iwanaga S, 1998, J BIOCHEM, V123, P1; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Johnson JK, 2001, INSECT BIOCHEM MOLEC, V31, P1125, DOI 10.1016/S0965-1748(01)00072-8; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kang S, 2008, KOREAN J PARASITOL, V46, P1, DOI 10.3347/kjp.2008.46.1.1; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; KAUL S. M., 1978, Journal of Communicable Diseases, V10, P208; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Konstandi OA, 2006, INT J DEV BIOL, V50, P543, DOI 10.1387/ijdb.052122ok; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, PROTEIN ENG, V15, P643, DOI 10.1093/protein/15.8.643; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25; Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; McCarthy CB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001304; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Mukhopadhyay A, 1992, SUSCEPTIBILITY PHLEB; Munks RJL, 2005, INSECT MOL BIOL, V14, P483, DOI 10.1111/j.1365-2583.2005.00579.x; Naidu R, 2006, MANAGING ARSENIC IN THE ENVIRONMENT: FROM SOIL TO HUMAN HEALTH, P331; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Orme S, 2012, PAN PESTICIDES DATAB; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Pereira C, 1998, PARASITOLOGY, V117, P63, DOI 10.1017/S003118209800273X; Pin OY, 1996, J CELL BIOL, V135, P1027, DOI 10.1083/jcb.135.4.1027; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; PREDKI PF, 1994, ENVIRON HEALTH PERSP, V102, P195, DOI 10.2307/3431786; Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2; Pridgeon JW, 2009, J MED ENTOMOL, V46, P810, DOI 10.1603/033.046.0411; Pridgeon JW, 2009, J MED ENTOMOL, V46, P580, DOI 10.1603/033.046.0324; Pridgeon JW, 2003, INSECT BIOCHEM MOLEC, V33, P1043, DOI 10.1016/S0965-1748(03)00120-6; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6; READY PD, 1979, J MED ENTOMOL, V16, P413, DOI 10.1093/jmedent/16.5.413; Reumer A, 2008, GEN COMP ENDOCR, V155, P22, DOI 10.1016/j.ygcen.2007.06.021; Rey Luís C., 2005, J. Pediatr. (Rio J.), V81, P73, DOI [10.2223/JPED.1286, 10.1590/S0021-75572005000100014]; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Ropert C, 2002, MICROBES INFECT, V4, P1015, DOI 10.1016/S1286-4579(02)01609-X; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Salomon OD, 2001, MEDICINA-BUENOS AIRE, V61, P174; Salomon OD, 2010, MEM I OSWALDO CRUZ, V105, P928, DOI 10.1590/S0074-02762010000700016; Shirafuji N, 1997, BLOOD, V90, P4567, DOI 10.1182/blood.V90.11.4567.4567_4567_4577; Singh S, 2006, INDIAN J MED RES, V123, P311; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; Santini MS, 2010, REV INST MED TROP SP, V52, P187, DOI 10.1590/S0036-46652010000400004; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Surendran SN, 2005, B ENTOMOL RES, V95, P371, DOI 10.1079/BER2005368; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; TOBIN SL, 1990, DEV GENET, V11, P15, DOI 10.1002/dvg.1020110104; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; WIKSTROM M, 1985, J INORG BIOCHEM, V23, P327, DOI 10.1016/0162-0134(85)85042-X; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x	147	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58645	10.1371/journal.pone.0058645	http://dx.doi.org/10.1371/journal.pone.0058645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554910	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500036
J	Ng, S; Ip, DKM; Fang, VJ; Chan, KH; Chiu, SS; Leung, GM; Peiris, JSM; Cowling, BJ				Ng, Sophia; Ip, Dennis K. M.; Fang, Vicky J.; Chan, Kwok-Hung; Chiu, Susan S.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.			The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009-10 Seasonal Trivalent Inactivated Influenza Vaccination in Children	PLOS ONE			English	Article							ANTIBODY-RESPONSES; PANDEMIC INFLUENZA; PROTECTIVE EFFICACY; ANNUAL IMMUNIZATION; CONSECUTIVE YEARS; IMMUNE-RESPONSE; HONG-KONG; VIRUS; VACCINES; STRAINS	Background: There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6-8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history. Methods and Findings: We conducted a randomized controlled trial of 2009-10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9-17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6-8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6-8 y of age regardless of vaccination history. Conclusions: Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.	[Ng, Sophia; Ip, Dennis K. M.; Fang, Vicky J.; Leung, Gabriel M.; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Hung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chiu, Susan S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Chan, Kwok Hung/ABD-5399-2021; Ng, Sophia/AAA-1461-2019; Chiu, Susan Shui Seng/C-4247-2009; Ip, Dennis Kai Ming/C-4283-2009	Cowling, Benjamin John/0000-0002-6297-7154; Ng, Sophia/0000-0001-7817-7744; Leung, Gabriel/0000-0002-2503-6283; Chiu, Susan Shui Seng/0000-0002-3908-1974; Ip, Dennis Kai Ming/0000-0003-3592-8709	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR [CHP-CE-03, PHE-2]; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Area of Excellence Scheme of the University Grants Committee of Hong Kong [AoE/M-12/06]; F. Hoffman-La Roche Ltd.; Crucell MV; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Area of Excellence Scheme of the University Grants Committee of Hong Kong; F. Hoffman-La Roche Ltd.; Crucell MV; MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grant nos. CHP-CE-03 and PHE-2), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558), and the Area of Excellence Scheme of the University Grants Committee of Hong Kong (grant no. AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. DKMI has received research funding from F. Hoffman-La Roche Ltd. JSMP receives research funding from Crucell MV and serves as an ad hoc consultant for GlaxoSmithKline and Sanofi. BJC has received research funding from MedImmune Inc., and consults for Crucell MV. BJC is an Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors report no other potential conflicts of interest.	Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Beyer WEP, 1998, VACCINE, V16, P1929, DOI 10.1016/S0264-410X(98)00123-6; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; BLACK SC, 2011, AM POETRY REV, V40, P30; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Brown F, 2003, P SCI WORKSH, pxi; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Cowling BJ, 2012, CLIN INFECT DIS, V55, P695, DOI 10.1093/cid/cis518; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2012, CLIN INFECT IN PRESS; de Bruijn IA, 1999, J INFECT DIS, V179, P31, DOI 10.1086/314540; de Groot JAH, 2008, STAT MED, V27, P5880, DOI 10.1002/sim.3410; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Gardner EM, 2001, VACCINE, V19, P4610, DOI 10.1016/S0264-410X(01)00246-8; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOWELLS CHL, 1975, LANCET, V1, P381; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Iorio AM, 2007, GERONTOLOGY, V53, P411, DOI 10.1159/000110579; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Keitel Wendy A, 2002, Semin Pediatr Infect Dis, V13, P112, DOI 10.1053/spid.2002.122998; Little R, 2004, STAT SINICA, V14, P949; Michiels B, 2006, VACCINE, V24, P3145, DOI 10.1016/j.vaccine.2006.01.040; Molenberghs G., 2007, MISSING DATA CLIN ST; Nabeshima S, 2007, J MED VIROL, V79, P320, DOI 10.1002/jmv.20801; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Ng S, 2012, PEDIATR INFECT DIS J, V31, P964, DOI 10.1097/INF.0b013e318263280e; Ohmit SE, 2013, CLIN INFECT IN PRESS; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Seidman JC, 2012, INFLUENZA OTHER RESP, V6, P52, DOI 10.1111/j.1750-2659.2011.00268.x; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; WHO, 2009, REC COMP INFL VIR VA; WHO Influenza Centre, 2009, REP WHO INFL CTR; World Health Organization (WHO), 2008, REC COMP INFL VIR VA; World Health Organization (WHO), 2007, REC COMP INFL VIR VA; Wright PF, 2008, PEDIATR INFECT DIS J, V27, P1004, DOI 10.1097/INF.0b013e31817d53c5; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	44	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59077	10.1371/journal.pone.0059077	http://dx.doi.org/10.1371/journal.pone.0059077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554974	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500065
J	Ranzani, OT; Zampieri, FG; Forte, DN; Azevedo, LCP; Park, M				Ranzani, Otavio T.; Zampieri, Fernando Godinho; Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo			C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; IN-HOSPITAL MORTALITY; INTENSIVE-CARE; PROTEIN-CONCENTRATION; RISK PREDICTION; ICU DISCHARGE; SEPSIS; SURVIVAL; MARKER; READMISSION	Introduction: Residual inflammation at ICU discharge may have impact upon long-term mortality. However, the of ongoing inflammation on mortality after ICU discharge is poorly described. C-reactive protein (CRP) and albumin are measured frequently in the ICU and exhibit opposing patterns during inflammation. Since infection is a potent trigger of inflammation, we hypothesized that CRP levels at discharge would correlate with long-term mortality in septic patients and that the CRP/albumin ratio would be a better marker of prognosis than CRP alone. Methods: We evaluated 334 patients admitted to the ICU as a result of severe sepsis or septic shock who were discharged alive after a minimum of 72 hours in the ICU. We evaluated the performance of both CRP and CRP/albumin to predict mortality at 90 days after ICU discharge. Two multivariate logistic models were generated based on measurements at discharge: one model included CRP (Model-CRP), and the other included the CRP/albumin ratio (Model-CRP/albumin). Results: There were 229 (67%) and 111 (33%) patients with severe sepsis and septic shock, respectively. During the 90 days of follow-up, 73 (22%) patients died. CRP/albumin ratios at admission and at discharge were associated with a poor outcome and showed greater accuracy than CRP alone at these time points (p = 0.0455 and p = 0.0438, respectively). CRP levels and the CRP/albumin ratio were independent predictors of mortality at 90 days (Model-CRP: adjusted OR 2.34, 95% CI 1.14-4.83, p = 0.021; Model-CRP/albumin: adjusted OR 2.18, 95% CI 1.10-4.67, p = 0.035). Both models showed similar accuracy (p = 0.2483). However, Model-CRP was not calibrated. Conclusions: Residual inflammation at ICU discharge assessed using the CRP/albumin ratio is an independent risk factor for mortality at 90 days in septic patients. The use of the CRP/albumin ratio as a long-term marker of prognosis provides more consistent results than standard CRP values alone.	[Ranzani, Otavio T.; Zampieri, Fernando Godinho; Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Univ Sao Paulo, Hosp Clin, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil; [Zampieri, Fernando Godinho] Hosp Alemao Oswaldo Cruz, Intens Care Unit, Sao Paulo, Brazil; [Forte, Daniel Neves; Pontes Azevedo, Luciano Cesar; Park, Marcelo] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Sirio Libanes	Ranzani, OT (corresponding author), Univ Sao Paulo, Hosp Clin, Emergency Med Discipline, Intens Care Unit, Sao Paulo, Brazil.	otavioranzani@yahoo.com.br	Ranzani, Otavio T./K-1196-2012; Azevedo, Luciano CP/H-2652-2012; Zampieri, Fernando/K-3305-2014	Ranzani, Otavio T./0000-0002-4677-6862; Azevedo, Luciano CP/0000-0001-6759-3910; Zampieri, Fernando/0000-0001-9315-6386				Al-Subaie N, 2010, BRIT J ANAESTH, V105, P318, DOI 10.1093/bja/aeq171; Araujo I, 2012, BIOMARKERS, V17, P180, DOI 10.3109/1354750X.2012.654407; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Carriere I, 2008, J AM GERIATR SOC, V56, P840, DOI 10.1111/j.1532-5415.2008.01677.x; Casalino E, 1998, CHEST, V113, P421, DOI 10.1378/chest.113.2.421; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; DEVILLOTA ED, 1980, INTENS CARE MED, V7, P19, DOI 10.1007/BF01692917; Fairclough E, 2009, CLIN MED, V9, P30, DOI 10.7861/clinmedicine.9-1-30; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grander W, 2010, CHEST, V138, P856, DOI 10.1378/chest.09-1677; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Ho KM, 2006, J CRIT CARE, V21, P259, DOI 10.1016/j.jcrc.2006.01.005; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaben A, 2008, CRIT CARE, V12, DOI 10.1186/cc7023; Lee JH, 2011, J CRIT CARE, V26, P287, DOI 10.1016/j.jcrc.2010.10.007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Pinilla JC, 1998, SURGERY, V124, P799, DOI 10.1067/msy.1998.91365; Povas P, 2005, CLIN INFECT DIS, V40, P1855, DOI 10.1086/430382; Povoa P, 2005, EUR RESPIR J, V25, P804, DOI 10.1183/09031936.05.00071704; Povoa P, 2002, INTENS CARE MED, V28, P235, DOI 10.1007/s00134-002-1209-6; Povoa P, 2006, CRIT CARE, V10, DOI 10.1186/cc4892; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Ranzani OT, 2011, BRAZ J MED BIOL RES, V44, P1184, DOI [10.1590/S0100-879X2011007500132, 10.1590/S0100-879X2011001100016]; Ranzani OT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.013; Rey C, 2007, INTENS CARE MED, V33, P477, DOI 10.1007/s00134-006-0509-7; Sakr Y, 2008, J CRIT CARE, V23, P475, DOI 10.1016/j.jcrc.2007.09.006; Silvestre J, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-17; Taori G, 2009, CRIT CARE, V13, DOI 10.1186/cc7988; Van Hemelrijck M, 2012, INT J MOL EPIDEMIOL, V3, P66; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	40	234	243	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59321	10.1371/journal.pone.0059321	http://dx.doi.org/10.1371/journal.pone.0059321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555017	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500080
J	Wolniczak, I; Caceres-DelAguila, JA; Palma-Ardiles, G; Arroyo, KJ; Solis-Visscher, R; Paredes-Yauri, S; Mego-Aquije, K; Bernabe-Ortiz, A				Wolniczak, Isabella; Alonso Caceres-DelAguila, Jose; Palma-Ardiles, Gabriela; Arroyo, Karen J.; Solis-Visscher, Rodrigo; Paredes-Yauri, Stephania; Mego-Aquije, Karina; Bernabe-Ortiz, Antonio			Association between Facebook Dependence and Poor Sleep Quality: A Study in a Sample of Undergraduate Students in Peru	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKING; UNIVERSITY-STUDENTS; HIGH-SCHOOL; ADDICTION; ADOLESCENTS; COMPUTER; DEPRESSION; TIME	Objectives: Internet can accelerate information exchange. Social networks are the most accessed especially Facebook. This kind of networks might create dependency with several negative consequences in people's life. The aim of this study was to assess potential association between Facebook dependence and poor sleep quality. Methodology/Principal Findings: A cross sectional study was performed enrolling undergraduate students of the Universidad Peruana de Ciencias Aplicadas, Lima, Peru. The Internet Addiction Questionnaire, adapted to the Facebook case, and the Pittsburgh Sleep Quality Index, were used. A global score of 6 or greater was defined as the cutoff to determine poor sleep quality. Generalized linear model were used to determine prevalence ratios (PR) and 95% confidence intervals (95% CI). A total of 418 students were analyzed; of them, 322 (77.0%) were women, with a mean age of 20.1 (SD: 2.5) years. Facebook dependence was found in 8.6% (95% CI: 5.9%-11.3%), whereas poor sleep quality was present in 55.0% (95% CI: 50.2%-59.8%). A significant association between Facebook dependence and poor sleep quality mainly explained by daytime dysfunction was found (PR = 1.31; IC95%: 1.04-1.67) after adjusting for age, sex and years in the faculty. Conclusions: There is a relationship between Facebook dependence and poor quality of sleep. More than half of students reported poor sleep quality. Strategies to moderate the use of this social network and to improve sleep quality in this population are needed.	[Wolniczak, Isabella; Alonso Caceres-DelAguila, Jose; Palma-Ardiles, Gabriela; Arroyo, Karen J.; Solis-Visscher, Rodrigo; Paredes-Yauri, Stephania; Mego-Aquije, Karina; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC)	Caceres-DelAguila, JA (corresponding author), Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Sch Med, Lima, Peru.	u711594@upc.edu.pe		Bernabe-Ortiz, Antonio/0000-0002-6834-1376; Caceres Del Aguila, Jose Alonso/0000-0001-7897-5033				Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311; Andreassen CS, 2012, PSYCHOL REP, V110, P501, DOI 10.2466/02.09.18.PR0.110.2.501-517; [Anonymous], 2013, FAC STAT KEY FACTS; Barion A, 2007, SLEEP MED, V8, P566, DOI 10.1016/j.sleep.2006.11.017; Buysse D J, 1989, Psychiatry Res, V28, P193; Cheng SH, 2012, PSYCHIAT RES; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Choi K, 2009, PSYCHIAT CLIN NEUROS, V63, P455, DOI 10.1111/j.1440-1819.2009.01925.x; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Echeburua E, 1999, ADICCIONES SIN DROGA; Echeburua E, 2010, ADICCIONES, V22, P91, DOI 10.20882/adicciones.196; Elphinston RA, 2011, CYBERPSYCH BEH SOC N, V14, P631, DOI 10.1089/cyber.2010.0318; Escobar-Cordoba F, 2005, REV NEUROLOGIA, V40, P150, DOI 10.33588/rn.4003.2004320; Gomes AA, 2011, CHRONOBIOL INT, V28, P786, DOI 10.3109/07420528.2011.606518; Griffiths MD, 2012, PSYCHOL REP, V110, P518, DOI 10.2466/01.07.18.PR0.110.2.518-520; Househ M, 2011, STUD HEALTH TECHNOL, V169, P616, DOI 10.3233/978-1-60750-806-9-616; Huang HY, 2009, CYBERPSYCHOL BEHAV, V12, P675, DOI 10.1089/cpb.2009.0060; Jimenez-Genchi A, 2008, GAC MED MEX, V144, P491; Luengo-Lopez A., 2004, REV PROFESIONAL ESPA, V2, P22; Mesquita G, 2007, ARQ NEURO-PSIQUIAT, V65, P428, DOI 10.1590/S0004-282X2007000300012; Mesquita G, 2010, ARQ NEURO-PSIQUIAT, V68, P720, DOI 10.1590/S0004-282X2010000500009; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P157, DOI 10.1001/archpediatrics.2011.180; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Pantic I, 2012, PSYCHIAT DANUB, V24, P90; Rocha CRS, 2010, ARQ NEURO-PSIQUIAT, V68, P903, DOI 10.1590/S0004-282X2010000600014; Rosales Mayor Edmundo, 2008, Acta méd. peruana, V25, P199; Ruder TD, 2011, CRISIS, V32, P280, DOI 10.1027/0227-5910/a000086; Schmit S, 2011, ENCEPHALE, V37, P217, DOI 10.1016/j.encep.2010.06.006; Sierra JC, 2002, SALUD MENT, V25, P35; Socialbakers, 2013, FAC STAT COUNTR; Tsai HF, 2009, PSYCHIAT RES, V167, P294, DOI 10.1016/j.psychres.2008.01.015; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Wilson K, 2010, CYBERPSYCH BEH SOC N, V13, P173, DOI 10.1089/cyber.2009.0094; Young K.S., 1999, INNOVATIONS CLIN PRA, V17, P351	34	114	122	1	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59087	10.1371/journal.pone.0059087	http://dx.doi.org/10.1371/journal.pone.0059087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554978	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500067
J	Zhu, LJ; Du, ML; Gu, DY; Ma, L; Chu, HY; Tong, N; Chen, JF; Zhang, ZD; Wang, ML				Zhu, Lingjun; Du, Mulong; Gu, Dongying; Ma, Lan; Chu, Haiyan; Tong, Na; Chen, Jinfei; Zhang, Zhengdong; Wang, Meilin			Genetic Variant rs7758229 in 6q26-q27 Is Not Associated with Colorectal Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY	Background: A recent genome-wide association study has identified a new genetic variant rs7758229 in SLC22A3 for colorectal cancer susceptibility in a Japanese population, but it is unknown whether this newly identified variant is associated with colorectal cancer in other populations, including the Chinese population. Methods: We examined the associations between rs7758229 and colorectal cancer risk among 1,147 cases and 1,203 controls matched by age and sex. Logistic regression model was used to assess the associations. Results: No significant association was found between rs7758229 and colorectal cancer risk (OR = 0.95, 95% CI = 0.84-1.09, P = 0.463). Similar results were observed in the stratification of tumor location (OR = 0.94, 95% CI = 0.80-1.11, P = 0.481 for colon cancer, and OR = 0.96, 95% CI = 0.82-1.13, P = 0.621 for rectum cancer). Conclusions: Our findings did not support an association between rs7758229 in 6q26-q27 and the risk of colorectal cancer in a Chinese population.	[Zhu, Lingjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Du, Mulong; Ma, Lan; Chu, Haiyan; Tong, Na; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Du, Mulong; Zhang, Zhengdong; Wang, Meilin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China; [Gu, Dongying; Chen, Jinfei] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, ML (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China.	mwang@njmu.edu.cn	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81201570, 81102089, 81230068]; National Natural Science Foundation of Jiangsu Province [BK2010080, BK2011773]; Key Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002]; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (81201570, 81102089, and 81230068), National Natural Science Foundation of Jiangsu Province (BK2010080 and BK2011773), the Key Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002), the Qing Lan Project of Jiangsu Provincial Department of Education, and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colditz GA, 2006, NAT REV CANCER, V6, P75, DOI 10.1038/nrc1784; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch HT, 1999, CANCER, V86, P2457, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2457::AID-CNCR2>3.0.CO;2-I; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	12	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59256	10.1371/journal.pone.0059256	http://dx.doi.org/10.1371/journal.pone.0059256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555006	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500077
J	Tang, XD; Xu, S; Wang, XW				Tang, Xiaoduan; Xu, Shen; Wang, Xinwei			Nanoscale Probing of Thermal, Stress, and Optical Fields under Near-Field Laser Heating	PLOS ONE			English	Article							HEMISPHERICAL CAVITY ARRAYS; RAMAN-SPECTROSCOPY; MICROSCOPY; RESOLUTION; SILICON; FABRICATION; SUPERLENS; LITHOGRAPHY; ENHANCEMENT; PARTICLES	Micro/nanoparticle induced near-field laser ultra-focusing and heating has been widely used in laser-assisted nanopatterning and nanolithography to pattern nanoscale features on a large-area substrate. Knowledge of the temperature and stress in the nanoscale near-field heating region is critical for process control and optimization. At present, probing of the nanoscale temperature, stress, and optical fields remains a great challenge since the heating area is very small (similar to 100 nm or less) and not immediately accessible for sensing. In this work, we report the first experimental study on nanoscale mapping of particle-induced thermal, stress, and optical fields by using a single laser for both near-field excitation and Raman probing. The mapping results based on Raman intensity variation, wavenumber shift, and linewidth broadening all give consistent conjugated thermal, stress, and near-field focusing effects at a 20 nm resolution (<lambda/26, lambda = 32 nm). Nanoscale mapping of near-field effects of particles from 1210 down to 160 nm demonstrates the strong capacity of such a technique. By developing a new strategy for physical analysis, we have de-conjugated the effects of temperature, stress, and near-field focusing from the Raman mapping. The temperature rise and stress in the nanoscale heating region is evaluated at different energy levels. High-fidelity electromagnetic and temperature field simulation is conducted to accurately interpret the experimental results.	[Tang, Xiaoduan; Xu, Shen; Wang, Xinwei] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Wang, Xinwei] Qingdao Technol Univ, Sch Environm & Municipal Engn, Qingdao, Shandong, Peoples R China	Iowa State University; Qingdao University of Technology	Wang, XW (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.	xwang3@iastate.edu	Xu, Shen/A-6921-2016; Tang, Xiaoduan/F-2525-2014; Wang, Xinwei/AAH-4694-2019	Xu, Shen/0000-0003-4973-3179; Tang, Xiaoduan/0000-0002-2880-134X; 	National Science Foundation [CMMI-0926704, CMMI-1200397, CBET-0932573]	National Science Foundation(National Science Foundation (NSF))	Financial support for this work was provided by the National Science Foundation (CMMI-0926704, CMMI-1200397, and CBET-0932573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, MICROELECTRON ENG, V85, P1443, DOI 10.1016/j.mee.2008.01.089; BEECHEM T, 2007, REV SCI INSTRUM, V78, DOI DOI 10.1063/1.2738946; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; DECKMAN HW, 1988, J VAC SCI TECHNOL B, V6, P333, DOI 10.1116/1.583991; Frey HG, 2002, APPL PHYS LETT, V81, P5030, DOI 10.1063/1.1530736; HART TR, 1970, PHYS REV B-SOLID ST, V1, P638, DOI 10.1103/PhysRevB.1.638; Huang SM, 2002, J APPL PHYS, V92, P2495, DOI 10.1063/1.1501768; HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726; Kouteva-Arguirova S, 2003, J APPL PHYS, V94, P4946, DOI 10.1063/1.1611282; Lee JY, 2009, NATURE, V460, P498, DOI 10.1038/nature08173; Li LP, 2004, NANOTECHNOLOGY, V15, P1655, DOI 10.1088/0957-4484/15/11/049; Li LP, 2004, J APPL PHYS, V96, P5144, DOI 10.1063/1.1796515; Li LP, 2004, NANOTECHNOLOGY, V15, P333, DOI 10.1088/0957-4484/15/3/017; Liu ZW, 2007, NANO LETT, V7, P403, DOI 10.1021/nl062635n; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; McLeod E, 2008, NAT NANOTECHNOL, V3, P413, DOI 10.1038/nnano.2008.150; Munzer HJ, 2001, J MICROSC-OXFORD, V202, P129, DOI 10.1046/j.1365-2818.2001.00876.x; Ng V, 2002, NANOTECHNOLOGY, V13, P554, DOI 10.1088/0957-4484/13/5/302; Reserbat-Plantey A, 2012, NAT NANOTECHNOL, V7, P151, DOI [10.1038/nnano.2011.250, 10.1038/NNANO.2011.250]; Rho J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1148; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shi L, 2000, APPL PHYS LETT, V77, P4295, DOI 10.1063/1.1334658; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Tang XD, 2012, OPT EXPRESS, V20, P14152, DOI 10.1364/OE.20.014152; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; Wang ZB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1211; WISCHNATH UF, 2008, REV SCI INSTRUM, V79, DOI DOI 10.1063/1.2955764; Yue YN, 2011, SMALL, V7, P3324, DOI 10.1002/smll.201101598; Yue YA, 2011, ACS NANO, V5, P4466, DOI 10.1021/nn2011442; ZENHAUSERN F, 1995, SCIENCE, V269, P1083, DOI 10.1126/science.269.5227.1083	30	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58030	10.1371/journal.pone.0058030	http://dx.doi.org/10.1371/journal.pone.0058030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555566	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200003
J	Judson, RN; Gray, SR; Walker, C; Carroll, AM; Itzstein, C; Lionikas, A; Zammit, PS; De Bari, C; Wackerhage, H				Judson, Robert N.; Gray, Stuart R.; Walker, Claire; Carroll, Andrew M.; Itzstein, Cecile; Lionikas, Arimantas; Zammit, Peter S.; De Bari, Cosimo; Wackerhage, Henning			Constitutive Expression of Yes-Associated Protein (Yap) in Adult Skeletal Muscle Fibres Induces Muscle Atrophy and Myopathy	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; SLOW-TWITCH MUSCLE; CARDIOMYOCYTE PROLIFERATION; GENE-EXPRESSION; CENTRONUCLEAR MYOPATHIES; MYOTUBULAR MYOPATHY; CELL-PROLIFERATION; SELF-RENEWAL; SIZE-CONTROL; ORGAN SIZE	The aim of this study was to investigate the function of the Hippo pathway member Yes-associated protein (Yap, gene name Yap1) in skeletal muscle fibres in vivo. Specifically we bred an inducible, skeletal muscle fibre-specific knock-in mouse model (MCK-tTA-hYAP1 S127A) to test whether the over expression of constitutively active Yap (hYAP1 S127A) is sufficient to drive muscle hypertrophy or stimulate changes in fibre type composition. Unexpectedly, after 5-7 weeks of constitutive hYAP1 S127A over expression, mice suddenly and rapidly lost 20-25% body weight and suffered from gait impairments and kyphosis. Skeletal muscles atrophied by 34-40% and the muscle fibre cross sectional area decreased by approximate to 40% when compared to control mice. Histological analysis revealed evidence of skeletal muscle degeneration and regeneration, necrotic fibres and a NADH-TR staining resembling centronuclear myopathy. In agreement with the histology, mRNA expression of markers of regenerative myogenesis (embryonic myosin heavy chain, Myf5, myogenin, Pax7) and muscle protein degradation (atrogin-1, MuRF1) were significantly elevated in muscles from trarisgenic mice versus control. No significant changes in fibre type composition were detected using ATPase staining. The phenotype was largely reversible, as a cessation of hYAP1 S127A expression rescued body and muscle weight, restored muscle morphology and prevented further pathological progression. To conclude, high Yap activity in muscle fibres does not induce fibre hypertrophy nor fibre type changes but instead results in a reversible atrophy and deterioration.	[Gray, Stuart R.; Lionikas, Arimantas; Wackerhage, Henning] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [Judson, Robert N.; Walker, Claire; Carroll, Andrew M.; Itzstein, Cecile; De Bari, Cosimo] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of Aberdeen; University of Aberdeen; University of London; King's College London	Wackerhage, H (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	h.wackerhage@abdn.ac.uk	Carroll, Andrew/G-7831-2017; Gray, Stuart R/L-2489-2017; Zammit, peter/GXV-7746-2022	Carroll, Andrew/0000-0001-9260-8352; Gray, Stuart R/0000-0001-8969-9636; zammit, peter/0000-0001-9562-3072	Oliver Bird PhD studentship for Robert Judson; Medical Research Council [99477]; NHS; Medical Research Council [G1100193] Funding Source: researchfish; MRC [G1100193] Funding Source: UKRI	Oliver Bird PhD studentship for Robert Judson; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by an Oliver Bird PhD studentship for Robert Judson, a NHS Grapian Endowment grant (Henning Wackerhage, Cosimo De Bad) and a Medical Research Council project grant (99477; Henning Wackerhage, Peter S. Zammit, Cosimo De Bari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carroll Andrew M., 2012, Frontiers in Genetics, V2, P99, DOI 10.3389/fgene.2011.00099; Carson JA, 1996, AM J PHYSIOL-CELL PH, V270, pC1624, DOI 10.1152/ajpcell.1996.270.6.C1624; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eghtesad S, 2011, MOL MED, V17, P917, DOI 10.2119/molmed.2010.00256; Fujimura-Kiyono C, 2008, NEUROL INDIA, V56, P325; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; HERON MI, 1993, J MORPHOL, V216, P35, DOI 10.1002/jmor.1052160106; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Judson RN, 2012, J CELL SCI; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Mielcarek M, 2002, MECH DEVELOP, V119, pS269, DOI 10.1016/S0925-4773(03)00127-8; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Philp A, 2011, J APPL PHYSIOL, V110, P561, DOI 10.1152/japplphysiol.00941.2010; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; SIEGEL AJ, 1983, JAMA-J AM MED ASSOC, V250, P2835, DOI 10.1001/jama.250.20.2835; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tiao G, 1997, AM J PHYSIOL-REG I, V272, pR849, DOI 10.1152/ajpregu.1997.272.3.R849; Tsika RW, 2008, J BIOL CHEM, V283, P36154, DOI 10.1074/jbc.M807461200; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	64	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59622	10.1371/journal.pone.0059622	http://dx.doi.org/10.1371/journal.pone.0059622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544078	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317480700038
J	Jurecka-Lubieniecka, B; Ploski, R; Kula, D; Krol, A; Bednarczuk, T; Kolosza, Z; Tukiendorf, A; Szpak-Ulczok, S; Stanjek-Cichoracka, A; Polanska, J; Jarzab, B				Jurecka-Lubieniecka, Beata; Ploski, Rafal; Kula, Dorota; Krol, Aleksandra; Bednarczuk, Tomasz; Kolosza, Zofia; Tukiendorf, Andrzej; Szpak-Ulczok, Sylwia; Stanjek-Cichoracka, Anita; Polanska, Joanna; Jarzab, Barbara			Association between Age at Diagnosis of Graves' Disease and Variants in Genes Involved in Immune Response	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; OPHTHALMOPATHY; SUSCEPTIBILITY; ANTICIPATION; HLA; POLYMORPHISM; CTLA-4; CHILDHOOD; PHENOTYPE; JAPANESE	Background: Graves disease (GD) is a complex disease in which genetic predisposition is modified by environmental factors. The aim of the study was to examine the association between genetic variants in genes encoding proteins involved in immune response and the age at diagnosis of GD. Methods: 735 GD patients and 1216 healthy controls from Poland were included into the study. Eight genetic variants in the HLA-DRB1, TNF, CTLA4, CD40, NFKb, PTPN22, IL4 and IL10 genes were genotyped. Patients were stratified by the age at diagnosis of GD and the association with genotype was analysed. Results: Polymorphism in the HLA-DRB1, TNF and CTLA4 genes were associated with GD. The carriers of the HLA DRB1*03 allele were more frequent in patients with age at GD diagnosis <= 30 years than in patients with older age at GD diagnosis. Conclusions: HLADRB1*03 allele is associated with young age at diagnosis of Graves' disease in polish population,	[Jurecka-Lubieniecka, Beata; Kula, Dorota; Krol, Aleksandra; Kolosza, Zofia; Tukiendorf, Andrzej; Szpak-Ulczok, Sylwia; Jarzab, Barbara] Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Maria Sklodowska Curie Mem Canc, Gliwice, Poland; [Ploski, Rafal; Bednarczuk, Tomasz] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Stanjek-Cichoracka, Anita] Med Univ Silesia, Dept Isotop Diagnost & Radiopharmaceut, Katowice, Poland; [Polanska, Joanna] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Medical University Silesia; Silesian University of Technology	Jarzab, B (corresponding author), Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Maria Sklodowska Curie Mem Canc, Gliwice, Poland.	bjarzab@io.gliwice.pl	Jarząb, Barbara/AAI-7942-2020; Bednarczuk, Tomasz/AFQ-8418-2022; Barbara, Jarzab/I-4654-2019; Polanska, Joanna/H-4513-2013	Jarząb, Barbara/0000-0001-9811-9584; Polanska, Joanna/0000-0001-8004-9864; Kolosza, Zofia/0000-0002-6064-1243; Krol, Aleksandra/0000-0002-2084-5014; Szpak-Ulczok, Sylwia/0000-0002-1432-5848; Jurecka-Lubieniecka, Beata/0000-0001-6333-0451; Stanjek-Cichoracka, Anita/0000-0002-5503-0149; Ploski, Rafal/0000-0001-6286-5526; Kula, Dorota/0000-0002-0986-1929	Ministry of Science and Higher Education [N N519 579938]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education, Grant number N N519 579938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahabadia A, 2001, LANCET, V358, P984, DOI 10.1016/S0140-6736(01)06125-6; [Anonymous], 2007, THYROID, V17, P1027, DOI 10.1089/thy.2007.1526; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Bednarczuk T, 2004, HUM IMMUNOL, V65, P632, DOI 10.1016/j.humimm.2004.02.033; Bednarczuk T, 2003, EUR J ENDOCRINOL, V148, P13, DOI 10.1530/eje.0.1480013; Bednarczuk T, 2007, CLIN ENDOCRINOL, V67, P3, DOI 10.1111/j.1365-2265.2007.02854.x; Bossowski AT, 2007, J ENDOCRINOL INVEST, V30, P388, DOI 10.1007/BF03346315; Brix TH, 2003, THYROID, V13, P447, DOI 10.1089/105072503322021106; Chan W, 2002, BRIT J OPHTHALMOL, V86, P740, DOI 10.1136/bjo.86.7.740; Cocco E, 2004, NEUROLOGY, V62, P1794, DOI 10.1212/01.WNL.0000125194.27381.D4; FARID NR, 1980, CLIN ENDOCRINOL, V13, P535, DOI 10.1111/j.1365-2265.1980.tb03421.x; Farid NR, 1998, THYROID, V8, P407, DOI 10.1089/thy.1998.8.407; FRECKER M, 1986, CLIN ENDOCRINOL, V25, P479, DOI 10.1111/j.1365-2265.1986.tb03599.x; Godakos Al, 2010, PEDIAT ENDOCRINOL S2, V7, p[L234, 44]; Goldstein SM, 2008, THYROID, V18, P997, DOI 10.1089/thy.2008.0014; Hemminki M, 2010, J AUTOIMMUN, V34, pJ307, DOI 10.1016/j.jaut.2009.11.019; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Hunt PJ, 2001, CLIN ENDOCRINOL, V55, P491, DOI 10.1046/j.1365-2265.2001.01356.x; Kavvoura FK, 2007, J CLIN ENDOCR METAB, V92, P3162, DOI 10.1210/jc.2007-0147; Khalilzadeh O, 2010, CLIN EXP MED, V10, P123, DOI 10.1007/s10238-009-0078-5; Kouki T, 2000, J IMMUNOL, V165, P6606, DOI 10.4049/jimmunol.165.11.6606; Krassas GE, 2005, EUR J ENDOCRINOL, V153, P515, DOI 10.1530/eje.1.01991; Kula D, 2006, THYROID, V16, P447, DOI 10.1089/thy.2006.16.447; Kurylowicz A, 2007, GENES IMMUN, V8, P532, DOI 10.1038/sj.gene.6364418; Kurylowicz A, 2005, THYROID, V15, P1119, DOI 10.1089/thy.2005.15.1119; Lavard L, 1997, TISSUE ANTIGENS, V50, P639, DOI 10.1111/j.1399-0039.1997.tb02922.x; Manji N, 2008, J CLIN ENDOCR METAB, V91, P4873; O'Sullivan B, 2007, EXPERT OPIN THER TAR, V11, P111, DOI 10.1517/14728222.11.2.111; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Paterson AD, 1996, AM J HUM GENET, V59, P264; Perrild H, 1997, EXP CLIN ENDOCR DIAB, V105, P55, DOI 10.1055/s-0029-1211934; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P605, DOI 10.1530/eje.0.1500605; Radstake TRDJ, 2001, J RHEUMATOL, V28, P962; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Sawai Y, 2000, J CLIN ENDOCR METAB, V85, P1176, DOI 10.1210/jc.85.3.1176; Segni M, 2001, J Pediatr Endocrinol Metab, V14 Suppl 5, P1271; Segni M, 2001, J PEDIAT ENDOCRIN S5, V14, P1297; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; Tomer Y, 2007, J AUTOIMMUN, V29, P69, DOI 10.1016/j.jaut.2007.05.006; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tomer Y, 2009, J AUTOIMMUN, V32, P231, DOI 10.1016/j.jaut.2009.02.007; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Villanueva R, 2000, THYROID, V10, P791, DOI 10.1089/thy.2000.10.791; Vos XG, 2009, EUR J ENDOCRINOL, V161, P113, DOI 10.1530/EJE-08-0991; WEETMAN AP, 1988, CLIN ENDOCRINOL, V28, P619, DOI 10.1111/j.1365-2265.1988.tb00236.x; Wong GWK, 1999, CLIN ENDOCRINOL, V50, P493; Yin XM, 2012, THYROID, V22, P730, DOI 10.1089/thy.2012.0007; Zamani M, 2000, AM J MED GENET, V95, P432, DOI 10.1002/1096-8628(20001218)95:5<432::AID-AJMG5>3.0.CO;2-7; Zeitlin AA, 2008, CLIN ENDOCRINOL, V68, P671, DOI 10.1111/j.1365-2265.2007.03075.x	49	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59349	10.1371/journal.pone.0059349	http://dx.doi.org/10.1371/journal.pone.0059349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544060	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700022
J	Mossel, EC; Ledermann, JP; Phillips, AT; Borland, EM; Powers, AM; Olson, KE				Mossel, Eric C.; Ledermann, Jeremy P.; Phillips, Aaron T.; Borland, Erin M.; Powers, Ann M.; Olson, Ken E.			Molecular Determinants of Mouse Neurovirulence and Mosquito Infection for Western Equine Encephalitis Virus	PLOS ONE			English	Article							SINDBIS-VIRUS; ENCEPHALOMYELITIS VIRUS; GENETIC-DETERMINANTS; E2 GLYCOPROTEIN; AEDES-AEGYPTI; ALPHAVIRUS; VIRULENCE; CALIFORNIA; STRAINS	Western equine encephalitis virus (WEEV) is a naturally occurring recombinant virus derived from ancestral Sindbis and Eastern equine encephalitis viruses. We previously showed that infection by WEEV isolates McMillan (McM) and IMP-181 (IMP) results in high (similar to 90-100%) and low (0%) mortality, respectively, in outbred CD-1 mice when virus is delivered by either subcutaneous or aerosol routes. However, relatively little is known about specific virulence determinants of WEEV We previously observed that IMP infected Culex tarsalis mosquitoes at a high rate (app. 80%) following ingestion of an infected bloodmeal but these mosquitoes were infected by McM at a much lower rate (10%). To understand the viral role in these phenotypic differences, we characterized the pathogenic phenotypes of McM/IMP chimeras. Chimeras encoding the E2 of McM on an IMP backbone (or the reciprocal) had the most significant effect on infection phenotypes in mice or mosquitoes. Furthermore, exchanging the arginine, present on IMP E2 glycoprotein at position 214, for the glutamine present at the same position on McM, ablated mouse mortality. Curiously, the reciprocal exchange did not confer mouse virulence to the IMP virus. Mosquito infectivity was also determined and significantly, one of the important loci was the same as the mouse virulence determinant identified above. Replacing either IMP E2 amino acid 181 or 214 with the corresponding McM amino acid lowered mosquito infection rates to McM-like levels. As with the mouse neurovirulence, reciprocal exchange of amino acids did not confer mosquito infectivity. The identification of WEEV E2 amino acid 214 as necessary for both IMP mosquito infectivity and McM mouse virulence indicates that they are mutually exclusive phenotypes and suggests an explanation for the lack of human or equine WEE cases even in the presence of active transmission.	[Mossel, Eric C.; Phillips, Aaron T.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Mossel, Eric C.; Ledermann, Jeremy P.; Borland, Erin M.; Powers, Ann M.] Ctr Dis Control, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Colorado State University	Olson, KE (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	kolson@colostate.edu	Borland, Erin/K-6607-2019	Borland, Erin/0000-0001-8631-9466	NIH/NIAID [U54AI-065357, R01 AI46435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046435, U54AI065357] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH/NIAID grant U54AI-065357 to the Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research (http://www.rmrce.colostate.edu/) and NIH/NIAID R01 AI46435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasheva S, 2010, J VIROL; BIANCHI TI, 1993, AM J TROP MED HYG, V49, P322, DOI 10.4269/ajtmh.1993.49.322; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Centers for Disease Control and Prevention website, 1964, CONF PROB W EQ ENC V; EMMONS R W, 1975, Proceedings and Papers of the Annual Conference of the California Mosquito Control Association, V43, P59; Forrester NL, 2008, VIROLOGY, V380, P170, DOI 10.1016/j.virol.2008.08.012; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Hardy JL, 1997, AM J TROP MED HYG, V57, P240, DOI 10.4269/ajtmh.1997.57.240; Jupille HJ, 2011, VIROLOGY, V410, P216, DOI 10.1016/j.virol.2010.11.012; Lee PY, 2002, J VIROL, V76, P6302, DOI 10.1128/JVI.76.12.6302-631-.2002; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Logue CH, 2009, J GEN VIROL, V90, P1848, DOI 10.1099/vir.0.008656-0; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Meyer KF, 1931, SCIENCE, V74, P227, DOI 10.1126/science.74.1913.227; MEYER WJ, 1993, J VIROL, V67, P5117, DOI 10.1128/JVI.67.9.5117-5125.1993; Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025; Nagata LP, 2006, J GEN VIROL, V87, P2353, DOI 10.1099/vir.0.81815-0; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Pierro DJ, 2007, J GEN VIROL, V88, P1545, DOI 10.1099/vir.0.82577-0; Reisen WK, 2008, AM J TROP MED HYG, V78, P681, DOI 10.4269/ajtmh.2008.78.681; Reisen WK, 2001, J MED ENTOMOL, V38, P393, DOI 10.1603/0022-2585-38.3.393; Reisen WK, 1988, ARBOVIRUSES EPIDEMIO, VV, P89; Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; Tsetsarkin KA, 2009, PLOS ONE, V4, pe6835; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WOODWARD TM, 1991, J GEN VIROL, V72, P2431, DOI 10.1099/0022-1317-72-10-2431; Zhang MT, 2011, VECTOR-BORNE ZOONOT, V11, P269, DOI 10.1089/vbz.2010.0078; Zhang R, 2011, EMBO J, V30, P3854, DOI 10.1038/emboj.2011.261	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60427	10.1371/journal.pone.0060427	http://dx.doi.org/10.1371/journal.pone.0060427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544138	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700097
J	Myeni, SK; Wang, L; Zhou, DG				Myeni, Sebenzile K.; Wang, Lu; Zhou, Daoguo			SipB-SipC Complex Is Essential for Translocon Formation	PLOS ONE			English	Article							CELL PLASMA-MEMBRANE; III SECRETION; SALMONELLA-TYPHIMURIUM; HOST-CELLS; EFFECTOR PROTEINS; ACTIN NUCLEATION; SHIGELLA; ENTRY; IPAC	The delivery of effector proteins by Salmonella across the host cell membrane requires a subset of effectors secreted by the type III secretion system (TTSS) known as translocators. SipC and SipB are translocator proteins that are inserted into host membranes and presumably form a channel that translocates type III effectors into the host cell. The molecular events of how these translocators insert into the host cell membrane remain unknown. We have previously shown that the SipC C-terminal amino acid region (321-409) is required for the translocation of effectors into host cells. In this study, we demonstrate that the ability to form SipC-SipB complex is essential for their insertion into the host membrane. The SipB-interacting domain of SipC is near its C-terminal amino acid region (340-409). In the absence of SipB, SipC was not detected in the membrane fraction. Furthermore, SipC mutants that no longer interact with SipB are defective in inserting into the host cell membrane. We propose a mechanism whereby SipC binds SipB through its C-terminal region to facilitate membrane-insertion and subsequent translocon formation in the host cell membrane.	[Myeni, Sebenzile K.; Wang, Lu; Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, DG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	zhoud@purdue.edu			 [NIAID-AI049978]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049978] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was funded by NIAID-AI049978. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Cain RJ, 2004, MOL MICROBIOL, V54, P887, DOI 10.1111/j.1365-2958.2004.04336.x; Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x; Chang JH, 2007, MOL MICROBIOL, V66, P1548, DOI 10.1111/j.1365-2958.2007.06024.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 1998, P NATL ACAD SCI USA, V95, P14006, DOI 10.1073/pnas.95.24.14006; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hayward RD, 2000, MOL MICROBIOL, V37, P727, DOI 10.1046/j.1365-2958.2000.02027.x; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HUECK CJ, 1995, MOL MICROBIOL, V18, P479, DOI 10.1111/j.1365-2958.1995.mmi_18030479.x; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Miki T, 2004, MICROB PATHOGENESIS, V37, P65, DOI 10.1016/j.micpath.2004.04.006; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Osiecki JC, 2001, MOL MICROBIOL, V42, P469, DOI 10.1046/j.1365-2958.2001.02654.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	34	27	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60499	10.1371/journal.pone.0060499	http://dx.doi.org/10.1371/journal.pone.0060499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544147	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700106
J	Shin, JH; Greer, B; Hakim, CH; Zhou, ZN; Chung, YC; Duan, Y; He, ZH; Duan, DS				Shin, Jin-Hong; Greer, Brian; Hakim, Chady H.; Zhou, Zhongna; Chung, Yu-chia; Duan, Ye; He, Zhihai; Duan, Dongsheng			Quantitative Phenotyping of Duchenne Muscular Dystrophy Dogs by Comprehensive Gait Analysis and Overnight Activity Monitoring	PLOS ONE			English	Article								The dystrophin-deficient dog is excellent large animal model for testing novel therapeutic modalities for Duchenne muscular dystrophy (DMD). Despite well-documented descriptions of dystrophic symptoms in these dogs, very few quantitative studies have been performed. Here, we developed a comprehensive set of non-invasive assays to quantify dog gait (stride length and speed), joint angle and limb mobility (for both forelimb and hind limb), and spontaneous activity at night To validate these assays, we examined three 8-m-old mix-breed dystrophic dogs. We also included three age-matched siblings as the normal control. High-resolution video recorders were used to digitize dog walking and spontaneous movement at night. Stride speed and length were significantly decreased in affected dogs. The mobility of the limb segments (forearm, front foot, lower thigh, rear foot) and the carpus and hock joints was significantly reduced in dystrophic dogs. There was also a significant reduction of the movement in affected dogs during overnight monitoring. In summary, we have established a comprehensive set of outcome measures for clinical phenotyping of DMD dogs. These non-invasive end points would be valuable in monitoring disease progression and therapeutic efficacy in translational studies in the DMD dog model.	[Shin, Jin-Hong; Greer, Brian; Hakim, Chady H.; Duan, Dongsheng] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Zhou, Zhongna; Chung, Yu-chia; He, Zhihai] Univ Missouri, Dept Elect & Comp Engn, Columbia, MO 65212 USA; [Duan, Ye] Univ Missouri, Dept Comp Sci, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Duan, DS (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.	duand@missouri.edu	Shin, Jin-Hong/AAZ-8809-2020	Shin, Jin-Hong/0000-0002-5174-286X; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; National Science Foundation [CNS-0931607]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health AR-49419 (DD), the Muscular Dystrophy Association (DD) and National Science Foundation CNS-0931607 (ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; Duan D, 2011, RES REP BIOL, V2, P31, DOI 10.2147/RRB.S13463; Fine DM, 2011, NEUROMUSCULAR DISORD, V21, P453, DOI 10.1016/j.nmd.2011.03.010; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Ganea R, 2011, J CHILD NEUROL; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Marsh AP, 2009, NEUROMUSCUL DISORD; MEIER H., 1958, CORNELL VET, V48, P313; Nakayama M, 2006, MOL THER, V13, pS53, DOI 10.1016/j.ymthe.2006.08.152; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; VALENTINE BA, 1986, ACTA NEUROPATHOL, V71, P301, DOI 10.1007/BF00688053; Yang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044438; Yue YP, 2011, METHODS MOL BIOL, V709, P313, DOI 10.1007/978-1-61737-982-6_21	18	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59875	10.1371/journal.pone.0059875	http://dx.doi.org/10.1371/journal.pone.0059875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544107	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700067
J	Skorokhod, A; Helmbold, P; Brors, B; Schirmacher, P; Enk, A; Penzel, R				Skorokhod, Alexander; Helmbold, Peter; Brors, Benedikt; Schirmacher, Peter; Enk, Alexander; Penzel, Roland			Automated Universal BRAF State Detection within the Activation Segment in Skin Metastases by Pyrosequencing-Based Assay U-BRAF(V600)	PLOS ONE			English	Article							B-RAF; BRAF(V600E) MUTATION; CUTANEOUS MELANOMA; NRAS MUTATIONS; GENE; ABSENCE; PREVALENCE; CARCINOMA; SPECIMENS; VARIANT	Malignant melanoma is a highly-aggressive type of malignancy with considerable metastatic potential and frequent resistance to cytotoxic agents. BRAF mutant protein was recently recognized as therapeutic target in metastatic melanoma. We present a newly-developed U-BRAF(V600) approach - a universal pyrosequencing-based assay for mutation detection within activation segment in exon 15 of human braf. We identified 5 different BRAF mutations in a single assay analyzing 75 different formalin-fixed paraffin-embedded (FFPE) samples of cutaneous melanoma metastases from 29 patients. We found BRAF mutations in 21 of 29 metastases. All mutant variants were quantitatively detectable by the newly-developed U-BRAF(V600) assay. These results were confirmed by ultra-deep-sequencing validation ((similar to)60,000-fold coverage). In contrast to all other BRAF state detection methods, the U-BRAF(V600) assay is capable of automated quantitative identification of at least 36 previously-published BRAF mutations. Under the precaution of a minimum of 3% mutated cells in front of a background of wild type cells, U-BRAF(V600) assay design completely excludes false wild-type results. The corresponding algorithm for classification of BRAF-mutated variants is provided. The single-reaction assay and data analysis automation makes our approach suitable for the assessment of large clinical sample sizes. Therefore, we suggest U-BRAF(V600) assay as a most powerful sequencing-based diagnostic tool to automatically identify BRAF state as a prerequisite to targeted therapy.	[Skorokhod, Alexander; Helmbold, Peter; Enk, Alexander] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, Dept Theoret Bioinformat, Heidelberg, Germany; [Schirmacher, Peter; Penzel, Roland] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Skorokhod, A (corresponding author), Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany.	Alexander.Skorokhod@med.uni-heidelberg.de	Brors, Benedikt/E-5620-2013	Brors, Benedikt/0000-0001-5940-3101	Deutsche Krebshilfe [DKH108856]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This research was funded by Deutsche Krebshilfe [DKH108856]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barzon L, 2008, EUR J ENDOCRINOL, V159, P77, DOI 10.1530/EJE-08-0239; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Carta C, 2006, CLIN ENDOCRINOL, V64, P105, DOI 10.1111/j.1365-2265.2005.02401.x; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chiosea S, 2009, ENDOCR PATHOL, V20, P122, DOI 10.1007/s12022-009-9073-3; Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cruz F, 2003, CANCER RES, V63, P5761; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deichmann M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-58; Deichmann M, 2004, ONCOLOGY-BASEL, V66, P411, DOI 10.1159/000079490; Deichmann M, 2006, INT J ONCOL, V29, P139; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Eisenhardt AE, 2011, INT J CANCER, V129, P2297, DOI 10.1002/ijc.25893; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gill M, 2004, J INVEST DERMATOL, V122, P1325, DOI 10.1111/j.0022-202X.2004.22530.x; Helmke BM, 2004, GASTROENTEROLOGY, V127, P1815, DOI 10.1053/j.gastro.2004.08.051; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; Hou P, 2007, CELL CYCLE, V6, P377, DOI 10.4161/cc.6.3.3818; Hunter SM, 2012, CLIN CANCER RES, V18, P5267, DOI 10.1158/1078-0432.CCR-12-1103; Indsto JO, 2007, J CUTAN PATHOL, V34, P448, DOI 10.1111/j.1600-0560.2006.00646.x; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jung CK, 2012, THYROID, V22, P791, DOI 10.1089/thy.2011.0123; Kim SK, 2008, DIAGN MOL PATHOL, V17, P118, DOI 10.1097/PDM.0b013e31815d059d; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matsuse M, 2013, INT J CANCER, V132, P738, DOI 10.1002/ijc.27709; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Sadow PM, 2010, ENDOCR PATHOL, V21, P73, DOI 10.1007/s12022-009-9101-3; Safaee Ardekani Gholamreza, 2012, PLoS One, V7, pe47054, DOI 10.1371/journal.pone.0047054; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; Satoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033891; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Schulten HJ, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-10; Skorokhod A, 2012, J AM ACAD DERMATOL, V67, P488, DOI 10.1016/j.jaad.2012.03.022; Spittle C, 2007, J MOL DIAGN, V9, P464, DOI 10.2353/jmoldx.2007.060191; Trovisco V, 2005, HUM PATHOL, V36, P694, DOI 10.1016/j.humpath.2005.04.011	43	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59221	10.1371/journal.pone.0059221	http://dx.doi.org/10.1371/journal.pone.0059221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555633	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500025
J	Lundberg, G; Jin, YS; Sehic, D; Ora, I; Versteeg, R; Gisselsson, D				Lundberg, Gisela; Jin, Yuesheng; Sehic, Daniel; Ora, Ingrid; Versteeg, Rogier; Gisselsson, David			Intratumour Diversity of Chromosome Copy Numbers in Neuroblastoma Mediated by On-Going Chromosome Loss from a Polyploid State	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; INTRAEPITHELIAL NEOPLASIA; TELOMERE DYSFUNCTION; CANCER-CELLS; SEGREGATION; INSTABILITY; MECHANISM; TRANSLOCATIONS; PLOIDY; ERRORS	Neuroblastomas (NBs) are tumours of the sympathetic nervous system accounting for 8-10% of paediatric cancers. NBs exhibit extensive intertumour genetic heterogeneity, but their extent of intratumour genetic diversity has remained unexplored. We aimed to assess intratumour genetic variation in NBs with a focus on whole chromosome changes and their underlying mechanism. Allelic ratios obtained by SNP-array data from 30 aneuploid primary NBs and NB cell lines were used to quantify the size of clones harbouring specific genomic imbalances. In 13 cases, this was supplemented by fluorescence in situ hybridisation to assess copy number diversity in detail. Computer simulations of different mitotic segregation errors, single cell cloning, analysis of mitotic figures, and time lapse imaging of dividing NB cells were used to infer the most likely mechanism behind intratumour variation in chromosome number. Combined SNP array and FISH analyses showed that all cases exhibited higher inter-cellular copy number variation than non-neoplastic control tissue, with up to 75% of tumour cells showing non-modal chromosome copy numbers. Comparisons of copy number profiles, resulting from simulations of different segregation errors to genomic profiles of 120 NBs indicated that loss of chromosomes from a tetraploid state was more likely than other mechanisms to explain numerical aberrations in NB. This was supported by a high frequency of lagging chromosomes at anaphase and polyploidisation events in growing NB cells. The dynamic nature of numerical aberrations was corroborated further by detecting substantial copy number diversity in cell populations grown from single NB cells. We conclude that aneuploid NBs typically show extensive intratumour chromosome copy number diversity, and that this phenomenon is most likely explained by continuous loss of chromosomes from a polyploid state.	[Lundberg, Gisela; Jin, Yuesheng; Sehic, Daniel; Gisselsson, David] Skane Univ & Reg Labs, Univ Lund, Dept Clin Genet, Lund, Sweden; [Ora, Ingrid] Lund Univ, Dept Paediat Oncol & Haematol, Skane Univ Hosp, Lund, Sweden; [Ora, Ingrid; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Gisselsson, David] Skane Univ & Reg Labs, Dept Pathol, Lund, Sweden	Lund University; Lund University; Skane University Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Gisselsson, D (corresponding author), Skane Univ & Reg Labs, Univ Lund, Dept Clin Genet, Lund, Sweden.	david.gisselsson@med.lu.se	Øra, Ingrid/J-2596-2013; Versteeg, Rogier/AAQ-1765-2020	Øra, Ingrid/0000-0002-3931-4125; Versteeg, Rogier/0000-0001-7172-0388	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Schyberg Foundation; Medical Faculty at Lund University	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Schyberg Foundation; Medical Faculty at Lund University	This work was supported by the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Medical Society, the Lund University Hospital Donation Funds, the Gunnar Nilsson Cancer Foundation, the Crafoord Foundation, the Erik-Philip Sorensen Foundation, the Lundgren Foundation, the Schyberg Foundation and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Choi CM, 2009, LUNG CANCER, V64, P66, DOI 10.1016/j.lungcan.2008.07.016; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; Duker NJ, 2002, AM J MED GENET, V115, P125, DOI 10.1002/ajmg.10688; Fukushi D, 2009, CANCER GENET CYTOGEN, V188, P32, DOI 10.1016/j.cancergencyto.2008.08.014; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Genesca A, 2011, ADV CANCER RES, V112, P11, DOI 10.1016/B978-0-12-387688-1.00002-8; Gisselsson D, 2011, CYTOGENET GENOME RES, V133, P190, DOI 10.1159/000322480; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gisselsson D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001871; Gisselsson D, 2010, P NATL ACAD SCI USA, V107, P20489, DOI 10.1073/pnas.1006829107; Gisselsson David, 2007, J Carcinog, V6, P15, DOI 10.1186/1477-3163-6-15; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heaphy CM, 2011, MODERN PATHOL, V24, P194, DOI 10.1038/modpathol.2010.198; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hong SM, 2011, MODERN PATHOL, V24, P256, DOI 10.1038/modpathol.2010.181; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Kaneko Y, 2000, GENE CHROMOSOME CANC, V29, P89, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1021>3.0.CO;2-Y; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Londono-Vallejo JA, 2012, TRENDS BIOCH SCI; Lundberg G, 2011, GENE CHROMOSOME CANC, V50, P250, DOI 10.1002/gcc.20850; Lundberg G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003099; Meeker AK, 2006, UROL ONCOL-SEMIN ORI, V24, P122, DOI 10.1016/j.urolonc.2005.11.002; Mitelman F, 2009, CANC CYTOGENETICS; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; Nickerson HJ, 2000, J CLIN ONCOL, V18, P477, DOI 10.1200/JCO.2000.18.3.477; Pampalona J, 2012, PLOS GENET, V8, P601, DOI 10.1371/journal.pgen.1002679; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Paulsson K, 2005, GENE CHROMOSOME CANC, V44, P113, DOI 10.1002/gcc.20222; Pentenero M, 2011, CANCER-AM CANCER SOC, V117, P5052, DOI 10.1002/cncr.26126; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Silvestre DC, 2011, STEM CELLS, V29, P440, DOI 10.1002/stem.600; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Thirthagiri E, 2007, CANCER LETT, V258, P276, DOI 10.1016/j.canlet.2007.09.008; Tonini GP, 2003, CANCER LETT, V197, P69, DOI 10.1016/S0304-3835(03)00081-8	43	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59268	10.1371/journal.pone.0059268	http://dx.doi.org/10.1371/journal.pone.0059268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555645	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400029
J	Chamling, X; Seo, SJ; Bugge, K; Searby, C; Guo, DF; Drack, AV; Rahmouni, K; Sheffield, VC				Chamling, Xitiz; Seo, Seongjin; Bugge, Kevin; Searby, Charles; Guo, Deng F.; Drack, Arlene V.; Rahmouni, Kamal; Sheffield, Val C.			Ectopic Expression of Human BBS4 Can Rescue Bardet-Biedl Syndrome Phenotypes in Bbs4 Null Mice	PLOS ONE			English	Article							SYNDROME PROTEINS; MOUSE MODELS; CILIOGENESIS; MUTATIONS; COMPLEX; OBESITY; CILIA	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous autosomal recessive disorder characterized by obesity, retinal degeneration, polydactyly, hypogenitalism and renal defects. Recent findings have associated the etiology of the disease with cilia, and BBS proteins have been implicated in trafficking various ciliary cargo proteins. To date, 17 different genes have been reported for BBS among which BBS1 is the most common cause of the disease followed by BBS10, and BBS4. A murine model of Bbs4 is known to phenocopy most of the human BBS phenotypes, and it is being used as a BBS disease model. To better understand the in vivo localization, cellular function, and interaction of BBS4 with other proteins, we generated a transgenic BBS4 mouse expressing the human BBS4 gene under control of the beta actin promoter. The transgene is expressed in various tissues including brain, eye, testis, heart, kidney, and adipose tissue. These mice were further bred to express the transgene in Bbs4 null mice, and their phenotype was characterized. Here we report that despite tissue specific variable expression of the transgene, human BBS4 was able to complement the deficiency of Bbs4 and rescue all the BBS phenotypes in the Bbs4 null mice. These results provide an encouraging prospective for gene therapy for BBS related phenotypes and potentially for other ciliopathies.	[Chamling, Xitiz; Bugge, Kevin; Searby, Charles; Sheffield, Val C.] Univ Iowa, Dept Pediat, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Seo, Seongjin; Drack, Arlene V.; Sheffield, Val C.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Bugge, Kevin; Searby, Charles; Sheffield, Val C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Guo, Deng F.; Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Guo, Deng F.; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Rahmouni, Kamal/Y-1788-2019	Drack, Arlene/0000-0002-8195-8426; Rahmouni, Kamal/0000-0001-5136-6748; Sheffield, Val/0000-0002-6282-0835; Seo, Seongjin/0000-0002-7908-3210; chamling, xitiz/0000-0001-6401-7715; Searby, Charles/0000-0002-8108-8782	National Institute of Health [R01EY022616, RO1EY017168, RO1EY110298]; NATIONAL EYE INSTITUTE [R01EY011298, R01EY017168, R01EY022616] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083543] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants R01EY022616 (to S.S.), RO1EY017168 and RO1EY110298 (to V.C.S.). V.C.S. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billingsley G, 2011, OPHTHALMIC GENET, V32, P181, DOI 10.3109/13816810.2011.567319; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; Eichers ER, 2006, HUM GENET, V120, P211, DOI 10.1007/s00439-006-0197-y; Forsythe E, 2012, EUR J HUM GENET; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Ittner LM, 2007, NAT PROTOC, V2, P1206, DOI 10.1038/nprot.2007.145; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pereiro I, 2010, MOL VIS, V16, P137; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108	24	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59101	10.1371/journal.pone.0059101	http://dx.doi.org/10.1371/journal.pone.0059101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554981	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800058
J	Hou, XD; Liu, QP; Smith, TJ; Li, N; Zong, MH				Hou, Xue-Dan; Liu, Qiu-Ping; Smith, Thomas J.; Li, Ning; Zong, Min-Hua			Evaluation of Toxicity and Biodegradability of Cholinium Amino Acids Ionic Liquids	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITIES; ACETYLCHOLINESTERASE; IMIDAZOLIUM; PYRIDINIUM; SACCHARINATE; PRETREATMENT; SOLVENTS; CHLORIDE; TARGETS; BIOMASS	Cholinium amino acid ionic liquids ([Ch][AA] ILs), which are wholly composed of renewable biomaterials, have recently been demonstrated to have very promising properties for applications in organic synthesis and biomass pretreatment. In this work, the toxicity of these ILs toward enzymes and bacteria was assessed, and the effect of the anion on these properties is discussed. The inhibitory potentials of this type of ILs to acetylcholinesterase were weaker approximately an order of magnitude than the traditional IL 1-butyl-3-methylimidazolium tetrafluoroborate. Additionally, the [Ch][AA] ILs displayed low toxicity toward the bacteria tested. Furthermore, the biodegradability of the [Ch][AA] ILs was evaluated via the closed bottle and CO2 headspace tests using wastewater microorganisms. All the ILs were classified as 'readily biodegradable' based on their high levels of mineralization (62-87%). The presence of extra carboxyl or amide groups on the amino acid side chain rendered the ILs significantly more susceptible to microbial breakdown. In addition, for most of the [Ch][AA] ILs, low toxicity correlated with good biodegradability. The low toxicity and high biodegradability of these novel [Ch][AA] make them promising candidates for use as environmentally friendly solvents in large-scale applications.	[Hou, Xue-Dan; Li, Ning; Zong, Min-Hua] S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Hou, Xue-Dan; Liu, Qiu-Ping] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Smith, Thomas J.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England	South China University of Technology; South China University of Technology; Sheffield Hallam University	Li, N (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	lining@scut.edu.cn; btmhzong@scut.edu.cn	Li, Ning/I-3417-2012	Li, Ning/0000-0003-1684-4454; Smith, Thomas/0000-0002-4246-5020	National Natural Science Foundation of China [20906032, 21072065]; Research Fund for the Doctoral Program of Higher Education [20090172110019]; Fundamental Research Funds for the Central Universities, SCUT [2012ZP0009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (20906032 and 21072065), the Research Fund for the Doctoral Program of Higher Education (20090172110019), and the Fundamental Research Funds for the Central Universities, SCUT (2012ZP0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arning J, 2008, GREEN CHEM, V10, P47, DOI 10.1039/b712109a; Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t; Coleman D, 2010, CHEM SOC REV, V39, P600, DOI 10.1039/b817717c; Docherty KM, 2007, BIODEGRADATION, V18, P481, DOI 10.1007/s10532-006-9081-7; Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ford L, 2010, GREEN CHEM, V12, P1783, DOI 10.1039/c0gc00082e; Fukumoto K, 2005, J AM CHEM SOC, V127, P2398, DOI 10.1021/ja043451i; Gathergood N, 2004, GREEN CHEM, V6, P166, DOI 10.1039/b315270g; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Hou XD, 2012, BIOTECHNOL BIOENG, V109, P2484, DOI 10.1002/bit.24522; Hu SQ, 2007, TETRAHEDRON LETT, V48, P5613, DOI 10.1016/j.tetlet.2007.06.051; Lee SH, 2006, BIOTECHNOL LETT, V28, P1335, DOI 10.1007/s10529-006-9095-6; Liu QP, 2012, GREEN CHEM, V14, P304, DOI 10.1039/c2gc16128a; Luo YR, 2009, CHEMOSPHERE, V77, P313, DOI 10.1016/j.chemosphere.2009.07.026; Machado MF, 2005, BIOTECHNOL LETT, V27, P1233, DOI 10.1007/s10529-005-0023-y; Maia A, 2011, MINI-REV ORG CHEM, V8, P178, DOI 10.2174/157019311795177826; Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108; Moriel P, 2010, TETRAHEDRON LETT, V51, P4877, DOI 10.1016/j.tetlet.2010.07.060; Nockemann P, 2007, J PHYS CHEM B, V111, P5254, DOI 10.1021/jp068446a; Pernak J, 2004, GREEN CHEM, V6, P323, DOI 10.1039/b404625k; Pernak J, 2001, EUR J MED CHEM, V36, P313, DOI 10.1016/S0223-5234(01)01226-0; Petkovic M, 2011, CHEM SOC REV, V40, P1383, DOI 10.1039/c004968a; Petkovic M, 2010, GREEN CHEM, V12, P643, DOI 10.1039/b922247b; Pinto PCAG, 2011, CHEMOSPHERE, V82, P1620, DOI 10.1016/j.chemosphere.2010.11.046; Plaquevent JC, 2008, CHEM REV, V108, P5035, DOI 10.1021/cr068218c; Plechkova NV, 2008, CHEM SOC REV, V37, P123, DOI 10.1039/b006677j; Rickwood CJ, 2004, AQUAT TOXICOL, V67, P45, DOI 10.1016/j.aquatox.2003.11.004; Romero A, 2008, J HAZARD MATER, V151, P268, DOI 10.1016/j.jhazmat.2007.10.079; Russell AD, 2003, J ANTIMICROB CHEMOTH, V52, P750, DOI 10.1093/jac/dkg422; Stasiewicz M, 2008, ECOTOX ENVIRON SAFE, V71, P157, DOI 10.1016/j.ecoenv.2007.08.011; Stock F, 2004, GREEN CHEM, V6, P286, DOI 10.1039/b402348j; Tao GH, 2006, GREEN CHEM, V8, P639, DOI 10.1039/b600813e; Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030; Turner MB, 2003, GREEN CHEM, V5, P443, DOI 10.1039/b302570e; Wang H, 2011, CHEMOSPHERE, V82, P1597, DOI 10.1016/j.chemosphere.2010.11.049; Weaver KD, 2010, GREEN CHEM, V12, P507, DOI 10.1039/b918726j; Yu YH, 2008, CHEM-EUR J, V14, P11174, DOI 10.1002/chem.200800620	38	243	255	4	216	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59145	10.1371/journal.pone.0059145	http://dx.doi.org/10.1371/journal.pone.0059145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554985	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800062
J	Jones, SI; Vodkin, LO				Jones, Sarah I.; Vodkin, Lila O.			Using RNA-Seq to Profile Soybean Seed Development from Fertilization to Maturity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; CELL-WALL PROTEIN; EXPRESSION ANALYSIS; PATTERNS; IDENTIFICATION; ACCUMULATION; SEQUENCES; ELEMENTS; GENES; AUXIN	To understand gene expression networks leading to functional properties and compositional traits of the soybean seed, we have undertaken a detailed examination of soybean seed development from a few days post-fertilization to the mature seed using Illumina high-throughput transcriptome sequencing (RNA-Seq). RNA was sequenced from seven different stages of seed development, yielding between 12 million and 78 million sequenced transcripts. These have been aligned to the 79,000 gene models predicted from the soybean genome recently sequenced by the Department of Energy Joint Genome Institute. Over one hundred gene models were identified with high expression exclusively in young seed stages, starting at just four days after fertilization. These were annotated as being related to many basic components and processes such as histones and proline-rich proteins. Genes encoding storage proteins such as glycinin and beta-conglycinin had their highest expression levels at the stages of largest fresh weight, confirming previous knowledge that these storage products are being rapidly accumulated before the seed begins the desiccation process. Other gene models showed high expression in the dry, mature seeds, perhaps indicating the preparation of pathways needed later, in the early stages of imbibition. Many highly-expressed gene models at the dry seed stage are, as expected, annotated as hydrophilic proteins associated with low water conditions, such as late embryogenesis abundant (LEA) proteins and dehydrins, which help preserve the cellular structures and nutrients within the seed during desiccation. More significantly, the power of RNA-Seq to detect genes expressed at low levels revealed hundreds of transcription factors with notable expression in at least one stage of seed development. Results from a second biological replicate demonstrate high reproducibility of these data revealing a comprehensive view of the transciptome of seed development in the cultivar Williams, the reference cultivar for the first soybean genome sequence.	[Jones, Sarah I.; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			Illinois Soybean Association; United Soybean Board; Illinois-Missouri Biotechnology Alliance	Illinois Soybean Association; United Soybean Board; Illinois-Missouri Biotechnology Alliance	This research was supported by grants from the Illinois Soybean Association, the United Soybean Board, and the Illinois-Missouri Biotechnology Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; BAULCOMBE DC, 1980, J BIOL CHEM, V255, P8907; Bewley JD, 2000, BIOCH MOL BIOL PLANT, P988; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Carlson JB, 2004, SOYBEANS IMPROVEMENT, V16, P59; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez DO, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-468; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HONG JC, 1989, PLANT CELL, V1, P937, DOI 10.1105/tpc.1.9.937; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Islas-Flores I, 2002, BBA-GEN SUBJECTS, V1571, P64, DOI 10.1016/S0304-4165(02)00210-6; Jenik PD, 2005, DEVELOPMENT, V132, P3577, DOI 10.1242/dev.01952; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le BH, 2007, PLANT PHYSIOL, V144, P562, DOI 10.1104/pp.107.100362; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; LINDSTROM JT, 1991, PLANT CELL, V3, P561, DOI 10.1105/tpc.3.6.561; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Panavas T, 1999, PLANT MOL BIOL, V40, P237, DOI 10.1023/A:1006146230602; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Ritchie S.W., 1996, 53 IOW STAT U SCI TE; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sha AH, 2012, MOL BIOL REP, V39, P2867, DOI 10.1007/s11033-011-1046-1; Shamimuzzaman M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-310; Skrzypczak-Jankun E, 2004, ACTA CRYSTALLOGR D, V60, P613, DOI 10.1107/S0907444904000861; Stephenson LC, 1998, PLANT PHYSIOL, V116, P923, DOI 10.1104/pp.116.3.923; Thibaud-Nissen FO, 2003, PLANT PHYSIOL, V132, P118, DOI 10.1104/pp.103.019968; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Zabala G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-177	41	98	102	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59270	10.1371/journal.pone.0059270	http://dx.doi.org/10.1371/journal.pone.0059270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555009	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800078
J	Yang, LN; Gao, FL; Shang, LP; Zhan, JS; McDonald, BA				Yang, Lina; Gao, Fangluan; Shang, Liping; Zhan, Jiasui; McDonald, Bruce A.			Association between Virulence and Triazole Tolerance in the Phytopathogenic Fungus Mycosphaerella graminicola	PLOS ONE			English	Article							MULTIPLE MECHANISMS ACCOUNT; POPULATION DIFFERENTIATION; CRYPTOCOCCUS-NEOFORMANS; QUANTITATIVE TRAITS; SEPTORIA-TRITICI; LOCAL ADAPTATION; IN-VITRO; RESISTANCE; MELANIN; EVOLUTION	Host resistance and synthetic antimicrobials such as fungicides are two of the main approaches used to control plant diseases in conventional agriculture. Although pathogens often evolve to overcome host resistance and antimicrobials, the majority of reports have involved qualitative host - pathogen interactions or antimicrobials targeting a single pathogen protein or metabolic pathway. Studies that consider jointly the evolution of virulence, defined as the degree of damage caused to a host by parasite infection, and antimicrobial resistance are rare. Here we compared virulence and fungicide tolerance in the fungal pathogen Mycosphaerella graminicola sampled from wheat fields across three continents and found a positive correlation between virulence and tolerance to a triazole fungicide. We also found that quantitative host resistance selected for higher pathogen virulence. The possible mechanisms responsible for these observations and their consequences for sustainable disease management are discussed.	[Yang, Lina; Zhan, Jiasui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Fujian, Peoples R China; [Yang, Lina; Gao, Fangluan; Shang, Liping; Zhan, Jiasui] Fujian Agr & Forestry Univ, Inst Plant Virol, Lab Plant Virol Fujian Prov, Fuzhou, Fujian, Peoples R China; [McDonald, Bruce A.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhan, JS (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Fujian, Peoples R China.	Jiasui.zhan@fafu.edu.cn	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172; Gao, Fangluan/0000-0001-9031-9944	Chinese National Science Foundation [31071655]; Swiss Federal Institute of Technology [TH-49a/02-1]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Swiss Federal Institute of Technology	The project was supported by Chinese National Science Foundation Grant no. 31071655 and Swiss Federal Institute of Technology Grant TH-49a/02-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; ANDERSSON S, 1993, BIOL J LINN SOC, V49, P185, DOI 10.1111/j.1095-8312.1993.tb00897.x; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Choi YE, 2011, APPL ENVIRON MICROB, V77, P942, DOI 10.1128/AEM.01830-10; CORDERO MJ, 1994, MOL PLANT MICROBE IN, V7, P23, DOI 10.1094/MPMI-7-0023; Cousin A, 2006, MOL PLANT PATHOL, V7, P269, DOI [10.1111/j.1364-3703.2006.00337.x, 10.1111/J.1364-3703.2006.00337.X]; Cowger C, 2002, PHYTOPATHOLOGY, V92, P624, DOI 10.1094/PHYTO.2002.92.6.624; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gisi U, 1997, PESTIC SCI, V51, P290, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;290::AID-PS637&gt;3.0.CO;2-H; GOODNIGHT CJ, 1989, AM NAT, V133, P888, DOI 10.1086/284958; Gupta A, 2008, FEMS MICROBIOL LETT, V278, P22, DOI 10.1111/j.1574-6968.2007.00937.x; Ikeda R, 2003, MICROBIOL IMMUNOL, V47, P271, DOI 10.1111/j.1348-0421.2003.tb03395.x; Janzac B, 2010, MOL PLANT MICROBE IN, V23, P823, DOI 10.1094/MPMI-23-6-0823; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Kelm C, 2012, MOL BREEDING, V29, P813, DOI 10.1007/s11032-011-9592-8; Kliebenstein DJ, 2012, ANNU REV PHYTOPATHOL, V50, P155, DOI 10.1146/annurev-phyto-081211-172950; KOJIMA KI, 1967, EVOLUTION, V21, P518, DOI [10.2307/2406613, 10.1111/j.1558-5646.1967.tb03408.x]; Kroner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023331; Lamari L, 2002, ASSESS LIMAGE ANAL S; Lannou C, 2012, ANNU REV PHYTOPATHOL, V50, P319, DOI 10.1146/annurev-phyto-081211-173031; Leroux P, 2011, PEST MANAG SCI, V67, P44, DOI 10.1002/ps.2028; Liaw SJ, 2010, INT J ANTIMICROB AG, V35, P126, DOI 10.1016/j.ijantimicag.2009.09.015; Liu X, 2010, PLANT DIS, V94, P1137, DOI 10.1094/PDIS-94-9-1137; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P389, DOI 10.1094/MPMI-19-0389; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708, DOI 10.1128/MMBR.63.3.708-724.1999; Ngamskulrungroj Popchai, 2009, Australasian Mycologist, V28, P9; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Orton ES, 2011, MOL PLANT PATHOL, V12, P413, DOI 10.1111/j.1364-3703.2010.00688.x; Ott R.L., 1992, INTRO STAT METHODS D; Palmer CL, 2002, MOL PLANT PATHOL, V3, P63, DOI 10.1046/j.1464-6722.2002.00100.x; Pariaud B, 2009, PHYTOPATHOLOGY, V99, P869, DOI 10.1094/PHYTO-99-7-0869; PINK DAC, 1992, EUPHYTICA, V63, P169, DOI 10.1007/BF00023921; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Risser P, 2011, PHYTOPATHOLOGY, V101, P1209, DOI 10.1094/PHYTO-08-10-0203; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; *SAS I INC, 1990, SAS US GUID STAT VER; SHAW MW, 1989, PLANT PATHOL, V38, P35, DOI 10.1111/j.1365-3059.1989.tb01425.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; SPITZE K, 1993, GENETICS, V135, P367; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; Taborda CP, 2008, MYCOPATHOLOGIA, V165, P331, DOI 10.1007/s11046-007-9061-4; Takuno S, 2007, GENETICS, V177, P949, DOI 10.1534/genetics.107.073825; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; Van de Wouw AP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001180; Vergne E., 2010, BMC PLANT BIOL, V10, P206, DOI DOI 10.1186/1471-2229-10-206; Wheeler M, 2000, INFECT IMMUN, V68, P3696, DOI 10.1128/IAI.68.6.3696-3703.2000; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Youngchim S, 2004, J MED MICROBIOL, V53, P175, DOI 10.1099/jmm.0.05421-0; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhan J, 2007, INT J PARASITOL, V37, P861, DOI 10.1016/j.ijpara.2007.03.003; Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI 10.1111/J.1364-3703.2006.00336.X; Zhan J, 2005, MOL ECOL, V14, P2683, DOI 10.1111/j.1365-294X.2005.02638.x; Zhan J, 2004, FUNGAL GENET BIOL, V41, P590, DOI 10.1016/j.fgb.2004.01.006; Zhan J, 1998, PHYTOPATHOLOGY, V88, P1330, DOI 10.1094/PHYTO.1998.88.12.1330; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8; Zhan J, 2002, J EVOLUTION BIOL, V15, P634, DOI 10.1046/j.1420-9101.2002.00428.x; Zhan J., 2009, POPULATION GENETICS, DOI [10.1002/9780470015902.a0021269, DOI 10.1002/9780470015902.A0021269]; Zhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038611; Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x	74	21	23	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59568	10.1371/journal.pone.0059568	http://dx.doi.org/10.1371/journal.pone.0059568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555044	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800100
J	Anders, C; Ashton, N; Ranjzad, P; Dilworth, MR; Woolf, AS				Anders, Corina; Ashton, Nick; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.			Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis	PLOS ONE			English	Article							APPARENT MINERALOCORTICOID EXCESS; STAGE RENAL-DISEASE; LOW-BIRTH-WEIGHT; AUTOSOMAL-DOMINANT; CORTISOL-LEVELS; BLOOD-PRESSURE; CYST FORMATION; ORGAN-CULTURE; MOUSE KIDNEY; IN-VITRO	Cyclic adenosine monophosphate (cAMP) drives genetic polycystic kidney disease (PKD) cystogenesis. Yet within certain PKD families, striking differences in disease severity exist between affected individuals, and genomic and/or environmental modifying factors have been evoked to explain these observations. We hypothesized that PKD cystogenesis is accentuated by an aberrant fetal milieu, specifically by glucocorticoids. The extent and nature of cystogenesis was assessed in explanted wild-type mouse embryonic metanephroi, using 8-Br-cAMP as a chemical to mimic genetic PKD and the glucocorticoid dexamethasone as the environmental modulator. Cysts and glomeruli were quantified by an observer blinded to culture conditions, and tubules were phenotyped using specific markers. Dexamethasone or 8-Br-cAMP applied on their own produced cysts predominantly arising in proximal tubules and descending limbs of loops of Henle. When applied together, however, dexamethasone over a wide concentration range synergized with 8-Br-cAMP to generate a more severe, glomerulocystic, phenotype; we note that prominent glomerular cysts have been reported in autosomal dominant PKD fetal kidneys. Our data support the idea that an adverse antenatal environment exacerbates renal cystogenesis.	[Anders, Corina; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Anders, Corina; Ranjzad, Parisa; Dilworth, Mark R.; Woolf, Adrian S.] St Marys & Manchester Childrens Hosp, Manchester, Lancs, England; [Ashton, Nick] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Anders, C (corresponding author), Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	corina.anders@manchester.ac.uk	Woolf, Adrian S./AAZ-1075-2020; Dilworth, Mark/J-6395-2015	Woolf, Adrian S./0000-0001-5541-1358; Dilworth, Mark/0000-0002-7106-7451; Ranjzad, Parisa/0000-0001-7413-4157; Ashton, Nick/0000-0003-3366-1617	Manchester Biomedical Research Centre; Medical Research Council; Kids Kidney Research	Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kids Kidney Research(Kidney Research UK (KRUK))	ASW and CA acknowledge research funding support from the Manchester Biomedical Research Centre. MRD acknowledges research funding from the Medical Research Council. ASW and PR acknowledge research funding support from Kids Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Ahrabi AK, 2010, NEPHROL DIAL TRANSPL, V25, P1067, DOI 10.1093/ndt/gfp611; Alwasel SH, 2012, PEDIATR NEPHROL, V27, P285, DOI 10.1007/s00467-011-1976-9; Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; AVNER ED, 1985, KIDNEY INT, V28, P447, DOI 10.1038/ki.1985.151; AVNER ED, 1984, LAB INVEST, V50, P208; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Bingham C, 2001, AM J HUM GENET, V68, P219, DOI 10.1086/316945; Cale CM, 1998, INT J DEV BIOL, V42, P663; Celsi G, 1998, PEDIATR RES, V44, P317, DOI 10.1203/00006450-199809000-00009; Chan SK, 2010, AM J PHYSIOL-RENAL, V298, pF346, DOI 10.1152/ajprenal.00574.2009; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Clark P, 2004, J AM SOC NEPHROL, V15, P299, DOI 10.1097/01.ASN.0000111248.23454.19; DAVIES J, 1994, DEV DYNAM, V199, P45, DOI 10.1002/aja.1001990105; DEGET F, 1995, CLIN GENET, V47, P248, DOI 10.1111/j.1399-0004.1995.tb04305.x; Dilworth MR, 2008, NEPHROL DIAL TRANSPL, V23, P871, DOI 10.1093/ndt/gfm671; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Furu L, 2003, J AM SOC NEPHROL, V14, P2004, DOI 10.1097/01.ASN.0000078805.87038.05; Gascue C, 2011, PEDIATR NEPHROL, V26, P1181, DOI 10.1007/s00467-010-1697-5; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Goilav B, 2008, PEDIATR NEPHROL, V23, P1473, DOI 10.1007/s00467-008-0851-9; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; HOYER JR, 1974, LAB INVEST, V30, P757; KAPLAN BS, 1988, AM J MED GENET, V29, P639, DOI 10.1002/ajmg.1320290323; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Magenheimer BS, 2006, J AM SOC NEPHROL, V17, P3424, DOI 10.1681/ASN.2006030295; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Marion V, 2011, KIDNEY INT, V79, P1013, DOI 10.1038/ki.2010.538; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Mears Katrina, 2004, J Obstet Gynaecol, V24, P129; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Morris RG, 2005, AM J PHYSIOL-RENAL, V289, pF194, DOI 10.1152/ajprenal.00121.2004; Moudgil A, 2000, PEDIATR NEPHROL, V15, P60, DOI 10.1007/s004670000377; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Nakanishi K, 2000, J AM SOC NEPHROL, V11, P760, DOI 10.1681/ASN.V114760; Nussey S, 2001, ENDOCRINOLOGY INTEGR; Orskov B, 2012, KIDNEY INT, V81, P919, DOI 10.1038/ki.2011.459; Potter EL, 1972, NORMAL ABNORMAL DEV, P1; REEDERS ST, 1986, LANCET, V2, P6; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Sam S, 2004, CLIN ENDOCRINOL, V60, P29, DOI 10.1111/j.1365-2265.2004.01923.x; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; Tarantal AF, 2001, KIDNEY INT, V59, P446, DOI 10.1046/j.1523-1755.2001.059002446.x; Torra R, 1997, KIDNEY INT, V52, P33, DOI 10.1038/ki.1997.300; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Welham SJM, 2005, PHYSIOL GENOMICS, V22, P48, DOI 10.1152/physiolgenomics.00167.2004; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; Winyard PJD, 1996, KIDNEY INT, V49, P135, DOI 10.1038/ki.1996.18; Woolf Adrian S, 2011, Klin Padiatr, V223 Suppl 1, pS10, DOI 10.1055/s-0030-1255876; WOOLF AS, 2009, PEDIAT NEPHROLOGY, P3; Woolf AS, 2006, HEPTINSTALLS PATHOLO, P71; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; Yang SP, 2001, AM J PATHOL, V159, P109, DOI 10.1016/S0002-9440(10)61678-1	65	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57797	10.1371/journal.pone.0057797	http://dx.doi.org/10.1371/journal.pone.0057797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554868	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500008
J	Chen, BZ; Gui, F; Xie, BG; Deng, YJ; Sun, XY; Lin, MY; Tao, YX; Li, SJ				Chen, Bingzhi; Gui, Fu; Xie, Baogui; Deng, Youjin; Sun, Xianyun; Lin, Mengying; Tao, Yongxin; Li, Shaojie			Composition and Expression of Genes Encoding Carbohydrate-Active Enzymes in the Straw-Degrading Mushroom Volvariella volvacea	PLOS ONE			English	Article							GENOME SEQUENCE; CLASSIFICATION; INSIGHTS; MECHANISMS	Volvariella volvacea is one of a few commercial cultivated mushrooms mainly using straw as carbon source. In this study, the genome of V. volcacea was sequenced and assembled. A total of 285 genes encoding carbohydrate-active enzymes (CAZymes) in V. volvacea were identified and annotated. Among 15 fungi with sequenced genomes, V. volvacea ranks seventh in the number of genes encoding CAZymes. In addition, the composition of glycoside hydrolases in V. volcacea is dramatically different from other basidiomycetes: it is particularly rich in members of the glycoside hydrolase families GH10 (hemicellulose degradation) and GH43 (hemicellulose and pectin degradation), and the lyase families PL1, PL3 and PL4 (pectin degradation) but lacks families GH5b, GH11, GH26, GH62, GH93, GH115, GH105, GH9, GH53, GH32, GH74 and CE12. Analysis of genome-wide gene expression profiles of 3 strains using 3'-tag digital gene expression (DGE) reveals that 239 CAZyme genes were expressed even in potato destrose broth medium. Our data also showed that the formation of a heterokaryotic strain could dramatically increase the expression of a number of genes which were poorly expressed in its parental homokaryotic strains.	[Chen, Bingzhi; Gui, Fu; Xie, Baogui; Deng, Youjin; Lin, Mengying; Tao, Yongxin] Fujian Agr & Forestry Univ, Mycol Res Ctr, Coll Life Sci, Fuzhou, Peoples R China; [Sun, Xianyun; Li, Shaojie] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xie, BG (corresponding author), Fujian Agr & Forestry Univ, Mycol Res Ctr, Coll Life Sci, Fuzhou, Peoples R China.	mrcfafu@163.com; shaojieli@gmail.com	sun, xianyun/AEJ-8467-2022; Li, Shaojie/AAH-2077-2020; Gui, Fu/AAG-6197-2020	Gui, Fu/0000-0001-8329-7118	China Agriculture Research System [CARS24]; Chinese Academy of Sciences	China Agriculture Research System; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by China Agriculture Research System (No. CARS24) and the grant "100 Talent Program" from the Chinese Academy of Sciences (to Shaojie Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos CJ, 1996, INTRO MYCOLOGY, P23; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; CAI YJ, 1994, MYCOL RES, V98, P1019, DOI 10.1016/S0953-7562(09)80428-0; Cai YJ, 1998, ENZYME MICROB TECH, V22, P122, DOI 10.1016/S0141-0229(97)00151-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen R, 2003, FOOD TECHNOL BIOTECH, V41, P339; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; Cone WJ, 2010, ADV ANIMAL BIOSCIENC, V1, P271, DOI [10.1017/S2040470010004140, DOI 10.1017/S2040470010004140]; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kues U, 2010, CURRENT TRENDS BIOTE, V4, P834; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wang J, 2008, BIORESOURCE TECHNOL, V99, P8524, DOI 10.1016/j.biortech.2008.03.007; Zhang JX, 2009, IND SCI DEV EDIBLE F, P40; Zhao FY, 2010, BIORESOURCE TECHNOL, V101, P6482, DOI 10.1016/j.biortech.2010.03.035; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	39	30	31	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58780	10.1371/journal.pone.0058780	http://dx.doi.org/10.1371/journal.pone.0058780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554925	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500043
J	Hardison, DR; Sunda, WG; Shea, D; Litaker, RW				Hardison, Donnie Ransom; Sunda, William G.; Shea, Damian; Litaker, Richard Wayne			Increased Toxicity of Karenia brevis during Phosphate Limited Growth: Ecological and Evolutionary Implications	PLOS ONE			English	Article							FLORIDA RED TIDE; CHEMICAL-COMPOSITION; MISSISSIPPI RIVER; NORTH-ATLANTIC; MARINE-PHYTOPLANKTON; NITROGEN LIMITATION; SODIUM-CHANNELS; HUMAN EXPOSURE; CELL-DENSITY; BREVETOXINS	Karenia brevis is the dominant toxic red tide algal species in the Gulf of Mexico. It produces potent neurotoxins (brevetoxins [PbTxs]), which negatively impact human and animal health, local economies, and ecosystem function. Field measurements have shown that cellular brevetoxin contents vary from 1-68 pg/cell but the source of this variability is uncertain. Increases in cellular toxicity caused by nutrient-limitation and inter-strain differences have been observed in many algal species. This study examined the effect of P-limitation of growth rate on cellular toxin concentrations in five Karenia brevis strains from different geographic locations. Phosphorous was selected because of evidence for regional P-limitation of algal growth in the Gulf of Mexico. Depending on the isolate, P-limited cells had 2.3- to 7.3-fold higher PbTx per cell than P-replete cells. The percent of cellular carbon associated with brevetoxins (%C-PbTx) was similar to 0.7 to 2.1% in P-replete cells, but increased to 1.6-5% under P-limitation. Because PbTxs are potent anti-grazing compounds, this increased investment in PbTxs should enhance cellular survival during periods of nutrient-limited growth. The % C-PbTx was inversely related to the specific growth rate in both the nutrient-replete and P-limited cultures of all strains. This inverse relationship is consistent with an evolutionary tradeoff between carbon investment in PbTxs and other grazing defenses, and C investment in growth and reproduction. In aquatic environments where nutrient supply and grazing pressure often vary on different temporal and spatial scales, this tradeoff would be selectively advantageous as it would result in increased net population growth rates. The variation in PbTx/cell values observed in this study can account for the range of values observed in the field, including the highest values, which are not observed under N-limitation. These results suggest P-limitation is an important factor regulating cellular toxicity and adverse impacts during at least some K. brevis blooms.	[Hardison, Donnie Ransom; Sunda, William G.; Litaker, Richard Wayne] Ctr Coastal Fisheries & Habitat Res, Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC 28516 USA; [Hardison, Donnie Ransom; Shea, Damian] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of North Carolina; North Carolina State University	Hardison, DR (corresponding author), Ctr Coastal Fisheries & Habitat Res, Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC 28516 USA.	rance.hardison@noaa.gov	Litaker, Richard Wayne/AAH-2036-2021; Shea, Damian/K-1360-2014	Litaker, Richard Wayne/0000-0001-6293-8000; Shea, Damian/0000-0003-1348-6639	National Oceanic and Atmospheric Administration (NOAA)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	This project was funded by National Oceanic and Atmospheric Administration (NOAA) program funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; ASAI S, 1984, J ALLERGY CLIN IMMUN, V73, P824, DOI 10.1016/0091-6749(84)90454-8; Backer LC, 2005, ENVIRON HEALTH PERSP, V113, P644, DOI 10.1289/ehp.7502; Backer LC, 2009, HARMFUL ALGAE, V8, P618, DOI 10.1016/j.hal.2008.11.008; Baden D.G., 2000, FOOD SCI TECHNOL N M, P505, DOI [10.1201/9780203909539.ch23, DOI 10.1201/9780203909539.CH23]; BADEN DG, 1988, TOXICON, V26, P961, DOI 10.1016/0041-0101(88)90261-9; Baker AR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018518; Bricelj VM, 2012, HARMFUL ALGAE, V16, P27, DOI 10.1016/j.hal.2012.01.001; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; BRYANT JP, 1985, ABSTR PAP AM CHEM S, V190, P91; Cheng YS, 2005, ENVIRON HEALTH PERSP, V113, P638, DOI 10.1289/ehp.7496; Cohen JH, 2007, J PLANKTON RES, V29, P301, DOI 10.1093/plankt/fbm016; DROOP MR, 1974, J MAR BIOL ASSOC UK, V54, P825, DOI 10.1017/S002531540005760X; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Echevarria M, 2012, AQUAT TOXICOL, V106, P85, DOI 10.1016/j.aquatox.2011.10.011; Flewelling LJ, 2005, NATURE, V435, P755, DOI 10.1038/nature435755a; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; Graneli E, 2006, ECOL STU AN, V189, P229, DOI 10.1007/978-3-540-32210-8_18; Hardison DR, 2012, J PHYCOL, V48, P844, DOI 10.1111/j.1529-8817.2012.01186.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Heil CA, 2007, LIMNOL OCEANOGR, V52, P1067, DOI 10.4319/lo.2007.52.3.1067; Heil DC, 2009, HARMFUL ALGAE, V8, P608, DOI 10.1016/j.hal.2008.11.007; Hill BH, 2011, WATER AIR SOIL POLL, V216, P605, DOI 10.1007/s11270-010-0556-0; Hitchcock GL, 2012, HARMFUL ALGAE, V13, P89, DOI 10.1016/j.hal.2011.10.008; Hoagland P, 2006, ECOL STU AN, V189, P391, DOI 10.1007/978-3-540-32210-8_30; Hoagland P, 2009, ENVIRON HEALTH PERSP, V117, P1239, DOI 10.1289/ehp.0900645; Hong JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036845; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Ianora A, 2011, MAR DRUGS, V9, P1625, DOI 10.3390/md9091625; Janowitz GS, 2008, CONT SHELF RES, V28, P177, DOI 10.1016/j.csr.2007.04.016; Janowitz GS, 2006, MAR ECOL PROG SER, V314, P49, DOI 10.3354/meps314049; Jickells T, 2006, BIOGEOSCI DISC, V3, P183, DOI DOI 10.5194/BGD-3-183-2006; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; Johansson N, 1999, J EXP MAR BIOL ECOL, V239, P243, DOI 10.1016/S0022-0981(99)00048-9; KELLER MD, 1988, J EXP MAR BIOL ECOL, V117, P279, DOI 10.1016/0022-0981(88)90063-9; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kirkpatrick B, 2006, HARMFUL ALGAE, V5, P526, DOI 10.1016/j.hal.2005.09.004; Kirkpatrick B, 2010, HARMFUL ALGAE, V9, P186, DOI 10.1016/j.hal.2009.09.003; Kubanek J, 2005, LIMNOL OCEANOGR, V50, P883, DOI 10.4319/lo.2005.50.3.0883; Lambers H, 2008, PLANT PHYSL ECOLOGY, P413; Landsberg JH, 2009, HARMFUL ALGAE, V8, P598, DOI 10.1016/j.hal.2008.11.010; Lekan DK, 2010, HARMFUL ALGAE, V9, P39, DOI 10.1016/j.hal.2009.07.004; Lenes JM, 2001, LIMNOL OCEANOGR, V46, P1261, DOI 10.4319/lo.2001.46.6.1261; Liu HB, 2001, J PHYCOL, V37, P500, DOI 10.1046/j.1529-8817.2001.037004500.x; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Mendoza WG, 2008, CHEMOSPHERE, V73, P1373, DOI 10.1016/j.chemosphere.2008.07.089; Mitra A, 2006, BIOL LETTERS, V2, P194, DOI 10.1098/rsbl.2006.0447; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Morgan KL, 2009, HARMFUL ALGAE, V8, P212, DOI 10.1016/j.hal.2008.05.002; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pan YL, 1996, J PHYCOL, V32, P371, DOI 10.1111/j.0022-3646.1996.00371.x; Pan Youlian, 1998, Natural Toxins, V6, P127, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<127::AID-NT9>3.3.CO;2-U; Pierce R, 2008, CONT SHELF RES, V28, P45, DOI 10.1016/j.csr.2007.04.012; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Pierce RH, 2005, HARMFUL ALGAE, V4, P965, DOI 10.1016/j.hal.2004.11.004; Plakas SM, 2010, TOXICON, V56, P137, DOI 10.1016/j.toxicon.2009.11.007; POLI MA, 1986, MOL PHARMACOL, V30, P129; Purkerson SL, 1999, NEUROTOXICOLOGY, V20, P909; Rabalais NN, 1996, ESTUARIES, V19, P386, DOI 10.2307/1352458; REDFIELD AC, 1958, AM SCI, V46, P205; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Rivera-Monroy VH, 2011, CRIT REV ENV SCI TEC, V41, P633, DOI 10.1080/10643389.2010.530907; SAKSHAUG E, 1989, LIMNOL OCEANOGR, V34, P198, DOI 10.4319/lo.1989.34.1.0198; Schaeffer BA, 2009, J PHYCOL, V45, P154, DOI 10.1111/j.1529-8817.2008.00627.x; SERRUYA C, 1975, J PHYCOL, V11, P155, DOI 10.1111/j.1529-8817.1975.tb02764.x; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Simpson TW, 2008, J ENVIRON QUAL, V37, P318, DOI 10.2134/jeq2007.0599; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Sohm JA, 2008, LIMNOL OCEANOGR, V53, P2495, DOI 10.4319/lo.2008.53.6.2495; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Sunda WG, 2010, MAR ECOL PROG SER, V401, P63, DOI 10.3354/meps08390; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sunda WG, 2007, AQUAT SCI, V69, P341, DOI 10.1007/s00027-007-0887-0; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Sylvan JB, 2006, ENVIRON SCI TECHNOL, V40, P7548, DOI 10.1021/es061417t; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Tester PA, 2008, CONT SHELF RES, V28, P59, DOI 10.1016/j.csr.2007.04.007; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; Vargo GA, 2002, HARMFUL ALGAE; Vargo GA, 2008, CONT SHELF RES, V28, P73, DOI 10.1016/j.csr.2007.04.008; Waggett RJ, 2012, MAR ECOL PROG SER, V444, P15, DOI 10.3354/meps09401; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walsh JJ, 2001, J GEOPHYS RES-OCEANS, V106, P11597, DOI 10.1029/1999JC000123; Watkins SM, 2008, MAR DRUGS, V6, P431, DOI 10.3390/md20080021; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	89	58	60	7	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58545	10.1371/journal.pone.0058545	http://dx.doi.org/10.1371/journal.pone.0058545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554901	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500029
J	Singh, A; Rahman, T; Malik, M; Hickey, AJ; Leifer, CA; Hazlett, KRO; Sellati, TJ				Singh, Anju; Rahman, Tabassum; Malik, Meenakshi; Hickey, Anthony J.; Leifer, Cynthia A.; Hazlett, Karsten R. O.; Sellati, Timothy J.			Discordant Results Obtained with Francisella tularensis during In Vitro and In Vivo Immunological Studies Are Attributable to Compromised Bacterial Structural Integrity	PLOS ONE			English	Article							RECEPTOR 2; INFLAMMATORY RESPONSES; AIM2 INFLAMMASOME; VIRULENCE FACTORS; DENDRITIC CELLS; IMMUNE-RESPONSE; CUTTING EDGE; MACROPHAGES; ACTIVATION; DNA	Francisella tularensis (Ft) is a highly infectious intracellular pathogen and the causative agent of tularemia. Because Ft can be dispersed via small droplet-aerosols and has a very low infectious dose it is characterized as a category A Select Agent of biological warfare. Respiratory infection with the attenuated Live Vaccine Strain (LVS) and the highly virulent SchuS4 strain of Ft engenders intense peribronchiolar and perivascular inflammation, but fails to elicit select pro-inflammatory mediators (e. g., TNF, IL-1 beta, IL-6, IL-12, and IFN-gamma) within the first similar to 72 h. This in vivo finding is discordant with the principally T(H)1-oriented response to Ft frequently observed in cell-based studies wherein the aforementioned cytokines are produced. An often overlooked confounding factor in the interpretation of experimental results is the influence of environmental cues on the bacterium's capacity to elicit certain host responses. Herein, we reveal that adaptation of Ft to its mammalian host imparts an inability to elicit select pro-inflammatory mediators throughout the course of infection. Furthermore, in vitro findings that non-host adapted Ft elicits such a response from host cells reflect aberrant recognition of the DNA of structurally-compromised bacteria by AIM2-dependent and -independent host cell cytosolic DNA sensors. Growth of Ft in Muller-Hinton Broth or on Muller-Hinton-based chocolate agar plates or genetic mutation of Ft was found to compromise the structural integrity of the bacterium thus rendering it capable of aberrantly eliciting pro-inflammatory mediators (e. g., TNF, IL-1 beta, IL-6, IL-12, and IFN-gamma). Our studies highlight the profound impact of different growth conditions on host cell response to infection and demonstrate that not all in vitro-derived findings may be relevant to tularemia pathogenesis in the mammalian host. Rational development of a vaccine and immunotherapeutics can only proceed from a foundation of knowledge based upon in vitro findings that recapitulate those observed during natural infection.	[Singh, Anju; Rahman, Tabassum; Malik, Meenakshi; Hickey, Anthony J.; Hazlett, Karsten R. O.; Sellati, Timothy J.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Leifer, Cynthia A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Albany Medical College; Cornell University	Sellati, TJ (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	sellatt@mail.amc.edu	Malik, Meenakshi/F-1501-2015; Sellati, Timothy/ABE-8023-2021	Malik, Meenakshi/0000-0003-0051-4485; 	US Army Research Laboratory; US Army Research Office [W911NF-11-1-0274];  [PO1AI056320];  [RO1AI075193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R01AI075193] Funding Source: NIH RePORTER	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This material is based upon work supported by, or in part by, the US Army Research Laboratory and the US Army Research Office under Contract/Grant Number W911NF-11-1-0274 and by PO1AI056320 (KROH), and PO1AI056320 and RO1AI075193 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Carlson PE, 2007, MICROB PATHOGENESIS, V42, P204, DOI 10.1016/j.micpath.2007.02.001; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cowley SC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00026; Faith SA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00126; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Lu Z, 2007, IMMUNOL LETT, V112, P92, DOI 10.1016/j.imlet.2007.07.006; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Periasamy S, 2011, J LEUKOCYTE BIOL, V90, P493, DOI 10.1189/jlb.0411197; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Ulland TK, 2010, J IMMUNOL, V185, P2670, DOI 10.4049/jimmunol.1001610; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195	32	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58513	10.1371/journal.pone.0058513	http://dx.doi.org/10.1371/journal.pone.0058513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554897	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500027
J	Vang, S; Wu, HT; Fischer, A; Miller, DH; MacLaughlan, S; Douglass, E; Steinhoff, M; Collins, C; Smith, PJS; Brard, L; Brodsky, AS				Vang, Souriya; Wu, Hsin-Ta; Fischer, Andrew; Miller, Daniel H.; MacLaughlan, Shannon; Douglass, Elijah; Steinhoff, Margaret; Collins, Colin; Smith, Peter J. S.; Brard, Laurent; Brodsky, Alexander S.			Identification of Ovarian Cancer Metastatic miRNAs	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; 3-DIMENSIONAL MODEL; MICRORNAS; TUMOR; MIR-150; TARGET; CELLS; CARCINOMA; RESISTANCE; BIOMARKERS	Serous epithelial ovarian cancer (EOC) patients often succumb to aggressive metastatic disease, yet little is known about the behavior and genetics of ovarian cancer metastasis. Here, we aim to understand how omental metastases differ from primary tumors and how these differences may influence chemotherapy. We analyzed the miRNA expression profiles of primary EOC tumors and their respective omental metastases from 9 patients using miRNA Taqman qPCR arrays. We find 17 miRNAs with differential expression in omental lesions compared to primary tumors. miR-21, miR-150, and miR-146a have low expression in most primary tumors with significantly increased expression in omental lesions, with concomitant decreased expression of predicted mRNA targets based on mRNA expression. We find that miR-150 and miR-146a mediate spheroid size. Both miR-146a and miR-150 increase the number of residual surviving cells by 2-4 fold when challenged with lethal cisplatin concentrations. These observations suggest that at least two of the miRNAs, miR-146a and miR-150, up-regulated in omental lesions, stimulate survival and increase drug tolerance. Our observations suggest that cancer cells in omental tumors express key miRNAs differently than primary tumors, and that at least some of these microRNAs may be critical regulators of the emergence of drug resistant disease.	[Vang, Souriya; Wu, Hsin-Ta; Fischer, Andrew; Miller, Daniel H.; Douglass, Elijah; Brodsky, Alexander S.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Wu, Hsin-Ta; Brodsky, Alexander S.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Brodsky, Alexander S.] Brown Univ, Ctr Genom & Prote, Providence, RI 02912 USA; [Wu, Hsin-Ta] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [MacLaughlan, Shannon] Brown Univ, Program Womens Oncol, Dept Obstet & Gynecol, Women & Infants Hosp,Alpert Med Sch, Providence, RI 02912 USA; [Steinhoff, Margaret] Brown Univ, Dept Pathol, Women & Infants Hosp, Alpert Med Sch, Providence, RI 02912 USA; [Collins, Colin] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Smith, Peter J. S.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Brard, Laurent] So Illinois Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Springfield, IL 62794 USA	Brown University; Brown University; Brown University; Brown University; Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; University of Southampton; Southern Illinois University System; Southern Illinois University	Brodsky, AS (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	alex_brodsky@brown.edu		Brard, Laurent/0000-0003-0065-1826; Smith, Peter/0000-0003-4400-6853; /0000-0002-4866-1145	Brown University Center for Computational Molecular Biology; Brown University National Center of Excellence in Women's Health; National Institutes of Health/National Center for Research Resources [5P41RR001395]; NIH [P30RR031153, P20RR0118/28, S10RR027634]; NSF [0554548]; Lifespan-Rhode Island Hospital; Division of Biology and Medicine; Brown University; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER	Brown University Center for Computational Molecular Biology; Brown University National Center of Excellence in Women's Health; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Lifespan-Rhode Island Hospital; Division of Biology and Medicine; Brown University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Brown University Center for Computational Molecular Biology, Seed award from the Brown University National Center of Excellence in Women's Health, and National Institutes of Health/National Center for Research Resources grant 5P41RR001395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christoph Schorl and the Brown University Center for Genomics and Proteomics, (partially supported by NIH grants P30RR031153, P20RR0118/28 and S10RR027634, NSF 0554548, Lifespan-Rhode Island Hospital and the Division of Biology and Medicine, and Brown University) for Affymetrix microarray processing. We thank the patients and their families for participating in this study.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Colella S, 2008, HEAD NECK-J SCI SPEC, V30, P1273, DOI 10.1002/hed.20871; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Grun B, 2009, CELL PROLIFERAT, V42, P219, DOI 10.1111/j.1365-2184.2008.00579.x; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YJ, 2011, ONCOL REP; Liu CJ, 2008, J PATHOL, V214, P489, DOI 10.1002/path.2306; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Ma Y, 2011, GUT; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Nielsen Boye Schnack, 2012, Methods Mol Biol, V822, P67, DOI 10.1007/978-1-61779-427-8_5; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Paris PL, 2006, NEOPLASIA, V8, P1083, DOI 10.1593/neo.06421; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Rahmanzadeh R, 2010, CANCER RES, V70, P9234, DOI 10.1158/0008-5472.CAN-10-1190; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rizvi I, 2010, CANCER RES, V70, P9319, DOI 10.1158/0008-5472.CAN-10-1783; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Suzuki Y, 2010, AM J PHYSIOL-HEART C, V299, pH1077, DOI 10.1152/ajpheart.00212.2010; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	52	70	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58226	10.1371/journal.pone.0058226	http://dx.doi.org/10.1371/journal.pone.0058226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554878	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000316252500017
J	Hamza, CA; Willoughby, T				Hamza, Chloe A.; Willoughby, Teena			Nonsuicidal Self-Injury and Suicidal Behavior: A Latent Class Analysis among Young Adults	PLOS ONE			English	Article							SOCIAL-ANXIETY; ADOLESCENTS; INVENTORY; DYSREGULATION; POPULATION; STATEMENTS; SYMPTOMS; CHILDREN	Although there is a general consensus among researchers that engagement in nonsuicidal self-injury (NSSI) is associated with increased risk for suicidal behavior, little attention has been given to whether suicidal risk varies among individuals engaging in NSSI. To identify individuals with a history of NSSI who are most at risk for suicidal behavior, we examined individual variability in both NSSI and suicidal behavior among a sample of young adults with a history of NSSI (N = 439 Mage = 19.1). Participants completed self-report measures assessing NSSI, suicidal behavior, and psychosocial adjustment (e.g., depressive symptoms, daily hassles). We conducted a latent class analysis using several characteristics of NSSI and suicidal behaviors as class indicators. Three subgroups of individuals were identified: 1) an infrequent NSSI/hot high risk for suicidal behavior group, 2) a frequent NSSI/not high risk for suicidal behavior group, and 3) a frequent NSSI/high risk for suicidal behavior group. Follow-up analyses indicated that individuals in the 'frequent NSSI/high risk for suicidal behavior' group met the clinical-cut off score for high suicidal risk and reported significantly greater levels of suicidal ideation attempts, and risk for future suicidal behavior as compared to the other two classes. Thus, this study is the first to identity variability in suicidal risk among individuals engaging in frequent and multiple methods of NSSI. Class 3 was also differentiated by higher levels of psychosocial impairment relative to the other two classes, as well as a comparison group of non-injuring young adults. Results underscore the importance of assessing individual differences in NSSI characteristics, as well as psychosocial impairment, when assessing risk for suicidal behavior.	[Hamza, Chloe A.; Willoughby, Teena] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada	Brock University	Hamza, CA (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada.	ch08za@brocku.ca		Hamza, Chloe/0000-0002-7402-0448	Social Sciences and Humanities Research Council of Canada [410-2011-1343]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada grant number 410-2011-1343 to Dr. Willoughby (www.sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andover MS, 2010, PSYCHIAT RES, V178, P101, DOI 10.1016/j.psychres.2010.03.019; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; Asarnow JR, 2011, J AM ACAD CHILD PSY, V50, P772, DOI 10.1016/j.jaac.2011.04.003; Barber BK, 1996, CHILD DEV, V67, P3296, DOI 10.2307/1131780; Bergman LR, 1997, DEV PSYCHOPATHOL, V9, P291, DOI 10.1017/S095457949700206X; Brausch AM, 2010, J YOUTH ADOLESCENCE, V39, P233, DOI 10.1007/s10964-009-9482-0; Briere J, 1998, AM J ORTHOPSYCHIAT, V68, P609, DOI 10.1037/h0080369; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Darche MA., 1990, PSYCHIATRIC HOSPITAL, V21, P31; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; Ginsburg GS, 1998, J ABNORM CHILD PSYCH, V26, P175, DOI 10.1023/A:1022668101048; Glenn CR, 2011, ASSESSMENT, V18, P375, DOI 10.1177/1073191111411669; Glenn CR, 2009, PERS INDIV DIFFER, V46, P25, DOI 10.1016/j.paid.2008.08.020; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gratz KL, 2002, AM J ORTHOPSYCHIAT, V72, P128, DOI 10.1037/0002-9432.72.1.128; Hamza CA, 2012, CLIN PSYCHOL REV, V32, P482, DOI 10.1016/j.cpr.2012.05.003; Heath N.L., 2008, J MENTAL HLTH COUNSE, V30, P137, DOI [DOI 10.17744/MEHC.30.2.8P879P3443514678, 10.17744/mehc.30.2.8p879p3443514678]; Heath NL, 2009, CAN J BEHAV SCI, V41, P180, DOI 10.1037/a0015732; HUIZINGA D, 1986, J QUANTITATIVE CRIMI, V0002; Jacobson CM, 2008, J CLIN CHILD ADOLESC, V37, P363, DOI 10.1080/15374410801955771; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kim SY, 2000, J FAM PSYCHOL, V14, P420, DOI 10.1037/0893-3200.14.3.420; Klonsky ED, 2008, J CONSULT CLIN PSYCH, V76, P22, DOI 10.1037/0022-006X.76.1.22; Klonsky ED, 2009, J PSYCHOPATHOL BEHAV, V31, P215, DOI 10.1007/s10862-008-9107-z; LAGRECA AM, 1993, J CLIN CHILD PSYCHOL, V22, P17, DOI 10.1207/s15374424jccp2201_2; Muehlenkamp JJ, 2011, J CHILD PSYCHOL PSYC, V52, P148, DOI 10.1111/j.1469-7610.2010.02305.x; Muris P, 2007, J INDIVID DIFFER, V28, P219; Muthen B., 2010, MPLUS USERS GUIDE; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Nock MK, 2009, UNDERSTANDING NONSUI, DOI DOI 10.1177/070674371405901101; Osman A., 2002, SUICIDE BEHAV QUESTI; Prinstein MJ, 2008, J CONSULT CLIN PSYCH, V76, P92, DOI 10.1037/0022-006X.76.1.92; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shapiro R, 1998, J ADOLESCENCE, V21, P143, DOI 10.1006/jado.1997.0138; SHEVLIN ME, 1995, PSYCHOL REP, V76, P707, DOI 10.2466/pr0.1995.76.3.707; Stats Canada, 2006, POP SEL ETHN OR; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Weinberg A, 2009, PSYCHOL ASSESSMENT, V21, P616, DOI 10.1037/a0016669; Whitlock J, 2007, ARCH PEDIAT ADOL MED, V161, P634, DOI 10.1001/archpedi.161.7.634; Whitlock J, 2006, PEDIATRICS, V117, P1939, DOI 10.1542/peds.2005-2543; Whitlock J, 2008, J CLIN CHILD ADOLESC, V37, P725, DOI 10.1080/15374410802359734; Wilcox HC, 2012, PSYCHOL MED, V42, P717, DOI 10.1017/S0033291711001814; Wilkinson P, 2011, AM J PSYCHIAT, V168, P495, DOI 10.1176/appi.ajp.2010.10050718	46	65	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59955	10.1371/journal.pone.0059955	http://dx.doi.org/10.1371/journal.pone.0059955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544113	Green Published, gold			2022-12-27	WOS:000317480700072
J	Job, ER; Bottazzi, B; Gilbertson, B; Edenborough, KM; Brown, LE; Mantovani, A; Brooks, AG; Reading, PC				Job, Emma R.; Bottazzi, Barbara; Gilbertson, Brad; Edenborough, Kathryn M.; Brown, Lorena E.; Mantovani, Alberto; Brooks, Andrew G.; Reading, Patrick C.			Serum Amyloid P Is a Sialylated Glycoprotein Inhibitor of Influenza A Viruses	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; MANNOSE-BINDING LECTIN; C-REACTIVE PROTEIN; CARBOHYDRATE-RECOGNITION DOMAIN; HEMAGGLUTININ RECEPTOR-BINDING; LONG PENTRAXIN PTX3; INNATE IMMUNITY; SIALIC ACIDS; IN-VITRO; ANTIVIRAL ACTIVITY	Members of the pentraxin family, including PTX3 and serum amyloid P component (SAP), have been reported to play a role in innate host defence against a range of microbial pathogens, yet little is known regarding their antiviral activities. In this study, we demonstrate that human SAP binds to human influenza A virus (IAV) strains and mediates a range of antiviral activities, including inhibition of IAV-induced hemagglutination (HA), neutralization of virus infectivity and inhibition of the enzymatic activity of the viral neuraminidase (NA). Characterization of the anti-IAV activity of SAP after periodate or bacterial sialidase treatment demonstrated that alpha(2,6)-linked sialic acid residues on the glycosidic moiety of SAP are critical for recognition by the HA of susceptible IAV strains. Other proteins of the innate immune system, namely human surfactant protein A and porcine surfactant protein D, have been reported to express sialylated glycans which facilitate inhibition of particular IAV strains, yet the specific viral determinants for recognition of these inhibitors have not been defined. Herein, we have selected virus mutants in the presence of human SAP and identified specific residues in the receptor-binding pocket of the viral HA which are critical for recognition and therefore susceptibility to the antiviral activities of SAP. Given the widespread expression of alpha(2,6)-linked sialic acid in the human respiratory tract, we propose that SAP may act as an effective receptor mimic to limit IAV infection of airway epithelial cells.	[Job, Emma R.; Gilbertson, Brad; Edenborough, Kathryn M.; Brown, Lorena E.; Brooks, Andrew G.; Reading, Patrick C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Bottazzi, Barbara; Mantovani, Alberto] Humanitas Clin & Res Ctr, Lab Res Immunol & Inflammat, Milan, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Reading, Patrick C.] WHO Collaborating Ctr Reference & Res Influenza, North Melbourne, Vic, Australia	University of Melbourne; University of Milan; World Health Organization	Reading, PC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	preading@unimelb.edu.au	bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022; Edenborough, Kathryn/K-2626-2019	bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; Edenborough, Kathryn/0000-0002-9598-5740; Brooks, Andrew/0000-0002-4085-9683; Brown, Lorena/0000-0001-9342-909X; Reading, Patrick/0000-0002-8860-5308; Gilbertson, Brad/0000-0001-7921-0032	National Health and Medical Research Council (NHMRC) of Australia [1032079]; Australian Government Department of Health and Ageing; European Research Council (ERC project HIIS); European Commission [FP7-HEALTH-2011-ADITEC-280873]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); European Research Council (ERC project HIIS); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Project Grant #1032079 from the National Health and Medical Research Council (NHMRC) of Australia. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The financial support of the European Research Council (ERC project HIIS) and of the European Commission (FP7-HEALTH-2011-ADITEC-280873) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; ANDERS EM, 1986, J VIROL, V60, P476, DOI 10.1128/JVI.60.2.476-482.1986; Anders EM, 1990, PNAS, V87; Andersen O, 1997, SCAND J IMMUNOL, V46, P331, DOI 10.1046/j.1365-3083.1997.d01-147.x; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BALTZ ML, 1982, BIOCHIM BIOPHYS ACTA, V701, P229, DOI 10.1016/0167-4838(82)90118-2; BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; BROWN LE, 1982, MOL IMMUNOL, V19, P329, DOI 10.1016/0161-5890(82)90347-9; Chang WC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-64; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; CORFIELD AP, 1983, BIOCHIM BIOPHYS ACTA, V744, P121, DOI 10.1016/0167-4838(83)90080-8; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Das T, 2004, GLYCOCONJUGATE J, V20, P537; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Dean MM, 2006, MOL IMMUNOL, V43, P950, DOI 10.1016/j.molimm.2005.06.023; Deban L, 2009, BIOFACTORS, V35, P138, DOI 10.1002/biof.21; DONG AC, 1994, J BIOL CHEM, V269, P6424; DWEK RA, 1993, ANNU REV BIOCHEM, V62, P65, DOI 10.1146/annurev.bi.62.070193.000433; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Farberman MM, 2010, EUR RESPIR J, V35, P410, DOI 10.1183/09031936.00020809; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gomi K, 2004, CHEST, V126, P95, DOI 10.1378/chest.126.1.95; Gottschalk A., 1972, GLYCOPROTEINS THEIR; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; HANAOKA K, 1989, J BIOL CHEM, V264, P9842; HARTLEY CA, 1992, J VIROL, V66, P4358, DOI 10.1128/JVI.66.7.4358-4363.1992; Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herbert J, 2002, MOL MED, V8, P9, DOI 10.1007/BF03401998; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Horvath A, 2001, ANTIVIR RES, V52, P43, DOI 10.1016/S0166-3542(01)00158-9; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Jambo KC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-42; Jayaraman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027517; Kase T, 1999, IMMUNOLOGY, V97, P385; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KOTTGEN E, 1992, J IMMUNOL, V149, P445; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Mikerov AN, 2008, MED MICROBIOL IMMUN, V197, P9, DOI 10.1007/s00430-007-0051-4; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Ryan-Poirier K, 1998, VIRUS RES, V56, P169, DOI 10.1016/S0168-1702(98)00067-7; Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Tate MD, 2011, MICROBES INFECT, V13, P202, DOI 10.1016/j.micinf.2010.10.004; Tecle T, 2007, ARCH VIROL, V152, P1731, DOI 10.1007/s00705-007-0983-4; Tecle T, 2008, BIOCHEM J, V412, P323, DOI 10.1042/BJ20071663; TENNENT GA, 1994, BIOCHEM SOC T, V22, P74, DOI 10.1042/bst0220074; Thompson D, 2002, J MOL BIOL, V320, P1081, DOI 10.1016/S0022-2836(02)00514-4; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; White MR, 2004, AM J PHYSIOL-LUNG C, V288, P831; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076	78	34	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59623	10.1371/journal.pone.0059623	http://dx.doi.org/10.1371/journal.pone.0059623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544079	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700039
J	Leff, JW; Fierer, N				Leff, Jonathan W.; Fierer, Noah			Bacterial Communities Associated with the Surfaces of Fresh Fruits and Vegetables	PLOS ONE			English	Article							MICROBIOLOGICAL QUALITY; DIVERSITY; SALMONELLA; MICROFLORA; ECOLOGY; UNIFRAC	Fresh fruits and vegetables can harbor large and diverse populations of bacteria. However, most of the work on produce-associated bacteria has focused on a relatively small number of pathogenic bacteria and, as a result, we know far less about the overall diversity and composition of those bacterial communities found on produce and how the structure of these communities varies across produce types. Moreover, we lack a comprehensive view of the potential effects of differing farming practices on the bacterial communities to which consumers are exposed. We addressed these knowledge gaps by assessing bacterial community structure on conventional and organic analogs of eleven store-bought produce types using a culture-independent approach, 16 S rRNA gene pyrosequencing. Our results demonstrated that the fruits and vegetables harbored diverse bacterial communities, and the communities on each produce type were significantly distinct from one another. However, certain produce types (i.e., sprouts, spinach, lettuce, tomatoes, peppers, and strawberries) tended to share more similar communities as they all had high relative abundances of taxa belonging to the family Enterobacteriaceae when compared to the other produce types (i.e., apples, peaches, grapes, and mushrooms) which were dominated by taxa belonging to the Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria phyla. Although potentially driven by factors other than farming practice, we also observed significant differences in community composition between conventional and organic analogs within produce types. These differences were often attributable to distinctions in the relative abundances of Enterobacteriaceae taxa, which were generally less abundant in organically-grown produce. Taken together, our results suggest that humans are exposed to substantially different bacteria depending on the types of fresh produce they consume with differences between conventionally and organically farmed varieties contributing to this variation.	[Leff, Jonathan W.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Fierer, N (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	Noah.Fierer@colorado.edu		FIERER, NOAH/0000-0002-6432-4261; Leff, Jonathan/0000-0003-3309-2709	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This work was supported with funding from the Alfred P. Sloan Foundation's Microbiology of the Built Environment Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadias M, 2008, INT J FOOD MICROBIOL, V123, P121, DOI 10.1016/j.ijfoodmicro.2007.12.013; Badosa E, 2008, J SCI FOOD AGR, V88, P605, DOI 10.1002/jsfa.3124; Beuchat LR, 1996, J FOOD PROTECT, V59, P204, DOI 10.4315/0362-028X-59.2.204; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; Critzer FJ, 2010, CURR OPIN BIOTECH, V21, P125, DOI 10.1016/j.copbio.2010.01.006; Dastager SG, 2009, LETT APPL MICROBIOL, V49, P20, DOI 10.1111/j.1472-765X.2009.02616.x; Enya J, 2007, MICROB ECOL, V53, P524, DOI 10.1007/s00248-006-9085-1; Fatica MK, 2011, VIRULENCE, V2, P573, DOI 10.4161/viru.2.6.17880; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flores GL, 2012, ENV MICROBI IN PRESS; Gitaitis RD, 1997, PLANT DIS, V81, P1096, DOI 10.1094/PDIS.1997.81.9.1096C; Gorley C.K., 2006, GETTING STARTED PRIM; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Granado J, 2008, MICROB ECOL, V56, P720, DOI 10.1007/s00248-008-9391-x; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Kim M, 2012, MICROB ECOL, V63, P674, DOI 10.1007/s00248-011-9953-1; KING AD, 1991, J FOOD SCI, V56, P459, DOI 10.1111/j.1365-2621.1991.tb05303.x; Kroupitski Y, 2011, FOOD MICROBIOL, V28, P990, DOI 10.1016/j.fm.2011.01.007; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Liao CS, 2001, J FOOD PROTECT, V64, P1110, DOI 10.4315/0362-028X-64.8.1110; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; NGUYENTHE C, 1994, CRIT REV FOOD SCI, V34, P371, DOI 10.1080/10408399409527668; Oliveira M, 2010, FOOD MICROBIOL, V27, P679, DOI 10.1016/j.fm.2010.03.008; Ottesen AR, 2009, J FOOD PROTECT, V72, P2321, DOI 10.4315/0362-028X-72.11.2321; Ponce AG, 2008, J FOOD SCI, V73, pM257, DOI 10.1111/j.1750-3841.2008.00789.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rudi K, 2002, APPL ENVIRON MICROB, V68, P1146, DOI 10.1128/AEM.68.3.1146-1156.2002; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Shi X, 2009, J APPL MICROBIOL, V107, P329, DOI 10.1111/j.1365-2672.2009.04211.x; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Teplitski M, 2011, TRENDS MICROBIOL, V19, P121, DOI 10.1016/j.tim.2010.11.007; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WRIGHT C, 1976, APPL ENVIRON MICROB, V31, P453, DOI 10.1128/AEM.31.3.453-454.1976; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x; Zagory D, 1999, POSTHARVEST BIOL TEC, V15, P313, DOI 10.1016/S0925-5214(98)00093-3	45	244	255	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59310	10.1371/journal.pone.0059310	http://dx.doi.org/10.1371/journal.pone.0059310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544058	gold, Green Published			2022-12-27	WOS:000317480700020
J	Sauerland, U; Gotzner, N				Sauerland, Uli; Gotzner, Nicole			Familial Sinistrals Avoid Exact Numbers	PLOS ONE			English	Article							CEREBRAL-DOMINANCE; LEFT-HANDEDNESS; LATERALITY; LANGUAGE; HANDERS; MODEL; SIZE; SEX	We report data from an Internet questionnaire of sixty number trivia. Participants were asked for the number of cups in their house, the number of cities they know and 58 other quantities. We compare the answers of familial sinistrals - individuals who are left-handed themselves or have a left-handed close blood-relative with those of pure familial dextrals - right-handed individuals who reported only having right-handed close blood-relatives. We show that familial sinistrals use rounder numbers than pure familial dextrals in the survey responses. Round numbers in the decimal system are those that are multiples of powers of 10 or of half or a quarter of a power of 10. Roundness is a gradient concept, e.g. 100 is rounder than 50 or 200. We show that very round number like 100 and 1000 are used with 25% greater likelihood by familial sinistrals than by pure familial dextrals, while pure familial dextrals are more likely to use less round numbers such as 25, 60, and 200. We then use Sigurd's (1988, Language in Society) index of the roundness of a number and report that familial sinistrals responses are significantly rounder on average than those of pure familial dextrals. To explain the difference, we propose that the cognitive effort of using exact numbers is greater for the familial sinistral group because their language and number systems tend to be more distributed over both hemispheres of the brain. Our data support the view that exact and approximate quantities are processed by two separate cognitive systems. Specifically, our behavioral data corroborates he view that the evolutionarily older, approximate number system is present in both hemispheres of the brain, while the exact number system tends to be localized in only one hemisphere.	[Sauerland, Uli] Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA; [Sauerland, Uli] Ctr Gen Linguist, Berlin, Germany; [Gotzner, Nicole] Humboldt Univ, Dept German Linguist, D-10099 Berlin, Germany	Harvard University; Leibniz Zentrum Allgemeine Sprachwissenschaft (ZAS); Humboldt University of Berlin	Sauerland, U (corresponding author), Harvard Univ, Dept Linguist, Cambridge, MA 02138 USA.	uli@alum.mit.edu		Gotzner, Nicole/0000-0002-9584-4518; Sauerland, Uli/0000-0003-2175-535X	German Science Foundation DFG [SA 925/1, SA 925/4]; Bundesministerium fur Bildung und Forschung (BMBF) [01UG0711]	German Science Foundation DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors' research was primarily funded by the German Science Foundation DFG (http://www.dfg.de) grants SA 925/1 and SA 925/4, the latter within the ESF Eurocores LogiCCC (www.esf.org/index.php?id=3241) coordinated research project VAAG. Furthermore, this work was supported in part by Bundesministerium fur Bildung und Forschung (BMBF, www.bmbf.de) (Grant Nr. 01UG0711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RJ, 1977, NEUROPSYCHOLOGIA, V15, P769, DOI 10.1016/0028-3932(77)90007-0; ANNETT M, 1990, NEUROPSYCHOLOGIA, V28, P61, DOI 10.1016/0028-3932(90)90086-4; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Broca Paul P, 1865, B SOCIETE ANTHROPOLO, V6, P377; BRYDEN MP, 1994, BRAIN COGNITION, V26, P103, DOI 10.1006/brcg.1994.1045; BRYDEN MP, 1965, NEUROPSYCHOLOGIA, V3, P1, DOI 10.1016/0028-3932(65)90015-1; Comrie B., 2005, WORLD ATLAS LANGUAGE; COWART W, 1989, J PSYCHOLINGUIST RES, V18, P89, DOI 10.1007/BF01069049; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S., 1999, NUMBER SENSE MIND CR; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HECAEN H, 1981, BRAIN LANG, V12, P261, DOI 10.1016/0093-934X(81)90018-3; Josse G, 2004, BRAIN RES REV, V44, P1, DOI 10.1016/j.brainresrev.2003.10.001; Krifka M., 2007, COGNITIVE FDN INTERP, P111; McKeever WF, 2000, LATERALITY, V5, P111, DOI 10.1080/713754367; Mckeever WF, 1995, NEUROPSYCHOLOGIA, V33, P1627, DOI 10.1016/0028-3932(95)00042-9; Nettle D, 2003, BRAIN COGNITION, V52, P390, DOI 10.1016/S0278-2626(03)00187-8; Papadatou-Pastou M, 2008, PSYCHOL BULL, V134, P677, DOI 10.1037/a0012814; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Sappington J, 2005, LATERALITY, V10, P369, DOI 10.1080/13576500442000157; SIGURD B, 1988, LANG SOC, V17, P243, DOI 10.1017/S0047404500012781; SUBIRANA A, 1958, BRAIN, V81, P415, DOI 10.1093/brain/81.3.415; Townsend DJ, 2001, BRAIN LANG, V78, P308, DOI 10.1006/brln.2001.2469; Tzourio-Mazoyer N, 2010, J NEUROSCI, V30, P13314, DOI 10.1523/JNEUROSCI.2593-10.2010; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Zolfonoun Ehsan, 2015, CLIN CHEM LAB MED, V103, P835, DOI [10.1515/ract-2015-2466, DOI 10.1515/CCLM-2022-0965]; ZURIF EB, 1969, NEUROPSYCHOLOGIA, V7, P179, DOI 10.1016/0028-3932(69)90015-3	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59103	10.1371/journal.pone.0059103	http://dx.doi.org/10.1371/journal.pone.0059103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	124QO	23544052	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700014
J	Weidner, M; Huwel, S; Ebert, F; Schwerdtle, T; Galla, HJ; Humpf, HU				Weidner, Maria; Huewel, Sabine; Ebert, Franziska; Schwerdtle, Tanja; Galla, Hans-Joachim; Humpf, Hans-Ulrich			Influence of T-2 and HT-2 Toxin on the Blood-Brain Barrier In Vitro: New Experimental Hints for Neurotoxic Effects	PLOS ONE			English	Article							OXIDATIVE STRESS; FUSARIUM TOXINS; PERMEABILITY; METABOLITES; TRANSPORT; TOXICITY; CELLS; TRICHOTHECENES; MODEL	The trichothecene mycotoxin T-2 toxin is a common contaminant of food and feed and is also present in processed cereal derived products. Cytotoxic effects of T-2 toxin and its main metabolite HT-2 toxin are already well described with apoptosis being a major mechanism of action. However, effects on the central nervous system were until now only reported rarely. In this study we investigated the effects of T-2 and HT-2 toxin on the blood-brain barrier (BBB) in vitro. Besides strong cytotoxic effects on the BBB as determined by the CCK-8 assay, impairment of the barrier function starting at low nanomolar concentrations were observed for T-2 toxin. HT-2 toxin, however, caused barrier disruption at higher concentrations compared to T-2 toxin. Further, the influence on the tight junction protein occludin was studied and permeability of both toxins across the BBB was detected when applied from the apical (blood) or the basolateral (brain) side respectively These results clearly indicate the ability of both toxins to enter the brain via the BBB.	[Weidner, Maria; Ebert, Franziska; Schwerdtle, Tanja; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, D-48149 Munster, Germany; [Huewel, Sabine; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, D-48149 Munster, Germany.	humpf@wwu.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058	German Research Foundation (DFG) [HU-730/7-2]; Brigitte and Wolfram Gedek-Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Brigitte and Wolfram Gedek-Foundation	German Research Foundation (DFG), Grant Number HU-730/7-2; Brigitte and Wolfram Gedek-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Beyer Marita, 2009, Mycotoxin Res, V25, P41, DOI 10.1007/s12550-009-0006-2; Bouaziz C, 2008, TOXICOLOGY, V254, P19, DOI 10.1016/j.tox.2008.08.020; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Chaudhary M, 2010, FOOD CHEM TOXICOL, V48, P3436, DOI 10.1016/j.fct.2010.09.018; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Doi K, 2011, INT J MOL SCI, V12, P5213, DOI 10.3390/ijms12085213; Edwards SG, 2009, FOOD ADDIT CONTAM A, V26, P1063, DOI 10.1080/02652030902788953; EFSA, 2011, EFSA J, V12; FAIRHURST S, 1987, TOXICOLOGY, V43, P31, DOI 10.1016/0300-483X(87)90072-2; Foroud NA, 2009, INT J MOL SCI, V10, P147, DOI 10.3390/ijms10010147; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Kroll S, 2009, ANN NY ACAD SCI, V1165, P228, DOI 10.1111/j.1749-6632.2009.04040.x; Li MX, 2006, TOXICOL APPL PHARM, V214, P318, DOI 10.1016/j.taap.2006.01.007; Li YS, 2011, J AGR FOOD CHEM, V59, P3441, DOI 10.1021/jf200767q; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Lohmann C, 2002, J DRUG TARGET, V10, P263, DOI 10.1080/10611860290031903; Mulac D, 2012, MOL NUTR FOOD RES, V56, P475, DOI 10.1002/mnfr.201100431; OHTA M, 1977, J BIOCHEM-TOKYO, V82, P1591, DOI 10.1093/oxfordjournals.jbchem.a131854; Ravindran J, 2011, TOXICOLOGY, V280, P44, DOI 10.1016/j.tox.2010.11.006; Rempe R, 2011, BIOCHEM BIOPH RES CO, V406, P64, DOI 10.1016/j.bbrc.2011.01.110; Schollenberger M, 2006, MYCOPATHOLOGIA, V161, P43, DOI 10.1007/s11046-005-0199-7; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; SIRKKA U, 1992, PHARMACOL TOXICOL, V70, P111, DOI 10.1111/j.1600-0773.1992.tb00438.x; Sudakin DL, 2003, TOXICOL LETT, V143, P97, DOI 10.1016/S0378-4274(03)00116-4; van der Fels-Klerx HJ, 2010, WORLD MYCOTOXIN J, V3, P349, DOI 10.3920/WMJ2010.1237; Wang J, 1998, FOOD CHEM TOXICOL, V36, P947, DOI 10.1016/S0278-6915(98)00078-7; Weidner M, 2013, CHEM RES TOXICOL, V26, P347, DOI 10.1021/tx3004664; Weidner M, 2012, J AGR FOOD CHEM, V60, P5676, DOI 10.1021/jf300634k; Wu Qinghua, 2012, Mycotoxin Res, V28, P191, DOI 10.1007/s12550-012-0134-y	36	58	59	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60484	10.1371/journal.pone.0060484	http://dx.doi.org/10.1371/journal.pone.0060484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544145	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700104
J	Tomosada, Y; Villena, J; Murata, K; Chiba, E; Shimazu, T; Aso, H; Iwabuchi, N; Xiao, J; Saito, T; Kitazawa, H				Tomosada, Yohsuke; Villena, Julio; Murata, Kozue; Chiba, Eriko; Shimazu, Tomoyuki; Aso, Hisashi; Iwabuchi, Noriyuki; Xiao, Jin-zhong; Saito, Tadao; Kitazawa, Haruki			Immunoregulatory Effect of Bifidobacteria Strains in Porcine Intestinal Epithelial Cells through Modulation of Ubiquitin-Editing Enzyme A20 Expression	PLOS ONE			English	Article							NF-KAPPA-B; NEGATIVE REGULATORS; IMMUNE-RESPONSE; GUT; INFLAMMATION; TOLL-LIKE-RECEPTOR-2; HOMEOSTASIS; ACTIVATION; INHIBITOR; SYSTEM	Background: We previously showed that evaluation of anti-inflammatory activities of lactic acid bacteria in porcine intestinal epithelial (PIE) cells is useful for selecting potentially immunobiotic strains. Objective: The aims of the present study were: i) to select potentially immunomodulatory bifidobacteria that beneficially modulate the Toll-like receptor (TLR)-4-triggered inflammatory response in PIE cells and; ii) to gain insight into the molecular mechanisms involved in the anti-inflammatory effect of immunobiotics by evaluating the role of TLR2 and TLR negative regulators in the modulation of proinflammatory cytokine production and activation of mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kappa B) pathways in PIE cells. Results: Bifidobacteria longum BB536 and B. breve M-16V strains significantly downregulated levels of interleukin (IL)-8, monocyte chemotactic protein (MCP)-1 and IL-6 in PIE cells challenged with heat-killed enterotoxigenic Escherichia coli. Moreover, BB536 and M-16V strains attenuated the proinflammatory response by modulating the NF-kappa B and MAPK pathways. In addition, our findings provide evidence for a key role for the ubiquitin-editing enzyme A20 in the anti-inflammatory effect of immunobiotic bifidobacteria in PIE cells. Conclusions: We show new data regarding the mechanism involved in the anti-inflammatory effect of immunobiotics. Several strains with immunoregulatory capabilities used a common mechanism to induce tolerance in PIE cells. Immunoregulatory strains interacted with TLR2, upregulated the expression of A20 in PIE cells, and beneficially modulated the subsequent TLR4 activation by reducing the activation of MAPK and NF-kappa B pathways and the production of proinflammatory cytokines. We also show that the combination of TLR2 activation and A20 induction can be used as biomarkers to screen and select potential immunoregulatory bifidobacteria strains.	[Tomosada, Yohsuke; Villena, Julio; Murata, Kozue; Chiba, Eriko; Saito, Tadao; Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Food & Feed Immunol Grp, Sendai, Miyagi 980, Japan; [Villena, Julio] Reference Ctr Lactobacilli CERELA CONICET, Lab Clin & Expt Biochem, San Miguel De Tucuman, Argentina; [Shimazu, Tomoyuki] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Breeding & Genet, Sendai, Miyagi 980, Japan; [Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Cell Biol Lab, Sendai, Miyagi 980, Japan; [Iwabuchi, Noriyuki; Xiao, Jin-zhong] Morinaga Milk Ind Co Ltd, Inst Food Sci & Technol, Zama, Kanagawa, Japan	Tohoku University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Tohoku University; Tohoku University; Morinaga Milk Industry Company, Ltd	Kitazawa, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Food & Feed Immunol Grp, Sendai, Miyagi 980, Japan.	haruki@bios.tohoku.ac.jp	Iwabuchi, Noriyuki/H-9139-2019	Kitazawa, Haruki/0000-0003-4586-5553	Japan Society for the Promotion of Science (JSPS) [21380164, 24380146, 23658216]; Kieikai Research Foundation; Japan Racing Association; JSPS [21-09335]; Morinaga Milk Industry Co., Ltd.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kieikai Research Foundation(Kieikai Research Foundation); Japan Racing Association(Japan Racing Association); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Morinaga Milk Industry Co., Ltd.	This study was supported by a Grant-in-Aid for Scientific Research (B)(2) (No. 21380164, 24380146) and Challenging Exploratory Research (No. 23658216) from the Japan Society for the Promotion of Science (JSPS), the Kieikai Research Foundation, and Japan Racing Association to Dr. H. Kitazawa. Dr. Julio Villena was supported by JSPS (Postdoctoral Fellowship for Foreign Researchers, Program No. 21-09335) and Morinaga Milk Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Fujie H, 2011, FEMS IMMUNOL MED MIC, V63, P129, DOI 10.1111/j.1574-695X.2011.00837.x; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Hosoya S, 2012, J MICROBIOL IN PRESS; Hosoya S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-111; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Villena J, 2012, PROBIOTICS IN PRESS; Villena J, 2012, CLIN VACCINE IMMUNOL, V19, P1038, DOI 10.1128/CVI.00199-12; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Westendorf AM, 2010, INT J MED MICROBIOL, V300, P11, DOI 10.1016/j.ijmm.2009.08.009; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; You J, 2012, FEMS IMMUNO IN PRESS; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	33	76	100	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59259	10.1371/journal.pone.0059259	http://dx.doi.org/10.1371/journal.pone.0059259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555642	Green Published, Green Submitted, gold			2022-12-27	WOS:000317418500028
J	Gaspar, JM; Thomas, WK				Gaspar, John M.; Thomas, W. Kelley			Assessing the Consequences of Denoising Marker-Based Metagenomic Data	PLOS ONE			English	Article							MICROBIAL DIVERSITY; RARE BIOSPHERE; ACCURACY; SEQUENCES; WRINKLES; QUALITY	Early marker-based metagenomic studies were performed without properly accounting for the effects of noise (sequencing errors, PCR single-base errors, and PCR chimeras). Denoising algorithms have been developed, but they were validated using data derived from mock communities, in which the true sequences were known. Since the algorithms were designed to be used in real community studies, it is important to evaluate the results in such cases. With this goal in mind, we processed a real 16S rRNA metagenomic dataset through five denoising pipelines. By reconstituting the sequence reads at each stage of the pipelines, we determined how the reads were being altered. In one denoising pipeline, AmpliconNoise, we found that the algorithm that was designed to remove pyrosequencing errors changed the reads in a manner inconsistent with the known spectrum of these errors, until one of the parameters was increased substantially from its default value. Additionally, because the longest read was picked as the representative for each cluster, sequences were added to the 39 ends of shorter reads that were often dissimilar from what had been removed by the truncations of the previous filtering step. In QIIME, the denoising algorithm caused a much larger number of changes to the reads unless the parameters were changed from their defaults. The denoising pipeline in mothur avoided some of these negative side-effects because of its strict default filtering criteria, but these criteria also greatly limited the sequence information produced at the end of the pipeline. We recommend that those using these denoising pipelines be cognizant of these issues and examine how their reads are being transformed by the denoising process as a component of their analysis.	[Gaspar, John M.; Thomas, W. Kelley] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Gaspar, JM (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	jsh58@unh.edu			NSF [DEB-1058458]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant DEB-1058458 to WKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; WILLIAMS BD, 1992, GENETICS, V131, P609	27	47	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2013	8	3							e60458	10.1371/journal.pone.0060458	http://dx.doi.org/10.1371/journal.pone.0060458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123NP	23536909	Green Published, gold, Green Submitted			2022-12-27	WOS:000317397200057
J	Braun, R; Finney, R; Yan, CH; Chen, QR; Hu, Y; Edmonson, M; Meerzaman, D; Buetow, K				Braun, Rosemary; Finney, Richard; Yan, Chunhua; Chen, Qing-Rong; Hu, Ying; Edmonson, Michael; Meerzaman, Daoud; Buetow, Kenneth			Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer Patients	PLOS ONE			English	Article							GENE-EXPRESSION; PLATINUM COMPLEXES; TUMOR RESPONSE; BREAST-CANCER; CHEMOTHERAPY; CARCINOMA; SUSCEPTIBILITY; VARIANTS; POLYMORPHISMS; PREDICTION	Background: Ovarian cancer remains a significant public health burden, with the highest mortality rate of all the gynecological cancers. This is attributable to the late stage at which the majority of ovarian cancers are diagnosed, coupled with the low and variable response of advanced tumors to standard chemotherapies. To date, clinically useful predictors of treatment response remain lacking. Identifying the genetic determinants of ovarian cancer survival and treatment response is crucial to the development of prognostic biomarkers and personalized therapies that may improve outcomes for the late-stage patients who comprise the majority of cases. Methods: To identify constitutional genetic variations contributing to ovarian cancer mortality, we systematically investigated associations between germline polymorphisms and ovarian cancer survival using data from The Cancer Genome Atlas Project (TCGA). Using stage-stratified Cox proportional hazards regression, we examined >650,000 SNP loci for association with survival. We additionally examined whether the association of significant SNPs with survival was modified by somatic alterations. Results: Germline polymorphisms at rs4934282 (AGAP11/C10orf116) and rs1857623 (DNAH14) were associated with stage-adjusted survival (p = 1.12e-07 and 1.80e-07, FDR q = 1.2e-04 and 2.4e-04, respectively). A third SNP, rs4869 (C10orf116), was additionally identified as significant in the exome sequencing data; it is in near-perfect LD with rs4934282. The associations with survival remained significant when somatic alterations. Conclusions: Discovery analysis of TCGA data reveals germline genetic variations that may play a role in ovarian cancer survival even among late-stage cases. The significant loci are located near genes previously reported as having a possible relationship to platinum and taxol response. Because the variant alleles at the significant loci are common (frequencies for rs4934282 A/C alleles = 0.54/0.46, respectively; rs1857623 A/G alleles = 0.55/0.45, respectively) and germline variants can be assayed noninvasively, our findings provide potential targets for further exploration as prognostic biomarkers and individualized therapies.	[Braun, Rosemary] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Braun, Rosemary; Finney, Richard; Yan, Chunhua; Chen, Qing-Rong; Hu, Ying; Edmonson, Michael; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Biomed Informat & Informat Technol, NIH, Bethesda, MD 20892 USA; [Buetow, Kenneth] Arizona State Univ, Computat Sci & Informat Program, Complex Adapt Syst Initiat, Phoenix, AZ USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Arizona State University; Arizona State University-Downtown Phoenix	Braun, R (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	rbraun@northwestern.edu	sun, lingdong/AAJ-8058-2020	sun, lingdong/0000-0002-4657-0346; Braun, Rosemary/0000-0001-9668-9866	National Cancer Institute, United States National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE [K22CA148779] Funding Source: NIH RePORTER	National Cancer Institute, United States National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported by the Intramural Research Program of the National Cancer Institute, United States National Institutes of Health, Bethesda, MD. There were no external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON K, 1991, NEUROLOGY, V41, P1800, DOI 10.1212/WNL.41.11.1800; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Aulchenko YS, 2007, GENABEL R LIB GENOME; Bartel F, 2008, CLIN CANCER RES, V14, P89, DOI 10.1158/1078-0432.CCR-07-1192; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKLEDGE G, 1989, BRIT J CANCER, V59, P650, DOI 10.1038/bjc.1989.132; Bolton KL, 2012, J INTERN MED, V271, P366, DOI 10.1111/j.1365-2796.2011.02509.x; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chang H, 2010, J CANCER RES CLIN, V136, P1901, DOI 10.1007/s00432-010-0849-0; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Fasching PA, 2009, MOL ONCOL, V3, P171, DOI 10.1016/j.molonc.2009.01.008; Fernandez-Ramires R, 2009, BRIT J CANCER, V101, P1469, DOI 10.1038/sj.bjc.6605275; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Han CH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-5; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Howlader N, 2011, SEER CANC STAT REV 1; Huang R, 2011, CLIN CANC RES; Indermaur MD, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.003; Jakupec MA, 2003, REV PHYSIOL BIOCH P, V146, P1, DOI 10.1007/s10254-002-0001-x; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kang HC, 2004, CLIN CANCER RES, V10, P272, DOI 10.1158/1078-0432.CCR-1025-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marsh S, 2007, J CLIN ONCOL, V25, P4528, DOI 10.1200/JCO.2006.10.4752; Matsuo K, 2010, AM J CLIN ONCOL-CANC, V33, P358, DOI 10.1097/COC.0b013e3181af30d3; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nikas JB, 2011, CANCER INFORM, V10, P233, DOI 10.4137/CIN.S8104; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rose PG, 2010, GYNECOL ONCOL, V117, P324, DOI 10.1016/j.ygyno.2010.01.040; Sano H, 2012, BREAST CANCER-TOKYO, V19, P37, DOI 10.1007/s12282-011-0263-8; Skubitz APN, 2006, TRANSL RES, V148, P223, DOI 10.1016/j.trsl.2006.06.001; TCGA, 2011, RES PUBL HER AR WHOL; Therneau T, 2011, SURVIVAL SURVIVAL AN; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang XY, 2010, ANTI-CANCER AGENT ME, V10, P396, DOI 10.2174/1871520611009050396; Zhang J, 2007, GENOME RES, V17, P1111, DOI 10.1101/gr.5963407; Ziliak D, 2012, MOL CANCER THER, V11, P2054, DOI 10.1158/1535-7163.MCT-12-0221	46	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e55037	10.1371/journal.pone.0055037	http://dx.doi.org/10.1371/journal.pone.0055037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555554	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400001
J	Iancu, OD; Oberbeck, D; Darakjian, P; Kawane, S; Erk, J; McWeeney, S; Hitzemann, R				Iancu, Ovidiu D.; Oberbeck, Denesa; Darakjian, Priscila; Kawane, Sunita; Erk, Jason; McWeeney, Shannon; Hitzemann, Robert			Differential Network Analysis Reveals Genetic Effects on Catalepsy Modules	PLOS ONE			English	Article							HALOPERIDOL-INDUCED CATALEPSY; QUANTITATIVE TRAIT LOCI; FALSE DISCOVERY RATE; COMBINATORIAL-CONTROL; MOUSE; EXPRESSION; MICE; TRANSCRIPTOME; DISEASE; IDENTIFICATION	We performed short-term bi-directional selective breeding for haloperidol-induced catalepsy, starting from three mouse populations of increasingly complex genetic structure: an F-2 intercross, a heterogeneous stock (HS) formed by crossing four inbred strains (HS4) and a heterogeneous stock (HS-CC) formed from the inbred strain founders of the Collaborative Cross (CC). All three selections were successful, with large differences in haloperidol response emerging within three generations. Using a custom differential network analysis procedure, we found that gene coexpression patterns changed significantly; importantly, a number of these changes were concordant across genetic backgrounds. In contrast, absolute geneexpression changes were modest and not concordant across genetic backgrounds, in spite of the large and similar phenotypic differences. By inferring strain contributions from the parental lines, we are able to identify significant differences in allelic content between the selected lines concurrent with large changes in transcript connectivity. Importantly, this observation implies that genetic polymorphisms can affect transcript and module connectivity without large changes in absolute expression levels. We conclude that, in this case, selective breeding acts at the subnetwork level, with the same modules but not the same transcripts affected across the three selections.	[Iancu, Ovidiu D.; Oberbeck, Denesa; Erk, Jason; Hitzemann, Robert] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Darakjian, Priscila; Kawane, Sunita; McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Biostat Publ Hlth & Preventat Med, Portland, OR 97201 USA; [Hitzemann, Robert] Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Res Serv, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Iancu, OD (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	iancuo@ohsu.edu		McWeeney, Shannon/0000-0001-8333-6607	Veterans Affairs Research Service;  [MH 51372];  [DA 005228]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005228] Funding Source: NIH RePORTER	Veterans Affairs Research Service(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by MH 51372, DA 005228, and the Veterans Affairs Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Bailly-Bechet M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-355; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Belknap JK, 1997, BEHAV GENET, V27, P55, DOI 10.1023/A:1025615409383; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorklund A, 2010, PROG BRAIN RES, V184, P53, DOI 10.1016/S0079-6123(10)84004-X; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Delic S, 2008, GENES BRAIN BEHAV, V7, P821, DOI 10.1111/j.1601-183X.2008.00412.x; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; Dorval Veronique, 2012, Front Neurol, V3, P12, DOI 10.3389/fneur.2012.00012; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EXCOFFIER L, 1992, GENETICS, V131, P479; Farber CR, 2010, J BONE MINER RES, V25, P2359, DOI 10.1002/jbmr.138; French CA, 2011, MOL PSYCHIAT; Hitzemann R, 1995, INT REV NEUROBIOL, V38, P43, DOI 10.1016/S0074-7742(08)60524-3; Hitzemann R, 2000, ALCOHOL RES HEALTH, V24, P149; Hofstetter JR, 2008, GENES BRAIN BEHAV, V7, P214, DOI 10.1111/j.1601-183X.2007.00340.x; Iancu OD, 2012, GENES BRAIN BEHAV, V11, P29, DOI 10.1111/j.1601-183X.2011.00736.x; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Kanes S, 1996, J PHARMACOL EXP THER, V277, P1016; KANES SJ, 1993, J PHARMACOL EXP THER, V267, P538; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keum JW, 2009, BIOTECHNOL BIOENG, V102, P577, DOI 10.1002/bit.22081; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Moretti R, 2008, BIOCHIMIE, V90, P1015, DOI 10.1016/j.biochi.2008.02.014; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mozhui K, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.24; Muers M, 2011, NAT REV GENET, V12, DOI [10.1038/nrg3059, 10.1038/nrg3058]; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nishi A, 2010, J PHARMACOL SCI, V114, P6, DOI 10.1254/jphs.10R01FM; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Patel NV, 1999, BEHAV GENET, V29, P303, DOI 10.1023/A:1021653732147; QIAN YF, 1993, J PHARMACOL EXP THER, V267, P1582; QIAN YF, 1992, J PHARMACOL EXP THER, V261, P341; Rasmussen E, 1999, J PHARMACOL EXP THER, V290, P1337; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Vadasz C, 2007, NEUROSCIENCE, V149, P561, DOI 10.1016/j.neuroscience.2007.06.049; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	56	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58951	10.1371/journal.pone.0058951	http://dx.doi.org/10.1371/journal.pone.0058951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555609	Green Submitted, Green Published, gold			2022-12-27	WOS:000316546400016
J	Liu, TY; Sanders, JL; Tsui, FC; Espino, JU; Dato, VM; Suyama, J				Liu, Timothy Y.; Sanders, Jason L.; Tsui, Fu-Chiang; Espino, Jeremy U.; Dato, Virginia M.; Suyama, Joe			Association of Over-The-Counter Pharmaceutical Sales with Influenza-Like-Illnesses to Patient Volume in an Urgent Care Setting	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; EMERGENCY; OUTBREAKS; VISITS	We studied the association between OTC pharmaceutical sales and volume of patients with influenza-like-illnesses (ILI) at an urgent care center over one year. OTC pharmaceutical sales explain 36% of the variance in the patient volume, and each standard deviation increase is associated with 4.7 more patient visits to the urgent care center (p<0.0001). Cross-correlation function analysis demonstrated that OTC pharmaceutical sales are significantly associated with patient volume during non-flu season (p<0.0001), but only the sales of cough and cold (p<0.0001) and thermometer (p<0.0001) categories were significant during flu season with a lag of two and one days, respectively. Our study is the first study to demonstrate and measure the relationship between OTC pharmaceutical sales and urgent care center patient volume, and presents strong evidence that OTC sales predict urgent care center patient volume year round.	[Liu, Timothy Y.; Sanders, Jason L.; Tsui, Fu-Chiang; Espino, Jeremy U.; Dato, Virginia M.; Suyama, Joe] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Tsui, Fu-Chiang; Espino, Jeremy U.] Real Time Outbreak & Dis Surveillance Lab, Pittsburgh, PA USA; [Suyama, Joe] Univ Pittsburgh, Med Ctr Urgent Care Shadyside, Pittsburgh, PA USA; [Dato, Virginia M.] Penn Dept Hlth, Harrisburg, PA 17108 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Suyama, J (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	suyamaj@upmc.edu						Batal H, 2001, ACAD EMERG MED, V8, P48, DOI 10.1111/j.1553-2712.2001.tb00550.x; *CDC, 1998, PREV EM INF DIS STRA, P12380; Das Debjani, 2005, MMWR Suppl, V54, P41; Edge VL, 2004, CAN J PUBLIC HEALTH, V95, P446, DOI 10.1007/BF03403991; Espino JU, 2001, J AM MED INFORM ASSN, P164; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hogan WR, 2003, J AM MED INFORM ASSN, V10, P555, DOI 10.1197/jamia.M1377; Holleman DR, 1996, J GEN INTERN MED, V11, P237, DOI 10.1007/BF02642481; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Magruder SF, 2003, J HOPKINS APL TECH D, V24, P349; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; McIsaac WJ, 1998, J FAM PRACTICE, V47, P366; Metzger Kristina B, 2004, MMWR Suppl, V53, P106; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Naphade M, 2004, SCI ENG BIOL INFORM, V2, P143; Salisbury C, 2003, BRIT J GEN PRACT, V53, P53; Schappert Susan M, 2011, Vital Health Stat 13, P1; Suyama J, 2003, ACAD EMERG MED, V10, P753, DOI 10.1111/j.1553-2712.2003.tb00070.x; Urgent Care Association of America, 2009, URG CAR IND INF KIT; Wagner Michael M, 2004, MMWR Suppl, V53, P40; Wagner MM, 2003, J AM MED INFORM ASSN, V10, P409, DOI 10.1197/jamia.M1357; Wagner MM, 2004, HDB BIOSURVEILLANCE; Wargon M, 2009, EMERG MED J, V26, P395, DOI 10.1136/emj.2008.062380; Zeng XM, 2001, J AM MED INFORM ASSN, P781	27	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59273	10.1371/journal.pone.0059273	http://dx.doi.org/10.1371/journal.pone.0059273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	111UM	23555647	Green Published, Green Accepted, gold			2022-12-27	WOS:000316546400030
J	Costessi, L; Porro, F; Iaconcig, A; Nedeljkovic, M; Muro, AF				Costessi, Luisa; Porro, Fabiola; Iaconcig, Alessandra; Nedeljkovic, Mirjana; Muro, Andres Fernando			Characterization of the Distal Polyadenylation Site of the beta-Adducin (Add2) Pre-mRNA	PLOS ONE			English	Article							UPSTREAM-SEQUENCE-ELEMENT; 3' UNTRANSLATED REGIONS; NUCLEAR FACTOR TDP-43; ALTERNATIVE POLYADENYLATION; EFFICIENT POLYADENYLATION; PROCESSING EFFICIENCY; SYNAPTIC PLASTICITY; FACTOR CSTF-64; FACTOR-I; PROTEIN	Most genes have multiple polyadenylation sites (PAS), which are often selected in a tissue-specific manner, altering protein products and affecting mRNA stability, subcellular localization and/or translability. Here we studied the polyadenylation mechanisms associated to the beta-adducin gene (Add2). We have previously shown that the Add2 gene has a very tight regulation of alternative polyadenylation, using proximal PAS in erythroid tissues, and a distal one in brain. Using chimeric minigenes and cell transfections we identified the core elements responsible for polyadenylation at the distal PAS. Deletion of either the hexanucleotide motif (Hm) or the downstream element (DSE) resulted in reduction of mature mRNA levels and activation of cryptic PAS, suggesting an important role for the DSE in polyadenylation of the distal Add2 PAS. Point mutation of the UG repeats present in the DSE, located immediately after the cleavage site, resulted in a reduction of processed mRNA and in the activation of the same cryptic site. RNA-EMSA showed that this region is active in forming RNA-protein complexes. Competition experiments showed that RNA lacking the DSE was not able to compete the RNA-protein complexes, supporting the hypothesis of an essential important role for the DSE. Next, using a RNA-pull down approach we identified some of the proteins bound to the DSE. Among these proteins we found PTB, TDP-43, FBP1 and FBP2, nucleolin, RNA helicase A and vigilin. All these proteins have a role in RNA metabolism, but only PTB has a reported function in polyadenylation. Additional experiments are needed to determine the precise functional role of these proteins in Add2 polyadenylation.	[Costessi, Luisa; Porro, Fabiola; Iaconcig, Alessandra; Nedeljkovic, Mirjana; Muro, Andres Fernando] ICGEB, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Muro, AF (corresponding author), ICGEB, Trieste, Italy.	muro@icgeb.org	Muro, Andrés F/K-3156-2016	Muro, Andrés F/0000-0002-9628-0494	ICGEB	ICGEB	This work was supported by ICGEB intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; BROWN PH, 1991, J VIROL, V65, P3340, DOI 10.1128/JVI.65.6.3340-3343.1991; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; CARSWELL S, 1989, MOL CELL BIOL, V9, P4248, DOI 10.1128/MCB.9.10.4248; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Chen F, 1998, NUCLEIC ACIDS RES, V26, P2891, DOI 10.1093/nar/26.12.2891; Costessi L, 2006, NUCLEIC ACIDS RES, V34, P243, DOI 10.1093/nar/gkj425; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; Danckwardt S, 2007, EMBO J, V26, P2658, DOI 10.1038/sj.emboj.7601699; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; Darmon SK, 2012, RNA BIOL, V9, P1255, DOI 10.4161/rna.21957; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kruse C, 2000, BIOCHEM J, V346, P107, DOI 10.1042/0264-6021:3460107; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; Lou H, 1999, MOL CELL BIOL, V19, P78; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Millevoi S, 2009, NUCLEIC ACIDS RES, V37, P4672, DOI 10.1093/nar/gkp470; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522; Morgan M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-708; Muro AF, 2000, BLOOD, V95, P3978; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Pielage J, 2011, NEURON, V69, P1114, DOI 10.1016/j.neuron.2011.02.007; Porro F, 2010, GENES BRAIN BEHAV, V9, P84, DOI 10.1111/j.1601-183X.2009.00537.x; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SEIDEL B, 1995, BRAIN RES, V700, P13, DOI 10.1016/0006-8993(95)00962-P; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TRIPODI G, 1991, BIOCHEM BIOPH RES CO, V177, P939, DOI 10.1016/0006-291X(91)90629-L; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; VALSAMAKIS A, 1991, P NATL ACAD SCI USA, V88, P2108, DOI 10.1073/pnas.88.6.2108; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; VIBEPEDERSEN K, 1984, EMBO J, V3, P2511, DOI 10.1002/j.1460-2075.1984.tb02165.x; Woo HH, 2011, MOL CELL BIOL, V31, P215, DOI 10.1128/MCB.01031-10; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109	72	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58879	10.1371/journal.pone.0058879	http://dx.doi.org/10.1371/journal.pone.0058879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554949	Green Submitted, Green Published, gold			2022-12-27	WOS:000316409800043
J	De Meyer, T; Mampaey, E; Vlemmix, M; Denil, S; Trooskens, G; Renard, JP; De Keulenaer, S; Dehan, P; Menschaert, G; Van Criekinge, W				De Meyer, Tim; Mampaey, Evi; Vlemmix, Michael; Denil, Simon; Trooskens, Geert; Renard, Jean-Pierre; De Keulenaer, Sarah; Dehan, Pierre; Menschaert, Gerben; Van Criekinge, Wim			Quality Evaluation of Methyl Binding Domain Based Kits for Enrichment DNA-Methylation Sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; GENOME; WIDE; EPIGENETICS; MICROARRAY; SITES	DNA-methylation is an important epigenetic feature in health and disease. Methylated sequence capturing by Methyl Binding Domain (MBD) based enrichment followed by second-generation sequencing provides the best combination of sensitivity and cost-efficiency for genome-wide DNA-methylation profiling. However, existing implementations are numerous, and quality control and optimization require expensive external validation. Therefore, this study has two aims: 1) to identify a best performing kit for MBD-based enrichment using independent validation data, and 2) to evaluate whether quality evaluation can also be performed solely based on the characteristics of the generated sequences. Five commercially available kits for MBD enrichment were combined with Illumina GAIIx sequencing for three cell lines (HCT15, DU145, PC3). Reduced representation bisulfite sequencing data (all three cell lines) and publicly available Illumina Infinium BeadChip data (DU145 and PC3) were used for benchmarking. Consistent large-scale differences in yield, sensitivity and specificity between the different kits could be identified, with Diagenode's MethylCap kit as overall best performing kit under the tested conditions. This kit could also be identified with the Fragment CpG-plot, which summarizes the CpG content of the captured fragments, implying that the latter can be used as a tool to monitor data quality. In conclusion, there are major quality differences between kits for MBD-based capturing of methylated DNA, with the MethylCap kit performing best under the used settings. The Fragment CpG-plot is able to monitor data quality based on inherent sequence data characteristics, and is therefore a cost-efficient tool for experimental optimization, but also to monitor quality throughout routine applications.	[De Meyer, Tim; Vlemmix, Michael; Denil, Simon; Trooskens, Geert; Renard, Jean-Pierre; De Keulenaer, Sarah; Menschaert, Gerben; Van Criekinge, Wim] Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium; [Mampaey, Evi] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium; [Renard, Jean-Pierre; Van Criekinge, Wim] MDX Hlth SA, Ghent, Belgium; [Dehan, Pierre] Univ Liege, Dept Expt Pathol, Liege, Belgium	Ghent University; Ghent University; University of Liege	De Meyer, T (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium.	Tim.DeMeyer@ugent.be	De Meyer, Tim/D-3892-2011	De Meyer, Tim/0000-0003-2994-9693; Menschaert, Gerben/0000-0002-7575-2085	MDX Health; N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University)	MDX Health; N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University)	MDX Health partially funded this study to improve their own experimental procedures with the generated knowledge. TDM wants to acknowledge and is funded on the N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership (Special Research Fund Ghent University). The study was designed in collaboration with MDX Health. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Burgoon LD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni167; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim YJ, 2011, CLIN CANCER RES, V17, P4523, DOI 10.1158/1078-0432.CCR-10-2817; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Vener T, 2008, CLIN CHEM, V54, P874, DOI 10.1373/clinchem.2007.094912; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Yang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-10	30	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59068	10.1371/journal.pone.0059068	http://dx.doi.org/10.1371/journal.pone.0059068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554971	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800053
J	He, HQ; Genovese, KJ; Swaggerty, CL; Nisbet, DJ; Kogut, MH				He, Haiqi; Genovese, Kenneth J.; Swaggerty, Christina L.; Nisbet, David J.; Kogut, Michael H.			Nitric Oxide as a Biomarker of Intracellular Salmonella Viability and Identification of the Bacteriostatic Activity of Protein Kinase A Inhibitor H-89	PLOS ONE			English	Article							PHOSPHOTHREONINE LYASE; PATHOGENICITY ISLAND-2; HOST; ENTERITIDIS; MACROPHAGES; ACTIVATION; RESPONSES; EFFECTOR; SURVIVAL; CHICKEN	Salmonella enterica serovar Enteritidis is one of the most prevalent Salmonella serovars in poultry and is often associated with human salmonellosis. S. Enteritidis is known to suppress nitric oxide (NO) production in infected chicken macrophage HD11 cells, while dead S. Enteritidis stimulates a high level of NO production, suggesting a bacterial inhibitory effect on NO production. Based on these observations, the present study was conducted to evaluate whether NO production in S. Enteritidis-infected HD11 cells can be used as a biomarker to identify molecules that kill intracellular Salmonella. Since Salmonella are known to manipulate the host cell kinase network to facilitate intracellular survival, we screened a group of pharmaceutical inhibitors of various kinases to test our hypothesis. A protein kinase A inhibitor, H-89, was found to reverse the suppression of NO production in S. Enteritidis-infected HD11 cells. Production of NO in S. Enteritidis-infected HD11 cells increased significantly following treatment with H-89 at or above 20 mu M. Inversely, the number of viable intracellular Salmonella decreased significantly in cells treated with H-89 at or above 30 mM. Furthermore, the growth rate of S. Enteritidis in culture was significantly inhibited by H-89 at concentrations from 20 to 100 mM. Our results demonstrate that NO-based screening using S. Enteritidis-infected HD11 cells is a viable tool to identify chemicals with anti-intracellular Salmonella activity. Using this method, we have shown H-89 has bacteriostatic activity against Salmonella, independent of host cell protein kinase A or Akt1 activity.	[He, Haiqi; Genovese, Kenneth J.; Swaggerty, Christina L.; Nisbet, David J.; Kogut, Michael H.] USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA	United States Department of Agriculture (USDA)	He, HQ (corresponding author), USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA.	haiqi.he@ars.usda.gov	Kogut, Michael H./Z-3119-2019	Kogut, Michael/0000-0001-5821-3728	USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported only by USDA-ARS intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Alam MS, 2008, MICROBIOL IMMUNOL, V52, P197, DOI 10.1111/j.1348-0421.2008.00030.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; Babu US, 2006, DEV COMP IMMUNOL, V30, P942, DOI 10.1016/j.dci.2005.12.001; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; *CDC, 2008, SALM SURV ANN SUMM 2; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cooper KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022260; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; FDA, 2010, NAT ANT RES MON SYST; Foley S L, 2008, J Anim Sci, V86, pE173; Gantois I, 2008, AVIAN PATHOL, V37, P399, DOI 10.1080/03079450802216611; Gast PK, 2004, AVIAN DIS, V48, P863, DOI 10.1637/7204-05050R; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Haneda T, 2012, CELL MICROBIOL, V14, P485, DOI 10.1111/j.1462-5822.2011.01733.x; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; He HQ, 2012, FOODBORNE PATHOG DIS, V9, P1104, DOI 10.1089/fpd.2012.1233; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; KOGUT MH, 1995, J LEUKOCYTE BIOL, V57, P56, DOI 10.1002/jlb.57.1.56; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lathers CM, 2001, J CLIN PHARMACOL, V41, P595, DOI 10.1177/00912700122010474; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malik-Kale P, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00125; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0; Okamura M, 2005, VET IMMUNOL IMMUNOP, V107, P327, DOI 10.1016/j.vetimm.2005.05.009; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Rogers LD, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001668; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; Withanage GSK, 2005, BRIT POULTRY SCI, V46, P261, DOI 10.1080/00071660500098608; Wu HX, 2012, CELL MICROBIOL, V14, P28, DOI 10.1111/j.1462-5822.2011.01694.x	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58873	10.1371/journal.pone.0058873	http://dx.doi.org/10.1371/journal.pone.0058873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554945	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800041
J	Mallez, S; Castagnone, C; Espada, M; Vieira, P; Eisenback, JD; Mota, M; Guillemaud, T; Castagnone-Sereno, P				Mallez, Sophie; Castagnone, Chantal; Espada, Margarida; Vieira, Paulo; Eisenback, Jonathan D.; Mota, Manuel; Guillemaud, Thomas; Castagnone-Sereno, Philippe			First Insights into the Genetic Diversity of the Pinewood Nematode in Its Native Area Using New Polymorphic Microsatellite Loci	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; APPROXIMATE BAYESIAN COMPUTATION; WILT DISEASE; POPULATION-STRUCTURE; WOOD NEMATODE; UNITED-STATES; DNA; COLEOPTERA; APHELENCHOIDIDAE; IDENTIFICATION	The pinewood nematode, Bursaphelenchus xylophilus, native to North America, is the causative agent of pine wilt disease and among the most important invasive forest pests in the East-Asian countries, such as Japan and China. Since 1999, it has been found in Europe in the Iberian Peninsula, where it also causes significant damage. In a previous study, 94 pairs of microsatellite primers have been identified in silico in the pinewood nematode genome. In the present study, specific PCR amplifications and polymorphism tests to validate these loci were performed and 17 microsatellite loci that were suitable for routine analysis of B. xylophilus genetic diversity were selected. The polymorphism of these markers was evaluated on nematodes from four field origins and one laboratory collection strain, all originate from the native area. The number of alleles and the expected heterozygosity varied between 2 and 11 and between 0.039 and 0.777, respectively. First insights into the population genetic structure of B. xylophilus were obtained using clustering and multivariate methods on the genotypes obtained from the field samples. The results showed that the pinewood nematode genetic diversity is spatially structured at the scale of the pine tree and probably at larger scales. The role of dispersal by the insect vector versus human activities in shaping this structure is discussed.	[Mallez, Sophie; Guillemaud, Thomas] INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Castagnone-Sereno, Philippe] INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Interact Plantes Nematodes, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Guillemaud, Thomas; Castagnone-Sereno, Philippe] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Mallez, Sophie; Castagnone, Chantal; Guillemaud, Thomas; Castagnone-Sereno, Philippe] CNRS, UMR 7254 Inst Sophia Agrobiotech, Sophia Antipolis, France; [Espada, Margarida; Vieira, Paulo; Mota, Manuel] Univ Evora Nucl Mitra, Inst Ciencias Agr & Ambientais Mediterra, NemaLab ICAAM, Evora, Portugal; [Eisenback, Jonathan D.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Evora; Virginia Polytechnic Institute & State University	Mallez, S (corresponding author), INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France.	sophie.mallez@sophia.inra.fr	Vieira, Paulo/I-7173-2019; Mota, Manuel/G-6031-2019; guillemaud, thomas/B-4899-2012	Vieira, Paulo/0000-0001-5627-2628; Mota, Manuel/0000-0002-4145-5031; guillemaud, thomas/0000-0003-0451-1644; Espada, Margarida/0000-0002-3826-711X	European Union [KBBE.2010.1.4-09 REPHRAME]	European Union(European Commission)	This work was supported by a grant from European Union (KBBE.2010.1.4-09 REPHRAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K, 1996, 5000 CNRS UMR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; DROPKIN VH, 1981, PLANT DIS, V65, P1022, DOI 10.1094/PD-65-1022; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans HF, 1996, OEPP EPPO B, V26, P199; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; He Y, 2003, NEMATOLOGY, V5, P809, DOI 10.1163/156854103773040718; Hunt D. J., 2007, Journal of Nematode Morphology and Systematics, V10, P99; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jung J, 2010, ANIM CELLS SYST, V14, P31, DOI 10.1080/19768351003770889; Jung J, 2010, GENES GENOM, V32, P151, DOI 10.1007/s13258-009-0842-7; Karaiskou N, 2008, ANN ZOOL FENN, V45, P478, DOI 10.5735/086.045.0602; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kim KS, 2007, ENVIRON ENTOMOL, V36, P637, DOI 10.1603/0046-225X(2007)36[637:GDILCO]2.0.CO;2; Leach M, 2012, PLANT DIS, V96, P30, DOI 10.1094/PDIS-02-11-0132; LINIT MJ, 1988, J NEMATOL, V20, P227; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; MAMIYA Y, 1976, JARQ, V10, P206; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; MAMIYA Y, 1988, J NEMATOL, V20, P219; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, Review of Plant Protection Research, V5, P46; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Metge K, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P175, DOI 10.1007/978-1-4020-8455-3_15; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Mulet K, 2011, EUR J PLANT PATHOL, V129, P501, DOI 10.1007/s10658-010-9721-y; Naves PM, 2007, J APPL ENTOMOL, V131, P21, DOI 10.1111/j.1439-0418.2006.01111.x; Picard D, 2004, MOL ECOL, V13, P2899, DOI 10.1111/j.1365-294X.2004.02275.x; Plantard O, 2004, MOL ECOL, V13, P33, DOI 10.1046/j.1365-294X.2003.02023.x; Plantard O, 2003, MOL ECOL NOTES, V3, P139, DOI 10.1046/j.1471-8286.2003.00383.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SHIBATA E, 1986, APPL ENTOMOL ZOOL, V21, P184, DOI 10.1303/aez.21.184; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Suzuki K., 2002, Dendrobiology, V48, P71; TARES S, 1992, HEREDITY, V68, P157, DOI 10.1038/hdy.1992.24; Thiery M, 2000, GENOME, V43, P160, DOI 10.1139/gen-43-1-160; Valadas V, 2013, J HELMINTHOL, V87, P457, DOI 10.1017/S0022149X12000673; Valadas V, 2012, NEMATOLOGY, P1; Vieira P, 2007, J NEMATOL, V39, P118; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WINGFIELD MJ, 1982, CAN J FOREST RES, V12, P71, DOI 10.1139/x82-010; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zhou ZH, 2007, PHYTOPATHOLOGY, V97, P304, DOI 10.1094/PHYTO-97-3-0304; [No title captured]	71	21	23	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59165	10.1371/journal.pone.0059165	http://dx.doi.org/10.1371/journal.pone.0059165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554990	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800065
J	Pavan, A; Contillo, A; Mather, G				Pavan, Andrea; Contillo, Adriano; Mather, George			Modelling Adaptation to Directional Motion Using the Adelson-Bergen Energy Sensor	PLOS ONE			English	Article							CAT STRIATE CORTEX; VISUAL-CORTEX; COMPLEX CELLS; TRANSPARENT MOTION; APPARENT MOTION; SINGLE CELLS; RESPONSES; DISCRIMINATION; NORMALIZATION; PERCEPTION	The motion energy sensor has been shown to account for a wide range of physiological and psychophysical results in motion detection and discrimination studies. It has become established as the standard computational model for retinal movement sensing in the human visual system. Adaptation effects have been extensively studied in the psychophysical literature on motion perception, and play a crucial role in theoretical debates, but the current implementation of the energy sensor does not provide directly for modelling adaptation-induced changes in output. We describe an extension of the model to incorporate changes in output due to adaptation. The extended model first computes a space-time representation of the output to a given stimulus, and then a RC gain-control circuit ("leaky integrator") is applied to the time-dependent output. The output of the extended model shows effects which mirror those observed in psychophysical studies of motion adaptation: a decline in sensor output during stimulation, and changes in the relative of outputs of different sensors following this adaptation.	[Pavan, Andrea; Contillo, Adriano] SISSA, I-34014 Trieste, Italy; [Pavan, Andrea] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Contillo, Adriano] Johannes Gutenberg Univ Mainz, PRISMA Cluster Excellence & Inst Phys THEP, D-55122 Mainz, Germany; [Mather, George] Lincoln Univ, Sch Psychol, Lincoln, England	International School for Advanced Studies (SISSA); University of Regensburg; Johannes Gutenberg University of Mainz; University of Lincoln	Pavan, A (corresponding author), SISSA, I-34014 Trieste, Italy.	andrea.pavan@psychologie.uni-regensburg.de	; Pavan, Andrea/Y-5507-2018	Mather, George/0000-0002-3102-4828; Pavan, Andrea/0000-0002-7697-6320; Pavan, Andrea/0000-0002-8257-8206	SISSA (International School for Advanced Studies); Alexander von Humboldt Foundation; University of Mainz; University of Lincoln; Wellcome Trust; Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program [SA/1975 1-1]	SISSA (International School for Advanced Studies); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); University of Mainz; University of Lincoln; Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program(German Research Foundation (DFG))	This research was supported by SISSA (International School for Advanced Studies), the Alexander von Humboldt Foundation, The University of Mainz, the University of Lincoln, and the Wellcome Trust. AC was also supported by the Deutsche Forschungsgemeinschaft (DFG) within the Emmy-Noether program (Grant SA/1975 1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; BERGEN JR, 1985, VISION RES, V25, P577, DOI 10.1016/0042-6989(85)90163-4; Challinor KL, 2010, VISION RES, V50, P1109, DOI 10.1016/j.visres.2010.04.002; de Grind WAV, 2003, VISION RES, V43, P117, DOI 10.1016/S0042-6989(02)00495-9; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; Garcia JO, 2009, EUR J NEUROSCI, V30, P1172, DOI 10.1111/j.1460-9568.2009.06893.x; Georgeson MA, 1999, VISION RES, V39, P4393, DOI 10.1016/S0042-6989(99)00147-9; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 1999, VISUAL NEUROSCI, V9, P181; HERSHENSON M, 1993, VISION RES, V33, P1913, DOI 10.1016/0042-6989(93)90018-R; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Mather G, 1998, MOTION AFTEREFFECT, P157; QIAN N, 1994, J NEUROSCI, V14, P7367; Rainville SJM, 2005, VISION RES, V45, P1115, DOI 10.1016/j.visres.2004.10.018; Rainville SJM, 2002, VISION RES, V42, P1727, DOI 10.1016/S0042-6989(02)00108-6; Rushton W. A. H., 1962, P ROY SOC LOND B BIO, V986, P20; STROUT JJ, 1994, VISION RES, V34, P3223, DOI 10.1016/0042-6989(94)90086-8; Takeuchi T, 1997, VISION RES, V37, P745, DOI 10.1016/S0042-6989(96)00207-6; TAYLOR MM, 1963, PERCEPT MOTOR SKILL, V16, P119, DOI 10.2466/pms.1963.16.1.119; van de Grind WA, 2004, VISION RES, V44, P2269, DOI 10.1016/j.visres.2004.04.012; vanWezel RJA, 1996, VISION RES, V36, P2805, DOI 10.1016/0042-6989(95)00324-X; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051	26	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59298	10.1371/journal.pone.0059298	http://dx.doi.org/10.1371/journal.pone.0059298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555013	Green Accepted, Green Published, gold			2022-12-27	WOS:000316409800081
J	Barca, L; Pezzulo, G; Castrataro, M; Rinaldi, P; Caselli, MC				Barca, Laura; Pezzulo, Giovanni; Castrataro, Marianna; Rinaldi, Pasquale; Caselli, Maria Cristina			Visual Word Recognition in Deaf Readers: Lexicality Is Modulated by Communication Mode	PLOS ONE			English	Article							ROUTE CASCADED MODEL; LANGUAGE; CHILDREN; COCHLEAR; ORGANIZATION; ACTIVATION; DYSLEXIA; IMPLANT; HEARING; AGE	Evidence indicates that adequate phonological abilities are necessary to develop proficient reading skills and that later in life phonology also has a role in the covert visual word recognition of expert readers. Impairments of acoustic perception, such as deafness, can lead to atypical phonological representations of written words and letters, which in turn can affect reading proficiency. Here, we report an experiment in which young adults with different levels of acoustic perception (i.e., hearing and deaf individuals) and different modes of communication (i.e., hearing individuals using spoken language, deaf individuals with a preference for sign language, and deaf individuals using the oral modality with less or no competence in sign language) performed a visual lexical decision task, which consisted of categorizing real words and consonant strings. The lexicality effect was restricted to deaf signers who responded faster to real words than consonant strings, showing over-reliance on whole word lexical processing of stimuli. No effect of stimulus type was found in deaf individuals using the oral modality or in hearing individuals. Thus, mode of communication modulates the lexicality effect. This suggests that learning a sign language during development shapes visuo-motor representations of words, which are tuned to the actions used to express them (phono-articulatory movements vs. hand movements) and to associated perceptions. As these visuo-motor representations are elicited during on-line linguistic processing and can overlap with the perceptual-motor processes required to execute the task, they can potentially produce interference or facilitation effects.	[Barca, Laura; Pezzulo, Giovanni; Castrataro, Marianna; Rinaldi, Pasquale; Caselli, Maria Cristina] Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy; [Pezzulo, Giovanni] Natl Res Council ILC CNR, Ist Linguist Computaz Antonio Zampolli, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Linguistica Computazionale "A. Zampolli" (ILC-CNR)	Barca, L (corresponding author), Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy.	laura.barca@istc.cnr.it	Barca, Laura/J-8274-2018; Pezzulo, Giovanni/F-6854-2014; Caselli, Maria Cristina/O-1373-2015; Pezzulo, Giovanni/AAY-3586-2020; Rinaldi, Pasquale/I-5907-2012	Barca, Laura/0000-0002-8553-7717; Pezzulo, Giovanni/0000-0001-6813-8282; Caselli, Maria Cristina/0000-0003-3460-0170; Pezzulo, Giovanni/0000-0001-6813-8282; Rinaldi, Pasquale/0000-0002-6544-7941	European's Community Seventh Framework Programme [PERG02-GA-2007-224919, FP7-270108]	European's Community Seventh Framework Programme	The research leading to these results was funded by the European's Community Seventh Framework Programme (FP7/2007-2013) under the grant agreement number PERG02-GA-2007-224919 (WoRHD) to Laura Barca; and number FP7-270108 (Goal-Leaders) to Giovanni Pezzulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barca L, 2007, READ WRIT, V20, P495, DOI 10.1007/s11145-006-9040-z; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Barca L, 2011, BRAIN LANG, V118, P53, DOI 10.1016/j.bandl.2010.09.003; Barca L, 2010, READ WRIT, V23, P569, DOI 10.1007/s11145-009-9192-8; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Beech J. R., 1997, J RES READ, V20, P105, DOI DOI 10.1111/1467-9817.00024; Bottari D, 2012, COGN NEUROSCI-UK, V3, P8, DOI 10.1080/17588928.2011.578209; Burani C, 2007, EUR J COGN PSYCHOL, V19, P828, DOI 10.1080/09541440600847946; CAMPBELL R, 1988, Q J EXP PSYCHOL-A, V40, P771, DOI 10.1080/14640748808402298; Caselli MC, 2012, J SPEECH LANG HEAR R, V55, P382, DOI 10.1044/1092-4388(2011/10-0248); Castles A, 1996, COGN NEUROPSYCHOL, V13, P25, DOI 10.1080/026432996382051; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Corina D, 2007, BRAIN RES, V1152, P111, DOI 10.1016/j.brainres.2007.03.054; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Cornoldi C., 1998, PROVE LETTURA MT; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Elliott EA, 2012, J DEAF STUD DEAF EDU, V17, P227, DOI 10.1093/deafed/enr047; Filik R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025782; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Goswami U, 2008, ANN NY ACAD SCI, V1145, P1, DOI 10.1196/annals.1416.018; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Leybaert J, 2006, MARDAGA BELGIQUE, P223; Lopez-Crespo G, 2012, RES DEV DISABIL, V33, P362, DOI 10.1016/j.ridd.2011.10.022; Mazzotta S, 2005, PSICOLOGICA CLIN SVI, V2, P247; Miller P, 2006, J DEAF STUD DEAF EDU, V11, P21, DOI 10.1093/deafed/enj001; Miller Paul, 2002, J Deaf Stud Deaf Educ, V7, P312, DOI 10.1093/deafed/7.4.312; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Nicholas JG, 2008, AM J SPEECH-LANG PAT, V17, P121, DOI 10.1044/1058-0360(2008/013); OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ormel E, 2010, J SPEECH LANG HEAR R, V53, P801, DOI 10.1044/1092-4388(2010/08-0033); Orsolini M, 2006, LANG COGNITIVE PROC, V21, P576, DOI 10.1080/01690960500139355; Pagliuca G, 2008, LANG COGNITIVE PROC, V23, P422, DOI 10.1080/01690960701626036; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Raven J.C., 1998, ADV PROGR MATRICES; Rinaldi P, 2009, J DEAF STUD DEAF EDU, V14, P63, DOI 10.1093/deafed/enn019; Steinbrink C, 2012, BRAIN LANG, V121, P1, DOI 10.1016/j.bandl.2011.12.003; Transler C, 2005, BRIT J DEV PSYCHOL, V23, P525, DOI 10.1348/026151005X26796; Waters GF, READING ITS DEV COMP, P323; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wilson T, 2005, EXP BRAIN RES, V162, P1, DOI 10.1007/s00221-004-2099-3; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	54	10	10	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59080	10.1371/journal.pone.0059080	http://dx.doi.org/10.1371/journal.pone.0059080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	107WV	23554976	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500066
J	Forrester, HB; Temple-Smith, P; Ham, S; de Kretser, D; Southwick, G; Sprung, CN				Forrester, Helen B.; Temple-Smith, Peter; Ham, Seungmin; de Kretser, David; Southwick, Graeme; Sprung, Carl N.			Genome-Wide Analysis Using Exon Arrays Demonstrates an Important Role for Expression of Extra-Cellular Matrix, Fibrotic Control and Tissue Remodelling Genes in Dupuytren's Disease	PLOS ONE			English	Article							COLLAGENASE CLOSTRIDIUM-HISTOLYTICUM; PERCUTANEOUS NEEDLE FASCIOTOMY; SMOOTH MUSCLE ACTIN; TGF-BETA; GROWTH-FACTOR; CONNECTIVE-TISSUE; ETIOLOGY; PROTEIN; EPIDEMIOLOGY; CONTRACTURE	Dupuytren's disease (DD) is a classic example of pathological fibrosis which results in a debilitating disorder affecting a large sector of the human population. It is characterized by excessive local proliferation of fibroblasts and over-production of collagen and other components of extracellular matrix (ECM) in the palmar fascia. The fibrosis progressively results in contracture of elements between the palmar fascia and skin causing flexion deformity or clawing of the fingers and a severe reduction in hand function. While much is known about the pathogenesis and surgical treatment of DD, little is known about the factors that cause its onset and progression, despite many years of research. Gene expression patterns in DD patients now offers the potential to identify genes that direct the pathogenesis of DD. In this study we used primary cultures of fibroblasts derived from excisional biopsies of fibrotic tissue from DD patients to compare the gene expression profiles on a genome-wide basis with normal control fibroblasts. Our investigations have identified genes that may be involved with DD pathogenesis including some which are directly relevant to fibrosis. In particular, these include significantly reduced expression levels of three matrix metallopeptidases (MMP1, MMP3, MMP16), follistatin, and STAT1, and significantly increased expression levels of fibroblast growth factors (FGF9, FGF11), a number of collagen genes and other ECM genes in DD patient samples. Many of these gene products are known to be involved in fibrosis, tumour formation and in the normal processes of tissue remodelling. In addition, alternative splicing was identified in some DD associated genes. These highly sensitive genomic investigations provide new insight into the molecular mechanisms that may underpin the development and progression of DD.	[Forrester, Helen B.; Sprung, Carl N.] Monash Univ, Monash Inst Med Res, Ctr Innate Immunol & Infect Dis, Clayton, Vic, Australia; [Temple-Smith, Peter; Ham, Seungmin] Monash Univ, Dept Obstet & Gynaecol, Southern Clin Sch, Monash Med Ctr, Clayton, Vic 3168, Australia; [Temple-Smith, Peter; Ham, Seungmin] Prince Henrys Inst, Clayton, Vic, Australia; [de Kretser, David] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [de Kretser, David; Southwick, Graeme] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Temple-Smith, Peter; Southwick, Graeme] Melbourne Inst Plast Surg, Malvern, Vic, Australia	Monash University; Monash University; Prince Henry's Institute of Medical Research; Monash University; Monash University	Sprung, CN (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immunol & Infect Dis, Clayton, Vic, Australia.	carl.sprung@monash.edu	Ham, Seungmin/AAK-5928-2021	Ham, Seungmin/0000-0002-3548-3431; Southwick, Graeme/0000-0002-1207-5638; , Peter/0000-0002-4754-369X	round of the Priority-driven Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Australian National Health and Medical Research Council [145780, 288713]; Australian National Breast Cancer Foundation [PG-08-06]; National Institute of Health [5U19AI067773-07]; Advanced Plastic Surgery Education Foundation; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	round of the Priority-driven Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advanced Plastic Surgery Education Foundation; Victorian Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through the 2010 round of the Priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council (grant numbers 145780, 288713; http://www.nhmrc.gov.au/); the Australian National Breast Cancer Foundation (grant PG-08-06; http://www.nbcf.org.au/); and the National Institute of Health (grant 5U19AI067773-07) and a grant from the Advanced Plastic Surgery Education Foundation. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S K, 1996, Hum Cell, V9, P181; Al-Qattan MM, 2006, J HAND SURG-AM, V31A, P1527, DOI 10.1016/j.jhsa.2006.08.012; Anthony Shawn G, 2008, Hand (N Y), V3, P87, DOI 10.1007/s11552-007-9076-9; Antsiferova M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1585; Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Augoff K, 2005, PLAST RECONSTR SURG, V115, P128, DOI 10.1097/01.PRS.0000146038.61595.4A; BADALAMENTE MA, 1992, J HAND SURG-AM, V17A, P317, DOI 10.1016/0363-5023(92)90414-K; Bainbridge C, 2012, J PLAST SURG HAND SU; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BAZIN S, 1980, EUR J CLIN INVEST, V10, P9, DOI 10.1111/j.1365-2362.1980.tb00317.x; Bengtsson H, 2006, AROMA AFFYMETRIS GEN, P745; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BOCANEGRA TS, 1981, J RHEUMATOL, V8, P1026; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Burge P, 1999, HAND CLIN, V15, P63; CHAMMAS M, 1995, J HAND SURG-AM, V20A, P109, DOI 10.1016/S0363-5023(05)80068-1; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Coleman S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-61; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Desai SS, 2010, EXPERT OPIN BIOL TH, V10, P1395, DOI 10.1517/14712598.2010.510509; Dolmans GH, 2011, NEW ENGL J MED, V365, P307, DOI 10.1056/NEJMoa1101029; Forrester HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053358; Forsman M, 2008, J SURG RES, V146, P271, DOI 10.1016/j.jss.2007.06.022; Gilpin D, 2010, J HAND SURG-AM, V35A, P2027, DOI 10.1016/j.jhsa.2010.08.007; Grootaert C, 2012, EXPERT REV PROTEOMIC, V9, P181, DOI [10.1586/EPR.12.12, 10.1586/epr.12.12]; Gudmundsson KG, 2000, J CLIN EPIDEMIOL, V53, P291, DOI 10.1016/S0895-4356(99)00145-6; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hueston JT, 1963, DUPUYTRENS CONTNRACT; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Johnston P, 2008, J HAND SURG-AM, V33A, P1160, DOI 10.1016/j.jhsa.2008.04.002; Johnston P, 2007, J HAND SURG-AM, V32A, P343, DOI 10.1016/j.jhsa.2006.12.010; Krause C, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-14; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; Lee LC, 2006, J HAND SURG-AM, V31A, P211, DOI 10.1016/j.jhsa.2005.09.007; LING RSM, 1963, J BONE JOINT SURG BR, V45, P709, DOI 10.1302/0301-620X.45B4.709; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; MURRELL GAC, 1987, BMJ-BRIT MED J, V295, P1373, DOI 10.1136/bmj.295.6610.1373; MURRELL GAC, 1990, AUST NZ J SURG, V60, P247, DOI 10.1111/j.1445-2197.1990.tb07362.x; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; NOBLE J, 1984, J BONE JOINT SURG BR, V66, P322, DOI 10.1302/0301-620X.66B3.6725338; O'Gorman DB, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-13; Pan D, 2003, ANN PLAS SURG, V50, P618, DOI 10.1097/01.SAP.0000069066.35253.B3; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Pegorier S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-85; Qian A, 2004, UROLOGY, V64, P399, DOI 10.1016/j.urology.2004.04.006; Ratkaj I, 2012, CELL PHYSIOL BIOCHEM, V30, P927, DOI 10.1159/000341470; Rayan Ghazi M, 2007, J Bone Joint Surg Am, V89, P189; Rayan GM, 1999, HAND CLIN, V15, P87; Rehman S, 2012, MOL BIOSYST; Rehman S, 2008, J HAND SURG-AM, V33A, P359, DOI 10.1016/j.jhsa.2007.11.010; Ross DC, 1999, HAND CLIN, V15, P53; Rozen WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043406; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; Satish L, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-10; Sgonc R, 2008, RHEUMATOLOGY, V47, pV5, DOI 10.1093/rheumatology/ken275; Shih B, 2012, ANN RHEUM DIS; Shih B, 2009, J HAND SURG-AM, V34A, P124, DOI 10.1016/j.jhsa.2008.09.017; Slattery D, 2010, ANZ J SURG, V80, P495, DOI 10.1111/j.1445-2197.2010.05364.x; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Thurston AJ, 2003, J BONE JOINT SURG BR, V85B, P469, DOI 10.1302/0301-620X.85B4.14215; Townley WA, 2006, BRIT MED J, V332, P397, DOI 10.1136/bmj.332.7538.397; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Van Rijssen AL, 2006, J HAND SURG-BRIT EUR, V31B, P498, DOI 10.1016/j.jhsb.2006.03.174; van Rijssen AL, 2006, J HAND SURG-AM, V31A, P717, DOI 10.1016/j.jhsa.2006.02.021; Yi IS, 1999, HAND CLIN, V15, P43; Zhang AY, 2008, J HAND SURG-EUR VOL, V33E, P783, DOI 10.1177/1753193408091352	70	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59056	10.1371/journal.pone.0059056	http://dx.doi.org/10.1371/journal.pone.0059056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554969	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500063
J	Herath, TDK; Darveau, RP; Seneviratne, CJ; Wang, CY; Wang, Y; Jin, LJ				Herath, Thanuja D. K.; Darveau, Richard P.; Seneviratne, Chaminda J.; Wang, Cun-Yu; Wang, Yu; Jin, Lijian			Tetra- and Penta-Acylated Lipid A Structures of Porphyromonas gingivalis LPS Differentially Activate TLR4-Mediated NF-kappa B Signal Transduction Cascade and Immuno-Inflammatory Response in Human Gingival Fibroblasts	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; INNATE HOST-DEFENSE; ESCHERICHIA-COLI; GENE-EXPRESSION; PERIODONTAL-DISEASE; HETEROGENEOUS EXPRESSION; INTERLEUKIN-8 SECRETION; CELL ACTIVATION	Background: Porphyromonas gingivalis is a major pathogen of periodontal disease that affects a majority of adults worldwide. Increasing evidence shows that periodontal disease is linked to various systemic diseases like diabetes and cardiovascular disease, by contributing to increased systemic levels of inflammation. Lipopolysaccharides (LPS), as a key virulent attribute of P. gingivalis, possesses significant amount of lipid A heterogeneity containing tetra- (LPS1435/1449) and penta-acylated (LPS1690) structures. Hitherto, the exact molecular mechanism of P. gingivalis LPS involved in periodontal pathogenesis remains unclear, due to limited understanding of the specific receptors and signaling pathways involved in LPS-host cell interactions. Methodology/Principal Findings: This study systematically investigated the effects of P. gingivalis LPS1435/1449 and LPS1690 on the expression of TLR2 and TLR4 signal transduction and the activation of pro-inflammatory cytokines IL-6 and IL-8 in human gingival fibroblasts (HGFs). We found that LPS1435/1449 and LPS1690 differentially modulated TLR2 and TLR4 expression. NF-kappa B pathway was significantly activated by LPS1690 but not by LPS1435/1449. In addition, LPS1690 induced significant expression of NF-kappa B and p38 MPAK pathways-related genes, such as NFKBIA, NFKB1, IKBKB, MAP2K4 and MAPK8. Notably, the pro-inflammatory genes including GM-CSF, CXCL10, G-CSF, IL-6, IL-8 and CCL2 were significantly upregulated by LPS1690 while down-regulated by LPS1435/1449. Blocking assays confirmed that TLR4-mediated NF-kappa B signaling was vital in LPS1690-induced expression of IL-6 and IL-8 in HGFs. Conclusions/Significance: The present study suggests that the tetra-and penta-acylated lipid A structures of P. gingivalis LPS differentially activate TLR4-mediated NF-kappa B signaling pathway, and significantly modulate the expression of IL-6 and IL-8 in HGFs. The ability to alter the lipid A structure of LPS could be one of the strategies carried-out by P. gingivalis to evade innate host defense in gingival tissues, thereby contributing to periodontal pathogenesis.	[Herath, Thanuja D. K.; Seneviratne, Chaminda J.; Jin, Lijian] Univ Hong Kong, Fac Dent, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Darveau, Richard P.] Univ Washington, Sch Dent, Seattle, WA 98195 USA; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of Hong Kong	Jin, LJ (corresponding author), Univ Hong Kong, Fac Dent, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	ljjin@hkucc.hku.hk		wang, yu/0000-0001-8697-2940; /0000-0003-0816-538X	Hong Kong Research Grants Council [HKU766909M, HKU768411M, HKU767512M]; Modern Dental Laboratory/HKU Endowment Fund; Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012768] Funding Source: NIH RePORTER	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund; Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Hong Kong Research Grants Council (HKU766909M, HKU768411M and HKU767512M to LJJ) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors would like to thank Mr. Raymond Tong and Mr. Alan Wong from the Faculty of Dentistry, The University of Hong Kong, for their technical assistance. We are grateful to Dr. David Green for proofreading the manuscript. This study received the Southeast Asian Division of the International Association for Dental Research (IADR-SEA) Unilever/Hatton Divisional Award in 2011.	Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Ara T, 2009, J PERIODONTAL RES, V44, P21, DOI 10.1111/j.1600-0765.2007.01041.x; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x; Bainbridge BW, 2001, ACTA ODONTOL SCAND, V59, P131, DOI 10.1080/000163501750266710; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baluchamy S, 2010, IN VITRO CELL DEV-AN, V46, P718, DOI 10.1007/s11626-010-9330-2; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chen C, 2007, CELL MICROBIOL, V9, P1028, DOI 10.1111/j.1462-5822.2006.00849.x; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Darveau RP, 2002, INFECT IMMUN, V70, P1867, DOI 10.1128/IAI.70.4.1867-1873.2002; Di Domenico G, 2003, Minerva Stomatol, V52, P81; Di Domenico G, 2003, MINERVA STOMATOL, V52, P87; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Erridge C, 2007, CARDIOVASC RES, V73, P181, DOI 10.1016/j.cardiores.2006.11.004; Faria Morandini AC, 2012, J PERIODONTOL; Gibson FC, 2007, CURR PHARM DESIGN, V13, P3665, DOI 10.2174/138161207783018554; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hajishengallis G, 2002, INFECT IMMUN, V70, P6658, DOI 10.1128/IAI.70.12.6658-6664.2002; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; Hayashi J, 1996, INFECT IMMUN, V64, P4946, DOI 10.1128/IAI.64.12.4946-4951.1996; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; KUMADA H, 1995, J BACTERIOL, V177, P2098, DOI 10.1128/jb.177.8.2098-2106.1995; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Liu RK, 2008, J PERIODONTOL, V79, P1241, DOI [10.1902/jop.2008.070575, 10.1902/jop.2008.070575 ]; Lu Q, 2009, INNATE IMMUN-LONDON, V15, P325, DOI 10.1177/1753425909104899; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Nemoto E, 2006, J DENT RES, V85, P733, DOI 10.1177/154405910608500809; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Reife RA, 2006, CELL MICROBIOL, V8, P857, DOI 10.1111/j.1462-5822.2005.00672.x; REIFE RA, 1995, INFECT IMMUN, V63, P4686, DOI 10.1128/IAI.63.12.4686-4694.1995; Ren L, 2005, J PERIODONTAL RES, V40, P407, DOI 10.1111/j.1600-0765.2005.00822.x; Ren L, 2009, J CLIN PERIODONTOL, V36, P619, DOI 10.1111/j.1600-051X.2009.01436.x; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SCHWARTZ J, 1972, J PERIODONTOL, V43, P270, DOI 10.1902/jop.1972.43.5.270; Seydel U, 2000, CHEM IMMUNOL, V74, P5; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Sugawara S, 1998, INFECT IMMUN, V66, P3043, DOI 10.1128/IAI.66.7.3043-3049.1998; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; TAMURA M, 1992, INFECT IMMUN, V60, P4932, DOI 10.1128/IAI.60.11.4932-4937.1992; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; Wang PL, 2001, BIOCHEM BIOPH RES CO, V288, P863, DOI 10.1006/bbrc.2001.5842; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Wang PL, 2000, BIOCHEM BIOPH RES CO, V273, P1161, DOI 10.1006/bbrc.2000.3060; Yamagishi VTK, 2011, J ENDODONT, V37, P812, DOI 10.1016/j.joen.2011.03.013; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang YH, 2008, ORG BIOMOL CHEM, V6, P3371, DOI 10.1039/b809090d	79	111	113	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58496	10.1371/journal.pone.0058496	http://dx.doi.org/10.1371/journal.pone.0058496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554896	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500026
J	Naidoo, K; Steenkamp, ET; Coetzee, MPA; Wingfield, MJ; Wingfield, BD				Naidoo, Kershney; Steenkamp, Emma T.; Coetzee, Martin P. A.; Wingfield, Michael J.; Wingfield, Brenda D.			Concerted Evolution in the Ribosomal RNA Cistron	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; GENE CONVERSION; DEATH EVOLUTION; BIRTH; DNA; MECHANISM; FAMILY; RDNA; POLYMORPHISM; CHROMOSOMES	Background: Gene conversion is the mechanism proposed to be responsible for the homogenization of multigene families such as the nuclear ribosomal gene clusters. This concerted evolutionary process prevents individual genes in gene clusters from accumulating mutations. The mechanism responsible for concerted evolution is not well understood but recombination during meiosis has been hypothesized to play a significant role in this homogenization. In this study we tested the hypothesis of unequal crossing over playing a significant role in gene conversion events within the ribosomal RNA cistron during meiosis, mitosis or both life stages in the fungal tree pathogen Ceratocystis manginecans. Methods: Ceratocystis manginecans, a haploid ascomycete, reproduces homothallically and was found to have two distinct sequences within the internally transcribed spacer (ITS) region of the ribosomal RNA cistron. The different ITS types were scored using PCR-RFLP assays and chi-square analyses to determine the level of significance of the changes in the ratios of the ITS types. Results: The relative ratios of the two ITS sequence types changed when the fungal isolates were cultured vegetatively or allowed to produced sexual structures and spores. These active changes were shown to occur more frequently during meiosis than mitosis. Conclusion: The evidence presented provides concrete support for homogenization in the rRNA gene clusters found in this fungus and that the most reasonable explanation for this process is unequal crossing over.	[Naidoo, Kershney; Coetzee, Martin P. A.; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Fac Nat & Agr Sci, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.] Univ Pretoria, Dept Microbiol & Plant Pathol, Fac Nat & Agr Sci, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Wingfield, BD (corresponding author), Univ Pretoria, Fac Nat & Agr Sci, Dept Genet, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa.	brenda.wingfield@fabi.up.ac.za	Naidoo, Kershney/P-8002-2016; Wingfield, Brenda D./B-1376-2008; Wingfield, Michael J/A-9473-2008; Steenkamp, Emma T/B-7958-2009; Coetzee, Martin P.A./B-1732-2008	Naidoo, Kershney/0000-0002-2668-5592; Wingfield, Brenda D./0000-0002-6189-1519; Steenkamp, Emma T/0000-0003-0217-8219; Coetzee, Martin P.A./0000-0001-7848-4111	Department of Science and Technology (DST)/National Research Foundation (NRF); Centre of Excellene in Tree Health Biotechnology (CTHB); Improving Academic Qualifications (IAQ) NRF grant	Department of Science and Technology (DST)/National Research Foundation (NRF); Centre of Excellene in Tree Health Biotechnology (CTHB); Improving Academic Qualifications (IAQ) NRF grant	This work was supported by members of the Tree Protection Co-operation Programme (TPCP), the Department of Science and Technology (DST)/National Research Foundation (NRF), the Centre of Excellene in Tree Health Biotechnology (CTHB) and the Improving Academic Qualifications (IAQ) NRF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2001, MYCOL RES, V105, P284, DOI 10.1017/S0953756201003628; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Innan H, 2011, GENES-BASEL, V2, P394, DOI 10.3390/genes2020394; LaFave M, 2009, PLOS GENET, V5, P1; Lange C, 2011, MOL MICROBIOL, V80, P666, DOI 10.1111/j.1365-2958.2011.07600.x; Liao D, 2003, NATURE ENCY HUMAN GE, P938; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lichten M, 2001, CURR BIOL, V11, pR253, DOI 10.1016/S0960-9822(01)00131-2; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Odorico DM, 1997, MOL BIOL EVOL, V14, P465, DOI 10.1093/oxfordjournals.molbev.a025783; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RITOSSA FM, 1968, P NATL ACAD SCI USA, V60, P509, DOI 10.1073/pnas.60.2.509; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sokal R.R., 2012, BIOMETRY; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; TARTOF KD, 1974, P NATL ACAD SCI USA, V71, P1272, DOI 10.1073/pnas.71.4.1272; TARTOF KD, 1988, GENETICS, V120, P1; van Wyk M, 2006, FUNGAL DIVERS, V21, P181; van Wyk M, 2007, FUNGAL DIVERS, V27, P213; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Witthuhn RC, 2000, CURR GENET, V38, P48, DOI 10.1007/s002940000131; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	42	50	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59355	10.1371/journal.pone.0059355	http://dx.doi.org/10.1371/journal.pone.0059355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555022	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500084
J	Vigueira, CC; Rauh, B; Mitchell-Olds, T; Lawton-Rauh, AL				Vigueira, Cynthia C.; Rauh, Brad; Mitchell-Olds, Thomas; Lawton-Rauh, Amy L.			Signatures of Demography and Recombination at Coding Genes in Naturally-Distributed Populations of Arabidopsis Lyrata Subsp Petraea	PLOS ONE			English	Article							GENOME-WIDE DEPARTURE; NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; STATISTICAL PROPERTIES; HELIANTHUS-ANNUUS; REGULATORY GENES; NEUTRAL MODEL; PATTERNS; DNA; DIVERSITY	Demography impacts the observed standing level of genetic diversity present in populations. Distinguishing the relative impacts of demography from selection requires a baseline of expressed gene variation in naturally occurring populations. Six nuclear genes were sequenced to estimate the patterns and levels of genetic diversity in natural Arabidopsis lyrata subsp. petraea populations that differ in demographic histories since the Pleistocene. As expected, northern European populations have genetic signatures of a strong population bottleneck likely due to glaciation during the Pleistocene. Levels of diversity in the northern populations are about half of that in central European populations. Bayesian estimates of historical population size changes indicate that central European populations also have signatures of population size change since the last glacial maxima, suggesting that these populations are not as stable as previously thought. Time since divergence amongst northern European populations is higher than amongst central European populations, suggesting that the northern European populations were established before the Pleistocene and survived glaciation in small separated refugia. Estimates of demography based on expressed genes are complementary to estimates based on microsatellites and transposable elements, elucidating temporal shifts in population dynamics and confirming the importance of marker selection for tests of demography.	[Vigueira, Cynthia C.; Rauh, Brad; Lawton-Rauh, Amy L.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Vigueira, Cynthia C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Rauh, Brad] Clemson Univ, Dept Hort, Clemson, SC 29634 USA; [Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC USA	Clemson University; Washington University (WUSTL); Clemson University; Duke University	Lawton-Rauh, AL (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	amylr@clemson.edu	; Mitchell-Olds, Thomas/K-8121-2012	Lawton-Rauh, Amy/0000-0003-4610-7367; Mitchell-Olds, Thomas/0000-0003-3439-9921	Clemson University; Calhoun Honors College Departmental Honors Research program; HHMI/SCLife program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086496] Funding Source: NIH RePORTER	Clemson University; Calhoun Honors College Departmental Honors Research program; HHMI/SCLife program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the following people for generously providing seeds from collected A. l. petraea populations: Maria J. Clauss (also provided seeds from the trio families used in this study), Marcus Koch, Sebastian Ramos-Onsins, and Outi Savolainen. We would also like to thank all undergraduate researchers who helped contribute to the data collection for this project: Peter Wehner (University of Jena, Germany) and at Clemson University: Sarah Walker, Margaret Beaudrot, and Kyle Gettler. The Clemson University undergraduates on this project were supported by internal internship grants from Clemson University, including the Calhoun Honors College Departmental Honors Research program, and the HHMI/SCLife program.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Andolfatto P, 2000, GENETICS, V156, P257; Ansell SW, 2010, HEREDITY, V105, P543, DOI 10.1038/hdy.2010.10; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bomblies K, 2007, CURR OPIN GENET DEV, V17, P500, DOI 10.1016/j.gde.2007.09.006; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heidel AJ, 2010, MOL ECOL, V19, P3364, DOI 10.1111/j.1365-294X.2010.04761.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 1997, GENETICS, V145, P833; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Ikeda H, 2009, MOL BIOL EVOL, V26, P2207, DOI 10.1093/molbev/msp128; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; JUKES T H, 1969, P21; Keller SR, 2010, MOL ECOL, V19, P1212, DOI 10.1111/j.1365-294X.2010.04546.x; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Lawton-Rauh A, 2007, MOL ECOL, V16, P3995, DOI 10.1111/j.1365-294X.2007.03445.x; Lawton-Rauh A, 2003, MOL ECOL, V12, P1301, DOI 10.1046/j.1365-294X.2003.01814.x; Lawton-Rauh A, 2008, CURR OPIN PLANT BIOL, V11, P103, DOI 10.1016/j.pbi.2008.02.009; Leinonen PH, 2009, AM J BOT, V96, P1129, DOI 10.3732/ajb.0800080; Lockton S, 2008, P NATL ACAD SCI USA, V105, P13965, DOI 10.1073/pnas.0804671105; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wang WK, 2010, NEW PHYTOL, V188, P488, DOI 10.1111/j.1469-8137.2010.03383.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035	60	6	7	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58916	10.1371/journal.pone.0058916	http://dx.doi.org/10.1371/journal.pone.0058916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554957	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500056
J	Testa, ND; Ghosh, SM; Shingleton, AW				Testa, Nicholas D.; Ghosh, Shampa M.; Shingleton, Alexander W.			Sex-Specific Weight Loss Mediates Sexual Size Dimorphism in Drosophila melanogaster	PLOS ONE			English	Article							BODY-SIZE; STATIC ALLOMETRY; GROWTH; EVOLUTION; CELL; METAMORPHOSIS; PERSPECTIVE; GENETICS; INSECTS	The selective pressures leading to the evolution of Sexual Size Dimorphism (SSD) have been well studied in many organisms, yet, the underlying developmental mechanisms are poorly understood. By generating a complete growth profile by sex in Drosophila melanogaster, we describe the sex-specific pattern of growth responsible for SSD. Growth rate and critical size for pupariation significantly contributed to adult SSD, whereas duration of growth did not. Surprisingly, SSD at peak larval mass was twice that of the uneclosed adult SSD with weight loss between peak larval mass and pupariation playing an important role in generating the final SSD. Our finding that weight loss is an important regulator of SSD adds additional complexity to our understanding of how body size is regulated in different sexes. Collectively, these data allow for the elucidation of the molecular-genetic mechanisms that generate SSD, an important component of understanding how SSD evolves.	[Testa, Nicholas D.; Ghosh, Shampa M.; Shingleton, Alexander W.] Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA	Michigan State University	Testa, ND (corresponding author), Michigan State Univ, Dept Zool & Ecol & Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	testanick@gmail.com		Shingleton, Alexander/0000-0001-9862-9947	National Science Foundation [IOS-0919855, IOS-0845847]; Michigan State University	National Science Foundation(National Science Foundation (NSF)); Michigan State University	This research was supported by National Science Foundation grants IOS-0919855 and IOS-0845847 to AWS, and fellowship support from Michigan State University to NDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Bininda-Emonds ORP, 2000, EVOLUTION, V54, P1011; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P2175, DOI 10.1016/j.cub.2005.11.041; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; D'Amico LJ, 2001, P ROY SOC B-BIOL SCI, V268, P1589, DOI 10.1098/rspb.2001.1698; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fischer K, 2001, ENTOMOL EXP APPL, V100, P325, DOI 10.1023/A:1019297222922; Freeman M, 1997, DEVELOPMENT, V124, P261; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Molleman F, 2011, J INSECT PHYSIOL, V57, P712, DOI 10.1016/j.jinsphys.2011.02.009; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1981, AM ZOOL, V21, P631; Norman MD, 2002, NEW ZEAL J MAR FRESH, V36, P733, DOI 10.1080/00288330.2002.9517126; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P2069, DOI 10.1098/rspb.2009.2277; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	41	54	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58936	10.1371/journal.pone.0058936	http://dx.doi.org/10.1371/journal.pone.0058936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555608	gold, Green Submitted, Green Published			2022-12-27	WOS:000317262200008
J	Bergstrom, J; Cederlund, K; Dahlen, B; Lantz, AS; Skedinger, M; Palmberg, L; Sundblad, BM; Larsson, K				Bergstrom, Jan; Cederlund, Kerstin; Dahlen, Barbro; Lantz, Ann-Sofie; Skedinger, Maria; Palmberg, Lena; Sundblad, Britt-Marie; Larsson, Kjell			Dental Health in Smokers with and without COPD	PLOS ONE			English	Article							LUNG-FUNCTION TESTS; REGRESSION EQUATIONS; PERIODONTAL-DISEASE; REFERENCE VALUES; SMOKING; ASSOCIATION; QUALITY	The association between chronic obstructive pulmonary disease (COPD) and periodontal disease is sparsely studied The aim was to describe the co-variation of periodontitis and lung function impairment in smokers. The hypothesis was that the destructive processes in the mouth and the lungs are interdependent due to a general individual susceptibility to detrimental effects of tobacco smoke. Smokers with COPD (n=28) stage II and III according to GOLD guidelines and smokers without COPD (n=29) and healthy non-smokers (n=23) participated in the study. The groups of smokers were matched for cumulative exposure to tobacco smoke. Radiographic, general and dental clinical examination, lung function measurements and quality of life (SF-36) assessment were conducted. The relationship between respiratory and dental outcomes was analyzed. Dental health, assessed by plaque, gingival bleeding, periodontal pocket depth and loss of teeth was impaired in the smokers compared with non-smokers with no major differences between smokers with and without COPD. There was, however, a weak correlation between periodontitis and emphysema/impaired diffusion capacity. Impaired quality of life was associated with smoking and impaired lung function but not influenced by dental status. In conclusion periodontitis was strongly associated with smoking, weakly associated with lung tissue destruction and very weakly or even not at all associated with chronic airflow limitation. The results indicate that, although there was a co-variation between periodontitis and pathologic lung processes in smokers, the risk of developing COPD, as defined by spirometric outcomes, is not associated with the risk of impaired dental health in smokers,	[Bergstrom, Jan] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Cederlund, Kerstin] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Med Imaging & Technol, Stockholm, Sweden; [Dahlen, Barbro; Lantz, Ann-Sofie; Skedinger, Maria] Karolinska Univ, Huddinge Hosp, Stockholm, Sweden; [Palmberg, Lena; Sundblad, Britt-Marie; Larsson, Kjell] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Larsson, K (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	kjell.larsson@ki.se		Sundblad, Britt-Marie/0000-0002-9939-418X	Swedish Heart and Lung Foundation; Karolinska Institutet; King Gustaf V's and Queen Victoria's Foundation; Stockholm County Council	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); King Gustaf V's and Queen Victoria's Foundation; Stockholm County Council(Stockholm County Council)	This study was supported by grants from the Swedish Heart and Lung Foundation, Karolinska Institutet, King Gustaf V's and Queen Victoria's Foundation and Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104; [Anonymous], 2009, GLOB STRAT DIAGN MAN; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Hayes C, 1998, Ann Periodontol, V3, P257, DOI 10.1902/annals.1998.3.1.257; HEDENSTROM H, 1986, UPSALA J MED SCI, V91, P299, DOI 10.3109/03009738609178670; HEDENSTROM H, 1985, B EUR PHYSIOPATH RES, V21, P551; Hyman JJ, 2004, J PERIODONTOL, V75, P9, DOI 10.1902/jop.2004.75.1.9; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-71; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Katancik JA, 2005, J PERIODONTOL, V76, P2161, DOI 10.1902/jop.2005.76.11-S.2161; Leuckfeld I, 2008, RESP MED, V102, P488, DOI 10.1016/j.rmed.2007.12.001; Pickard AS, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-26; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Scannapieco FA, 2001, J PERIODONTOL, V72, P50, DOI 10.1902/jop.2001.72.1.50; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wang ZM, 2009, J CLIN PERIODONTOL, V36, P750, DOI 10.1111/j.1600-051X.2009.01448.x	19	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59492	10.1371/journal.pone.0059492	http://dx.doi.org/10.1371/journal.pone.0059492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544074	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700034
J	Koprulu, AD; Kastner, R; Wienerroither, S; Lassnig, C; Putz, EM; Majer, O; Reutterer, B; Sexl, V; Kuchler, K; Muller, M; Decker, T; Ellmeier, W				Koepruelue, Afitap Derya; Kastner, Renate; Wienerroither, Sebastian; Lassnig, Caroline; Putz, Eva Maria; Majer, Olivia; Reutterer, Benjamin; Sexl, Veronika; Kuchler, Karl; Mueller, Mathias; Decker, Thomas; Ellmeier, Wilfried			The Tyrosine Kinase Btk Regulates the Macrophage Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; INTERFERON-GAMMA PRODUCTION; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; TEC FAMILY KINASES; PATTERN-RECOGNITION; REACTIVE OXYGEN; INNATE IMMUNITY; DOMAIN	In this study we investigated the role of Bruton's tyrosine kinase (Btk) in the immune response to the Gram-positive intracellular bacterium Listeria monocytogenes (Lm). In response to Lm infection, Btk was activated in bone marrow-derived macrophages (BMMs) and Btk(-/-) BMMs showed enhanced TNF-alpha, IL-6 and IL-12p40 secretion, while type I interferons were produced at levels similar to wild-type (wt) BMMs. Although Btk-deficient BMMs displayed reduced phagocytosis of E. coli fragments, there was no difference between wt and Btk(-/-) BMMs in the uptake of Lm upon infection. Moreover, there was no difference in the response to heat-killed Lm between wt and Btk(-/)- BMMs, suggesting a role for Btk in signaling pathways that are induced by intracellular Lm. Finally Btk(-/-) mice displayed enhanced resistance and an increased mean. survival time upon Lm infection in comparison to wt mice. This correlated with elevated IFN-gamma and IL-12p70 serum levels in Btk(-/-) mice at day 1 after infection. Taken together, our data suggest an important regulatory role for Btk in macrophages during Lm infection.	[Koepruelue, Afitap Derya; Ellmeier, Wilfried] Med Univ Vienna, Div Immunobiol, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria; [Kastner, Renate; Wienerroither, Sebastian; Reutterer, Benjamin; Decker, Thomas] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Vienna, Austria; [Lassnig, Caroline; Mueller, Mathias] Univ Vet Med, Inst Anim Breeding & Genet & Biomodels Austria, Vienna, Austria; [Putz, Eva Maria; Sexl, Veronika] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Majer, Olivia; Kuchler, Karl] Med Univ Vienna, Dept Mol Genet, Max F Perutz Labs, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ellmeier, W (corresponding author), Med Univ Vienna, Div Immunobiol, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Vienna, Austria.	wilfried.ellmeier@meduniwien.ac.at	kuchler, karl/AAL-6937-2020; König, Eva Maria/AAF-4041-2019; Sexl, Veronika/B-8657-2016	kuchler, karl/0000-0003-2719-5955; König, Eva Maria/0000-0002-9990-4477; Putz, Eva Maria/0000-0002-5309-4114; Ellmeier, Wilfried/0000-0001-8192-8481; Muller, Mathias/0000-0002-7879-3552; LASSNIG, Caroline/0000-0001-7905-3620; Sexl, Veronika/0000-0001-9363-0412	Austrian Science Fund (FWF)/Medical University of Vienna [DK W1212]; Austrian Science Fund [P19930]; Medical University of Vienna; University of Vienna; Austrian Science Fund (FWF) [SFB F28]; Austrian Science Fund (FWF) [P 23641] Funding Source: researchfish	Austrian Science Fund (FWF)/Medical University of Vienna(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); Medical University of Vienna; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work in the laboratory of W.E. was supported by the Austrian Science Fund (FWF)/Medical University of Vienna doctoral program (DK W1212) "Inflammation and Immunity", by the Austrian Science Fund (P19930), and by the Medical University of Vienna and University of Vienna cluster collaboration grant "Microbial Infections & Host Immune Response" to K.K., W.E. and T.D. M.M., V.S. and T.D were also supported by the Austrian Science Fund (FWF) project SFB F28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoras ALB, 2003, J INVEST ALLERG CLIN, V13, P181; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Bao Y, 2012, J BIOL CHEM; Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; BURGESS AW, 1985, J BIOL CHEM, V260, P6004; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Gonzalez-Serrano ME, 2012, J CLIN IMMUNOL, V32, P967, DOI 10.1007/s10875-012-9706-z; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Koprulu AD, 2009, CRIT REV IMMUNOL, V29, P317, DOI 10.1615/CritRevImmunol.v29.i4.30; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Marron TU, 2012, J ALLERGY CLIN IMMUN, V129, P184, DOI 10.1016/j.jaci.2011.10.009; Melcher M, 2008, J IMMUNOL, V180, P8048, DOI 10.4049/jimmunol.180.12.8048; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Ohteki T, 1999, J EXP MED, V189, P1981, DOI 10.1084/jem.189.12.1981; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Williams MA, 2012, TRENDS IMMUNOL, V33, P488, DOI 10.1016/j.it.2012.04.007; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60476	10.1371/journal.pone.0060476	http://dx.doi.org/10.1371/journal.pone.0060476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544144	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700103
J	Liu, L; Wei, JR; Zhang, HS; Xin, JH; Huang, JP				Liu, Lu; Wei, Jianrong; Zhang, Huishu; Xin, Jianhong; Huang, Jiping			A Statistical Physics View of Pitch Fluctuations in the Classical Music from Bach to Chopin: Evidence for Scaling	PLOS ONE			English	Article							POWER-LAW; CLASSIFICATION; BEHAVIOR	Because classical music has greatly affected our life and culture in its long history, it has attracted extensive attention from researchers to understand laws behind it. Based on statistical physics, here we use a different method to investigate classical music, namely, by analyzing cumulative distribution functions (CDFs) and autocorrelation functions of pitch fluctuations in compositions. We analyze 1,876 compositions of five representative classical music composers across 164 years from Bach, to Mozart, to Beethoven, to Mendelsohn, and to Chopin. We report that the biggest pitch fluctuations of a composer gradually increase as time evolves from Bach time to Mendelsohn/Chopin time. In particular, for the compositions of a composer, the positive and negative tails of a CDF of pitch fluctuations are distributed not only in power laws (with the scale-free property), but also in symmetry (namely, the probability of a treble following a bass and that of a bass following a treble are basically the same for each composer). The power-law exponent decreases as time elapses. Further, we also calculate the autocorrelation function of the pitch fluctuation. The autocorrelation function shows a power-law distribution for each composer. Especially, the power law exponents vary with the composers, indicating their different levels of long-range correlation of notes. This work not only suggests a way understand and develop music from a viewpoint of statistical physics, but also enriches the realm of traditional statistical physics by analyzing music.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn			National Natural Science Foundation of China [11075035, 11222544]; Program for New Century Excellent Talents in University; Fok Ying Tung Education Foundation [131008]; Shanghai Rising-Star Program [12QA1400200]; CNKBRSF [2011CB922004]; National Fund for Talent Training in Basic Science [J1103204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Shanghai Rising-Star Program; CNKBRSF(National Basic Research Program of China); National Fund for Talent Training in Basic Science	The authors acknowledge the financial support by the National Natural Science Foundation of China under Grant Nos. 11075035 and 11222544, by the Program for New Century Excellent Talents in University, by Fok Ying Tung Education Foundation under Grant No. 131008, by Shanghai Rising-Star Program (No. 12QA1400200), by CNKBRSF under Grant No. 2011CB922004, and by National Fund for Talent Training in Basic Science (No. J1103204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, RANDOM DATA ANAL MEA; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Box GE., 2011, TIME SERIES ANAL FOR, V734; Cavanagh Lynn, 2009, WAM WEBZINE AUDIO MU; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Johnson J., 2002, WHO NEEDS CLASSICAL; Kennedy M, 2006, OXFORD DICT MUSIC AN, P1008; King A, 1973, P ROYAL MUSICAL ASS, V100, P1; Levitin DJ, 2012, P NATL ACAD SCI USA, V109, P3716, DOI 10.1073/pnas.1113828109; Liu XF, 2010, PHYSICA A, V389, P126, DOI 10.1016/j.physa.2009.08.035; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Perreault J, 2004, THEMATIC CATALOGUE M; Petersen A, 2012, SCI REPORTS; Song KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033588; Taruskin R, 2009, OXFORD HIST W MUSIC, V3; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; VOSS RF, 1989, PHYSICA D, V38, P362, DOI 10.1016/0167-2789(89)90220-0; Young RW, 1939, J ACOUST SOC AM, V11, P134, DOI 10.1121/1.1916017; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108; Zhou WC, 2009, PHYSICA A, V388, P891, DOI 10.1016/j.physa.2008.11.028; Zwillinger D., 2000, CRC STANDARD PROBABI	22	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58710	10.1371/journal.pone.0058710	http://dx.doi.org/10.1371/journal.pone.0058710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	124QO	23544047	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700010
J	Vinceti, B; Loo, J; Gaisberger, H; van Zonneveld, MJ; Schueler, S; Konrad, H; Kadu, CAC; Geburek, T				Vinceti, Barbara; Loo, Judy; Gaisberger, Hannes; van Zonneveld, Maarten J.; Schueler, Silvio; Konrad, Heino; Kadu, Caroline A. C.; Geburek, Thomas			Conservation Priorities for Prunus africana Defined with the Aid of Spatial Analysis of Genetic Data and Climatic Variables	PLOS ONE			English	Article							TROPICAL TREES; DIVERSITY; BIODIVERSITY; POPULATIONS; FOREST; STRATEGIES; MITOCHONDRIAL; PREDICTION; PROTECTION; MANAGEMENT	Conservation priorities for Prunus africana, a tree species found across Afromontane regions, which is of great commercial interest internationally and of local value for rural communities, were defined with the aid of spatial analyses applied to a set of georeferenced molecular marker data (chloroplast and nuclear microsatellites) from 32 populations in 9 African countries. Two approaches for the selection of priority populations for conservation were used differing in the way they optimize representation of intra-specific diversity of P. africana across a minimum number of populations. The first method (Si) was aimed at maximizing genetic diversity of the conservation units and their distinctiveness with regard to climatic conditions, the second method (S2) at optimizing representativeness of the genetic diversity found throughout the species' range. Populations in East African countries (especially Kenya and Tanzania) were found to be of great conservation value, as suggested by previous findings. These populations are complemented by those in Madagascar and Cameroon. The combination of the two methods for prioritization led to the identification of a set of 6 priority populations. The potential distribution of P. africana was then modeled based on a dataset of 1,500 georeferenced observations. This enabled an assessment of whether the priority populations identified are exposed to threats from agricultural expansion and climate change, and whether they are located within the boundaries of protected areas. The range of the species has been affected by past climate change and the modeled distribution of P. africana indicates that the species is likely to be negatively affected in future, with an expected decrease in distribution by 2050. Based on these insights, further research at the regional and national scale is recommended, in order to strengthen P. africana conservation efforts.	[Vinceti, Barbara; Loo, Judy; Gaisberger, Hannes] Biovers Int, Headquarters, Rome, Italy; [van Zonneveld, Maarten J.] Biovers Int, Reg Off Amer, Cali, Colombia; [Schueler, Silvio; Konrad, Heino; Geburek, Thomas] Fed Res & Training Ctr Forests Nat Hazards & Land, Dept Genet, Vienna, Austria; [Kadu, Caroline A. C.] Kenyatta Univ, Dept Biochem & Biotechnol, Sch Pure & Appl Sci, Nairobi, Kenya; [van Zonneveld, Maarten J.] Univ Ghent, Fac Biosci Engn, B-9000 Ghent, Belgium	Alliance; Bioversity International; Alliance; Bioversity International; Kenyatta University; Ghent University	Vinceti, B (corresponding author), Biovers Int, Headquarters, Rome, Italy.	b.vinceti@cgiar.org	Konrad, Heino/ABH-1018-2021; Schueler, Silvio/V-2612-2019	Schueler, Silvio/0000-0003-0155-5692; Gaisberger, Hannes/0000-0002-6023-1236; Konrad, Heino/0000-0003-1820-9550	Austrian Development Agency	Austrian Development Agency	This research was funded by the Austrian Development Agency. It is the result of a collaboration between Bioversity International and the Federal Research and Training Centre for Forests, Natural Hazards and Landscape in Austria, and of a partnership with research institutions in African countries: Kenyatta University, Nairobi, Kenya; University of the Witwatersrand, Johannesburg, South Africa; Silo National des Graines Forestieres, Madagascar; Tanzania Forestry Research Institute, Tanzania; Institute of Agricultural Research for Development (IRAD), Cameroon; Faculty of Agriculture and Environmental Science, Bindura University of Science Education, Zimbabwe; National Forestry Resources Research Institute, Uganda; Coordinador Nacional de la COMIFAC Ministerio de Agricultura y Bosques, Equatorial Guinea within the framework of the project 'Development of strategies for the conservation and sustainable use of Prunus africana to improve the livelihood of small-scale farmers'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DAT PROT AR; [Anonymous], DOWNSC GCM DAT PORT; Avana T, 2004, BOIS FOR TROP, V28, P41; Ayele TB, 2011, J NAT CONSERV, V19, P8, DOI 10.1016/j.jnc.2010.03.001; Barker N, 1994, STRELITZIA, V1, P221; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Boshier D. H., 2000, ECOLOGICAL CONSEQUEN, P267; BUTYNSKI TM, 1994, BIODIVERS CONSERV, V3, P893, DOI 10.1007/BF00129665; Cavers S, 2009, SILVAE GENET, V58, P276, DOI 10.1515/sg-2009-0035; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Chapman AD., 2005, PRINCIPLES METHODS D; Cunningham A. B., 2002, People and Plants Working Paper, UNESCO; Cunningham A.B, 2005, 16 M PLANTS COMM LIM, P3; Cunningham AB, 2006, ETUDE CITES COMMERCE, P57; Dawson IK, 2009, BIODIVERS CONSERV, V18, P969, DOI 10.1007/s10531-008-9516-z; Dawson IK, 1999, MOL ECOL, V8, P151, DOI 10.1046/j.1365-294X.1999.00518.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; European Commission Joint Research Center Global Environment Monitoring Unit, 2000, GLOB LAND COV MAP; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; FAO, 2010, FOR RES ASS FRA; Farwig N, 2006, OECOLOGIA, V147, P238, DOI 10.1007/s00442-005-0288-9; Farwig N, 2008, CONSERV GENET, V9, P317, DOI 10.1007/s10592-007-9343-x; Fashing PJ, 2004, BIOL CONSERV, V120, P449, DOI 10.1016/j.biocon.2004.03.018; Diniz JAF, 2006, GENET MOL BIOL, V29, P207, DOI 10.1590/S1415-47572006000200004; Diniz JAF, 2012, CONSERV GENET, V13, P1085, DOI 10.1007/s10592-012-0356-8; Ford-Lloyd B., 2008, P110; Frankel OH, 1995, CONSERVATION PLANT B, P91; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Franzel S, 2009, ADV EC BOT, V17, P408; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Gamache I, 2003, MOL ECOL, V12, P891, DOI 10.1046/j.1365-294X.2003.01800.x; GBIF data portal, US NAT PLANT GERMPL; Geldenhuys C. J., 1981, South African Forestry Journal, P61; GRAUDAL L, 1995, FOREST ECOL MANAG, V73, P117, DOI 10.1016/0378-1127(94)03497-K; Graudal L, 2004, FOREST GENETIC RESOU, V1, P25; Guarino L., 2002, P387, DOI 10.1079/9780851995229.0387; GURIES RP, 1982, EVOLUTION, V36, P387, DOI 10.2307/2408058; Gyau A, 2012, INT FOREST REV, V14, P265, DOI 10.1505/146554812802646620; Hall JB, 2000, SCH AGR FOREST SCI P, V18, P104; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2005, DIVA GIS 2005 MANUAL; Hollingsworth PM, 2005, MOL ECOL, V14, P497, DOI 10.1111/j.1365-294X.2005.02431.x; Ingram V, 2009, NATL PRUNUS AFRICANA, P156; Ingram V., 2007, NATURE FAUNE, V22, P29; Jamnadass R., 2009, Tropical Plant Biology, V2, P1, DOI 10.1007/s12042-008-9027-9; Jimu L., 2011, Journal of Ecology and the Natural Environment, V3, P118; Jimu L, 2013, AFR J ECOL, V51, P102, DOI 10.1111/aje.12011; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kadu CAC, 2011, MOL ECOL, V20, P165, DOI 10.1111/j.1365-294X.2010.04931.x; Kadu CAC, 2012, ANN BOT IN PRESS; Kadu CAC, 2012, PHYTOCHEMISTRY, V83, P70, DOI 10.1016/j.phytochem.2012.06.001; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Laikre L, 2010, CONSERV BIOL, V24, P86, DOI 10.1111/j.1523-1739.2009.01425.x; LEDIG FT, 1986, FOREST ECOL MANAG, V14, P77, DOI 10.1016/0378-1127(86)90093-9; Lee SL, 2006, BIOL CONSERV, V131, P72, DOI 10.1016/j.biocon.2006.02.005; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Maxted N, 2008, CONSERVING PLANT GENETIC DIVERSITY IN PROTECTED AREAS: POPULATION MANAGEMENT OF CROP WILD RELATIVES, P65, DOI 10.1079/9781845932824.0065; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Mbatudde M, 2011, AFR J ECOL, DOI [10.1111/j.1365-2028.2012.01327.x, DOI 10.1111/41365-2028.2012.01327.X]; Metrick A, 1998, J ECON PERSPECT, V12, P21, DOI 10.1257/jep.12.3.21; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Muchugi A, 2006, S AFR J BOT, V72, P498, DOI 10.1016/j.sajb.2006.01.003; Muir G, 2004, ANN BOT-LONDON, V93, P691, DOI 10.1093/aob/mch096; Muona O, 1990, SCAND J FOREST RES, V5, P97, DOI 10.1080/02827589009382596; Navarro-Cerrillo RM, 2008, AFR J ECOL, V46, P620, DOI 10.1111/j.1365-2028.2008.00944.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nichols KM, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P123; Njoroge, 2012, ETHNOBOTANY RES APPL, V10, P329, DOI DOI 10.17348/ERA.10.0.329-338; Orwa C., 2009, AGROFORESTREE DATABA; Pandey M, 2010, CONSERV GENET, V11, P977, DOI 10.1007/s10592-009-9940-y; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Philips J, 2009, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2016, R FDN STAT COMP; Rajora OP, 2002, CAN J BOT, V80, P1173, DOI [10.1139/b02-105, 10.1139/B02-105]; REBELO AG, 1992, CONSERV BIOL, V6, P243, DOI 10.1046/j.1523-1739.1992.620243.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Scheldeman X., 2010, TRAINING MANUAL SPAT; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Smith T.B., 1993, Biodiversity Letters, V1, P164, DOI 10.2307/2999740; Sneath PHA, 1973, NUMERICAL TAXONOMY P, P278; SOLOW A, 1993, J ENVIRON ECON MANAG, V24, P60, DOI 10.1006/jeem.1993.1004; St Clair JB, 2011, TURK J BOT, V35, P403, DOI 10.3906/bot-1012-98; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V7; Stewart KM, 2003, J ETHNOPHARMACOL, V89, P3, DOI 10.1016/j.jep.2003.08.002; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Sunderland TCH, 1999, EXPLOITATION P UNPUB; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Theilade I., 2001, CONSERVATION PLAN GE; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; Thomassen HA, 2011, EVOL APPL, V4, P397, DOI 10.1111/j.1752-4571.2010.00172.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Tymchuk WV, 2010, MOL ECOL, V19, P1842, DOI 10.1111/j.1365-294X.2010.04596.x; UNEP WCMC, 2009, CITES TRAD DAT; van Breugel P, 2011, POTENTIAL NATURAL VE; van der Heide CM, 2005, ECOL ECON, V55, P218, DOI 10.1016/j.ecolecon.2004.12.018; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; van Zonneveld M, 2009, FOREST ECOL MANAG, V257, P1566, DOI 10.1016/j.foreco.2008.12.027; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Were J, 2004, COMP STORAGE BIOL TR, P67; White F., 1983, SONDERBD NATURWISS V, V7, P87; Williams PH, 2002, J BIOSCIENCES, V27, P327, DOI 10.1007/BF02704963	120	45	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59987	10.1371/journal.pone.0059987	http://dx.doi.org/10.1371/journal.pone.0059987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544118	Green Published, gold			2022-12-27	WOS:000317480700077
J	Chen, XF; Liu, YQ; Roe, OD; Qian, YY; Guo, RH; Zhu, LJ; Yin, YM; Shu, YQ				Chen, Xiaofeng; Liu, Yiqian; Roe, Oluf Dimitri; Qian, Yingying; Guo, Renhua; Zhu, Lingjun; Yin, Yongmei; Shu, Yongqian			Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review	PLOS ONE			English	Article							PHASE-III TRIAL; DOUBLE-BLIND; 1ST-LINE TREATMENT; OPEN-LABEL; CHEMOTHERAPY; PLACEBO; MULTICENTER; GEMCITABINE; CARBOPLATIN; CISPLATIN	Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC). The studies are quite heterogenous regarding study size and populations, and a synopsis of these data could give some more insight in the role of maintenance therapy with TKI. Methods: In September 2012 we performed a search in the pubmed, EMBASE and Cochrane library databases for randomized phase III trials exploring the role of gefitinib or erlotinib in advanced non-small cell lung cancer. Through a rigorous selection process with specific criteria, five trials (n = 2436 patients) were included for analysis. Standard statistical methods for meta-analysis were applied. Results: TKIs (gefitinib and erlotinib) significantly increased progression-free survival (PFS) [ hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.50-0.76, I-2 = 78.1%] and overall survival (HR 0.84, 95% CI 0.76-0.93, I-2 = 0.0%) compared with placebo or observation. The PFS benefit was consistent in all subgroups including stage, sex, ethnicity, performance status, smoking status, histology, EGFR mutation status, and previous response to chemotherapy. Patients with clinical features such as female, never smoker, adenocarcinoma, Asian ethnicity and EGFR mutation positive had more pronounced PFS benefit. Overall survival benefit was observed in patients with clinical features such as female, non-smoker, smoker, adenocarcinoma, and previous stable to induction chemotherapy. Severe adverse events were not frequent. Main limitations of this analysis are that it is not based on individual patient data, and not all studies provided detailed subgroups analysis. Conclusions: The results show that maintenance therapy with erlotinib or gefitinib produces a significant PFS and OS benefit for unselected patients with advanced NSCLC compared with placebo or observation. Given the less toxicity of TKIs than chemotherapy and simple oral administration, this treatment strategy seems to be of important clinical value.	[Chen, Xiaofeng; Liu, Yiqian; Qian, Yingying; Guo, Renhua; Zhu, Lingjun; Yin, Yongmei; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Roe, Oluf Dimitri] Nord Trondelag Hlth Trust, Levanger Hosp, Canc Clin, Levanger, Norway	Nanjing Medical University; Norwegian University of Science & Technology (NTNU)	Yin, YM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	ym.yin@hotmail.com; yongqianshu@126.com	Shu, Yongqian/ABD-5698-2021	Roe, Oluf Dimitri/0000-0002-4870-5822	Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (Nanjing Medical University)	Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (Nanjing Medical University)	This work is supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (Nanjing Medical University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Behera M, 2012, LUNG CANCER, V77, P331, DOI 10.1016/j.lungcan.2012.03.019; Belani CP, 2012, LANCET ONCOL, V13, P292, DOI 10.1016/S1470-2045(11)70339-4; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.lungcan.2006.01.006; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chang A, 2006, J THORAC ONCOL, V1, P847, DOI 10.1097/01243894-200610000-00014; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gaafar RM, 2011, EUR J CANCER, V47, P2331, DOI 10.1016/j.ejca.2011.06.045; Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569; Kabbinavar VAM, 2010, J CLIN ONCOL, V28; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Miller POC, 2009, J CLIN ONCOL, V27; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Petrelli F, 2011, ANTI-CANCER DRUG, V22, P1010, DOI 10.1097/CAD.0b013e328349d80d; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soon YY, 2009, J CLIN ONCOL, V27, P3277, DOI 10.1200/JCO.2008.19.4522; Takeda K, 2010, J CLIN ONCOL, V28, P753, DOI 10.1200/JCO.2009.23.3445; Wu YL, 2012, LUNG CANCER, V77, P339, DOI 10.1016/j.lungcan.2012.03.012; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	29	45	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e59314	10.1371/journal.pone.0059314	http://dx.doi.org/10.1371/journal.pone.0059314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555654	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400033
J	Chen, SC; Kim, DK; Chase, MW; Kim, JH				Chen, Shichao; Kim, Dong-Kap; Chase, Mark W.; Kim, Joo-Hwan			Networks in a Large-Scale Phylogenetic Analysis: Reconstructing Evolutionary History of Asparagales (Lilianae) Based on Four Plastid Genes	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CHLOROPLAST DNA; 18S RDNA; RBCL; CLASSIFICATION; MITOCHONDRIAL; INFERENCE; ACCURACY; MATK; AGE	Phylogenetic analysis aims to produce a bifurcating tree, which disregards conflicting signals and displays only those that are present in a large proportion of the data. However, any character (or tree) conflict in a dataset allows the exploration of support for various evolutionary hypotheses. Although data-display network approaches exist, biologists cannot easily and routinely use them to compute rooted phylogenetic networks on real datasets containing hundreds of taxa. Here, we constructed an original neighbour-net for a large dataset of Asparagales to highlight the aspects of the resulting network that will be important for interpreting phylogeny. The analyses were largely conducted with new data collected for the same loci as in previous studies, but from different species accessions and greater sampling in many cases than in published analyses. The network tree summarised the majority data pattern in the characters of plastid sequences before tree building, which largely confirmed the currently recognised phylogenetic relationships. Most conflicting signals are at the base of each group along the Asparagales backbone, which helps us to establish the expectancy and advance our understanding of some difficult taxa relationships and their phylogeny. The network method should play a greater role in phylogenetic analyses than it has in the past. To advance the understanding of evolutionary history of the largest order of monocots Asparagales, absolute diversification times were estimated for family-level clades using relaxed molecular clock analyses.	[Chen, Shichao] Tongji Univ, Coll Life Sci & Technol, Shanghai 200092, Peoples R China; [Kim, Dong-Kap] Korea Natl Arboretum, Div Forest Resource Conservat, Pochon, Gyeonggi Do, South Korea; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Kim, Joo-Hwan] Gachon Univ, Dept Life Sci, Songnam 200092, Gyeonggi Do, South Korea	Tongji University; Korea National Arboretum; Royal Botanic Gardens, Kew; Gachon University	Kim, JH (corresponding author), Gachon Univ, Dept Life Sci, Songnam 200092, Gyeonggi Do, South Korea.	kimjh2009@gachon.ac.kr	Chase, Mark W/A-6642-2011		Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2010-0029131, 2008-0060631]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0029131, 2008-0060631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; BANDELT HJ, 1992, ADV MATH, V92, P47, DOI 10.1016/0001-8708(92)90061-O; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P685; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P109, DOI DOI 10.1016/0378-8741(87)90103-6; Chase Mark W., 2006, Aliso, V22, P63; Chase MW, 2009, BOT J LINN SOC, V161, P132, DOI 10.1111/j.1095-8339.2009.00999.x; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Chase MW, 2000, ANN BOT-LONDON, V86, P935, DOI 10.1006/anbo.2000.1262; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Dahlgren R., 1985, FAMILIES MONOCOTYLED; Dohm JC, 2006, J MOL EVOL, V63, P437, DOI 10.1007/s00239-005-0094-3; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dressler R.L., 1990, ORCHIDS NATURAL HIST; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emadzade K, 2010, TAXON, V59, P809, DOI 10.1002/tax.593011; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Fay MF, 1996, TAXON, V45, P441, DOI 10.2307/1224136; Fay MF., 2000, MONOCOTS SYSTEMATICS, P360; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J, 2004, INFERRING PHYTOGENIE; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Friis E., 1988, TERTIARY RES, V9, P7; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Goldblatt P, 2008, SYST BOT, V33, P495, DOI 10.1600/036364408785679806; Graham Sean W., 2006, Aliso, V22, P3; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Grimm GW, 2006, EVOL BIOINFORM, V2, P7; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Huson DH, 2009, BIOINFORMATICS, V25, pI85, DOI 10.1093/bioinformatics/btp217; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kim DK, 2012, J PLANT BIOL, V55, P325, DOI 10.1007/s12374-011-0016-4; Kim JH, 2010, ANN BOT-LONDON, V106, P775, DOI 10.1093/aob/mcq167; Kocyan A, 2011, MOL PHYLOGENET EVOL, V60, P122, DOI 10.1016/j.ympev.2011.02.021; Kuhl JC, 2005, GENOME, V48, P1052, DOI 10.1139/G05-073; Li XX, 2007, ACTA PHYTOTAXON SIN, V45, P113, DOI 10.1360/aps06148; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; Maddison WP., 2000, MACCLADE ANAL PHYLOG; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McPherson M, 2001, INFERENCE ASPARAGALE; Morrison D. A, 2000, MONOCOTS SYSTEMATICS, P3; Morrison DA, 2010, MOL BIOL EVOL, V27, P1044, DOI 10.1093/molbev/msp309; Nakhleh L, 2011, PROBLEM SOLVING HANDBOOK IN COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, P125, DOI 10.1007/978-0-387-09760-2_7; NICKRENT DL, 1995, ANN MO BOT GARD, V82, P208, DOI 10.2307/2399878; Nylander J, 2004, MRMODELTEST V2 EVOLU; O'Hara RJ, 1997, ZOOL SCR, V26, P323, DOI 10.1111/j.1463-6409.1997.tb00422.x; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P249, DOI 10.2307/2399768; Pires J. Chris, 2006, Aliso, V22, P287; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Rambaut A., 2007, TRACER V1 4; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rudall P, 2002, INT J PLANT SCI, V163, P261, DOI 10.1086/338323; Rudall PJ, 1998, BOT J LINN SOC, V127, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seberg O, 2012, AM J BOT, V99, P875, DOI 10.3732/ajb.1100468; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V48, P176, DOI 10.1016/j.ympev.2008.02.023; SHINWARI ZK, 1994, PLANT SYST EVOL, V192, P263, DOI 10.1007/BF00986256; Soltis PS, 1998, MOL SYSTEMATICS PLAN, P188, DOI DOI 10.1007/978-1-4615-5419-6_7; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Stevenson D. W., 1995, MONOCOTYLEDONS SYSTE, P543; Swofford DL, 2007, PAUP PHYLOGENETIC AN; Terry RG, 1997, SYST BOT, V22, P333, DOI 10.2307/2419461; Vogl C, 2003, J MOL EVOL, V56, P330, DOI 10.1007/s00239-002-2404-3; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Wu Q, 2008, FEMS YEAST RES, V8, P641, DOI 10.1111/j.1567-1364.2008.00362.x; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	91	54	59	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59472	10.1371/journal.pone.0059472	http://dx.doi.org/10.1371/journal.pone.0059472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23544071	Green Submitted, gold, Green Published			2022-12-27	WOS:000316411600059
J	Kennedy, A; Nirantharakumar, K; Chimen, M; Pang, TT; Hemming, K; Andrews, RC; Narendran, P				Kennedy, Amy; Nirantharakumar, Krishnarajah; Chimen, Myriam; Pang, Terence T.; Hemming, Karla; Andrews, Rob C.; Narendran, Parth			Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; METABOLIC-CONTROL; INSULIN SENSITIVITY; AEROBIC EXERCISE; MELLITUS; CHILDREN; FITNESS; ADOLESCENTS; PROGRAM	Objective: Whilst regular exercise is advocated for people with type 1 diabetes, the benefits of this therapy are poorly delineated. Our objective was to review the evidence for a glycaemic benefit of exercise in type 1 diabetes. Research Design and Methods: Electronic database searches were carried out in MEDLINE, Embase, Cochrane's Controlled Trials Register and SPORTDiscus. In addition, we searched for as yet unpublished but completed trials. Glycaemic benefit was defined as an improvement in glycosylated haemoglobin (HbA1c). Both randomised and non-randomised controlled trials were included. Results: Thirteen studies were identified in the systematic review. Meta-analysis of twelve of these (including 452 patients) demonstrated an HbA1c reduction but this was not statistically significant (standardised mean difference (SMD) -0.25; 95% CI, -0.59 to 0.09). Conclusions: This meta-analysis does not reveal evidence for a glycaemic benefit of exercise as measured by HbA1c. Reasons for this finding could include increased calorie intake, insulin dose reductions around the time of exercise or lack of power. We also suggest that HbA1c may not be a sensitive indicator of glycaemic control, and that improvement in glycaemic variability may not be reflected in this measure. Exercise does however have other proven benefits in type 1 diabetes, and remains an important part of its management.	[Kennedy, Amy; Chimen, Myriam; Pang, Terence T.; Narendran, Parth] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Kennedy, Amy; Narendran, Parth] Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet, Birmingham, W Midlands, England; [Nirantharakumar, Krishnarajah; Hemming, Karla] Univ Birmingham, Birmingham, W Midlands, England; [Pang, Terence T.] Dudley Grp Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Dudley, W Midlands, England; [Andrews, Rob C.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Andrews, Rob C.] Taunton & Somerset NHS Fdn Trust, Dept Endocrinol & Diabet, Taunton, Somerset, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Bristol	Narendran, P (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England.	p.narendran@bham.ac.uk	Hemming, karla/AAB-3391-2021; Chimen, Myriam/D-6344-2015	Hemming, karla/0000-0002-2226-6550; Chimen, Myriam/0000-0002-3567-1731; Narendran, Parth/0000-0002-4583-8793; andrews, robert/0000-0003-4939-1738	National Institute for Health Research [PB-PG-0609-19093] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Aouadi R, 2011, J SPORT MED PHYS FIT, V51, P393; Balducci S, 2006, J DIABETES COMPLICAT, V20, P216, DOI 10.1016/j.jdiacomp.2005.07.005; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; CAMPAIGNE BN, 1984, DIABETES CARE, V7, P57, DOI 10.2337/diacare.7.1.57; Centre for Reviews and Dissemination, 2009, CRDS GUID UND REV HL; Chief Medical Officers of England S Wales and Northern Ireland, 2011, START ACT STAY ACT R, P62; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; D'hooge R, 2011, CLIN REHABIL, V25, P349, DOI 10.1177/0269215510386254; DAHLJORGENSEN K, 1980, ACTA PAEDIATR SCAND, P53; Dube MC, 2006, DIABETES RES CLIN PR, V72, P20, DOI 10.1016/j.diabres.2005.08.008; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; Heyman E, 2007, PEDIATR EXERC SCI, V19, P408, DOI 10.1123/pes.19.4.408; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HUTTUNEN NP, 1989, DIABETES CARE, V12, P737, DOI 10.2337/diacare.12.10.737; Kapitza Christoph, 2010, J Diabetes Sci Technol, V4, P123; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; LANDT KW, 1985, DIABETES CARE, V8, P461, DOI 10.2337/diacare.8.5.461; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x; Perry TL, 1997, EUR J CLIN NUTR, V51, P757, DOI 10.1038/sj.ejcn.1600478; Salem MA, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-47; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Tonoli C, 2012, SPORTS MED, V42, P1059, DOI 10.2165/11635380-000000000-00000; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; van Dijk JW, 2012, DIABETOLOGIA, V55, P1273, DOI 10.1007/s00125-011-2380-5; WALLBERGHENRIKSSON H, 1986, DIABETOLOGIA, V29, P53, DOI 10.1007/BF02427281; Wong CH, 2011, J CLIN NURS, V20, P681, DOI 10.1111/j.1365-2702.2010.03533.x; YKIJARVINEN H, 1984, DIABETES CARE, V7, P520, DOI 10.2337/diacare.7.6.520	31	100	101	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58861	10.1371/journal.pone.0058861	http://dx.doi.org/10.1371/journal.pone.0058861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554942	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800038
J	Skupin, A; Biberstine, JR; Borner, K				Skupin, Andre; Biberstine, Joseph R.; Boerner, Katy			Visualizing the Topical Structure of the Medical Sciences: A Self-Organizing Map Approach	PLOS ONE			English	Article								Background: We implement a high-resolution visualization of the medical knowledge domain using the self-organizing map (SOM) method, based on a corpus of over two million publications. While self-organizing maps have been used for document visualization for some time, (1) little is known about how to deal with truly large document collections in conjunction with a large number of SOM neurons, (2) post-training geometric and semiotic transformations of the SOM tend to be limited, and (3) no user studies have been conducted with domain experts to validate the utility and readability of the resulting visualizations. Our study makes key contributions to all of these issues. Methodology: Documents extracted from Medline and Scopus are analyzed on the basis of indexer-assigned MeSH terms. Initial dimensionality is reduced to include only the top 10% most frequent terms and the resulting document vectors are then used to train a large SOM consisting of over 75,000 neurons. The resulting two-dimensional model of the high-dimensional input space is then transformed into a large-format map by using geographic information system (GIS) techniques and cartographic design principles. This map is then annotated and evaluated by ten experts stemming from the biomedical and other domains. Conclusions: Study results demonstrate that it is possible to transform a very large document corpus into a map that is visually engaging and conceptually stimulating to subject experts from both inside and outside of the particular knowledge domain. The challenges of dealing with a truly large corpus come to the fore and require embracing parallelization and use of supercomputing resources to solve otherwise intractable computational tasks. Among the envisaged future efforts are the creation of a highly interactive interface and the elaboration of the notion of this map of medicine acting as a base map, onto which other knowledge artifacts could be overlaid.	[Skupin, Andre] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Biberstine, Joseph R.; Boerner, Katy] Indiana Univ, Sch Lib & Informat Sci, Cyberinfrastruct Network Sci Ctr, Bloomington, IN 47401 USA	California State University System; San Diego State University; Indiana University System; Indiana University Bloomington	Skupin, A (corresponding author), San Diego State Univ, Dept Geog, San Diego, CA 92182 USA.	skupin@mail.sdsu.edu		Skupin, Andre/0000-0002-8398-8119	National Institutes of Health (NIH) SBIR [HHSN268200900053C]; James S. McDonnell Foundation	National Institutes of Health (NIH) SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation	This work was supported by National Institutes of Health (NIH) SBIR Contract HHSN268200900053C and a James S. McDonnell Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borner K, 2011, COMMUN ACM, V54, P60, DOI 10.1145/1897852.1897871; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack K, 2000, ANAL PATENT DATABASE; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Chen HC, 1996, J VIS COMMUN IMAGE R, V7, P88, DOI 10.1006/jvci.1996.0008; Davidson GS, 1998, J INTELL INF SYST, V11, P259, DOI 10.1023/A:1008690008856; De Nooy W., 2005, EXPLORATORY SOCIAL N; Herr BW, 2009, INFORMATION VISUALIZATION, IV 2009, PROCEEDINGS, P505, DOI 10.1109/IV.2009.105; Jinha AE, 2010, LEARN PUBL, V23, P258, DOI 10.1087/20100308; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Kohonen T, 1999, KOHONEN MAPS, P171, DOI 10.1016/B978-044450270-4/50013-9; Kohonen T., 1995, SELF ORG MAPS, V30, DOI 10.1007/978-3-642-97610-0; Kohonen T., 1996, SOM PAK SELF ORG MAP; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lawrence RD, 1999, DATA MIN KNOWL DISC, V3, P171, DOI 10.1023/A:1009817804059; LIN X, 1992, VISUALIZATION 92 : PROCEEDINGS, P274; NWB Team, 2006, NETW WORKB TOOL; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; SALTON G, 1989, AUTOMATED TEXT PROCE; Skupin A, 2004, P NATL ACAD SCI USA, V101, P5274, DOI 10.1073/pnas.0307654100; Skupin A, 2002, LECT NOTES COMPUT SC, V2539, P161; Skupin A, 2002, IEEE COMPUT GRAPH, V22, P50, DOI 10.1109/38.974518; Skupin A., 2008, SELF ORG MAPS APPL G, P1, DOI [10.1002/9780470021699, DOI 10.1002/9780470021699.CH1]; Skupin A, 2011, GLIMPSE ART SCI SEEI, V3, P69; Skupin A, 2009, J INFORMETR, V3, P233, DOI 10.1016/j.joi.2009.03.002; Wise JA, 1999, J AM SOC INFORM SCI, V50, P1224, DOI 10.1002/(SICI)1097-4571(1999)50:13<1224::AID-ASI8>3.0.CO;2-4	28	41	41	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58779	10.1371/journal.pone.0058779	http://dx.doi.org/10.1371/journal.pone.0058779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554924	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500042
J	Krishnapuram, R; Dhurandhar, EJ; Dubuisson, O; Hegde, V; Dhurandhar, NV				Krishnapuram, Rashmi; Dhurandhar, Emily J.; Dubuisson, Olga; Hegde, Vijay; Dhurandhar, Nikhil V.			Doxycycline-Regulated 3T3-L1 Preadipocyte Cell Line with Inducible, Stable Expression of Adenoviral E4orf1 Gene: A Cell Model to Study Insulin-Independent Glucose Disposal	PLOS ONE			English	Article							MAMMALIAN-CELLS; MESSENGER-RNA; RESISTANCE; ADIPOSITY; SYSTEM; AD-36	Impaired glycemic control and excessive adiposity are major risk factors for Type 2 Diabetes mellitus. In rodent models Ad36, a human adenovirus, improves glycemic control, independent of dietary fat intake or adiposity. It is impractical to use Ad36 for therapeutic action. Instead, we identified that E4orf1 protein of Ad36, mediates its anti-hyperglycemic action independent of insulin signaling. To further evaluate the therapeutic potential of E4orf1 to improve glycemic control, we established a stable 3T3-L1 cell system in which E4orf1 expression can be regulated. The development and characterization of this cell line is described here. Full-length adenoviral-36 E4orf1 cDNA obtained by PCR was cloned into a tetracycline responsive element containing vector (pTRE-Tight-E4orf1). Upon screening dozens of pTRE-Tight-E4orf1 clones, we identified the one with the highest expression of E4orf1 in response to doxycycline treatment. Furthermore, using this inducible system we characterized the ability of E4orf1 to improve glucose disposal in a time dependent manner. This stable cell line offers a valuable resource to carefully study the novel signaling pathways E4orf1 uses to enhance cellular glucose disposal independent of insulin.	[Krishnapuram, Rashmi; Dhurandhar, Emily J.; Dubuisson, Olga; Hegde, Vijay; Dhurandhar, Nikhil V.] Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, NV (corresponding author), Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA.	Nikhil.Dhurandhar@PBRC.EDU			Vital Health Interventions, LLC; COBRE [NIH 8 P20- GM103528, NIH 8 P20 GM103528]; NORC center from the National Institutes of Health [NIH 2P30-DK072476, NIH 2P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Vital Health Interventions, LLC; COBRE; NORC center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was funded in part by Vital Health Interventions, LLC, awarded to NVD. In addition, this work utilized the facilities of the Cell Biology and Bioimaging Core of the Pennington Biomedical Research Center, that are supported in part by COBRE (NIH 8 P20- GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health. Also, this work used Genomics core facilities of the Pennington Biomedical Research Center, that are supported in part by COBRE (NIH 8 P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Dhurandhar N, 2012, J DIABETES IN PRESS; Ewald D, 1996, SCIENCE, V273, P1384, DOI 10.1126/science.273.5280.1384; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Iida A, 1996, J VIROL, V70, P6054, DOI 10.1128/JVI.70.9.6054-6059.1996; JAVIER R, 1992, SCIENCE, V257, P1267, DOI 10.1126/science.1519063; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Krishnapuram R, 2012, INT J OBESI IN PRESS; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rathod M, 2007, INT J OBESITY, V31, P78, DOI 10.1038/sj.ijo.0803358; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Yarranton Geoffrey T., 1992, Current Opinion in Biotechnology, V3, P506, DOI 10.1016/0958-1669(92)90078-W	24	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60651	10.1371/journal.pone.0060651	http://dx.doi.org/10.1371/journal.pone.0060651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544159	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700118
J	Liu, YL; Barua, D; Liu, P; Wilson, BS; Oliver, JM; Hlavacek, WS; Singh, AK				Liu, Yanli; Barua, Dipak; Liu, Peng; Wilson, Bridget S.; Oliver, Janet M.; Hlavacek, William S.; Singh, Anup K.			Single-Cell Measurements of IgE-Mediated Fc epsilon RI Signaling Using an Integrated Microfluidic Platform	PLOS ONE			English	Article							MAST-CELLS; TYROSINE PHOSPHORYLATION; FLOW-CYTOMETRY; EARLY EVENTS; DYNAMICS; LYN; RECEPTOR; PATHWAYS; BINDING; ACTIVATION	Heterogeneity in responses of cells to a stimulus, such as a pathogen or allergen, can potentially play an important role in deciding the fate of the responding cell population and the overall systemic response. Measuring heterogeneous responses requires tools capable of interrogating individual cells. Cell signaling studies commonly do not have single-cell resolution because of the limitations of techniques used such as Westerns, ELISAs, mass spectrometry, and DNA microarrays. Microfluidics devices are increasingly being used to overcome these limitations. Here, we report on a microfluidic platform for cell signaling analysis that combines two orthogonal single-cell measurement technologies: on-chip flow cytometry and optical imaging. The device seamlessly integrates cell culture, stimulation, and preparation with downstream measurements permitting hands-free, automated analysis to minimize experimental variability. The platform was used to interrogate IgE receptor (Fc epsilon RI) signaling, which is responsible for triggering allergic reactions, in RBL-2H3 cells. Following on-chip crosslinking of IgE-Fc epsilon RI complexes by multivalent antigen, we monitored signaling events including protein phosphorylation, calcium mobilization and the release of inflammatory mediators. The results demonstrate the ability of our platform to produce quantitative measurements on a cell-by-cell basis from just a few hundred cells. Model-based analysis of the Syk phosphorylation data suggests that heterogeneity in Syk phosphorylation can be attributed to protein copy number variations, with the level of Syk phosphorylation being particularly sensitive to the copy number of Lyn.	[Liu, Yanli; Liu, Peng; Singh, Anup K.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Barua, Dipak; Hlavacek, William S.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA; [Barua, Dipak; Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Wilson, Bridget S.; Oliver, Janet M.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Wilson, Bridget S.; Oliver, Janet M.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; University of New Mexico	Singh, AK (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA.	aksingh@sandia.gov		Barua, Dipak/0000-0001-8394-1233; Hlavacek, William/0000-0003-4383-8711	U.S. Department of Energy [DE-AC04-94AL85000]; Los Alamos National Laboratory [DE-AC52-06NA25396]; National Institutes of Health/National Institute of General Medical Sciences [P50GM085273]; United States Department of Energy [DE-AC04-94AL85000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amanda Carroll-Portillo and Anna Holmes of University of New Mexico, and Thomas Perroud, Nimisha Srivastava, Ronald F. Renzi, Jim Van De Vreugde and Jim He of Sandia National Laboratories for providing materials and assistance with instrumentation. Sandia is a multiprogram laboratory operated by Sandia Corp., a Lockheed Martin Co., for the U.S. Department of Energy under Contract DE-AC04-94AL85000. Los Alamos National Laboratory is operated under Contract DE-AC52-06NA25396.; This work was supported by National Institutes of Health/National Institute of General Medical Sciences grant P50GM085273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Yanli Liu, Peng Liu, and K. Singh are employed by Sandia National Laboratories. The authors thank Sandia National Laboratories for providing materials and assistance with instrumentation. Sandia is a multiprogram laboratory operated by Sandia Corp., a Lockheed Martin Co., for the United States Department of Energy under Contract DE-AC04-94AL85000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anand RK, 2012, CURR OPIN CHEM BIOL, V16, P391, DOI 10.1016/j.cbpa.2012.05.187; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Barua D, 2012, J IMMUNOL, V189, P646, DOI 10.4049/jimmunol.1102003; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Carroll-Portillo A, 2010, J IMMUNOL, V184, P1328, DOI 10.4049/jimmunol.0903071; Casale TB, 1996, AM J RESP CELL MOL, V15, P35, DOI 10.1165/ajrcmb.15.1.8679220; Cheung LSL, 2010, J MICROELECTROMECH S, V19, P752, DOI 10.1109/JMEMS.2010.2052021; Cohen S. D., 1996, Computers in Physics, V10, P138; Couzon C, 2009, EUR BIOPHYS J BIOPHY, V38, P1035, DOI 10.1007/s00249-009-0506-1; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEMBO M, 1978, J IMMUNOL, V121, P345; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1991, CURR OPIN IMMUNOL, V3, P865, DOI 10.1016/S0952-7915(05)80005-6; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hernandez-Hansen V, 2005, J IMMUNOL, V175, P7880, DOI 10.4049/jimmunol.175.12.7880; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Lee PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938253; LEE RJ, 1995, MOL BIOL CELL, V6, P825, DOI 10.1091/mbc.6.7.825; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; LIU FT, 1980, J IMMUNOL, V124, P2728; Liu P, 2011, LAB CHIP, V11, P2673, DOI 10.1039/c1lc20151d; Liu YL, 2009, LAB CHIP, V9, P1033, DOI 10.1039/b820985e; MILLARD PJ, 1988, P NATL ACAD SCI USA, V85, P1854, DOI 10.1073/pnas.85.6.1854; Naal RMZG, 2004, BIOSENS BIOELECTRON, V20, P791, DOI 10.1016/j.bios.2004.03.017; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Neill SK, 2011, IMMUNITY, V35, P746, DOI 10.1016/j.immuni.2011.10.011; Perroud TD, 2008, ANAL CHEM, V80, P6365, DOI 10.1021/ac8007779; Perroud TD, 2009, LAB CHIP, V9, P507, DOI 10.1039/b817285d; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Srivastava N, 2009, ANAL CHEM, V81, P3261, DOI 10.1021/ac8024224; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Torigoe C, 1997, P NATL ACAD SCI USA, V94, P1372, DOI 10.1073/pnas.94.4.1372; Wang JP, 2011, P NATL ACAD SCI USA, V108, P6909, DOI 10.1073/pnas.1014753108; Wilson BS, 2011, ADV EXP MED BIOL, V716, P91, DOI 10.1007/978-1-4419-9533-9_6; WILSON BS, 1991, J CELL PHYSIOL, V149, P403, DOI 10.1002/jcp.1041490307; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wu MY, 2012, LAB CHIP, V12, P2823, DOI 10.1039/c2lc40344g; Wu MY, 2012, CURR OPIN BIOTECH, V23, P83, DOI 10.1016/j.copbio.2011.11.023; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Xu KL, 1998, J IMMUNOL, V160, P3225	60	22	23	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60159	10.1371/journal.pone.0060159	http://dx.doi.org/10.1371/journal.pone.0060159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544131	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700090
J	Maruthupandian, J; Marimuthu, G				Maruthupandian, Jayabalan; Marimuthu, Ganapathy			Cunnilingus Apparently Increases Duration of Copulation in the Indian Flying Fox, Pteropus giganteus	PLOS ONE			English	Article							SPERM COMPETITION; MATING SYSTEM; BEHAVIOR; BAT	We observed a total of 57 incidences of copulation in a colony of the Indian flying fox, Pteropus giganteus, over 13 months under natural conditions. The colony consisted of about 420 individuals, roosting in a Ficus religiosa tree. Copulations occurred between 07.00 h and 09.30 h from July to January, with more occurring in October and November. Initially males groomed their penis before approaching a nearby female. Females typically moved away and males followed. When the female stopped moving, the male started licking her vagina (cunnilingus). Typically each bout of cunnilingus lasted for about 50 s. In 57 out of 69 observations, the male mounted the female and copulated. The duration of copulation varied from 10 to 20 sec. After completion of copulation, the male continued cunnilingus for 94 to 188 sec. The duration of precopulatory cunnilingus and copulation was positively correlated whereas, the duration of pre- and post-copulatory cunnilingus was negatively correlated. Apart from humans, oral sex as foreplay prior to copulation is uncommon in mammals. Another pteropodid bat, Cynopterus sphinx exhibits fellatio with females licking the penis of males during copulation. It appears that bats, especially pteropodids perform oral sex, either cunnilingus or fellatio, possibly for achieving longer copulation.	[Maruthupandian, Jayabalan; Marimuthu, Ganapathy] Madurai Kamaraj Univ, Sch Biol Sci, Dept Anim Behav & Physiol, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Marimuthu, G (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Anim Behav & Physiol, Madurai 625021, Tamil Nadu, India.	emailboxgm@gmail.com	Marimuthu, Ganapathy/I-7689-2013	Marimuthu, Ganapathy/0000-0001-7874-645X	University Grants Commission, New Delhi; UGC-CAS HI	University Grants Commission, New Delhi(University Grants Commission, India); UGC-CAS HI	The study was supported by the University Grants Commission, New Delhi with a Major Research Project to GM. Additional support was provided by UGC-CAS HI to the School of Biological Sciences, Madurai Kamaraj University. In both cases UGC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADBURY JW, 1977, Z TIERPSYCHOL, V45, P225; DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Keeley ATH, 2004, J MAMMAL, V85, P113, DOI 10.1644/BME-004; Koilraj BJ, 2001, CURR SCI INDIA, V80, P15; Markus N, 2002, ACTA CHIROPTEROL, V4, P153, DOI 10.3161/001.004.0204; Mathur Virendra, 2012, Journal of Threatened Taxa, V4, P2699; NELSON J. E., 1965, AUSTRALIAN J ZOOL, V13, P53, DOI 10.1071/ZO9650053; NEUWEILER G, 1969, Zeitschrift fuer Tierpsychologie, V26, P166; Tan M, 2009, PLOS ONE, V4, P1; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123	12	7	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59743	10.1371/journal.pone.0059743	http://dx.doi.org/10.1371/journal.pone.0059743			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544092	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700052
J	Vanhauteghem, D; Janssens, GPJ; Lauwaerts, A; Sys, S; Boyen, F; Cox, E; Meyer, E				Vanhauteghem, Donna; Janssens, Geert Paul Jules; Lauwaerts, Angelo; Sys, Stanislas; Boyen, Filip; Cox, Eric; Meyer, Evelyne			Exposure to the Proton Scavenger Glycine under Alkaline Conditions Induces Escherichia coli Viability Loss	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; ATP SYNTHESIS; INORGANIC POLYPHOSPHATE; ANTIMICROBIAL ACTIVITY; PH HOMEOSTASIS; FLOW-CYTOMETRY; CYTOPLASMIC PH; BACTERIA; STRESS; INDUCTION	Our previous work described a clear loss of Escherichia coli (E coli) membrane integrity after incubation with glycine or its N-methylated derivatives N-methylglycine (sarcosine) and N,N-dimethylglycine (DMG), but not N,,N,N-trimethylglycine (betaine), under alkaline stress conditions. The. current study offers a thorough viability analysis, based on a combination of real-time physiological techniques, of E. colt exposed to glycine and its N-methylated derivatives at alkaline pH. Flow cytometry was applied to assess various physiological parameters such as membrane permeability, esterase activity, respiratory activity and membrane potential. ATP and inorganic phosphate concentrations were also determined. Membrane damage was confirmed through the measurement of nucleic acid leakage. Results further showed no loss of esterase or respiratory activity, while an instant and significant decrease in the ATP concentration occurred upon exposure to either glycine, sarcosine or DMG, but not betaine; There was a clear membrane hyperpolarization as well as a significant increase in cellular inorganic phosphate concentration Based on these results, we suggest that the inability to sustain an adequate level of ATP combined with a decrease in membrane functionality leads to the loss of bacterial viability when exposed to the proton scavengers glycine, sarcosine and DMG at alkaline pH.	[Vanhauteghem, Donna; Janssens, Geert Paul Jules] Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium; [Vanhauteghem, Donna; Meyer, Evelyne] Univ Ghent, Dept Pharmacol Toxicol & Biochem, Fac Vet Med, Merelbeke, Belgium; [Lauwaerts, Angelo] Taminco, Ghent, Belgium; [Sys, Stanislas] Univ Ghent, Dept Internal Med & Clin Biol Large Anim, Fac Vet Med, Merelbeke, Belgium; [Boyen, Filip] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Fac Vet Med, Merelbeke, Belgium; [Cox, Eric] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	Vanhauteghem, D (corresponding author), Univ Ghent, Dept Nutr Genet & Ethol, Fac Vet Med, Merelbeke, Belgium.	Donna.Vanhauteghem@Ugent.be	Janssens, Geert/C-2264-2008; Lauwaerts, Angelo/AAG-7259-2021; Boyen, Filip/AAF-6109-2020	Boyen, Filip/0000-0002-4777-6880; Cox, Eric/0000-0003-4281-2990	IWT (Agency for Innovation through Science and Technology in Flanders); Taminco Ltd. (Ghent, Belgium); Taminco Ltd.	IWT (Agency for Innovation through Science and Technology in Flanders); Taminco Ltd. (Ghent, Belgium); Taminco Ltd.	A PhD scholarship funded this research through a R&D project granted by IWT (Agency for Innovation through Science and Technology in Flanders; www.iwt.be) in cooperation with Taminco Ltd. (Ghent, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A PhD scholarship funded this research through a R&D project granted by IWT (Agency for Innovation through Science and Technology in Flanders; www.iwt.be) in cooperation with Taminco Ltd. Even though one of the authors has an affiliation to Taminco Ltd., this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Baatout S, 2005, ANN MICROBIOL, V55, P73; Baatout S, 2007, ACTA ASTRONAUT, V60, P451, DOI 10.1016/j.actaastro.2006.09.012; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Berney M, 2006, MICROBIOL-SGM, V152, P1719, DOI 10.1099/mic.0.28617-0; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bot CT, 2010, BIOPHYS CHEM, V146, P133, DOI 10.1016/j.bpc.2009.11.005; Breeuwer P, 2000, INT J FOOD MICROBIOL, V55, P193, DOI 10.1016/S0168-1605(00)00163-X; Breeuwer P, 2004, MOL MICROBIAL ECOLOG, P1563, DOI DOI 10.1007/978-1-4020-2177-0_; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Capaldi RA, 2000, J EXP BIOL, V203, P29; Castaneda-Garcia A, 2011, J ANTIMICROB CHEMOTH, V66, P1489, DOI 10.1093/jac/dkr165; Creach V, 2003, J MICROBIOL METH, V52, P19, DOI 10.1016/S0167-7012(02)00128-8; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Dimroth P, 2000, J EXP BIOL, V203, P51; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Grillo-Puertas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050368; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaim G, 1998, FEBS LETT, V434, P57, DOI 10.1016/S0014-5793(98)00969-7; KINOSHITA N, 1984, J BACTERIOL, V160, P1074, DOI 10.1128/JB.160.3.1074-1077.1984; KOBAYASHI H, 1985, J BIOL CHEM, V260, P72; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Nobmann P, 2010, J APPL MICROBIOL, V108, P2152, DOI 10.1111/j.1365-2672.2009.04622.x; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Sanchez L, 2007, AMINO ACIDS, V32, P133, DOI 10.1007/s00726-006-0318-x; Sanchez L, 2006, TOXICOL LETT, V161, P53, DOI 10.1016/j.toxlet.2005.07.015; SCHULDINER S, 1986, J BACTERIOL, V168, P936, DOI 10.1128/jb.168.2.936-939.1986; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Strauber H, 2010, CYTOM PART A, V77A, P623, DOI 10.1002/cyto.a.20920; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; TAGLICHT D, 1987, J BACTERIOL, V169, P885, DOI 10.1128/jb.169.2.885-887.1987; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Vanhauteghem D, 2012, AMINO ACIDS, V43, P245, DOI 10.1007/s00726-011-1068-y; Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Yohannes E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-59; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404	49	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60328	10.1371/journal.pone.0060328	http://dx.doi.org/10.1371/journal.pone.0060328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544135	Green Published, gold			2022-12-27	WOS:000317480700094
J	Bigdeli, M; Zafar, S; Assad, H; Ghaffar, A				Bigdeli, Maryam; Zafar, Shamsa; Assad, Hafeez; Ghaffar, Adbul			Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice	PLOS ONE			English	Article							COUNTRIES	Severe pre-eclampsia and eclampsia are rare but serious complications of pregnancy that threaten the lives of mothers during childbirth. Evidence supports the use of magnesium sulfate (MgSO4) as the first line treatment option for severe pre-eclampsia and eclampsia. Eclampsia is the third major cause of maternal mortality in Pakistan. As in many other Low-and Middle-Income Countries (LMIC), it is suspected that MgSO4 is critically under-utilized in the country. There is however a lack of information on context-specific health system barriers that prevent optimal use of this life-saving medicine in Pakistan. Combining quantitative and qualitative methods, namely policy document review, key informant interviews, focus group discussions and direct observation at health facility, we explored context-specific health system barriers and enablers that affect access and use of MgSO4 for severe pre-eclampsia and eclampsia in Pakistan. Our study finds that while international recommendations on MgSO4 have been adequately translated in national policies in Pakistan, the gap remains in implementation of national policies into practice. Barriers to access to and effective use of MgSO4 occur at health facility level where the medicine was not available and health staff was reluctant to use it. Low price of the medicine and the small market related to its narrow indications acted as disincentives for effective marketing. Results of our survey were further discussed in a multi-stakeholder round-table meeting and an action plan for increasing access to this life-saving medicine was identified.	[Bigdeli, Maryam; Ghaffar, Adbul] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland; [Zafar, Shamsa] Hlth Serv Acad, Ctr Excellence Maternal Newborn & Child Hlth, Islamabad, Pakistan; [Assad, Hafeez] Hlth Serv Acad, Islamabad, Pakistan	World Health Organization; Health Services Academy; Health Services Academy	Bigdeli, M (corresponding author), WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland.	Bigdelim@who.int			UK Department for International Development (DfID)	UK Department for International Development (DfID)	This study was funded by a grant from the UK Department for International Development (DfID) to the Alliance for Health Policy and Systems Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaserud M, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-68; [Anonymous], 2005, CURR COMM MIDW; [Anonymous], 2007, NAT ESS MED LIST PAK; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2007, BJOG-INT J OBSTET GY, V114, P300, DOI 10.1111/j.1471-0528.2006.01166.x; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; Gilson L, 2011, PLOS MED, V8; Lumbiganon P, 2007, B WORLD HEALTH ORGAN, V85, P763, DOI 10.2471/BLT.06.037911; National Institute of Population Studies (NIPS) and Macro International, 2006, PAKISTAN DEMOGRAPHIC; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Partnership for Maternal Newborn and Child Health, 2010, KNOWL SUMM 5 WOM CHI; Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340; Sevene E, 2005, BMJ-BRIT MED J, V331, P765, DOI 10.1136/bmj.331.7519.765; Sheikh K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001073; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308; Villar J, 2004, INT J GYNECOL OBSTET, V85, pS28, DOI 10.1016/j.ijgo.2004.03.009; WHO, 2011, PRIOR MED MOTH CHILD; World Health Organization, 2010, NEWBORN CHILD HLTH	19	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59158	10.1371/journal.pone.0059158	http://dx.doi.org/10.1371/journal.pone.0059158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555626	Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500023
J	Miao, M; Wang, ZL; Yang, ZQ; Yuan, LL; Parker, DM; Putaporntip, C; Jongwutiwes, S; Xangsayarath, P; Pongvongsa, T; Moji, H; Tuong, TD; Abe, T; Nakazawa, S; Kyaw, MP; Yan, GY; Sirichaisinthop, J; Sattabongkot, J; Mu, JB; Su, XZ; Kaneko, O; Cui, LW				Miao, Miao; Wang, Zenglei; Yang, Zhaoqing; Yuan, Lili; Parker, Daniel M.; Putaporntip, Chaturong; Jongwutiwes, Somchai; Xangsayarath, Phonepadith; Pongvongsa, Tiengkham; Moji, Hazuhiko; Trinh Dinh Tuong; Abe, Tomoko; Nakazawa, Shusuke; Kyaw, Myat Phone; Yan, Guiyun; Sirichaisinthop, Jeeraphat; Sattabongkot, Jetsumon; Mu, Jianbing; Su, Xin-zhuan; Kaneko, Osamu; Cui, Liwang			Genetic Diversity and Lack of Artemisinin Selection Signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion	PLOS ONE			English	Article							IN-VITRO; MITOCHONDRIAL-DNA; POINT MUTATIONS; S769N MUTATION; SERCA PFATP6; RESISTANCE; MALARIA; POLYMORPHISM; ARTESUNATE; CA2+-ATPASE	The recent detection of clinical Artemisinin (ART) resistance manifested as delayed parasite clearance in the Cambodia-Thailand border area raises a serious concern. The mechanism of ART resistance is not clear; but the P. falciparum sarco/endoplasmic reticulum Ca2+-ATPase (PfSERCA or PfATP6) has been speculated to be the target of ARTs and thus a potential marker for ART resistance. Here we amplified and sequenced pfatp6 gene (similar to 3.6 Kb) in 213 samples collected after 2005 from the Greater Mekong Subregion, where ART drugs have been used extensively in the past. A total of 24 single nucleotide polymorphisms (SNPs), including 8 newly found in this study and 13 nonsynonymous, were identified. However, these mutations were either uncommon or also present in other geographical regions with limited ART use. None of the mutations were suggestive of directional selection by ARTs. We further analyzed pfatp6 from a worldwide collection of 862 P. falciparum isolates in 19 populations from Asia, Africa, South America and Oceania, which include samples from regions prior to and after deployments ART drugs. A total of 71 SNPs were identified, resulting in 106 nucleotide haplotypes. Similarly, many of the mutations were continent-specific and present at frequencies below 5%. The most predominant and perhaps the ancestral haplotype occurred in 441 samples and was present in 16 populations from Asia, Africa, and Oceania. The 3D7 haplotype found in 54 samples was the second most common haplotype and present in nine populations from all four continents. Assessment of the selection strength on pfatp6 in the 19 parasite populations found that pfatp6 in most of these populations was under purifying selection with an average dN/dS ratio of 0.333. Molecular evolution analyses did not detect significant departures from neutrality in pfatp6 for most populations, challenging the suitability of this gene as a marker for monitoring ART resistance.	[Miao, Miao; Wang, Zenglei; Parker, Daniel M.; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Yang, Zhaoqing; Yuan, Lili] Kunming Med Coll, Dept Parasitol, Kunming, Yunnan, Peoples R China; [Putaporntip, Chaturong; Jongwutiwes, Somchai] Chulalongkorn Univ, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok, Thailand; [Xangsayarath, Phonepadith; Abe, Tomoko; Nakazawa, Shusuke; Kaneko, Osamu] Nagasaki Univ, Dept Protozool, Inst Trop Med NEKKEN, Nagasaki, Japan; [Xangsayarath, Phonepadith; Abe, Tomoko; Nakazawa, Shusuke; Kaneko, Osamu] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki, Japan; [Pongvongsa, Tiengkham] Stn Malariol Parasitol & Entomol, Kaysone Dist, Savannakhet Pro, Laos; [Moji, Hazuhiko] Res Inst Humanity & Nat, Kyoto, Japan; [Trinh Dinh Tuong] Natl Inst Malariol Parasitol & Entomol, Dept Epidemiol, Hanoi, Vietnam; [Kyaw, Myat Phone] Dept Med Res Lower Myanmar, Parasitol Res Div, Yangon, Myanmar; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Sirichaisinthop, Jeeraphat] Vector Borne Dis Training Ctr, Sara Buri, Thailand; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Mu, Jianbing; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Kunming Medical University; Chulalongkorn University; Nagasaki University; Nagasaki University; Research Institute for Humanity & Nature (RIHN); University of California System; University of California Irvine; Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu	, Myat-Phone-Kyaw/P-1750-2019; Parker, Daniel M./B-5471-2013; Prachumsri, Jetsumon/AAZ-7732-2021	Parker, Daniel M./0000-0002-5352-7338; Sattabongkot, Jetsumon/0000-0002-3938-4588; Su, Xinzhuan/0000-0003-3246-3248	Divisions of Intramural Research, the National Institute of Allergy and Infectious Diseases, National Institutes of Health [U19 AI089672, 1R01AI075429]; Grants-in-Aid for Scientific Research [23406022] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, R01AI075429] Funding Source: NIH RePORTER	Divisions of Intramural Research, the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by grants (U19 AI089672 and 1R01AI075429) and by the Divisions of Intramural Research, the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Bacon DJ, 2009, ANTIMICROB AGENTS CH, V53, P2042, DOI 10.1128/AAC.01677-08; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertaux L, 2009, ANTIMICROB AGENTS CH, V53, P4570, DOI 10.1128/AAC.00684-09; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Cui LW, 2009, EXPERT REV ANTI-INFE, V7, P999, DOI [10.1586/eri.09.68, 10.1586/ERI.09.68]; Cui L, 2012, MOL MICROBIOL, V86, P111, DOI 10.1111/j.1365-2958.2012.08180.x; Cui L, 2012, ANTIMICROB AGENTS CH, V56, P2546, DOI 10.1128/AAC.05943-11; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Ferreira ID, 2007, TROP MED INT HEALTH, V12, P353, DOI 10.1111/j.1365-3156.2006.01789.x; FU YX, 1993, GENETICS, V133, P693; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Ibrahim ML, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-28; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jambou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009424; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Krishna S, 2010, TRENDS PARASITOL, V26, P517, DOI 10.1016/j.pt.2010.06.014; Kwansa-Bentum B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-187; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Menegon M, 2008, PARASITOL INT, V57, P233, DOI 10.1016/j.parint.2007.12.004; Meng H, 2010, ANTIMICROB AGENTS CH, V54, P4306, DOI 10.1128/AAC.00321-10; Mugittu K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-126; NEI M, 1986, MOL BIOL EVOL, V3, P418; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Pele J, 2012, BIOS2MDS BIOL SEQUEN; Pillai DR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-131; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Shahinas D, 2010, EMERG INFECT DIS, V16, P1608, DOI [10.3201/eid1610.100427, 10.3201/eid1610.100116]; Tahar R, 2009, AM J TROP MED HYG, V81, P13; TAJIMA F, 1989, GENETICS, V123, P229; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe K, 2004, J MOL EVOL, V59, P687, DOI 10.1007/s00239-004-2662-3; Tanabe K, 2011, ANTIMICROB AGENTS CH, V55, P94, DOI 10.1128/AAC.01156-10; Tanabe K, 2010, CURR BIOL, V20, P1283, DOI 10.1016/j.cub.2010.05.053; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoshima C, 2003, FEBS LETT, V555, P106, DOI 10.1016/S0014-5793(03)01086-X; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Valderramos SG, 2010, ANTIMICROB AGENTS CH, V54, P3842, DOI 10.1128/AAC.00121-10; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, GLOB PLAN ART RES CO, P87; Woodrow Charles J, 2012, Malar J, V11, P186, DOI 10.1186/1475-2875-11-186; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Zhang GQ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-122	66	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59192	10.1371/journal.pone.0059192	http://dx.doi.org/10.1371/journal.pone.0059192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555629	Green Submitted, gold, Green Published			2022-12-27	WOS:000317418500024
J	Fernandez-Real, JM; Puig, J; Serrano, M; Sabater, M; Rubio, A; Moreno-Navarrete, JM; Fontan, M; Casamitjana, R; Xifra, G; Ortega, FJ; Salvador, J; Fruhbeck, G; Ricart, W				Manuel Fernandez-Real, Jose; Puig, Josep; Serrano, Marta; Sabater, Monica; Rubio, Antoni; Maria Moreno-Navarrete, Jose; Fontan, Marina; Casamitjana, Roser; Xifra, Gemma; Jose Ortega, Francisco; Salvador, Javier; Fruehbeck, Gema; Ricart, Wifredo			Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations	PLOS ONE			English	Article							DOMINANT HYPOPHOSPHATEMIC RICKETS; LEFT-VENTRICULAR HYPERTROPHY; FGF23; MORTALITY; FGF-23; BONE; FIBROBLAST-GROWTH-FACTOR-23; OSTEOMALACIA; SENSITIVITY; PHOSPHATE	Fibroblast growth factor 23 (FGF-23) is known to be produced by the bone and linked to metabolic risk. We aimed to explore circulating FGF-23 in association with fatness and insulin sensitivity, atherosclerosis and bone mineral density (BMD). Circulating intact FGF-23 (iFGF-23) and C-terminal (CtFGF-23) concentrations (ELISA) were measured in 133 middle aged men from the general population in association with insulin sensitivity (Cohort 1); and in association with fat mass and bone mineral density (DEXA) and atherosclerosis (intima media thickness, IMT) in 78 subjects (52 women) with a wide range of adiposity (Cohort 2). Circulating iFGF-23 was also measured before and after weight loss. In all subjects as a whole, serum intact and C-terminal concentrations were linearly and positively associated with BMI. In cohort 1, both serum iFGF-23 and CtFGF-23 concentrations increased with insulin resistance. Serum creatinine contributed to iFGF-23 variance, while serum ferritin and insulin sensitivity (but not BMI, age or serum creatinine) contributed to 17% of CtFGF-23 variance. In cohort 2, CtFGF-23 levels were higher in women vs. men, and increased with BMI, fat mass, fasting and post-load serum glucose, insulin, HOMA-IR and PTH, being negatively associated with circulating vitamin D and ferritin levels. The associations of CtFGF-23 with bone density in the radius, lumbar spine and carotid IMT were no longer significant after controlling for BMI. Weight loss led to decreased iFGF-23 concentrations. In summary, the associations of circulating FGF-23 concentration with parameters of glucose metabolism, bone density and atherosclerosis are dependent on iron and obesity status-associated insulin resistance.	[Manuel Fernandez-Real, Jose; Serrano, Marta; Sabater, Monica; Maria Moreno-Navarrete, Jose; Xifra, Gemma; Jose Ortega, Francisco; Ricart, Wifredo] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona, Girona, Spain; [Puig, Josep] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Radiol, Inst Invest Biomed Girona, Girona, Spain; [Rubio, Antoni] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Nucl Med, Inst Invest Biomed Girona, Girona, Spain; [Fontan, Marina] CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Biochem, Inst Invest Biomed Girona, Girona, Spain; [Casamitjana, Roser] CIBERdem, Hormonal Lab, Barcelona, Spain; [Salvador, Javier; Fruehbeck, Gema] CIBERobn Fisiopatol Obesidad & Nutr, Dept Endocrinol & Nutr, Clin Univ Navarra, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Fernandez-Real, JM (corresponding author), CIBERobn Fisiopatol Obesidad & Nutr CB06 03 010, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona, Girona, Spain.	jmfreal@idibgi.org	Ortega, Francisco José J/F-3883-2016; Moreno-Navarrete, José María/ABG-5548-2021; Moreno-Navarrete, José María/H-9772-2015; Sabater-Masdeu, Mònica/G-1168-2016; Fernández-Real, Jose Manuel/AGH-3599-2022	Ortega, Francisco José J/0000-0003-2111-769X; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Sabater-Masdeu, Mònica/0000-0001-9636-0921; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Ricart, Wifredo/0000-0002-3452-9098	Ministerio de Educacion y Ciencia [SAF2005-02073]; Generalitat de Catalunya [2005SGR00947, 2005SGR00467]	Ministerio de Educacion y Ciencia(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (SAF2005-02073), and Generalitat de Catalunya (2005SGR00947 and 2005SGR00467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Durham BH, 2007, ANN CLIN BIOCHEM, V44, P463, DOI 10.1258/000456307781646102; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Grethen E, 2012, J CLIN ENDOCR METAB, V97, P1655, DOI 10.1210/jc.2011-2280; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Holecki M, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/707126; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Marsell R, 2009, OSTEOPOROSIS INT, V20, P1167, DOI 10.1007/s00198-008-0780-2; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Sabater M, 2010, J CLIN ENDOCR METAB, V95, P4720, DOI 10.1210/jc.2010-0630; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Winther K, 2012, SCAND J CLIN LAB INV, V72, P108, DOI 10.3109/00365513.2011.640407; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; World Health Organization Study Group on Assessment of Fracture Risk and Its Application to Screening and Postmenopausal Osteoporosis, 1994, WHO TECHN REP SER, V84; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105	33	31	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58961	10.1371/journal.pone.0058961	http://dx.doi.org/10.1371/journal.pone.0058961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555610	Green Published, Green Submitted, gold			2022-12-27	WOS:000316546400017
J	Chen, CH; Chen, W; Chen, CS; Moyzis, R; He, QH; Lei, XM; Li, J; Wang, YX; Liu, B; Xiu, DM; Zhu, B; Dong, Q				Chen, Chunhui; Chen, Wen; Chen, Chuansheng; Moyzis, Robert; He, Qinghua; Lei, Xuemei; Li, Jin; Wang, Yunxin; Liu, Bin; Xiu, Daiming; Zhu, Bi; Dong, Qi			Genetic Variations in the Serotoninergic System Contribute to Body-Mass Index in Chinese Adolescents	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; RECEPTOR GENE; PROMOTER POLYMORPHISM; ANOREXIA-NERVOSA; FUNCTIONAL POLYMORPHISM; ENVIRONMENTAL-FACTORS; OBESITY RISK; FOOD-INTAKE; ASSOCIATION; TRANSPORTER	Objective: Obesity has become a worldwide health problem in the past decades. Human and animal studies have implicated serotonin in appetite regulation, and behavior genetic studies have shown that body mass index (BMI) has a strong genetic component. However, the roles of genes related to the serotoninergic (5-hydroxytryptamine, 5-HT) system in obesity/BMI are not well understood, especially in Chinese subjects. Subjects and Design: With a sample of 478 healthy Chinese volunteers, this study investigated the relation between BMI and genetic variations of the serotoninergic system as characterized by 136 representative polymorphisms. We used a system-level approach to identify SNPs associated with BMI, then estimated their overall contribution to BMI by multiple regression and verified it by permutation. Results: We identified 12 SNPs that made statistically significant contributions to BMI. After controlling for gender and age, four of these SNPs accounted for 7.7% additional variance of BMI. Permutation analysis showed that the probability of obtaining these findings by chance was low (p = 0.015, permuted for 1000 times). Conclusion: These results showed that genetic variations in the serotoninergic system made a moderate contribution to individual differences in BMI among a healthy Chinese sample, suggesting that a similar approach can be used to study obesity.	[Chen, Chunhui; Chen, Wen; Lei, Xuemei; Li, Jin; Wang, Yunxin; Liu, Bin; Xiu, Daiming; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [He, Qinghua] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	Beijing Normal University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California	Dong, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn	He, Qinghua/B-2573-2008	He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495	111 Project of the Ministry of Education of China [B07008]; National Natural Science Foundation of China [31100807]; Research Fund for the Dectoral Program of Higher Education [20110003120001]	111 Project of the Ministry of Education of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Dectoral Program of Higher Education	This study was supported by the 111 Project (B07008) of the Ministry of Education of China, National Natural Science Foundation of China (31100807), and The Research Fund for the Dectoral Program of Higher Education (20110003120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 2011, J PINEAL RES, V50, P207, DOI 10.1111/j.1600-079X.2010.00830.x; Albay Ricardo III, 2009, BMC Physiology, V9, P4, DOI 10.1186/1472-6793-9-4; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Austin MA, 1997, OBES RES, V5, P326, DOI 10.1002/j.1550-8528.1997.tb00559.x; Bah J, 2010, METABOLISM, V59, P1156, DOI 10.1016/j.metabol.2009.11.007; Bickerdike MJ, 1999, DIABETES OBES METAB, V1, P207, DOI 10.1046/j.1463-1326.1999.00037.x; Bloom SR, 2008, MOL INTERV, V8, P82, DOI 10.1124/mi.8.2.6; Calati R, 2011, INT J EAT DISORDER, V44, P191, DOI 10.1002/eat.20811; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chen CH, 2012, ADDICT BIOL, V17, P479, DOI 10.1111/j.1369-1600.2011.00348.x; Chen CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021636; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Collier DA, 1997, LANCET, V350, P412, DOI 10.1016/S0140-6736(05)64135-9; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cowen PJ, 1996, PSYCHOL MED, V26, P1155, DOI 10.1017/S003329170003587X; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; De Luca V, 2007, INT J NEUROPSYCHOPH, V10, P697, DOI 10.1017/S1461145707007547; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Edwards TL, 2012, AM J EPIDEMIOL, V175, P11, DOI 10.1093/aje/kwr272; Enoch MA, 1998, LANCET, V351, P1785, DOI 10.1016/S0140-6736(05)78746-8; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; FABSITZ RR, 1994, AM J EPIDEMIOL, V140, P711, DOI 10.1093/oxfordjournals.aje.a117319; Farber L, 2004, SCAND J RHEUMATOL, V33, P2, DOI 10.1080/03009740410006943; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fox CS, 2005, J CLIN ENDOCR METAB, V90, P3197, DOI 10.1210/jc.2004-1752; Fuemmeler BF, 2008, OBESITY, V16, P348, DOI 10.1038/oby.2007.65; Furnes MW, 2009, J PHYSIOL PHARMACOL, V60, P25; Ge KeYou, 1997, Asia Pacific Journal of Clinical Nutrition, V6, P175; Godlewska BR, 2009, PHARMACOGENOMICS J, V9, P234, DOI 10.1038/tpj.2009.18; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139; Gunes A, 2009, J CLIN PSYCHOPHARM, V29, P65, DOI 10.1097/JCP.0b013e31819302c3; Halder Indrani, 2007, Metabolic Syndrome and Related Disorders, V5, P323, DOI 10.1089/met.2007.0008; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Hayashi M, 1999, J NEUROCHEM, V73, P2538, DOI 10.1046/j.1471-4159.1999.0732538.x; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hinney A., 1997, Life Sciences, V61, pPL295, DOI 10.1016/S0024-3205(97)00888-6; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hoekstra PJ, 2010, J CHILD ADOL PSYCHOP, V20, P473, DOI 10.1089/cap.2009.0071; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jorm AF, 2003, AUST NZ J PUBL HEAL, V27, P434, DOI 10.1111/j.1467-842X.2003.tb00423.x; Kato M, 2006, WOODHEAD MATERIALS, P3, DOI 10.1533/9781845691127.1.3; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lan MY, 2009, J ENDOCRINOL INVEST, V32, P119, DOI 10.1007/BF03345699; Lei SF, 2006, EUR J CLIN NUTR, V60, P511, DOI 10.1038/sj.ejcn.1602345; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Levitan RD, 2001, BIOL PSYCHIAT, V50, P640, DOI 10.1016/S0006-3223(01)01201-X; Lim JS, 2011, INT J OBESITY, V35, P744, DOI 10.1038/ijo.2010.188; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lohoff' FW, 2008, NEUROSCI LETT, V434, P41, DOI 10.1016/j.neulet.2008.01.024; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MAHATA SK, 1993, NEUROSCI LETT, V156, P70, DOI 10.1016/0304-3940(93)90442-N; Mekhmoukh A, 2012, APPETITE, V59, P90, DOI 10.1016/j.appet.2012.03.021; Mergen H, 2007, ENDOCR J, V54, P89, DOI 10.1507/endocrj.K06-023; Monteleone P, 2006, PSYCHOSOM MED, V68, P99, DOI 10.1097/01.psy.0000195746.52074.63; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nakamura T, 1999, MOL PSYCHIATR, V4, P85, DOI 10.1038/sj.mp.4000474; Need AC, 2006, ANN HUM GENET, V70, P293, DOI 10.1111/j.1469-1809.2005.00228.x; Park YM, 2008, J CLIN PHARM THER, V33, P55, DOI 10.1111/j.1365-2710.2008.00872.x; PETER D, 1995, J NEUROSCI, V15, P6179; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064; Reynolds Gavin P, 2006, J Psychopharmacol, V20, P15, DOI 10.1177/1359786806066040; Ricca V, 2004, NEUROSCI LETT, V365, P92, DOI 10.1016/j.neulet.2004.04.057; Rosmond R, 2002, OBES RES, V10, P585, DOI 10.1038/oby.2002.79; Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701; Ryu S, 2007, PROG NEURO-PSYCHOPH, V31, P673, DOI 10.1016/j.pnpbp.2006.12.021; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Saelens BE, 2012, AM J PREV MED, V42, pE57, DOI 10.1016/j.amepre.2012.02.008; Sakamaki R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-4; Sargent BJ, 2009, BRIT J CLIN PHARMACO, V68, P852, DOI 10.1111/j.1365-2125.2009.03550.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shinozaki G, 2012, PSYCHIAT GENET; Sookoian S, 2008, OBESITY, V16, P488, DOI 10.1038/oby.2007.64; Sorli JV, 2008, APPETITE, V50, P260, DOI 10.1016/j.appet.2007.07.011; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Story M, 2009, J ADOLESCENT HEALTH, V45, pS1, DOI 10.1016/j.jadohealth.2009.06.022; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Sugai T, 2006, PHARMACOGENOMICS J, V6, P351, DOI 10.1038/sj.tpj.6500382; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; van Strien T, 2010, J PSYCHIATR RES, V44, P1035, DOI 10.1016/j.jpsychires.2010.03.012; Vimaleswaran KS, 2010, INT J OBESITY, V34, P1028, DOI 10.1038/ijo.2009.292; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; WHO (World Health Organization), 2009, GLOB DAT BOD MASS IN; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wolden-Hanson T, 2000, ENDOCRINOLOGY, V141, P487, DOI 10.1210/en.141.2.487; World Health Organization, 2000, WHO TECHN REP SER, V894; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhao CM, 2008, CELL TISSUE RES, V331, P575, DOI 10.1007/s00441-007-0514-3; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268; Zhu B, 2012, NEUROPSYCHOBIOLOGY, V65, P83, DOI 10.1159/000329555	99	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58717	10.1371/journal.pone.0058717	http://dx.doi.org/10.1371/journal.pone.0058717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554917	gold, Green Published			2022-12-27	WOS:000316409800023
J	Gu, LJ; Xiong, XX; Wei, DT; Gao, XW; Krams, S; Zhao, H				Gu, Lijuan; Xiong, Xiaoxing; Wei, Dingtai; Gao, Xuwen; Krams, Sheri; Zhao, Heng			T Cells Contribute to Stroke-Induced Lymphopenia in Rats	PLOS ONE			English	Article							ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; ACUTE-PHASE; REG CELLS; IN-VITRO; IMMUNODEPRESSION; BRAIN; HMGB1; IMMUNOSUPPRESSION	Stroke-induced immunodepression (SIID) results when T cell and non-T immune cells, such as B cells, NK cells and monocytes, are reduced in the peripheral blood and spleen after stroke. We investigated the hypothesis that T cells are required for the reductions in non-T cell subsets observed in SIID, and further examined a potential correlation between lymphopenia and High-mobility group protein B1 (HMGB1) release, a protein that regulates inflammation and immunodepression. Our results showed that focal ischemia resulted in similar cortical infarct sizes in both wild type (WT) Sprague Dawley (SD) rats and nude rats with a SD genetic background, which excludes the possibility of different infarct sizes affecting SIID. In addition, the numbers of CD68-positive macrophages in the ischemic brain did not differ between WT and nude rats. Numbers of total peripheral blood mononuclear cells (PBMCs) or splenocytes and lymphocyte subsets, including T cells, CD4(+) or CD8(+) T cells, B cells and monocytes in the blood and spleen, were decreased after stroke in WT rats. In nude rats, however, the total number of PBMCs and absolute numbers of NK cells, B cells and monocytes were increased in the peripheral blood after stroke; nude rats are athymic therefore they have few T cells present. Adoptive transfer of WT splenocytes into nude rats before stroke resulted in lymphopenia after stroke similar to WT rats. Moreover, in vitro T cell proliferation stimulated by Concanavalin A was significantly inhibited in WT rats as well as in nude rats receiving WT splenocyte adoptive transfer, suggesting that T cell function is indeed inhibited after stroke. Lastly, we demonstrated that stroke-induced lymphopenia is associated with a reduction in HMGB1 release in the peripheral blood. In conclusion, T cells are required for stroke-induced reductions in non-T immune cells and they are the most crucial lymphocytes for SIID.	[Gu, Lijuan] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Gu, Lijuan; Xiong, Xiaoxing; Wei, Dingtai; Gao, Xuwen; Zhao, Heng] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Krams, Sheri] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	Zhejiang University; Stanford University; Stanford University	Zhao, H (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Krams, Sheri/0000-0002-6049-5119; Xiong, Xiaoxing/0000-0001-6983-8547	NIH [R01 NS27292-03]; AHA;  [1R01NS064136-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064136, R01NS027292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH R01 NS27292-03 (GKS/HZ), AHA grant in aid and 1R01NS064136-01 (HZ). The funders had no role in study design data collection and analysis decision to publish or preparation of the manuscript.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; BROWN M, 1973, JAMA-J AM MED ASSOC, V224, P1493, DOI 10.1001/jama.224.11.1493; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; Emsley Hedley C. A., 2010, Infectious Disorders - Drug Targets, V10, P91; Gao XW, 2010, TRANSL STROKE RES, V1, P202, DOI 10.1007/s12975-010-0017-5; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hirasawa T, 1998, EXP ANIM TOKYO, V47, P63, DOI 10.1538/expanim.47.63; Huang LF, 2009, SHOCK, V31, P322, DOI 10.1097/SHK.0b013e3181834070; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Inatsu A, 2011, J IMMUNOL, V187, P2155, DOI 10.4049/jimmunol.1003235; Juneja S, 1995, CLIN LAB HAEMATOL, V17, P335; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; KOSTIC V, 1988, EUR NEUROL, V28, P331, DOI 10.1159/000116296; Kurabayashi H, 1996, J MED, V27, P171; Lee MK, 2006, TRANSPLANTATION, V81, P1063, DOI 10.1097/01.tp.0000168365.80771.5a; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; Lommatzsch M, 2005, AM J RESP CRIT CARE, V171, P115, DOI 10.1164/rccm.200406-758OC; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Millicevic NM, 2001, BLOOD, V98, P3035, DOI 10.1182/blood.V98.10.3035; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Sakamoto R, 2001, BIOL PHARM BULL, V24, P906, DOI 10.1248/bpb.24.906; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Schulte-Herbruggen O, 2009, NEUROIMMUNOMODULAT, V16, P213, DOI 10.1159/000205514; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Tarkowski E, 1991, J Clin Lab Immunol, V35, P171; Theodorou GL, 2008, CLIN EXP IMMUNOL, V152, P456, DOI 10.1111/j.1365-2249.2008.03650.x; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030892; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhu XM, 2011, CYTOKINE, V54, P296, DOI 10.1016/j.cyto.2011.02.017	52	20	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59602	10.1371/journal.pone.0059602	http://dx.doi.org/10.1371/journal.pone.0059602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555048	gold, Green Submitted, Green Published			2022-12-27	WOS:000316409800104
J	Tan, WC; Bourbeau, J; Hernandez, P; Chapman, KR; Cowie, R; FitzGerald, JM; Aaron, S; Marciniuk, DD; Maltais, F; Buist, AS; O'Donnell, DE; Sin, DD				Tan, Wan C.; Bourbeau, Jean; Hernandez, Paul; Chapman, Kenneth R.; Cowie, Robert; FitzGerald, J. Mark; Aaron, Shawn; Marciniuk, Darcy D.; Maltais, Francois; Buist, A. Sonia; O'Donnell, Denis E.; Sin, Don D.		CanCOLD Collaborative Res Grp	Bronchodilator Responsiveness and Reported Respiratory Symptoms in an Adult Population	PLOS ONE			English	Article							INSPIRATORY CAPACITY; REVERSIBILITY; COPD; PREVALENCE; EXERCISE; BURDEN; VOLUME	Background: The relationship between patient-reported symptoms and objective measures of lung function is poorly understood. Aim: To determine the association between responsiveness to bronchodilator and respiratory symptoms in random population samples. Methods: 4669 people aged 40 years and older from 8 sites in Canada completed interviewer-administered respiratory questionnaires and performed spirometry before and after administration of 200 ug of inhaled salbutamol. The effect of anthropometric variables, smoking exposure and doctor-diagnosed asthma ( DDA) on bronchodilator responsiveness in forced expiratory volume in 1 second ( FEV1) and in forced vital capacity ( FVC) were evaluated. Multiple logistic regression was used to test for association between quintiles of increasing changes in FEV1 and in FVC after bronchodilator and several respiratory symptoms. Results: Determinants of bronchodilator change in FEV1 and FVC included age, DDA, smoking, respiratory drug use and female gender [p<0.005 to p<0.0001]. In subjects without doctor-diagnosed asthma or COPD, bronchodilator response in FEV1 was associated with wheezing [p for trend<0.0001], while bronchodilator response for FVC was associated with breathlessness. [p for trend <0.0001]. Conclusions: Bronchodilator responsiveness in FEV1 or FVC are associated with different respiratory symptoms in the community. Both flow and volume bronchodilator responses are useful parameters which together can be predictive of both wheezing and breathlessness in the general population.	[Tan, Wan C.; Sin, Don D.] Univ British Columbia, St Pauls Hosp, Providence Heart Lung Inst, UBC James Hogg Res Labs, Vancouver, BC V5Z 1M9, Canada; [Bourbeau, Jean] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Hernandez, Paul] Dalhousie Univ, Dept Med, QEII Hlth Sci Ctr, Div Resp, Halifax, NS, Canada; [Chapman, Kenneth R.] Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON, Canada; [Chapman, Kenneth R.] Univ Toronto, Toronto, ON, Canada; [Cowie, Robert] Univ Calgary, Dept Med, Calgary, AB, Canada; [Cowie, Robert] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [FitzGerald, J. Mark] Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Aaron, Shawn] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Marciniuk, Darcy D.] Univ Saskatchewan, Div Respirol Crit Care & Sleep Med, Saskatoon, SK, Canada; [Marciniuk, Darcy D.] Univ Saskatchewan, Airway Res Grp, Saskatoon, SK, Canada; [Maltais, Francois] Inst Univ Cardiol & Paneumol Quebec, Ctr Pneumol, Quebec City, PQ, Canada; [Buist, A. Sonia] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [O'Donnell, Denis E.] Queens Univ, Div Resp & Crit Care Med, Kingston, ON, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Calgary; University of Calgary; University of British Columbia; University of Ottawa; Ottawa Hospital Research Institute; University of Saskatchewan; University of Saskatchewan; Oregon Health & Science University; Queens University - Canada	Tan, WC (corresponding author), Univ British Columbia, St Pauls Hosp, Providence Heart Lung Inst, UBC James Hogg Res Labs, Vancouver, BC V5Z 1M9, Canada.	wan.tan@hli.ubc.ca	Sin, Don/AAC-2219-2021; Puhan, Milo/ABE-6298-2020; Coxson, Harvey O/A-9861-2017; Lo, Christine/E-4285-2015	Puhan, Milo/0000-0003-4721-1879; Coxson, Harvey O/0000-0001-5750-9711; Aaron, Shawn/0000-0002-4762-3542; Chapman, Kenneth/0000-0002-2498-9859; Lo, Christine/0000-0002-5671-3881	Canadian Institute of Heath Research (CIHR) [93326]; Astra Zeneca Canada Ltd.; Boehringer-Ingelheim Canada Ltd; GlaxoSmithKline Canada Ltd; Merck; Novartis Pharma Canada Inc.; Nycomed Canada Inc.; Pfizer Canada Ltd; Respiratory Health Network of the FRSQ	Canadian Institute of Heath Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Astra Zeneca Canada Ltd.(AstraZeneca); Boehringer-Ingelheim Canada Ltd(Boehringer Ingelheim); GlaxoSmithKline Canada Ltd; Merck(Merck & Company); Novartis Pharma Canada Inc.; Nycomed Canada Inc.; Pfizer Canada Ltd; Respiratory Health Network of the FRSQ	The Canadian Cohort of Obstructive Lung Disease (CanCOLD) is funded by the Canadian Institute of Heath Research (CIHR/Rx&D Collaborative Research Program Operating Grants- 93326); industry partners Astra Zeneca Canada Ltd., Boehringer-Ingelheim Canada Ltd, GlaxoSmithKline Canada Ltd, Merck, Novartis Pharma Canada Inc., Nycomed Canada Inc., Pfizer Canada Ltd; and the Respiratory Health Network of the FRSQ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Ben Saad H, 2008, PULM PHARMACOL THER, V21, P767, DOI 10.1016/j.pupt.2008.04.005; BRAND PLP, 1992, THORAX, V47, P429, DOI 10.1136/thx.47.6.429; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Cerveri I, 2000, J APPL PHYSIOL, V88, P1989, DOI 10.1152/jappl.2000.88.6.1989; DALES RE, 1988, AM REV RESPIR DIS, V138, P317, DOI 10.1164/ajrccm/138.2.317; Di Marco F, 2003, EUR RESPIR J, V21, P86, DOI 10.1183/09031936.03.00020102; Diaz O, 2000, EUR RESPIR J, V16, P269, DOI 10.1034/j.1399-3003.2000.16b14.x; ELIASSON O, 1985, AM REV RESPIR DIS, V132, P858; Hanania NA, 2011, CHEST, V140, P1055, DOI 10.1378/chest.10-2974; Hansen EF, 2005, EUR RESPIR J, V26, P6, DOI 10.1183/09031936.05.00052805; Hyatt RE, 2009, CHEST, V135, P419, DOI 10.1378/chest.08-1235; Kainu A, 2008, CHEST, V134, P387, DOI 10.1378/chest.07-2207; Lehmann S, 2004, RESP MED, V98, P1071, DOI 10.1016/j.rmed.2004.03.019; Lehmann S, 2007, RESP MED, V101, P1183, DOI 10.1016/j.rmed.2006.11.007; Methvin JN, 2009, CHEST, V135, P102, DOI 10.1378/chest.08-1315; Newton MF, 2002, CHEST, V121, P1042, DOI 10.1378/chest.121.4.1042; O'Donnell DE, 1998, AM J RESP CRIT CARE, V158, P1557, DOI 10.1164/ajrccm.158.5.9804004; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; RAMSDELL JW, 1979, CHEST, V76, P622, DOI 10.1378/chest.76.6.622; SOURK RL, 1983, AM REV RESPIR DIS, V128, P153, DOI 10.1164/arrd.1983.128.1.153; Tan WC, 2011, INT J TUBERC LUNG D, V15, P1691, DOI 10.5588/ijtld.11.0211; Tan WC, 2012, THORAX, V67, P718, DOI 10.1136/thoraxjnl-2011-201445; Tashkin DP, 2008, EUR RESPIR J, V31, P742, DOI 10.1183/09031936.00129607; van Schayck CP, 2002, BMJ-BRIT MED J, V324, P1370, DOI 10.1136/bmj.324.7350.1370; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Walker PP, 2008, COPD, V5, P147, DOI 10.1080/15412550802092928	28	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58932	10.1371/journal.pone.0058932	http://dx.doi.org/10.1371/journal.pone.0058932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554960	Green Published, gold			2022-12-27	WOS:000316409800048
J	Bieringer, M; Han, JW; Kendl, S; Khosravi, M; Plattet, P; Schneider-Schaulies, J				Bieringer, Maria; Han, Jung Woo; Kendl, Sabine; Khosravi, Mojtaba; Plattet, Philippe; Schneider-Schaulies, Juergen			Experimental Adaptation of Wild-Type Canine Distemper Virus (CDV) to the Human Entry Receptor CD150	PLOS ONE			English	Article							MEASLES-VIRUS; CELLULAR RECEPTOR; SLAM CD150; NATURAL INFECTION; RHESUS-MONKEYS; HEMAGGLUTININ; PROTEIN; MORBILLIVIRUSES; NECTIN4; CDW150	Canine distemper virus (CDV), a close relative of measles virus (MV), is widespread and well known for its broad host range. When the goal of measles eradication may be achieved, and when measles vaccination will be stopped, CDV might eventually cross the species barrier to humans and emerge as a new human pathogen. In order to get an impression how fast such alterations may occur, we characterized required adaptive mutations to the human entry receptors CD150 (SLAM) and nectin-4 as first step to infect human target cells. Recombinant wild-type CDV-A75/17(red) adapted quickly to growth in human H358 epithelial cells expressing human nectin-4. Sequencing of the viral attachment proteins (hemagglutinin, H, and fusion protein, F) genes revealed that no adaptive alteration was required to utilize human nectin-4. In contrast, the virus replicated only to low titres (10(2) pfu/ml) in Vero cells expressing human CD150 (Vero-hSLAM). After three passages using these cells virus was adapted to human CD150 and replicated to high titres (10(5) pfu/ml). Sequence analyses revealed that only one amino acid exchange in the H-protein at position 540 Asp -> Gly (D540G) was required for functional adaptation to human CD150. Structural modelling suggests that the adaptive mutation D540G in H reflects the sequence alteration from canine to human CD150 at position 70 and 71 from Pro to Leu (P70L) and Gly to Glu (G71E), and compensates for the gain of a negative charge in the human CD150 molecule. Using this model system our data indicate that only a minimal alteration, in this case one adaptive mutation, is required for adaptation of CDV to the human entry receptors, and help to understand the molecular basis why this adaptive mutation occurs.	[Bieringer, Maria; Han, Jung Woo; Kendl, Sabine; Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Khosravi, Mojtaba; Plattet, Philippe] Univ Bern, Dept Clin Vet Med, Vetsuisse Fac, Bern, Switzerland	University of Wurzburg; University of Bern	Schneider-Schaulies, J (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, Wurzburg, Germany.	jss@vim.uni-wuerzburg.de	khosravi, mojtaba/AAV-5148-2021	Schneider-Schaulies, Jurgen/0000-0001-7713-5518	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL MJG, 1984, ARCH VIROL, V82, P73, DOI 10.1007/BF01309369; Baron MD, 2005, J GEN VIROL, V86, P1753, DOI 10.1099/vir.0.80836-0; Beineke A, 2009, VET IMMUNOL IMMUNOP, V127, P1, DOI 10.1016/j.vetimm.2008.09.023; de Vries RD, 2010, J VIROL, V84, P4714, DOI 10.1128/JVI.02633-09; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; Harder TC, 1997, TRENDS MICROBIOL, V5, P120, DOI 10.1016/S0966-842X(97)01010-X; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Muhlebach MD, 2011, NATURE; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; OSTERHAUS ADME, 1989, VET REC, V125, P647; Otsuki N, 2013, VIROLOGY, V435, P485, DOI 10.1016/j.virol.2012.10.033; Pratakpiriya W, 2012, J VIROL, V86, P10207, DOI 10.1128/JVI.00824-12; Qiu W, 2011, EMERG INFECT DIS, V17, P1541, DOI 10.3201/eid1708.101153; Rivals JP, 2007, VIROLOGY, V359, P6, DOI 10.1016/j.virol.2006.07.054; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; ROHOWSKYKOCHAN C, 1995, NEUROLOGY, V45, P1554, DOI 10.1212/WNL.45.8.1554; Sakai K, 2012, J VIROL; Sawatsky B, 2012, J VIROL, V86, P3658, DOI 10.1128/JVI.06414-11; Seki F, 2003, J VIROL, V77, P9943, DOI 10.1128/JVI.77.18.9943-9950.2003; Strebel PM, 2011, J INFECT DIS, V204, pS1, DOI 10.1093/infdis/jir111; Sun ZZ, 2010, VET MICROBIOL, V141, P374, DOI 10.1016/j.vetmic.2009.09.024; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2002, MICROBIOL IMMUNOL, V46, P135, DOI 10.1111/j.1348-0421.2002.tb02678.x; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wiener D, 2010, VIRUS RES, V153, P234, DOI 10.1016/j.virusres.2010.08.007; YOSHIKAWA Y, 1989, VET MICROBIOL, V20, P193, DOI 10.1016/0378-1135(89)90043-6; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	33	55	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e57488	10.1371/journal.pone.0057488	http://dx.doi.org/10.1371/journal.pone.0057488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554862	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500004
J	Demircik, F; Buch, T; Waisman, A				Demircik, Filiz; Buch, Thorsten; Waisman, Ari			Efficient B Cell Depletion via Diphtheria Toxin in CD19-Cre/iDTR Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASES; IN-VIVO; RITUXIMAB; LYMPHOMA; LYMPHOCYTES	B cells were first discovered as antibody producing cell as B-1 B cells and finally as effector cells. In recent years their capacity to serve as antigen presenting cells is Increasingly appreciated, and better tools are needed to study their function. We have previously described a new mouse model, the IDTR mice, that allow for the Cre-mediated expression of the diphtheria toxin receptor, thus rendering cells that express the Cre-recombinase sensitivity to diphtheria toxin. Herein describe a new mouse line, the B-DTR mice, where the CD19-Cre was crossed to the iDTR mice. B-DTR allows for the efficient and cost-effective depletion of different B cell subpopulations, but only partially plasma cells. These mice can therefore be used to study the importance of B cells versus plasma cells in different immune responses and autoimmune diseases.	[Demircik, Filiz; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany	Johannes Gutenberg University of Mainz; Technical University of Munich	Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany.	waisman@uni-mainz.de	Buch, Thorsten/P-1659-2019; Waisman, Ari/C-7383-2015	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school [GRK 1043]; DFG [WA 1600/3-1, SFB/TR 52, FOR1336]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by funds via the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) graduate school GRK 1043 to AW and by the DFG grants WA 1600/3-1, SFB/TR 52 and the DFG research group FOR1336 to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barun B, 2011, CLIN IMMUNOL; Beck LH, 2011, J AM SOC NEPHROL, V22, P1543, DOI 10.1681/ASN.2010111125; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CERNY A, 1989, CLIN EXP IMMUNOL, V77, P124; CERNY A, 1987, J IMMUNOL, V138, P4222; Cooper N, 2010, BRIT J HAEMATOL, V149, P3, DOI 10.1111/j.1365-2141.2010.08076.x; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dorner T, 2009, AUTOIMMUN REV, V9, P82, DOI 10.1016/j.autrev.2009.08.007; Ezconycji AN, 2011, RHEUMATOLOGY; Hagemeister F, 2010, DRUGS, V70, P261, DOI 10.2165/11532180-000000000-00000; Hagenbeek A, 2008, BLOOD, V111, P5486, DOI 10.1182/blood-2007-10-117671; Hasegawa M, 2006, AM J PATHOL, V169, P954, DOI 10.2353/ajpath.2006.060205; Hauser Stephen L, 2008, N Engl J Med, V358, P676, DOI 10.1056/NEJMoa0706383; Kessel A, 2008, CLIN REV ALLERG IMMU, V34, P74, DOI 10.1007/s12016-008-8074-1; Lehmann-Horn K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-146; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Martinez-Gamboa L, 2006, AUTOIMMUN REV, V5, P437, DOI 10.1016/j.autrev.2006.02.004; RAYFIELD LS, 1989, IMMUNOL LETT, V20, P21, DOI 10.1016/0165-2478(89)90063-1; Reff M E, 1994, Blood, V83, P435; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rubtsov AV, 2011, BLOOD; SCHEUERMANN RH, 1995, LEUKEMIA LYMPHOMA, V18, P385, DOI 10.3109/10428199509059636; SLAPERCORTENBACH ICM, 1990, EXP HEMATOL, V18, P49; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Waisman A, 2008, MED MICROBIOL IMMUN, V197, P145, DOI 10.1007/s00430-008-0088-z; WALDOR MK, 1984, P NATL ACAD SCI-BIOL, V81, P2855, DOI 10.1073/pnas.81.9.2855; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; WINTER JN, 1987, INT J CANCER, V39, P670, DOI 10.1002/ijc.2910390603; Zocher M, 2003, INT IMMUNOL, V15, P789, DOI 10.1093/intimm/dxg076	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60643	10.1371/journal.pone.0060643	http://dx.doi.org/10.1371/journal.pone.0060643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544158	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700117
J	Gotz, A; Jessberger, R				Goetz, Anne; Jessberger, Rolf			Dendritic Cell Podosome Dynamics Does Not Depend on the F-actin Regulator SWAP-70	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; OSTEOCLASTS; ADHESION; ZONE	In addition to classical adhesion structures like filopodia or focal adhesions, dendritic cells similar to macrophages osteoclasts assemble highly dynamic F-actin structures called podosomes. They are involved in cellular processes such as extracellular matrix degradation, bone resorption by osteoclasts, and trans-cellular diapedesis of lymphocytes. Besides adhesion and migration, podosomes enable dendritic cells to degrade connective tissue by matrix metalloproteinases. SWAP-70 interacts with RhoGTPases and F-actin and regulates migration of dendritic cells. SWAP-70 deficient osteoclasts are impaired in F-actin-ring formation and bone resorption. In the present study, we demonstrate that SWAP-70 is not required for podosome formation and F-actin turnover in dendritic cells. Furthermore, we found that toll like receptor 4 ligand induced podosome disassembly and podosome-mediated matrix degradation is not affected by SWAP-70 in dendritic cells. Thus, podosome formation and function in dendritic cells is independent SWAP-70.	[Goetz, Anne; Jessberger, Rolf] Tech Univ Dresden, Inst Physiol Chem, Fac Med Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden	Jessberger, R (corresponding author), Tech Univ Dresden, Inst Physiol Chem, Fac Med Carl Gustav Carus, Dresden, Germany.	rolf.jessberger@tu-dresden.de	Goetz, Anton/M-7208-2017	Goetz, Anton/0000-0002-3847-6376	DFG (German Research Foundation) [JE 150/10-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number JE 150/10-1 from the DFG (German Research Foundation); http://www.dfg.de.	Altman A, 2009, IMMUNITY, V31, P1, DOI 10.1016/j.immuni.2009.06.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chacon Martinez CA, 2011, REGULATION ACTIN DYN; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chopin M, 2011, EUR J IMMUNOL, V41, P3063, DOI 10.1002/eji.201141742; Chopin M, 2010, EUR J IMMUNOL, V40, P3544, DOI 10.1002/eji.201040556; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Garbe AI, 2012, J BONE MINER RES, V27, P2085, DOI 10.1002/jbmr.1670; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Hilpela P, 2003, MOL BIOL CELL, V14, P3242, DOI 10.1091/mbc.e03-01-0043; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Ihara S, 2006, J CELL SCI, V119, P500, DOI 10.1242/jcs.02767; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oberbanscheidt P, 2007, EUR J CELL BIOL, V86, P13, DOI 10.1016/j.ejcb.2006.08.005; Ocana-Morgner C, 2011, J IMMUNOL, V186, P5345, DOI 10.4049/jimmunol.1003461; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Sivalenka RR, 2004, MOL CELL BIOL, V24, P10277, DOI 10.1128/MCB.24.23.10277-10288.2004; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; West MA, 2008, J CELL BIOL, V182, P993, DOI 10.1083/jcb.200801022	35	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60642	10.1371/journal.pone.0060642	http://dx.doi.org/10.1371/journal.pone.0060642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544157	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700116
J	Li, R; Wang, YM; Liu, YJ; Chen, QJ; Fu, WC; Wang, H; Cai, H; Peng, W; Zhang, XM				Li, Rui; Wang, Yunman; Liu, Yujun; Chen, Qijing; Fu, Wencheng; Wang, Hao; Cai, Hui; Peng, Wen; Zhang, Xuemei			Curcumin Inhibits Transforming Growth Factor-beta 1-Induced EMT via PPAR gamma Pathway, Not Smad Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; TGF-BETA; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; GENE-EXPRESSION; MULTIPLE SITES; FIBROSIS; RATS; MECHANISMS; PHOSPHORYLATION	Tubulointerstitial fibrosis (TIF) is the final common pathway in the end-stage renal disease. Epithelial-to-mesenchymal transition (EMT) is considered a major contributor to the TIF by increasing the number of myofibroblasts. Curcumin, a polyphenolic compound derived from rhizomes of Curcuma, has been shown to possess potent anti-fibrotic properties but the mechanism remains elusive. We found that curcumin inhibited the EMT as assessed by reduced expression of alpha-SMA and PAI-1, and increased E-cadherin in TGF-beta 1 treated proximal tubular epithelial cell HK-2 cells. Both of the conventional TGF-beta 1/Smad pathway and non-Smad pathway were investigated. Curcumin reduced TGF-beta receptor type I (T beta R-I) and TGF-beta receptor type II (T beta R II), but had no effect on phosphorylation of Smad2 and Smad3. On the other hand, in non-Smad pathway curcumin reduced TGF-beta 1-induced ERK phosphorylation and PPAR gamma phosphorylation, and promoted nuclear translocation of PPAR gamma. Further, the effect of curcumin on alpha-SMA, PAI-1, E-cadherin, T beta R I and T beta R II were reversed by ERK inhibitor U0126 or PPAR gamma inhibitor BADGE, or PPAR gamma shRNA. Blocking PPAR gamma signaling pathway by inhibitor BADGE or shRNA had no effect on the phosphorylation of ERK whereas the suppression of ERK signaling pathway inhibited the phosphorylation of PPAR gamma. We conclude that curcumin counteracted TGF-beta 1-induced EMT in renal tubular epithelial cells via ERK-dependent and then PPAR gamma-dependent pathway.	[Li, Rui; Chen, Qijing; Zhang, Xuemei] Fudan Univ, Dept Pharmacol, Sch Pharm, Shanghai 200433, Peoples R China; [Wang, Yunman; Liu, Yujun; Fu, Wencheng; Wang, Hao; Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai, Peoples R China; [Cai, Hui] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA; [Cai, Hui] Atlanta Vet Adm Med Ctr, Renal Sect, Decatur, GA USA	Fudan University; Shanghai University of Traditional Chinese Medicine; Emory University	Peng, W (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai, Peoples R China.	wenpeng@shutcm.edu.cn; xuemzhang@fudan.edu.cn			Natural Science Foundation of Shanghai [11ZR1433200]; Science Foundation of Shanghai Education Commission [2010JW61]; Science and Technology of Putuo District, Shanghai [2008PTKW010]; College of the Shanghai Municipal Education Commission, China	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Science Foundation of Shanghai Education Commission; Science and Technology of Putuo District, Shanghai; College of the Shanghai Municipal Education Commission, China	This research was supported by Natural Science Foundation of Shanghai (NO.11ZR1433200), Science Foundation of Shanghai Education Commission (NO.2010JW61), Science and Technology of Putuo District, Shanghai (NO.2008PTKW010) and the Innovation Team of the College of the Shanghai Municipal Education Commission, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P246, DOI 10.1016/j.reprotox.2008.10.001; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Burgermeister E, 2008, PPAR RES, V2008, DOI 10.1155/2008/309469; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Chen AP, 2005, AM J PHYSIOL-GASTR L, V288, pG447, DOI 10.1152/ajpgi.00209.2004; Chung BH, 2005, NEPHROLOGY, V10, pS40, DOI 10.1111/j.1440-1797.2005.00456.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gao JS, 2011, EUR J PHARMACOL, V654, P92, DOI 10.1016/j.ejphar.2010.12.008; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Han JY, 2010, J KOREAN MED SCI, V25, P35, DOI 10.3346/jkms.2010.25.1.35; Hu Y, 2010, AM J NEPHROL, V31, P332, DOI 10.1159/000287230; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kiss-Toth E, 2008, PPAR RES, V2008, DOI 10.1155/2008/183108; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Kuwabara N, 2006, UROLOGY, V67, P440, DOI 10.1016/j.urology.2005.09.028; Li Yu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1224; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Narala VR, 2009, GENE THER MOL BIOL, V13, P20; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang JC, 2009, CLIN SCI, V116, P17, DOI 10.1042/CS20070462; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yao QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-156; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	42	58	62	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58848	10.1371/journal.pone.0058848	http://dx.doi.org/10.1371/journal.pone.0058848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544048	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700011
J	Shao, L; Xu, L; You, QS; Wang, YX; Chen, CX; Yang, H; Zhou, JQ; Jonas, JB; Wei, WB				Shao, Lei; Xu, Liang; You, Qi Sheng; Wang, Ya Xing; Chen, Chang Xi; Yang, Hua; Zhou, Jin Qiong; Jonas, Jost B.; Wei, Wen Bin			Prevalence and Associations of Incomplete Posterior Vitreous Detachment in Adult Chinese: The Beijing Eye Study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VITREOMACULAR TRACTION; MACULAR THICKNESS; POPULATION	Purpose: To determine prevalence and associations of incomplete posterior vitreous detachment (PVD). Methods: The population-based cross-sectional Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed including spectral-domain optical coherence tomography (SD-OCT). Incomplete PVD was differentiated into type 1 (shallow PVD with circular perifoveal vitreous attachment), type 2 (PVD reaching fovea but not foveola), type 3 (shallow PVD with pinpoint vitreous attachment at the foveola), and type 4 (PVD completely detached from the macula, attached to the optic disc). Results: An incomplete PVD was detected in 3948 eyes (prevalence: 60.5 +/- 0.6%; 95% Confidence Interval (CD: 59.3%,61.7%) of 2198 subjects (67.1 +/- 0.8%;95%CI: 65.6%,68.7%). Type 1 PVD was seen in 3090 (78.3%) eyes, type 2 PVD in 504 (12.8%) eyes, type 3 PVD in 70 (1.8%) eyes, and type 4 PVD in 284 (7.2%) eyes. Prevalence of incomplete PVD was associated with younger age (P<0.001;OR:0.91), male gender (P<0.001;OR:0.64), rural region of habitation (P<0.001;OR:0.49), larger corneal diameter (P=0.04;OR:0.91), better best corrected visual acuity (P=0.02;OR:0.41), and hyperopic refractive error (P<0.001;OR:1.15). The type of incomplete PVD was associated with higher age (P<0.001), urban region of habitation (P<0.001), myopic refractive error (P=0.001), thinner cornea (P=0.005), and better best corrected visual acuity (P=0.056). Conclusions: In adult Chinese in Greater Beijing, prevalence of an incomplete PVD (detected in 67.1% subjects) was associated with younger age, male gender, rural region of habitation, larger corneal diameter, better best corrected visual acuity and hyperopic refractive error.	[Shao, Lei; Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Xu, Liang; You, Qi Sheng; Wang, Ya Xing; Chen, Chang Xi; Yang, Hua; Zhou, Jin Qiong; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China.	wenbing_wei@yahoo.com.cn	You, Qisheng/AAG-7153-2020; wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016; You, Qisheng/A-3619-2014	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	This work was supported by State Natural Sciences Fund (grant #81041018) and Natural Sciences Fund of Beijing government (grant #7092021, 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung CM, 2013, AM J OPHTHA IN PRESS; Chuo JY, 2006, AM J OPHTHALMOL, V142, P931, DOI 10.1016/j.ajo.2006.08.002; Duan XR, 2010, OPHTHALMOLOGY, V117, P1585, DOI 10.1016/j.ophtha.2009.12.036; Eriksson U, 2009, ACTA OPHTHALMOL, V87, P741, DOI 10.1111/j.1755-3768.2008.01357.x; Gallemore RP, 2000, RETINA-J RET VIT DIS, V20, P115, DOI 10.1097/00006982-200002000-00002; Hayreh SS, 2004, OPHTHALMOLOGICA, V218, P333, DOI 10.1159/000079476; HEE MR, 1995, OPHTHALMOLOGY, V102, P748, DOI 10.1016/S0161-6420(95)30959-1; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P2351, DOI 10.1167/iovs.05-1396; Johnson MW, 2005, AM J OPHTHALMOL, V140, P184, DOI 10.1016/j.ajo.2005.01.033; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe185, DOI 10.1111/j.1755-3768.2011.02316.x; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; Koizumi H, 2008, AM J OPHTHALMOL, V145, P509, DOI 10.1016/j.ajo.2007.10.014; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Mirza RG, 2007, SURV OPHTHALMOL, V52, P397, DOI 10.1016/j.survophthal.2007.04.007; Panozzo G, 2007, ARCH OPHTHALMOL-CHIC, V125, P767, DOI 10.1001/archopht.125.6.767; Schwab C, 2012, ACTA OPHTHALMOL, V90, pe179, DOI 10.1111/j.1755-3768.2011.02310.x; Sebag J, 1989, VITREOUS STRUCTURE F, P80; Shui YB, 2009, ARCH OPHTHALMOL-CHIC, V127, P475, DOI 10.1001/archophthalmol.2008.621; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Uchino E, 2001, ARCH OPHTHALMOL-CHIC, V119, P1475; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004	22	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58498	10.1371/journal.pone.0058498	http://dx.doi.org/10.1371/journal.pone.0058498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544043	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700006
J	Wang, MY; Jiang, XB; Wu, WL; Zhang, DF				Wang, Meiyun; Jiang, Xiubo; Wu, Wenlong; Zhang, Dongfeng			Endothelial NO Synthase Gene Polymorphisms and Risk of Ischemic Stroke in Asian Population: A Meta-Analysis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; 27-BP REPEAT POLYMORPHISM; GLU298ASP POLYMORPHISM; CHINESE POPULATION; INDIAN POPULATION; SERUM-CHOLESTEROL; ENOS GENE; ASSOCIATION; INTRON-4; HYPERTENSION	Background:The association between polymorphism 4b/a, T-786C and G894T in endothelial NO synthase gene (eNOS) and ischemic stroke (IS) remains controversial in Asian. A meta-analysis was performed to better clarify the association between eNOS gene and IS risk. Methods: Based on the search of PubMed, Web of Science (ISI), CNKI (National Knowledge Infrastructure), Wan Fang Med Online and CBM (Chinese Biology Medical Literature Database) databases, all eligible case-control or cohort studies were identified. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) from fixed and random effect models were calculated. Heterogeneity among studies was evaluated using the I-2. Meta-regression was used to explore the potential sources of between-study heterogeneity. Begg's test was used to estimate publication bias. Results:Our study included 27 articles, contained 28 independent case-control studies, involved a total of 3,742 cases and 3,691 controls about 4b/a, 1,800 cases and 1,751 controls about T-786C and 2,747 cases and 2,872 controls about G894T. A significant association of 4a allele with increased risk of IS was found in dominant (FEM: OR= 1.498, 95% CI = 1.329-1.689), recessive (FEM: OR 2.132, 95% CI = 1.383-3.286) and codominant (REM: OR = 1.456, 95% CI = 1.235-1.716) models. For T-786C and G894T, there were significant associations with dominant and codominant genetic models, but not with recessive genetic model. Conclusions:The meta-analysis indicated that eNOS gene 4b/a, T-786C, G894T polymorphism might be associated with IS.	[Wang, Meiyun; Jiang, Xiubo; Wu, Wenlong; Zhang, Dongfeng] Qingdao Univ, Coll Med, Dept Epidemiol & Hlth Stat, Qingdao, Shandong, Peoples R China	Qingdao University	Jiang, XB (corresponding author), Qingdao Univ, Coll Med, Dept Epidemiol & Hlth Stat, Qingdao, Shandong, Peoples R China.	jiangxiubo2005@126.com; zhangdf1961@126.com			Natural Science Foundation of Shandong Province [ZR2010HM100]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by the Natural Science Foundation of Shandong Province (grant # ZR2010HM100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 1996, J CEREBR BLOOD F MET, V16, P539, DOI 10.1097/00004647-199607000-00002; Banerjee I, 2008, BRAIN RES BULL, V75, P158, DOI 10.1016/j.brainresbull.2007.08.007; Begg CB, 2002, STAT MED, V21, P1803, DOI 10.1002/sim.1162; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; Cheng JQ, 2008, CLIN CHIM ACTA, V392, P46, DOI 10.1016/j.cca.2008.03.004; [崔金环 CUI JinHuan], 2007, [中国老年学杂志, Chinese Journal of Gerontology], V27, P2197; Di Q, 2004, CHIN MED ABSTR GER, V13, P245; Duggirala R, 1996, STROKE, V27, P833, DOI 10.1161/01.STR.27.5.833; [方玲 Fang Ling], 2011, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V37, P687; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Guldiken B, 2009, MOL BIOL REP, V36, P1539, DOI 10.1007/s11033-008-9348-7; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hou L, 2001, NEUROLOGY, V56, P490, DOI 10.1212/WNL.56.4.490; Ioannidis JPA, 2006, INT J EPIDEMIOL, V35, P572, DOI 10.1093/ije/dyl003; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Kim OJ, 2010, MOL MED REP, V3, P509, DOI 10.3892/mmr_00000289; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li X, 2011, J MUDANJIANG MED U, V32, P31; Li YY, 2011, INTERNAL MED, V50, P2099, DOI 10.2169/internalmedicine.50.5856; Luo N, 2011, MED INNOVAT CHINA, V8, P1; Lv H, 2004, CHINESE J CLIN REHAB, V4, P69; Majumdar V, 2010, J ATHEROSCLER THROMB, V17, P45, DOI 10.5551/jat.1560; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Moc KT, 2008, EUR J NEUROL, V15, P1309; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munshi A, 2010, BRAIN RES BULL, V82, P247, DOI 10.1016/j.brainresbull.2010.05.008; NADAUD S, 1994, BIOCHEM BIOPH RES CO, V198, P1027, DOI 10.1006/bbrc.1994.1146; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; Pereira AC, 2006, ATHEROSCLEROSIS, V184, P193, DOI 10.1016/j.atherosclerosis.2005.03.035; Pu XY, 2003, J CLIN NEUROL, V16, P199; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Salanti G, 2008, STAT MED, V27, P764, DOI 10.1002/sim.2919; Salanti G, 2009, AM J EPIDEMIOL, V170, P537, DOI 10.1093/aje/kwp145; Sawada T, 2008, PREV MED, V47, P167, DOI 10.1016/j.ypmed.2008.04.006; Song J, 2010, INT J MOL MED, V25, P819, DOI 10.3892/ijmm_00000410; Song YQ, 2005, CHINJ GERIATR, V24, P809; Tao HM, 2009, NEUROSCI RES, V64, P311, DOI 10.1016/j.neures.2009.04.001; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Wang L, 2007, J FUJIAN MED U; [许丹 Xu Dan], 2004, [中国老年学杂志, Chinese Journal of Gerontology], V24, P340; Yahashi Y, 1998, BLOOD COAGUL FIBRIN, V9, P405, DOI 10.1097/00001721-199807000-00002; Yan JT, 2011, ACTA PHARMACOL SIN, V32, P1357, DOI 10.1038/aps.2011.114; Yemisci M, 2009, FREE RADICAL RES, V43, P272, DOI 10.1080/10715760802691489; Zhang C, 2004, ACTA ACAD MED QINGDA, V40, P283; Zhang XM, 2007, J ZHENGZHOU U; Zhang ZI, 2009, HLTH RES, V29, P180; Zhou XY, 2009, J NINGXIA MED U, V31, P306; 孟秀君, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P1567; 韩红星, 2010, [中国老年学杂志, Chinese Journal of Gerontology], V30, P1352	56	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60472	10.1371/journal.pone.0060472	http://dx.doi.org/10.1371/journal.pone.0060472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544143	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700102
J	Demir, M; Lang, S; Schlattjan, M; Drebber, U; Wedemeyer, I; Nierhoff, D; Kaul, I; Sowa, J; Canbay, A; Tox, U; Steffen, HM				Demir, Muenevver; Lang, Sonja; Schlattjan, Martin; Drebber, Uta; Wedemeyer, Inga; Nierhoff, Dirk; Kaul, Ingrid; Sowa, Jan; Canbay, Ali; Toex, Ulrich; Steffen, Hans-Michael			NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HUMAN NONALCOHOLIC STEATOHEPATITIS; MARKERS; PREDICT; VALIDATION; MORTALITY; DIAGNOSIS; BIOPSY; OBESE	Aims: To develop, validate and compare a non-invasive fibrosis scoring system for non-alcoholic fatty liver disease (NAFLD) derived from routinely obtained clinical and biochemical parameters. Methods: 267 consecutive patients with biopsy proven fatty liver or non-alcoholic steatohepatitis were randomly assigned to the estimation (2/3) or validation (1/3) group to develop a model for the prediction of advanced fibrosis. Univariate statistics were performed to compare patients with and without advanced fibrosis, and following a multivariate logistic regression analysis a new scoring system was constructed. This non-invasive Koeln-Essen-index (NIKEI) was validated and compared to the FIB-4 index by calculating the area under the receiver operating characteristic curve (AUC). We evaluated a stepwise combination of both scoring systems for the precise prediction of advanced fibrosis. To set in contrast, we additionally tested the diagnostic accuracy of the AST/ALT ratio, BARD score and the NAFLD fibrosis score in our cohort. Results: Age, AST, AST/ALT ratio, and total bilirubin were identified as significant predictors of advanced fibrosis and used to construct the NIKEI with an AUC of 0.968 [ 0.937; 0.998] compared to 0.929 [ 0.869; 0.989] for the FIB-4 index. The absence of advanced fibrosis could be confirmed with excellent accuracy (99-100%). The positive predictive value of the FIB-4 index was higher (100% vs. 60%), however, the false negative rate was also high (33%). With a stepwise combination of both indices 82%-84% of biopsies would have been avoidable without a single misclassification. The AUROC for AST/ALT ratio, the NAFLD fibrosis score, and the BARD score were 0.81 (95% CI, 0.72-0.90), 0.96 (95% CI 0.92-0.99), and 0.67 (95% CI 0.55-0.78), respectively. Conclusion: The NIKEI can reliably exclude advanced fibrosis in subjects with NAFLD. In combination with the FIB-4 index misclassification with inadequate clinical management can be avoided while the need for liver biopsies can be reduced.	[Demir, Muenevver; Lang, Sonja; Nierhoff, Dirk; Toex, Ulrich; Steffen, Hans-Michael] Univ Hosp Cologne, Clin Gastroenterol & Hepatol, Cologne, Germany; [Schlattjan, Martin; Sowa, Jan; Canbay, Ali] Univ Hosp Essen, Clin Gastroenterol & Hepatol, Essen, Germany; [Drebber, Uta; Wedemeyer, Inga] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Kaul, Ingrid] Univ Hosp Cologne, Inst Med Stat Informat & Epidemiol, Cologne, Germany	University of Cologne; University of Duisburg Essen; University of Cologne; University of Cologne	Demir, M (corresponding author), Univ Hosp Cologne, Clin Gastroenterol & Hepatol, Cologne, Germany.	muenevver.demir@uk-koeln.de	Canbay, Ali/AAL-9620-2020; Sowa, Jan-Peter/AAQ-6318-2020	Canbay, Ali/0000-0001-6069-7899; Demir, Munevver/0000-0002-7050-797X; Becker, Ingrid/0000-0001-5829-3553				Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; dos Santos VN, 2005, BRAZ J MED BIOL RES, V38, P747, DOI 10.1590/S0100-879X2005000500012; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Francque SMA, 2012, CLIN GASTROENTEROL H, V10, P1162, DOI 10.1016/j.cgh.2012.06.019; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Horoz M, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-35; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Lydatakis H, 2006, LIVER INT, V26, P864, DOI 10.1111/j.1478-3231.2006.01312.x; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Miller MH, 2011, LIVER INT, V31, P461, DOI 10.1111/j.1478-3231.2011.02451.x; MUSSO G, 2010, ANN MED; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; Nazal L, 2010, OBES SURG, V20, P1400, DOI 10.1007/s11695-009-0051-0; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Ratziu V, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-6; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Stepanova M, 2010, ALIMENT PHARM THER, V31, P1085, DOI 10.1111/j.1365-2036.2010.04266.x; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yoneda M, 2007, J GASTROENTEROL, V42, P573, DOI 10.1007/s00535-007-2060-x; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	36	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58360	10.1371/journal.pone.0058360	http://dx.doi.org/10.1371/journal.pone.0058360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555578	Green Submitted, Green Published, gold			2022-12-27	WOS:000317418500009
J	Kammoun, H; Roux, X; Raze, D; Debrie, AS; De Filette, M; Ysenbaert, T; Mielcarek, N; Saelens, X; Fiers, W; Locht, C				Kammoun, Hana; Roux, Xavier; Raze, Dominique; Debrie, Anne-Sophie; De Filette, Marina; Ysenbaert, Tine; Mielcarek, Nathalie; Saelens, Xavier; Fiers, Walter; Locht, Camille			Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; FILAMENTOUS HEMAGGLUTININ; STRAIN BPZE1; A VACCINE; IMMUNITY; INFECTION; PROTECTION; DELIVERY; SEQUENCE; ADHESIN	Background: Intranasal delivery of vaccines directed against respiratory pathogens is an attractive alternative to parenteral administration. However, using this delivery route for inactivated vaccines usually requires the use of potent mucosal adjuvants, and no such adjuvant has yet been approved for human use. Methodology/Principal Findings: We have developed a live attenuated Bordetella pertussis vaccine, called BPZE1, and show here that it can be used to present the universal influenza virus epitope M2e to the mouse respiratory tract to prime for protective immunity against viral challenge. Three copies of M2e were genetically fused to the N-terminal domain of filamentous hemagglutinin (FHA) and produced in recombinant BPZE1 derivatives in the presence or absence of endogenous full-length FHA. Only in the absence of FHA intranasal administration of the recombinant BPZE1 derivative induced antibody responses to M2e and effectively primed BALB/c mice for protection against influenza virus-induced mortality and reduced the viral load after challenge. Strong M2e-specific antibody responses and protection were observed after a single nasal administration with the recombinant BPZE1 derivative, followed by a single administration of M2e linked to a virus-like particle without adjuvant, whereas priming alone with the vaccine strain did not protect. Conclusions/Significance: Using recombinant FHA-3M2e-producing BPZE1 derivatives for priming and the universal influenza M2e peptide linked to virus-like particles for boosting may constitute a promising approach for needle-free and adjuvant-free nasal vaccination against influenza.	[Kammoun, Hana; Roux, Xavier; Raze, Dominique; Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] INSERM, U1019, F-59045 Lille, France; [Kammoun, Hana; Roux, Xavier; Raze, Dominique; Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Kammoun, Hana; Roux, Xavier; Raze, Dominique; Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Inst Pasteur, Ctr Infect & Immun Lille, Lille, France; [Kammoun, Hana; Roux, Xavier; Raze, Dominique; Debrie, Anne-Sophie; Mielcarek, Nathalie; Locht, Camille] Univ Lille Nord France, Lille, France; [De Filette, Marina; Ysenbaert, Tine; Saelens, Xavier; Fiers, Walter] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium; [De Filette, Marina; Ysenbaert, Tine; Saelens, Xavier; Fiers, Walter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Locht, C (corresponding author), INSERM, U1019, F-59045 Lille, France.	camille.locht@pasteur-lille.fr	Locht, Camille/L-3516-2018; Saelens, Xavier/N-5728-2015; Raze, Dominique/F-3965-2018	Raze, Dominique/0000-0001-5836-063X; Mielcarek, Nathalie/0000-0002-5968-9442; Debrie, Anne-Sophie/0000-0003-0570-4413; Locht, Camille/0000-0001-7295-7336; , Xavier/0000-0002-3861-6965	European Commission [201502]; Institut Pasteur de Lille; University Lille 2; FWO-Vlaanderen [G.0375.10N.]; Ghent University IOF [IOF08/STEP/001]; Sanofi Pasteur	European Commission(European CommissionEuropean Commission Joint Research Centre); Institut Pasteur de Lille; University Lille 2; FWO-Vlaanderen(FWO); Ghent University IOF(Ghent University); Sanofi Pasteur	This work was supported by a grant from the European Commission under the grant agreement #201502 (Child-Innovac). HK holds a fellowship of Institut Pasteur de Lille and University Lille 2. Research related to M2e-based influenza vaccines in the group of XS is supported by FWO-Vlaanderen project G.0375.10N., Ghent University IOF-grant Stepstone IOF08/STEP/001, and a research collaboration with Sanofi Pasteur. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2009, VACCINE, V27, P2099, DOI 10.1016/j.vaccine.2009.02.011; Alonso S, 2005, INFECT IMMUN, V73, P4295, DOI 10.1128/IAI.73.7.4295-4301.2005; Alonso S, 2002, INFECT IMMUN, V70, P4142, DOI 10.1128/IAI.70.8.4142-4147.2002; Alonso S, 2001, INFECT IMMUN, V69, P6038, DOI 10.1128/IAI.69.10.6038-6043.2001; Antoine R, 2000, J BACTERIOL, V182, P5902, DOI 10.1128/JB.182.20.5902-5905.2000; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Atsmon J, 2012, J CLIN IMMUNOL, V32, P595, DOI 10.1007/s10875-011-9632-5; Beigel JH, 2008, CRIT CARE MED, V36, P2660, DOI 10.1097/CCM.0b013e318180b039; Coppens I, 2001, INFECT IMMUN, V69, P5440, DOI 10.1128/IAI.69.9.5440-5446.2001; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Feunou PF, 2008, VACCINE, V26, P5722, DOI 10.1016/j.vaccine.2008.08.018; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; Ho SY, 2008, INFECT IMMUN, V76, P111, DOI 10.1128/IAI.00795-07; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Kavanagh H, 2010, CLIN EXP ALLERGY, V40, P933, DOI 10.1111/j.1365-2222.2010.03459.x; KILBOURNE ED, 1978, J IMMUNOL, V120, P1447; KIMURA A, 1990, INFECT IMMUN, V58, P7, DOI 10.1128/IAI.58.1.7-16.1990; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li R, 2012, ALLERGY, V67, P1250, DOI 10.1111/j.1398-9995.2012.02884.x; Li R, 2011, VACCINE, V29, P5502, DOI 10.1016/j.vaccine.2011.05.052; Li R, 2010, J VIROL, V84, P7105, DOI 10.1128/JVI.02542-09; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; MENOZZI FD, 1994, INFECT IMMUN, V62, P4261, DOI 10.1128/IAI.62.10.4261-4269.1994; MENOZZI FD, 1994, INFECT IMMUN, V62, P769, DOI 10.1128/IAI.62.3.769-778.1994; Mielcarek N, 1998, NAT BIOTECHNOL, V16, P454, DOI 10.1038/nbt0598-454; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Mielcarek N, 2010, CLIN VACCINE IMMUNOL, V17, P317, DOI 10.1128/CVI.00322-09; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMra1108296, 10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; RenauldMongenie G, 1996, J BACTERIOL, V178, P1053, DOI 10.1128/jb.178.4.1053-1060.1996; Reveneau N, 2001, VACCINE, V20, P926, DOI 10.1016/S0264-410X(01)00380-2; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skerry CM, 2009, CLIN VACCINE IMMUNOL, V16, P1344, DOI 10.1128/CVI.00082-09; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	50	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59198	10.1371/journal.pone.0059198	http://dx.doi.org/10.1371/journal.pone.0059198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23555631	Green Published, gold			2022-12-27	WOS:000317562100090
J	Li, FJ; Wu, NQ; Lu, HY; Zhang, JP; Wang, WL; Ma, MZ; Zhang, XH; Yang, XY				Li, Fengjiang; Wu, Naiqin; Lu, Houyuan; Zhang, Jianping; Wang, Weilin; Ma, Mingzhi; Zhang, Xiaohu; Yang, Xiaoyan			Mid-Neolithic Exploitation of Mollusks in the Guanzhong Basin of Northwestern China: Preliminary Results	PLOS ONE			English	Article							LUOCHUAN LOESS SEQUENCE; RADIOCARBON TIME SCALE; ISOTOPE RATIOS; TERRESTRIAL MOLLUSKS; MONSOON VARIABILITY; RECORD; PLATEAU; ASSEMBLAGES; SHELLS; RECONSTRUCTION	Mollusk remains are abundant in archaeological sites in the Guanzhong Basin of Northwestern China, providing good opportunities for investigations into the use of mollusks by prehistoric humans. Here we report on freshwater gastropod and bivalve mollusks covering the time interval from about 5600 to 4500 cal. yrs BP from sites of Mid-Late Neolithic age. They are identified as Cipangopaludina chinensis and Unio douglasiae, both of which are currently food for humans. The shells are well preserved and have no signs of abrasion. They are all freshwater gastropods and bivalves found in pits without water-reworked deposits and have modern representatives which can be observed in rivers, reservoirs, and paddy fields in the studied region. Mollusk shells were frequently recovered in association with mammal bones, lithic artifacts, and pottery. These lines of evidence indicate that the mollusks are the remains of prehistoric meals. The mollusk shells were likely discarded into the pits by prehistoric humans after the flesh was eaten. However, these mollusk remains may not have been staple food since they are not found in large quantities. Mollusk shell tools and ornaments are also observed. Shell tools include shell knives, shell reaphooks and arrowheads, whereas shell ornaments are composed of pendants and loops. All the shell tools and ornaments are made of bivalve mollusks and do not occur in large numbers. The finding of these freshwater mollusk remains supports the view that the middle Holocene climate in the Guanzhong Basin may have been warm and moist, which was probably favorable to freshwater mollusks growing and developing in the region.	[Li, Fengjiang; Wu, Naiqin; Lu, Houyuan; Zhang, Jianping] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Wang, Weilin; Ma, Mingzhi] Shaanxi Prov Inst Archaeol, Xian, Peoples R China; [Zhang, Xiaohu] Inst Cultural Rel Henan Prov, Zhengzhou, Peoples R China; [Yang, Xiaoyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Li, FJ (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	fengjiangli@mail.iggcas.ac.cn	Lu, houyuan/L-8661-2019; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014; Liu, Kam-Biu/B-4966-2012	Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X; Liu, Kam-Biu/0000-0002-0038-2198; Li, Fengjiang/0000-0003-3748-8305	Chinese Academy of Sciences [KZCX2-EW-QN107]; National Basic Research Program of China [2010CB950204]; Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues [XDA05130604]; National Natural Science Foundation of China [41230104, 41072130, 41272205]; National Social Science Foundation of China [ZD183]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This study is supported by the Chinese Academy of Sciences (KZCX2-EW-QN107), the National Basic Research Program of China (No. 2010CB950204), the Strategic Priority Research Program: Climate Change, Carbon Budget and Relevant Issues (XDA05130604), the National Natural Science Foundation of China (Projects 41230104, 41072130, and 41272205), the National Social Science Foundation of China (11&ZD183) and the president excellent prize of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL PI, 1985, CHEM GEOL, V58, P183, DOI 10.1016/0168-9622(85)90037-5; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Bahn P, 1983, PYRENEAN PREHISTORY; Barandiaran I, 1989, TRABAJOS ARQUEOLOGIA, P275; Braun A, 1847, GEOGN GEOLOGY PETERF, V1, P49; CASS (Institute of Archaeology at the Chinese Acadeny of Social Sciences), 1983, BAOJ BEISH; Chenorkian R, 1989, MOLLUSQUES TESTACES; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; FARRAND W.R., 2000, DEPOSITIONAL HIST FR; Fernandez-Armesto F, 2002, NEAR 1000S TABLES HI; GIROD A., 2003, HOLOCENE MOLLUSCS ED, V13, P35; GOODFRIEND GA, 1992, QUATERNARY SCI REV, V11, P665, DOI 10.1016/0277-3791(92)90076-K; GOODFRIEND GA, 1987, EARTH PLANET SC LETT, V86, P377, DOI 10.1016/0012-821X(87)90234-2; GOODFRIEND GA, 1988, NATURE, V333, P757, DOI 10.1038/333757a0; [顾海滨 Gu Haibin], 2006, [第四纪研究, Quaternary Sciences], V26, P562; Gutierrez Zugasti FI, 2009, MESOLITHIC HORIZONS, P161; Hu SM, 2001, ARCHAEOLOGY CULTURAL, V22, P53; Hu SM, 2011, ARCHAEOL CULT REL, V32, P97; [胡松梅 HU Songmei], 2007, [西北大学学报. 自然科学版, Journal of Northwest University. Natural Science Edition], V37, P115; Keen DH, 1995, QUATERNARY SCI REV, V14, P699, DOI 10.1016/0277-3791(95)00087-9; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Li FJ, 2006, SCI CHINA SER D, V49, P724, DOI 10.1007/s11430-006-0724-7; Li FJ, 2010, GLOBAL PLANET CHANGE, V72, P73, DOI 10.1016/j.gloplacha.2010.04.006; Li FJ, 2008, EARTH PLANET SC LETT, V274, P439, DOI 10.1016/j.epsl.2008.07.038; Li FJ, 2006, GEOLOGY, V34, P405, DOI 10.1130/G22232.1; Li XQ, 2007, SCI CHINA SER D, V50, P1707, DOI 10.1007/s11430-007-0066-0; Li XQ, 2009, HOLOCENE, V19, P1213, DOI 10.1177/0959683609345083; Li YM, 1979, J ZHENGZHOU U PHILOS, V4, P97; Liu TS., 1985, LOESS ENV; Liu YY, 1979, EC FAUNA SINICA CHIN; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; LUBELL D, 1976, SCIENCE, V191, P910, DOI 10.1126/science.191.4230.910; Lubell D., 2004, DOCUMENTA PRAEHISTOR, V31, P1; Lubell D., 2004, PETITS ANIMAUX SOC H, P77; Luo X, 1994, WORLD ANTIQUITY, P67; MAGARITZ M, 1983, ISOT GEOSCI, V1, P243; MAGARITZ M, 1981, EARTH PLANET SC LETT, V52, P101, DOI 10.1016/0012-821X(81)90212-0; Mienis Henk K., 2004, Archaeomalacology Group Newsletter, V6, P3; Mienis Henk K., 2012, Archaeomalacology Group Newsletter, V21, P9; Mienis HK, 2012, ARCHAEOMALACOGY GROU, V21, P8; Miracle P., 2001, DOCUMENTA PRAEHISTOR, V26, P177, DOI DOI 10.4312/DP.28.10; Moine O, 2002, QUATERNARY RES, V57, P162, DOI 10.1006/qres.2001.2286; Pearson GW, 1993, RADIOCARBON, V35, P193; Rizner M, 2009, MESOLITHIC HORIZONS, P527; Rousseau DD, 2009, CLIM PAST, V5, P157, DOI 10.5194/cp-5-157-2009; Rousseau DD, 1997, GEOLOGY, V25, P275, DOI 10.1130/0091-7613(1997)025<0275:ANMROT>2.3.CO;2; Rousseau DD, 1999, QUATERNARY RES, V52, P286, DOI 10.1006/qres.1999.2078; ROUSSEAU DD, 1991, QUATERNARY RES, V36, P195, DOI 10.1016/0033-5894(91)90025-Z; Rousseau DD, 2000, GLOBAL PLANET CHANGE, V26, P199, DOI 10.1016/S0921-8181(00)00086-2; School of Archaeology and Museology of Northwest University, 2000, EXC REP ANB ARCH SIT; Shaanxi Provincial Institute of Archaeology Archaeology Team of Baoji City, 2007, GUANT ARCH SIT BAOJ; Shang X, 2010, REV PALAEOBOT PALYNO, V160, P46, DOI 10.1016/j.revpalbo.2010.01.004; SONG YQ, 2002, CONSIDERATION RELATI; State Administration of Cultural Heritage, 1998, ATL CHIN REL; Straus LG, 1992, IBERIA IBERIANS STON, P194; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; The Archaeology Department of Peking University The Institute of Archaeology Chinese Academy of Social Sciences, 2003, 6 PEK U ARCH DEP PEK; The Institute of Archaeology Chinese Academy of Social Sciences, 1994, BAIJ ARCH SIT LINT C; The Institute of Archaeology Chinese Academy of Social Sciences, 1988, EXC REP WUG COUNT HU; Waselkov GA, 1987, ADV ARCHAEOL METH TH, V10, P93, DOI DOI 10.1016/B978-0-12-003110-8.50006-2; Wei S, 1999, RELICS MUSEOLGY, P5; Wu NQ, 2007, QUATERNARY SCI REV, V26, P1884, DOI 10.1016/j.quascirev.2007.04.006; Wu NQ, 1996, SCI CHINA SER D, V39, P494; Wu NQ, 2000, CHINESE SCI BULL, V45, P1617, DOI 10.1007/BF02886225; Wu NQ, 2006, PALAEOGEOGR PALAEOCL, V233, P287, DOI 10.1016/j.palaeo.2005.10.006; Wu NQ, 2002, BOREAS, V31, P20, DOI 10.1080/03009480210648; Wu NQ, 2001, J GEOPHYS RES-ATMOS, V106, P20045, DOI 10.1029/2001JD900224; Xi'an Banpo Musem Shaanxi Provincial Institute of Archaeology Lintong County Musem, 1988, JIANGZH EXC REP NEOL; Zhang HY., 2007, ACTA ARCHAEOL SIN, V2, P153; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; ZHANG ZP, 2003, QUANHU VILLAGE HUA C; Zheng J, 1996, CULTURAL RELICS CENT, P11; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	74	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58999	10.1371/journal.pone.0058999	http://dx.doi.org/10.1371/journal.pone.0058999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23544050	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600023
J	Mokili, JL; Dutilh, BE; Lim, YW; Schneider, BS; Taylor, T; Haynes, MR; Metzgar, D; Myers, CA; Blair, PJ; Nosrat, B; Wolfe, ND; Rohwer, F				Mokili, John L.; Dutilh, Bas E.; Lim, Yan Wei; Schneider, Bradley S.; Taylor, Travis; Haynes, Matthew R.; Metzgar, David; Myers, Christopher A.; Blair, Patrick J.; Nosrat, Bahador; Wolfe, Nathan D.; Rohwer, Forest			Identification of a Novel Human Papillomavirus by Metagenomic Analysis of Samples from Patients with Febrile Respiratory Illness	PLOS ONE			English	Article							AMPLIFICATION; PLASMID; REGIONS; DNA	As part of a virus discovery investigation using a metagenomic approach, a highly divergent novel Human papillomavirus type was identified in pooled convenience nasal/oropharyngeal swab samples collected from patients with febrile respiratory illness. Phylogenetic analysis of the whole genome and the L1 gene reveals that the new HPV identified in this study clusters with previously described gamma papillomaviruses, sharing only 61.1% (whole genome) and 63.1% (L1) sequence identity with its closest relative in the Papillomavirus episteme (PAVE) database. This new virus was named HPV_SD2 pending official classification. The complete genome of HPV-SD2 is 7,299 bp long (36.3% G/C) and contains 7 open reading frames (L2, L1, E6, E7, E1, E2 and E4) and a non-coding long control region (LCR) between L1 and E6. The metagenomic procedures, coupled with the bioinformatic methods described herein are well suited to detect small circular genomes such as those of human papillomaviruses.	[Mokili, John L.; Lim, Yan Wei; Haynes, Matthew R.; Nosrat, Bahador; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Mokili, John L.; Lim, Yan Wei; Schneider, Bradley S.; Taylor, Travis; Wolfe, Nathan D.] Metabiota, San Francisco, CA USA; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Metzgar, David; Myers, Christopher A.; Blair, Patrick J.] USN, Naval Hlth Res Ctr, San Diego, CA 92152 USA; [Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA	California State University System; San Diego State University; Radboud University Nijmegen; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); California State University System; San Diego State University	Mokili, JL (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	jmokili@gmail.com	Rohwer, Forest/AAC-5315-2019; Dutilh, Bas E./B-9719-2011	Dutilh, Bas E./0000-0003-2329-7890; Schneider, Bradley S/0000-0001-7642-0018; Rohwer, Forest/0000-0003-1548-5429	Dutch Science Foundation (NWO) [016.111.075]; U.S. Department of Defense Global Emerging Infections, Surveillance and Response Systems (DoD GEIS); Defense Threat Reduction Agency (DTRA); Cooperative Biological Engagement Program (CBEP); Google.org; Skoll Foundation; U.S. Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project [GHN-A-OO-09-00010-00]	Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); U.S. Department of Defense Global Emerging Infections, Surveillance and Response Systems (DoD GEIS); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Cooperative Biological Engagement Program (CBEP); Google.org(Google Incorporated); Skoll Foundation; U.S. Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project(United States Agency for International Development (USAID))	BED is supported by the Dutch Science Foundation (NWO) Veni grant (016.111.075). Global Viral Forecasting (JLM, BSS and NDW) was graciously supported by the U.S. Department of Defense Global Emerging Infections, Surveillance and Response Systems (DoD GEIS) and the Defense Threat Reduction Agency (DTRA), Cooperative Biological Engagement Program (CBEP), Google.org, the Skoll Foundation, and the U.S. Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHN-A-OO-09-00010-00. The Surveillance conducted by Naval Health Research Center (NHRC) was supported by the Global Emerging Infections System division of the Armed Forces Health Surveillance Center. The views expressed in this work are those of the authors and do not reflect the official policy of the Department of the Navy, Department of Defense, or the US Government. Approved for public releases; distribution is unlimited. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; Bartholomew DA, 2011, J CLIN VIROL, V51, P38, DOI 10.1016/j.jcv.2011.01.016; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Deutsch MJ, 2010, J VIROL, V84, P2533, DOI 10.1128/JVI.01909-09; Dong XL, 2004, NUCLEIC ACIDS RES, V32, pW660, DOI 10.1093/nar/gkh410; Drummond A. J., 2011, GENEIOUS V5 4; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; FIGGE J, 1988, J VIROL, V62, P1814, DOI 10.1128/JVI.62.5.1814-1818.1988; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KRUBKE J, 1987, J GEN VIROL, V68, P3091, DOI 10.1099/0022-1317-68-12-3091; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Ott E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018609; Ramamoorthy Sonia, 2010, Infect Agent Cancer, V5, P17, DOI 10.1186/1750-9378-5-17; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; Trindade-Silva AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039905; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; Wegley L, 2006, ENVIRON MICROBIOL, V8, P1775, DOI 10.1111/j.1462-2920.2006.01062.x	32	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58404	10.1371/journal.pone.0058404	http://dx.doi.org/10.1371/journal.pone.0058404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554892	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800015
J	Wang, XG; Dong, J; Wang, XL; Wu, Q				Wang, Xiaogang; Dong, Jing; Wang, Xiaoliang; Wu, Qiang			IOL Tilt and Decentration Estimation from 3 Dimensional Reconstruction of OCT Image	PLOS ONE			English	Article							INTRAOCULAR-LENS DECENTRATION; OPTICAL COHERENCE TOMOGRAPHY; HIGH-REFRACTIVE SILICONE; WAVE-FRONT ABERRATION; ULTRASOUND BIOMICROSCOPY; CAPSULOTOMY; ASTIGMATISM; POSITION; OUTCOMES	Purpose: To evaluate intraocular lens (IOL) tilt and decentration by anterior segment optical coherence tomography (AS-OCT) using 3-dimensional (3D) reconstruction method. Design: Prospective observational case series. Participants: Thirty-nine patients (39 eyes) were included. Methods: The IOL positions of all eyes were examined by AS-OCT. Images were obtained in 4 axes (0-180 degrees, 45-225 degrees, 90-270 degrees, and 135-315 degrees) using the quadrant-scan model. The cross-sectional images were analyzed with MATLAB software. Main Outcome Measures: The angle (theta) between the reference pupillary plane and the IOL plane, the distances between the center points of the pupil circle and the IOL on the x-axis (dx) and y-axis (dy) and the spatial distance (ds) were calculated after 3D-reconstruction. Results: The mean angle (h) between the pupillary plane and the IOL plane was 2.94 +/- 0.99 degrees. The mean IOL decentration of dx and dy was 0.32 +/- 0.26 mm and 0.40 +/- 0.27 mm, respectively. The ds of the IOL decentration was 0.56 +/- 0.31 mm. There was no significant correlation between the ocular residual astigmatism (ORA) and the tilted angle or the decentration distance. There was a significant correlation between the ORA and total astigmatism (r = 0.742, P<0.001). There was no significant correlation between the postoperative best corrected visual acuity (BCVA) and the ORA (r = 0.156; P = 0.344), total astigmatism (r = 0.012; P = 0.942), tilted angle (theta; r = 0.172; P = 0.295) or decentration distance (dx:r = 0.191, P = 0.244; dy: r = 0.253, P = 0.121; ds: r = 0.298, P = 0.065). Conclusions: AS-OCT can be used as an alternative for the analysis of IOL tilt and decentration using 3D-reconstruction.	[Wang, Xiaogang; Wu, Qiang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Dong, Jing] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Xiaoliang] Shanghai Jiao Tong Univ, Sch Aeronaut & Astronaut, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanxi Medical University; Shanghai Jiao Tong University	Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	movie6521@gmail.com						Alpins NA, 2004, SURV OPHTHALMOL, V49, P109, DOI 10.1016/j.survophthal.2003.10.010; APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9; Baumeister M, 2005, AM J OPHTHALMOL, V140, P1051, DOI 10.1016/j.ajo.2005.07.026; Baumeister M, 2002, DEV OPHTHALMOL, V34, P187; Baumeister M, 2009, J CATARACT REFR SURG, V35, P1006, DOI 10.1016/j.jcrs.2009.01.023; Bianciotto C, 2011, OPHTHALMOLOGY, V118, P1297, DOI 10.1016/j.ophtha.2010.11.011; de Castro A, 2007, J CATARACT REFR SURG, V33, P418, DOI 10.1016/j.jcrs.2006.10.054; Detry-Morel ML, 2006, J CATARACT REFR SURG, V32, P1866, DOI 10.1016/j.jcrs.2006.08.018; ERICKSON P, 1990, J CATARACT REFR SURG, V16, P305, DOI 10.1016/S0886-3350(13)80699-2; Gimbel HV, 2005, J CATARACT REFR SURG, V31, P2193, DOI 10.1016/j.jcrs.2005.06.053; Kanellopoulos AJ, 2012, CLIN OPHTHALMOL, V6, P645, DOI 10.2147/OPTH.S31250; Kiddee W, 2012, J GLAUCOMA; Kim JS, 2001, J CATARACT REFR SURG, V27, P533, DOI 10.1016/S0886-3350(00)00649-0; Korynta J, 1999, J CATARACT REFR SURG, V25, P100, DOI 10.1016/S0886-3350(99)80019-4; Kranitz K, 2012, J REFRACT SURG, V28, P259, DOI 10.3928/1081597X-20120309-01; Kumar DA, 2011, AM J OPHTHALMOL, V151, P406, DOI 10.1016/j.ajo.2010.09.013; KUMAR S, 1990, J CATARACT REFR SURG, V16, P712, DOI 10.1016/S0886-3350(13)81011-5; Leysen I, 2009, J CATARACT REFR SURG, V35, P1013, DOI 10.1016/j.jcrs.2009.01.024; Loya N, 2001, J CATARACT REFR SURG, V27, P1423, DOI 10.1016/S0886-3350(01)00786-6; Mura JJ, 2010, AM J OPHTHALMOL, V149, P245, DOI 10.1016/j.ajo.2009.08.022; Mutlu FM, 1998, OPHTHALMOLOGICA, V212, P359, DOI 10.1159/000027368; Nejima R, 2004, BRIT J OPHTHALMOL, V88, P746, DOI 10.1136/bjo.2003.037663; Oshika T, 2007, BRIT J OPHTHALMOL, V91, P185, DOI 10.1136/bjo.2006.099945; Oshika T, 2005, AM J OPHTHALMOL, V140, P744, DOI 10.1016/j.ajo.2005.04.026; PHILLIPS P, 1988, J CATARACT REFR SURG, V14, P129, DOI 10.1016/S0886-3350(88)80086-5; Takei K, 1995, JPN J OPHTHALMOL, V39, P390; Taketani F, 2004, J CATARACT REFR SURG, V30, P2158, DOI 10.1016/j.jcrs.2004.02.072; Wang MC, 1998, J CATARACT REFR SURG, V24, P1652, DOI 10.1016/S0886-3350(98)80359-3; Werner L, 2012, J CATARACT REFR SURG, V38, P1077, DOI 10.1016/j.jcrs.2012.01.027; Yang HC, 2000, J CATARACT REFR SURG, V26, P586, DOI 10.1016/S0886-3350(99)00412-5	30	21	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59109	10.1371/journal.pone.0059109	http://dx.doi.org/10.1371/journal.pone.0059109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554982	gold, Green Published			2022-12-27	WOS:000316409800059
J	Lee, JY; Stearns, T				Lee, Joanna Y.; Stearns, Tim			FOP Is a Centriolar Satellite Protein Involved in Ciliogenesis	PLOS ONE			English	Article							PRIMARY CILIUM; MYELOPROLIFERATIVE DISORDERS; MOLECULAR CHARACTERIZATION; CENTROSOMAL PROTEINS; BBS PROTEINS; CEP290; GENE; INTERACTS; LEUKEMIA; COMPLEX	Centriolar satellites are proteinaceous granules that are often clustered around the centrosome. Although centriolar satellites have been implicated in protein trafficking in relation to the centrosome and cilium, the details of their function and composition remain unknown. FOP (FGFR1 Oncogene Partner) is a known centrosome protein with homology to the centriolar satellite proteins FOR20 and OFD1. We find that FOP partially co-localizes with the satellite component PCM1 in a cell cycle-dependent manner, similarly to the satellite and cilium component BBS4. As for BBS4, FOP localization to satellites is cell cycle dependent, with few satellites labeled in G(1), when FOP protein levels are lowest, and most labeled in G(2). FOP-FGFR1, an oncogenic fusion that causes a form of leukemia called myeloproliferative neoplasm, also localizes to centriolar satellites where it increases tyrosine phosphorylation. Depletion of FOP strongly inhibits primary cilium formation in human RPE-1 cells. These results suggest that FOP is a centriolar satellite cargo protein and, as for several other satellite-associated proteins, is involved in ciliogenesis. Localization of the FOP-FGFR1 fusion kinase to centriolar satellites may be relevant to myeloproliferative neoplasm disease progression.	[Lee, Joanna Y.; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Sch Med, Dept Genet, Stanford, CA USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582	NIH Cell and Molecular Biology Training Grant; ARCS Foundation; NIH [GM52022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	NIH Cell and Molecular Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH Cell and Molecular Biology Training Grant to J.Y.L. (http://www.nigms.nih.gov/Training/InstPredoc/PredocTrainingDescription.htm), an ARCS Foundation Award to J.Y.L. (https://www.arcsfoundation.org), and NIH Grant GM52022 to T. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2009, CELL CYCLE, V8, P1217, DOI 10.4161/cc.8.8.8248; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aubusson-Fleury A, 2012, J CELL SCI; Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delaval B, 2005, LEUKEMIA, V19, P1739, DOI 10.1038/sj.leu.2403926; Delaval B, 2005, CANCER RES, V65, P7231, DOI 10.1158/0008-5472.CAN-04-4167; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Murati A, 2005, LEUKEMIA, V19, P1692, DOI 10.1038/sj.leu.2403879; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rosnet O, 2007, HAEMATOLOGICA, V92, P728, DOI 10.3324/haematol.11387; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	37	31	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58589	10.1371/journal.pone.0058589	http://dx.doi.org/10.1371/journal.pone.0058589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554904	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500032
J	Naithani, KJ; Baldwin, DC; Gaines, KP; Lin, H; Eissenstat, DM				Naithani, Kusum J.; Baldwin, Doug C.; Gaines, Katie P.; Lin, Henry; Eissenstat, David M.			Spatial Distribution of Tree Species Governs the Spatio-Temporal Interaction of Leaf Area Index and Soil Moisture across a Forested Landscape	PLOS ONE			English	Article							SHALE HILLS CATCHMENT; TROPICAL DRY FOREST; WATER AVAILABILITY; TEMPORAL DYNAMICS; WOODY-PLANTS; PHENOLOGY; VEGETATION; MODEL; VARIABILITY; RESPONSES	Quantifying coupled spatio-temporal dynamics of phenology and hydrology and understanding underlying processes is a fundamental challenge in ecohydrology. While variation in phenology and factors influencing it have attracted the attention of ecologists for a long time, the influence of biodiversity on coupled dynamics of phenology and hydrology across a landscape is largely untested. We measured leaf area index (L) and volumetric soil water content (theta) on a co-located spatial grid to characterize forest phenology and hydrology across a forested catchment in central Pennsylvania during 2010. We used hierarchical Bayesian modeling to quantify spatio-temporal patterns of L and theta. Our results suggest that the spatial distribution of tree species across the landscape created unique spatio-temporal patterns of L, which created patterns of water demand reflected in variable soil moisture across space and time. We found a lag of about 11 days between increase in L and decline in theta. Vegetation and soil moisture become increasingly homogenized and coupled from leaf-onset to maturity but heterogeneous and uncoupled from leaf maturity to senescence. Our results provide insight into spatio-temporal coupling between biodiversity and soil hydrology that is useful to enhance ecohydrological modeling in humid temperate forests.	[Naithani, Kusum J.; Baldwin, Doug C.] Penn State Univ, Dept Geog, University Pk, PA 16802 USA; [Naithani, Kusum J.; Gaines, Katie P.; Eissenstat, David M.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Gaines, Katie P.; Lin, Henry; Eissenstat, David M.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Naithani, KJ (corresponding author), Penn State Univ, Dept Geog, University Pk, PA 16802 USA.	naithani@psu.edu	Eissenstat, David/AAE-2793-2020; Naithani, Kusum/A-5441-2009; Lin, Henry/E-8234-2011	Naithani, Kusum/0000-0003-2503-113X; 	U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory [EAR 0725019]; Directorate For Geosciences [1239285] Funding Source: National Science Foundation; Division Of Earth Sciences [0725019] Funding Source: National Science Foundation	U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the U.S. National Science Foundation through the Susquehanna Shale Hills Critical Zone Observatory (EAR 0725019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Asbjornsen H, 2004, FOREST ECOL MANAG, V192, P313, DOI 10.1016/j.foreco.2004.01.035; Asbjornsen H, 2011, J PLANT ECOL, V4, P3, DOI 10.1093/jpe/rtr005; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; BORCHERT R, 1994, TREES-STRUCT FUNCT, V8, P198, DOI 10.1007/BF00196847; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Breshears DD, 2009, ECOHYDROLOGY, V2, P503, DOI 10.1002/eco.75; Breshears DD, 1999, LANDSCAPE ECOL, V14, P465, DOI 10.1023/A:1008040327508; Brooks JR, 2006, PLANT CELL ENVIRON, V29, P138, DOI 10.1111/j.1365-3040.2005.01409.x; CHEN JM, 1992, PLANT CELL ENVIRON, V15, P421, DOI 10.1111/j.1365-3040.1992.tb00992.x; Choler P, 2010, BIOGEOSCIENCES, V7, P907, DOI 10.5194/bg-7-907-2010; Crockford RH, 2000, HYDROL PROCESS, V14, P2903, DOI [10.1002/1099-1085(200011/12)14:16/17<2903::AID-HYP126>3.0.CO;2-6, 10.1002/1099-1085(200011/12)14:16/17&lt;2903::AID-HYP126&gt;3.0.CO;2-6]; Diggle P.J., 2002, GEOGR ENV MODEL, V6, P129, DOI [DOI 10.1080/1361593022000029467, 10.1080/1361593022000029467]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Duniway MC, 2010, ECOHYDROLOGY, V3, P55, DOI 10.1002/eco.94; Estrella N, 2009, CLIM RES, V39, P235, DOI 10.3354/cr00818; Guo QH, 2010, PHOTOGRAMM ENG REM S, V76, P701, DOI 10.14358/PERS.76.6.701; Guo X, 2008, INT ARCH PHOTOGRAM B, VXXXVII; Jin M, 2002, METEOROL ATMOS PHYS, V80, P117, DOI 10.1007/s007030200019; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; KIKUZAWA K, 1983, CAN J BOT, V61, P2133, DOI 10.1139/b83-230; Kikuzawa K., 1988, PLANT SPEC BIOL, V3, P67, DOI DOI 10.1111/j.1442-1984.1988.tb00172.x; Lin H, 2006, VADOSE ZONE J, V5, P317, DOI 10.2136/vzj2005.0058; Lin H, 2005, ADV AGRON, V85, P1, DOI 10.1016/S0065-2113(04)85001-6; Naithani KJ, 2012, J HYDROL, V464, P176, DOI 10.1016/j.jhydrol.2012.07.008; NEMANI R, 1993, INT J REMOTE SENS, V14, P2519, DOI 10.1080/01431169308904290; Okin GS, 2001, REMOTE SENS ENVIRON, V77, P212, DOI 10.1016/S0034-4257(01)00207-3; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Potts DL, 2010, ECOHYDROLOGY, V3, P20, DOI 10.1002/eco.91; Reich PB, 2004, ECOL MONOGR, V74, P3, DOI 10.1890/02-4047; Ribeiro Jr P. J., 2001, R NEWS, V1, P14; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Richardson JJ, 2009, AGR FOREST METEOROL, V149, P1152, DOI 10.1016/j.agrformet.2009.02.007; Seiwa K, 1999, ANN BOT-LONDON, V83, P355, DOI 10.1006/anbo.1998.0831; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Sigurdsson BD, 2001, TREES-STRUCT FUNCT, V15, P403, DOI 10.1007/s004680100121; Sprintsin M, 2007, REMOTE SENS ENVIRON, V109, P416, DOI 10.1016/j.rse.2007.01.020; Stogsdill Jr W, 1989, FOREST ECOL MANAG, V29, P105; Tabacchi E, 2000, HYDROL PROCESS, V14, P2959, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2959::AID-HYP129&gt;3.0.CO;2-B; Takagi K, 2012, GEODERMA, V173, P289, DOI 10.1016/j.geoderma.2011.11.003; Takagi K, 2011, VADOSE ZONE J, V10, P832, DOI 10.2136/vzj2010.0134; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Vivoni ER, 2012, J HYDROMETEOROL, V13, P1631, DOI 10.1175/JHM-D-11-0131.1; Vivoni ER, 2012, ECOHYDROLOGY, V5, P235, DOI 10.1002/eco.1248; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2; Zhu Q, 2010, SOIL SCI SOC AM J, V74, P1750, DOI 10.2136/sssaj2010.0055	50	34	36	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58704	10.1371/journal.pone.0058704	http://dx.doi.org/10.1371/journal.pone.0058704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554915	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500039
J	Terao, C; Hashimoto, M; Yamamoto, K; Murakami, K; Ohmura, K; Nakashima, R; Yamakawa, N; Yoshifuji, H; Yukawa, N; Kawabata, D; Usui, T; Yoshitomi, H; Furu, M; Yamada, R; Matsuda, F; Ito, H; Fujii, T; Mimori, T				Terao, Chikashi; Hashimoto, Motomu; Yamamoto, Keiichi; Murakami, Kosaku; Ohmura, Koichiro; Nakashima, Ran; Yamakawa, Noriyuki; Yoshifuji, Hajime; Yukawa, Naoichiro; Kawabata, Daisuke; Usui, Takashi; Yoshitomi, Hiroyuki; Furu, Moritoshi; Yamada, Ryo; Matsuda, Fumihiko; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo			Three Groups in the 28 Joints for Rheumatoid Arthritis Synovitis - Analysis Using More than 17,000 Assessments in the KURAMA Database	PLOS ONE			English	Article							DISEASE-ACTIVITY INDEX; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; ACTIVITY SCORE; VALIDITY; SYSTEM; DAMAGE; TRIAL	Rheumatoid arthritis (RA) is a joint-destructive autoimmune disease. Three composite indices evaluating the same 28 joints are commonly used for the evaluation of RA activity. However, the relationship between, and the frequency of, the joint involvements are still not fully understood. Here, we obtained and analyzed 17,311 assessments for 28 joints in 1,314 patients with RA from 2005 to 2011 from electronic clinical chart templates stored in the KURAMA (Kyoto University Rheumatoid Arthritis Management Alliance) database. Affected rates for swelling and tenderness were assessed for each of the 28 joints and compared between two different sets of RA patients. Correlations of joint symptoms were analyzed for swellings and tenderness using kappa coefficient and eigen vectors by principal component analysis. As a result, we found that joint affected rates greatly varied from joint to joint both for tenderness and swelling for the two sets. Right wrist joint is the most affected joint of the 28 joints. Tenderness and swellings are well correlated in the same joints except for the shoulder joints. Patients with RA tended to demonstrate right-dominant joint involvement and joint destruction. We also found that RA synovitis could be classified into three categories of joints in the correlation analyses: large joints with wrist joints, PIP joints, and MCP joints. Clustering analysis based on distribution of synovitis revealed that patients with RA could be classified into six subgroups. We confirmed the symmetric joint involvement in RA. Our results suggested that RA synovitis can be classified into subgroups and that several different mechanisms may underlie the pathophysiology in RA synovitis.	[Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Terao, Chikashi; Hashimoto, Motomu; Murakami, Kosaku; Ohmura, Koichiro; Nakashima, Ran; Yamakawa, Noriyuki; Yoshifuji, Hajime; Yukawa, Naoichiro; Kawabata, Daisuke; Usui, Takashi; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yamamoto, Keiichi] Kyoto Univ, Translat Res Ctr, Dept Clin Trial Design & Management, Kyoto, Japan; [Yoshitomi, Hiroyuki; Furu, Moritoshi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Stat Genet, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan; [Matsuda, Fumihiko] Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Japan Science & Technology Agency (JST)	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	a0001101@kuhp.kyoto-u.ac.jp	Kosaku, Murakami/T-8806-2019; Yamamoto, Keiichi/AFQ-9006-2022; Yoshifuji, Hajime/AAZ-1657-2020	Yamamoto, Keiichi/0000-0003-3278-5001; , Hiroyuki/0000-0001-7339-9030; Yamada, Ryo/0000-0002-1587-630X	Mitsubishi Tanabe Pharma Corporation; Eisai Co., Ltd.; Abbott Japan Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Bristol-Myyers K.K.; Bristol-Myyers; Grants-in-Aid for Scientific Research [23791112, 24659274] Funding Source: KAKEN	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Eisai Co., Ltd.(Eisai Co Ltd); Abbott Japan Co., Ltd.(Abbott Laboratories); Chugai Pharmaceutical Co., Ltd.; Pfizer Japan Inc.(Pfizer); Bristol-Myyers K.K.; Bristol-Myyers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from Mitsubishi Tanabe Pharma Corporation (http://www.mt-pharma.co.jp/e/), Eisai Co., Ltd. (http://www.eisai.co.jp/index.html), Abbott Japan Co., Ltd. (http://www.abbott.co.jp/), Chugai Pharmaceutical Co., Ltd. (http://www.chugai-pharm.co.jp/hc/ss/english/index.html), Pfizer Japan Inc. (http://www.pfizer.co.jp/pfizer/english/company/), and Bristol-Myyers K.K. (http://www.bms.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The KURAMA database was supported by funding from Mitsubishi Tanabe Pharma Corporation, Eisai Co., Ltd., Abbott Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc. and Bristol-Myyers. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Machold KP, 2002, J RHEUMATOL, V29, P2278; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, P552; Scheel AK, 2005, ARTHRITIS RHEUM-US, V52, P733, DOI 10.1002/art.20939; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Smolen JS, 2006, ARTHRITIS RHEUM-US, V54, P702, DOI 10.1002/art.21678; van der Heijde D, 2000, J RHEUMATOL, V27, P261; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; VANDERHEIJDE DMFM, 1992, ANN RHEUM DIS, V51, P177, DOI 10.1136/ard.51.2.177; Yamamoto K, 2012, CLIN TRIALS, V9, P408, DOI 10.1177/1740774512445912	17	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59341	10.1371/journal.pone.0059341	http://dx.doi.org/10.1371/journal.pone.0059341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555018	Green Submitted, gold, Green Published			2022-12-27	WOS:000316252500081
J	Dodla, R; Wilson, CJ				Dodla, Ramana; Wilson, Charles J.			Effect of Sharp Jumps at the Edges of Phase Response Curves on Synchronization of Electrically Coupled Neuronal Oscillators	PLOS ONE			English	Article							RESETTING CURVES; SPIKING NEURONS; STABILITY; NETWORKS; DYNAMICS; SYNAPSES; LOCKING	We study synchronization phenomenon of coupled neuronal oscillators using the theory of weakly coupled oscillators. The role of sudden jumps in the phase response curve profiles found in some experimental recordings and models on the ability of coupled neurons to exhibit synchronous and antisynchronous behavior is investigated, when the coupling between the neurons is electrical. The level of jumps in the phase response curve at either end, spike width and frequency of voltage time course of the coupled neurons are parameterized using piecewise linear functional forms, and the conditions for stable synchrony and stable antisynchrony in terms of those parameters are computed analytically. The role of the peak position of the phase response curve on phase-locking is also investigated.	[Dodla, Ramana; Wilson, Charles J.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	Dodla, R (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	ramana.dodla@utsa.edu	Wilson, Charles/D-2529-2011; Dodla, Ramana/B-3608-2008	Wilson, Charles/0000-0002-9004-2145; Dodla, Ramana/0000-0002-8057-9571	National Institutes of Health [NS047085]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS047085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant NS047085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Chow CC, 2000, NEURAL COMPUT, V12, P1643, DOI 10.1162/089976600300015295; Dodla R, 2012, NEUR M PLANN; Dror R, 1999, BIOL CYBERN, V80, P11, DOI 10.1007/s004220050501; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Farries MA, 2012, J NEUROPHYSIOL, V108, P1838, DOI 10.1152/jn.00054.2012; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Gouwens NW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000951; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Jeong HY, 2007, NEURAL COMPUT, V19, P706, DOI 10.1162/neco.2007.19.3.706; KAWAHARA K, 1988, BIOL CYBERN, V58, P235, DOI 10.1007/BF00364129; Ladenbauer J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002478; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Maran SK, 2008, J COMPUT NEUROSCI, V24, P37, DOI 10.1007/s10827-007-0040-z; Neltner L, 2001, NEURAL COMPUT, V13, P765, DOI 10.1162/089976601300014330; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; NEU JC, 1979, SIAM J APPL MATH, V37, P307, DOI 10.1137/0137022; NEU JC, 1979, SIAM J APPL MATH, V36, P509, DOI 10.1137/0136038; Pfeuty B, 2005, NEURAL COMPUT, V17, P633, DOI 10.1162/0899766053019917; Pfeuty B, 2003, J NEUROSCI, V23, P6280; Pravlidis P, 1973, BIOL OSCILLATORS THE; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Tuckwell HC, 1998, INTRO THEORETICAL NE, V1; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Wang XJ, 1996, J NEUROSCI, V16, P6402; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58922	10.1371/journal.pone.0058922	http://dx.doi.org/10.1371/journal.pone.0058922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23555607	Green Published, gold, Green Submitted			2022-12-27	WOS:000317263900008
J	Peng, H; Liu, HH; Zhao, SW; Wu, J; Fan, JP; Liao, JC				Peng, Hu; Liu, Huanhai; Zhao, Shuwei; Wu, Jian; Fan, Jingping; Liao, Jianchun			Silencing of RASSF3 by DNA Hypermethylation Is Associated with Tumorigenesis in Somatotroph Adenomas	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PITUITARY-ADENOMAS; METHYLATION LEVELS; PROMOTER; PATHOGENESIS; CANCER; IDENTIFICATION; INACTIVATION; DISEASE	The pathogenic mechanisms underlying pituitary somatotroph adenoma formation, progression are poorly understood. To identify candidate tumor suppressor genes involved in pituitary somatotroph adenoma tumorigenesis, we used HG18 CpG plus Promoter Microarray in 27 human somatotroph adenomas and 4 normal human adenohypophyses. RASSF3 was found with frequent methylation of CpG island in its promoter region in somatotroph adenomas but rarely in adenohypophyses. This result was confirmed by pyrosequencing analysis. We also found that RASSF3 mRNA level correlated negatively to its gene promoter methylation level. RASSF3 hypermethylation and downregulation was also observed in rat GH3 and mouse GT1.1 somatotroph adenoma cell lines. 5-Aza-2' deoxycytidine and trichostatin-A treatment induced RASSF3 promoter demethylation, and restored its expression in GH3 and GT1.1 cell lines. RASSF3 overexpression in GH3 and GT1.1 cells inhibited proliferation, induced apoptosis accompanied by increased Bax, p53, and caspase-3 protein and decreased Bcl-2 protein expression. We also found that the antitumor effect of RASSF3 was p53 dependent, and p53 knockdown blocked RASSF3-induced apoptosis and growth inhibition. Taken together, our results suggest that hypermethylation-induced RASSF3 silencing plays an important role in the tumorigenesis of pituitary somatotroph adenomas.	[Peng, Hu; Liu, Huanhai; Zhao, Shuwei; Wu, Jian; Fan, Jingping; Liao, Jianchun] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Naval Medical University	Fan, JP (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	fanjingp@163.com; jianchunliao@163.com			Natural Science Foundation of Science Committee of Shanghai [09411950900]	Natural Science Foundation of Science Committee of Shanghai	This work was supported by the Natural Science Foundation of Science Committee of Shanghai (No. 09411950900, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asa SL, 1998, ENDOCR REV, V19, P798, DOI 10.1210/er.19.6.798; Asa SL, 2002, NAT REV CANCER, V2, P836, DOI 10.1038/nrc926; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Chesnokova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017924; Djos A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-40; Dworakowska Dorota, 2011, Front Biosci (Schol Ed), V3, P105, DOI 10.2741/s136; Faglia G, 2001, J NEURO-ONCOL, V54, P95, DOI 10.1023/A:1012988828164; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hesson L, 2004, ONCOGENE, V23, P2408, DOI 10.1038/sj.onc.1207407; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Hoque MO, 2006, J CLIN ONCOL, V24, P4262, DOI 10.1200/JCO.2005.01.3516; Jacquemart IC, 2009, INT J ONCOL, V34, P517, DOI 10.3892/ijo_00000177; Kawai Y, 2010, ANN ONCOL, V21, P1612, DOI 10.1093/annonc/mdp577; Martins AT, 2011, BREAST CANCER RES TR, V129, P1, DOI 10.1007/s10549-010-1160-0; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Meng W, 2012, MOL BIOL INT, V2012; Michaelis KA, 2011, ENDOCRINOLOGY, V152, P3603, DOI 10.1210/en.2011-0109; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; Pelizzola M, 2008, GENOME RES, V18, P1652, DOI 10.1101/gr.080721.108; Prando ED, 2011, EPIGENETICS-US, V6, P1413, DOI 10.4161/epi.6.12.18271; Qian ZR, 2007, MODERN PATHOL, V20, P1269, DOI 10.1038/modpathol.3800965; Qian ZR, 2005, LAB INVEST, V85, P464, DOI 10.1038/labinvest.3700248; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Simpson DJ, 2000, CANCER RES, V60, P1211; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Stutterheim J, 2012, CLIN CANCER RES, V18, P808, DOI 10.1158/1078-0432.CCR-11-0849; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Vandeva S, 2010, BEST PRACT RES CL EN, V24, P461, DOI 10.1016/j.beem.2010.03.001; Zhu X, 2007, AM J PATHOL, V170, P1618, DOI 10.2353/ajpath.2007.061111	32	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e59024	10.1371/journal.pone.0059024	http://dx.doi.org/10.1371/journal.pone.0059024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	23555615	Green Published, gold, Green Submitted			2022-12-27	WOS:000317262200010
J	Duan, JL; Shao, F; Shao, YG; Li, JY; Ling, Y; Teng, KD; Li, HW; Wu, CX				Duan, Jinlin; Shao, Fan; Shao, Yonggang; Li, Junying; Ling, Yao; Teng, Kedao; Li, Hongwei; Wu, Changxin			Androgen Inhibits Abdominal Fat Accumulation and Negatively Regulates the PCK1 Gene in Male Chickens	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; STAT SIGNALING PATHWAY; TESTOSTERONE REPLACEMENT; INSULIN SENSITIVITY; EXPRESSION PATTERNS; CYTOSOLIC FORM; OBESITY; MEN; CAPONIZATION; MASS	Capons are male chickens whose testes have been surgically incised. Capons show a significant increase in fat accumulation compared to intact male chickens. However, while caponization leads to a significant reduction in androgen levels in roosters, little is known about the molecular mechanisms through which androgen status affects lipogenesis in avian species. Therefore, investigation of the influence of androgens on fat accumulation in the chicken will provide insights into this process. In this study, Affymetrix microarray technology was used to analyze the gene expression profiles of livers from capons and intact male chickens because the liver is the major site of lipogenesis in avian species. Through gene ontology, we found that genes involved in hepatic lipogenic biosynthesis were the most highly enriched. Interestingly, among the upregulated genes, the cytosolic form of the phosphoenolpyruvate carboxykinase (PCK1) gene showed the greatest fold change. Additionally, in conjunction with quantitative real-time PCR data, our results suggested that androgen status negatively regulated the PCK1 gene in male chickens.	[Duan, Jinlin; Shao, Fan; Li, Junying; Ling, Yao; Li, Hongwei; Wu, Changxin] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Shao, Yonggang] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Teng, Kedao; Li, Hongwei] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Xinjiang Agricultural University; China Agricultural University	Li, HW (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	lhwcau@163.com						ANDREONE TL, 1982, J BIOL CHEM, V257, P35; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bhasin S, 2001, J ENDOCRINOL, V170, P27, DOI 10.1677/joe.0.1700027; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Blouin K, 2010, CLIN ENDOCRINOL, V72, P176, DOI 10.1111/j.1365-2265.2009.03645.x; Brodsky IG, 1996, J CLIN ENDOCR METAB, V81, P3469, DOI 10.1210/jc.81.10.3469; Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Charles C, 2000, J CLIN ENDOCR METAB, V85, P1026; Chen KL, 2007, POULTRY SCI, V86, P1754, DOI 10.1093/ps/86.8.1754; Chen KL, 2006, ASIAN AUSTRAL J ANIM, V19, P438, DOI 10.5713/ajas.2006.438; Chen KL, 2005, POULTRY SCI, V84, P547, DOI 10.1093/ps/84.4.547; Chen KL, 2010, POULTRY SCI, V88, P887; Chen KL, 2000, J AGR ASSOC CHINA, V1, P54; Chen KuoLung, 2000, Journal of the Chinese Society of Animal Science, V29, P77; COOK JS, 1986, P NATL ACAD SCI USA, V83, P7583, DOI 10.1073/pnas.83.20.7583; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; FENNELL MJ, 1992, POULTRY SCI, V71, P357, DOI 10.3382/ps.0710357; Fennell MJ, 1990, GEN COMP ENDOCR, V77, P763; FIELD RA, 1971, J ANIM SCI, V32, P849; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Garcia E, 1999, J ENDOCRINOL, V161, P89, DOI 10.1677/joe.0.1610089; Gomez-Valades AG, 2006, MOL THER, V13, P401, DOI 10.1016/j.ymthe.2005.08.026; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Gondret F, 2001, J LIPID RES, V42, P106; GUNN JM, 1975, BIOCHEM J, V150, P195, DOI 10.1042/bj1500195; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hsieh CW, 2011, J LIPID RES, V52, P1352, DOI 10.1194/jlr.M012666; Hsieh CW, 2009, J NUTR, V139, P2257, DOI 10.3945/jn.109.113092; Hsieh CY, 2001, J CHIN SOC ANIM SCI, V30, P229; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Khaw K T, 1992, Ann Epidemiol, V2, P675, DOI 10.1016/1047-2797(92)90012-F; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LACASA D, 1995, ENDOCRINE, V3, P789, DOI 10.1007/BF02935682; Lacasa D, 1997, ENDOCRINOLOGY, V138, P3181, DOI 10.1210/en.138.8.3181; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; MULLER MJ, 1982, ENDOCRINOLOGY, V111, P1469; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; PASQUALI R, 1991, METABOLISM, V40, P101, DOI 10.1016/0026-0495(91)90199-7; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Rajan S, 2003, ENDOCRINOLOGY, V144, P5081; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Rosalim SY, 1976, METHODS RADIOIMMUNOA; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; SHRAGO E, 1971, METABOLISM, V20, P54, DOI 10.1016/0026-0495(71)90059-X; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; TILGHMAN S M, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1304, DOI 10.1073/pnas.71.4.1304; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WATFORD M, 1981, J BIOL CHEM, V256, P23; WICKS WD, 1972, BIOCHIM BIOPHYS ACTA, V264, P177, DOI 10.1016/0304-4165(72)90129-8; WILSON JD, 1988, ENDOCR REV, V9, P181, DOI 10.1210/edrv-9-2-181; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	70	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59636	10.1371/journal.pone.0059636	http://dx.doi.org/10.1371/journal.pone.0059636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544081	gold, Green Submitted, Green Published			2022-12-27	WOS:000317480700041
J	Horn, N; Wegmann, U; Dertlit, E; Mulholland, F; Conine, SRA; Waldront, KW; Bongaerts, RJ; Mayer, MJ; Narbad, A				Horn, Nikki; Wegmann, Udo; Dertlit, Enes; Mulholland, Francis; Conine, Samuel R. A.; Waldront, Keith W.; Bongaerts, Roy J.; Mayer, Melinda J.; Narbad, Arjan			Spontaneous Mutation Reveals Influence of Exopolysaccharide on Lactobacillus johnsonii Surface Characteristics	PLOS ONE			English	Article							LACTIC-ACID BACTERIA/; STREPTOCOCCUS-PNEUMONIAE; GASTROINTESTINAL-TRACT; COMPETITIVE-EXCLUSION; FUNCTIONAL-ANALYSIS; LACTOCOCCUS-LACTIS; GENOME SEQUENCE; GENE CLUSTERS; IN-VITRO; BIOSYNTHESIS	As a competitive exclusion agent, Lactobacillus johnsonii FI9785 has been shown to prevent the colonization of selected pathogenic bacteria from the chicken gastrointestinal tract. During growth of the bacterium a rare but consistent emergence of an altered phenotype was noted, generating smooth colonies in contrast to the wild type rough form. A smooth colony variant was isolated and two-dimensional gel analysis of both strains revealed a protein spot with different migration properties in the two phenotypes. The spot in both gels was identified as a putative tyrosine kinase (EpsC), associated with a predicted exopolysaccharide gene cluster. Sequencing of the epsC gene from the smooth mutant revealed a single substitution (G to A) in the coding strand, resulting in the amino acid change D88N in the corresponding gene product. A native plasmid of L. johnsonii was engineered to produce a novel vector for constitutive expression and this was used to demonstrate that expression of the wild type epsC gene in the smooth mutant produced a reversion to the rough colony phenotype. Both the mutant and epsC complemented strains had increased levels of exopolysaccharides compared to the wild type strain, indicating that the rough phenotype is not solely associated with the quantity of exopolysaccharide. Another gene in the cluster, epsE, that encoded a putative undecaprenyl-phosphate galactosephosphotransferase, was deleted in order to investigate its role in exopolysaccharide biosynthesis. The Delta epsE strain exhibited a large increase in cell aggregation and a reduction in exopolysaccharide content, while plasmid complementation of epsE restored the wild type phenotype. Flow cytometry showed that the wild type and derivative strains exhibited clear differences in their adhesive ability to HT29 monolayers in tissue culture, demonstrating an impact of EPS on surface properties and bacteria-host interactions.	[Horn, Nikki; Wegmann, Udo; Dertlit, Enes; Mayer, Melinda J.; Narbad, Arjan] Inst Food Res, Dept Gut Hlth & Food Safety, Norwich, Norfolk, England; [Dertlit, Enes] Bayburt Univ, Dept Food Engn, Bayburt, Turkey; [Mulholland, Francis] Inst Food Res, Prote Unit, Norwich, Norfolk, England; [Conine, Samuel R. A.; Waldront, Keith W.] Inst Food Res, Dept Food & Hlth, Norwich, Norfolk, England; [Bongaerts, Roy J.] Inst Food Res, Analyt Sci Unit, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Bayburt University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Mayer, MJ (corresponding author), Inst Food Res, Dept Gut Hlth & Food Safety, Norwich, Norfolk, England.	Melinda.Mayer@IFR.ac.uk		Wegmann, Udo/0000-0003-1690-3688	Biotechnology and Biological Science Research Council [IFR/08/1, BB/J004529/1, BB/J004545/1]; Turkish Ministry of Education; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044476, BBS/E/F/00042291, BBS/E/F/00044453] Funding Source: researchfish; BBSRC [BBS/E/F/00044476, BBS/E/F/00044453] Funding Source: UKRI	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by strategic core grants (IFR/08/1, BB/J004529/1 and BB/J004545/1) from the Biotechnology and Biological Science Research Council. ED is grateful to the Turkish Ministry of Education for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Broadbent JR, 2003, J DAIRY SCI, V86, P407, DOI 10.3168/jds.S0022-0302(03)73619-4; Cesena C, 2001, J DAIRY SCI, V84, P1001, DOI 10.3168/jds.S0022-0302(01)74559-6; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; De Vuyst L, 2001, INT DAIRY J, V11, P687, DOI 10.1016/S0958-6946(01)00114-5; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Granato D, 1999, APPL ENVIRON MICROB, V65, P1071; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Horn N, 2005, PLASMID, V54, P176, DOI 10.1016/j.plasmid.2005.01.005; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Jolly L, 2001, INT DAIRY J, V11, P733, DOI 10.1016/S0958-6946(01)00117-0; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lebeer S, 2011, LETT APPL MICROBIOL, V52, P220, DOI 10.1111/j.1472-765X.2010.02994.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lee JH, 2011, J BACTERIOL, V193, P5030, DOI 10.1128/JB.05640-11; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Pinto MGV, 2007, J FOOD PROTECT, V70, P125, DOI 10.4315/0362-028X-70.1.125; Pitino I, 2012, FOOD MICROBIOL, V31, P57, DOI 10.1016/j.fm.2012.02.013; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Stingele F, 1999, J BACTERIOL, V181, P6354, DOI 10.1128/JB.181.20.6354-6360.1999; Tallon R, 2003, RES MICROBIOL, V154, P705, DOI 10.1016/j.resmic.2003.09.006; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Ventura M, 2002, APPL ENVIRON MICROB, V68, P6172, DOI 10.1128/AEM.68.12.6172-6181.2002; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Wang YP, 2008, INT J BIOL MACROMOL, V43, P283, DOI 10.1016/j.ijbiomac.2008.06.011; Wegmann U, 1999, APPL ENVIRON MICROB, V65, P4729; Wegmann U, 2009, J BACTERIOL, V191, P7142, DOI 10.1128/JB.01182-09; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	47	52	55	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59957	10.1371/journal.pone.0059957	http://dx.doi.org/10.1371/journal.pone.0059957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544114	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700073
J	Kawamoto, Y; Takemoto, H; Higuchi, S; Sakamaki, T; Hart, JA; Hart, TB; Tokuyama, N; Reinartz, GE; Guislain, P; Dupain, J; Cobden, AK; Mulavwa, MN; Yangozene, K; Darroze, S; Devos, C; Furuichi, T				Kawamoto, Yoshi; Takemoto, Hiroyuki; Higuchi, Shoko; Sakamaki, Tetsuya; Hart, John A.; Hart, Terese B.; Tokuyama, Nahoko; Reinartz, Gay E.; Guislain, Patrick; Dupain, Jef; Cobden, Amy K.; Mulavwa, Mbangi N.; Yangozene, Kumugo; Darroze, Serge; Devos, Celine; Furuichi, Takeshi			Genetic Structure of Wild Bonobo Populations: Diversity of Mitochondrial DNA and Geographical Distribution	PLOS ONE			English	Article							PAN-PANISCUS; PLEISTOCENE REFUGIA; CENTRAL-AFRICA; RIVERS; FOREST; DISPERSAL; REGION; CONGO	Bonobos (Pan paniscus) inhabit regions south of the Congo River including all areas between its southerly tributaries. To investigate the genetic diversity and evolutionary relationship among bonobo populations, we sequenced mitochondrial DNA from 376 fecal samples collected in seven study populations located within the eastern and western limits of the species' range. In 136 effective samples from different individuals (range: 7-37 per population), we distinguished 54 haplotypes in six clades (A1, A2, B1, B2, C, D), which included a newly identified clade (D). MtDNA haplotypes were regionally clustered; 83 percent of haplotypes were locality-specific. The distribution of haplotypes across populations and the genetic diversity within populations thus showed highly geographical patterns. Using population distance measures, seven populations were categorized in three clusters: the east, central, and west cohorts. Although further elucidation of historical changes in the geological setting is required, the geographical patterns of genetic diversity seem to be shaped by paleoenvironmental changes during the Pleistocene. The present day riverine barriers appeared to have a weak effect on gene flow among populations, except for the Lomami River, which separates the TL2 population from the others. The central cohort preserves a high genetic diversity, and two unique clades of haplotypes were found in the Wamba/Iyondji populations in the central cohort and in the TL2 population in the eastern cohort respectively. This knowledge may contribute to the planning of bonobo conservation.	[Kawamoto, Yoshi; Takemoto, Hiroyuki; Higuchi, Shoko; Sakamaki, Tetsuya; Tokuyama, Nahoko; Furuichi, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Hart, John A.; Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Reinartz, Gay E.; Guislain, Patrick] Zool Soc Milwaukee, Bonobo & Congo Biodivers Initiat, Milwaukee, WI USA; [Dupain, Jef; Cobden, Amy K.] African Wildlife Fdn, Kinshasa, DEM REP CONGO; [Mulavwa, Mbangi N.; Yangozene, Kumugo] Minist High Educ & Sci Res, Res Ctr Ecol & Forestry, Mabali, DEM REP CONGO; [Darroze, Serge; Devos, Celine] World Wide Fund Nat, Kinshasa, DEM REP CONGO; [Cobden, Amy K.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Kyoto University; World Wildlife Fund; Emory University	Furuichi, T (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.	furuichi@pri.kyoto-u.ac.jp	Tokuyama, Nahoko/AAB-4866-2021	DARROZE, SERGE/0000-0002-6092-004X	Environment Research and Technology Development Fund [D-1007]; Global Environment Research Fund of the Ministry of the Environment, Japan [F-061]; Japan Society for the Promotion of Science (JSPS) [17255005, 22255007]; JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project [AS-22-027, ITP-23-006]; US Fish and Wildlife; Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award [96200-0-G017]; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF [623-A-00-06-00072-00]; Susan McConnell; Wildlife Conservation Network; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID); Grants-in-Aid for Scientific Research [25257407, 22570089] Funding Source: KAKEN	Environment Research and Technology Development Fund; Global Environment Research Fund of the Ministry of the Environment, Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asia-Africa Science Platform Program; JSPS Primate Origins of Human Evolution (HOPE) Project; US Fish and Wildlife(US Fish & Wildlife Service); Arcus Foundation; Wood Tiger Foundation; Full Circle Foundation; US Fish and Wildlife Service Assistance Award; Columbus Zoo and Aquarium; Barron Wall; L.L. Leakey Foundation; Congo Basin Forest Partnership/USAID-WWF(United States Agency for International Development (USAID)); Susan McConnell; Wildlife Conservation Network; AZA Ape TAG Conservation Initiative; WWF Belgium; WWF Netherlands; Belgian Cooperation; CARPE program (USAID)(United States Agency for International Development (USAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Environment Research and Technology Development Fund (D-1007) (to TF); the Global Environment Research Fund (F-061) of the Ministry of the Environment, Japan (to Nishida); Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research (17255005 and 22255007, to TF); the JSPS Asia-Africa Science Platform Program (2009-2011, 2012-2014 to TF); the JSPS Primate Origins of Human Evolution (HOPE) Project (AS-22-027 and ITP-23-006, to TS); US Fish and Wildlife (2007-2009, 2010-2011, to Lukuru Wildlife Research Foundation); Arcus Foundation (2007-2008, 2010, 2012, to Lukuru Wildlife Research Foundation); Wood Tiger Foundation (2010, 2012, to Lukuru Wildlife Research Foundation); Full Circle Foundation (2011, to Lukuru Wildlife Research Foundation); the US Fish and Wildlife Service Assistance Award (96200-0-G017, to African Wildlife Foundation); Arcus Foundation, the Columbus Zoo and Aquarium, and Barron Wall (to AWF); the L.L. Leakey Foundation (to AKC); the Congo Basin Forest Partnership/USAID-WWF (623-A-00-06-00072-00, to ZSM); Susan McConnell and Richard Scheller (Wildlife Conservation Network) (to ZSM); the AZA Ape TAG Conservation Initiative (to ZSM); WWF Belgium, WWF Netherlands, Belgian Cooperation funding for co-financing, and CARPE program (USAID) for program coordination, for WWF bonobo project in the Lac Tumba Landscape. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; COLYN M, 1991, J BIOGEOGR, V18, P403, DOI 10.2307/2845482; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Dupain J, 2000, BIOL CONSERV, V94, P265, DOI 10.1016/S0006-3207(00)00004-5; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Furuichi Takeshi, 2012, P413; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Grubb Peter, 2001, P88; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hashimoto C, 1996, PRIMATES, V37, P305, DOI 10.1007/BF02381862; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Idani G, 2008, BONOBOS BEHAV ECOLOG, P291; Inogwabini BI, 2007, ORYX, V41, P532, DOI 10.1017/S0030605307414120; Kano T., 1992, LAST APE PYGMY CHIMP; KINGDON J S, 1980, Transactions of the Zoological Society of London, V35, P425; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maley J., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P68; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Nei M., 1987, MOL EVOLUTIONARY GEN; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Reinartz GE, 2006, INT J PRIMATOL, V27, P603, DOI 10.1007/s10764-006-9020-9; Rommerskirchen F, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001223; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stankiewicz J, 2006, J AFR EARTH SCI, V44, P75, DOI 10.1016/j.jafrearsci.2005.11.008; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White P. Scott, 1992, P29; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Zhang BW, 2006, BIOCHEM GENET, V44, P503, DOI 10.1007/s10528-006-9050-1; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	41	48	49	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59660	10.1371/journal.pone.0059660	http://dx.doi.org/10.1371/journal.pone.0059660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544084	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700044
J	Li, XH; Chen, JX; Yue, GX; Liu, YY; Zhao, X; Guo, XL; Liu, Q; Jiang, YM; Bai, MH				Li, Xiao-Hong; Chen, Jia-Xu; Yue, Guang-Xin; Liu, Yue-Yun; Zhao, Xin; Guo, Xiao-Ling; Liu, Qun; Jiang, You-Ming; Bai, Ming-Hua			Gene Expression Profile of the Hippocampus of Rats Subjected to Chronic Immobilization Stress	PLOS ONE			English	Article							C-REACTIVE PROTEIN; T-CELL DEVELOPMENT; GLUCOCORTICOID-RECEPTOR; DENDRITIC CELLS; HORMONE RECEPTOR-2; IMMUNE-RESPONSE; HUMAN MONOCYTES; DOWN-REGULATION; NERVOUS-SYSTEM; MESSENGER-RNA	Objective: This study systematically investigated the effect of chronic stress on the hippocampus and its damage mechanism at the whole genome level. Methods: The rat whole genome expression chips (Illumina) were used to detect gene expression differences in the hippocampus of rats subjected to chronic immobilization stress (daily immobilization stress for 3 h, for 7 or 21 days). The hippocampus gene expression profile was studied through gene ontology and signal pathway analyses using bioinformatics. A differentially expressed transcription regulation network was also established. Real-time quantitative polymerase chain reaction (RT-PCR) was used to verify the microarray results and determine expression of the Gabra1, Fadd, Crhr2, and Cdk6 genes in the hippocampal tissues. Results: Compared to the control group, 602 differentially expressed genes were detected in the hippocampus of rats subjected to stress for 7 days, while 566 differentially expressed genes were expressed in the animals experiencing stress for 21 days. The stress significantly inhibited the primary immune system functions of the hippocampus in animals subjected to stress for both 7 and 21 days. Immobilization activated the extracellular matrix receptor interaction pathway after 7 day exposure to stress and the cytokine-cytokine receptor interaction pathway. The enhanced collagen synthesis capacity of the hippocampal tissue was the core molecular event of the stress regulation network in the 7-day group, while the inhibition of hippocampal cell growth was the core molecular event in the 21-day group. For the Gabra1, Fadd, Crhr2, and Cdk6 genes, RT-PCR results were nearly in line with gene chip assay results. Conclusion: During the 7-day and 21-day stress processes, the combined action of polygenic, multilevel, and multi-signal pathways leads to the disorder of the immunologic functions of the hippocampus, hippocampal apoptosis, and proliferation disequilibrium.	[Li, Xiao-Hong; Chen, Jia-Xu; Liu, Yue-Yun; Zhao, Xin; Guo, Xiao-Ling; Liu, Qun; Jiang, You-Ming; Bai, Ming-Hua] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China; [Li, Xiao-Hong] Guangxi Univ Chinese Med, Sch Preclin Med, Nanning, Peoples R China; [Yue, Guang-Xin] Chinese Acad Med Sci, Inst Basic Theory TCM, Beijing, Peoples R China	Beijing University of Chinese Medicine; Guangxi University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Theory for Chinese Medicine, CACMS	Chen, JX (corresponding author), Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China.	chenjx@bucm.edu.cn	Bai, Minghua/ABB-2223-2020		National Natural Science Foundation of China [30672578, 81072756]; China National Funds for Distinguished Young Scientists [30825046]; Program for Innovative Research Team in Beijing University of Chinese Medicine [2011CXTD-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Beijing University of Chinese Medicine	This research is supported by National Natural Science Foundation of China (No. 30672578, 81072756: http://www.nsfc.gov.cn/), China National Funds for Distinguished Young Scientists (No. 30825046: http://www.nsfc.gov.cn/), and Program for Innovative Research Team in Beijing University of Chinese Medicine (2011CXTD-07: http://www.bucm.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Balasubramanian S, 1999, ONCOGENE, V18, P1297, DOI 10.1038/sj.onc.1202417; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Bartolomucci A, 2003, J NEUROIMMUNOL, V141, P58, DOI 10.1016/S0165-5728(03)00220-0; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BLALOCK JE, 1994, IMMUNOL TODAY, V15, P504, DOI 10.1016/0167-5699(94)90205-4; Blotta MH, 1997, J IMMUNOL, V158, P5589; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Brin S., 1998, COMPUT NETW ISDN SYS, V30, P107, DOI [DOI 10.1016/S0169-7552(98)00110-X, 10.1016/s0169-7552(98)00110-x]; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chao HM, 1998, ENDOCRINOLOGY, V139, P1810, DOI 10.1210/en.139.4.1810; Chen JX, 2008, CELL MOL NEUROBIOL, V28, P745, DOI 10.1007/s10571-007-9169-6; Chen JX, 2008, CELL MOL NEUROBIOL, V28, P237, DOI 10.1007/s10571-007-9170-0; Chen Jia-Xu, 2004, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V20, P71; [陈家旭 CHEN Jiaxu], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P1296; Chen JX, 2004, CHINA J TRADITIONAL, V19, P83; Chen JX, 2006, CHINESE REMEDIES CLI, V3, P223; Chiaretti S, 2006, BLOOD, V107, P197, DOI 10.1182/blood-2005-04-1755; Chiu BC, 2002, MECH AGEING DEV, V123, P313, DOI 10.1016/S0047-6374(01)00372-4; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dodd JS, 2009, J IMMUNOL, V183, P7006, DOI 10.4049/jimmunol.0900085; Dong C, 2008, J IMMUNOTOXICOL, V5, P43, DOI 10.1080/15476910801897953; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Dozmorov IM, 1998, J IMMUNOL, V160, P2700; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Franchimont D, 2000, J IMMUNOL, V164, P1768, DOI 10.4049/jimmunol.164.4.1768; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Herman JP, 1998, J NEUROSCI, V18, P7462; Herman JP, 1999, ENDOCRINOLOGY, V140, P3981, DOI 10.1210/en.140.9.3981; Hornberger LK, 2000, CIRC RES, V87, P508; Huaux F, 2003, J IMMUNOL, V171, P5470, DOI 10.4049/jimmunol.171.10.5470; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kondo S, 1998, FASEB J, V12, P801, DOI 10.1096/fasebj.12.10.801; Lawrence DA, 2000, TOXICOLOGY, V142, P189, DOI 10.1016/S0300-483X(99)00144-4; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Matsuda S, 2004, EMBO J, V23, P2577, DOI 10.1038/sj.emboj.7600268; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nakanishi T, 1997, J BIOCHEM-TOKYO, V121, P197; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Osborne John D, 2007, Methods Mol Biol, V377, P223; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pan JP, 2001, IMMUNOL LETT, V76, P153, DOI 10.1016/S0165-2478(01)00183-3; Parnet P, 2002, J NEUROIMMUNOL, V125, P5, DOI 10.1016/S0165-5728(02)00022-X; RINEHART JJ, 1974, J CLIN INVEST, V54, P1337, DOI 10.1172/JCI107880; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Ryu J, 2007, CARDIOVASC RES, V75, P555, DOI 10.1016/j.cardiores.2007.04.027; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V5, P925; Savoysky E, 1996, BIOCHEM BIOPH RES CO, V226, P329, DOI 10.1006/bbrc.1996.1356; SCHEDLOWSKI M, 1993, NEUROPSYCHOBIOLOGY, V28, P87, DOI 10.1159/000119006; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheela DR, 1993, NEUROIMMUNOL, V42, P193; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skjoaas KA, 2000, VET IMMUNOL IMMUNOP, V87, P79; Starkie RL, 2005, BRAIN BEHAV IMMUN, V19, P404, DOI 10.1016/j.bbi.2005.03.005; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; [唐已婷 Tang Yiting], 2002, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V25, P23; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Wang AJ, 1996, ACTA PHYSL SIN, V48, P348; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; Zhao X, 2003, LAB ANIMAIL SCI MANA, V20, P6	91	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e57621	10.1371/journal.pone.0057621	http://dx.doi.org/10.1371/journal.pone.0057621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544040	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700003
J	Liu, Y; Zhang, S; Li, DW; Jiang, SJ				Liu, Yao; Zhang, Song; Li, Dao-wei; Jiang, Shu-juan			Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials	PLOS ONE			English	Article							SPUTUM EOSINOPHIL COUNTS; AIRWAY HYPERRESPONSIVENESS; MESSENGER-RNA; INTERLEUKIN-5; EXACERBATIONS; IL-5; INFLAMMATION; EXPRESSION; QUALITY	Background: Interleukin (IL)-5 is believed to be a key cytokine in eosinophil inflammatory infiltration in asthma. Previous clinical trials have evaluated the efficacy and safety of mepolizumab, a monoclonal antibody against IL-5, in patients with asthma. However, most of these studies were small, the conclusions were inconsistent, and the precise effects are therefore debatable. Methods: A meta-analysis of randomized placebo-controlled trials was conducted to evaluate the effect of intravenous infusion of mepolizumab on clinical outcomes in patients with asthma. Trials were searched in PubMed, Embase, Web of Science, Cochrane CENTRAL, Scopus, reviews, and reference lists of relevant articles. The outcome variables analyzed included eosinophil counts in blood and sputum, airways outcome measures, exacerbations, asthma control, and quality of life scores. Results: Seven studies met final inclusion criteria (total n=1131). From the pooled analyses, mepolizumab significantly reduced eosinophils in blood (MD -0.29x10(9)/L, 95% CI -0.44 to -0.14x10(9)/L, P=0.0001) and sputum (MD -6.05%, 95% CI -9.34 to -2.77%, P=0.0003). Mepolizumab was also associated with significantly decreased exacerbation risk than placebo (OR 0.30, 95%CI 0.13 to 0.67, P=0.004), and with a significant improvement in the scores on the Asthma Quality of Life Questionnaire (AQLQ) (MD 0.26, 95% CI 0.03 to 0.49, P=0.03) in patients with eosinophilic asthma. There were no statistical differences between the groups with respect to FEV1, PEF, or histamine PC20 (all P>0.05), and a non-significant trend for improvement in scores on the Juniper Asthma Control Questionnaire (JACQ) (MD -0.21, 95% CI -0.43 to 0.01, P=0.06) in the mepolizumab group was observed. Conclusions: Mepolizumab reduces the risk of exacerbations and improves quality of life in patients with eosinophilic asthma, but no significant improvement in lung function outcomes was observed. Further research is required to establish the possible role of anti-IL-5 as a therapy for asthma.	[Liu, Yao; Zhang, Song; Li, Dao-wei; Jiang, Shu-juan] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China	Shandong University	Jiang, SJ (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.	doctorliuyao@126.com						BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P803, DOI 10.1016/j.jaci.2009.11.048; Buttner C, 2003, EUR RESPIR J, V21, P799, DOI 10.1183/09031936.03.00027302; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; COYLE AJ, 1993, AM REV RESPIR DIS, V147, P896, DOI 10.1164/ajrccm/147.4.896; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; FILLEY WV, 1982, LANCET, V2, P11; FitzGerald JM, 2006, THORAX, V61, P992, DOI 10.1136/thx.2005.045195; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; Higgins J., 2009, COCHRANE HDB SYSTEMA; Humbert M, 1997, AM J RESP CRIT CARE, V156, P704, DOI 10.1164/ajrccm.156.3.9610033; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; SEHMI R, 1992, BLOOD, V79, P2952; Wardlaw AJ, 2002, CLIN SCI, V103, P201; YAMAGUCHI Y, 1988, J EXP MED, V167, P1737, DOI 10.1084/jem.167.5.1737	28	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59872	10.1371/journal.pone.0059872	http://dx.doi.org/10.1371/journal.pone.0059872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544105	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700065
J	Meineke, EK; Dunn, RR; Sexton, JO; Frank, SD				Meineke, Emily K.; Dunn, Robert R.; Sexton, Joseph O.; Frank, Steven D.			Urban Warming Drives Insect Pest Abundance on Street Trees	PLOS ONE			English	Article							NATURAL ENEMIES; LAND-USE; TEMPERATURE; WATER; HOMOPTERA; PLANT; SIZE; URBANIZATION; CONSEQUENCES; RESPONSES	Cities profoundly alter biological communities, favoring some species over others, though the mechanisms that govern these changes are largely unknown. Herbivorous arthropod Pests are often more abundant in urban than in rural areas,. and urban outbreaks have been attributed to reduced control by predators and parasitoids and to increased susceptibility of stressed urban plants. These hypotheses, however, leave many outbreaks unexplained and fail to predict variation in pest abundance within cities. Here we show that the abundance of a common insect pest is positively related to temperature even when controlling for other habitat characteristics The scale insect Parthenolecanium quercifex was 13 times more abundant on willow oak trees in the hottest parts of Raleigh, NC, in the southeastern United States, than in cooler areas, though parasitism rates were similar. We further separated the effects of heat from those of natural enemies and plant quality in a greenhouse reciprocal transplant experiment. P. quercifex collected from hot urban trees became more abundant in hot greenhouses than in cool greenhouses, whereas the abundance of P. quercifex collected from cooler urban trees remained low in hot and cool greenhouses. Parthenolecanium quercifex living in urban hot spots succeed with warming, and they do so because some demes have either acclimatized or adapted to high temperatures. Our results provide the first evidence that heat can be a key driver of insect pest outbreaks on urban trees. Since urban warming is similar in magnitude to global warming predicted in the next 50 years, pest abundance on city trees may foreshadow widespread outbreaks as natural forests also grow warmer.	[Meineke, Emily K.; Frank, Steven D.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Sexton, Joseph O.] Univ Maryland, Dept Geog, College Pk, MD 20742 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University System of Maryland; University of Maryland College Park	Meineke, EK (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	ekmeinek@ncsu.edu		Dunn, Robert/0000-0002-6030-4837	USGS Southeast Regional Climate Science Center; NASA [ROSES-NNX09AK22G]; NSF [0953390]; USDA Southern Region IPM [2010-02678]; North Carolina Nursery and Landscape Association; Horticultural Research Institute; USDA; NCSU Department of Entomology; EPA STAR Fellowship	USGS Southeast Regional Climate Science Center; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); USDA Southern Region IPM; North Carolina Nursery and Landscape Association; Horticultural Research Institute; USDA(United States Department of Agriculture (USDA)); NCSU Department of Entomology; EPA STAR Fellowship(United States Environmental Protection Agency)	This work was supported by a grant from the USGS Southeast Regional Climate Science Center to RRD and SDF. RRD was also supported by NASA Biodiversity Grant (ROSES-NNX09AK22G) and an NSF Career grant (0953390). SDF was also supported by grants from USDA Southern Region IPM (2010-02678), North Carolina Nursery and Landscape Association, the Horticultural Research Institute, and the USDA IR-4 Project. EKM was also funded by the NCSU Department of Entomology and an EPA STAR Fellowship. (URLs: http://www.epa.gov/ncer/fellow/; http://ir4.rutgers.edu; http://www.doi.gov/csc/southeast/index.cfm; http://cce.nasa.gov/cce/biodiversity.htm; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 503214; http://www.cals.ncsu.edu/entomology/; http://www.csrees.usda.gov/funding/rfas/ipm_southern.html; http://www.hriresearch.org; http://www.ncnla.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTAD DN, 1990, EVOL ECOL, V4, P43, DOI 10.1007/BF02270714; Angilletta MJ, 2009, BIO HABIT, P35; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Ben-Dov Y, 1997, SOFT SCALE INSECTS T; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; EDMUNDS GF, 1978, SCIENCE, V199, P941, DOI 10.1126/science.199.4332.941; Ernsting G, 2000, AM NAT, V155, P804, DOI 10.1086/303361; Fluckiger W, 1999, ACTA HORTIC, P325; Gibbs M, 2010, J INSECT PHYSIOL, V56, P1275, DOI 10.1016/j.jinsphys.2010.04.009; Gomes V, 2011, BIODIVERS CONSERV, V20, P3577, DOI 10.1007/s10531-011-0149-2; Green DM, 2009, POPUL ECOL, V51, P253, DOI 10.1007/s10144-008-0131-3; Gregg BM, 2001, J ARBORICULT, V27, P8; Gullan PJ, 1997, ANN REV ENTOMOLOGY, V42; HANKS LM, 1993, ECOLOGY, V74, P1081, DOI 10.2307/1940478; HANKS LM, 1994, ECOLOGY, V75, P2301, DOI 10.2307/1940885; Hart M, 2009, THEOR APPL CLIMATOL, V95, P397, DOI 10.1007/s00704-008-0017-5; Hodkinson ID, 2006, GLOBAL CHANGE BIOL, V12, P1308, DOI 10.1111/j.1365-2486.2006.01155.x; Howard L, 1833, CLIMATE LONDON DEDUC; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jenerette GD, 2011, ECOL APPL, V21, P2637, DOI 10.1890/10-1493.1; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Mattson W.J., 1987, P365; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; Preisser EL, 2008, ECOL ENTOMOL, V33, P709, DOI 10.1111/j.1365-2311.2008.01021.x; Putnam J., 1880, P DAVENPORT ACAD SCI, V2, P293; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; San Martin y Gomez G, 2012, OECOLOGIA, V169; Schnitzler FR, 2011, ECOL ENTOMOL, V36, P241, DOI 10.1111/j.1365-2311.2011.01266.x; SCHULTZ PB, 1984, ENVIRON ENTOMOL, V13, P1515, DOI 10.1093/ee/13.6.1515; Solomon S., 2007, PHYS SCI BASIS WORKI; Speight MR, 1998, ECOLOGY, V79, P1503, DOI 10.1890/0012-9658(1998)079[1503:HCSPRH]2.0.CO;2; Steigenga MJ, 2007, ENTOMOL EXP APPL, V125, P195, DOI 10.1111/j.1570-7458.2007.00610.x; WIERSUM LK, 1983, PLANT SOIL, V75, P443, DOI 10.1007/BF02369978	40	132	143	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59687	10.1371/journal.pone.0059687	http://dx.doi.org/10.1371/journal.pone.0059687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544087	Green Published, Green Submitted, gold			2022-12-27	WOS:000317480700047
J	Mulder, C; Mulleners, B; Borgdorff, MW; van Leth, F				Mulder, Christiaan; Mulleners, Brigit; Borgdorff, Martien W.; van Leth, Frank			Predictive Value of the Tuberculin Skin Test among Newly Arriving Immigrants	PLOS ONE			English	Article							QUANTIFERON(R)-TB GOLD; LATENT TUBERCULOSIS; COST-EFFECTIVENESS; ASYLUM SEEKERS; INFECTION; DIAGNOSIS; DISEASE; ASSAY	Rationale: Screening and treating newly arriving immigrants for latent tuberculosis infection (LTBI) in low-incidence countries could be promising to reduce the tuberculosis incidence among this population. The effectiveness of screening with the tuberculin skin test (TST) is unknown. Objectives:To estimate the risk of progression to tuberculosis within two years after entry, stratified by TST result at entry. Methods: In a case-base design, we determined the prevalence of TST positives (10 mm and 15 mm) among a representative cohort of immunocompetent immigrants (n = 643) aged >= 18 years who arrived between April 2009 and March 2011 in the Netherlands (base cohort). Immigrants who progressed to tuberculosis within two years after arrival in 2005, 2006 or 2007 were extracted from the Netherlands Tuberculosis Register (case source cohort). The prevalence of TST positives from the base cohort was projected on the case source cohort to estimate the risk of progression to active tuberculosis by using Bayesian analyses to adjust for the sensitivity of the TST and Poisson regression analyses to take into account the random error of the number of extracted cases. Results:The prevalence of TST positives was 42% and 23% for a cut-off value of 10 mm and 15 mm, respectively. The overall risk of progression to tuberculosis if TST positive was 238 per 100,000 population (95% CI 151-343) and 295 per 100,000 population (95% CI 161-473) for a cut-off value of >= 10 mm and >= 15 mm, respectively. The corresponding risk for TST negatives was 19 (95% CI 0-59) and 58 (95% CI 25-103). Conclusion: The TST has the discriminatory ability to differentiate between individuals at low and high risk of disease.	[Mulder, Christiaan; Mulleners, Brigit; van Leth, Frank] KNCV TB Fdn, The Hague, Netherlands; [Mulder, Christiaan; Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Borgdorff, Martien W.] Publ Hlth Serv, Dept Infect Dis, Amsterdam, Netherlands; [Borgdorff, Martien W.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Mulder, C (corresponding author), KNCV TB Fdn, The Hague, Netherlands.	mulderc@kncvtbc.nl		van Leth, Frank/0000-0002-5490-8968	Netherlands Organization for Health Research and Development (ZonMw) [125010011]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work and its open access publication were supported by the Netherlands Organization for Health Research and Development (ZonMw, Grant number: 125010011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalhamid B, 2010, J CLIN MICROBIOL, V48, P2955, DOI 10.1128/JCM.02253-09; Bwire R, 2000, NETH J MED, V56, P63, DOI 10.1016/S0300-2977(99)00118-7; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Greenaway C, 2011, CAN MED ASSOC J, V183, pE939, DOI 10.1503/cmaj.090302; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Harstad I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-670; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; KNCV Tuberculosis Foundation, 2010, TUB NED 2010; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; Mulder C, 2012, EUR RESPIR J, V40, P1443, DOI 10.1183/09031936.00010612; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Winje BA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-65	21	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e60130	10.1371/journal.pone.0060130	http://dx.doi.org/10.1371/journal.pone.0060130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544128	Green Submitted, Green Published, gold			2022-12-27	WOS:000317480700087
J	Pincheira-Donoso, D; Bauer, AM; Meiri, S; Uetz, P				Pincheira-Donoso, Daniel; Bauer, Aaron M.; Meiri, Shai; Uetz, Peter			Global Taxonomic Diversity of Living Reptiles	PLOS ONE			English	Article							LIZARD GENUS LIOLAEMUS; BODY-SIZE; PHYLOGENETIC-RELATIONSHIPS; ECOLOGICAL OPPORTUNITY; MITOCHONDRIAL GENOMES; DIVERSIFICATION; EVOLUTION; EXTINCTION; SPECIATION; RADIATION	Reptiles are one of the most ecologically and evolutionarily remarkable groups of living organisms, having successfully colonized most of the planet, including the oceans and some of the harshest and more environmentally unstable ecosystems on earth. Here, based on a complete dataset of all the world's diversity of living reptiles, we analyse lineage taxonomic richness both within and among clades, at different levels of the phylogenetic hierarchy. We also analyse the historical tendencies in the descriptions of new reptile species from Linnaeus to March 2012. Although (non-avian) reptiles are the second most species-rich group of amniotes after birds, most of their diversity (96.3%) is concentrated in squamates (59% lizards, 35% snakes, and 2% amphisbaenians). In strong contrast, turtles (3.4%), crocodilians (0.3%), and tuataras (0.01%) are far less diverse. In terms of species discoveries, most turtles and crocodilians were described early, while descriptions of lizards, snakes and amphisbaenians are multimodal with respect to time. Lizard descriptions, in particular, have reached unprecedented levels during the last decade. Finally, despite such remarkably asymmetric distributions of reptile taxonomic diversity among groups, we found that the distributions of lineage richness are consistently right-skewed, with most clades (monophyletic families and genera) containing few lineages (monophyletic genera and species, respectively), while only a few have radiated greatly (notably the families Colubridae and Scincidae, and the lizard genera Anolis and Liolaemus). Therefore, such consistency in the frequency distribution of richness among clades and among phylogenetic levels suggests that the nature of reptile biodiversity is fundamentally fractal (i.e., it is scale invariant). We then compared current reptile diversity with the global reptile diversity and taxonomy known in 1980. Despite substantial differences in the taxonomies (relative to 2012), the patterns of lineage richness remain qualitatively identical, hence reinforcing our conclusions about the fractal nature of reptile biodiversity.	[Pincheira-Donoso, Daniel] Lincoln Univ, Sch Life Sci, Lab Evolutionary Ecol Adaptat, Lincoln, England; [Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Meiri, Shai] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA	University of Lincoln; Villanova University; Tel Aviv University; Virginia Commonwealth University	Pincheira-Donoso, D (corresponding author), Lincoln Univ, Sch Life Sci, Lab Evolutionary Ecol Adaptat, Riseholme Pk, Lincoln, England.	DPincheiraDonoso@lincoln.ac.uk	Uetz, Peter/A-7119-2012; Meiri, Shai/D-2403-2010	Uetz, Peter/0000-0001-6194-4927; Pincheira-Donoso, Daniel/0000-0002-0050-6410; Meiri, Shai/0000-0003-3839-6330				Albino AM, 2008, AMEGHINIANA, V45, P775; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barraclough TG, 1998, EVOL ECOL, V12, P751; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; BirdLife-International, 2011, BIRDLIFE CHECKL BIRD; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Cei JM, 1986, REPTILES CENTRO CENT; Cei Jose M., 1993, Museo Regionale di Scienze Naturali Monografie (Turin), V14, P1; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Coyne J.A., 2004, SPECIATION; Darwin C.R., 1859, ORIGIN SPECIES MEANS; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fontanella FM, 2012, ZOOL J LINN SOC-LOND, V164, P825, DOI 10.1111/j.1096-3642.2011.00786.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Frost DR, 2011, AMPHIBIAN SPECIES WO; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Galis F, 2001, CHARACTER CONCEPT EV, P583; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hay JM, 2010, CONSERV GENET, V11, P1063, DOI 10.1007/s10592-009-9952-7; Hedges S.B., 2012, Zootaxa, V3288, P1; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hubbell Stephen P., 2001, V32, pi; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; King G.M., 1996, REPTILES HERBIVORY; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; Labra A, 2009, AM NAT, V174, P204, DOI 10.1086/600088; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lourenco JM, 2012, MOL PHYLOGENET EVOL, V62, P496, DOI 10.1016/j.ympev.2011.10.022; Mayr E., 1963, ANIMAL SPECIES EVOLU; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Nicholson KE, 2012, ZOOTAXA, P1; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nunn C. L., 2011, COMP APPROACH EVOLUT; Okajima Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-141; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pincheira-Donoso D., 2005, PUBLICACION OCASIONA, V59, P1; Pincheira-Donoso Daniel, 2008, Zootaxa, V1800, P1; Pincheira-Donoso D, 2013, GLOBAL ECOL BIOGEOGR, V22, P857, DOI 10.1111/geb.12052; Pincheira-Donoso D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028942; Pincheira-Donoso D, 2011, EVOL BIOL, V38, P197, DOI 10.1007/s11692-011-9118-7; Pincheira-Donoso D, 2009, ECOL RES, V24, P1223, DOI 10.1007/s11284-009-0607-4; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Pough FH, 2004, HERPETOLOGY; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Reed RN, 2002, GLOBAL ECOL BIOGEOGR, V11, P41, DOI 10.1046/j.1466-822X.2002.00260.x; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Reisz RR, 1997, TRENDS ECOL EVOL, V12, P218, DOI 10.1016/S0169-5347(97)01060-4; Ribas CC, 2007, P ROY SOC B-BIOL SCI, V274, P2399, DOI 10.1098/rspb.2007.0613; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; ROSS CA, 1990, P BIOL SOC WASH, V103, P955; SAVAGE J M, 1989, Amphibia-Reptilia, V10, P105, DOI 10.1163/156853889X00142; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitz A, 2003, CR PALEVOL, V2, P703, DOI 10.1016/j.crpv.2003.07.002; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Schulte JA, 2004, J EVOLUTION BIOL, V17, P408, DOI 10.1046/j.1420-9101.2003.00659.x; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Shine R, 1988, BIOL REPTILIA, V16, P276; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; Thomas GH, 2008, GLOBAL ECOL BIOGEOGR, V17, P340, DOI 10.1111/j.1466-8238.2008.00384.x; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., 2012, REPTILE DATABASE; Uetz P, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2334.1.3; Uetz Peter, 2000, Herpetological Review, V31, P13; Vitt LJ, 2009, HERPETOLOGY; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Wood PL, 2012, MOL PHYLOGENET EVOL, V65, P992, DOI 10.1016/j.ympev.2012.08.025; Zhang M, 2011, MOL PHYLOGENET EVOL, V60, P62, DOI 10.1016/j.ympev.2011.03.029	82	95	106	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59741	10.1371/journal.pone.0059741	http://dx.doi.org/10.1371/journal.pone.0059741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544091	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700051
J	Sato, T; Arai, E; Kohno, T; Tsuta, K; Watanabe, S; Soejima, K; Betsuyaku, T; Kanai, Y				Sato, Takashi; Arai, Eri; Kohno, Takashi; Tsuta, Koji; Watanabe, Shun-ichi; Soejima, Kenzo; Betsuyaku, Tomoko; Kanai, Yae			DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma	PLOS ONE			English	Article							CANCER; HYPERMETHYLATION; IDENTIFICATION; DISRUPTION; CARCINOMAS; MUTATIONS; APOPTOSIS; GENES	The aim of this study was to clarify the significance of DNA methylation alterations at precancerous stages of lung adenocarcinoma. Using single-CpG resolution lnfinium array, genome-wide DNA methylation analysis was performed in 36 samples of normal lung tissue obtained from patients without any primary lung tumor, 145 samples of non-cancerous lung tissue (N) obtained from patients with lung adenocarcinomas, and 145 samples of tumorous tissue (T). Stepwise progression of DNA methylation alterations from normal lung tissue to non-cancerous lung tissue obtained from patients with lung adenocarcinomas, and then tumorous tissue samples, was observed at 3,270 CpG sites, suggesting that non-cancerous lung tissue obtained from patients with lung adenocarcinomas was at precancerous stages with DNA methylation alterations. At CpG sites of 2,083 genes, DNA methylation status in samples of non-cancerous lung tissue obtained from patients with lung adenocarcinomas was significantly correlated with recurrence after establishment of lung adenocarcinomas. Among such recurrence-related genes, 28 genes are normally unmethylated (average beta-values based on lnfinium assay in normal lung tissue samples was less than 0.2) and their DNA hypermethylation at precancerous stages was strengthened during progression to lung adenocarcinomas (Delta beta(T-N)>0.1). Among these 28 genes, we focused on 6 for which implications in transcription regulation, apoptosis or cell adhesion had been reported. DNA hypermethylation of the ADCY5, EVX1, GFRA1, PDE9A, and TBX20 genes resulted in reduced mRNA expression in tumorous tissue samples. 5-Aza-2'-deoxycytidine treatment of lung cancer cell lines restored the mRNA expression levels of these 5 genes. Reduced mRNA expression in tumorous tissue samples was significantly correlated with tumor aggressiveness. These data suggest that DNA methylation alterations at precancerous stages determine tumor aggressiveness and outcome through silencing of specific genes.	[Sato, Takashi; Arai, Eri; Kanai, Yae] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Sato, Takashi; Soejima, Kenzo; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 160, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol & Clin Labs, Div Pathol, Tokyo, Japan; [Watanabe, Shun-ichi] Natl Canc Ctr, Thorac Surg Div, Dept Thorac Oncol, Tokyo, Japan	National Cancer Center - Japan; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Arai, E (corresponding author), Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan.	earai@ncc.go.jp	Kanai, Yae/AAE-6987-2019; Soejima, Kenzo/T-9878-2019	Soejima, Kenzo/0000-0001-9749-995X; Sato, Takashi/0000-0002-2338-1665	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio) [10-42]; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund [23-A-11]; Japan Society for the Promotion of Science (JSPS) [233900 90, 23790456]; National Cancer Center Research and Development Fund, Japan [23-A-1]; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [23390096, 23790456] Funding Source: KAKEN	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund, Japan; Foundation for Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio, 10-42, http://www.nibio.go.jp/part/promote/fundamental/doc/index.html) and partially supported by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (2, http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo14/09.html), National Cancer Center Research and Development Fund (23-A-11, http://www.ncc.go.jp/jp/about/rinri/kaihatsu/files/h24_ncc_research_list.pdf), and Grants-in-Aid for Scientific Research (B, 233900 90, http://www.jsps.go.jp/j-grantsinaid/) and for Young Scientists (B, 23790456, http://www.jsps.go.jp/j-grantsinaid/) from the Japan Society for the Promotion of Science (JSPS). National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund (23-A-1, http://www.ncc.go.jp/jp/about/rinri/kaihatsu/files/h24_ncc_research_list.pdf), Japan. T. Sato is an awardee of a research resident fellowship from the Foundation for Promotion of Cancer Research in Japan (http://www.fpcr.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Arai E, 2009, CARCINOGENESIS, V30, P214, DOI 10.1093/carcin/bgn268; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bralten LBC, 2010, ONCOGENE, V29, P6138, DOI 10.1038/onc.2010.342; BRIATA P, 1995, J BIOL CHEM, V270, P27695, DOI 10.1074/jbc.270.46.27695; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Carvalho RH, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-9; Chakraborty S, 2012, DEV BIOL, V363, P234, DOI 10.1016/j.ydbio.2011.12.034; de Fraipont F, 2012, CLIN CANCER RES, V18, P2976, DOI 10.1158/1078-0432.CCR-11-2797; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Eguchi K, 1997, CANCER RES, V57, P4913; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Hamilton JP, 2011, DIGEST DIS, V29, P130, DOI 10.1159/000323874; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kanai Y, 2008, PATHOL INT, V58, P544, DOI 10.1111/j.1440-1827.2008.02270.x; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Lockwood WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037775; Moran A, 2012, INT J ONCOL, V40, P739, DOI 10.3892/ijo.2011.1253; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Okumura S, 2007, CIRCULATION, V116, P1776, DOI 10.1161/CIRCULATIONAHA.107.698662; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; Saravani R, 2012, CELL PROLIFERAT, V45, P199, DOI 10.1111/j.1365-2184.2012.00819.x; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Travis WD, 2004, WHO CLASSIFICATION T, P35; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Truong M, 2012, BRIT J CANCER, V107, P100, DOI 10.1038/bjc.2012.216; Verri C, 2009, AM J RESP CRIT CARE, V179, P396, DOI 10.1164/rccm.200807-1153OC; Wu DG, 2012, LUNG CANCER, V76, P106, DOI 10.1016/j.lungcan.2011.09.005; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zochbauer-Muller S, 2003, INT J CANCER, V107, P612, DOI 10.1002/ijc.11458	43	41	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59444	10.1371/journal.pone.0059444	http://dx.doi.org/10.1371/journal.pone.0059444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544068	gold, Green Published, Green Submitted			2022-12-27	WOS:000317480700029
J	Vidal-Dupiol, J; Zoccola, D; Tambutte, E; Grunau, C; Cosseau, C; Smith, KM; Freitag, M; Dheilly, NM; Allemand, D; Tambutte, S				Vidal-Dupiol, Jeremie; Zoccola, Didier; Tambutte, Eric; Grunau, Christoph; Cosseau, Celine; Smith, Kristina M.; Freitag, Michael; Dheilly, Nolwenn M.; Allemand, Denis; Tambutte, Sylvie			Genes Related to Ion-Transport and Energy Production Are Upregulated in Response to CO2-Driven pH Decrease in Corals: New Insights from Transcriptome Analysis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SEAWATER ACIDIFICATION; SCLERACTINIAN CORALS; EXPRESSION PATTERNS; MOLECULAR-CLONING; CARBONIC-ACID; SEA-ANEMONE; CALCIFICATION; STRESS; LOCALIZATION	Since the preindustrial era, the average surface ocean pH has declined by 0.1 pH units and is predicted to decline by an additional 0.3 units by the year 2100. Although subtle, this decreasing pH has profound effects on the seawater saturation state of carbonate minerals and is thus predicted to impact on calcifying organisms. Among these are the scleractinian corals, which are the main builders of tropical coral reefs. Several recent studies have evaluated the physiological impact of low pH, particularly in relation to coral growth and calcification. However, very few studies have focused on the impact of low pH at the global molecular level. In this context we investigated global transcriptomic modifications in a scleractinian coral (Pocillopora damicornis) exposed to pH 7.4 compared to pH 8.1 during a 3-week period. The RNAseq approach shows that 16% of our transcriptome was affected by the treatment with 6% of upregulations and 10% of downregulations. A more detailed analysis suggests that the downregulations are less coordinated than the upregulations and allowed the identification of several biological functions of interest. In order to better understand the links between these functions and the pH, transcript abundance of 48 candidate genes was quantified by q-RT-PCR (corals exposed at pH 7.2 and 7.8 for 3 weeks). The combined results of these two approaches suggest that pH >= 7.4 induces an upregulation of genes coding for proteins involved in calcium and carbonate transport, conversion of CO2 into HCO3- and organic matrix that may sustain calcification. Concomitantly, genes coding for heterotrophic and autotrophic related proteins are upregulated. This can reflect that low pH may increase the coral energy requirements, leading to an increase of energetic metabolism with the mobilization of energy reserves. In addition, the uncoordinated downregulations measured can reflect a general trade-off mechanism that may enable energy reallocation.	[Vidal-Dupiol, Jeremie; Zoccola, Didier; Tambutte, Eric; Allemand, Denis; Tambutte, Sylvie] Ctr Sci Monaco, Monaco, Monaco; [Grunau, Christoph; Cosseau, Celine; Dheilly, Nolwenn M.] Univ Perpignan Via Domitia, Ecol & Evolut Interact UMR 5244, Perpignan, France; [Grunau, Christoph; Cosseau, Celine; Dheilly, Nolwenn M.] CNRS, Ecol & Evolut Interact UMR 5244, Perpignan, France; [Smith, Kristina M.; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Oregon State University	Vidal-Dupiol, J (corresponding author), Ctr Sci Monaco, Monaco, Monaco.	jeremie.vidal-dupiol@univ-perp.fr	Dheilly, Nolwenn/AAU-9185-2020; Cosseau, Celine/G-8240-2011; Vidal-Dupiol, Jérémie/B-3165-2010; Zoccola, Didier/A-5997-2009; Dheilly, Nolwenn Marie M/A-7213-2011; Vidal-Dupiol, Jeremie/ABG-8874-2020; Grunau, Christoph/A-6989-2010	Dheilly, Nolwenn/0000-0002-3675-5013; Zoccola, Didier/0000-0002-1524-8098; Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Vidal-Dupiol, Jeremie/0000-0002-0577-2953; Grunau, Christoph/0000-0002-2161-412X	American Cancer Society [RSG-08-030-01-CCG]; OSU Computational and Genome Biology Initiative; Centre Scientifique de Monaco (CSM)	American Cancer Society(American Cancer Society); OSU Computational and Genome Biology Initiative; Centre Scientifique de Monaco (CSM)	This work was supported by funds from the American Cancer Society (RSG-08-030-01-CCG) and start-up funds from the OSU Computational and Genome Biology Initiative. JV-D's postdoctoral fellowship was supported by the Centre Scientifique de Monaco (CSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Bluthgen N, 2004, GENE ONTOLOGY; Brulle F, 2007, COMP BIOCHEM PHYS C, V144, P334, DOI 10.1016/j.cbpc.2006.10.007; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029568; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fox S, 2010, PLANT SYSTEMS BIOL, P79; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hashimoto K, 2004, CORAL REEFS, V23, P485, DOI 10.1007/s00338-004-0410-1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; Inoue M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047786; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; McCulloch M, 2012, NAT CLIM CHANG; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Moya A, 2008, COMP BIOCHEM PHYS A, V151, P29, DOI 10.1016/j.cbpa.2008.05.009; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Pomraning KR, 2012, FUNGAL SECONDARY MET; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robinson JL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P363, DOI 10.1086/660162; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Romano SL, 2000, B MAR SCI, V67, P1043; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Sabourault C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-333; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; Su JG, 2009, FISH SHELLFISH IMMUN, V27, P33, DOI 10.1016/j.fsi.2009.02.016; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Towanda T, 2012, BIOL OPEN, V1, P615, DOI 10.1242/bio.2012521; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; van Heuven S., 2009, MATLAB PROGRAM DEV C; Venn A, P NATL ACAD IN PRESS; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wilkinson C.R., 2008, STATUS CORAL REEFS W; Wong KKW, 2011, COMP BIOCHEM PHYS D, V6, P310, DOI 10.1016/j.cbd.2011.07.001; Zerbino D, 2010, USING VELVET DE NOVO, P1; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zippay ML, 2010, J SHELLFISH RES, V29, P429, DOI 10.2983/035.029.0220; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010; Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6	96	106	108	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e58652	10.1371/journal.pone.0058652	http://dx.doi.org/10.1371/journal.pone.0058652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23544045	Green Published, gold, Green Submitted			2022-12-27	WOS:000317480700008
J	Bandyopadhyay, K; Li, PC; Gjerset, RA				Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.			The p14ARF Alternate Reading Frame Protein Enhances DNA Binding of Topoisomerase I by Interacting with the Serine 506-Phosphorylated Core Domain	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR P53; KINASE CK2 ACTIVITY; ILLEGITIMATE RECOMBINATION; P53-DEPENDENT APOPTOSIS; P14(ARF) EXPRESSION; RELAXATION ACTIVITY; CASEIN KINASE-2; COLON-CANCER; PHOSPHORYLATION	In addition to its well-characterized function as a tumor suppressor, p14ARF (ARF) is a positive regulator of topoisomerase I (topo I), a central enzyme in DNA metabolism and a target for cancer therapy. We previously showed that topo I hyperphosphorylation, a cancer-associated event mediated by elevated levels of the protein kinase CK2, increases topo I activity and the cellular sensitivity to topo I-targeted drugs. Topo I hyperphosphorylation also increases its interaction with ARF. Because the ARF-topo I interaction could be highly relevant to DNA metabolism and cancer treatment, we identified the regions of topo I involved in ARF binding and characterized the effects of ARF binding on topo I function. Using a series of topo I deletion constructs, we found that ARF interacted with the topo I core domain, which encompasses most of the catalytic and DNA-interacting residues. ARF binding increased the DNA relaxation activity of hyperphosphorylated topo I by enhancing its association with DNA, but did not affect the topo I catalytic rate. In cells, ARF promoted the chromatin association of hyperphosphorylated, but not basal phosphorylated, topo I, and increased topo I-mediated DNA nicking under conditions of oxidative stress. The aberrant nicking was found to correlate with increased formation of DNA double-strand breaks, which are precursors of many genome destabilizing events. The results suggest that the convergent actions of oxidative stress and elevated CK2 and ARF levels, which are common features of cancer cells, lead to a dysregulation of topo I that may contribute both to the cellular response to topo I-targeted drugs and to genome instability.	[Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.] Torrey Pines Inst Mol Studies San Diego, San Diego, CA 92121 USA		Gjerset, RA (corresponding author), Torrey Pines Inst Mol Studies San Diego, San Diego, CA 92121 USA.	rgjerset@tpims.org			United States National Institutes of Health/National Cancer Institute [CA111868, CA135369]; NATIONAL CANCER INSTITUTE [R01CA135369, R01CA111868] Funding Source: NIH RePORTER	United States National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the United States National Institutes of Health/National Cancer Institute (CA111868 and CA135369); http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RD, 1994, MUTAT RES-FUND MOL M, V309, P109, DOI 10.1016/0027-5107(94)90048-5; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2010, DNA REPAIR, V9, P678, DOI 10.1016/j.dnarep.2010.03.005; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Bandyopadhyay K, 2007, BIOCHEMISTRY-US, V46, P14325, DOI 10.1021/bi7013618; Bandyopadhyay K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050427; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chowdhury AR, 2002, BIOCHEM J, V366, P653, DOI 10.1042/BJ20020098; CODERONI S, 1990, MOL BIOL REP, V14, P35, DOI 10.1007/BF00422713; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Faust RA, 1999, INT J BIOCHEM CELL B, V31, P941, DOI 10.1016/S1357-2725(99)00050-3; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Hackbarth JS, 2008, J BIOL CHEM, V283, P16711, DOI 10.1074/jbc.M802246200; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; KAISERMAN HB, 1988, BIOCHEMISTRY-US, V27, P3216, DOI 10.1021/bi00409a014; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larsen A K, 1999, Pathol Oncol Res, V5, P171, DOI 10.1053/paor.1999.0209; Lee M, 2006, PATHOL RES PRACT, V202, P415, DOI 10.1016/j.prp.2005.11.011; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; LIU LF, 1983, J BIOL CHEM, V258, P5365; Martinez EJ, 1999, P NATL ACAD SCI USA, V96, P3496, DOI 10.1073/pnas.96.7.3496; MCCONAUGHY BL, 1981, BIOCHIM BIOPHYS ACTA, V655, P1, DOI 10.1016/0005-2787(81)90059-9; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Olivier A, 2003, ONCOGENE, V22, P1945, DOI 10.1038/sj.onc.1206214; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Reikhardt B A, 2003, Neurosci Behav Physiol, V33, P799, DOI 10.1023/A:1025101516128; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SAMUELS DS, 1989, FEBS LETT, V259, P57, DOI 10.1016/0014-5793(89)81493-0; Sanchez-Aguilera A, 2002, BLOOD, V99, P1411, DOI 10.1182/blood.V99.4.1411; Sano T, 2000, PATHOL INT, V50, P709, DOI 10.1046/j.1440-1827.2000.01109.x; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; Soe K, 2001, NUCLEIC ACIDS RES, V29, P3195, DOI 10.1093/nar/29.15.3195; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; TSAO YP, 1993, CANCER RES, V53, P5908; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vestey SB, 2004, BREAST CANCER RES, V6, pR571, DOI 10.1186/bcr912; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; Zhu J, 1996, MOL CELL BIOL, V16, P1805; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e58835	10.1371/journal.pone.0058835	http://dx.doi.org/10.1371/journal.pone.0058835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	123VE	23555599	gold, Green Submitted, Green Published			2022-12-27	WOS:000317418500017
J	Francis, SC; Baisley, K; Lees, SS; Andrew, B; Zalwango, F; Seeley, J; Vandepitte, J; Ao, TT; van de Wijgert, J; Watson-Jones, D; Kapiga, S; Grosskurth, H; Hayes, RJ				Francis, Suzanna C.; Baisley, Kathy; Lees, Shelley S.; Andrew, Bahati; Zalwango, Flavia; Seeley, Janet; Vandepitte, Judith; Ao, Trong T.; van de Wijgert, Janneke; Watson-Jones, Deborah; Kapiga, Saidi; Grosskurth, Heiner; Hayes, Richard J.			Vaginal Practices among Women at High Risk of HIV Infection in Uganda and Tanzania: Recorded Behaviour from a Daily Pictorial Diary	PLOS ONE			English	Article							INTRAVAGINAL PRACTICES; SEXUAL PRACTICES; MICROBICIDES; ACQUISITION; PREFERENCES	Background: Intravaginal practices (IVP) are highly prevalent in sub-Saharan African and have been implicated as risk factors for HIV acquisition. However, types of IVP vary between populations, and detailed information on IVP among women at risk for HIV in different populations is needed. We investigated IVP among women who practice transactional sex in two populations: semi-urban, facility workers in Tanzania who engage in opportunistic sex work; and urban, self-identified sex workers and bar workers in Uganda. The aim of the study was to describe and compare IVP using a daily pictorial diary. Methodology/Principal Findings: Two hundred women were recruited from a HIV prevention intervention feasibility study in Kampala, Uganda and in North-West Tanzania. Women were given diaries to record IVP daily for six weeks. Baseline data showed that Ugandan participants had more lifetime partners and transactional sex than Tanzanian participants. Results from the diary showed that 96% of Tanzanian participants and 100% of Ugandan participants reported intravaginal cleansing during the six week study period. The most common types of cleansing were with water only or water and soap. In both countries, intravaginal insertion (e.g. with herbs) was less common than cleansing, but insertion was practiced by more participants in Uganda (46%) than in Tanzania (10%). In Uganda, participants also reported more frequent sex, and more insertion related to sex. In both populations, cleansing was more often reported on days with reported sex and during menstruation, and in Uganda, when participants experienced vaginal discomfort. Participants were more likely to cleanse after sex if they reported no condom use. Conclusions: While intravaginal cleansing was commonly practiced in both cohorts, there was higher frequency of cleansing and insertion in Uganda. Differences in IVP were likely to reflect differences in sexual behaviour between populations, and may warrant different approaches to interventions targeting IVP. Vaginal practices among women at high risk in Uganda and Tanzania: recorded behaviour from a daily pictorial diary.	[Francis, Suzanna C.; Baisley, Kathy; Lees, Shelley S.; Seeley, Janet; Ao, Trong T.; Kapiga, Saidi; Grosskurth, Heiner; Hayes, Richard J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Francis, Suzanna C.; Lees, Shelley S.; Andrew, Bahati; Ao, Trong T.; Watson-Jones, Deborah; Kapiga, Saidi] Natl Inst Med Res, Mwanza Ctr, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Zalwango, Flavia; Seeley, Janet; Vandepitte, Judith; Grosskurth, Heiner] Uganda Virus Res Inst, MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Watson-Jones, Deborah] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Uganda Virus Research Institute; University of East Anglia; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine	Francis, SC (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	suzanna.francis@lshtm.ac.uk		Kapiga, Saidi/0000-0003-1753-4060; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Seeley, Janet/0000-0002-0583-5272; Hayes, Richard/0000-0002-1729-9892; Grosskurth, Heiner/0000-0001-9960-7280; Francis, Suzanna Carter/0000-0002-3724-4813	United Kingdom Medical Research Council; European and Developing Countries Clinical Trials Partnership; MRC [G0901756, G0701039, G0700837, G1002369, MC_U950097154] Funding Source: UKRI; Medical Research Council [G1002369, G0901756, G0701039, MC_U950097154, G0700837] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries Clinical Trials Partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for the Intravaginal Practices Project was provided by the United Kingdom Medical Research Council, and the European and Developing Countries Clinical Trials Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CF, 2007, SEX TRANSM INFECT, V83, P490, DOI 10.1136/sti.2007.024810; Braunstein S, 2005, J WOMENS HEALTH, V14, P424, DOI 10.1089/jwh.2005.14.424; Brown JE, 2000, SEX TRANSM DIS, V27, P183, DOI 10.1097/00007435-200004000-00001; BROWN JE, 1993, SOC SCI MED, V37, P989, DOI 10.1016/0277-9536(93)90433-5; BROWN RC, 1993, SEX TRANSM DIS, V20, P96, DOI 10.1097/00007435-199303000-00007; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Ferguson AG, 2006, CULT HEALTH SEX, V8, P175, DOI 10.1080/13691050600665006; Francis SC, 2010, 2010 AIDS C VIENN AU; Francis SC, 2012, SEX TRANSM DIS, V39, P614, DOI 10.1097/OLQ.0b013e3182515fe4; Gafos M, 2010, CULT HEALTH SEX, V12, P929, DOI 10.1080/13691058.2010.507876; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 2013, PLSO ONE UNPUB; Lees S, 2010, SEX TRANSM DIS, V37, P497, DOI 10.1097/OLQ.0b013e3181d4722d; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Ramjee G, 1999, SEX TRANSM DIS, V26, P374, DOI 10.1097/00007435-199908000-00002; van de Wijgert JHHM, 2000, J INFECT DIS, V181, P587, DOI 10.1086/315227; van de Wijgert JHHM, 2000, J ACQ IMMUN DEF SYND, V24, P62; Vandepitte J, 2010, SEXUALLY TRANSMITTED, V38, P316; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c	22	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2013	8	3							e59085	10.1371/journal.pone.0059085	http://dx.doi.org/10.1371/journal.pone.0059085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	123VE	23555618	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000317418500020
J	Genchev, GZ; Kobayashi, T; Lu, H				Genchev, Georgi Z.; Kobayashi, Tomoyoshi; Lu, Hui			Calcium Induced Regulation of Skeletal Troponin - Computational Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							THIN-FILAMENTS; CA2+ BINDING; ANGSTROM RESOLUTION; MUSCLE-CONTRACTION; STRUCTURAL BASIS; ACTIN-FILAMENTS; TERMINAL DOMAIN; N-DOMAIN; CALMODULIN; PROTEINS	The interaction between calcium and the regulatory site(s) of striated muscle regulatory protein troponin switches on and off muscle contraction. In skeletal troponin binding of calcium to sites I and II of the TnC subunit results in a set of structural changes in the troponin complex, displaces tropomyosin along the actin filament and allows myosin-actin interaction to produce mechanical force. In this study, we used molecular dynamics simulations to characterize the calcium dependent dynamics of the fast skeletal troponin molecule and its TnC subunit in the calcium saturated and depleted states. We focused on the N-lobe and on describing the atomic level events that take place subsequent to removal of the calcium ion from the regulatory sites I and II. A main structural event - a closure of the A/B helix hydrophobic pocket results from the integrated effect of the following conformational changes: the breakage of H-bond interactions between the backbone nitrogen atoms of the residues at positions 2, 9 and sidechain oxygen atoms of the residue at position 12 (N-2-OE12/N-9-OE12) in sites I and II; expansion of sites I and II and increased site II N-terminal end-segment flexibility; strengthening of the beta-sheet scaffold; and the subsequent re-packing of the N-lobe hydrophobic residues. Additionally, the calcium release allows the N-lobe to rotate relative to the rest of the Tn molecule. Based on the findings presented herein we propose a novel model of skeletal thin filament regulation.	[Genchev, Georgi Z.; Lu, Hui] Univ Illinois, Dept Bioengn, Bioinformat Program, Chicago, IL 60680 USA; [Kobayashi, Tomoyoshi] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Kobayashi, Tomoyoshi] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60680 USA; [Lu, Hui] Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200040, Peoples R China; [Lu, Hui] Minist Hlth, Key Lab Embryo Mol Biol, Shanghai, Peoples R China; [Lu, Hui] Shanghai Lab Embryo & Reprod Engn, Shanghai, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Kobayashi, T (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.	tkoba@uic.edu; huilu@uic.edu	Lu, Hui/K-3264-2019	Lu, Hui/0000-0001-8347-0830	National Science Foundation [TG-MCB090005]; National Institutes of Health U.S.A. [R01HL082923, T32HL007692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, T32HL007692] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Science Foundation through XSEDE resources provided by TACC-Lonestar (TG-MCB090005), and R01HL082923 and T32HL007692 from the National Institutes of Health U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga GM, 2002, ANN MED, V34, P248, DOI 10.1080/078538902320322510; Barkema GT, 1996, PHYS REV LETT, V77, P4358, DOI 10.1103/PhysRevLett.77.4358; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Deriu MA, 2012, PROTEINS, V80, P1598, DOI 10.1002/prot.24053; Deriu MA, 2011, J BIOMECH, V44, P630, DOI 10.1016/j.jbiomech.2010.11.014; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dupuis L, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3671986; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Ertz-Berger BR, 2005, P NATL ACAD SCI USA, V102, P18219, DOI 10.1073/pnas.0509181102; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fan J, 2012, BIOPHYS J, V103, P1334, DOI 10.1016/j.bpj.2012.08.029; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; Grabarek Z, 2005, J MOL BIOL, V346, P1351, DOI 10.1016/j.jmb.2005.01.004; GRABAREK Z, 1990, NATURE, V345, P132, DOI 10.1038/345132a0; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knowles AC, 2012, J MOL BIOL, V421, P125, DOI 10.1016/j.jmb.2012.05.005; Kobayashi C, 2006, BIOPHYS J, V90, P3043, DOI 10.1529/biophysj.105.078071; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Li Y, 2000, P NATL ACAD SCI USA, V97, P5140, DOI 10.1073/pnas.090098997; Lindert S, 2012, J PHYS CHEM B, V116, P8449, DOI 10.1021/jp212173f; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Paakkonen K, 1998, J BIOL CHEM, V273, P15633, DOI 10.1074/jbc.273.25.15633; Paul DM, 2009, J BIOL CHEM, V284, P15007, DOI 10.1074/jbc.M808615200; Pearlstone JR, 2000, J BIOL CHEM, V275, P35106, DOI 10.1074/jbc.M001000200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Strynadka NCJ, 1997, J MOL BIOL, V273, P238, DOI 10.1006/jmbi.1997.1257; Varughese JF, 2011, J BIOMOL STRUCT DYN, V29, P123, DOI 10.1080/07391102.2011.10507378; Varughese JF, 2010, J BIOMOL STRUCT DYN, V28, P159, DOI 10.1080/07391102.2010.10507350; Vigil D, 2001, BIOPHYS J, V80, P2082, DOI 10.1016/S0006-3495(01)76182-6; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102	55	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e58313	10.1371/journal.pone.0058313	http://dx.doi.org/10.1371/journal.pone.0058313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554884	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800012
J	Li, XX; Shi, J; Ge, ML; Shao, YQ; Huang, JB; Huang, ZD; Zhang, J; Nie, N; Zheng, YZ				Li, Xingxin; Shi, Jun; Ge, Meili; Shao, Yingqi; Huang, Jinbo; Huang, Zhendong; Zhang, Jing; Nie, Neng; Zheng, Yizhou			Outcomes of Optimized over Standard Protocol of Rabbit Antithymocyte Globulin for Severe Aplastic Anemia: A Single-Center Experience	PLOS ONE			English	Article							ANTI-THYMOCYTE GLOBULIN; COLONY-STIMULATING FACTOR; ANTILYMPHOCYTE GLOBULIN; IMMUNOSUPPRESSIVE THERAPY; MARROW FAILURE; CYCLOSPORINE; THYMOGLOBULIN; MULTICENTER; TRIAL; ATGAM	Background: Previous reports showed that outcome of rabbit antithymocyte globulin (rATG) was not satisfactory as the first-line therapy for severe aplastic anemia (SAA). We explored a modifying schedule of administration of rATG. Design and Methods: Outcomes of a cohort of 175 SAA patients, including 51 patients administered with standard protocol (3.55 mg/kg/d for 5 days) and 124 cases with optimized protocol (1.97 mg/kg/d for 9 days) of rATG plus cyclosporine (CSA), were analyzed retrospectively. Results: Of all 175 patients, response rates at 3 and 6 months were 36.6% and 56.0%, respectively. 51 cases received standard protocol had poor responses at 3 (25.5%) and 6 months (41.2%). However, 124 patients received optimized protocol had better responses at 3 (41.1%, P = 0.14) and 6 (62.1%, P = 0.01). Higher incidences of infection (57.1% versus 37.9%, P = 0.02) and early mortality (17.9% versus 0.8%, P < 0.001) occurred in patients received standard protocol compared with optimized protocol. The 5-year overall survival in favor of the optimized over standard rATG protocol (76.0% versus. 50.3%, P < 0.001) was observed. By multivariate analysis, optimized protocol (RR = 2.21, P = 0.04), response at 3 months (RR = 10.31, P = 0.03) and shorter interval (<23 days) between diagnosis and initial dose of rATG (RR = 5.35, P = 0.002) were independent favorable predictors of overall survival. Conclusions: Optimized instead of standard rATG protocol in combination with CSA remained efficacious as a first-line immunosuppressive regimen for SAA.	[Li, Xingxin; Shi, Jun; Ge, Meili; Shao, Yingqi; Huang, Jinbo; Huang, Zhendong; Zhang, Jing; Nie, Neng; Zheng, Yizhou] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Severe Aplast Anemia Studying Program, Tianjin, Peoples R China; [Li, Xingxin; Shi, Jun; Ge, Meili; Shao, Yingqi; Huang, Jinbo; Huang, Zhendong; Zhang, Jing; Nie, Neng; Zheng, Yizhou] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Li, Xingxin; Shi, Jun; Ge, Meili; Shao, Yingqi; Huang, Jinbo; Huang, Zhendong; Zhang, Jing; Nie, Neng; Zheng, Yizhou] Peking Union Med Coll, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zheng, YZ (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Severe Aplast Anemia Studying Program, Tianjin, Peoples R China.	zheng_yizhou@hotmail.com			National Science and Technology Major Project [2011ZX09302-007-04]; National Public Health Benefit Research Foundation [201202017]	National Science and Technology Major Project; National Public Health Benefit Research Foundation	The study was partially supported by a grant from National Science and Technology Major Project (2011ZX09302-007-04), and a grant from National Public Health Benefit Research Foundation (201202017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afable MG, 2011, HAEMATOL-HEMATOL J, V96, P1269, DOI 10.3324/haematol.2011.042622; Agha IA, 2002, TRANSPLANTATION, V73, P473, DOI 10.1097/00007890-200202150-00025; Atta EH, 2010, ANN HEMATOL, V89, P851, DOI 10.1007/s00277-010-0944-y; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; CHAMPLIN R, 1983, NEW ENGL J MED, V308, P113, DOI 10.1056/NEJM198301203080301; DEPLANQUE MM, 1989, BRIT J HAEMATOL, V73, P121; Di Bona E, 1999, BRIT J HAEMATOL, V107, P330, DOI 10.1046/j.1365-2141.1999.01693.x; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; Gaber AO, 1998, TRANSPLANTATION, V66, P29, DOI 10.1097/00007890-199807150-00005; GLUCKMAN E, 1982, BRIT J HAEMATOL, V51, P541, DOI 10.1111/j.1365-2141.1982.tb02817.x; Locasciulli A, 2007, HAEMATOL-HEMATOL J, V92, P11, DOI 10.3324/haematol.10075; Marsh JC, 2012, BLOOD, V119, P5391, DOI 10.1182/blood-2012-02-407684; Passweg JR, 2009, HAEMATOL-HEMATOL J, V94, P310, DOI 10.3324/haematol.2008.002329; PILLOW RP, 1966, NEW ENGL J MED, V275, P94, DOI 10.1056/NEJM196607142750209; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Pulsipher MA, 2011, BIOL BLOOD MARROW TR, V17, P291, DOI 10.1016/j.bbmt.2010.10.028; Remberger M, 2004, TRANSPLANTATION, V78, P122, DOI 10.1097/01.TP.0000133513.29923.44; Risitano AM, 2012, CURR OPIN HEMATOL, V19, P3, DOI 10.1097/MOH.0b013e32834da9a4; Risitano AM, 2011, BRIT J HAEMATOL, V152, P127, DOI 10.1111/j.1365-2141.2010.08439.x; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Saracco P, 2008, BRIT J HAEMATOL, V140, P197, DOI 10.1111/j.1365-2141.2007.06903.x; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P622, DOI 10.1111/j.1365-2141.2006.06098.x; Scheinberg P, 2011, NEW ENGL J MED, V365, P430, DOI 10.1056/NEJMoa1103975; SPECK B, 1977, LANCET, V2, P1145; Teramura M, 2007, BLOOD, V110, P1756, DOI 10.1182/blood-2006-11-050526; THOMAS ED, 1972, LANCET, V1, P284; THOMAS ED, 1964, JAMA-J AM MED ASSOC, V188, P1041; Tichelli A, 2011, BLOOD, V117, P4434, DOI 10.1182/blood-2010-08-304071; YOUNG N, 1988, BLOOD, V72, P1861; Zheng YZ, 2006, EXP HEMATOL, V34, P826, DOI 10.1016/j.exphem.2006.03.017	33	25	28	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e56648	10.1371/journal.pone.0056648	http://dx.doi.org/10.1371/journal.pone.0056648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554855	gold, Green Published, Green Submitted			2022-12-27	WOS:000316409800003
J	Tanaka, H; Tanabe, N; Kawato, T; Nakai, K; Kariya, T; Matsumoto, S; Zhao, N; Motohashi, M; Maeno, M				Tanaka, Hideki; Tanabe, Natsuko; Kawato, Takayuki; Nakai, Kumiko; Kariya, Taro; Matsumoto, Sakurako; Zhao, Ning; Motohashi, Masafumi; Maeno, Masao			Nicotine Affects Bone Resorption and Suppresses the Expression of Cathepsin K, MMP-9 and Vacuolar-Type H+-ATPase d2 and Actin Organization in Osteoclasts	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; NF-KAPPA-B; CIGARETTE-SMOKING; PERIODONTAL-DISEASE; MATRIX METALLOPROTEINASES; GINGIVAL FIBROBLASTS; GENE-EXPRESSION; RISK-FACTORS; CELLS; SUBUNIT	Tobacco smoking is an important risk factor for the development of several cancers, osteoporosis, and inflammatory diseases such as periodontitis. Nicotine is one of the major components of tobacco. In previous study, we showed that nicotine inhibits mineralized nodule formation by osteoblasts, and the culture medium from osteoblasts containing nicotine and lipopolysaccharide increases osteoclast differentiation. However, the direct effect of nicotine on the differentiation and function of osteoclasts is poorly understood. Thus, we examined the direct effects of nicotine on the expression of nicotine receptors and bone resorption-related enzymes, mineral resorption, actin organization, and bone resorption using RAW264.7 cells and bone marrow cells as osteoclast precursors. Cells were cultured with 10(-5), 10(-4), or 10(-3) M nicotine and/or 50 mu M alpha-bungarotoxin (btx), an 7 nicotine receptor antagonist, in differentiation medium containing the soluble RANKL for up 7 days. 1-5, 7, 9, and 10 nicotine receptors were expressed on RAW264.7 cells. The expression of 7 nicotine receptor was increased by the addition of nicotine. Nicotine suppressed the number of tartrate-resistant acid phosphatase positive multinuclear osteoclasts with large nuclei(>= 10 nuclei), and decreased the planar area of each cell. Nicotine decreased expression of cathepsin K, MMP-9, and V-ATPase d2. Btx inhibited nicotine effects. Nicotine increased CA II expression although decreased the expression of V-ATPase d2 and the distribution of F-actin. Nicotine suppressed the planar area of resorption pit by osteoclasts, but did not affect mineral resorption. These results suggest that nicotine increased the number of osteoclasts with small nuclei, but suppressed the number of osteoclasts with large nuclei. Moreover, nicotine reduced the planar area of resorption pit by suppressing the number of osteoclasts with large nuclei, V-ATPase d2, cathepsin K and MMP-9 expression and actin organization.	[Tanaka, Hideki; Kawato, Takayuki; Motohashi, Masafumi; Maeno, Masao] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Tanabe, Natsuko; Zhao, Ning] Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan; [Tanabe, Natsuko; Kawato, Takayuki; Motohashi, Masafumi; Maeno, Masao] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol, Tokyo 101, Japan; [Nakai, Kumiko; Kariya, Taro; Matsumoto, Sakurako] Nihon Univ, Grad Sch Dent, Tokyo, Japan; [Zhao, Ning] Shandong Univ, Sch Dent, Dept Endodont, Jinan 250100, Shandong Provin, Peoples R China	Nihon University; Nihon University; Nihon University; Nihon University; Shandong University	Tanabe, N (corresponding author), Nihon Univ, Sch Dent, Dept Biochem, Tokyo 101, Japan.	tanabe.natsuko@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Society for the Promotion of Science [21592401]; Strategic Research Base Development Program for Private Universities; MEXT [S1001024]; Promotion and Mutual Aid Corporation for Private Schools of Japan; Sato Fund, Nihon University School of Dentistry	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Base Development Program for Private Universities; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Sato Fund, Nihon University School of Dentistry	The present study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to promote multidisciplinary research projects; a Grant-in-Aid for Scientific Research (C) from the Japanese Society for the Promotion of Science (number 21592401); the Strategic Research Base Development Program for Private Universities, subsidized by MEXT, 2010 (S1001024); and the Promotion and Mutual Aid Corporation for Private Schools of Japan. The present study was also supported by the Sato Fund, Nihon University School of Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2000, J PERIODONTOL, V71, P1874, DOI 10.1902/jop.2000.71.12.1874; ALOIA JF, 1985, AM J MED, V78, P95, DOI 10.1016/0002-9343(85)90468-1; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; BENOWITZ NL, 1989, ANN INTERN MED, V111, P112, DOI 10.7326/0003-4819-111-2-112; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; CLARKE NG, 1984, ARCH ORAL BIOL, V29, P789, DOI 10.1016/0003-9969(84)90008-6; CLARKE NG, 1981, ORAL SURG ORAL MED O, V52, P577, DOI 10.1016/0030-4220(81)90071-2; DANIELL HW, 1976, ARCH INTERN MED, V136, P298, DOI 10.1001/archinte.136.3.298; David JP, 2001, J CELL PHYSIOL, V188, P89, DOI 10.1002/jcp.1099; Denlinger LC, 1996, J BIOL CHEM, V271, P337, DOI 10.1074/jbc.271.1.337; Fujisaki K, 2007, LIFE SCI, V80, P1311, DOI 10.1016/j.lfs.2006.12.037; Giannopoulou C, 2001, J CLIN PERIODONTOL, V28, P769, DOI 10.1034/j.1600-051X.2001.280808.x; Hapidin H, 2007, J BONE MINER METAB, V25, P93, DOI 10.1007/s00774-006-0733-9; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Johnson GK, 2004, J PERIODONTOL, V75, P196, DOI 10.1902/jop.2004.75.2.196; Katono T, 2006, ACTA BIOCH BIOPH SIN, V38, P874, DOI 10.1111/j.1745-7270.2006.00240.x; Kuwabara A, 2011, J HARD TISSUE BIOL, V20, P247, DOI 10.2485/jhtb.20.247; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li Q, 2011, LIFE SCI, V89, P395, DOI 10.1016/j.lfs.2011.07.008; Liu B, 2003, J ORAL PATHOL MED, V32, P367, DOI 10.1034/j.1600-0714.2003.00126.x; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; MERLETTI F, 1989, CANCER RES, V49, P4919; NEHER GH, 1974, TOXICOL APPL PHARM, V27, P253, DOI 10.1016/0041-008X(74)90196-3; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PAGE RC, 1976, LAB INVEST, V34, P235; Pennypacker B, 2009, BONE, V44, P199, DOI 10.1016/j.bone.2008.08.130; PERKINS KA, 1986, PSYCHOPHARMACOLOGY, V90, P373; Ryder MI, 1998, J PERIODONTAL RES, V33, P359, DOI 10.1111/j.1600-0765.1998.tb02211.x; Schoonderwoert VTG, 2002, MOL MEMBR BIOL, V19, P67, DOI 10.1080/09687680110112910; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takahashi N, 2003, METH MOLEC MED, V80, P129; Tanaka H, 2006, LIFE SCI, V78, P1733, DOI 10.1016/j.lfs.2005.08.017; Tanaka H, 2005, LIFE SCI, V77, P2273, DOI 10.1016/j.lfs.2005.02.022; Tanigawa S, 2011, J HARD TISSUE BIOL, V20, P195, DOI 10.2485/jhtb.20.195; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tipton DA, 1995, J PERIODONTOL, V66, P1056, DOI 10.1902/jop.1995.66.12.1056; Torrungruang K, 2005, J PERIODONTOL, V76, P566, DOI 10.1902/jop.2005.76.4.566; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Voronov I, 2008, BIOCHEM PHARMACOL, V75, P2034, DOI 10.1016/j.bcp.2008.02.025; Voronov I, 2005, BIOCHEM PHARMACOL, V70, P300, DOI 10.1016/j.bcp.2005.04.028; WARR GA, 1973, AM REV RESPIR DIS, V108, P371; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623	49	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59402	10.1371/journal.pone.0059402	http://dx.doi.org/10.1371/journal.pone.0059402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23555029	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800087
J	Xanthopoulos, K; Lagoudaki, R; Kontana, A; Kyratsous, C; Panagiotidis, C; Grigoriadis, N; Yiangou, M; Sklaviadis, T				Xanthopoulos, Konstantinos; Lagoudaki, Rosa; Kontana, Anastasia; Kyratsous, Christos; Panagiotidis, Christos; Grigoriadis, Nikolaos; Yiangou, Minas; Sklaviadis, Theodoros			Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; HEAT-SHOCK PROTEINS; MONOCLONAL-ANTIBODIES; LYMPHOTOXIN PATHWAY; MICE; SCRAPIE; DISEASE; DELAYS; REPLICATION	Transmissible spongiform encephalopathies are neurodegenerative diseases, which despite fervent research remain incurable. Immunization approaches have shown great potential at providing protection, however tolerance effects hamper active immunization protocols. In this study we evaluated the antigenic potential of various forms of recombinant murine prion protein and estimated their protective efficacy in a mouse model of prion diseases. One of the forms tested provided a significant elongation of survival interval. The elongation was mediated via an acute depletion of mature follicular dendritic cells, which are associated with propagation of the prion infectious agent in the periphery and in part to the development of humoral immunity against prion protein. This unprecedented result could offer new strategies for protection against transmissible encephalopathies as well as other diseases associated with follicular dendritic cells.	[Xanthopoulos, Konstantinos; Sklaviadis, Theodoros] Aristotle Univ Thessaloniki, Sch Pharm, Pharmacol Lab, GR-54006 Thessaloniki, Greece; [Lagoudaki, Rosa; Grigoriadis, Nikolaos] AHEPA Univ Hosp, Dept Neurol, Lab Expt Neurol & Neuroimmunol, Thessaloniki, Greece; [Kontana, Anastasia; Yiangou, Minas] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Kyratsous, Christos; Panagiotidis, Christos] Aristotle Univ Thessaloniki, Sch Pharm, Cell Biol Lab, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Sklaviadis, T (corresponding author), Aristotle Univ Thessaloniki, Sch Pharm, Pharmacol Lab, GR-54006 Thessaloniki, Greece.	sklaviad@pharm.auth.gr	Sklaviadis, Theoodoros/AGK-6763-2022; Dafou, Dimitra/N-6094-2015	Dafou, Dimitra/0000-0003-4170-0612; Panagiotidis, Christos/0000-0001-9683-7320; Sklaviadis, Theodoros/0000-0002-0246-3100	Alexander S. Onassis Public Benefit Foundation; research committee of Aristotle University of Thessaloniki	Alexander S. Onassis Public Benefit Foundation; research committee of Aristotle University of Thessaloniki	This work was partially supported by Alexander S. Onassis Public Benefit Foundation and the research committee of Aristotle University of Thessaloniki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2004, NAT REV IMMUNOL, V4, P725, DOI 10.1038/nri1437; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DINTZIS RZ, 1983, J IMMUNOL, V131, P2196; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Falara V, 2008, PLANT MOL BIOL, V68, P633, DOI 10.1007/s11103-008-9399-0; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gonzalez SF, 2009, CURR OPIN IMMUNOL, V21, P251, DOI 10.1016/j.coi.2009.05.013; Heikenwalder M, 2008, IMMUNITY, V29, P998, DOI 10.1016/j.immuni.2008.10.014; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Koller MF, 2002, J NEUROIMMUNOL, V132, P113, DOI 10.1016/S0165-5728(02)00316-8; Kyratsous CA, 2009, GENE, V440, P9, DOI 10.1016/j.gene.2009.03.011; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Magri G, 2005, VACCINE, V23, P2862, DOI 10.1016/j.vaccine.2004.11.067; Mok SWF, 2012, J IMMUNOL, V188, P5032, DOI 10.4049/jimmunol.1200349; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; O'Connor T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002867; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; Polymenidou M, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-23; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sachsamanoglou M, 2004, J NEUROIMMUNOL, V146, P22, DOI 10.1016/j.jneuroim.2003.09.018; Sambrook J., 2002, MOL CLONING LAB MANU; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava PK, 2001, VACCINE, V19, P2590, DOI 10.1016/S0264-410X(00)00492-8; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; YIANGOU M, 1989, INT ARCH ALLER A IMM, V89, P217, DOI 10.1159/000234949	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59143	10.1371/journal.pone.0059143	http://dx.doi.org/10.1371/journal.pone.0059143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	23554984	Green Published, Green Submitted, gold			2022-12-27	WOS:000316409800061
J	Chiyomaru, T; Yamamura, S; Fukuhara, S; Hidaka, H; Majid, S; Saini, S; Arora, S; Deng, GR; Shahryari, V; Chang, I; Tanaka, Y; Tabatabai, ZL; Enokida, H; Seki, N; Nakagawa, M; Dahiya, R				Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Hidaka, Hideo; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Enokida, Hideki; Seki, Naohiko; Nakagawa, Masayuki; Dahiya, Rajvir			Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MATRIX-METALLOPROTEINASE TYPE-2; INHIBITS CELL-PROLIFERATION; ENRICHMENT ANALYSIS; INDUCED APOPTOSIS; GENE-EXPRESSION; TARGETING EGFR; INVASION; PROGRESSION; METASTASIS	Genistein has been shown to inhibit cancers both in vitro and in vivo, by altering the expression of several microRNAs (miRNAs). In this study, we focused on tumor suppressor miRNAs regulated by genistein and investigated their function in prostate cancer (PCa) and target pathways. Using miRNA microarray analysis and real-time RT-PCR we observed that miR-574-3p was significantly up-regulated in PCa cells treated with genistein compared with vehicle control. The expression of miR-574-3p was significantly lower in PCa cell lines and clinical PCa tissues compared with normal prostate cells (RWPE-1) and adjacent normal tissues. Low expression level of miR-574-3p was correlated with advanced tumor stage and higher Gleason score in PCa specimens. Re-expression of miR-574-3p in PCa cells significantly inhibited cell proliferation, migration and invasion in vitro and in vivo. miR-574-3p restoration induced apoptosis through reducing Bcl-xL and activating caspase-9 and caspase-3. Using GeneCodis software analysis, several pathways affected by miR-574-3p were identified, such as 'Pathways in cancer', 'Jak-STAT signaling pathway', and 'Wnt signaling pathway'. Luciferase reporter assays demonstrated that miR-574-3p directly binds to the 39 UTR of several target genes (such as RAC1, EGFR and EP300) that are components of 'Pathways in cancer'. Quantitative real-time PCR and Western analysis showed that the mRNA and protein expression levels of the three target genes in PCa cells were markedly down-regulated with miR-574-3p. Loss-of-function studies demonstrated that the three target genes significantly affect cell proliferation, migration and invasion in PCa cell lines. Our results show that genistein up-regulates tumor suppressor miR-574-3p expression targeting several cell signaling pathways. These findings enhance understanding of how genistein regulates with miRNA in PCa.	[Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Chiyomaru, Takeshi; Yamamura, Soichiro; Fukuhara, Shinichiro; Majid, Shahana; Saini, Sharanjot; Arora, Sumit; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hidaka, Hideo; Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Dept Urol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Tabatabai, Z. Laura] San Francisco VA Med Ctr, Dept Pathol, San Francisco, CA USA; [Seki, Naohiko] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Kagoshima University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Chiba University	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			National Center for Research Resources of the National Institutes of Health [R01CA160079, R01CA138642, T32DK007790]; VA Merit Review; VA Program Project; NATIONAL CANCER INSTITUTE [R01CA138642, R01CA160079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007790] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Review(US Department of Veterans Affairs); VA Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Center for Research Resources of the National Institutes of Health through Grant Numbers R01CA160079, R01CA138642, T32DK007790 and VA Merit Review and VA Program Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar RM, 2009, CLIN CANCER RES, V15, P3251, DOI 10.1158/1078-0432.CCR-08-1171; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chan LWC, 2012, CURR TOP MED CHEM, V12, P920; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de Souza PL, 2010, NUTR REV, V68, P542, DOI 10.1111/j.1753-4887.2010.00314.x; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fuse M, 2012, J HUM GENET IN PRESS; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo YP, 2007, J NUTR BIOCHEM, V18, P408, DOI 10.1016/j.jnutbio.2006.08.006; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Kim YS, 2012, J NUTR BIOCHEM, V23, P691, DOI 10.1016/j.jnutbio.2012.03.002; Kumi-Diaka J, 2000, BIOL CELL, V92, P595, DOI 10.1016/S0248-4900(00)01109-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li XY, 2001, CANCER RES, V61, P1699; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Li YW, 2002, J NUTR, V132, P3623, DOI 10.1093/jn/132.12.3623; Li YW, 2002, CLIN CANCER RES, V8, P2369; Luedde Tom, 2010, Hepatology, V52, P1164, DOI 10.1002/hep.23854; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Su YY, 2012, INT IMMUNOPHARMACOL, V13, P468, DOI 10.1016/j.intimp.2012.05.016; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Tatarano S, 2011, INT J ONCOL, V39, P13, DOI 10.3892/ijo.2011.1012; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Vader P, 2011, ANGIOGENESIS, V14, P457, DOI 10.1007/s10456-011-9229-x; Wang H.X., 2012, TOXICOL IND HEALTH, V1, P1; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Yamaguchi G, 2012, BIOCHEM BIOPH RES CO, V420, P411, DOI 10.1016/j.bbrc.2012.03.008; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347	55	118	122	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58929	10.1371/journal.pone.0058929	http://dx.doi.org/10.1371/journal.pone.0058929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23554959	Green Submitted, Green Published, gold			2022-12-27	WOS:000316252500058
J	Herlihy, SE; Tang, YT; Gomer, RH				Herlihy, Sarah E.; Tang, Yitai; Gomer, Richard H.			A Dictyostelium Secreted Factor Requires a PTEN-Like Phosphatase to Slow Proliferation and Induce Chemorepulsion	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; PROTEIN-KINASE B; PHOSPHATIDYLINOSITOL 3-KINASE; TUMOR-SUPPRESSOR; LEADING-EDGE; CHEMOTAXIS; DISCOIDEUM; SIZE; ACTIVATION; GRADIENTS	In Dictyostelium discoideum, AprA and CfaD are secreted proteins that inhibit cell proliferation. We found that the proliferation of cells lacking CnrN, a phosphatase and tensin homolog (PTEN)-like phosphatase, is not inhibited by exogenous AprA and is increased by exogenous CfaD. The expression of CnrN in cnr (N) over bar cells partially rescues these altered sensitivities, suggesting that CnrN is necessary for the ability of AprA and CfaD to inhibit proliferation. Cells lacking CnrN accumulate normal levels of AprA and CfaD. Like cells lacking AprA and CfaD, cnr (N) over bar cells proliferate faster and reach a higher maximum cell density than wild type cells, tend to be multinucleate, accumulate normal levels of mass and protein per nucleus, and form less viable spores. When cnr (N) over bar cells expressing myc-tagged CnrN are stimulated with a mixture of rAprA and rCfaD, levels of membrane-associated myc-CnrN increase. AprA also causes chemorepulsion of Dictyostelium cells, and CnrN is required for this process. Combined, these results suggest that CnrN functions in a signal transduction pathway downstream of AprA and CfaD mediating some, but not all, of the effects of AprA and CfaD.	[Herlihy, Sarah E.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Tang, Yitai] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Texas A&M University System; Texas A&M University College Station; Stanford University	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Herlihy, Sarah/0000-0002-1457-211X	National Institutes of Health GM grant [GM074990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074990] Funding Source: NIH RePORTER	National Institutes of Health GM grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM grant GM074990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bowman RL, 2011, EUKARYOT CELL, V10, P494, DOI 10.1128/EC.00270-10; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brock DA, 1999, GENE DEV, V13, P1960, DOI 10.1101/gad.13.15.1960; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Furnari FB, 1998, CANCER RES, V58, P5002; Gamer LW, 2003, DEV CELL, V4, P143, DOI 10.1016/S1534-5807(03)00027-3; Gomer R, 2002, J MUSCLE RES CELL M, V23, P809, DOI 10.1023/A:1024487930787; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Phillips JE, 2012, P NATL ACAD SCI USA, V109, P10990, DOI 10.1073/pnas.1206350109; Phillips JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021765; Phillips JE, 2010, EUKARYOT CELL, V9, P1557, DOI 10.1128/EC.00121-10; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sen P, 2003, MOL CELL BIOCHEM, V253, P241, DOI 10.1023/A:1026020101379; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Tang YT, 2008, EUKARYOT CELL, V7, P1758, DOI 10.1128/EC.00210-08; Tang Yitai, 2008, Communicative & Integrative Biology, V1, P185; Weng LP, 1999, CANCER RES, V59, P5808; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e59365	10.1371/journal.pone.0059365	http://dx.doi.org/10.1371/journal.pone.0059365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23555023	Green Published, gold, Green Submitted			2022-12-27	WOS:000316252500085
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	24223232	Green Published, gold, Green Submitted			2022-12-27	WOS:000321200500073
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wang, Jinfeng/0000-0002-6687-9420; Zhang, An/0000-0002-9338-6250; Dow, Max/0000-0001-8245-2294; Wenzel, Sally/0000-0002-4242-0164	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	24223232	Green Submitted, gold, Green Published			2022-12-27	WOS:000317480700121
J	Zhao, QB; Zhou, ZJ; Xu, HB; Chen, S; Xu, F; Fan, WL; Han, L				Zhao, Qingbai; Zhou, Zhijin; Xu, Haibo; Chen, Shi; Xu, Fang; Fan, Wenliang; Han, Lei			Dynamic Neural Network of Insight: A Functional Magnetic Resonance Imaging Study on Solving Chinese 'Chengyu' Riddles	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEFAULT MODE; AMYGDALA; BRAIN; AHA; CONFLICT; ACTIVATION; SYSTEM; TASK; EEG	The key components of insight include breaking mental sets and forming the novel, task-related associations. The majority of researchers have agreed that the anterior cingulate cortex may mediate processes of breaking ones mental set, while the exact neural correlates of forming novel associations are still debatable. In the present study, we used a paradigm of answer selection to explore brain activations of insight by using event-related functional magnetic resonance imaging during solving Chinese chengyu (in Chinese pinyin) riddles. Based on the participants choice, the trials were classified into the insight and non-insight conditions. Both stimulus-locked and response-locked analyses are conducted to detect the neural activity corresponding to the early and late periods of insight solution, respectively. Our data indicate that the early period of insight solution shows more activation in the middle temporal gyrus, the middle frontal gyrus and the anterior cingulate cortex. These activities might be associated to the extensive semantic processing, as well as detecting and resolving cognitive conflicts. In contrast, the late period of insight solution produced increased activities in the hippocampus and the amygdala, possibly reflecting the forming of novel association and the concomitant Aha feeling. Our study supports the key role of hippocampus in forming novel associations, and indicates a dynamic neural network during insight solution.	[Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Cent China Normal Univ, Sch Psychol, Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China; [Xu, Haibo; Fan, Wenliang] Huazhong Univ Sci & Technol, MRI Ctr Union Hosp, Wuhan 430074, Peoples R China; [Han, Lei] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China	Central China Normal University; Huazhong University of Science & Technology; Shandong Normal University	Zhou, ZJ (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzj@mail.ccnu.edu.cn; xuhaibo1120@hotmail.com		Fan, Wenliang/0000-0001-8949-6775	National Natural Science Foundation of China [81171386, 30770623]; Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china [10YJCXLX065]; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities [CCNU11C01005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (grant 81171386 and 30770623), the Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china (grant 10YJCXLX065), and the "Twelfth Five" Plan Project from Social Science Foundation of Hubei Province, as well as by the Fundamental Research Funds for Central Universities (grant CCNU11C01005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, BRAIN LANG, V100, P163, DOI 10.1016/j.bandl.2005.10.004; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bink M.L., 2000, REV GEN PSYCHOL, V4, P59, DOI DOI 10.1037/1089-2680.4.1.59; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Cranford EA, 2012, J PROBL SOLVING, V4, P128, DOI 10.7771/1932-6246.1129; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Huang FR, 2013, ACTA PSYCHOL SINICA, V45, P36; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kershaw TC, 2004, J EXP PSYCHOL LEARN, V30, P3, DOI 10.1037/0278-7393.30.1.3; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Kohler W., 1925, MENTALITY APES; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Luo J, 2002, HIPPOCAMPUS, V12, P487, DOI 10.1002/hipo.10027; Luo J, 2006, BRAIN RES BULL, V70, P430, DOI 10.1016/j.brainresbull.2006.07.005; [罗劲 Luo Jing], 2004, [心理学报, Acta Psychologica Sinica], V36, P219; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mai XQ, 2004, HUM BRAIN MAPP, V22, P261, DOI 10.1002/hbm.20030; Mashal N, 2008, CORTEX, V44, P848, DOI 10.1016/j.cortex.2007.04.004; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Qiu J, 2008, BRAIN COGNITION, V68, P100, DOI 10.1016/j.bandc.2008.03.004; Qiu J, 2008, EXP BRAIN RES, V186, P629, DOI 10.1007/s00221-008-1270-7; Qiu J, 2006, NEUROREPORT, V17, P679, DOI 10.1097/00001756-200604240-00025; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Weisberg RW, 1996, NATURE INSIGHT; Zhang M, 2011, BRAIN RES BULL, V84, P210, DOI 10.1016/j.brainresbull.2011.01.001	47	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59351	10.1371/journal.pone.0059351	http://dx.doi.org/10.1371/journal.pone.0059351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24282623	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800084
J	Xu, JY; Yu, Y; Wu, X; Wu, YF; Jiang, C; Wang, SZ; Huang, QH; Liu, JM				Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Wang, Shengzhang; Huang, Qinghai; Liu, Jianmin			Morphological and Hemodynamic Analysis of Mirror Posterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; COMPUTATIONAL FLUID-DYNAMICS; INTERNAL CAROTID-ARTERY; ASPECT RATIO; CEREBRAL ANEURYSMS; SACCULAR ANEURYSM; FLOW DYNAMICS; RUPTURE RISK; SIZE	Background and Purpose: Hemodynamic factors are commonly believed to play an important role in the pathogenesis, progression, and rupture of cerebral aneurysms. In this study, we aimed to identify significant hemodynamic and morphological parameters that discriminate intracranial aneurysm rupture status using 3-dimensional-angiography and computational fluid dynamics technology. Materials and Methods: 3D-DSA was performed in 8 patients with mirror posterior communicating artery aneurysms (Pcom-MANs). Each pair was divided into ruptured and unruptured groups. Five morphological and three hemodynamic parameters were evaluated for significance with respect to rupture. Results: The normalized mean wall shear stress (WSS) of the aneurysm sac in the ruptured group was significantly lower than that in the unruptured group (0.52 +/- 0.20 versus 0.81 +/- 0.21, P = .012). The percentage of the low WSS area in the ruptured group was higher than that in the unruptured group (4.11 +/- 4.66% versus 0.02 +/- 0.06%, P = .018). The AR was 1.04 +/- 0.21 in the ruptured group, which was significantly higher than 0.70 +/- 0.17 in the unruptured group (P = .012). By contrast, parameters that had no significant differences between the two groups were OSI (P = .674), aneurysm size (P = .327), size ratio (P = .779), vessel angle (P = 1.000) and aneurysm inclination angle (P = 1.000). Conclusions: Pcom-MANs may be a useful disease model to investigate possible causes of aneurysm rupture. The ruptured aneurysms manifested lower WSS, higher percentage of low WSS area, and higher AR, compared with the unruptured one. And hemodynamics is as important as morphology in discriminating aneurysm rupture status.	[Xu, Jinyu; Yu, Ying; Wu, Xi; Wu, Yongfa; Jiang, Che; Huang, Qinghai; Liu, Jianmin] Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Naval Medical University; Fudan University	Huang, QH (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changhai Hosp, Shanghai, Peoples R China.	ocinhqh@163.com; chstroke@163.com		Smith, M. Kumi/0000-0001-5861-8100; xu, junjie/0000-0003-4303-7295	National Natural Science Foundation of China [81171092, 81171093]; Shanghai Science and Technology Committee [11QA1408400, 11JC1415800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported by the National Natural Science Foundation of China (Grant No. 81171092 and 81171093), Rising-star Plan and Key Project of Shanghai Science and Technology Committee (Grant No. 11QA1408400 and 11JC1415800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2009, ACTA NEUROCHIR, V151, P1569, DOI 10.1007/s00701-009-0316-3; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Beck J, 2006, SURG NEUROL, V65, P18, DOI 10.1016/j.surneu.2005.05.019; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Castro MA, 2009, AM J NEURORADIOL, V30, P297, DOI 10.3174/ajnr.A1323; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Goubergrits L, 2012, J R SOC INTERFACE, V9, P677, DOI 10.1098/rsif.2011.0490; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; NISHIOKA H, 1984, ARCH NEUROL-CHICAGO, V41, P1142, DOI 10.1001/archneur.1984.04050220036011; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Tremmel M, 2009, NEUROSURGERY, V64, P622, DOI 10.1227/01.NEU.0000341529.11231.69; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Valencia A, 2006, INT J NUMER METH FL, V50, P751, DOI 10.1002/fld.1078; Weir B, 2003, J NEUROSURG, V99, P447, DOI 10.3171/jns.2003.99.3.0447; White PM, 2003, J NEURORADIOLOGY, V30, P336; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Zeng Z, 2011, AM J NEURORADIOL, V32, P595, DOI 10.3174/ajnr.A2324; Zeng ZJ, 2011, J BIOMECH, V44, P2809, DOI 10.1016/j.jbiomech.2011.08.002	30	82	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55413	10.1371/journal.pone.0055413	http://dx.doi.org/10.1371/journal.pone.0055413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383184	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600100
J	Hoffer, ME; Balaban, C; Slade, MD; Tsao, JW; Hoffer, B				Hoffer, Michael E.; Balaban, Carey; Slade, Martin D.; Tsao, Jack W.; Hoffer, Barry			Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled Study	PLOS ONE			English	Article							TYMPANIC MEMBRANE; RAT MODEL; NOISE; ACETYLCYSTEINE; RELIABILITY; MECHANISMS; INDUCTION; PRESSURE; PROTECTS; EXPOSURE	Background: Mild traumatic brain injury (mTBI) secondary to blast exposure is the most common battlefield injury in Southwest Asia. There has been little prospective work in the combat setting to test the efficacy of new countermeasures. The goal of this study was to compare the efficacy of N-acetyl cysteine (NAC) versus placebo on the symptoms associated with blast exposure mTBI in a combat setting. Methods: This study was a randomized double blind, placebo-controlled study that was conducted on active duty service members at a forward deployed field hospital in Iraq. All symptomatic U. S. service members who were exposed to significant ordnance blast and who met the criteria for mTBI were offered participation in the study and 81 individuals agreed to participate. Individuals underwent a baseline evaluation and then were randomly assigned to receive either N-acetyl cysteine (NAC) or placebo for seven days. Each subject was re-evaluated at 3 and 7 days. Outcome measures were the presence of the following sequelae of mTBI: dizziness, hearing loss, headache, memory loss, sleep disturbances, and neurocognitive dysfunction. The resolution of these symptoms seven days after the blast exposure was the main outcome measure in this study. Logistic regression on the outcome of 'no day 7 symptoms' indicated that NAC treatment was significantly better than placebo (OR = 3.6, p = 0.006). Secondary analysis revealed subjects receiving NAC within 24 hours of blast had an 86% chance of symptom resolution with no reported side effects versus 42% for those seen early who received placebo. Conclusion: This study, conducted in an active theatre of war, demonstrates that NAC, a safe pharmaceutical countermeasure, has beneficial effects on the severity and resolution of sequelae of blast induced mTBI. This is the first demonstration of an effective short term countermeasure for mTBI. Further work on long term outcomes and the potential use of NAC in civilian mTBI is warranted.	[Hoffer, Michael E.] USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA; [Balaban, Carey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Balaban, Carey] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Balaban, Carey; Slade, Martin D.] Yale Univ, Dept Internal Med, New Haven, CT USA; [Tsao, Jack W.] USN, Bur Med & Surg, Wounded Ill & Injured Directorate M9, Washington, DC USA; [Hoffer, Barry] Case Western Reserve Univ, Dept Neurosurg, Cleveland, OH 44106 USA	United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; United States Department of Defense; United States Navy; Case Western Reserve University	Hoffer, ME (corresponding author), USN, Med Ctr, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA 92152 USA.	Michael.hoffer@med.navy.mil	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844	Department of Defense	Department of Defense(United States Department of Defense)	Supported by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2011, OTOL NEUROTOL, V32, P1309, DOI 10.1097/MAO.0b013e31822e5bee; Balaban CD, 2012, BRAIN INJUR IN PRESS; Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; De Vries H, 1996, PHARMACOL REV, V49, P143; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; French L., 2009, CARE COMBAT AMPUTEE, P399; Gabaix X., 2008, FDN POSITIVE NORMATI, P292, DOI [10.1093/acprof:oso/9780195328318.003.0012, DOI 10.1093/ACPROF:OSO/9780195328318.003.0012]; GARTH RJN, 1994, J LARYNGOL OTOL, V108, P925, DOI 10.1017/S0022215100128555; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; James DJ, 1982, 0482 ARM WEAP RES ES; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Reitan RM, 1992, TRAIL MAKIGN TEST MA; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Saljo A, 2003, J NEUROTRAUM, V20, P787, DOI 10.1089/089771503767870014; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santangelo F, 2003, CURR MED CHEM, V10, P2599, DOI 10.2174/0929867033456567; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Strauss E., 1998, COMPENDIUM NEUROPSYC, P447; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tombaugh TN, 1998, COMPENDIUM NEUROPSYC, P481; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024	46	158	162	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54163	10.1371/journal.pone.0054163	http://dx.doi.org/10.1371/journal.pone.0054163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544123	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000314021500034
J	Park, M; Wetzler, M; Jardetzky, TS; Barron, AE				Park, Minyoung; Wetzler, Modi; Jardetzky, Theodore S.; Barron, Annelise E.			A Readily Applicable Strategy to Convert Peptides to Peptoid-based Therapeutics	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; SIDE-CHAIN; ANTIMICROBIAL PEPTIDES; SCANNING MUTAGENESIS; HIV-1 ENTRY; PROLINE; DESIGN; PROTEIN; RESIDUES; ANALOGS	Incorporation of unnatural amino acids and peptidomimetic residues into therapeutic peptides is highly efficacious and commonly employed, but generally requires laborious trial-and-error approaches. Previously, we demonstrated that C-20 peptide has the potential to be a potential antiviral agent. Herein we report our attempt to improve the biological properties of this peptide by introducing peptidomimetics. Through combined alanine, proline, and sarcosine scans coupled with a competitive fluorescence polarization assay developed for identifying antiviral peptides, we enabled to pinpoint peptoid-tolerant peptide residues within C-20 peptide. The synergistic benefits of combining these (and other) commonly employed methods could lead to a easily applicable strategy for designing and refining therapeutically-attractive peptidomimetics.	[Park, Minyoung] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA; [Wetzler, Modi; Barron, Annelise E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Jardetzky, Theodore S.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Barron, AE (corresponding author), Stanford Univ, Dept Bioengn, Sch Engn, Stanford, CA 94305 USA.	aebarron@stanford.edu	; Viner, Russell/A-1441-2009; Sovio, Ulla/H-8532-2019	Barron, Annelise/0000-0002-0735-6873; Viner, Russell/0000-0003-3047-2247; Sovio, Ulla/0000-0002-0799-1105; Park, Min Hae/0000-0002-2563-4910	National Institutes of Health [R01-GM61050, R01-AI072666]; Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants (R01-GM61050 to TSJ and R01-AI072666 to AEB) and the Bio-X Interdisciplinary Initiatives Program at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosova Z, 2009, TRENDS BIOTECHNOL, V27, P628, DOI 10.1016/j.tibtech.2009.07.009; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Cantel S, 2008, J ORG CHEM, V73, P5663, DOI 10.1021/jo800142s; Caporale A, 2010, J PEPT SCI, V16, P480, DOI 10.1002/psc.1265; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Culf AS, 2010, MOLECULES, V15, P5282, DOI 10.3390/molecules15085282; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dohm MT, 2011, CURR PHARM DESIGN, V17, P2732; Eggenberger K, 2009, CHEMBIOCHEM, V10, P2504, DOI 10.1002/cbic.200900331; Eyles SJ, 2001, NAT STRUCT BIOL, V8, P380, DOI 10.1038/87524; Hoffmann B, 2006, PROTEIN PEPTIDE LETT, V13, P829, DOI 10.2174/092986606777841299; Isaad AL, 2009, J PEPT SCI, V15, P451, DOI 10.1002/psc.1141; Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m; Kodadek T, 2010, NAT CHEM BIOL, V6, P162, DOI 10.1038/nchembio.303; Kondo T, 2011, PLANT CELL PHYSIOL, V52, P30, DOI 10.1093/pcp/pcq146; Lee BC, 2011, ACS CHEM BIOL, V6, P1367, DOI 10.1021/cb200300w; Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n; Nguyen JT, 2000, CHEM BIOL, V7, P463, DOI 10.1016/S1074-5521(00)00130-7; Ni L, 2005, ANTIVIR THER, V10, P833; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Park M, 2011, ANAL BIOCHEM, V409, P195, DOI 10.1016/j.ab.2010.10.020; Parthasarathy R, 1995, PROG BIOPHYS MOL BIO, V64, P1, DOI 10.1016/0079-6107(95)00009-7; Punna S, 2004, SYNLETT, P99, DOI 10.1055/s-2003-43375; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Ruijtenbeek R, 2001, CHEMBIOCHEM, V2, P171, DOI 10.1002/1439-7633(20010302)2:3<171::AID-CBIC171>3.0.CO;2-B; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Udugamasooriya DG, 2008, BIOORG MED CHEM LETT, V18, P5892, DOI 10.1016/j.bmcl.2008.07.023; Unciti-Broceta A, 2009, BIOORGAN MED CHEM, V17, P959, DOI 10.1016/j.bmc.2008.02.068; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang EX, 2003, BIOCHEM BIOPH RES CO, V302, P469, DOI 10.1016/S0006-291X(03)00197-9; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Zhu WL, 2007, J PEPT SCI, V13, P529, DOI 10.1002/psc.882; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+; Zimmermann J, 2003, J BIOL CHEM, V278, P36810, DOI 10.1074/jbc.M305934200; ZUCKERMANN RN, 1992, J AM CHEM SOC, V114, P10646, DOI 10.1021/ja00052a076; Zuckermann RN, 2009, CURR OPIN MOL THER, V11, P299	44	42	48	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2013	8	3							e58874	10.1371/journal.pone.0058874	http://dx.doi.org/10.1371/journal.pone.0058874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111UM	23555603	Green Published, gold, Green Submitted			2022-12-27	WOS:000316546400014
J	Chen, YY; Chen, F; Gunnell, D; Yip, PSF				Chen, Ying-Yeh; Chen, Feng; Gunnell, David; Yip, Paul S. F.			The Impact of Media Reporting on the Emergence of Charcoal Burning Suicide in Taiwan	PLOS ONE			English	Article							PROCESS INTENSITY FUNCTION; ESTIMATORS	We investigated the association of the intensity of newspaper reporting of charcoal burning suicide with the incidence of such deaths in Taiwan during 1998-2002. A counting process approach was used to estimate the incidence of suicides and intensity of news reporting. Conditional Poisson generalized linear autoregressive models were performed to assess the association of the intensity of newspaper reporting of charcoal burning and non-charcoal burning suicides with the actual number of charcoal burning and non-charcoal burning suicides the following day. We found that increases in the reporting of charcoal burning suicide were associated with increases in the incidence of charcoal burning suicide on the following day, with each reported charcoal burning news item being associated with a 16% increase in next day charcoal burning suicide (p<.0001). However, the reporting of other methods of suicide was not related to their incidence. We conclude that extensive media reporting of charcoal burning suicides appears to have contributed to the rapid rise in the incidence of the novel method in Taiwan during the initial stage of the suicide epidemic. Regulating media reporting of novel suicide methods may prevent an epidemic spread of such new methods.	[Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Feng] Univ New S Wales, Dept Stat, Sydney, NSW, Australia; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of New South Wales Sydney; University of Bristol; University of Hong Kong; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Chen, Ying-Yeh/AAY-1478-2021; Gunnell, David/ABE-6653-2020; Chen, Feng/B-5366-2009	Gunnell, David/0000-0002-0829-6470; Chen, Feng/0000-0002-9646-3338; Chen, Ying-Yeh/0000-0001-5543-5704	National Science Council, Taiwan [101-2314-B-532-005-MY2]; Department of Health, Taipei City Government [96001-61-001-043]; National Health Research Institute, Taiwan [NHRI-EX100-10024PC]; University of Hong Kong [HKU7030-PPR-12, HKU784210]; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taipei City Government; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); University of Hong Kong(University of Hong Kong); National Institute for Health Research(National Institute for Health Research (NIHR))	Y-YC was supported by the National Science Council, Taiwan (grant number 101-2314-B-532-005-MY2), Department of Health, Taipei City Government (grant number 96001-61-001-043) and the National Health Research Institute, Taiwan (grant number NHRI-EX100-10024PC). DG is a National Institute for Health Research senior investigator. PSFY was supported by General Research Fund grants of the University of Hong Kong (grant number HKU7030-PPR-12 and HKU784210). The funding agency has no role in the design, analysis, interpretation and the presentation of the data.	Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; Chen F, 2008, COMMUN STAT-THEOR M, V37, P294, DOI 10.1080/03610920701649035; Chen F, 2011, SCAND J STAT, V38, P631, DOI 10.1111/j.1467-9469.2011.00733.x; Chen F, 2011, STAT SINICA, V21, P107; Chen YY, 2011, J EPIDEMIOL COMMUN H, V65, P934, DOI 10.1136/jech.2010.117903; Chen YY, 2010, SOC SCI MED, V71, P2083, DOI 10.1016/j.socscimed.2010.09.043; Guan RJ, 2010, PC HOME PERSONAL NEW; Lin JJ, 2008, J EPIDEMIOL COMMUN H, V62, P566, DOI 10.1136/jech.2007.065771; Lin LY, 2008, MASS COMMUNICATION R, V95, P183; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Niederkrotenthaler T., 2009, SOC SCI MED, V69, P1085, DOI DOI 10.1016/j.socscimed.2009.07.041; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Pirkis JE, 2006, SOC SCI MED, V62, P2874, DOI 10.1016/j.socscimed.2005.11.033; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Taiwan Suicide Prevention Center, 2009, SURV RES; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; Yip PSF, 2007, CRISIS, V28, P21, DOI 10.1027/0227-5910.28.S1.21	19	112	117	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55000	10.1371/journal.pone.0055000	http://dx.doi.org/10.1371/journal.pone.0055000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23555643	Green Published, gold			2022-12-27	WOS:000315563800097
J	Regier, JC; Mitter, C; Zwick, A; Bazinet, AL; Cummings, MP; Kawahara, AY; Sohn, JC; Zwickl, DJ; Cho, S; Davis, DR; Baixeras, J; Brown, J; Parr, C; Weller, S; Lees, DC; Mitter, KT				Regier, Jerome C.; Mitter, Charles; Zwick, Andreas; Bazinet, Adam L.; Cummings, Michael P.; Kawahara, Akito Y.; Sohn, Jae-Cheon; Zwickl, Derrick J.; Cho, Soowon; Davis, Donald R.; Baixeras, Joaquin; Brown, John; Parr, Cynthia; Weller, Susan; Lees, David C.; Mitter, Kim T.			A Large-Scale, Higher-Level, Molecular Phylogenetic Study of the Insect Order Lepidoptera (Moths and Butterflies)	PLOS ONE			English	Article							EVOLUTION; GENE; BOOTSTRAP; TREE; CLASSIFICATION; HOMOLOGIES; SUPPORT	Background: Higher-level relationships within the Lepidoptera, and particularly within the species-rich subclade Ditrysia, are generally not well understood, although recent studies have yielded progress. We present the most comprehensive molecular analysis of lepidopteran phylogeny to date, focusing on relationships among superfamilies. Methodology / Principal Findings: 483 taxa spanning 115 of 124 families were sampled for 19 protein-coding nuclear genes, from which maximum likelihood tree estimates and bootstrap percentages were obtained using GARLI. Assessment of heuristic search effectiveness showed that better trees and higher bootstrap percentages probably remain to be discovered even after 1000 or more search replicates, but further search proved impractical even with grid computing. Other analyses explored the effects of sampling nonsynonymous change only versus partitioned and unpartitioned total nucleotide change; deletion of rogue taxa; and compositional heterogeneity. Relationships among the non-ditrysian lineages previously inferred from morphology were largely confirmed, plus some new ones, with strong support. Robust support was also found for divergences among non-apoditrysian lineages of Ditrysia, but only rarely so within Apoditrysia. Paraphyly for Tineoidea is strongly supported by analysis of nonsynonymous-only signal; conflicting, strong support for tineoid monophyly when synonymous signal was added back is shown to result from compositional heterogeneity. Conclusions / Significance: Support for among-superfamily relationships outside the Apoditrysia is now generally strong. Comparable support is mostly lacking within Apoditrysia, but dramatically increased bootstrap percentages for some nodes after rogue taxon removal, and concordance with other evidence, strongly suggest that our picture of apoditrysian phylogeny is approximately correct. This study highlights the challenge of finding optimal topologies when analyzing hundreds of taxa. It also shows that some nodes get strong support only when analysis is restricted to nonsynonymous change, while total change is necessary for strong support of others. Thus, multiple types of analyses will be necessary to fully resolve lepidopteran phylogeny.	[Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.; Mitter, Charles; Sohn, Jae-Cheon; Mitter, Kim T.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Stuttgart, Germany; [Bazinet, Adam L.; Cummings, Michael P.] Univ Maryland, Lab Mol Evolut, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Zwickl, Derrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Cho, Soowon] Chungbuk Natl Univ, Dept Plant Med, Chonju, South Korea; [Davis, Donald R.] Smithsonian Inst, Dept Entomol, Washington, DC 20560 USA; [Baixeras, Joaquin] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Brown, John] ARS, Systemat Entomol Lab, USDA, Beltsville, MD USA; [Parr, Cynthia] Smithsonian Inst, Encyclopedia Life, Washington, DC 20560 USA; [Weller, Susan] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Lees, David C.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida; University of Arizona; Chungbuk National University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Valencia; Smithsonian Institution; United States Department of Agriculture (USDA); Smithsonian Institution; University of Minnesota System; University of Minnesota Twin Cities; Natural History Museum London	Regier, JC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	regier@umd.edu; cmitter@umd.edu	Lees, David/AAD-7382-2021; Pedraza-Diaz, Susana/HGB-3199-2022; Cho, Soowon/AAF-7890-2019; Yakovlev, Roman/J-7243-2013; Zwick, Andreas/A-5735-2015; Bazinet, Adam/H-3182-2019; Almela, Joaquin Baixeras/L-1734-2014; Ortega-Mora, Luis-Miguel/F-1470-2016; Pedraza-Diaz, Susana/F-3988-2018	Zwick, Andreas/0000-0002-7532-1752; Almela, Joaquin Baixeras/0000-0002-6092-0496; Regidor Cerrillo, Javier/0000-0001-5831-6970; Ortega-Mora, Luis-Miguel/0000-0002-4986-6783; Diez-Fuertes, Francisco/0000-0003-2413-9229; Moore, Dadin/0000-0001-6735-3810; Gonzalez-Warleta, Marta/0000-0003-3315-5757; Katzer, Frank/0000-0001-5902-4136; Mezo, Mercedes/0000-0001-8819-453X; Pedraza-Diaz, Susana/0000-0001-9401-6473; Schares, Gereon R. M./0000-0002-3217-289X; GARCIA-CULEBRAS, ALICIA/0000-0003-2362-0117	U. S. National Science Foundation's Assembling the Tree of Life program [1042845, 0531626, 0531769]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	U. S. National Science Foundation's Assembling the Tree of Life program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the U. S. National Science Foundation's Assembling the Tree of Life program, award numbers 1042845, 0531626, and 0531769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Bazinet A, 2008, DISTRIBUTED GRID COM, P2; Bazinet A. L., 2011, 2011 IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, P1896, DOI 10.1109/IPDPS.2011.344; Bazinet AL, 2009, THESIS U MARYLAND US; Cho S, 2011, SYST BIOL, V60, P782, DOI 10.1093/sysbio/syr079; Cummings MP, 2003, SYST BIOL, V52, P477, DOI 10.1080/10635150390218213; Davi D. R., 1998, SMITHSONIAN CONTRIBU, V597, P1; de Jong Rienk, 2007, Tijdschrift voor Entomologie, V150, P319; DeBry RW, 2000, SYST BIOL, V49, P171; Drummond A. J., 2011, GENEIOUS VERSION 5 4; Epstein Marc E., 2003, Zootaxa, V247, P1; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Hennig W., 1953, Beitraege zur Entomologie Berlin, V3, P1; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; Kristensen NP, 2012, SYST ENTOMOL, V37, P237, DOI 10.1111/j.1365-3113.2012.00619.x; KRISTENSEN NP, 2003, HDB ZOOLOGY 36, V4; Kristensen NP., 1998, HDB ZOOLOGY, VIV, P7; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; MILLER JS, 1991, B AM MUS NAT HIST, V204, P1; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; MINET J, 1986, Alexanor, V14, P291; MINET J, 1983, ANN SOC ENTOMOL FR, V19, P175; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Myers DS, 2008, GRID COMPUTING FOR BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P71; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Rammert U, 1993, THESIS U BIELEFELD G; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2012, SYST ENTOMOL, V37, P635, DOI 10.1111/j.1365-3113.2012.00641.x; Regier JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035574; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ripplinger J, 2010, MOL PHYLOGENET EVOL, V56, P642, DOI 10.1016/j.ympev.2010.04.035; Robinson GS, 1993, MONOGRAPHS AUSTR S2; Roe AD, 2009, GENETICS MOL BIOL LE, P1, DOI [10.1201/9781420060201-c1, DOI 10.1201/9781420060201-C1]; Rota J, 2011, SYST ENTOMOL, V36, P317, DOI 10.1111/j.1365-3113.2010.00563.x; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; Sihvonen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020356; Sohn J-C, 2013, PLOS ONE IN PRESS; Sohn JC, 2012, ZOOTAXA, P1; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Wagner David L., 2001, P249; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Young CJ, 2006, ZOOTAXA, P1; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zwick A., 2006, THESIS AUSTR NATL U; Zwick A, 2008, SYST ENTOMOL, V33, P190, DOI 10.1111/j.1365-3113.2007.00410.x; Zwick A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047450; Zwickl DJ., 2006, THESIS	67	222	234	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e58568	10.1371/journal.pone.0058568	http://dx.doi.org/10.1371/journal.pone.0058568			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	23940816	Green Published, Green Submitted, gold			2022-12-27	WOS:000316252500031
J	Chakraborty, P; Roy, SK				Chakraborty, Prabuddha; Roy, Shyamal K.			Expression of Estrogen Receptor alpha 36 (ESR36) in the Hamster Ovary throughout the Estrous Cycle: Effects of Gonadotropins	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ER-ALPHA; DIFFERENTIAL REGULATION; TARGETED DISRUPTION; LUTEINIZING-HORMONE; DOWN-REGULATION; MEMBRANE; BETA; VARIANT; MOUSE	Estradiol-17 beta (E) plays an important role in ovarian follicular development. Evidence indicates that some of the effect of E is mediated by the transmembrane estrogen receptor. In this study, we examined the spatio-temporal expression of recently discovered ER alpha 36 (ESR36), a splice variant of Esr1 and a receptor for non-genomic E signaling, in the hamster ovary during the estrous cycle and the role of gonadotropins and ovarian steroid hormones in ESR36 expression. ESR36 expression was high on estrus (D1:0900 h) and declined precipitously by proestrus (D4:0900 h) and remained low up to D4:1600 h. Immunofluorescence findings corroborated immunoblot findings and revealed that ESR36 was expressed only in the cell membrane of both follicular and non-follicular cells, except the oocytes. Ovarian ESR36 was capable of binding to the E-affinity matrix, and have different molecular weight than that of the ESR1 or GPER. Hypophysectomy (Hx) resulted in a marked decline in ESR36 protein levels. FSH and LH, alone or combined, markedly upregulated ESR36 protein in Hx hamsters to the levels observed in D1 hamsters, but neither E nor P had any effect. Inhibition of the gonadotropin surge by phenobarbital treatment on D4:1100 h attenuated ESR36 expression in D1:0900 h ovaries, but the decline was restored by either FSH or LH replacement on D4 afternoon. This is the first report to show that ESR36, which is distinct from ESR1 or GPER is expressed in the plasma membrane of ovarian follicular and non-follicular cells, binds to E and its expression is regulated directly by the gonadotropins. In light of our previous findings, the results suggest that ovarian cells contain at least two distinct membrane estrogen receptors, such as GPER and ESR36, and strongly suggest for a non-genomic action of E regulating ovarian follicular functions.	[Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA; [Chakraborty, Prabuddha; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Integrat Physiol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, SK (corresponding author), Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA.	skroy@unmc.edu			National Institutes of Child Health and Human Development [RO1-HD38468]; Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038468] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by a grant (RO1-HD38468) from the National Institutes of Child Health and Human Development and by the Olson Foundation to S.K.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BAST JD, 1974, ENDOCRINOLOGY, V94, P1295, DOI 10.1210/endo-94-5-1295; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Drummond AE, 1999, MOL CELL ENDOCRINOL, V151, P57, DOI 10.1016/S0303-7207(99)00038-6; Dupont S, 2000, DEVELOPMENT, V127, P4277; Falkenstein E, 2000, PHARMACOL REV, V52, P513; GREENWALD GS, 1974, ENDOCRINOLOGY, V95, P1282, DOI 10.1210/endo-95-5-1282; GREENWALD GS, 1994, PHYSL REPRODUCTION, V2, P629, DOI DOI 10.1039/C7RA00224F; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Le Mellay V, 1999, J CELL BIOCHEM, V75, P138, DOI 10.1002/(SICI)1097-4644(19991001)75:1<138::AID-JCB14>3.0.CO;2-I; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; MERK FB, 1972, ENDOCRINOLOGY, V90, P992, DOI 10.1210/endo-90-4-992; MOORE PJ, 1974, AM J ANAT, V139, P37, DOI 10.1002/aja.1001390103; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDS JS, 1980, PHYSIOL REV, V60, P51, DOI 10.1152/physrev.1980.60.1.51; ROY SK, 1986, J REPROD FERTIL, V78, P201, DOI 10.1530/jrf.0.0780201; ROY SK, 1987, BIOL REPROD, V37, P39, DOI 10.1095/biolreprod37.1.39; ROY SK, 1995, ENDOCRINOLOGY, V136, P4610, DOI 10.1210/en.136.10.4610; Roy SK, 2000, BIOL REPROD, V62, P1858, DOI 10.1095/biolreprod62.6.1858; ROY SK, 1994, MICROSC RES TECHNIQ, V27, P83, DOI 10.1002/jemt.1070270203; Roy SK., 1999, COMP ENDOCRINOLOGY R, P315; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Tu BB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.015; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2007, ENDOCRINOLOGY, V148, P4853, DOI 10.1210/en.2007-0727; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Xu BZ, 2009, HISTOCHEM CELL BIOL, V131, P347, DOI 10.1007/s00418-008-0526-4; Yang PX, 2002, ENDOCRINOLOGY, V143, P2385, DOI 10.1210/en.143.6.2385; Zhang YM, 2004, BIOL REPROD, V70, P1580, DOI 10.1095/biolreprod.103.026898	41	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e58291	10.1371/journal.pone.0058291	http://dx.doi.org/10.1371/journal.pone.0058291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23894315	Green Published, Green Submitted, gold			2022-12-27	WOS:000317263900005
J	Cheng, YC; Hsieh, FY; Chiang, MC; Scotting, PJ; Shih, HY; Lin, SJ; Wu, HL; Lee, HT				Cheng, Yi-Chuan; Hsieh, Fu-Yu; Chiang, Ming-Chang; Scotting, Paul J.; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting			Akt1 Mediates Neuronal Differentiation in Zebrafish via a Reciprocal Interaction with Notch Signaling	PLOS ONE			English	Article							THREONINE PROTEIN-KINASE; IN-VITRO; NERVOUS-SYSTEM; MOLECULAR-CLONING; CELLS; NEUROGENESIS; ACTIVATION; MICE; TRANSCRIPTION; LEUKEMIA	Akt1 is well known for its role in regulating cell proliferation, differentiation, and apoptosis and is implicated in tumors and several neurological disorders. However, the role of Akt1 in neural development has not been well defined. We have isolated zebrafish akt1 and shown that this gene is primarily transcribed in the developing nervous system, and its spatiotemporal expression pattern suggests a role in neural differentiation. Injection of akt1 morpholinos resulted in loss of neuronal precursors with a concomitant increase in post-mitotic neurons, indicating that knockdown of Akt1 is sufficient to cause premature differentiation of neurons. A similar phenotype was observed in embryos deficient for Notch signaling. Both the ligand (deltaA) and the downstream target of Notch (her8a) were downregulated in akt1 morphants, indicating that Akt1 is required for Delta-Notch signaling. Furthermore, akt1 expression was downregulated in Delta-Notch signaling-deficient embryos and could be induced by constitutive activation of Notch signaling. In addition, knockdown of Akt1 was able to nullify the inhibition of neuronal differentiation caused by constitutive activation of Notch signaling. Taken together, these results provide in vivo evidence that Akt1 interacts with Notch signaling reciprocally and provide an explanation of why Akt1 is essential for the inhibition of neuronal differentiation.	[Cheng, Yi-Chuan; Hsieh, Fu-Yu; Shih, Hung-Yu; Lin, Sheng-Jia; Wu, Hui-Lan; Lee, Han-Ting] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chiang, Ming-Chang] Fu Jen Catholic Univ, Dept Life Sci, New Taipei City, Taiwan; [Scotting, Paul J.] Univ Nottingham, Ctr Genet & Genom, Childrens Brain Tumour Res Ctr, Queens Med Ctr, Nottingham NG7 2RD, England	Chang Gung University; Fu Jen Catholic University; University of Nottingham	Cheng, YC (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	yccheng@mail.cgu.edu.tw	Lin, Sheng-Jia/AGC-3315-2022	Lin, Sheng-Jia/0000-0002-7559-6529; ozturk, nail can/0000-0001-9459-2120; Shih, Hung-Yu/0000-0002-3490-1750	Chang Gung Memorial Hospital [CMRPD170513]; National Science Council of Taiwan [96-2745-B-182-003-URD]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital (CMRPD170513) and the National Science Council of Taiwan (96-2745-B-182-003-URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bang OS, 2001, J CELL SCI, V114, P81; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Chung PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019394; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jo HS, 2012, EMBO J, V31, P817, DOI 10.1038/emboj.2011.443; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lai WS, 2006, P NATL ACAD SCI USA, V103, P16906, DOI 10.1073/pnas.0604994103; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Namikawa K, 2000, J NEUROSCI, V20, P2875; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Vojtek AB, 2003, MOL CELL BIOL, V23, P4417, DOI 10.1128/MCB.23.13.4417-4427.2003; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu QL, 1995, DEVELOPMENT, V121, P4005; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	59	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54262	10.1371/journal.pone.0054262	http://dx.doi.org/10.1371/journal.pone.0054262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23544149	Green Published, gold, Green Submitted			2022-12-27	WOS:000314759400138
J	Zhao, Q; Wang, LX; Tao, T; Xu, B				Zhao, Qi; Wang, Lixia; Tao, Tao; Xu, Biao			Impacts of the "transport subsidy initiative on poor TB patients" in Rural China: A Patient-Cohort Based Longitudinal Study in Rural China	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; INCENTIVES; SERVICES; BARRIERS; ACCESS	Objective: To describe the financial burden on TB patients for transportation during treatment, and to evaluate the impacts of the "transportation subsidy initiative on poor TB patients" in rural China for improving poor patients' access to TB treatment. Methods: A Case-cohort of 429 TB patients was investigated through questionnaire interviews in four counties of two provinces in China. Information on the financial burden for transportation during TB diagnosis and treatment was collected. Qualitative in-depth interviews with 26 TB patients were carried out to understand their perceptions of transportation subsidy initiative. Results: The mean transportation cost of TB medical care was 97 CNY (70 CNY in median), varying from 0 to 700 CNY. About 51% of the patients spent more than 10 CNY per round trip to the TB dispensary. Of the 429 TB patients investigated, 139 had received transportation subsidies after getting TB diagnosis; 15/139 (10.9%) showed dissatisfaction, mainly because the subsidy amount being insufficient. The income of patients receiving transportation subsidies was significantly lower than those not receiving the subsidies (p<0.05). The impression that an appropriate transportation subsidy enables patients to complete the required visits during their TB treatment was obtained after observation of over 80% of the patients. Conclusion: The transportation subsidy plays an important role in reducing financial burden on poor TB patients for the completion of treatment. However, the coverage was limited and the amount of subsidy was not enough under the present policy. Considering the poverty of rural TB patients, a universal coverage and a rational amount of transportation subsidy should be proposed.	[Zhao, Qi; Tao, Tao; Xu, Biao] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Lixia] Natl Ctr TB Prevent & Control, Beijing, Peoples R China	Fudan University	Xu, B (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	bxu@shmu.edu.cn		Fan, Wenliang/0000-0001-8949-6775	WHO/CHN China [CHN/09/STB/000539, CHN/09/STB/000540]; Shanghai Leading Academic Discipline Project [12GWZX0101]; Distinguished Professorship Award by China Medical Board [G16916403]; Swedish International Development Cooperation Agency [EPI-4]	WHO/CHN China; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Distinguished Professorship Award by China Medical Board; Swedish International Development Cooperation Agency	This investigation received financial support from WHO/CHN China granted project (Grant No. CHN/09/STB/000539 & CHN/09/STB/000540). It also has been supported by the Shanghai Leading Academic Discipline Project (Project Number: 12GWZX0101), the Distinguished Professorship Award to the corresponding author granted by China Medical Board (No. G16916403), and the Swedish International Development Cooperation Agency granted project "Evidence for Policy and Implementation (EPI-4) Intensifying efforts to achieve the health-related MDGs in four countries with developing economies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beith A, 2007, PERFORMANCE BASED IN; Bowong S, 2010, COMMUN NONLINEAR SCI, V15, P3621, DOI 10.1016/j.cnsns.2010.01.007; Chen C, 2007, CHINESE J ANTITUBERC, V29, P293; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Hu D, 2008, CHINESE J HLTH ED, V24, P436; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Liu XY, 2007, TROP MED INT HEALTH, V12, P1464, DOI 10.1111/j.1365-3156.2007.01953.x; Lonnroth K, 2001, SOC SCI MED, V52, P935, DOI 10.1016/S0277-9536(00)00195-7; MOH, 2002, CHIN TUB PREV CONTR; MOH, 2008, GUID PROV TRANSP SUB; Mookherj S, 2005, FOOD SUPPORT TUBERCU; Mookherji S, 2005, SUMMARY CURRENT EVID; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Squire SB, 2006, LANCET, V367, P955, DOI 10.1016/S0140-6736(06)68393-1; Wang Y, 2011, 5 NATL EPIDEMIOLOGY; Wares DF, 2001, INT J TUBERC LUNG D, V5, P732; Wei X, 2008, INT J TUBERC LUNG D, V12, P538; Weil D, 2004, MAPPING MOTIVATIONS; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), 2005, ADDR POV TB CONTR; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Yao H, 2008, INT J TUBERC LUNG D, V12, P1166; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhao J, 2008, CHINESE J ANTITUBERC, V30, P452	28	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82503	10.1371/journal.pone.0082503	http://dx.doi.org/10.1371/journal.pone.0082503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282623	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500127
J	Haupt, VJ; Daminelli, S; Schroeder, M				Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael			Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key	PLOS ONE			English	Article							MOLECULAR COMPLEXITY; DATABASE; PHARMACOLOGY; ALGORITHM; MECHANISM; BIOLOGY; UPDATE; ALIGN	Drug repositioning applies established drugs to new disease indications with increasing success. A pre-requisite for drug repurposing is drug promiscuity (polypharmacology) - a drug's ability to bind to several targets. There is a long standing debate on the reasons for drug promiscuity. Based on large compound screens, hydrophobicity and molecular weight have been suggested as key reasons. However, the results are sometimes contradictory and leave space for further analysis. Protein structures offer a structural dimension to explain promiscuity: Can a drug bind multiple targets because the drug is flexible or because the targets are structurally similar or even share similar binding sites? We present a systematic study of drug promiscuity based on structural data of PDB target proteins with a set of 164 promiscuous drugs. We show that there is no correlation between the degree of promiscuity and ligand properties such as hydrophobicity or molecular weight but a weak correlation to conformational flexibility. However, we do find a correlation between promiscuity and structural similarity as well as binding site similarity of protein targets. In particular, 71% of the drugs have at least two targets with similar binding sites. In order to overcome issues in detection of remotely similar binding sites, we employed a score for binding site similarity: LigandRMSD measures the similarity of the aligned ligands and uncovers remote local similarities in proteins. It can be applied to arbitrary structural binding site alignments. Three representative examples, namely the anticancer drug methotrexate, the natural product quercetin and the anti-diabetic drug acarbose are discussed in detail. Our findings suggest that global structural and binding site similarity play a more important role to explain the observed drug promiscuity in the PDB than physicochemical drug properties like hydrophobicity or molecular weight. Additionally, we find ligand flexibility to have a minor influence.	[Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany	Technische Universitat Dresden	Schroeder, M (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany.	michael.schroeder@biotec.tu-dresden.de	Schroeder, Michael/A-3040-2010	Weller, Aron/0000-0002-0663-4384; Schroeder, Mariana/0000-0002-9517-4243	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	Funding by the EU project "Ponte" (http://www.ponte-project.eu) and the German Federal Ministry of Economics and Technology project "GeneCloud" (http://transinsight.com/genecloud) is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bottegoni G, 2006, BIOINFORMATICS, V22, pE58, DOI 10.1093/bioinformatics/btl212; Brandt W, 2010, CURR TOP MED CHEM, V10, P1361, DOI 10.2174/156802610792232060; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gunther S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-293; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; Heinrich JC, 2011, J CANCER RES CLIN, V137, P1349, DOI 10.1007/s00432-011-1005-1; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konc J, 2012, J CHEM INF MODEL, V52, P604, DOI 10.1021/ci2005687; Kroeze W. K., 2012, POLYPHARMACOLOGY DRU, P133, DOI [10.1002/9781118098141.ch7, DOI 10.1002/9781118098141.CH7]; Leach AR, 2011, CURR OPIN CHEM BIOL, V15, P489, DOI 10.1016/j.cbpa.2011.05.008; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Painter J, 2004, J APPL CRYSTALLOGR, V37, P174, DOI 10.1107/S0021889803025639; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; [No title captured]	64	109	109	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65894	10.1371/journal.pone.0065894	http://dx.doi.org/10.1371/journal.pone.0065894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805191	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500019
J	Shen, LJ; Chen, FY; Zhang, Y; Cao, LF; Kuang, Y; Zhong, M; Wang, T; Zhong, H				Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Cao, Lan-Fang; Kuang, Ying; Zhong, Min; Wang, Ting; Zhong, Hua			MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS; TGF-BETA; C-MYC; DIFFERENTIATION; SCL; PROLIFERATION; ARREST; GROWTH	Background: Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown. Methodology/Principal Findings: We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN: HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating sc1 and Imo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor beta(TGF beta) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells. Conclusion/Significance: The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.	[Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Zhong, Min; Wang, Ting; Zhong, Hua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Cao, Lan-Fang] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Renji Hosp, Shanghai 200030, Peoples R China; [Kuang, Ying] Shanghai Res Ctr Biomodel Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, FY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	chenfangyuan62@163.com	; Rehman, Jalees/J-8258-2012	Marsboom, Glenn/0000-0001-6309-7557; Rehman, Jalees/0000-0002-2787-9292; Zhou, Yongqiang/0000-0003-1402-345X; Toth, Peter/0000-0003-2168-0124; Osburn, Christopher/0000-0002-9334-4202	National Natural Science Foundation of China [30900636]; Science and Technology Commission of Shanghai Municipality Grant [08JCI414900]; Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine [09XJ21066]; Science and Technology Commission of Shanghai Fund Project of TCM guide project [12401906700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Fund Project of TCM guide project	This work was supported in part by National Natural Science Foundation of China Grant (30900636), Science and Technology Commission of Shanghai Municipality Grant (08JCI414900), Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine (09XJ21066), Science and Technology Commission of Shanghai Fund Project of TCM guide project (12401906700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Halloran MC, 2000, DEVELOPMENT, V127, P1953; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le HY, 2008, J BIOL CHEM, V283, P17652, DOI 10.1074/jbc.M710517200; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rinaldi A, 2011, BRIT J HAEMATOL, V154, P590, DOI 10.1111/j.1365-2141.2011.08789.x; Rowley AF, 1997, THROMB HAEMOSTASIS, V77, P227; Scandurra M, 2010, HEMATOL ONCOL, V28, P62, DOI 10.1002/hon.932; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Sheppard RD, 1998, ONCOGENE, V17, P2073, DOI 10.1038/sj.onc.1202125; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Sun W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-22; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904	47	209	220	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59070	10.1371/journal.pone.0059070	http://dx.doi.org/10.1371/journal.pone.0059070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24204740	Green Published, gold, Green Submitted			2022-12-27	WOS:000316409800054
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-27	WOS:000314021500075
J	Li, X; Yao, XP; Wang, YB; Hu, FL; Wang, F; Jiang, LY; Liu, YP; Wang, D; Sun, GZ; Zhao, YS				Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Wang, Da; Sun, Guizhi; Zhao, Yashuang			MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; LYNCH-SYNDROME; COLON-CANCER; INSTITUTE WORKSHOP; GENE METHYLATION; BRAF MUTATION; HEREDITARY; HYPERMETHYLATION	Purpose: To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis. Methods: A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of MLH1 promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: The pooled frequency of MLH1 promoter methylation in unselected CRC was 20.3% (95% CI: 16.8-24.1%). They were 18.7% (95% CI: 14.7-23.6%) and 16.4% (95% CI: 11.9-22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between MLH1 promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215-2.215; P = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715-5.329; P<0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464-3.102; P<0.001), MSI (OR: 27.096, 95% CI: 13.717-53.526; P<0.001). Significant associations were also observed between MLH1 promoter methylation and MLH1 protein expression, BRAF mutation (OR = 14.919 (95% CI: 6.427-34.631; P<0.001) and 9.419 (95% CI: 2.613-33.953; P = 0.001), respectively). Conclusion: The frequency of MLH1 promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. MLH1 promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, MLH1 protein expression, and BRAF mutation.	[Li, Xia; Yao, Xiaoping; Wang, Yibaina; Hu, Fulan; Wang, Fan; Jiang, Liying; Liu, Yupeng; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China; [Sun, Guizhi] Harbin Med Univ, Canc Hosp, Dept Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; Zhao, Yashuang/I-6145-2019; li, xia/HHZ-7468-2022; Li, Xiaobing/B-1267-2019; Liu, YuPeng/P-3181-2018	Wang, Fan/0000-0002-9869-9504; Liu, Guowen/0000-0002-2672-6104; Li, Xiaobing/0000-0001-9105-6365; Liu, YuPeng/0000-0002-8652-1987	National Natural Science Foundation of China for Priority Areas [NSFC 30972538]; Education Bureau of Heilongjiang Province [11531100]; Graduate Foundation; Scientific Research of Heilongjiang Province [YJSCX2009-224HLJ]; Harbin Medical University [HCXB2009009]	National Natural Science Foundation of China for Priority Areas; Education Bureau of Heilongjiang Province; Graduate Foundation; Scientific Research of Heilongjiang Province; Harbin Medical University	This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94; Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Arnold CN, 2004, CANCER BIOL THER, V3, P73, DOI 10.4161/cbt.3.1.590; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belshaw NJ, 2004, CANCER EPIDEM BIOMAR, V13, P1495; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boland CR, 1998, CANCER RES, V58, P5248; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Cunningham JM, 1998, CANCER RES, V58, P3455; de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782; Deng GR, 2004, CLIN CANCER RES, V10, P191, DOI 10.1158/1078-0432.CCR-1118-3; Deng GR, 1999, CANCER RES, V59, P2029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dykes SL, 2003, CANCER-AM CANCER SOC, V98, P48, DOI 10.1002/cncr.11445; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox EJ, 2006, J MOL DIAGN, V8, P68, DOI 10.2353/jmoldx.2006.050084; Garagnani P, 2012, CURR PHARM DES; Gay LJ, 2011, NUTR CANCER, V63, P1000, DOI 10.1080/01635581.2011.596987; Gazzoli I, 2002, CANCER RES, V62, P3925; GLOBOCAN, 2008, CANC FACT SHEET; Grady WM, 2001, CANCER RES, V61, P900; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Q, 2012, DIAGN MOL PATHOL, V21, P24, DOI 10.1097/PDM.0b013e318230effd; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Jass JR, 2002, EUR J CANCER, V38, P858, DOI 10.1016/S0959-8049(02)00041-2; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kane MF, 1997, CANCER RES, V57, P808; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Mathers JC, ADV GENET, V71, P3; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Mirchev M, 2007, J IMAB ANN P SCI PAP, P95; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nakagawa H, 2001, CANCER RES, V61, P6991; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Park IJ, 2007, J KOREAN MED SCI, V22, pS91, DOI 10.3346/jkms.2007.22.S.S91; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Potocnik U, 2001, CANCER GENET CYTOGEN, V126, P85, DOI 10.1016/S0165-4608(00)00399-X; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Shannon BA, 2001, CANCER LETT, V167, P91, DOI 10.1016/S0304-3835(01)00431-1; Shi XZ, 2006, BIOMED CHROMATOGR, V20, P815, DOI 10.1002/bmc.606; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Strazzullo M, 2003, CANCER-AM CANCER SOC, V98, P1540, DOI 10.1002/cncr.11651; Tannergard P, 1997, HUM GENET, V101, P51, DOI 10.1007/s004390050585; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Velayos FS, 2005, J GASTROINTEST SURG, V9, P329, DOI 10.1016/j.gassur.2004.05.007; Vilkin A, 2009, CANCER-AM CANCER SOC, V115, P760, DOI 10.1002/cncr.24019; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Ward RL, 2005, J PATHOL, V207, P377, DOI 10.1002/path.1851; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; Yiu R, 2005, DIS COLON RECTUM, V48, P2061, DOI 10.1007/s10350-005-0171-0; Zhou HH, 2008, WORLD J GASTROENTERO, V14, P7329, DOI 10.3748/wjg.14.7329	78	84	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2013	8	3							e59064	10.1371/journal.pone.0059064	http://dx.doi.org/10.1371/journal.pone.0059064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121SG	23861826	gold, Green Published, Green Submitted			2022-12-27	WOS:000317263900009
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24349335	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24349335	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600043
